Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 144.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"CACO-2: 23.5;Hep G2: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	23.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	12.5	144.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.0	0.0	26.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	60.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	150.2	0.0	3.7	2.1	0.0	0.0	71.3	9.8	1.2	0.0	0.0	0.0	0.6	116.5	5.3	0.4	11.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	337.9	0.0	0.0	0.3	52.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	83.8	0.0	0.0	0.1	147.5	118.4	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	35.1	0.1
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 1678.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1319.0;Endothelial cells: 797.7;Hepatic stellate cells: 526.1;Hepatocytes: 910.1;Horizontal cells: 681.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Group enriched"	"Detected in some"	5	"AF22: 772.0;ASC diff: 223.5;Hep G2: 649.8;SK-MEL-30: 230.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	NA	NA	1630000000000	170000000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	451.5	182.3	157.5	149.8	158.5	5.6	295.3	169.3	223.5	227.2	163.3	257.0	141.2	306.2	244.1	218.3	228.4	452.4	312.8	149.8	175.0	311.4	1250.0	1678.3	98.2	192.9	167.6	101.7	91.5	153.7	135.3	445.2	193.0	293.8	316.3	129.9	131.8	226.7	147.8	71.5	182.7	520.0	196.2	240.6	171.6	58.9	190.7	53.9	202.7	285.6	59.2	847.0	160.2	192.7	0.3	0.0	772.0	0.0	223.5	16.2	2.0	93.1	25.5	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	10.1	649.8	0.0	0.8	0.8	36.9	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.2	2.0	3.3	0.0	0.1	1.8	0.9	0.8	0.0	0.3	0.3	0.7	1.8	0.0	230.1	3.2	0.0	0.3	0.3	0.1	6.7	1.5	0.5	0.7	0.3	0.7	0.2	0.5	15.4	0.0	0.1	0.0	1.5	0.0	0.8	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	157.5	158.5	169.3	223.5	149.8	175.0	192.9	167.6	193.0	196.2	190.7	192.7	1319.0	12.8	85.6	5.2	9.0	19.5	2.3	0.0	12.0	5.5	10.8	95.5	106.1	22.8	6.8	1.8	8.4	2.5	8.1	0.0	0.0	0.2	18.8	8.3	54.7	797.7	0.0	45.9	3.2	5.5	2.9	241.3	9.2	14.7	27.8	2.5	526.1	910.1	233.0	681.4	2.9	0.0	0.0	123.1	41.4	36.8	77.3	130.7	23.2	355.1	37.8	6.1	1.0	5.5	4.7	0.2	0.0	141.4	11.2	4.7	0.0	0.3	4.4	21.2	335.2	22.1	328.0	2.7	8.8	8.2	14.1	4.1	13.0	73.3	0.0	3.6
AARD	"C8orf85, LOC441376"	ENSG00000205002	"Alanine and arginine rich domain containing protein"	Q4LEZ3	8	116938207-116944487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5;urinary bladder: 7.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 27.6;Breast glandular cells: 26.0;Breast myoepithelial cells: 29.0;granulocytes: 14.5;Late spermatids: 18.4;Proximal tubular cells: 14.9;Spermatocytes: 57.4"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 27.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.7;JURKAT: 7.2;SK-BR-3: 11.8;U-2 OS: 5.5;U-266/84: 4.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"midbrain: 4.4"	HPA068290			Approved	"Lipid droplets"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Lipid droplets"		"HPA068290: "	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.28e-8)"	"unprognostic (3.42e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.29e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.20e-1)"	"unprognostic (2.23e-6)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.77e-2)"	"unprognostic (5.27e-4)"	0.6	0.9	0.5	0.4	0.8	0.2	4.3	0.4	0.9	0.3	0.9	5.9	0.1	0.8	0.2	2.4	0.1	0.2	0.0	0.6	0.6	1.0	0.0	2.5	0.8	1.2	1.0	0.0	0.0	0.0	0.0	0.4	0.9	0.6	0.5	0.1	2.0	0.1	0.1	1.5	1.0	1.0	0.8	0.1	6.8	22.5	0.7	0.0	0.1	0.0	0.4	7.7	0.2	1.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.8	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.5	0.0	0.2	0.1	2.4	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.0	7.2	0.0	2.4	0.1	0.5	0.9	0.1	1.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	1.9	0.3	0.0	11.8	0.1	0.2	0.5	0.0	0.0	0.1	5.5	0.2	0.0	1.6	4.5	0.0	3.0	0.0	0.3	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.3	0.1	0.2	0.6	0.0	0.5	0.8	0.4	0.9	0.6	0.6	1.2	1.0	0.9	0.8	0.7	1.3	0.2	12.8	27.6	0.0	0.1	0.8	0.6	0.2	0.0	0.4	26.0	29.0	0.9	0.0	5.0	7.3	0.0	0.2	0.8	0.1	1.9	0.1	9.3	0.1	1.7	0.9	0.0	0.0	0.8	0.0	0.9	1.4	0.0	0.0	14.5	0.1	0.0	0.1	0.0	1.7	2.1	0.0	0.0	0.0	0.3	18.4	4.1	0.5	0.0	0.0	0.1	0.1	4.1	0.0	0.2	0.1	0.0	0.7	0.0	0.6	0.0	14.9	0.7	0.2	0.0	0.5	1.1	57.4	7.3	0.0	0.6	0.3	0.8	2.0	0.0	0.4
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81110487-81166221	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 184.7"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 243.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 60.1;SH-SY5Y: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	3.3	4.2	35.4	3.1	79.2	3.7	2.3	43.4	82.0	2.8	0.0	7.7	30.9	0.9	0.5	1.8	2.8	2.7	3.9	30.6	30.8	1.0	0.9	9.5	0.9	99.2	67.9	0.9	20.6	3.0	17.3	2.0	63.4	5.2	0.5	2.1	5.9	3.3	0.6	4.5	23.7	0.8	38.8	9.7	5.8	0.7	78.4	0.1	2.9	1.0	0.2	2.8	4.2	184.7	0.3	0.5	0.7	4.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	60.1	0.2	0.0	0.3	0.0	0.0	1.2	0.6	0.0	0.0	0.0	2.0	2.2	3.2	2.8	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	0.0	6.6	0.0	0.2	0.7	0.6	0.3	2.1	4.1	0.6	0.0	0.2	4.5	17.1	0.2	0.4	2.3	0.2	1.1	2.2	2.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	0.2	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	35.4	79.2	43.4	82.0	30.6	30.8	99.2	67.9	63.4	38.8	78.4	184.7	6.3	32.1	20.3	17.0	0.3	0.3	1.0	1.9	0.6	43.0	1.3	5.1	2.2	2.8	0.1	0.0	4.2	0.1	0.5	6.8	0.0	0.6	0.0	0.4	0.2	1.8	1.8	0.0	34.6	1.8	0.1	0.5	7.1	0.6	6.3	2.0	1.1	0.1	2.1	21.9	36.0	4.6	0.0	2.8	0.4	0.0	1.5	8.2	5.4	2.8	1.5	9.6	4.1	21.1	243.2	1.1	4.2	2.6	0.1	0.9	34.1	0.9	0.0	4.4	0.0	4.3	0.8	0.4	0.5	0.0	0.3	2.3	1.4	0.4	7.0	0.2
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	27.7	94.6	4.7	105.4	2.2	5.1	85.2	103.4	3.8	70.7	7.6	43.6	3.8	9.6	7.7	6.2	4.4	14.1	90.2	120.7	133.3	345.6	4.5	5.0	90.8	107.4	10.5	138.3	8.2	55.8	3.4	137.6	21.7	7.8	29.6	6.5	3.5	1.6	2.7	20.1	2.7	88.1	4.1	7.4	13.4	137.9	4.2	29.3	1.4	5.9	9.9	4.1	70.9	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	94.6	105.4	85.2	103.4	90.2	120.7	90.8	107.4	137.6	88.1	137.9	70.9	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141895	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 77.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.5;Fibroblasts: 117.6;Hepatocytes: 110.3;Inhibitory neurons: 77.8;Leydig cells: 51.3;Microglial cells: 93.7;Theca cells: 45.4"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 39.9;ASC TERT1: 56.0;HSkMC: 25.3;HUVEC TERT2: 54.8;RT4: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	23.3	5.5	1.3	2.6	5.5	0.0	15.9	5.1	3.2	10.5	3.1	8.0	2.2	5.9	2.8	5.9	11.3	10.1	17.5	1.1	4.1	3.6	77.9	10.9	5.0	14.3	3.0	29.8	2.3	1.3	2.1	2.1	9.4	2.9	4.4	0.8	9.0	2.0	5.4	6.6	5.5	3.7	7.1	1.5	5.7	1.8	3.4	1.4	8.6	11.7	3.2	14.2	8.9	21.3	0.0	0.0	0.0	0.0	39.9	56.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	25.3	0.1	3.2	0.9	1.5	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	5.5	5.1	3.2	1.1	4.1	14.3	3.0	9.4	7.1	3.4	21.3	12.5	0.0	0.0	2.9	2.0	3.1	1.5	0.4	4.0	11.6	1.8	2.2	6.0	4.3	0.9	3.7	6.2	0.0	1.7	1.8	0.0	0.5	3.3	0.7	5.1	3.2	2.4	2.7	62.5	0.2	0.0	117.6	2.0	2.5	0.0	4.0	3.3	110.3	1.6	0.0	77.8	0.7	0.0	2.5	42.1	2.7	51.3	20.3	5.4	93.7	0.7	3.2	0.0	4.5	33.4	0.4	1.1	12.0	1.2	0.1	0.5	0.9	0.7	13.3	0.0	20.0	14.3	2.0	0.9	1.4	2.8	0.0	1.2	45.4	0.3	0.5
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.2;liver: 121.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 70.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 204.4;Hep G2: 208.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	1.6	0.4	0.2	0.7	0.4	0.8	3.0	0.5	0.3	0.5	0.1	0.6	39.1	0.4	0.2	0.3	0.7	24.4	0.2	0.3	0.2	18.5	121.7	0.5	0.7	0.4	0.3	0.3	1.1	0.1	0.1	0.5	0.4	0.4	0.4	3.9	0.5	0.2	1.1	1.7	40.2	0.2	0.2	1.4	0.7	0.7	0.3	0.8	0.4	0.7	0.5	1.3	0.5	0.6	0.3	204.4	3.5	10.2	15.3	12.0	3.4	0.5	1.3	0.5	0.6	44.6	0.3	0.4	0.3	0.7	0.5	1.3	0.3	0.4	0.6	0.5	0.3	0.0	1.0	208.7	0.5	0.3	0.7	1.9	13.9	1.5	1.4	0.2	0.4	0.6	0.0	0.3	0.2	1.0	0.2	1.4	0.3	39.8	0.3	0.3	0.2	0.4	1.4	0.3	0.1	0.2	0.5	3.4	25.9	0.4	0.1	0.4	0.7	0.6	0.6	0.9	0.6	0.8	0.1	0.2	16.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.2	0.4	0.3	0.4	0.2	0.3	0.6	0.7	0.0	0.0	2.3	0.4	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.5	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	2.6	2.9	0.2	0.3	0.0	0.4	1.0	0.4	0.0	1.7	0.0	0.6	1.3	0.1	1.4	70.7	0.2	0.0	1.3	0.6	0.0	1.0	0.0	1.1	0.3	0.4	5.4	1.9	0.3	0.1	0.0	1.0	2.2	0.1	0.0	0.0	0.1	0.2	15.5	10.7	2.8	1.5	0.0	0.4	0.5	1.2	0.7	0.1	0.0	1.6	0.4	0.1	0.4	0.0
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16149565-16223522	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 16.7;renal cancer: 5.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 68.4"	"Not detected"	"Not detected"							HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	5.6	3.6	0.7	0.3	0.7	0.7	3.8	0.7	1.1	1.0	0.8	5.7	13.2	0.3	0.6	0.3	1.5	2.9	2.6	0.7	0.7	27.4	134.2	7.4	0.0	0.8	0.9	1.0	17.2	2.1	0.9	0.2	0.8	2.9	2.8	0.3	12.7	1.0	4.6	0.4	7.9	0.3	0.7	0.7	6.4	0.4	0.8	0.0	5.6	0.1	0.0	0.4	0.7	0.7	0.0	1.5	0.7	0.0	0.0	0.8	1.8	0.0	0.4	1.0	1.6	7.1	2.3	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.6	0.0	0.7	1.8	0.2	68.4	0.4	0.0	0.0	2.7	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	1.0	0.0	0.8	0.1	0.3	8.4	5.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.3	28.9	31.5	2.9	1.9	0.1	0.5	3.2	0.0	1.0	4.3	3.6	3.3	18.6	8.7	9.2	0.0	0.0	0.0	13.7	45.0	2.2	0.5	4.8	1.0	0.8	3.0	2.7	1.0	7.9	0.0	1.7	13.3	1.0	1.3	1.9	1.8	77.9	1.0	0.0	1.1	10.9	0.0	3.5	0.0	0.7	1.5	1.8	1.8	3.7	3.1	1.5	0.0	1.0	0.4	2.2	8.1	5.7	0.3	2.0	33.7	151.1	25.4	0.6	0.0	0.3	1.2	0.4	0.3	0.2	0.9	0.0	1.4	1.8	11.9	0.7
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797389-21942529	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 60.3;Astrocytes: 72.1;Hepatocytes: 99.4;Sertoli cells: 131.5;Smooth muscle cells: 140.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.9;BJ hTERT+: 14.0;CACO-2: 20.8;HSkMC: 27.1;U-138 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	27.4	5.9	4.5	3.4	5.4	1.7	9.2	3.1	9.2	8.2	11.6	7.4	4.0	19.1	8.3	6.2	12.3	11.7	28.3	5.4	3.6	6.6	45.2	7.7	3.5	4.8	7.4	10.9	3.5	1.9	2.2	3.6	3.7	7.9	1.8	3.2	4.5	9.9	41.9	4.2	3.1	21.0	3.4	4.4	8.1	1.2	5.1	1.8	6.3	30.3	1.5	5.3	5.1	7.2	0.9	0.2	11.9	0.3	24.9	11.0	0.3	6.1	14.0	7.0	3.5	20.8	1.0	0.5	1.2	0.6	0.8	0.3	0.0	0.0	7.2	0.3	0.2	0.5	0.8	0.3	0.1	0.5	0.6	27.1	0.0	6.7	2.5	0.4	0.0	0.4	0.3	1.2	0.3	1.4	0.2	0.4	1.4	1.2	0.6	0.5	0.3	0.3	0.0	1.2	0.4	1.7	0.4	0.5	0.2	1.7	1.2	0.3	0.3	27.0	1.9	2.2	8.7	1.1	1.3	0.4	6.7	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.5	5.4	3.1	9.2	5.4	3.6	4.8	7.4	3.7	3.4	5.1	7.2	33.8	35.3	60.3	72.1	0.2	3.4	1.5	5.0	0.6	0.8	0.5	0.8	38.2	0.0	25.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.8	20.6	19.7	0.0	0.0	17.2	0.2	0.1	26.2	1.1	0.6	24.0	0.0	7.1	99.4	0.1	1.7	1.0	0.0	0.0	2.4	5.9	0.1	0.3	2.5	10.6	2.8	0.0	15.9	0.0	1.5	1.4	0.1	0.0	0.4	0.0	0.5	0.0	0.1	20.4	1.2	131.5	11.1	140.7	0.4	1.6	1.1	2.3	0.3	2.5	0.2	0.0	2.2
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 35.5;neutrophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	17.2	37.7	18.3	12.1	25.5	8.1	15.2	14.4	20.2	8.1	20.0	14.1	17.5	4.9	3.9	4.1	6.3	13.8	10.5	15.5	17.0	10.2	6.3	29.4	18.1	12.0	19.9	6.3	5.3	24.4	10.7	13.7	13.3	6.2	15.0	29.1	16.1	7.0	19.6	16.8	22.0	4.0	12.2	31.2	15.9	1.1	20.3	18.9	8.5	6.2	12.1	12.9	5.0	24.7	0.0	6.0	4.6	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.1	1.9	0.8	0.0	0.7	0.9	0.0	8.8	0.0	8.5	0.5	10.2	19.2	0.0	17.4	0.0	0.4	2.0	25.5	0.1	3.9	0.0	18.2	38.4	0.0	0.1	0.0	33.2	31.5	0.2	1.4	54.9	10.3	0.4	0.0	25.8	0.0	2.8	22.3	5.8	3.7	13.5	0.0	0.4	5.7	0.9	11.8	0.0	4.7	0.1	0.0	13.1	4.2	0.0	0.1	3.3	0.5	1.7	1.7	35.5	3.0	0.5	5.6	5.5	6.1	6.0	1.1	7.0	5.8	5.0	36.6	7.4	0.3	2.5	7.4	2.1	18.3	25.5	14.4	20.2	15.5	17.0	12.0	19.9	13.3	12.2	20.3	24.7	38.2	6.4	8.2	0.3	21.3	8.9	6.9	3.2	5.7	48.4	4.1	6.9	9.5	4.3	5.9	25.8	50.1	7.0	7.0	33.4	3.9	2.6	4.5	21.6	6.3	33.8	3.5	5.7	13.2	1.2	1.8	7.5	11.2	45.3	0.0	1.2	42.8	0.6	16.0	11.8	17.8	12.1	8.2	44.5	23.4	7.6	0.3	20.9	3.6	7.5	4.3	16.1	3.1	43.2	40.6	2.3	8.3	1.9	4.0	3.0	36.6	1.1	4.5	122.6	6.6	1.6	3.5	0.6	0.5	1.0	6.7	63.1	21.4	10.4	1.1	9.1
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882988	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"intestine: 31.5;liver: 63.4"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 32.0;Proximal enterocytes: 13.8"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"Hep G2: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.0	0.4	0.1	0.3	0.1	0.0	0.2	1.1	0.0	0.0	0.2	29.8	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.4	0.3	63.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	31.5	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.1	0.2	0.4	0.3	0.1	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.8	0.6	1.8	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.2	0.7	0.6	0.0	2.7	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	32.0	0.0	0.0	2.8	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0
ABHD12B	"BEM46L3, C14orf29"	ENSG00000131969	"Abhydrolase domain containing 12B"	Q7Z5M8	14	50872053-50904970	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 6.8;retina: 15.6;skin 1: 10.5"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 188.1"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.0;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"thalamus: 2.1"	"Low region specificity"	"Detected in many"			HPA002873	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"		"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA002873: AB_2220573"	"unprognostic (6.61e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.99e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.31e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.68e-1)"	0.5	0.0	2.7	0.1	6.5	1.6	1.3	0.0	2.6	0.0	0.9	0.7	0.0	0.3	0.0	0.2	1.0	0.1	0.1	1.4	1.7	0.2	0.0	0.3	0.1	0.2	5.0	0.0	0.0	0.2	0.1	0.1	1.4	0.0	1.0	15.6	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.6	6.8	0.3	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.7	6.5	0.0	2.6	1.4	1.7	0.2	5.0	1.4	0.0	6.8	1.0	2.4	0.0	0.0	0.3	0.1	0.4	0.1	1.5	0.0	3.4	0.1	0.1	1.9	0.0	5.0	1.8	2.1	0.1	0.0	2.2	0.0	0.0	7.7	2.5	0.2	0.7	0.0	0.0	9.9	0.0	0.0	0.7	0.0	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.0	4.1	0.0	0.0	5.8	1.2	0.1	0.0	0.0	0.0	188.1	0.0	1.0	4.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	26.4	18.1	0.0	0.1	1.2	0.3	0.2	0.0	1.4	0.3	0.1	0.0	1.8	0.2
ABHD5	"CGI-58, NCIE2"	ENSG00000011198	"Abhydrolase domain containing 5, lysophosphatidic acid acyltransferase"	Q8WTS1	3	43690108-43734371	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Cataract, Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 67.8;neutrophil: 42.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 67.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020685, HPA035851, HPA035852"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB020685: , HPA035851: AB_10671942, HPA035852: AB_10672073"	"unprognostic (2.58e-1)"	"unprognostic (2.73e-1)"	"prognostic favorable (8.89e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.56e-2)"	"unprognostic (4.13e-3)"	"prognostic favorable (9.17e-5)"	"unprognostic (2.48e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.18e-2)"	38.8	12.5	6.7	8.5	8.6	39.6	27.9	10.5	8.9	9.8	6.0	12.3	9.9	5.7	4.1	31.1	5.1	11.6	13.4	6.8	7.4	12.0	21.7	16.4	3.4	9.2	8.2	4.6	16.0	12.2	5.6	10.2	9.1	7.1	7.5	6.3	27.4	8.4	15.0	38.0	10.5	9.3	9.3	9.4	12.1	10.8	8.4	6.8	15.5	18.5	7.9	16.7	16.9	11.9	18.9	6.8	8.2	9.7	32.0	12.8	17.1	77.4	27.1	18.8	14.9	9.4	6.4	16.2	10.9	23.2	15.8	5.8	16.5	18.5	22.6	58.4	13.2	36.6	24.4	7.5	15.7	9.2	13.2	13.0	64.6	31.3	28.5	18.8	33.3	10.8	23.9	14.2	46.9	11.0	7.6	6.9	22.8	16.7	20.4	3.1	24.1	8.6	27.9	40.4	10.6	13.6	36.9	20.5	9.8	9.8	18.9	8.9	19.3	18.1	13.6	35.0	34.5	11.1	34.0	7.7	20.3	17.3	16.0	67.8	14.7	9.5	2.3	7.9	1.7	3.5	1.7	2.7	6.8	4.0	1.6	2.5	42.5	2.0	5.7	1.9	4.8	5.3	6.7	8.6	10.5	8.9	6.8	7.4	9.2	8.2	9.1	9.3	8.4	11.9	117.5	25.6	51.8	12.7	44.8	39.9	27.5	25.9	88.8	11.9	149.9	116.2	10.3	14.3	49.6	27.6	27.1	16.7	80.3	65.0	33.2	57.5	19.5	47.5	49.0	34.6	36.2	69.0	24.1	61.5	24.9	53.7	67.8	114.0	16.5	8.8	18.2	12.7	18.0	3.3	24.1	23.7	34.6	44.1	17.4	17.1	5.3	79.8	7.2	11.2	35.9	11.0	12.3	18.1	28.8	75.2	49.8	5.7	41.8	25.5	98.5	39.8	19.1	17.4	0.0	32.0	46.4	47.3	41.9	111.7	40.9	205.4	42.6	15.2	21.9	71.6
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 204.8;tongue: 73.5"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 93.2;Inhibitory neurons: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 13.8;SiHa: 5.9;U-2197: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	7.3	4.0	2.7	1.6	11.0	0.1	5.1	0.0	9.9	2.5	0.0	2.3	0.5	1.2	0.7	13.1	1.8	1.3	7.1	2.7	10.4	7.0	0.9	3.3	1.0	1.4	0.0	0.6	3.4	1.3	6.8	0.6	1.1	1.5	1.7	5.0	5.4	0.5	204.8	6.9	1.6	1.9	0.0	20.5	1.4	1.0	1.4	1.7	3.0	73.5	2.2	1.9	4.1	0.0	1.1	0.0	0.2	1.6	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.5	3.1	0.3	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.7	2.1	0.1	0.0	1.2	2.9	0.9	0.2	1.0	0.7	0.2	0.0	13.8	1.0	5.9	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.7	11.0	0.0	9.9	2.7	10.4	1.4	0.0	1.1	0.0	1.4	0.0	4.4	0.0	1.1	9.4	0.5	2.5	0.1	0.1	0.6	6.4	0.4	0.3	4.7	1.5	0.3	3.7	0.0	0.0	0.6	7.9	0.0	3.5	2.2	5.2	0.7	3.5	10.7	0.0	93.2	4.3	0.6	0.9	2.6	0.2	2.5	0.5	0.7	0.4	0.1	11.8	67.6	3.8	0.0	0.6	0.7	5.1	0.0	0.3	0.0	2.8	0.0	3.1	0.0	16.1	17.6	3.5	5.1	3.8	0.1	0.3	14.3	0.6	1.7	3.2	6.6	7.0	3.5	0.2	2.0	2.0	6.3	0.0	0.7	4.0	5.8	0.3
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 197.6;Cardiomyocytes: 61.7;Hepatocytes: 116.0;Oligodendrocyte precursor cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 75.3;HHSteC: 77.6;HSkMC: 89.4;hTERT-HME1: 90.9;hTERT-RPE1: 76.2;TIME: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		30000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	68.4	7.4	19.2	3.8	18.0	0.5	57.6	49.7	19.1	12.5	6.8	11.1	2.7	10.4	6.3	33.2	14.4	7.1	87.8	20.4	26.7	19.8	115.8	20.0	5.3	37.2	25.2	3.9	2.7	59.6	6.8	34.4	28.7	9.1	5.0	28.6	6.5	8.2	45.8	8.3	7.8	10.6	34.0	8.7	5.4	2.0	29.9	2.2	9.2	38.7	4.5	14.1	17.7	30.2	23.6	4.8	0.0	0.2	39.6	75.3	0.1	16.1	44.8	9.1	15.8	0.1	16.2	0.0	2.7	20.5	47.9	0.5	0.1	18.9	17.7	0.1	0.2	0.0	1.4	0.6	77.6	0.0	0.1	89.4	5.1	32.5	90.9	76.2	41.1	0.0	0.0	7.2	54.8	9.2	0.0	0.0	0.2	1.5	63.0	0.0	0.1	0.0	50.3	16.0	6.3	0.1	3.3	1.1	8.7	1.2	1.5	0.1	103.9	18.9	4.2	19.9	27.7	0.1	0.0	0.0	33.5	0.0	55.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	2.7	19.2	18.0	49.7	19.1	20.4	26.7	37.2	25.2	28.7	34.0	29.9	30.2	197.6	0.0	3.7	21.5	1.3	1.5	1.2	2.6	0.6	2.5	7.6	3.9	61.7	18.6	5.3	0.0	0.0	0.2	0.3	0.0	5.9	8.7	3.0	0.5	2.5	39.6	0.0	0.0	31.0	3.5	0.7	9.4	3.6	2.5	1.3	0.0	34.2	116.0	12.3	28.6	33.7	0.0	8.2	13.5	1.1	0.5	0.3	8.5	5.4	21.5	0.9	19.3	0.0	63.8	25.6	22.5	0.0	0.7	0.1	2.5	0.0	23.5	4.9	25.1	0.0	7.4	7.7	1.7	2.7	2.0	1.6	0.4	0.7	0.5	0.0	22.2
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028745-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 440.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 501.5;NB-4: 530.8;U-937: 515.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		9200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	20.1	9.6	16.8	73.7	16.2	87.7	44.9	13.5	20.8	20.7	14.7	95.0	74.1	22.0	136.0	42.0	12.4	36.0	13.3	18.6	15.7	50.0	60.7	31.2	123.1	14.7	14.6	4.1	16.1	49.1	14.4	29.1	16.2	16.3	86.5	5.4	40.8	12.2	3.0	38.8	74.4	23.5	14.9	73.9	34.4	32.3	16.4	139.6	42.4	7.5	87.9	79.6	17.1	16.0	76.8	40.7	100.7	94.8	39.7	62.2	110.6	59.7	42.9	44.5	91.2	91.2	87.4	0.4	105.8	59.8	189.5	112.9	90.4	130.0	51.9	204.4	167.4	297.8	20.7	31.6	57.6	501.5	130.5	55.9	108.2	59.9	49.1	79.4	237.5	204.9	38.4	100.4	129.5	162.7	314.2	530.8	120.9	119.1	78.5	199.8	62.3	23.8	121.7	225.0	225.4	24.8	40.5	112.3	194.5	141.9	45.1	369.8	175.7	28.2	24.0	58.9	107.7	54.1	169.2	20.9	35.7	515.5	84.2	232.3	178.0	114.2	161.1	334.3	252.2	93.8	259.3	208.2	193.9	96.9	250.9	235.9	48.8	152.1	514.5	215.9	260.2	347.8	16.8	16.2	13.5	20.8	18.6	15.7	14.7	14.6	16.2	14.9	16.4	16.0	54.2	19.2	22.2	2.0	87.1	139.6	71.4	195.2	108.1	0.3	86.6	67.8	3.8	27.1	126.2	44.1	0.0	77.1	151.3	304.5	60.7	145.3	4.8	85.8	20.1	55.0	43.1	75.7	12.8	145.0	207.7	23.5	55.5	129.0	79.4	59.9	53.6	254.3	353.1	0.0	9.1	116.8	162.8	286.1	133.9	13.7	4.7	187.6	87.2	5.6	167.9	49.8	189.5	1.0	1.0	167.4	250.6	12.8	121.0	47.9	247.5	440.3	74.1	1.3	32.9	7.2	37.3	3.6	7.7	116.6	90.1	48.6	198.5	17.7	123.6	133.8
AC005726.1		ENSG00000258472	"Novel protein"		17	28455752-28614185	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 13.2;Club cells: 5.6;granulocytes: 6.3;Proximal tubular cells: 20.4;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA					"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: AB_2679710"	"unprognostic (1.26e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (7.25e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.58e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.49e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	9.6	13.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.4	0.0	0.0	5.6	3.7	0.0	1.7	0.5	0.0	1.9	1.2	0.0	1.7	2.4	1.4	0.0	0.0	0.0	2.0	0.8	1.6	0.0	3.2	6.3	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	20.4	5.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.3	1.1	1.2	0.0	0.0
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 212.6;liver: 659.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 356.8;Hepatocytes: 686.0;Proximal enterocytes: 441.1;Proximal tubular cells: 721.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 224.0;SK-BR-3: 342.9"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	42.8	54.1	47.5	24.0	54.4	44.7	41.2	54.3	49.5	28.3	42.3	56.9	101.0	20.8	44.6	56.7	19.4	29.8	84.8	44.6	48.7	212.6	659.3	34.9	26.1	54.2	50.4	20.9	59.3	47.9	24.8	17.2	53.0	55.1	51.2	4.9	38.9	25.3	48.2	30.7	89.5	18.7	50.9	41.3	42.1	15.5	53.6	28.0	32.1	53.8	30.0	43.7	33.5	54.9	35.5	39.8	13.0	40.7	55.6	32.2	44.6	32.2	47.0	36.3	34.5	52.8	38.8	21.1	22.6	52.0	17.4	24.5	34.9	54.0	20.0	31.0	37.2	27.0	35.4	155.5	35.3	63.3	59.8	59.0	39.3	31.2	22.5	23.9	49.9	49.7	26.2	24.2	41.3	49.2	60.3	45.3	13.3	224.0	47.0	13.9	25.0	34.3	103.4	110.4	10.9	16.5	31.7	342.9	23.7	18.0	35.1	48.9	36.8	21.9	21.1	43.2	44.2	31.9	21.7	16.1	34.8	54.4	34.7	79.9	114.4	130.4	48.8	159.1	41.2	33.9	45.7	47.4	178.1	36.0	45.2	42.5	76.3	71.9	187.7	104.5	77.2	82.1	47.5	54.4	54.3	49.5	44.6	48.7	54.2	50.4	53.0	50.9	53.6	54.9	30.7	41.7	38.7	50.6	45.6	33.3	56.5	57.6	40.9	36.9	48.7	37.1	3.2	98.7	44.3	66.2	14.6	91.6	61.7	356.8	166.3	98.0	4.5	40.7	38.6	25.4	55.1	40.4	25.6	78.4	64.5	34.4	76.5	39.1	19.0	32.5	37.1	686.0	81.7	8.4	24.7	73.1	48.8	93.5	86.8	9.6	35.8	83.2	58.7	14.0	89.5	43.1	53.5	12.5	30.9	100.9	270.6	33.1	44.5	60.6	441.1	721.8	26.3	16.7	32.9	28.5	27.4	19.8	11.7	48.1	35.5	99.3	44.4	186.7	84.3	87.0
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782164-49813953	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1011.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 331.1;Hepatocytes: 810.5;Proximal tubular cells: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3800000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	126.3	74.2	56.9	44.4	64.9	32.5	79.1	63.7	63.9	24.9	68.4	168.7	170.0	29.0	29.8	30.3	24.4	46.9	223.7	53.2	59.8	378.2	1011.9	48.9	36.6	65.1	61.4	34.8	54.1	35.1	34.9	29.6	64.0	26.4	109.6	31.9	20.3	34.0	165.3	28.0	165.2	44.5	62.8	33.6	37.4	37.7	64.3	39.9	55.8	236.6	31.9	41.6	28.6	64.2	3.9	70.5	110.0	97.5	129.9	69.5	57.4	35.2	52.4	53.6	41.2	146.3	58.9	61.1	73.5	117.5	56.7	4.8	176.8	21.0	51.4	190.5	50.4	45.5	79.0	171.4	62.5	0.7	78.3	91.7	6.7	84.8	26.2	44.6	90.0	87.7	42.5	54.7	147.5	81.8	2.7	89.7	101.5	24.8	26.7	150.8	233.0	217.6	177.7	2.8	163.4	130.9	2.7	76.2	5.6	82.1	45.7	60.0	48.1	49.8	60.5	67.8	36.4	112.3	139.7	157.3	35.0	85.7	47.1	53.0	87.4	96.1	99.2	106.5	123.0	43.2	58.3	88.7	103.2	36.3	50.2	73.2	8.3	120.0	108.1	50.1	76.4	112.7	56.9	64.9	63.7	63.9	53.2	59.8	65.1	61.4	64.0	62.8	64.3	64.2	28.4	38.5	47.3	11.8	31.4	3.6	14.2	15.5	11.4	6.7	25.0	25.5	189.9	234.4	23.7	55.2	4.2	36.5	48.2	331.1	295.4	148.5	71.2	7.9	33.9	30.0	40.1	53.6	1.7	45.7	56.0	47.3	23.9	7.7	45.1	63.3	41.4	810.5	109.6	1.7	4.6	73.0	24.4	64.8	18.5	153.9	48.1	50.6	19.6	13.1	57.2	62.2	106.1	4.5	8.7	101.8	161.2	37.2	41.2	9.8	226.6	708.0	26.4	29.5	19.7	42.1	34.9	51.1	42.7	11.1	4.8	27.0	52.2	93.0	144.8	9.6
ACAD11	FLJ12592	ENSG00000240303	"Acyl-CoA dehydrogenase family member 11"	Q709F0	3	132558138-132660082	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.4;liver: 103.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Erythroid cells: 5.7;Plasma cells: 7.6;Syncytiotrophoblasts: 9.7"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048317	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"			"HPA048317: AB_2680354"	"unprognostic (5.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.93e-1)"	16.2	7.6	8.6	2.8	11.3	7.8	6.1	9.3	13.3	8.5	23.3	7.7	17.0	8.0	6.7	4.0	8.5	4.0	15.4	8.8	9.0	64.4	103.6	5.8	3.3	10.2	9.9	9.9	8.2	8.8	9.8	9.8	10.0	6.6	3.4	11.7	5.7	6.0	4.3	6.3	15.8	6.4	9.6	4.3	4.8	8.2	10.3	4.6	6.4	2.0	3.2	5.5	6.5	11.5	5.8	5.2	10.5	13.6	23.2	17.9	10.5	13.6	21.0	8.0	10.5	19.3	2.1	3.9	7.6	7.7	9.0	4.3	8.0	11.9	12.7	6.7	5.6	4.3	5.5	18.1	23.0	4.7	4.1	12.2	8.9	11.0	27.2	18.6	7.9	5.0	2.3	8.2	11.2	7.8	3.0	3.2	6.2	2.8	5.2	3.3	8.4	6.4	18.0	3.8	4.1	6.7	10.5	5.0	28.5	10.9	10.5	3.4	6.5	6.3	3.9	3.6	4.8	6.7	2.3	4.0	8.4	1.6	5.2	0.0	0.2	0.0	0.6	0.4	0.5	0.6	0.6	0.3	0.2	0.6	1.4	0.7	0.0	0.9	0.3	0.9	0.3	0.2	8.6	11.3	9.3	13.3	8.8	9.0	10.2	9.9	10.0	9.6	10.3	11.5	1.4	6.4	3.2	0.0	2.1	0.1	0.2	0.7	2.8	0.9	0.6	0.4	0.0	0.0	0.8	0.0	0.0	4.2	0.8	0.4	0.0	0.8	0.6	1.5	2.0	1.0	4.8	5.7	0.0	1.1	0.9	1.6	0.0	0.8	1.3	1.5	0.4	3.9	0.7	0.0	0.0	0.5	0.0	0.8	0.2	0.2	0.6	0.8	0.0	0.0	2.3	0.6	4.1	0.0	0.0	0.4	0.2	0.7	7.6	0.2	4.4	1.6	1.0	2.9	0.0	0.9	1.1	0.1	0.3	0.9	0.3	9.7	2.2	1.1	0.7	0.1
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724431-75787575	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 367.3;skeletal muscle: 380.0;tongue: 475.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 373.1;Distal tubular cells: 344.4;Hepatocytes: 261.2;Proximal tubular cells: 564.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 289.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		930000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	81.9	82.2	25.2	24.3	25.0	17.3	69.9	26.6	42.2	29.3	30.4	46.8	103.9	20.0	25.3	51.3	30.6	27.8	217.8	24.3	25.9	295.9	367.3	22.6	42.6	26.9	26.8	35.7	35.9	66.3	19.2	16.9	25.8	26.8	49.5	21.2	31.4	26.2	380.0	14.4	75.6	25.5	26.2	27.4	52.8	35.7	25.8	29.7	38.4	475.9	44.3	32.7	21.3	25.2	25.8	20.5	61.0	26.8	53.1	42.1	17.5	48.1	40.4	46.1	38.5	38.3	39.5	289.1	40.7	34.4	39.0	22.8	54.9	41.8	57.8	113.0	25.5	94.4	58.5	58.3	36.4	80.0	23.9	50.7	23.5	39.8	22.8	35.0	36.2	56.6	102.3	60.4	50.5	9.6	96.3	40.6	50.2	80.4	49.5	118.8	83.8	30.6	77.9	70.7	33.8	43.0	38.0	111.6	102.0	43.1	32.7	107.6	20.2	29.9	29.6	26.6	78.1	38.6	62.0	128.1	25.8	67.0	35.3	15.3	14.2	19.3	17.1	20.9	27.3	40.7	17.8	21.5	21.4	24.6	20.3	23.6	0.5	25.0	20.4	23.2	19.5	19.5	25.2	25.0	26.6	42.2	24.3	25.9	26.9	26.8	25.8	26.2	25.8	25.2	42.9	57.7	58.3	29.7	56.5	27.3	41.8	69.0	44.3	39.0	49.0	40.9	373.1	52.9	63.0	58.8	25.0	35.8	39.4	42.6	344.4	37.9	55.4	27.1	32.2	36.2	40.7	67.6	51.6	26.5	19.5	47.6	26.0	25.4	44.9	61.5	43.9	261.2	75.7	30.3	46.7	38.7	63.1	45.6	22.2	24.4	46.9	38.2	51.6	19.7	32.8	53.7	29.9	36.2	36.0	21.2	49.7	45.5	74.9	24.2	88.0	564.8	106.7	30.0	0.0	38.6	43.7	76.3	86.1	46.6	27.0	15.3	39.4	72.5	46.7	35.9
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 360.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.8	27.4	8.0	7.1	8.5	3.8	23.9	13.9	10.3	7.8	13.1	15.9	52.4	9.9	7.7	12.6	9.7	7.6	38.5	8.6	6.7	90.2	360.1	12.7	8.2	6.3	7.6	12.8	15.8	33.4	8.8	5.1	6.8	22.7	16.8	12.4	15.7	11.2	42.4	9.8	11.0	8.5	5.9	6.4	14.0	8.4	8.0	7.4	12.3	69.1	10.3	10.8	8.1	8.4	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	8.0	8.5	13.9	10.3	8.6	6.7	6.3	7.6	6.8	5.9	8.0	8.4	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351477	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0"	"Cell type enriched"	"Detected in many"	6	"Late spermatids: 3430.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	5.6	1.1	0.4	18.9	0.5	41.0	2.1	0.5	0.8	2.3	0.5	7.4	4.1	1.5	0.3	4.2	4.0	3.6	2.1	0.3	0.4	4.6	5.2	16.1	39.5	0.6	0.5	0.9	1.2	0.1	1.3	0.5	0.6	3.8	2.1	0.2	3.6	0.4	0.9	2.5	43.3	0.9	0.5	96.0	5.0	0.8	0.8	25.8	5.2	0.8	22.6	4.3	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.0	23.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	8.8	0.1	0.0	0.1	11.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	42.4	0.0	29.4	0.0	0.0	14.5	37.9	0.4	0.0	0.0	15.1	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.0	0.1	0.0	0.0	9.1	8.2	10.9	0.1	24.9	0.0	28.8	7.9	30.8	29.6	2.4	33.3	20.2	31.5	32.1	13.7	21.3	26.7	27.5	22.6	32.5	0.4	17.3	39.0	22.3	0.4	0.5	0.5	0.8	0.3	0.4	0.6	0.5	0.6	0.5	0.8	0.6	3.8	9.6	5.5	1.6	150.9	8.3	7.6	25.1	2.8	15.8	7.0	8.1	32.9	7.2	12.3	5.5	18.8	3.9	160.7	2.0	7.9	3.9	498.1	8.3	5.4	5.0	3.6	22.9	0.3	3.7	3.2	8.0	5.6	3.4	40.5	1.8	7.1	5.3	7.5	0.0	1.9	2.7	8.2	26.2	39.5	3430.7	20.2	27.9	24.9	2.8	38.3	11.7	332.7	0.5	1.0	5.5	0.0	15.4	68.0	4.6	1.3	3.8	44.6	20.4	19.7	7.5	8.1	15.6	10.5	1.5	7.4	4.4	268.3	0.9	1.6	3.5
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108116695-108147603	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 622.7;liver: 969.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 508.4;Distal tubular cells: 698.5;Hepatocytes: 663.4;Proximal tubular cells: 1484.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 420.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		1400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	135.4	151.3	45.2	24.3	45.3	38.4	56.9	47.1	60.1	41.0	91.8	96.3	103.9	44.0	34.1	45.0	39.1	25.6	289.4	42.7	46.8	622.7	969.5	43.7	28.2	44.8	45.2	64.7	110.6	95.9	30.9	24.7	45.2	45.6	85.6	26.2	104.1	60.2	461.1	45.3	53.2	57.1	46.7	29.3	81.9	66.3	45.6	19.1	65.5	410.8	29.7	44.1	34.6	47.7	76.9	57.7	48.2	139.3	155.9	138.7	25.1	71.7	78.8	77.7	91.7	168.1	77.3	41.3	116.8	83.6	119.7	78.1	142.3	70.3	83.3	84.9	114.6	117.4	64.6	163.9	107.6	112.9	64.9	124.6	77.1	69.2	127.4	91.5	85.0	92.3	172.1	61.8	128.6	45.8	57.4	122.4	48.2	103.1	135.0	88.1	96.9	420.4	114.7	50.4	75.7	88.1	111.6	152.7	83.0	37.0	132.2	97.6	87.4	83.2	44.5	73.5	88.8	18.9	57.8	77.7	37.6	233.1	59.6	1.4	17.1	4.7	25.3	25.5	29.9	29.2	28.8	30.0	33.5	13.8	25.5	22.4	1.8	13.4	27.8	11.3	35.7	23.4	45.2	45.3	47.1	60.1	42.7	46.8	44.8	45.2	45.2	46.7	45.6	47.7	50.5	54.5	91.8	17.9	37.2	43.1	52.2	48.9	23.9	30.1	34.6	29.6	508.4	78.6	33.5	104.8	27.1	39.9	29.2	125.0	698.5	43.1	345.7	62.2	42.1	62.5	30.0	74.7	35.1	60.5	41.5	57.1	29.0	25.7	27.8	48.6	99.2	663.4	97.9	38.7	37.8	38.5	97.6	73.6	27.8	65.3	66.5	39.1	58.7	30.0	50.1	39.1	25.7	22.6	26.5	33.8	93.8	82.4	52.7	27.8	51.4	1484.0	101.8	28.8	65.7	54.2	69.2	172.7	27.2	39.2	48.4	25.2	38.1	61.6	84.5	24.4
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 265.1;testis: 101.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 543.6;Late spermatids: 1322.9;Proximal enterocytes: 1172.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.1"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC TERT1: 63.3;HUVEC TERT2: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	170000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	13.4	4.9	1.7	4.8	8.1	0.1	8.1	0.2	2.5	18.1	0.5	11.2	176.4	8.1	3.5	4.1	6.3	8.2	10.4	1.3	1.0	10.8	1.9	49.0	4.9	1.3	0.9	1.9	6.2	18.7	9.2	11.6	1.3	8.9	6.1	0.4	7.6	23.8	16.1	3.8	265.1	9.6	0.8	2.8	8.3	101.9	2.0	0.8	19.2	10.0	2.1	5.5	3.8	1.1	0.0	0.0	0.0	0.0	2.6	63.3	0.6	2.4	4.7	0.0	0.0	0.9	5.1	1.3	1.8	11.4	0.1	0.0	3.1	0.0	0.0	0.0	1.4	6.6	0.0	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	1.2	33.8	0.0	5.8	0.0	0.1	1.1	0.0	1.4	0.4	11.7	0.7	0.1	0.5	0.9	0.0	0.0	8.2	5.6	0.0	0.0	0.0	1.3	2.9	0.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	8.1	0.2	2.5	1.3	1.0	1.3	0.9	1.3	0.8	2.0	1.1	50.0	0.0	3.3	0.0	0.5	1.5	2.6	0.1	1.2	4.0	3.6	1.9	2.1	1.5	0.7	0.0	0.0	0.1	0.3	11.9	0.0	5.9	543.6	10.8	8.0	34.7	18.0	0.0	4.7	0.4	0.1	11.5	2.0	36.3	7.0	24.1	3.6	0.8	4.2	0.0	1.8	39.8	0.0	33.7	3.5	1322.9	4.4	13.6	3.6	4.7	0.0	1.8	0.0	1.0	0.2	0.7	40.9	2.6	0.1	4.2	1172.8	21.7	0.0	1.1	0.0	2.0	4.2	13.5	6.4	0.2	0.1	0.1	2.2	0.3	26.2	2.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15494566-15607236	"Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.5;intestine: 242.2;kidney: 87.6"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 294.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 13.9;renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;NTERA-2: 1.2;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		400000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	8.9	0.5	0.1	1.4	0.1	0.6	4.3	0.4	0.3	0.6	1.9	9.9	183.3	0.5	0.5	1.8	1.5	65.5	42.7	0.2	0.2	87.6	5.7	0.8	0.4	0.2	0.2	1.8	2.5	1.5	0.1	1.2	0.2	0.4	5.9	0.3	1.4	4.1	0.7	0.3	242.2	0.5	0.1	0.1	2.6	49.7	0.2	0.5	4.5	0.5	0.2	0.8	1.2	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.8	0.1	0.0	0.2	0.2	0.2	0.3	0.4	0.3	0.0	0.3	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	1.2	1.2	0.0	0.0	0.3	0.2	0.5	0.2	0.4	0.2	0.9	0.0	0.4	0.0	1.9	0.4	0.4	0.1	0.0	0.0	0.3	0.4	0.1	0.5	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.5	1.3	1.4	0.1	0.5	5.0	0.0	0.0	1.6	0.0	11.2	55.8	2.6	0.0	0.0	4.2	0.1	22.9	3.9	1.2	0.5	1.1	0.3	1.0	7.2	0.0	0.8	0.8	0.3	4.6	0.0	0.6	0.0	3.9	0.0	0.9	0.8	0.0	0.8	8.2	0.0	0.0	0.0	1.4	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	6.0	0.0	1.0	294.8	48.8	2.0	0.0	19.7	0.0	8.9	1.1	1.0	0.0	0.1	12.7	0.3	0.1	10.6	2.2
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409009-19452505	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"stomach 1: 61.8;urinary bladder: 39.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.7;Gastric mucus-secreting cells: 21.9;Inhibitory neurons: 10.3;Microglial cells: 26.2;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BEWO: 29.7;RT4: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	6.9	1.4	4.5	1.1	3.4	0.6	5.0	2.7	5.0	1.7	2.0	3.3	4.5	1.4	4.2	2.2	3.7	1.7	2.9	4.4	3.1	1.9	2.4	2.2	1.0	3.2	3.1	1.0	6.8	2.5	1.1	9.7	4.3	3.7	4.3	3.8	1.9	4.5	1.2	5.9	2.7	1.3	2.8	1.4	61.8	1.9	5.9	2.4	2.5	1.0	1.3	39.2	1.7	3.7	1.2	2.0	3.9	2.0	6.2	0.5	29.7	2.1	1.4	0.7	1.0	0.6	1.9	1.3	0.7	0.3	0.4	4.5	0.8	5.8	1.5	2.4	1.1	2.1	1.6	3.0	1.3	0.5	2.0	1.8	5.6	2.2	2.4	0.6	6.2	2.1	3.1	3.8	2.0	1.7	3.6	1.8	3.1	11.1	0.9	3.2	1.0	0.7	0.6	73.6	6.9	1.8	0.4	2.2	0.5	9.3	2.7	2.5	3.1	0.5	1.5	0.6	0.9	1.4	1.7	1.4	0.6	1.5	1.3	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.5	3.4	2.7	5.0	4.4	3.1	3.2	3.1	4.3	2.8	5.9	3.7	3.2	0.0	0.0	1.0	0.7	0.3	0.4	0.1	0.6	1.0	0.3	0.4	0.1	0.0	0.1	0.0	2.1	0.5	0.4	0.0	0.0	0.1	2.6	0.3	0.2	0.8	0.0	0.8	19.7	0.0	0.6	0.3	21.9	0.4	0.0	0.0	1.4	0.0	0.1	0.0	10.3	0.0	0.0	0.0	0.0	4.0	0.3	0.2	0.0	26.2	0.0	0.6	0.0	5.5	7.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.6	0.0	0.6	0.4	0.4	0.4	0.8	0.0	4.0	0.3	0.0	0.0	1.1
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838616-134902034	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 141.1;liver: 162.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 120.2;Proximal tubular cells: 408.1"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"RPTEC TERT1: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010533, HPA011179"	Enhanced		Approved	Cytosol		NA	NA		12000	"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	7.1	0.2	0.0	0.3	141.1	162.5	0.1	0.3	0.8	0.2	0.7	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.6	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.3	0.8	0.3	1.2	0.2	0.5	0.1	0.6	0.3	26.7	0.4	1.0	0.3	0.1	0.3	0.4	0.8	0.2	0.7	1.0	0.0	0.4	0.2	0.8	0.2	0.1	0.5	0.2	0.3	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.9	0.3	0.0	0.3	0.8	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.2	50.1	0.0	9.2	0.0	0.0	0.0	0.0	54.8	0.2	0.0	0.0	0.1	0.0	0.0	2.7	8.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	120.2	0.0	0.0	7.3	0.0	0.0	1.9	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.0	0.0	2.5	1.9	0.1	0.0	0.0	0.0	0.0	0.0	408.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 134.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 194.4;Proximal tubular cells: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	96.6	50.5	15.2	16.1	15.4	3.5	50.1	14.6	15.3	19.8	19.1	23.7	48.6	19.2	30.2	15.4	14.6	15.6	36.3	14.0	16.2	89.2	134.5	20.3	8.8	15.8	15.8	17.4	37.6	22.8	13.1	16.1	14.9	21.9	20.6	12.9	16.6	19.1	25.1	12.0	35.8	22.9	15.3	9.3	28.7	17.6	16.9	13.6	34.5	37.8	7.1	24.4	13.7	14.1	37.5	33.7	25.7	40.7	194.5	104.8	11.6	69.3	169.1	31.2	24.5	36.0	11.4	7.4	21.6	73.1	84.9	5.1	51.3	66.3	62.3	23.8	13.8	54.7	33.4	39.3	97.4	5.1	21.2	91.7	20.1	80.4	56.1	95.6	81.7	28.4	20.0	15.7	89.9	9.9	29.5	26.4	26.9	23.3	35.5	22.8	38.0	7.8	118.9	34.1	3.3	10.5	71.9	2.8	7.6	27.1	16.7	13.5	89.2	112.5	38.2	38.2	18.2	7.8	15.5	14.7	78.7	18.2	10.2	33.2	11.3	3.3	9.2	11.3	8.0	5.6	6.2	6.9	9.3	5.0	8.1	8.2	1.2	6.7	10.0	4.3	3.9	8.4	15.2	15.4	14.6	15.3	14.0	16.2	15.8	15.8	14.9	15.3	16.9	14.1	16.3	3.2	25.7	43.8	6.7	4.5	7.9	11.9	9.1	21.4	17.8	7.4	45.5	38.6	11.7	23.9	22.9	50.8	6.2	26.4	19.6	19.0	8.7	10.0	30.7	18.7	4.9	11.6	24.6	41.0	22.1	29.7	39.3	13.9	2.5	17.1	15.7	194.4	15.1	33.7	46.5	27.7	10.2	14.8	6.7	6.9	23.6	15.6	7.2	20.6	8.6	25.7	8.2	22.1	24.1	19.4	23.7	23.3	7.2	10.1	56.1	183.4	10.7	14.3	19.7	30.5	22.2	9.8	19.4	10.3	5.4	53.5	7.5	22.2	34.6	8.7
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41447830-41529273	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 567.7;skeletal muscle: 660.4;tongue: 695.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 374.2;Proximal tubular cells: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	88.8	81.6	154.2	38.6	152.2	32.0	52.4	153.0	190.0	39.5	160.1	94.4	162.9	42.0	26.1	60.4	53.6	36.5	567.7	155.2	153.1	138.9	73.9	40.7	40.5	146.1	145.3	30.8	53.8	233.8	33.6	30.5	147.8	41.2	69.6	46.9	72.0	49.5	660.4	45.5	158.5	43.7	152.5	44.7	110.2	35.1	186.3	38.0	53.7	695.8	43.3	52.5	42.4	159.6	47.2	55.8	56.5	116.3	101.2	69.8	78.7	43.7	60.9	79.0	71.9	81.2	63.5	115.7	72.2	70.6	60.3	109.8	108.8	88.3	42.8	75.8	80.2	51.0	73.7	95.0	86.7	147.8	77.8	120.8	64.4	78.9	83.2	61.7	81.2	61.5	72.9	118.4	65.4	91.7	73.7	47.9	37.0	282.6	115.1	102.3	37.8	162.1	106.8	97.3	37.8	33.9	112.2	128.7	82.0	44.9	74.9	74.7	55.5	60.0	68.7	50.2	45.0	64.7	92.1	80.6	102.0	64.0	66.5	10.3	52.9	18.1	32.0	76.4	29.3	49.4	25.5	34.9	69.0	46.4	29.2	30.8	9.0	39.4	97.1	24.0	41.2	58.6	154.2	152.2	153.0	190.0	155.2	153.1	146.1	145.3	147.8	152.5	186.3	159.6	26.3	25.6	31.8	45.4	49.4	18.7	54.5	102.7	31.3	60.6	28.0	23.2	9.1	64.3	63.5	60.7	81.3	100.3	33.3	190.8	131.0	58.3	14.5	37.2	17.7	26.1	53.2	30.3	28.8	42.6	60.0	24.0	77.5	37.1	40.6	56.7	20.7	64.6	91.5	53.8	34.0	99.1	89.5	35.5	26.4	8.9	24.2	39.2	35.6	7.5	68.3	73.9	34.0	12.1	20.9	43.9	103.5	27.8	63.2	34.4	374.2	285.7	59.2	73.5	59.2	28.6	38.4	26.4	38.2	35.8	16.1	193.2	30.7	54.4	113.6	64.9
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 100.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	2.7	100.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.5	0.3	0.5	0.3	0.3	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 847.1;Proximal tubular cells: 525.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	6.3	6.1	7.2	4.8	7.5	3.4	3.8	7.9	7.3	3.4	6.0	9.1	6.5	3.1	3.7	3.4	3.6	4.9	12.0	6.6	7.8	19.2	30.6	4.6	5.2	7.2	7.8	3.9	6.6	7.2	5.1	3.0	7.4	6.5	7.4	9.6	5.0	3.3	12.2	5.5	6.1	3.1	7.1	4.8	5.5	7.0	8.2	5.1	5.7	10.3	3.4	3.5	3.1	7.4	5.9	7.6	7.6	13.6	10.5	13.1	4.2	4.8	5.8	3.5	5.4	10.1	7.5	11.1	16.2	5.5	18.4	6.4	6.7	9.7	5.4	17.4	6.2	10.4	7.7	7.0	5.3	6.7	4.6	7.6	9.4	4.7	9.0	8.5	8.3	11.3	17.0	5.7	7.0	6.1	12.1	12.9	5.1	11.7	5.9	10.4	6.6	14.0	11.7	5.4	15.0	5.2	5.7	19.1	14.1	8.8	13.2	5.5	9.7	6.2	3.5	1.7	4.6	10.7	29.3	11.1	6.5	23.8	19.1	4.8	5.3	3.6	4.4	5.7	6.1	6.9	4.9	5.0	4.7	4.9	5.7	5.1	6.2	4.6	5.8	3.7	5.3	4.8	7.2	7.5	7.9	7.3	6.6	7.8	7.2	7.8	7.4	7.1	8.2	7.4	27.9	67.3	41.7	19.6	19.7	17.2	26.6	66.4	18.8	18.7	29.4	32.3	94.6	45.8	46.9	31.3	16.7	56.8	22.6	88.4	158.5	43.2	847.1	34.0	31.3	24.0	54.7	37.2	12.1	40.2	31.1	26.2	23.9	31.8	14.5	30.3	21.4	215.5	86.7	5.0	14.3	85.8	67.1	24.5	23.7	131.5	19.6	35.0	26.6	14.0	68.9	41.7	18.6	15.6	18.7	29.2	130.7	24.0	25.4	23.2	47.1	525.2	56.8	31.8	26.3	50.6	64.2	117.1	27.3	19.5	23.4	40.0	20.5	43.4	69.4	28.6
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591873-73595766	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;liver: 16.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 26.4;Proximal tubular cells: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.6;MCF7: 14.1;SK-BR-3: 27.9;T-47d: 69.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	4.9	1.4	3.7	1.1	3.7	0.6	4.6	4.2	4.3	3.9	2.4	3.0	4.3	0.8	2.6	1.5	0.9	0.9	0.9	3.6	2.9	15.0	16.8	3.6	1.3	3.1	2.7	0.9	1.5	1.0	0.4	1.8	3.3	1.4	3.4	0.8	1.7	1.8	0.6	0.6	3.3	1.5	2.5	1.5	2.0	2.2	2.9	1.0	1.3	0.6	1.3	1.2	0.9	3.2	10.7	2.9	0.3	0.1	1.3	0.6	0.0	0.6	0.0	0.7	1.2	0.3	17.6	0.0	0.6	1.0	0.0	1.1	0.0	0.1	0.1	5.8	0.1	0.0	3.5	0.0	2.0	0.0	9.5	0.8	1.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.6	14.1	0.3	1.9	0.9	3.7	2.8	0.0	0.0	0.0	0.4	5.2	1.5	0.3	6.9	27.9	2.1	0.1	69.7	10.5	0.2	0.0	6.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	11.5	0.0	1.4	14.7	0.6	7.3	2.1	6.9	8.4	0.4	3.3	4.0	8.5	0.0	7.2	0.2	0.9	7.2	5.3	3.7	3.7	4.2	4.3	3.6	2.9	3.1	2.7	3.3	2.5	2.9	3.2	0.4	0.0	2.7	1.0	1.0	0.3	1.1	3.8	1.2	0.2	5.5	4.2	1.7	7.2	2.8	11.0	0.0	15.9	3.6	8.3	15.6	4.2	1.8	4.1	1.1	0.5	0.0	0.0	1.4	9.2	13.8	1.5	3.1	5.6	5.7	4.1	0.0	26.4	11.2	1.7	0.8	3.2	8.2	3.0	0.3	5.3	0.3	2.1	0.0	1.9	1.0	0.7	11.3	0.5	0.3	6.2	2.6	0.4	1.5	1.1	15.7	59.8	2.9	0.5	0.0	1.5	1.1	3.2	15.8	2.6	0.3	4.5	5.1	0.4	2.6	1.3
ACOT6	C14orf42	ENSG00000205669	"Acyl-CoA thioesterase 6"	Q3I5F7	14	73610945-73619888	"Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;kidney: 3.7;liver: 3.1;skeletal muscle: 4.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.3;Excitatory neurons: 2.7;Hepatocytes: 3.4;Inhibitory neurons: 2.8;Proximal tubular cells: 5.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"T-47d: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058258	Uncertain					NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA058258: AB_2683656"	"unprognostic (1.88e-1)"				"unprognostic (1.77e-1)"		"unprognostic (5.17e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.15e-2)"		"unprognostic (6.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.07e-2)"		"unprognostic (2.28e-1)"	"unprognostic (5.04e-1)"	1.7	0.6	0.8	0.1	1.3	0.0	0.1	5.0	2.5	0.0	2.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.8	1.2	0.0	3.7	3.1	0.1	0.1	0.6	0.3	0.5	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.2	0.0	4.0	0.0	0.1	0.0	0.4	0.2	0.0	0.5	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	1.8	0.1	0.0	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	5.0	2.5	1.2	0.0	0.6	0.3	1.0	0.4	0.5	0.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6393767	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 128.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"NK-cell: 40.2;plasmacytoid DC: 35.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.7;NK-cells: 40.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		26000	"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	11.3	20.4	72.8	18.7	72.8	14.7	9.9	56.2	108.2	17.8	16.7	32.7	55.1	18.2	5.5	35.0	11.0	8.2	17.3	75.1	107.2	47.8	22.0	17.9	22.4	96.1	88.5	11.2	9.0	3.8	65.1	10.4	128.7	12.9	21.4	24.5	11.9	6.9	5.2	27.1	56.1	23.5	46.9	20.7	19.2	38.1	83.9	28.3	6.1	4.7	19.4	18.0	23.5	68.4	117.6	100.0	96.6	104.6	21.7	35.6	36.4	98.6	50.6	142.7	85.1	347.7	37.0	142.4	70.6	80.4	110.3	113.0	156.9	263.2	53.2	126.0	136.7	75.2	74.4	124.9	88.7	88.8	59.9	32.1	49.6	118.2	139.2	38.1	81.2	174.8	62.3	29.8	76.8	136.6	187.0	94.0	48.5	116.9	228.2	219.9	110.6	95.6	80.9	44.2	52.6	149.1	88.9	134.5	317.9	47.3	47.9	41.2	133.0	129.1	75.4	129.6	158.9	24.9	110.6	202.1	81.8	153.7	80.3	0.0	0.3	0.2	7.3	1.2	1.8	2.1	5.8	6.2	5.4	0.7	2.0	3.9	0.7	40.2	0.9	35.7	8.2	5.3	72.8	72.8	56.2	108.2	75.1	107.2	96.1	88.5	128.7	46.9	83.9	68.4	3.4	6.4	16.4	9.4	4.9	31.7	16.5	24.2	12.5	46.8	4.1	7.5	9.8	8.6	14.9	9.2	10.4	20.9	14.4	45.4	15.6	22.7	95.5	4.0	6.1	19.1	4.8	26.5	38.6	7.2	29.7	11.5	19.9	7.6	137.2	13.2	8.6	16.8	30.1	47.1	38.9	110.2	36.7	4.8	85.9	160.8	3.7	13.4	39.2	5.6	15.7	12.8	8.2	22.6	21.0	23.2	41.8	7.2	9.3	9.5	179.4	253.7	7.1	24.4	0.0	6.7	17.6	37.8	28.0	26.2	29.5	17.2	21.7	13.7	51.3	19.6
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537283	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 177.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		29000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	8.8	8.3	4.1	2.1	4.6	0.1	5.8	4.4	4.5	9.3	16.8	12.9	25.4	9.4	5.8	6.3	10.8	8.2	16.7	4.3	4.5	42.1	177.3	6.2	1.7	5.3	4.8	11.2	4.6	9.6	4.6	3.4	4.4	10.8	8.3	1.8	7.2	9.8	8.2	2.9	21.6	11.2	4.5	1.4	4.0	4.9	4.9	4.0	16.1	17.0	1.2	8.7	6.0	4.1	0.0	0.0	0.2	0.0	16.4	25.9	4.7	3.1	0.2	0.0	0.4	0.8	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.6	4.4	4.5	4.3	4.5	5.3	4.8	4.4	4.5	4.9	4.1	1.9	3.2	5.8	11.1	0.6	0.6	7.6	0.5	5.7	0.3	1.3	3.8	14.3	4.3	0.9	3.7	0.0	0.7	0.0	4.2	15.6	0.3	0.1	0.4	1.3	1.6	3.0	2.7	0.6	1.9	0.4	8.6	2.0	0.2	1.3	8.6	6.1	89.0	5.2	1.7	0.6	5.1	0.0	1.9	0.4	1.8	10.8	1.7	0.0	1.0	0.5	10.8	0.0	0.5	0.0	0.4	0.8	8.6	0.1	0.6	27.9	51.0	0.0	0.8	6.6	7.0	5.2	0.4	0.4	3.0	0.3	0.8	0.3	9.6	4.6	3.8
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 174.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 426.9;Hofbauer cells: 426.7;Macrophages: 298.2;Proximal tubular cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 200.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.1;K-562: 30.4;RPMI-8226: 41.4;SK-MEL-30: 127.6;U-138 MG: 102.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		4000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	9.4	6.0	2.2	42.4	3.9	9.4	25.6	2.5	21.4	34.7	3.0	46.4	31.9	19.2	7.8	23.4	8.6	26.7	5.1	1.9	3.9	74.0	32.5	174.1	87.1	4.1	3.1	20.3	11.9	2.4	1.3	13.3	6.0	19.6	36.4	20.1	14.3	7.0	1.4	24.9	30.2	13.3	4.1	43.5	38.7	4.0	15.7	25.4	3.0	5.0	43.6	33.1	11.3	5.7	10.2	1.1	0.0	0.2	0.5	0.0	41.1	1.1	25.8	0.0	0.1	0.4	0.3	1.4	1.8	9.0	5.9	0.3	0.0	4.5	0.1	12.1	0.8	0.3	0.0	5.0	1.4	0.1	0.6	0.0	4.1	0.4	0.0	0.0	0.0	0.0	30.4	0.2	0.0	2.3	0.9	1.4	0.8	0.3	0.7	0.4	1.8	41.4	0.0	0.4	0.7	1.0	0.0	0.0	127.6	1.1	0.2	0.4	0.9	102.9	1.2	1.8	0.3	0.7	5.7	0.6	23.7	0.1	4.0	0.4	35.3	76.6	15.8	36.1	8.8	200.1	26.0	19.6	7.3	110.9	35.3	20.2	10.4	13.3	36.3	62.5	67.8	36.4	2.2	3.9	2.5	21.4	1.9	3.9	4.1	3.1	6.0	4.1	15.7	5.7	2.2	9.6	7.8	0.0	75.7	10.3	11.0	21.8	25.0	18.3	14.6	18.4	1.4	15.7	5.7	7.3	18.8	33.4	21.2	7.0	9.8	1.8	0.2	0.7	9.1	30.9	3.0	24.5	0.0	11.3	32.7	19.8	10.7	0.9	63.7	0.8	426.9	8.4	426.7	1.7	0.0	4.7	10.2	106.0	68.6	0.7	1.8	298.2	14.2	1.0	79.8	48.5	8.2	0.0	0.1	4.4	20.4	12.0	33.4	14.5	12.7	145.8	2.5	41.4	0.0	0.4	2.8	0.1	0.2	14.6	11.1	26.1	29.5	0.1	6.7	6.1
ACSBG2	"BGR, DKFZp434K1635, PRTD-NY3"	ENSG00000130377	"Acyl-CoA synthetase bubblegum family member 2"	Q5FVE4	19	6135247-6193094	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fatty acid metabolism, Lipid metabolism, Spermatogenesis"	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	89	"testis: 129.3"	"Group enriched"	"Detected in some"	75	"Early spermatids: 533.6;Late spermatids: 1782.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043421, HPA051013"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA043421: AB_10794182, HPA051013: AB_2681311"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.96e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.70e-4)"	0.1	0.0	0.2	0.0	0.2	0.0	0.2	1.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	129.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.2	0.3	0.1	0.7	0.3	0.2	0.1	0.2	0.9	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	533.6	0.0	0.1	0.6	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	1782.3	11.8	0.8	0.0	1.9	0.0	0.0	0.0	1.5	3.1	0.0	0.0	7.2	0.0	0.0	0.0	1.9	0.0	0.0	6.6	0.0	0.1	15.4	9.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0
ACSF2	"ACSMW, FLJ20920"	ENSG00000167107	"Acyl-CoA synthetase family member 2"	Q96CM8	17	50426158-50474845	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 142.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 85.8;Proximal enterocytes: 78.2;Proximal tubular cells: 128.4;Syncytiotrophoblasts: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 97.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024693	Enhanced		Uncertain	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Microtubules, Cytosol"		"HPA024693: AB_2671654"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.49e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.45e-2)"	"prognostic favorable (2.41e-4)"	24.8	71.9	7.6	5.7	8.5	3.3	21.0	7.7	10.1	18.9	8.6	26.9	22.1	6.7	15.8	7.7	9.7	10.8	25.9	7.1	7.0	142.1	36.4	17.8	8.5	8.5	7.3	19.3	6.8	9.9	2.9	15.4	8.0	15.0	17.5	1.1	15.8	16.0	41.3	22.5	20.2	5.4	8.2	8.4	18.8	4.9	7.9	5.6	42.5	25.8	8.2	17.8	13.4	7.7	24.8	8.1	6.6	15.8	68.1	12.1	38.1	5.9	8.6	12.6	24.5	32.1	47.2	15.7	12.6	7.3	11.5	14.7	4.7	29.2	15.3	19.5	11.2	27.3	3.9	58.5	11.4	3.3	24.3	54.9	44.4	15.8	2.1	45.4	17.4	20.3	3.2	8.8	13.7	31.3	8.8	11.1	1.1	47.5	11.9	20.6	4.8	41.2	4.2	97.2	21.6	11.3	11.8	17.3	12.3	13.7	15.5	22.8	12.7	22.5	6.8	3.5	1.9	15.4	3.1	8.2	9.3	17.1	1.4	0.0	2.9	15.3	2.0	7.7	1.7	8.6	1.5	2.1	16.1	2.0	0.7	0.9	0.5	1.6	7.0	6.3	5.5	2.7	7.6	8.5	7.7	10.1	7.1	7.0	8.5	7.3	8.0	8.2	7.9	7.7	3.2	28.9	24.3	27.1	7.3	6.0	23.3	17.0	25.0	0.0	20.8	16.0	25.9	11.5	19.9	3.7	0.0	85.8	1.7	59.5	11.7	13.5	0.4	4.9	3.5	4.9	10.2	1.3	0.3	4.3	11.7	6.5	21.9	7.7	22.2	24.5	4.2	44.4	21.9	0.0	0.3	20.6	2.0	9.8	11.0	1.6	26.8	11.0	3.6	17.8	12.7	6.1	5.2	3.5	0.5	5.7	53.1	14.3	2.6	3.5	78.2	128.4	14.6	0.2	0.0	2.7	5.9	0.2	2.2	5.4	7.0	81.0	4.1	12.1	25.8	14.0
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 217.8;intestine: 418.0;liver: 165.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 87.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	23.8	4.2	13.1	29.0	12.6	16.2	21.3	13.0	15.5	51.4	10.4	111.7	358.9	30.3	217.8	7.9	45.0	21.5	9.4	12.1	13.4	9.0	165.5	35.6	28.0	14.4	13.1	17.0	5.5	2.2	2.6	8.6	14.9	12.3	116.6	1.5	5.5	20.3	3.9	3.4	418.0	15.5	14.0	25.7	44.2	9.6	15.3	16.4	7.2	8.8	28.0	76.3	7.6	13.2	38.6	0.9	0.7	0.1	2.5	0.4	3.3	1.1	7.3	0.3	0.6	34.8	138.8	46.7	8.4	1.9	6.8	0.3	0.0	0.2	0.8	39.4	0.0	36.5	1.3	60.9	8.8	57.3	59.2	5.9	0.0	0.8	0.0	2.7	2.8	0.0	0.1	20.6	0.1	0.0	0.1	26.3	0.1	32.2	1.3	12.9	0.2	28.6	3.8	143.3	0.1	0.9	55.8	21.0	0.1	0.1	0.1	31.7	40.5	0.5	0.4	2.2	2.5	14.8	0.1	22.6	1.2	70.5	0.1	27.4	15.1	27.5	25.2	27.9	24.9	16.3	20.4	27.8	31.1	13.1	13.8	21.4	3.9	26.1	27.7	9.8	41.5	21.1	13.1	12.6	13.0	15.5	12.1	13.4	14.4	13.1	14.9	14.0	15.3	13.2	23.4	12.8	51.3	0.0	20.1	3.8	10.3	10.7	8.6	0.1	7.0	4.6	1.7	12.8	23.6	0.0	4.2	1.8	10.5	164.9	0.0	13.3	92.6	159.9	37.6	24.7	40.8	10.7	1.3	6.4	2.6	5.7	41.8	292.3	17.2	0.5	16.1	88.6	18.9	0.0	1.1	79.0	0.0	22.4	57.8	42.6	15.8	24.9	3.6	17.8	11.5	0.1	16.5	1.0	1.0	48.0	122.4	12.0	20.3	7.1	462.5	0.2	8.2	1.2	0.0	0.8	3.3	4.0	1.9	3.3	1.7	0.7	24.0	6.4	103.3	50.0
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.6;brain: 32.0;retina: 45.8;testis: 20.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 229.2;Cone photoreceptor cells: 229.4;Erythroid cells: 110.5;Inhibitory neurons: 110.6;Rod photoreceptor cells: 130.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 7.6;U-937: 6.2"									HPA040470	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.2	4.2	14.8	1.4	18.3	22.6	0.2	26.3	32.0	0.1	1.2	0.5	4.7	0.1	0.5	0.3	0.2	0.3	1.4	18.6	12.8	1.9	2.0	0.3	2.4	22.2	18.2	0.0	1.1	11.3	4.2	0.6	18.9	0.3	0.3	45.8	0.3	18.0	2.3	0.1	2.4	0.1	13.8	1.1	0.6	20.7	25.0	0.6	0.4	1.4	1.0	0.2	0.1	14.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.2	6.2	0.3	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.7	1.6	0.0	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.3	14.8	18.3	26.3	32.0	18.6	12.8	22.2	18.2	18.9	13.8	25.0	14.3	0.6	25.6	29.2	229.2	1.4	1.9	1.5	0.0	2.2	65.2	2.1	0.4	0.0	1.5	16.1	1.8	229.4	0.3	3.3	0.6	7.9	0.6	43.7	0.3	0.1	3.9	2.4	110.5	70.6	0.2	0.1	4.2	0.0	0.2	10.1	0.2	1.8	8.4	0.1	21.9	110.6	1.8	0.0	1.0	15.9	7.9	0.3	6.4	0.0	15.9	0.9	24.5	0.0	41.7	9.8	0.3	1.6	1.9	0.8	1.1	1.8	0.4	8.1	130.0	0.0	2.3	1.1	45.3	1.7	0.1	1.3	0.3	15.3	0.1	0.4	1.3
ACSM2A	"A-923A4.1, ACSM2, MGC150530"	ENSG00000183747	"Acyl-CoA synthetase medium chain family member 2A"	Q08AH3	16	20451461-20487669	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	1182	"kidney: 277.2;liver: 363.3"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 708.7;Proximal tubular cells: 372.5"	"Group enriched"	"Detected in some"	479	"liver cancer: 22.7;renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.9"									HPA057699	Supported					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA057699: AB_2683506"	"unprognostic (1.17e-4)"						"prognostic favorable (1.41e-5)"				"unprognostic (5.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.09e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	277.2	363.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	4.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	21.5	0.0	7.3	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	2.7	0.0	13.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	708.7	0.0	0.0	0.2	0.0	0.0	18.3	0.0	0.2	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	372.5	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.0	0.1	0.3	1.7	0.0	0.0	0.1
ACSM2B	"ACSM2, HXMA, HYST1046"	ENSG00000066813	"Acyl-CoA synthetase medium chain family member 2B"	Q68CK6	16	20536226-20576427	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	173	"kidney: 414.1;liver: 523.5"	"Group enriched"	"Detected in some"	20	"Hepatocytes: 1036.1;Proximal tubular cells: 441.9"	"Group enriched"	"Detected in some"	449	"liver cancer: 30.9;renal cancer: 17.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;Hep G2: 5.5;U-937: 1.9"									HPA057699	Supported					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA057699: AB_2683506"	"unprognostic (1.34e-2)"						"prognostic favorable (3.31e-4)"				"unprognostic (7.13e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"		0.4	0.5	0.4	0.0	1.0	0.2	0.3	2.7	1.6	0.1	0.1	0.8	0.3	0.3	0.3	0.3	0.4	0.5	0.6	0.6	0.8	414.1	523.5	0.4	0.2	0.7	0.5	0.4	0.2	0.2	0.1	0.1	0.7	0.2	0.0	0.5	0.1	0.0	0.9	0.8	0.1	0.1	0.1	0.3	0.6	0.9	0.4	0.1	1.0	0.0	0.1	0.0	0.1	0.8	0.5	0.0	2.9	0.7	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.7	0.5	0.0	1.4	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.4	0.1	0.7	5.5	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.5	0.0	0.0	0.4	0.3	0.5	0.6	0.7	0.0	0.0	0.6	0.1	0.0	0.1	0.9	0.5	1.4	0.0	0.5	0.1	1.1	0.2	0.0	0.0	0.5	0.0	0.4	0.3	0.2	0.3	0.2	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.0	2.7	1.6	0.6	0.8	0.7	0.5	0.7	0.1	0.4	0.8	0.5	0.0	0.0	0.0	6.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	7.3	0.0	0.0	0.0	0.2	35.2	0.1	0.8	0.0	0.0	2.2	1.8	24.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.7	1036.1	0.1	0.0	0.0	0.0	0.0	23.2	0.4	0.7	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	441.9	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	2.7	0.1	0.0	0.0
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 276.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 237.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 5.3;ASC TERT1: 11.5;HSkMC: 13.8;U-87 MG: 8.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	25.5	2.5	7.1	0.6	5.2	0.6	10.7	4.7	5.0	2.8	3.0	3.7	0.8	1.2	7.1	1.0	1.7	2.3	3.3	5.5	7.9	25.4	276.6	2.1	1.9	6.3	6.8	0.8	0.6	1.0	0.5	1.4	6.8	0.6	1.2	0.5	0.9	0.9	13.9	2.3	1.9	1.0	6.7	4.6	3.4	0.9	8.2	0.7	4.2	1.7	0.7	1.1	2.2	8.2	0.0	0.0	0.1	0.1	5.3	11.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	13.8	0.0	0.8	0.1	0.2	0.0	0.0	0.1	0.5	1.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	0.1	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	7.1	5.2	4.7	5.0	5.5	7.9	6.3	6.8	6.8	6.7	8.2	8.2	0.4	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.5	0.5	0.0	0.3	1.2	0.0	13.5	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	6.1	237.8	3.7	0.0	0.2	0.0	0.0	11.7	1.5	0.8	9.3	3.5	0.0	7.5	1.3	0.9	0.0	1.5	0.1	0.0	0.0	6.0	0.0	0.2	0.0	52.1	0.0	0.1	0.0	11.3	0.3	0.2	0.3	0.1	0.6	0.0	0.7	0.9	0.1	0.2
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 117.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 137.7;Hepatocytes: 138.9;Intestinal goblet cells: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 22.6;granulocytes: 34.3;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved					NA	NA		16000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	69.3	23.7	4.0	10.7	9.3	7.5	27.2	6.8	7.8	15.1	6.0	54.6	64.2	13.7	34.3	18.6	22.1	10.7	49.8	3.3	6.4	22.0	46.9	23.2	4.0	12.1	5.9	13.0	14.8	19.6	3.8	17.2	12.7	12.2	32.9	5.3	38.1	16.2	117.3	17.1	46.8	11.3	5.1	8.1	37.7	10.6	7.2	4.0	9.6	99.2	7.0	9.3	11.9	16.3	32.8	11.6	17.1	10.7	69.5	59.1	25.5	14.5	32.4	13.9	21.7	27.3	40.6	0.1	18.6	24.1	50.2	26.0	20.1	132.4	9.5	0.1	7.1	37.2	6.6	18.5	46.2	6.6	28.1	50.3	34.2	24.8	34.5	27.8	27.7	4.2	22.0	7.1	15.8	13.3	2.4	18.8	3.3	27.6	44.1	15.9	20.3	83.4	62.5	9.0	2.9	14.5	24.7	49.1	32.1	21.2	19.6	24.4	23.5	12.3	7.8	12.4	7.9	24.0	19.7	9.1	32.3	9.3	9.1	34.3	21.8	6.6	1.2	13.3	1.2	0.7	3.0	1.3	22.6	1.1	5.3	2.9	12.2	0.7	6.4	4.2	2.0	9.2	4.0	9.3	6.8	7.8	3.3	6.4	12.1	5.9	12.7	5.1	7.2	16.3	8.8	12.8	41.1	17.6	4.2	7.8	9.4	13.5	10.2	6.4	27.6	10.9	82.2	20.0	16.6	11.0	6.2	15.5	3.7	137.7	11.7	20.8	9.0	8.0	8.2	13.5	7.8	29.0	18.5	33.7	11.2	11.4	58.1	13.0	9.5	35.3	13.6	138.9	16.4	8.4	18.2	100.6	18.3	17.9	13.9	7.2	11.5	15.6	14.2	17.8	19.4	9.1	1.0	5.5	86.5	23.4	66.4	4.5	14.6	11.2	70.4	60.5	7.6	4.1	13.1	7.2	9.8	32.1	20.3	12.3	10.9	20.9	5.1	7.8	75.1	13.0
ACVRL1	"ACVRLK1, ALK1, HHT, HHT2, ORW2"	ENSG00000139567	"Activin A receptor like type 1"	P37023	12	51906908-51923361	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 96.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 107.3;Distal enterocytes: 182.7;Endothelial cells: 84.7;Fibroblasts: 56.0;Hepatic stellate cells: 60.3;Paneth cells: 74.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 1.5;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	19	"dendritic cells: 2.1;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 61.4;ASC TERT1: 42.1;EFO-21: 61.0;HUVEC TERT2: 200.0;TIME: 161.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007041	Approved				"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA007041: AB_1078097"	"unprognostic (2.50e-1)"	"unprognostic (4.83e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.60e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	49.2	12.1	17.1	20.1	14.5	0.6	38.4	15.5	14.9	35.9	10.5	39.2	10.2	28.1	4.3	11.4	32.7	14.3	38.5	13.3	14.6	29.8	3.3	96.3	15.1	17.8	16.7	4.8	12.0	23.6	6.2	83.8	18.7	17.7	28.4	0.7	11.8	13.3	18.2	18.5	28.5	16.2	14.0	29.2	19.1	1.7	22.0	4.6	29.2	15.7	6.1	25.1	25.6	15.0	0.0	0.7	0.4	0.0	61.4	42.1	0.1	3.0	5.6	0.1	0.3	0.3	0.4	0.1	61.0	24.0	0.2	0.0	0.0	0.0	0.1	0.1	2.1	1.4	0.0	0.0	9.0	0.0	1.3	16.8	0.1	0.4	0.0	0.0	200.0	0.0	0.2	0.1	1.1	0.5	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.4	0.0	4.1	161.2	0.0	0.4	0.7	0.0	0.0	0.1	0.2	0.3	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	17.1	14.5	15.5	14.9	13.3	14.6	17.8	16.7	18.7	14.0	22.0	15.0	107.3	3.2	7.9	0.0	0.6	5.2	0.3	0.0	0.6	0.4	1.0	1.3	4.0	0.0	1.3	0.0	0.0	0.6	0.3	182.7	0.0	4.0	0.0	1.4	19.9	84.7	5.4	0.0	0.1	1.4	36.9	56.0	0.5	0.7	0.0	0.0	60.3	0.1	12.0	0.0	0.0	26.4	0.0	30.9	12.4	1.2	11.8	7.8	5.4	25.3	9.9	2.0	0.0	1.0	0.1	0.0	74.7	3.4	0.1	0.6	4.5	0.0	2.8	0.4	39.5	32.9	18.2	0.1	0.8	0.6	5.4	2.6	1.2	0.6	49.3	1.0
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983340-51989197	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"intestine: 181.5;kidney: 449.9;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 128.0"									"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		23000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	19.2	24.0	5.6	7.3	5.7	8.8	20.7	6.4	7.3	13.9	11.6	30.6	181.5	4.3	21.8	10.7	13.0	10.7	14.5	5.1	6.0	449.9	274.9	9.2	7.2	6.5	5.9	4.8	8.7	28.2	4.7	9.7	6.6	14.3	30.5	1.9	16.4	11.1	20.2	8.2	138.2	6.9	6.7	8.1	23.6	3.2	6.1	5.1	21.0	34.6	9.2	12.5	7.1	6.6	15.9	26.2	13.2	34.1	28.9	39.4	40.5	12.6	28.2	29.4	14.9	41.2	67.9	7.2	12.2	22.0	13.2	20.0	14.7	81.2	11.5	21.8	10.7	25.3	13.9	128.0	49.7	19.8	21.0	48.0	67.2	25.4	69.1	25.8	11.5	14.6	47.1	23.9	29.9	35.2	0.6	38.9	23.4	92.1	39.3	8.0	14.1	63.5	74.5	50.8	16.9	18.2	12.6	62.6	29.5	7.5	42.3	27.9	7.1	22.0	21.9	24.8	18.8	61.7	16.9	12.1	28.1	42.9	29.0	9.1	15.7	0.4	10.7	15.1	5.7	7.4	2.6	4.5	21.2	6.1	4.1	4.7	0.0	20.4	6.4	2.8	3.8	9.7	5.6	5.7	6.4	7.3	5.1	6.0	6.5	5.9	6.6	6.7	6.1	6.6	0.5	3.2	3.2	0.0	4.9	0.6	1.0	1.9	17.1	0.2	2.7	1.3	0.2	1.5	2.5	5.5	0.0	3.9	0.3	31.6	9.8	16.6	0.2	0.2	0.9	0.9	2.4	15.8	0.0	8.3	4.5	4.3	32.6	0.6	7.0	0.2	1.1	13.1	1.9	0.0	0.0	11.2	4.1	1.9	0.3	0.8	0.6	4.2	0.0	0.0	9.3	0.8	1.0	0.0	0.0	16.4	23.3	0.0	14.9	0.6	144.8	92.0	1.7	1.1	0.0	0.6	2.0	0.1	0.2	18.5	0.4	4.1	2.6	1.0	14.5	0.4
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650730	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 77.7;kidney: 58.2;liver: 33.8;pancreas: 22.2"	"Group enriched"	"Detected in many"	8	"Proximal enterocytes: 255.7;Proximal tubular cells: 437.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 34.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.7;monocytes: 34.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA		13000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	4.0	4.2	3.0	1.4	0.9	3.6	3.5	10.5	2.0	6.7	77.7	0.5	0.8	0.8	0.9	1.9	0.0	4.1	5.0	58.2	33.8	0.2	7.0	5.0	3.5	0.2	22.2	0.4	0.3	0.2	4.3	0.6	4.5	0.0	2.4	0.4	0.0	0.2	70.8	0.3	5.7	1.4	11.9	0.1	5.1	1.9	0.1	0.0	8.9	0.3	0.1	4.6	0.2	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.6	15.3	57.7	0.6	0.0	1.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.1	2.1	2.5	0.0	15.3	0.0	1.8	0.0	9.8	0.0	0.0	0.0	0.1	0.3	1.3	0.1	0.0	0.1	2.8	0.2	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	6.4	0.5	0.0	0.7	0.0	0.2	7.6	0.7	1.3	0.4	0.2	3.8	1.4	1.3	0.9	0.0	3.9	34.1	8.7	0.0	1.9	4.0	3.0	3.6	3.5	4.1	5.0	5.0	3.5	4.3	5.7	5.1	4.6	0.1	0.0	1.7	0.0	4.7	0.0	0.1	0.7	0.0	0.0	1.6	2.2	0.5	8.6	1.6	22.0	0.0	0.2	0.1	9.2	31.3	4.1	0.0	0.5	0.2	0.1	1.2	0.0	0.0	10.4	0.3	0.1	19.4	0.9	0.0	0.0	0.0	25.3	2.2	0.0	0.0	40.8	0.0	0.6	0.9	0.0	0.0	3.0	5.4	10.3	0.4	0.0	0.0	0.0	0.0	5.7	10.6	0.0	3.3	0.5	255.7	437.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.7	0.1	14.7	0.9
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892019	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 25.2;Fibroblasts: 22.9;Leydig cells: 22.1;Microglial cells: 73.1;Sertoli cells: 52.6;Theca cells: 55.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 47.4;hTERT-RPE1: 88.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	9.0	5.2	0.9	1.6	0.7	0.0	7.8	0.5	0.4	2.7	1.7	2.5	0.5	3.8	0.5	0.9	3.2	4.0	1.6	0.2	0.4	1.3	1.4	5.6	0.9	1.2	0.9	2.7	0.6	0.5	0.6	3.9	1.0	1.3	1.0	0.7	0.9	1.4	0.8	1.5	1.1	6.5	1.5	0.5	1.2	2.0	1.3	0.3	1.9	0.7	0.6	2.2	2.0	3.3	28.7	0.9	25.5	0.0	35.9	17.2	0.0	13.3	33.1	16.8	19.5	0.0	0.0	0.0	0.0	9.0	29.1	0.8	0.7	16.7	24.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	13.8	0.0	47.4	12.2	88.0	0.0	0.0	0.0	0.1	26.6	0.0	0.0	0.0	5.0	0.0	0.0	0.0	29.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	28.0	36.2	0.3	7.9	4.4	3.5	0.0	23.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.5	0.4	0.2	0.4	1.2	0.9	1.0	1.5	1.3	3.3	6.4	0.0	0.0	1.3	0.5	0.8	0.0	0.0	0.0	0.1	1.5	2.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	4.9	1.2	25.2	2.1	0.0	0.0	3.0	0.2	0.4	22.9	0.0	0.6	0.0	3.3	11.4	0.2	0.6	0.0	6.2	0.0	0.0	0.3	2.1	3.0	22.1	0.2	7.2	73.1	0.0	5.3	0.0	0.5	7.8	0.1	0.0	17.7	0.0	0.1	0.0	2.4	0.7	0.2	52.6	1.7	19.1	0.4	4.7	0.1	0.9	0.8	0.3	55.4	0.0	0.1
ADAMTS17	"FLJ16363, FLJ32769"	ENSG00000140470	"ADAM metallopeptidase with thrombospondin type 1 motif 17"	Q8TE56	15	99971437-100342005	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Deafness, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.7"	"Group enriched"	"Detected in many"	8	"Astrocytes: 116.9;Early spermatids: 108.4;Inhibitory neurons: 275.7;Late spermatids: 91.0;Oligodendrocyte precursor cells: 337.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEK 293: 6.4;JURKAT: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062487			Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA				"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA062487: AB_2684780"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.43e-2)"	0.8	1.2	1.6	0.5	1.1	0.6	0.6	0.3	2.7	1.4	6.0	0.9	0.6	1.2	0.6	2.1	1.8	0.3	1.3	1.3	0.6	1.1	7.5	1.5	0.5	1.2	0.7	1.7	5.0	0.2	1.2	0.5	0.8	1.0	0.4	0.7	2.6	0.5	5.6	2.2	1.2	0.5	0.7	0.9	1.0	2.7	1.0	10.7	0.7	0.1	0.5	1.6	1.4	1.1	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.2	0.3	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.7	2.0	0.5	0.2	0.9	1.0	0.0	0.3	2.3	0.0	0.2	1.7	0.2	0.2	2.2	2.7	0.4	0.0	0.2	0.3	0.0	0.6	0.6	0.0	0.2	0.0	0.0	0.0	0.4	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.3	2.7	1.3	0.6	1.2	0.7	0.8	0.7	1.0	1.1	0.7	0.0	0.0	116.9	0.3	1.0	0.9	0.1	3.4	0.8	1.5	1.3	4.3	1.5	0.9	0.0	0.0	0.1	2.6	0.4	1.9	0.1	108.4	1.2	2.8	0.9	0.0	0.0	8.2	0.9	0.0	1.6	5.1	1.8	0.0	0.1	0.4	4.4	8.2	21.9	275.7	0.7	0.0	0.6	0.3	91.0	2.1	0.4	0.0	22.5	0.0	1.3	1.0	337.3	9.5	0.3	0.2	0.0	0.8	1.6	0.5	0.1	0.0	0.7	0.0	3.2	0.9	1.7	1.9	2.1	0.6	0.1	3.7	2.5	0.4	0.9
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"		5	129460281-129738683	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	10	"brain: 3.3;cervix: 10.2;endometrium 1: 9.8;placenta: 3.7;smooth muscle: 5.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 82.6;Inhibitory neurons: 79.7;Oligodendrocytes: 31.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7;testis cancer: 1.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 15.9;SH-SY5Y: 34.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 2.6"	"Low region specificity"	"Detected in many"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"	Yes	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Midbody"		"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.0	0.6	1.0	0.0	3.3	0.0	0.0	0.0	1.5	10.2	0.1	0.2	0.1	9.8	0.0	0.2	0.2	0.0	0.2	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	3.7	0.0	0.1	0.3	0.5	0.3	0.0	0.5	0.0	0.1	5.9	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	15.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	34.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	3.3	0.0	1.5	0.8	0.2	0.0	0.5	0.0	0.0	0.3	0.6	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	1.4	0.0	0.0	1.8	0.0	15.6	0.0	0.3	0.0	0.0	1.5	0.5	8.9	0.2	0.0	0.0	82.6	0.2	0.7	1.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	79.7	0.1	0.0	0.0	0.3	0.7	0.0	0.1	0.0	1.0	0.0	1.1	0.0	12.5	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.1	0.1	0.0	5.2	0.1	0.1	0.3	0.0
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 73.2;liver: 35.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Endothelial cells: 5.7;Fibroblasts: 8.5;Microglial cells: 12.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 7.4;RPMI-8226: 10.1;SH-SY5Y: 30.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		170000000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA045634: AB_2679399, HPA053812: AB_2682271"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.7	28.5	6.8	1.0	7.3	0.1	1.5	12.0	10.1	2.3	1.4	2.7	1.4	3.1	3.1	1.8	3.1	2.5	73.2	5.8	7.9	25.9	35.8	23.2	3.4	19.3	11.1	4.9	7.1	1.2	15.9	1.5	20.8	8.4	0.3	0.3	3.4	2.2	4.3	0.8	3.2	0.9	8.5	6.4	2.3	3.1	9.3	0.6	12.1	0.5	0.6	5.3	1.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.6	0.5	0.0	1.1	0.7	10.1	0.0	0.0	1.4	30.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.3	12.0	10.1	5.8	7.9	19.3	11.1	20.8	8.5	9.3	7.6	1.4	0.0	0.5	4.9	0.1	0.1	0.1	0.0	0.0	4.2	0.0	0.1	2.3	0.0	0.0	1.8	0.0	0.1	0.0	1.4	5.9	0.2	0.1	0.1	0.1	5.7	5.3	0.0	5.0	0.0	0.1	8.5	0.0	0.0	0.0	0.1	4.6	0.9	0.3	0.0	3.8	0.4	0.0	0.3	0.8	1.1	4.7	0.6	0.0	12.2	0.0	0.4	0.0	2.5	4.0	0.2	0.5	3.0	0.0	0.2	0.0	0.7	0.0	0.2	6.6	1.1	1.6	0.1	0.8	0.4	0.3	0.0	0.6	0.7	1.1	0.2
ADAMTSL3	"KIAA1233, punctin-2"	ENSG00000156218	"ADAMTS like 3"	P82987	15	83654088-84039842	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 141.1;Alveolar cells type 2: 111.8;Astrocytes: 86.5;Club cells: 61.7;granulocytes: 63.1;Inhibitory neurons: 91.6;Oligodendrocytes: 75.2;Respiratory ciliated cells: 56.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 12.1;hTERT-RPE1: 3.6;RPTEC TERT1: 14.0;TIME: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034773, HPA034774"	Uncertain		Uncertain	Vesicles	"Secreted in other tissues"	NA	NA		270000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA034773: AB_10601965, HPA034774: AB_2674326"	"unprognostic (2.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.89e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.27e-1)"	"unprognostic (9.18e-3)"	"unprognostic (5.92e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.00e-3)"	"unprognostic (4.62e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.95e-5)"	6.3	4.2	1.1	1.0	1.7	0.0	1.7	1.4	1.0	3.1	4.4	10.6	1.4	6.9	1.5	3.3	4.4	1.1	10.7	1.1	1.1	3.3	10.4	7.4	1.1	1.4	1.5	1.2	7.3	0.8	1.4	10.4	1.7	6.6	3.2	0.3	2.4	7.1	2.6	1.4	1.8	4.7	1.5	1.9	4.6	2.7	1.1	1.0	2.6	4.8	0.5	5.2	2.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	14.0	0.0	0.0	0.0	0.2	0.2	0.0	1.3	0.0	0.0	13.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.4	1.0	1.1	1.1	1.4	1.5	1.7	1.5	1.1	3.0	8.7	141.1	111.8	86.5	0.1	7.0	5.2	1.7	0.6	0.2	0.2	0.3	9.4	0.0	61.7	1.8	0.0	0.1	0.8	0.0	0.0	0.5	14.9	0.6	0.4	10.6	0.0	0.0	31.3	2.4	0.2	29.0	1.5	1.2	63.1	0.1	1.1	10.2	0.2	6.7	91.6	0.0	0.0	0.6	0.5	16.9	49.4	5.9	0.0	5.6	0.0	0.1	1.0	4.5	75.2	1.0	0.0	17.0	0.4	2.4	0.0	0.6	56.4	0.2	26.3	13.0	8.3	2.1	2.8	0.6	1.1	0.1	5.0	0.4	0.0	2.3
ADCY4	AC4	ENSG00000129467	"Adenylate cyclase 4"	Q8NFM4	14	24318349-24335093	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 90.9;Endothelial cells: 74.6;Hepatic stellate cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 2.9;TIME: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005070, HPA048344"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB005070: AB_2273639, HPA048344: AB_2680366"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-4)"	"prognostic favorable (8.20e-4)"	"unprognostic (4.06e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.75e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (8.02e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	18.0	2.6	2.8	2.3	2.2	0.0	16.1	2.2	2.8	9.2	2.0	3.9	0.9	8.8	0.5	3.7	8.2	2.9	16.9	2.0	2.1	10.2	1.4	9.9	1.6	2.7	2.5	2.4	2.3	1.0	1.7	9.9	2.6	5.3	0.7	0.0	3.7	1.4	4.3	4.7	4.5	1.9	2.4	9.9	3.7	1.1	3.0	0.4	7.7	2.8	0.8	5.9	6.7	2.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	2.2	2.2	2.8	2.0	2.1	2.7	2.5	2.6	2.4	3.0	2.3	90.9	0.0	1.8	0.3	1.0	3.6	0.4	0.3	3.4	0.0	1.5	1.5	10.6	0.0	0.9	1.8	0.0	0.2	1.6	2.9	0.0	1.2	1.3	0.5	1.1	74.6	1.2	0.4	0.2	3.1	0.1	4.7	7.1	0.6	1.3	0.0	50.3	0.2	1.4	1.7	0.2	7.9	0.0	5.0	3.1	6.9	0.0	1.5	7.2	12.2	2.5	0.9	1.0	0.0	0.0	2.1	3.8	0.0	1.4	0.4	2.4	0.0	1.1	0.2	6.6	1.7	5.7	0.3	0.8	0.6	2.8	0.0	1.6	0.5	2.1	0.2
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 402.4;Rod photoreceptor cells: 624.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	104.4	70.0	96.4	60.7	119.7	65.9	89.1	86.7	117.7	96.5	46.4	127.9	65.5	121.4	57.9	71.9	96.3	69.0	111.2	99.2	90.9	74.1	53.7	93.5	65.3	91.5	100.4	129.5	56.4	67.5	70.1	66.0	92.3	86.1	62.7	269.1	61.9	107.3	166.3	69.4	92.3	110.2	76.0	88.9	84.3	53.2	113.2	76.0	71.7	115.0	62.1	115.3	82.9	116.2	74.7	61.2	142.0	73.8	205.8	152.6	53.2	123.2	146.9	125.6	105.3	90.5	91.8	38.7	63.0	212.3	146.6	46.6	107.5	103.4	104.3	49.9	49.4	109.5	50.4	87.9	100.4	65.8	74.7	151.6	95.2	110.4	44.0	130.1	158.5	71.9	116.0	90.8	145.1	43.7	203.7	91.6	80.0	67.9	85.7	89.1	78.6	45.7	91.2	162.2	84.8	110.0	88.9	35.8	76.9	107.0	84.2	61.7	193.4	102.1	52.4	84.7	103.0	72.5	63.3	48.9	98.2	80.4	100.9	20.1	7.6	35.5	19.1	7.3	17.6	23.8	10.6	16.3	12.0	31.2	9.8	11.8	10.5	27.2	11.4	25.4	14.8	16.0	96.4	119.7	86.7	117.7	99.2	90.9	91.5	100.4	92.3	76.0	113.2	116.2	89.3	70.5	45.4	141.3	66.5	26.9	29.8	33.0	27.9	99.5	41.2	41.5	78.0	40.0	46.3	60.7	402.4	35.5	84.0	51.3	15.6	37.3	48.5	43.9	61.2	89.4	57.7	57.9	85.7	45.8	32.5	72.9	39.8	58.1	37.3	53.0	84.3	41.8	41.8	111.0	83.2	39.3	28.5	51.6	42.2	35.9	77.6	47.4	35.6	72.1	58.3	233.8	120.5	68.9	178.6	53.2	39.4	121.9	49.7	35.8	48.6	44.6	40.4	624.3	98.6	58.4	73.1	45.3	33.2	30.5	36.7	36.5	55.6	80.7	45.1	33.0
ADGRA2	"DKFZp434C211, DKFZp434J0911, FLJ14390, GPR124, KIAA1531, TEM5"	ENSG00000020181	"Adhesion G protein-coupled receptor A2"	Q96PE1	8	37784191-37844896	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.6;Endometrial stromal cells: 49.4;Fibroblasts: 36.4;Hepatic stellate cells: 31.4;Leydig cells: 56.5;Microglial cells: 24.4;Muller glia cells: 25.0;Peritubular cells: 41.8;Sertoli cells: 46.0;Smooth muscle cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 83.6;ASC TERT1: 64.8;BJ hTERT+: 75.2;fHDF/TERT166: 77.6;HSkMC: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012393	Uncertain					NA	NA		270000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA012393: AB_1849256"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.18e-7)"	"unprognostic (2.65e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.60e-3)"	29.1	4.8	10.0	12.2	8.6	2.0	26.4	8.7	10.1	59.8	5.9	24.1	7.7	45.1	18.2	24.8	43.8	26.2	17.6	9.8	6.5	9.6	4.3	16.2	7.7	7.7	8.3	35.9	5.5	2.2	10.0	48.7	7.8	44.4	8.2	6.7	9.0	54.9	6.6	13.1	12.8	27.8	7.0	11.9	12.3	3.5	11.2	5.2	11.3	8.3	5.6	39.6	32.0	6.6	0.2	2.3	0.3	4.7	83.6	64.8	0.6	38.5	75.2	4.6	12.4	0.5	0.2	0.0	6.9	77.6	3.1	0.9	3.5	0.2	1.5	1.6	1.8	0.2	2.2	0.2	38.1	0.0	0.0	39.4	0.4	3.4	0.8	3.3	22.3	3.0	0.2	0.7	1.2	1.2	0.1	8.0	3.5	0.0	0.6	6.5	4.2	0.4	0.0	0.1	0.3	18.1	1.0	0.2	5.7	17.7	0.2	16.9	18.2	7.6	9.6	11.2	3.5	6.2	0.5	0.1	1.0	20.3	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	8.6	8.7	10.1	9.8	6.5	7.7	8.3	7.8	7.0	11.2	6.6	30.6	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.0	1.0	1.0	1.1	1.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	1.9	0.1	0.2	1.5	49.4	17.8	0.0	0.0	7.8	1.6	0.6	36.4	0.0	2.2	0.0	0.1	31.4	0.1	2.1	0.0	7.8	0.2	0.0	1.6	0.0	3.1	56.5	1.5	0.0	24.4	1.0	25.0	1.0	3.0	0.8	0.3	0.1	41.8	0.1	0.3	0.0	0.0	0.0	0.7	46.0	5.5	36.0	0.3	0.8	0.5	0.0	2.3	0.4	2.6	0.3	0.2
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.4;Early spermatids: 12.0;Late spermatids: 28.0;Microglial cells: 5.6;Oligodendrocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.4;U-937: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA044500	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus"	Cytosol	"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.1	0.1	0.5	0.4	0.3	0.4	0.0	1.0	0.6	0.0	0.5	0.1	0.5	0.1	0.0	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.1	0.1	0.5	0.6	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.2	0.5	0.4	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.5	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.2	0.0	1.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	1.4	0.4	0.9	0.0	0.0	0.8	0.7	0.3	0.0	1.1	0.8	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.7	0.7	1.2	0.0	1.4	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.3	1.0	0.6	0.4	0.4	0.6	0.3	0.4	0.3	0.4	0.4	0.4	0.0	0.0	11.4	1.3	0.0	0.3	0.0	0.0	0.9	0.3	0.4	0.7	0.0	0.0	0.0	2.1	0.1	0.8	0.0	0.0	0.1	12.0	0.9	1.1	0.2	0.0	0.0	3.4	0.0	0.1	0.2	0.5	0.8	0.0	0.2	0.0	0.2	0.1	1.7	4.1	0.1	0.0	0.0	0.0	28.0	0.0	0.5	0.0	5.6	0.3	0.2	0.0	3.0	6.3	0.1	0.0	0.0	2.7	0.1	0.4	0.1	0.0	1.2	0.0	0.2	0.3	1.5	0.4	0.1	0.0	0.1	0.9	0.2	0.2	0.1
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79282124	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 73.1"	"Group enriched"	"Detected in many"	5	"Adipocytes: 559.9;Endothelial cells: 276.0;Hepatic stellate cells: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 101.2;HUVEC TERT2: 330.0;TIME: 379.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		3800000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	73.1	8.2	7.7	9.7	8.2	0.7	64.0	8.5	13.8	22.1	7.0	9.3	4.7	16.3	6.2	9.0	12.1	22.4	24.2	8.0	8.0	15.2	14.3	18.0	9.9	9.1	7.7	4.8	4.7	9.7	5.1	22.5	9.1	9.4	6.3	3.0	7.9	8.9	14.2	9.0	8.6	27.6	7.6	39.8	8.0	6.7	9.8	4.6	20.8	23.6	7.1	24.0	10.4	8.4	0.0	0.0	25.7	0.2	7.3	24.7	0.0	7.8	7.7	0.5	0.3	0.8	0.2	0.2	0.6	22.5	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.5	0.7	0.1	25.3	0.0	0.3	17.8	0.4	55.7	0.3	101.2	330.0	0.2	0.4	2.5	7.0	0.0	0.0	1.0	0.4	0.2	0.4	0.2	0.0	0.0	61.1	3.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	379.3	0.2	5.8	2.0	0.0	0.8	0.5	0.1	0.3	0.5	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	8.2	8.5	13.8	8.0	8.0	9.1	7.7	9.1	7.6	9.8	8.4	559.9	0.0	6.0	0.3	1.2	0.0	0.4	0.0	4.6	0.0	1.8	2.5	7.6	5.7	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	45.3	0.8	1.5	276.0	0.0	2.7	1.5	0.2	0.0	10.2	0.0	3.8	0.0	0.0	287.7	3.5	0.6	1.7	1.0	0.0	0.0	19.2	0.0	57.9	0.6	1.5	0.0	72.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.4	1.2	1.3	0.0	0.0	0.0	0.4	0.0	5.1	5.7	7.2	1.8	1.0	0.0	0.0	1.1	5.4	0.0	0.7
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"adrenal gland: 533.0"	"Cell type enriched"	"Detected in many"	8	"Astrocytes: 2207.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;HAP1: 23.0;K-562: 9.8;NTERA-2: 11.6;SCLC-21H: 11.1;SuSa: 15.0;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067503	Approved		Approved	"Lipid droplets"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Lipid droplets"		"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.0	533.0	36.9	0.0	47.8	0.6	3.6	12.7	40.3	0.9	22.4	1.0	0.3	0.1	0.7	2.4	0.2	12.3	0.2	39.1	11.6	21.5	42.3	2.1	0.0	9.4	12.8	0.2	1.5	0.8	15.1	4.1	9.4	1.3	1.0	18.2	2.3	0.2	0.2	2.1	0.5	0.0	7.3	0.3	1.1	1.4	18.3	0.8	17.5	0.0	0.4	10.4	1.9	26.1	0.5	2.1	15.5	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	1.7	0.2	0.3	0.4	0.0	0.4	0.2	23.0	0.2	0.0	1.0	4.3	4.1	2.0	1.4	0.0	0.3	0.1	0.0	4.8	0.0	0.1	0.1	0.0	0.1	9.8	2.6	0.0	2.1	0.1	0.2	11.6	2.9	4.2	0.0	0.4	2.1	0.0	0.5	11.1	2.7	3.4	2.2	0.2	15.0	5.9	0.0	0.8	0.4	1.9	0.5	1.1	13.4	4.1	0.6	0.7	0.2	0.0	3.2	0.9	2.8	1.0	0.7	1.7	1.5	1.1	1.4	0.5	2.9	1.7	0.9	4.6	1.1	0.5	1.2	1.6	0.2	36.9	47.8	12.7	40.3	39.1	11.6	9.4	12.8	9.4	7.3	18.3	26.1	0.4	25.6	26.5	2207.3	0.0	0.0	6.1	0.0	1.8	28.0	15.5	7.4	2.4	2.8	5.6	5.5	264.8	3.0	0.4	0.6	1.9	1.9	43.5	3.3	0.3	1.1	7.3	0.0	54.0	4.2	2.6	1.1	4.6	1.9	0.0	6.7	0.0	12.4	0.2	10.1	21.9	0.4	0.0	0.8	0.0	54.8	0.6	0.5	0.0	51.5	1.2	8.9	1.0	40.2	7.4	1.7	1.2	0.4	0.1	2.1	0.1	24.2	7.3	84.4	0.0	0.3	0.4	3.6	4.5	2.9	0.0	4.1	0.6	0.2	1.2	9.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 703.8"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 325.5;Proximal tubular cells: 92.4"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 44.7"	"Not detected"	"Not detected"							"HPA067946, HPA069081"	Enhanced					NA	NA		3400000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	8.2	41.5	0.3	0.0	0.3	9.2	7.7	0.0	0.0	0.0	52.3	703.8	0.2	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.1	0.1	8.6	0.0	0.0	0.1	0.0	1.8	22.6	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	44.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	9.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.5	0.1	0.5	0.0	0.0	0.0	0.0	0.3	15.7	1.1	5.5	0.0	0.0	0.0	7.8	7.9	0.3	0.0	11.2	0.3	0.4	12.1	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.0	7.1	325.5	0.0	0.0	0.1	8.9	8.2	5.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	31.1	92.4	15.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	12.7	0.1
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497366-3519531	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 590.7"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 888.3;Hepatocytes: 1234.6;Proximal tubular cells: 1546.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	55.1	76.9	31.1	28.0	32.6	31.7	50.4	31.7	42.1	54.2	43.3	58.3	105.2	45.6	43.3	48.2	45.2	66.7	146.4	32.0	31.0	200.2	590.7	44.6	30.1	33.0	32.2	50.0	34.9	49.6	33.5	41.3	33.6	101.1	52.3	17.1	53.6	55.9	121.1	35.7	68.9	37.9	31.6	57.2	82.4	16.7	31.6	26.9	36.5	56.0	34.5	57.9	36.5	34.7	46.5	64.5	55.9	50.2	187.5	85.0	91.9	95.6	124.1	102.7	74.5	86.9	59.2	22.1	143.4	109.5	21.4	45.1	62.9	49.0	59.2	39.5	131.4	67.6	42.2	184.1	165.4	71.2	151.3	91.4	72.3	55.0	63.7	45.3	75.8	36.1	51.8	45.3	87.4	137.8	25.6	147.1	44.4	131.9	86.4	27.1	31.3	128.2	90.2	83.3	57.0	54.0	53.0	75.0	37.2	36.8	55.6	95.5	54.1	75.9	29.0	35.9	56.6	35.4	91.6	88.7	58.6	115.5	41.0	87.6	134.3	336.9	28.5	126.5	31.8	66.8	67.4	26.7	127.7	53.4	79.3	25.6	59.4	54.5	117.4	186.3	67.4	189.0	31.1	32.6	31.7	42.1	32.0	31.0	33.0	32.2	33.6	31.6	31.6	34.7	44.8	67.3	111.1	25.1	73.1	76.0	154.5	107.8	92.2	9.2	103.0	88.9	275.8	338.8	109.5	152.6	14.6	395.0	80.6	140.1	888.3	157.2	8.8	65.9	116.3	61.6	57.2	123.1	9.4	87.2	247.1	129.1	66.3	116.3	41.8	75.1	207.8	1234.6	263.2	8.4	15.0	146.1	236.0	168.8	67.6	23.8	137.0	90.0	204.5	7.5	108.2	197.2	40.2	5.5	19.0	79.7	272.5	210.3	97.4	143.6	409.8	1546.8	38.0	15.3	164.3	45.5	109.3	5.3	11.3	113.6	76.9	381.4	53.0	120.8	147.2	156.9
ADM2	"AM2, FLJ21135"	ENSG00000128165	"Adrenomedullin 2"	Q7Z4H4	22	50481543-50486440	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.3;pancreas: 15.5;thyroid gland: 11.6"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 10.0;Gastric mucus-secreting cells: 7.1;Intestinal goblet cells: 7.1;Pancreatic endocrine cells: 9.4;Proximal enterocytes: 7.4;Proximal tubular cells: 28.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 37.1;hTCEpi: 23.8;Karpas-707: 38.2;SK-MEL-30: 25.9;U-266/70: 25.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	61300			"Cluster 25: Pancreas - Digestion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.30e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.26e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.41e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (1.06e-2)"	0.3	0.2	0.2	1.7	0.3	0.4	0.4	0.6	0.4	0.9	0.0	1.1	3.7	0.1	1.7	3.0	0.2	1.2	0.1	0.1	0.1	8.3	3.8	0.8	2.6	0.2	0.2	0.0	15.5	0.3	0.4	0.2	0.2	2.6	0.6	0.0	5.6	0.4	0.0	0.4	2.9	0.2	0.0	1.1	4.0	0.6	0.4	1.0	11.6	0.0	1.9	0.3	0.3	0.2	1.8	0.3	0.5	2.0	1.2	2.1	7.0	9.1	0.8	1.3	2.9	3.9	1.5	0.0	1.3	7.9	1.5	1.4	2.0	1.2	0.5	17.3	0.0	0.1	0.5	2.8	37.1	3.8	2.5	7.5	23.8	4.1	8.6	0.1	0.1	10.1	2.4	38.2	0.3	5.8	0.3	0.7	1.2	10.7	5.7	0.0	0.0	15.1	1.7	0.2	1.0	4.0	0.1	5.5	25.9	1.2	7.6	12.2	0.0	0.0	8.1	0.0	0.0	25.6	4.2	5.0	0.3	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.4	0.1	0.1	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.0	3.0	0.0	2.5	0.0	0.9	1.0	0.0	0.0	3.6	1.8	1.4	1.5	0.5	0.0	0.0	0.1	0.6	3.9	3.9	2.6	0.0	0.5	0.4	0.3	1.2	0.0	0.0	10.0	0.7	0.2	7.1	1.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	7.1	0.0	0.0	0.3	0.2	0.0	0.4	1.8	0.0	0.6	0.0	1.0	0.0	0.0	9.4	1.4	0.0	3.1	2.0	7.4	28.1	0.1	0.0	0.0	1.1	0.7	0.2	1.0	0.0	0.4	1.0	1.2	0.0	1.1	0.9
ADORA1	RDC7	ENSG00000163485	"Adenosine A1 receptor"	P30542	1	203090654-203167405	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.8;testis: 21.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 18.1;granulocytes: 22.3;Muller glia cells: 44.4;Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 31.5"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.3;MCF7: 24.4;RH-30: 65.4;RPTEC TERT1: 31.7;SK-BR-3: 35.2;U-138 MG: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044383			Supported	"Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA044383: AB_2678921"	"unprognostic (3.93e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.76e-4)"	3.7	0.2	31.9	1.6	34.6	0.0	4.6	28.6	33.8	1.0	0.0	1.0	1.0	1.2	0.6	1.1	1.2	0.9	11.4	29.6	23.0	9.3	0.4	1.7	0.6	35.7	35.0	0.3	13.2	8.0	1.9	6.8	41.8	1.0	0.6	4.8	6.4	0.4	1.7	4.6	1.2	0.4	23.6	6.3	1.0	21.4	54.8	0.4	2.2	2.5	0.5	1.6	0.7	41.5	0.3	3.0	0.6	0.2	0.2	1.6	0.2	2.0	3.0	0.7	0.4	40.3	0.7	0.0	8.9	7.3	4.8	0.1	0.7	0.0	0.2	0.0	1.1	0.0	0.4	0.0	0.6	0.0	0.1	0.9	0.0	0.9	0.0	6.4	0.0	6.4	0.0	0.1	6.2	24.4	0.1	0.0	10.2	0.0	0.0	0.0	65.4	2.3	31.7	0.0	0.8	0.7	4.4	35.2	0.5	3.6	2.0	1.0	0.0	20.9	10.6	0.0	11.7	0.0	0.2	0.0	10.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	34.6	28.6	33.8	29.6	23.0	35.7	35.0	41.8	23.6	54.8	41.5	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	1.1	9.4	6.9	3.1	7.2	0.0	3.7	0.0	0.1	0.1	0.1	0.0	11.7	0.1	0.0	0.4	0.3	0.0	0.0	18.1	3.3	1.3	1.1	0.0	0.1	22.3	0.8	0.0	0.0	0.9	0.0	2.9	0.0	0.0	1.0	1.0	0.5	0.0	0.6	1.8	1.9	0.2	44.4	0.0	35.2	31.5	0.5	0.0	0.7	0.0	0.0	0.0	3.0	0.0	1.6	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442357	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 40.6;brain: 101.4;lymphoid tissue: 54.1"	"Group enriched"	"Detected in some"	6	"B-cells: 5.8;monocytes: 10.9;Plasma cells: 11.8;T-cells: 3.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"basal ganglia: 101.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.3;Karpas-707: 52.8;RPMI-8226: 41.1;SK-BR-3: 74.0;U-266/70: 52.8;U-266/84: 74.4;U-698: 55.0"	"Region enriched"	"Detected in many"	9	"basal ganglia: 399.8"	"Region enriched"	"Detected in many"	50	"basal ganglia: 142.2"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported				NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	3.4	5.4	12.3	13.5	101.4	40.6	2.5	10.8	19.2	4.0	8.0	4.1	6.6	2.9	1.6	2.0	3.7	3.0	13.5	11.6	10.0	17.5	14.5	14.6	20.5	10.2	10.4	3.9	2.3	0.2	6.7	1.8	10.4	5.5	1.0	2.1	3.2	1.7	2.5	1.6	7.0	0.9	9.9	15.2	4.0	3.1	19.9	54.1	4.3	1.4	10.4	5.3	3.4	9.7	0.5	0.9	1.0	0.3	0.4	0.3	1.0	0.7	23.2	1.3	2.4	4.5	0.3	39.3	2.6	0.7	2.4	1.0	2.4	0.0	0.0	4.7	6.6	0.7	0.2	5.6	0.4	0.8	18.7	0.2	0.2	7.2	0.0	0.5	8.2	5.8	0.3	52.8	0.0	0.7	14.0	4.2	1.6	5.0	0.1	0.6	1.7	41.1	0.1	0.3	3.9	21.6	1.1	74.0	0.3	1.1	0.8	3.7	0.5	2.2	3.7	0.5	0.4	52.8	74.4	55.0	11.5	13.6	0.3	9.6	2.1	11.6	20.0	6.5	46.9	21.9	37.4	39.2	2.6	38.3	51.5	42.4	32.6	6.3	23.1	2.9	54.0	27.1	12.3	101.4	10.8	19.2	11.6	10.0	10.2	10.4	10.4	9.9	19.9	9.7	0.0	0.0	0.5	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.5	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1
ADORA3	AD026	ENSG00000282608	"Adenosine A3 receptor"	P0DMS8	1	111499429-111503633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 17.9;Kupffer cells: 79.2;Late spermatids: 18.2;Macrophages: 26.3"					"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	40	"eosinophil: 601.6"	"Lineage enriched"	"Detected in many"	40	"granulocytes: 601.6"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 108.1"	"Low region specificity"	"Detected in many"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"																					4.5	15.0	8.9	4.3	9.2	0.2	5.5	10.6	14.6	4.4	8.8	6.6	4.5	1.9	0.2	2.5	3.6	5.8	3.4	8.8	12.3	1.6	3.3	3.5	6.4	16.1	11.1	1.8	1.8	3.1	2.6	2.8	14.9	2.4	5.1	1.0	2.8	2.4	0.5	0.9	9.4	4.8	13.5	4.3	3.0	1.2	16.9	3.5	1.4	1.0	2.7	4.3	1.7	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.0	0.0	108.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.0	8.1	601.6	0.0	5.6	0.1	0.2	0.0	0.0	15.0	0.1	0.1	0.1	2.0	0.1	2.1	3.0	0.0	2.5	8.9	9.2	10.6	14.6	8.8	12.3	16.1	11.1	14.9	13.5	16.9	21.8	0.2	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	7.3	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	1.8	0.2	17.9	0.0	0.0	0.0	0.0	79.2	4.4	18.2	0.3	26.3	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.1	0.4	0.0	1.6	0.0	0.0	0.1
ADRA2A	"ADRA2, ADRA2R, ADRAR"	ENSG00000150594	"Adrenoceptor alpha 2A"	P08913	10	111077029-111080907	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 50.5;cervix: 46.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Paneth cells: 105.9;Smooth muscle cells: 118.7"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 17.7"	"Region enhanced"	"Detected in all"		"pons: 26.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.5;ASC TERT1: 12.9;HEL: 20.3;HeLa: 10.7;HSkMC: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.06e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (5.86e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-3)"	50.5	1.7	3.4	4.9	3.4	0.0	32.9	1.6	4.3	46.6	7.7	7.4	10.0	6.8	1.6	2.9	4.1	19.9	2.1	3.4	7.4	6.0	1.1	4.3	11.2	5.9	5.8	18.1	30.5	1.3	2.3	3.7	26.8	6.9	3.7	0.0	7.0	6.1	1.0	10.9	4.9	2.8	1.4	14.7	3.7	5.0	3.2	1.0	9.0	0.6	13.1	15.9	23.4	6.1	0.0	0.0	0.0	0.0	10.5	12.9	0.0	0.1	0.0	1.1	2.5	0.0	0.0	0.0	0.1	6.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	20.3	10.7	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.4	1.6	4.3	3.4	7.4	5.9	5.8	26.8	1.4	3.2	6.1	8.3	0.0	1.3	1.0	0.0	10.3	0.4	0.0	1.2	0.0	17.2	12.2	1.5	52.9	1.3	0.0	0.0	0.1	0.0	11.7	0.0	5.9	3.5	6.9	9.1	4.9	12.4	0.0	2.2	3.3	0.1	7.3	10.7	25.8	7.0	19.4	0.7	0.0	0.1	0.0	5.9	3.5	0.0	0.3	17.3	1.2	22.4	7.3	28.4	1.0	0.0	0.0	0.0	0.0	0.2	0.3	105.9	4.9	0.0	0.9	3.5	0.6	0.0	0.0	6.6	3.1	118.7	5.4	0.1	0.2	6.1	0.1	1.2	8.5	8.6	1.1
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104345-44114562	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 103.0;Fibroblasts: 263.2;Leydig cells: 151.6;Peritubular cells: 508.9;Smooth muscle cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.1;BJ: 193.0;BJ hTERT+: 126.0;fHDF/TERT166: 208.9;JURKAT: 145.0;WM-115: 117.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 57.6"	"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2700000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	190.5	59.9	45.0	59.8	56.0	10.6	153.0	38.6	44.8	312.1	28.0	95.3	19.2	268.8	59.6	65.7	199.8	155.9	156.7	47.3	92.9	68.7	20.3	166.0	45.5	114.7	81.5	253.7	28.9	10.1	43.3	89.0	79.6	112.1	25.0	1.3	50.7	213.5	21.3	84.8	79.1	119.3	74.3	54.4	71.2	40.4	52.1	73.3	83.7	14.1	16.7	138.7	198.0	66.6	0.6	0.0	44.5	0.1	141.1	49.6	1.0	193.0	126.0	21.6	4.5	0.0	0.1	5.3	20.9	208.9	0.2	0.1	2.4	3.5	9.1	0.6	0.0	13.3	0.1	0.0	39.6	0.1	0.3	75.8	0.0	72.9	0.1	1.1	9.7	145.0	8.3	0.3	0.0	0.2	86.9	16.1	19.1	0.0	0.4	71.3	1.7	1.7	5.0	0.0	4.9	25.3	0.1	0.3	85.9	41.9	0.4	14.4	34.1	0.0	86.2	0.5	0.3	1.0	0.9	102.8	0.4	0.2	117.9	0.0	0.0	0.0	0.3	0.0	0.2	1.5	0.2	0.0	0.0	1.4	0.9	0.5	0.0	0.1	0.0	7.6	0.0	0.3	45.0	56.0	38.6	44.8	47.3	92.9	114.7	81.5	79.6	74.3	52.1	66.6	23.6	0.0	2.5	32.3	11.8	34.5	5.7	1.3	1.8	0.8	2.0	14.6	26.4	1.5	1.4	7.3	0.0	2.0	22.7	0.0	0.0	0.9	3.1	3.3	103.0	18.0	0.0	1.3	0.1	0.0	3.3	263.2	8.6	2.9	2.5	33.3	30.4	0.6	3.6	0.0	0.3	0.0	0.0	1.8	42.0	18.0	151.6	3.2	85.4	17.8	1.0	0.2	1.0	6.0	0.3	0.4	0.0	508.9	9.7	16.9	0.0	2.2	2.2	0.8	39.5	23.6	173.4	4.0	4.6	1.5	27.4	3.4	4.8	28.7	0.0	2.4
AFAP1L1	FLJ36748	ENSG00000157510	"Actin filament associated protein 1 like 1"	Q8TED9	5	149271859-149343637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 62.4;Cardiomyocytes: 39.3;Early spermatids: 105.4;Endothelial cells: 72.0;Extravillous trophoblasts: 47.1;Hepatic stellate cells: 47.2;Late spermatids: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 42.6;HUVEC TERT2: 20.8;TIME: 33.9;WM-115: 79.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.91e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.52e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.88e-2)"	23.9	2.8	1.7	2.1	0.9	0.1	15.2	1.1	1.3	4.2	1.0	3.5	0.8	7.1	0.6	4.3	10.1	4.0	26.1	0.9	1.0	4.1	2.1	13.3	2.3	1.4	1.1	3.3	1.0	6.1	2.4	14.4	1.4	3.3	0.7	1.3	3.4	1.9	31.6	6.0	3.4	3.5	1.1	2.9	2.4	2.3	1.8	3.4	7.4	16.6	0.8	4.6	3.7	0.9	7.0	2.4	0.1	0.3	9.9	2.1	42.6	1.5	5.5	5.4	8.9	0.1	4.1	0.0	3.3	2.5	13.7	1.4	0.8	6.2	2.2	0.0	1.0	1.6	0.9	0.0	5.2	0.0	0.1	7.3	1.0	3.0	11.6	4.3	20.8	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.0	0.0	5.4	0.0	0.0	0.0	3.5	1.1	0.7	1.1	4.4	0.1	14.8	1.5	0.2	0.4	33.9	2.5	7.7	0.1	1.2	0.0	0.0	0.0	0.5	0.1	79.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.9	1.1	1.3	0.9	1.0	1.4	1.1	1.4	1.1	1.8	0.9	62.4	0.0	1.3	0.3	0.2	1.5	1.4	4.6	0.0	0.3	0.4	0.5	39.3	1.5	4.1	0.0	0.0	14.2	0.2	0.0	0.0	0.3	105.4	0.3	0.4	72.0	0.0	0.0	2.9	0.0	47.1	4.5	0.0	0.2	1.3	0.0	47.2	0.6	2.7	0.0	1.2	0.0	0.0	4.2	1.3	50.4	9.6	0.7	7.2	10.3	0.0	0.5	0.0	2.0	0.3	0.0	0.0	15.8	0.0	4.0	0.0	0.8	6.4	5.3	13.1	4.6	4.0	0.5	4.8	0.3	1.4	6.4	0.5	1.8	0.0	5.4
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100192428	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 154.9;Excitatory neurons: 491.3;Inhibitory neurons: 300.7;Oligodendrocyte precursor cells: 211.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 11.4;prostate cancer: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	17	"B-cells: 44.2;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 51.1;U-698: 56.5"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"	3.3	1.6	3.1	6.2	3.9	11.2	11.6	17.4	13.2	3.5	0.0	5.1	1.1	7.7	0.8	3.5	4.5	2.2	4.3	9.7	5.0	1.4	1.7	6.5	14.2	2.2	0.0	6.3	0.4	0.1	4.4	6.2	1.8	16.2	2.2	4.2	1.9	2.5	0.7	0.9	6.0	5.9	0.0	7.3	4.6	5.4	0.0	7.7	1.2	0.7	12.2	6.7	2.2	9.8	0.2	0.0	18.0	6.4	0.0	0.6	0.0	2.8	0.7	5.6	1.9	0.0	0.0	51.1	0.1	3.8	12.4	0.2	0.5	0.0	4.0	14.3	6.3	0.0	0.0	0.0	0.4	0.2	12.4	0.8	0.0	12.8	0.2	13.8	0.0	2.2	0.3	0.1	0.0	0.1	4.3	0.3	1.8	0.0	3.2	7.5	0.0	0.3	0.0	0.0	17.4	6.5	0.0	0.3	11.0	1.5	17.9	16.5	6.7	19.1	3.4	0.5	2.9	0.8	0.1	56.5	15.9	1.5	2.0	0.6	0.5	0.1	0.0	0.5	0.3	31.0	0.2	0.0	5.1	44.2	1.9	0.0	0.0	1.0	0.4	23.9	0.0	0.8	3.1	3.9	17.4	13.2	9.7	5.0	2.2	0.0	1.8	0.0	0.0	9.8	1.2	6.4	40.9	41.8	154.9	1.8	0.4	0.0	1.8	21.8	78.9	37.7	11.1	0.0	3.7	0.0	12.5	0.4	32.8	0.1	0.0	0.0	33.9	0.9	19.8	6.0	22.9	3.4	491.3	0.0	0.2	13.5	1.1	1.1	0.0	31.6	0.7	1.2	1.8	47.1	300.7	0.5	0.0	9.2	18.2	38.5	10.8	16.5	14.2	66.5	5.2	6.8	0.0	211.6	46.7	0.0	0.1	21.1	0.8	14.3	0.1	1.9	0.0	1.7	0.0	1.1	8.5	10.5	9.8	0.0	1.3	0.1	6.1	5.7	0.6	0.3
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481745-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 961.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 300.4"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	8700000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	79.7	961.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.2	4.3	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	300.4	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AGAP2	CENTG1	ENSG00000135439	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 2"	Q99490	12	57723761-57742157	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 219.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 16.4;Excitatory neurons: 22.2;Inhibitory neurons: 12.3;NK-cells: 17.5;Sertoli cells: 32.9;Smooth muscle cells: 16.2;T-cells: 16.4"	"Cancer enriched"	"Detected in many"	12	"glioma: 20.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 219.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.3;Karpas-707: 39.8;RH-30: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023474, HPA075831"	Enhanced		Supported	"Nucleoplasm,Midbody ring,Cytosol"		Yes	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Midbody ring"	"HPA023474: AB_1855378, HPA075831: "	"unprognostic (1.87e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.26e-2)"	"unprognostic (5.56e-4)"	"unprognostic (3.95e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.81e-9)"	"unprognostic (3.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.75e-2)"	6.3	2.5	85.4	10.0	69.0	14.5	1.8	0.6	219.9	0.8	0.0	2.2	2.9	2.0	0.3	2.3	1.0	4.3	23.5	162.1	0.0	0.8	1.1	3.4	16.9	0.0	0.0	1.5	3.7	1.8	7.5	2.5	0.0	1.9	1.5	4.6	2.3	0.8	15.1	3.2	5.8	1.0	0.0	11.4	3.3	1.0	0.0	15.0	2.5	9.9	11.3	3.2	1.0	38.7	7.3	10.5	19.8	5.8	0.0	0.0	11.3	4.8	0.9	0.1	0.5	1.2	6.6	18.4	1.5	0.0	3.6	4.4	0.1	0.2	0.0	20.3	3.1	20.5	1.6	3.4	0.1	21.2	40.3	0.0	0.0	0.1	0.1	8.4	0.0	21.3	0.0	39.8	0.0	12.6	37.4	13.5	3.2	2.3	10.6	15.5	98.8	13.4	0.0	6.0	5.6	20.5	2.6	3.6	4.3	0.1	2.6	14.8	11.2	5.5	9.0	10.5	3.6	16.8	10.9	9.4	9.8	13.9	9.4	3.8	0.5	0.6	2.7	0.8	2.9	1.2	2.8	3.0	0.8	0.8	1.1	1.7	3.8	1.4	0.4	0.8	4.2	1.1	85.4	69.0	0.6	219.9	162.1	0.0	0.0	0.0	0.0	0.0	0.0	38.7	3.6	3.2	1.1	0.0	5.7	0.0	0.3	0.0	0.0	10.0	0.8	0.5	5.8	1.5	0.6	0.0	0.0	0.1	16.4	0.2	0.0	0.1	0.4	0.1	0.7	4.2	0.0	2.1	22.2	0.0	0.2	0.9	2.0	0.2	2.5	0.0	1.1	0.1	1.3	8.4	12.3	0.5	0.0	2.2	1.1	1.1	0.0	3.0	0.0	1.9	3.9	0.5	17.5	5.0	1.2	0.1	0.1	0.7	11.4	0.3	0.3	0.1	0.0	2.3	32.9	2.2	16.2	0.8	0.4	0.2	0.4	0.0	16.4	0.3	0.2	0.0
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15571699-15585051	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 133.9;liver: 62.1;skeletal muscle: 34.2"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 306.8"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 8.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		240000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.4	1.1	1.3	3.2	1.2	1.0	0.3	1.6	1.5	0.5	1.1	9.2	17.9	0.5	0.3	0.5	0.3	0.5	0.1	1.1	1.3	133.9	62.1	0.2	4.0	0.7	0.6	0.1	0.6	2.2	0.3	0.2	0.8	0.5	6.8	0.4	4.6	0.1	34.2	0.4	13.4	0.7	0.4	1.6	1.8	0.7	0.9	2.1	0.5	6.1	4.1	0.8	0.1	1.2	7.7	6.3	0.5	0.3	0.1	0.8	0.2	1.3	1.4	0.8	0.5	36.7	5.1	0.1	0.2	0.9	0.2	0.2	0.0	0.0	0.9	7.6	0.1	5.2	5.1	92.6	0.9	4.0	0.2	0.9	0.4	2.4	0.0	0.6	0.7	0.1	0.1	10.3	1.9	8.6	0.2	4.0	8.1	6.5	3.7	0.1	0.0	22.3	0.2	2.2	1.5	1.1	10.9	0.4	1.3	0.4	1.5	8.2	1.1	0.3	0.3	2.1	0.1	0.3	6.1	5.0	0.4	0.1	0.2	1.2	0.3	0.2	2.1	0.3	2.6	4.1	4.5	2.4	0.2	2.7	8.4	5.0	1.4	0.5	0.2	0.4	6.4	2.0	1.3	1.2	1.6	1.5	1.1	1.3	0.7	0.6	0.8	0.4	0.9	1.2	0.2	0.0	0.0	1.0	5.9	0.3	1.7	0.5	0.0	1.3	0.5	0.9	0.6	2.8	0.3	3.7	0.0	0.9	0.5	7.4	31.3	1.1	9.4	1.2	1.1	0.6	1.2	2.1	1.9	0.9	0.8	0.7	5.1	2.1	0.0	1.4	1.8	42.5	1.1	3.3	2.2	9.6	2.0	2.9	0.8	4.2	0.3	2.0	1.8	3.7	1.9	1.0	5.2	0.5	0.4	2.3	6.0	0.0	2.0	1.7	27.0	306.8	1.4	2.4	0.0	4.7	0.5	1.6	3.5	1.2	0.6	0.8	5.0	3.4	18.9	3.0
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200317-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 122.5"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 83.0;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 38.5;Proximal enterocytes: 30.5;Proximal tubular cells: 16.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.5;Karpas-707: 7.7;NTERA-2: 3.5;SCLC-21H: 3.2;TIME: 4.0;WM-115: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057900			Uncertain	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	2.8	0.1	0.9	0.6	2.4	0.1	1.8	0.7	1.9	0.1	0.1	1.2	9.7	0.1	14.5	0.1	0.1	3.6	0.4	0.7	1.4	8.9	122.5	0.2	0.5	1.5	1.4	0.1	0.1	0.0	0.4	0.8	1.5	0.0	0.6	0.1	0.2	0.1	0.3	0.2	14.9	0.1	0.9	0.0	0.3	3.0	1.8	0.2	0.4	0.4	0.1	1.2	0.1	4.1	0.0	2.2	0.0	1.9	0.2	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	1.2	0.0	0.7	3.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.0	1.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	15.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.9	2.4	0.7	1.9	0.7	1.4	1.5	1.4	1.5	0.9	1.8	4.1	10.0	0.0	0.0	6.8	0.3	0.1	0.1	0.7	0.0	0.0	0.2	0.3	0.1	11.5	0.4	3.7	0.0	0.1	0.1	0.5	0.0	0.0	1.3	0.3	0.1	1.2	1.8	2.7	1.3	0.0	0.2	1.2	0.0	0.0	0.0	0.0	1.1	83.0	0.1	0.0	1.7	0.4	0.0	1.6	0.5	1.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	33.7	38.5	0.9	0.1	0.0	0.0	0.0	30.5	16.9	0.3	0.0	6.6	0.4	2.4	1.7	6.4	0.1	0.0	0.1	0.2	0.1	0.6	0.0
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230690776-230745576	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1603.7"	"Group enriched"	"Detected in many"	9	"Cholangiocytes: 985.1;Hepatocytes: 2244.9"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 646.2;THP-1: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	65000000000		"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	11.7	14.6	252.9	2.6	259.8	0.4	4.4	267.5	243.6	9.7	138.2	5.6	2.5	3.2	1.9	2.6	6.0	92.7	154.7	236.0	242.1	52.5	1603.7	5.1	1.0	352.4	314.4	3.5	7.9	6.0	25.8	0.7	304.9	16.3	3.6	26.4	4.9	2.2	43.6	2.0	9.7	5.8	340.5	1.3	4.9	4.1	273.5	1.7	13.2	25.8	0.1	7.0	4.5	322.4	0.2	0.4	0.2	0.2	15.6	0.0	0.9	0.6	0.2	0.0	0.0	80.6	0.1	0.3	0.7	0.2	0.7	0.7	0.0	0.0	0.0	11.4	0.2	0.2	0.3	646.2	1.9	1.0	0.5	26.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	5.5	0.7	0.0	0.2	0.6	0.6	0.1	0.2	0.3	2.4	0.1	0.1	0.3	0.9	0.6	0.4	0.1	5.5	0.1	0.0	243.6	0.1	0.4	1.3	0.4	1.2	3.5	47.0	0.4	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.9	259.8	267.5	243.6	236.0	242.1	352.4	314.4	304.9	340.5	273.5	322.4	0.8	0.0	1.7	140.0	11.3	0.6	1.1	0.0	0.0	4.7	0.8	0.3	60.0	985.1	0.6	3.7	35.5	0.1	0.0	0.0	25.4	169.8	62.2	0.3	0.4	5.5	0.0	50.8	0.3	10.0	0.2	27.2	0.5	0.1	0.0	0.0	39.3	2244.9	2.1	3.3	1.5	1.1	0.0	56.9	0.4	48.5	4.1	0.9	8.8	5.6	0.6	75.1	0.0	3.5	6.8	13.7	1.2	3.4	0.0	26.2	24.2	146.9	0.1	49.8	13.1	7.2	94.1	0.4	0.4	0.0	0.0	0.7	3.9	0.0	0.4	1.9
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	315	"liver: 2199.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.9	2199.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
AGXT2	AGT2	ENSG00000113492	"Alanine--glyoxylate aminotransferase 2"	Q9BYV1	5	34998101-35048135	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"kidney: 207.9;liver: 123.5"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 105.9;Proximal tubular cells: 359.5"	"Group enriched"	"Detected in some"	112	"liver cancer: 9.2;renal cancer: 12.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037382	Enhanced					NA	NA		13000		"Cluster 81: Kidney & Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA037382: AB_10670851"	"unprognostic (2.61e-1)"						"unprognostic (1.40e-2)"						"prognostic favorable (7.47e-4)"	"unprognostic (8.24e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	207.9	123.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	2.8	0.0	9.2	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	105.9	0.0	0.0	0.2	0.6	0.0	2.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	1.2	0.4	0.0	0.0	6.7	359.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 275.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041225, HPA044675"	Approved		Supported	Cytosol		NA	NA		5000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	44.9	56.7	38.5	34.3	41.1	59.3	71.0	41.7	40.1	69.2	45.2	61.8	72.7	55.8	65.7	140.9	75.8	31.1	67.1	38.8	42.8	155.5	187.4	41.5	45.4	42.1	42.2	116.4	161.5	65.5	45.4	39.5	43.3	83.9	58.0	24.6	57.7	49.6	109.3	50.9	54.8	43.6	42.5	39.9	75.8	82.0	42.5	51.7	95.1	63.6	55.9	59.3	66.9	44.6	270.8	345.9	143.6	254.7	163.6	174.8	164.4	108.1	153.9	235.5	186.1	942.0	226.2	417.0	188.0	139.4	152.0	301.2	340.7	606.4	150.3	55.6	207.6	503.9	157.3	612.7	175.5	238.1	158.3	364.1	271.2	146.9	233.8	125.9	162.9	152.0	250.1	102.7	126.8	285.2	313.3	224.2	185.0	343.0	332.7	231.8	364.6	294.1	212.7	188.3	247.8	164.8	216.1	252.6	364.5	112.8	380.3	217.9	104.5	203.3	215.5	104.1	207.6	151.7	239.0	252.3	150.2	144.4	111.3	9.0	32.9	1.0	8.9	60.7	15.0	20.5	13.0	11.5	48.8	19.4	13.8	16.1	2.7	11.6	40.8	55.1	16.4	28.2	38.5	41.1	41.7	40.1	38.8	42.8	42.1	42.2	43.3	42.5	42.5	44.6	13.2	41.7	23.2	5.5	35.3	36.7	88.2	106.1	68.9	11.7	77.6	82.0	47.8	44.3	43.2	27.6	0.0	109.0	31.4	36.6	58.7	73.5	76.5	30.9	110.6	27.1	21.0	60.8	9.0	82.4	165.3	35.6	83.6	42.8	21.0	42.8	19.6	70.4	115.7	11.8	8.4	73.5	30.5	52.2	32.4	187.4	42.6	34.5	26.6	2.8	26.4	42.4	5.2	5.0	16.4	60.4	41.2	40.6	66.2	95.8	51.4	275.0	17.9	15.2	13.1	27.8	34.6	43.5	45.3	100.8	39.5	91.9	19.8	84.3	117.1	82.6
AHCYL2	"IRBIT2, KIAA0828, long-IRBIT"	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 488.0;intestine: 177.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 567.4;Distal enterocytes: 334.0;Excitatory neurons: 131.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 235.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	7.1	10.2	25.4	15.6	35.9	3.2	8.4	27.2	34.4	10.6	488.0	157.4	57.8	9.1	7.2	9.6	7.4	55.8	4.6	47.3	32.5	28.5	7.7	65.8	10.8	30.3	28.1	11.4	13.7	19.2	21.3	12.1	22.5	9.3	177.4	57.8	30.6	7.0	37.3	24.3	38.6	11.8	27.8	7.0	41.9	10.5	39.0	9.4	42.6	27.7	9.4	16.1	7.6	25.2	8.7	13.5	25.4	15.3	6.8	9.9	5.4	6.8	9.4	7.5	6.6	7.9	5.7	5.3	6.9	7.4	15.9	6.0	12.8	10.7	8.3	235.7	16.0	12.4	14.5	6.4	4.0	9.3	15.4	9.1	13.5	6.0	9.1	12.7	15.1	10.1	5.8	28.7	9.9	8.2	13.7	12.1	12.7	8.6	9.5	9.0	6.9	14.4	15.0	11.5	11.6	7.3	15.5	6.5	9.3	21.0	6.1	6.6	8.6	6.4	3.6	16.9	7.2	12.0	14.6	7.2	16.4	9.8	9.9	0.1	0.4	0.7	0.3	0.9	0.4	0.3	0.5	0.2	0.4	0.1	0.4	0.1	0.1	1.3	0.4	0.1	1.8	0.2	25.4	35.9	27.2	34.4	47.3	32.5	30.3	28.1	22.5	27.8	39.0	25.2	4.7	60.9	98.6	567.4	9.3	15.6	5.1	7.2	31.3	10.8	4.8	4.3	7.3	18.6	16.4	5.5	6.2	12.5	2.2	334.0	11.7	4.5	61.7	5.9	5.3	5.2	9.1	3.4	131.2	5.3	2.9	3.6	30.1	8.7	5.7	6.0	5.7	6.0	4.7	5.0	115.5	32.9	6.1	10.0	6.1	30.6	4.1	7.3	24.9	99.3	7.7	91.0	2.1	127.2	77.5	6.2	71.8	6.8	7.4	6.2	27.0	17.1	8.7	5.9	6.6	5.1	4.3	5.1	2.3	17.8	9.8	15.2	7.3	8.3	46.1	15.1
AHRR	"AHH, AHHR, bHLHe77, KIAA1234"	ENSG00000063438	"Aryl-hydrocarbon receptor repressor"	A9YTQ3	5	321759-438291	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 46.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 299.1;Late spermatids: 168.8;Spermatocytes: 123.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 59.6;HMC-1: 76.8;NB-4: 91.1;WM-115: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA021483			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA021483: AB_1855110"	"unprognostic (2.06e-4)"	"unprognostic (3.48e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.33e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-5)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-6)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.55e-2)"	1.4	0.7	2.2	0.6	1.8	0.4	0.8	0.0	6.0	3.8	1.1	2.1	0.7	1.6	0.5	2.2	0.7	1.2	0.5	5.0	1.7	1.6	0.7	2.2	0.4	0.4	0.7	2.6	0.6	0.1	1.5	2.0	0.0	1.0	1.1	0.1	0.7	0.1	0.5	5.9	1.9	0.3	0.0	5.7	1.1	46.4	2.6	0.2	1.4	0.0	0.4	3.4	2.2	0.0	0.4	5.8	1.4	1.0	6.1	11.9	11.0	22.5	30.0	10.7	18.4	0.6	6.7	0.6	10.1	38.6	2.2	0.5	0.9	0.5	5.1	1.2	2.8	8.6	59.6	0.9	3.5	1.6	76.8	1.4	0.8	7.3	1.3	17.3	3.4	0.8	1.0	0.6	11.8	0.7	0.3	91.1	0.5	2.6	8.9	1.3	0.5	0.4	0.5	0.2	10.0	0.4	27.6	3.7	14.7	0.1	0.5	36.4	6.1	20.5	1.6	21.5	0.4	2.6	3.6	0.8	8.3	0.8	53.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.8	0.0	6.0	5.0	1.7	0.4	0.7	0.0	0.0	2.6	0.0	0.6	0.0	0.0	2.0	0.2	2.2	0.0	0.1	0.0	0.4	0.2	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	299.1	0.3	0.8	3.6	0.0	0.0	11.1	0.2	5.8	2.7	0.5	0.7	0.0	0.3	0.0	0.0	0.8	0.0	9.5	0.1	0.0	0.0	9.7	168.8	3.4	1.5	19.6	3.7	5.7	0.2	0.0	3.5	2.9	0.2	0.0	1.2	0.1	0.3	0.1	0.1	0.2	0.2	6.6	0.0	3.0	123.7	6.9	0.1	1.4	0.8	1.2	0.7	0.1	0.2
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615217-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 235.0;lymphoid tissue: 346.6"	"Group enriched"	"Detected in many"	22	"Hofbauer cells: 1777.1;Kupffer cells: 2140.2;Langerhans cells: 1359.1;Macrophages: 1494.0;monocytes: 1022.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	26	"classical monocyte: 3823.3;intermediate monocyte: 6550.1;myeloid DC: 2043.3;neutrophil: 2943.0;non-classical monocyte: 7744.5"	"Group enriched"	"Detected in all"	74	"dendritic cells: 2043.3;granulocytes: 2943.0;monocytes: 7744.5"	"Group enriched"	"Detected in some"	4	"HEL: 204.6;HMC-1: 329.6;NB-4: 264.7;THP-1: 184.2;U-937: 114.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	79.6	46.6	24.9	182.3	25.5	235.0	47.2	26.6	33.0	29.3	32.2	48.3	36.4	17.1	12.1	18.7	19.7	61.3	21.1	25.0	31.3	74.3	81.2	99.3	116.8	45.1	36.4	14.4	12.4	12.9	17.3	109.5	36.8	22.3	57.2	3.9	20.3	24.0	6.1	11.7	44.5	74.7	34.3	346.6	22.2	8.7	32.1	69.1	13.8	16.6	57.1	95.3	13.5	42.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	204.6	0.0	0.0	0.0	30.0	329.6	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.9	0.2	0.0	0.0	2.3	264.7	0.4	0.0	0.0	35.9	0.4	8.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	184.2	0.1	0.0	0.2	0.1	0.3	0.2	0.0	1.3	0.2	114.6	0.0	33.1	3823.3	177.9	10.2	6550.1	12.7	57.5	10.8	9.3	2043.3	6.3	33.1	26.2	2943.0	14.5	7744.5	144.2	10.7	4449.8	24.9	25.5	26.6	33.0	25.0	31.3	45.1	36.4	36.8	34.3	32.1	42.7	12.0	25.6	59.6	0.0	39.2	32.5	0.7	0.0	0.6	0.1	5.3	24.3	7.5	18.6	19.2	42.3	0.0	11.1	31.2	1.0	0.0	0.3	1.9	0.6	0.7	28.7	1.2	65.0	0.0	0.4	15.4	20.6	0.5	0.4	68.3	0.4	35.3	13.4	1777.1	0.0	0.0	0.1	0.0	2140.2	1359.1	4.9	7.5	1494.0	39.2	10.3	1022.6	0.0	32.0	0.5	0.1	0.2	11.1	0.7	7.2	0.4	0.3	4.2	10.2	0.1	52.6	4.7	6.5	0.5	1.5	2.1	28.3	22.7	46.1	1.9	0.6	0.3
AIFM1	"AIF, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130124666-130165879	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"DNA-binding, Oxidoreductase"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Dwarfism, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 165.4;Proximal tubular cells: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced		Supported	Mitochondria		NA	NA		230000	"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003764: AB_289587, HPA030611: AB_2673549"	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favorable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	21.0	65.2	10.5	17.6	11.2	11.8	17.8	11.9	12.8	15.7	24.7	34.3	52.9	15.3	8.9	20.8	22.1	10.1	107.7	10.9	11.6	97.3	110.6	13.9	16.2	11.3	11.0	11.9	27.8	29.7	16.2	10.3	11.4	14.8	15.9	8.5	18.6	7.6	68.9	15.2	29.9	10.1	11.2	20.3	41.2	30.3	12.1	18.5	14.7	25.2	11.0	18.4	13.4	11.6	52.8	95.4	22.6	85.2	24.1	14.6	50.0	28.6	19.0	33.5	25.2	55.8	36.4	105.0	113.3	17.5	39.3	47.2	61.3	33.3	12.7	48.2	73.4	61.6	59.1	68.9	34.0	51.5	63.5	26.1	21.7	34.5	22.0	12.1	27.2	83.4	62.6	50.7	13.1	96.7	57.6	74.5	24.4	53.6	65.1	55.6	31.7	132.7	60.8	36.6	46.0	28.2	35.5	68.0	67.5	13.2	46.0	40.8	31.7	20.5	20.4	63.9	58.7	24.2	45.0	47.5	25.3	86.4	33.4	4.1	21.0	14.1	11.8	26.6	13.1	14.6	12.8	14.6	31.7	10.3	12.7	12.6	2.4	20.7	24.8	14.7	17.9	12.4	10.5	11.2	11.9	12.8	10.9	11.6	11.3	11.0	11.4	11.2	12.1	11.6	12.6	16.0	20.1	17.0	17.1	8.7	8.2	25.0	9.1	19.3	13.0	8.3	165.4	22.8	21.2	40.5	22.9	58.0	14.2	31.6	92.0	24.9	1.8	36.7	17.3	11.5	9.6	26.3	10.8	20.5	29.0	16.4	27.0	50.4	10.8	33.1	14.3	92.3	38.0	15.2	12.1	24.0	34.6	14.4	7.4	4.9	17.4	16.8	10.6	8.4	16.6	17.2	20.6	8.0	19.6	18.0	18.9	17.3	19.2	7.9	45.6	326.1	21.3	48.1	6.6	11.3	39.3	10.2	32.0	17.1	6.8	39.7	15.8	45.9	37.2	9.8
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 183.5;liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 242.6;Proximal tubular cells: 595.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.1;myeloid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 208.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	Yes		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (4.36e-4)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	24.7	1.9	19.5	6.6	21.0	4.9	26.6	17.8	20.8	6.1	17.5	19.7	4.3	7.0	4.2	23.4	7.6	13.7	51.7	21.4	21.2	183.5	104.0	2.8	1.6	19.0	22.8	4.6	1.2	18.3	4.7	8.3	22.8	16.2	14.0	21.9	9.6	12.7	1.7	27.4	6.6	21.4	18.5	1.2	15.0	11.3	22.7	5.7	2.5	38.8	3.3	19.1	11.8	21.1	73.2	5.0	5.6	23.9	51.6	48.7	12.0	12.1	15.0	25.6	70.8	108.1	8.6	39.1	31.0	19.0	32.1	46.1	18.8	89.9	101.9	33.0	21.5	37.9	21.9	208.6	2.5	29.9	4.6	27.2	49.6	25.1	73.0	42.2	0.9	12.2	48.0	0.6	39.6	31.2	1.1	1.3	24.6	1.0	42.5	0.2	41.0	7.1	37.8	3.2	20.5	15.4	21.6	1.5	16.7	25.8	29.7	12.9	4.2	42.4	36.2	3.3	20.9	39.5	18.8	2.1	68.7	10.9	2.5	0.9	3.1	0.0	0.1	0.6	0.2	0.2	0.1	0.2	2.7	0.1	0.1	0.1	0.4	0.3	0.1	0.4	0.0	0.8	19.5	21.0	17.8	20.8	21.4	21.2	19.0	22.8	22.8	18.5	22.7	21.1	11.2	0.0	0.5	51.2	4.7	49.7	23.6	44.2	63.7	24.5	48.9	44.7	105.7	52.9	14.3	31.3	2.1	2.2	0.6	15.8	56.7	18.6	3.4	30.1	8.2	19.6	5.4	13.9	17.1	12.1	21.1	11.4	27.5	52.2	0.0	36.4	11.7	242.6	3.3	16.8	7.7	8.7	24.4	7.8	9.2	5.8	4.1	6.9	24.9	3.7	5.7	32.7	0.0	9.5	2.5	31.9	4.3	9.4	0.4	38.7	18.8	595.5	12.3	6.5	6.6	5.6	18.8	1.8	9.5	43.1	74.3	4.9	3.6	0.7	23.1	20.4
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 872.9;Proximal tubular cells: 1215.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	68.8	72.7	37.6	73.4	41.4	48.6	123.1	41.3	38.9	84.0	49.1	106.6	188.7	59.9	90.7	151.9	88.9	61.7	67.6	37.2	41.0	323.5	323.7	75.8	97.3	44.0	39.3	61.8	158.1	60.8	99.4	63.9	44.1	75.9	115.4	23.2	123.0	60.0	46.5	73.5	171.6	79.0	43.3	92.5	112.9	21.1	44.4	77.3	80.7	42.6	117.0	72.3	70.9	53.2	74.3	94.5	91.2	73.7	173.1	124.8	67.9	78.3	178.0	68.8	133.5	40.1	50.3	179.5	68.5	86.2	71.6	94.5	94.0	118.3	60.0	74.3	92.6	101.2	82.2	167.8	152.0	132.4	102.7	140.2	104.7	87.0	157.4	123.4	154.7	125.1	59.4	131.2	77.1	49.1	147.3	61.2	106.0	219.4	68.2	170.1	119.5	211.9	185.5	89.3	117.5	65.3	71.8	271.1	108.5	113.2	80.3	72.3	97.2	30.2	72.0	113.1	54.2	97.0	140.5	87.6	59.1	168.7	26.6	141.8	229.5	45.4	65.3	224.5	71.6	99.8	59.6	63.5	196.8	108.9	51.4	52.4	11.1	66.1	174.8	170.0	81.9	182.7	37.6	41.4	41.3	38.9	37.2	41.0	44.0	39.3	44.1	43.3	44.4	53.2	53.0	48.1	57.3	7.2	96.6	49.2	99.3	210.0	87.6	21.2	121.0	94.7	46.1	95.8	173.8	79.1	37.5	115.2	45.1	113.7	181.9	195.9	5.4	48.7	49.1	58.6	118.4	48.0	8.3	156.5	142.1	82.0	135.5	54.7	112.1	59.2	78.1	294.5	399.3	16.8	7.1	201.9	118.0	141.8	153.7	9.6	68.3	142.1	81.8	20.6	140.3	33.6	49.4	9.0	16.2	123.6	199.9	56.1	187.2	115.1	872.9	1215.0	131.6	38.0	6.6	40.3	132.5	5.9	32.2	158.5	47.0	67.9	49.5	59.0	198.5	129.6
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 441.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 83.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 244.0;gdT-cell: 102.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 244.0;T-cells: 102.6"	"Cell line enhanced"	"Detected in many"		"A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	164.4	50.2	31.1	25.4	34.6	42.3	115.2	32.1	42.4	21.9	30.2	185.9	441.3	25.9	4.4	53.2	42.1	261.1	42.9	31.5	35.6	177.7	268.0	48.3	7.6	30.3	33.9	17.8	36.4	22.5	10.4	4.7	32.3	10.3	98.0	19.1	40.5	19.4	116.9	27.0	270.9	39.2	30.3	3.8	237.4	10.0	31.5	37.4	26.4	34.8	6.6	84.7	22.2	31.1	0.1	1615.1	1.1	413.0	811.9	292.2	1.0	0.0	21.4	0.4	1.4	47.6	24.5	0.2	78.7	19.4	45.0	11.5	1.5	28.8	1.1	3.0	0.5	3.2	438.4	699.6	4.3	0.7	0.2	160.9	57.1	20.0	0.7	25.8	28.1	3.4	10.8	0.0	42.6	3.8	9.8	2.6	0.7	3025.3	4.3	3.3	9.6	43.7	149.0	639.2	1.0	2.9	232.2	0.0	0.3	0.9	0.5	0.2	221.7	5.2	4.7	87.8	3.1	0.7	0.7	0.3	45.8	62.8	4.4	244.0	2.9	4.8	102.6	0.9	6.9	0.0	19.0	18.7	2.1	0.5	11.6	8.9	7.3	21.1	1.4	39.6	21.4	42.4	31.1	34.6	32.1	42.4	31.5	35.6	30.3	33.9	32.3	30.3	31.5	31.1	144.2	44.8	5.3	4.9	4.3	12.0	3.7	393.1	2.8	2.0	15.8	5.5	3.9	0.0	172.9	36.8	0.0	0.4	64.4	133.8	43.0	114.6	3.3	67.5	4.5	67.5	19.2	34.9	2.5	722.5	0.0	44.3	158.0	66.4	5.7	0.1	0.0	0.0	1.6	1.7	3.2	65.9	61.1	0.0	14.0	4.9	78.3	14.8	21.4	7.5	4.1	132.7	202.9	14.6	0.0	266.1	219.6	106.8	3.1	1.3	576.9	601.8	112.8	5.3	26.3	15.5	20.3	0.5	4.3	20.2	10.7	0.0	14.4	7.8	196.9	46.4
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 717.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	41.8	0.0	0.0	0.0	0.3	717.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282573-19288770	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 248.9;liver: 154.6;pancreas: 288.4;stomach 1: 224.4"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 348.1;Proximal enterocytes: 1132.3;Proximal tubular cells: 766.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 15.9;SK-BR-3: 25.0"									HPA064638			Supported	"Golgi apparatus,Cytosol"		NA	NA		1900000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Golgi apparatus"	"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	1.6	4.0	2.3	2.6	2.4	0.3	4.2	2.8	3.2	2.3	16.7	29.2	248.9	1.4	0.4	1.8	1.8	38.0	0.6	3.3	2.6	71.1	154.6	1.0	0.4	2.7	2.9	2.6	288.4	0.3	2.2	0.2	2.6	1.9	17.4	1.5	3.5	0.3	0.4	2.6	144.8	1.4	2.5	1.3	224.4	2.1	2.9	0.1	1.8	0.1	0.2	1.0	1.6	2.6	0.5	0.0	0.5	0.3	0.5	0.2	1.8	0.1	0.1	0.2	0.1	0.5	1.9	0.2	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.5	0.2	0.7	0.8	0.2	0.2	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.7	0.5	1.7	0.3	15.9	0.6	0.7	0.1	1.6	0.0	0.1	0.9	1.4	0.3	25.0	0.6	0.1	4.1	0.5	0.4	0.3	0.2	0.9	0.3	1.2	0.3	0.3	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	2.4	2.8	3.2	3.3	2.6	2.7	2.9	2.6	2.5	2.9	2.6	0.4	0.0	0.0	7.5	3.3	0.8	0.7	0.2	0.6	1.0	13.8	9.5	0.8	140.2	0.3	29.5	0.0	0.5	0.5	133.3	119.3	3.9	3.5	0.5	0.4	0.8	20.8	11.2	4.1	31.8	0.3	0.5	348.1	0.4	4.5	0.9	4.2	119.0	0.3	0.0	3.6	87.6	4.1	3.5	0.0	4.7	0.3	4.4	0.0	1.9	0.1	3.6	0.0	2.5	1.9	18.3	125.0	0.4	0.8	1.2	1132.3	766.6	3.2	1.1	0.0	0.7	0.4	1.8	1.1	1.1	0.6	0.5	3.0	0.7	130.2	0.4
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 212494.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000			"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	8.3	3.7	0.9	0.0	1.0	0.0	5.9	0.6	1.3	1.9	0.6	2.5	0.0	1.8	15.4	2.6	4.3	3.8	8.2	0.7	0.9	465.2	212494.0	6.7	1.3	0.7	0.8	2.5	1569.1	1.0	3.4	4.5	0.7	2.2	0.1	0.5	2.1	0.1	1.9	3.3	2.3	0.0	0.7	37.0	10.1	3.6	1.0	0.3	3.6	0.1	1.4	0.9	1.7	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.6	1.3	0.7	0.9	0.7	0.8	0.7	0.7	1.0	0.8	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392702-38398661	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 172.7;smooth muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 183.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	21.2	10.4	3.2	31.4	3.2	2.9	8.9	4.1	4.0	8.5	6.4	61.5	22.9	57.7	5.7	32.7	34.9	29.0	14.7	2.7	4.8	59.2	172.7	7.3	5.1	3.5	3.3	12.6	11.3	8.5	2.5	5.2	4.3	36.9	35.5	1.5	11.1	54.5	55.8	6.3	24.8	128.0	3.4	7.2	28.2	8.3	4.0	5.1	15.4	35.9	5.6	85.1	10.5	4.1	72.2	65.5	19.8	31.8	27.6	32.5	15.8	33.6	16.9	27.8	28.3	44.2	13.7	45.2	19.7	47.4	42.0	10.0	66.0	71.4	27.4	50.8	28.5	22.4	44.7	132.2	20.0	36.0	24.0	39.0	15.3	22.6	19.5	56.6	26.8	10.6	65.6	42.8	42.8	27.3	0.1	14.4	59.1	183.3	29.0	14.9	119.9	34.5	25.1	31.7	43.3	19.9	25.7	16.7	19.4	20.6	15.9	27.9	18.2	31.9	52.4	26.9	42.5	6.5	13.2	17.8	16.4	36.0	22.1	0.3	4.2	0.2	6.7	9.2	9.6	5.5	6.5	6.1	9.5	2.6	5.1	6.2	1.0	8.0	11.9	1.2	5.0	5.3	3.2	3.2	4.1	4.0	2.7	4.8	3.5	3.3	4.3	3.4	4.0	4.1	3.3	9.6	1.7	0.0	3.7	1.0	5.7	9.4	2.2	1.2	3.7	4.2	6.6	85.8	3.8	16.5	2.1	2.0	1.2	12.8	17.6	64.1	0.6	2.3	6.4	4.7	15.6	12.8	0.5	6.9	46.6	6.6	8.2	3.4	8.9	12.8	8.9	128.1	7.2	0.0	1.1	25.5	6.1	4.1	2.4	2.2	6.5	4.2	0.0	0.0	5.5	2.1	0.0	0.5	0.5	15.0	7.7	6.8	3.7	6.1	10.3	165.0	0.3	0.7	0.0	6.0	16.1	0.6	0.8	2.1	1.0	1.8	3.3	91.7	71.7	2.8
ALDH1L1	"10-fTHF, FDH, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 369.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 633.3;Proximal tubular cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		3000000		"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	76.4	37.2	53.4	2.0	63.2	0.4	28.8	55.9	63.6	15.6	37.7	10.1	0.2	7.2	2.5	6.6	16.0	2.3	26.5	47.5	56.2	116.6	369.7	3.1	0.3	56.7	52.9	45.3	44.3	15.1	4.5	0.0	53.0	14.6	5.4	8.7	88.6	6.9	90.7	3.5	5.6	2.0	48.4	0.4	9.5	15.0	53.9	3.7	2.6	59.9	4.6	28.3	6.4	46.0	1.3	0.0	0.0	0.0	36.5	0.0	0.4	0.3	1.5	0.4	0.6	0.0	3.2	2.6	10.2	0.0	2.1	0.4	0.6	1.5	0.7	0.0	0.2	0.1	0.3	78.1	10.6	10.6	0.2	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	82.0	1.6	0.0	0.0	0.2	0.3	1.1	0.0	0.1	0.2	45.0	0.7	219.1	0.4	0.3	1.3	10.6	0.0	0.6	0.1	0.0	0.3	1.4	6.2	0.0	0.1	44.8	14.8	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	63.2	55.9	63.6	47.5	56.2	56.7	52.9	53.0	48.4	53.9	46.0	0.8	0.0	6.0	92.7	4.6	0.1	53.5	9.1	1.8	0.2	14.4	2.2	16.1	38.6	44.0	12.9	0.0	0.0	0.1	7.2	72.4	2.9	22.3	57.2	5.2	4.6	1.2	34.7	0.6	5.6	0.2	9.1	0.0	3.6	27.8	12.4	17.2	633.3	0.1	0.0	3.0	17.6	2.0	24.5	1.9	35.0	26.4	9.3	3.6	3.7	0.0	40.0	0.0	11.1	0.2	2.2	0.4	22.6	0.0	12.2	0.8	197.4	32.2	1.4	6.6	10.5	5.3	1.6	4.3	1.7	0.0	0.1	2.8	0.9	5.6	61.7
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family member"	P05091	12	111766887-111817532	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 857.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 857.0;monocytes: 940.8;Proximal tubular cells: 882.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 212.0;myeloid DC: 213.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 213.2;monocytes: 212.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.8;HHSteC: 97.0;OE19: 152.2;SK-BR-3: 201.0;THP-1: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051065	Approved					NA	NA		2200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	303.8	102.4	139.7	39.8	146.1	29.2	77.2	136.5	163.5	25.0	123.3	73.3	73.7	30.1	21.3	73.6	32.3	37.4	111.3	132.2	139.7	177.7	857.7	111.6	18.7	140.7	144.9	42.0	23.3	2.6	23.3	7.0	141.1	34.6	72.3	29.2	32.4	29.5	130.8	127.9	74.8	30.2	143.0	20.6	101.5	13.0	151.8	27.1	30.8	165.7	52.9	50.0	29.0	144.5	8.8	13.1	18.7	31.9	86.8	13.0	60.9	9.3	16.8	4.3	3.1	23.5	12.1	0.5	45.3	20.8	11.9	16.2	0.1	4.6	2.7	0.6	6.1	0.7	8.4	64.7	97.0	0.9	0.9	23.9	22.6	14.8	0.3	17.7	26.9	0.9	17.9	3.0	4.1	0.5	1.0	23.4	24.8	152.2	2.1	0.6	0.4	1.9	31.4	0.6	7.5	23.1	22.8	201.0	0.2	33.7	20.3	92.1	1.1	0.4	16.5	0.6	0.4	5.5	3.0	25.7	22.0	0.8	0.4	6.5	212.0	51.1	0.7	93.0	0.9	6.2	0.3	0.7	213.2	5.2	0.7	0.5	10.7	3.4	25.4	70.6	0.5	123.5	139.7	146.1	136.5	163.5	132.2	139.7	140.7	144.9	141.1	143.0	151.8	144.5	27.7	147.4	242.7	51.2	22.6	60.0	205.2	311.1	80.8	78.7	35.0	23.7	378.9	165.8	243.1	66.2	18.8	62.4	48.6	260.3	399.2	127.5	4.3	27.8	24.5	66.2	55.2	42.1	11.7	218.0	127.5	103.1	200.3	47.7	30.9	29.0	139.6	857.0	129.2	35.3	18.2	231.0	101.7	278.5	124.1	10.6	79.9	189.3	35.6	26.2	940.8	130.2	8.2	14.1	6.8	130.2	366.5	149.0	12.5	84.4	384.3	882.0	89.4	42.6	46.0	46.0	67.6	3.0	3.9	105.1	124.7	42.1	13.1	81.0	272.6	150.4
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902724	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 200.4;liver: 436.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 83.7;SK-BR-3: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		58000	"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	70.8	16.1	73.9	3.9	88.9	11.7	21.6	73.8	95.9	12.6	106.5	6.8	1.6	9.8	4.7	36.3	8.3	5.5	33.0	68.2	73.8	200.4	436.6	6.2	3.4	72.9	82.8	7.3	4.6	23.0	9.7	13.2	70.0	29.5	2.7	6.5	9.1	27.1	74.2	19.2	4.7	7.1	65.6	7.5	12.5	3.2	92.4	11.7	7.1	74.8	4.2	19.3	16.8	66.1	12.7	17.8	9.5	29.2	40.0	5.7	25.2	13.1	7.1	11.8	9.5	13.7	8.9	8.8	16.6	15.6	5.7	34.0	16.7	35.4	4.5	4.8	15.9	5.9	5.0	83.7	12.6	4.4	15.1	15.6	19.2	6.5	6.6	9.0	13.5	14.0	21.0	5.7	8.1	32.3	4.3	20.2	4.7	26.0	10.1	27.9	8.4	10.0	12.1	32.0	19.6	7.6	21.9	85.0	16.1	14.7	38.7	6.3	11.3	10.2	14.0	12.2	4.5	7.1	17.9	2.5	3.4	33.7	13.5	0.0	2.7	1.5	0.6	3.6	0.5	0.8	0.3	0.8	4.4	0.7	0.2	0.5	0.3	0.1	2.0	1.5	0.6	1.5	73.9	88.9	73.8	95.9	68.2	73.8	72.9	82.8	70.0	65.6	92.4	66.1	2.6	0.0	2.8	27.1	4.3	7.5	17.9	12.5	17.6	3.7	9.8	8.5	20.9	34.3	2.9	46.0	10.4	78.0	2.0	2.0	46.9	6.5	0.5	1.1	1.7	3.1	2.4	32.2	1.2	0.9	12.6	3.2	7.7	3.9	4.5	2.1	15.4	385.1	13.8	20.2	1.6	3.6	6.1	17.2	1.4	0.6	1.2	4.7	3.6	1.9	10.9	14.0	1.0	5.5	1.3	2.5	1.8	2.6	4.4	12.0	0.3	279.4	1.7	4.8	6.6	2.6	4.7	2.2	3.9	21.7	5.4	86.6	2.6	4.5	4.0	9.5
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056847-74084492	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 379.1;liver: 367.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 201.5;Hepatocytes: 523.6;Proximal tubular cells: 962.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 43.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.2"	"Cell line enhanced"	"Detected in all"		"T-47d: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		37000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	38.7	14.7	58.6	4.8	66.0	3.3	14.4	58.8	59.3	17.3	61.4	15.2	26.6	11.4	9.8	9.8	12.8	9.4	40.3	51.0	54.0	379.1	367.1	9.4	5.1	63.3	54.0	28.3	23.4	37.0	6.6	7.6	55.6	25.4	15.8	15.2	19.8	16.1	27.5	6.2	23.4	9.0	56.4	5.4	24.0	17.1	69.8	5.7	28.3	34.8	5.3	11.4	7.0	62.6	8.9	7.8	11.0	23.5	39.3	19.2	17.5	6.3	11.8	6.8	11.5	17.3	10.2	10.5	13.6	13.5	5.3	4.8	24.9	7.0	14.5	9.5	3.5	5.1	8.0	19.2	45.0	2.7	2.4	28.2	12.0	8.7	20.7	17.0	12.0	23.7	8.1	14.7	4.6	36.2	7.6	4.0	8.7	32.6	5.2	15.1	11.2	14.6	9.2	5.8	4.4	7.0	21.0	21.9	5.7	18.0	57.5	9.6	3.8	7.4	9.0	11.7	2.4	9.3	18.9	10.2	9.9	3.2	7.3	29.1	6.2	43.2	6.9	4.8	10.6	7.2	7.8	8.4	9.2	6.1	9.9	7.0	2.4	9.7	4.2	5.3	6.1	4.9	58.6	66.0	58.8	59.3	51.0	54.0	63.3	54.0	55.6	56.4	69.8	62.6	15.4	38.5	60.4	24.5	11.8	9.2	26.8	10.0	20.5	20.6	28.4	18.9	81.4	67.2	22.9	66.2	4.2	31.0	7.1	18.9	201.5	11.6	23.4	26.2	27.5	27.0	16.9	28.6	5.5	3.1	14.8	25.9	34.7	90.2	7.6	27.1	87.4	523.6	17.7	11.8	10.0	39.3	8.2	26.5	8.9	19.0	28.9	13.4	24.9	1.9	15.8	98.5	9.2	12.5	23.4	4.1	16.3	48.2	8.0	27.6	55.3	962.4	15.4	17.0	13.1	25.6	16.9	11.0	4.2	25.2	7.4	30.6	11.0	10.2	35.7	17.2
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917393-134950115	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"kidney: 72.2;liver: 247.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 142.5;Proximal tubular cells: 136.9"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;Hep G2: 2.9;K-562: 3.0;RPTEC TERT1: 3.3;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		110000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	1.3	1.3	6.4	0.7	7.1	2.4	1.2	6.9	9.8	1.5	2.2	3.3	0.8	1.2	2.1	0.8	1.0	0.9	0.7	6.5	3.8	72.2	247.2	0.9	0.6	5.3	4.4	0.5	0.9	0.4	0.8	0.5	6.2	1.7	0.8	2.8	0.8	0.8	3.6	1.7	1.1	0.9	3.1	1.3	1.2	0.5	5.4	0.7	0.6	0.3	0.6	1.9	0.9	8.3	0.1	0.5	0.8	0.5	0.2	0.1	0.6	0.2	0.2	0.0	0.5	0.2	0.3	0.1	0.2	0.0	0.1	0.6	0.6	0.0	0.4	0.6	2.9	2.0	2.1	2.9	0.3	0.8	1.0	0.8	0.9	0.2	0.4	0.6	0.2	0.8	3.0	1.1	0.1	0.0	0.9	1.0	0.2	0.2	0.3	0.0	0.2	0.2	3.3	0.4	0.8	0.2	0.1	0.0	0.5	0.2	0.3	0.2	0.2	0.2	1.6	0.6	0.8	2.8	1.0	0.5	0.3	0.7	0.2	2.5	0.3	0.3	0.4	0.1	0.1	0.4	0.4	0.2	0.0	0.4	0.3	0.3	0.8	0.8	0.1	0.4	0.5	0.3	6.4	7.1	6.9	9.8	6.5	3.8	5.3	4.4	6.2	3.1	5.4	8.3	0.3	3.2	0.6	3.6	0.8	0.0	0.2	0.2	0.0	2.6	0.7	0.9	0.6	1.5	0.7	31.3	0.0	0.2	0.3	0.1	19.6	0.2	0.1	0.4	0.4	0.7	0.0	0.0	14.3	0.0	1.7	0.4	0.0	1.6	0.0	0.5	2.5	142.5	0.1	3.3	12.9	0.1	0.0	2.5	0.3	0.0	0.0	0.8	0.0	1.0	0.7	0.3	0.0	3.0	9.6	0.0	0.1	0.0	0.3	0.1	0.0	136.9	0.0	1.8	0.0	1.2	0.5	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.2	0.1
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420560-101449664	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"intestine: 5736.6;kidney: 7181.0;liver: 11160.8"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 20078.3;Proximal tubular cells: 7956.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;NB-4: 21.0;RPMI-8226: 28.6;SH-SY5Y: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002198, CAB020827"	Enhanced					NA	NA		560000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	3.3	1.4	0.4	17.0	0.7	0.0	0.7	1.0	2.3	0.2	0.0	30.1	4073.8	2.8	1.0	0.7	0.4	176.9	1.0	2.4	0.0	7181.0	11160.8	0.5	4.9	0.0	0.0	0.5	292.7	0.0	5.6	0.4	0.0	2.1	5.6	0.3	0.3	0.0	0.4	0.5	5736.6	7.0	0.0	2.0	34.3	1.1	0.0	0.7	0.3	0.0	0.8	0.1	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.5	0.0	4.5	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	2.2	0.0	1.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.3	21.0	0.4	0.5	0.0	0.3	4.6	28.6	0.0	0.0	4.3	20.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	1.0	7.1	0.3	0.5	0.7	2.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.0	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	39.4	0.0	0.0	0.3	0.0	1.1	0.0	0.0	1.1	308.8	0.8	150.8	0.0	0.0	0.0	13.5	620.3	4.9	0.0	0.0	0.4	3.6	0.0	50.8	0.5	253.3	0.1	0.0	0.0	0.3	0.0	0.0	49.2	3225.4	0.2	3.3	0.2	464.9	0.0	66.2	0.0	0.0	0.0	38.1	0.0	0.0	3.6	0.3	0.0	0.0	0.3	182.1	997.4	0.0	0.1	0.0	20078.3	7956.0	0.2	0.6	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.3	20.6	0.2	412.7	0.0
ALKAL2	"AUGA, FAM150B"	ENSG00000189292	"ALK and LTK ligand 2"	Q6UX46	2	279558-288851	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 205.4"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 20.3;Ductal cells: 37.0;Endometrial ciliated cells: 24.0;Glandular and luminal cells: 50.3;Granulosa cells: 64.3;Proximal tubular cells: 28.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"AF22: 138.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;basal ganglia: 3.0;cerebral cortex: 2.5;hippocampal formation: 3.4;spinal cord: 2.3"						"Secreted - unknown location"	NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (1.39e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.35e-1)"	"unprognostic (9.29e-3)"	"unprognostic (5.19e-2)"	"unprognostic (3.68e-1)"	28.8	205.4	4.6	2.0	6.3	0.6	26.6	3.5	2.9	4.9	4.8	8.2	3.7	26.4	13.4	2.0	26.2	10.7	2.2	3.1	5.4	21.1	4.5	34.0	0.9	3.6	2.1	74.4	64.3	2.3	8.6	9.6	2.7	6.5	6.5	0.4	5.4	2.6	1.5	17.3	7.7	9.9	1.8	12.3	17.3	35.5	5.1	1.7	10.4	0.5	1.6	4.7	5.3	4.8	0.0	0.0	138.8	0.1	0.8	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.4	1.3	0.0	0.0	0.2	0.5	0.0	0.0	0.5	0.3	0.0	0.1	0.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.2	2.4	0.0	0.0	6.8	0.4	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.1	0.1	0.2	0.2	0.3	0.7	0.1	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.1	4.6	6.3	3.5	2.9	3.1	5.4	3.6	2.1	2.7	1.8	5.1	4.8	2.5	0.0	11.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	14.6	20.3	0.0	0.0	0.0	1.8	0.0	0.1	1.4	0.0	3.9	37.0	0.0	24.0	6.3	4.5	0.0	0.0	0.0	0.7	0.1	3.1	0.0	50.3	0.0	64.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.1	0.6	0.9	0.0	0.0
ALLC	ALC	ENSG00000151360	Allantoicase	Q8N6M5	2	3658200-3702671	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	17	"testis: 16.5"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 140.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"U-266/84: 6.1"	"Not detected"	"Not detected"													NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"							"unprognostic (5.47e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.91e-3)"	"unprognostic (4.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"			0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.4	0.6	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.2	3.4	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.2	0.0	0.0	0.0	0.5	0.0	0.0	13.1	0.0	0.1	5.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Leukotriene biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 487.2;lung: 183.3;lymphoid tissue: 138.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 691.3;granulocytes: 609.1;Hofbauer cells: 492.2;Langerhans cells: 335.4;Macrophages: 637.0;NK-cells: 280.2;T-cells: 368.6"	"Cancer enhanced"	"Detected in all"		"glioma: 49.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 9703.9;eosinophil: 4033.4;neutrophil: 4968.7;plasmacytoid DC: 3555.3"	"Group enriched"	"Detected in all"	8	"dendritic cells: 3555.3;granulocytes: 9703.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 658.4;HL-60: 352.3;HMC-1: 1072.9;THP-1: 434.2;U-937: 321.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA026592: AB_10601115"	"unprognostic (1.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.83e-2)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	51.6	36.1	10.8	100.6	11.6	487.2	25.7	12.5	18.1	18.8	13.4	22.8	21.6	17.4	7.1	21.8	24.5	40.0	12.4	10.2	15.7	13.3	19.7	183.3	77.2	21.0	15.6	10.6	14.1	9.6	6.1	37.2	21.1	13.2	21.4	3.7	19.9	15.5	3.8	7.4	28.3	42.6	16.6	138.5	20.0	4.3	17.7	93.2	9.1	24.7	108.2	65.6	11.9	31.3	0.6	0.8	1.2	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	1.3	7.1	156.3	2.2	0.0	5.2	1.2	0.0	4.6	0.1	658.4	0.0	18.7	0.3	1.0	0.7	352.3	1072.9	0.8	0.2	0.1	37.9	8.1	1.4	33.3	0.1	3.2	1.9	0.1	19.8	12.7	0.0	0.0	0.2	3.2	3.9	12.4	1.4	0.3	10.2	0.1	0.2	0.3	0.9	2.3	0.0	434.2	1.1	0.0	3.2	0.3	2.6	66.2	0.5	103.8	1.0	321.1	1.4	9703.9	322.4	4033.4	546.0	17.2	808.3	477.9	536.4	449.0	198.5	489.2	271.6	260.7	4968.7	98.0	12.4	3555.3	843.9	775.2	10.8	11.6	12.5	18.1	10.2	15.7	21.0	15.6	21.1	16.6	17.7	31.3	3.5	41.7	102.0	0.0	117.6	23.7	2.6	1.8	1.2	0.0	3.3	9.1	4.1	10.0	23.7	0.0	0.0	3.1	691.3	4.0	15.6	2.3	5.6	14.3	0.7	17.2	26.4	27.1	0.4	1.0	4.0	11.2	21.4	0.7	609.1	1.9	7.1	1.8	492.2	0.0	0.4	2.0	4.1	144.3	335.4	4.5	4.7	637.0	42.7	13.1	217.1	0.1	280.2	0.5	0.3	6.4	3.1	4.1	31.1	1.5	7.3	2.0	11.1	0.1	32.9	4.4	4.0	0.4	1.1	1.7	24.7	4.9	368.6	0.0	2.0	1.4
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
ALS2CL	"DKFZp686I0110, FLJ36525, RN49018"	ENSG00000178038	"ALS2 C-terminal like"	Q60I27	3	46668995-46693704	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.5;kidney: 30.7;skin 1: 32.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Gastric mucus-secreting cells: 41.3;Respiratory ciliated cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 31.6;HaCaT: 17.1;HBEC3-KT: 33.1;hTCEpi: 20.9;RT4: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB046465, HPA048301"	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB046465: AB_10638285, HPA048301: AB_2680346"	"unprognostic (6.38e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-3)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.60e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.45e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (4.14e-3)"	4.7	2.2	0.8	1.6	0.9	0.8	5.1	1.8	2.0	10.1	0.5	5.6	3.5	2.2	0.1	37.5	4.4	2.7	10.1	0.6	0.8	30.7	7.2	10.8	1.7	1.5	0.6	1.8	5.8	0.5	4.3	1.3	1.4	4.5	1.0	0.0	11.0	2.2	5.3	32.3	4.7	0.8	0.5	6.5	3.5	0.8	0.6	1.1	15.6	1.9	1.4	4.8	19.5	0.6	9.8	2.2	0.0	0.0	0.0	0.0	0.1	0.7	1.1	0.0	0.3	0.1	31.6	0.0	8.9	0.8	0.5	17.1	0.0	33.1	0.1	0.1	0.0	0.8	3.7	0.0	0.3	0.0	0.0	0.0	20.9	0.0	3.2	0.2	0.9	2.0	0.0	0.2	0.0	0.9	0.0	0.1	0.3	4.7	1.9	0.1	0.0	12.0	7.7	15.8	0.3	0.2	12.6	9.7	0.0	0.5	2.2	0.2	6.6	0.1	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.9	1.8	2.0	0.6	0.8	1.5	0.6	1.4	0.5	0.6	0.6	17.5	73.7	15.3	2.3	0.5	15.2	8.4	21.8	12.0	0.3	4.7	5.5	10.2	18.6	29.9	11.0	0.0	1.5	0.1	29.0	0.0	10.1	0.6	5.1	1.8	13.1	0.0	0.0	8.0	13.5	7.3	4.5	41.3	5.5	1.3	0.1	7.1	7.6	2.7	0.0	2.9	6.4	24.4	0.3	4.1	0.2	0.3	1.4	1.8	10.3	0.8	0.1	0.0	0.0	0.3	26.3	12.0	0.0	0.1	17.7	5.9	0.4	46.9	0.1	19.7	5.6	8.5	1.3	2.7	22.3	16.3	2.1	1.3	0.3	11.8	27.7
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280220-85301784	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.9;kidney: 6.1"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 32.0"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 10.4;HEK 293: 23.3;HUVEC TERT2: 17.2;SK-MEL-30: 29.5;THP-1: 18.0;WM-115: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear bodies"	"Nucleoplasm, Golgi apparatus"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	0.2	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.3	1.0	0.4	0.0	0.0	0.7	3.9	0.0	2.3	0.0	0.0	0.2	0.3	6.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.2	1.9	0.9	0.0	1.6	0.0	0.3	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.8	0.0	0.4	0.3	0.2	0.0	6.0	0.0	0.0	0.7	0.7	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	3.6	0.0	10.4	0.5	0.0	0.0	23.3	0.0	4.1	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	9.3	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.7	5.8	0.0	0.0	29.5	4.1	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	2.2	0.2	1.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986165-34008104	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 134.3;liver: 180.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5"	"Group enriched"	"Detected in all"	4	"liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 175.4;U-266/84: 98.0"	"Low region specificity"	"Detected in all"							"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		70000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	8.6	15.0	5.9	5.0	5.5	3.0	6.4	4.6	6.0	6.5	4.6	40.0	18.0	4.7	9.6	15.6	6.2	20.5	10.1	5.4	7.8	134.3	180.6	9.2	3.6	5.9	6.4	7.8	13.8	13.0	5.7	7.7	6.6	39.3	42.9	12.0	60.7	12.5	19.2	4.9	15.9	7.0	5.8	5.4	34.8	4.3	8.4	4.8	8.3	14.9	5.6	8.8	8.5	5.8	12.7	20.2	11.1	14.3	7.7	11.9	19.1	16.6	12.2	7.6	5.7	66.1	15.1	4.1	8.7	23.6	28.6	5.8	2.8	12.0	7.7	12.7	10.9	9.8	13.7	19.0	5.4	6.0	3.0	18.1	6.0	9.7	3.6	10.7	8.5	8.3	3.8	14.7	22.4	9.6	5.0	7.6	10.0	9.4	32.9	6.0	18.6	6.5	33.2	62.4	6.1	8.7	27.6	19.3	16.9	9.1	14.9	5.9	15.6	24.6	5.4	6.2	13.6	175.4	98.0	7.4	7.0	12.1	18.8	0.3	6.0	9.3	8.3	8.0	7.0	7.1	7.2	6.4	8.9	5.2	6.6	4.8	10.0	8.7	14.2	4.6	7.9	6.0	5.9	5.5	4.6	6.0	5.4	7.8	5.9	6.4	6.6	5.8	8.4	5.8	0.8	3.2	4.1	0.0	2.2	0.4	0.4	0.9	1.8	4.3	1.4	0.9	1.1	8.6	3.7	1.8	0.0	1.0	2.2	19.7	5.9	0.8	8.9	2.3	1.2	3.0	4.2	2.1	0.0	3.8	1.0	2.9	4.1	1.5	0.0	1.2	1.1	21.6	1.1	5.0	0.0	5.1	4.1	0.9	0.2	21.6	0.6	1.2	0.0	0.0	1.5	9.3	3.1	0.0	0.0	2.6	4.5	2.2	1.6	0.6	4.7	38.5	3.1	0.9	0.0	1.7	3.7	0.7	0.7	3.4	0.6	0.3	1.5	1.2	4.4	0.4
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.7	8.2	6.5	11.2	6.1	0.4	5.5	11.8	0.3	6.9	1.4	5.1	3.0	0.4	2.6	0.7	1.7	1.7	7.6	6.9	5.8	60.7	2.3	4.4	15.5	8.6	1.4	3.3	0.7	0.5	2.0	9.5	2.8	0.2	1.8	2.0	0.2	27.3	5.8	5.0	0.6	2.7	5.9	4.8	13.1	8.0	0.6	0.9	0.9	0.4	0.3	0.2	15.4	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.2	11.2	5.5	11.8	7.6	6.9	15.5	8.6	9.5	2.7	8.0	15.4	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
AMN	amnionless	ENSG00000166126	"Amnion associated transmembrane protein"	Q9BXJ7	14	102922663-102933596	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Protein transport, Transport"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 83.5;kidney: 39.8;liver: 37.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 672.6;Intestinal goblet cells: 283.9;Paneth cells: 724.4;Proximal enterocytes: 2014.8;Proximal tubular cells: 348.9;Undifferentiated cells: 272.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 8.1;Hep G2: 9.9;U-698: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA000817	Approved				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA000817: AB_1078146"	"unprognostic (2.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.39e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.88e-3)"	"unprognostic (8.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (8.02e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"	1.4	0.0	0.1	1.1	0.2	0.1	0.5	0.1	0.2	1.5	0.0	33.0	43.5	0.1	0.0	5.6	1.1	1.9	0.0	0.2	0.1	39.8	37.8	1.7	0.1	0.3	0.1	0.1	0.7	0.0	0.5	0.0	0.3	0.7	3.0	0.0	1.2	0.0	0.0	2.3	83.5	0.1	0.1	0.5	8.0	0.8	0.1	0.1	0.8	0.0	0.0	0.3	2.5	0.3	0.3	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	9.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.7	1.2	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.7	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.3	0.1	0.1	0.3	0.2	9.6	0.5	0.7	18.0	13.4	23.4	1.3	12.0	3.3	13.1	2.0	1.5	140.2	6.1	20.2	0.0	2.7	4.7	672.6	33.2	1.8	4.8	8.2	1.1	0.6	19.2	0.8	0.1	0.7	4.1	0.9	61.7	10.5	4.5	1.9	0.4	52.6	0.6	1.7	0.1	283.9	6.1	1.6	2.3	6.3	0.6	3.1	7.2	0.0	0.1	0.2	1.0	0.0	0.1	11.1	724.4	0.7	4.5	28.1	2014.8	348.9	4.5	1.2	0.0	0.5	0.9	21.2	25.7	17.1	20.9	1.4	5.2	0.4	272.4	65.7
ANGPTL1	"ANG3, ANGPT3, AngY, ARP1"	ENSG00000116194	"Angiopoietin like 1"	O95841	1	178849535-178871077	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 133.8"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 81.7;Leydig cells: 425.9;Peritubular cells: 212.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"ASC diff: 149.9;ASC TERT1: 60.1;HHSteC: 64.9;HSkMC: 147.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009976	Approved				"Secreted to blood"	NA	NA		380000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA009976: AB_1844822"	"unprognostic (2.59e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.63e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (3.81e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.31e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.61e-3)"	56.6	45.1	2.0	10.5	2.7	0.9	26.9	2.3	2.7	21.3	1.5	56.7	9.6	69.2	14.0	33.8	59.0	27.9	22.8	2.9	1.9	17.5	23.9	12.6	3.5	2.1	1.5	68.2	21.9	1.1	2.1	133.8	1.4	12.3	27.5	9.6	36.3	9.5	30.3	9.0	26.7	65.5	2.2	10.9	21.6	15.6	1.7	8.6	41.1	57.3	6.9	23.9	17.1	2.3	0.2	0.0	4.0	0.0	149.9	60.1	0.0	0.1	0.0	0.4	0.8	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	64.9	0.0	0.1	147.5	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	2.7	2.3	2.7	2.9	1.9	2.1	1.5	1.4	2.2	1.7	2.3	16.5	0.0	0.0	9.4	1.3	3.7	0.0	0.0	1.2	2.3	0.8	0.5	3.7	41.5	0.0	1.8	6.2	0.6	0.1	0.0	1.9	2.4	1.4	3.3	40.3	4.1	0.0	0.0	14.8	0.4	0.4	81.7	1.1	5.5	0.0	1.6	8.9	1.0	1.4	0.0	14.9	0.0	0.0	0.0	4.6	10.6	425.9	0.8	3.6	8.4	0.0	31.6	0.0	21.6	0.7	0.0	5.0	212.1	0.4	0.1	0.1	0.1	0.7	10.9	39.5	10.0	51.8	0.8	0.6	0.2	3.7	1.4	0.5	2.7	0.0	0.1
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597520-62606313	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 675.7"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 567.6;Proximal tubular cells: 272.5"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038097	Approved				"Secreted to blood"	NA	NA	225000000	120000000		"Cluster 85: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	53.0	675.7	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	11.5	0.0	5.5	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.1	0.1	0.7	0.0	16.0	0.1	0.2	0.1	0.0	2.6	0.3	0.0	0.0	9.7	567.6	0.1	0.0	0.1	0.0	0.0	16.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	272.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0
ANKRD30B	NY-BR-1.1	ENSG00000180777	"Ankyrin repeat domain 30B"	Q9BXX2	18	14728272-14854038	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.2"	"Group enriched"	"Detected in some"	8	"Early spermatids: 13.1;Excitatory neurons: 32.6;Inhibitory neurons: 39.3;Late spermatids: 13.9;Spermatocytes: 23.7"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 63.1"									"HPA060455, HPA071849"	Uncertain		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA060455: AB_2684282, HPA071849: "	"unprognostic (1.53e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.01e-2)"				"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-9)"	"unprognostic (1.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"		0.1	0.1	0.2	0.0	0.4	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	8.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	13.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.7	0.0	1.1	4.4	0.3	63.1	0.0	6.7	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.4	0.4	0.4	0.1	0.1	0.2	0.1	0.5	0.0	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.0	0.0	2.8	1.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.9	0.0	13.1	0.7	0.1	0.2	1.8	0.0	32.6	0.0	0.4	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.1	0.0	39.3	1.6	0.0	0.3	0.0	13.9	0.9	0.2	0.0	1.0	0.0	0.0	0.0	2.5	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	23.7	1.7	0.0	0.3	0.5	0.1	0.0	1.1	0.3
ANKRD33B		ENSG00000164236	"Ankyrin repeat domain 33B"	A6NCL7	5	10564070-10657816	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.5;retina: 50.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 350.3;Excitatory neurons: 110.4;Rod photoreceptor cells: 73.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.4"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;HDLM-2: 47.0;HMC-1: 29.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 7.7;basal ganglia: 16.2;cerebral cortex: 19.6;hippocampal formation: 16.0;olfactory bulb: 10.0"	HPA056974	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA056974: AB_2683295"	"unprognostic (6.19e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.16e-5)"	"unprognostic (1.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.47e-2)"	2.7	0.1	5.0	2.2	6.3	9.1	1.7	0.0	12.9	2.2	0.1	2.1	0.4	4.9	0.5	1.9	3.4	0.9	4.3	20.5	0.0	5.9	0.4	1.7	3.5	0.0	0.1	0.4	1.5	0.3	0.5	2.1	0.0	1.8	1.0	50.8	0.8	2.4	4.4	6.9	2.4	3.8	0.0	7.2	1.7	1.0	0.5	7.0	0.4	8.4	4.4	3.0	3.2	4.3	4.3	6.3	0.4	0.5	14.3	6.7	18.5	1.2	2.1	2.5	2.9	7.8	3.4	23.7	20.7	4.0	3.0	4.3	2.1	2.1	2.8	47.0	1.4	9.3	5.7	0.0	6.5	7.1	29.8	3.3	1.6	1.3	8.3	0.6	3.1	1.7	2.1	11.1	0.6	0.0	0.3	8.6	4.9	0.0	1.9	1.9	4.7	0.8	8.3	3.0	0.1	0.2	0.1	0.4	0.7	15.5	0.0	8.8	9.0	1.4	9.0	7.5	2.3	12.9	15.3	2.0	0.4	11.3	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	6.3	0.0	12.9	20.5	0.0	0.0	0.1	0.0	0.0	0.5	4.3	1.6	12.8	1.5	9.8	14.4	0.4	2.5	0.0	2.2	26.5	0.6	0.4	5.6	4.3	0.6	3.7	350.3	1.6	0.7	0.0	1.9	1.7	6.5	14.2	20.7	2.4	0.0	2.1	110.4	0.2	0.8	8.6	0.5	24.2	0.0	0.0	3.3	0.0	0.2	6.7	24.5	0.0	0.0	0.0	0.8	0.6	1.5	4.3	1.8	6.5	15.4	10.2	0.0	5.5	1.5	0.2	0.0	0.0	30.8	7.3	0.0	18.4	0.0	73.4	0.0	7.8	6.0	0.1	3.3	6.3	1.1	0.5	2.9	2.8	0.0	2.0
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 60.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 56.4;Fibroblasts: 31.2;Leydig cells: 36.4;Muller glia cells: 57.7;Peritubular cells: 50.8;Skeletal myocytes: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.6;THP-1: 6.8;TIME: 8.4;U-87 MG: 8.3;U-937: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favorable (9.35e-4)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	4.0	1.3	8.2	1.1	7.9	0.3	4.6	7.6	9.7	20.6	6.4	6.0	0.5	5.8	1.4	24.7	6.6	1.3	2.9	7.5	8.6	0.8	2.5	2.3	0.4	8.7	9.5	4.4	0.7	0.0	2.0	0.1	8.5	6.6	0.8	1.3	11.4	2.7	8.2	60.8	2.5	2.1	8.4	0.5	3.9	1.6	9.0	0.5	1.7	3.8	6.7	7.3	20.6	7.6	0.1	0.0	0.0	0.0	2.2	9.6	0.2	1.4	3.6	0.4	1.2	0.4	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.1	2.9	0.1	3.3	0.4	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.2	0.0	0.0	3.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.5	0.0	0.0	2.1	0.0	0.7	0.8	0.1	0.0	0.3	1.1	0.3	0.0	0.2	0.7	0.1	0.7	0.2	0.5	0.7	0.7	8.2	7.9	7.6	9.7	7.5	8.6	8.7	9.5	8.5	8.4	9.0	7.6	1.6	0.0	0.0	6.8	0.3	4.6	16.8	10.2	0.0	1.1	6.3	13.5	1.5	2.8	9.5	1.8	0.0	0.1	2.2	0.0	0.0	0.0	3.5	56.4	10.9	1.3	0.0	2.7	5.6	0.4	0.1	31.2	0.5	17.2	19.1	0.0	2.2	13.9	11.0	0.0	2.1	0.0	14.2	1.2	4.6	5.9	36.4	1.1	5.4	1.0	1.1	57.7	5.2	3.0	0.6	0.1	0.0	50.8	0.4	5.3	0.0	0.1	9.8	2.7	0.0	29.5	6.4	0.1	1.0	10.4	12.4	0.3	5.5	1.1	0.0	13.6
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233699-21253850	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 12.3;kidney: 5.9;liver: 13.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.0	0.0	0.1	0.6	0.2	0.1	0.0	2.1	0.2	0.0	0.0	8.9	9.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	5.9	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.1	0.2	0.0	0.0	0.7	0.1	12.3	0.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.8	2.8	0.6	1.8	0.0	0.0	0.0	63.4	0.0	0.2	0.8	0.3	0.1	0.3	25.1	0.0	1.3	1.7	0.0	0.2	0.0	0.1	1.3	0.0	0.4	28.0	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.3	38.2	0.0	0.0	0.5	113.0	37.5	0.0	0.3	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.4
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 6.6"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	16.3	2.2	0.3	3.6	1.6	0.1	86.8	0.8	1.3	46.7	0.1	14.3	3.6	40.0	181.7	12.7	59.1	54.4	21.9	0.5	0.1	6.4	108.5	16.1	3.4	1.0	0.2	2.9	9.1	48.0	4.4	5.2	1.1	17.1	11.0	0.9	180.5	209.2	12.7	97.4	4.6	30.1	0.2	1.2	48.3	10.4	0.1	1.5	35.4	33.0	4.0	6.7	12.8	0.5	140.2	5.3	0.3	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	207.9	0.0	2.5	0.0	0.3	254.0	0.0	0.7	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.0	1.0	0.5	0.3	1.1	182.2	19.6	0.3	0.0	0.7	0.0	0.2	7.3	0.2	0.1	43.1	0.8	1.4	16.2	0.5	0.5	0.3	1.1	0.0	3.5	0.1	0.3	0.2	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.8	1.3	0.5	0.1	1.0	0.2	1.1	0.2	0.1	0.5	7.2	0.0	0.0	0.7	0.4	17.7	21.5	4.2	0.0	0.0	30.5	70.2	3.5	17.2	2.0	0.0	0.0	1.3	0.2	0.4	0.0	4.1	54.9	10.0	27.5	5.6	0.0	2.7	0.7	0.0	0.6	4.2	36.7	18.5	4.5	0.0	3.3	141.3	0.2	0.0	20.4	13.3	0.0	1.6	3.0	75.1	1.8	0.7	5.4	2.8	0.0	0.8	0.0	1.5	0.7	1.0	0.5	1.5	0.3	22.6	0.0	0.7	0.3	0.4	46.0	1.1	52.5	1.4	2.3	1.4	46.7	4.1	0.7	0.1	0.4	20.9
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784895-89815401	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 2384.1;pancreas: 675.0"	"Cell type enriched"	"Detected in many"	14	"Proximal enterocytes: 6315.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 9.2;thalamus: 17.4"	"Immune cell enriched"	"Detected in many"	4	"neutrophil: 227.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 227.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 14.8"	"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	55.4	7.0	1.6	36.6	1.6	103.4	55.9	1.3	9.2	41.4	3.4	266.8	2384.1	3.6	1.7	4.8	8.0	120.3	6.9	1.3	1.5	249.7	271.8	34.3	12.8	1.5	2.1	1.9	675.0	0.8	1.9	33.1	2.5	94.0	59.9	0.0	42.1	5.5	2.5	32.5	1970.6	29.7	1.3	25.9	8.0	2.0	17.4	7.1	8.2	3.8	4.7	16.8	15.0	1.2	0.1	45.6	0.0	0.5	613.7	764.2	6.2	738.4	1135.6	95.3	81.6	5.8	0.4	0.2	8.4	703.8	0.0	0.6	5.6	0.2	38.6	0.1	0.1	137.3	4.6	122.8	352.0	11.4	660.3	670.0	1.4	302.3	0.3	4.4	874.8	0.0	3.8	0.8	37.8	0.1	0.6	355.4	1.9	0.0	49.9	0.3	0.1	9.5	449.2	0.0	1.2	7.2	0.1	1.3	0.1	1.8	0.5	72.1	815.1	385.3	0.6	891.4	0.1	0.4	0.1	0.1	0.9	0.9	20.5	22.2	56.3	41.1	0.1	27.4	0.0	0.2	0.0	0.0	26.2	0.2	0.0	0.0	227.1	0.0	49.7	0.7	0.0	25.7	1.6	1.6	1.3	9.2	1.3	1.5	1.5	2.1	2.5	1.3	17.4	1.2	2.4	0.0	3.0	0.0	5.2	9.9	2.8	1.4	0.6	0.0	35.7	12.8	1.2	391.7	19.7	20.2	0.0	13.0	0.7	429.8	43.0	15.4	0.2	0.5	10.1	8.4	3.0	6.6	0.3	386.2	16.3	31.0	0.0	0.4	24.1	0.3	79.2	192.4	37.5	0.0	0.3	199.6	2.0	54.1	63.2	0.2	2.8	71.9	3.6	0.0	38.3	0.0	0.0	0.0	0.1	75.5	316.9	1.5	2.1	20.9	6315.2	435.0	3.3	0.0	26.3	0.8	8.1	0.3	0.5	0.2	5.8	6.4	3.7	187.8	290.9	1.4
ANTXR1	"ATR, FLJ10601, FLJ21776, TEM8"	ENSG00000169604	"ANTXR cell adhesion molecule 1"	Q9H6X2	2	69013176-69249327	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	Hypotrichosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 130.6;Endometrial stromal cells: 78.1;Oligodendrocyte precursor cells: 141.8;Skeletal myocytes: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 367.9;TIME: 240.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054785			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		11000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA054785: "	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.26e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.09e-2)"	38.7	63.1	25.7	20.3	24.1	0.2	32.7	26.6	16.1	77.8	70.2	32.7	12.9	81.4	25.2	33.9	44.1	114.6	39.9	27.9	69.2	11.0	8.2	44.8	12.1	42.5	49.5	107.2	6.7	35.4	14.6	78.8	45.6	47.9	21.4	9.5	28.6	55.4	11.3	39.3	20.2	62.1	36.5	28.3	14.5	11.7	38.3	10.5	43.3	24.0	13.0	52.3	42.4	36.6	36.8	39.5	36.4	33.9	162.7	78.8	0.6	57.1	115.6	63.2	51.5	0.4	3.0	0.0	31.6	147.4	41.7	31.7	30.7	33.8	59.9	0.1	24.4	9.5	90.5	11.9	71.1	7.6	5.1	129.7	13.4	55.5	36.4	140.9	17.3	19.4	6.7	0.1	367.9	15.2	22.1	0.5	35.8	0.0	26.5	0.1	186.3	0.6	13.8	27.9	21.1	91.0	104.3	0.5	37.5	23.7	11.0	2.3	240.4	71.3	61.6	72.1	59.6	0.2	0.1	0.2	37.3	6.7	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.7	24.1	26.6	16.1	27.9	69.2	42.5	49.5	45.6	36.5	38.3	36.6	4.7	6.4	20.0	130.6	0.0	49.5	21.1	15.4	17.6	1.7	7.9	13.8	6.8	0.0	8.3	0.0	0.0	0.7	0.1	0.0	0.0	1.5	37.9	5.5	78.1	4.3	0.0	0.0	61.9	2.6	1.9	68.2	0.0	11.7	1.3	22.1	3.3	0.1	4.0	0.0	64.3	0.0	4.1	0.8	19.8	33.9	42.6	2.9	24.9	40.3	0.6	13.6	0.0	141.8	1.3	1.1	0.0	67.7	1.2	10.1	0.0	0.1	9.9	0.8	19.7	111.7	59.6	5.2	2.7	4.6	23.4	1.4	1.7	26.4	0.0	8.9
ANTXR2	"CMG-2, CMG2, FLJ31074"	ENSG00000163297	"ANTXR cell adhesion molecule 2"	P58335	4	79901146-80125454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.4;HHSteC: 197.9;LHCN-M2: 221.0;U-2197: 176.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		13000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-1)"	60.9	30.0	4.1	35.4	4.1	18.7	18.7	3.6	6.4	52.2	5.0	39.9	23.0	95.4	21.9	24.5	31.2	54.9	31.8	3.6	5.0	17.1	34.4	24.7	16.2	4.7	5.0	75.0	4.6	27.8	1.6	90.0	4.2	110.2	42.7	1.6	10.1	90.3	6.1	6.1	29.6	108.3	5.5	18.3	23.2	8.4	4.0	10.7	4.9	21.7	16.1	53.1	12.0	4.4	15.5	1.9	34.6	6.6	215.4	118.0	3.1	48.3	124.6	17.5	19.9	0.6	11.8	0.0	0.8	76.8	11.4	4.5	4.4	49.7	66.9	2.2	4.2	12.2	1.3	4.8	197.9	51.6	29.5	145.3	15.2	132.7	68.3	150.2	52.6	1.6	27.1	35.8	221.0	0.0	1.1	57.1	5.7	21.7	70.3	2.4	19.8	9.0	12.0	14.4	30.6	41.2	4.9	0.6	8.2	16.3	0.7	11.0	69.8	155.7	9.7	176.7	103.4	3.1	0.0	0.1	78.6	39.4	49.0	72.7	17.5	61.6	12.8	9.5	13.8	23.5	21.4	13.1	32.2	9.4	11.3	5.9	54.4	4.3	18.0	32.2	40.4	14.0	4.1	4.1	3.6	6.4	3.6	5.0	4.7	5.0	4.2	5.5	4.0	4.4	6.4	12.8	10.0	23.5	25.7	7.0	15.5	6.5	4.0	6.9	4.0	2.2	24.9	4.3	10.2	0.0	29.2	18.3	24.9	42.4	3.9	4.2	2.3	7.7	69.3	15.5	18.6	6.3	25.4	6.7	29.0	58.7	4.1	6.1	60.1	8.9	15.0	24.9	17.7	0.0	2.1	15.1	4.1	13.4	28.9	5.3	39.1	28.3	1.8	45.9	53.7	6.9	4.1	19.1	0.8	45.5	28.9	63.9	14.1	13.9	16.9	2.5	4.9	21.4	39.5	32.5	28.5	0.6	2.1	0.9	4.3	6.6	24.4	18.3	13.3	1.6
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 422.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 307.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	422.8	48.4	2.6	31.9	3.2	1.4	169.2	2.5	4.2	52.8	2.7	210.8	17.3	95.1	33.5	88.0	84.8	50.7	50.2	2.9	2.5	24.1	19.1	218.6	12.4	2.5	2.5	26.5	12.0	8.4	5.4	28.0	2.6	59.1	41.0	1.7	14.7	103.6	17.8	24.6	57.6	144.8	2.3	21.4	66.6	12.8	2.4	5.9	28.2	22.9	3.9	142.1	50.9	2.5	0.1	1.5	0.2	1.0	307.5	0.3	5.0	0.3	0.1	0.2	0.8	0.9	0.0	0.7	0.7	0.1	0.2	0.5	0.8	0.2	0.8	1.5	5.7	0.4	0.5	18.4	0.8	0.3	1.0	3.3	1.0	0.3	0.8	0.0	0.2	2.2	0.3	1.7	0.6	0.2	0.2	1.4	0.7	0.1	0.4	0.7	0.8	3.0	0.1	2.2	0.3	0.4	0.0	0.2	2.0	2.2	0.1	0.1	0.0	0.3	2.7	1.2	0.4	4.8	5.9	0.6	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	3.2	2.5	4.2	2.9	2.5	2.5	2.5	2.6	2.3	2.4	2.5	58.2	3.2	6.0	0.0	0.5	2.9	0.1	0.0	2.2	0.0	1.1	2.2	9.5	0.0	1.9	0.0	0.0	0.1	0.4	0.1	0.0	0.2	4.5	0.8	2.3	12.3	0.0	0.0	0.4	0.2	0.1	11.3	0.0	1.4	1.3	2.1	20.7	0.2	1.4	0.0	0.3	0.1	0.0	1.4	2.7	2.6	3.4	0.9	3.6	3.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	74.9	0.0	0.4	0.1	1.4	1.0	0.4	118.3	2.6	93.0	1.1	1.3	0.7	1.8	0.3	0.6	74.6	0.1	0.3
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 300.5;liver: 891.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 749.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	87.6	300.5	0.6	3.2	2.9	0.5	50.2	0.1	2.4	17.9	3.6	12.0	0.8	10.8	12.3	8.2	48.2	9.9	14.9	1.1	1.5	103.2	891.0	19.5	4.7	1.3	1.0	48.0	85.0	1.3	2.8	1.7	1.2	22.3	4.5	0.5	15.3	28.3	12.9	20.1	12.7	7.1	0.5	4.1	14.3	19.4	4.0	2.0	17.7	11.0	1.5	38.6	17.7	3.6	0.6	0.2	0.0	0.0	377.3	191.5	0.2	6.6	12.2	5.4	9.7	0.0	0.1	0.1	0.5	8.4	2.3	0.2	0.1	18.6	22.0	0.2	0.6	0.0	4.6	20.7	25.4	0.9	0.0	78.2	4.6	26.1	81.2	5.4	0.2	0.2	0.2	0.1	18.3	0.5	0.0	0.1	8.0	0.1	5.2	0.0	0.5	0.1	0.2	0.2	0.4	0.3	4.8	0.0	0.3	0.4	0.1	0.2	31.9	13.8	11.2	0.2	2.5	0.2	0.1	2.6	10.7	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.1	2.4	1.1	1.5	1.3	1.0	1.2	0.5	4.0	3.6	1.0	3.2	1.1	0.7	3.6	1.8	0.5	1.2	1.2	0.1	0.2	0.3	0.9	17.2	0.1	3.7	0.0	0.1	0.0	0.1	11.7	0.7	0.8	0.4	3.0	2.6	3.0	37.5	0.9	26.2	0.2	22.9	0.0	8.2	0.0	0.1	15.4	749.1	0.4	0.0	2.5	0.1	2.0	19.8	3.6	4.4	74.0	1.7	3.6	1.0	0.0	0.6	0.0	5.0	6.9	11.5	0.0	82.0	0.0	7.5	0.1	162.2	0.1	0.1	0.0	5.3	3.0	0.8	1.3	0.1	1.6	0.0	2.0	2.3	0.1	0.4
AP003108.2		ENSG00000256591	"Novel transcript"		11	61429220-61485822	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 1.4;Endometrial stromal cells: 1.5;Glandular and luminal cells: 1.4;Granulosa cells: 3.4;Respiratory ciliated cells: 1.5;Theca cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 28.0"					"Low region specificity"	"Detected in all"			HPA039732	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"			"HPA039732: AB_10962868"	"unprognostic (1.23e-1)"	"unprognostic (8.61e-2)"	"unprognostic (9.60e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.98e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-7)"	"unprognostic (5.74e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.66e-3)"	5.1	4.7	2.7	4.0	3.1	8.7	4.0	3.0	3.9	5.9	2.6	2.7	2.2	3.6	3.1	3.4	3.2	4.8	7.0	3.1	3.4	3.6	2.4	3.8	4.6	3.2	3.3	2.1	2.0	2.3	1.3	3.1	3.3	3.3	3.3	1.0	2.6	2.7	1.8	1.7	2.6	4.2	3.0	4.4	3.4	2.9	3.2	7.7	5.1	5.9	4.8	5.4	1.9	3.1	6.8	3.3	3.8	6.1	9.7	8.1	2.0	8.9	7.6	6.6	6.2	2.6	4.5	7.1	14.5	8.3	5.5	3.0	4.5	6.3	3.9	6.3	5.3	5.4	0.9	0.9	11.4	4.2	2.0	15.6	3.8	9.8	7.8	4.2	16.7	9.2	5.8	6.0	10.9	5.3	14.1	4.0	8.5	5.8	4.5	8.4	5.8	8.6	4.4	5.4	3.0	3.8	3.7	3.5	12.6	2.5	4.9	4.8	28.0	8.4	4.7	4.5	5.0	2.2	9.5	4.8	7.2	5.5	6.3	5.9	8.0	8.4	11.6	7.3	14.6	5.9	11.5	11.8	6.3	6.8	13.2	12.3	11.2	7.4	6.8	6.8	12.9	10.2	2.7	3.1	3.0	3.9	3.1	3.4	3.2	3.3	3.3	3.0	3.2	3.1	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.6	3.7	0.0	0.3	1.4	0.0	0.0	0.2	0.0	0.7	1.5	0.6	0.0	0.0	0.0	0.2	0.4	0.3	0.0	1.4	1.3	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.6	1.5	0.0	0.0
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 subunit sigma 2"	P56377	X	15825806-15854931	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 663.3"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 259.8;Kupffer cells: 392.6;Langerhans cells: 609.2;Macrophages: 362.7;monocytes: 630.0"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 13.1;glioma: 22.0;melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 326.8;intermediate monocyte: 325.0;myeloid DC: 221.1;non-classical monocyte: 175.4;plasmacytoid DC: 82.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 221.1;monocytes: 326.8"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 298.0;SK-MEL-30: 442.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favorable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	28.3	21.4	24.6	36.7	28.4	38.3	15.0	32.0	36.9	31.6	27.3	42.1	11.9	52.2	663.3	21.4	13.5	20.1	74.8	25.1	48.0	13.1	15.9	25.8	33.2	42.7	35.8	8.8	7.8	16.7	19.4	42.0	47.0	11.6	22.0	43.7	9.5	30.5	70.1	14.0	20.1	76.3	34.4	43.0	19.5	23.4	29.6	28.7	12.5	93.7	28.8	26.1	12.7	33.8	12.0	14.2	130.1	78.4	29.5	19.1	5.0	47.1	22.7	31.1	41.1	9.6	11.1	22.6	183.0	72.6	50.4	16.1	31.7	10.8	57.0	30.1	64.9	15.3	16.7	14.7	24.2	63.1	16.9	12.2	11.2	36.0	33.1	50.4	78.1	19.1	14.3	298.0	72.4	8.7	12.9	39.5	171.0	6.4	42.5	29.5	116.7	50.6	37.4	2.5	14.8	69.2	18.4	4.8	442.2	84.1	52.7	69.2	43.9	67.8	21.2	92.5	41.9	25.5	58.7	37.3	33.6	28.0	159.7	50.9	326.8	34.6	21.1	325.0	24.8	30.8	25.5	20.6	221.1	28.0	18.5	18.1	52.8	27.9	175.4	82.2	38.1	228.0	24.6	28.4	32.0	36.9	25.1	48.0	42.7	35.8	47.0	34.4	29.6	33.8	130.8	3.2	13.1	37.2	77.0	55.2	12.7	9.1	8.6	34.7	12.0	11.4	195.6	12.8	3.2	9.2	12.5	5.3	114.2	9.2	33.2	13.7	5.1	50.4	32.6	166.3	26.9	32.6	15.1	6.4	18.9	38.0	7.7	78.0	78.6	15.6	147.4	8.6	259.8	11.8	73.2	8.4	12.2	392.6	609.2	17.5	17.4	362.7	149.4	31.9	630.0	21.1	62.8	19.1	85.0	10.3	14.0	7.2	26.0	19.0	6.5	9.0	1.6	39.3	39.5	26.7	39.1	55.7	28.8	10.6	51.6	5.6	58.3	4.0	8.5	6.7
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.0	1.6	4.3	0.7	4.4	0.7	0.9	8.7	8.4	2.9	0.0	1.3	0.4	1.2	0.4	1.7	1.6	0.3	0.4	8.0	2.5	0.9	0.9	3.3	0.6	3.3	2.4	1.1	5.9	0.0	7.6	0.1	2.4	2.5	0.2	1.1	0.4	0.1	0.1	1.0	4.9	0.0	2.2	10.7	1.4	5.7	3.0	1.4	2.7	0.0	0.7	1.3	1.5	4.9	0.0	1.6	0.7	3.7	0.0	0.0	0.0	0.9	1.4	0.1	0.5	0.0	0.0	0.0	3.5	0.0	2.3	0.0	0.5	0.0	0.0	0.0	3.1	8.4	0.0	0.1	3.1	0.0	0.2	0.4	2.5	0.4	0.0	0.4	4.4	1.8	5.0	0.2	0.0	0.5	0.2	2.4	1.1	0.0	3.3	0.0	0.4	0.2	0.0	0.0	5.4	20.0	0.0	0.0	0.2	0.1	0.0	1.0	4.4	0.0	4.4	0.0	0.9	0.0	0.1	0.0	0.1	14.9	1.7	0.0	0.0	0.0	0.9	0.0	0.2	0.0	1.5	3.3	0.0	0.0	5.4	5.6	0.1	1.3	0.0	0.0	0.0	2.0	4.3	4.4	8.7	8.4	8.0	2.5	3.3	2.4	2.4	2.2	3.0	4.9	0.5	0.0	0.6	53.2	1.8	0.4	0.2	0.0	0.0	21.5	1.9	2.3	1.4	0.0	0.1	0.0	0.0	0.1	36.5	0.1	1.9	1.8	18.9	2.9	6.4	1.2	0.0	2.1	142.7	5.8	0.2	2.2	0.0	2.1	0.0	1.9	3.6	0.5	1.2	89.2	106.1	0.3	0.0	1.6	0.4	10.4	1.8	0.8	3.6	33.7	1.9	1.3	63.8	97.0	74.1	3.3	0.0	3.8	12.3	0.1	0.0	0.3	0.2	4.5	0.0	0.4	2.1	1.6	14.5	0.4	0.3	0.1	30.7	10.6	0.0	0.1
APCDD1	B7323	ENSG00000154856	"APC down-regulated 1"	Q8J025	18	10454635-10489949	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"		"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 129.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.5;Cholangiocytes: 85.8;Endometrial stromal cells: 429.5;Melanocytes: 80.0;Oligodendrocyte precursor cells: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 32.0;BJ hTERT+: 70.4;HaCaT: 43.0;HHSteC: 18.9;HSkMC: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"				"unprognostic (1.21e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.39e-4)"	"prognostic favorable (8.23e-4)"	"unprognostic (5.61e-3)"	"unprognostic (6.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	52.5	14.2	33.4	6.9	31.1	0.4	31.4	30.4	34.3	35.6	17.0	12.8	3.5	32.7	15.6	27.7	32.6	21.9	32.0	39.5	33.0	6.2	1.4	13.2	1.2	33.0	36.9	33.0	8.9	3.4	3.2	26.9	29.8	33.3	13.2	1.6	10.6	14.1	7.3	129.8	14.5	10.6	26.6	4.1	23.8	2.7	33.8	2.2	5.3	18.5	4.7	36.6	35.5	29.6	0.0	0.0	32.0	0.0	5.4	0.0	0.1	2.4	70.4	3.1	4.9	0.1	0.1	0.0	0.0	13.0	0.0	43.0	0.3	0.0	3.3	0.0	1.6	0.1	0.2	0.7	18.9	0.0	0.0	39.3	1.4	6.1	0.0	0.0	0.5	0.0	0.0	0.1	3.1	2.1	1.8	0.5	5.2	15.3	0.0	0.9	0.0	1.2	0.0	0.4	0.8	0.3	0.0	0.0	3.6	2.0	0.0	0.4	0.0	3.8	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	4.8	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.2	33.4	31.1	30.4	34.3	39.5	33.0	33.0	36.9	29.8	26.6	33.8	29.6	3.1	0.0	12.6	120.5	0.4	65.6	3.6	3.6	11.4	4.1	14.1	20.4	4.2	85.8	2.7	3.7	0.0	2.4	1.7	0.1	0.0	11.2	0.7	28.7	429.5	47.1	3.6	0.0	0.2	0.4	0.4	64.4	0.5	10.9	1.3	0.4	1.8	0.2	1.3	0.0	2.1	1.1	2.0	0.3	35.0	0.8	8.7	3.3	80.0	67.5	1.3	0.2	0.0	110.1	15.3	0.2	0.0	37.6	1.6	11.7	0.1	0.1	5.9	2.2	26.3	18.7	28.1	0.3	1.4	13.1	53.8	1.0	4.2	1.3	1.4	4.5
APELA	"ELA, Ende, tdl"	ENSG00000248329	"Apelin receptor early endogenous ligand"	P0DMC3	4	164877178-164898965	"Predicted secreted proteins"	"Angiogenesis, Differentiation, Gastrulation"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.2;prostate: 4.2"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 28.2;Proximal tubular cells: 28.5;Syncytiotrophoblasts: 40.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 41.7;SuSa: 25.1"														"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.97e-2)"	"unprognostic (6.97e-2)"	"unprognostic (9.83e-4)"	"unprognostic (8.92e-3)"		"unprognostic (1.43e-3)"		"unprognostic (4.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.95e-4)"	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	2.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.2	0.0	0.2	0.1	0.0	0.1	1.1	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	3.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	5.7	4.3	0.3	0.0	0.0	1.8	0.0	28.2	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	28.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	40.9	0.1	0.1	0.0	0.3
APLN	"apelin, XNPEP2"	ENSG00000171388	Apelin	Q9ULZ1	X	129645259-129654956	"Predicted secreted proteins"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8;placenta: 54.0"	"Cell type enriched"	"Detected in some"	7	"Endothelial cells: 68.2"	"Group enriched"	"Detected in all"	6	"glioma: 44.2;renal cancer: 21.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"HUVEC TERT2: 502.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.50e-1)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (9.32e-4)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (4.71e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.42e-2)"	4.7	9.2	19.9	2.2	21.2	0.0	3.0	19.0	24.0	0.6	6.8	1.0	0.8	0.7	0.3	0.6	1.2	0.4	12.6	15.4	23.8	7.5	1.4	13.4	0.1	30.1	25.9	2.4	0.3	1.0	5.4	54.0	25.4	1.1	0.3	0.3	0.6	0.5	3.7	1.5	0.8	1.9	29.7	0.7	1.2	1.1	33.6	0.3	0.9	1.1	0.2	3.4	0.4	35.8	0.2	0.6	58.5	0.5	1.9	3.6	0.0	0.2	0.0	1.1	1.8	0.0	0.0	0.0	6.2	0.2	2.5	0.0	1.4	14.1	1.0	0.0	0.1	0.0	0.6	0.1	0.2	3.3	1.4	7.7	0.1	7.2	0.0	0.0	502.1	1.7	0.1	1.9	2.6	0.0	0.2	0.7	1.5	0.0	26.8	0.3	0.5	0.9	0.0	0.0	2.0	6.2	0.2	0.1	0.0	0.1	0.1	0.9	86.2	2.1	0.2	36.5	2.1	0.8	0.0	0.0	34.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	21.2	19.0	24.0	15.4	23.8	30.1	25.9	25.4	29.7	33.6	35.8	3.0	0.0	1.3	8.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	9.4	6.8	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.1	0.1	68.2	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.2	1.3	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.8	1.9	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.1	1.2	0.2	2.9	0.0	0.0
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879792	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 1201.6"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 147.1;Horizontal cells: 161.5;Oligodendrocytes: 461.3"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.6;AN3-CA: 162.9;HMC-1: 76.0;SCLC-21H: 87.2;SH-SY5Y: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		6400000	"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (2.65e-5)"	3.0	31.5	417.1	3.1	718.0	0.4	1.4	680.9	552.4	3.1	218.6	4.4	1.8	3.1	1.3	1.5	2.7	5.5	10.8	438.3	465.8	4.9	0.6	1.9	1.4	783.2	627.4	1.4	75.0	22.3	151.4	0.9	710.7	2.1	2.2	56.3	1.8	1.9	0.5	1.1	2.1	3.2	605.9	0.5	28.1	13.1	598.3	0.8	1.5	0.5	1.5	1.2	2.1	1201.6	4.4	40.0	81.6	162.9	7.1	3.2	10.4	5.6	3.5	7.8	1.1	7.3	6.3	0.8	66.5	21.0	27.7	2.2	26.1	2.6	5.2	48.9	3.7	0.3	10.6	5.2	2.0	0.2	76.0	3.6	1.8	3.2	0.1	28.8	3.1	6.1	2.7	1.2	25.0	8.3	0.2	0.3	3.9	16.5	16.5	7.2	0.4	1.1	1.4	1.1	87.2	89.3	23.1	3.8	0.8	23.9	20.8	4.3	1.3	61.3	28.8	32.9	4.3	2.4	1.6	0.3	42.3	1.1	33.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	417.1	718.0	680.9	552.4	438.3	465.8	783.2	627.4	710.7	605.9	598.3	1201.6	2.5	6.4	0.0	12.4	0.6	1.3	2.6	0.7	1.2	147.1	0.4	1.1	6.2	1.5	0.2	0.0	12.5	0.3	0.3	0.4	0.0	2.0	27.6	1.3	1.2	2.8	34.9	0.0	55.5	4.2	6.4	2.8	10.2	3.2	0.0	0.1	0.7	0.4	0.4	161.5	46.8	1.1	2.0	0.3	1.6	15.8	1.2	1.1	5.4	12.2	0.0	14.6	0.0	19.1	461.3	3.1	0.1	0.0	0.4	1.9	0.0	0.1	0.2	38.6	0.0	1.9	1.8	14.5	28.7	0.1	0.6	0.4	0.5	0.1	0.2	1.3
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.6;dendritic cells: 9.6;Hofbauer cells: 4.9;monocytes: 10.5;NK-cells: 6.2;T-cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.2;MAIT T-cell: 9.4;memory CD4 T-cell: 12.1;memory CD8 T-cell: 19.4;naive CD8 T-cell: 8.9;NK-cell: 19.7;T-reg: 11.9"	"Group enriched"	"Detected in many"	13	"NK-cells: 19.7;T-cells: 23.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HDLM-2: 2.7;Karpas-707: 6.9;U-266/70: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (8.43e-7)"	0.7	0.8	0.3	2.3	0.5	3.6	0.6	1.0	0.7	0.7	0.0	1.8	0.5	0.8	3.6	1.1	1.3	1.6	0.5	0.3	0.3	0.8	0.6	2.4	3.8	0.7	0.4	0.5	0.3	0.6	0.7	1.0	0.6	0.7	3.3	0.6	0.9	1.5	0.6	0.5	1.2	1.2	0.2	3.1	0.9	1.6	0.5	2.9	0.7	0.0	2.1	1.4	0.6	0.5	0.0	0.5	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.2	0.0	0.0	0.2	2.8	1.0	0.3	0.0	0.1	0.0	0.6	0.0	2.7	0.3	0.7	0.1	0.0	0.2	0.0	2.0	1.8	1.6	0.2	0.2	0.2	0.0	0.1	0.0	6.9	0.9	0.9	1.4	0.2	0.0	0.0	0.0	1.6	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	4.8	0.7	0.2	0.2	1.2	0.1	0.1	0.3	0.0	23.2	0.5	9.4	1.4	12.1	19.4	0.2	0.4	0.6	8.9	0.0	19.7	1.6	0.0	11.9	4.7	0.3	0.5	1.0	0.7	0.3	0.3	0.7	0.4	0.6	0.2	0.5	0.5	0.4	0.0	4.2	0.0	1.6	0.1	0.6	0.9	1.2	0.0	0.2	0.3	0.1	0.0	2.4	0.0	0.0	6.6	9.6	0.1	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.6	0.1	0.5	0.1	3.8	0.1	0.4	0.2	4.9	0.0	0.2	0.0	2.0	1.0	0.6	0.5	0.0	1.0	0.0	0.0	10.5	0.0	6.2	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.9	0.1	0.2	0.2	0.0	1.5	20.8	0.0	0.0	0.5
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44946035-44949565	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	83	"liver: 9641.4"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1170.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	30	"NK-cells: 3.2"	"Group enriched"	"Detected in many"	4	"Hep G2: 713.0;THP-1: 1354.4"									HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	49000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	1.2	5.4	49.5	1.7	55.2	1.1	5.3	55.1	116.2	4.5	44.7	4.3	41.4	1.2	4.8	2.4	4.3	3.7	0.8	50.7	69.2	16.3	9641.4	34.9	15.8	65.3	64.9	0.4	2.2	6.6	3.0	2.9	74.3	1.3	4.4	2.8	2.4	2.1	1.9	4.3	65.6	0.7	63.3	3.9	2.7	1.1	59.9	3.2	0.9	0.7	9.9	2.2	0.8	75.0	2.9	0.6	0.3	0.4	0.5	0.6	1.3	0.1	0.0	0.0	0.1	2.0	2.8	0.7	0.3	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.1	123.0	2.7	713.0	0.2	15.4	237.5	0.2	0.3	0.0	0.0	0.3	0.0	0.1	1.7	2.9	0.1	0.8	0.9	126.3	0.5	3.2	0.4	0.8	5.2	1.1	0.0	1.5	0.1	0.1	1.9	0.2	7.7	0.0	0.7	1354.4	0.0	0.3	0.6	0.8	0.8	2.3	0.9	2.2	0.2	3.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	49.5	55.2	55.1	116.2	50.7	69.2	65.3	64.9	74.3	63.3	59.9	75.0	0.1	0.0	2.3	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.1	11.5	0.0	3.7	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	13.6	1170.2	33.8	0.0	0.0	0.4	0.0	15.5	1.2	0.0	0.0	24.0	7.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.1	17.7	32.3	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.4	0.3	1.8	0.0	1.3	0.0
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27649.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			4.1	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.4	0.0	7.2	907.0	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.2	27649.0	1.4	0.9	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.2	1106.7	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905791-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 3453.9;liver: 6592.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 9363.4;Hofbauer cells: 6072.6;Muller glia cells: 9454.8;Peritubular cells: 4958.2;Proximal tubular cells: 8155.9;Theca cells: 7201.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1867.0;CACO-2: 466.1;Hep G2: 935.3;HSkMC: 1374.2;SK-MEL-30: 1956.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	51800000000	29000000000		"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	522.1	3453.9	813.4	92.8	1164.2	66.5	325.1	775.0	943.2	271.2	329.2	130.9	40.3	81.5	20.0	37.2	72.2	100.2	176.3	606.1	841.6	1066.0	6592.5	258.8	352.2	1016.0	1037.0	508.2	41.9	34.5	110.9	102.2	1106.9	45.4	22.9	87.6	80.5	10.8	31.1	381.2	165.9	12.6	823.2	620.3	83.3	140.5	962.6	57.8	146.4	10.4	46.1	93.4	135.5	964.4	3.2	5.2	9.5	2.6	1867.0	76.3	69.4	1.5	4.3	8.4	1.4	466.1	2.8	2.0	9.9	0.3	9.1	6.4	12.6	2.1	0.7	1.7	4.0	3.3	1.7	935.3	192.4	6.8	2.3	1374.2	2.5	14.8	1.3	15.6	1.0	0.7	124.9	2.8	1.2	3.3	1.9	2.5	243.2	3.0	1.3	2.6	8.0	1.8	2.8	0.9	5.6	2.4	4.5	1.4	1956.0	131.6	165.3	52.8	3.3	13.2	3.1	1.4	1.6	5.9	8.6	3.8	5.9	4.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	813.4	1164.2	775.0	943.2	606.1	841.6	1016.0	1037.0	1106.9	823.2	962.6	964.4	136.7	0.0	8.2	444.0	66.1	935.2	12.3	18.3	67.7	81.7	86.7	565.8	2.2	450.4	5.2	228.1	41.7	46.3	6.0	2.2	682.9	1.8	73.6	33.8	936.6	140.2	0.0	331.6	1.1	0.7	43.8	860.7	3.6	22.9	174.4	103.6	208.9	9363.4	6072.6	38.7	2.1	0.6	4.1	718.0	292.6	355.3	2629.4	940.6	2481.3	60.9	70.3	9454.8	0.0	12.1	2.2	0.6	0.3	4958.2	7.2	15.0	0.2	8155.9	1.0	311.4	223.5	2958.4	345.5	14.8	12.8	15.1	1684.9	74.3	60.6	7201.0	1.7	4.7
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	563	"liver: 17965.3"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.9	0.3	0.0	0.1	0.1	0.4	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.6	0.2	0.0	31.9	17965.3	5.6	0.3	0.2	0.1	0.2	10.9	0.0	0.2	0.4	0.1	0.2	0.7	0.2	0.1	0.3	0.1	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253071-36267530	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 220.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 106.1;Glandular and luminal cells: 216.2;Hepatocytes: 115.6;Pancreatic endocrine cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 243.9;HDLM-2: 166.1;HHSteC: 120.3;RPTEC TERT1: 91.1;RT4: 146.8"									"HPA018885, CAB056156"	Supported				"Secreted to blood"	NA	NA	1640000000	9200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB056156: AB_2665576, HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favorable (2.01e-5)"	45.3	15.8	8.1	62.5	8.2	4.2	28.4	7.8	9.8	53.8	9.4	32.0	32.7	38.8	17.7	25.7	36.7	69.0	29.5	7.4	8.4	44.5	220.5	59.5	23.1	10.0	8.5	24.8	9.0	4.9	14.1	53.0	9.6	37.5	27.2	0.9	29.7	52.2	11.7	7.1	28.9	65.4	9.0	56.8	64.9	7.9	10.8	24.9	18.0	13.8	23.6	117.7	29.9	8.2	21.6	5.1	0.1	0.6	46.8	44.6	14.2	2.3	9.0	13.7	38.6	0.6	34.4	7.0	243.9	24.8	31.3	5.3	0.0	19.2	3.6	166.1	0.2	6.1	3.2	41.4	120.3	2.4	20.2	8.3	1.7	38.0	0.8	2.0	27.3	1.3	23.8	85.1	2.4	0.2	8.5	2.1	0.6	0.6	0.2	13.6	2.6	3.2	91.1	146.8	1.9	0.1	10.9	5.8	2.1	0.3	0.8	7.8	24.7	29.5	12.4	3.2	1.5	6.5	4.0	1.6	16.0	12.4	4.6	15.6	6.1	5.5	12.6	6.8	10.7	2.6	8.1	11.2	4.3	1.4	4.6	6.3	16.1	22.4	10.3	0.5	5.4	7.2	8.1	8.2	7.8	9.8	7.4	8.4	10.0	8.5	9.6	9.0	10.8	8.2	37.4	57.7	34.3	0.3	7.2	1.7	21.4	73.5	2.8	0.5	6.3	3.0	3.6	15.7	67.1	18.4	2.1	11.0	12.6	31.2	0.0	37.8	0.8	106.1	48.8	41.3	7.7	3.8	0.1	20.0	8.2	27.3	45.9	216.2	11.4	4.3	49.6	115.6	9.1	0.0	0.1	17.7	32.6	15.8	5.3	1.4	27.4	10.9	0.0	7.5	19.4	0.1	36.0	0.0	0.0	105.1	19.9	24.0	15.0	31.2	20.5	2.1	60.5	1.3	6.6	5.5	10.6	0.4	0.4	3.4	2.3	6.7	12.9	1.6	4.6	62.5
APOM	"G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 390.7"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 665.9;Proximal tubular cells: 681.1"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 38.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	8200000000	"Cluster 34: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	4.9	5.3	0.6	0.1	0.6	2.5	5.2	1.0	0.9	3.7	0.5	3.8	0.6	3.9	1.0	4.1	4.1	0.5	3.5	0.6	0.7	93.7	390.7	2.6	0.6	0.7	0.7	6.2	6.0	0.7	4.7	0.1	0.7	3.8	0.4	0.4	3.5	0.5	7.2	6.4	9.0	0.4	0.7	4.1	5.3	16.0	0.6	1.2	5.5	0.6	1.1	3.3	3.3	0.8	0.5	0.3	0.6	0.7	0.6	0.8	0.0	0.4	1.1	0.4	0.9	3.2	1.0	1.4	0.2	1.1	0.2	0.6	0.4	0.6	0.8	0.8	0.7	0.8	0.3	38.2	1.3	1.7	0.1	1.2	0.4	0.3	1.0	0.5	0.3	0.9	1.2	0.4	1.1	1.1	1.1	0.9	0.5	0.6	0.2	0.8	0.4	1.5	1.1	0.6	0.5	0.2	0.4	0.0	0.5	0.2	1.5	1.2	0.4	0.2	0.1	0.3	0.3	1.1	1.2	1.5	0.2	1.8	0.1	3.0	0.6	0.6	0.3	0.3	0.5	1.1	0.4	0.3	0.5	0.5	0.5	0.6	0.4	0.3	0.7	0.3	0.7	0.3	0.6	0.6	1.0	0.9	0.6	0.7	0.7	0.7	0.7	0.7	0.6	0.8	1.5	0.0	7.4	2.3	9.0	6.4	6.7	6.7	9.1	1.5	6.6	12.4	1.6	12.8	3.0	14.7	4.2	2.0	1.6	4.1	76.3	4.3	60.2	5.2	3.1	2.0	4.2	11.4	0.3	6.9	0.9	4.3	5.1	1.6	5.1	1.8	8.9	665.9	5.4	0.0	0.4	4.9	2.0	14.5	4.2	38.4	9.3	6.1	5.4	0.0	2.5	14.6	1.0	0.5	1.3	6.4	4.9	6.4	7.4	4.2	81.4	681.1	4.6	2.5	0.0	6.2	3.1	33.1	6.6	5.3	6.5	1.2	5.6	4.6	6.5	6.1
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610356	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.6;liver: 16.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.0;Hepatocytes: 35.9;Late spermatids: 65.0;Muller glia cells: 30.7;Proximal enterocytes: 33.2;Spermatocytes: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;GAMG: 12.3;Hep G2: 13.6;OE19: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	13.2	3.4	0.7	3.0	0.6	1.2	4.6	3.3	0.8	1.0	2.3	28.6	0.8	1.0	0.4	0.8	1.2	0.8	2.6	3.4	6.0	16.1	0.5	0.8	3.3	3.1	6.0	4.0	0.5	1.5	0.8	3.5	4.0	2.1	5.6	0.7	0.4	0.9	0.9	25.3	0.4	2.7	0.9	2.4	8.1	3.0	0.1	1.5	0.2	0.1	0.8	0.6	3.0	1.0	3.4	1.4	2.2	3.1	0.8	1.3	1.6	0.8	1.6	0.7	8.2	1.6	1.6	0.7	0.8	12.3	0.9	0.6	0.1	0.8	4.7	1.2	1.3	1.3	13.6	1.0	2.8	1.4	0.8	0.3	0.9	0.2	1.9	0.3	0.4	0.9	1.0	1.9	1.7	0.9	2.0	1.4	7.8	3.1	1.3	3.3	0.6	0.9	1.2	1.3	0.9	2.1	0.5	0.8	1.1	1.5	0.3	0.9	1.2	3.7	2.4	1.0	1.0	0.8	1.3	0.4	0.2	1.8	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.6	0.2	0.0	0.7	0.0	0.0	0.0	0.2	3.4	3.0	4.6	3.3	2.6	3.4	3.3	3.1	3.5	2.7	3.0	3.0	0.6	0.0	0.0	3.9	0.8	0.1	0.9	0.4	1.8	7.5	2.1	1.3	0.7	7.2	0.2	1.8	0.0	7.5	0.6	10.8	0.0	1.1	42.0	1.2	0.8	0.5	4.2	0.0	13.5	4.0	11.4	1.5	3.6	0.8	4.5	17.1	0.4	35.9	1.2	0.0	14.6	2.9	0.0	0.6	0.4	65.0	15.5	0.5	1.8	1.0	0.0	30.7	0.0	9.0	9.9	2.5	5.5	11.3	0.3	1.4	33.2	19.9	0.2	5.0	0.0	0.5	1.2	56.0	6.4	0.4	0.1	15.9	0.7	21.4	6.4	0.4
AQP7	"AQP7L, AQP9, AQPap"	ENSG00000165269	"Aquaporin 7"	O14520	9	33383179-33402682	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 252.7;breast: 104.9;heart muscle: 108.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 129.7;Cardiomyocytes: 86.0;Early spermatids: 128.5;Proximal enterocytes: 160.7;Proximal tubular cells: 61.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	43	"ASC diff: 196.0"	"Not detected"	"Not detected"													NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (3.25e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.25e-5)"	"unprognostic (7.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.56e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	252.7	5.0	0.9	1.9	1.3	0.0	104.9	4.4	1.4	1.3	0.0	6.6	17.9	1.7	2.9	2.8	5.9	3.4	108.5	0.8	0.7	24.2	23.5	1.2	0.7	4.8	0.7	1.8	3.8	18.3	0.3	0.5	5.8	1.2	4.0	0.3	6.4	2.5	33.8	6.2	26.8	2.5	0.3	1.3	2.8	30.4	1.0	1.0	4.8	51.9	0.2	4.7	2.2	1.2	0.1	1.9	0.2	0.1	196.0	4.5	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.1	0.1	0.1	0.3	0.1	1.1	0.0	0.1	0.0	0.1	0.4	2.2	0.2	0.0	0.2	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	4.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	1.3	4.4	1.4	0.8	0.7	4.8	0.7	5.8	0.3	1.0	1.2	129.7	6.4	7.3	0.3	0.2	1.5	0.3	0.3	0.0	0.0	0.8	1.5	86.0	14.3	0.9	35.0	0.0	0.0	0.6	30.7	5.9	1.9	128.5	9.1	0.2	11.2	0.0	0.0	0.1	0.2	0.3	4.1	0.0	0.7	0.0	0.2	2.9	20.1	0.1	0.0	0.1	9.2	0.0	0.3	0.3	21.4	2.1	1.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.2	22.5	1.9	0.1	0.5	160.7	61.4	7.7	0.0	6.6	1.7	9.6	4.1	0.7	1.3	2.6	0.0	0.3	0.9	4.3	2.1
ARAP3	"CENTD3, DRAG1, FLJ21065"	ENSG00000120318	"ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3"	Q8WWN8	5	141653401-141682230	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.2;Endothelial cells: 28.3;Hepatic stellate cells: 28.5;Horizontal cells: 38.7;Microglial cells: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 3.3;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.4;HUVEC TERT2: 74.3;TIME: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042887	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042887: AB_10796681"	"unprognostic (1.98e-1)"	"unprognostic (4.88e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.77e-3)"	"unprognostic (9.76e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.98e-2)"	11.4	4.1	4.6	5.4	4.7	6.2	10.1	5.2	5.4	9.5	1.5	4.5	3.2	7.5	5.4	3.2	7.8	6.7	14.1	3.3	2.9	7.8	2.1	15.8	2.3	4.1	4.4	3.7	2.5	5.3	5.1	11.9	4.4	7.4	2.6	3.9	3.9	5.8	7.0	2.6	4.6	5.9	3.1	7.3	4.3	1.6	6.3	0.7	8.5	9.2	1.2	7.8	7.3	2.9	11.9	7.5	29.4	0.0	1.8	4.5	0.3	7.0	7.9	7.2	9.2	4.7	0.9	0.1	39.4	2.6	11.7	12.8	5.0	16.8	5.5	0.2	2.1	11.0	12.6	0.1	8.2	0.9	0.4	8.3	7.6	3.9	8.9	20.1	74.3	0.0	0.8	0.1	1.0	0.3	0.0	9.5	17.4	3.9	9.4	0.2	2.3	0.0	0.8	5.4	0.5	24.7	15.1	0.8	12.7	10.6	0.4	2.8	53.3	4.8	10.8	1.3	14.7	0.0	0.1	0.1	12.4	12.6	24.3	0.3	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.1	0.2	4.6	4.7	5.2	5.4	3.3	2.9	4.1	4.4	4.4	3.1	6.3	2.9	33.2	3.2	8.6	0.3	0.3	0.5	1.7	3.1	0.0	6.1	0.9	2.2	5.2	0.0	2.6	1.8	0.0	0.1	1.6	1.3	0.0	1.2	0.0	0.7	2.3	28.3	0.0	0.0	2.4	0.7	0.1	2.2	1.1	1.2	1.3	0.0	28.5	0.3	1.3	38.7	3.2	1.3	2.0	4.4	2.1	0.6	0.3	2.2	0.0	15.0	2.7	3.6	2.1	1.5	0.1	4.6	1.8	1.5	1.6	2.8	0.0	0.1	0.9	0.9	0.0	1.2	3.3	0.5	0.9	0.8	0.4	0.1	1.5	0.4	2.7	3.6
ARHGAP26	"GRAF, KIAA0621, OPHN1L, OPHN1L1"	ENSG00000145819	"Rho GTPase activating protein 26"	Q9UNA1	5	142770377-143229011	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 237.3;Excitatory neurons: 611.6;Inhibitory neurons: 261.5;Late spermatids: 153.3;Microglial cells: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"neutrophil: 24.7;NK-cell: 9.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 24.7;NK-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 85.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035106, HPA035107"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA035106: AB_2674465, HPA035107: AB_10669855"	"prognostic favorable (2.05e-4)"	"prognostic favorable (1.36e-4)"	"prognostic favorable (6.95e-4)"	"prognostic favorable (5.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-2)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (9.43e-3)"	"unprognostic (7.19e-3)"	"unprognostic (8.65e-2)"	"unprognostic (3.21e-3)"	"unprognostic (5.67e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.88e-6)"	11.0	4.5	10.9	17.7	6.5	36.4	11.3	19.3	17.0	11.9	0.6	12.9	12.0	7.7	9.1	6.4	15.5	14.2	15.0	10.8	3.4	8.9	6.8	19.0	6.4	0.5	2.7	3.0	4.9	3.9	12.2	20.9	0.3	7.4	12.7	17.2	12.8	4.2	12.6	7.4	11.3	9.7	2.3	16.7	15.2	15.4	10.1	13.8	8.3	10.5	12.2	12.2	5.8	9.9	16.4	29.1	8.0	7.6	12.3	12.7	12.4	2.2	2.4	7.6	12.1	44.9	33.0	2.0	16.1	4.9	21.5	7.5	4.1	15.3	8.7	33.8	4.6	0.1	5.3	26.9	7.8	22.6	2.9	4.7	23.0	12.8	31.0	5.6	10.2	9.9	0.6	85.4	2.4	2.3	12.9	9.2	4.3	23.2	7.7	5.2	12.5	36.5	20.4	25.6	3.4	4.7	3.8	4.4	7.1	6.5	2.4	6.2	21.0	4.1	5.8	0.4	8.1	4.0	14.0	0.4	10.7	21.3	5.6	4.0	3.9	2.3	3.8	2.5	1.7	0.5	0.8	2.4	3.0	0.4	0.3	1.1	24.7	9.8	1.6	0.7	0.3	1.8	10.9	6.5	19.3	17.0	10.8	3.4	0.5	2.7	0.3	2.3	10.1	9.9	39.4	16.0	22.5	237.3	5.8	6.9	13.8	13.2	5.7	15.9	20.7	17.0	37.6	21.5	14.1	0.0	8.4	1.3	41.6	38.7	0.0	17.9	77.2	17.9	4.0	32.5	3.6	11.8	611.6	21.1	0.6	13.6	39.8	55.6	26.6	6.4	40.0	6.5	26.4	75.7	261.5	26.4	0.0	48.0	44.9	153.3	6.5	51.6	10.6	326.0	47.3	7.5	40.2	30.7	29.8	21.1	27.8	14.3	14.5	29.3	27.9	5.8	16.1	52.6	46.0	27.6	17.7	2.6	8.7	7.5	5.5	1.9	29.3	50.5	26.8	36.2
ARHGAP28	"FLJ10312, KIAA1314"	ENSG00000088756	"Rho GTPase activating protein 28"	Q9P2N2	18	6729716-6915716	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"placenta: 25.9;testis: 77.5"	"Group enriched"	"Detected in many"	14	"Early spermatids: 536.8;Late spermatids: 488.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"AF22: 30.4;CACO-2: 32.8;SuSa: 22.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030413, HPA030414, HPA030415"	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Cell Junctions"		"HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598"	"unprognostic (8.33e-2)"	"unprognostic (8.79e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.94e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.56e-3)"	"unprognostic (9.52e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.59e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.76e-2)"	4.7	1.9	1.1	1.7	1.2	0.8	2.7	1.7	1.6	8.6	0.8	1.9	1.7	2.9	8.7	1.9	3.1	6.6	2.0	1.5	1.6	8.4	0.9	4.6	1.7	0.4	0.2	10.4	3.8	3.0	0.8	25.9	0.5	3.9	2.3	1.4	0.8	2.2	4.9	2.1	1.8	1.4	0.1	12.6	2.1	77.5	1.1	3.8	2.9	1.6	0.9	5.4	3.0	0.8	0.2	0.2	30.4	3.1	6.3	10.5	4.9	2.2	5.1	2.5	5.3	32.8	0.2	0.2	1.0	0.4	1.7	1.4	0.1	0.8	3.7	1.0	1.8	0.1	2.9	0.2	1.1	0.1	0.1	12.6	0.6	2.7	0.2	0.3	7.8	0.5	0.8	2.5	4.1	0.5	0.5	0.3	9.6	0.4	1.4	0.1	2.7	0.2	0.0	2.9	2.9	11.9	0.1	2.8	0.5	22.6	0.2	0.1	1.3	0.5	13.1	10.1	0.4	0.2	0.1	0.1	5.0	0.3	1.1	0.7	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	3.0	0.1	0.0	0.2	0.0	0.0	1.1	1.2	1.7	1.6	1.5	1.6	0.4	0.2	0.5	0.1	1.1	0.8	8.3	0.0	1.9	6.2	0.1	1.9	1.3	0.2	0.0	1.5	0.9	0.5	1.8	0.0	0.7	1.8	20.9	14.9	0.0	0.0	0.0	1.1	536.8	0.5	14.6	7.9	0.0	0.0	7.1	2.7	2.7	16.1	0.0	0.4	0.0	25.8	4.2	0.2	2.1	0.0	34.4	0.1	0.0	0.3	0.4	488.0	18.3	0.5	0.0	12.2	0.0	0.2	0.0	24.6	3.6	0.7	0.0	14.3	0.1	4.7	0.0	3.8	0.0	0.8	0.0	11.0	5.4	14.3	3.7	0.8	1.4	6.6	0.3	23.7	0.0	1.3
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 171.0;Early spermatids: 96.8;NK-cells: 123.6;Spermatocytes: 89.0;T-cells: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 27.6;HMC-1: 116.2;MOLT-4: 22.5;NB-4: 22.1;THP-1: 34.9;U-937: 27.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	10.8	4.2	4.2	34.3	6.1	119.7	4.1	8.1	11.1	2.6	4.7	7.7	8.2	3.4	1.6	4.6	7.4	10.5	3.9	4.4	5.3	5.1	7.5	22.0	56.9	7.8	5.8	1.6	3.5	0.6	2.2	5.2	8.8	4.3	10.7	0.5	4.7	1.8	1.3	2.2	37.6	5.9	5.6	100.7	8.8	19.3	6.1	34.9	4.5	6.4	60.7	9.5	3.6	6.4	0.2	0.0	0.2	0.5	0.0	0.0	0.1	0.4	0.5	0.1	0.2	0.1	0.0	14.3	0.3	0.3	0.0	0.2	0.4	0.0	0.0	0.7	0.0	27.6	0.1	0.0	1.1	16.4	116.2	0.7	0.0	0.0	0.3	0.2	0.0	14.3	0.5	7.9	0.0	0.0	22.5	22.1	1.0	0.0	0.0	9.1	10.2	4.6	0.0	0.1	3.9	3.0	0.0	0.0	0.4	0.5	0.0	34.9	0.9	0.2	0.3	0.1	0.1	9.2	7.2	13.3	0.3	27.3	0.5	51.9	86.1	243.4	43.3	89.2	30.0	35.9	47.3	39.6	72.1	44.0	61.9	46.0	388.9	68.2	71.0	97.4	63.6	70.8	4.2	6.1	8.1	11.1	4.4	5.3	7.8	5.8	8.8	5.6	6.1	6.4	2.2	0.0	14.2	1.0	49.1	1.5	0.2	0.0	1.8	0.2	1.6	2.9	2.1	1.5	1.3	0.0	2.1	0.4	171.0	0.6	0.0	0.2	96.8	0.6	0.8	1.5	0.0	11.6	3.7	0.0	0.6	2.4	4.6	0.8	12.0	0.0	3.6	1.2	43.5	0.0	1.9	0.5	0.0	39.0	19.7	44.8	1.8	35.1	0.0	8.4	34.8	0.0	123.6	0.0	0.2	0.2	0.1	0.0	50.8	0.2	0.0	0.3	2.2	0.7	0.0	0.6	1.2	89.0	17.5	0.4	1.4	0.3	108.2	0.3	0.4	0.1
ARHGEF25	"GEFT, p63RhoGEF"	ENSG00000240771	"Rho guanine nucleotide exchange factor 25"	Q86VW2	12	57610180-57617245	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 151.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 20.8;Leydig cells: 24.8;Peritubular cells: 45.9;Sertoli cells: 26.3;Smooth muscle cells: 38.9"	"Cancer enhanced"	"Detected in all"		"glioma: 23.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 59.1;RH-30: 129.7;SH-SY5Y: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052016	Approved					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA052016: AB_2681695"	"unprognostic (8.43e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.13e-3)"	"unprognostic (6.95e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.20e-7)"	"unprognostic (1.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.22e-3)"	34.4	12.0	30.7	10.7	38.7	0.1	29.1	38.5	72.1	64.5	12.6	151.2	10.3	92.8	44.3	29.6	85.5	23.6	24.6	72.0	21.7	17.7	5.0	21.7	6.2	20.6	21.1	58.2	8.5	9.4	26.4	9.4	20.8	60.6	19.5	13.2	13.9	80.4	11.4	12.0	34.4	68.8	17.3	20.1	45.0	10.6	22.5	2.1	14.1	13.8	4.9	84.3	51.4	40.5	0.8	8.9	41.6	26.1	0.1	0.0	3.3	12.7	37.4	16.5	20.2	5.2	8.1	3.5	10.7	23.4	7.7	0.4	16.2	0.7	13.9	11.7	13.9	7.4	6.1	11.4	11.6	0.2	19.2	11.5	3.5	7.5	1.1	59.1	6.5	2.0	15.5	16.0	12.2	3.0	2.7	0.3	26.5	0.4	0.4	0.0	129.7	0.7	0.7	0.7	24.1	58.7	2.4	1.2	4.8	14.8	4.3	8.9	0.0	14.8	14.0	9.7	4.7	33.5	5.4	0.1	12.4	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	38.7	38.5	72.1	72.0	21.7	20.6	21.1	20.8	17.3	22.5	40.5	5.6	0.0	0.0	8.5	0.0	2.0	1.8	0.2	4.6	17.7	1.8	8.6	11.6	0.0	0.6	0.0	2.1	0.2	0.6	0.0	0.0	0.5	0.2	1.1	20.8	4.4	0.0	0.0	15.3	1.4	0.5	12.6	0.5	0.6	0.0	2.6	6.8	0.0	0.5	8.4	8.5	0.0	0.0	0.0	1.7	1.5	24.8	0.2	0.0	8.4	0.0	5.4	2.1	3.0	1.6	0.3	0.0	45.9	0.3	0.8	0.0	0.4	0.0	2.8	26.3	6.3	38.9	1.4	1.4	0.9	1.1	0.3	0.5	9.6	0.0	0.4
ARHGEF3	"DKFZP434F2429, GEF3, STA3, XPLN"	ENSG00000163947	"Rho guanine nucleotide exchange factor 3"	Q9NR81	3	56727418-57079329	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 157.8;NK-cells: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 88.8;RPMI-8226: 92.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034715, HPA064945"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA034715: AB_10600780, HPA064945: AB_2685389"	"unprognostic (1.84e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (8.25e-2)"	"prognostic favorable (2.61e-4)"	"unprognostic (9.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.44e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.99e-2)"	"prognostic favorable (1.96e-7)"	"unprognostic (8.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.84e-2)"	16.8	43.2	11.2	20.6	14.8	9.8	13.8	14.4	17.4	16.0	30.9	14.3	6.4	38.0	12.5	19.0	23.2	22.3	12.7	25.9	10.8	25.3	5.2	24.8	29.3	11.2	9.1	20.6	29.1	52.3	21.6	21.3	10.7	14.8	13.5	8.2	21.5	15.3	8.0	12.6	9.6	34.5	7.6	21.5	15.8	14.3	11.6	36.1	14.2	8.5	28.7	17.2	11.6	12.8	24.2	8.4	1.2	7.7	2.7	2.2	16.5	2.6	2.2	2.6	3.4	4.1	22.3	12.6	2.5	4.7	25.3	12.1	7.2	30.8	3.0	18.4	3.5	10.3	5.2	88.8	6.6	0.0	10.9	9.7	19.9	2.3	3.5	23.6	25.5	13.3	2.9	27.2	5.9	3.7	34.8	1.3	2.3	19.5	12.9	0.2	9.2	92.2	19.8	13.2	1.4	3.8	15.3	11.2	6.9	8.5	2.9	10.6	11.8	1.3	6.0	5.4	4.0	35.0	14.2	45.1	21.7	12.2	10.9	20.6	23.0	3.7	96.1	25.5	72.5	26.0	73.6	85.0	13.9	16.9	59.3	73.5	8.3	39.7	32.2	5.9	67.4	76.0	11.2	14.8	14.4	17.4	25.9	10.8	11.2	9.1	10.7	7.6	11.6	12.8	22.7	16.0	22.4	30.0	24.2	11.1	8.6	16.3	32.5	9.5	7.6	9.9	9.8	2.8	12.6	23.9	4.2	11.4	57.5	4.8	11.7	11.0	22.6	10.1	7.0	40.3	9.6	14.1	157.8	10.2	7.9	13.5	36.2	16.5	13.9	4.8	22.9	0.1	7.6	0.0	70.8	1.3	2.0	38.1	8.2	14.1	17.7	18.7	10.6	63.7	19.9	9.0	137.0	68.3	80.0	7.5	1.4	24.0	22.1	11.2	0.2	7.3	9.5	1.2	0.0	8.0	4.4	3.3	2.6	37.9	14.9	11.9	64.3	3.2	3.2	13.4
ARL11	"ARLTS1, FLJ33930"	ENSG00000152213	"ADP ribosylation factor like GTPase 11"	Q969Q4	13	49628507-49633872	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Hofbauer cells: 31.3;Kupffer cells: 34.8;Macrophages: 18.2;monocytes: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 38.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.9;HMC-1: 10.7;NB-4: 11.1;THP-1: 14.5;U-698: 6.6;U-937: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040855, HPA040887"	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Intermediate filaments, Cytosol"		"HPA040855: AB_10793864, HPA040887: AB_10796229"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.72e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.14e-2)"	0.8	0.8	0.5	3.9	0.5	3.5	0.7	0.6	0.7	0.6	0.8	1.0	1.2	0.2	0.2	1.0	0.3	1.1	0.4	0.4	0.6	0.1	0.6	2.2	6.9	1.0	0.7	0.2	0.1	0.3	0.3	1.9	0.8	0.2	1.5	0.1	0.6	0.2	0.3	0.6	1.9	0.7	0.7	4.8	0.6	0.3	1.0	3.7	0.4	0.4	3.9	1.3	0.8	1.2	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.6	0.0	5.2	10.7	0.1	0.1	0.0	0.0	0.0	0.4	5.1	0.3	0.1	0.0	1.3	4.9	11.1	0.1	0.0	0.0	5.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	3.5	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.6	0.0	6.3	0.0	21.8	15.3	16.3	0.1	17.9	0.2	7.9	0.3	0.3	8.1	10.1	0.8	0.4	38.0	0.8	13.4	8.6	0.3	4.4	0.5	0.5	0.6	0.7	0.4	0.6	1.0	0.7	0.8	0.7	1.0	1.2	0.9	0.0	1.1	0.0	18.2	0.3	0.3	0.2	1.2	0.7	1.0	0.9	0.6	2.8	0.0	0.0	0.0	4.7	3.4	1.7	0.0	0.0	1.7	0.1	0.1	1.2	1.2	6.9	0.0	0.0	5.1	0.3	0.0	0.1	7.6	0.0	1.8	0.6	31.3	0.0	0.0	3.4	0.0	34.8	3.5	1.3	0.3	18.2	0.0	3.7	19.2	0.3	1.0	0.0	0.1	0.1	10.2	0.0	2.9	0.1	4.2	0.1	2.3	0.5	0.0	0.3	0.2	1.5	0.3	4.1	0.0	1.5	1.2	0.5	3.1	0.4
ARMH4	"C14orf37, UT2"	ENSG00000139971	"Armadillo like helical domain containing 4"	Q86TY3	14	57999735-58298139	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.8;kidney: 8.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 15.8;Collecting duct cells: 12.9;Endometrial ciliated cells: 10.2;Endometrial stromal cells: 7.7;Granulosa cells: 26.0;Theca cells: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.7;AN3-CA: 6.1;fHDF/TERT166: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001580, HPA001789"	Enhanced		Approved	"Plasma membrane"		NA	NA		1800000		"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"		"HPA001580: AB_2666366, HPA001789: AB_1078328"	"unprognostic (2.56e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.87e-8)"	"unprognostic (5.22e-6)"	"unprognostic (4.93e-2)"	"unprognostic (8.74e-4)"	"unprognostic (3.01e-4)"	1.2	2.5	2.3	0.6	3.6	0.7	0.8	8.5	3.5	1.8	0.0	0.7	0.5	3.0	1.8	0.8	2.1	1.8	3.1	2.6	2.1	8.3	0.8	0.7	0.4	11.5	5.1	4.3	1.0	3.6	1.3	0.4	12.8	1.6	1.0	1.2	0.7	1.4	0.2	1.0	0.7	2.3	1.0	0.5	1.4	2.2	1.6	0.2	1.5	1.9	0.3	1.2	0.9	0.7	0.0	0.0	9.7	6.1	4.7	1.7	0.0	1.9	1.5	0.3	0.3	0.5	0.1	0.0	0.6	10.8	1.2	0.0	2.9	0.0	0.4	0.1	1.0	0.0	0.0	0.5	0.2	0.0	4.8	1.8	0.0	0.2	0.2	2.7	0.5	0.8	0.1	0.3	1.2	0.3	0.0	0.0	4.5	0.0	2.0	1.4	0.3	2.5	3.9	0.3	1.1	0.0	0.1	0.0	0.3	2.7	0.2	0.2	0.1	1.3	3.5	0.5	2.6	0.3	0.2	0.0	3.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.6	8.5	3.5	2.6	2.1	11.5	5.1	12.8	1.0	1.6	0.7	15.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	12.9	0.0	0.2	0.7	0.0	0.0	2.1	0.0	10.2	7.7	2.3	0.0	0.0	0.0	1.3	0.4	3.0	0.0	2.4	0.0	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.3	44.5	0.0	0.0
ARRDC3	"KIAA1376, TLIMP"	ENSG00000113369	"Arrestin domain containing 3"	Q96B67	5	91368631-91383317	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 394.2;Syncytiotrophoblasts: 339.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 115.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"				"unprognostic (2.28e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.25e-8)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.15e-1)"	36.8	80.1	16.9	26.8	22.6	167.4	94.6	23.7	32.5	44.8	24.0	19.9	9.9	40.5	27.1	38.7	24.9	39.0	24.7	16.3	20.1	52.7	75.9	44.5	29.3	27.8	20.2	93.2	20.8	54.3	21.5	76.8	22.3	30.3	27.5	75.1	63.9	24.3	34.2	41.3	16.8	33.0	23.8	37.1	25.7	16.6	18.1	28.0	84.0	44.9	28.2	57.0	42.0	41.9	6.6	10.7	12.1	16.6	18.4	31.0	40.2	15.8	14.7	9.3	16.2	5.2	26.9	7.9	13.0	16.2	26.1	14.6	13.4	13.3	8.5	8.2	1.4	3.9	43.3	8.5	14.3	27.9	1.6	13.3	21.2	8.1	20.9	56.4	26.1	7.6	11.5	37.7	14.4	3.7	29.9	4.1	4.3	2.8	11.3	24.8	15.2	41.5	60.4	11.9	21.1	14.0	48.2	3.7	2.9	30.2	17.9	13.1	28.3	7.7	11.2	12.4	9.6	28.6	40.9	16.1	45.8	16.4	8.7	28.7	15.2	20.4	29.1	13.1	21.1	12.3	18.3	22.8	9.3	9.4	24.0	37.7	115.3	14.9	22.2	2.2	21.9	19.9	16.9	22.6	23.7	32.5	16.3	20.1	27.8	20.2	22.3	23.8	18.1	41.9	53.8	51.3	166.5	6.5	47.0	112.0	17.6	51.2	9.1	30.9	89.5	48.5	34.5	20.0	72.4	97.5	31.3	89.9	110.2	21.2	154.6	72.6	27.1	28.9	43.1	143.3	73.0	37.1	10.5	79.5	81.6	95.7	38.7	51.4	37.3	36.4	37.5	155.1	48.7	32.0	15.5	32.4	10.2	106.9	394.2	22.3	21.1	100.3	120.9	14.0	56.6	97.0	50.4	13.6	28.3	41.2	16.1	15.1	58.8	31.2	9.3	57.3	28.5	67.2	19.7	32.1	54.9	8.1	9.6	55.6	118.3	339.4	66.3	23.4	20.2	22.7
ARSF		ENSG00000062096	"Arylsulfatase F"	P54793	X	3041471-3112727	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;kidney: 7.6;skin 1: 5.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Distal tubular cells: 1.9;Inhibitory neurons: 4.6;Oligodendrocyte precursor cells: 2.5;Proximal tubular cells: 10.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA000549			Uncertain	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA000549: AB_1845055"	"unprognostic (2.19e-2)"	"unprognostic (8.88e-2)"		"unprognostic (2.87e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.70e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.48e-1)"	0.0	3.0	2.6	0.0	3.6	0.1	0.2	3.0	2.7	0.4	1.5	0.0	0.0	0.0	1.6	2.6	0.0	0.0	0.0	3.2	2.1	7.6	1.6	0.0	0.0	4.9	2.9	0.0	0.6	0.3	0.0	0.0	3.1	0.1	0.0	0.1	0.2	0.0	0.1	5.6	0.0	0.0	2.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.5	0.2	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.6	3.6	3.0	2.7	3.2	2.1	4.9	2.9	3.1	2.8	3.0	2.1	0.0	0.0	0.0	9.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3
ARSL	"ARSE, CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase L"	P51690	X	2934521-2968475	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.6;liver: 86.3;pancreas: 105.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 34.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA060518: AB_2684301, HPA070651: AB_2732160"	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.4	0.7	2.6	2.2	2.7	0.3	1.1	2.1	2.8	1.7	4.5	20.8	17.9	3.2	2.2	0.4	4.1	8.2	1.0	2.8	2.6	36.6	86.3	2.7	0.1	2.8	2.8	7.1	105.2	0.0	0.7	0.7	2.9	0.5	16.7	0.3	1.3	2.9	0.2	0.2	13.6	1.9	2.4	0.0	2.9	0.4	2.6	0.0	0.2	0.3	0.1	0.5	1.6	2.3	4.5	68.9	8.2	0.0	3.3	4.0	1.3	3.9	6.4	4.0	4.0	42.7	0.0	0.0	13.7	0.1	30.8	0.0	0.0	0.9	2.3	0.0	4.5	0.0	0.0	64.1	1.8	0.0	0.1	9.6	0.0	3.8	0.0	7.3	3.8	0.0	0.0	0.1	10.5	0.1	0.0	0.0	33.6	2.4	0.2	2.8	1.1	0.3	7.1	0.0	0.1	0.2	0.0	0.0	2.6	13.7	0.0	0.2	5.0	0.1	0.2	0.0	7.4	0.0	0.0	0.1	9.1	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	2.1	2.8	2.8	2.6	2.8	2.8	2.9	2.4	2.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ASB15	FLJ43370	ENSG00000146809	"Ankyrin repeat and SOCS box containing 15"	Q8WXK1	7	123567010-123639481	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 27.3;skeletal muscle: 119.3;tongue: 84.1"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 54.2;Early spermatids: 35.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.19e-1)"					"unprognostic (7.45e-2)"	"unprognostic (1.37e-1)"					"unprognostic (5.98e-1)"	"unprognostic (6.09e-6)"	"unprognostic (7.31e-2)"	"unprognostic (6.39e-2)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	27.3	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.5	0.0	119.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	84.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.4	0.0	1.7	0.3	0.3	54.2	0.0	0.2	0.0	0.0	0.2	0.2	0.3	1.9	0.2	35.0	0.8	0.4	0.4	0.0	0.0	0.4	0.4	1.4	0.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	5.6	0.6	0.0	3.6	0.0	0.0	0.3	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.7	0.1	10.4	0.1	0.1	0.0	6.9	0.8	1.2	0.4	0.0	0.1	1.1	0.2	0.3	0.2	0.3
ASL	ASAL	ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075800-66094697	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 396.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		12000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	21.7	16.1	5.9	16.7	6.0	23.9	22.0	6.6	8.5	18.2	8.7	53.8	60.7	17.0	6.7	28.7	18.1	27.7	16.9	5.9	8.0	61.2	396.4	27.4	10.3	7.4	7.1	19.7	37.1	15.1	19.8	9.1	9.8	19.5	35.7	2.4	18.3	9.8	8.7	15.1	45.6	10.1	6.2	30.5	43.9	4.5	7.6	5.3	24.9	6.9	8.8	19.3	19.8	6.7	48.4	18.9	11.2	36.7	26.3	18.1	22.1	34.0	31.8	49.5	43.6	43.7	59.0	15.9	53.7	48.5	36.6	13.4	7.1	59.1	11.1	10.5	8.9	18.8	17.9	77.2	48.8	24.0	51.3	38.3	19.5	31.8	51.8	12.5	48.1	11.3	34.4	27.8	25.4	36.6	4.8	28.9	15.8	65.5	26.1	12.1	11.0	51.6	31.9	31.6	18.4	24.3	32.3	109.7	12.3	11.4	46.0	19.7	55.1	53.7	30.8	23.5	45.2	30.2	16.9	19.0	55.0	41.5	49.5	34.2	42.6	50.8	16.9	46.6	15.1	21.8	11.5	13.4	46.2	13.8	8.2	8.5	7.3	73.7	36.1	2.5	23.4	27.3	5.9	6.0	6.6	8.5	5.9	8.0	7.4	7.1	9.8	6.2	7.6	6.7	34.5	19.2	61.4	5.2	20.4	5.5	21.4	24.2	9.1	12.7	24.5	20.4	9.2	124.4	25.8	31.3	22.9	20.7	25.4	294.6	52.8	73.7	4.0	41.2	12.1	30.7	54.0	47.1	9.4	218.6	45.7	14.4	115.7	34.1	44.5	12.0	42.8	578.0	46.0	15.2	9.7	126.5	16.2	41.2	17.6	6.3	9.3	22.3	8.8	1.9	48.3	7.2	34.0	2.5	4.8	118.3	240.4	8.2	23.4	14.9	259.9	243.1	42.8	13.2	13.1	16.9	17.5	3.2	5.7	19.5	4.3	22.3	18.0	13.5	189.4	22.0
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503405	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;kidney: 38.2"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 49.7;Melanocytes: 46.2;Oligodendrocytes: 217.0;Peritubular cells: 48.2;Proximal enterocytes: 37.5;Proximal tubular cells: 74.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.4;ASC TERT1: 4.1;CACO-2: 3.8;HSkMC: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	13.9	4.3	25.9	1.8	46.4	1.8	4.1	27.6	40.9	7.5	14.2	4.3	11.2	4.5	6.0	4.9	5.5	3.6	2.7	25.8	27.7	38.2	15.0	3.5	1.5	30.4	35.4	2.9	1.0	0.8	0.8	3.5	29.5	4.1	4.9	2.8	1.8	5.0	11.9	5.2	15.6	3.1	24.7	5.4	4.4	6.6	42.4	0.6	2.1	15.0	0.7	6.3	4.3	69.0	0.2	0.1	0.5	0.5	5.4	4.1	0.3	0.2	0.1	0.2	0.1	3.8	0.2	0.6	0.2	0.7	0.3	0.3	0.3	0.1	0.2	2.0	0.1	0.4	0.7	0.2	0.5	0.4	0.4	7.5	0.3	0.4	0.1	0.1	0.1	0.4	0.3	1.1	0.2	0.2	0.2	0.6	0.4	0.2	0.3	0.3	0.3	0.6	0.2	1.1	0.4	0.3	1.1	0.3	0.9	0.4	0.3	0.2	0.4	0.6	0.4	0.4	0.3	0.7	0.4	0.4	0.2	0.4	0.5	1.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.7	0.3	0.1	0.2	0.1	0.0	25.9	46.4	27.6	40.9	25.8	27.7	30.4	35.4	29.5	24.7	42.4	69.0	5.1	9.6	1.5	12.1	0.1	5.2	1.5	1.6	6.2	5.5	2.1	0.8	1.3	2.8	1.0	25.8	0.0	0.0	0.0	0.3	7.9	0.2	5.0	0.1	4.1	1.1	2.4	2.7	0.6	0.2	0.1	15.0	2.0	0.2	0.0	0.1	3.9	11.5	0.2	8.4	0.4	0.8	2.0	0.8	1.5	2.5	49.7	0.8	46.2	3.7	0.0	4.1	0.0	1.5	217.0	0.0	2.5	48.2	0.2	0.4	37.5	74.8	0.1	0.5	0.0	8.5	11.6	11.1	0.6	0.7	1.7	0.1	0.4	28.3	1.8	2.7
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.1;kidney: 39.0;liver: 132.4"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 135.8;Proximal tubular cells: 487.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;MOLT-4: 16.5;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042631, HPA042654"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		200000		"Cluster 15: Liver - Metabolism"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	0.5	2.5	18.1	0.9	20.9	0.5	0.0	23.7	40.1	0.0	7.3	0.2	6.6	0.2	0.0	0.3	0.0	1.7	0.3	19.8	17.3	39.0	132.4	0.2	0.9	17.0	17.5	0.0	0.8	0.0	19.6	0.0	16.8	0.3	0.0	5.4	1.6	0.0	0.3	1.1	2.5	0.0	13.4	0.6	0.3	0.2	22.9	2.4	0.9	0.0	0.0	0.1	0.1	21.9	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.6	0.0	0.7	3.8	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	1.7	0.0	1.6	16.5	0.1	0.0	0.6	0.2	0.4	0.3	1.1	0.0	0.2	1.7	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	3.6	0.8	1.8	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	20.9	23.7	40.1	19.8	17.3	17.0	17.5	16.8	13.4	22.9	21.9	0.0	0.0	0.0	3.3	2.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.4	1.5	0.0	9.2	4.2	0.0	0.0	0.1	45.0	0.0	0.7	0.0	0.0	0.1	7.1	10.7	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	135.8	0.0	0.0	4.4	0.1	0.0	1.9	0.0	2.5	0.0	3.4	0.0	2.8	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.8	487.2	0.0	4.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085686-104115582	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.4;liver: 151.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 21.4;Distal enterocytes: 21.2;Granulosa cells: 66.8;Hepatocytes: 93.9;Proximal tubular cells: 49.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA069761	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 40: Granulosa cells - Unknown function"			"HPA069761: AB_2686191"	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	1.1	1.4	0.1	0.2	0.2	0.0	0.7	0.0	0.4	5.4	0.2	4.7	1.5	2.2	1.1	34.0	6.2	0.1	102.4	0.3	0.3	12.8	151.1	2.3	0.0	0.4	0.6	11.4	0.2	0.8	2.3	1.8	0.2	0.3	1.9	0.3	2.8	0.1	0.5	9.9	0.5	1.2	0.0	0.2	3.1	1.1	1.1	0.1	5.9	0.0	3.7	2.3	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.5	0.4	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.3	0.4	0.6	0.2	0.0	1.1	0.0	0.0	6.4	1.7	0.3	0.5	1.8	0.2	0.7	0.0	1.1	0.6	0.8	21.4	2.8	2.4	0.0	0.0	0.2	0.0	21.2	3.9	0.0	0.4	0.7	0.1	0.5	1.8	0.0	0.1	0.2	0.2	4.3	4.6	0.7	0.0	66.8	3.6	93.9	0.2	5.0	0.1	16.0	0.0	1.6	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	7.6	1.2	0.0	0.1	0.9	49.7	1.6	0.3	0.0	0.0	0.6	0.3	1.5	8.4	9.1	0.5	0.3	3.9	5.4	3.0
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 95.3;smooth muscle: 110.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 67.2;Fibroblasts: 94.6;Microglial cells: 24.4;Sertoli cells: 39.5;Smooth muscle cells: 73.5;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in all"		"breast cancer: 51.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.0;BJ hTERT+: 5.7;HHSteC: 23.2;HSkMC: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007894, HPA008435, HPA024230"	Approved		Uncertain	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		2100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA007894: , HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	29.6	7.6	1.2	5.7	1.7	0.1	11.8	2.3	2.0	40.9	0.9	25.5	9.6	69.6	9.7	10.1	16.9	65.9	95.3	1.2	1.2	11.2	41.1	14.3	3.0	1.3	1.2	7.1	13.4	3.8	2.5	4.3	1.6	4.7	11.3	0.2	3.2	11.7	7.8	12.1	17.6	110.5	1.0	2.3	12.0	1.2	1.8	2.5	11.1	19.8	5.5	13.4	5.0	1.7	0.1	0.0	0.0	0.0	1.4	16.0	0.2	2.6	5.7	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	23.2	0.2	0.0	4.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	1.2	1.7	2.3	2.0	1.2	1.2	1.3	1.2	1.6	1.0	1.8	1.7	12.9	0.0	1.1	0.3	0.1	67.2	0.1	0.0	0.0	0.4	0.4	0.1	8.5	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	4.2	6.8	0.0	0.0	2.0	0.0	0.1	94.6	0.5	0.2	1.3	0.1	13.9	0.4	0.2	0.0	1.7	0.0	0.0	0.0	13.5	0.6	5.9	0.8	14.2	24.4	0.0	0.1	0.0	1.5	1.1	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.7	0.6	39.5	4.3	73.5	0.0	0.1	0.3	27.0	0.0	1.7	0.3	0.0	0.0
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444961-130501274	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 1284.8;liver: 2037.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 398.7;Hepatocytes: 1062.0;Proximal enterocytes: 618.2;Proximal tubular cells: 1408.9;Urothelial cells: 413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 893.9;HaCaT: 850.4;hTCEpi: 817.8;RPMI-8226: 1444.5;THP-1: 1061.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		6400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	215.0	146.8	29.6	51.3	29.7	0.2	168.2	25.0	31.0	67.0	61.7	157.2	124.5	111.3	124.8	51.1	166.3	110.2	66.5	31.5	38.3	1284.8	2037.7	52.9	7.5	40.2	42.2	57.2	68.4	11.4	45.0	50.6	51.7	56.2	167.9	6.9	119.4	132.6	74.4	131.3	194.8	61.2	28.4	20.0	53.2	35.9	38.4	7.8	92.3	71.4	15.6	288.7	66.6	25.3	124.5	11.9	13.7	23.1	88.4	223.1	43.6	146.2	893.9	28.2	85.5	52.5	34.0	0.4	95.9	300.2	8.2	850.4	59.9	5.2	19.5	21.7	27.1	0.3	18.3	137.3	305.4	18.3	1.6	148.2	817.8	45.4	81.2	0.3	1.1	384.0	5.3	530.6	28.8	619.8	7.2	262.7	19.2	635.9	26.7	1.7	15.4	1444.5	78.8	61.3	342.4	5.8	515.4	534.7	41.5	53.5	366.1	1061.5	0.4	11.3	68.3	2.3	13.0	88.1	91.5	32.1	219.0	137.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	29.6	29.7	25.0	31.0	31.5	38.3	40.2	42.2	51.7	28.4	38.4	25.3	72.1	25.6	28.6	2.6	21.3	70.5	55.7	179.8	53.5	0.1	23.7	17.3	5.4	138.7	104.4	47.8	0.0	178.5	0.4	398.7	133.1	116.5	1.2	4.7	30.5	68.0	12.0	93.7	2.2	110.5	8.9	21.5	20.4	6.2	5.7	55.5	65.7	1062.0	14.7	0.0	8.0	186.8	24.4	40.1	6.5	7.8	31.1	8.0	3.6	7.5	1.6	10.6	0.0	0.0	0.2	70.8	310.4	124.8	11.7	104.0	618.2	1408.9	32.7	0.4	0.0	18.7	13.4	1.4	2.6	23.5	17.5	144.1	11.5	62.0	165.6	413.2
ATG9B	"APG9L2, FLJ14885, NOS3AS, SONE"	ENSG00000181652	"Autophagy related 9B"	Q674R7	7	151012209-151024499	"Metabolic proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;skin 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.7;Endometrial ciliated cells: 28.6;Late spermatids: 30.3;Respiratory ciliated cells: 25.9;Syncytiotrophoblasts: 115.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.9"	"Group enriched"	"Detected in some"	5	"BEWO: 13.0;CAPAN-2: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (1.59e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.79e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.08e-6)"	"unprognostic (2.82e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.63e-1)"	0.0	0.5	1.1	0.4	1.7	0.2	0.2	0.4	1.0	1.7	0.3	0.0	0.0	0.4	1.1	8.3	1.0	0.2	0.0	0.5	2.1	0.0	0.0	0.2	0.8	2.0	1.7	0.1	0.0	0.0	1.5	4.1	1.1	0.2	0.0	0.8	0.5	0.0	0.2	11.5	0.0	0.0	1.0	0.1	0.1	2.0	2.1	0.3	0.1	0.0	0.8	0.1	1.6	0.4	0.6	0.0	0.7	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.1	4.2	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.5	0.4	0.6	0.0	1.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.0	1.0	0.9	5.0	1.3	0.0	1.6	8.9	3.4	0.0	0.4	0.1	0.7	5.4	1.4	1.1	1.7	0.4	1.0	0.5	2.1	2.0	1.7	1.1	1.0	2.1	0.4	0.4	0.0	0.0	0.0	2.8	0.0	0.2	1.9	0.6	4.0	0.7	0.9	1.4	1.5	1.6	0.0	0.0	10.2	1.5	0.3	0.0	0.3	50.7	28.6	3.3	1.1	0.0	0.0	2.7	0.2	2.5	0.5	0.0	15.4	14.7	7.8	2.2	0.0	1.9	0.0	7.7	0.0	4.1	0.3	0.4	30.3	0.6	0.8	0.0	0.0	0.3	0.5	1.0	0.5	0.6	3.8	0.0	0.7	0.4	0.3	0.0	0.1	25.9	0.6	0.0	0.0	0.9	19.8	12.7	0.8	0.3	115.5	4.7	0.1	0.2	1.9
ATL1	"AD-FSP, FSP1, SPG3, SPG3A"	ENSG00000198513	"Atlastin GTPase 1"	Q8WXF7	14	50532509-50634017	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.6;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 136.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 22.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.8;SCLC-21H: 17.1;SH-SY5Y: 15.4;SiHa: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027550	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA027550: AB_10600983"	"unprognostic (2.06e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.23e-2)"	4.1	5.6	29.1	3.3	33.2	0.2	11.3	18.8	42.8	5.7	2.2	8.1	3.9	9.0	2.9	5.3	6.5	4.8	2.1	37.1	30.3	4.0	0.3	4.3	1.7	25.2	21.5	10.5	3.7	1.9	7.7	0.5	29.6	8.3	5.6	9.5	13.2	8.6	1.1	9.6	4.9	15.6	24.9	1.1	4.6	8.7	25.0	1.1	2.5	2.2	1.8	6.7	5.3	30.0	1.2	1.1	4.8	4.6	0.3	0.0	3.4	5.7	9.6	6.2	7.4	0.0	4.1	3.7	2.5	0.1	4.5	1.4	8.4	1.1	2.4	19.8	1.8	1.2	0.8	0.3	0.2	0.2	3.1	3.6	1.9	8.6	1.6	0.3	0.4	4.2	0.1	0.5	8.7	0.4	1.2	0.6	4.4	1.4	1.5	0.6	12.1	0.4	1.7	2.5	17.1	15.4	18.9	1.1	0.6	0.0	0.0	2.1	1.3	6.0	4.6	0.0	2.9	0.9	4.7	1.7	3.9	0.2	0.2	22.9	0.1	4.9	2.5	0.0	0.5	3.8	0.9	2.1	1.2	1.1	2.1	4.2	0.3	0.6	0.5	2.8	0.4	2.0	29.1	33.2	18.8	42.8	37.1	30.3	25.2	21.5	29.6	24.9	25.0	30.0	3.0	6.4	2.6	31.6	3.7	5.1	6.2	10.3	6.2	27.8	18.1	16.3	1.9	5.7	6.6	5.5	0.0	0.4	6.7	9.3	0.0	10.6	31.4	4.2	5.4	4.8	7.2	0.4	138.6	13.1	1.1	14.6	5.6	2.3	6.3	1.2	5.0	0.0	1.6	11.8	95.5	1.9	2.0	0.0	3.6	5.7	13.4	5.5	8.8	20.6	1.3	23.0	2.1	81.4	136.7	7.2	6.0	17.0	5.2	3.9	13.2	3.4	14.2	8.6	19.7	4.5	10.8	31.9	5.7	4.1	5.5	0.1	3.8	0.2	3.6	3.3
ATOH7	"bHLHa13, Math5"	ENSG00000179774	"Atonal bHLH transcription factor 7"	Q8N100	10	68230595-68232113	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;liver: 3.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Excitatory neurons: 1.7;Hepatocytes: 1.1;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 7.5"	"Region enriched"	"Detected in some"	9	"cerebellum: 28.7"	"Low region specificity"	"Detected in some"			HPA027008	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA027008: AB_10600783"	"unprognostic (7.17e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.20e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.28e-4)"	"unprognostic (4.96e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.06e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.18e-2)"	0.1	0.2	1.4	0.0	1.5	0.0	0.1	3.0	2.0	0.1	0.7	0.2	0.2	0.2	0.1	0.0	0.1	0.0	0.0	2.0	1.0	1.2	3.0	0.0	0.0	0.8	0.8	0.1	0.4	0.0	0.2	0.0	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.3	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	7.5	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	3.0	2.0	2.0	1.0	0.8	0.8	0.8	0.8	0.8	1.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	0.3	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.1	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	1.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.5	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"kidney: 63.6;salivary gland: 78.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 55.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.2	0.0	0.3	0.0	0.4	0.0	4.7	0.1	0.5	3.7	3.1	0.0	0.1	0.1	1.2	4.9	0.0	0.0	0.0	0.6	0.2	63.6	0.0	0.4	0.0	0.3	0.2	0.0	0.1	1.6	0.1	2.5	0.2	0.9	0.0	0.0	78.4	1.5	0.0	10.2	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.4	0.0	0.0	3.7	0.1	0.2	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.6	0.6	1.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	5.0	1.9	0.0	0.1	0.0	0.1	0.1	0.6	0.0	4.5	0.2	0.0	0.0	0.1	55.7	1.9	2.9	0.1	0.0	0.2	0.6	1.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.6	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.0	0.0	1.1	0.3	0.0	0.0	1.1	0.9	0.0	0.0	2.5	1.4	0.5	0.0	1.7	16.5	2.1	13.4	0.3	0.0	31.3	0.0	2.2	0.9	0.1	0.1	0.0	0.0	1.4	0.0	0.7	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	57.0	0.0	0.0	2.8	0.3	0.0	7.2	1.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	4.4	0.1	0.0	0.0	0.1	0.6	0.7	0.0	0.1	5.1	0.2	0.0	0.0	1.3
ATP6V0D2	"ATP6D2, FLJ38708, VMA6"	ENSG00000147614	"ATPase H+ transporting V0 subunit d2"	Q8N8Y2	8	85987323-86154225	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 60.5"	"Cell type enriched"	"Detected in some"	6	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 36.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.3;SuSa: 5.8;U-87 MG: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055327, HPA058496"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA055327: AB_2682784, HPA058496: "	"unprognostic (3.79e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.36e-5)"	"unprognostic (4.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	0.3	0.0	0.6	0.7	1.4	1.9	0.8	0.4	0.7	0.4	0.4	3.1	1.6	0.3	1.4	0.7	0.0	0.5	0.4	0.5	0.7	60.5	0.4	2.6	1.3	0.6	1.1	0.0	0.4	1.3	0.0	0.8	0.6	1.4	3.5	14.0	1.1	2.5	0.0	1.7	1.3	0.4	0.3	1.1	0.3	0.2	1.0	0.5	1.0	0.0	1.1	0.5	0.0	1.4	0.4	0.6	0.3	0.4	0.0	0.3	1.3	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.0	1.4	1.2	0.4	0.9	0.2	0.2	0.0	0.5	0.7	0.1	0.0	0.4	0.6	0.3	0.0	0.2	0.4	1.1	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	2.0	0.1	0.0	0.4	3.3	5.8	0.9	0.0	0.2	0.3	0.4	0.2	0.3	0.2	0.1	0.3	5.1	0.3	0.4	0.7	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.2	0.2	1.0	0.5	0.2	0.4	0.2	0.1	0.6	1.4	0.4	0.7	0.5	0.7	0.6	1.1	0.6	0.3	1.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.4	0.1	0.0	0.4	0.0	0.1	7.3	31.3	0.0	0.0	0.0	209.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	30.5	0.0	1.1	0.0	0.0	6.9	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.0	1.0	0.0	11.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.2
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 127.4;salivary gland: 139.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	2.2	0.5	0.5	0.2	0.3	0.0	11.8	0.7	0.9	31.1	0.0	0.6	0.5	1.4	1.2	1.6	12.8	0.2	1.1	0.2	0.0	127.4	0.2	1.7	0.5	0.1	0.0	1.2	3.3	0.8	4.2	17.9	0.1	2.0	0.1	3.9	139.8	1.4	0.5	32.5	0.6	0.8	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.2	0.0	0.6	0.8	0.3	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721100-10785110	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 80.3;salivary gland: 103.2;skin 1: 87.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.2;Distal tubular cells: 45.0;Enteroendocrine cells: 41.5;Glandular and luminal cells: 73.4;Ionocytes: 93.6;Syncytiotrophoblasts: 169.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BEWO: 78.4;SK-BR-3: 27.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	3.4	4.0	1.4	1.7	2.1	4.3	5.7	0.7	1.4	57.5	0.9	2.4	0.9	4.7	80.3	18.3	2.9	0.9	3.0	1.8	0.8	43.3	6.0	2.8	2.0	0.7	0.8	2.9	3.8	1.2	23.5	36.7	0.6	5.1	2.5	1.6	103.2	6.8	1.0	87.6	2.7	0.2	0.6	4.0	2.4	2.0	0.9	0.5	3.8	0.0	5.0	2.0	19.0	1.6	0.6	0.9	2.4	2.7	0.0	0.0	78.4	1.1	0.0	0.0	0.0	1.5	1.9	1.9	1.3	0.0	1.2	1.2	1.3	0.1	0.1	1.1	2.6	0.9	1.4	2.7	0.0	1.8	1.0	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.9	3.6	0.0	2.1	0.7	2.9	1.8	1.1	0.8	1.6	1.4	5.5	0.0	1.7	1.9	2.3	0.7	27.2	0.8	10.0	2.4	4.0	0.4	0.9	1.8	1.1	1.1	6.2	2.5	1.1	1.1	1.5	0.8	0.0	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	1.4	2.1	0.7	1.4	1.8	0.8	0.7	0.8	0.6	0.6	0.9	1.6	13.6	0.0	2.6	0.3	1.0	0.4	3.7	2.8	1.2	0.0	1.4	1.8	0.9	0.0	6.6	7.3	0.0	147.2	0.8	0.3	45.0	0.1	0.7	31.3	13.4	1.4	41.5	0.0	2.4	0.2	33.0	2.7	1.1	73.4	2.5	0.3	0.0	0.2	13.8	0.0	1.2	0.2	93.6	0.8	0.8	0.4	0.6	0.9	0.0	2.8	0.0	0.0	0.0	0.5	1.3	0.2	0.1	0.0	4.0	1.1	0.0	1.1	4.4	0.0	0.0	0.7	1.2	0.2	1.2	0.6	2.4	169.1	1.0	0.3	0.8	0.4
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"kidney: 59.3"	"Cell type enriched"	"Detected in some"	48	"Distal tubular cells: 444.1"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.8;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028701	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	1.1	0.8	0.3	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	444.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2
ATRNL1	"ALP, FLJ45344, KIAA0534"	ENSG00000107518	"Attractin like 1"	Q5VV63	10	115093365-115948999	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 91.1"	"Group enriched"	"Detected in many"	13	"Excitatory neurons: 2134.6;Inhibitory neurons: 1473.4;Oligodendrocyte precursor cells: 1456.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 91.1;white matter: 58.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.4;RH-30: 18.4;U-266/70: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038070			Approved	Nucleoplasm,Mitochondria		NA	NA		160000000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"		"HPA038070: AB_10697237"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.08e-3)"	0.7	10.7	3.8	0.2	9.5	0.0	1.0	0.0	91.1	0.9	0.0	2.4	0.3	6.2	0.3	0.5	1.0	0.2	1.8	18.3	0.0	2.8	1.5	0.1	0.4	0.0	0.2	9.7	1.3	2.1	5.8	1.9	1.0	3.1	0.2	6.3	1.0	3.8	2.8	0.2	0.8	5.8	0.0	0.3	0.4	12.6	0.0	0.4	1.0	0.0	0.4	0.6	1.0	58.7	0.0	0.6	6.3	21.4	0.0	0.0	0.0	0.1	0.6	3.9	4.6	0.2	0.2	0.0	1.5	0.5	5.1	0.0	1.6	0.0	4.0	0.1	4.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	6.4	0.0	11.3	0.0	5.3	10.4	0.2	9.9	0.0	9.1	0.0	0.1	7.5	18.4	11.4	3.9	0.0	3.6	10.5	0.0	0.1	0.4	4.3	1.8	0.0	0.0	0.0	2.7	0.1	3.3	14.2	0.0	4.6	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.5	0.0	91.1	18.3	0.0	0.0	0.2	1.0	0.0	0.0	58.7	0.0	0.0	0.0	55.8	0.8	0.6	0.1	0.8	0.6	35.4	2.1	0.5	2.5	0.0	0.1	0.0	2.1	0.1	0.2	0.2	0.0	0.7	45.6	0.8	1.5	1.5	0.0	0.0	2134.6	0.4	0.0	5.3	0.0	1.8	0.0	24.9	21.0	0.1	3.0	10.1	1473.4	0.0	0.0	1.9	0.4	47.8	1.5	0.3	0.0	128.4	0.0	4.3	0.0	1456.7	34.2	0.3	0.0	0.7	0.0	0.1	0.0	0.5	0.1	4.7	0.0	2.4	2.6	46.6	11.5	0.0	0.1	0.3	0.1	53.1	0.0	0.1
ATXN10	"E46L, FLJ37990, SCA10"	ENSG00000130638	"Ataxin 10"	Q9UBB4	22	45671798-45845307	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049531	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		40000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA049531: AB_2680806"	"unprognostic (5.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.48e-2)"	"unprognostic (6.98e-2)"	40.9	59.5	42.2	34.7	46.1	41.9	41.7	35.3	56.8	50.6	26.9	43.7	23.8	50.0	39.0	46.4	56.1	39.6	74.5	50.2	49.6	53.5	64.8	38.2	48.3	37.6	40.1	57.7	57.4	64.9	56.1	48.8	42.1	46.5	36.3	55.1	41.6	40.9	70.6	34.9	27.8	50.2	42.5	34.2	34.4	57.3	46.5	65.9	63.0	59.3	51.6	51.1	45.8	44.5	163.4	84.9	156.2	95.0	70.5	107.6	85.4	181.0	194.3	128.1	139.4	42.9	106.4	169.3	73.2	184.5	66.4	94.4	114.3	121.3	137.7	32.8	119.4	78.9	141.7	79.8	101.9	213.1	56.4	109.0	82.9	66.5	103.1	153.1	96.3	76.2	58.7	89.8	197.2	69.6	116.7	95.6	104.2	90.8	64.0	166.2	60.7	135.9	162.6	152.3	86.9	136.6	113.5	67.2	129.2	119.8	101.4	111.9	87.6	127.5	47.7	46.0	61.4	87.8	57.3	136.8	79.5	88.5	138.5	80.5	99.9	91.8	69.0	121.7	92.3	72.1	68.0	84.3	163.9	72.6	74.4	71.9	4.7	86.2	138.5	58.1	70.8	120.2	42.2	46.1	35.3	56.8	50.2	49.6	37.6	40.1	42.1	42.5	46.5	44.5	38.1	35.3	33.3	127.3	50.6	50.5	124.2	156.0	68.9	66.3	45.4	50.0	94.2	65.8	76.7	58.8	20.9	101.9	32.3	17.1	68.4	91.1	69.2	53.7	53.7	44.4	60.3	63.1	148.6	69.5	106.3	70.7	34.1	49.8	39.9	93.5	36.4	54.9	72.2	70.7	157.9	35.4	79.3	49.0	36.5	40.6	57.5	48.3	24.9	103.0	67.9	79.3	27.8	186.5	168.1	51.6	24.0	75.6	53.3	115.2	18.6	66.9	67.6	53.6	46.0	45.1	54.6	133.8	108.3	65.1	41.5	52.3	47.8	102.2	44.5	102.0
AVP	"ADH, ARVP"	ENSG00000101200	"Arginine vasopressin"	P01185	20	3082556-3084724	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Hormone, Vasoactive, Vasoconstrictor"	"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1308	"brain: 7951.2"	"Group enriched"	"Detected in some"	6	"Late spermatids: 26.2;Proximal tubular cells: 46.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	131	"hypothalamus: 7951.2"	"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.7"	"Cell line enriched"	"Detected in single"	13	"NB-4: 2.3"	"Region enriched"	"Detected in many"	10	"hypothalamus: 232.9"	"Group enriched"	"Detected in many"	337	"basal ganglia: 815.6;hypothalamus: 743.3"	"CAB025318, HPA071892"	Enhanced	Supported			"Secreted to blood"	NA	NA	19300		"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB025318: , HPA071892: AB_2732190"										"unprognostic (1.15e-1)"					"unprognostic (2.61e-1)"			0.3	0.3	24.5	0.0	7.0	0.8	0.2	1.2	60.5	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.6	7951.2	1.5	0.3	0.1	0.0	0.2	0.7	0.1	0.1	0.0	6.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.0	1.0	0.0	0.0	1.4	10.8	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	24.5	7.0	1.2	60.5	1.6	7951.2	0.2	0.7	0.3	1.0	10.8	0.5	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	5.7	0.0	0.2	0.0	0.0	4.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.0	0.2	0.0	0.0	0.0	0.3	26.2	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	46.6	0.0	0.1	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0
AXDND1	"C1orf125, FLJ32940"	ENSG00000162779	"Axonemal dynein light chain domain containing 1"	Q5T1B0	1	179365720-179554735	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 15.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 226.5;Late spermatids: 247.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA071114	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA071114: AB_2686345"	"unprognostic (1.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.78e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.48e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.25e-1)"	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	15.7	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.4	0.2	0.3	0.2	0.2	0.1	0.0	0.5	8.8	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.8	0.0	0.8	0.0	2.1	0.1	0.1	16.3	0.0	0.2	226.5	3.1	0.3	0.2	0.0	0.0	3.1	0.2	0.3	0.1	31.6	0.3	0.0	0.2	0.0	0.0	0.1	0.0	3.2	1.5	0.0	0.0	0.0	247.2	1.5	0.5	0.0	1.0	0.0	0.6	0.0	2.0	2.5	0.6	3.8	1.9	0.1	0.1	2.0	0.1	3.2	0.7	0.0	0.0	0.2	50.2	4.3	0.0	0.0	0.1	0.2	0.6	6.1	0.2
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2809.6;salivary gland: 3847.3"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	128.6	3.9	17.1	2.7	28.8	0.4	1061.4	23.1	18.8	3.4	16.0	6.7	30.9	1.5	2.5	22.0	3.0	38.7	114.7	14.9	22.2	326.8	2809.6	14.8	0.4	20.2	23.3	6.0	752.1	0.1	1.3	0.5	27.1	1051.4	4.2	3.6	3847.3	40.2	1.7	206.8	28.6	0.3	14.0	1.4	315.2	25.9	21.4	0.8	1.9	2.3	1.5	5.8	7.5	24.5	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	28.8	23.1	18.8	14.9	22.2	20.2	23.3	27.1	14.0	21.4	24.5	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
B3GLCT	"B3GALTL, B3Glc-T, B3GTL"	ENSG00000187676	"Beta 3-glucosyltransferase"	Q6Y288	13	31199975-31332276	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism"	"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (3.31e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.74e-2)"	"unprognostic (5.51e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-1)"	3.7	2.0	8.6	3.1	11.4	3.9	4.6	6.2	7.8	3.5	12.8	3.1	2.8	12.9	3.9	3.0	6.0	3.5	18.2	8.2	6.9	6.6	3.4	3.7	3.8	6.9	11.2	4.8	3.1	8.1	3.0	7.0	7.1	3.5	3.3	8.0	3.8	6.2	4.7	3.4	2.9	12.7	8.0	3.5	3.4	3.8	13.2	4.9	4.9	2.8	5.6	2.5	3.5	8.0	4.8	6.7	27.1	4.9	5.1	5.1	4.4	11.6	13.0	13.9	9.8	3.5	13.2	19.4	8.3	13.6	26.2	7.9	6.1	7.5	12.9	59.8	11.7	1.3	5.9	5.1	3.2	7.8	10.1	5.9	8.4	8.0	6.8	14.2	12.5	9.5	3.5	3.0	11.0	6.1	11.7	2.4	7.9	7.0	4.1	10.4	8.8	0.6	6.2	6.7	2.5	11.0	10.0	4.7	13.2	6.3	2.3	8.9	17.6	14.0	9.4	6.5	11.7	2.4	5.6	7.3	4.5	5.8	18.9	1.7	0.4	1.3	2.4	0.4	3.5	1.3	1.5	2.7	0.4	0.6	1.2	1.6	0.2	1.4	0.4	0.4	0.9	1.4	8.6	11.4	6.2	7.8	8.2	6.9	6.9	11.2	7.1	8.0	13.2	8.0	4.5	0.0	3.1	0.0	6.6	0.0	3.6	0.0	14.2	10.6	5.1	3.4	23.7	2.8	0.6	9.2	16.7	0.3	7.9	2.5	1.9	4.3	12.1	9.2	5.3	6.5	1.2	1.7	0.0	4.6	2.1	9.0	5.6	4.2	0.0	3.3	8.9	5.5	3.6	0.0	0.0	1.5	0.0	3.2	0.0	2.5	1.5	3.3	0.0	0.0	0.9	5.8	6.2	0.0	0.0	5.6	2.3	3.4	6.4	2.3	2.6	2.6	1.5	4.3	13.1	4.1	5.2	2.1	13.5	7.7	0.0	0.3	6.5	2.3	1.7	1.6
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203681-122208952	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;skin 1: 3.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 3.3;Excitatory neurons: 3.2;Proximal tubular cells: 9.7;Spermatogonia: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.1;hTCEpi: 4.0;T-47d: 4.2;U-266/84: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.2	0.7	2.3	0.1	2.6	1.5	0.2	4.9	3.1	0.3	0.0	0.3	0.2	0.1	0.0	1.3	0.6	0.2	0.1	3.8	0.5	2.7	0.4	0.3	0.1	0.0	0.0	0.2	0.3	0.3	1.4	0.1	0.0	0.4	0.0	0.5	0.5	0.0	0.2	3.1	0.3	0.0	0.0	0.5	0.3	1.6	0.9	0.0	0.4	0.0	0.1	0.1	0.5	1.2	3.4	0.6	0.2	1.4	0.1	0.1	0.6	0.1	0.0	0.2	0.3	2.2	0.3	0.3	0.5	0.0	0.2	1.3	1.7	1.2	0.1	5.1	1.9	0.1	1.3	0.2	0.4	0.5	0.7	0.3	4.0	0.1	0.2	0.5	0.0	1.3	1.0	0.4	0.0	3.2	0.0	0.5	0.4	0.1	1.4	0.2	0.4	0.7	0.5	0.4	0.8	1.1	0.9	0.7	0.4	0.5	4.2	0.1	0.1	0.3	1.7	0.4	0.2	0.4	3.6	0.8	0.3	0.5	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.3	2.6	4.9	3.1	3.8	0.5	0.0	0.0	0.0	0.0	0.9	1.2	0.4	0.0	1.8	0.7	0.3	1.3	0.7	3.3	0.6	0.2	0.7	0.8	0.5	0.0	1.1	0.0	0.0	0.5	0.5	0.6	1.9	1.0	0.4	0.6	0.3	0.3	0.0	0.0	3.2	0.2	1.1	0.3	0.0	0.8	0.0	0.1	0.4	0.0	0.2	0.0	1.4	0.0	2.0	0.6	0.6	0.1	0.3	0.3	0.0	1.9	0.0	0.2	0.0	0.5	0.6	0.4	1.3	0.0	0.4	0.3	0.1	9.7	1.1	0.2	0.0	0.5	0.2	0.8	2.9	0.8	1.4	0.5	0.4	0.1	0.3	0.4
B3GNT9	MGC4655	ENSG00000237172	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9"	Q6UX72	16	67148104-67150998	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 12.9;Leydig cells: 11.5;Peritubular cells: 13.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SiHa: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052743, HPA062734"	Approved		Approved	"Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoli fibrillar center"	"HPA052743: AB_2681934, HPA062734: AB_2684854"	"unprognostic (2.56e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.56e-3)"	7.7	8.4	7.1	4.2	8.0	0.2	5.7	7.5	6.8	15.0	8.4	7.6	3.2	13.4	7.3	5.2	13.7	6.8	13.8	7.1	8.0	7.4	2.5	9.0	2.9	8.7	9.7	15.0	3.5	21.8	20.5	7.9	8.7	11.8	3.3	1.4	9.0	14.8	1.9	5.9	5.6	7.8	9.3	5.6	6.1	6.0	7.7	1.5	18.7	2.1	2.5	11.7	8.9	11.1	4.9	8.8	0.7	0.9	27.7	28.6	1.0	22.5	36.2	14.4	18.5	4.0	0.8	0.6	1.5	34.9	6.0	11.1	0.3	1.0	7.8	7.6	3.2	0.7	9.7	3.5	22.3	0.6	0.5	23.7	8.3	14.0	0.4	35.8	2.0	0.5	1.0	2.7	22.6	2.6	2.6	1.2	5.4	3.8	7.7	7.4	12.9	4.4	2.3	6.0	5.0	11.2	50.9	0.2	0.8	4.3	1.3	3.9	4.6	25.6	1.1	25.9	10.2	3.2	2.4	0.8	31.9	1.3	12.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.1	8.0	7.5	6.8	7.1	8.0	8.7	9.7	8.7	9.3	7.7	11.1	1.2	6.4	5.0	1.0	1.2	3.2	2.8	2.4	9.6	1.6	3.2	2.3	2.6	5.7	2.4	3.7	0.0	0.3	0.1	0.4	0.0	1.3	5.3	2.5	7.6	2.0	2.4	0.0	0.4	1.7	0.5	12.9	2.6	2.2	0.0	3.0	6.4	0.1	1.8	0.0	1.3	0.9	2.0	0.6	3.3	6.9	11.5	0.4	1.8	0.0	0.1	0.9	0.0	1.0	2.3	0.9	0.1	13.5	4.7	2.4	0.1	0.9	4.2	0.3	6.6	3.2	6.6	4.4	2.8	2.7	4.1	0.8	1.5	2.9	0.8	1.3
BAALC		ENSG00000164929	"BAALC binder of MAP3K1 and KLF4"	Q8WXS3	8	103140713-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 300.9;choroid plexus: 108.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.8;Astrocytes: 198.2;Excitatory neurons: 131.4;Inhibitory neurons: 62.3;Muller glia cells: 132.4;Oligodendrocyte precursor cells: 125.7"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"NK-cell: 3.7"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"AF22: 51.7;BJ hTERT+: 18.1;SCLC-21H: 27.9;SH-SY5Y: 20.5;U-87 MG: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: AB_2685971"	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	9.3	15.6	196.7	2.1	209.2	3.4	7.0	182.2	226.6	1.6	108.2	3.1	0.9	1.7	0.4	0.7	3.8	1.6	3.1	201.1	206.8	4.3	2.9	7.3	1.4	240.0	237.4	3.3	2.1	0.4	25.9	5.3	219.5	1.1	1.6	19.4	1.0	0.9	2.0	2.0	2.7	1.8	229.2	14.5	2.4	1.3	300.9	0.6	4.5	1.4	0.8	2.5	1.4	205.3	0.5	3.0	51.7	0.5	0.5	14.9	0.0	2.6	18.1	0.1	0.2	0.5	0.1	0.2	0.5	10.1	0.2	0.8	0.9	0.1	0.1	0.1	3.1	0.5	0.8	0.1	1.2	0.0	1.1	3.0	2.9	0.6	0.0	2.7	0.4	0.1	0.0	0.4	0.1	0.4	0.0	0.2	1.3	0.4	1.0	0.2	0.3	1.2	0.0	0.1	27.9	20.5	0.6	0.0	0.1	4.5	0.2	0.3	3.0	16.0	1.0	0.4	1.0	0.0	0.2	0.2	75.7	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.2	196.7	209.2	182.2	226.6	201.1	206.8	240.0	237.4	219.5	229.2	300.9	205.3	67.8	0.0	1.8	198.2	0.3	5.5	0.7	4.5	0.6	2.1	2.0	1.1	0.8	17.2	5.9	0.0	0.0	0.1	2.1	0.3	7.9	32.0	2.9	15.6	2.3	33.4	17.8	6.1	131.4	25.6	0.1	1.6	0.0	34.0	0.0	0.0	23.6	0.8	0.9	0.0	62.3	3.4	22.4	1.3	6.2	8.7	1.5	2.1	14.2	18.7	4.6	132.4	2.1	125.7	46.1	4.1	1.2	0.0	0.8	0.8	0.1	0.1	21.7	3.3	0.0	2.1	8.1	0.1	0.1	0.3	4.0	0.0	1.3	0.3	0.1	1.1
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 119.1;pancreas: 271.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	15.4	16.0	34.3	8.0	68.5	3.3	11.7	68.7	44.0	18.3	11.9	13.7	6.1	19.7	8.8	13.5	15.9	19.1	11.4	34.3	44.5	14.8	25.6	14.4	5.1	89.7	67.0	20.5	271.5	18.5	10.7	13.8	76.6	13.4	7.6	44.7	11.0	18.3	12.5	11.4	7.7	21.3	61.6	12.4	9.8	11.2	59.9	3.8	12.2	9.1	5.0	12.4	14.3	119.1	11.5	10.7	22.9	37.3	80.9	82.3	1.0	62.9	44.4	24.4	19.0	4.5	16.4	1.4	14.6	88.3	18.4	17.9	24.3	12.1	20.5	3.1	12.1	6.0	17.3	5.1	36.5	2.5	1.7	68.1	20.2	29.7	31.8	68.0	21.4	3.8	2.7	1.1	46.5	33.4	2.5	2.1	15.5	10.6	25.9	6.4	11.6	1.6	12.2	5.9	31.7	36.7	22.5	2.6	5.9	23.5	26.2	7.6	31.4	45.2	5.0	48.2	19.4	0.7	1.0	1.1	23.8	2.0	34.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.3	68.5	68.7	44.0	34.3	44.5	89.7	67.0	76.6	61.6	59.9	119.1	12.1	19.2	10.1	16.3	0.3	4.7	4.1	3.4	9.1	53.7	8.7	9.0	8.7	18.6	13.3	5.5	118.9	1.0	0.1	2.0	5.9	7.4	99.9	5.1	32.1	8.3	21.7	1.7	24.9	20.0	1.3	19.5	3.1	8.9	2.5	15.8	6.8	38.6	9.4	57.2	32.0	5.1	2.0	17.2	7.7	343.0	19.3	7.9	3.6	14.0	4.0	17.9	0.0	22.1	99.8	4.3	6.3	22.2	0.1	2.4	1.7	6.3	3.4	55.2	6.6	18.1	14.2	3.4	1.7	10.6	3.4	0.8	1.2	68.0	4.5	3.4
BAIAP2L2	"FLJ22582, pinkbar"	ENSG00000128298	"BAR/IMD domain containing adaptor protein 2 like 2"	Q6UXY1	22	38084652-38111015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 98.6;kidney: 42.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 68.2;Intestinal goblet cells: 58.4;Oligodendrocytes: 31.0;Paneth cells: 32.6;Proximal enterocytes: 125.8;Undifferentiated cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 14.1;OE19: 44.2;RPTEC TERT1: 27.3;SK-MEL-30: 38.4;WM-115: 29.8"	"Region enhanced"	"Detected in many"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in many"			HPA003043	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"			"HPA003043: AB_2227864"	"unprognostic (2.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.51e-2)"	2.5	1.1	3.1	2.8	3.0	0.1	1.8	2.6	6.1	3.7	2.8	41.0	98.6	2.1	0.4	9.7	1.9	14.9	0.8	3.1	2.6	42.5	3.7	0.9	0.3	2.8	2.8	1.5	2.7	0.1	3.5	0.2	2.9	2.5	12.7	0.4	1.9	0.3	1.2	2.4	81.6	0.8	2.6	1.4	8.5	5.9	2.7	0.6	3.1	0.1	0.4	1.2	3.4	3.7	0.2	12.3	0.0	0.0	0.3	1.9	1.5	3.0	0.0	0.0	0.2	9.6	0.8	0.2	4.6	2.7	0.0	1.6	0.0	0.4	0.0	0.3	0.4	0.9	0.0	14.1	0.6	0.0	0.8	0.3	0.7	7.0	0.5	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.6	0.3	1.1	44.2	0.0	0.4	0.0	0.8	27.3	0.1	0.2	0.2	0.0	5.3	38.4	0.1	0.3	0.2	0.1	0.1	0.4	0.0	0.0	0.9	0.1	0.2	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	2.6	6.1	3.1	2.6	2.8	2.8	2.9	2.6	2.7	3.7	0.2	0.0	0.0	7.8	0.5	0.8	0.2	1.0	1.2	2.8	0.3	0.3	1.1	17.2	0.2	0.0	2.1	0.3	0.2	68.2	1.9	0.6	0.7	2.2	3.8	0.3	27.6	0.0	17.2	0.0	1.2	0.8	21.9	12.8	0.0	0.5	0.4	0.9	0.5	6.7	13.1	58.4	0.0	0.3	0.2	0.5	1.2	0.2	5.4	5.6	0.1	0.2	1.0	7.5	31.0	5.4	32.6	1.2	0.3	0.2	125.8	19.1	0.1	1.4	0.0	0.2	1.3	1.3	4.4	1.4	1.1	0.4	0.5	0.3	41.4	0.5
BBOX1	"BBH, BBOX, G-BBH, gamma-BBH"	ENSG00000129151	"Gamma-butyrobetaine hydroxylase 1"	O75936	11	27040725-27127809	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carnitine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 467.9;liver: 131.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 1623.0"	"Group enriched"	"Detected in many"	6	"glioma: 23.7;renal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTCEpi: 13.7;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007600, HPA027823"	Enhanced	Approved	Uncertain	"Vesicles,Actin filaments"		NA	NA		35000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Actin filaments"	"HPA007600: AB_1845284, HPA027823: AB_10602394"	"unprognostic (9.96e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (7.03e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.73e-3)"	1.4	0.0	24.3	0.0	23.4	0.0	25.1	28.8	34.0	5.1	17.3	0.2	0.0	0.1	8.1	17.5	9.0	9.6	0.0	22.8	25.6	467.9	131.9	0.3	0.1	27.2	33.1	0.0	0.8	0.0	6.9	0.3	35.0	0.5	0.0	0.4	6.1	4.1	0.9	51.8	0.0	0.0	28.8	0.0	0.2	0.1	25.2	1.1	9.6	0.0	0.6	0.1	11.3	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	13.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.2	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	23.4	28.8	34.0	22.8	25.6	27.2	33.1	35.0	28.8	25.2	27.0	0.1	0.0	0.6	66.3	5.3	8.2	9.0	80.9	0.6	0.0	16.3	11.0	0.0	15.7	18.1	46.0	0.0	0.3	0.2	0.0	223.0	0.7	1.1	10.3	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.4	27.9	0.0	0.0	0.8	0.0	12.2	0.6	1.1	1.1	0.0	7.1	1.8	4.7	0.0	13.8	0.0	2.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	1623.0	9.4	0.4	0.0	0.0	1.4	0.0	0.6	16.9	35.8	0.3	5.0	0.0	0.0	2.6
BCAT1	BCT1	ENSG00000060982	"Branched chain amino acid transaminase 1"	P54687	12	24810024-24949101	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Branched-chain amino acid biosynthesis"	"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 58.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 203.2;Early spermatids: 161.4;Exocrine glandular cells: 139.9;Langerhans cells: 265.8;Late spermatids: 370.3"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 19.0;glioma: 10.7;lung cancer: 7.2;ovarian cancer: 24.0;testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 17.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 5.8;monocytes: 17.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 261.3;NTERA-2: 287.4;RH-30: 310.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048592	Uncertain					NA	NA		97000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 34: Spermatids - Unknown function"			"HPA048592: AB_2680454"	"unprognostic (1.90e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (3.05e-5)"	"unprognostic (9.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.97e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.38e-4)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (7.55e-2)"	"prognostic unfavorable (8.54e-4)"	6.7	5.9	4.1	7.1	5.7	2.4	2.1	11.1	10.6	3.6	0.0	3.0	0.8	8.6	1.0	2.0	7.2	4.4	1.8	3.0	19.6	1.2	1.3	9.6	6.4	19.4	19.8	7.2	58.2	0.4	6.6	15.2	22.7	0.9	2.6	14.5	1.7	0.8	0.7	0.6	3.6	5.7	6.4	2.0	1.8	7.1	14.0	5.2	1.2	2.0	5.3	4.1	1.3	7.9	30.3	12.1	106.8	0.2	30.5	59.0	54.9	60.9	40.6	33.4	55.2	67.1	83.1	114.0	0.3	100.7	6.5	12.0	77.2	0.5	88.2	261.3	15.4	91.1	2.0	37.3	112.3	105.9	31.6	77.4	2.0	85.1	17.8	73.0	114.3	56.9	88.5	1.1	28.7	0.6	65.2	30.1	287.4	0.0	8.1	0.1	310.3	1.4	0.1	10.4	0.1	60.1	0.1	0.2	0.5	114.8	0.2	45.2	150.8	19.7	72.9	80.4	58.1	13.2	13.9	152.7	69.9	62.4	0.3	0.0	2.3	0.0	0.0	3.6	0.1	1.1	0.0	0.1	5.8	0.0	0.0	0.0	1.0	0.1	17.1	3.4	0.2	1.0	4.1	5.7	11.1	10.6	3.0	19.6	19.4	19.8	22.7	6.4	14.0	7.9	1.7	16.0	26.0	1.6	1.3	8.7	0.1	2.5	0.0	203.2	0.3	0.3	1.6	1.5	2.2	0.0	2.1	61.2	4.3	0.0	1.9	1.8	161.4	41.5	92.6	16.8	0.0	20.8	39.6	139.9	23.2	27.6	0.0	89.1	11.4	117.4	7.9	0.3	72.3	42.1	81.8	0.0	14.2	87.1	265.8	370.3	7.2	59.9	7.2	38.4	22.3	7.1	0.0	84.4	57.4	49.6	0.0	4.1	0.7	0.2	0.0	0.1	3.3	12.2	6.6	14.9	17.4	1.9	1.6	0.5	7.2	22.4	2.8	41.3	0.1	0.1
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 525.1"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 420.3;Oligodendrocyte precursor cells: 210.1"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Karpas-707: 785.6"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		9400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	30.4	11.6	9.3	2.7	7.4	0.0	4.7	7.5	12.0	22.0	5.0	36.1	4.7	41.0	24.3	25.8	36.2	6.0	9.7	7.9	7.3	4.9	525.1	10.9	0.2	7.9	9.4	3.7	2.3	0.1	1.8	0.0	7.8	12.5	16.1	8.8	1.9	32.3	2.7	8.7	10.6	29.7	7.4	5.9	3.5	1.3	12.2	2.9	1.3	5.1	0.1	11.3	5.1	9.4	0.0	2.1	82.1	0.1	0.2	0.0	0.1	0.0	1.5	0.6	7.3	0.0	0.1	0.3	30.7	0.0	0.0	0.5	5.7	0.4	5.8	0.4	0.8	0.0	0.0	0.0	6.3	0.2	0.4	23.5	1.4	0.0	8.1	25.3	3.6	30.0	0.0	785.6	0.0	0.0	0.0	0.1	2.1	0.0	0.8	0.0	28.4	67.3	0.7	0.0	0.0	0.8	0.1	0.0	46.5	0.0	34.0	0.2	0.0	19.3	0.5	0.0	8.3	3.5	0.0	1.6	8.2	0.2	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	7.4	7.5	12.0	7.9	7.3	7.9	9.4	7.8	7.4	12.2	9.4	5.8	0.0	0.0	1.0	0.7	5.5	0.9	0.0	1.8	1.4	0.0	0.1	9.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.7	3.4	0.0	8.0	3.0	0.0	0.0	22.0	0.5	0.0	0.0	0.2	8.9	420.3	0.1	1.7	10.5	0.4	0.0	4.7	1.5	8.7	2.1	0.3	19.6	3.7	0.0	31.7	0.0	210.1	16.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	1.2	0.0	0.8	6.5	0.3	0.3	0.6	3.4	0.0	1.1	0.1	0.0	0.1
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"JURKAT: 38.3;MOLT-4: 47.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.4	0.3	8.0	5.1	21.2	4.9	1.1	0.0	17.2	0.9	0.0	1.2	2.0	0.2	0.5	4.3	0.3	0.9	0.1	18.9	1.1	0.3	0.4	1.1	10.2	0.3	0.8	0.2	0.1	0.0	0.2	0.1	0.0	0.5	1.4	0.0	1.7	0.3	0.2	15.0	3.5	0.2	1.5	4.4	1.9	0.5	2.0	36.6	0.8	0.0	7.5	1.3	2.9	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.0	0.0	38.3	0.0	4.1	0.0	2.8	47.3	0.8	0.5	3.6	0.0	7.0	0.0	0.0	0.0	2.6	3.7	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.2	0.0	2.6	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.1	2.0	0.0	1.8	0.0	2.8	2.4	0.0	0.0	4.6	3.1	0.0	0.3	0.0	0.0	2.0	0.8	8.0	21.2	0.0	17.2	18.9	1.1	0.3	0.8	0.0	1.5	2.0	3.9	1.3	3.2	0.0	1.3	6.4	62.8	1.6	6.3	73.4	0.4	4.3	4.4	3.8	4.3	1.3	0.0	0.0	0.1	44.2	3.8	1.9	0.2	0.2	0.2	0.2	1.2	1.2	5.3	57.5	0.5	0.0	3.3	2.0	0.3	5.1	0.2	3.3	0.3	0.3	0.0	105.7	4.9	2.0	1.0	11.4	0.4	0.6	4.0	5.4	1.0	4.9	0.0	51.5	32.2	2.0	1.1	5.4	0.0	24.4	0.6	10.1	0.5	0.3	0.1	0.0	0.5	1.9	1.6	5.8	42.7	71.3	0.0	133.4	0.1	9.7	0.6
BCL6B	"BAZF, ZBTB28, ZNF62"	ENSG00000161940	"BCL6B transcription repressor"	Q8N143	17	7023050-7030290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 37.8;Endothelial cells: 45.0;Hepatic stellate cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 53.2;HUVEC TERT2: 96.2;TIME: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059147, HPA075112"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA059147: AB_2683928, HPA075112: AB_2732279"	"unprognostic (5.61e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (8.56e-5)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.26e-2)"	29.8	5.6	8.1	5.7	7.0	0.1	15.4	6.2	9.2	5.7	4.4	4.4	3.2	7.7	0.7	3.8	5.1	13.4	23.3	6.5	6.9	13.4	4.0	28.9	5.5	7.8	7.1	2.9	3.8	3.1	5.5	19.9	7.3	4.5	2.2	0.6	4.0	3.5	11.5	4.4	4.9	7.7	6.6	13.0	4.3	2.0	10.1	2.0	12.0	14.7	2.1	7.9	4.8	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	18.2	0.0	0.0	0.5	0.0	53.2	0.0	0.0	0.0	0.1	0.0	96.2	0.2	3.4	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	38.2	0.8	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.2	9.2	6.5	6.9	7.8	7.1	7.3	6.6	10.1	6.7	37.8	3.2	4.2	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	45.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	23.6	0.2	0.1	0.0	0.0	0.2	0.0	1.9	2.3	0.0	0.0	0.3	3.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.2	0.0	0.9	0.8	0.6	1.5	0.4	1.3	0.1	0.2	0.9	0.0	0.5
BCL7C		ENSG00000099385	"BAF chromatin remodeling complex subunit BCL7C"	Q8WUZ0	16	30833626-30894302	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 217.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018676, HPA052654"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA018676: AB_1845322, HPA052654: AB_2681903"	"unprognostic (2.27e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.85e-1)"	30.2	18.5	41.9	22.2	43.8	40.7	28.8	42.9	52.2	35.4	38.3	32.2	22.3	27.2	14.9	25.8	28.1	21.4	32.6	39.1	42.9	39.4	19.0	20.8	27.6	46.2	44.2	40.5	23.2	20.6	21.3	18.0	45.8	27.3	15.6	7.9	33.2	35.0	34.8	32.1	25.0	23.2	42.4	23.6	23.9	24.5	43.7	19.5	24.6	25.5	21.3	30.2	27.2	42.8	84.3	51.4	46.4	132.7	34.5	52.3	32.4	54.8	51.9	65.1	47.2	47.2	54.4	1.8	79.9	69.1	35.7	44.7	22.9	58.0	26.0	53.0	101.2	18.5	37.8	77.0	49.1	34.3	42.5	60.1	58.5	43.3	22.4	27.6	65.9	37.1	46.2	27.5	54.1	120.3	35.9	103.4	26.8	48.7	84.5	74.0	48.7	66.8	38.2	30.1	30.8	52.5	56.2	51.8	42.5	22.7	83.8	53.8	35.4	85.8	81.0	52.0	53.3	28.2	25.9	37.2	57.2	61.1	61.3	8.1	4.6	8.0	7.7	3.1	8.8	9.0	6.7	9.5	4.3	5.8	5.4	6.5	2.9	2.9	3.4	5.7	7.3	2.4	41.9	43.8	42.9	52.2	39.1	42.9	46.2	44.2	45.8	42.4	43.7	42.8	76.4	12.8	11.4	21.9	31.5	39.6	80.5	21.9	37.5	11.4	67.7	100.5	17.2	47.1	14.0	71.7	6.2	54.3	66.8	45.5	217.2	36.2	21.5	37.2	49.4	52.8	37.3	33.4	7.6	35.5	58.5	67.7	23.9	42.5	2.5	55.9	51.4	26.5	57.1	13.5	20.8	42.8	16.2	38.6	49.1	26.9	55.9	39.5	55.2	16.9	65.6	49.1	64.9	22.1	21.4	48.1	25.2	51.6	17.2	51.4	42.0	78.0	8.8	13.8	19.7	47.3	88.9	5.7	3.5	53.3	42.6	25.0	56.4	49.4	64.3	77.1
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103077592-103099870	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 162.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 211.3;Proximal tubular cells: 795.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	45.0	96.6	23.3	4.3	25.8	3.5	39.7	27.0	27.3	46.6	27.1	31.8	39.4	31.2	16.6	27.2	43.4	14.9	46.6	20.3	27.8	162.1	70.5	35.9	6.7	28.4	26.5	54.8	23.2	30.8	29.2	7.7	27.0	31.9	10.3	8.5	32.8	14.1	24.6	26.1	39.6	9.6	25.2	21.2	38.9	14.8	28.2	17.5	62.9	16.7	7.3	37.1	37.3	26.5	3.1	5.3	26.5	10.0	30.4	29.4	3.4	6.7	17.8	6.9	10.6	3.4	11.8	12.4	11.1	10.2	2.1	1.5	17.3	10.1	8.2	8.2	8.5	1.5	6.4	8.1	15.0	7.4	2.1	24.8	9.1	10.6	2.6	23.0	20.7	14.3	8.0	5.5	24.1	1.0	37.2	6.3	9.6	2.0	2.1	24.5	30.7	7.9	46.4	3.6	4.5	12.0	12.8	6.7	7.9	9.6	5.7	5.3	9.9	10.7	3.4	5.5	3.7	8.1	7.9	12.5	11.8	8.9	5.4	2.6	2.5	0.2	7.6	1.4	8.8	4.8	6.6	6.0	3.2	6.7	9.8	10.4	0.4	6.5	0.2	5.0	10.2	4.0	23.3	25.8	27.0	27.3	20.3	27.8	28.4	26.5	27.0	25.2	28.2	26.5	37.7	32.1	57.8	33.6	10.2	30.3	47.1	59.4	36.5	2.5	31.9	36.1	9.6	64.3	46.9	108.5	0.0	7.9	19.0	18.0	211.3	58.2	1.9	60.6	45.5	30.3	22.9	16.4	1.2	21.3	18.5	75.2	41.8	27.9	19.6	39.1	27.8	71.6	20.4	3.3	3.8	24.4	46.8	10.9	16.9	4.8	69.9	12.5	23.2	14.0	14.9	50.4	14.4	3.5	21.8	23.0	18.6	77.8	8.0	18.9	162.3	795.7	48.7	3.8	13.1	40.9	36.5	0.9	4.0	25.9	26.7	3.4	18.2	52.6	37.6	37.5
BDKRB1	"B1BKR, BKR1, bradyb1"	ENSG00000100739	"Bradykinin receptor B1"	P46663	14	96256210-96268967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 23.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 40.8;Basal squamous epithelial cells: 41.5;Fibroblasts: 17.0;Squamous epithelial cells: 22.5;Suprabasal keratinocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.0;fHDF/TERT166: 18.8;HHSteC: 29.2;hTEC/SVTERT24-B: 29.2;U-2197: 27.9;U-87 MG: 90.1"	"Low region specificity"	"Detected in single"							HPA002935	Approved					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA002935: AB_1078274"	"unprognostic (6.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.96e-6)"	"unprognostic (2.33e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.66e-2)"	10.7	0.2	0.4	5.2	0.7	0.0	1.2	1.3	0.9	6.9	0.3	4.2	1.8	0.9	0.6	13.4	5.1	14.1	1.6	0.5	0.3	8.3	0.2	1.3	0.1	0.5	0.4	0.4	6.5	0.0	0.2	0.7	0.5	1.5	2.7	0.2	1.9	0.2	0.1	3.3	3.6	6.0	0.3	0.1	4.5	2.3	0.4	0.1	1.1	0.5	0.4	23.4	7.4	0.6	0.5	1.4	0.0	1.2	2.9	9.9	0.1	2.3	32.0	3.1	0.5	0.0	0.6	0.0	0.1	18.8	1.4	2.4	0.0	0.4	5.0	0.3	0.1	0.0	2.7	0.0	29.2	0.0	0.1	1.0	2.4	29.2	0.6	0.2	0.0	0.0	0.0	0.1	4.2	0.4	0.0	0.0	0.0	1.7	0.2	0.0	7.2	0.2	0.2	0.1	0.7	0.0	8.2	2.4	0.0	0.3	0.0	0.0	0.0	9.5	0.6	27.9	1.8	4.6	9.3	0.0	90.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.7	1.3	0.9	0.5	0.3	0.5	0.4	0.5	0.3	0.4	0.6	1.4	0.0	0.5	0.0	0.0	40.8	2.9	9.0	41.5	1.7	0.0	0.3	0.8	0.0	3.2	0.0	0.0	0.3	0.0	5.5	7.9	2.3	1.1	0.9	3.7	5.0	0.0	0.0	0.4	1.2	1.4	17.0	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	8.2	0.0	6.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.3	4.9	0.4	0.0	1.6	2.3	0.1	3.3	0.1	0.0	1.6	2.5	0.9	1.3	22.5	17.2	1.5	0.2	0.0	0.4	2.8
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 41.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.3;Endothelial cells: 18.2;Fibroblasts: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.2;BJ hTERT+: 94.5;U-87 MG: 39.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA003551, HPA050841"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	14.0	1.4	0.8	5.5	1.0	0.0	5.8	3.8	1.1	15.6	0.9	12.4	7.9	6.7	2.4	17.2	7.2	20.8	1.2	0.9	0.8	13.4	0.7	2.5	0.3	4.9	1.3	1.0	9.4	0.9	0.8	1.3	5.0	4.8	12.2	0.0	3.5	6.2	0.9	5.4	9.7	10.2	1.0	0.1	4.9	0.2	1.5	0.9	3.6	1.8	1.7	41.1	15.4	1.2	1.7	6.1	0.1	11.0	16.2	49.2	0.0	5.5	94.5	3.2	3.7	0.3	10.4	0.0	0.2	8.7	3.7	14.8	0.0	2.4	2.8	1.2	0.1	0.0	1.1	0.0	7.8	0.0	0.0	15.1	7.5	9.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.1	20.4	0.0	0.0	2.2	0.0	3.2	0.0	3.4	1.1	1.8	15.6	0.1	2.1	1.0	0.0	0.0	0.3	0.3	3.3	0.1	0.2	0.0	0.0	39.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.0	3.8	1.1	0.9	0.8	4.9	1.3	5.0	1.0	1.5	1.2	8.2	3.2	3.1	0.0	0.0	9.2	0.7	5.3	6.8	0.0	0.2	0.5	0.6	10.0	11.6	9.2	0.0	1.2	0.0	19.3	7.9	11.5	0.0	7.5	16.1	18.2	7.1	0.0	1.8	3.8	3.6	25.8	1.1	4.6	0.0	0.0	3.3	0.2	0.2	0.0	0.4	7.2	8.2	0.0	15.2	0.0	0.9	0.4	5.4	0.0	0.0	0.0	0.0	1.0	1.9	6.9	6.2	1.2	0.0	1.0	10.6	0.2	12.5	0.0	0.0	4.5	1.2	0.0	0.0	15.3	5.8	4.0	0.3	0.1	0.9	2.9
BFSP2	"CP47, CP49, LIFL-L, phakinin"	ENSG00000170819	"Beaded filament structural protein 2"	Q13515	3	133400056-133475222	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"B-cells: 6.3;Melanocytes: 5.4;Plasma cells: 10.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"T-reg: 13.4"	"Lineage enriched"	"Detected in single"	43	"T-cells: 13.4"	"Group enriched"	"Detected in some"	6	"Daudi: 2.4;U-698: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038464, HPA062959"	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"		"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"		"HPA038464: AB_10672746, HPA062959: AB_2684912"	"unprognostic (1.58e-3)"	"unprognostic (7.47e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.04e-5)"	"unprognostic (8.13e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.4	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.1	5.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.6	0.0	1.0	0.1	0.1	0.0
BGN	"DSPG1, SLRR1A"	ENSG00000182492	Biglycan	P21810	X	153494980-153509546	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 795.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 223.5;Peritubular cells: 782.7;Sertoli cells: 1485.7;Smooth muscle cells: 401.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 312.6;BJ hTERT+: 400.8;fHDF/TERT166: 568.9;HSkMC: 283.9;hTEC/SVTERT24-B: 235.2;HUVEC TERT2: 561.2;U-138 MG: 249.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003157, CAB003678"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		3300000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB003678: AB_425325, HPA003157: AB_1078282"	"unprognostic (1.74e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-3)"	"unprognostic (3.60e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (6.00e-8)"	"unprognostic (7.05e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.57e-3)"	165.8	213.0	54.1	93.1	57.6	0.3	118.0	51.2	91.5	371.0	69.5	69.3	22.0	234.4	83.7	45.8	143.7	326.1	795.8	56.1	48.7	396.5	347.9	477.3	42.4	50.6	50.8	94.9	67.9	26.6	144.1	199.1	53.2	184.2	24.8	1.1	107.7	135.5	32.4	118.9	48.8	213.2	45.5	352.1	51.6	69.9	64.6	15.9	250.0	46.7	35.9	126.8	180.0	65.4	0.0	0.0	29.7	0.1	31.5	70.5	1.1	312.6	400.8	56.7	18.6	39.5	0.0	0.0	56.9	568.9	2.0	0.1	0.0	0.0	10.2	0.0	0.0	0.0	0.6	3.9	27.0	0.0	0.2	283.9	2.2	235.2	10.7	29.0	561.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.5	0.3	0.2	0.0	0.1	0.0	0.6	0.4	0.0	0.0	1.1	11.8	1.3	0.0	120.0	249.5	2.3	1.0	1.5	0.9	0.1	0.0	0.1	0.3	114.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	57.6	51.2	91.5	56.1	48.7	50.6	50.8	53.2	45.5	64.6	65.4	30.5	3.2	5.6	5.9	0.6	104.1	1.3	7.3	5.7	0.2	1.2	5.6	16.1	4.3	2.5	9.2	0.0	15.5	0.7	0.0	1.9	2.7	1.8	1.4	28.3	45.2	0.0	5.3	0.1	0.2	50.0	180.0	7.7	1.1	3.8	8.4	223.5	1.6	4.4	3.3	0.1	0.0	0.0	4.0	43.6	13.5	147.9	3.0	35.6	25.3	2.0	0.1	0.0	20.6	0.0	1.2	0.0	782.7	0.0	3.0	0.0	0.8	1.6	0.2	1485.7	3.1	401.3	0.8	1.2	1.8	54.1	56.9	3.0	7.7	0.0	1.6
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111809-79132288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"kidney: 778.9;liver: 1141.8"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 604.2;Proximal tubular cells: 996.1"	"Group enriched"	"Detected in some"	4	"liver cancer: 90.6;renal cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.6;NTERA-2: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		10000000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.7	0.3	0.3	0.0	0.8	0.0	0.5	0.0	0.5	0.3	0.1	0.6	1.2	0.2	1.8	0.1	0.2	0.2	0.2	0.5	0.3	778.9	1141.8	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	3.2	0.3	0.3	0.5	0.4	0.0	0.0	11.6	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.5	0.3	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	4.3	0.0	16.5	0.0	0.0	0.0	0.0	78.2	0.0	0.5	0.1	0.8	0.8	0.0	13.5	0.9	0.0	0.1	0.1	8.2	0.2	0.0	0.1	8.9	604.2	0.0	0.0	0.2	0.4	0.0	12.2	0.0	0.5	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.6	0.0	0.0	0.0	996.1	0.0	0.4	0.0	0.2	0.1	0.2	1.0	0.0	0.0	0.1	4.2	0.5	0.1	0.3
BHMT2		ENSG00000132840	"Betaine--homocysteine S-methyltransferase 2"	Q9H2M3	5	79069767-79090069	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 333.1;liver: 429.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Hepatocytes: 201.2;Proximal tubular cells: 408.6"	"Group enriched"	"Detected in many"	14	"liver cancer: 79.6;renal cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 17.5;Hep G2: 78.2;hTEC/SVTERT24-B: 46.0;U-87 MG: 18.6"	"Not detected"	"Not detected"							HPA044573	Enhanced					NA	NA		1900000	"Cluster 17: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044573: AB_10795044"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-3)"	31.3	16.6	5.6	3.0	6.0	0.3	15.5	4.5	5.0	8.5	14.2	15.7	1.7	12.1	37.6	7.6	7.6	7.4	13.6	4.9	7.3	333.1	429.9	3.1	1.3	5.2	7.0	7.8	1.8	0.5	12.3	0.4	6.2	12.0	2.4	1.3	2.1	14.4	10.2	2.4	6.1	13.0	4.7	0.6	9.1	3.8	6.9	0.9	18.8	4.8	1.0	18.1	3.8	4.7	0.0	0.2	0.1	0.1	8.5	6.0	2.8	7.8	17.5	4.0	7.7	0.0	0.1	0.1	0.1	9.7	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.4	0.4	78.2	6.6	0.4	0.1	7.3	0.0	46.0	0.0	7.9	0.0	0.0	0.4	0.4	1.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.2	2.2	0.1	0.5	0.0	0.1	0.5	0.1	0.2	0.0	0.3	0.1	0.3	0.1	0.1	0.1	0.3	18.6	0.4	0.1	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.3	0.0	0.1	0.0	0.0	5.6	6.0	4.5	5.0	4.9	7.3	5.2	7.0	6.2	4.7	6.9	4.7	1.4	6.4	0.5	6.2	1.2	0.8	0.4	0.1	0.0	1.5	0.2	0.1	4.4	1.5	0.0	46.0	2.1	0.2	0.0	0.0	95.9	0.1	0.5	0.4	11.7	2.9	1.2	2.7	4.1	0.0	0.4	17.3	0.0	0.4	0.0	4.5	2.5	201.2	0.3	0.0	0.6	0.1	0.0	4.4	1.2	1.3	27.4	2.5	0.0	11.2	0.3	4.2	0.0	2.0	0.6	0.0	0.0	37.2	0.1	0.4	0.0	408.6	0.1	1.2	6.6	6.2	3.1	0.4	0.5	0.1	1.0	0.3	2.2	30.0	0.0	1.0
BIN1	"AMPH2, AMPHL, SH3P9"	ENSG00000136717	"Bridging integrator 1"	O00499	2	127048027-127107288	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 2105.3;tongue: 803.2"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 164.9;NK-cells: 176.1;Oligodendrocytes: 186.4;Proximal tubular cells: 255.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 186.6;MAIT T-cell: 163.9;memory B-cell: 165.9;memory CD4 T-cell: 192.1;memory CD8 T-cell: 187.4;naive B-cell: 181.2;naive CD4 T-cell: 177.1;naive CD8 T-cell: 171.1;NK-cell: 178.9;T-reg: 249.8"	"Group enriched"	"Detected in all"	9	"B-cells: 181.2;NK-cells: 178.9;T-cells: 249.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 126.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001945, HPA003894, HPA005437"	Enhanced		Supported	Cytosol		NA	NA		430000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB001945: , HPA003894: AB_1845360, HPA005437: AB_1078284"	"unprognostic (2.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.22e-3)"	43.7	93.2	178.8	25.7	232.8	12.0	37.3	162.6	209.6	53.8	85.9	35.2	17.4	38.7	16.8	33.5	53.5	22.6	16.5	174.2	160.6	83.4	34.7	22.7	41.0	204.2	194.8	34.4	21.5	19.6	41.0	23.5	189.8	58.1	13.1	53.7	42.6	24.0	2105.3	14.8	31.5	19.6	155.4	54.7	45.0	10.4	199.2	18.4	28.5	803.2	27.5	89.0	36.6	310.5	52.0	27.9	32.8	39.3	95.9	76.5	11.4	15.3	33.1	35.8	23.4	107.6	31.3	0.0	46.0	28.9	20.8	6.8	14.6	25.0	9.5	5.9	4.1	15.1	46.9	7.1	86.2	0.2	2.8	70.2	6.1	77.3	14.0	46.4	49.1	5.1	3.2	1.6	44.8	1.1	4.9	43.3	24.8	114.2	31.4	11.8	36.3	4.8	126.7	0.1	22.4	61.9	55.5	21.2	17.7	34.7	1.3	9.7	59.3	40.9	39.9	52.8	52.1	1.3	1.4	0.3	60.3	2.6	19.2	1.2	3.1	0.6	186.6	2.0	163.9	165.9	192.1	187.4	15.1	181.2	177.1	171.1	6.0	178.9	3.2	21.5	249.8	133.5	178.8	232.8	162.6	209.6	174.2	160.6	204.2	194.8	189.8	155.4	199.2	310.5	15.6	9.6	10.0	10.7	80.1	18.6	10.0	3.3	1.2	144.1	10.7	9.1	5.6	44.3	5.5	14.7	125.1	1.8	98.3	18.6	37.2	15.2	16.1	11.7	46.2	21.9	46.0	11.6	36.9	29.4	4.2	68.7	29.0	19.0	2.5	28.7	15.0	18.3	164.9	30.3	47.2	28.0	10.2	27.0	62.3	55.8	78.6	50.1	23.2	58.1	10.4	25.3	176.1	11.6	186.4	16.7	18.1	30.5	14.6	26.2	14.3	255.7	1.4	133.4	13.1	75.7	28.8	2.6	10.9	1.6	8.9	2.9	98.2	40.0	50.1	9.8
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"	Q9UBW5	12	51281038-51324668	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 101.3;lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 213.6;Extravillous trophoblasts: 172.1;NK-cells: 598.3;Syncytiotrophoblasts: 158.6;T-cells: 165.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 82.6;HMC-1: 134.9;Karpas-707: 59.1;NB-4: 140.8;RPMI-8226: 55.4;THP-1: 117.4;U-937: 76.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038666, HPA038667"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		19000000	"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	7.1	3.7	3.6	32.5	3.5	101.3	3.3	3.6	4.8	3.6	4.2	8.9	6.2	2.1	1.0	3.2	3.1	9.2	2.3	3.2	3.8	3.0	7.3	16.4	41.9	5.9	4.7	1.7	1.3	1.0	1.1	19.5	5.1	2.1	9.2	0.4	3.4	2.0	1.5	1.3	10.7	6.4	4.4	48.7	7.4	7.9	6.4	48.6	2.2	4.3	36.4	10.1	2.0	6.2	0.1	0.1	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	38.3	0.1	82.6	0.0	0.0	0.0	34.7	134.9	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.1	59.1	0.0	0.5	24.2	140.8	0.1	0.1	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	117.4	0.1	0.0	0.1	0.1	0.1	31.5	0.1	8.0	0.1	76.8	0.0	663.7	199.8	245.9	281.0	311.8	227.7	49.2	188.9	237.2	107.2	74.0	145.4	193.5	380.1	235.6	411.7	39.7	267.1	479.5	3.6	3.5	3.6	4.8	3.2	3.8	5.9	4.7	5.1	4.4	6.4	6.2	1.5	3.2	17.6	1.3	54.0	0.6	0.1	0.0	0.0	0.1	1.3	1.5	0.6	1.5	2.6	1.8	0.0	103.9	213.6	4.5	17.6	0.1	26.5	0.1	0.2	3.5	1.2	16.2	0.7	0.0	172.1	2.7	3.1	0.2	56.3	0.1	8.2	1.2	56.9	0.0	0.6	8.5	0.0	73.0	22.3	25.7	0.6	111.2	1.8	44.0	77.6	0.0	598.3	2.0	0.6	0.0	4.6	0.4	51.3	0.1	0.1	1.6	3.7	0.1	0.0	1.0	0.9	39.6	11.3	0.4	0.6	158.6	165.7	0.1	5.4	0.1
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726099-7881728	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.0;Hepatic stellate cells: 16.8;Inhibitory neurons: 22.8;Microglial cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 37.0;HUVEC TERT2: 149.6;Karpas-707: 81.6;SiHa: 70.0;TIME: 74.3;U-266/84: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	46000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	16.5	3.1	5.1	2.2	5.9	0.4	12.7	3.9	6.2	3.2	7.8	3.7	3.0	3.5	0.6	2.0	2.4	2.1	5.1	3.9	3.7	17.8	1.9	9.1	1.5	4.9	4.5	8.2	0.6	0.6	4.6	18.1	4.7	2.8	2.7	0.1	2.3	2.6	3.1	3.5	3.0	2.3	4.8	4.6	4.7	2.2	5.7	0.9	1.5	1.3	2.4	3.3	3.0	4.1	0.9	2.4	0.3	0.0	0.4	0.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	37.0	1.1	1.6	0.5	1.1	0.2	0.0	0.0	5.7	15.9	21.8	1.4	0.8	1.1	16.7	0.0	0.0	0.7	2.4	9.6	149.6	0.0	0.0	81.6	0.0	0.3	0.0	0.0	0.8	0.5	12.0	0.6	0.0	15.3	0.5	0.0	12.3	0.0	70.0	0.0	0.0	9.3	0.0	0.0	74.3	0.0	4.7	0.5	2.6	11.3	41.3	0.1	2.3	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.1	5.9	3.9	6.2	3.9	3.7	4.9	4.5	4.7	4.8	5.7	4.1	23.0	0.0	0.5	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3.5	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.8	0.2	8.9	0.0	0.0	7.8	0.0	0.1	2.0	0.0	2.0	0.0	1.5	16.8	0.6	0.3	0.0	22.8	0.0	0.0	0.8	2.1	4.2	0.0	1.5	1.8	74.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.8	0.3	0.0	0.0	0.3	0.0	0.0	4.7	0.4	0.1	1.3	0.1	0.1	0.3	0.4	0.4	0.0	0.0
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168753-57266641	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;choroid plexus: 43.8;thyroid gland: 45.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Basal squamous epithelial cells: 51.8;Cytotrophoblasts: 137.4;Oligodendrocyte precursor cells: 74.4;Squamous epithelial cells: 44.2;Syncytiotrophoblasts: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 172.1;MCF7: 202.3;OE19: 94.4;RPMI-8226: 77.8;SK-BR-3: 128.4;U-698: 237.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"	NA	NA	248000			"Cluster 27: Brain & Skin - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	6.5	33.1	1.9	34.6	0.0	1.3	37.2	27.9	8.5	43.8	2.9	2.2	1.2	17.2	23.9	9.5	0.4	13.8	35.6	28.5	6.3	0.0	1.6	1.0	36.2	36.3	0.2	0.5	0.0	2.7	25.7	34.7	5.9	1.7	5.3	3.9	9.2	0.3	22.5	1.9	0.3	32.8	0.6	3.6	0.7	39.7	3.8	45.9	0.0	2.1	6.8	13.0	42.8	0.3	0.7	23.4	5.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	20.0	6.8	172.1	41.3	0.0	8.7	48.3	5.2	0.0	0.0	0.4	17.2	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	202.3	0.0	0.1	12.3	94.4	0.0	0.1	0.1	77.8	0.0	0.2	0.4	17.8	5.5	128.4	0.5	15.2	0.9	0.4	0.4	0.1	10.9	0.0	0.1	0.2	0.3	237.6	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	34.6	37.2	27.9	35.6	28.5	36.2	36.3	34.7	32.8	39.7	42.8	0.6	6.4	2.2	74.1	0.4	13.8	13.4	12.9	51.8	4.7	0.9	4.6	15.1	0.0	4.2	1.8	0.0	137.4	0.1	0.2	0.0	0.0	5.3	1.7	2.4	1.2	2.4	0.0	0.9	0.0	21.0	13.5	2.0	2.5	21.6	0.1	0.0	0.0	11.0	1.7	4.7	1.5	6.1	0.0	1.9	4.9	0.3	0.4	3.6	2.8	0.1	38.4	0.0	74.4	8.7	0.0	0.3	0.4	2.5	6.6	0.2	2.2	1.9	2.4	0.0	1.3	0.8	1.8	3.4	44.2	9.7	56.9	0.9	0.7	1.5	18.1
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932825	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.7;Inhibitory neurons: 79.9;Oligodendrocyte precursor cells: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"CAB019398: "	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.05e-3)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (8.93e-4)"	"unprognostic (3.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.07e-1)"	9.1	6.4	4.3	4.5	5.2	0.0	10.3	5.4	5.5	8.1	4.9	9.9	5.4	12.9	11.9	7.8	7.4	9.6	7.8	4.7	6.1	7.0	4.3	7.3	2.9	6.8	5.8	11.6	5.8	9.9	2.6	6.5	6.3	12.5	8.2	4.8	12.1	13.0	7.9	9.3	8.6	12.5	6.2	2.9	7.3	5.2	4.6	2.9	19.1	4.8	3.0	7.9	4.1	6.5	14.6	7.8	27.6	26.8	15.0	10.6	5.5	14.5	18.3	9.4	11.3	11.0	13.1	4.7	6.1	19.2	5.9	15.0	15.8	14.3	14.1	5.5	8.2	5.9	6.9	19.0	10.2	7.4	37.7	10.7	8.5	11.2	9.5	13.9	0.0	8.1	7.6	2.7	12.3	7.0	6.7	7.8	17.6	5.2	4.2	0.0	12.3	0.1	18.9	12.1	3.7	12.8	17.8	8.4	12.6	34.1	15.0	4.1	6.2	7.0	9.8	12.7	13.3	0.3	12.3	5.3	6.5	5.6	6.0	0.3	0.0	0.0	0.3	0.0	0.2	0.3	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.0	4.3	5.2	5.4	5.5	4.7	6.1	6.8	5.8	6.3	6.2	4.6	6.5	3.5	35.3	22.4	142.7	3.5	12.1	7.1	9.9	17.6	7.5	10.2	10.2	22.6	18.6	10.5	11.0	20.9	14.1	2.3	10.7	1.9	10.6	0.7	10.7	19.7	4.5	18.0	0.0	63.8	9.5	1.0	20.6	19.4	13.9	15.2	22.9	9.3	7.2	3.4	11.8	79.9	13.9	8.2	4.8	6.1	4.1	33.5	2.3	8.8	34.7	0.8	12.9	2.1	122.2	64.3	8.9	4.9	31.2	3.2	13.7	10.6	5.5	16.5	20.4	6.6	20.3	19.2	2.1	6.6	11.5	9.8	5.1	4.3	11.9	11.1	6.7
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 110.4;liver: 84.8"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 99.7;Proximal tubular cells: 336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		NA	NA		14000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favorable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	24.1	15.3	9.4	3.9	9.8	3.5	11.2	9.5	14.5	9.3	11.8	10.6	33.8	7.0	28.8	13.2	11.1	8.9	11.6	10.1	10.8	110.4	84.8	5.2	4.4	9.8	10.2	6.5	11.5	10.8	12.7	5.0	10.7	6.8	9.4	4.2	11.3	4.7	15.5	11.2	32.8	5.8	8.6	3.9	10.0	5.0	9.8	4.8	5.5	12.5	5.9	9.0	9.1	10.8	12.0	13.8	26.8	30.6	22.5	16.2	10.2	7.1	8.7	8.6	11.4	12.4	15.3	18.6	19.7	9.2	21.4	22.1	11.7	8.0	7.6	24.8	10.5	2.7	5.4	21.8	7.9	6.3	1.8	16.9	14.1	6.3	6.0	17.7	15.5	18.8	7.2	3.0	19.9	18.2	14.8	8.3	22.5	21.1	21.9	16.1	17.7	27.9	19.7	30.3	31.7	23.3	13.2	9.0	58.4	39.4	25.6	2.2	7.7	12.5	3.4	13.1	4.9	8.6	27.8	20.4	3.5	4.0	18.4	13.6	9.8	0.0	8.2	12.9	10.9	17.5	9.7	8.4	15.3	12.8	9.1	12.7	0.6	14.6	7.8	8.4	5.4	7.5	9.4	9.8	9.5	14.5	10.1	10.8	9.8	10.2	10.7	8.6	9.8	10.8	15.9	6.4	9.3	11.1	8.2	8.9	8.6	26.0	10.8	11.1	15.1	19.0	4.8	31.5	19.3	16.5	20.9	28.6	5.6	13.6	70.5	28.1	0.5	13.6	14.0	9.1	16.1	6.9	9.3	13.5	32.2	12.2	11.2	8.2	2.5	31.8	6.1	70.9	23.7	16.8	12.8	14.9	38.7	2.2	8.3	1.6	14.9	8.0	32.0	10.3	13.9	12.2	7.2	9.0	4.7	19.6	14.8	13.9	4.5	8.4	99.7	336.3	38.2	6.9	6.6	19.0	12.5	6.8	20.6	13.9	9.2	14.0	7.6	32.9	19.0	8.1
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312562	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 141.8;pituitary gland: 53.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.8;Excitatory neurons: 30.1;Horizontal cells: 38.7;Inhibitory neurons: 27.6;Oligodendrocyte precursor cells: 17.1;Oligodendrocytes: 29.4;Proximal enterocytes: 23.6"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 56.4;SH-SY5Y: 51.8;WM-115: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.5	12.0	75.0	3.7	90.1	0.5	2.6	47.5	141.8	5.9	0.0	11.8	3.8	8.3	4.0	3.2	5.4	4.4	12.8	103.2	66.1	2.4	0.7	1.9	2.7	70.4	54.8	5.5	2.8	16.9	53.0	1.1	66.8	8.3	1.6	20.4	2.3	5.0	0.7	1.5	4.7	5.6	32.9	1.8	4.9	11.4	74.1	2.3	3.1	1.4	1.4	6.3	4.6	105.5	0.8	2.8	33.2	17.6	0.1	1.4	0.3	5.9	7.7	7.1	10.3	13.1	5.9	7.0	3.7	6.2	6.6	0.3	7.0	0.3	6.6	33.3	28.0	4.6	4.0	1.4	7.0	1.5	12.8	4.6	0.6	7.3	0.0	27.4	0.3	17.9	6.6	40.8	6.5	1.9	9.0	1.7	24.9	0.7	2.3	20.4	8.5	1.1	0.5	0.0	56.4	51.8	0.1	1.0	12.8	9.2	2.9	3.8	0.0	13.7	15.2	7.7	10.8	37.9	28.0	16.6	13.8	3.1	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	90.1	47.5	141.8	103.2	66.1	70.4	54.8	66.8	32.9	74.1	105.5	0.3	0.0	1.3	9.4	5.2	0.1	1.0	0.1	1.2	34.8	0.9	2.2	1.2	0.0	0.6	1.8	2.1	0.0	1.2	10.4	0.0	0.4	1.2	0.3	3.8	0.9	3.5	0.0	30.1	0.0	0.0	1.2	0.5	0.3	0.0	2.3	0.0	0.0	1.6	38.7	27.6	1.6	0.0	6.6	0.4	0.3	0.6	1.0	0.0	1.0	2.3	4.1	3.1	17.1	29.4	0.5	0.1	4.9	9.8	1.0	23.6	0.9	0.2	10.1	0.0	0.6	2.1	3.9	7.0	0.0	0.0	0.0	1.1	2.8	1.9	0.2
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23202696-23344845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 5.1;fallopian tube: 4.8;testis: 12.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 38.5;Early spermatids: 40.2;Endometrial ciliated cells: 18.2;Late spermatids: 32.8;Proximal tubular cells: 17.9;Respiratory ciliated cells: 35.7;Spermatocytes: 70.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.0;SiHa: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038131	Approved		Approved	Vesicles,Microtubules,Mitochondria		NA	No			"Cluster 35: T-regs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Microtubules, Mitochondria"		"HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.0	0.2	1.5	0.2	1.4	0.3	0.1	0.9	1.6	0.1	5.1	0.1	0.5	0.2	1.4	0.1	4.8	0.2	0.7	1.7	1.3	3.5	0.4	2.9	0.3	2.0	2.2	0.5	0.2	0.4	1.2	0.1	1.5	0.0	0.0	0.9	0.1	0.1	0.5	1.3	0.3	0.0	1.3	0.2	0.1	12.4	1.9	0.0	0.6	0.1	0.1	0.0	0.0	2.0	0.7	0.1	0.9	0.1	0.0	0.2	0.3	0.1	0.0	0.9	0.8	0.2	1.3	0.1	0.1	0.8	0.1	3.0	0.1	0.3	0.8	0.3	0.2	0.3	0.7	0.2	0.5	0.1	0.2	0.2	1.0	0.3	0.4	0.1	0.0	0.1	0.3	0.5	0.0	0.3	0.1	0.2	0.5	0.0	0.1	0.1	0.1	0.1	0.7	0.2	0.5	0.2	3.9	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.8	0.2	0.1	0.5	0.1	0.0	1.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.0	0.2	0.1	0.2	1.2	0.0	1.5	1.4	0.9	1.6	1.7	1.3	2.0	2.2	1.5	1.3	1.9	2.0	0.0	38.5	2.4	0.3	0.0	2.8	0.1	1.9	0.0	0.4	0.0	0.0	1.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.9	0.2	40.2	18.2	0.2	0.1	0.0	0.0	4.7	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	32.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.2	0.0	0.7	0.0	0.0	0.0	17.9	35.7	1.6	6.6	0.0	0.1	70.1	5.2	0.0	1.3	0.0	0.3	0.5	0.1	0.0
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295628-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 50.4;heart muscle: 20.0;lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 68.1;dendritic cells: 29.4;Macrophages: 20.3;monocytes: 28.4;NK-cells: 47.4;T-cells: 16.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 51.7;HL-60: 19.7;NB-4: 18.4;THP-1: 12.7;U-937: 22.2"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.4	0.6	0.3	7.1	0.4	50.4	0.6	0.4	0.4	1.6	0.2	0.9	0.6	0.6	0.3	0.6	0.7	2.1	20.0	0.3	0.3	0.7	1.3	4.7	14.0	1.1	0.5	0.2	0.4	0.1	0.3	0.6	0.8	0.6	1.3	0.0	1.5	0.4	1.0	1.3	3.5	1.0	0.6	14.9	2.6	0.3	0.4	3.6	0.9	0.2	7.3	1.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	51.7	0.1	0.1	0.5	19.7	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	22.2	0.0	80.3	14.9	45.8	23.8	31.4	16.1	4.7	7.8	18.8	17.1	5.8	11.6	16.3	12.6	23.9	58.4	1.7	6.1	16.5	0.3	0.4	0.4	0.4	0.3	0.3	1.1	0.5	0.8	0.6	0.4	1.0	0.2	0.0	4.2	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.1	0.3	68.1	2.8	0.0	0.0	0.0	0.1	29.4	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	13.9	0.0	0.0	0.2	1.7	0.5	0.0	15.8	0.0	2.5	0.0	3.7	0.0	0.0	0.0	0.0	12.5	15.5	0.0	0.0	20.3	1.8	0.0	28.4	0.0	47.4	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.4	0.0	16.0	0.0	0.0	0.0
C11orf54	PTD012	ENSG00000182919	"Chromosome 11 open reading frame 54"	Q9H0W9	11	93741591-93764749	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 569.9;liver: 258.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 370.4;Proximal tubular cells: 1136.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040088, HPA040511"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		1300000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"	Nucleoplasm	"HPA040088: AB_10795518, HPA040511: AB_10795369"	"unprognostic (3.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (5.06e-6)"	"unprognostic (2.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.53e-3)"	20.1	24.6	10.2	19.1	16.4	7.4	31.4	15.2	14.8	20.7	18.0	40.8	53.0	21.7	19.6	17.6	32.3	47.2	21.5	9.5	14.8	569.9	258.8	30.3	21.5	18.3	12.9	30.1	51.6	20.9	16.7	25.3	16.5	39.6	43.8	20.7	28.9	25.0	41.8	21.2	51.5	20.8	13.0	17.3	37.9	19.8	12.9	28.1	35.9	54.7	23.4	17.0	12.9	25.2	9.4	13.5	30.9	18.3	23.5	26.8	36.1	13.8	23.6	13.8	19.0	5.6	52.9	39.4	85.5	25.6	14.4	22.2	37.5	10.0	19.4	39.9	11.4	21.7	34.9	26.5	27.7	20.7	11.0	24.7	17.0	24.7	16.6	34.8	21.6	26.2	29.6	26.6	12.8	8.0	33.0	23.7	10.5	64.9	22.1	31.4	40.8	62.2	74.6	19.6	15.2	20.2	23.0	28.2	27.7	22.7	65.9	13.4	13.5	13.0	10.0	22.5	6.6	12.0	38.2	37.8	9.8	29.2	23.3	75.0	30.0	74.0	21.7	21.5	22.3	27.1	22.1	24.7	23.0	23.0	27.0	23.7	100.9	24.8	19.0	31.9	31.5	18.8	10.2	16.4	15.2	14.8	9.5	14.8	18.3	12.9	16.5	13.0	12.9	25.2	25.1	64.1	54.7	28.1	27.4	5.5	10.6	18.4	21.1	18.0	21.6	14.6	34.7	190.1	33.5	47.8	16.7	51.4	21.6	53.6	178.1	17.4	14.4	34.2	20.5	18.3	22.2	23.1	23.7	13.9	14.8	23.9	32.6	43.6	15.2	40.2	29.6	370.4	17.5	15.2	27.8	37.1	28.5	29.2	7.2	6.4	25.7	22.2	8.8	15.9	18.2	17.0	10.3	25.6	37.8	13.1	38.4	23.0	25.7	29.0	75.0	1136.3	36.2	19.7	6.6	28.9	17.0	38.6	17.4	17.6	9.9	62.0	21.1	16.3	35.6	22.9
C11orf86	FLJ22675	ENSG00000173237	"Chromosome 11 open reading frame 86"	A6NJI1	11	66975277-66977004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 68.0"	"Group enriched"	"Detected in some"	20	"Distal enterocytes: 212.2;Paneth cells: 132.8;Proximal enterocytes: 506.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;SiHa: 24.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039348	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA039348: AB_10673421"		"unprognostic (1.54e-2)"	"unprognostic (7.67e-3)"		"unprognostic (3.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"prognostic unfavorable (8.97e-4)"		"unprognostic (4.17e-1)"	"prognostic unfavorable (6.97e-5)"		"prognostic unfavorable (1.02e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.58e-3)"	0.1	15.4	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.0	0.1	10.4	68.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.0	64.2	0.7	0.1	0.0	2.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	212.2	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	132.8	0.0	0.0	0.0	506.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	8.4	0.2
C11orf95	MGC3032	ENSG00000188070	"Chromosome 11 open reading frame 95"	C9JLR9	11	63759892-63768775	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045002			Approved	"Intermediate filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Intermediate filaments"		"HPA045002: AB_2679179"	"unprognostic (4.23e-3)"	"unprognostic (7.24e-3)"	"unprognostic (6.47e-2)"	"unprognostic (9.01e-3)"	"unprognostic (7.54e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.00e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.85e-2)"	"unprognostic (6.60e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-3)"	12.4	7.1	13.6	5.1	13.5	2.0	9.6	8.4	17.6	16.4	3.8	13.7	3.8	20.3	6.8	4.9	13.6	6.9	9.6	16.1	15.3	12.0	9.6	5.8	6.0	9.0	8.9	22.8	8.7	5.3	11.4	11.0	7.1	8.8	3.5	4.2	6.8	10.1	7.7	4.6	7.5	11.3	7.0	6.7	7.3	4.8	15.2	8.2	11.4	5.4	5.5	12.1	11.3	9.3	3.5	4.6	34.7	11.6	17.7	20.3	5.5	13.0	9.3	6.0	4.2	11.4	2.2	11.2	18.6	12.6	4.5	7.9	15.2	5.2	6.8	11.0	10.3	7.5	8.9	5.2	6.2	3.6	6.0	15.2	1.8	9.9	3.2	19.8	13.5	10.0	9.7	5.0	9.7	4.6	13.6	18.5	16.2	2.1	13.4	31.9	6.6	3.5	8.7	4.4	14.6	30.8	6.2	6.6	18.3	14.1	9.3	8.8	21.3	12.2	11.4	15.7	7.6	4.5	6.3	13.5	3.3	9.1	6.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	13.6	13.5	8.4	17.6	16.1	15.3	9.0	8.9	7.1	7.0	15.2	9.3	8.0	0.0	5.3	6.8	2.2	5.1	1.3	2.8	3.4	4.6	6.3	9.5	7.2	11.5	2.3	0.0	0.0	6.4	2.6	1.0	3.9	2.6	0.3	2.8	11.8	9.0	4.9	0.8	3.9	2.2	0.5	11.3	0.5	4.9	1.3	8.6	13.9	7.0	1.7	6.7	3.0	2.7	4.1	1.6	6.3	1.3	18.3	2.0	3.6	3.7	3.8	11.8	0.0	2.5	0.5	2.1	1.2	7.9	0.7	1.5	0.7	3.6	1.5	3.1	13.1	6.8	11.2	0.4	4.2	1.4	3.4	1.5	1.1	2.3	2.5	1.0
C11orf97	LINC01171	ENSG00000257057	"Chromosome 11 open reading frame 97"	A0A1B0GVM6	11	94512461-94532123	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 19.1;testis: 18.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 239.3;Endometrial ciliated cells: 258.2;Respiratory ciliated cells: 109.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"							"unprognostic (3.62e-3)"	"unprognostic (1.29e-1)"		"unprognostic (1.22e-1)"	"unprognostic (4.18e-1)"		"unprognostic (4.70e-1)"	"unprognostic (9.64e-3)"		"unprognostic (9.44e-3)"	"unprognostic (3.86e-3)"				0.0	0.0	1.4	0.0	2.6	0.3	0.0	0.2	1.7	1.2	4.0	0.0	0.0	0.5	0.1	0.0	19.1	0.1	0.0	1.5	1.1	0.9	1.3	2.5	0.0	2.2	2.5	0.0	0.5	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	18.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.6	0.2	1.7	1.5	1.1	2.2	2.5	1.6	1.9	1.5	1.5	0.0	3.2	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	11.2	0.0	0.0	0.3	0.0	0.1	0.0	0.4	239.3	258.2	1.4	0.6	0.0	0.0	3.4	0.2	0.0	0.5	0.0	3.2	0.0	0.0	0.0	4.5	0.1	0.0	2.0	0.0	0.0	0.0	0.0	34.4	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	18.1	109.3	0.0	0.0	0.0	0.0	37.9	9.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1
C12orf56		ENSG00000185306	"Chromosome 12 open reading frame 56"	Q8IXR9	12	64264762-64390758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 6.6;testis: 7.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 59.8;Late spermatids: 33.9;Oligodendrocytes: 13.5;Spermatocytes: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"hTEC/SVTERT24-B: 5.2;SCLC-21H: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA056986	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA056986: AB_2683300"	"unprognostic (5.85e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.35e-4)"	"unprognostic (1.79e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.38e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.69e-2)"	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.9	6.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	1.4	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	7.5	0.6	1.9	0.0	0.0	0.0	0.0	1.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.4	0.2	0.6	0.5	0.4	0.6	0.1	0.6	1.7	0.1	0.0	0.0	3.9	0.5	0.4	1.5	0.4	1.8	0.2	0.0	0.0	1.2	0.0	0.4	0.0	0.0	5.6	0.0	0.7	5.9	0.0	59.8	1.2	0.0	0.2	0.0	0.0	2.0	0.0	4.3	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	2.2	1.7	0.0	0.0	2.2	33.9	0.0	0.2	0.0	0.0	0.0	10.4	0.0	1.5	13.5	0.4	1.0	0.4	0.0	1.0	0.0	9.7	0.5	0.7	0.0	0.0	0.0	19.0	2.3	3.1	0.3	1.8	0.0	0.0	1.4	2.4
C16orf87		ENSG00000155330	"Chromosome 16 open reading frame 87"	Q6PH81	16	46796603-46831180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 129.3;Spermatocytes: 194.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041179	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041179: AB_10795002"	"unprognostic (2.44e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (7.95e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.84e-2)"	3.7	4.7	2.3	3.3	3.1	11.9	3.4	1.4	3.1	3.9	2.0	4.1	2.7	4.1	1.6	4.6	3.3	2.6	6.2	2.5	1.7	7.5	13.1	4.0	6.1	0.8	1.1	3.1	2.5	5.3	3.9	3.6	0.8	2.9	2.3	2.4	3.3	1.9	13.7	3.7	4.7	2.9	0.7	3.9	2.9	18.4	1.7	3.7	2.9	7.5	4.0	4.2	3.3	2.1	8.2	3.2	14.3	7.7	3.0	3.4	12.1	8.3	6.3	6.2	3.3	5.4	6.1	10.0	9.7	4.7	4.5	5.3	13.2	3.8	7.3	9.9	8.0	6.9	6.1	6.8	6.2	8.3	11.3	4.1	4.1	8.0	7.9	10.3	4.4	13.7	6.9	2.1	7.3	4.6	11.5	11.2	11.2	5.2	5.4	19.3	15.0	8.3	10.6	4.0	7.5	7.5	9.8	9.6	4.8	25.7	5.1	12.5	7.0	7.0	6.6	7.5	4.4	9.7	10.2	29.7	2.7	6.8	7.0	2.6	6.4	8.1	4.6	8.8	2.4	11.9	6.3	5.6	9.7	7.4	5.5	4.0	0.9	3.3	8.2	5.3	13.6	4.0	2.3	3.1	1.4	3.1	2.5	1.7	0.8	1.1	0.8	0.7	1.7	2.1	13.9	16.0	11.5	9.4	26.0	47.2	16.9	19.2	61.5	8.9	17.1	17.8	38.2	21.5	11.6	16.5	22.9	68.9	15.5	6.7	31.3	20.4	45.1	28.0	35.1	16.0	19.1	14.1	28.2	12.2	53.4	21.8	9.7	30.8	14.0	20.6	15.0	40.7	22.7	30.3	14.5	12.4	22.4	23.9	71.5	25.9	17.1	27.8	33.8	9.4	23.9	24.2	13.4	24.6	9.8	12.4	7.5	14.3	27.9	24.4	32.9	129.3	6.0	10.5	32.9	15.3	26.5	194.6	93.2	42.8	41.9	34.3	22.0	13.7	14.0	16.0
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 98.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 90.1;Langerhans cells: 33.4;Macrophages: 59.2;monocytes: 86.7;Plasma cells: 24.7;Spermatocytes: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"classical monocyte: 282.3;eosinophil: 169.4;intermediate monocyte: 312.5;myeloid DC: 162.2;neutrophil: 230.1;non-classical monocyte: 392.8"	"Group enriched"	"Detected in all"	20	"dendritic cells: 162.2;granulocytes: 230.1;monocytes: 392.8"	"Cell line enriched"	"Detected in some"	4	"U-937: 50.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA012150: AB_10603448, HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favorable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	3.6	1.0	3.5	11.2	3.9	98.0	1.2	4.2	4.5	2.1	3.5	1.8	1.7	1.0	2.7	1.0	2.3	2.9	0.9	3.4	4.1	1.2	3.2	6.1	5.2	5.2	4.3	2.0	1.7	0.4	0.8	1.8	5.2	1.3	1.2	0.7	0.9	0.9	2.7	0.5	2.3	3.4	4.6	21.7	1.6	11.1	4.0	3.2	0.5	1.5	3.0	4.6	1.6	6.0	2.4	0.1	0.2	0.4	2.2	1.2	0.2	0.4	0.1	0.4	0.9	0.2	0.4	5.9	0.5	0.0	0.2	0.2	0.3	0.3	0.3	2.7	0.6	0.3	0.0	0.0	1.6	3.9	0.6	6.0	0.7	1.0	0.3	0.1	0.1	0.6	0.3	12.2	0.2	2.2	0.2	9.3	0.5	0.4	0.4	4.5	0.0	3.1	0.0	0.2	0.3	0.1	1.2	0.0	0.9	0.1	0.2	8.7	0.0	0.1	0.0	1.1	0.1	7.3	3.7	1.7	0.0	50.9	0.0	7.8	282.3	169.4	0.6	312.5	1.6	13.0	0.8	0.8	162.2	8.5	4.9	1.5	230.1	8.0	392.8	3.6	2.3	157.7	3.5	3.9	4.2	4.5	3.4	4.1	5.2	4.3	5.2	4.6	4.0	6.0	0.3	0.0	1.8	1.6	10.6	0.8	0.4	2.1	1.2	0.1	0.6	0.5	1.1	0.0	1.7	1.8	2.1	1.0	0.7	0.3	0.0	0.1	3.7	0.9	0.3	1.1	0.0	4.8	0.9	1.3	0.9	1.6	4.1	1.0	2.5	0.3	0.4	1.1	22.3	0.0	0.9	0.6	2.0	90.1	33.4	6.1	0.9	59.2	1.8	0.0	86.7	3.1	4.1	0.0	3.1	0.1	3.5	0.7	24.7	0.3	0.2	0.7	5.1	1.1	6.6	0.5	0.6	28.5	19.2	0.3	0.9	0.7	2.1	0.1	0.6	0.6
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 115.0;lymphoid tissue: 134.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 182.3;Hofbauer cells: 195.3;Kupffer cells: 797.4;Langerhans cells: 226.7;Macrophages: 413.5;monocytes: 278.6;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"HDLM-2: 141.3;HL-60: 70.4;NB-4: 40.3;THP-1: 55.2;U-937: 117.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	45.4	23.6	16.3	70.8	16.2	115.0	22.3	17.2	29.0	13.2	19.6	15.8	7.3	11.5	6.3	9.8	22.5	31.2	18.1	16.3	18.4	12.5	41.9	85.7	70.4	20.6	17.3	9.4	9.4	4.8	9.1	15.2	19.7	11.7	17.9	9.5	11.2	6.6	10.1	7.8	21.2	37.6	16.7	134.5	12.5	7.6	23.3	27.7	10.0	7.4	55.9	25.1	10.8	21.4	0.3	0.1	0.5	1.1	0.4	0.6	0.6	0.9	0.1	0.3	0.3	0.2	0.4	0.5	0.5	0.2	0.1	0.2	0.8	0.5	0.6	141.3	0.4	0.4	0.5	0.0	0.4	70.4	11.1	0.0	2.6	0.8	0.9	1.0	2.0	0.7	0.5	0.4	0.5	0.5	0.6	40.3	0.2	0.7	0.8	0.1	0.7	0.1	0.3	0.1	0.5	0.2	0.5	0.6	0.8	0.6	0.3	55.2	0.0	0.8	1.0	0.7	0.6	0.6	0.1	0.6	0.3	117.9	1.2	1114.1	1026.8	1294.8	166.6	1529.2	47.6	231.0	206.5	97.3	1021.6	296.4	318.0	193.6	143.3	536.7	1173.4	302.8	66.7	1189.5	16.3	16.2	17.2	29.0	16.3	18.4	20.6	17.3	19.7	16.7	23.3	21.4	4.4	22.4	43.9	8.1	84.1	7.9	0.7	0.4	0.6	4.0	2.2	5.2	3.8	10.0	4.5	7.3	2.1	1.0	103.4	0.6	0.0	0.2	36.7	0.8	0.9	8.1	1.8	23.5	9.2	0.2	2.0	3.2	0.5	1.0	182.3	0.9	15.7	8.9	195.3	0.0	13.0	0.0	0.0	797.4	226.7	90.7	2.8	413.5	12.4	12.2	278.6	0.2	355.3	6.0	7.7	0.2	0.0	0.7	4.2	0.8	0.9	1.0	0.9	4.2	32.9	2.4	2.9	2.4	2.0	0.2	6.5	1.6	59.8	0.3	0.7	0.3
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636628-22639678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1092.6"	"Group enriched"	"Detected in many"	9	"Hofbauer cells: 1663.2;Kupffer cells: 5007.4;Macrophages: 1874.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"intermediate monocyte: 226.1;non-classical monocyte: 181.7"	"Lineage enriched"	"Detected in many"	60	"monocytes: 226.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;NB-4: 1.4;RPMI-8226: 7.1;SCLC-21H: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	NA	NA		2700000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	375.1	235.6	86.6	134.0	85.6	53.9	95.9	85.8	135.3	75.8	120.0	142.8	172.3	43.1	26.0	58.3	75.6	172.4	74.8	82.9	93.7	56.2	208.8	404.3	532.3	126.7	110.1	37.5	34.3	26.2	46.3	256.3	110.3	47.1	120.2	4.1	48.1	54.6	14.8	21.8	190.1	195.0	107.5	1092.6	90.8	38.2	109.4	100.3	36.5	49.3	68.0	257.5	30.4	131.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.3	0.0	0.0	0.5	0.2	7.1	0.0	0.0	3.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.4	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.1	5.2	0.1	0.1	226.1	0.0	0.0	0.1	0.1	3.7	0.0	0.0	0.0	0.5	0.3	181.7	0.0	0.0	9.7	86.6	85.6	85.8	135.3	82.9	93.7	126.7	110.1	110.3	107.5	109.4	131.6	17.4	35.3	55.8	0.0	19.0	18.4	2.3	0.0	2.2	0.4	5.1	24.6	8.9	37.1	18.0	0.0	0.0	8.7	2.7	0.5	0.0	0.0	4.5	0.2	0.5	46.0	1.8	41.0	0.0	0.2	11.3	9.6	0.0	0.2	21.5	0.2	76.1	26.2	1663.2	0.0	0.0	0.1	0.0	5007.4	291.4	9.9	13.1	1874.2	26.6	20.6	16.7	0.3	0.0	0.0	0.1	0.0	0.1	0.4	2.8	1.3	0.1	1.1	15.3	0.8	78.9	7.4	4.6	0.7	2.1	4.2	16.8	18.2	11.8	0.0	0.2	1.3
C1QB		ENSG00000173369	"Complement C1q B chain"		1	22652762-22661637	"Human disease related genes, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"lung: 546.4;lymphoid tissue: 990.2"	"Group enriched"	"Detected in many"	28	"Hofbauer cells: 1451.0;Kupffer cells: 4559.7;Macrophages: 1747.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	71	"intermediate monocyte: 140.6;non-classical monocyte: 101.2"	"Lineage enriched"	"Detected in many"	85	"monocytes: 140.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA052116: AB_2681735"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.20e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (4.14e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.35e-2)"	439.2	229.0	95.8	149.4	94.2	53.5	87.1	97.2	148.7	65.4	132.6	162.0	186.0	27.7	26.4	63.0	50.5	194.9	62.6	89.8	107.7	18.3	243.4	546.4	514.6	161.0	143.3	39.6	40.0	28.5	1.8	249.2	138.4	28.0	146.0	7.8	44.9	51.2	5.3	6.1	186.1	261.4	138.2	990.2	88.0	39.9	142.2	72.0	23.6	38.6	58.4	255.8	1.1	185.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.4	0.0	0.0	0.5	0.3	0.6	0.0	0.0	0.5	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.8	0.0	0.1	0.1	0.0	0.2	0.0	1.7	0.0	0.0	140.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.8	101.2	0.0	0.0	5.3	95.8	94.2	97.2	148.7	89.8	107.7	161.0	143.3	138.4	138.2	142.2	185.8	13.8	12.8	22.1	0.0	17.1	6.2	2.1	0.0	1.8	1.2	4.9	23.1	5.5	24.3	10.5	3.7	0.0	6.6	2.7	0.6	0.0	0.0	3.3	0.1	0.2	65.9	0.0	32.8	0.1	0.0	9.6	5.9	0.0	0.1	11.4	0.1	52.1	26.0	1451.0	0.0	0.1	0.0	0.0	4559.7	92.1	7.8	8.4	1747.2	0.0	34.7	5.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	2.3	1.0	0.3	1.1	3.6	3.9	59.2	4.0	3.2	0.4	0.9	5.7	4.5	9.6	6.1	0.2	0.0	1.5
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643633-22648110	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 950.7"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 1356.5;Kupffer cells: 2134.6;Macrophages: 1040.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"intermediate monocyte: 57.2"	"Lineage enriched"	"Detected in single"	541	"monocytes: 57.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;RPMI-8226: 2.6;U-266/70: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	NA	NA	513000000	2100000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	285.2	196.0	60.1	159.7	58.6	43.5	70.5	64.8	97.1	51.9	90.6	133.2	179.9	36.3	13.5	55.3	67.4	155.4	58.6	54.9	75.5	41.2	169.6	290.8	370.2	124.7	105.4	32.1	37.5	22.1	39.6	204.9	105.0	37.8	91.3	3.9	51.6	44.5	12.9	18.3	195.7	164.7	100.4	950.7	94.8	33.9	106.0	75.7	29.2	31.8	50.7	191.8	24.6	159.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	1.0	0.2	0.0	0.0	0.6	0.2	2.6	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	1.2	60.1	58.6	64.8	97.1	54.9	75.5	124.7	105.4	105.0	100.4	106.0	159.3	13.4	6.4	5.2	0.3	13.7	8.9	1.1	0.0	2.8	0.6	4.9	24.5	1.6	15.7	3.1	0.0	0.0	5.8	2.3	0.4	0.0	0.0	3.2	0.0	0.1	34.5	0.0	27.2	0.0	0.2	9.5	4.4	0.0	0.1	5.1	0.1	25.4	6.6	1356.5	0.0	0.1	0.1	0.0	2134.6	202.4	3.6	6.2	1040.7	7.2	29.0	23.6	0.4	0.0	0.0	0.0	0.0	1.1	1.2	0.9	0.4	0.0	0.4	0.7	0.6	46.0	2.5	1.8	0.4	0.8	3.3	6.5	9.9	3.5	0.0	0.0	0.7
C1QL1	"C1QRF, C1QTNF14, CRF, CTRP14"	ENSG00000131094	"Complement C1q like 1"	O75973	17	44959693-44968303	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 134.0"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 673.0"	"Cancer enriched"	"Detected in all"	7	"glioma: 116.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 34.8;SH-SY5Y: 24.8;U-2 OS: 89.0;U-251 MG: 28.1;U-87 MG: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.34e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (1.31e-8)"	"unprognostic (2.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.04e-1)"	7.7	0.7	18.5	0.4	17.2	0.0	0.9	26.6	32.1	3.0	16.2	4.9	2.0	13.0	0.3	1.8	4.4	0.3	4.1	15.5	21.4	21.0	0.7	0.2	0.0	134.0	41.9	0.7	4.6	0.0	2.1	0.0	24.9	7.3	0.3	8.1	0.7	0.0	0.1	0.5	6.2	0.6	32.4	0.1	3.9	0.8	21.6	0.1	0.3	0.2	0.0	6.4	1.2	24.3	4.6	5.1	1.1	17.8	0.3	0.0	0.3	0.8	0.7	0.5	1.6	0.7	0.6	0.2	3.0	0.4	5.3	0.6	2.8	0.2	0.2	12.7	7.5	0.0	7.9	0.1	2.1	0.0	2.2	0.4	0.0	0.7	0.2	6.2	0.0	3.1	0.1	0.2	0.5	1.1	4.0	0.1	3.1	0.5	10.7	6.7	0.2	0.3	0.1	0.4	34.8	24.8	15.6	1.3	1.3	0.9	4.1	0.2	0.1	1.4	89.0	0.9	28.1	1.0	0.0	0.1	27.8	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	17.2	26.6	32.1	15.5	21.4	134.0	41.9	24.9	32.4	21.6	24.3	0.1	0.0	0.0	4.2	0.0	0.3	0.2	1.0	0.0	22.3	0.4	3.2	1.1	5.7	0.0	0.0	10.4	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.5	0.4	5.3	0.0	0.5	0.0	0.1	1.9	0.0	0.5	0.0	0.3	1.1	0.1	0.0	673.0	11.7	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.0	0.0	17.6	0.0	84.4	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.7	0.2	1.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 6.8;skin 1: 6.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.5;Extravillous trophoblasts: 11.2;Proximal tubular cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 4.1;U-2 OS: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	38200000		"Cluster 40: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.3	0.1	0.4	0.2	0.4	0.0	0.7	0.3	0.5	0.5	0.0	3.4	6.8	0.3	0.0	1.3	0.5	0.1	0.8	0.4	0.7	3.4	0.5	0.4	0.0	0.8	0.4	0.2	0.2	0.0	0.3	0.2	0.5	0.3	0.7	0.0	0.3	0.0	0.4	6.6	6.7	0.0	0.4	0.2	0.4	2.4	0.9	0.0	0.4	0.0	0.1	0.3	0.6	0.5	0.1	0.0	0.0	0.3	0.2	0.0	0.8	0.6	0.0	0.0	0.0	0.3	0.2	0.0	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	0.1	0.4	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	4.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.5	0.4	0.7	0.8	0.4	0.5	0.4	0.9	0.5	19.5	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	3.9	0.5	0.0	0.6	1.2	0.7	0.0	0.0	0.0	0.8	11.2	0.5	0.0	0.7	2.5	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	45.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.0	0.0
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347754-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 23.7;Leydig cells: 23.3;Peritubular cells: 29.7;Skeletal myocytes: 16.9;Smooth muscle cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"RH-30: 34.4;U-138 MG: 15.1;U-2 OS: 8.3;WM-115: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Centrosome"		"HPA061290: AB_2684468"	"unprognostic (2.28e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.92e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.11e-5)"	"unprognostic (5.40e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.10e-2)"	2.8	0.6	0.9	0.7	0.9	0.1	1.9	1.2	1.3	4.7	0.1	2.5	1.2	3.3	1.1	1.4	2.3	1.8	3.9	0.9	0.8	0.6	0.4	2.4	0.3	0.3	1.3	1.3	0.3	0.2	0.5	0.8	0.2	1.9	1.1	0.2	1.3	1.0	1.9	1.4	2.3	1.8	0.2	0.6	2.0	1.8	2.5	0.1	2.1	2.1	0.3	2.1	2.6	0.8	0.3	0.0	0.5	0.1	0.0	0.0	0.0	3.9	5.3	0.9	3.3	0.1	0.9	0.0	0.1	1.4	0.6	0.2	0.1	0.4	0.2	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	34.4	0.0	0.0	0.2	0.0	0.8	1.0	0.1	0.2	0.1	0.4	0.1	0.2	15.1	8.3	1.5	4.4	0.1	0.0	0.0	0.5	0.0	6.8	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.9	0.9	1.2	1.3	0.9	0.8	0.3	1.3	0.2	0.2	2.5	0.8	2.0	0.0	0.0	0.0	0.0	6.5	0.2	0.2	0.6	0.8	0.3	0.4	1.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.1	0.0	0.1	1.0	4.2	0.0	0.0	0.6	0.2	0.3	23.7	0.5	0.2	0.0	0.2	1.1	0.0	1.1	0.0	6.2	0.1	0.0	0.0	6.2	0.4	23.3	0.5	5.4	1.0	0.6	0.1	0.0	1.0	0.3	0.1	0.1	29.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	16.9	22.8	0.1	0.5	0.6	3.8	0.8	0.3	2.1	0.1	0.3
C2CD4B	"FAM148B, NLF2"	ENSG00000205502	"C2 calcium dependent domain containing 4B"	A6NLJ0	15	62163535-62165285	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pancreas: 99.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 169.8;Endothelial cells: 116.2;Enteroendocrine cells: 214.4;Glandular and luminal cells: 128.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HUVEC TERT2: 1.9"									HPA046880	Uncertain					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA046880: AB_10959458"	"unprognostic (6.60e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (2.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.16e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.24e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.48e-1)"	23.1	1.2	1.5	0.6	1.0	3.0	19.6	0.8	1.2	7.2	0.5	2.5	2.2	4.1	0.0	1.6	2.8	1.6	6.3	0.9	0.9	5.5	1.9	13.0	0.4	1.5	1.3	1.0	99.3	0.3	6.5	0.4	1.5	2.3	0.4	0.0	1.6	0.2	2.8	4.7	2.4	0.7	1.7	0.5	24.4	1.0	2.1	2.7	2.7	1.3	0.0	5.0	2.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.8	1.2	0.9	0.9	1.5	1.3	1.5	1.7	2.1	0.9	169.8	3.2	5.5	0.0	0.1	6.8	3.0	0.1	0.6	0.8	14.5	4.3	1.3	5.7	0.9	1.8	0.0	0.0	0.9	6.1	0.0	2.1	0.0	40.4	15.2	116.2	214.4	0.0	0.0	24.0	0.0	3.2	17.9	128.9	2.5	0.0	11.4	0.4	0.4	0.0	0.1	22.5	6.1	1.0	12.1	0.0	0.0	1.3	3.6	1.9	1.6	0.1	0.0	0.0	0.0	9.8	1.3	0.0	0.1	2.4	1.3	0.0	0.1	0.6	0.0	6.8	4.1	0.1	0.4	0.8	7.0	0.0	1.7	0.5	4.3	3.5
C3AR1	"AZ3B, C3AR"	ENSG00000171860	"Complement C3a receptor 1"	Q16581	12	8056844-8066359	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.1"	"Cell type enhanced"	"Detected in some"		"granulocytes: 36.8;Hofbauer cells: 161.5;Kupffer cells: 139.7;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 898.6;eosinophil: 450.8;intermediate monocyte: 273.6;non-classical monocyte: 371.3"	"Group enriched"	"Detected in many"	20	"granulocytes: 898.6;monocytes: 371.3"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 148.0"	"Low region specificity"	"Detected in many"							CAB009405	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009405: AB_2066739"	"unprognostic (1.11e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.16e-2)"	18.0	10.6	3.8	40.1	4.0	22.9	6.7	4.7	5.7	6.8	4.4	7.4	6.6	3.8	1.5	3.9	5.9	16.2	4.4	3.9	6.9	3.1	10.8	18.6	12.4	10.1	6.3	3.7	6.0	3.3	2.5	22.0	9.0	3.3	6.8	0.8	5.6	4.3	1.4	2.0	9.7	15.6	8.3	21.4	5.3	2.1	7.8	4.9	2.4	2.6	5.1	15.2	2.7	15.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.9	0.5	3.8	0.0	0.0	1.6	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.0	12.0	0.0	0.0	1.4	15.6	148.0	0.7	0.0	0.2	0.4	0.3	0.7	1.2	4.0	8.2	0.7	0.0	0.7	5.2	0.1	0.0	0.0	0.1	3.1	15.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	6.6	0.6	0.5	0.4	0.1	0.3	0.3	0.0	0.4	8.5	6.4	0.4	898.6	105.0	450.8	21.8	273.6	26.9	0.2	10.6	14.5	31.1	0.3	2.0	7.8	14.0	4.1	371.3	2.8	11.0	76.0	3.8	4.0	4.7	5.7	3.9	6.9	10.1	6.3	9.0	8.3	7.8	15.6	0.7	0.0	3.0	0.3	1.1	0.5	0.1	0.1	0.0	0.1	0.3	0.9	0.6	1.5	2.5	0.0	2.1	0.7	5.9	0.0	0.0	0.0	3.0	0.0	0.1	6.6	0.0	0.8	0.4	0.2	1.0	0.6	0.0	0.0	36.8	0.0	1.8	0.8	161.5	0.0	0.3	0.0	0.0	139.7	19.8	4.2	1.2	105.7	0.0	8.4	16.2	0.0	8.2	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.7	0.4	19.7	0.7	1.0	0.0	0.2	0.0	0.6	1.5	8.6	0.1	0.0	0.0
C3orf85	FLJ22763	ENSG00000241224	"Chromosome 3 open reading frame 85"	A0A1B0GTC6	3	109118252-109151401	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 70.4;kidney: 13.9;liver: 19.8"	"Cell type enriched"	"Detected in some"	9	"Proximal tubular cells: 169.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		2900000		"Cluster 56: Intestine - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"						"unprognostic (9.10e-2)"				"unprognostic (9.48e-3)"						"unprognostic (3.80e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.70e-2)"			0.1	0.0	0.2	0.4	0.4	0.0	0.0	0.5	0.2	0.0	0.0	5.4	70.4	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.2	13.9	19.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	0.0	0.0	64.6	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.5	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 115.8;liver: 336.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 46.4;Cardiomyocytes: 8.3;Club cells: 13.6;Fibroblasts: 19.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 58.5;HSkMC: 72.8;U-266/70: 17.1;U-266/84: 33.9"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	NA	NA	342000000	120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	27.9	115.8	0.2	10.6	1.6	0.4	15.7	0.3	2.2	12.6	0.2	31.3	7.5	16.9	11.8	2.6	29.9	2.3	21.8	0.5	1.2	43.1	336.8	14.9	4.5	5.8	1.9	57.5	23.0	0.6	20.6	0.5	2.3	11.1	3.7	5.5	14.2	0.0	1.7	1.7	17.0	0.0	0.5	15.3	11.7	4.1	1.7	4.2	44.5	0.0	2.9	23.1	4.1	1.4	0.0	0.3	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.7	0.2	0.1	0.1	0.4	0.0	58.5	0.5	0.0	0.3	1.0	0.0	0.0	0.0	72.8	0.0	0.0	0.0	0.5	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.2	17.1	33.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.3	2.2	0.5	1.2	5.8	1.9	2.3	0.5	1.7	1.4	0.0	9.6	46.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	8.3	2.8	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.5	4.4	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0
C4orf54	"FOPV, LOC285556"	ENSG00000248713	"Chromosome 4 open reading frame 54"	D6RIA3	4	99636529-99654648	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 72.7"	"Cell type enriched"	"Detected in single"	17	"Endometrial ciliated cells: 14.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.6;SK-BR-3: 1.1"	"Low region specificity"	"Detected in single"							HPA079091			Approved	"Nuclear bodies,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear bodies"	Cytosol	"HPA079091: "	"unprognostic (3.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.20e-1)"		"unprognostic (2.42e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.20e-3)"	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	6.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	72.7	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.7	0.0	14.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
C5orf49	LOC134121	ENSG00000215217	"Chromosome 5 open reading frame 49"	A4QMS7	5	7830378-7851151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.1;choroid plexus: 27.4;fallopian tube: 75.7;testis: 37.1"	"Group enriched"	"Detected in many"	11	"Early spermatids: 821.2;Endometrial ciliated cells: 353.9;Late spermatids: 410.2;Respiratory ciliated cells: 502.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043759	Enhanced					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA043759: AB_2678655"	"unprognostic (1.55e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.93e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.20e-2)"	0.2	0.5	15.2	0.1	17.0	0.0	0.8	12.3	16.5	4.2	27.4	0.1	0.1	1.4	1.7	0.0	75.7	0.5	0.2	15.9	18.1	3.9	3.3	6.0	0.0	21.9	29.1	1.0	2.7	6.2	10.4	0.1	22.0	3.5	0.0	1.4	0.3	1.3	0.0	0.6	0.1	0.3	19.1	0.1	0.6	37.1	19.7	0.7	0.8	0.0	0.0	0.2	0.8	18.1	0.0	0.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.2	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	17.0	12.3	16.5	15.9	18.1	21.9	29.1	22.0	19.1	19.7	18.1	0.1	0.0	5.4	2.3	1.0	0.0	2.6	32.0	0.0	0.4	4.7	3.0	0.4	1.5	41.4	9.2	0.0	0.2	0.0	0.0	3.9	5.6	821.2	353.9	4.3	1.2	5.4	0.0	2.8	0.9	2.9	1.7	0.0	5.8	1.3	0.2	0.4	0.8	0.1	1.7	3.5	0.2	46.8	0.0	0.4	410.2	8.7	0.8	3.6	1.0	0.0	2.3	0.0	1.5	0.2	1.6	0.0	3.8	0.0	4.1	0.0	39.9	502.4	3.6	6.6	0.8	13.4	41.1	8.4	0.0	0.6	0.3	0.9	0.1	0.0	1.5
C7		ENSG00000112936	"Complement C7"	P10643	5	40909497-40984643	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 735.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 578.4;Hepatic stellate cells: 662.5;Leydig cells: 1058.5;Sertoli cells: 309.0;Theca cells: 503.1"	"Cancer enriched"	"Detected in all"	4	"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 116.5;HHSteC: 155.1;HSkMC: 212.1;SH-SY5Y: 146.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"spinal cord: 13.7"	HPA001465	Approved				"Secreted to blood"	NA	NA		48000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favorable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	470.9	607.7	2.6	21.7	3.5	0.2	46.4	2.6	9.6	118.5	13.6	165.3	19.3	124.6	163.6	52.9	377.3	211.7	558.7	2.8	2.5	298.1	110.6	206.7	99.2	4.4	2.7	735.4	149.8	15.0	23.1	359.2	3.0	101.6	32.5	1.5	18.0	105.7	4.3	12.6	139.8	256.3	4.3	138.2	120.2	28.0	3.0	32.2	105.1	1.6	22.5	122.1	118.3	3.0	0.0	0.0	0.0	0.0	116.5	16.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	155.1	0.0	0.0	212.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	146.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.6	3.5	2.6	9.6	2.8	2.5	4.4	2.7	3.0	4.3	3.0	3.0	7.9	6.4	4.1	0.0	1.4	0.6	0.5	0.0	1.8	2.1	1.2	0.3	56.7	7.2	2.5	0.0	0.0	0.2	0.1	0.4	0.0	0.2	4.7	0.5	7.9	127.6	54.8	26.7	0.1	1.3	0.1	578.4	0.0	0.2	1.3	2.7	662.5	8.3	0.5	43.7	0.3	1.3	0.0	14.5	4.2	29.8	1058.5	1.5	0.0	58.1	0.6	3.7	0.0	0.0	0.0	0.9	0.9	18.0	1.0	1.3	0.2	0.1	0.0	0.9	309.0	2.2	23.7	2.6	2.5	6.5	0.6	0.3	1.2	503.1	3.0	0.8
C7orf57		ENSG00000164746	"Chromosome 7 open reading frame 57"	Q8NEG2	7	48035511-48061304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.0;choroid plexus: 6.4;fallopian tube: 13.9"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 52.7;Respiratory ciliated cells: 127.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.4;hTERT-HME1: 5.5;U-266/70: 3.2;U-698: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021286	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA021286: AB_1845760"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-5)"	"unprognostic (5.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.20e-1)"	0.0	0.0	0.7	0.0	0.8	0.2	0.1	0.5	0.3	0.4	6.4	0.0	0.1	0.4	0.0	0.8	13.9	0.0	0.1	0.7	0.9	0.1	0.0	2.2	0.0	4.0	3.8	0.0	0.0	0.6	0.2	0.0	2.3	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	3.7	0.9	0.0	0.2	0.0	0.1	0.0	0.4	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	1.3	0.0	0.1	0.1	3.4	0.2	0.0	0.5	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.5	0.2	0.3	3.2	0.5	1.9	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.5	0.3	0.7	0.9	4.0	3.8	2.3	2.9	0.9	2.0	0.0	0.0	3.0	0.3	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.1	1.0	0.0	15.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.9	52.7	0.6	0.2	0.0	0.0	0.5	0.0	0.1	0.6	0.0	1.1	2.5	0.0	0.0	0.0	0.1	0.0	0.5	0.0	6.1	0.0	0.4	3.5	0.0	0.3	0.0	0.0	0.0	1.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	127.6	0.9	0.0	0.0	2.7	16.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1
CA10	"CA-RPX, CARPX, HUCEP-15"	ENSG00000154975	"Carbonic anhydrase 10"	Q9NS85	17	51630313-52160017	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 54.9;cervix: 21.8;retina: 44.5"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 1607.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.2;RT4: 2.1;SCLC-21H: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054825, HPA057837"	Supported		Approved	Vesicles	"Secreted in brain"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA054825: AB_2682617, HPA057837: AB_2683542"		"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.18e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"		0.0	3.2	22.9	0.0	21.0	0.0	0.0	54.9	27.2	21.8	7.9	0.4	0.3	0.2	0.0	0.0	0.4	0.1	0.0	23.0	20.6	7.2	0.0	0.0	0.0	33.4	19.3	1.9	0.2	0.0	3.9	1.0	33.4	0.0	0.1	44.5	1.2	0.0	0.0	0.0	0.5	0.1	19.5	0.0	0.1	10.2	30.6	0.0	0.0	0.0	0.0	0.1	0.1	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	2.1	6.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	21.0	54.9	27.2	23.0	20.6	33.4	19.3	33.4	19.5	30.6	17.6	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	0.0	211.9	0.0	0.0	0.4	0.0	0.0	3.7	4.2	0.0	0.1	0.0	15.6	0.0	134.5	0.0	0.0	0.3	0.0	0.0	343.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	17.0	0.0	0.0	0.0	0.2	84.4	1.2	0.1	0.0	14.0	0.0	5.1	0.0	1607.5	4.2	0.0	0.0	0.7	0.1	0.2	0.0	0.2	0.0	11.9	0.0	0.1	0.0	1.5	1.3	0.0	0.0	0.1	2.2	0.0	0.0	0.1
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 42.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 188.7;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 34.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;NB-4: 1.0;NTERA-2: 1.1;U-266/70: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.0	1.0	33.5	0.6	30.5	1.2	0.0	0.0	34.6	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.7	0.0	0.3	42.8	3.4	1.3	0.0	0.1	0.4	4.6	6.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.2	9.7	0.4	0.1	1.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	33.5	30.5	0.0	34.6	42.8	3.4	4.6	6.2	0.9	9.7	3.8	1.1	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.4	0.0	0.0	188.7	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	116.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.5	0.0	0.2	0.0	73.9	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970729	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 916.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		39000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	225.8	119.2	27.3	164.9	35.0	1.3	161.1	28.1	47.6	241.6	37.2	916.1	80.3	523.3	150.7	275.6	304.4	203.2	115.0	26.9	29.1	134.7	224.4	155.5	75.4	32.3	30.4	326.2	52.5	32.7	53.3	430.0	30.9	348.9	149.8	13.1	70.3	781.7	46.5	76.0	233.1	688.4	27.9	129.2	324.2	52.7	33.4	28.5	114.1	75.2	34.4	505.3	208.0	28.8	115.9	75.3	163.3	146.1	572.7	464.8	161.6	661.6	736.3	227.2	246.6	138.3	3.5	0.7	153.3	1202.8	148.1	26.9	106.0	202.3	308.4	1.5	38.9	4.0	87.8	94.7	375.6	1.5	0.8	360.9	153.6	252.8	147.4	343.6	193.0	0.0	0.6	1.6	338.7	0.3	0.6	3.2	197.7	0.1	25.6	1.4	146.6	2.3	46.9	32.2	29.0	72.1	235.3	31.7	90.0	491.0	7.2	1.4	508.5	733.2	130.0	143.8	230.3	0.9	1.1	1.3	259.0	0.8	573.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	2.9	27.3	35.0	28.1	47.6	26.9	29.1	32.3	30.4	30.9	27.9	33.4	28.8	400.6	22.4	17.6	43.1	7.3	420.4	379.6	218.8	164.4	172.0	115.5	466.1	456.5	228.8	33.5	44.1	6.2	202.7	5.0	0.3	23.5	392.6	61.0	89.4	1190.3	432.9	3.6	16.0	95.4	23.6	903.9	886.9	16.3	206.2	5.1	251.0	422.0	638.4	43.5	92.5	58.3	1.2	28.5	21.0	112.8	83.6	1745.0	38.8	336.2	94.6	8.4	140.6	6.2	98.5	158.8	146.0	0.2	2005.6	4.2	456.9	0.1	332.1	11.3	21.2	2294.3	326.1	2549.3	12.1	12.2	70.1	171.8	276.6	27.5	414.1	0.8	36.7
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 23.1"	"Group enriched"	"Detected in some"	24	"Cytotrophoblasts: 28.2;Syncytiotrophoblasts: 54.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048014			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA048014: "										"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.2	0.0	0.0
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524961-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 507.1;skin 1: 179.0;vagina: 200.8"	"Cell type enriched"	"Detected in some"	8	"Squamous epithelial cells: 1257.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 150.9;head and neck cancer: 196.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 21.5;hTCEpi: 8.6;RPMI-8226: 6.0"	"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved					NA	NA		1200000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB010070: , HPA044999: AB_2679177"	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.5	0.1	0.2	0.0	0.2	0.0	5.4	1.5	0.1	107.9	0.0	0.1	0.0	0.1	0.1	507.1	1.2	0.0	0.1	0.0	0.3	17.3	1.6	0.0	0.0	0.5	0.3	0.1	0.2	0.0	0.3	0.0	0.2	2.9	0.0	0.0	121.0	0.1	1.0	179.0	0.2	0.0	0.0	0.1	0.3	1.7	0.7	79.5	0.1	0.0	39.8	0.2	200.8	0.0	21.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.5	0.1	0.0	0.3	0.5	0.3	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	28.4	29.8	6.3	157.1	2.2	13.3	22.4	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	4.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	28.5	0.0	1.4	8.3	0.3	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	6.5	0.0	59.6	0.7	0.3	0.0	0.0	0.9	6.7	0.1	1257.1	55.0	0.0	0.7	0.0	0.2	30.6
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206079	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 91.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 184.3;non-classical monocyte: 216.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 216.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA051109: AB_2681346"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	5.2	5.1	2.9	14.5	2.9	4.5	3.1	3.9	3.8	9.2	12.6	70.1	91.9	3.3	1.4	2.1	19.3	18.7	1.2	3.1	2.7	29.1	15.0	5.1	3.9	2.8	2.7	1.7	7.0	0.9	3.5	5.4	2.9	6.2	64.7	4.3	2.2	4.4	3.4	4.8	76.0	7.3	2.4	5.9	15.6	3.3	3.0	4.5	1.6	0.7	4.0	3.5	2.3	3.3	3.4	11.6	7.9	4.8	1.6	1.7	5.7	2.2	2.3	4.8	3.0	22.1	29.8	3.7	3.0	1.9	3.7	15.1	18.2	2.8	2.0	3.3	16.9	6.7	21.6	7.9	3.5	5.8	14.7	1.6	4.4	1.8	3.4	3.0	5.9	10.8	6.2	3.9	0.7	10.2	14.5	12.6	8.5	24.1	3.4	30.1	8.1	8.2	1.3	6.0	4.4	4.3	3.5	3.2	9.9	3.1	2.8	12.6	3.5	5.0	4.5	9.2	8.7	14.4	9.4	10.0	3.3	14.9	2.2	0.1	43.7	0.2	0.1	184.3	0.6	0.6	0.6	0.2	29.1	0.1	0.5	0.3	21.3	0.0	216.9	1.4	0.4	18.3	2.9	2.9	3.9	3.8	3.1	2.7	2.8	2.7	2.9	2.4	3.0	3.3	1.3	0.0	1.5	3.3	0.7	1.5	0.8	2.8	1.8	11.1	0.4	0.1	0.3	12.8	15.8	3.7	0.0	0.5	0.3	49.2	0.0	2.5	6.5	9.4	0.6	6.4	7.7	1.3	3.8	4.3	0.5	3.2	31.6	0.4	0.0	0.4	5.0	8.1	3.9	8.4	4.0	17.1	0.0	11.7	1.5	0.5	3.7	8.1	0.0	4.7	3.9	2.0	2.1	3.0	3.4	3.0	39.3	6.8	2.4	1.1	36.2	25.4	107.8	3.1	0.0	1.1	0.7	0.0	0.4	1.3	2.0	0.1	1.2	0.1	21.1	1.1
CAPN12		ENSG00000182472	"Calpain 12"	Q6ZSI9	19	38730187-38769904	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 22.8;liver: 24.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 41.4;Cholangiocytes: 41.5;NK-cells: 39.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"basophil: 59.3;NK-cell: 25.5"	"Group enriched"	"Detected in many"	9	"granulocytes: 59.3;NK-cells: 25.5"	"Cell line enriched"	"Detected in some"	14	"HMC-1: 35.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 3.0"	HPA053322			Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Focal adhesion sites"	Nucleoplasm	"HPA053322: AB_2682111"	"unprognostic (1.81e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-3)"	"unprognostic (7.20e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (5.90e-6)"	"unprognostic (7.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.59e-2)"	0.5	0.2	0.4	1.3	0.4	0.5	0.6	0.3	0.7	5.3	0.3	1.1	2.6	1.1	0.7	1.0	2.9	22.8	1.1	0.3	0.7	3.5	24.8	2.5	2.2	0.5	0.4	0.3	1.9	0.5	0.3	0.2	0.7	0.4	1.0	0.0	5.3	1.2	0.4	4.0	1.0	0.8	0.3	1.9	2.0	0.5	0.7	1.3	0.3	0.0	2.8	0.5	0.9	0.4	0.2	1.4	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	0.1	2.4	0.1	0.6	0.0	0.0	0.3	1.0	0.0	0.6	0.0	0.1	0.0	0.2	0.7	0.7	0.0	0.0	35.1	0.6	2.0	0.2	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.4	0.7	0.6	0.0	0.1	0.0	0.5	59.3	0.1	3.6	4.4	0.0	4.4	2.6	1.3	2.4	0.1	3.8	0.0	1.1	0.7	25.5	0.0	0.0	1.0	1.2	0.4	0.4	0.3	0.7	0.3	0.7	0.5	0.4	0.7	0.3	0.7	0.4	2.5	12.8	41.4	0.7	14.8	9.4	9.2	16.5	4.0	1.6	3.3	4.6	0.9	41.5	8.5	5.5	0.0	1.7	17.7	4.3	0.0	11.6	0.8	7.8	2.8	2.6	3.6	1.3	0.5	7.2	9.4	1.1	8.6	21.2	5.1	0.9	2.5	16.1	1.0	0.0	0.2	21.4	10.2	1.3	3.3	0.6	0.6	1.4	3.6	1.0	1.0	1.4	39.1	0.0	0.3	5.4	6.0	0.4	9.8	5.4	9.7	21.7	10.0	0.6	0.0	2.3	3.0	0.3	2.4	3.4	9.5	2.9	19.1	2.2	15.7	4.8
CAPN14		ENSG00000214711	"Calpain 14"	A8MX76	2	31173056-31233858	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"esophagus: 144.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.2;Inhibitory neurons: 4.2;Squamous epithelial cells: 8.2;Urothelial cells: 15.5"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.9;head and neck cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 1.1;U-266/70: 3.4"					"Not detected"	"Not detected"									NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (5.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.71e-4)"	"unprognostic (8.42e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.47e-4)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	144.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.5	0.1	0.6	0.8	0.1	0.0	1.7	0.0	0.7	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.6	0.8	0.1	0.2	0.0	0.0	3.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	1.7	4.2	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.5	0.5	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	8.2	0.0	1.4	0.1	0.0	0.1	15.5
CAPZA3	"CAPPA3, Gsg3"	ENSG00000177938	"Capping actin protein of muscle Z-line subunit alpha 3"	Q96KX2	12	18738119-18739188	"Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"testis: 182.5"	"Group enriched"	"Detected in some"	186	"Early spermatids: 2526.3;Late spermatids: 7326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA038688	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA038688: AB_2676151"	"unprognostic (5.56e-2)"						"unprognostic (1.43e-1)"				"unprognostic (4.45e-3)"			"unprognostic (5.67e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.0	2.1	0.0	0.0	0.0	0.0	1.3	182.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2526.3	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7326.9	26.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	25.3	14.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CARD11	"BIMP3, CARMA1"	ENSG00000198286	"Caspase recruitment domain family member 11"	Q9BXL7	7	2906142-3043867	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Immunity		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 34.9;dendritic cells: 47.2;Microglial cells: 49.6;NK-cells: 28.8;Pancreatic endocrine cells: 24.9;Plasma cells: 26.7;T-cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 31.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 122.7;K-562: 50.1;RT4: 91.4;U-698: 108.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052984	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA052984: AB_2682005"	"unprognostic (3.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.81e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.10e-4)"	1.3	3.1	6.9	21.8	1.5	18.5	1.2	1.8	1.5	2.3	1.0	2.4	3.7	1.3	0.2	1.3	2.2	8.8	1.0	1.3	4.9	1.6	1.6	4.7	47.3	4.2	8.4	1.3	1.4	0.7	0.9	0.5	3.7	1.4	2.3	0.2	3.3	1.6	0.6	0.7	18.3	0.6	3.0	31.5	7.5	1.7	14.0	20.9	1.5	0.2	29.5	17.1	1.3	4.6	16.7	2.6	0.1	0.1	0.0	0.0	12.2	0.1	0.0	0.5	0.0	32.4	35.5	122.7	29.2	0.0	0.0	27.2	0.0	0.4	0.3	42.1	1.1	0.1	3.1	0.3	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.8	23.1	13.3	50.1	0.0	0.0	0.3	4.7	0.0	44.9	20.6	0.1	5.9	0.1	30.7	11.4	91.4	0.3	1.5	0.1	0.2	0.1	17.7	0.2	2.5	15.4	0.2	11.8	0.1	0.1	12.3	0.1	108.0	0.0	0.0	0.2	0.5	0.0	0.0	7.7	0.0	7.2	5.4	4.4	5.2	0.9	6.2	2.9	5.3	0.2	5.5	0.0	31.4	3.5	2.9	6.9	1.5	1.8	1.5	1.3	4.9	4.2	8.4	3.7	3.0	14.0	4.6	0.5	0.0	0.0	0.7	34.9	0.0	0.3	0.3	0.6	0.6	0.3	0.4	2.0	0.0	0.3	1.8	0.0	0.0	47.2	0.7	0.0	4.6	0.2	0.4	0.3	0.6	0.0	0.8	2.1	5.3	0.0	1.6	14.3	0.7	5.7	8.6	0.4	0.2	1.5	0.0	1.6	0.3	0.0	2.4	1.8	0.4	0.3	5.4	3.6	49.6	1.0	0.1	28.8	1.0	0.6	24.9	0.0	0.0	26.7	0.3	0.0	0.1	1.0	0.2	0.0	0.3	0.9	1.5	0.2	0.0	0.3	0.0	28.6	4.5	0.4	8.1
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183668-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"parathyroid gland: 654.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039686, HPA050335"	Enhanced					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 40: Granulosa cells - Unknown function"			"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.1	0.1	1.5	0.1	1.0	0.8	0.0	1.7	1.6	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.1	4.2	0.0	1.0	0.6	22.4	0.2	0.0	0.2	0.6	1.1	0.5	9.6	654.4	0.2	0.0	0.8	0.1	0.2	1.5	0.1	0.0	0.1	0.2	0.5	0.0	0.2	0.1	2.8	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	1.7	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.0	1.7	1.6	1.0	0.6	0.6	1.1	0.8	0.2	1.7	1.7	0.0	25.6	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	27.1	5.6	3.7	0.0	0.0	0.0	0.0	13.7	4.3	0.5	0.0	0.0	0.5	11.5	0.0	0.3	0.2	0.0	1.6	0.0	0.0	1.3	20.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	1.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.0	0.0	0.2	15.3	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.9	0.8	0.0	0.0
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524994-116561179	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 14.6;memory B-cell: 5.1"	"Group enriched"	"Detected in many"	57	"B-cells: 5.1;granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 122.1"	"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	621.1	17.4	12.7	44.7	15.3	0.6	284.5	14.3	21.6	267.0	11.8	298.8	32.3	190.9	72.5	135.1	152.5	148.2	276.5	12.2	13.9	18.4	26.6	592.0	30.3	15.1	13.4	137.4	24.6	21.4	6.8	449.2	14.6	110.3	93.6	31.4	58.0	175.5	102.9	104.9	89.4	274.2	14.3	199.1	120.8	25.8	16.1	25.2	168.4	184.6	20.3	202.0	124.1	16.2	458.7	344.3	9.5	3.7	1406.6	2140.5	20.6	1055.8	2371.6	566.0	591.2	3.0	652.4	0.1	365.8	1228.5	494.8	828.2	2.2	2333.7	840.3	36.0	19.5	0.4	128.7	0.3	196.9	0.1	2.1	736.9	481.6	805.7	536.0	539.0	1749.9	0.2	0.3	23.4	2372.1	45.2	0.5	0.8	33.7	1.2	173.9	5.2	25.2	251.0	317.0	2.0	1.0	0.6	328.3	20.1	52.3	137.8	1.6	3.9	1349.3	1894.8	212.4	730.6	298.9	96.8	15.8	1.9	758.4	0.9	701.0	14.6	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	12.7	15.3	14.3	21.6	12.2	13.9	15.1	13.4	14.6	14.3	16.1	16.2	2160.5	3557.7	123.0	0.0	15.8	1375.3	392.0	534.8	316.4	8.3	17.9	190.8	286.6	107.2	342.0	7.3	2.1	64.3	7.0	0.3	5.9	76.8	2.6	17.5	102.3	1024.0	1.8	16.0	0.4	0.7	449.5	326.8	1.5	21.3	13.9	6.3	450.5	5.2	15.0	0.0	0.5	7.0	20.3	11.0	187.1	13.4	377.2	10.7	439.4	19.7	3.7	249.0	0.0	1.0	1.3	43.1	0.1	565.4	56.2	512.7	0.7	0.3	30.6	7.7	558.8	152.4	751.4	2.1	5.7	39.4	610.9	117.0	16.7	59.7	2.4	93.3
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834310-191847088	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 1296.7;Alveolar cells type 1: 413.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 49.0;neutrophil: 24.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 49.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.3;HEL: 119.8;HUVEC TERT2: 362.3;LHCN-M2: 561.1;TIME: 148.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		Yes	No		88000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: AB_2684688"	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.45e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	164.9	25.1	17.9	13.0	20.1	6.5	60.9	16.9	20.2	56.8	13.1	69.4	11.5	38.9	13.2	48.2	53.9	51.8	96.7	15.1	16.5	25.9	31.2	93.9	15.3	19.5	17.3	53.0	22.5	12.9	7.1	34.0	19.5	30.2	24.9	1.1	7.1	30.0	32.3	6.9	21.1	58.1	15.9	111.9	15.0	4.3	22.3	4.1	78.3	59.9	5.6	42.7	19.5	17.0	0.0	20.2	6.8	0.1	1.0	3.4	0.1	4.1	3.5	0.8	1.5	0.0	0.0	0.1	24.8	162.3	0.0	3.4	0.0	31.8	2.3	0.1	0.0	119.8	1.4	45.6	43.6	0.0	0.0	8.4	20.5	3.4	9.6	2.2	362.3	0.0	43.9	0.0	561.1	0.0	0.0	0.1	0.1	0.0	1.0	0.0	32.3	0.2	41.7	0.0	0.0	0.1	0.0	0.0	0.0	9.1	0.0	0.1	148.9	0.0	12.4	7.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	49.0	2.4	1.2	0.2	0.8	0.3	0.1	0.0	0.0	2.3	0.3	0.2	0.0	24.3	1.3	1.5	3.1	0.5	121.3	17.9	20.1	16.9	20.2	15.1	16.5	19.5	17.3	19.5	15.9	22.3	17.0	1296.7	413.5	76.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.7	15.6	0.0	0.0	81.7	0.0	0.0	0.2	2.6	0.0	5.9	1.6	0.0	0.4	5.4	164.5	0.0	0.0	0.0	0.2	0.2	15.0	0.0	0.6	185.4	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	29.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.1	1.5	16.4	0.0	0.0
CCDC102A	MGC10992	ENSG00000135736	"Coiled-coil domain containing 102A"	Q96A19	16	57512181-57536571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040598, HPA040958"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA040598: AB_10794035, HPA040958: AB_10794156"	"unprognostic (3.46e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.40e-3)"	"unprognostic (4.08e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.42e-3)"	5.0	3.7	1.8	2.7	1.6	0.5	4.8	1.7	2.4	10.9	4.1	11.1	2.3	11.0	1.1	3.5	8.8	1.5	6.8	1.6	1.7	5.2	1.5	4.5	3.0	2.5	2.4	8.0	3.3	1.5	2.3	2.5	2.0	8.4	0.5	0.1	4.0	3.8	1.6	4.9	4.7	2.4	2.1	5.1	4.8	3.0	2.4	1.6	5.8	0.5	1.7	11.9	8.2	1.5	6.6	7.9	3.0	4.3	1.0	1.4	6.2	4.2	2.3	2.4	1.2	3.2	7.5	6.0	16.4	1.3	3.2	4.8	1.5	2.2	0.9	4.9	6.8	0.8	3.8	1.3	3.7	0.4	7.7	3.5	1.4	2.0	0.5	5.2	1.9	2.1	4.6	0.0	0.8	2.7	5.4	5.3	7.1	0.7	14.6	4.8	3.4	2.4	3.0	1.0	0.5	7.8	6.6	2.1	3.2	1.1	4.5	2.9	5.2	4.4	14.5	0.4	3.8	6.9	2.7	2.2	2.5	2.1	7.4	0.0	0.0	0.0	1.1	0.0	0.9	0.9	0.2	1.2	0.0	0.5	0.5	0.8	0.1	0.6	0.0	0.3	0.0	0.2	1.8	1.6	1.7	2.4	1.6	1.7	2.5	2.4	2.0	2.1	2.4	1.5	8.8	0.0	3.0	0.7	8.2	12.9	8.0	2.4	14.8	0.0	4.9	10.3	3.1	5.7	2.2	7.3	0.0	1.6	16.3	0.5	9.8	1.9	0.6	6.0	8.5	10.6	0.0	3.4	0.0	0.9	1.1	13.2	2.0	1.8	0.0	14.6	7.1	0.9	0.3	0.0	0.1	1.0	0.0	0.6	2.8	1.3	19.6	1.5	1.8	1.0	0.5	3.5	18.6	0.0	0.0	0.9	0.1	34.6	18.8	10.6	1.1	10.5	3.1	0.2	19.7	10.8	11.8	2.8	8.9	2.3	5.7	0.3	10.5	3.3	1.0	3.2
CCDC150	FLJ39660	ENSG00000144395	"Coiled-coil domain containing 150"	Q8NCX0	2	196639554-196763490	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.6;testis: 4.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.5;Granulosa cells: 16.5;Late spermatids: 20.9;Oligodendrocytes: 16.4;Spermatocytes: 32.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048104	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA048104: AB_2680264"	"unprognostic (1.92e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.58e-4)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.91e-4)"	"unprognostic (2.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.17e-3)"	"unprognostic (5.66e-4)"	"unprognostic (7.29e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.69e-5)"	0.1	0.0	0.2	0.2	0.2	0.6	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.6	1.2	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	4.9	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.2	1.0	0.3	4.4	2.8	0.1	0.3	1.9	1.0	0.5	0.7	1.9	1.5	0.9	0.6	0.5	0.7	0.6	1.3	1.7	0.8	1.9	4.2	2.4	1.4	2.4	2.5	0.0	0.9	0.6	0.0	0.1	1.0	0.5	0.2	0.5	1.5	2.0	1.8	0.5	0.5	0.8	1.3	2.6	0.3	1.0	1.8	0.6	0.6	0.3	0.4	4.6	0.9	0.7	0.4	0.2	2.2	0.7	0.5	0.9	1.5	1.4	1.4	0.9	0.8	0.8	1.4	0.5	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	1.5	3.2	1.7	2.3	1.0	1.5	2.2	0.2	0.0	3.6	0.6	1.3	1.5	1.5	0.1	0.0	2.1	2.2	0.7	1.4	1.9	0.3	54.5	2.1	1.7	2.6	0.0	2.1	1.1	0.4	2.0	2.3	1.5	3.8	3.8	16.5	1.4	3.8	1.3	1.7	3.0	1.4	0.0	1.3	2.5	20.9	1.5	1.3	7.2	0.0	0.5	1.1	2.1	2.0	16.4	0.4	1.2	1.9	2.4	1.3	0.7	12.5	2.5	1.3	0.0	4.0	2.3	32.2	14.8	2.0	1.0	0.7	1.2	2.8	1.7	1.3
CCDC200	"LINC00854, TMEM106A-AS1"	ENSG00000236383	"Coiled-coil domain containing 200"	A0A1B0GVQ3	17	43216941-43305397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 45.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.8;NK-cell: 7.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 8.8;NK-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 7.6;Hep G2: 6.8;HMC-1: 4.6"	"Not detected"	"Not detected"													NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (3.14e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.19e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.88e-4)"	"unprognostic (2.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.08e-2)"	0.9	0.7	0.7	2.1	2.3	2.2	0.6	9.7	1.3	1.2	0.0	0.6	0.6	0.7	0.6	0.9	0.8	0.9	0.7	0.4	1.6	3.7	0.7	1.2	2.5	2.6	2.0	1.2	0.6	0.0	0.6	0.8	1.6	0.9	0.1	4.5	0.9	0.0	1.7	2.4	1.0	0.2	0.2	2.7	1.0	45.2	2.3	0.1	1.7	0.0	0.5	0.7	0.6	4.3	0.8	3.2	0.6	0.9	0.1	0.1	1.4	1.0	0.0	0.2	0.0	2.9	0.8	1.7	0.8	0.5	0.4	0.9	0.0	0.0	0.0	1.0	2.4	1.1	7.6	6.8	0.5	0.9	4.6	0.0	0.3	0.0	0.0	0.4	0.0	1.5	0.3	1.0	0.0	2.8	1.5	4.0	0.2	1.2	0.4	2.5	0.8	0.2	0.0	0.2	2.0	0.1	0.6	0.9	0.5	0.5	0.4	1.7	2.6	1.1	0.7	1.0	0.5	1.2	0.4	0.4	0.6	2.0	1.1	8.8	1.0	1.1	0.6	0.8	0.3	0.9	0.4	0.4	0.3	1.7	0.4	0.4	3.1	7.3	0.3	1.7	0.4	0.4	0.7	2.3	9.7	1.3	0.4	1.6	2.6	2.0	1.6	0.2	2.3	4.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC80	"CL2, DRO1, LINC01279, SSG1, TCONS_00006930, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596797-112649530	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 450.8;Fibroblasts: 921.6;Late spermatids: 353.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 521.4;fHDF/TERT166: 1281.3;hTERT-RPE1: 2404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002266	Approved				"Secreted to extracellular matrix"	NA	NA		510000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.26e-4)"	244.9	15.0	6.4	83.5	6.9	1.1	218.3	9.6	8.6	305.3	24.4	74.5	8.7	276.5	76.8	92.4	82.2	234.0	218.8	6.8	10.2	17.7	6.6	74.0	18.5	12.2	11.4	62.2	28.7	12.4	10.8	26.0	9.3	67.8	73.4	9.4	34.7	78.7	13.4	79.1	25.1	360.3	11.1	34.8	47.5	42.7	9.2	17.1	87.5	34.9	30.8	194.4	131.8	13.5	26.1	11.0	127.6	5.8	521.4	411.2	6.9	359.0	108.5	118.6	171.8	2.9	2.1	1.2	13.5	1281.3	11.4	33.5	5.3	4.8	123.7	24.3	1.2	0.7	27.7	0.7	109.5	1.0	0.5	409.7	14.4	174.9	11.0	2404.9	27.8	0.6	0.4	1.0	352.7	0.5	0.3	0.7	31.6	0.7	4.2	0.3	14.0	0.6	3.3	0.5	0.4	2.5	53.5	2.3	1.8	23.0	2.1	1.0	141.7	345.6	56.6	66.6	160.1	1.6	0.8	1.2	102.4	0.7	56.8	0.9	0.3	0.2	0.3	0.1	0.3	0.4	0.3	0.3	0.1	0.6	0.4	0.4	0.3	0.3	0.2	0.7	0.2	0.0	6.4	6.9	9.6	8.6	6.8	10.2	12.2	11.4	9.3	11.1	9.2	13.5	104.5	6.4	15.9	13.1	1.5	60.9	4.2	44.7	26.7	1.1	5.9	59.7	22.5	10.0	62.7	5.5	0.0	57.9	1.0	0.3	1.9	23.7	450.8	95.4	93.2	43.9	0.0	0.0	1.0	1.2	101.5	921.6	16.8	18.4	1.3	44.3	53.6	0.9	9.4	0.0	0.3	0.8	30.5	2.2	121.5	353.6	77.0	9.7	144.1	3.7	2.0	101.4	0.0	0.0	0.0	13.5	0.0	34.6	5.8	3.6	0.0	0.1	112.4	2.5	19.7	177.7	198.4	6.9	4.9	11.9	51.7	27.9	9.0	23.0	0.1	1.9
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340204-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.6;lymphoid tissue: 86.1"	"Cell type enhanced"	"Detected in many"		"NK-cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.7;HMC-1: 83.3;Karpas-707: 22.0;THP-1: 34.5;U-937: 25.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA026652	Approved		Supported	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	8.5	6.7	14.9	15.1	15.1	47.6	5.3	20.1	21.6	5.6	15.3	17.8	4.0	3.5	0.3	12.9	6.5	8.5	5.5	15.3	15.0	6.5	7.3	21.1	28.6	17.2	15.5	3.1	4.1	0.9	4.5	1.7	17.5	7.8	3.6	1.4	14.4	2.5	1.2	4.5	34.1	1.2	15.4	86.1	8.9	17.4	15.4	17.4	5.4	0.8	13.8	8.3	7.7	15.9	0.3	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	3.4	19.7	2.9	1.1	0.5	1.6	0.1	0.6	0.0	21.7	0.0	15.0	4.6	1.1	0.8	9.4	83.3	0.0	0.0	0.2	0.0	1.3	0.5	6.3	0.5	22.0	0.7	0.9	12.7	7.7	0.7	3.7	0.5	11.9	0.3	18.5	0.3	0.3	4.8	0.0	0.0	0.5	1.1	0.1	2.6	34.5	0.0	0.0	0.7	0.1	0.2	4.7	1.5	15.8	1.0	25.3	0.4	2.9	4.6	6.7	3.5	3.6	1.0	1.6	2.0	2.9	1.6	2.0	1.8	2.2	9.2	6.5	2.5	2.7	0.6	1.3	14.9	15.1	20.1	21.6	15.3	15.0	17.2	15.5	17.5	15.4	15.4	15.9	3.3	0.0	10.7	5.2	30.3	2.7	4.5	10.5	0.6	45.2	5.7	4.8	13.5	4.3	9.9	9.2	0.0	2.9	34.9	46.0	0.0	12.8	11.1	8.7	2.6	4.4	18.0	7.0	2.6	28.9	5.8	3.1	51.0	6.8	26.6	2.2	6.1	10.4	14.5	0.0	2.0	24.4	8.2	26.0	26.6	15.8	1.5	27.3	5.4	12.2	35.0	15.4	64.9	2.0	0.6	35.0	33.2	0.7	24.9	2.9	36.1	3.2	22.7	4.7	0.0	2.8	2.8	13.7	8.7	2.0	1.6	1.4	31.7	10.0	32.4	15.7
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36001553	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 83.0;liver: 31.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 35.4;OE19: 28.7"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	3270000	11000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.2	0.4	0.1	7.8	0.1	0.1	0.4	0.1	0.3	0.3	0.0	59.7	37.6	0.1	0.0	0.2	9.6	9.2	0.0	0.1	0.1	10.0	31.6	2.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	83.0	0.0	0.1	0.1	0.0	0.1	62.0	1.4	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	4.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	7.2	5.0	0.0	0.0	0.0	0.0	262.6	0.0	0.0	0.0	12.2	0.1	0.7	71.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	8.9	0.0	2.5	40.2	0.1	0.0	0.0	208.3	2.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	380.6	0.0	0.0	0.0	461.4	61.3	76.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	138.2	0.2
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103827-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 3753.7;Hofbauer cells: 849.7;Macrophages: 1168.2;NK-cells: 1232.8;Plasma cells: 974.5;T-cells: 1948.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 414.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 135.0;T-cells: 414.7"	"Group enriched"	"Detected in some"	6	"U-266/70: 51.6;U-266/84: 13.3"									CAB007805	Approved				"Secreted to blood"	NA	NA	144000		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.54e-4)"	"prognostic favorable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	38.9	28.0	2.0	32.0	2.0	192.9	10.5	3.4	5.5	16.0	4.1	9.9	7.6	10.3	6.4	15.0	8.2	45.1	4.4	2.0	1.9	6.8	84.2	33.9	34.3	3.2	2.9	5.0	15.6	12.0	2.5	17.8	2.8	7.6	11.1	0.1	5.1	3.4	1.0	0.9	11.4	18.0	2.5	65.3	10.3	2.7	2.1	24.1	5.9	4.5	15.4	56.4	4.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	51.6	13.3	0.2	0.2	0.1	0.0	14.4	3.4	135.0	414.7	4.8	101.6	8.4	46.0	240.6	2.3	17.7	13.8	181.7	55.8	42.8	11.1	2.6	0.5	138.9	2.0	2.0	3.4	5.5	2.0	1.9	3.2	2.9	2.8	2.5	2.1	3.3	52.3	0.0	54.5	0.0	135.9	15.6	1.9	0.3	24.5	1.5	26.3	49.3	11.2	14.3	7.2	0.0	0.0	9.7	3753.7	1.2	0.0	0.4	20.8	3.7	4.7	77.6	1.2	60.9	0.0	0.4	11.3	18.9	118.3	5.5	60.8	0.2	21.4	10.5	849.7	1.7	0.0	1.5	0.0	429.4	428.0	32.6	0.9	1168.2	51.6	3.7	10.5	1.1	1232.8	0.0	0.0	0.2	0.1	0.4	974.5	0.8	0.4	2.8	5.8	5.2	0.0	3.9	20.9	0.4	0.4	11.0	14.5	25.9	1948.3	0.0	0.9	1.6
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 122.1;lymphoid tissue: 135.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2049.9;NK-cells: 2344.0;T-cells: 1947.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 6788.6;memory CD8 T-cell: 7164.3"	"Group enriched"	"Detected in all"	7	"NK-cells: 2041.1;T-cells: 7164.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 94.1;NB-4: 539.9;THP-1: 139.9;U-937: 120.1"									CAB078447	Enhanced				"Secreted to blood"	NA	NA	20100000	2900000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB078447: AB_223462"	"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	17.2	17.1	3.9	36.3	4.0	122.1	19.5	3.8	6.5	15.5	5.4	27.7	48.7	15.7	14.4	15.8	14.0	42.9	8.9	3.9	3.7	7.5	28.4	57.4	135.2	7.3	4.3	16.9	7.0	3.0	3.8	6.3	6.4	10.4	25.6	0.3	33.5	7.9	4.8	4.0	84.5	10.5	5.8	123.9	47.9	4.6	4.7	29.5	11.5	2.7	33.4	31.4	9.5	6.1	0.7	0.5	0.2	0.0	0.5	0.4	0.8	0.3	4.0	17.8	20.8	0.4	1.7	0.3	1.6	0.9	1.3	0.9	0.0	0.0	2.3	6.5	0.3	0.0	1.5	0.6	0.5	94.1	0.8	0.1	0.2	5.5	0.3	0.0	0.2	0.1	0.1	12.5	0.2	0.6	0.1	539.9	0.5	0.0	0.0	0.6	0.2	14.0	0.2	0.5	0.1	0.5	0.2	1.2	13.4	0.5	0.2	139.9	0.3	0.6	0.3	0.6	0.4	14.2	6.6	0.8	0.4	120.1	1.3	657.8	30.0	35.8	6788.6	21.3	4221.0	61.3	1394.5	7164.3	49.8	41.6	332.4	4032.4	189.9	2041.1	26.1	46.5	25.9	6664.4	3.9	4.0	3.8	6.5	3.9	3.7	7.3	4.3	6.4	5.8	4.7	6.1	22.4	99.3	244.4	0.3	55.2	7.4	1.3	6.0	4.6	1.3	19.9	18.2	5.4	21.5	41.7	1.8	0.0	1.8	2049.9	3.1	1.9	6.3	1.2	5.5	5.4	24.2	1.8	106.3	0.5	0.2	7.1	26.0	46.9	6.7	80.8	0.2	45.0	7.0	33.8	0.0	0.3	3.5	0.0	48.0	25.0	0.1	0.3	256.3	12.4	2.8	38.5	0.4	2344.0	0.0	0.4	1.6	6.9	0.4	179.5	1.7	2.4	6.7	29.2	1.1	0.0	6.5	28.2	1.1	1.2	5.5	6.3	16.0	1947.0	0.1	3.5	1.9
CCN3	"IGFBP9, NOV"	ENSG00000136999	"Cellular communication network factor 3"	P48745	8	119416446-119424434	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	44	"adrenal gland: 1105.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.2;Endothelial cells: 2.7;Fibroblasts: 9.8;Smooth muscle cells: 4.6"	"Cancer enriched"	"Detected in all"	4	"melanoma: 62.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	116	"eosinophil: 64.8;neutrophil: 30.8"	"Lineage enriched"	"Detected in single"	157	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.0;hTERT-RPE1: 38.1;U-2197: 128.2"	"Group enriched"	"Detected in all"	6	"amygdala: 129.2;basal ganglia: 51.5;cerebral cortex: 99.5;hippocampal formation: 152.5;white matter: 85.0"	"Region enriched"	"Detected in all"	6	"spinal cord: 114.6"	"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	23.7	1105.4	7.6	3.6	11.5	1.7	8.1	6.7	12.2	11.2	5.9	6.9	3.9	8.6	6.3	5.5	9.0	6.3	18.1	16.2	9.7	6.9	1.1	6.8	2.2	5.6	6.5	3.1	6.8	9.4	21.8	0.6	4.9	22.8	7.0	1.2	2.7	20.0	4.7	13.8	4.4	8.4	8.7	1.5	4.9	3.6	6.3	1.0	25.3	7.2	1.9	4.4	8.0	6.2	0.1	3.1	1.7	0.0	11.1	2.9	0.1	16.9	125.0	14.9	8.6	0.0	0.3	0.0	12.9	21.2	11.6	10.5	0.6	0.0	5.1	0.0	0.3	0.0	9.1	0.0	0.4	0.0	0.0	0.6	0.1	5.7	0.6	38.1	0.4	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.2	1.2	24.9	0.1	0.0	0.0	15.8	0.1	3.9	0.1	6.3	0.1	24.2	0.0	0.0	0.0	0.0	10.6	15.8	128.2	3.5	0.0	0.0	0.0	16.7	5.4	12.5	0.0	0.3	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.1	7.6	11.5	6.7	12.2	16.2	9.7	5.6	6.5	4.9	8.7	6.3	6.2	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCRL2	"ACKR5, CKRX, CRAM-A, CRAM-B, HCR"	ENSG00000121797	"C-C motif chemokine receptor like 2"	O00421	3	46407166-46412997	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.0;Erythroid cells: 26.5;Hofbauer cells: 42.7;Kupffer cells: 22.1;Langerhans cells: 36.5;Macrophages: 56.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 21.0;OE19: 8.4;PC-3: 15.3;RT4: 8.3;TIME: 15.4;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043238	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"			"HPA043238: AB_10794924"	"unprognostic (3.94e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (9.67e-5)"	11.7	1.6	2.1	11.4	2.1	9.0	8.4	2.2	3.7	2.3	2.2	11.5	11.7	1.2	0.6	0.9	1.1	5.5	2.7	2.1	2.2	2.2	4.4	12.4	4.9	2.8	2.3	0.5	1.5	0.8	0.8	5.1	3.1	0.8	10.4	0.2	0.9	0.8	1.1	0.7	12.1	2.5	2.6	8.5	5.5	0.3	2.9	7.7	1.3	1.1	3.8	6.0	1.1	3.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.2	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.7	4.6	0.0	21.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	5.0	0.2	0.0	7.2	4.2	2.8	0.1	5.0	0.0	1.6	2.6	0.0	8.4	15.3	0.4	0.3	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	15.4	0.6	0.3	0.7	0.3	0.0	8.6	0.2	7.5	6.5	0.0	8.7	15.4	4.3	2.8	22.1	3.4	1.7	1.6	4.7	9.9	3.9	1.0	2.5	2.6	6.7	10.1	3.0	4.7	5.0	2.1	2.1	2.2	3.7	2.1	2.2	2.8	2.3	3.1	2.6	2.9	3.3	35.0	0.0	4.7	0.0	4.4	2.0	0.2	0.2	0.0	0.0	0.4	0.4	1.1	1.5	1.2	0.0	0.0	0.3	4.5	19.5	0.0	0.6	0.1	0.1	0.2	12.1	0.0	26.5	0.0	8.8	1.2	1.4	4.6	0.1	9.5	0.1	6.4	0.4	42.7	0.0	0.0	16.6	0.0	22.1	36.5	0.0	0.0	56.2	1.8	1.9	6.7	0.0	0.0	0.0	0.0	9.8	12.4	0.0	4.2	0.2	17.2	0.2	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	1.1	2.5	6.4	0.4	9.2	1.1
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 403.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 2809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3697.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 942.3;monocytes: 3697.0"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;CACO-2: 17.0;SiHa: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	10000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	134.5	151.3	15.9	236.1	16.0	68.8	50.5	14.7	33.1	27.9	26.8	55.9	31.4	23.5	21.0	23.9	40.5	79.8	35.6	14.5	23.2	41.6	403.4	91.6	107.9	33.6	26.4	21.4	27.0	16.7	35.5	183.0	29.6	18.3	47.6	4.0	121.8	30.4	10.6	13.5	38.0	111.7	25.4	87.6	33.9	26.6	30.3	20.9	23.0	17.5	23.0	102.5	12.6	42.1	0.1	10.1	0.1	0.8	1.3	0.3	0.5	0.9	4.7	1.9	2.1	17.0	3.1	0.4	1.0	5.9	1.4	4.9	0.0	2.6	0.5	0.1	1.4	0.3	1.1	2.0	5.1	1.1	0.3	4.8	0.3	0.3	1.5	0.4	0.0	0.3	0.3	0.3	1.7	0.3	0.1	1.2	0.4	0.3	0.3	0.4	0.6	1.8	0.2	0.1	3.6	1.3	21.1	0.5	0.5	0.2	0.3	2.1	0.6	0.4	0.4	1.9	2.1	0.8	1.6	0.8	0.4	0.5	0.1	13.5	3697.0	21.7	6.8	677.3	8.7	12.1	3.7	3.9	440.4	1.9	5.2	3.6	942.3	3.8	95.1	25.2	3.7	3034.0	15.9	16.0	14.7	33.1	14.5	23.2	33.6	26.4	29.6	25.4	30.3	42.1	17.9	9.6	27.6	0.7	9.0	5.1	3.4	5.2	6.2	7.2	164.9	23.4	2.6	22.8	18.3	1.8	0.0	18.1	5.3	77.2	1.9	5.1	2.3	0.6	1.7	46.5	7.2	29.5	0.7	1.8	16.3	19.7	1.1	1.0	8.8	0.6	340.2	348.0	2809.2	33.7	0.9	5.9	4.1	668.4	75.9	6.1	5.0	652.8	8.8	23.4	285.3	30.0	11.3	0.5	0.4	1.8	35.3	5.3	1.8	1.7	5.0	7.0	9.8	5.1	32.9	25.8	9.7	1.5	2.0	4.4	4.3	46.1	5.5	2.1	7.4	4.9
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470811-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 240.5"	"Cell type enriched"	"Detected in many"	4	"Kupffer cells: 1756.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 76.1;myeloid DC: 65.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 65.2;monocytes: 76.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;HSkMC: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	171.8	85.6	6.1	152.5	7.0	17.6	50.8	5.2	18.4	25.6	21.5	48.7	12.4	27.3	3.6	16.4	68.1	43.5	52.7	4.9	7.9	27.3	89.7	131.7	54.4	15.8	10.9	23.1	21.4	8.8	11.4	109.4	18.0	15.5	21.6	4.3	25.9	7.2	11.4	15.3	52.9	130.4	7.2	240.5	35.6	9.7	55.9	18.7	17.2	17.6	7.2	68.5	16.3	10.3	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	76.1	0.5	0.1	6.4	0.0	0.0	0.0	0.1	65.2	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.1	20.1	6.1	7.0	5.2	18.4	4.9	7.9	15.8	10.9	18.0	7.2	55.9	10.3	2.7	3.2	8.3	0.0	3.8	1.5	0.2	0.0	0.0	0.1	0.1	0.3	4.6	7.2	5.0	0.0	2.1	1.5	0.5	0.0	0.0	0.0	4.3	0.0	0.1	13.9	0.0	3.6	0.4	0.0	1.9	3.0	0.5	0.0	5.1	0.1	17.9	13.9	269.9	0.0	0.5	0.0	0.0	1756.1	30.9	6.4	5.0	387.9	0.0	2.8	41.1	0.9	1.0	0.0	0.0	0.0	0.0	1.2	1.0	0.1	0.0	0.2	1.6	0.2	118.3	1.7	4.0	3.9	2.6	0.5	1.0	3.0	1.3	0.0	0.0	0.1
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	25	"HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	4.6	4.6	0.6	51.3	0.7	11.4	7.6	0.6	1.0	5.8	0.8	13.9	17.2	3.7	2.8	8.4	4.2	16.8	2.6	0.5	0.8	2.5	7.8	21.0	119.6	1.7	0.7	2.8	2.9	0.9	0.7	1.0	1.1	5.2	16.0	0.0	8.6	2.3	1.4	3.5	28.4	4.4	1.0	44.1	24.1	1.8	1.0	249.8	3.8	1.7	79.1	20.8	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.1	0.0	0.4	0.0	0.0	0.0	0.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.1	0.5	0.0	0.0	166.9	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.4	0.0	11.3	5.2	1.6	421.8	3.7	403.1	3.8	610.2	714.1	95.4	2.5	316.3	486.2	14.1	1108.0	2.8	21.0	655.2	565.1	0.6	0.7	0.6	1.0	0.5	0.8	1.7	0.7	1.1	1.0	1.0	1.1	5.0	3.2	17.5	0.0	12.3	5.0	0.4	0.0	2.2	0.0	4.0	4.7	2.1	0.0	2.5	3.7	0.0	0.1	158.3	0.2	0.0	0.5	23.5	1.1	1.0	2.9	3.0	24.0	0.0	0.0	0.0	2.5	10.7	0.9	5.1	0.0	8.2	1.5	0.6	0.0	0.0	0.0	0.0	10.9	16.6	7.8	0.6	19.1	1.8	1.0	15.5	0.0	178.2	0.0	0.0	0.0	0.0	0.4	42.3	0.1	0.0	1.7	0.0	0.0	0.0	2.9	4.1	0.3	0.2	0.4	3.7	0.0	476.8	0.0	0.5	0.2
CD200	"MOX1, MOX2, MRC, OX-2"	ENSG00000091972	"CD200 molecule"	P41217	3	112332347-112362812	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 97.4;Excitatory neurons: 54.5;Inhibitory neurons: 55.7;Syncytiotrophoblasts: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"memory B-cell: 30.7;naive B-cell: 83.6"	"Lineage enriched"	"Detected in many"	23	"B-cells: 83.6"	"Cell line enhanced"	"Detected in some"		"AF22: 75.9;HHSteC: 27.2;NTERA-2: 47.7;REH: 42.4;SK-MEL-30: 29.8;WM-115: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031149	Approved					NA	NA		26000	"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA031149: AB_10600694"	"unprognostic (1.84e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.03e-3)"	"unprognostic (4.97e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.22e-2)"	25.3	12.1	27.7	15.6	27.3	2.4	11.6	13.2	34.0	20.1	2.9	6.7	3.3	28.4	7.1	8.9	26.7	13.1	9.3	27.9	41.3	8.5	1.0	9.6	26.1	11.9	16.3	11.6	4.9	10.5	26.8	28.2	18.8	12.1	8.2	15.1	9.0	16.5	1.8	4.4	6.9	18.3	15.1	6.2	5.2	2.9	30.4	23.6	18.9	3.6	24.9	27.5	5.9	18.3	0.0	0.0	75.9	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.1	0.2	4.1	0.0	0.9	0.1	8.2	0.4	0.2	0.2	0.5	0.0	0.3	0.4	27.2	0.0	0.1	0.5	0.2	1.6	0.2	0.2	10.8	0.0	0.1	0.7	0.2	0.0	1.2	0.0	47.7	0.0	0.0	42.4	0.1	0.5	0.6	0.1	19.9	23.0	0.0	0.4	29.8	14.0	0.0	0.3	0.1	0.3	2.6	0.0	0.2	0.1	0.1	0.0	0.6	0.2	83.7	3.6	0.4	0.3	0.3	0.1	3.5	30.7	2.0	0.6	1.3	83.6	2.1	1.3	1.7	1.6	0.3	2.8	1.0	3.4	27.7	27.3	13.2	34.0	27.9	41.3	11.9	16.3	18.8	15.1	30.4	18.3	15.2	3.2	9.1	10.7	27.8	4.2	12.6	0.3	0.0	26.8	0.7	13.0	0.8	1.5	1.3	1.8	0.0	3.0	1.6	0.8	0.0	0.3	25.1	20.6	4.2	97.4	38.4	0.8	54.5	0.0	12.1	13.0	3.1	41.0	2.5	0.7	1.4	0.0	1.0	3.3	55.7	8.1	0.0	0.3	6.1	30.3	0.3	1.1	8.8	6.5	14.0	7.1	0.0	29.7	38.5	0.2	10.7	0.0	1.9	15.4	0.9	0.3	2.7	2.5	0.0	13.1	2.6	0.6	0.4	0.7	3.3	75.9	2.9	9.3	7.1	21.6
CD209	"CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1"	ENSG00000090659	"CD209 molecule"	Q9NNX6	19	7739993-7747564	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.2;placenta: 22.8"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 15.6;Langerhans cells: 14.7;Macrophages: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.4;intermediate monocyte: 1.4;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;monocytes: 1.4"	"Cell line enriched"	"Detected in single"	14	"THP-1: 3.3"									"CAB032436, CAB033831"	Supported				"Intracellular and membrane"	NA	NA		3100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB032436: AB_639039, CAB033831: AB_1121347"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.09e-1)"	34.2	3.9	0.3	8.6	0.6	0.4	4.4	1.3	3.0	4.0	5.7	10.5	14.3	1.4	1.0	4.8	2.5	8.6	4.5	0.3	0.7	2.1	3.3	4.9	18.1	1.0	0.6	1.0	1.0	0.8	0.7	22.8	0.8	0.8	13.9	0.1	2.1	1.9	0.9	1.4	19.3	10.6	0.9	2.4	4.1	2.1	0.6	5.4	1.4	1.5	2.3	20.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.4	0.3	0.6	1.3	3.0	0.3	0.7	1.0	0.6	0.8	0.9	0.6	0.8	0.3	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	15.6	14.7	0.3	0.0	12.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.1
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862887	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 16.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 28.4;Kupffer cells: 17.7;NK-cells: 66.9;T-cells: 21.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 472.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 472.1"	"Cell line enhanced"	"Detected in some"		"HEL: 20.6;HMC-1: 69.4;NB-4: 14.4;U-937: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		280000	"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.1	0.4	0.3	3.7	0.4	10.0	0.4	0.3	0.5	0.3	0.3	1.1	3.0	0.3	0.3	0.4	0.5	1.0	0.6	0.4	0.3	0.3	4.2	3.3	3.4	0.4	0.3	1.0	0.1	0.1	0.1	0.4	0.3	0.4	1.4	0.0	1.1	0.4	0.3	0.3	2.8	1.1	0.3	16.8	1.0	2.7	0.3	2.8	0.2	0.2	2.0	1.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.4	6.8	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	2.1	14.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.1	0.0	28.7	0.0	472.1	43.3	107.9	71.3	59.1	35.2	0.3	3.7	39.7	41.0	0.2	5.3	36.0	3.1	78.5	73.6	2.4	0.2	70.7	0.3	0.4	0.3	0.5	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.4	0.1	3.2	6.1	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	5.2	0.0	0.1	0.2	0.0	2.1	0.7	1.7	0.0	0.3	0.5	0.1	3.8	0.0	0.7	0.2	0.6	0.0	0.1	0.0	0.0	17.7	3.1	2.4	1.8	8.3	0.0	0.0	8.5	0.0	66.9	0.0	0.2	0.0	0.0	2.2	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.0	0.1	0.0	21.9	0.5	0.0	0.0
CD247	"CD3H, CD3Q, CD3Z"	ENSG00000198821	"CD247 molecule"	P20963	1	167430640-167518610	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 49.0;lymphoid tissue: 179.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 492.1;NK-cells: 727.1;T-cells: 247.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"gdT-cell: 376.4;MAIT T-cell: 208.9;memory CD4 T-cell: 190.0;memory CD8 T-cell: 219.7;naive CD4 T-cell: 237.8;naive CD8 T-cell: 195.1;NK-cell: 225.3;T-reg: 254.5"	"Group enriched"	"Detected in all"	32	"NK-cells: 225.3;T-cells: 376.4"	"Group enriched"	"Detected in some"	25	"HDLM-2: 155.9;JURKAT: 113.1;MOLT-4: 167.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB004651: AB_425347, HPA008750: AB_1857863"	"prognostic favorable (9.12e-4)"	"unprognostic (3.21e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (8.63e-6)"	"unprognostic (1.99e-2)"	"prognostic favorable (3.98e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.46e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (1.60e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.94e-3)"	3.2	1.7	2.3	25.3	2.3	49.0	1.9	2.2	2.5	1.9	1.9	4.3	7.1	2.3	3.1	2.1	1.8	5.5	1.3	2.3	2.3	2.0	5.4	10.9	57.7	2.3	2.2	0.8	0.8	0.5	0.8	1.4	2.2	1.8	4.6	0.2	2.4	1.6	1.4	1.1	14.3	1.5	2.1	40.2	7.0	0.4	2.9	179.4	2.5	0.9	36.4	7.3	1.9	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	155.9	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.1	0.0	0.1	0.0	0.0	167.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	8.3	1.0	0.4	376.4	1.4	208.9	9.3	190.0	219.7	1.5	4.9	237.8	195.1	8.7	225.3	1.2	2.8	254.5	231.2	2.3	2.3	2.2	2.5	2.3	2.3	2.3	2.2	2.2	2.1	2.9	2.5	3.4	3.2	16.0	3.3	8.2	1.5	0.1	0.0	0.6	0.4	3.5	3.2	0.6	1.5	1.3	0.0	0.0	0.1	492.1	0.4	0.0	0.5	0.2	0.7	0.8	1.8	0.0	14.7	8.8	0.0	0.1	2.2	6.1	1.1	6.3	0.4	7.1	1.4	0.3	3.3	9.4	0.5	0.0	7.8	1.4	0.2	0.0	5.9	3.6	14.0	7.6	0.1	727.1	0.5	3.7	0.0	1.2	0.0	51.9	0.1	0.2	1.3	2.2	0.2	0.0	0.9	1.2	0.1	2.5	1.4	0.6	0.1	247.2	0.0	0.1	0.1
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 27.7;granulocytes: 28.4;Langerhans cells: 50.9;monocytes: 42.4;Syncytiotrophoblasts: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 89.6;HHSteC: 55.5;U-251 MG: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, HPA003528: "	"prognostic favorable (8.89e-4)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.64e-5)"	"unprognostic (1.27e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.67e-4)"	"unprognostic (7.39e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.02e-2)"	2.6	2.0	1.0	10.3	0.9	1.9	1.5	0.9	1.2	1.8	0.6	1.4	2.7	1.5	1.8	2.5	1.8	4.0	8.9	0.8	1.9	2.6	3.4	16.8	6.6	1.8	1.6	1.5	1.9	5.0	2.6	6.8	2.0	2.0	2.1	1.2	1.5	1.5	4.5	0.7	1.9	2.2	1.7	10.2	1.9	0.9	1.6	13.0	3.5	4.3	5.3	7.2	1.3	1.1	15.6	0.2	0.0	0.5	0.1	0.1	0.0	30.5	25.7	7.7	10.4	0.0	5.0	0.2	0.6	0.8	3.8	0.6	0.0	13.2	24.6	89.6	0.0	9.0	0.3	0.0	55.5	0.0	0.0	0.5	0.1	15.7	22.9	7.7	15.0	0.9	0.0	2.9	23.4	0.0	0.4	0.1	0.0	0.0	0.3	0.1	4.2	0.8	1.6	0.3	0.0	0.3	0.4	2.4	1.9	2.2	0.1	0.3	28.1	16.1	5.1	0.5	98.1	0.5	0.2	0.3	5.4	0.3	0.2	6.6	0.0	0.2	0.7	0.1	1.2	0.5	1.4	1.1	0.0	0.1	0.7	0.4	3.6	0.3	0.0	0.0	0.7	0.4	1.0	0.9	0.9	1.2	0.8	1.9	1.8	1.6	2.0	1.7	1.6	1.1	3.0	12.8	11.4	0.7	1.9	4.6	1.5	4.4	1.8	1.4	1.4	1.3	7.8	0.0	2.9	0.0	0.0	6.1	2.4	2.6	0.0	5.9	1.0	1.4	0.3	5.5	0.0	3.2	1.9	4.4	27.7	1.9	0.5	0.9	28.4	0.2	7.1	0.8	5.7	0.0	3.3	0.5	4.1	2.9	50.9	0.2	0.3	4.2	3.6	8.4	42.4	0.5	1.0	1.0	0.9	19.0	0.1	0.4	2.2	2.1	1.9	0.4	4.0	0.2	0.0	2.3	0.9	1.0	0.8	1.2	2.6	44.5	3.1	0.1	0.4	2.0
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 30.8;placenta: 14.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 34.1;T-cells: 52.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 101.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 101.9"	"Group enriched"	"Detected in some"	14	"Karpas-707: 360.6;RPMI-8226: 173.2;U-266/70: 294.1;U-266/84: 283.7"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"Not detected"	"Not detected"			HPA070003	Enhanced					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"	4.0	0.3	0.0	14.9	0.1	3.3	0.8	0.1	0.1	1.1	0.9	1.7	1.1	0.7	0.3	0.9	0.5	4.1	0.6	0.1	0.1	0.5	1.3	1.9	28.0	0.1	0.0	0.3	0.5	0.2	0.1	14.8	0.1	1.0	1.9	0.1	0.6	0.8	0.3	0.3	3.0	1.4	0.1	7.2	2.5	0.7	0.2	30.8	0.5	0.1	18.6	4.6	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.7	2.0	0.0	360.6	0.2	0.0	19.9	0.0	0.1	0.0	0.0	0.1	0.3	173.2	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.3	294.1	283.7	2.9	0.3	0.1	0.0	1.7	0.6	1.0	8.3	0.5	50.6	0.3	54.5	26.1	0.1	0.3	48.1	18.6	13.8	0.2	0.5	0.2	101.9	14.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.5	0.0	1.3	0.0	2.4	2.9	0.1	0.0	0.6	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.2	3.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	1.0	2.0	0.1	1.3	0.0	0.0	0.1	34.1	0.0	0.0	0.0	0.0	0.8	5.3	0.2	0.0	4.4	0.0	1.0	1.5	0.0	2.1	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.2	1.6	0.1	52.6	0.0	0.0	0.0
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541073-74546115	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.7;lung: 8.4;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	5	"granulocytes: 15.2;Hofbauer cells: 32.1;Kupffer cells: 26.3;Langerhans cells: 15.3;Macrophages: 36.1;monocytes: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 228.3;non-classical monocyte: 242.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;HMC-1: 33.1;THP-1: 6.5;U-937: 16.2"					"Low region specificity"	"Detected in some"			"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	4.0	1.3	0.7	6.8	1.1	9.7	0.8	0.8	5.5	0.6	1.1	1.3	1.1	0.6	0.1	0.6	0.7	2.0	0.9	0.7	1.4	0.7	1.5	8.4	2.1	1.7	1.8	0.3	0.6	0.4	0.4	2.9	2.1	0.5	1.3	0.0	0.7	0.5	0.3	0.4	1.2	3.1	1.4	7.3	0.7	0.3	2.7	1.0	1.0	0.2	1.1	3.8	0.4	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	3.3	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	16.2	0.0	51.8	142.1	7.0	0.7	228.3	0.4	2.7	0.3	0.3	158.8	2.4	0.2	0.2	5.2	43.9	242.7	10.5	0.2	64.6	0.7	1.1	0.8	5.5	0.7	1.4	1.7	1.8	2.1	1.4	2.7	2.2	0.1	0.0	1.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	15.2	0.0	0.0	0.2	32.1	0.0	0.0	0.0	0.0	26.3	15.3	0.1	0.0	36.1	1.8	1.0	19.6	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	1.3	0.0	0.0	0.0
CD302	"BIMLEC, CLEC13A, DCL-1, KIAA0022"	ENSG00000241399	"CD302 molecule"	Q8IX05	2	159768628-159798255	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 193.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 352.2;Kupffer cells: 382.4;Macrophages: 194.3;monocytes: 166.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	215	"dendritic cells: 24.4;granulocytes: 32.2;monocytes: 33.0"	"Cell line enriched"	"Detected in many"	5	"ASC diff: 246.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		110000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.52e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.12e-3)"	"unprognostic (5.29e-3)"	"unprognostic (2.37e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-3)"	49.4	25.5	6.5	15.5	6.6	30.6	31.0	7.1	9.2	34.6	10.6	16.8	24.1	21.8	14.2	11.7	15.0	30.7	13.3	6.1	7.5	16.9	193.8	50.0	11.7	8.8	7.2	41.9	17.6	10.9	3.2	19.4	8.5	21.3	20.7	2.1	12.0	20.4	2.9	6.2	28.1	22.5	7.5	31.3	15.7	9.0	6.6	9.7	31.1	17.3	9.9	24.6	13.3	8.5	0.1	1.4	1.2	0.0	246.9	51.5	0.0	5.3	25.9	7.4	10.9	1.6	2.2	0.4	2.0	13.5	7.8	0.0	5.5	3.0	10.1	1.6	8.6	7.0	1.3	3.6	12.3	18.6	6.0	41.2	1.4	8.0	0.0	6.0	18.9	0.0	0.6	5.8	9.5	0.6	0.0	13.1	2.4	0.0	6.7	0.0	1.8	0.2	1.6	0.2	2.7	2.9	1.8	5.9	5.7	3.8	4.8	18.3	4.1	13.7	0.0	0.2	4.1	0.5	0.0	0.0	9.9	1.5	3.1	13.5	33.0	32.2	0.0	24.1	0.0	0.1	0.0	0.0	24.4	0.1	0.0	0.0	29.2	0.1	26.1	6.8	0.0	12.5	6.5	6.6	7.1	9.2	6.1	7.5	8.8	7.2	8.5	7.5	6.6	8.5	28.0	44.8	111.9	0.0	5.0	6.6	15.9	2.4	16.5	3.3	20.2	15.2	3.9	31.5	26.5	3.7	0.0	2.5	19.3	3.7	0.0	4.0	31.7	3.0	38.7	25.3	9.6	21.0	0.0	3.5	10.5	80.5	20.4	3.0	30.9	26.7	65.7	352.2	42.7	3.3	0.0	25.2	0.0	382.4	97.3	16.4	122.7	194.3	19.6	0.0	166.6	2.1	2.1	0.0	0.0	2.3	12.2	93.6	3.5	13.9	19.6	4.1	17.1	2.4	65.7	24.8	30.7	27.9	11.6	3.6	4.4	2.7	6.5	8.6	22.7	10.4
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.4;lymphoid tissue: 23.9"	"Group enriched"	"Detected in some"	6	"granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.5;monocytes: 166.5"	"Cell line enhanced"	"Detected in some"		"HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1"									"CAB011442, HPA035832, HPA064807, CAB079996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		3400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane"		"CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	7.9	3.4	1.1	11.2	1.2	32.4	2.5	1.5	1.6	3.0	2.5	3.2	3.3	1.7	1.3	2.0	2.5	6.6	2.0	1.1	1.8	1.4	5.5	12.6	10.1	2.5	1.6	1.4	1.4	1.2	0.9	6.9	2.4	1.4	4.2	0.2	1.8	2.6	0.9	2.7	4.4	7.1	1.9	23.9	2.3	1.0	2.3	3.5	0.9	0.8	3.5	6.2	1.3	3.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	5.5	0.4	0.0	1.3	0.3	0.0	0.2	0.0	0.1	0.1	86.1	0.3	0.0	0.0	115.6	82.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	16.2	21.2	0.2	0.0	0.0	55.2	0.2	0.0	25.9	0.0	4.4	62.5	0.4	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	67.0	0.7	14.0	1.1	1.8	0.1	0.3	7.6	0.2	9.6	84.1	0.4	17.9	166.5	11.0	0.3	122.0	0.4	0.1	0.2	0.5	213.5	0.4	0.3	0.2	20.5	15.5	57.8	6.3	1.1	77.8	1.1	1.2	1.5	1.6	1.1	1.8	2.5	1.6	2.4	1.9	2.3	3.6	0.7	0.0	6.7	0.0	1.0	1.8	0.5	0.0	0.0	0.2	1.4	0.4	0.8	0.0	0.6	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.7	0.1	0.1	3.0	0.0	4.2	0.0	0.0	0.5	1.1	0.0	0.1	76.0	0.1	5.3	0.7	78.8	0.0	0.0	0.0	0.0	131.2	41.4	1.7	0.3	53.5	1.8	11.2	65.0	0.2	1.0	0.5	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.7	0.6	0.0	1.1	0.3	0.7	0.5	0.0	1.0	0.8	2.5	0.1	0.0	0.4
CD3D	T3D	ENSG00000167286	"CD3d molecule"	P04234	11	118339075-118342705	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	30	"lymphoid tissue: 906.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 231.0;T-cells: 665.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	52	"gdT-cell: 1462.4;MAIT T-cell: 990.0;memory CD4 T-cell: 1206.1;memory CD8 T-cell: 1368.7;naive CD4 T-cell: 1091.4;naive CD8 T-cell: 1338.9;T-reg: 1660.4"	"Lineage enriched"	"Detected in all"	66	"T-cells: 1660.4"	"Group enriched"	"Detected in some"	4	"JURKAT: 621.5;MOLT-4: 1299.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013055, HPA071778"	Enhanced		Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"CAB013055: , HPA071778: "	"prognostic favorable (3.00e-4)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (6.00e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (9.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.16e-4)"	4.1	3.8	0.3	77.5	0.4	28.6	9.9	0.4	1.4	5.2	0.7	18.8	21.7	3.6	5.7	7.6	4.5	15.7	3.7	0.3	0.6	2.3	7.9	20.6	222.7	1.1	0.4	3.2	1.3	0.9	0.8	1.2	0.6	5.9	22.4	0.3	8.3	3.1	2.5	4.0	30.1	3.9	0.7	60.9	23.8	2.4	0.5	906.7	3.8	1.4	166.9	26.7	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	621.5	49.8	0.0	0.0	0.0	1299.8	237.2	1.2	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.2	0.8	0.0	0.5	0.0	1.5	1.1	0.0	0.9	1.1	0.4	0.0	0.1	0.0	10.1	5.3	4.6	1462.4	3.3	990.0	9.6	1206.1	1368.7	5.0	3.7	1091.4	1338.9	25.1	4.2	5.3	6.0	1660.4	1138.7	0.3	0.4	0.4	1.4	0.3	0.6	1.1	0.4	0.6	0.7	0.5	0.8	5.9	6.4	29.6	0.0	18.6	15.3	0.3	0.0	1.8	0.0	5.4	6.7	2.8	7.2	2.6	3.7	0.0	0.4	231.0	0.9	0.0	1.3	0.4	0.8	0.8	5.0	1.2	16.8	0.0	0.0	0.0	8.3	21.4	0.9	12.6	0.0	7.9	3.1	0.6	0.0	0.0	0.2	0.0	14.9	28.4	0.7	0.0	14.2	12.4	1.0	25.0	0.0	32.0	0.0	0.0	0.1	0.2	0.0	21.0	0.3	0.0	3.4	1.5	0.0	0.0	2.5	5.8	0.1	1.2	1.4	11.8	0.3	665.7	0.0	1.1	0.2
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Group enriched"	"Detected in some"	67	"JURKAT: 544.9;MOLT-4: 764.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	6.4	5.6	0.9	85.8	1.1	36.7	6.7	0.9	1.2	7.1	1.3	15.3	22.0	5.8	4.6	9.5	5.4	20.1	3.8	0.7	1.0	3.5	9.7	23.0	209.6	1.8	0.9	3.8	2.2	0.7	1.0	1.6	1.4	6.6	19.3	0.0	11.6	3.0	1.9	5.4	36.4	5.1	1.2	78.9	24.4	1.7	1.3	640.4	5.3	1.6	147.0	24.8	4.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	544.9	0.9	2.0	0.0	0.0	764.9	0.6	0.3	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	1.6	8.0	9.8	0.0	0.6	0.0	16.4	1.8	2.4	490.6	1.3	420.8	1.6	414.4	463.5	1.5	2.1	491.7	501.3	12.2	202.2	2.0	8.6	426.3	333.0	0.9	1.1	0.9	1.2	0.7	1.0	1.8	0.9	1.4	1.2	1.3	1.6	4.9	0.0	8.6	0.0	12.9	5.2	0.3	0.0	0.0	0.0	3.8	4.8	0.3	0.0	0.6	1.8	0.0	0.2	213.6	0.4	0.0	0.2	7.0	0.5	0.9	2.5	0.0	6.9	0.1	0.0	0.0	5.3	24.5	0.9	7.6	0.0	8.9	2.4	0.3	0.0	0.1	0.0	0.0	7.6	8.3	0.2	0.0	12.6	12.4	1.0	8.4	0.0	154.5	0.0	0.1	0.0	1.1	0.0	41.4	0.1	0.2	2.1	0.0	0.0	0.0	1.3	2.7	0.0	0.0	1.6	5.4	0.3	601.4	0.0	0.6	0.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 139.6;T-cells: 294.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Group enriched"	"Detected in some"	52	"JURKAT: 70.9;MOLT-4: 193.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	0.7	0.8	0.6	10.5	0.8	1.3	1.0	1.1	0.8	0.7	1.1	2.3	3.3	0.5	0.6	1.4	0.9	2.5	0.5	0.5	0.4	0.6	1.6	2.8	27.9	0.9	0.6	0.4	0.5	0.2	0.0	0.3	0.8	0.9	2.7	0.4	1.6	0.3	10.5	0.9	4.6	0.6	0.3	11.5	4.1	0.4	0.8	94.7	0.6	0.3	20.4	3.0	0.4	1.9	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	70.9	2.5	0.3	0.0	0.6	193.8	1.3	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.7	0.3	0.2	0.2	0.1	9.2	1.2	1.2	229.0	0.6	135.6	0.8	187.3	197.3	0.6	0.9	192.6	241.7	6.4	1.4	1.2	1.5	200.0	90.4	0.6	0.8	1.1	0.8	0.5	0.4	0.9	0.6	0.8	0.3	0.8	1.9	3.2	3.2	6.9	0.0	7.8	2.3	0.1	0.0	1.8	0.2	2.0	2.9	0.8	1.5	1.9	0.0	0.0	0.1	139.6	0.4	0.0	0.3	1.0	0.4	0.4	1.4	0.0	3.4	0.1	0.0	0.0	2.3	13.7	0.4	6.3	0.0	4.2	1.7	0.1	0.0	0.1	0.2	0.0	3.8	5.8	1.4	0.0	7.7	5.4	1.0	8.1	0.0	14.4	0.0	0.3	0.0	0.1	0.0	18.5	0.0	0.0	0.6	0.7	0.8	0.0	1.3	1.6	0.2	0.4	0.6	2.4	0.3	294.0	0.1	0.3	0.0
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648158-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 15.5"	"Cell type enriched"	"Detected in some"	8	"T-cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1"	"Lineage enriched"	"Detected in many"	39	"T-cells: 80.5"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 23.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045827, HPA072480"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA	776000	20000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus, Plasma membrane"		"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	0.8	0.3	0.1	7.9	0.0	1.9	1.1	0.2	0.2	0.9	0.2	1.9	1.8	0.3	0.2	1.0	0.4	2.0	0.2	0.1	0.2	0.4	1.0	2.4	15.5	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.8	3.1	0.0	0.6	0.3	0.1	0.6	3.8	0.6	0.0	4.9	2.0	0.3	0.1	15.5	0.5	0.2	14.8	2.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.3	26.3	0.1	64.1	0.1	80.5	11.7	0.2	0.0	76.1	0.7	1.3	0.8	0.1	0.1	10.5	13.6	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.2	0.6	0.0	2.4	0.0	2.4	1.3	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.6	2.6	0.0	1.3	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.6	4.0	8.9	0.0	2.9	1.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.1	2.0	0.0	76.6	0.0	0.0	0.1
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711831	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 148.4;lymphoid tissue: 283.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 336.1;dendritic cells: 251.2;Kupffer cells: 245.8;Macrophages: 218.3;monocytes: 366.6;NK-cells: 454.2;T-cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 220.9;HMC-1: 236.9;U-266/70: 501.4;U-266/84: 360.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002497, HPA055146"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	11.8	5.9	1.4	115.3	1.5	148.4	18.8	1.5	4.7	10.2	2.3	24.9	20.5	6.7	5.0	8.4	5.7	26.6	4.3	1.3	1.7	4.4	19.9	31.0	283.9	2.6	1.8	3.1	2.0	1.6	1.6	5.8	2.7	8.1	32.5	0.1	14.0	4.4	2.9	3.5	48.3	12.5	2.1	160.0	32.5	2.9	3.2	138.9	5.2	3.4	256.8	41.8	4.5	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	220.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	6.0	0.0	2.1	0.0	0.0	0.0	27.1	236.9	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.4	78.6	0.0	0.0	78.9	38.4	0.1	0.0	0.0	4.7	0.1	34.3	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.1	0.0	0.3	0.2	0.4	501.4	360.3	89.9	0.2	66.7	0.1	218.1	327.1	230.8	242.8	470.2	335.8	206.2	275.2	283.4	329.7	161.2	277.9	301.6	82.1	160.7	487.4	57.0	229.9	603.5	1.4	1.5	1.5	4.7	1.3	1.7	2.6	1.8	2.7	2.1	3.2	4.1	3.7	0.0	9.6	0.7	336.1	5.5	0.8	0.0	1.8	0.0	2.0	1.7	1.1	2.8	1.3	3.7	0.0	0.6	251.2	0.1	1.9	0.2	0.1	0.7	0.5	2.8	1.2	21.5	0.1	0.2	0.8	2.4	6.6	0.6	90.7	0.1	7.1	2.0	86.4	0.0	0.1	0.1	0.0	245.8	106.5	0.5	1.8	218.3	39.2	1.0	366.6	0.0	454.2	0.5	0.0	0.1	0.0	0.4	127.4	0.4	0.0	4.9	2.2	0.0	0.0	1.7	2.1	0.5	0.3	0.7	3.0	0.4	376.2	0.0	1.2	0.5
CD5	"LEU1, T1"	ENSG00000110448	"CD5 molecule"	P06127	11	61102489-61127852	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.5;Langerhans cells: 9.3;Muller glia cells: 16.0;T-cells: 57.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 138.2"	"Lineage enriched"	"Detected in many"	33	"T-cells: 138.2"	"Group enriched"	"Detected in some"	66	"JURKAT: 21.0;MOLT-4: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015392, CAB020308, HPA043416, HPA060839"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376"	"prognostic favorable (4.05e-4)"	"prognostic favorable (9.16e-5)"	"unprognostic (2.33e-1)"	"prognostic favorable (9.00e-5)"	"unprognostic (1.02e-2)"	"prognostic favorable (7.41e-6)"	"unprognostic (2.45e-3)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.94e-5)"	"unprognostic (4.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.06e-1)"	1.4	0.9	0.4	22.6	0.4	12.2	1.0	0.1	0.5	0.9	0.0	2.8	3.1	0.7	0.4	2.3	0.8	4.9	0.9	0.6	0.4	0.8	1.5	5.7	38.0	0.2	0.0	0.8	0.4	0.2	0.4	0.3	0.5	1.0	2.7	1.8	6.4	0.3	0.6	1.4	7.1	1.2	0.0	14.1	7.9	0.8	0.3	46.5	1.0	0.3	22.2	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.1	70.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.6	45.9	0.4	32.8	1.5	108.7	72.5	3.7	3.4	88.4	69.8	1.8	0.4	3.4	4.1	138.2	61.5	0.4	0.4	0.1	0.5	0.6	0.4	0.2	0.0	0.5	0.0	0.3	0.0	0.4	0.0	1.7	0.0	4.1	0.9	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	2.7	0.0	0.1	0.2	0.0	1.3	0.3	0.0	0.0	0.9	2.6	0.1	1.3	0.0	1.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	9.3	0.9	0.0	1.8	3.6	0.0	2.1	16.0	1.0	0.0	0.1	0.1	0.3	0.0	6.3	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.6	0.4	0.7	0.2	0.3	0.0	57.0	0.0	0.2	0.2
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.6;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 25.7;NK-cells: 49.4;Plasma cells: 18.5;T-cells: 107.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"gdT-cell: 27.7;MAIT T-cell: 24.7;memory CD4 T-cell: 51.4;memory CD8 T-cell: 48.4;naive CD4 T-cell: 34.4;naive CD8 T-cell: 25.2;T-reg: 25.5"	"Lineage enriched"	"Detected in many"	51	"T-cells: 51.4"	"Group enriched"	"Detected in some"	12	"JURKAT: 10.2;MOLT-4: 39.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	NA	NA	5270000	160000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB002489: AB_563605, CAB016252: AB_631163"	"prognostic favorable (1.95e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (4.47e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.06e-2)"	"prognostic favorable (5.10e-6)"	"unprognostic (8.45e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.87e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.35e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.96e-2)"	1.4	0.9	1.5	21.9	0.9	11.3	1.2	0.5	1.1	1.3	0.7	3.2	4.0	0.9	0.7	1.8	1.4	3.9	0.5	0.6	1.7	1.0	1.4	6.6	43.1	1.5	2.0	0.9	0.6	0.2	0.4	0.3	1.7	1.1	3.1	0.2	3.2	0.4	0.8	1.3	13.6	0.7	0.9	18.0	6.6	0.7	2.5	39.6	1.4	0.3	29.0	4.8	1.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.2	0.0	0.0	0.0	39.2	0.1	0.2	0.2	0.1	0.1	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.4	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.7	0.0	24.7	1.0	51.4	48.4	0.3	0.9	34.4	25.2	0.7	0.2	0.0	0.0	25.5	13.8	1.5	0.9	0.5	1.1	0.6	1.7	1.5	2.0	1.7	0.9	2.5	0.9	3.2	0.0	2.5	0.3	10.8	2.0	0.2	0.1	0.0	1.4	0.9	0.8	2.6	1.5	0.1	0.0	0.0	0.2	25.7	0.2	0.0	0.2	0.9	0.4	0.3	1.2	0.0	0.0	0.8	0.6	0.2	1.5	8.2	0.3	0.0	0.1	2.5	0.8	2.0	1.7	0.9	0.0	0.0	1.9	4.4	0.4	0.3	3.4	3.6	1.0	2.4	0.0	49.4	0.0	0.2	0.7	0.2	0.0	18.5	0.0	0.1	0.2	0.1	0.2	0.0	1.0	0.9	0.4	0.9	1.0	1.4	0.3	107.3	0.7	0.5	0.4
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 169.1;lymphoid tissue: 94.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1017.1;dendritic cells: 694.0;granulocytes: 1455.3;Plasma cells: 308.8;T-cells: 1185.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 26.7;T-cells: 30.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 30.0;JURKAT: 19.5;K-562: 58.4;MOLT-4: 20.9;U-266/70: 22.5;U-698: 25.6;U-937: 97.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002503: AB_563625, HPA050525: AB_2681157"	"prognostic favorable (3.31e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.10e-3)"	"unprognostic (4.76e-3)"	"unprognostic (9.53e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"	14.0	6.2	0.9	48.1	0.7	169.1	18.9	1.2	1.0	9.3	2.2	8.9	8.2	6.0	2.9	11.9	7.7	27.3	3.5	0.7	1.7	4.9	12.9	22.6	94.4	1.7	1.1	2.6	1.7	2.0	4.0	2.6	1.6	10.4	21.3	0.2	5.1	2.9	0.7	4.3	19.5	14.3	2.2	43.6	11.8	1.3	1.0	57.0	6.9	4.6	60.1	18.0	7.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	12.1	0.0	0.0	1.5	30.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	19.5	58.4	0.0	0.0	0.0	20.9	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.9	8.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.5	2.7	25.6	0.0	97.8	0.0	1.3	0.1	5.9	22.9	0.1	30.8	6.0	14.5	16.9	0.1	6.2	20.6	15.6	0.3	26.7	0.0	0.0	7.9	7.3	0.9	0.7	1.2	1.0	0.7	1.7	1.7	1.1	1.6	2.2	1.0	2.4	13.5	41.7	116.7	0.0	1017.1	18.5	3.8	0.0	10.8	0.1	11.8	14.7	2.0	7.2	5.0	1.8	0.0	0.9	694.0	1.1	0.0	1.1	0.4	5.7	3.6	14.3	0.0	33.7	0.0	0.0	0.3	15.4	63.7	16.7	1455.3	0.0	14.6	2.4	16.6	0.0	0.0	0.2	0.0	15.4	77.1	0.3	0.0	80.1	33.8	10.3	3.2	0.1	57.7	0.0	0.1	0.0	0.1	0.0	308.8	2.2	0.4	2.1	1.5	0.6	0.0	4.3	9.2	0.1	0.3	4.2	18.2	1.9	1185.9	0.0	0.9	3.3
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055362-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 121.3;Kupffer cells: 107.8;Langerhans cells: 148.3;Macrophages: 151.8;Microglial cells: 78.7;monocytes: 489.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 79.9;intermediate monocyte: 79.0;memory B-cell: 41.0;myeloid DC: 78.8;naive B-cell: 28.5;non-classical monocyte: 85.2"	"Group enriched"	"Detected in many"	18	"B-cells: 41.0;dendritic cells: 78.8;monocytes: 85.2"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 296.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		160000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	"Centriolar satellite"	"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (9.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.67e-2)"	7.8	5.3	3.5	34.5	3.4	10.3	4.4	4.0	3.6	3.5	4.8	6.3	3.7	2.4	1.0	4.0	2.1	14.3	2.7	3.2	6.1	1.9	11.2	18.6	28.8	7.2	5.5	2.1	2.6	2.9	1.1	15.0	7.0	2.4	7.7	0.9	2.3	2.5	0.8	2.0	6.8	7.4	5.3	23.4	5.2	3.1	5.0	10.6	1.3	0.8	22.0	14.9	1.0	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	296.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.2	0.0	32.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.4	0.0	0.1	0.0	0.1	15.1	0.6	35.1	0.0	0.9	0.0	0.1	79.9	0.8	0.0	79.0	0.0	41.0	0.2	0.3	78.8	28.5	0.2	0.1	0.9	3.7	85.2	8.3	1.6	33.4	3.5	3.4	4.0	3.6	3.2	6.1	7.2	5.5	7.0	5.3	5.0	10.2	0.9	0.0	7.7	0.3	36.5	3.6	0.1	1.3	0.0	0.0	0.4	1.3	0.3	1.5	3.2	1.8	0.0	1.8	3.3	0.0	0.0	0.2	3.7	0.1	0.0	2.6	0.0	1.3	0.2	3.5	0.8	0.8	0.5	0.0	2.5	0.1	1.8	0.8	121.3	0.0	0.3	0.0	0.0	107.8	148.3	2.7	0.0	151.8	7.2	78.7	489.4	0.0	0.0	0.5	0.1	0.3	0.0	0.0	20.6	0.3	0.0	0.1	0.1	0.4	0.0	0.3	0.7	0.2	0.3	0.2	4.0	1.9	2.1	0.1	0.0	0.3
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 369.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 111.7;T-cells: 242.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"MAIT T-cell: 234.4;memory CD8 T-cell: 523.0;naive CD8 T-cell: 476.8"	"Lineage enriched"	"Detected in many"	19	"T-cells: 523.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 4.0;MOLT-4: 15.2;RPMI-8226: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648"	"unprognostic (1.29e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favorable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"	5.3	4.6	2.1	21.2	2.8	22.5	4.7	1.9	3.0	3.8	1.4	4.9	11.8	3.0	3.6	4.4	4.0	9.8	2.3	2.1	2.1	1.8	7.4	10.5	45.0	2.8	2.1	2.5	2.6	1.1	1.5	0.6	2.5	3.4	5.9	0.2	8.3	1.9	0.8	1.3	20.7	2.4	2.2	117.1	16.4	1.0	2.3	369.0	4.4	0.4	21.4	9.1	4.0	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.6	15.2	0.9	0.5	0.1	0.2	0.1	0.7	3.3	0.0	0.3	0.7	1.9	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	30.0	0.3	234.4	0.6	2.3	523.0	0.4	0.6	2.2	476.8	4.3	27.9	0.9	1.2	0.8	152.4	2.1	2.8	1.9	3.0	2.1	2.1	2.8	2.1	2.5	2.2	2.3	2.1	2.2	0.0	4.6	0.0	5.7	2.0	0.2	0.0	0.0	0.3	1.5	1.5	3.4	1.5	0.6	0.0	0.0	0.0	111.7	0.2	0.0	0.2	0.3	0.5	0.3	1.3	0.0	7.8	4.2	0.0	0.0	2.6	8.2	0.4	2.5	0.0	6.4	2.3	0.1	0.0	3.1	0.3	0.0	1.9	11.5	0.2	0.0	6.6	0.0	1.0	5.9	0.1	38.1	0.0	0.2	0.0	0.0	0.0	30.8	0.2	0.0	0.4	1.5	0.4	0.0	1.1	1.4	0.4	0.4	1.1	1.8	0.1	242.4	0.0	0.6	0.1
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 459.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 53.2;T-cells: 162.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"memory CD8 T-cell: 601.8;naive CD8 T-cell: 1053.9"	"Lineage enriched"	"Detected in all"	25	"T-cells: 1053.9"	"Cell line enriched"	"Detected in some"	60	"RPMI-8226: 1113.4"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favorable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"	1.9	1.9	0.4	10.6	0.3	8.3	2.9	1.1	0.6	33.4	0.1	2.1	5.0	1.2	1.1	1.6	1.5	4.3	1.0	0.1	1.2	1.0	1.6	4.2	25.9	5.0	2.1	0.9	0.9	4.6	8.8	0.3	4.8	1.7	3.0	0.0	2.4	1.0	0.6	1.4	15.1	1.1	0.7	15.6	5.1	0.4	2.4	459.6	2.0	0.4	15.1	3.4	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.2	0.0	1113.4	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	42.0	1.0	0.8	15.7	1.1	79.3	0.7	1.9	601.8	0.6	1.2	4.6	1053.9	6.1	1.1	1.7	1.0	2.2	427.6	0.4	0.3	1.1	0.6	0.1	1.2	5.0	2.1	4.8	0.7	2.4	0.5	1.3	6.4	5.5	0.0	4.4	4.0	2.2	0.0	0.6	0.0	2.2	2.8	1.0	1.5	0.0	0.0	0.0	0.1	53.2	0.1	0.0	0.1	0.5	0.2	0.5	0.7	0.0	1.7	0.4	0.0	0.0	2.0	7.1	0.2	0.0	0.0	0.7	0.5	0.1	0.0	0.5	4.6	0.0	4.0	4.3	0.5	0.0	4.1	5.4	5.6	7.5	0.0	10.3	0.0	0.1	0.0	0.1	0.0	10.8	0.7	12.4	0.2	0.0	0.0	0.0	2.0	1.2	0.2	0.1	0.5	2.8	0.0	162.9	0.0	7.5	0.3
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 137.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		550000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	81.4	11.9	2.7	43.5	2.6	16.4	41.0	2.8	6.5	23.9	6.5	13.8	9.8	17.8	6.1	19.0	23.4	39.7	34.3	2.7	3.5	25.6	16.3	64.6	14.0	5.4	4.3	6.2	13.2	10.8	6.6	137.6	5.4	11.3	12.1	1.4	9.7	10.9	24.2	12.2	14.5	43.5	4.0	23.4	13.0	4.6	7.1	9.3	21.4	34.4	10.6	41.3	12.8	3.5	0.2	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	346.0	0.0	0.9	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.9	0.2	27.8	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	105.3	442.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	593.5	0.1	0.0	25.8	0.4	0.3	16.8	0.0	0.0	0.2	0.1	9.1	0.0	0.0	0.0	27.8	0.1	7.5	1.2	0.5	9.9	2.7	2.6	2.8	6.5	2.7	3.5	5.4	4.3	5.4	4.0	7.1	3.5	321.5	3.2	7.4	0.0	2.4	15.0	1.0	0.0	6.2	0.0	1.0	1.8	14.3	5.7	3.7	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.4	0.4	0.7	309.2	0.0	1.3	0.0	0.0	0.5	9.8	0.5	0.4	5.1	0.0	162.8	1.9	19.9	0.0	0.2	0.0	0.0	156.4	52.5	0.8	1.8	102.4	8.8	4.7	131.8	0.2	6.2	0.0	0.1	0.1	0.0	27.8	2.1	4.1	0.0	0.3	3.0	0.1	19.7	5.7	8.0	0.0	0.2	1.6	10.1	0.4	2.4	3.0	0.0	4.0
CD96	TACTILE	ENSG00000153283	"CD96 molecule"	P40200	3	111292719-111665750	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 96.8;NK-cells: 58.7;T-cells: 199.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 74.0;MAIT T-cell: 117.2;memory CD4 T-cell: 67.0;memory CD8 T-cell: 85.3;naive CD4 T-cell: 68.7;naive CD8 T-cell: 81.8;NK-cell: 79.5;T-reg: 47.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 79.5;T-cells: 117.2"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;JURKAT: 18.2;MOLT-4: 68.7;RT4: 58.2;U-937: 59.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066754	Enhanced					NA	NA		85000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA066754: AB_2685714"	"unprognostic (1.06e-3)"	"unprognostic (3.95e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.91e-5)"	"unprognostic (4.72e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.06e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (5.23e-5)"	5.2	1.7	0.7	12.2	0.8	16.0	2.8	1.2	1.0	3.1	1.8	5.0	6.0	2.6	0.9	1.8	1.9	5.8	0.8	0.8	0.8	1.6	3.7	8.3	26.9	1.8	0.7	0.9	0.4	0.2	0.7	1.0	1.2	2.1	5.9	0.1	2.7	1.1	0.4	1.0	10.1	1.4	0.7	12.8	6.8	0.8	1.2	61.8	3.9	0.1	20.2	11.8	2.6	2.2	0.1	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.3	1.6	0.3	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.2	0.0	15.9	0.2	0.2	0.0	0.8	1.3	0.0	0.0	0.1	0.1	1.2	0.0	18.2	0.3	2.0	0.0	0.0	68.7	0.2	0.6	0.0	0.0	0.1	1.9	0.5	0.6	58.2	0.1	0.0	0.2	0.9	0.1	0.3	0.3	0.2	0.0	0.3	1.1	0.3	0.1	5.6	1.9	0.0	0.3	59.0	12.2	2.3	0.5	15.6	74.0	0.3	117.2	10.8	67.0	85.3	0.3	18.8	68.7	81.8	2.7	79.5	0.7	0.5	47.4	46.4	0.7	0.8	1.2	1.0	0.8	0.8	1.8	0.7	1.2	0.7	1.2	2.2	1.5	19.2	19.0	0.0	12.5	3.2	0.8	0.1	1.2	1.6	1.6	1.4	1.0	0.0	9.3	1.8	0.0	0.6	96.8	0.8	0.0	0.1	0.8	2.1	0.8	3.0	0.0	9.3	0.7	0.0	0.2	4.3	8.6	1.6	16.4	0.4	2.2	0.9	0.2	0.0	0.4	0.7	0.0	5.0	6.7	1.1	0.3	6.7	3.6	6.5	2.9	0.5	58.7	0.0	0.1	0.0	1.3	0.0	29.6	0.3	0.0	0.4	1.7	2.1	0.0	0.8	1.0	0.4	0.7	0.6	3.1	1.9	199.9	0.2	0.5	0.6
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDC20B	FLJ37927	ENSG00000164287	"Cell division cycle 20B"	Q86Y33	5	55112971-55173177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 2.1;kidney: 1.1;testis: 2.6"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 18.8;Ionocytes: 12.2;Respiratory ciliated cells: 24.5"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053900	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA053900: AB_2682299"	"unprognostic (7.39e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.15e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.29e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.3	2.4	1.2	0.0	0.9	2.3	0.5	0.0	2.1	0.0	0.0	0.1	0.2	1.6	0.0	0.1	0.3	18.8	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.7	3.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.5	12.2	0.6	4.1	0.0	0.0	0.7	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	3.7	0.9	2.7	0.8	24.5	0.0	0.0	0.5	0.5	1.3	0.8	0.7	0.1	0.1	0.3	0.1	0.7	0.1
CDC37	P50CDC37	ENSG00000105401	"Cell division cycle 37, HSP90 cochaperone"	Q16543	19	10391133-10420121	"Cancer-related genes, Predicted intracellular proteins, Transporters"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003928, CAB004214"	Supported		Supported	Cytosol		NA	NA		610000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB004214: AB_627232, HPA003928: AB_1846373"	"unprognostic (2.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.02e-2)"	149.9	93.6	82.2	81.3	84.6	89.5	130.6	75.0	104.2	111.4	72.1	109.9	58.1	110.0	34.2	125.7	98.5	39.8	186.0	86.3	85.8	123.2	102.2	129.9	66.5	85.9	85.8	105.9	100.3	59.3	74.6	62.7	88.1	105.0	48.2	34.6	96.6	52.2	313.2	100.9	96.3	50.2	75.7	137.5	102.8	77.5	82.5	69.3	100.8	222.6	52.4	110.3	103.0	87.8	279.2	181.2	95.5	137.5	128.8	111.8	122.9	322.8	144.6	198.3	168.8	209.1	106.7	165.3	254.7	198.3	117.2	169.9	130.6	208.7	136.4	133.6	387.2	313.9	147.2	300.9	202.5	183.9	137.9	136.9	112.5	231.8	104.0	113.5	258.1	142.2	248.2	193.8	156.1	265.3	184.3	450.2	234.6	175.5	317.8	181.0	128.3	190.3	185.1	178.2	111.5	161.9	151.5	158.1	143.1	72.7	108.4	195.7	290.0	230.8	133.9	319.9	262.2	261.3	276.5	204.4	181.4	294.1	191.2	77.2	110.8	97.1	114.4	107.9	103.1	73.2	91.8	103.5	105.2	62.9	70.0	81.8	60.2	101.1	112.6	89.4	106.8	145.6	82.2	84.6	75.0	104.2	86.3	85.8	85.9	85.8	88.1	75.7	82.5	87.8	420.1	54.5	95.5	51.6	163.7	148.6	119.3	149.0	127.5	78.0	85.0	75.8	71.3	75.8	114.8	64.4	39.6	188.9	166.1	192.3	101.8	199.8	119.0	88.2	120.5	267.5	81.3	89.8	35.0	199.0	430.2	108.3	226.8	126.4	134.3	90.8	172.1	45.3	210.2	89.2	24.6	181.3	105.8	83.9	313.8	253.8	106.2	165.6	138.7	29.0	165.1	75.8	135.9	21.1	32.5	297.6	183.5	103.4	170.5	120.1	117.9	89.7	78.2	84.4	78.9	94.4	138.6	72.4	73.5	138.1	133.7	242.4	164.2	123.0	186.1	156.1
CDC42SE2	"FLJ21967, SPEC2"	ENSG00000158985	"CDC42 small effector 2"	Q9NRR3	5	131245493-131398447	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-cells: 242.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038624	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA038624: AB_10670783"	"unprognostic (1.26e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (4.50e-5)"	"unprognostic (2.37e-3)"	"unprognostic (7.38e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.65e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (7.50e-4)"	16.5	10.6	30.7	53.6	32.5	78.7	22.8	26.8	42.3	22.1	20.2	46.6	39.2	18.7	21.0	13.2	16.6	27.4	11.2	35.5	27.8	31.3	21.7	24.7	81.2	28.5	29.6	18.9	27.3	23.9	12.3	15.2	27.7	20.4	48.4	7.1	16.5	16.0	12.9	16.8	45.5	17.2	30.0	57.8	32.0	30.9	28.2	48.6	36.7	11.0	66.4	29.3	9.8	37.0	31.6	33.8	22.4	33.4	22.4	11.5	42.2	23.0	14.8	15.4	15.9	37.4	86.7	49.5	50.5	16.4	25.9	22.1	17.6	43.4	22.4	88.2	11.1	39.9	13.9	24.0	27.9	48.2	51.5	15.2	81.2	21.0	46.7	15.9	23.3	56.5	27.2	67.1	26.5	20.4	84.1	51.8	18.2	21.6	10.1	43.5	38.1	63.2	67.6	51.3	23.8	18.1	32.1	20.4	29.6	31.9	24.4	55.9	29.3	21.3	18.4	12.8	28.9	42.1	66.4	62.4	19.1	54.0	18.9	233.4	42.8	134.4	111.5	44.7	131.1	74.9	131.4	137.7	64.1	51.5	131.6	148.6	114.7	113.4	44.6	54.6	117.9	181.4	30.7	32.5	26.8	42.3	35.5	27.8	28.5	29.6	27.7	30.0	28.2	37.0	38.0	32.1	20.6	44.1	166.8	54.2	38.5	45.6	21.6	9.2	30.6	22.4	14.4	52.9	30.0	104.8	8.4	35.4	211.5	148.6	99.7	50.9	29.2	73.7	27.2	33.7	85.6	37.5	84.3	51.0	106.0	18.3	33.6	104.1	54.5	30.6	35.0	35.5	37.9	6.7	78.8	65.7	40.7	111.9	192.3	21.9	14.0	77.6	46.2	72.1	119.9	21.7	134.9	51.8	149.2	66.3	60.6	17.3	113.1	54.4	79.3	148.0	27.3	7.5	0.0	17.7	22.1	58.7	57.7	11.8	45.5	24.8	242.7	15.7	67.2	60.8
CDH11	"CAD11, OB"	ENSG00000140937	"Cadherin 11"	P55287	16	64943753-65126112	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 178.2;placenta: 122.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.0;Endometrial stromal cells: 125.0;Excitatory neurons: 122.2;Fibroblasts: 102.2;Microglial cells: 145.2;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 106.3;Theca cells: 160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 246.5;BJ hTERT+: 139.3;fHDF/TERT166: 332.3;HSkMC: 217.4;PC-3: 291.2;U-2197: 194.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013072	Enhanced					NA	Yes		4800000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB013072: AB_2533068"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.93e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.75e-2)"	"prognostic unfavorable (2.48e-9)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.07e-3)"	15.1	8.6	12.4	25.7	27.9	0.3	10.7	10.8	15.8	57.7	13.8	11.4	7.0	52.8	9.5	7.4	12.5	58.6	10.2	19.2	21.4	10.2	1.8	45.6	17.5	17.1	24.1	178.2	3.4	2.6	10.4	122.2	17.3	20.0	12.2	14.0	12.7	24.3	2.6	10.9	8.9	54.3	21.1	89.3	11.8	8.0	19.3	3.7	8.1	3.1	13.0	47.6	13.6	21.4	0.2	0.0	51.4	0.1	35.7	77.5	0.3	246.5	139.3	61.0	34.5	4.6	0.2	0.0	0.0	332.3	0.0	0.1	0.1	1.7	43.4	0.0	2.1	0.0	1.4	0.0	29.7	0.0	14.4	217.4	0.1	74.7	14.9	0.0	17.4	0.0	0.0	0.0	33.1	0.3	0.1	0.3	19.2	37.4	291.2	0.8	38.0	0.0	0.0	0.0	0.8	36.0	0.1	0.3	0.2	64.5	0.3	0.1	0.0	124.4	17.2	194.0	70.1	0.0	0.0	0.1	21.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	27.9	10.8	15.8	19.2	21.4	17.1	24.1	17.3	21.1	19.3	21.4	11.4	3.2	0.0	93.0	0.1	3.8	1.0	7.9	0.0	19.9	1.0	7.4	3.1	1.5	3.3	0.0	0.0	2.6	0.2	0.1	0.0	0.1	2.7	3.9	125.0	17.8	0.0	2.7	122.2	0.0	2.3	102.2	0.5	2.7	0.0	60.0	68.9	0.0	4.7	0.0	67.6	0.6	0.0	0.6	6.9	4.2	52.5	0.9	5.4	145.2	0.0	41.9	0.0	158.3	106.3	0.8	0.0	77.5	0.0	1.6	0.0	1.4	0.4	2.1	26.3	12.8	38.0	1.7	1.1	0.5	3.1	5.6	1.1	160.2	0.3	0.5
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 235.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 752.5;TIME: 655.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1300000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	84.5	13.8	16.3	14.9	15.9	0.2	71.4	15.1	16.6	16.2	11.3	16.8	7.9	19.9	8.6	12.4	17.1	29.7	84.4	13.8	14.6	19.1	24.0	95.0	13.1	16.7	16.6	8.1	7.7	10.3	7.4	235.9	17.9	11.6	10.2	1.3	12.0	9.1	41.8	16.7	17.0	27.8	15.5	20.4	13.3	10.5	22.6	5.2	37.5	58.9	7.9	22.1	14.2	15.5	0.5	0.6	4.6	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	119.8	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	752.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	15.7	0.0	2.4	0.0	0.1	655.1	0.0	0.9	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	15.9	15.1	16.6	13.8	14.6	16.7	16.6	17.9	15.5	22.6	15.5	311.9	0.0	6.2	1.3	0.7	4.1	0.0	0.0	1.8	0.0	1.0	2.7	17.9	5.7	0.6	1.8	0.0	6.6	0.5	0.0	0.0	0.2	33.5	0.5	0.6	206.1	0.0	10.7	0.1	0.0	48.9	7.1	0.0	1.3	3.8	0.0	185.6	1.7	2.3	0.0	0.1	0.0	0.0	35.7	6.3	84.6	6.2	1.2	12.4	28.1	0.1	0.3	0.0	0.5	0.1	0.0	0.0	2.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.4	10.9	0.3	0.3	3.0	80.7	1.5	3.0	0.1	0.2
CDH9		ENSG00000113100	"Cadherin 9"	Q9ULB4	5	26880597-27121150	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;kidney: 5.7"	"Group enriched"	"Detected in some"	33	"Excitatory neurons: 307.2;Inhibitory neurons: 459.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 6.8;basal ganglia: 4.3;cerebral cortex: 6.4;hippocampal formation: 5.8"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.9"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"K-562: 7.3;NTERA-2: 10.1;U-698: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007167	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA007167: AB_1078489"					"unprognostic (1.49e-1)"								"unprognostic (2.27e-4)"					0.3	0.2	6.8	0.6	4.3	1.9	0.3	0.0	6.4	0.0	0.0	0.4	0.5	0.5	0.6	0.4	0.2	0.4	0.1	5.8	0.0	5.7	0.1	0.3	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.5	0.6	1.3	0.2	0.1	0.1	1.0	0.8	0.4	0.0	0.4	0.5	2.2	0.0	0.2	1.0	0.1	1.0	0.3	0.0	0.9	1.9	0.7	0.4	0.6	0.2	0.0	1.2	0.0	0.3	0.1	0.2	0.0	0.7	1.0	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.4	0.6	2.2	0.0	0.0	1.2	0.2	0.3	0.0	0.0	0.0	0.1	0.6	7.3	1.8	0.0	1.3	0.6	0.4	10.1	0.2	0.4	0.2	0.2	0.3	0.3	0.4	2.2	0.2	0.0	0.3	0.3	1.8	0.3	0.7	1.3	0.1	0.7	0.6	0.2	2.0	0.8	4.6	0.6	0.8	0.6	1.2	0.1	0.2	0.1	0.4	0.3	2.3	0.1	0.1	0.1	1.6	0.1	0.3	4.9	0.0	0.7	0.5	0.5	0.6	6.8	4.3	0.0	6.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	10.4	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	459.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	11.6	5.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 275.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 167.0;Early spermatids: 182.4;Late spermatids: 680.0;Paneth cells: 215.0;Proximal enterocytes: 611.4"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"Hep G2: 22.2"	"Region enriched"	"Detected in single"	6	"hypothalamus: 2.1"	"Low region specificity"	"Detected in all"			"HPA012569, HPA017053"	Enhanced					NA	NA		8800000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.0	0.1	0.8	4.5	0.4	0.2	0.0	0.1	0.7	0.0	0.0	23.2	275.8	0.1	0.0	0.1	0.6	5.0	0.0	1.2	0.4	10.1	30.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.1	238.3	1.1	0.0	0.1	12.4	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.5	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.1	0.7	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	8.6	0.0	1.8	0.0	0.0	0.3	167.0	0.0	4.0	182.4	3.2	0.1	0.2	33.6	0.0	3.9	1.0	0.0	0.0	55.0	0.1	0.0	0.0	0.0	15.3	0.0	0.0	4.2	42.7	0.0	0.6	0.0	680.0	1.5	0.5	0.0	1.0	0.0	1.6	0.0	1.5	0.5	15.3	215.0	2.2	0.1	0.0	611.4	13.7	0.7	0.3	0.0	0.0	0.1	3.8	2.0	0.0	0.0	0.1	0.7	3.5	19.8	0.0
CDHR3	"CDH28, FLJ23834, FLJ44366"	ENSG00000128536	"Cadherin related family member 3"	Q6ZTQ4	7	105876796-106036432	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 46.4;fallopian tube: 108.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.7;Endometrial ciliated cells: 136.4;Excitatory neurons: 70.2;Inhibitory neurons: 63.8;Respiratory ciliated cells: 358.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.0;naive B-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 5.7;Daudi: 6.5;WM-115: 4.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 11.8"	HPA011218	Supported					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011218: AB_1078886"	"unprognostic (4.38e-4)"	"unprognostic (9.18e-2)"	"unprognostic (8.16e-3)"	"unprognostic (8.08e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.51e-3)"	1.2	0.9	4.6	0.9	3.9	0.9	4.1	4.2	5.0	4.6	46.4	7.5	1.9	1.7	3.2	0.5	108.8	0.2	1.7	5.7	2.3	2.0	2.1	14.2	0.7	9.8	20.4	2.4	1.0	0.0	1.6	0.1	7.8	0.9	1.6	6.7	0.4	0.6	0.8	0.7	4.7	3.2	7.0	0.2	9.3	0.5	5.6	0.1	2.6	0.4	0.9	0.7	0.8	5.6	0.1	0.3	5.7	0.7	1.5	2.1	0.1	0.3	0.3	0.3	0.1	0.0	0.1	6.5	0.0	0.3	0.6	0.0	1.4	0.0	0.2	0.4	0.8	0.0	0.2	0.7	0.0	0.1	0.2	0.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	1.1	2.2	0.4	0.0	0.0	0.2	0.1	0.1	0.4	2.1	0.0	0.4	0.3	0.8	0.0	0.0	0.2	1.0	0.2	1.3	0.0	0.0	0.0	2.1	0.1	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.9	0.1	0.0	0.9	0.3	0.1	0.1	0.3	0.1	4.6	3.9	4.2	5.0	5.7	2.3	9.8	20.4	7.8	7.0	5.6	5.6	2.5	3.2	10.4	170.7	1.7	2.7	1.6	9.5	2.8	6.4	1.8	3.4	1.4	5.7	37.6	0.0	0.0	0.6	2.8	2.0	5.9	0.7	8.5	136.4	1.4	1.8	29.9	0.0	70.2	0.6	0.3	2.8	15.3	2.9	3.8	3.8	0.0	2.9	0.1	0.0	63.8	4.9	8.2	0.0	2.7	3.8	2.8	0.7	8.8	16.9	0.0	10.2	6.2	4.0	4.3	0.2	3.3	1.5	1.4	0.7	5.0	6.2	358.4	1.3	6.6	2.2	8.8	1.2	3.2	0.6	2.0	0.3	2.4	1.4	3.0	0.7
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616577-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 296.8;liver: 129.8"	"Group enriched"	"Detected in some"	7	"Distal enterocytes: 811.5;Paneth cells: 732.4;Proximal enterocytes: 2545.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 61.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	NA	NA		190000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.9	0.2	4.0	0.6	0.1	0.4	0.5	0.4	0.1	2.2	102.2	241.2	0.2	0.0	0.3	0.3	3.9	0.0	0.2	0.0	44.9	129.8	0.2	0.2	0.2	0.1	0.2	1.8	0.0	0.6	0.0	0.3	0.1	51.9	0.1	0.0	0.1	0.1	0.1	296.8	2.7	0.0	0.1	4.3	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	13.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.4	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	11.5	0.0	1.8	0.0	0.0	1.4	811.5	13.7	0.3	2.8	0.1	0.2	0.1	92.8	0.0	0.0	1.3	0.0	0.0	33.6	0.4	13.4	0.0	4.6	126.1	0.1	0.0	0.1	193.2	0.0	4.3	0.0	18.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	732.4	0.0	0.0	0.0	2545.8	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	154.6	0.0
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 15.2;ovary: 6.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"	"Group enriched"	"Detected in some"	28	"basophil: 1.8;eosinophil: 3.7"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	0.7	0.3	0.0	0.2	0.0	0.0	0.8	2.4	0.4	0.8	0.0	0.5	0.3	0.6	15.2	0.6	0.5	1.9	0.2	0.5	0.0	0.3	0.0	1.0	0.1	0.4	0.1	6.1	0.1	0.2	0.3	0.0	0.4	0.7	0.7	0.0	0.3	0.3	0.9	0.6	0.8	0.4	0.1	0.0	0.7	1.9	0.1	0.2	0.1	0.7	0.1	0.8	0.5	0.3	0.3	0.0	0.0	0.0	1.6	2.8	0.0	5.9	22.6	10.2	20.7	0.0	3.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	30.9	0.0	0.1	1.9	0.0	0.0	0.3	0.1	58.4	3.4	0.0	2.7	1.5	0.4	0.0	0.0	0.0	0.1	19.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.5	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.5	0.0	0.4	0.1	0.4	0.1	0.1	0.3	0.1	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	40.3	0.3	0.1	3.6	1.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.5	0.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.5;Oligodendrocytes: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 134.8;TIME: 160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	21.4	11.2	26.3	18.9	45.9	48.1	18.4	23.0	34.7	13.2	8.3	17.0	11.9	26.2	9.1	14.6	13.9	16.2	11.4	36.7	28.6	11.6	16.3	20.6	21.7	23.2	23.0	15.7	10.5	10.6	8.0	31.8	23.0	14.0	12.2	19.3	8.7	11.1	8.8	11.0	11.5	29.5	27.4	21.8	10.5	26.6	28.5	24.8	11.6	12.3	22.2	17.1	12.8	54.0	15.4	12.5	32.5	8.9	15.9	41.2	24.1	34.8	46.9	29.1	27.2	7.7	8.8	22.7	23.0	24.5	15.6	13.8	19.8	20.9	39.5	24.9	15.5	32.7	8.5	10.9	34.4	17.9	18.4	30.0	21.3	43.0	77.1	51.8	134.8	18.9	24.7	18.1	66.8	9.5	17.0	28.1	14.4	7.6	22.8	29.2	18.0	19.8	35.1	12.7	17.1	11.7	19.9	18.4	25.9	24.7	14.0	15.7	160.5	25.6	10.0	13.8	18.7	26.0	21.1	24.1	9.6	7.6	19.2	66.7	6.4	17.1	22.2	9.3	24.0	17.5	17.9	25.1	10.0	16.6	25.0	21.7	23.2	31.4	9.0	7.3	15.8	16.6	26.3	45.9	23.0	34.7	36.7	28.6	23.2	23.0	23.0	27.4	28.5	54.0	58.1	16.0	6.5	54.5	37.3	26.8	10.7	8.6	19.4	11.8	13.8	9.8	11.9	7.2	10.3	9.2	16.7	12.0	64.4	7.2	0.0	4.9	3.3	17.6	10.0	51.7	15.0	17.9	101.5	3.6	27.9	24.0	21.4	17.2	18.3	8.9	34.2	10.8	12.1	5.0	59.2	7.9	4.1	14.5	20.7	4.1	9.9	16.7	17.8	64.6	8.6	22.6	32.0	52.3	259.2	7.4	3.4	9.4	64.7	12.5	6.5	8.6	15.4	9.6	6.6	22.7	22.0	8.8	21.6	24.2	25.9	13.7	63.2	10.7	6.0	15.1
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966781-55972789	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 540.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	15.3	9.2	3.5	16.3	3.4	36.0	14.2	3.6	4.9	13.4	6.4	12.5	9.8	13.7	6.3	14.9	13.7	10.8	10.9	3.5	3.8	14.7	16.2	22.9	21.6	4.7	4.0	16.3	10.0	7.9	4.9	47.3	4.1	12.6	14.9	6.5	10.9	14.3	7.0	22.7	12.3	19.5	4.2	14.5	12.2	6.6	4.1	37.2	9.6	8.1	24.8	18.1	12.9	3.9	81.7	39.1	93.6	52.4	19.2	24.9	172.2	98.9	53.5	123.3	114.8	89.4	76.3	77.5	70.9	37.9	46.4	50.8	73.4	44.9	126.8	86.9	68.0	89.0	65.0	34.6	6.3	70.4	61.4	12.6	10.9	83.8	29.1	36.1	63.1	76.8	85.6	68.0	88.3	60.8	149.9	61.7	36.9	55.8	60.7	143.7	86.2	57.1	36.5	77.1	37.4	48.1	114.1	41.7	540.3	54.9	88.9	51.1	34.5	82.9	76.3	65.0	71.0	37.4	46.3	95.5	47.4	51.1	74.2	3.6	2.6	2.2	4.7	2.7	4.6	6.5	2.1	3.5	1.9	3.7	2.0	3.7	1.2	3.4	1.2	7.9	5.4	3.3	3.5	3.4	3.6	4.9	3.5	3.8	4.7	4.0	4.1	4.2	4.1	3.9	17.9	16.0	4.8	1.3	7.3	28.0	23.9	6.2	12.5	0.0	14.5	8.9	3.1	11.5	7.6	1.8	0.0	92.8	7.1	3.7	1.9	11.5	0.6	7.4	6.5	18.2	5.4	14.7	0.1	5.7	84.7	15.7	9.2	13.0	10.8	12.0	10.4	9.1	13.3	1.7	0.1	7.2	6.1	4.7	43.8	0.8	14.9	4.9	87.2	1.9	28.4	4.2	5.2	0.0	0.5	12.3	1.5	4.5	11.8	13.4	2.8	4.5	4.4	3.6	0.0	10.1	11.6	3.1	7.4	14.5	31.4	170.7	9.6	4.8	9.7	19.3
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.6	11.7	12.4	9.8	18.0	24.4	14.4	14.1	12.7	14.2	20.6	15.1	5.6	11.5	7.7	12.1	11.9	9.2	17.6	12.5	12.9	8.0	15.7	10.6	15.1	15.4	16.2	17.1	9.5	13.3	12.2	8.6	15.1	13.7	8.6	12.9	22.2	10.5	47.9	16.0	11.0	10.4	13.6	11.5	12.9	20.8	14.9	20.9	11.6	29.6	14.7	12.5	11.1	17.2	19.6	33.8	45.9	27.8	19.3	28.4	24.6	24.6	18.9	27.3	25.4	26.8	25.1	36.3	11.1	24.3	18.7	42.1	36.5	28.3	26.1	29.3	14.7	31.0	62.1	47.7	18.1	38.5	19.9	51.4	18.5	24.3	31.8	20.6	24.1	43.0	29.2	30.6	36.4	44.2	41.8	24.7	42.6	41.5	25.3	40.3	54.5	17.1	19.5	15.4	29.9	34.3	42.9	23.3	28.8	19.7	54.6	26.3	16.1	23.6	25.7	28.0	28.4	22.2	33.4	39.7	24.6	24.4	50.8	15.7	1.7	3.0	3.4	1.7	3.3	5.0	3.2	3.2	1.0	5.8	2.6	2.7	2.4	4.0	4.7	2.2	2.9	1.8	12.4	18.0	14.1	12.7	12.5	12.9	15.4	16.2	15.1	13.6	14.9	17.2	11.6	28.9	39.5	64.9	21.2	7.0	13.5	11.9	13.1	23.7	18.0	17.5	53.8	15.7	19.3	1.8	16.7	13.2	25.8	12.3	7.9	12.6	37.5	24.8	18.1	13.7	8.4	35.3	43.2	14.3	12.7	20.4	10.7	23.7	17.1	41.4	8.6	22.2	10.8	18.5	38.4	12.1	18.3	9.4	8.6	30.6	22.1	25.8	12.4	26.2	13.2	20.4	24.7	66.9	148.7	11.8	8.1	23.3	27.7	9.5	5.6	4.6	35.0	28.9	32.9	43.6	22.3	58.4	36.4	17.8	6.8	7.3	23.1	23.0	11.6	7.7
CDKN1C	"BWCR, BWS, KIP2, P57"	ENSG00000129757	"Cyclin dependent kinase inhibitor 1C"	P49918	11	2883213-2885775	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 206.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 575.3;Extravillous trophoblasts: 1531.7;Syncytiotrophoblasts: 2241.2;Theca cells: 781.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 155.1;non-classical monocyte: 376.4"	"Lineage enriched"	"Detected in many"	14	"monocytes: 376.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.0;HeLa: 12.8;RPMI-8226: 18.7;SH-SY5Y: 33.0;SiHa: 25.2;SK-MEL-30: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002924	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA002924: AB_1079548"	"unprognostic (5.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.79e-3)"	"unprognostic (4.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	127.4	182.9	8.2	3.3	38.0	1.7	92.5	43.3	18.7	73.7	6.5	48.1	1.4	70.6	0.2	29.9	70.7	0.8	82.6	11.7	18.8	149.5	8.3	34.5	0.2	55.1	33.5	206.4	28.5	0.2	27.8	28.1	45.0	33.1	0.2	0.5	21.7	1.5	60.3	26.6	25.0	0.4	31.8	20.6	54.1	8.6	34.3	0.2	17.0	0.9	0.4	75.0	49.4	95.3	0.1	0.1	1.6	0.0	0.4	0.5	1.8	0.3	0.6	0.3	0.0	3.3	0.4	0.0	12.0	0.2	0.1	0.5	0.3	0.3	0.1	5.6	1.2	0.1	12.8	0.0	3.3	0.0	1.4	2.4	1.6	0.0	0.2	0.1	0.3	0.1	2.7	0.8	0.5	0.1	0.0	6.0	10.6	0.5	4.0	2.2	0.0	18.7	0.7	0.0	3.5	33.0	25.2	0.3	15.2	0.9	0.2	2.8	0.4	0.0	2.2	0.0	0.1	7.3	0.0	0.1	0.0	1.8	6.8	9.1	1.2	0.9	0.4	155.1	1.8	0.0	0.4	0.6	26.9	0.3	1.0	0.3	2.2	0.0	376.4	0.2	0.7	14.7	8.2	38.0	43.3	18.7	11.7	18.8	55.1	33.5	45.0	31.8	34.3	95.3	357.3	3.2	5.8	1.0	11.6	10.7	81.7	4.9	30.7	11.9	81.0	150.5	45.3	61.5	10.8	31.3	6.2	575.3	46.9	20.3	15.6	9.8	176.5	38.8	101.5	100.8	106.5	0.8	0.6	0.6	1531.7	141.0	17.9	56.2	0.0	31.2	74.6	4.0	91.0	8.4	1.2	25.0	12.2	23.5	23.2	276.4	74.3	54.9	35.6	4.7	14.1	68.3	0.0	3.5	65.7	4.3	4.2	44.4	12.9	64.6	4.0	78.5	7.5	27.4	32.9	238.3	71.4	2.1	3.5	17.3	11.8	2241.2	25.1	781.8	15.2	71.8
CDKN2B	"CDK4I, INK4B, MTS2, P15, p15INK4b, TP15"	ENSG00000147883	"Cyclin dependent kinase inhibitor 2B"	P42772	9	22002903-22009305	"Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.2;intestine: 30.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 240.7;Pancreatic endocrine cells: 164.5;Proximal enterocytes: 139.0;Squamous epithelial cells: 142.0;Urothelial cells: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 3.3;intermediate monocyte: 3.3;non-classical monocyte: 9.0"	"Lineage enriched"	"Detected in single"	17	"monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.1;HaCaT: 35.0;HeLa: 33.9;hTERT-RPE1: 60.1;SiHa: 48.0;SK-MEL-30: 35.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB000349, HPA052838, HPA063327"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB000349: , HPA052838: , HPA063327: AB_2684987"	"unprognostic (2.30e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.47e-6)"	"unprognostic (2.10e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (9.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.28e-2)"	18.7	1.9	2.0	2.9	1.8	0.4	8.6	1.1	1.9	9.6	9.1	22.4	21.7	3.8	0.6	36.2	1.7	2.4	1.0	1.6	2.2	1.2	1.2	12.6	1.1	2.7	1.5	0.9	1.2	3.3	3.5	2.3	2.3	3.6	19.7	2.8	6.7	4.7	7.2	12.9	30.9	2.1	1.7	4.6	6.0	5.3	2.4	0.8	1.1	1.1	8.1	7.9	20.2	2.4	0.0	0.0	0.3	2.1	28.2	38.1	0.7	1.8	0.0	4.6	12.6	3.6	10.3	0.0	3.4	2.3	0.0	35.0	0.8	6.9	5.5	2.6	9.7	0.0	33.9	1.5	14.4	1.1	6.1	8.1	0.0	6.5	25.8	60.1	4.4	0.0	0.0	17.1	7.3	2.8	0.0	0.1	1.7	1.7	19.5	0.0	2.4	0.7	10.0	0.0	5.4	0.1	48.0	11.5	35.7	25.8	3.0	0.0	14.8	0.0	0.7	0.1	0.0	13.5	8.4	0.1	0.0	1.0	0.0	0.0	3.3	0.0	0.1	3.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.1	0.0	0.0	9.0	0.0	0.0	1.0	2.0	1.8	1.1	1.9	1.6	2.2	2.7	1.5	2.3	1.7	2.4	2.4	3.5	67.3	6.7	0.3	2.9	5.4	27.0	40.5	5.7	3.2	6.4	9.8	3.1	1.5	37.5	5.5	0.0	1.2	3.2	240.7	0.0	57.7	11.3	31.8	7.5	4.1	7.7	0.0	0.1	38.2	0.8	11.5	30.5	37.2	0.0	0.4	1.8	0.1	1.2	0.0	0.5	31.6	14.2	17.6	3.8	2.7	0.6	5.6	3.6	2.8	3.2	4.8	0.0	1.0	0.5	164.5	75.6	1.2	2.1	65.3	139.0	0.1	17.9	7.2	0.0	2.7	8.9	13.8	3.5	142.0	24.2	3.1	2.9	1.2	23.3	241.6
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816659	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 506.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 329.4;Hepatocytes: 149.5;Leydig cells: 91.0;Syncytiotrophoblasts: 481.9;Theca cells: 104.7"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 48.1;ASC diff: 57.9;ASC TERT1: 22.3;GAMG: 17.2;HAP1: 17.1;NTERA-2: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	119.3	18.1	26.1	3.3	28.2	0.2	35.9	24.6	31.2	9.5	109.8	4.8	0.7	8.3	140.3	3.5	13.7	10.5	26.1	28.3	30.7	3.1	506.7	11.7	6.6	23.6	26.2	25.8	14.2	0.7	20.7	35.2	25.6	9.1	1.8	15.9	7.2	72.8	8.5	3.0	4.0	6.2	25.6	3.7	4.1	15.6	26.7	1.3	9.6	19.9	3.1	8.1	5.7	25.6	0.0	0.0	48.1	0.0	57.9	22.3	0.2	1.4	0.4	4.6	4.5	0.0	0.0	0.0	0.0	0.6	17.2	0.1	17.1	0.0	6.6	0.1	8.5	1.7	0.0	1.4	0.2	0.1	0.0	8.5	0.0	0.7	0.0	1.2	6.3	0.0	0.0	0.0	5.5	0.0	1.2	0.2	17.8	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	11.0	0.1	0.0	0.0	4.0	0.0	5.4	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	26.1	28.2	24.6	31.2	28.3	30.7	23.6	26.2	25.6	25.6	26.7	25.6	4.1	0.0	1.3	6.8	0.7	0.8	0.8	0.0	0.6	27.3	1.0	7.1	3.4	0.0	0.0	1.8	6.2	329.4	0.3	0.0	0.0	9.9	6.0	0.3	7.1	3.1	1.8	2.7	12.2	0.2	17.0	27.8	0.0	0.3	0.0	7.5	33.9	149.5	23.4	1.7	16.4	0.0	0.0	5.7	1.6	15.0	91.0	0.6	1.8	1.0	0.6	31.4	0.0	5.5	3.1	0.3	0.0	37.6	0.0	0.9	0.0	2.0	0.0	3.8	13.1	7.3	3.9	1.6	1.4	0.5	1.3	481.9	0.9	104.7	0.0	0.1
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"CEA cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 246.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 335.2;Distal enterocytes: 731.7;Paneth cells: 585.4;Prostatic glandular cells: 244.9;Urothelial cells: 618.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 43.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"eosinophil: 43.6;neutrophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 43.6"	"Group enriched"	"Detected in many"	5	"CAPAN-2: 30.6;Hep G2: 101.0;OE19: 80.9;RT4: 59.2;SK-MEL-30: 67.4"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	11.9	10.6	1.3	31.1	0.8	74.5	13.3	3.2	1.8	16.4	0.0	246.3	53.3	11.1	3.9	64.9	6.0	7.4	4.0	1.9	0.0	31.9	60.5	6.8	4.3	0.4	0.1	1.1	2.4	1.7	3.8	33.1	0.5	20.2	141.2	0.6	58.9	10.3	2.7	3.3	51.0	13.1	0.0	7.9	19.9	3.7	0.2	2.3	3.1	3.1	21.5	37.0	29.2	0.0	0.6	5.6	0.3	0.3	0.0	0.0	14.4	0.0	0.2	1.0	0.5	2.3	30.6	1.7	12.2	0.0	3.2	0.8	0.0	7.9	0.4	0.1	0.5	0.3	0.2	101.0	1.7	0.2	13.3	0.0	0.1	0.1	0.1	0.0	0.7	1.4	0.0	5.0	0.0	3.2	0.3	0.2	0.9	80.9	1.7	2.6	0.0	1.3	0.6	59.2	0.5	0.2	0.0	0.2	67.4	7.3	0.3	0.0	2.1	0.3	1.2	1.4	0.5	1.8	0.0	3.7	0.2	0.4	1.0	0.8	0.0	43.6	0.1	1.7	0.3	3.3	0.9	0.4	0.2	0.8	0.6	0.2	26.3	0.1	3.3	0.1	2.7	0.6	1.3	0.8	3.2	1.8	1.9	0.0	0.4	0.1	0.5	0.0	0.2	0.0	16.7	6.4	8.2	1.0	6.0	1.3	335.2	10.4	2.8	6.0	16.3	12.7	1.8	7.2	14.7	0.0	4.2	2.0	0.7	731.7	0.0	21.3	3.5	5.0	5.2	22.3	17.3	0.4	1.7	16.1	9.4	2.9	12.8	28.7	8.9	4.6	41.4	37.7	1.4	5.0	1.4	46.1	4.1	5.9	3.1	0.2	0.0	2.6	7.2	0.0	0.9	1.3	2.1	0.5	0.6	58.7	585.4	0.7	0.2	244.9	97.5	11.1	3.9	6.4	0.0	2.7	3.1	4.3	3.9	9.2	1.0	0.7	5.5	2.2	33.2	618.9
CEACAM19	CEAL1	ENSG00000186567	"CEA cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.9;Skeletal myocytes: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.2;RPTEC TERT1: 15.8;TIME: 20.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: AB_2669006, HPA052865: AB_2681976"	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	3.9	5.6	3.7	1.3	3.7	1.5	3.8	4.9	5.1	7.0	3.5	4.7	3.0	5.2	1.7	5.1	6.8	2.4	11.7	4.0	3.8	9.4	8.2	8.2	1.1	2.8	3.0	6.6	8.9	1.5	7.0	2.2	2.7	7.8	3.4	2.4	5.7	3.1	13.8	12.4	3.8	3.1	1.9	3.5	4.6	5.7	3.7	0.9	6.5	3.4	2.2	4.2	8.7	4.7	5.1	10.3	1.5	1.0	3.5	4.0	3.8	2.8	4.2	0.9	1.8	0.4	1.1	0.1	1.0	3.8	1.0	6.2	2.6	1.1	0.8	1.5	5.8	0.1	6.7	1.7	3.6	0.2	1.0	1.3	10.0	2.6	6.1	12.2	2.4	0.7	0.3	0.3	1.4	1.2	0.0	0.6	0.9	1.4	1.1	0.0	1.8	0.2	15.8	1.2	1.9	0.5	1.1	1.1	0.9	1.4	1.4	0.3	20.9	0.4	6.8	1.5	0.9	0.1	0.3	0.0	0.5	2.0	1.7	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.7	3.7	4.9	5.1	4.0	3.8	2.8	3.0	2.7	1.9	3.7	4.7	3.6	3.2	2.2	2.0	0.0	2.0	0.9	2.1	1.2	2.9	1.9	1.5	4.5	1.5	2.4	0.0	0.0	0.2	0.1	2.1	0.0	1.6	3.8	0.9	0.9	4.1	1.8	0.0	7.9	3.3	0.2	1.0	3.6	2.4	0.0	0.8	4.6	2.6	0.3	0.0	6.1	2.3	4.1	0.6	0.8	1.9	3.1	0.5	0.0	1.9	0.4	0.3	1.0	2.0	2.4	4.5	2.6	2.6	0.0	1.8	1.2	0.4	1.8	0.6	0.0	8.8	1.7	3.1	0.9	1.2	6.0	0.0	0.2	1.6	2.5	0.9
CEACAM4	CGM7	ENSG00000105352	"CEA cell adhesion molecule 4"	O75871	19	41618971-41627074	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 21.3;lymphoid tissue: 32.6"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 41.1;Macrophages: 20.9;monocytes: 9.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 122.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 122.7"	"Cell line enriched"	"Detected in single"	6	"U-937: 4.1"															NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (1.10e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-9)"	"unprognostic (3.65e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.34e-1)"	2.1	0.5	0.1	4.8	0.1	21.3	0.5	0.1	0.2	0.4	0.2	0.7	0.3	0.3	0.8	1.0	1.0	1.0	0.8	0.1	0.1	0.8	1.0	5.7	0.9	0.2	0.2	0.2	1.2	0.0	0.3	0.3	0.2	1.1	0.2	0.0	0.8	0.0	0.2	0.3	1.8	1.0	0.1	32.6	0.8	0.1	0.2	0.3	0.4	0.6	0.6	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	30.1	5.6	0.0	23.1	0.1	0.7	1.2	0.0	23.3	0.0	0.7	0.0	122.7	0.0	9.9	0.2	11.3	12.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.0	3.9	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	0.0	41.1	1.6	0.2	0.0	20.9	1.8	1.9	9.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0
CEBPG	"GPE1BP, IG/EBP-1"	ENSG00000153879	"CCAAT enhancer binding protein gamma"	P53567	19	33373685-33382686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012024	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA012024: AB_1846503"	"unprognostic (5.56e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.01e-2)"	19.1	8.8	16.0	14.2	16.9	15.4	15.1	17.6	23.8	11.0	12.4	30.2	34.1	12.0	9.1	20.1	11.9	11.4	14.8	15.6	19.3	12.9	34.6	16.0	12.4	17.0	17.6	5.3	28.3	15.1	11.0	16.8	17.6	12.0	28.8	17.3	13.5	9.4	47.4	27.7	35.3	14.6	18.7	9.7	18.8	12.5	19.0	14.1	25.7	44.2	13.8	16.3	14.2	18.4	33.4	29.7	30.9	31.0	14.8	21.6	41.8	24.8	22.1	21.9	26.4	35.3	14.4	54.0	19.1	11.8	26.2	16.6	54.8	25.0	37.5	91.7	23.3	29.1	15.6	34.5	49.3	49.1	31.0	28.6	121.0	27.7	86.7	11.1	27.7	45.1	39.3	49.7	17.9	20.4	33.0	25.7	17.5	94.2	18.2	35.1	21.0	22.5	12.4	19.9	61.1	37.2	25.8	26.7	61.3	22.6	22.7	96.8	26.7	22.2	26.3	23.8	39.6	28.4	27.0	32.4	23.4	53.2	31.4	7.5	9.7	4.4	3.6	11.8	4.3	4.6	4.9	5.6	10.3	3.7	5.2	5.0	0.8	3.0	19.1	3.2	6.0	5.6	16.0	16.9	17.6	23.8	15.6	19.3	17.0	17.6	17.6	18.7	19.0	18.4	61.3	19.2	13.2	2.6	30.5	124.3	95.8	51.5	67.7	11.3	32.8	31.9	15.1	48.6	29.6	14.7	8.4	42.6	27.6	160.5	19.6	37.0	90.3	43.2	14.9	50.4	35.3	22.3	11.7	54.1	71.5	26.1	34.1	26.6	26.0	9.5	31.4	66.2	45.6	3.3	8.3	81.8	34.6	35.4	65.1	74.5	6.8	34.4	28.4	10.3	63.9	27.7	28.8	6.0	3.9	75.8	107.7	9.1	30.5	70.2	115.7	30.4	49.4	12.9	6.6	24.7	31.5	76.4	45.2	57.8	155.7	74.8	29.4	5.1	67.8	120.4
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151700058-151716803	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.7;pituitary gland: 109.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 101.4;Cone photoreceptor cells: 39.6;Enteroendocrine cells: 52.8;Excitatory neurons: 21.1;Horizontal cells: 20.2;Inhibitory neurons: 20.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 42.1;SH-SY5Y: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	0.1	11.2	41.9	0.2	41.1	0.3	0.0	22.1	70.7	0.0	0.0	2.1	3.0	0.0	0.0	0.0	0.8	0.0	0.1	48.5	37.5	0.1	0.0	0.1	0.0	8.6	16.4	0.0	6.1	0.0	109.0	0.1	10.9	0.1	0.7	23.6	0.0	0.0	0.0	0.1	2.1	0.2	5.2	0.0	4.9	3.1	28.5	0.0	0.1	0.0	0.0	0.1	0.2	20.5	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	42.1	29.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	41.1	22.1	70.7	48.5	37.5	8.6	16.4	10.9	5.2	28.5	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	101.4	0.0	0.0	0.9	0.0	0.0	0.0	39.6	0.1	0.0	0.3	0.0	0.0	13.1	0.3	0.0	0.0	52.8	0.0	21.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.2	20.4	1.5	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	6.0	0.7	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.0	5.5	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1
CENATAC	"CCDC84, DLNB14"	ENSG00000186166	"Centrosomal AT-AC splicing factor"	Q86UT8	11	118998138-119015793	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Cardiomyocytes: 8.5;Cytotrophoblasts: 15.3;dendritic cells: 12.1;Hofbauer cells: 9.2;Plasma cells: 8.1;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039906, HPA071715"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA039906: AB_2676740, HPA071715: AB_2686436"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (8.14e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	11.1	14.0	6.8	2.0	6.9	3.5	11.1	7.3	11.5	14.2	8.6	13.6	1.9	9.5	3.0	11.2	11.7	1.3	12.7	6.8	7.0	15.4	19.0	15.4	2.9	6.8	6.9	11.0	11.2	2.2	15.1	1.7	6.9	16.2	1.7	3.6	10.4	2.7	10.9	13.0	13.9	1.8	6.7	21.7	10.7	7.0	7.0	2.8	15.3	2.1	2.8	13.1	11.8	7.2	3.8	3.2	2.7	3.7	2.7	0.9	3.0	3.4	3.5	2.9	1.8	19.1	2.4	1.4	10.7	3.8	4.5	9.8	1.3	1.8	2.9	5.3	2.2	6.4	6.2	5.5	2.6	2.7	3.5	1.1	1.9	2.9	3.3	3.0	1.7	4.3	1.4	4.8	2.9	6.1	7.0	5.1	3.7	5.6	8.6	9.5	5.5	6.4	4.4	5.6	3.8	2.6	8.6	2.4	0.8	4.3	7.7	2.7	1.9	2.8	13.7	4.0	2.3	3.9	4.0	5.8	2.3	5.3	5.3	0.4	1.3	2.6	2.7	0.9	3.4	4.1	3.6	3.0	2.2	4.2	3.4	2.6	2.1	3.7	0.9	2.6	5.8	1.9	6.8	6.9	7.3	11.5	6.8	7.0	6.8	6.9	6.9	6.7	7.0	7.2	9.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	15.3	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0
CEND1	"BM88, FLJ90066"	ENSG00000184524	"Cell cycle exit and neuronal differentiation 1"	Q8N111	11	787115-790113	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 234.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 94.2;Excitatory neurons: 42.9;Horizontal cells: 75.7;Inhibitory neurons: 45.6;Rod photoreceptor cells: 25.5"	"Cancer enriched"	"Detected in many"	13	"glioma: 24.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.6;Karpas-707: 31.0;SCLC-21H: 54.1;SH-SY5Y: 20.4;U-266/70: 21.1;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042527	Enhanced	Supported	Approved	Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA042527: AB_2678038"	"unprognostic (4.62e-3)"	"unprognostic (1.34e-4)"	"unprognostic (9.66e-3)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (2.20e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.94e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	0.1	5.5	55.0	1.0	78.8	0.0	0.1	56.9	234.7	0.2	20.0	4.0	0.6	0.9	0.2	0.4	0.1	0.0	1.1	67.4	79.3	1.2	0.3	0.2	0.3	103.8	57.9	0.2	0.2	0.3	26.0	0.0	93.4	3.2	0.1	7.6	0.2	1.5	0.2	0.2	1.4	0.5	21.6	0.3	0.9	0.3	106.3	0.0	0.2	0.0	0.1	0.8	1.1	116.6	0.0	0.7	0.7	1.4	0.2	0.3	0.2	1.3	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.5	13.6	0.5	0.0	0.0	0.0	8.5	0.3	0.0	0.1	0.0	0.1	0.0	5.3	0.6	0.0	0.8	0.0	0.0	0.2	0.0	0.0	31.0	0.5	0.1	0.3	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	54.1	20.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	1.2	0.9	21.1	6.2	1.3	28.6	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	55.0	78.8	56.9	234.7	67.4	79.3	103.8	57.9	93.4	21.6	106.3	116.6	0.1	0.0	0.0	17.6	0.5	0.1	0.1	0.0	0.0	94.2	0.0	0.0	0.5	0.0	0.0	0.0	10.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.4	0.6	0.0	0.0	42.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	75.7	45.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.5	0.0	6.7	0.0	15.1	10.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	25.5	0.0	0.1	1.7	0.0	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0
CENPO	"CENP-O, MGC11266"	ENSG00000138092	"Centromere protein O"	Q9BU64	2	24793136-24822376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 11.2;Extravillous trophoblasts: 11.5;Spermatocytes: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046189			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA046189: AB_2679579"	"unprognostic (1.67e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.56e-2)"	"unprognostic (4.02e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.71e-13)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	5.2	4.0	3.5	3.5	3.3	9.2	4.6	2.9	4.1	4.0	2.3	3.3	3.2	3.1	0.8	4.5	3.0	1.5	2.8	3.7	3.5	2.9	2.6	3.6	4.9	3.7	3.4	4.5	1.9	1.6	3.6	3.2	3.5	3.1	3.7	1.4	2.5	1.1	3.0	3.8	3.9	2.2	3.2	4.3	2.7	8.3	3.8	11.4	3.4	2.0	5.8	2.5	3.7	3.1	31.1	36.4	40.7	21.7	4.8	7.3	22.7	36.8	21.7	51.0	38.7	46.2	15.5	21.4	4.2	22.8	29.8	16.3	40.6	14.0	34.1	28.1	21.1	34.3	23.9	31.0	2.4	28.7	24.4	3.6	2.5	51.5	11.4	9.3	24.0	25.4	40.3	23.8	31.8	21.8	39.2	20.6	29.3	21.0	22.8	31.0	53.4	11.5	12.9	18.6	27.0	29.3	22.1	16.9	7.9	18.5	16.3	11.8	15.4	46.9	42.8	15.9	41.6	14.5	20.1	42.8	14.5	27.5	36.4	0.0	0.3	0.0	1.0	0.2	0.4	0.4	0.4	0.5	0.4	0.3	0.3	0.7	0.1	0.7	0.3	1.1	0.7	0.3	3.5	3.3	2.9	4.1	3.7	3.5	3.7	3.4	3.5	3.2	3.8	3.1	0.7	3.2	2.2	4.2	1.5	1.1	0.7	1.3	2.2	0.9	1.9	1.4	6.5	0.0	1.2	3.7	0.0	3.9	1.9	3.0	1.9	1.5	3.9	1.5	2.2	2.0	0.0	11.2	5.3	1.3	11.5	2.4	6.6	1.5	1.3	6.5	1.8	0.9	4.9	1.7	4.9	1.6	0.0	1.6	1.1	9.6	0.3	1.1	1.8	3.7	1.2	1.6	1.0	2.0	2.5	1.1	0.5	1.2	8.6	0.5	1.8	1.7	0.7	0.7	0.0	1.1	3.3	11.7	9.5	3.3	1.4	2.9	1.4	2.8	2.7	0.9
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 703.3;liver: 345.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 794.4;Hepatocytes: 518.5;Paneth cells: 519.2;Proximal enterocytes: 2529.8;Undifferentiated cells: 499.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 104.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA018897, HPA074629"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558, HPA074629: "	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	18.8	38.1	21.2	18.1	20.6	6.3	13.5	24.1	23.0	22.0	25.6	191.2	703.3	14.6	14.4	132.7	17.9	19.5	51.4	22.1	20.6	96.5	345.7	15.6	11.9	20.8	20.8	17.0	14.4	38.0	15.7	10.1	20.6	16.7	178.8	16.2	32.9	15.0	33.8	32.7	576.5	19.7	20.0	12.4	41.6	9.3	20.9	13.1	27.9	14.3	20.8	13.7	33.5	20.5	11.6	16.6	18.4	25.9	19.5	17.9	14.5	15.9	25.8	17.6	22.1	17.3	23.5	15.7	14.3	20.9	13.3	35.4	14.2	39.8	15.3	10.7	18.9	14.4	9.6	44.2	26.3	21.6	26.3	25.4	82.5	26.0	46.7	24.6	14.1	11.3	22.2	10.9	35.7	9.1	17.7	21.4	10.8	16.3	18.8	20.9	19.1	19.8	60.7	18.6	11.6	16.0	50.9	12.6	14.5	8.1	21.0	26.5	17.5	22.4	12.6	15.3	11.1	23.3	24.0	18.4	36.7	17.3	17.4	4.1	5.4	1.6	5.1	3.8	4.5	3.0	4.1	5.8	4.5	3.1	4.8	4.5	1.6	4.3	4.1	4.3	3.2	3.1	21.2	20.6	24.1	23.0	22.1	20.6	20.8	20.8	20.6	20.0	20.9	20.5	13.2	32.1	24.6	8.8	18.8	19.5	13.5	32.8	39.3	31.2	12.4	18.3	33.6	115.8	19.8	53.3	20.9	16.1	12.9	794.4	37.2	24.6	2.1	26.9	15.0	14.1	24.1	7.8	7.0	33.8	5.7	15.3	60.6	33.7	27.3	80.7	28.5	518.5	19.6	28.6	9.7	196.0	18.3	37.0	9.6	2.3	18.6	15.3	10.6	10.3	19.5	19.0	21.6	8.0	5.9	51.8	519.2	18.0	8.5	19.1	2529.8	176.0	85.4	24.2	32.9	19.5	15.2	47.2	19.7	116.1	20.5	13.5	13.0	22.1	499.5	16.7
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961245-66975149	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.2;liver: 52.5;skeletal muscle: 24.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 120.1;Granulosa cells: 58.5;Hepatocytes: 53.4;Intestinal goblet cells: 32.0;Paneth cells: 67.0;Proximal enterocytes: 66.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.4;Daudi: 8.5;JURKAT: 13.5;U-937: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.8	0.5	3.1	3.2	2.7	0.9	2.3	2.5	2.9	1.3	1.3	38.2	30.0	0.7	0.2	4.2	2.9	0.9	0.7	3.8	2.0	12.2	52.5	0.7	0.3	3.3	2.7	0.6	4.1	1.0	1.9	0.6	3.5	0.5	31.3	0.6	12.0	0.3	24.7	1.2	23.7	1.2	1.4	0.4	7.7	1.1	2.2	0.2	0.4	1.5	0.2	0.1	0.8	2.2	0.4	3.1	0.3	7.4	0.2	0.2	1.2	0.2	0.2	0.3	0.5	0.5	3.8	8.5	2.4	0.0	0.2	0.6	1.1	0.5	0.1	1.5	5.5	4.3	1.3	2.6	0.0	0.9	0.7	0.3	0.9	0.8	0.1	0.2	0.0	13.5	2.8	1.7	0.3	1.1	1.4	1.4	1.5	2.6	0.4	1.3	0.7	1.3	0.1	0.4	0.4	0.8	0.2	5.8	0.2	0.6	5.0	6.5	0.3	0.4	2.4	0.7	0.2	0.9	3.6	1.3	0.3	7.2	0.2	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	3.1	2.7	2.5	2.9	3.8	2.0	3.3	2.7	3.5	1.4	2.2	2.2	0.1	3.2	6.7	0.7	0.4	0.5	0.0	1.3	1.2	0.2	9.1	5.7	1.4	2.8	0.9	0.0	0.0	0.0	0.0	120.1	0.0	0.2	0.5	3.2	0.3	0.2	19.7	0.0	1.8	0.9	0.0	0.2	11.7	4.4	1.3	58.5	0.4	53.4	0.3	0.0	2.9	32.0	0.0	3.2	0.9	5.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	1.5	0.1	1.0	67.0	1.2	0.1	0.1	66.0	9.9	4.8	0.2	0.0	0.6	0.2	2.3	2.9	1.1	0.3	0.0	0.4	0.1	44.3	0.2
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 13.5;fallopian tube: 44.8;testis: 28.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 256.4;Endometrial ciliated cells: 98.2;Late spermatids: 57.4;Respiratory ciliated cells: 166.9;Spermatocytes: 43.7"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;HEL: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.6	0.1	1.8	0.4	1.3	0.8	0.6	1.0	0.9	2.7	13.5	0.3	0.2	1.4	0.0	0.4	44.8	0.2	0.8	1.7	1.8	0.7	0.1	5.0	0.2	7.9	7.0	0.3	0.2	0.1	0.4	0.4	4.7	0.4	0.1	0.0	0.3	0.4	0.2	0.5	0.3	0.4	5.9	0.7	0.6	28.4	2.3	0.3	0.7	0.1	0.2	0.5	0.3	4.1	2.1	0.4	0.0	0.0	0.1	0.2	9.0	1.1	1.3	1.9	0.8	1.5	2.7	0.8	0.4	0.3	1.0	1.3	0.2	0.3	1.1	0.3	0.2	12.2	0.5	0.0	0.4	1.1	0.4	0.8	0.6	2.1	0.7	2.8	1.4	0.2	1.3	0.4	0.3	3.0	0.2	0.9	0.5	1.7	1.0	0.0	0.9	0.4	0.1	0.5	0.8	0.1	1.0	3.2	0.3	2.6	3.1	0.2	1.8	0.8	2.4	1.6	2.0	0.8	0.0	0.2	4.3	0.3	0.7	0.0	0.1	3.0	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.0	0.2	2.4	0.0	0.0	0.1	0.0	0.1	1.8	1.3	1.0	0.9	1.7	1.8	7.9	7.0	4.7	5.9	2.3	4.1	2.0	0.0	4.8	0.0	0.4	0.0	0.9	0.0	0.6	0.1	1.4	0.9	5.5	0.0	29.7	5.5	0.0	1.6	0.6	0.0	0.0	1.9	256.4	98.2	1.3	3.2	0.0	0.0	0.1	2.2	7.4	1.2	0.0	3.2	3.8	0.1	1.4	0.0	0.4	0.0	0.1	0.1	0.0	0.6	0.0	57.4	2.1	4.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	1.6	0.0	1.5	3.2	1.3	0.1	0.4	166.9	0.0	0.0	0.7	0.9	43.7	3.1	1.2	0.0	0.8	1.2	0.6	0.1	1.1
CFAP58	"bA554P13.1, C10orf80, CCDC147, FLJ35908"	ENSG00000120051	"Cilia and flagella associated protein 58"	Q5T655	10	104353833-104455102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.4;testis: 13.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 73.3;Endometrial ciliated cells: 25.1;Late spermatids: 58.9;Respiratory ciliated cells: 56.9;Spermatocytes: 34.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.1;U-2 OS: 6.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.9"	"HPA036555, HPA071938"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	"Plasma membrane, Cytosol"	"HPA036555: AB_10673622, HPA071938: "	"unprognostic (5.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.57e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.62e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.81e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.59e-1)"	0.4	0.6	1.0	0.5	1.3	0.4	0.4	0.4	0.7	2.2	2.4	0.5	0.1	1.8	0.2	0.2	8.4	0.2	2.5	0.8	1.2	0.7	0.1	1.3	0.3	2.9	3.7	0.5	0.3	0.7	1.5	0.4	2.2	0.5	0.0	0.6	0.2	0.4	1.3	0.3	0.2	0.6	2.0	0.3	0.3	13.4	1.0	0.1	0.8	0.8	0.4	0.3	0.6	1.1	0.1	0.0	0.7	0.1	0.1	0.3	0.1	1.0	3.1	0.6	1.6	0.0	0.0	2.4	0.2	0.4	1.7	0.2	0.0	0.2	1.8	0.3	0.1	0.5	0.9	0.0	0.3	0.3	0.4	0.3	1.3	0.5	1.6	1.3	1.0	0.1	0.7	0.7	0.8	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.2	0.3	0.3	0.0	0.4	0.2	0.0	0.1	0.5	0.7	0.1	0.4	2.0	0.6	6.5	0.3	1.8	0.2	0.0	0.1	0.7	0.8	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.4	0.7	0.8	1.2	2.9	3.7	2.2	2.0	1.0	1.1	0.4	0.0	0.5	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	10.0	0.0	9.3	0.0	0.0	0.1	0.1	0.0	0.0	0.6	73.3	25.1	0.3	0.4	0.0	0.0	4.0	0.2	0.4	0.7	0.0	0.4	0.0	0.3	1.8	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.0	58.9	0.6	0.2	0.0	1.9	0.1	0.7	1.0	1.0	0.0	0.3	0.0	1.2	0.0	0.2	0.0	0.0	56.9	0.3	0.0	0.8	1.0	34.4	4.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	45.1	50.2	8.1	12.6	8.2	0.1	17.4	7.7	13.2	36.8	10.4	7.4	38.0	39.2	80.3	9.3	74.0	73.0	25.0	8.3	9.6	224.9	1098.8	50.7	8.9	15.6	10.2	32.1	26.0	3.1	8.4	24.1	10.7	8.3	6.4	53.0	15.0	26.7	3.9	2.7	22.3	24.3	10.5	33.1	14.4	8.8	9.2	2.3	14.5	4.6	7.5	34.1	8.3	10.6	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.2	7.7	13.2	8.3	9.6	15.6	10.2	10.7	10.5	9.2	10.6	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
CGB7	CG-beta-a	ENSG00000196337	"Chorionic gonadotropin subunit beta 7"	P0DN87	19	49054275-49058860	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 3.2;skin 1: 3.9"	"Group enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 16.5;Syncytiotrophoblasts: 58.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HaCaT: 3.1;hTCEpi: 3.2;U-251 MG: 7.5"									"HPA038925, HPA038934"	Supported		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA038925: AB_2676272, HPA038934: AB_2676277"	"unprognostic (9.53e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.60e-5)"	"unprognostic (2.64e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.83e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.89e-8)"	"unprognostic (1.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.28e-2)"	0.1	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.3	1.1	0.2	0.0	0.1	0.1	0.1	2.4	0.6	0.0	0.1	0.2	0.1	0.2	0.0	0.6	0.0	0.1	0.3	0.1	0.7	0.0	1.5	0.4	0.1	3.2	0.0	0.0	1.1	0.4	2.2	3.9	0.0	0.0	0.1	0.1	0.0	1.1	0.1	0.2	0.2	0.1	0.0	1.1	1.8	0.1	2.2	0.3	0.1	1.0	0.0	0.0	2.7	0.3	0.0	0.6	0.8	0.5	1.8	0.0	0.1	0.5	1.2	3.1	0.0	2.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	3.2	0.2	0.4	1.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	1.0	0.0	0.0	1.1	0.6	0.1	0.0	1.5	1.5	0.0	7.5	0.2	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.6	0.1	0.6	1.8	0.0	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.0	58.7	0.0	0.0	0.0	0.1
CHDH		ENSG00000016391	"Choline dehydrogenase"	Q8NE62	3	53812335-53846419	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 37.6;liver: 35.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Hepatocytes: 51.8;Proximal enterocytes: 70.1;Proximal tubular cells: 87.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 3.1;T-reg: 1.3"	"Group enriched"	"Detected in many"	17	"granulocytes: 3.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.4;Hep G2: 35.8;OE19: 25.3;T-47d: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036633, HPA058130"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036633: AB_10670841, HPA058130: AB_2683615"	"unprognostic (3.40e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.26e-3)"	"unprognostic (7.17e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.12e-2)"	"prognostic favorable (1.88e-8)"	"unprognostic (3.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.29e-2)"	0.6	2.8	13.6	1.8	14.3	0.6	7.3	12.5	11.4	3.7	16.5	8.9	8.4	2.7	1.4	0.9	2.6	2.7	2.4	11.3	10.9	37.6	35.8	2.4	1.0	14.5	13.9	1.3	16.4	8.3	7.8	0.4	10.1	5.8	9.2	1.5	15.0	1.0	3.9	2.4	14.7	0.9	10.3	0.5	8.0	6.9	15.9	0.2	2.6	1.2	1.2	0.4	0.9	12.0	0.4	4.6	1.2	0.1	0.0	0.0	5.2	0.3	0.5	0.0	0.0	11.4	0.8	0.4	0.8	0.8	0.1	0.0	7.4	0.0	0.0	0.0	4.0	0.0	1.7	35.8	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	5.7	0.7	0.0	6.9	0.0	0.1	7.2	25.3	0.8	0.0	1.8	8.2	5.1	4.0	3.0	4.0	1.8	0.1	0.0	0.9	11.2	0.1	0.0	0.0	0.8	0.2	1.0	1.0	1.6	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	13.6	14.3	12.5	11.4	11.3	10.9	14.5	13.9	10.1	10.3	15.9	12.0	0.6	3.2	6.8	19.6	1.3	6.6	5.6	1.1	1.2	23.8	23.5	19.8	11.3	52.9	5.9	11.0	14.6	3.7	0.4	16.6	7.9	19.4	28.9	3.2	11.0	1.4	47.9	0.0	2.4	13.8	2.3	2.3	21.4	9.4	7.0	2.2	1.4	51.8	0.3	1.7	3.5	38.9	0.0	1.9	2.5	46.2	5.9	2.6	3.6	1.0	0.1	18.8	0.0	27.2	5.2	8.0	15.1	15.4	5.3	19.8	70.1	87.8	3.8	13.4	0.0	1.0	3.4	15.1	2.3	0.7	5.3	0.8	2.4	2.0	45.4	2.2
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911510-5925353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"adrenal gland: 3466.0;pituitary gland: 1425.3"	"Cell type enriched"	"Detected in many"	5	"Enteroendocrine cells: 1036.1"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"SCLC-21H: 355.0;SH-SY5Y: 541.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	27.5	3466.0	17.1	5.3	9.9	0.8	2.1	134.2	90.9	0.6	0.0	7.9	60.2	1.6	4.2	0.6	13.7	0.4	71.9	101.9	92.2	8.3	0.7	2.4	3.1	76.5	100.2	25.8	92.8	6.4	1425.3	0.7	188.4	5.3	14.2	56.9	6.1	3.8	11.0	1.7	31.6	0.9	12.8	0.3	133.3	14.9	19.3	4.0	9.7	0.8	1.4	0.4	2.3	14.2	0.0	7.9	0.9	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.0	1.9	0.0	0.0	4.3	0.0	4.9	0.1	0.0	0.1	0.1	0.6	0.1	2.6	0.0	1.6	0.1	4.2	0.2	1.5	0.0	0.0	2.1	0.1	0.1	0.2	0.4	0.1	1.0	0.0	0.1	0.9	19.7	1.3	0.0	0.1	0.0	0.4	0.5	0.2	355.0	541.8	0.0	0.5	0.4	2.1	0.3	0.4	0.3	0.1	6.4	0.4	3.3	0.0	0.7	2.7	0.5	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.1	9.9	134.2	90.9	101.9	92.2	76.5	100.2	188.4	12.8	19.3	14.2	0.0	3.2	2.4	7.5	0.3	4.2	9.9	0.8	0.0	93.3	0.1	0.3	114.4	0.0	0.7	69.9	20.9	0.1	0.0	1.6	1.9	0.5	7.1	0.2	0.7	3.0	1036.1	0.0	31.6	0.4	0.0	18.9	4.1	0.3	0.0	202.8	0.0	0.3	0.1	75.7	28.8	61.9	65.1	0.3	9.5	8.3	0.9	1.6	7.2	9.4	1.1	13.7	1.0	7.5	5.2	22.9	17.7	0.4	0.0	3.3	3.2	0.3	4.4	75.6	13.1	3.0	1.6	76.6	41.8	0.0	3.7	0.3	1.0	3.0	2.2	4.2
CHI3L1	"GP39, YK-40, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186704	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 232.4;brain: 239.4;liver: 447.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 88.7;Ductal cells: 88.9;Hepatocytes: 61.8;Hofbauer cells: 317.5"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	495	"neutrophil: 470.4"	"Lineage enriched"	"Detected in single"	495	"granulocytes: 470.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 322.9;ASC TERT1: 712.9;HSkMC: 637.0;THP-1: 1068.4;U-138 MG: 303.5;U-87 MG: 303.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	10	"olfactory bulb: 16.0"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	180000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	79.8	2.0	58.9	138.9	75.9	232.4	62.8	55.3	94.7	30.5	56.8	6.5	0.4	19.5	1.0	14.4	23.4	3.0	9.8	47.4	129.6	60.9	447.8	38.4	32.4	239.4	112.8	6.6	13.8	0.2	134.5	10.1	135.6	13.7	2.0	50.9	99.4	0.9	21.0	75.6	16.8	6.8	70.0	13.9	9.7	1.0	156.4	12.4	15.0	1.0	36.9	97.8	9.1	70.8	0.8	0.0	0.0	0.3	322.9	712.9	0.0	0.0	0.2	0.0	0.0	75.3	0.2	0.1	1.2	0.4	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	8.3	0.3	0.3	637.0	0.0	1.9	0.3	30.8	0.0	0.0	0.0	1.0	0.2	0.3	0.0	5.8	2.7	0.0	0.0	0.0	0.1	15.4	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.2	0.0	1068.4	0.0	303.5	1.6	0.0	0.4	2.3	41.9	0.3	303.7	1.2	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	470.4	0.0	0.9	0.0	0.0	1.3	58.9	75.9	55.3	94.7	47.4	129.6	239.4	112.8	135.6	70.0	156.4	70.8	0.7	6.4	42.8	20.5	0.1	4.2	47.1	88.7	0.0	0.1	29.8	21.5	1.0	2.8	17.3	27.6	0.0	1.3	0.6	0.0	0.0	88.9	0.0	4.8	2.2	2.1	0.0	0.4	1.1	0.0	1.1	18.6	0.0	7.2	0.0	0.0	0.0	61.8	317.5	0.0	0.1	0.0	6.1	0.8	0.4	0.0	0.9	23.7	14.2	0.0	1.0	45.1	0.0	0.0	0.1	2.0	0.0	0.0	1.4	4.2	0.0	0.2	3.4	2.8	0.0	1.0	2.3	0.0	0.0	1.5	1.1	0.8	0.9	0.0	0.0	2.2
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23755026-23758935	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 305.0;skin 1: 149.7"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055198, CAB072806"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB072806: , HPA055198: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.4	0.2	1.1	3.8	1.1	2.2	4.3	3.6	1.3	14.0	0.0	146.7	305.0	0.9	1.1	0.6	0.9	0.4	0.4	0.7	1.6	4.1	0.7	0.6	0.8	0.5	0.1	0.4	0.5	0.1	0.0	1.4	0.9	3.8	147.4	1.3	0.8	4.5	1.2	149.7	250.5	6.5	0.1	0.3	1.1	7.3	0.9	0.5	0.6	0.2	0.4	9.0	4.2	2.9	1.0	2.2	0.5	0.6	1.2	1.3	1.2	2.9	1.1	0.3	1.0	0.5	2.3	0.4	0.9	2.5	1.2	1.4	0.4	2.9	0.6	0.7	0.2	0.5	4.1	1.6	1.7	0.3	0.7	0.9	0.8	2.5	7.3	10.2	1.1	0.3	1.2	1.0	1.2	0.1	0.1	8.7	0.3	0.5	2.1	0.2	0.1	1.4	1.1	0.7	0.6	0.7	0.8	0.2	0.0	0.6	0.2	0.2	1.3	0.5	0.6	0.7	0.1	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.1	0.1	0.0	0.0	1.1	1.1	3.6	1.3	0.7	1.6	0.5	0.1	0.9	0.1	0.9	2.9	0.0	0.0	0.0	0.0	0.0	10.3	8.7	6.1	0.0	0.0	0.0	0.1	0.1	0.0	24.4	1.8	0.0	0.9	0.0	345.0	0.0	0.0	0.6	1.3	0.5	0.2	9.1	0.0	0.0	0.0	4.1	0.2	0.0	3.6	4.5	0.7	0.0	0.0	0.1	0.0	0.0	70.0	12.2	0.0	1.6	0.5	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	274.0	0.0	0.0	2.5	654.2	12.9	4.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	67.5	0.7	0.2	0.2	205.4	29.9
CHRNA4	"BFNC, EBN, EBN1"	ENSG00000101204	"Cholinergic receptor nicotinic alpha 4 subunit"	P43681	20	63343223-63378401	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.8;liver: 58.0"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 42.0;Horizontal cells: 139.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"midbrain: 21.8;pons: 20.5;thalamus: 33.5"	CAB034064	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"			"CAB034064: AB_2080535"	"unprognostic (3.40e-1)"	"unprognostic (1.71e-1)"		"unprognostic (2.87e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.10e-3)"	"unprognostic (5.72e-4)"	"unprognostic (9.02e-3)"	"unprognostic (9.79e-4)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.81e-2)"		0.0	0.2	6.7	0.0	6.5	0.0	0.0	0.6	6.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.7	8.7	3.4	58.0	0.0	0.0	5.7	15.7	0.1	0.0	12.7	0.8	0.0	6.2	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.0	1.6	28.8	0.0	0.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.5	0.6	6.2	6.7	8.7	5.7	15.7	6.2	0.5	28.8	4.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.0	0.0	139.7	8.8	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.9	0.0	7.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	2.7	0.0	1.7	0.1	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524155-126543291	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 59.6;testis: 18.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 104.0;Hepatocytes: 40.3;Spermatocytes: 126.2"	"Group enriched"	"Detected in many"	4	"liver cancer: 25.0;renal cancer: 6.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 155.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 155.2"	"Group enriched"	"Detected in some"	8	"CACO-2: 15.6;Hep G2: 28.4;NB-4: 19.0;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA067960			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA067960: "	"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.3	0.4	0.2	0.4	0.2	0.6	0.1	0.0	0.3	0.1	0.0	0.9	0.6	0.1	0.0	0.0	0.2	0.0	0.4	0.3	0.2	3.2	59.6	0.6	0.1	0.4	0.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.4	3.5	0.4	18.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.7	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.7	0.3	28.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.9	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.1	33.0	155.2	0.0	20.5	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	30.7	0.0	17.5	0.0	0.0	13.1	0.2	0.2	0.0	0.3	0.3	0.2	0.4	0.5	0.2	0.4	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	104.0	0.6	0.0	0.1	1.2	5.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.7	40.3	13.1	0.0	0.0	1.0	0.0	7.5	1.3	16.9	1.5	6.2	0.0	1.9	7.2	0.0	0.0	0.0	0.1	0.0	2.8	1.2	0.3	0.0	8.5	9.9	0.1	0.0	0.0	0.0	0.0	126.2	2.8	0.0	0.0	0.3	0.2	0.0	1.8	0.0
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119771-143124014	"Metabolic proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	5	"monocytes: 11.4;NK-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: AB_2668861"	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	7.7	2.7	17.8	8.1	13.7	16.8	6.3	16.7	14.6	5.7	6.0	3.0	2.1	8.4	1.4	1.1	2.1	1.7	5.6	9.7	13.4	8.4	1.3	7.5	7.7	31.0	18.4	4.9	1.3	0.9	6.9	10.3	28.1	7.4	1.1	11.0	2.7	9.9	1.6	4.4	7.5	3.7	21.4	18.2	3.4	1.7	28.7	14.5	6.7	0.8	5.4	7.1	7.6	48.4	0.0	0.3	3.1	2.6	57.7	58.8	0.2	3.3	9.5	2.3	2.1	0.0	0.0	0.6	2.0	2.3	3.1	0.1	2.3	8.2	1.2	0.8	1.5	48.2	0.1	0.0	118.4	1.2	55.4	62.3	9.7	3.1	10.1	3.6	3.6	7.2	5.5	2.9	15.4	0.0	9.1	12.2	16.5	0.0	8.0	0.5	1.0	0.1	1.7	2.2	3.7	0.0	0.7	0.0	5.6	2.9	0.0	1.9	12.3	7.0	4.1	9.5	13.9	52.4	0.8	3.3	13.8	9.3	37.4	0.7	0.5	0.7	0.3	4.3	0.0	1.1	0.1	0.2	1.6	0.8	0.6	0.5	0.3	4.9	11.4	0.1	0.5	0.9	17.8	13.7	16.7	14.6	9.7	13.4	31.0	18.4	28.1	21.4	28.7	48.4	11.3	0.0	0.0	3.6	17.7	2.4	7.3	2.5	0.0	25.0	2.8	2.7	1.4	0.0	1.8	3.7	2.1	0.6	41.9	0.0	0.0	0.4	0.2	5.7	29.8	9.4	0.0	39.1	6.8	0.2	0.6	14.4	2.0	6.5	11.4	12.5	3.6	0.4	2.8	1.7	8.1	0.0	0.0	10.3	32.2	1.3	12.8	20.2	17.8	1.0	13.6	114.4	233.8	2.5	6.1	5.9	0.0	2.2	79.3	13.1	0.0	0.0	0.1	23.8	92.1	0.8	20.2	0.0	2.2	0.1	0.6	1.0	9.8	58.1	1.3	14.8
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573765-46598496	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 35.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 45.4;monocytes: 55.5;Peritubular cells: 60.2;Sertoli cells: 52.6;Skeletal myocytes: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 18.5"	"Group enriched"	"Detected in many"	10	"granulocytes: 10.9;monocytes: 10.2;T-cells: 18.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 22.8;NTERA-2: 20.5;PC-3: 17.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		9800	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favorable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.2	3.4	5.4	1.7	7.3	2.5	7.5	6.4	7.0	11.2	3.7	3.7	0.8	5.8	0.4	2.5	4.9	1.9	17.4	5.4	7.1	4.0	7.5	3.6	1.8	6.1	7.3	35.3	2.0	1.2	4.2	2.0	6.0	4.1	0.8	0.9	3.5	1.4	4.4	7.3	4.0	1.4	4.7	10.2	3.4	2.1	8.0	1.4	5.8	3.9	0.7	4.5	7.7	4.0	5.5	4.7	3.9	3.5	10.8	7.5	0.2	7.6	5.4	2.0	2.6	1.2	2.1	0.0	22.8	3.1	1.3	4.1	3.8	1.3	1.7	3.2	8.1	1.1	0.3	4.1	16.6	1.9	0.1	2.5	1.1	3.8	3.1	3.4	6.2	2.5	0.0	4.7	1.5	2.6	0.7	2.4	20.5	0.4	17.0	3.6	3.2	10.3	5.5	0.2	8.8	3.4	1.1	0.2	0.9	9.6	1.3	0.4	1.4	6.1	0.6	3.3	3.5	11.0	2.4	1.7	6.8	0.1	0.4	2.4	2.2	0.7	1.5	7.1	1.4	1.2	5.8	2.8	1.2	0.6	1.2	1.1	10.9	0.6	10.2	0.8	18.5	1.9	5.4	7.3	6.4	7.0	5.4	7.1	6.1	7.3	6.0	4.7	8.0	4.0	33.8	0.0	3.1	22.9	2.5	12.4	2.0	4.8	1.2	0.8	2.2	3.7	7.4	10.0	2.6	1.8	0.0	5.3	11.5	1.7	1.9	2.8	0.0	3.6	20.8	16.3	0.0	0.0	0.9	2.5	4.3	23.6	0.0	1.6	0.0	19.7	15.7	4.5	11.5	3.3	4.1	2.9	0.0	14.2	45.4	0.3	19.0	14.1	14.2	4.7	55.5	5.2	4.1	13.0	1.0	1.8	1.5	60.2	4.7	6.7	0.7	2.1	1.9	0.8	52.6	43.1	11.2	0.5	1.3	1.3	13.2	1.4	9.9	11.4	0.9	3.3
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175727-101252048	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	27.5	18.6	10.3	18.5	9.8	23.0	21.7	9.0	11.8	19.5	14.4	7.7	6.0	17.3	9.5	10.8	14.9	22.7	20.1	9.2	10.3	13.7	10.0	23.6	11.6	14.2	13.8	19.7	7.3	7.4	8.5	46.7	11.9	14.4	8.2	7.0	10.1	11.4	6.5	15.0	7.7	20.0	11.5	13.9	10.4	8.7	12.5	10.5	10.0	7.4	10.3	34.8	14.0	9.8	9.1	11.2	36.8	18.7	18.9	25.0	24.5	21.8	19.2	25.8	26.2	9.7	7.1	22.0	12.7	36.3	16.8	24.7	24.5	27.7	28.2	24.6	12.4	43.4	12.2	11.4	23.3	66.9	42.9	23.2	22.8	22.3	20.1	29.3	30.8	9.7	16.2	216.3	19.7	7.9	9.2	46.3	42.5	17.7	7.9	20.6	36.9	32.8	18.1	17.7	6.4	34.6	23.0	11.1	40.8	29.8	12.6	81.6	26.2	41.9	24.1	20.0	46.5	38.2	94.5	12.7	32.5	62.2	32.0	0.0	1.3	2.9	1.5	0.8	1.7	0.9	0.9	1.6	0.8	1.0	0.5	1.0	4.9	0.7	0.9	0.5	1.8	0.6	10.3	9.8	9.0	11.8	9.2	10.3	14.2	13.8	11.9	11.5	12.5	9.8	55.0	0.0	15.7	27.7	11.4	57.9	20.7	10.1	20.5	10.7	41.9	29.8	9.3	5.7	9.4	16.5	6.2	6.1	14.6	1.6	1.9	5.3	1.2	10.0	33.4	45.8	3.0	12.0	34.2	2.2	28.8	40.0	5.1	13.8	25.9	51.9	60.0	5.4	16.6	38.7	36.1	3.6	10.2	17.8	37.1	2.5	55.0	41.2	26.6	59.0	10.2	9.2	10.3	21.1	24.2	5.5	2.5	47.0	9.3	19.3	1.2	2.4	8.1	7.5	46.0	47.9	53.5	3.9	7.5	10.5	62.5	13.8	15.2	23.0	3.9	10.2
CILP	HsT18872	ENSG00000138615	"Cartilage intermediate layer protein"	O75339	15	65194760-65211473	"Disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 138.1;Leydig cells: 231.5;Peritubular cells: 57.6;Theca cells: 83.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 30.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;ASC TERT1: 2.5;EFO-21: 1.1;HSkMC: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003195	Uncertain				"Secreted to extracellular matrix"	NA	NA		13000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA003195: AB_1078524"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-13)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (4.68e-3)"	49.8	0.8	0.2	9.5	0.2	0.1	21.9	0.3	0.3	44.9	0.1	20.3	2.3	13.8	3.6	11.0	15.8	36.8	27.4	0.2	0.2	1.0	1.6	2.9	1.6	0.2	0.2	7.5	3.0	0.3	0.7	2.5	0.2	3.1	6.9	0.5	9.4	4.8	15.5	14.0	22.6	51.0	0.2	0.6	8.3	12.1	0.2	1.8	2.4	32.9	0.8	26.9	28.1	0.2	0.0	0.0	0.0	0.0	4.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	8.1	0.0	0.0	0.0	0.0	5.2	0.1	0.2	0.0	0.9	0.4	0.5	2.1	0.0	0.4	1.8	0.0	0.0	0.2	0.1	0.0	0.1	1.7	1.2	42.9	1.5	0.0	0.0	0.3	0.0	0.0	138.1	4.1	1.7	0.0	0.1	2.2	0.1	0.1	0.0	0.6	0.1	2.0	0.0	11.9	7.1	231.5	1.7	1.8	1.9	0.0	0.2	0.0	1.0	0.3	0.0	0.0	57.6	0.3	0.1	0.0	0.0	0.0	0.1	0.0	14.7	6.6	0.6	0.3	0.1	6.1	0.0	1.6	83.5	0.2	0.0
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233320-81266398	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	49	"heart muscle: 1240.1;skeletal muscle: 1430.8;tongue: 2324.4"	"Cell type enriched"	"Detected in many"	20	"Cardiomyocytes: 814.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 3.5;T-47d: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051880	Enhanced					NA	NA		3000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA051880: AB_2681650"	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	18.2	33.6	12.3	0.8	15.0	0.1	4.6	17.3	12.3	8.1	24.4	3.2	1.1	6.4	11.4	20.2	6.9	8.1	1240.1	11.2	15.0	14.7	1.0	2.5	1.3	16.3	16.8	10.2	7.7	15.7	4.5	0.7	14.9	13.1	0.7	1.6	26.3	13.1	1430.8	4.7	2.8	8.8	12.0	1.8	17.9	3.6	16.1	0.8	4.9	2324.4	0.4	4.1	4.1	17.7	0.3	0.7	0.8	1.3	1.9	0.4	3.5	0.1	0.0	0.0	0.0	2.4	0.2	1.4	0.4	0.0	1.0	0.0	0.0	0.0	0.0	1.5	2.4	0.1	1.0	3.2	2.6	0.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	2.1	0.3	0.5	0.0	2.2	1.2	0.2	1.0	0.0	0.7	0.6	1.0	0.1	0.0	0.0	1.4	1.0	1.2	0.3	1.4	1.5	6.3	0.3	0.7	0.4	1.2	0.7	0.2	0.2	0.1	1.3	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	12.3	15.0	17.3	12.3	11.2	15.0	16.3	16.8	14.9	12.0	16.1	17.7	1.8	0.0	0.5	40.1	0.0	0.1	0.4	0.0	1.2	0.9	0.9	0.8	814.1	7.2	0.6	12.9	0.0	0.1	0.0	0.1	37.2	1.7	25.1	13.6	3.5	9.8	0.0	0.0	11.4	0.6	0.4	16.2	6.6	27.8	0.0	0.8	0.0	0.0	0.1	0.0	18.1	0.3	0.0	0.0	0.0	2.2	7.2	0.3	3.6	23.4	0.0	1.4	0.0	4.5	9.1	0.4	0.0	15.1	0.0	0.3	0.3	0.6	0.7	1.0	0.0	11.6	15.0	1.0	0.4	0.1	0.1	0.3	0.8	23.7	2.5	0.2
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311195-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 177.3;testis: 186.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 474.6;Spermatocytes: 692.7;Spermatogonia: 503.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 187.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	13.6	82.9	9.6	38.5	10.0	177.3	20.1	11.9	26.9	10.1	11.8	44.1	43.3	13.0	8.8	53.2	12.1	18.7	10.3	12.7	10.3	35.6	31.2	24.0	102.8	10.5	10.1	9.4	4.2	19.8	4.8	44.3	11.0	15.0	41.0	27.9	10.8	17.8	9.4	19.9	33.1	17.6	10.6	32.6	20.4	186.3	10.8	121.1	12.8	4.8	84.7	26.5	19.9	11.3	685.9	570.1	342.6	230.6	98.7	89.1	249.5	396.1	211.4	428.1	340.0	236.1	328.6	504.9	228.4	149.1	761.4	466.5	415.5	305.1	488.2	398.1	335.5	257.5	378.9	637.5	42.4	531.7	281.2	33.0	69.2	307.2	269.1	162.9	403.2	409.1	313.2	430.6	556.0	509.1	420.7	928.3	501.6	795.5	521.5	358.4	376.4	303.7	342.8	153.5	288.4	171.7	328.7	314.9	324.5	318.4	379.7	304.2	231.4	184.1	350.3	449.6	588.2	345.9	759.2	415.3	271.3	303.1	268.5	40.8	19.5	44.1	22.6	26.5	25.3	61.3	30.4	21.9	22.5	44.7	16.3	21.8	14.5	40.9	14.8	187.9	62.7	23.6	9.6	10.0	11.9	26.9	12.7	10.3	10.5	10.1	11.0	10.6	10.8	11.3	138.6	38.5	103.9	0.3	175.7	280.2	92.1	126.1	259.0	4.1	107.2	169.0	61.3	5.7	49.9	14.7	0.0	231.1	201.1	79.4	23.5	20.1	37.3	149.7	66.4	66.1	122.3	266.9	1.2	11.2	379.4	63.1	74.9	250.2	145.0	144.7	29.3	25.0	184.6	0.0	1.9	164.9	111.9	40.5	474.6	77.0	25.7	164.3	140.5	1.9	31.0	26.1	28.8	1.0	1.1	31.1	67.1	16.6	89.3	72.1	37.6	209.7	32.8	7.3	46.0	75.2	206.5	692.7	503.6	197.5	299.1	199.5	156.0	70.3	162.7	102.1
CLASP2	KIAA0627	ENSG00000163539	"Cytoplasmic linker associated protein 2"	O75122	3	33496245-33718356	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 176.6;retina: 126.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.5;Excitatory neurons: 514.2;Inhibitory neurons: 526.3;Oligodendrocyte precursor cells: 739.9;Oligodendrocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067071			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA067071: AB_2685775"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (7.24e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.48e-6)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.72e-2)"	14.0	25.1	43.4	12.1	84.1	12.3	15.8	100.7	79.1	21.4	0.0	16.9	9.9	20.5	11.3	17.9	16.0	17.7	40.4	44.8	57.5	18.1	10.8	15.3	15.4	69.0	49.9	27.3	11.5	17.7	33.3	15.6	85.9	16.6	13.1	126.4	8.8	20.7	64.9	13.0	11.0	19.4	67.8	14.5	11.2	11.8	60.0	16.1	14.1	63.4	15.9	14.5	11.5	176.6	13.5	29.4	32.9	27.8	20.9	20.4	23.6	24.8	23.2	28.5	30.6	17.2	13.8	44.4	14.1	19.6	18.3	11.5	43.0	19.7	34.4	36.0	30.5	43.7	24.6	15.4	9.9	43.6	35.8	12.7	19.3	30.9	29.2	16.5	28.0	27.0	43.3	24.8	31.1	7.6	32.5	18.6	24.5	13.5	18.4	34.5	30.9	24.1	17.9	15.2	27.4	46.4	28.7	22.1	24.7	26.5	20.9	38.1	27.0	22.3	19.4	16.9	27.7	17.3	34.6	36.5	20.2	29.6	28.8	3.7	4.6	2.6	3.3	4.5	5.1	6.1	2.9	3.2	6.5	3.7	3.9	3.6	0.9	9.1	7.0	6.1	3.5	4.8	43.4	84.1	100.7	79.1	44.8	57.5	69.0	49.9	85.9	67.8	60.0	176.6	19.7	6.4	11.7	294.5	29.9	21.0	8.6	8.8	18.8	103.3	26.0	13.8	37.4	15.7	12.7	14.7	156.4	12.3	36.2	9.9	1.9	6.4	2.8	20.8	15.6	16.1	14.4	12.2	514.2	7.0	8.1	19.2	26.5	27.9	12.0	17.8	16.1	13.9	15.0	92.5	526.3	8.8	8.2	32.3	26.6	2.9	14.3	26.0	16.0	128.4	19.5	32.0	22.6	739.9	1315.9	8.0	5.6	13.5	28.8	12.3	6.1	12.2	13.8	120.6	6.6	34.2	22.9	11.1	14.4	19.3	30.7	12.9	25.6	15.5	11.2	8.8
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922596-50099235	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"epididymis: 23.7;kidney: 46.2;liver: 16.9"	"Cell type enriched"	"Detected in many"	4	"Skeletal myocytes: 214.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.6;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"CACO-2: 49.0;RH-30: 66.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	2.1	2.5	1.7	1.7	1.9	1.5	1.6	3.8	1.6	1.8	2.5	2.4	4.9	4.0	23.7	2.4	3.0	3.9	1.3	1.5	2.9	46.2	16.9	2.8	1.3	3.2	3.2	7.0	2.1	1.4	2.3	5.8	3.7	1.7	2.8	3.4	2.5	1.0	4.0	4.8	3.8	2.9	2.5	1.8	2.9	2.1	2.7	1.1	2.2	2.8	1.2	1.4	2.0	2.3	2.9	5.4	4.2	5.5	12.8	7.5	7.9	2.8	1.2	1.6	1.9	49.0	3.0	3.5	1.2	2.5	9.7	2.8	9.9	1.7	2.2	1.1	7.5	3.3	2.7	12.8	7.2	4.1	5.7	4.9	1.6	3.7	5.9	1.2	5.8	4.0	4.3	4.7	5.3	3.2	1.6	1.4	5.7	7.4	2.4	1.9	66.0	5.2	6.0	5.5	7.2	5.2	3.3	3.0	5.1	14.1	3.0	2.1	3.8	1.6	3.7	12.7	1.4	3.6	11.9	7.3	2.8	6.6	8.5	0.0	0.9	0.0	0.1	0.9	0.1	0.1	0.2	0.2	2.6	0.1	0.0	0.0	0.2	0.1	0.1	2.8	0.0	0.3	1.7	1.9	3.8	1.6	1.5	2.9	3.2	3.2	3.7	2.5	2.7	2.3	4.3	9.6	8.4	20.5	2.1	7.1	1.8	1.6	5.2	27.4	1.8	1.4	1.9	2.8	2.3	12.9	2.1	6.2	17.7	11.3	11.7	4.1	2.0	8.0	10.0	5.5	0.0	3.4	11.5	3.5	2.6	7.9	8.6	22.8	2.5	0.8	1.4	35.2	11.1	8.4	15.6	6.6	4.1	17.6	19.8	0.6	5.3	10.9	3.6	46.9	10.1	2.7	2.1	20.6	9.6	7.7	7.3	13.2	2.2	4.0	20.4	38.8	4.2	4.3	0.0	214.4	4.8	0.9	2.3	8.1	9.5	5.1	1.9	9.3	7.0	4.8
CLCNKB	hClC-Kb	ENSG00000184908	"Chloride voltage-gated channel Kb"	P51801	1	16043736-16057308	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 209.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 23.9;Distal tubular cells: 58.7;Early spermatids: 24.6;Ionocytes: 116.0;Late spermatids: 104.2"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 24.9"	"Region enriched"	"Detected in some"	6	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.6;HeLa: 1.1"									HPA057717	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA057717: AB_2683509"	"unprognostic (9.05e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.27e-7)"	"unprognostic (2.04e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.14e-2)"	0.6	1.7	0.1	0.0	0.3	0.0	0.3	7.0	0.3	0.7	0.6	0.4	0.0	0.9	0.7	0.2	0.4	0.2	4.0	0.1	0.3	209.7	0.0	0.4	0.0	0.4	0.5	1.3	1.1	4.9	2.5	0.3	1.2	0.7	0.3	1.2	48.1	1.5	0.1	0.1	0.1	0.3	0.3	0.1	0.7	2.8	0.5	0.1	16.1	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.7	0.0	1.6	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	7.0	0.3	0.1	0.3	0.4	0.5	1.2	0.3	0.5	0.6	0.0	3.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.1	0.3	4.2	0.0	1.4	23.9	0.0	0.3	0.0	0.6	58.7	1.0	24.6	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.3	116.0	0.0	0.0	104.2	0.9	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	1.6	0.9	0.0	0.0	0.5	0.1	0.0	0.9	0.1
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 63.6"	"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 187.9"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	153	"EFO-21: 691.6;RPTEC TERT1: 233.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.1	0.7	0.3	0.2	0.4	0.0	0.2	0.0	0.5	0.1	1.5	0.0	0.0	0.3	0.6	0.5	2.9	0.7	0.0	0.2	0.2	63.6	2.2	0.4	1.5	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.4	0.9	0.0	3.2	0.0	0.4	0.1	0.1	0.1	0.1	0.3	0.3	9.7	0.0	1.0	0.3	0.2	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	691.6	0.0	0.3	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	233.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	2.2	0.0	0.3	1.4	1.2	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.5	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.6	0.1	0.0	0.0	0.3	0.0	7.0	5.8	2.6	0.6	0.3	0.8	0.3	0.4	4.3	1.6	9.2	0.0	0.4	0.0	0.0	187.9	3.4	2.0	3.0	0.1	0.2	0.0	0.0	5.0	0.4	0.2	0.9	0.0	0.5	1.3	0.3	0.0	1.6	0.1	3.3	3.6	0.0	0.0	0.3	1.2	0.2	0.0	0.4	5.4	2.8	0.0	0.2	0.0	4.0	0.1	0.5	0.0	0.4	0.0	6.7	0.0	0.9	22.1	0.2	0.0	0.8	0.6	0.3	0.3	0.9	12.6	6.2	0.2	0.2	0.0	3.1
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"choroid plexus: 19.8;kidney: 39.1;placenta: 9.8"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 221.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.4"	"Region enriched"	"Detected in many"	6	"spinal cord: 41.8"							NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	0.8	0.1	0.1	0.0	0.1	0.1	1.1	0.4	0.5	0.0	19.8	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	1.3	0.0	39.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.6	0.3	0.0	0.0	0.8	0.7	0.2	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.9	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.5	1.3	0.0	0.1	0.0	0.6	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	8.3	0.3	0.0	0.6	12.9	0.0	12.5	0.0	0.0	33.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	221.6	0.7	0.0	0.2	0.0	0.0	0.7	0.0	5.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	12.4	0.1	0.2	0.1	0.0
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 114.7;gallbladder: 101.6;kidney: 165.2;seminal vesicle: 90.1"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	5	"hippocampal formation: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 296.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.7"	"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.7	3.0	0.1	2.2	0.1	0.1	0.6	1.6	0.5	0.0	114.7	2.1	21.0	0.1	33.7	0.1	0.3	101.6	0.0	8.4	0.0	165.2	44.2	1.3	0.0	0.2	0.2	0.0	13.2	0.0	0.2	0.0	0.1	1.2	4.5	0.7	0.1	90.1	0.2	0.3	24.5	0.2	0.0	0.0	7.7	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.4	0.2	0.0	0.0	0.1	46.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.5	8.4	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	14.3	0.0	1.8	0.0	0.0	0.0	0.3	15.6	77.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	49.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.3	2.7	0.0	0.8	0.0	1.4	0.0	0.7	0.0	0.0	1.6	1.6	0.0	1.0	0.2	30.9	3.6	0.0	0.0	0.0	32.9	153.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.2	0.0
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 439.7;breast: 420.9;lung: 398.7"	"Group enriched"	"Detected in many"	10	"Adipocytes: 2644.3;Endothelial cells: 775.2;Hepatic stellate cells: 701.4"	"Cancer enriched"	"Detected in all"	4	"glioma: 32.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 18.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 18.8"	"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 85.4;SCLC-21H: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002607	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002607: "	"unprognostic (1.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.96e-2)"	439.7	16.2	124.1	6.1	101.0	0.3	420.9	111.7	127.4	70.2	205.2	75.9	9.2	86.1	3.0	54.4	83.1	6.5	138.3	93.8	103.3	45.5	16.9	398.7	9.6	124.5	114.0	36.4	20.7	1.5	16.9	12.5	127.8	50.2	3.6	2.0	36.0	3.5	101.6	95.9	71.0	6.4	109.2	44.8	41.4	10.5	160.7	1.8	122.5	14.9	2.2	103.7	75.9	107.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.1	0.1	0.2	1.1	0.0	0.0	0.0	0.0	85.4	0.1	0.7	0.2	0.1	0.0	0.1	0.5	0.2	0.0	0.2	0.9	0.7	0.1	0.0	0.0	53.0	0.3	0.0	0.0	0.0	0.0	0.4	0.2	7.1	0.1	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2	18.8	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	4.6	0.2	5.8	0.0	0.1	0.1	0.0	26.9	124.1	101.0	111.7	127.4	93.8	103.3	124.5	114.0	127.8	109.2	160.7	107.4	2644.3	3.2	7.7	0.7	2.4	32.4	1.1	0.1	3.4	1.8	5.9	7.6	14.8	2.8	0.6	7.3	0.0	0.3	4.2	0.0	0.0	0.7	5.0	8.1	0.7	775.2	2.4	8.0	0.0	0.8	0.1	12.5	0.0	1.0	1.3	0.3	701.4	2.7	0.8	0.0	0.1	0.2	4.1	17.0	33.3	5.5	5.3	46.2	14.2	129.3	0.7	2.4	1.0	0.5	0.3	0.0	0.0	0.7	2.8	4.0	0.0	0.0	0.3	7.3	0.0	61.7	12.1	1.1	1.9	1.2	30.5	0.0	4.6	25.0	0.0	6.7
CLDN8		ENSG00000156284	"Claudin 8"	P56748	21	30214006-30216097	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.9;intestine: 50.8;kidney: 69.3;salivary gland: 40.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 224.3;Distal enterocytes: 110.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 31.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HaCaT: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060605	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA060605: AB_2684331"	"unprognostic (3.74e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"		"unprognostic (3.04e-2)"		"unprognostic (1.17e-1)"		"unprognostic (1.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.32e-4)"			"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	68.9	0.0	0.0	1.7	0.0	27.2	0.0	0.1	9.3	3.9	1.1	0.0	0.0	0.0	0.0	69.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.5	0.0	7.5	50.8	0.0	40.1	13.9	0.0	8.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	0.3	0.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	10.8	2.7	0.0	0.0	29.9	11.6	0.0	0.0	10.5	224.3	0.0	0.0	0.1	110.2	11.7	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.4	0.0	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	15.9	0.6	0.4	20.3	0.0	0.0	0.0	0.3	0.0	0.0	4.6	8.4	0.0	0.4	0.0	18.0	23.1
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723364-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 132.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Fibroblasts: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 363.0;HMC-1: 637.3;NB-4: 901.1;THP-1: 694.7;U-937: 358.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"	NA	NA		1300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	17.5	17.5	5.0	7.0	5.6	132.6	14.1	7.9	9.1	44.4	2.9	12.0	4.8	31.9	1.6	8.4	37.5	6.2	16.3	4.4	7.2	21.1	12.1	15.0	2.7	10.2	7.9	31.5	7.5	2.4	22.3	5.5	8.1	22.5	1.9	0.7	6.9	4.8	4.4	16.8	9.7	8.1	7.2	14.0	8.0	9.1	6.2	2.6	12.8	1.0	0.8	19.2	28.2	6.0	2.6	3.5	0.0	2.9	33.7	45.3	79.2	139.3	37.9	15.6	15.7	0.1	0.0	0.4	1.7	70.2	0.8	1.6	0.4	0.2	10.7	0.6	22.9	363.0	0.1	0.0	21.3	0.2	637.3	33.7	0.2	1.9	2.3	0.1	17.9	16.1	4.1	2.2	29.0	2.6	3.1	901.1	1.6	0.3	4.6	30.7	0.2	0.2	0.8	0.4	0.0	3.8	4.2	0.0	58.1	0.0	0.9	694.7	100.3	1.1	41.6	0.7	0.7	2.1	2.2	0.5	47.3	358.7	44.2	1.4	24.3	0.4	0.9	11.5	0.1	0.6	0.3	0.2	17.7	0.4	2.0	4.5	1.6	5.7	5.6	4.8	0.2	8.2	5.0	5.6	7.9	9.1	4.4	7.2	10.2	7.9	8.1	7.2	6.2	6.0	12.4	3.2	5.4	10.4	3.9	32.0	32.2	2.9	27.3	20.5	30.8	31.9	3.4	8.6	4.0	29.5	10.4	8.6	5.0	1.7	119.3	11.0	6.5	17.0	70.7	16.9	26.5	36.4	9.0	3.1	72.4	107.2	4.1	14.1	5.7	18.9	51.4	6.3	49.4	21.9	8.3	4.5	10.2	21.5	73.3	19.9	70.8	29.6	78.2	9.4	11.2	70.4	14.4	8.0	12.9	3.1	1.7	67.4	0.9	21.4	0.5	13.7	5.0	20.7	65.7	20.2	59.2	17.2	21.7	26.3	45.9	18.3	5.8	56.7	3.5	17.8
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254000-38256093	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		4100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	67.1	9.5	13.6	7.9	13.4	0.1	50.6	13.8	15.2	24.8	10.9	15.2	10.1	31.2	7.6	11.1	22.6	19.0	65.1	11.5	13.3	15.9	9.4	55.5	6.6	15.0	13.9	9.5	7.8	10.5	6.1	25.0	15.4	14.5	7.2	0.8	13.6	9.8	33.2	15.8	18.8	19.8	13.1	16.7	13.8	3.5	14.9	4.6	31.4	43.3	4.2	19.2	16.8	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	451.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	13.4	13.8	15.2	11.5	13.3	15.0	13.9	15.4	13.1	14.9	15.6	396.6	0.0	3.2	0.0	0.9	3.4	0.2	0.0	1.8	0.1	1.5	2.5	6.4	1.5	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.2	0.5	272.8	0.0	0.0	0.4	0.2	0.1	31.0	0.0	0.3	1.3	0.1	567.2	2.1	0.4	0.0	0.2	0.0	0.0	6.4	3.1	1.0	0.6	1.1	5.4	15.0	0.0	0.2	0.0	4.0	2.9	0.0	0.0	0.4	1.4	0.2	0.0	0.0	0.0	0.5	0.0	14.1	7.5	1.6	0.9	0.9	3.1	0.1	1.3	6.7	0.0	0.3
CLEC18A	MRCL	ENSG00000157322	"C-type lectin domain family 18 member A"	A5D8T8	16	69950705-69964452	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 23.9"	"Cell type enriched"	"Detected in some"	23	"Proximal tubular cells: 78.0"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"	"unprognostic (1.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.14e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.77e-4)"	"unprognostic (6.73e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.03e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	0.2	0.9	0.1	0.0	0.2	0.3	0.3	0.6	0.5	0.3	2.8	0.4	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.2	0.2	23.9	0.2	0.4	0.1	0.2	0.2	0.2	0.4	0.1	0.4	0.0	0.4	0.3	0.1	0.1	0.6	0.0	0.2	0.3	0.7	0.0	0.2	1.2	0.5	3.2	0.2	0.3	0.4	0.1	0.1	0.3	0.1	0.3	0.0	0.1	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.5	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.3	0.0	1.1	0.0	0.9	0.1	0.0	0.2	0.0	1.6	0.3	0.4	0.5	2.8	0.4	0.0	2.1	0.1	0.3	3.3	1.9	0.3	0.4	0.4	0.1	0.4	0.0	0.0	0.3	0.2	0.1	0.3	2.0	0.5	0.0	0.6	2.5	0.4	0.4	3.3	0.4	1.0	0.0	0.6	0.3	0.8	0.3	1.1	0.0	0.0	0.9	0.9	1.0	0.0	0.0	0.5	0.4	0.0	0.2	0.2	1.5	78.0	0.7	1.3	0.0	0.7	1.3	0.5	0.2	0.0	0.0	0.3	0.6	0.6	1.3	0.2
CLEC18B	MRCL2	ENSG00000140839	"C-type lectin domain family 18 member B"	Q6UXF7	16	74408270-74421953	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 33.4;testis: 11.8"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 26.8"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;renal cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;JURKAT: 1.6;K-562: 3.1;U-266/70: 1.1"									HPA048976	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"	"unprognostic (5.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.30e-3)"	"unprognostic (9.37e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.43e-2)"	"unprognostic (4.27e-2)"	0.1	1.9	3.4	0.4	3.7	0.1	0.2	4.5	4.9	0.5	2.6	0.2	0.4	0.1	0.6	2.7	0.3	0.3	0.2	3.8	3.8	33.4	0.6	0.2	0.1	3.7	3.6	0.2	0.6	0.0	0.8	0.1	4.0	0.5	0.1	2.3	0.6	0.0	0.2	0.2	0.3	0.1	3.6	0.6	0.3	11.8	3.3	0.2	0.6	0.0	0.0	0.1	1.7	4.4	0.0	0.6	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.2	0.4	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.2	0.0	1.6	3.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.3	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	1.1	0.7	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.7	4.5	4.9	3.8	3.8	3.7	3.6	4.0	3.6	3.3	4.4	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.9	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.4	26.8	0.0	1.4	0.0	0.0	0.2	0.5	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0
CLEC18C	"MGC34761, MRCL3"	ENSG00000157335	"C-type lectin domain family 18 member C"	Q8NCF0	16	70173322-70187361	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 17.8"	"Cell type enriched"	"Detected in single"	46	"Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048976	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA048976: AB_2680582"		"unprognostic (3.90e-1)"		"unprognostic (3.03e-1)"	"unprognostic (1.20e-4)"					"unprognostic (5.55e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (7.64e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.61e-3)"		"unprognostic (6.98e-2)"	0.0	0.1	0.1	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	17.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CLEC1A	"CLEC1, MGC34328"	ENSG00000150048	"C-type lectin domain family 1 member A"	Q8NC01	12	10069554-10111627	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 50.2;placenta: 49.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 51.4;Cytotrophoblasts: 51.5;Endothelial cells: 38.1;Extravillous trophoblasts: 61.7;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 21.3;HUVEC TERT2: 18.3;SuSa: 5.6;U-266/70: 4.9;U-266/84: 11.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (7.63e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-2)"	16.2	3.2	4.4	4.1	4.2	0.4	14.8	6.6	5.6	11.4	4.1	4.3	1.5	6.8	2.7	3.8	9.2	5.7	9.0	3.9	3.8	5.8	2.9	29.8	5.9	4.8	4.5	5.4	2.3	1.6	3.7	49.0	4.7	6.3	2.0	0.6	2.9	2.4	3.9	4.1	4.4	8.7	4.3	8.0	3.7	2.1	5.1	50.2	7.6	4.4	3.5	6.1	8.6	4.1	0.0	0.0	0.3	0.3	0.2	0.2	21.3	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	18.3	0.0	0.0	1.9	0.0	0.0	0.0	0.4	3.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.3	0.3	0.0	5.6	0.0	0.0	1.4	0.0	0.2	0.2	0.0	4.9	11.5	0.0	0.2	0.1	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	4.4	4.2	6.6	5.6	3.9	3.8	4.8	4.5	4.7	4.3	5.1	4.1	51.4	0.0	0.5	0.0	0.5	2.2	0.1	0.0	1.2	0.0	0.3	0.1	1.3	0.0	0.0	0.0	0.0	51.5	0.2	0.0	0.0	0.0	0.4	0.0	0.1	38.1	0.0	0.0	0.0	0.0	61.7	1.2	0.0	0.0	0.0	0.0	16.8	0.2	5.0	0.0	0.0	0.0	0.0	4.7	14.1	0.6	7.5	4.0	3.6	11.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.9	4.0	2.9	0.3	1.6	52.1	0.6	0.3	0.0	0.5
CLEC4G	"LSECtin, UNQ431"	ENSG00000182566	"C-type lectin domain family 4 member G"	Q6UXB4	19	7728958-7733906	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.9;liver: 53.3;lymphoid tissue: 15.1"	"Cell type enriched"	"Detected in some"	15	"Hepatic stellate cells: 730.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 18.8;myeloid DC: 15.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.1;monocytes: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003789, HPA014044"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB003789: , HPA014044: AB_1846916"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.13e-8)"	"unprognostic (5.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.65e-2)"	14.9	0.5	1.9	2.4	1.9	1.2	2.6	4.0	2.9	0.1	2.0	1.4	0.4	0.1	0.3	0.4	4.8	1.6	1.2	2.5	1.9	0.5	53.3	1.0	15.1	2.3	2.1	0.5	0.3	0.0	0.1	1.0	2.1	0.3	0.9	0.0	1.1	0.3	0.4	1.1	2.0	1.0	2.1	3.4	0.9	0.4	4.3	0.2	0.5	0.0	0.3	7.7	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	18.8	0.0	0.0	4.2	0.0	0.3	0.0	0.0	15.1	4.2	0.1	0.0	0.4	0.5	0.5	0.7	0.0	4.5	1.9	1.9	4.0	2.9	2.5	1.9	2.3	2.1	2.1	2.1	4.3	2.1	0.1	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	18.7	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	730.3	7.1	0.8	0.0	1.1	0.0	0.0	46.7	2.9	0.0	0.3	2.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.0	0.3	0.3	1.1	0.8	0.0	0.1
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 41.3"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 18.0;Langerhans cells: 67.5;Macrophages: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"classical monocyte: 9.1"	"Lineage enriched"	"Detected in many"	8	"monocytes: 9.1"	"Group enriched"	"Detected in some"	23	"HL-60: 40.9;U-937: 157.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.1	1.8	1.1	7.3	1.2	41.3	0.6	1.3	2.6	0.7	2.1	0.2	0.1	0.3	0.0	1.2	0.5	1.8	0.5	1.0	3.3	0.5	1.8	4.0	0.1	2.2	3.3	0.3	1.3	1.2	0.5	0.9	2.2	0.4	0.3	1.0	1.2	0.5	0.0	2.6	0.0	1.3	1.6	1.1	0.2	0.5	4.9	0.6	0.7	0.0	0.1	2.3	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.3	0.0	0.0	9.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	1.8	1.1	1.2	1.3	2.6	1.0	3.3	2.2	3.3	2.2	1.6	4.9	2.4	0.1	0.0	4.8	0.7	0.6	1.9	0.0	0.0	0.0	0.2	0.1	0.1	0.3	1.5	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.5	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.0	2.5	0.0	0.0	0.0	18.0	0.0	0.2	0.0	0.0	4.7	67.5	0.7	0.0	58.1	1.8	7.5	6.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.9	0.4	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.3	0.4	0.0	0.0	0.0
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 84.0;lung: 30.9;lymphoid tissue: 44.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 87.2;Kupffer cells: 415.2;Langerhans cells: 291.5;Macrophages: 255.5;monocytes: 186.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 249.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"Karpas-707: 192.2;U-266/84: 168.1"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"	9.9	5.9	2.2	44.5	2.0	84.0	4.5	2.6	3.7	3.5	3.3	7.5	5.6	3.2	3.7	9.7	5.8	11.1	5.7	1.9	3.3	3.5	11.0	30.9	14.4	5.0	2.7	2.4	2.9	2.0	2.7	7.3	4.0	3.3	7.3	1.7	7.3	3.2	1.3	3.8	8.6	8.7	3.6	34.2	4.6	1.5	3.8	10.0	2.6	2.0	11.9	9.1	4.8	6.1	0.3	0.4	0.1	0.2	0.0	0.0	1.1	0.0	0.5	0.2	0.1	0.1	0.4	0.1	0.1	0.0	1.1	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.7	0.1	0.8	0.1	0.0	0.2	0.1	0.2	0.0	192.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	4.3	0.0	5.2	0.3	0.2	0.3	0.6	0.0	1.4	0.4	0.1	0.3	0.1	0.2	0.2	0.2	11.4	168.1	0.1	0.3	1.0	0.2	1.4	122.9	2.2	0.3	137.2	0.5	0.3	0.3	0.2	60.6	0.3	0.3	0.2	249.6	0.4	148.1	1.0	0.4	40.4	2.2	2.0	2.6	3.7	1.9	3.3	5.0	2.7	4.0	3.6	3.8	6.1	2.0	12.8	15.1	0.3	5.9	3.7	0.2	0.9	8.6	0.0	3.1	2.8	0.9	0.0	9.7	0.0	0.0	1.5	2.1	0.2	0.0	0.1	1.7	0.2	0.1	9.3	0.0	0.0	0.1	0.0	14.1	2.4	0.0	0.1	6.3	0.0	6.1	2.1	87.2	0.0	0.1	0.0	4.1	415.2	291.5	2.2	0.3	255.5	3.6	27.2	186.1	0.0	8.2	0.0	0.0	0.0	1.1	0.0	1.1	0.1	0.0	1.3	2.4	0.4	13.1	1.1	1.0	0.1	0.5	13.2	3.0	5.3	4.1	0.0	0.0	0.5
CLIC2	"CLCNL2, XAP121"	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 47.9;monocytes: 18.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	23.1	7.1	6.9	16.7	7.8	9.8	16.7	6.9	18.1	20.1	7.6	10.9	8.7	22.6	7.8	9.4	12.5	19.0	14.6	7.1	7.0	5.8	12.8	30.6	30.2	7.7	6.9	21.6	3.5	4.6	4.5	9.3	7.4	4.6	13.6	2.4	6.2	6.3	4.4	6.1	10.3	17.7	7.7	50.1	8.5	3.2	8.5	14.5	31.8	14.3	25.6	15.9	10.7	7.8	0.7	0.0	1.0	0.9	1.0	4.7	0.0	0.2	2.8	0.0	0.4	0.0	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.0	0.0	103.3	0.5	16.4	0.3	0.0	0.0	0.4	0.6	1.4	0.0	0.0	0.1	0.5	0.1	0.5	60.4	53.4	0.3	0.2	0.1	1.3	0.2	0.1	0.4	0.4	0.0	92.2	0.2	0.2	0.7	0.9	0.0	0.1	0.4	0.2	0.0	1.0	0.0	5.3	1.6	2.0	0.9	3.3	4.6	0.0	2.7	2.6	1.7	0.0	3.5	0.2	0.0	18.6	0.3	0.0	0.1	0.1	47.9	0.0	0.0	0.0	1.4	2.0	14.2	5.2	0.0	2.1	6.9	7.8	6.9	18.1	7.1	7.0	7.7	6.9	7.4	7.7	8.5	7.8	51.2	89.8	54.9	3.9	1.1	13.3	0.8	0.2	2.2	1.2	0.7	1.3	3.2	0.0	5.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.5	11.3	60.4	1.2	70.7	8.6	0.2	0.1	25.6	0.5	0.4	3.8	0.5	27.1	1.2	4.7	0.0	7.0	0.6	0.0	73.5	135.0	1.1	13.7	34.5	17.8	8.4	71.4	0.2	0.0	3.0	2.4	0.1	0.0	9.4	2.0	0.5	0.0	0.6	1.5	0.3	6.6	2.5	4.6	0.3	0.3	0.4	13.8	0.0	2.6	5.2	0.1	1.9
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 5.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	18.9	1.5	3.2	4.3	4.4	0.2	6.5	1.5	2.9	19.0	0.5	28.6	20.9	2.1	0.9	2.9	4.5	3.0	102.7	2.1	5.0	54.7	0.3	70.8	1.7	2.1	3.8	0.5	1.1	1.7	3.0	16.5	2.2	2.6	25.8	16.9	2.7	1.4	289.7	1.2	36.6	2.3	1.8	44.5	1.6	1.4	5.5	1.0	7.3	98.3	1.9	2.0	2.6	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.5	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.4	1.6	0.0	11.9	0.3	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.1	0.1	2.0	1.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.5	3.2	4.4	1.5	2.9	2.1	5.0	2.1	3.8	2.2	1.8	5.5	1.9	59.6	509.6	30.0	4.6	1.4	0.1	0.1	0.0	1.2	0.3	0.5	0.4	285.7	5.7	26.9	14.7	0.0	0.2	0.7	164.2	0.0	1.7	52.9	4.6	0.5	29.8	13.1	0.4	8.6	0.2	0.1	7.9	0.5	5.7	1.3	0.0	0.7	0.0	0.0	0.0	5.4	23.5	0.0	0.0	0.0	93.8	0.9	0.7	0.0	34.7	0.6	53.8	0.0	0.5	2.9	2.9	51.1	0.7	3.4	3.2	126.0	2.9	11.4	1.8	0.0	6.1	4.3	1.0	0.1	0.1	0.1	2.2	5.8	0.1	13.5	4.3
CLMP	"ACAM, ASAM, FLJ22415"	ENSG00000166250	"CXADR like membrane protein"	Q9H6B4	11	123069872-123195248	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 63.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 75.7;Fibroblasts: 95.1;Inhibitory neurons: 31.9;Peritubular cells: 57.9;Skeletal myocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 124.8;BJ: 171.8;BJ hTERT+: 160.3;fHDF/TERT166: 126.6;hTEC/SVTERT24-B: 129.1;hTERT-HME1: 155.6;U-138 MG: 232.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		310000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (1.63e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.46e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.02e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.78e-8)"	"unprognostic (3.88e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.69e-2)"	63.2	6.5	0.9	14.7	0.8	0.4	24.5	7.8	2.7	20.5	3.6	41.1	7.3	30.3	4.3	10.1	18.4	23.1	12.9	5.3	0.4	6.0	0.4	8.1	7.4	4.2	2.1	9.1	2.0	0.2	1.9	26.3	1.8	7.4	10.6	0.9	5.4	8.5	1.7	6.5	17.3	36.3	2.0	8.1	16.0	2.6	2.1	0.8	2.4	3.4	5.0	16.7	14.0	5.2	3.0	3.3	7.5	15.2	124.8	108.1	45.5	171.8	160.3	23.9	43.8	7.4	0.2	0.0	0.4	126.6	82.4	0.1	0.3	45.5	27.3	0.9	0.3	0.0	7.1	0.1	40.7	0.0	0.1	61.0	30.6	129.1	155.6	59.7	11.7	0.1	0.0	0.4	33.3	0.1	0.0	0.2	17.4	0.0	20.2	0.1	2.5	0.1	12.6	0.0	20.5	50.3	0.0	0.4	0.1	3.2	0.6	0.0	43.3	232.7	2.3	96.0	21.6	0.1	0.0	0.1	63.1	0.0	7.5	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.9	0.8	7.8	2.7	5.3	0.4	4.2	2.1	1.8	2.0	2.1	5.2	2.3	0.0	3.9	2.0	0.2	1.5	0.3	2.4	0.0	3.8	1.2	14.6	5.1	0.0	0.4	0.0	0.0	9.8	0.3	0.1	0.0	1.9	0.7	2.4	75.7	1.4	6.7	0.0	26.5	1.3	20.4	95.1	0.0	1.4	0.0	5.3	2.2	0.0	3.6	1.7	31.9	0.5	0.0	0.0	1.9	0.7	20.8	0.9	0.0	4.7	0.0	0.5	0.0	1.0	3.6	0.9	0.0	57.9	0.6	2.0	0.1	0.1	0.2	1.1	0.0	65.0	8.5	0.1	0.1	0.4	1.0	10.4	1.1	2.2	0.3	0.5
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.2"	"Cell type enriched"	"Detected in many"	5	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 4.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.3	0.2	0.5	0.9	0.4	0.4	0.6	1.5	0.7	0.2	0.5	0.3	0.6	0.4	1.2	0.4	0.2	0.5	0.2	0.5	0.5	6.2	0.9	0.6	3.0	0.4	0.2	0.4	0.1	0.1	1.3	1.0	0.5	0.4	0.4	0.3	0.5	0.3	0.2	0.8	0.9	0.1	0.1	1.5	1.1	0.8	0.5	1.4	0.3	0.0	2.0	0.3	0.0	0.9	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.2	0.1	0.5	0.1	0.2	0.2	0.1	0.1	1.4	0.4	0.1	2.6	1.1	0.1	0.1	0.4	2.0	0.0	0.6	1.8	0.2	0.5	0.4	1.5	0.7	0.5	0.5	0.4	0.2	0.5	0.1	0.5	0.9	0.1	3.2	3.0	1.0	12.9	0.8	0.8	0.0	0.0	1.3	0.3	0.3	0.7	0.0	0.9	0.0	2.1	0.3	4.6	0.1	13.7	0.0	5.3	0.7	0.2	0.4	0.0	5.3	1.7	0.0	2.2	0.5	0.5	0.9	11.4	0.2	0.7	0.3	0.3	0.0	1.6	0.2	73.2	1.9	5.5	5.4	0.3	3.5	1.8	1.9	0.5	0.4	0.0	1.0	0.7	0.1	0.0	2.2	1.1	0.7	0.0	0.2	0.2	1.0	0.0	1.1	0.5	1.9	0.8	0.0	0.4	0.1	6.0	1.3	0.0	0.7
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892941	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 89.0;kidney: 43.9;liver: 79.9"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 102.0;Enteroendocrine cells: 41.5;Hepatocytes: 43.0;Intestinal goblet cells: 75.3;Paneth cells: 95.9;Proximal enterocytes: 155.4;Proximal tubular cells: 68.3;Undifferentiated cells: 45.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.3;renal cancer: 30.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"OE19: 96.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA014482	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.6	0.1	0.4	5.6	0.4	0.0	0.3	0.3	0.5	0.0	0.3	71.1	73.4	0.1	0.0	0.0	0.0	15.2	0.0	0.4	0.3	43.9	79.9	0.0	0.1	0.3	0.3	0.0	0.3	0.0	0.2	0.0	0.4	0.0	70.3	0.0	0.0	0.2	0.0	0.0	89.0	1.7	0.3	0.1	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	96.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.5	0.4	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	102.0	15.6	0.4	0.0	0.2	0.0	0.1	41.5	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	43.0	0.0	0.0	0.1	75.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	95.9	0.0	0.0	0.0	155.4	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.6	0.0
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15675012	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 486.4"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 885.4"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.5	0.8	0.5	0.0	0.6	0.3	2.0	0.7	0.8	1.0	16.6	0.6	1.3	1.5	3.1	0.6	2.4	3.7	1.1	0.7	0.6	486.4	61.5	1.7	0.4	0.6	0.5	3.2	5.3	10.5	0.6	0.5	0.6	1.5	0.3	1.2	0.8	1.3	0.1	1.2	0.4	0.4	0.4	0.2	10.9	1.0	0.5	0.8	4.1	0.1	0.3	0.8	0.4	0.9	2.3	1.8	1.1	0.3	0.7	1.0	0.7	0.0	0.0	0.1	0.1	0.1	0.5	0.1	1.6	0.2	0.2	8.5	0.7	2.3	0.0	0.3	0.7	0.2	0.0	0.8	1.0	0.0	0.0	0.2	2.0	0.3	5.2	0.6	0.0	2.1	0.5	0.4	0.2	2.8	0.1	0.3	2.9	0.8	2.6	0.2	0.3	0.9	8.5	0.1	1.1	1.0	0.6	0.1	1.8	5.1	0.6	0.2	0.0	0.2	0.4	0.3	0.0	0.4	0.2	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.7	0.8	0.7	0.6	0.6	0.5	0.6	0.4	0.5	0.9	0.1	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	1.8	27.6	0.0	2.1	0.0	0.0	54.8	25.1	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.6	0.5	0.3	0.0	3.3	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	885.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.7	0.5	0.0	0.0
CLYBL	CLB	ENSG00000125246	"Citramalyl-CoA lyase"	Q8N0X4	13	99606669-99897134	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.9;Distal tubular cells: 138.9;Hepatocytes: 84.1;Proximal tubular cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 56.1;SCLC-21H: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039959, HPA040691"	Enhanced					NA	NA		7300	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039959: AB_10793857, HPA040691: AB_10794746"	"unprognostic (1.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.30e-3)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.74e-2)"	"unprognostic (5.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (7.82e-2)"	7.1	16.2	11.4	5.5	11.8	5.1	10.5	24.4	12.7	7.7	35.3	20.6	25.0	6.5	13.0	11.3	7.9	6.9	22.6	12.6	8.6	66.0	109.7	5.6	10.4	9.1	9.0	5.7	9.8	14.4	6.7	3.7	7.3	6.9	21.9	7.3	12.3	8.9	43.3	9.3	23.5	6.4	5.6	8.6	8.7	9.3	10.7	5.8	12.3	69.5	10.8	7.4	6.9	8.8	0.4	2.3	16.6	7.5	7.6	7.0	3.6	0.8	1.6	1.4	2.6	0.3	12.4	3.0	4.8	1.0	3.2	3.9	1.5	2.8	1.8	15.3	2.4	19.2	4.9	11.8	5.2	10.4	1.3	3.8	8.3	0.2	6.4	1.6	2.2	15.7	2.7	9.8	1.6	4.3	4.7	14.3	10.8	56.1	3.4	6.0	0.7	7.1	16.6	1.1	53.1	8.1	3.4	3.8	3.6	5.9	8.0	13.2	0.3	0.7	1.9	1.4	2.7	22.3	4.7	0.6	11.3	14.9	2.3	1.7	4.5	0.5	9.9	10.0	12.0	14.5	17.4	13.9	9.4	15.7	13.3	15.8	0.6	14.2	4.8	10.3	24.2	7.7	11.4	11.8	24.4	12.7	12.6	8.6	9.1	9.0	7.3	5.6	10.7	8.8	7.4	6.4	5.0	84.9	8.6	5.5	9.1	18.4	8.6	2.3	8.9	11.3	36.1	21.5	10.9	14.7	2.1	14.3	9.2	17.9	138.9	11.6	1.6	6.1	4.1	6.2	1.2	2.5	30.6	8.1	3.2	5.9	5.6	4.4	6.3	7.1	4.6	84.1	7.6	0.0	25.6	11.5	10.2	6.7	4.5	4.8	2.1	5.4	16.0	48.7	4.4	6.5	7.2	21.6	9.5	4.0	13.8	4.1	3.8	4.3	23.1	144.7	4.1	5.0	0.0	7.6	18.1	3.0	10.5	6.9	6.3	7.4	8.3	13.6	19.1	6.7
CMBL	FLJ23617	ENSG00000164237	"Carboxymethylenebutenolidase homolog"	Q96DG6	5	10275875-10307902	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 172.4;skeletal muscle: 164.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 185.2;Distal tubular cells: 215.2;Proximal enterocytes: 716.0;Proximal tubular cells: 465.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 48.5;K-562: 51.4;PC-3: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036571	Uncertain					NA	NA		580000		"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036571: AB_10670114"	"unprognostic (1.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-1)"	11.3	31.5	8.9	3.8	8.7	4.0	10.6	7.2	10.2	7.2	8.1	53.6	95.8	8.5	9.9	3.8	13.5	14.2	22.9	8.5	8.5	168.5	172.4	6.8	1.2	8.5	8.9	23.3	16.6	26.6	10.6	2.1	9.0	14.3	34.7	1.3	9.6	7.4	164.4	2.8	85.0	6.4	8.0	2.7	28.5	3.2	10.0	2.9	9.8	42.4	0.5	9.7	6.4	7.7	5.9	7.2	8.2	20.3	32.0	35.7	41.2	9.7	11.1	3.0	4.5	3.0	30.9	0.1	15.4	7.8	14.5	0.1	19.7	12.8	4.1	0.3	13.4	27.4	28.6	24.3	9.8	0.2	0.2	48.5	8.5	6.7	6.1	11.7	9.4	0.0	51.4	0.4	11.6	1.3	0.1	1.1	12.1	0.0	46.0	5.9	0.0	0.6	32.2	3.8	6.3	9.7	23.1	2.2	0.7	9.7	16.7	1.0	2.7	4.6	6.0	7.6	0.1	0.2	0.1	0.1	8.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	8.9	8.7	7.2	10.2	8.5	8.5	8.5	8.9	9.0	8.0	10.0	7.7	4.0	25.6	17.2	2.9	2.2	3.7	17.8	6.3	14.8	2.0	40.1	16.8	86.0	55.8	14.8	23.9	4.2	15.3	0.9	185.2	215.2	10.7	3.2	26.5	25.8	7.1	19.2	56.1	5.0	15.6	10.6	37.1	133.0	19.2	13.3	47.4	14.3	161.2	12.1	0.0	6.9	100.5	2.0	4.1	3.8	3.5	47.8	5.5	1.8	1.9	0.4	17.5	1.0	4.0	0.4	16.1	118.6	41.3	0.5	17.5	716.0	465.4	13.0	3.1	0.0	31.0	12.7	1.0	5.9	5.2	3.8	4.9	4.4	145.0	162.7	15.6
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534500-74587212	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 85.6"	"Cell type enriched"	"Detected in some"	10	"Oligodendrocytes: 361.7"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	38	"U-266/84: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008933, HPA073283"	Enhanced				"Secreted to blood"	NA	NA		2100000000		"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	0.0	0.0	27.4	0.0	74.2	0.1	0.0	80.4	39.0	0.0	6.0	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	30.5	51.3	0.5	12.9	0.0	0.0	85.6	76.9	0.0	0.0	0.0	0.2	0.0	74.3	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.2	0.0	39.7	0.0	0.0	0.3	74.9	0.0	0.2	0.0	0.0	0.0	0.0	80.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	27.4	74.2	80.4	39.0	30.5	51.3	85.6	76.9	74.3	39.7	74.9	80.7	0.2	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.0	0.6	0.5	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	8.6	0.5	0.2	0.2	0.0	2.7	1.2	0.2	0.0	0.3	0.0	1.5	0.0	0.2	0.7	35.1	0.1	0.0	1.5	0.7	0.0	1.2	1.1	3.1	0.0	0.2	0.0	1.0	0.0	0.5	0.0	3.0	361.7	0.2	0.1	0.0	0.0	0.4	0.4	24.5	0.0	1.0	0.0	0.6	0.2	1.0	0.4	0.0	0.3	0.0	0.4	0.0	0.5	0.2
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026586-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 274.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA		8400000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: AB_2680627"	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	76.7	22.1	6.3	149.8	7.9	208.8	82.1	9.0	11.2	88.2	30.3	64.1	25.6	118.0	20.0	131.7	88.7	78.8	60.2	6.1	6.7	65.0	42.9	152.2	184.2	9.5	7.7	164.7	69.2	8.6	22.4	37.8	9.6	84.1	33.6	7.5	89.4	68.4	8.1	76.5	64.8	56.0	7.9	154.0	75.1	12.1	9.0	52.2	79.0	7.7	169.9	86.4	79.7	13.3	230.7	75.6	206.9	257.3	104.5	196.9	162.6	204.3	221.8	249.2	192.5	263.0	191.8	151.2	203.9	367.9	58.9	221.3	123.9	324.1	164.7	104.7	10.6	109.6	122.0	205.9	415.0	97.4	230.1	337.2	150.9	158.1	118.5	405.6	142.9	110.1	64.0	225.2	206.0	44.0	8.9	91.5	256.2	184.0	35.0	52.8	72.5	170.9	247.5	265.9	0.5	14.8	252.6	34.3	27.5	149.6	247.6	163.6	349.4	134.8	140.0	210.0	208.9	105.2	86.8	297.8	79.6	117.7	220.9	560.2	142.2	631.5	243.1	180.6	393.5	231.0	301.6	324.2	217.5	201.9	250.1	252.0	845.4	213.8	209.4	96.7	347.3	393.3	6.3	7.9	9.0	11.2	6.1	6.7	9.5	7.7	9.6	7.9	9.0	13.3	10.3	60.9	60.6	0.0	140.4	97.6	274.2	142.9	178.2	1.2	36.5	66.4	6.1	15.7	78.4	36.8	10.4	12.0	66.4	47.0	62.6	63.6	0.5	29.1	52.9	26.3	15.4	44.1	0.1	138.6	99.8	50.4	49.5	40.0	59.5	44.3	37.9	29.8	54.9	0.0	0.1	51.2	42.7	87.9	103.1	1.8	8.1	90.7	14.2	2.8	129.9	0.9	91.6	0.0	0.6	186.9	27.1	76.8	85.8	60.9	3.3	5.9	37.8	7.5	32.9	10.4	70.6	1.7	3.8	135.0	87.8	11.4	160.8	1.7	32.1	170.9
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927223	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"glioma: 315.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 10.5;naive CD4 T-cell: 11.6"	"Group enriched"	"Detected in many"	12	"B-cells: 10.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"		NA	NA		660000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: AB_2681399"	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.99e-4)"	163.9	255.6	152.7	78.9	153.7	2.1	160.0	148.6	186.3	164.8	147.7	142.4	135.9	214.0	71.0	149.7	147.1	152.3	127.6	151.7	189.9	245.1	143.7	209.0	51.4	197.4	170.9	153.1	83.3	53.1	101.7	256.0	173.1	126.2	82.8	125.0	125.5	133.7	26.3	62.5	100.0	196.0	180.8	94.1	111.8	50.2	164.5	55.1	125.0	52.6	44.3	156.5	166.2	174.0	416.6	77.9	429.0	380.1	286.0	264.2	191.7	197.2	381.3	319.4	511.2	348.7	35.6	0.1	436.6	243.4	315.7	116.2	307.2	169.9	428.1	1.6	113.0	18.8	47.5	256.2	545.0	0.2	0.8	246.2	25.5	394.1	89.4	539.6	282.8	26.7	4.1	35.3	798.9	0.2	19.8	0.9	333.6	0.3	43.3	0.6	524.2	1.8	392.9	156.6	26.3	264.2	163.0	65.0	272.8	301.7	124.8	38.5	182.4	212.2	364.9	80.2	647.0	43.9	27.2	1.5	46.0	0.6	327.1	0.2	0.0	0.0	2.2	0.1	3.4	4.6	2.1	1.2	0.1	10.5	11.6	8.3	0.4	0.9	0.1	0.0	0.0	2.6	152.7	153.7	148.6	186.3	151.7	189.9	197.4	170.9	173.1	180.8	164.5	174.0	183.5	150.6	80.7	82.9	18.1	78.3	435.7	232.3	48.9	11.9	122.2	64.1	42.2	88.6	156.2	126.9	20.9	236.1	3.2	36.0	436.3	275.1	156.1	77.4	151.1	278.3	72.4	20.0	12.9	240.7	40.9	287.8	33.1	104.9	14.0	164.4	373.0	152.1	22.6	1.7	16.9	58.7	429.3	20.1	56.3	150.7	274.6	9.3	197.5	29.0	4.7	394.6	0.0	62.4	22.7	130.8	53.2	382.1	2.6	319.1	117.9	518.5	95.1	14.4	263.0	399.8	374.9	10.8	34.7	91.4	77.7	205.8	14.9	214.5	131.0	327.4
CNPY4	"MGC40499, PRAT4B"	ENSG00000166997	"Canopy FGF signaling regulator 4"	Q8N129	7	100119634-100125508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Leydig cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014166, HPA025240"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA014166: AB_1853895, HPA025240: AB_2082630"	"unprognostic (9.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-3)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.35e-2)"	13.7	16.8	13.3	9.6	13.9	6.1	11.0	14.3	14.9	24.6	14.7	14.1	6.4	21.2	14.8	5.7	15.4	16.7	13.1	13.1	13.7	10.4	6.6	9.2	10.8	14.2	13.8	24.5	4.5	12.8	16.6	21.3	14.1	10.8	9.9	17.2	5.7	15.9	5.1	8.3	9.7	21.4	13.8	13.6	7.8	6.8	13.6	14.3	10.4	7.1	9.8	12.4	14.8	14.3	7.9	13.5	33.2	59.6	76.0	36.5	16.6	29.0	31.2	14.9	27.8	7.5	7.0	17.2	32.9	52.5	10.9	7.9	13.0	14.2	15.6	16.2	13.4	7.1	23.3	10.4	21.5	12.1	12.8	33.4	3.8	13.7	6.2	32.7	52.4	8.2	6.0	11.1	21.5	22.9	25.8	15.9	17.1	5.0	19.2	7.5	24.9	9.2	15.4	2.0	8.3	16.9	27.8	22.4	15.4	21.4	11.3	6.7	42.9	47.5	28.5	20.2	13.3	9.4	16.3	15.3	27.8	18.4	19.7	11.8	5.1	8.6	15.1	11.2	19.8	3.9	15.6	19.0	7.2	2.9	12.7	19.0	2.3	12.3	13.9	4.6	13.8	6.7	13.3	13.9	14.3	14.9	13.1	13.7	14.2	13.8	14.1	13.8	13.6	14.3	15.2	6.4	2.6	4.2	3.4	3.6	2.3	7.9	2.8	6.9	3.4	6.2	3.4	5.7	4.0	12.9	2.1	35.3	5.2	3.7	1.9	6.4	0.5	5.1	20.2	15.0	2.4	11.8	3.4	2.5	10.3	28.4	1.1	4.2	9.5	16.1	18.2	1.3	14.0	8.4	4.0	1.9	4.1	2.5	2.4	2.2	35.1	4.7	16.0	2.8	5.1	26.6	8.2	2.0	2.8	2.4	2.8	31.6	1.9	0.5	2.8	3.3	4.4	15.8	13.1	12.7	15.5	1.1	4.5	2.1	3.8	18.3	8.6	30.5	2.3	1.0
CNTN1	"F3, GP135"	ENSG00000018236	"Contactin 1"	Q12860	12	40692439-41072415	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 158.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 763.9;Excitatory neurons: 844.8;Inhibitory neurons: 699.0;Oligodendrocyte precursor cells: 1021.4"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 224.4;HaCaT: 40.3;SCLC-21H: 68.5;SH-SY5Y: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025200, HPA070467"	Enhanced	Approved			"Intracellular and membrane"	NA	NA		450000000	"Cluster 17: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB025200: , HPA070467: AB_2732156"	"unprognostic (3.18e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-4)"	"unprognostic (6.98e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (3.75e-4)"	3.9	33.2	64.0	2.5	75.3	0.2	8.8	119.4	84.2	14.1	0.0	3.1	1.7	11.5	2.6	9.1	2.2	11.7	0.8	93.6	59.8	12.4	1.2	4.4	4.5	72.6	94.7	49.2	6.0	1.4	10.4	0.3	70.0	27.8	3.8	26.8	5.4	27.7	0.8	12.8	3.0	10.6	129.0	8.2	5.0	9.4	79.2	1.0	1.2	1.6	3.9	21.5	6.6	158.2	0.1	224.4	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.3	0.3	0.1	0.1	0.0	0.0	40.3	6.0	11.2	0.0	0.2	2.4	0.0	0.7	0.0	0.0	0.0	0.7	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.2	1.5	0.2	0.1	0.0	1.0	0.3	0.0	0.0	68.5	40.3	0.1	2.5	2.7	1.0	0.1	0.6	0.0	0.1	4.3	0.1	10.0	2.8	0.1	0.0	0.3	0.0	0.9	2.6	0.5	0.7	0.3	0.2	0.3	0.4	0.2	0.2	0.1	0.4	0.4	0.2	1.2	0.7	0.4	0.9	0.2	0.0	64.0	75.3	119.4	84.2	93.6	59.8	72.6	94.7	70.0	129.0	79.2	158.2	0.3	0.0	5.9	763.9	0.1	5.2	1.1	1.6	4.0	32.1	0.4	1.8	0.7	0.0	4.5	5.5	29.2	0.0	0.0	0.0	1.9	0.0	34.9	4.3	7.1	0.7	0.0	0.0	844.8	0.0	0.0	13.3	0.0	0.3	0.0	5.0	0.0	0.0	0.1	11.8	699.0	0.0	2.0	0.0	4.0	149.5	62.7	0.1	10.6	54.4	0.0	34.6	0.0	1021.4	23.9	0.7	0.0	60.2	0.0	0.3	0.0	0.0	0.4	5.9	0.0	0.5	3.6	0.6	0.8	2.1	13.5	0.0	0.5	0.3	0.0	0.2
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein family member 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 7.9"	"Group enriched"	"Detected in some"	49	"Excitatory neurons: 554.6;Inhibitory neurons: 906.4;Oligodendrocyte precursor cells: 760.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;SH-SY5Y: 2.6"					"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: AB_2686083, HPA069356: AB_2686127"				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.0	0.5	2.4	0.0	0.6	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.3	5.1	0.1	0.0	0.0	0.0	6.8	6.3	0.0	0.1	0.0	0.0	0.0	7.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	7.9	4.3	5.1	6.8	6.3	7.3	0.0	7.2	0.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.1	0.0	0.0	554.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	906.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.4	0.0	1.0	0.0	760.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206267	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial stromal cells: 44.3;Excitatory neurons: 52.9;Fibroblasts: 99.7;Leydig cells: 60.3;Sertoli cells: 46.0;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"fHDF/TERT166: 1432.1;SiHa: 846.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 29.1"	"HPA009143, HPA010021"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		9100000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Cytosol	"HPA009143: AB_1847095, HPA010021: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	105.1	15.7	2.2	16.0	1.9	0.0	65.4	0.8	2.7	112.8	0.4	74.9	8.7	124.5	5.5	36.2	42.2	20.9	25.5	1.0	1.2	25.9	3.5	24.6	7.2	1.8	4.8	123.2	5.9	5.0	4.8	1.8	0.6	20.8	17.2	0.4	16.1	42.4	14.4	48.9	40.6	72.1	0.6	11.4	18.1	4.6	2.0	5.5	19.3	12.5	4.2	26.3	45.8	0.8	0.2	2.2	11.5	0.2	270.2	162.0	28.3	275.4	229.3	186.2	257.3	27.5	0.7	0.0	27.7	1432.1	3.9	59.2	0.5	28.7	174.6	0.2	1.4	0.2	101.1	0.1	97.9	0.3	0.2	234.9	5.0	42.2	50.6	173.6	32.0	0.1	0.0	0.0	29.4	0.2	0.1	0.2	6.4	0.0	15.3	0.1	23.1	0.2	8.9	14.4	0.0	0.0	846.1	21.2	0.3	15.5	131.8	0.5	0.2	78.5	97.0	41.5	91.4	0.1	0.1	0.4	26.4	0.3	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.8	2.7	1.0	1.2	1.8	4.8	0.6	0.6	2.0	0.8	14.2	76.9	5.1	2.3	0.0	20.6	0.6	12.7	5.2	0.4	4.7	7.1	4.1	0.0	4.7	3.7	0.0	0.6	0.0	0.0	0.0	1.4	24.1	6.3	44.3	11.0	0.0	0.0	52.9	4.6	1.3	99.7	2.6	14.1	1.3	0.1	3.3	0.0	0.8	0.0	32.4	0.0	0.0	0.3	18.4	14.7	60.3	1.8	21.4	38.4	0.0	0.0	0.0	19.6	1.2	6.7	0.0	13.2	0.1	1.7	0.0	0.9	1.7	0.0	46.0	20.0	48.6	0.3	0.6	0.6	13.1	0.7	2.5	1.4	0.1	0.3
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120373573	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 205.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;Endometrial stromal cells: 97.0;Fibroblasts: 235.9;Smooth muscle cells: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 54.4;hTERT-RPE1: 29.7;RH-30: 123.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		3200000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	69.0	16.2	1.6	42.2	1.9	0.3	58.8	1.5	2.4	205.8	2.9	39.8	7.7	78.2	35.2	50.2	46.2	142.2	45.4	1.5	2.0	32.1	19.5	27.7	12.8	3.4	2.2	83.2	15.7	6.0	4.0	152.7	2.7	43.8	53.9	0.6	13.5	24.9	7.0	13.3	35.3	147.6	3.1	28.4	25.6	5.5	2.4	5.3	43.2	36.1	16.5	108.5	93.0	3.0	0.0	0.0	0.9	0.0	5.4	54.4	0.1	0.1	6.7	0.2	0.1	0.0	0.0	0.6	1.8	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	1.8	0.0	13.2	0.2	0.2	14.4	0.3	2.6	0.0	29.7	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.4	4.2	0.0	0.0	0.0	123.4	0.2	4.8	0.0	0.5	0.2	0.1	0.1	0.1	3.2	0.0	0.1	0.0	1.3	0.3	0.2	2.9	0.4	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.5	2.4	1.5	2.0	3.4	2.2	2.7	3.1	2.4	3.0	8.0	0.0	1.1	0.0	0.1	11.3	0.4	2.1	75.1	0.1	1.8	25.3	13.2	0.0	4.3	1.8	0.0	34.4	0.3	0.0	0.0	0.0	1.0	6.9	97.0	7.8	0.0	0.0	5.6	0.0	4.0	235.9	6.1	11.3	3.8	0.2	18.5	0.0	6.2	0.0	5.2	0.0	0.0	0.0	18.5	1.4	14.6	1.7	5.4	5.6	0.0	0.1	0.0	1.0	3.3	0.0	0.0	15.4	0.5	0.6	0.0	0.0	0.1	0.5	0.0	4.2	118.2	4.4	2.8	3.9	9.7	25.3	2.7	4.5	0.0	0.3
COL16A1		ENSG00000084636	"Collagen type XVI alpha 1 chain"	Q07092	1	31652263-31704319	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 109.0;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 122.0;Peritubular cells: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 133.1;ASC TERT1: 102.9;BJ hTERT+: 115.9;fHDF/TERT166: 106.5;HSkMC: 98.7;U-2197: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027237			Uncertain	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		960000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA027237: AB_10600699"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (4.00e-9)"	"unprognostic (9.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.15e-2)"	33.6	17.3	19.0	14.4	44.7	0.3	41.0	35.9	32.4	169.7	7.6	78.9	14.8	93.6	23.7	22.4	37.4	39.4	33.6	18.9	29.8	11.5	3.2	31.1	8.5	55.5	43.2	177.9	7.8	3.5	28.6	21.1	48.6	102.8	10.9	8.8	35.5	91.3	8.4	69.3	35.8	56.2	34.0	9.9	42.1	40.9	40.3	5.6	46.8	7.4	4.1	106.9	86.8	57.5	0.1	2.0	0.0	0.1	133.1	102.9	14.6	60.5	115.9	15.1	16.1	0.4	11.0	0.0	1.9	106.5	2.3	48.3	0.0	65.8	3.5	0.0	0.2	0.0	8.1	21.3	45.1	0.0	0.3	98.7	44.6	43.2	22.7	3.8	0.1	0.3	0.0	0.2	2.1	0.0	0.1	0.5	0.1	0.4	0.2	0.2	1.3	0.4	0.0	0.4	1.5	2.7	7.3	1.2	9.6	0.5	1.2	0.0	0.2	52.3	52.5	92.1	1.3	0.1	0.2	0.0	36.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	44.7	35.9	32.4	18.9	29.8	55.5	43.2	48.6	34.0	40.3	57.5	4.3	9.6	3.9	109.0	0.1	30.7	14.8	37.5	15.9	2.4	7.9	21.3	8.4	0.0	9.8	18.4	2.1	1.9	0.6	2.0	0.0	4.6	13.6	2.6	11.5	2.8	27.6	0.4	23.9	0.7	3.8	54.3	8.2	2.4	7.0	0.2	5.0	0.0	1.3	0.0	8.2	30.9	8.2	0.6	11.4	26.8	43.8	0.7	14.2	10.3	0.0	31.3	0.0	62.4	122.0	1.2	4.7	91.4	0.3	9.3	16.8	2.1	15.0	2.5	0.0	5.4	25.0	14.9	3.8	1.9	21.2	2.2	2.2	0.5	6.8	15.3
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866556-70212468	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.1;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.5;Excitatory neurons: 66.6;Inhibitory neurons: 164.2;Oligodendrocyte precursor cells: 39.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 9.1"	"Group enriched"	"Detected in some"	218	"memory B-cell: 14.6;naive B-cell: 31.9"	"Lineage enriched"	"Detected in single"	299	"B-cells: 31.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.3;RH-30: 11.4;SCLC-21H: 3.7;SH-SY5Y: 2.9;SK-MEL-30: 9.6;WM-115: 9.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042422	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	0.0	0.1	1.2	1.5	1.6	0.3	0.0	9.1	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.7	2.3	0.1	1.4	0.1	0.0	2.6	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.3	0.7	0.7	0.6	0.1	0.0	0.7	0.0	0.7	0.0	0.0	1.6	1.1	0.4	0.0	1.1	0.0	0.2	3.2	2.2	0.2	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.4	0.0	0.0	0.0	3.7	2.9	0.0	0.0	9.6	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	31.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	1.6	9.1	1.9	2.3	0.1	0.2	0.2	0.3	0.0	0.0	2.1	0.0	0.0	0.0	11.1	33.5	0.1	0.2	0.0	0.0	4.4	0.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	66.6	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.7	0.1	0.0	0.0	164.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	8.4	0.3	0.1	1.0	39.7	10.6	0.0	0.0	0.0	0.9	0.0	0.0	3.8	0.7	0.1	0.0	11.2	0.4	1.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50184101-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1331.8;gallbladder: 1211.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2044.3;Fibroblasts: 1944.4;Leydig cells: 556.0;Smooth muscle cells: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1689.5;BJ: 3428.1;fHDF/TERT166: 5206.1;HSkMC: 2490.3;U-138 MG: 2687.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 115.9"	"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		80000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	312.1	39.9	1.8	272.8	5.3	4.5	184.9	1.3	15.9	1331.8	12.0	223.2	37.7	531.4	23.4	110.2	234.1	1211.3	126.6	1.5	1.9	34.7	29.7	139.0	78.1	3.2	1.4	377.3	39.8	14.1	80.5	503.5	2.0	137.5	46.5	0.4	51.3	98.6	21.2	362.0	86.6	801.2	2.2	46.9	109.9	38.2	17.3	14.4	50.8	13.0	21.1	616.3	342.2	6.7	6.0	5.0	16.4	3.2	702.9	1689.5	29.2	3428.1	915.8	826.6	517.6	64.2	14.6	0.6	7.8	5206.1	5.7	9.1	8.3	3.4	150.1	5.2	6.1	0.4	92.2	4.2	1309.3	1.2	0.8	2490.3	45.7	1016.2	4.6	126.9	0.5	4.8	2.2	0.4	425.4	8.5	1.4	1.0	17.0	10.7	10.5	6.1	2.1	2.7	3.9	0.2	2.0	8.8	5.6	5.0	0.2	245.4	39.8	0.6	1.5	2687.4	562.6	405.0	16.2	2.8	5.9	0.7	200.1	1.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.3	1.3	15.9	1.5	1.9	3.2	1.4	2.0	2.2	17.3	6.7	66.9	9.6	13.8	0.0	2.1	188.0	12.4	31.6	10.8	0.2	9.1	10.0	12.5	5.7	13.2	7.3	0.0	45.7	1.7	1.4	0.0	13.3	1.9	64.6	2044.3	33.4	3.0	0.0	0.1	4.2	45.5	1944.4	17.9	49.2	2.5	8.1	378.0	3.4	67.6	0.0	0.3	5.4	6.1	0.3	318.1	18.2	556.0	13.1	188.5	12.2	0.0	2.5	0.0	0.0	0.0	23.8	0.3	268.1	1.3	10.7	0.1	0.7	9.8	0.2	78.9	74.8	1024.9	4.0	2.6	4.3	163.5	111.8	29.4	57.3	2.9	9.1
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394895-94431227	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 1831.7;gallbladder: 1378.0;smooth muscle: 1416.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 774.5;Fibroblasts: 2148.2;Glandular and luminal cells: 592.2;Leydig cells: 991.9;Peritubular cells: 501.0;Smooth muscle cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3899.2;ASC TERT1: 4637.0;BJ: 3995.6;BJ hTERT+: 2901.2;fHDF/TERT166: 13615.1;HSkMC: 4058.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 133.7"	"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		27000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: AB_2684116"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	514.8	52.4	6.8	266.2	9.3	2.0	314.5	7.1	17.4	1831.7	18.1	175.7	61.1	411.2	61.6	263.2	206.6	1378.0	275.4	6.0	6.8	40.8	27.4	229.5	91.6	8.7	6.7	297.2	57.1	32.5	33.5	624.6	7.9	196.2	141.8	1.6	60.2	232.3	51.6	424.6	103.2	1416.9	8.8	69.3	89.1	136.6	15.6	32.8	86.4	102.1	60.1	805.6	295.2	8.2	0.1	0.0	22.8	1488.5	3899.2	4637.0	1.3	3995.6	2901.2	642.6	850.5	0.0	2.8	0.3	2.7	13615.1	0.0	0.6	2.2	1.5	160.9	0.1	0.2	0.1	0.0	0.0	1018.6	1.1	0.5	4058.4	0.1	507.9	2.4	0.3	0.5	0.0	0.3	0.3	551.0	0.0	0.6	1.5	2.5	0.0	6.3	0.5	0.8	0.8	0.1	0.0	12.9	1.4	0.3	1.0	0.1	296.0	2.1	0.1	15.9	1626.3	0.8	1022.7	115.5	1.2	0.1	0.4	408.6	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	9.3	7.1	17.4	6.0	6.8	8.7	6.7	7.9	8.8	15.6	8.2	112.9	3.2	12.9	1.0	0.8	223.1	0.7	9.3	4.6	0.2	7.2	8.6	21.7	0.0	3.3	1.8	0.0	31.5	2.5	0.0	0.0	3.0	8.4	183.2	774.5	57.2	0.0	0.0	0.0	0.2	31.7	2148.2	26.5	592.2	10.1	16.4	258.8	1.9	116.9	0.0	0.1	0.0	0.0	1.0	394.5	45.1	991.9	16.7	238.3	97.4	2.6	3.2	0.0	0.0	0.2	5.2	0.0	501.0	4.5	1.0	0.0	0.5	0.8	0.4	302.4	249.9	770.7	9.9	4.5	6.2	187.4	70.7	30.6	214.8	0.0	0.8
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.1;placenta: 28.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Cardiomyocytes: 36.9;Extravillous trophoblasts: 75.3;Inhibitory neurons: 63.3;Respiratory ciliated cells: 51.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 23.4;BEWO: 7.6;HSkMC: 24.0;SuSa: 11.1"					"Low region specificity"	"Detected in all"			HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"	NA	NA		290000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	2.6	1.4	2.6	0.6	3.2	0.0	1.4	3.3	1.9	24.1	11.4	7.8	0.5	12.4	2.8	2.4	7.4	3.8	4.2	2.4	5.6	1.1	1.2	7.6	0.5	2.7	6.3	3.7	1.9	0.6	1.9	28.3	3.1	3.5	2.0	0.0	5.0	10.7	1.3	6.6	1.3	7.9	1.5	0.5	2.7	2.7	4.0	0.7	1.0	6.6	0.5	6.1	6.0	2.7	0.0	3.4	0.2	0.0	1.3	23.4	7.6	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.2	0.1	0.0	24.0	0.9	0.0	0.3	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.2	3.3	1.9	2.4	5.6	2.7	6.3	3.1	1.5	4.0	2.7	6.4	0.0	1.5	66.6	0.0	5.9	2.2	2.8	2.2	0.0	0.3	0.4	36.9	0.0	8.2	0.0	0.0	27.5	0.1	0.0	0.0	0.0	7.4	24.8	10.6	6.6	0.0	0.0	16.0	0.0	75.3	28.2	0.5	1.2	0.0	0.2	2.9	0.0	6.1	0.0	63.3	0.0	16.2	0.3	3.0	1.7	15.2	0.3	5.4	0.0	0.0	0.0	0.0	3.5	1.6	0.0	0.0	12.4	0.0	0.1	0.1	0.1	51.3	0.0	0.0	7.3	15.0	1.2	2.5	1.0	4.1	23.3	0.4	2.1	0.2	1.3
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974373-189012746	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 2369.0;gallbladder: 2092.8;placenta: 1981.7;smooth muscle: 2140.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 2812.0;Fibroblasts: 1764.2;Smooth muscle cells: 643.0;Theca cells: 466.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebral cortex: 15.0;thalamus: 10.9;white matter: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 1362.4;ASC diff: 2465.0;ASC TERT1: 4252.6;fHDF/TERT166: 1815.7;HHSteC: 1690.0;HSkMC: 3189.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 61.1"	"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		32000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	763.6	48.9	1.1	575.5	2.3	1.1	340.0	1.4	15.0	2369.0	11.5	275.9	84.5	768.9	60.9	298.5	177.6	2092.8	234.6	1.3	1.4	42.9	97.4	187.0	119.0	1.8	2.0	146.9	45.2	37.0	13.6	1981.7	2.2	147.5	334.7	0.0	65.6	276.9	67.1	329.8	152.5	2140.7	1.9	134.7	156.9	63.5	10.9	40.9	71.8	71.8	73.1	1097.6	273.8	4.6	0.0	0.2	1362.4	53.0	2465.0	4252.6	0.9	558.6	495.3	239.4	212.8	8.1	0.0	0.6	0.3	1815.7	0.1	0.8	1.1	1.0	26.4	0.0	0.9	0.7	228.9	0.2	1690.0	2.0	0.6	3189.5	0.0	291.5	46.9	1.0	12.5	0.0	0.4	0.0	146.4	0.0	0.2	1.4	2.6	0.1	1.7	0.3	38.5	0.5	0.0	7.2	1.3	21.1	14.5	0.4	0.0	954.8	0.1	0.0	0.7	2.3	28.0	117.3	0.5	2.8	1.3	0.4	0.5	1.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.3	1.4	15.0	1.3	1.4	1.8	2.0	2.2	1.9	10.9	4.6	111.8	3.2	13.7	0.0	0.6	171.6	0.4	1.9	3.4	0.0	7.7	9.9	11.1	0.0	1.3	0.0	0.0	57.9	1.6	0.0	0.0	2.4	29.0	75.4	2812.0	68.4	6.0	0.0	0.0	0.0	58.1	1764.2	4.1	60.7	6.3	9.7	235.2	0.9	91.1	0.0	0.2	0.0	0.0	0.6	275.3	20.8	323.1	17.5	172.5	20.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	235.9	1.5	0.6	0.0	0.2	1.6	0.0	453.6	224.3	643.0	0.9	1.5	2.2	155.7	126.3	29.1	466.8	0.0	0.4
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 32.6;urinary bladder: 40.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 24.5;Basal respiratory cells: 16.0;Cardiomyocytes: 13.1;Prostatic glandular cells: 12.1;Urothelial cells: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.0;HeLa: 40.1;HHSteC: 59.2;hTERT-HME1: 44.1;HUVEC TERT2: 41.7;TIME: 94.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"		"HPA065393: AB_2685483"	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	3.0	0.5	0.3	0.4	0.3	0.0	2.0	0.2	0.2	12.6	1.3	1.9	1.4	32.6	17.0	5.5	14.9	13.3	5.4	0.3	0.7	4.2	0.1	1.0	0.1	0.9	1.7	9.3	0.1	5.5	7.2	3.2	1.0	12.5	2.1	1.2	1.4	21.5	1.4	6.5	1.5	24.5	0.4	1.4	13.3	1.2	0.3	0.9	0.7	1.2	0.1	40.7	9.2	0.6	0.1	31.1	9.9	0.0	24.2	1.7	0.0	0.0	1.8	0.3	0.2	17.9	0.0	0.0	0.0	0.0	3.9	5.8	10.3	46.0	0.8	0.4	8.8	0.8	40.1	0.3	59.2	0.0	0.0	2.6	27.8	6.5	44.1	0.1	41.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	14.0	0.0	3.8	0.0	0.0	0.0	1.9	3.4	0.0	0.0	2.4	0.0	0.0	18.2	0.9	0.0	94.2	0.0	0.1	5.5	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.7	0.9	1.7	1.0	0.4	0.3	0.6	0.1	0.0	0.0	6.2	0.0	6.4	24.5	16.0	3.4	0.2	2.3	6.1	13.1	0.0	2.6	1.8	0.0	0.1	0.0	0.0	1.9	0.0	2.1	0.7	6.0	0.4	0.0	0.0	0.4	0.0	0.0	6.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	2.0	0.0	0.3	0.3	4.1	0.0	0.0	8.4	0.0	5.5	0.0	0.0	0.6	0.1	0.0	9.1	0.0	12.1	0.0	0.0	2.2	0.4	0.0	0.4	7.2	0.2	0.2	0.1	3.7	0.0	0.1	0.8	0.0	15.2
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641803-134844843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 146.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 141.1;Fibroblasts: 134.9;Leydig cells: 61.2;Sertoli cells: 52.6;Skeletal myocytes: 78.3;Smooth muscle cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 446.6;fHDF/TERT166: 414.6;HeLa: 297.0;HHSteC: 265.8;SiHa: 290.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	No	No		15000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA030769: AB_2673603"	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	39.3	12.0	1.3	39.1	1.5	1.0	20.0	1.9	2.7	146.6	3.4	72.0	13.5	118.2	11.1	23.2	59.6	77.6	32.8	1.2	1.9	11.5	7.6	35.7	5.5	4.0	2.5	51.9	7.0	6.8	6.6	95.8	1.3	43.8	16.3	3.1	9.3	28.9	10.2	24.6	22.0	89.6	1.8	17.6	31.4	6.2	4.6	2.3	10.1	7.3	2.9	51.6	63.4	1.4	0.6	16.7	13.0	20.7	192.2	202.4	7.9	446.6	89.0	73.6	78.6	0.2	0.3	0.0	95.3	414.6	39.8	5.6	0.0	0.1	21.3	0.1	1.0	0.3	297.0	0.1	265.8	0.2	2.7	200.0	0.2	71.1	5.6	0.0	89.2	0.1	0.1	1.2	39.5	4.1	0.3	0.9	7.6	0.0	8.5	15.7	50.3	1.8	0.1	0.1	5.3	2.5	290.0	1.8	0.2	173.7	0.6	0.2	152.6	154.4	61.9	190.4	93.7	0.3	0.2	0.4	121.6	0.1	26.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.9	2.7	1.2	1.9	4.0	2.5	1.3	1.8	4.6	1.4	7.9	0.0	1.8	0.7	0.3	14.5	3.5	0.8	3.4	8.5	0.8	2.7	9.0	0.0	0.0	1.8	2.1	6.4	0.3	0.0	1.9	2.2	5.5	4.2	141.1	8.8	0.0	0.0	6.6	0.0	12.3	134.9	1.5	4.8	0.0	1.2	21.8	0.0	8.9	0.0	1.2	0.0	0.0	0.3	15.3	15.6	61.2	1.5	7.2	12.2	0.0	6.4	0.0	5.5	0.3	1.3	0.0	38.7	0.3	1.0	0.0	0.3	0.0	1.2	52.6	78.3	57.5	0.5	0.8	0.6	7.7	10.4	2.6	11.7	0.0	0.4
COL5A2		ENSG00000204262	"Collagen type V alpha 2 chain"	P05997	2	189031898-189225312	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 186.0;Excitatory neurons: 185.2;Fibroblasts: 145.7;Skeletal myocytes: 76.4;Smooth muscle cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 447.8;BJ hTERT+ SV40 Large T+ RasG12V: 382.4;fHDF/TERT166: 430.3;HSkMC: 340.2;SuSa: 373.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		820000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (7.45e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.53e-10)"	"unprognostic (4.57e-3)"	"unprognostic (3.76e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (3.58e-4)"	61.0	4.8	2.3	42.5	5.7	0.2	25.7	0.0	15.6	83.4	3.1	48.7	10.0	43.4	32.7	23.6	21.2	81.9	19.5	17.6	0.8	6.3	12.4	26.1	9.3	2.0	17.4	25.2	7.1	7.5	7.3	111.5	3.8	14.8	25.4	1.6	7.4	12.8	7.8	12.9	22.8	98.3	1.9	10.0	21.5	6.8	1.0	4.7	9.8	26.8	10.3	57.3	29.7	2.5	0.4	93.5	143.9	67.5	212.0	285.3	0.8	213.7	242.3	447.8	382.4	63.2	0.7	0.2	2.2	430.3	23.2	1.6	4.1	2.3	153.3	0.9	1.3	1.0	2.1	0.6	282.6	0.6	0.4	340.2	7.8	129.8	45.3	92.2	108.5	0.9	0.5	0.4	109.1	2.4	0.3	0.3	20.9	0.9	124.3	0.5	33.9	0.4	0.5	24.9	2.0	1.4	5.2	2.5	5.2	373.0	2.1	0.2	91.6	212.8	22.9	52.6	44.6	0.8	0.4	0.6	32.2	0.1	235.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	5.7	0.0	15.6	17.6	0.8	2.0	17.4	3.8	1.9	1.0	2.5	36.7	0.0	1.5	29.7	0.3	26.1	0.2	7.2	6.2	1.3	1.6	3.7	2.8	0.0	0.7	1.8	0.0	4.6	0.2	0.5	1.9	0.6	0.7	22.4	186.0	9.1	38.7	0.0	185.2	0.7	3.9	145.7	0.5	5.1	0.0	4.2	25.7	7.4	6.6	0.0	23.8	0.2	4.1	0.3	27.4	1.7	48.7	1.4	21.4	25.3	0.6	0.7	0.0	21.6	10.9	1.1	0.1	19.5	0.4	0.3	0.1	1.0	1.9	0.8	46.0	76.4	116.0	3.9	1.8	2.0	18.8	6.2	2.8	27.4	0.0	0.4
COL5A3		ENSG00000080573	"Collagen type V alpha 3 chain"	P25940	19	9959561-10010504	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Astrocytes: 510.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 38.9;BJ: 23.6;BJ hTERT+: 26.2;BJ hTERT+ SV40 Large T+: 14.4;HSkMC: 28.2;WM-115: 26.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA041695, HPA048256"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		330000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA041695: , HPA048256: AB_2680330"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.84e-3)"	"unprognostic (3.01e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.17e-8)"	"unprognostic (3.25e-2)"	"unprognostic (7.31e-3)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (6.87e-5)"	47.4	5.0	33.2	9.9	33.2	0.1	32.3	30.6	45.9	44.9	43.6	19.3	3.7	27.3	1.9	9.0	22.8	4.1	33.5	33.3	26.4	7.9	13.4	14.2	3.2	35.2	30.2	6.3	5.2	3.0	3.5	32.8	32.3	16.6	2.0	21.1	7.3	8.9	15.3	21.7	11.7	10.3	31.0	1.7	9.9	4.7	30.2	4.5	12.7	6.0	3.9	12.6	26.4	28.4	0.0	0.0	0.5	0.0	12.4	38.9	0.0	23.6	26.2	14.4	5.7	0.0	0.0	0.0	0.2	4.4	0.3	2.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	28.2	0.6	5.2	5.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.1	0.0	0.0	0.0	11.6	5.5	0.5	0.0	0.0	0.0	0.0	1.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	33.2	30.6	45.9	33.3	26.4	35.2	30.2	32.3	31.0	30.2	28.4	13.7	0.0	0.0	510.3	0.0	4.2	0.1	0.2	2.2	65.1	0.3	0.9	6.4	0.0	0.1	0.0	6.2	0.1	0.3	1.3	0.0	0.2	6.9	0.4	12.0	8.1	0.0	0.0	15.6	0.0	0.2	17.5	0.5	0.4	0.0	0.0	3.9	22.9	0.6	3.3	3.4	0.0	0.0	0.0	3.2	2.1	17.4	0.4	14.2	36.5	0.1	2.6	0.0	73.9	2.5	0.3	0.1	8.2	0.0	0.3	0.2	0.1	0.9	28.3	92.1	8.5	58.0	0.3	0.3	3.2	7.1	0.1	1.9	0.9	0.0	0.3
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098112-46132848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 453.2;Fibroblasts: 1455.4;Leydig cells: 605.5;Peritubular cells: 472.1;Smooth muscle cells: 555.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 4.5;MAIT T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1155.7;ASC TERT1: 2116.9;BJ: 1073.7;BJ hTERT+: 982.8;fHDF/TERT166: 775.0;HHSteC: 1129.2;HSkMC: 1524.4;U-138 MG: 1128.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 49.6"	"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		8200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	732.4	96.2	10.1	219.9	10.8	4.5	455.0	8.7	14.4	873.3	21.6	1287.5	97.7	1001.7	36.5	178.8	675.1	283.8	484.3	10.0	14.9	96.5	97.6	394.2	55.7	14.0	19.4	723.6	78.6	24.0	112.2	335.3	11.2	569.9	60.2	0.9	156.2	274.6	123.4	390.6	402.2	275.4	9.8	175.1	441.6	77.0	11.7	35.6	201.3	67.2	25.6	918.6	595.9	12.3	9.4	12.5	34.8	31.2	1155.7	2116.9	10.0	1073.7	982.8	265.5	121.5	2.3	42.4	0.2	79.2	775.0	170.8	0.9	8.1	0.7	21.7	0.8	12.3	0.2	0.2	0.2	1129.2	0.5	4.8	1524.4	0.2	503.6	10.2	0.1	0.6	0.6	0.6	0.8	108.7	5.2	0.4	2.4	19.3	0.0	130.5	0.4	66.9	1.8	0.0	0.1	1.1	54.2	41.6	0.6	0.7	19.4	1.2	6.6	0.2	1128.1	131.5	421.5	270.3	0.7	0.4	0.9	578.1	0.5	164.8	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.4	2.4	0.0	0.0	0.4	1.2	0.0	0.3	0.0	0.0	0.1	0.5	10.1	10.8	8.7	14.4	10.0	14.9	14.0	19.4	11.2	9.8	11.7	12.3	127.3	3.2	0.6	2.0	3.1	164.4	4.3	0.6	9.1	0.7	12.7	33.5	8.7	4.3	0.6	7.3	0.0	17.6	41.2	0.4	0.0	15.1	4.0	13.2	453.2	101.4	0.0	2.7	0.1	0.4	25.1	1455.4	13.3	10.3	0.0	36.1	123.1	1.4	35.3	0.0	0.8	0.1	0.0	3.1	219.7	23.7	605.5	11.7	181.5	44.0	2.4	3.1	32.0	0.0	0.1	5.9	1.0	472.1	12.1	11.2	0.0	0.4	0.1	0.5	295.9	284.8	555.2	3.7	11.5	4.6	140.4	40.4	32.7	125.3	0.4	3.9
COL6A3		ENSG00000163359	"Collagen type VI alpha 3 chain"	P12111	2	237324003-237414207	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Congenital muscular dystrophy, Disease variant, Dystonia, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 391.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 355.2;Fibroblasts: 567.9;Leydig cells: 315.1;Smooth muscle cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3311.7;ASC TERT1: 4227.5;BJ hTERT+: 1279.6;HSkMC: 2705.3"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Region enriched"	"Detected in many"	4	"spinal cord: 12.0"	"HPA010007, HPA010080"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA010007: , HPA010080: AB_1078550"	"unprognostic (8.94e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.20e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (5.57e-11)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-3)"	150.8	8.3	0.1	126.5	1.0	0.4	74.5	0.2	3.0	212.6	5.2	94.8	22.9	156.3	10.2	44.1	91.8	236.4	61.2	2.4	0.1	5.7	10.3	65.8	30.7	0.6	0.1	123.8	21.1	17.3	2.8	132.9	0.7	47.7	51.7	0.0	45.2	55.4	32.5	35.7	46.6	391.3	0.8	19.0	41.5	15.6	1.8	24.8	38.1	62.3	16.1	188.4	62.7	0.9	0.2	0.5	0.6	0.0	3311.7	4227.5	60.9	815.6	1279.6	167.0	188.2	0.0	0.1	4.5	0.1	818.7	67.4	0.6	0.7	0.9	98.8	2.0	0.1	0.0	0.0	0.0	669.9	0.0	0.4	2705.3	0.0	596.3	1.8	7.8	0.2	0.0	0.1	0.6	6.2	0.0	0.1	0.2	0.5	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	17.3	0.0	0.4	2.9	19.0	45.1	27.6	142.4	1.0	0.0	0.1	859.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	3.0	2.4	0.1	0.6	0.1	0.7	0.8	1.8	0.9	48.2	0.0	10.5	0.3	0.6	61.1	0.5	0.5	1.8	1.0	2.5	2.9	10.6	1.5	3.8	0.0	0.0	4.5	1.2	0.0	0.0	0.9	5.4	11.0	355.2	17.6	0.0	0.0	0.8	0.0	6.2	567.9	6.6	8.7	1.3	1.8	25.4	1.8	8.1	0.0	0.4	0.0	0.0	1.3	85.4	9.6	315.1	5.5	72.9	29.0	2.2	1.1	1.0	0.0	0.3	2.4	0.0	103.4	2.0	0.9	0.0	0.2	1.0	2.3	32.9	19.2	197.7	1.5	1.3	3.3	61.5	5.7	9.3	48.7	0.0	1.0
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595329	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 98.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 72.5;Basal respiratory cells: 59.3;Basal squamous epithelial cells: 67.2;Endometrial stromal cells: 45.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 41.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 65.7;HaCaT: 63.5;HBEC3-KT: 100.6;HDLM-2: 97.8;HeLa: 146.2;SiHa: 82.8"									"CAB016357, HPA018877, HPA042420"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		6000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	Vesicles	"CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	0.8	1.1	1.4	3.8	1.0	0.1	4.9	2.8	2.1	24.3	0.4	2.9	1.7	12.1	6.7	21.8	6.4	4.0	3.2	0.3	6.5	7.4	1.3	1.7	1.2	7.0	3.2	3.4	0.4	0.0	2.5	1.6	3.0	34.2	0.9	1.4	11.5	12.2	3.5	98.2	4.1	2.5	2.6	6.5	2.1	3.6	6.5	1.2	0.5	0.6	1.3	6.6	29.2	0.6	0.2	25.4	1.2	0.5	9.2	12.3	31.0	65.7	40.8	16.9	10.0	0.4	0.5	0.1	2.0	15.0	15.4	63.5	0.0	100.6	3.1	97.8	0.5	0.2	146.2	4.3	25.6	0.0	0.4	19.9	58.8	34.4	26.8	23.1	0.0	0.7	0.5	0.7	2.0	0.3	0.0	0.9	3.1	1.3	1.3	0.5	2.2	0.2	9.2	0.2	0.2	0.2	82.8	0.1	0.8	3.7	1.3	0.3	0.0	5.6	3.2	3.2	50.1	1.8	1.8	0.1	49.0	0.4	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	2.8	2.1	0.3	6.5	7.0	3.2	3.0	2.6	6.5	0.6	0.4	0.0	0.0	10.7	0.2	72.5	24.1	59.3	67.2	17.7	1.0	10.2	6.6	0.0	10.6	11.0	10.4	1.4	0.1	0.6	0.0	0.9	11.8	3.1	45.3	1.4	1.8	0.0	6.8	0.7	1.0	8.3	1.1	4.0	0.0	0.8	0.4	0.7	1.6	8.4	11.6	0.7	0.0	0.3	4.2	6.3	5.0	0.8	8.8	8.4	0.1	2.6	0.0	4.0	4.4	15.6	0.1	5.7	0.0	5.7	0.2	0.3	2.5	12.9	0.0	2.0	13.4	2.6	1.5	11.3	24.2	1.2	0.8	5.0	0.2	5.8
COLEC12	"CL-P1, SCARA4, SRCL"	ENSG00000158270	"Collectin subfamily member 12"	Q5KU26	18	316737-500722	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 31.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 104.4;Cytotrophoblasts: 149.0;Fibroblasts: 79.6;Hofbauer cells: 155.9;Microglial cells: 245.4;Muller glia cells: 74.5;Syncytiotrophoblasts: 111.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 24.3;BJ: 12.1;HSkMC: 20.0;U-2197: 31.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047917, HPA071056"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cell Junctions"		NA	NA		580000	"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Cell Junctions"	"HPA047917: AB_2680208, HPA071056: AB_2686338"	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.01e-3)"	12.4	1.7	5.1	2.4	4.8	0.2	5.5	4.7	5.7	31.6	9.7	5.5	1.5	9.0	1.0	2.0	6.5	4.4	6.6	4.6	7.2	2.4	0.3	11.4	2.0	7.7	6.5	2.0	1.1	0.9	0.9	20.0	5.2	4.0	2.4	5.3	4.1	1.4	3.1	3.6	3.5	5.1	4.3	0.3	3.4	1.4	6.5	1.3	5.2	2.0	2.5	8.1	4.0	5.5	0.0	0.0	2.1	0.0	2.3	24.3	0.8	12.1	4.2	1.7	3.1	0.0	0.0	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.0	0.0	20.0	0.0	1.0	0.0	0.7	4.7	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.7	0.0	6.5	0.0	0.0	0.1	0.3	0.0	0.1	0.0	1.9	0.1	0.0	0.0	2.8	0.4	31.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	5.1	4.8	4.7	5.7	4.6	7.2	7.7	6.5	5.2	4.3	6.5	5.5	6.8	3.2	104.4	34.3	2.1	4.1	3.2	0.0	1.2	6.4	2.6	1.7	4.0	2.8	10.7	3.7	10.4	149.0	1.4	0.3	0.0	0.2	11.1	0.5	3.9	15.8	15.7	2.7	0.5	0.0	5.3	79.6	0.0	0.8	13.9	1.2	5.7	0.4	155.9	6.7	1.4	1.0	0.0	4.9	8.9	31.4	61.5	32.1	1.8	245.4	16.2	74.5	3.1	2.0	10.4	0.3	0.6	7.2	1.2	6.5	1.4	0.2	1.7	12.4	0.0	13.2	21.6	1.3	2.5	1.8	3.8	111.2	4.8	11.6	0.8	1.3
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941371-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 818.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		43000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	78.1	180.7	99.3	39.6	108.9	71.8	85.5	114.4	140.4	105.3	119.6	80.1	55.0	76.9	47.7	198.0	65.2	60.3	81.7	96.6	107.4	94.2	292.3	93.3	49.7	117.4	107.9	107.4	74.0	61.5	48.7	116.9	117.3	87.2	20.7	17.2	133.7	70.5	98.6	119.7	64.1	38.3	109.2	63.6	99.8	51.7	102.7	26.9	59.1	49.9	26.0	86.9	124.1	124.3	131.3	131.7	15.0	128.3	141.2	122.5	6.0	143.9	178.8	120.3	133.6	112.1	148.6	51.7	62.7	208.9	48.6	172.9	23.6	152.0	26.2	115.1	163.4	92.5	65.1	267.1	265.1	155.0	35.3	159.2	180.7	104.3	101.3	116.6	113.2	82.0	383.2	109.4	100.6	818.5	63.4	267.9	32.4	361.1	42.9	88.2	127.9	72.8	129.0	404.5	60.4	53.8	47.7	405.7	125.7	7.6	84.0	436.6	137.5	212.7	82.2	71.0	109.6	37.5	18.0	41.2	236.0	211.3	152.5	62.2	312.2	59.6	77.9	218.1	64.0	56.8	52.6	62.6	251.5	57.8	45.5	51.7	12.0	73.5	151.5	291.4	72.6	178.6	99.3	108.9	114.4	140.4	96.6	107.4	117.4	107.9	117.3	109.2	102.7	124.3	99.1	125.0	88.1	22.9	33.1	102.1	231.9	248.1	188.4	73.4	174.9	218.4	41.9	104.4	162.7	152.6	10.4	885.9	80.1	53.0	320.8	201.0	4.6	59.1	72.2	86.7	84.5	70.0	16.8	193.0	113.5	103.1	46.4	46.9	71.7	95.7	77.1	262.0	311.4	25.2	17.2	97.7	191.2	177.0	107.7	13.3	134.2	137.0	240.1	20.6	137.0	158.7	41.2	25.1	45.7	170.2	108.8	179.8	45.5	132.4	179.9	73.8	135.8	43.2	138.1	143.3	113.1	8.4	5.7	236.4	123.5	648.5	41.8	222.0	122.3	206.6
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578993-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.4;retina: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Bipolar cells: 43.2;Cone photoreceptor cells: 37.5;Excitatory neurons: 96.6;Inhibitory neurons: 50.0;Oligodendrocytes: 146.4"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;ASC TERT1: 57.5;HSkMC: 41.6;hTEC/SVTERT24-B: 34.6;U-87 MG: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced	Supported	Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	3.5	44.1	2.0	60.9	0.7	7.2	62.1	66.5	7.2	28.2	5.9	1.2	7.5	2.2	1.4	27.5	4.7	16.4	48.1	43.5	9.2	1.3	5.1	1.8	62.4	62.7	14.9	2.2	0.5	3.5	3.2	58.0	4.3	1.5	45.2	2.7	4.9	2.6	4.1	2.8	6.3	51.9	3.9	3.1	1.0	66.5	1.3	6.1	4.5	0.8	4.1	3.7	83.4	0.6	0.8	26.2	2.2	26.8	57.5	0.0	13.7	15.0	2.3	3.2	0.3	3.0	3.5	1.6	2.3	3.7	0.2	1.0	0.3	9.5	0.0	1.2	0.0	0.0	1.2	9.8	0.0	0.4	41.6	0.3	34.6	2.0	20.4	1.0	0.0	0.0	0.1	24.4	0.1	0.0	0.1	6.5	0.0	0.1	2.2	0.1	1.2	3.7	0.0	15.3	0.3	0.2	0.0	7.8	4.8	0.0	3.1	0.2	7.8	8.9	1.7	18.3	0.0	0.0	3.5	59.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.1	60.9	62.1	66.5	48.1	43.5	62.4	62.7	58.0	51.9	66.5	83.4	2.8	0.0	0.0	57.1	1.1	1.0	0.4	0.0	0.0	43.2	0.1	1.0	1.5	0.0	0.0	7.3	37.5	0.0	0.0	0.0	0.0	3.8	0.4	2.1	11.6	3.0	3.6	0.0	96.6	0.6	0.0	8.0	0.0	0.3	0.0	0.9	6.4	0.0	0.2	0.0	50.0	0.3	0.0	0.3	0.7	0.7	7.8	0.3	7.2	11.2	0.1	12.5	0.0	17.1	146.4	0.6	0.0	0.4	0.0	0.1	0.0	0.1	8.1	21.4	6.6	1.4	2.1	0.2	0.5	0.1	0.9	0.0	0.1	7.5	0.0	0.1
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428360	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	46	"heart muscle: 3905.3;skeletal muscle: 6742.0;tongue: 2096.1"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 4861.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	150	"NK-cell: 15.0"	"Lineage enriched"	"Detected in single"	150	"NK-cells: 15.0"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			1.9	0.9	1.8	0.1	1.3	0.0	2.9	2.3	2.3	0.4	0.2	1.4	1.1	1.0	0.0	74.8	0.9	0.0	3905.3	0.9	2.1	4.5	15.9	3.3	0.4	1.6	2.6	1.2	3.0	2.9	11.9	0.1	7.3	38.9	0.0	1.0	92.1	0.1	6742.0	3.5	1.2	0.0	0.8	0.5	1.3	1.3	2.6	0.5	2.0	2096.1	0.1	0.3	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	1.8	1.3	2.3	2.3	0.9	2.1	1.6	2.6	7.3	0.8	2.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.4	4861.8	2.8	0.0	3.7	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.1	48.8	0.0	0.0	0.0	0.4	0.0	96.2	0.0	0.1	0.0	0.2	0.4	75.7	2.9	3.3	0.0	0.1	0.0	1.6	0.0	0.8	0.3	1.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.1	1.3	24.9	0.0	4.2	19.7	258.0	53.7	0.2	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498547	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 643.3;retina: 741.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4"	"Cancer enhanced"	"Detected in all"		"glioma: 240.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		600000		"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	138.1	151.7	554.8	20.5	593.0	1.8	97.5	550.9	604.0	53.9	311.9	44.6	22.0	67.7	404.6	74.8	88.6	65.7	100.7	584.3	643.3	68.4	26.7	50.1	37.5	417.0	494.2	104.0	170.4	89.9	328.4	7.7	456.2	295.1	36.8	741.7	104.5	84.7	56.2	45.1	30.7	83.3	448.3	11.6	80.2	146.2	578.2	68.8	179.7	47.5	35.2	33.8	73.4	446.2	0.2	8.4	54.4	10.5	41.4	4.5	2.4	0.1	21.5	8.1	16.5	0.0	0.5	0.0	15.8	0.6	1.9	1.2	20.4	4.4	4.7	0.3	78.6	0.0	21.6	311.6	3.0	0.3	0.5	102.3	21.5	0.3	0.4	104.0	0.2	0.0	0.1	2.1	11.2	15.4	0.4	2.7	34.4	0.2	12.1	0.3	0.2	1.1	0.7	3.4	418.2	138.0	629.0	77.9	0.0	342.6	46.7	1.9	0.0	16.7	42.5	1.5	1.5	23.5	0.6	2.2	15.5	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	554.8	593.0	550.9	604.0	584.3	643.3	417.0	494.2	456.2	448.3	578.2	446.2	87.1	0.0	5.6	727.4	0.6	26.1	81.7	10.3	66.0	569.1	25.6	52.1	54.5	54.3	5.0	22.0	621.3	0.6	1.4	2.9	0.0	19.7	6.7	2.2	12.1	130.4	587.4	2.7	234.8	1.8	0.3	249.0	31.6	1.3	0.0	8.6	274.2	15.1	1.0	70.7	129.0	16.2	38.7	5.4	41.2	23.3	500.8	6.3	87.2	94.6	1.0	530.9	0.0	211.6	23.0	12.4	3.7	621.0	0.7	434.6	10.2	12.7	1.2	803.3	854.6	14.1	519.4	19.7	13.3	14.0	20.9	0.8	5.5	15.4	4.0	18.9
CPED1	"C7orf58, FLJ21986"	ENSG00000106034	"Cadherin like and PC-esterase domain containing 1"	A4D0V7	7	120988697-121297442	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 78.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 48.4;Microglial cells: 229.5;Peritubular cells: 81.6;Theca cells: 94.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 10.8;intermediate monocyte: 11.3;myeloid DC: 25.2;non-classical monocyte: 7.6;plasmacytoid DC: 15.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 25.2;monocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 87.6;Hep G2: 51.6;K-562: 182.3;LHCN-M2: 60.0;U-138 MG: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012058	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA012058: AB_1845761"	"unprognostic (7.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.52e-3)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.28e-3)"	"unprognostic (5.05e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.54e-4)"	55.0	18.5	2.1	6.5	2.6	0.9	10.0	2.4	2.6	25.2	5.5	16.1	9.1	32.9	13.3	16.5	15.8	26.7	21.5	1.8	2.6	7.1	44.3	16.7	1.8	4.5	3.1	78.5	3.4	1.4	3.3	24.9	4.5	28.1	15.0	1.1	4.1	36.7	17.4	2.0	11.5	38.6	4.1	17.8	10.3	5.5	4.5	1.9	3.7	38.7	1.8	20.7	6.1	5.4	6.3	0.0	0.3	0.1	14.0	40.7	0.3	25.5	87.6	8.6	23.5	0.8	0.3	0.9	0.3	14.0	9.7	0.3	0.4	0.0	22.4	0.3	0.9	7.1	0.3	51.6	24.3	0.2	0.2	16.7	0.0	20.0	0.4	6.9	4.4	0.1	182.3	12.8	60.0	0.0	0.1	0.2	0.1	0.0	1.1	0.1	34.6	17.3	0.0	0.6	0.0	2.2	0.0	0.1	0.6	0.4	0.1	0.6	2.6	50.2	1.3	42.5	24.3	5.6	0.1	0.6	5.8	0.2	2.5	2.0	10.8	0.0	0.0	11.3	0.1	1.4	0.0	0.0	25.2	0.5	0.0	0.0	0.4	0.0	7.6	15.0	0.0	2.9	2.1	2.6	2.4	2.6	1.8	2.6	4.5	3.1	4.5	4.1	4.5	5.4	19.1	19.2	0.5	12.4	2.5	3.1	0.6	0.0	1.2	0.1	0.6	1.7	20.3	1.5	0.0	0.0	0.0	0.4	8.3	0.0	0.0	0.0	0.2	0.8	23.2	6.9	0.0	2.1	0.9	0.0	2.9	48.4	0.5	0.5	0.0	11.9	28.2	21.9	4.3	3.3	14.7	0.0	0.0	14.5	28.5	1.9	21.1	23.1	3.6	229.5	5.3	14.0	1.0	1.5	0.7	0.0	0.0	81.6	3.0	1.5	0.0	0.2	0.0	0.4	0.0	9.1	32.1	0.6	0.7	1.0	2.0	0.4	0.8	94.5	0.0	2.6
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826129	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 273.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 45.5;Bipolar cells: 33.4;Endothelial cells: 29.6;Excitatory neurons: 44.2;Inhibitory neurons: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 84.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	17.2	13.4	26.1	1.2	43.0	0.1	18.2	59.7	273.5	16.9	0.0	5.0	1.0	10.8	0.1	5.7	16.4	0.4	11.5	18.5	72.8	10.9	8.3	9.4	0.8	135.5	25.1	9.4	3.2	1.4	12.8	0.3	128.2	13.8	0.2	5.7	9.6	0.7	4.1	3.4	5.1	0.4	13.9	27.2	4.9	8.6	124.2	3.6	7.5	0.2	0.2	8.3	12.9	89.9	5.7	0.5	0.1	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	16.3	1.7	4.2	1.9	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.4	0.0	1.8	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	2.3	2.0	0.3	0.0	2.5	2.3	0.0	2.6	4.4	2.6	0.1	0.0	1.6	0.0	0.4	84.3	11.8	0.4	5.5	0.0	0.2	8.5	0.3	0.1	0.0	0.5	0.1	0.1	0.2	4.7	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	26.1	43.0	59.7	273.5	18.5	72.8	135.5	25.1	128.2	13.9	124.2	89.9	45.5	0.0	0.0	5.9	0.4	1.0	3.2	0.4	1.8	33.4	7.8	8.1	3.6	0.0	1.9	0.0	4.2	0.1	2.8	2.5	1.9	1.2	1.4	1.1	5.4	29.6	21.5	0.0	44.2	0.8	3.2	1.8	2.6	1.4	0.0	0.3	14.3	4.8	0.2	18.5	90.7	2.1	0.0	0.3	1.9	2.3	1.8	0.5	1.8	8.4	0.0	16.8	0.0	8.0	4.7	0.8	5.2	0.0	0.6	2.6	0.3	1.2	0.0	21.7	0.0	0.4	2.3	4.3	9.8	0.2	1.1	1.0	1.6	0.8	2.7	1.3
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339768-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 218.6"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 171.8"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"Hep G2: 61.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.4	3.0	0.7	0.4	0.6	1.5	0.2	0.6	1.1	0.2	0.0	0.2	0.0	0.4	0.4	0.1	0.2	0.4	1.0	0.7	0.8	14.7	218.6	0.2	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.4	0.2	0.2	0.2	1.1	0.2	0.1	0.1	0.6	0.2	0.2	0.0	1.2	0.4	0.7	0.4	0.1	0.3	0.0	0.2	0.1	0.0	1.1	0.2	0.1	0.3	0.3	0.1	0.8	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.3	0.8	0.4	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.6	61.8	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.5	0.6	0.0	0.3	0.2	0.3	0.3	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.2	1.4	1.6	0.2	2.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.7	0.8	0.2	0.2	0.2	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	171.8	0.2	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CPNE6		ENSG00000100884	"Copine 6"	O95741	14	24070837-24078100	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 54.3;retina: 16.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.3;Bipolar cells: 26.3;Horizontal cells: 32.0;Inhibitory neurons: 11.4;Late spermatids: 18.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/84: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031636, HPA076665"	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 62: Horizontal cells - Visual perception"			"HPA031636: AB_10601203, HPA076665: "	"unprognostic (1.02e-2)"	"unprognostic (3.26e-4)"	"unprognostic (1.64e-1)"	"unprognostic (5.66e-5)"	"unprognostic (3.51e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.71e-1)"	0.2	0.2	42.1	0.2	37.7	0.2	0.0	20.0	41.1	0.2	12.2	1.5	2.5	0.2	0.3	1.7	0.3	0.0	0.2	54.3	24.9	7.0	2.1	0.1	0.0	31.4	23.2	0.1	0.0	0.0	8.0	0.0	32.7	2.8	0.5	16.4	0.0	12.3	0.1	0.4	3.4	0.3	20.8	0.0	0.4	0.5	31.3	0.1	0.2	0.1	0.0	0.7	0.4	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	37.7	20.0	41.1	54.3	24.9	31.4	23.2	32.7	20.8	31.3	26.0	0.0	0.0	0.0	15.3	0.0	0.1	0.0	0.0	0.0	26.3	0.0	0.0	1.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	6.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	11.4	0.2	0.0	0.0	0.0	18.1	0.6	0.0	0.0	1.0	0.0	1.4	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.3	6.5	2.4	0.0	3.8	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CPNE8		ENSG00000139117	"Copine 8"	Q86YQ8	12	38646822-38907430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 115.5;Microglial cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 66.8;THP-1: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038600	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038600: AB_10674690"	"unprognostic (1.57e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.93e-3)"	"unprognostic (6.28e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.40e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.21e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.73e-3)"	12.0	8.3	7.0	5.4	7.6	4.6	9.6	3.1	11.5	7.8	9.2	8.1	3.3	5.1	3.5	5.4	5.0	9.0	12.2	10.1	8.9	11.2	15.5	10.1	5.4	5.0	6.5	5.7	3.2	2.5	3.3	12.0	4.6	3.7	10.2	6.0	3.2	8.9	2.9	6.1	4.6	9.1	8.8	10.6	3.7	5.8	8.0	3.1	7.8	5.3	3.2	10.1	5.3	5.5	3.1	18.7	1.3	18.5	17.0	14.3	8.6	1.6	0.1	0.0	0.0	9.4	18.2	0.0	26.3	12.7	6.8	1.0	10.8	5.6	0.0	0.0	11.3	9.9	26.3	2.2	11.3	0.0	7.8	6.7	14.2	4.2	14.9	12.9	14.3	0.0	6.0	0.0	0.0	0.0	0.0	0.1	13.8	11.5	19.0	0.0	0.0	4.3	66.8	0.5	0.0	0.5	26.0	4.7	14.1	18.8	2.3	38.8	13.6	0.0	12.7	21.6	0.1	6.5	19.3	0.2	17.2	17.8	11.0	2.7	12.0	0.0	1.6	9.4	0.3	0.2	2.1	1.8	7.7	0.6	0.9	1.5	0.7	4.5	6.3	2.5	2.1	2.5	7.0	7.6	3.1	11.5	10.1	8.9	5.0	6.5	4.6	8.8	8.0	5.5	68.8	12.8	8.2	66.3	1.6	31.1	5.9	40.8	19.9	2.1	0.6	6.5	20.3	15.7	23.3	12.9	0.0	29.2	6.9	35.8	15.6	7.6	68.9	2.7	9.4	55.9	11.5	7.4	115.5	4.9	27.2	27.1	0.0	3.0	3.8	18.5	36.0	16.5	25.7	0.0	36.3	9.1	6.1	34.1	42.4	14.5	9.6	19.4	46.2	77.8	19.8	36.4	2.1	25.6	2.9	3.6	51.3	8.2	3.3	7.4	0.0	20.9	17.0	2.7	0.0	24.5	16.9	2.7	2.1	6.1	11.2	7.8	4.3	8.6	8.9	3.5
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.2;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 32.6;Erythroid cells: 20.4;Kupffer cells: 59.1;Macrophages: 24.9;monocytes: 13.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.7;eosinophil: 17.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 53.7"	"Group enriched"	"Detected in some"	9	"HL-60: 9.9;HMC-1: 21.8;NB-4: 9.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					NA	NA		33000000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	13.2	0.8	0.1	27.2	0.5	10.5	0.6	0.1	2.9	1.2	1.3	1.5	1.3	0.5	0.2	0.9	1.4	2.1	0.6	0.2	0.2	2.5	2.6	3.2	20.1	0.7	0.5	0.2	0.3	0.1	0.2	9.1	1.6	0.2	1.5	0.0	0.4	0.4	0.2	0.1	4.4	6.3	0.1	24.4	1.7	0.6	2.1	1.6	0.3	1.0	17.9	6.7	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	9.9	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.7	4.2	17.2	0.0	2.4	0.7	4.5	0.9	0.4	0.3	2.2	0.2	0.1	15.6	0.0	2.3	0.0	0.0	1.3	0.1	0.5	0.1	2.9	0.2	0.2	0.7	0.5	1.6	0.1	2.1	1.8	0.3	0.0	4.2	0.3	32.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.0	20.4	0.3	0.0	0.1	0.6	0.0	0.2	1.3	0.3	0.0	0.4	9.7	0.0	0.4	0.0	0.0	59.1	1.4	0.0	0.0	24.9	0.0	1.9	13.3	0.0	0.0	1.5	4.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.0	0.0
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094142-129111189	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 227.5;tongue: 201.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 181.2;Late spermatids: 521.8;Proximal enterocytes: 136.4;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		8100	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	36.1	51.3	26.4	5.4	26.6	9.0	29.2	27.0	33.8	31.7	27.5	36.1	33.0	24.8	4.0	37.3	23.1	6.6	68.2	25.1	27.8	46.9	151.2	15.2	3.2	28.8	28.2	23.0	107.1	26.3	12.3	6.6	30.6	42.2	4.2	1.7	32.8	8.9	227.5	29.6	37.2	6.8	26.7	15.2	34.0	146.4	30.2	3.1	21.5	201.3	1.6	31.3	27.5	24.4	0.1	39.3	10.7	21.3	13.4	25.9	17.0	15.0	16.6	18.9	12.0	7.8	14.0	1.5	9.2	25.9	23.2	6.7	2.2	4.9	7.2	23.6	0.3	7.3	19.1	30.4	34.1	0.0	26.1	26.3	0.0	15.7	0.9	15.8	26.2	7.2	3.6	5.7	20.0	9.1	0.5	15.9	2.8	32.0	18.0	16.8	21.8	12.2	18.0	0.6	4.2	12.1	0.0	7.1	4.8	3.4	49.7	5.5	22.6	23.0	1.6	32.1	15.4	25.5	22.6	0.1	28.8	4.2	16.8	1.6	8.4	3.5	3.2	5.5	6.7	1.5	4.4	4.3	8.6	1.3	2.6	3.1	1.1	4.4	5.6	3.9	4.5	6.1	26.4	26.6	27.0	33.8	25.1	27.8	28.8	28.2	30.6	26.7	30.2	24.4	10.5	6.4	3.7	5.5	4.9	3.2	4.7	10.8	0.6	1.5	9.7	8.1	57.8	21.5	8.2	3.7	2.1	45.9	6.0	64.5	17.6	22.6	181.2	3.5	15.7	12.9	15.5	17.4	5.3	22.4	55.6	19.3	16.8	9.9	7.0	12.9	14.6	65.7	20.7	1.7	6.1	23.6	14.2	13.9	10.5	521.8	22.1	12.4	5.4	6.5	8.3	15.5	6.2	3.5	4.0	11.6	47.6	24.5	9.6	9.3	136.4	52.0	2.8	1.3	6.6	10.5	15.7	123.5	8.6	57.4	4.5	50.3	7.6	20.1	29.3	13.8
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs cell polarity complex component 1"	P82279	1	197268204-197478455	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.3;retina: 74.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 469.5;Cone photoreceptor cells: 164.7;Inhibitory neurons: 130.1;Muller glia cells: 79.7;Oligodendrocyte precursor cells: 280.0;Oligodendrocytes: 105.6;Rod photoreceptor cells: 149.3"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 7.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 7.7"	"Cell line enriched"	"Detected in some"	8	"HeLa: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Secreted in brain"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA061250: AB_2684458, HPA063127: AB_2684944"	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	0.1	0.1	15.7	0.0	17.6	0.4	0.1	19.8	20.5	0.0	9.6	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.2	15.8	14.2	0.1	0.0	0.1	0.1	18.7	18.4	0.7	0.4	0.0	2.2	0.0	17.5	0.0	0.0	74.7	0.0	0.0	0.7	0.0	0.0	0.0	18.9	0.0	0.2	2.9	16.1	0.0	0.2	0.5	0.0	0.0	0.0	21.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	15.7	17.6	19.8	20.5	15.8	14.2	18.7	18.4	17.5	18.9	16.1	21.3	0.0	0.0	0.0	469.5	0.0	0.3	0.2	0.3	0.0	15.0	0.2	0.1	1.1	0.0	0.2	0.0	164.7	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.7	0.0	11.6	53.2	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.7	130.1	0.0	2.0	0.0	0.5	1.6	1.8	0.0	0.0	24.4	0.0	79.7	0.0	280.0	105.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.9	149.3	0.0	0.2	0.1	1.8	0.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0
CRB2	"FLJ16786, FLJ38464"	ENSG00000148204	"Crumbs cell polarity complex component 2"	Q5IJ48	9	123356170-123380324	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Gastrulation, Sensory transduction, Vision"	"Developmental protein"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.9;choroid plexus: 14.1;retina: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 40.5;Bipolar cells: 29.7;Cone photoreceptor cells: 118.9;Oligodendrocytes: 26.8;Rod photoreceptor cells: 110.1"	"Group enriched"	"Detected in some"	7	"glioma: 9.4;ovarian cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"AF22: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043674	Approved	Supported			"Intracellular and membrane"	NA	NA		210000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA043674: AB_10962974"	"unprognostic (1.38e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.56e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.38e-1)"	1.6	0.0	14.5	0.5	21.5	0.3	0.1	11.0	12.5	0.0	14.1	0.7	0.1	1.5	0.1	0.0	1.0	0.0	0.1	13.8	13.7	5.8	0.0	0.0	0.7	24.0	20.3	0.2	0.0	0.0	1.4	0.0	14.9	0.0	0.4	8.1	0.0	0.0	0.0	0.1	0.3	0.3	22.2	0.5	0.2	0.5	24.9	0.2	0.1	0.0	0.6	0.2	0.0	23.0	0.0	0.1	32.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.6	0.0	0.0	4.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	21.5	11.0	12.5	13.8	13.7	24.0	20.3	14.9	22.2	24.9	23.0	0.0	0.0	0.0	40.5	0.5	0.3	0.1	0.0	0.0	29.7	0.0	2.2	2.8	0.0	0.0	1.8	118.9	0.1	0.0	0.7	0.0	0.0	3.9	0.4	1.3	0.4	3.0	0.0	4.2	0.0	0.1	2.5	0.0	0.1	1.3	0.0	0.0	0.0	0.2	3.3	0.4	2.8	0.0	0.0	1.0	7.7	1.8	0.1	0.0	0.0	0.1	6.1	1.0	2.0	26.8	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	110.1	0.0	0.5	0.3	0.1	0.3	0.0	0.6	0.3	0.1	0.1	5.3	0.1
CREB3L2	"BBF2H7, TCAG_1951439"	ENSG00000182158	"CAMP responsive element binding protein 3 like 2"	Q70SY1	7	137874979-138002086	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 141.1;Syncytiotrophoblasts: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015068, HPA015534"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Endoplasmic reticulum"		"HPA015068: AB_1847224, HPA015534: AB_2669210"	"unprognostic (8.50e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.50e-1)"	"unprognostic (4.77e-1)"	"unprognostic (8.93e-2)"	"unprognostic (9.48e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.32e-2)"	20.7	29.7	8.3	18.5	13.9	23.8	22.8	8.3	12.2	30.3	46.5	22.4	22.3	33.9	26.8	15.0	22.6	15.0	25.9	8.1	9.6	19.6	12.5	19.3	12.8	13.2	10.8	29.0	30.1	59.5	25.1	39.4	12.1	21.6	17.6	5.0	28.7	23.2	6.1	8.7	22.9	29.2	9.6	13.0	17.4	9.0	16.1	10.0	65.3	9.4	20.4	19.5	19.9	17.3	13.1	19.9	37.6	0.6	62.9	61.7	28.1	65.1	104.0	44.4	44.7	27.5	11.7	2.6	16.8	71.1	24.1	6.9	21.9	47.1	86.9	19.1	10.8	83.4	26.7	67.6	41.4	25.3	115.5	25.4	29.2	56.0	65.3	45.5	59.7	6.5	43.8	37.4	52.9	23.5	8.0	31.6	13.6	17.9	13.7	17.5	19.8	22.1	35.3	13.2	9.4	22.3	21.1	54.0	29.1	21.7	7.9	18.9	63.1	59.5	8.7	72.3	24.2	43.9	16.2	16.9	70.9	71.3	135.0	10.4	5.5	6.0	7.3	3.0	9.8	3.9	5.4	8.2	5.7	3.9	2.0	3.4	2.0	7.2	1.6	11.9	12.5	3.2	8.3	13.9	8.3	12.2	8.1	9.6	13.2	10.8	12.1	9.6	16.1	17.3	30.6	6.4	25.9	18.6	27.3	12.2	9.7	18.9	8.0	12.0	32.0	25.4	17.5	21.5	34.9	23.9	10.4	62.6	39.5	24.7	13.7	10.2	56.3	18.1	86.6	31.6	15.7	12.0	7.5	17.6	93.0	49.6	16.3	42.4	49.4	27.8	29.6	24.3	56.3	15.2	10.6	21.0	20.3	34.9	25.6	18.7	61.8	30.7	26.6	63.7	21.4	5.4	40.2	55.8	48.0	14.4	18.2	103.0	141.1	35.1	66.2	7.9	22.4	12.3	39.5	62.3	50.2	3.4	7.4	9.5	7.1	144.5	26.6	11.1	17.0	44.0
CREG2		ENSG00000175874	"Cellular repressor of E1A stimulated genes 2"	Q8IUH2	2	101345550-101387503	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"brain: 27.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 66.0;Inhibitory neurons: 27.6;Oligodendrocytes: 12.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"amygdala: 8.7;basal ganglia: 17.2;cerebral cortex: 26.3;hippocampal formation: 27.8;white matter: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;HaCaT: 6.3;HeLa: 2.5;OE19: 7.1;PC-3: 2.4;RT4: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038224	Enhanced				"Secreted in brain"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038224: AB_10673167"	"unprognostic (5.09e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.10e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.63e-3)"	"unprognostic (9.68e-3)"	"unprognostic (4.52e-8)"	"unprognostic (3.86e-4)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.26e-3)"	"unprognostic (7.77e-2)"	0.0	0.1	8.7	0.0	17.2	0.1	0.0	0.0	26.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	27.8	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.7	9.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	2.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.7	17.2	0.0	26.3	27.8	0.0	1.3	0.0	0.6	0.0	1.4	9.0	0.0	0.0	0.0	2.9	0.0	0.0	0.6	0.5	0.0	0.8	0.1	0.1	0.9	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.5	0.0	0.0	66.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.1	2.0	0.0	0.0	6.5	0.0	0.2	0.0	6.5	0.0	0.8	0.0	2.5	12.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.5	0.0	0.2	0.1	1.5	5.6	0.5	0.0	0.1	0.0	0.2	0.0	1.5
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76953045-76981158	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 166.5"	"Group enriched"	"Detected in some"	6	"Granulosa cells: 480.8;Hepatic stellate cells: 1319.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 4.4;BJ hTERT+ SV40 Large T+ RasG12V: 4.4;HBF TERT88: 7.7;hTEC/SVTERT24-B: 2.6;RPMI-8226: 2.5;U-698: 7.6;U-87 MG: 4.3;WM-115: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"	NA	NA		69000000		"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	22.2	13.7	4.1	0.7	5.6	3.2	6.2	3.2	7.5	3.7	2.2	0.4	0.6	2.6	0.9	0.2	1.8	0.8	7.4	5.8	15.8	36.5	166.5	0.5	0.9	7.0	9.1	1.3	0.1	0.6	0.1	10.2	11.9	1.1	0.4	0.1	1.1	4.1	0.9	0.5	0.7	1.5	3.7	37.2	0.3	0.8	20.1	0.5	4.1	1.3	0.6	0.9	0.8	7.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	4.4	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	7.6	4.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.1	5.6	3.2	7.5	5.8	15.8	7.0	9.1	11.9	3.7	20.1	7.0	134.9	0.0	0.0	1.3	8.8	0.4	0.0	0.0	0.0	0.0	0.4	1.1	0.7	17.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	45.9	0.0	39.4	0.8	0.2	0.2	0.3	0.0	0.0	0.0	480.8	1319.7	9.9	1.8	0.0	32.4	0.0	0.0	75.0	2.1	1.0	0.3	3.8	0.0	4.7	0.3	0.0	0.0	0.5	11.1	0.0	0.0	0.0	0.9	0.0	0.0	3.6	0.0	0.0	0.0	0.1	2.3	0.5	1.9	0.1	0.0	0.0	1.7	0.0	0.0	0.1
CRISP2	"CRISP-2, CT36, GAPDL5, TPX1"	ENSG00000124490	"Cysteine rich secretory protein 2"	P16562	6	49692358-49713590	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"testis: 505.0"	"Group enriched"	"Detected in some"	33	"Early spermatids: 5765.5;Late spermatids: 21517.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031248	Enhanced				"Secreted in male reproductive system"	NA	NA		820000		"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA031248: AB_10602211"	"unprognostic (1.10e-1)"							"unprognostic (1.51e-1)"		"unprognostic (1.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.35e-2)"		"unprognostic (9.23e-3)"	"unprognostic (4.05e-2)"			0.1	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	1.9	0.7	0.0	0.1	0.2	0.9	3.6	17.6	7.7	0.1	0.0	0.2	0.8	0.2	1.2	0.0	0.1	0.1	0.1	0.6	0.0	2.0	0.0	0.0	1.2	0.0	0.1	15.6	2.5	0.2	0.5	0.3	0.0	0.0	0.5	0.1	505.0	0.1	0.0	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.3	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5765.5	17.8	0.5	6.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	21517.6	133.9	6.1	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	83.8	0.0	2.8	0.2	0.1	24.1	0.0	65.7	0.0	0.0	409.8	65.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3
CRYBB1		ENSG00000100122	"Crystallin beta B1"	P53674	22	26599278-26618027	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 9.6"	"Cell type enriched"	"Detected in some"	21	"Hofbauer cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 10.3;non-classical monocyte: 7.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 10.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 43.3;RPMI-8226: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA003448, CAB010058"	Supported					NA	NA		89000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB010058: AB_668166, HPA003448: AB_2732396"	"unprognostic (1.31e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-2)"	1.3	1.6	1.5	0.9	1.6	0.6	0.6	1.6	2.4	0.6	1.3	0.5	0.4	0.3	9.6	0.4	0.4	1.2	0.4	1.6	1.6	0.2	0.4	0.5	1.2	1.9	1.8	0.2	0.2	0.3	0.5	3.3	2.3	0.2	0.4	0.0	0.4	0.2	0.1	0.1	0.4	0.9	1.9	1.6	0.3	0.3	2.2	0.4	0.2	0.2	0.5	1.1	0.2	2.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	1.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	43.3	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.8	0.0	82.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.2	0.5	0.0	0.0	0.7	0.2	1.8	0.0	2.2	0.0	0.0	1.0	0.0	0.0	10.3	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.5	7.5	0.0	0.0	0.6	1.5	1.6	1.6	2.4	1.6	1.6	1.9	1.8	2.3	1.9	2.2	2.1	0.1	0.0	0.0	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.9	0.0	0.5	0.2	0.0	0.1	1.3	0.0	0.0	0.2	82.6	0.0	0.2	0.0	0.0	3.5	0.8	0.6	0.0	2.8	1.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.2	0.0	0.0
CRYBB3	CRYB3	ENSG00000100053	"Crystallin beta B3"	P26998	22	25199858-25207359	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 2.6;Distal tubular cells: 1.9;granulocytes: 4.5;Muller glia cells: 4.3;Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.4;HEK 293: 1.4;HeLa: 1.8;hTERT-HME1: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA055840	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA055840: AB_2682939"	"unprognostic (1.36e-2)"	"unprognostic (6.27e-4)"	"unprognostic (6.30e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.20e-3)"	0.2	0.5	0.9	0.1	0.6	0.0	0.7	0.0	1.0	0.5	0.0	0.6	0.3	0.3	0.2	0.6	0.4	0.4	0.5	0.9	0.0	2.0	2.0	0.3	0.1	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.8	0.4	0.7	1.0	0.4	0.7	0.9	0.7	0.1	0.0	0.1	0.5	0.2	0.5	0.2	1.3	0.1	0.3	0.1	0.4	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.2	1.4	0.8	0.6	0.0	0.0	1.4	0.0	1.8	1.0	0.0	0.0	0.0	0.0	0.7	0.4	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	1.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.5	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	1.0	0.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.6	0.3	0.4	1.5	0.1	0.0	0.0	0.0	0.0	2.6	1.9	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.3	10.5	0.4	0.3	0.0	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.1	0.0	0.3	0.1
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428832-151440813	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"thyroid gland: 15.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.3;Breast myoepithelial cells: 1.1;Endometrial stromal cells: 1.4;Oligodendrocyte precursor cells: 1.0"	"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.1;white matter: 11.4"	"Not detected"	"Not detected"			HPA050788	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.8	0.2	0.9	0.1	0.6	0.1	0.5	0.2	0.7	1.7	1.4	0.9	0.1	0.9	0.1	0.1	0.9	0.2	0.1	0.9	0.3	0.4	0.0	0.1	0.6	0.2	0.1	0.7	0.2	1.3	1.2	0.3	0.1	0.7	0.0	0.2	0.2	3.3	0.0	0.0	0.3	0.1	0.1	1.0	0.2	0.1	0.3	0.1	15.4	0.0	0.0	1.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.6	0.2	0.7	0.9	0.3	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 329.8;liver: 254.1"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 485.2;Hepatocytes: 306.1;Proximal enterocytes: 509.9;Proximal tubular cells: 1033.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040403, HPA058848"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA		690000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632, HPA058848: "	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	33.7	31.8	69.5	15.4	81.3	11.2	27.1	75.4	78.1	33.0	65.6	62.1	190.2	30.5	51.7	24.7	26.5	30.0	30.4	65.2	79.0	329.8	254.1	19.9	19.4	76.3	71.9	19.8	46.9	31.4	38.1	16.1	76.1	32.2	49.3	20.7	41.6	36.5	17.0	16.3	131.6	22.8	77.2	23.3	45.2	4.9	71.9	18.0	35.0	20.7	16.3	20.9	23.6	89.8	8.1	6.9	6.4	42.7	31.6	36.1	5.8	11.1	20.0	4.8	3.9	2.6	7.8	0.1	20.6	15.5	10.9	1.9	5.7	9.9	4.9	19.4	4.7	14.2	0.8	55.1	18.1	4.6	12.2	21.5	6.4	3.9	22.0	17.1	51.7	20.3	1.0	5.8	12.7	29.2	12.7	7.2	0.4	68.7	10.2	6.4	3.8	1.0	40.8	16.9	4.2	5.0	6.6	3.1	51.0	3.0	21.2	18.0	50.1	5.8	2.6	14.3	7.1	7.6	1.6	0.0	11.1	7.9	24.5	5.8	50.7	3.2	23.2	59.6	18.9	20.5	30.6	22.1	60.5	23.1	23.5	22.2	1.7	15.6	50.6	6.4	37.5	43.8	69.5	81.3	75.4	78.1	65.2	79.0	76.3	71.9	76.1	77.2	71.9	89.8	29.2	6.4	10.3	57.8	17.7	10.3	15.9	29.7	6.2	6.1	22.0	11.6	10.5	35.8	25.6	77.3	12.5	22.0	10.0	138.5	485.2	26.1	3.6	32.5	8.8	29.1	9.1	6.9	54.5	31.6	11.2	29.8	34.1	27.2	25.3	8.8	50.7	306.1	71.4	1.7	35.3	89.0	32.6	91.6	34.3	4.3	26.1	51.3	37.4	13.1	19.3	112.2	9.2	33.7	114.1	43.2	219.1	24.0	14.3	23.0	509.9	1033.9	20.9	12.6	19.7	23.4	14.7	1.0	2.7	13.0	9.2	20.8	20.1	20.7	105.2	15.0
CRYM	DFNA40	ENSG00000103316	"Crystallin mu"	Q14894	16	21238874-21303083	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.7;heart muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.0;Ionocytes: 114.0;Muller glia cells: 640.7;Proximal tubular cells: 190.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 82.0"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 82.0"	"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 100.3"	"Group enriched"	"Detected in all"	11	"amygdala: 124.0;basal ganglia: 275.1;cerebral cortex: 124.7;hippocampal formation: 324.3;white matter: 128.4"	"Low region specificity"	"Detected in all"			"HPA019086, HPA030619"	Enhanced		Supported	Cytosol		NA	NA		150000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA019086: AB_1847260, HPA030619: AB_2673551"	"unprognostic (1.32e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.11e-3)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.31e-1)"	1.9	0.8	37.4	0.9	78.7	1.0	2.7	40.6	62.2	3.7	13.6	6.9	1.6	1.0	0.2	7.6	1.1	7.0	175.3	54.0	31.6	64.4	14.2	8.5	1.1	13.9	19.8	0.3	1.8	8.9	55.6	0.4	15.6	35.4	8.4	54.7	20.6	0.2	13.4	4.1	2.6	0.3	14.1	0.3	1.3	5.1	20.5	0.3	0.4	0.9	3.8	21.8	3.6	31.3	0.2	4.0	0.0	0.0	0.2	0.4	0.7	0.0	2.1	0.1	0.2	0.2	0.2	0.3	1.0	0.0	1.8	0.6	5.4	0.0	0.0	0.0	0.8	23.2	0.1	2.3	0.0	0.1	2.2	0.8	0.0	0.8	1.0	0.0	0.0	0.5	0.0	0.4	0.7	0.3	0.0	0.9	9.7	1.6	0.1	0.1	0.0	0.5	100.3	0.1	3.7	5.2	0.2	0.1	2.6	4.8	0.1	0.0	0.0	0.5	0.7	6.8	0.0	0.2	0.0	0.5	16.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.1	3.9	0.0	0.0	0.3	0.0	0.0	82.0	0.0	1.2	37.4	78.7	40.6	62.2	54.0	31.6	13.9	19.8	15.6	14.1	20.5	31.3	0.3	0.0	20.1	5.2	4.1	2.3	25.4	16.3	0.0	6.3	0.4	11.7	126.0	2.8	56.1	14.7	4.2	0.0	11.4	7.1	17.6	0.1	19.7	3.2	1.5	3.0	13.1	4.8	43.8	0.0	0.0	7.1	6.1	7.7	1.3	1.3	0.4	8.3	0.1	1.7	5.9	20.6	114.0	1.6	0.7	12.4	0.0	1.5	33.8	10.3	0.7	640.7	0.0	7.1	6.6	0.4	2.8	0.0	0.3	19.0	7.5	190.1	19.9	26.2	0.0	0.2	4.3	6.7	7.3	0.2	1.3	0.1	1.1	0.1	8.2	68.0
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41561010-41577741	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 143.8;heart muscle: 288.2;ovary: 133.6"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 75.0;Distal tubular cells: 19.6;Granulosa cells: 30.7;Muller glia cells: 51.7;Proximal tubular cells: 42.5;Sertoli cells: 72.3;Smooth muscle cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 12.4;U-2 OS: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA003073: AB_1078578, HPA076549: AB_2686807"	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	6.8	143.8	29.4	1.6	21.8	0.1	3.2	64.5	32.1	69.9	4.1	16.5	0.8	83.5	1.4	3.2	24.1	2.3	288.2	30.5	35.3	40.4	2.6	11.5	0.2	44.4	41.0	133.6	51.1	0.0	20.5	0.4	36.9	26.2	0.5	5.2	1.0	10.4	2.7	2.1	3.2	10.9	26.1	1.1	4.5	31.3	44.9	0.0	2.5	2.7	0.0	27.4	29.0	22.7	0.0	0.2	1.5	0.2	0.0	0.0	0.1	3.4	0.2	0.1	0.1	0.9	0.0	0.0	0.5	4.7	0.5	0.1	0.0	0.0	0.0	0.0	2.9	0.0	12.4	1.5	3.5	0.0	0.0	1.9	0.1	0.0	0.0	3.5	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.1	1.1	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.1	41.8	0.3	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	29.4	21.8	64.5	32.1	30.5	35.3	44.4	41.0	36.9	26.1	44.9	22.7	0.1	0.0	0.0	4.6	0.5	0.3	0.2	0.3	0.6	9.9	0.1	0.6	75.0	0.0	0.0	7.3	2.1	0.1	0.0	0.0	19.6	0.3	1.5	0.2	6.0	0.9	0.0	0.0	6.8	10.4	0.1	5.1	0.0	0.1	0.0	30.7	0.4	0.2	0.2	6.7	11.0	0.0	0.0	0.0	0.0	5.1	5.3	0.3	1.8	0.0	0.0	51.7	0.0	1.0	0.6	2.4	0.0	2.6	0.0	0.2	0.0	42.5	0.7	3.2	72.3	0.4	19.9	2.1	0.3	0.0	0.1	0.3	0.2	0.3	0.0	0.0
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.3;placenta: 103.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 103.2;Hofbauer cells: 340.4;Kupffer cells: 291.2;Langerhans cells: 73.4;Macrophages: 196.3;Microglial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 444.6;non-classical monocyte: 646.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 646.9"	"Group enriched"	"Detected in some"	4	"BEWO: 123.0;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	51.3	31.0	19.6	75.1	17.1	5.6	19.3	20.2	21.4	21.6	19.3	21.9	24.3	12.1	5.8	21.0	17.2	40.6	16.6	19.8	33.8	7.1	27.5	36.6	54.4	41.4	35.5	12.7	9.9	11.8	5.7	103.3	40.1	9.1	21.5	1.5	10.1	20.8	3.2	13.4	37.3	41.9	36.6	113.3	21.0	7.0	40.6	14.3	6.0	11.8	21.7	42.6	3.8	67.6	4.5	0.2	0.0	0.0	1.9	0.4	123.0	0.2	0.2	0.0	0.0	3.8	0.0	5.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.1	3.0	0.0	6.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.1	0.1	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.2	0.2	0.0	47.8	0.0	1.9	0.0	20.7	0.0	0.8	0.2	0.1	3.3	0.0	0.3	0.1	6.6	2.6	0.0	3.0	138.4	4.0	0.6	444.6	0.6	0.3	0.2	0.4	139.0	0.2	0.3	0.2	21.6	0.2	646.9	11.1	0.5	132.7	19.6	17.1	20.2	21.4	19.8	33.8	41.4	35.5	40.1	36.6	40.6	67.6	2.0	0.0	3.8	0.0	4.3	2.8	0.0	0.0	1.2	0.0	0.5	2.3	3.1	4.3	0.0	0.0	0.0	6.2	2.8	0.0	0.0	0.0	4.8	0.0	0.1	10.5	0.0	2.5	0.4	0.0	103.2	2.2	1.5	0.2	2.5	8.3	2.9	1.5	340.4	0.0	0.5	0.3	0.0	291.2	73.4	5.4	1.8	196.3	3.6	134.9	39.4	0.0	1.0	1.5	0.3	0.1	1.7	0.0	1.0	0.0	0.0	0.1	0.7	0.5	13.1	1.2	2.0	2.2	0.2	0.4	1.3	26.4	1.3	2.2	0.2	0.0
CSRP1	"CSRP, CYRP, D1S181E"	ENSG00000159176	"Cysteine and glycine rich protein 1"	P21291	1	201483530-201509456	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 2743.3;seminal vesicle: 2571.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 341.2;Breast myoepithelial cells: 737.5;Extravillous trophoblasts: 388.5;Smooth muscle cells: 419.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					NA	NA		11000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA045617: AB_2679391"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.96e-3)"	344.5	127.2	713.6	224.5	871.4	41.0	321.8	742.5	717.3	542.4	467.6	2743.3	180.6	1904.4	308.4	884.1	1025.6	152.7	194.2	647.3	735.1	192.5	114.7	386.0	64.9	840.1	837.4	319.0	114.6	188.0	117.0	118.3	719.0	947.2	432.0	24.2	250.1	2571.3	64.0	219.8	503.6	2009.6	713.5	165.6	748.3	44.2	848.5	48.0	186.4	53.8	65.7	1494.5	469.1	766.6	83.0	195.3	52.0	116.4	83.2	107.7	273.6	605.7	514.3	455.3	360.9	211.1	57.7	78.7	36.1	325.0	96.7	144.7	32.7	120.3	321.2	169.5	29.3	90.7	220.1	30.7	387.4	72.1	10.2	99.3	105.3	373.0	163.1	253.1	508.1	34.9	4.5	71.9	302.1	232.9	46.6	11.8	0.8	99.0	73.2	18.3	304.9	266.8	212.6	129.7	27.1	22.5	238.0	503.8	163.9	25.6	87.0	74.3	610.6	303.7	195.7	206.6	250.6	40.5	82.6	30.6	303.5	137.6	202.6	75.5	49.8	65.6	37.4	49.3	36.9	25.0	35.8	34.9	65.0	18.1	20.5	25.2	5.0	34.3	54.2	5.2	54.1	46.5	713.6	871.4	742.5	717.3	647.3	735.1	840.1	837.4	719.0	713.5	848.5	766.6	151.8	38.5	47.8	86.5	21.8	49.2	341.2	24.6	207.7	3.4	123.7	737.5	24.8	21.5	36.9	47.8	0.0	88.8	23.3	96.6	49.0	165.1	21.5	30.1	73.6	86.9	57.9	19.1	2.4	171.7	388.5	86.7	36.7	38.9	27.9	13.9	91.1	28.3	66.0	0.0	2.1	80.0	14.2	29.1	55.8	44.9	41.0	37.0	126.3	10.3	73.5	137.4	15.5	6.6	114.8	140.5	71.4	292.3	61.5	113.8	97.2	28.4	25.2	3.1	144.7	37.7	419.9	2.4	3.2	75.3	34.9	160.9	31.2	30.4	69.7	103.6
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 4217.6"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 18746.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4"	"Group enriched"	"Detected in all"	9	"dendritic cells: 7959.0;monocytes: 6424.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1733.4;ASC TERT1: 1179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	2800000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	1046.2	707.6	3041.2	262.3	3117.9	170.8	900.3	2823.3	4217.6	587.8	3094.8	788.7	389.6	708.3	875.9	557.1	802.7	583.0	1275.3	2976.3	2707.6	517.4	833.6	595.8	463.5	3258.4	3096.2	575.8	944.1	320.0	670.1	165.9	2939.3	773.9	416.9	46.9	2008.0	441.5	749.0	497.1	800.3	367.6	3028.1	723.7	979.9	761.3	3302.7	418.9	658.8	517.4	208.1	703.0	618.4	2883.1	155.2	328.2	75.4	175.8	1733.4	1179.8	145.3	261.4	350.7	170.3	137.7	625.1	219.7	0.8	241.0	345.2	221.3	496.2	69.6	499.9	51.9	0.9	253.5	157.6	61.1	1082.9	621.2	7.5	251.0	919.0	415.9	226.6	241.5	352.5	268.5	18.5	147.6	4.0	239.5	234.4	1.5	162.2	103.5	461.9	752.2	5.7	96.4	215.2	708.0	328.3	84.7	98.2	191.1	54.6	343.3	107.7	156.5	548.2	702.0	163.4	119.0	231.6	97.7	157.1	6.2	1.8	138.0	339.5	184.0	48.1	4967.5	33.2	66.9	6424.5	25.5	23.1	18.3	45.8	7959.0	13.6	16.9	31.1	809.3	191.4	4297.7	4427.4	13.6	4250.8	3041.2	3117.9	2823.3	4217.6	2976.3	2707.6	3258.4	3096.2	2939.3	3028.1	3302.7	2883.1	662.4	115.4	168.8	849.5	93.8	942.9	571.1	568.2	213.9	152.4	660.2	512.1	240.7	1361.2	514.5	641.9	29.2	476.8	603.3	1889.9	414.8	489.9	46.2	441.1	795.0	728.2	882.1	252.1	4.5	783.6	308.7	3026.2	981.7	631.0	359.9	687.0	491.9	2563.0	1816.7	48.8	11.2	1360.6	691.7	4301.1	18746.6	184.3	2132.6	4542.6	1563.5	87.1	2025.6	248.7	99.9	263.9	6.0	1458.5	2342.1	1790.4	67.9	786.0	4301.1	1098.6	364.4	36.3	2195.7	1417.0	846.2	125.5	400.6	461.5	822.0	469.0	117.4	208.1	1039.4	1079.7
CTCF	"CFAP108, FAP108"	ENSG00000102974	"CCCTC-binding factor"	P49711	16	67562467-67639177	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Chromosome partition, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004122, CAB062550, CAB068181, CAB068182"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB062550: AB_2665624, CAB068181: AB_2665625, CAB068182: AB_2665626, HPA004122: AB_2667139"	"unprognostic (2.70e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (3.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-2)"	17.3	14.5	10.6	20.6	12.2	34.6	17.5	17.4	12.7	21.3	7.4	18.9	15.9	20.8	13.8	20.2	19.9	14.6	15.9	10.7	11.9	18.4	18.7	16.4	29.0	10.3	10.2	22.3	18.4	28.3	12.9	20.4	10.3	17.2	21.6	18.4	17.1	17.7	30.5	23.3	19.4	20.3	9.0	22.7	18.3	10.5	10.2	69.6	19.3	28.4	35.4	19.7	20.0	16.2	34.6	51.2	66.9	26.7	29.9	25.5	54.2	32.4	33.6	45.9	43.5	42.3	34.5	106.6	26.0	27.7	26.2	43.8	65.3	35.7	51.5	38.5	44.0	63.9	28.5	49.3	20.4	73.7	59.7	20.8	42.5	34.6	38.2	27.5	35.5	83.1	57.7	43.3	38.6	66.7	156.8	27.4	58.3	38.7	34.5	113.5	54.9	58.7	28.2	48.7	57.0	40.0	57.3	33.2	27.9	35.2	41.0	45.3	33.8	39.3	41.3	30.5	35.7	38.6	52.6	151.2	23.1	43.1	43.1	6.8	2.3	3.4	4.3	2.4	4.1	5.5	4.8	3.5	2.1	7.4	3.8	4.4	6.8	3.5	4.8	5.6	3.9	1.4	10.6	12.2	17.4	12.7	10.7	11.9	10.3	10.2	10.3	9.0	10.2	16.2	38.0	22.4	29.8	19.9	50.4	22.3	24.3	11.4	35.3	35.5	35.6	33.9	32.6	27.1	28.1	23.9	8.4	27.4	54.0	29.2	19.6	31.3	2.1	29.8	43.9	37.3	31.2	52.6	23.0	33.6	33.7	29.9	27.0	40.2	19.6	39.1	23.9	24.0	24.0	45.4	24.2	26.4	16.2	26.7	12.6	3.6	24.8	31.1	12.4	32.8	29.2	32.3	49.4	17.1	32.8	32.5	16.5	28.6	62.6	35.6	18.8	24.5	16.7	27.6	19.7	38.6	41.4	18.4	27.3	38.8	24.7	29.6	47.9	32.6	23.8	30.0
CTLA4	"CD, CD152, CELIAC3, CTLA-4, GSE, IDDM12"	ENSG00000163599	"Cytotoxic T-lymphocyte associated protein 4"	P16410	2	203867771-203873965	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Diabetes mellitus, Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 37.4"	"Cell type enriched"	"Detected in some"	8	"T-cells: 41.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	7	"T-reg: 44.5"	"Lineage enriched"	"Detected in single"	445	"T-cells: 44.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.5;SK-MEL-30: 3.0;U-266/70: 4.3;U-266/84: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.92e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.47e-3)"	"unprognostic (9.89e-6)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.76e-1)"	"unprognostic (9.86e-10)"	"unprognostic (4.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-2)"	1.1	0.2	0.4	18.5	0.4	6.1	1.0	0.4	0.7	0.6	0.5	1.3	0.3	0.3	0.0	1.6	0.6	5.2	0.5	0.5	0.5	0.6	0.7	2.9	37.4	1.3	0.7	0.1	0.4	0.5	0.3	0.3	1.1	1.5	3.2	0.0	0.5	1.0	0.1	0.7	6.2	0.8	0.6	3.9	2.9	1.1	0.5	10.1	1.1	0.2	17.0	5.8	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	4.3	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	6.2	0.8	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	44.5	0.6	0.4	0.4	0.4	0.7	0.5	0.5	1.3	0.7	1.1	0.6	0.5	0.5	0.4	0.0	3.2	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	4.1	0.0	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	3.3	0.0	2.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	1.0	0.2	0.9	0.1	41.9	0.0	0.0	0.1
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 368.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 445.6;Proximal enterocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 856.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		28000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	80.4	368.3	56.8	75.3	58.1	75.6	61.9	63.6	65.6	47.6	96.0	178.6	100.9	55.1	39.0	60.4	39.3	89.7	97.2	59.7	63.8	188.1	95.7	90.9	61.6	62.6	59.1	62.2	52.9	104.4	43.8	76.4	61.4	38.5	170.4	44.0	61.3	48.4	56.0	95.2	109.2	67.3	59.4	108.5	63.3	33.5	70.2	23.0	47.4	61.7	58.8	82.8	49.2	68.4	111.9	114.1	17.6	89.2	856.5	438.6	47.0	150.3	424.0	169.6	217.5	214.4	291.8	24.1	176.2	299.9	638.1	168.6	55.9	105.6	95.7	47.6	53.6	54.3	53.4	375.9	187.3	98.0	240.9	349.0	123.6	107.9	22.5	421.9	190.1	28.2	61.0	355.1	186.9	232.1	25.8	82.4	19.4	172.6	272.1	37.8	107.3	135.7	138.2	96.7	36.9	37.8	263.2	450.3	444.4	51.5	108.5	141.8	172.5	335.0	76.2	178.9	123.7	162.1	238.5	15.7	599.3	128.6	142.4	480.7	305.9	530.5	44.9	168.8	185.5	42.0	75.6	78.3	102.4	25.7	26.6	39.8	152.4	81.2	120.1	40.6	155.4	378.1	56.8	58.1	63.6	65.6	59.7	63.8	62.6	59.1	61.4	59.4	70.2	68.4	53.7	35.3	32.6	26.1	38.2	24.2	38.9	88.8	17.6	58.4	18.4	15.9	12.6	65.8	64.1	71.7	60.5	104.1	27.5	445.6	39.2	246.0	3.3	22.3	39.5	56.0	54.0	22.1	20.4	166.4	109.2	86.8	29.6	62.4	9.5	50.8	102.1	67.9	297.1	47.1	25.2	74.5	95.6	177.1	25.1	4.8	32.9	273.1	112.1	12.2	135.6	86.6	37.0	7.1	10.2	135.0	216.0	27.4	41.9	18.6	301.8	245.8	34.2	46.1	26.3	33.7	54.5	15.3	31.9	24.0	22.9	144.1	49.1	91.3	113.9	36.2
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	443.9	304.5	65.6	399.7	71.2	87.0	249.0	65.9	77.2	583.2	101.0	312.4	120.8	379.2	116.9	421.6	368.4	230.6	447.0	64.7	95.5	420.6	497.2	428.9	289.6	100.4	90.8	169.1	135.4	79.6	156.8	253.2	107.4	255.5	159.3	33.6	437.3	156.6	237.4	184.7	260.2	316.1	91.9	521.1	194.3	33.2	204.5	60.9	1150.7	99.3	104.0	431.9	477.8	159.2	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	65.6	71.2	65.9	77.2	64.7	95.5	100.4	90.8	107.4	91.9	204.5	159.2	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 349.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8"	"Group enriched"	"Detected in all"	5	"B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		8700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	34.3	36.4	29.4	100.6	30.2	36.9	48.8	29.9	47.1	112.8	31.4	32.5	77.8	46.7	26.8	37.9	57.6	104.6	51.3	29.6	32.9	238.2	89.5	349.6	191.8	30.8	31.4	30.0	75.5	77.6	10.1	25.7	31.5	59.7	27.3	4.7	63.0	70.7	16.3	48.4	56.7	43.1	30.7	51.8	93.9	10.1	32.7	51.8	27.7	37.7	131.3	202.2	30.6	32.4	122.0	10.0	1.2	30.5	5.4	0.5	20.3	8.6	3.0	13.9	7.0	17.6	306.4	34.6	12.6	0.0	13.5	228.2	5.2	52.6	10.1	183.0	0.4	3.0	1.3	38.4	12.1	0.4	7.1	5.6	10.7	0.2	0.0	59.4	1.0	5.9	76.0	0.0	17.9	2.8	32.6	87.8	8.9	197.4	4.9	0.3	0.4	5.9	49.9	362.1	2.6	5.2	41.5	27.8	75.4	10.1	12.5	48.0	16.4	0.2	6.2	0.0	5.3	0.8	92.4	19.5	0.1	89.2	12.3	0.0	208.5	2.0	7.6	137.7	29.7	83.3	20.5	7.4	183.6	56.0	1.8	3.8	8.7	3.2	94.8	22.9	18.3	147.5	29.4	30.2	29.9	47.1	29.6	32.9	30.8	31.4	31.5	30.7	32.7	32.4	169.8	237.2	1569.9	59.1	127.4	24.2	280.7	363.9	30.1	1.3	45.5	41.7	26.2	358.9	258.7	367.8	4.2	19.8	8.1	9.1	84.1	225.0	25.3	67.0	86.0	124.5	9.1	3.0	2.2	142.0	39.6	53.8	106.0	42.8	32.8	2.7	14.3	115.5	256.7	0.0	2.9	18.6	101.7	177.8	259.6	22.6	73.0	350.4	80.0	15.9	360.9	22.6	5.2	1.5	1.1	84.6	16.0	6.0	155.8	112.0	153.0	523.2	261.6	6.6	19.7	4.5	22.3	12.3	56.4	41.6	18.6	23.4	29.4	17.8	40.1	340.4
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029677-97156556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 643.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 63.7;Cytotrophoblasts: 122.3;Extravillous trophoblasts: 153.0;Granulosa cells: 54.2;Syncytiotrophoblasts: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.1"	"Group enriched"	"Detected in many"	8	"BEWO: 592.6;SuSa: 739.0"					"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.2	0.2	0.6	0.3	0.7	0.3	5.8	0.8	1.6	43.1	0.8	2.9	1.1	2.8	1.7	19.8	1.3	0.5	0.1	0.6	0.5	21.3	0.2	0.9	0.1	0.7	0.6	0.2	2.1	1.4	1.5	16.8	0.6	0.7	3.2	17.2	9.4	0.1	0.7	52.5	0.4	0.8	0.5	0.2	2.8	65.8	0.6	643.6	1.3	0.1	6.0	0.4	20.1	1.0	37.1	5.2	12.1	33.1	0.6	0.0	592.6	0.5	0.0	7.1	4.7	81.0	37.7	0.3	2.8	0.5	50.5	67.2	58.8	43.9	9.7	0.1	4.4	0.8	1.9	3.1	0.2	0.1	3.3	0.0	9.2	1.5	0.8	0.9	2.4	8.5	0.5	0.2	14.4	15.2	0.9	0.3	76.2	78.9	10.7	0.0	27.3	0.1	11.4	3.7	2.4	3.6	39.1	13.1	13.2	739.0	21.1	3.2	0.0	1.0	23.6	0.2	3.5	5.7	20.6	0.8	1.6	0.4	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.2	3.3	0.0	15.1	0.0	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.7	0.6	0.6	0.5	0.6	1.0	0.9	0.0	1.1	0.3	0.9	30.3	13.0	63.7	19.9	4.6	13.1	9.9	1.3	0.0	17.4	1.8	10.4	122.3	6.9	4.7	1.9	1.8	2.6	15.0	2.9	1.8	1.8	0.0	0.6	0.8	153.0	3.2	0.0	24.0	0.0	54.2	0.4	0.0	13.6	0.0	0.9	1.5	10.2	0.8	3.0	8.2	4.1	2.4	0.0	0.0	0.2	6.5	0.0	0.0	3.5	0.5	10.5	1.2	0.0	8.1	0.1	22.1	4.2	36.6	6.6	1.4	3.6	46.7	33.7	8.2	11.9	67.3	0.5	0.7	4.2	8.4
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.3;lymphoid tissue: 42.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1"	"Group enriched"	"Detected in all"	39	"NK-cells: 2276.1;T-cells: 1376.3"	"Group enriched"	"Detected in some"	22	"HEL: 156.7;NB-4: 363.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB016345, HPA066903"	Enhanced				"Intracellular and membrane"	NA	NA		270000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB016345: AB_626813, HPA066903: "	"prognostic favorable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.1	2.9	0.8	12.9	0.9	116.3	3.7	1.8	1.6	2.6	0.6	5.6	6.1	6.7	2.8	3.1	4.0	6.2	2.9	0.8	0.9	2.1	6.5	24.0	29.5	1.6	0.7	2.4	1.8	0.5	1.1	3.3	1.2	2.1	6.3	0.0	9.1	3.9	1.3	2.7	6.1	2.7	1.2	42.4	8.3	1.2	1.1	7.8	3.2	0.4	13.9	8.6	2.5	1.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	156.7	0.3	0.0	0.0	11.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.0	9.1	0.2	0.2	1.9	363.4	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	5.6	0.1	0.0	0.1	0.4	0.1	0.3	0.5	0.0	0.2	9.9	0.3	46.4	3.4	4.8	1376.3	4.0	869.4	5.1	145.3	892.8	37.6	3.7	86.0	636.3	25.7	2276.1	5.4	23.3	23.7	809.3	0.8	0.9	1.8	1.6	0.8	0.9	1.6	0.7	1.2	1.2	1.1	1.1	5.1	0.0	4.2	0.0	9.7	4.6	0.4	0.0	1.8	0.0	2.3	2.2	0.4	2.8	1.4	0.0	0.0	0.4	717.8	0.3	0.0	0.3	2.0	0.9	0.9	1.9	0.0	44.1	0.0	0.0	0.2	4.0	12.8	1.1	71.7	0.1	5.7	1.6	1.9	0.0	0.0	0.2	0.0	5.6	34.1	11.1	0.0	9.9	17.8	0.0	6.1	0.0	867.2	0.0	0.2	0.0	0.0	0.0	57.7	0.3	0.0	1.1	0.8	0.0	0.0	1.6	1.9	0.3	1.2	0.8	6.3	0.3	352.6	0.1	0.3	0.3
CTXN3		ENSG00000205279	"Cortexin 3"	Q4LDR2	5	127649044-127658630	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 79.8"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 201.3"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"													NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"								"unprognostic (7.32e-2)"	"unprognostic (9.88e-2)"		"unprognostic (1.19e-1)"				"unprognostic (1.29e-1)"	"unprognostic (6.20e-3)"					0.0	0.0	3.1	0.0	4.2	0.0	0.0	1.9	10.2	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	4.8	79.8	0.0	0.1	0.0	8.3	11.8	0.0	0.0	0.2	5.3	0.0	10.2	0.5	0.0	0.2	0.2	0.0	12.9	0.0	0.0	0.0	2.6	0.0	0.0	0.1	5.3	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	4.2	1.9	10.2	5.1	4.8	8.3	11.8	10.2	2.6	5.3	3.6	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	23.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	201.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CUBN	"gp280, IFCR, MGA1"	ENSG00000107611	Cubilin	O60494	10	16823966-17129811	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 140.4"	"Group enriched"	"Detected in many"	7	"Proximal enterocytes: 257.7;Proximal tubular cells: 325.0"	"Cancer enriched"	"Detected in some"	15	"renal cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 14.8;ASC TERT1: 3.0;SK-MEL-30: 2.8;WM-115: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004133, HPA043854"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA004133: AB_2732398, HPA043854: AB_2732510"	"unprognostic (1.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-3)"	"unprognostic (8.61e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.24e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.93e-1)"	0.7	0.8	0.8	0.4	0.9	0.4	0.8	0.8	0.7	1.2	1.3	0.5	0.2	0.7	3.1	0.2	2.1	0.3	0.6	0.8	0.8	140.4	0.1	0.6	0.8	2.5	1.7	2.5	0.5	0.6	2.2	2.6	2.4	1.1	0.2	3.0	0.7	0.4	0.3	0.8	28.0	0.4	1.7	0.9	0.4	2.0	1.0	1.7	3.8	0.5	0.7	0.4	0.7	0.6	0.0	0.0	1.5	14.8	0.5	3.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.6	1.5	0.6	0.1	0.2	0.2	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.8	0.1	0.0	0.1	1.6	0.1	0.2	0.3	0.1	0.5	0.0	0.0	0.4	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.9	0.8	0.7	0.8	0.8	2.5	1.7	2.4	1.7	1.0	0.6	3.2	0.0	1.5	23.8	3.7	0.5	0.4	0.2	0.6	2.9	0.6	0.6	1.7	0.0	3.2	5.5	2.1	0.0	3.3	0.1	13.7	0.0	37.3	3.1	2.2	5.7	0.0	0.0	8.4	0.2	0.0	2.3	0.0	2.2	0.0	2.2	1.4	0.0	0.1	0.0	9.0	3.7	0.0	0.3	0.4	31.8	2.8	3.1	7.2	7.5	0.1	6.5	1.0	9.0	5.5	0.1	5.0	1.2	1.6	0.4	257.7	325.0	3.5	4.0	0.0	19.0	1.6	1.1	0.9	0.1	0.9	0.1	2.9	1.2	1.2	0.2
CWH43	"CWH43-C, FLJ21511, PGAP2IP"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986275-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.0;prostate: 42.8;skin 1: 25.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA042814, HPA048140"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"		"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	6.0	0.0	16.9	0.4	0.6	0.4	21.0	14.5	0.0	0.0	0.0	0.0	9.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	42.8	15.6	0.0	3.0	7.7	0.0	25.5	0.0	0.8	0.1	0.0	9.6	0.0	0.1	0.1	10.2	0.0	1.5	2.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.9	0.1	0.8	0.0	0.0	0.6	0.1	0.6	0.0	2.3	7.3	0.0	0.0	0.0	10.4	1.9	0.0	0.2	41.3	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.7	21.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	15.4	0.0	0.0	7.6	0.0	2.9	29.5	0.0	0.0	0.0	0.5	0.0	0.5	3.2	9.1	0.0	0.2	0.0	15.0	0.3
CXCL12	"PBSF, SCYB12, SDF-1a, SDF-1b, SDF1, SDF1A, SDF1B, TLSF-a, TLSF-b, TPAR1"	ENSG00000107562	"C-X-C motif chemokine ligand 12"	P48061	10	44370165-44386493	"Predicted secreted proteins"	"Chemotaxis, Host-virus interaction"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 347.2;Distal tubular cells: 172.1;Fibroblasts: 566.4;Kupffer cells: 191.8;Smooth muscle cells: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 509.6;BJ hTERT+: 303.5;BJ hTERT+ SV40 Large T+: 294.9;BJ hTERT+ SV40 Large T+ RasG12V: 441.2;fHDF/TERT166: 501.8;HSkMC: 1293.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017564	Approved				"Secreted to blood"	NA	NA	1030000	560000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017564: AB_2088170"	"unprognostic (2.41e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	366.8	82.6	19.4	143.8	20.2	35.1	237.4	19.1	28.1	268.4	24.5	124.3	53.6	360.7	54.3	138.5	122.1	263.3	190.3	19.4	18.6	124.8	252.8	71.0	215.8	22.3	21.1	112.3	131.2	126.7	21.3	8.5	19.1	47.8	115.5	2.1	116.3	66.2	158.9	99.4	96.5	343.5	19.9	356.6	45.4	19.4	21.0	142.6	103.4	181.3	119.7	107.0	174.3	17.7	0.0	0.0	0.4	0.6	509.6	78.9	0.4	187.7	303.5	294.9	441.2	0.0	0.1	0.2	1.9	501.8	0.0	0.1	0.8	0.2	97.1	187.2	2.4	0.0	0.0	0.0	172.8	0.4	0.9	1293.8	0.0	63.8	0.1	0.0	0.2	0.1	0.1	0.0	1.0	0.4	0.7	0.6	32.2	0.0	0.6	0.8	0.3	224.3	0.2	0.0	0.6	0.6	0.3	0.7	0.0	63.6	272.2	0.4	0.4	0.4	0.5	205.0	0.2	0.2	0.1	0.1	0.6	0.3	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	20.2	19.1	28.1	19.4	18.6	22.3	21.1	19.1	19.9	21.0	17.7	347.2	0.0	1.1	1.3	1.4	76.3	0.3	0.0	9.6	1.5	8.1	14.0	25.0	10.0	0.6	5.5	0.0	0.3	2.1	0.0	172.1	0.8	2.2	1.7	46.8	134.1	0.0	0.0	0.6	20.5	0.3	566.4	1.5	1.0	0.0	0.4	55.6	2.5	2.6	0.0	6.6	3.9	0.0	191.8	110.1	3.7	70.2	27.9	135.2	74.0	0.0	1.9	0.0	12.1	0.1	3.0	0.0	8.6	1.0	1.0	0.1	25.5	0.0	0.8	85.5	43.7	146.1	1.8	5.9	6.3	62.7	0.7	9.6	33.2	0.5	0.5
CXCL14	"BMAC, bolekine, BRAK, Kec, KS1, MIP-2g, NJAC, SCYB14"	ENSG00000145824	"C-X-C motif chemokine ligand 14"	O95715	5	135570679-135579279	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 780.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 3435.4;Basal squamous epithelial cells: 3284.9;Breast myoepithelial cells: 1544.3;Fibroblasts: 2220.8;Glandular and luminal cells: 1201.1;Proximal tubular cells: 3662.8;Suprabasal keratinocytes: 2115.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HAP1: 61.6;hTCEpi: 79.9;RPTEC TERT1: 222.2;SuSa: 115.2;U-2 OS: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB029996	Uncertain				"Secreted to blood"	NA	NA	800000		"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 33: Fibroblasts - ECM organization"			"CAB029996: AB_2086070"	"unprognostic (1.82e-3)"	"prognostic favorable (1.71e-4)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	366.1	5.2	77.6	76.2	84.5	0.6	229.1	70.6	102.7	166.3	74.8	152.4	214.0	6.9	66.6	92.9	32.9	19.8	14.0	83.7	73.8	345.6	58.5	7.4	90.7	72.4	91.0	5.5	11.6	1.9	122.0	170.7	72.4	10.1	181.3	17.5	293.5	17.6	81.1	780.3	247.0	6.3	68.7	87.5	107.3	3.7	90.2	26.6	55.2	36.5	128.5	76.6	96.3	77.9	0.0	0.0	2.7	0.0	0.2	0.2	0.7	2.9	0.8	0.2	0.0	0.0	9.1	0.0	2.7	0.1	3.8	0.2	61.6	1.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	79.9	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	4.0	0.0	0.0	0.2	0.0	1.1	222.2	0.0	1.1	0.7	0.2	0.2	0.0	115.2	0.1	0.0	0.0	0.1	84.9	0.4	0.1	0.3	0.0	0.0	1.4	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	77.6	84.5	70.6	102.7	83.7	73.8	72.4	91.0	72.4	68.7	90.2	77.9	123.8	0.0	1.1	32.7	13.1	3435.4	14.4	276.9	3284.9	245.7	47.5	1544.3	4.1	0.0	5.1	283.3	0.0	35.9	6.1	0.0	563.4	0.0	0.8	45.0	140.8	45.9	0.0	0.0	1.0	0.0	25.4	2220.8	0.5	1201.1	0.0	0.0	43.5	0.2	63.6	6.7	150.8	0.0	240.1	0.9	887.9	1.3	20.8	35.3	439.4	8.4	0.0	6.7	0.0	4.5	4.2	0.1	0.0	0.4	13.3	10.6	0.0	3662.8	2.1	19.0	0.0	889.8	99.2	0.4	5.2	69.3	2115.0	77.2	43.4	0.3	0.1	9.3
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118149	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1175.1;lymphoid tissue: 549.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 1446.9;dendritic cells: 1015.1;Langerhans cells: 486.2;Macrophages: 513.6;Plasma cells: 534.2;T-cells: 1436.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 580.8;JURKAT: 323.6;Karpas-707: 302.1;MOLT-4: 538.9;REH: 281.0;U-266/70: 648.5;U-698: 677.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	51.8	184.5	11.8	297.9	11.4	1175.1	39.6	14.6	23.8	36.1	20.1	33.2	12.6	35.2	5.5	34.9	64.9	84.5	21.8	10.6	19.7	29.0	52.4	95.5	383.8	24.3	12.8	12.9	10.0	12.3	32.6	57.5	18.2	34.1	48.6	7.8	30.2	11.8	5.2	9.8	246.5	28.1	16.7	346.5	64.0	4.0	15.2	491.2	36.7	12.0	549.3	99.3	26.9	32.3	0.8	0.3	9.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	580.8	1.8	0.0	0.4	0.7	1.7	0.0	0.0	29.6	6.9	35.1	84.3	0.0	0.0	81.5	60.7	0.0	0.0	0.0	0.0	0.0	54.5	323.6	1.0	302.1	0.0	1.5	538.9	72.8	9.3	45.4	2.9	281.0	62.6	102.5	4.5	0.0	30.9	26.1	0.6	2.0	0.3	2.9	0.7	156.7	8.1	0.0	2.0	0.5	0.4	648.5	116.7	677.4	0.1	131.8	0.1	87.0	28.5	117.8	83.8	15.6	67.3	115.6	76.5	79.6	25.7	166.2	113.1	109.5	143.3	17.2	9.1	63.7	76.1	51.9	11.8	11.4	14.6	23.8	10.6	19.7	24.3	12.8	18.2	16.7	15.2	32.3	32.0	16.0	42.2	8.5	1446.9	41.0	5.7	0.3	9.6	8.6	46.1	42.2	5.2	11.5	4.4	3.7	0.0	1.5	1015.1	1.1	13.7	5.1	1.2	20.0	8.9	67.6	1.8	67.5	0.0	0.9	4.2	28.9	52.0	71.0	12.6	9.0	29.6	9.1	159.9	0.0	0.2	2.0	10.2	270.0	486.2	2.9	1.5	513.6	113.8	3.7	189.2	1.0	153.5	0.0	2.0	2.3	1.1	2.6	534.2	3.2	0.0	3.2	2.4	0.8	46.0	99.1	23.1	0.5	7.8	8.5	35.7	6.3	1436.5	4.6	1.8	4.5
CXCR6	"BONZO, CD186, STRL33, TYMSTR"	ENSG00000172215	"C-X-C motif chemokine receptor 6"	O00574	3	45940933-45948351	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 74.1;T-cells: 58.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 445.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 445.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CAPAN-2: 11.2;JURKAT: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (2.05e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.77e-3)"	"prognostic favorable (6.74e-6)"	"unprognostic (6.67e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.57e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.57e-2)"	1.7	1.7	0.4	7.1	1.3	1.6	3.3	0.5	0.6	2.8	0.8	4.1	4.4	1.1	1.6	2.7	2.3	5.9	1.0	0.5	1.3	0.9	4.0	4.0	17.0	2.3	0.7	2.1	1.5	0.3	0.4	10.8	2.2	1.5	3.7	2.7	1.9	0.8	10.2	0.7	9.5	1.1	1.6	13.3	8.7	0.5	1.2	4.9	1.4	0.0	10.8	7.2	1.6	2.4	0.2	0.0	0.0	0.2	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.8	11.2	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.2	0.3	0.0	0.2	0.6	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.2	0.7	0.0	1.4	0.2	0.6	0.3	1.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.5	0.2	92.8	0.2	445.8	0.3	26.5	112.1	0.1	0.2	1.3	16.0	0.8	89.8	0.4	0.6	87.0	24.7	0.4	1.3	0.5	0.6	0.5	1.3	2.3	0.7	2.2	1.6	1.2	2.4	0.3	0.0	0.0	0.0	1.1	1.0	0.1	0.0	0.0	1.1	0.2	0.1	0.7	0.0	0.0	0.0	2.1	8.4	4.2	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	5.3	0.0	0.0	74.1	1.2	1.5	0.1	1.3	0.0	1.4	0.8	0.8	0.0	0.0	0.2	0.0	2.8	1.8	0.0	0.0	0.8	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.1	0.0	4.7	0.0	0.2	0.3	0.0	0.0	0.1	1.1	10.3	58.5	0.0	0.1	0.1
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250846-74291973	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 889.6;liver: 2472.0"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1117.0;RT4: 513.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		No	No		1400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750"	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	309.5	109.6	38.4	31.2	39.7	25.3	253.5	42.2	45.2	86.0	37.6	146.5	438.2	44.9	176.2	78.1	81.9	301.2	84.8	37.5	38.8	889.6	2472.0	356.6	43.7	43.1	39.7	223.9	461.3	236.0	58.5	81.8	41.9	95.9	103.4	10.3	59.1	122.8	41.4	118.4	381.7	46.7	40.8	75.6	194.8	57.9	40.0	51.6	42.5	42.1	35.2	155.5	68.3	43.5	78.8	130.8	67.4	0.6	1117.0	198.2	89.5	52.6	113.8	111.0	163.8	156.2	82.7	95.6	36.7	97.6	54.4	170.6	0.1	73.1	86.9	179.8	91.7	34.9	65.6	418.1	174.6	67.3	44.1	334.1	57.4	63.0	32.3	66.0	63.6	85.8	58.6	35.0	93.7	140.9	38.3	80.5	30.4	110.0	86.8	93.6	21.9	2.3	111.9	513.2	190.4	79.7	51.4	137.1	65.8	56.6	271.5	63.7	57.9	0.6	85.8	26.6	68.1	24.6	109.2	30.3	67.0	19.2	64.3	4.1	29.5	7.5	51.3	36.3	116.2	93.7	55.6	60.2	53.7	112.7	54.5	68.6	3.7	36.3	45.7	47.8	48.8	43.2	38.4	39.7	42.2	45.2	37.5	38.8	43.1	39.7	41.9	40.8	40.0	43.5	169.7	637.8	1371.0	11.4	76.0	98.0	82.1	368.6	50.7	9.9	345.8	213.2	90.7	836.4	1053.2	842.4	4.2	229.3	29.4	197.0	2156.1	239.4	7.5	163.1	76.6	119.9	164.2	180.0	13.1	504.6	169.8	141.4	208.9	345.6	39.9	55.0	177.4	3376.3	97.4	8.4	12.6	236.5	457.7	128.6	72.9	26.7	158.1	60.8	90.7	10.3	224.1	39.2	32.0	14.1	22.7	266.7	358.9	149.7	33.4	142.0	1856.4	3630.6	619.5	14.0	52.6	49.6	85.0	15.3	42.0	141.2	223.9	44.5	52.6	1123.6	329.9	220.7
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780059-37813461	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.9;lymphoid tissue: 158.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.2;Kupffer cells: 456.0;Macrophages: 469.3;monocytes: 396.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 276.3;intermediate monocyte: 261.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 90.9;granulocytes: 110.5;monocytes: 276.3"	"Group enriched"	"Detected in some"	5	"Daudi: 52.8;NB-4: 64.2;REH: 54.6;RPMI-8226: 210.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051227	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	40.5	28.4	5.5	158.9	5.3	160.9	15.2	6.5	5.5	12.3	12.4	22.3	19.3	9.3	4.3	8.9	9.9	26.2	8.0	4.7	9.1	8.0	27.5	91.5	97.1	15.1	9.6	6.9	4.0	4.4	2.5	54.6	13.3	6.7	30.6	1.7	7.0	9.7	3.7	2.2	22.3	55.5	12.5	89.0	17.2	4.7	11.1	18.3	5.3	5.5	73.2	46.8	2.3	24.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	52.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	3.6	0.6	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.1	64.2	0.2	0.0	0.3	54.6	0.0	210.4	0.0	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	20.0	0.0	0.0	0.1	0.1	0.2	0.6	1.6	3.4	0.0	8.9	0.0	2.2	276.3	110.5	0.4	261.6	0.5	39.6	0.3	0.4	62.8	32.8	0.3	0.2	19.2	0.6	237.1	90.9	0.9	162.5	5.5	5.3	6.5	5.5	4.7	9.1	15.1	9.6	13.3	12.5	11.1	24.0	2.4	25.6	25.4	0.7	99.9	1.0	0.1	0.0	0.6	0.1	1.0	3.0	11.0	2.8	13.0	1.8	0.0	0.9	82.7	2.0	0.0	0.0	0.6	0.2	0.1	8.1	0.0	5.2	1.6	0.4	1.1	4.4	4.1	0.1	7.6	0.1	5.0	3.2	157.2	1.7	1.6	0.7	0.0	456.0	25.0	0.7	0.6	469.3	1.8	76.8	396.6	0.1	14.4	0.0	0.1	0.1	0.5	0.0	13.6	0.0	0.6	0.5	7.3	0.7	13.1	1.6	1.2	0.0	0.6	1.9	1.3	1.8	7.5	0.0	1.3	0.1
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558129	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	"Oxidoreductase, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 221.2;Fibroblasts: 243.4;Leydig cells: 202.0;Peritubular cells: 221.5;Proximal enterocytes: 689.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.4;intermediate monocyte: 17.7;myeloid DC: 16.8;neutrophil: 9.8;non-classical monocyte: 13.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.8;granulocytes: 9.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1064.0;ASC TERT1: 453.8;BJ hTERT+: 408.2;HSkMC: 327.3;hTERT-RPE1: 276.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014757	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA014757: AB_1847374"	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	166.7	97.5	32.6	24.4	38.8	18.3	148.7	33.9	34.1	140.0	32.6	68.7	197.7	100.2	49.7	70.6	88.2	153.7	128.6	28.2	45.9	32.0	21.7	129.9	33.8	45.2	38.7	180.9	21.6	12.0	26.1	38.1	40.5	70.6	39.0	22.2	63.7	76.7	23.3	85.0	233.4	87.9	35.6	30.6	53.3	23.8	35.9	27.9	231.0	82.8	30.1	84.3	90.4	43.0	24.8	18.1	10.1	19.2	1064.0	453.8	1.3	88.3	408.2	45.0	56.4	1.1	33.8	0.0	14.8	214.2	46.2	12.2	8.4	7.2	53.2	18.9	2.2	20.7	26.1	0.4	222.7	22.0	1.9	327.3	68.8	70.5	13.7	276.3	29.6	12.4	7.0	0.2	128.3	0.0	7.1	20.4	5.1	0.0	4.6	2.5	125.3	1.5	7.0	1.4	1.3	4.7	104.2	0.2	56.5	3.6	35.8	13.5	59.5	101.0	14.4	96.1	38.3	0.3	0.4	0.2	49.5	18.3	55.6	0.0	17.4	0.8	1.6	17.7	0.3	0.0	0.3	0.2	16.8	0.0	0.0	0.0	9.8	3.6	13.7	0.7	0.0	7.5	32.6	38.8	33.9	34.1	28.2	45.9	45.2	38.7	40.5	35.6	35.9	43.0	37.6	221.2	109.0	45.1	0.9	121.2	47.3	20.3	38.7	0.0	54.7	48.0	18.4	37.1	34.7	25.8	0.0	1.9	3.4	16.1	0.0	1.0	1.5	4.2	35.6	33.9	0.0	85.0	0.9	6.4	2.3	243.4	13.3	8.3	2.5	1.6	73.5	2.4	48.5	0.0	1.5	22.2	2.0	60.7	92.0	6.1	202.0	28.4	44.4	36.5	29.3	27.9	4.1	12.1	54.2	1.8	16.2	221.5	2.2	22.5	689.4	0.3	6.9	1.5	19.7	89.6	49.9	1.2	1.2	7.0	60.1	1.4	5.9	2.8	27.6	18.2
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 104.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	79.6	20.8	10.1	12.0	10.7	1.7	55.1	20.6	13.6	27.7	14.1	27.1	21.1	19.6	4.6	12.8	20.4	13.2	104.4	9.5	15.8	12.4	19.0	27.8	7.2	17.5	26.0	13.8	12.8	11.7	10.9	8.9	26.8	29.9	9.3	77.6	14.2	11.0	19.3	19.5	26.6	5.9	10.1	12.2	22.9	5.3	14.3	5.3	50.1	9.6	2.6	50.7	25.6	9.8	0.2	1.1	1.8	0.4	79.6	23.1	26.1	0.7	2.0	0.3	0.9	0.0	0.3	0.2	24.1	2.4	0.3	0.7	0.1	33.7	0.1	0.1	0.2	0.4	0.4	61.7	120.7	0.0	0.0	95.4	7.2	2.5	2.5	0.4	0.3	0.8	0.3	0.1	1.2	0.8	0.2	0.4	0.3	0.0	1.4	0.5	0.3	0.2	0.4	0.1	0.6	129.8	0.1	0.0	2.7	5.9	0.2	0.6	0.2	3.1	1.6	0.3	0.0	1.2	0.3	0.3	0.2	0.3	9.9	0.0	0.1	0.1	0.2	0.1	0.1	1.6	0.1	0.0	0.1	2.2	0.2	0.5	0.9	1.0	0.0	0.0	0.2	0.2	10.1	10.7	20.6	13.6	9.5	15.8	17.5	26.0	26.8	10.1	14.3	9.8	94.3	3.2	2.0	2.0	3.5	10.8	1.3	17.3	3.4	38.5	1.4	5.7	6.1	0.0	6.7	0.0	0.0	1.4	1.9	0.1	0.0	0.8	0.7	2.9	4.2	23.1	0.0	0.0	2.4	0.2	0.6	87.6	1.5	0.7	0.0	0.2	2.2	1.2	0.4	8.4	12.3	0.0	0.0	0.0	13.3	2.5	95.7	2.6	78.2	3.7	0.0	22.1	0.0	1.0	1.0	0.1	0.0	23.3	0.6	0.8	0.0	0.2	21.1	12.9	92.1	21.8	95.6	1.6	1.4	0.7	6.7	2.9	2.6	9.2	0.0	1.0
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease variant, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 170.8;Prostatic glandular cells: 747.6;Urothelial cells: 498.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"classical monocyte: 156.9"	"Lineage enriched"	"Detected in many"	24	"monocytes: 156.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 128.7;ASC TERT1: 136.8;HSkMC: 551.3;hTERT-RPE1: 128.9;SiHa: 270.0;U-87 MG: 142.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 34.6"	"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	28.4	12.0	2.7	31.9	6.2	2.0	29.4	1.6	8.9	34.9	10.4	3.7	2.2	41.0	19.5	7.6	44.9	23.8	29.2	2.5	2.3	24.1	7.0	16.8	11.6	3.6	2.9	5.6	7.2	0.9	14.8	4.5	3.0	34.7	2.1	1.2	4.3	39.2	3.4	6.3	5.8	35.1	3.6	27.3	15.9	8.0	7.3	28.3	8.7	5.5	1.9	35.0	6.7	1.5	7.0	71.9	2.3	0.0	128.7	136.8	0.4	0.6	4.4	1.3	12.3	0.2	30.1	0.0	19.1	17.8	3.1	58.7	0.3	4.0	2.3	5.5	3.8	0.0	21.2	0.0	36.0	0.2	0.1	551.3	55.3	30.7	1.4	128.9	0.0	0.3	0.7	0.2	0.7	29.2	0.3	22.5	7.5	10.4	14.2	0.1	0.0	0.2	13.4	0.9	0.5	2.1	270.0	38.8	0.0	7.5	49.4	10.8	0.0	1.1	0.2	107.9	0.1	0.3	0.2	0.0	142.2	0.1	11.8	1.6	156.9	0.0	0.1	23.2	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.1	6.5	0.1	18.6	0.7	0.1	70.2	2.7	6.2	1.6	8.9	2.5	2.3	3.6	2.9	3.0	3.6	7.3	1.5	56.8	19.2	66.3	0.0	1.7	17.7	118.4	86.9	8.0	0.7	18.3	42.0	3.4	0.0	79.7	46.0	0.0	0.3	1.1	0.9	15.6	6.0	15.1	11.7	100.4	103.8	1.8	0.0	4.5	0.5	0.8	114.1	3.6	28.2	3.8	0.1	7.5	12.2	12.6	0.0	0.3	1.3	4.1	103.0	50.6	12.1	159.7	112.2	17.8	64.6	140.1	1.6	3.1	0.0	0.2	0.6	0.1	170.8	0.3	747.6	0.1	1.6	11.2	0.5	19.7	4.5	32.7	12.6	2.6	2.4	14.2	0.3	2.4	1.3	1.0	498.7
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038327-32041644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"adrenal gland: 2041.7"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	2.0	2041.7	0.0	0.0	0.0	0.0	1.5	0.0	0.6	1.9	0.0	2.5	0.0	1.5	0.6	0.6	2.4	0.0	2.9	0.0	0.0	7.0	44.8	0.8	0.0	0.0	0.0	4.3	0.9	0.0	1.9	0.0	0.0	1.9	0.0	0.0	4.0	0.0	0.3	0.7	1.1	0.0	0.0	5.5	0.8	0.8	0.0	0.0	2.3	0.0	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	2.4	0.5	0.3	1.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.8	0.9	1.8	0.0	0.1	0.0	0.0	1.6	0.0	0.2	1.3	0.4	0.0	15.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.8	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	2.0	1.2	0.6	0.0	0.3	0.6	0.6	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153446-54173986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 18.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"A549: 411.5;Hep G2: 122.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022261, HPA063771"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.0	0.0	0.2	0.4	0.4	0.0	3.7	0.0	0.3	1.7	0.0	0.0	0.1	14.9	0.2	3.8	0.2	0.0	0.0	0.1	1.8	35.3	0.4	0.7	0.2	0.4	2.0	0.0	0.0	0.0	0.2	10.0	0.3	2.9	0.0	0.0	0.3	2.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.2	1.3	0.0	10.5	28.7	1.3	0.2	0.5	411.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.6	0.0	3.2	0.0	0.9	15.8	0.0	0.1	0.1	0.0	0.0	0.0	6.5	122.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	7.0	1.3	0.0	2.6	0.6	0.0	0.1	0.1	0.0	0.0	0.0	16.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.1	1.8	0.4	2.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	1.3	22.8	48.3	142.7	74.0	0.0	11.0	8.6	0.4	0.0	47.0	0.0	0.0	0.1	0.1	0.1	5.9	0.1	0.0	0.7	0.5	0.3	0.0	0.0	0.2	0.0	0.1	2.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	9.8	0.0	61.3	13.1	0.0	0.0	0.0	0.6	0.0	0.0	3.3	19.6	0.1	0.1	0.0	0.2	36.7
CYP27B1	"CYP1, P450c1, PDDR, VDD1"	ENSG00000111012	"Cytochrome P450 family 27 subfamily B member 1"	O15528	12	57762334-57768986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 15.2;thyroid gland: 5.7"	"Group enriched"	"Detected in many"	5	"Exocrine glandular cells: 22.1;monocytes: 22.8;Proximal tubular cells: 36.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 13.6;RH-30: 22.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (8.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.10e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.67e-3)"	0.3	0.9	0.3	0.7	0.3	0.8	0.8	0.3	0.4	0.2	0.3	0.4	0.4	0.2	0.6	0.4	0.2	0.5	0.1	0.3	0.3	15.2	0.6	0.5	0.9	0.3	0.3	0.2	1.6	1.0	0.4	0.3	0.3	0.3	0.6	3.3	0.5	0.2	0.1	0.6	0.5	0.1	0.3	0.2	0.5	0.4	0.3	0.2	5.7	0.0	0.7	2.2	0.2	0.5	2.8	0.4	0.0	0.3	0.2	0.4	1.1	0.1	3.1	1.0	0.3	3.7	1.0	2.0	0.1	0.4	0.3	3.3	0.5	5.9	3.1	0.6	0.4	0.9	0.0	1.0	0.3	1.2	2.5	0.5	1.9	0.8	13.6	1.2	0.4	2.6	1.3	1.2	0.4	0.4	0.4	1.1	1.3	2.8	2.3	0.8	22.6	1.7	0.5	0.3	0.7	0.8	2.0	0.4	0.1	0.1	1.7	2.3	0.2	0.2	1.6	1.1	0.4	1.4	1.2	0.4	1.2	2.6	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.0	0.0	0.7	3.0	5.2	1.3	1.1	0.6	0.7	5.1	2.7	0.7	2.8	1.9	0.0	2.1	0.1	0.0	0.6	1.9	2.0	0.9	1.1	0.5	0.5	0.0	0.0	0.3	22.1	0.4	0.6	0.0	1.7	4.5	0.4	0.4	0.3	2.3	0.0	0.2	0.6	0.0	0.3	0.8	0.0	0.0	1.5	0.0	0.0	22.8	0.6	0.0	0.0	0.1	5.4	0.1	0.4	1.7	1.4	0.5	36.9	0.6	5.2	0.0	1.5	1.1	0.3	0.7	1.3	2.7	0.1	0.5	0.4	0.9	0.6
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991282-41018398	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 533.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 420.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;OE19: 1.8"					"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.0	0.0	0.2	0.2	0.2	0.5	0.1	0.6	0.3	0.0	0.3	4.7	5.1	0.1	0.0	0.0	0.0	0.7	0.1	0.3	0.1	15.1	533.7	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.8	0.0	0.1	0.2	0.0	6.7	0.6	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	1.8	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.6	0.3	0.3	0.1	0.3	0.1	0.2	0.0	0.2	0.4	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.2	7.2	1.4	1.8	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.4	420.9	0.0	0.0	0.1	1.6	0.0	11.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.1	38.3	16.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	4.3	0.7
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94990091	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 1719.9"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 1704.9"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, CAB016123, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.0	1.2	0.0	2.7	87.8	0.0	0.0	7.7	0.0	7.9	0.0	0.0	0.0	4.3	1719.9	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	2.3	46.2	0.1	0.0	0.5	18.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.6	0.2	1.8	0.0	0.0	0.0	1.5	0.0	7.6	0.0	0.8	0.7	1.1	0.0	16.0	0.0	0.7	0.0	0.2	44.4	7.4	0.0	0.0	26.7	1704.9	0.0	0.0	0.1	1.4	0.0	34.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.6	0.0	0.1	0.0	65.3	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	1.9	0.0	2.7	0.0
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926773	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.7;intestine: 83.4;liver: 146.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 91.4;Cytotrophoblasts: 116.2;Hepatocytes: 58.3;Oligodendrocytes: 68.5;Proximal enterocytes: 134.6;Syncytiotrophoblasts: 240.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"OE19: 16.9;RT4: 62.3;SK-BR-3: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	1.2	0.4	18.3	1.2	22.1	0.1	9.3	23.6	19.1	2.3	8.4	19.0	34.1	1.0	0.8	13.1	0.9	2.0	89.7	14.7	19.4	3.0	146.2	1.4	0.2	20.7	20.7	0.0	2.2	0.0	0.9	22.3	18.9	3.3	21.3	3.5	14.5	0.7	25.3	8.9	83.4	1.8	20.2	0.1	4.7	0.6	28.0	0.5	0.1	6.4	0.7	5.8	3.6	21.8	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	2.7	0.1	1.2	0.3	2.8	0.0	0.8	0.0	3.5	0.9	0.0	0.9	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	3.2	0.0	0.0	1.5	16.9	2.6	0.0	6.3	0.0	3.4	62.3	0.9	3.8	0.1	16.4	0.6	0.1	4.1	0.0	0.0	2.2	2.5	0.0	0.9	1.9	0.1	0.0	0.5	0.0	6.9	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.3	0.2	0.0	0.4	2.9	2.6	0.0	0.4	0.0	0.6	0.0	0.4	18.3	22.1	23.6	19.1	14.7	19.4	20.7	20.7	18.9	20.2	28.0	21.8	0.0	3.2	4.1	35.6	0.7	0.4	1.7	5.5	7.4	0.0	5.1	3.0	91.4	11.5	28.9	0.0	0.0	116.2	0.1	26.4	0.0	9.5	22.7	3.1	1.7	1.3	9.0	0.0	0.1	0.9	9.3	2.3	4.1	7.7	0.0	1.5	0.0	58.3	7.0	0.0	0.4	18.7	6.1	0.8	0.3	23.3	0.0	0.2	0.0	1.9	0.6	12.5	0.0	29.7	68.5	2.0	18.1	0.0	0.3	1.5	134.6	2.5	20.1	0.9	0.0	0.7	1.0	0.3	0.2	7.3	2.3	240.9	0.2	0.4	24.1	2.1
CYP2U1	"SPG49, SPG56"	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931549-107953461	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 84.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.2;Inhibitory neurons: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	7.7	6.4	6.6	4.0	8.3	0.5	4.5	7.6	7.3	5.1	10.1	5.8	3.4	6.6	3.6	3.5	7.8	5.6	7.7	6.5	8.7	5.3	5.9	5.7	6.3	9.0	7.9	9.5	2.3	10.7	4.7	2.4	8.2	9.9	3.9	5.8	3.4	8.7	3.6	2.7	4.7	10.2	8.1	7.6	3.2	3.0	8.0	84.9	3.6	7.2	4.7	4.7	3.8	9.5	4.0	1.9	5.2	9.5	28.6	13.4	0.8	16.8	25.3	10.2	15.7	0.1	2.5	10.8	1.1	10.1	7.8	0.2	8.1	6.4	15.4	3.0	2.5	2.3	3.5	0.5	11.3	3.2	0.0	15.3	5.3	4.7	3.2	20.8	4.0	12.0	0.1	5.0	8.4	2.9	11.8	0.0	5.4	0.4	4.7	6.5	6.3	0.1	3.3	6.7	10.0	7.6	4.2	7.3	18.6	4.3	3.6	1.5	10.6	6.5	0.8	9.3	6.9	21.1	21.2	3.4	5.5	0.0	7.4	0.0	0.1	0.3	0.4	0.5	0.3	0.8	0.3	0.4	0.9	1.1	0.7	0.5	0.0	0.7	2.8	1.1	0.0	0.2	6.6	8.3	7.6	7.3	6.5	8.7	9.0	7.9	8.2	8.1	8.0	9.5	5.5	3.2	3.9	18.6	12.9	1.1	4.6	2.2	15.4	4.1	2.8	5.8	6.2	1.5	2.4	9.2	4.2	0.4	10.1	1.4	0.0	0.9	13.2	6.9	6.3	5.8	3.0	1.7	30.2	2.0	0.3	12.6	3.1	6.2	4.5	2.5	8.6	7.3	2.3	1.7	34.3	1.2	0.0	6.2	3.3	9.5	17.7	4.7	19.6	5.6	3.7	9.5	1.0	20.1	12.1	0.4	0.1	17.7	4.2	1.5	9.9	3.0	8.6	3.1	0.0	20.0	8.1	1.0	4.2	2.0	1.4	0.3	3.6	5.1	3.1	0.8
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3796.2"	"Group enriched"	"Detected in some"	40	"Hepatocytes: 2612.9;Proximal enterocytes: 1685.2"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0"					"Low region specificity"	"Detected in all"			"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 24: NB-4 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.3	3.8	0.1	1.1	0.3	0.0	0.3	0.0	0.8	0.1	0.0	4.6	797.6	0.6	0.2	0.4	0.1	0.6	0.1	0.1	0.0	4.9	3796.2	0.1	0.9	0.0	0.0	0.1	43.4	0.0	1.0	0.0	0.0	0.2	2.2	0.4	0.3	0.0	2.4	1.9	853.0	0.0	0.0	0.1	1.1	1.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.0	0.0	0.8	3.4	0.0	0.1	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	2.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.4	32.9	0.0	0.0	0.0	0.3	0.0	5.6	0.0	0.1	0.4	0.0	0.0	1.4	0.0	26.7	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	30.0	2612.9	0.0	0.0	0.6	29.6	2.0	52.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	38.9	0.0	0.0	0.6	1685.2	3.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.9	0.1	2.3	0.5	16.1	1.1
CYP4A11	"CYP4A2, CYP4AII"	ENSG00000187048	"Cytochrome P450 family 4 subfamily A member 11"	Q02928	1	46929177-46941484	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	333	"kidney: 218.8;liver: 857.1"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 563.8"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 73.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"		"unprognostic (4.43e-2)"	"unprognostic (4.11e-1)"	"unprognostic (7.81e-5)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.68e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.6	0.0	1.4	0.0	0.1	1.1	0.1	0.0	0.1	218.8	857.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	32.9	0.0	7.3	0.0	0.0	0.0	0.0	17.6	0.0	0.5	0.8	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	563.8	0.0	0.0	0.1	0.0	0.0	7.3	0.2	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.1	108.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0
CYP4A22		ENSG00000162365	"Cytochrome P450 family 4 subfamily A member 22"	Q5TCH4	1	47137435-47149735	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 214.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 143.0"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 20.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"															NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.19e-2)"			"unprognostic (2.88e-3)"	"unprognostic (2.76e-3)"		"unprognostic (1.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.59e-4)"	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.1	0.0	32.9	214.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	143.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CYP4F12		ENSG00000186204	"Cytochrome P450 family 4 subfamily F member 12"	Q9HCS2	19	15673018-15697174	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.5;liver: 40.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 58.8;Gastric mucus-secreting cells: 57.6;Paneth cells: 51.9;Proximal enterocytes: 125.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	54	"basophil: 6.1;eosinophil: 14.8"	"Lineage enriched"	"Detected in single"	88	"granulocytes: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 17.6;HaCaT: 32.0;Hep G2: 9.8;Karpas-707: 20.9;OE19: 46.3"									HPA058960	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"			"HPA058960: AB_2683862"	"unprognostic (4.30e-4)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.84e-3)"	"unprognostic (9.13e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (2.33e-4)"	3.2	1.1	0.6	1.2	0.9	0.9	2.7	0.6	1.5	6.0	0.4	15.1	39.1	1.5	0.5	18.1	3.2	2.4	1.5	0.9	2.4	1.8	40.1	1.2	0.5	0.9	1.1	1.6	0.3	0.0	0.5	0.5	1.1	5.0	7.8	0.1	4.3	1.0	0.6	21.1	41.5	1.9	0.7	1.0	12.0	0.2	0.7	0.8	0.9	0.9	2.6	10.5	11.2	1.9	0.0	4.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.6	0.5	0.0	0.0	0.3	32.0	0.0	0.0	0.0	2.0	0.0	0.0	1.7	9.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.1	0.0	46.3	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.1	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.1	0.0	14.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.6	1.5	0.9	2.4	0.9	1.1	1.1	0.7	0.7	1.9	6.3	0.0	1.8	2.6	0.5	14.0	10.0	8.3	13.1	0.0	0.5	0.3	1.0	5.7	7.1	0.0	0.0	0.1	0.0	58.8	0.0	0.6	1.6	0.2	0.1	3.0	7.8	8.0	0.2	0.0	0.1	3.8	57.6	0.3	0.0	0.0	1.4	30.3	0.4	0.0	0.2	24.8	2.0	0.9	1.6	3.2	4.1	0.3	1.8	0.0	0.0	2.7	0.0	0.0	0.4	1.9	51.9	1.2	0.2	3.5	125.3	2.2	4.9	0.1	0.0	0.3	2.5	0.4	0.1	20.5	21.2	0.3	0.5	0.1	29.6	24.8
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898077	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 80.2;kidney: 40.9;liver: 166.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 139.7;Proximal enterocytes: 204.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 3.8"					"Low region specificity"	"Detected in all"			"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.0	0.0	0.1	0.1	0.1	1.1	0.2	0.1	0.3	0.1	0.5	2.2	79.9	0.0	25.8	0.2	0.0	3.3	0.0	0.2	0.1	40.9	166.7	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.1	6.6	0.9	0.0	0.0	0.1	0.0	0.8	80.2	0.0	0.3	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	12.3	1.9	0.1	5.8	0.0	0.0	0.1	1.8	5.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.4	139.7	0.0	0.0	0.0	8.9	0.0	3.8	0.0	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	204.6	37.7	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.2	0.1	5.6	0.2
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 80.2;liver: 235.8"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 562.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	63	"neutrophil: 84.1"	"Lineage enriched"	"Detected in single"	177	"granulocytes: 84.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 33.0;HaCaT: 14.9;Hep G2: 18.3;OE19: 49.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058960	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	1.6	0.1	0.9	1.2	3.3	80.2	0.2	2.3	1.3	6.9	0.3	2.1	9.4	0.1	0.8	26.7	1.1	15.5	0.3	1.8	2.2	27.3	235.8	2.3	0.1	2.8	3.0	0.0	0.6	0.0	0.5	0.4	2.9	0.6	1.8	0.0	3.4	0.6	0.1	3.9	15.0	0.3	1.9	7.8	5.1	0.3	1.9	0.7	0.1	0.6	0.7	2.9	9.0	4.1	0.3	7.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.1	0.2	0.0	0.1	14.9	0.0	0.2	0.0	0.6	0.0	0.1	3.5	18.3	0.0	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	49.3	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	84.1	0.0	0.1	0.0	0.0	0.1	0.9	3.3	2.3	1.3	1.8	2.2	2.8	3.0	2.9	1.9	1.9	4.1	0.0	9.6	3.7	0.7	2.0	1.0	2.1	2.5	1.2	0.0	0.1	0.1	0.9	62.9	5.0	0.0	0.0	0.0	1.4	10.0	0.0	2.3	0.1	0.9	0.2	0.7	53.1	17.3	0.0	0.2	0.2	0.8	7.7	3.1	1.3	0.0	8.2	562.4	0.0	0.0	0.0	14.4	8.2	11.4	0.3	0.7	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.0	7.4	0.0	0.0	3.2	69.9	32.1	1.9	0.0	0.0	0.7	1.3	0.0	0.3	25.7	6.5	0.0	1.1	0.0	10.9	13.1
CYP8B1	CYP12	ENSG00000180432	"Cytochrome P450 family 8 subfamily B member 1"	Q9UNU6	3	42856005-42875898	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 404.5"	"Cell type enriched"	"Detected in some"	76	"Hepatocytes: 920.2"	"Cancer enriched"	"Detected in some"	46	"liver cancer: 69.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;SK-BR-3: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (5.86e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	0.3	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.2	0.1	0.5	0.1	0.2	0.1	14.4	404.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	1.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.9	920.2	0.1	0.0	0.0	0.0	0.0	10.7	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0
CYTH3	"ARNO3, cytohesin-3, GRP1, PSCD3"	ENSG00000008256	"Cytohesin 3"	O43739	7	6161776-6272644	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 66.5;Inhibitory neurons: 96.5;Microglial cells: 57.1"	"Cancer enriched"	"Detected in all"	5	"melanoma: 47.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 102.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013979	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Nucleoplasm	"HPA013979: AB_1855799"	"unprognostic (6.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (2.63e-5)"	28.8	9.5	16.9	5.4	17.7	7.7	26.5	16.3	20.9	16.4	11.8	18.3	16.5	17.5	6.6	14.0	15.6	11.8	28.5	18.5	15.3	14.2	4.1	19.7	5.4	14.4	15.5	13.9	7.5	11.5	9.8	31.7	15.4	10.2	6.9	5.7	11.9	8.6	15.2	21.6	16.7	12.1	14.2	10.9	13.9	18.6	16.6	5.8	27.7	19.7	4.7	13.8	15.9	17.5	64.7	16.1	15.0	10.4	68.4	80.0	21.2	37.4	32.3	36.1	34.2	25.0	31.3	8.7	22.1	75.5	46.4	59.5	10.4	27.1	23.8	0.6	14.8	2.4	19.8	3.2	32.4	2.7	4.0	57.0	12.1	19.3	27.6	16.2	6.4	12.6	10.3	1.4	26.7	10.6	2.2	11.5	10.4	8.6	21.5	11.5	40.0	5.0	28.0	7.7	9.6	18.4	23.2	79.7	67.0	12.7	4.8	18.1	23.3	24.6	64.4	26.9	23.2	2.9	1.1	9.1	7.9	6.9	102.8	0.3	0.2	0.0	0.9	0.0	2.5	0.1	0.4	1.0	0.1	0.2	0.0	0.6	0.1	1.5	0.2	0.8	0.3	0.2	16.9	17.7	16.3	20.9	18.5	15.3	14.4	15.5	15.4	14.2	16.6	17.5	40.1	16.0	5.8	14.7	3.1	15.2	2.1	1.8	4.0	6.5	9.2	7.5	17.4	2.8	3.2	3.7	8.4	15.4	8.7	9.7	5.9	4.1	14.1	9.4	10.2	14.6	3.0	2.1	66.5	2.8	9.1	24.0	8.2	15.9	12.7	15.8	18.5	1.4	11.9	15.2	96.5	5.5	4.1	4.1	10.9	16.7	16.4	5.9	32.0	57.1	1.9	10.8	3.1	23.1	10.8	10.0	5.4	13.2	4.4	3.9	14.6	1.4	3.7	2.0	39.5	6.1	39.2	24.3	11.2	7.0	11.4	15.2	10.2	10.9	7.1	2.1
CYYR1	C21orf95	ENSG00000166265	"Cysteine and tyrosine rich 1"	Q96J86	21	26466209-26573286	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 200.0;Endothelial cells: 150.0;Hepatic stellate cells: 79.9;Microglial cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	38	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 31.4"	"Cell line enhanced"	"Detected in some"		"AF22: 14.1;NTERA-2: 39.2;PC-3: 11.0;RH-30: 16.6;SCLC-21H: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034921, HPA067685"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB034921: AB_2089315, HPA067685: AB_2685887"	"unprognostic (5.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-3)"	"unprognostic (9.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	36.4	46.4	9.7	8.1	9.0	7.8	30.2	8.7	11.4	16.4	8.4	8.4	6.1	19.2	8.1	9.0	12.9	16.1	22.3	8.1	9.4	12.7	4.8	23.7	6.0	9.9	10.5	4.5	5.5	15.5	3.8	36.3	10.6	9.5	6.6	0.9	6.8	11.4	15.1	8.2	9.6	23.6	9.6	32.5	7.7	1.9	10.8	6.0	14.1	31.8	4.6	12.6	9.5	9.4	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.1	1.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	6.5	0.0	0.4	0.0	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.1	39.2	0.0	11.0	0.0	16.6	0.0	1.7	0.0	33.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	31.4	0.0	0.1	9.7	9.0	8.7	11.4	8.1	9.4	9.9	10.5	10.6	9.6	10.8	9.4	200.0	0.0	0.6	1.6	1.5	11.7	2.0	10.2	27.3	0.1	14.9	15.0	6.7	0.0	1.7	14.7	0.0	0.1	14.9	0.0	3.9	0.0	0.7	0.4	6.9	150.0	0.0	11.1	1.6	0.0	0.2	8.3	0.0	0.4	0.0	3.7	79.9	0.4	0.3	0.0	4.6	0.0	2.0	3.2	8.0	1.5	2.1	1.4	7.2	58.1	0.7	0.5	0.0	0.0	0.7	0.1	0.0	0.0	2.5	1.1	0.0	6.8	1.1	0.3	0.0	13.3	4.4	0.2	1.3	4.9	5.4	0.3	1.5	0.4	0.0	0.7
DAB2	DOC-2	ENSG00000153071	"DAB adaptor protein 2"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 179.1;placenta: 226.6"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 1756.4;Proximal tubular cells: 1653.7;Syncytiotrophoblasts: 1324.5"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	8	"plasmacytoid DC: 48.7"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 48.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 220.1;ASC TERT1: 234.5;fHDF/TERT166: 356.8;TIME: 211.1;U-138 MG: 237.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"		NA	NA		130000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: AB_2672814"	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	76.9	113.6	7.3	33.1	8.3	4.1	48.2	13.4	13.1	48.4	26.2	33.2	13.5	32.5	116.8	16.8	21.6	50.1	20.0	7.5	7.7	179.1	27.3	53.3	33.2	14.6	10.0	34.0	22.8	10.1	7.9	226.6	12.6	13.0	54.5	11.6	24.2	19.8	11.4	21.2	25.6	47.8	7.8	58.5	16.6	10.6	20.1	20.9	23.5	16.4	19.0	44.6	20.6	10.8	0.2	8.3	12.9	27.9	220.1	234.5	16.0	145.7	149.5	56.3	92.5	108.1	0.5	0.1	8.8	356.8	54.8	0.3	2.0	5.2	78.9	0.2	4.2	19.9	191.1	35.5	52.4	0.2	24.3	146.5	0.2	91.7	16.5	87.2	172.4	9.9	0.0	5.0	95.2	0.6	2.1	0.3	8.9	4.1	15.8	5.4	32.7	0.0	37.8	3.2	0.1	0.4	17.4	9.3	79.2	20.4	0.6	4.9	211.1	237.9	26.1	27.7	11.9	0.2	0.1	0.3	82.6	18.1	31.5	5.8	2.3	0.5	2.1	4.6	0.1	0.1	0.3	1.4	6.3	0.2	0.2	1.7	3.2	1.7	1.3	48.7	0.4	12.7	7.3	8.3	13.4	13.1	7.5	7.7	14.6	10.0	12.6	7.8	20.1	10.8	100.2	38.5	42.2	0.0	14.5	14.5	1.2	15.3	3.4	1.1	38.3	26.7	55.1	70.1	9.9	95.6	70.9	170.8	83.8	29.6	197.6	75.7	1.4	31.7	161.0	116.9	9.7	10.1	11.0	2.0	20.1	139.5	3.6	36.4	25.3	50.6	187.4	3.7	1756.4	8.4	2.8	7.6	2.0	175.2	77.9	4.5	122.4	287.4	12.4	92.8	10.9	81.5	63.8	27.2	0.3	6.5	10.2	64.3	1.4	7.0	33.8	1653.7	7.5	3.5	6.6	62.4	50.4	0.5	4.8	3.5	13.4	1324.5	13.4	104.8	27.5	1.3
DACT1	"DAPPER, DAPPER1, FRODO, HDPR1, THYEX3"	ENSG00000165617	"Dishevelled binding antagonist of beta catenin 1"	Q9NYF0	14	58633967-58648321	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.0;Late spermatids: 17.9;Peritubular cells: 27.8;Smooth muscle cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 13.5;SuSa: 17.2;U-138 MG: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003016, HPA074619"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA003016: AB_1078623, HPA074619: "	"unprognostic (2.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	8.6	7.9	5.2	4.1	4.2	1.5	6.5	17.4	3.3	12.0	0.6	6.3	5.9	7.6	5.8	2.9	5.9	24.9	8.0	3.6	2.5	5.5	2.7	9.3	4.1	1.6	3.2	24.4	2.3	8.0	3.8	12.1	2.0	11.8	6.7	2.0	3.5	13.1	2.4	2.7	3.9	8.9	2.0	7.2	6.9	9.8	2.4	3.6	10.7	4.4	2.3	14.0	6.6	3.4	0.0	0.0	4.0	0.1	4.5	5.0	0.1	2.3	2.9	2.4	2.1	0.3	0.2	0.0	0.1	6.9	4.0	3.6	11.5	0.0	1.3	2.7	2.4	0.0	0.1	0.0	8.2	0.0	1.3	5.9	0.3	9.0	0.0	9.0	0.1	0.8	0.0	0.0	1.6	0.0	0.9	0.1	3.8	0.2	0.9	4.9	5.6	0.0	0.0	0.0	0.1	0.0	6.5	0.0	13.5	17.2	0.0	0.4	0.0	31.7	10.8	0.5	8.5	4.4	1.8	0.0	3.4	1.4	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.2	4.2	17.4	3.3	3.6	2.5	1.6	3.2	2.0	2.0	2.4	3.4	1.1	0.0	0.0	0.3	1.0	0.8	1.2	0.0	1.2	0.4	0.3	1.5	3.9	7.2	0.0	1.8	0.0	0.2	0.2	0.3	0.0	1.7	56.0	0.4	9.3	1.4	0.0	0.0	2.7	2.3	0.8	11.7	2.0	0.3	0.0	2.3	4.2	0.0	1.2	0.0	4.0	1.0	0.0	2.9	2.1	17.9	12.2	0.6	1.8	6.5	0.0	4.5	0.0	1.5	0.8	3.1	0.0	27.8	0.6	0.4	0.0	1.0	0.0	0.5	0.0	2.9	15.7	12.6	8.6	0.3	1.3	0.1	0.5	3.6	0.5	0.4
DACT3	"DAPPER3, MGC15476, RRR1"	ENSG00000197380	"Dishevelled binding antagonist of beta catenin 3"	Q96B18	19	46647551-46661182	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Oligodendrocytes: 27.2;Smooth muscle cells: 22.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 10.5;SH-SY5Y: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoplasm	"HPA043053: AB_10794769"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.30e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.59e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.66e-4)"	9.1	3.3	42.1	5.9	42.0	1.4	5.4	41.1	54.4	34.7	3.6	53.9	3.9	48.2	14.3	7.4	37.4	7.2	27.5	48.6	33.4	5.9	2.6	14.0	1.1	45.4	40.1	17.0	1.1	1.9	4.1	1.7	39.9	19.7	6.7	5.8	1.7	24.6	2.2	4.1	13.0	31.6	34.7	6.8	18.0	18.7	46.3	0.5	4.8	2.9	0.9	39.0	15.9	58.0	0.2	0.2	5.6	5.3	1.9	1.5	0.5	3.1	5.2	1.0	1.5	0.2	0.3	0.5	2.0	10.5	1.0	0.3	3.6	0.1	1.0	0.3	1.9	1.2	0.8	0.2	2.7	0.1	2.1	4.9	0.1	1.3	0.1	0.6	0.4	0.7	1.8	1.8	0.9	0.4	0.2	1.4	2.2	0.0	0.8	4.6	1.3	0.3	0.2	0.3	2.1	24.6	0.4	0.2	0.4	5.7	0.4	0.5	0.4	2.6	3.2	2.6	0.5	1.6	0.5	0.8	0.5	0.8	1.9	2.6	0.3	0.3	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.5	0.2	0.2	1.6	0.7	0.2	0.3	0.2	0.1	42.1	42.0	41.1	54.4	48.6	33.4	45.4	40.1	39.9	34.7	46.3	58.0	1.9	6.4	5.5	13.7	0.2	2.3	1.5	0.0	0.0	16.5	1.0	2.4	17.8	1.5	0.7	0.0	2.1	5.4	0.5	0.3	0.0	0.0	23.9	0.4	9.3	3.1	1.8	0.0	9.2	0.0	2.6	7.4	0.0	0.8	6.3	0.5	1.8	0.2	1.1	1.7	16.7	0.2	2.0	1.6	9.2	8.6	7.8	1.4	3.6	7.5	1.2	9.2	2.1	15.1	27.2	0.1	1.2	14.7	0.1	1.0	0.2	0.3	0.2	6.3	6.6	2.3	22.9	2.3	2.5	0.4	3.3	9.9	1.0	4.3	0.2	1.0
DAO	"DAAO, DAMOX"	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 71.4;kidney: 90.3;liver: 149.9"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 46.1;Proximal tubular cells: 86.8"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Group enriched"	"Detected in some"	10	"cerebellum: 66.4;pons and medulla: 20.2"	"Low region specificity"	"Detected in all"			"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.1	0.0	0.9	0.0	6.9	0.0	0.0	71.4	1.6	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.3	90.3	149.9	0.2	0.0	41.9	14.8	0.0	0.2	0.0	0.0	0.0	29.5	0.0	2.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	44.0	0.1	0.1	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.9	71.4	1.6	0.8	3.3	41.9	14.8	29.5	44.0	4.3	59.1	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.7	0.0	4.6	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	46.1	0.2	0.0	1.2	0.0	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	86.8	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	0.0	0.2	0.0
DBF4	"ASK, chif, DBF4A, ZDBF1"	ENSG00000006634	"DBF4 zinc finger"	Q9UBU7	7	87876216-87909553	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 15.1"	"Group enriched"	"Detected in all"	4	"Early spermatids: 468.6;Spermatocytes: 569.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042923			Supported	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA042923: AB_2678222"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (6.42e-7)"	"unprognostic (1.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	0.1	0.2	0.2	0.2	0.4	0.6	0.2	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.3	0.2	15.1	0.2	0.6	0.3	0.0	0.5	0.1	0.1	0.3	0.9	0.8	2.0	2.5	0.4	0.4	0.5	1.0	0.2	1.0	2.1	1.4	0.6	2.1	0.6	0.6	1.7	0.9	2.2	0.5	1.0	1.6	1.3	1.3	1.0	0.4	0.1	1.7	1.0	0.4	0.6	1.2	1.0	0.3	0.9	1.9	1.2	4.2	1.4	1.7	2.8	2.0	2.0	2.1	1.9	0.7	3.1	2.5	0.8	0.1	3.0	1.8	1.2	2.2	1.0	1.6	0.9	1.6	0.1	1.2	1.4	3.1	2.0	2.3	5.2	2.1	0.8	3.1	2.5	1.0	0.1	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.4	0.1	0.2	0.4	0.7	0.4	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	13.3	3.2	12.6	5.5	38.4	15.6	16.4	10.7	12.0	6.6	13.0	16.8	3.7	2.8	7.7	9.2	12.5	19.6	59.2	9.7	3.9	8.3	468.6	12.1	23.6	11.1	14.9	40.8	14.7	14.7	36.4	12.4	14.3	17.7	31.0	19.4	6.4	6.5	16.1	3.3	9.1	20.6	16.2	9.1	15.5	116.0	15.5	20.8	12.4	2.8	11.0	2.1	24.7	6.0	6.7	14.1	8.5	9.4	48.9	18.4	4.2	5.8	10.2	16.6	13.1	9.7	11.4	569.4	74.6	20.5	12.6	9.6	44.4	13.5	22.3	11.7
DBI	"ACBD1, ACBP"	ENSG00000155368	"Diazepam binding inhibitor, acyl-CoA binding protein"	P07108	2	119366921-119372560	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 2215.1;Proximal tubular cells: 2834.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 2479.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051428	Approved					NA	NA		9100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA051428: AB_2681482"	"unprognostic (1.24e-1)"	"prognostic favorable (5.77e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.45e-1)"	358.3	153.9	486.0	158.7	470.8	121.9	717.3	495.6	726.7	218.6	452.3	322.8	312.8	73.5	653.7	667.7	85.8	129.7	515.4	493.0	498.5	536.2	971.1	236.0	182.9	499.4	495.1	86.0	143.8	866.9	76.9	116.3	510.0	451.5	297.3	116.3	369.9	215.1	273.0	451.0	229.6	97.2	512.7	115.5	185.1	201.3	487.6	173.3	133.7	460.5	324.5	136.5	327.7	516.4	543.0	276.9	557.1	257.2	1339.7	1131.9	350.7	281.3	708.7	387.0	746.1	580.6	427.8	747.3	312.1	440.6	938.5	277.9	397.0	588.3	345.9	498.2	262.1	641.4	279.9	775.8	335.6	206.1	2479.2	648.2	376.5	596.2	222.1	255.4	464.3	358.8	77.0	679.2	558.8	559.1	436.5	585.9	370.2	349.7	429.7	157.4	541.4	658.5	948.1	816.5	263.2	210.1	235.3	548.5	634.9	388.8	338.0	952.8	332.5	259.3	329.8	288.8	346.3	220.9	170.5	610.0	365.7	364.8	315.3	1180.7	439.9	1077.9	472.9	489.1	347.3	461.4	367.8	465.2	748.8	505.3	279.1	419.2	285.8	450.7	402.5	791.0	615.7	792.2	486.0	470.8	495.6	726.7	493.0	498.5	499.4	495.1	510.0	512.7	487.6	516.4	505.2	150.6	613.0	46.0	256.7	289.2	249.4	724.2	190.1	37.9	806.5	1025.9	1079.6	663.4	390.0	310.8	14.6	796.5	395.6	737.5	1197.4	466.9	844.4	154.8	194.7	206.2	371.3	108.8	5.2	670.3	643.2	258.2	243.1	185.6	433.4	219.4	167.8	2215.1	1069.4	30.3	3.9	495.0	524.9	305.0	785.7	325.7	152.2	476.1	1058.3	15.0	871.5	928.6	552.0	33.2	25.0	372.7	612.0	127.5	192.0	355.0	753.6	2834.8	340.5	59.1	151.2	267.2	289.9	462.0	30.1	972.6	684.9	516.3	260.8	456.0	673.2	361.0
DBX2	FLJ16139	ENSG00000185610	"Developing brain homeobox 2"	Q6ZNG2	12	45014672-45051099	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"brain: 9.3"	"Group enriched"	"Detected in some"	9	"Astrocytes: 11.4;Oligodendrocyte precursor cells: 14.1;Spermatogonia: 5.1"	"Cancer enriched"	"Detected in single"	32	"glioma: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065045, HPA066053"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane"	Vesicles	"HPA065045: , HPA066053: AB_2685605"	"unprognostic (1.13e-4)"			"unprognostic (9.99e-2)"	"unprognostic (7.82e-3)"	"unprognostic (5.24e-2)"				"unprognostic (5.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.22e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.19e-1)"		0.4	0.0	3.6	0.0	4.0	0.0	0.2	3.7	3.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	3.6	0.1	0.0	0.0	0.0	8.2	4.6	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	9.3	0.0	0.0	0.6	5.2	0.0	0.2	0.2	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.0	3.7	3.7	3.4	3.6	8.2	4.6	5.6	9.3	5.2	7.4	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0
DCHS1	"CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16"	ENSG00000166341	"Dachsous cadherin-related 1"	Q96JQ0	11	6621330-6655809	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 34.8;Endometrial stromal cells: 17.3;Endothelial cells: 29.0;Fibroblasts: 17.0;Granulosa cells: 19.3;Hepatic stellate cells: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 33.5;HUVEC TERT2: 47.1;REH: 23.5;SH-SY5Y: 32.4;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017970, HPA050246"	Approved		Approved	"Plasma membrane"		NA	NA		4000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA017970: AB_2669718, HPA050246: AB_2681062"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.52e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-3)"	9.4	2.5	7.4	8.4	6.8	0.7	9.3	6.1	6.3	19.5	0.9	19.0	4.1	28.9	2.4	5.0	13.2	8.3	9.2	6.6	10.1	4.6	2.0	10.1	4.0	7.6	6.3	11.6	3.3	2.0	3.2	10.1	5.7	9.3	3.4	0.6	3.5	11.5	4.2	3.7	8.3	16.2	4.7	12.9	8.2	3.0	8.7	3.8	4.1	4.6	2.2	14.8	9.3	3.8	0.0	0.1	33.5	0.1	0.0	0.1	0.3	1.2	8.7	5.4	6.0	0.3	0.0	0.1	5.1	9.9	0.4	0.0	2.7	0.1	3.7	0.1	0.9	0.7	0.0	0.0	0.3	0.2	0.0	1.0	0.1	2.5	0.0	0.0	47.1	0.1	0.2	0.0	2.0	0.0	1.2	0.6	5.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	2.4	32.4	0.0	0.3	0.2	3.5	0.0	1.3	20.4	0.1	10.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	7.4	6.8	6.1	6.3	6.6	10.1	7.6	6.3	5.7	4.7	8.7	3.8	34.8	0.0	0.5	12.1	0.2	2.9	0.3	0.0	0.0	1.5	1.7	3.0	3.8	4.3	0.0	0.0	0.0	0.2	1.4	0.2	0.0	1.0	3.1	0.8	17.3	29.0	0.0	2.7	2.0	0.4	0.3	17.0	1.1	0.7	0.0	19.3	61.1	0.2	2.2	0.0	7.4	0.7	0.0	4.7	4.2	3.4	1.2	2.4	16.0	4.7	0.2	0.9	0.0	10.1	1.4	0.1	0.1	1.9	0.2	0.3	0.1	0.1	0.0	0.5	0.0	7.4	4.9	4.9	0.6	0.5	1.7	0.3	1.2	4.6	1.1	0.1
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Differentiation, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 4.5;epididymis: 2.0;lung: 3.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 7.1;Macrophages: 6.5"	"Cancer enriched"	"Detected in some"	46	"thyroid cancer: 45.3"	"Group enriched"	"Detected in some"	4	"amygdala: 4.5;basal ganglia: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.61e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.34e-3)"	0.8	0.0	4.5	0.1	2.6	0.2	0.3	0.0	0.8	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.8	0.1	0.0	0.4	3.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.5	2.6	0.0	0.8	0.8	0.1	0.0	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCXR	"DCR, HCR2, KIDCR, P34H, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037709	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 1851.6"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4"	"Group enriched"	"Detected in all"	5	"liver cancer: 305.9;prostate cancer: 163.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 365.2;MCF7: 446.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		NA	NA		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	106.7	43.9	93.1	15.2	95.3	25.3	107.6	102.5	111.1	52.0	84.4	49.6	29.2	39.5	281.3	96.6	59.2	10.8	132.7	87.6	100.7	239.9	1851.6	61.0	16.6	102.4	98.0	70.0	71.6	46.1	63.9	20.2	105.9	138.0	20.9	9.7	103.4	33.6	187.3	87.6	44.4	10.4	91.8	35.8	167.0	44.8	105.9	26.1	60.7	80.6	19.6	48.9	62.1	94.9	50.3	68.2	32.8	56.4	123.2	31.8	80.4	25.0	33.9	68.5	48.4	122.0	21.3	100.3	47.4	35.9	9.4	57.4	59.6	52.6	24.1	21.4	145.9	96.9	48.8	365.2	143.2	75.6	114.5	44.6	62.2	22.7	79.8	16.0	41.1	61.1	112.4	76.3	36.5	446.2	63.7	184.1	35.0	242.9	71.3	57.9	42.0	135.3	53.3	71.9	85.5	51.0	35.5	287.5	46.0	19.7	213.4	74.5	20.5	36.6	45.0	48.9	48.2	73.7	56.2	50.2	31.4	83.0	26.7	49.5	92.6	77.9	66.5	92.0	64.1	86.8	83.0	64.7	151.3	99.2	117.7	85.4	47.2	108.9	88.1	121.6	98.9	110.1	93.1	95.3	102.5	111.1	87.6	100.7	102.4	98.0	105.9	91.8	105.9	94.9	29.0	51.3	198.2	16.6	133.6	58.5	200.3	113.5	109.8	16.0	301.8	269.2	120.7	183.0	123.4	178.4	18.8	372.1	116.6	152.9	812.0	41.4	6.0	67.0	50.9	44.6	54.7	335.7	4.7	42.6	450.6	65.0	151.4	102.3	64.7	62.7	138.5	3510.3	164.7	21.9	9.0	170.4	189.2	165.7	65.6	22.6	70.8	82.3	179.7	1.9	52.8	145.1	78.2	5.5	10.5	30.4	135.7	47.4	98.6	215.2	158.9	2919.4	55.4	26.5	19.7	40.6	79.6	10.3	48.2	219.9	73.2	342.6	135.7	118.6	154.6	178.8
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	96.5	17.2	26.6	12.0	24.7	10.8	81.2	24.2	44.7	131.5	26.1	72.2	4.4	94.4	8.7	39.0	80.5	44.0	63.2	23.9	33.5	67.1	32.1	62.3	20.6	31.8	28.2	67.7	16.5	17.5	26.0	18.3	28.1	65.2	7.7	5.8	58.2	27.0	13.4	67.7	38.9	11.9	32.0	49.4	35.4	13.4	27.4	9.6	65.1	4.5	7.8	61.0	91.0	30.9	2.0	20.1	0.7	28.5	17.0	26.6	3.8	0.0	10.6	10.9	7.3	40.4	6.7	0.4	24.4	26.5	0.9	2.4	0.5	9.7	1.9	0.0	14.2	1.9	7.8	22.4	18.2	0.3	1.5	18.8	1.2	12.2	0.9	3.7	33.3	14.1	0.4	11.1	4.8	63.0	1.5	27.5	4.1	4.3	12.2	0.2	0.9	10.5	21.6	0.5	1.5	5.7	0.0	4.7	27.4	2.9	37.7	7.8	0.1	16.9	24.7	11.2	0.0	4.1	12.8	3.3	11.3	5.9	4.3	141.3	15.4	135.0	14.8	37.4	5.8	49.7	4.0	5.3	26.8	39.6	2.7	3.4	27.8	29.2	44.9	93.9	4.1	11.4	26.6	24.7	24.2	44.7	23.9	33.5	31.8	28.2	28.1	32.0	27.4	30.9	102.3	28.9	14.7	10.4	76.8	66.9	88.7	49.6	56.3	4.5	132.8	96.0	39.5	62.9	36.9	82.8	29.2	15.5	84.4	386.3	178.1	148.2	83.1	62.6	94.2	101.2	150.0	20.4	0.3	32.3	37.3	154.1	33.1	75.0	113.3	121.7	94.9	31.9	223.2	0.0	0.3	71.5	109.9	139.7	301.2	23.6	180.5	95.7	103.2	14.0	64.2	120.9	40.2	4.5	2.7	85.1	299.5	153.1	24.5	95.2	61.5	165.8	50.5	25.7	105.2	122.7	153.0	4.1	12.5	35.8	59.2	18.1	41.1	21.3	104.6	67.0
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.8;kidney: 314.9;retina: 175.6"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Group enriched"	"Detected in many"	9	"midbrain: 86.3;pons: 29.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	48.9	0.1	2.3	0.7	0.0	1.0	0.0	0.6	0.0	0.2	36.5	154.8	0.0	9.1	0.1	0.0	0.1	0.0	0.2	2.2	314.9	54.6	2.0	0.1	6.1	86.3	0.8	15.8	0.0	0.0	0.0	29.4	0.6	37.5	175.6	0.0	0.0	0.0	0.1	165.8	1.7	0.0	0.1	18.1	1.5	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.2	2.2	6.1	86.3	29.4	0.0	1.9	0.2	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
DDN	KIAA0749	ENSG00000181418	Dendrin	O94850	12	48995149-48999375	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 165.7;skeletal muscle: 297.1"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Excitatory neurons: 5.9;Inhibitory neurons: 2.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2;head and neck cancer: 2.6"	"Group enriched"	"Detected in many"	31	"amygdala: 142.5;basal ganglia: 115.5;cerebral cortex: 165.7;hippocampal formation: 126.2;white matter: 54.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.0;NB-4: 7.0;RPMI-8226: 23.3;SCLC-21H: 11.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"amygdala: 165.3;basal ganglia: 212.8;cerebral cortex: 178.3;hippocampal formation: 171.2;olfactory bulb: 62.7"	HPA060952	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA060952: AB_2684396"	"unprognostic (2.80e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.56e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.20e-5)"	"unprognostic (8.61e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-6)"	"unprognostic (1.72e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.53e-2)"	0.1	0.1	142.5	0.2	115.5	1.0	0.1	0.0	165.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	126.2	0.0	19.5	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	1.3	0.0	0.0	1.4	0.0	0.3	1.6	0.0	297.1	0.3	0.1	0.0	0.0	0.3	0.3	0.2	3.9	0.0	0.1	9.2	0.2	0.0	0.1	54.2	0.4	0.4	0.2	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	5.2	0.5	0.0	0.2	0.1	0.0	1.8	12.0	0.0	0.1	0.6	5.4	2.7	0.6	1.2	0.0	6.5	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.0	4.0	0.2	0.2	6.3	7.0	0.1	0.9	1.6	5.7	0.3	23.3	0.0	0.1	11.8	1.1	0.2	0.6	0.3	0.1	0.3	0.9	0.1	0.3	0.5	0.3	0.0	1.4	2.8	5.5	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	142.5	115.5	0.0	165.7	126.2	0.0	0.0	0.2	0.0	0.0	3.9	54.2	0.4	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.4	0.6	0.0	0.0	3.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.8	5.9	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415575	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.4;Muller glia cells: 8.2;Oligodendrocytes: 13.3;Paneth cells: 8.5;Proximal enterocytes: 8.5;Proximal tubular cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.3;myeloid DC: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.5;RPMI-8226: 15.9;U-937: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	1.9	8.2	4.5	0.8	7.0	1.4	2.5	5.0	4.8	1.9	4.3	2.3	7.4	2.1	2.7	0.8	4.9	2.9	18.4	4.4	4.5	10.6	11.1	3.2	1.0	5.4	4.9	0.3	2.6	5.3	1.2	1.6	5.3	2.0	3.2	2.4	4.2	2.3	10.9	0.4	7.0	2.2	4.8	2.1	1.1	0.1	4.7	0.4	1.3	7.4	0.2	1.6	0.9	5.9	0.2	0.0	0.0	0.1	0.0	0.2	1.1	0.1	5.4	1.3	0.9	0.0	0.1	0.0	0.7	0.7	11.5	0.0	0.0	0.0	2.3	5.0	0.0	5.1	0.1	4.3	1.6	0.0	0.0	0.1	0.0	2.7	0.1	2.3	0.0	0.0	0.0	1.9	4.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	3.0	15.9	0.0	4.9	0.1	0.2	0.0	0.5	0.6	0.0	0.7	1.1	0.9	1.0	0.1	0.0	2.6	0.1	0.4	0.0	2.0	17.4	0.0	0.0	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	1.1	4.5	7.0	5.0	4.8	4.4	4.5	5.4	4.9	5.3	4.8	4.7	5.9	1.1	0.0	0.0	4.9	0.0	0.0	0.7	0.7	0.6	0.0	1.4	1.1	17.4	0.0	0.4	0.0	2.1	0.2	0.1	1.8	3.9	4.5	0.3	3.6	0.5	0.7	4.2	0.0	0.0	2.2	0.2	0.6	0.0	0.9	0.0	0.1	2.5	4.9	1.7	0.0	0.1	6.0	0.0	3.1	0.4	0.0	0.3	1.6	0.0	0.0	2.0	8.2	0.0	3.5	13.3	0.8	8.5	0.0	0.0	0.4	8.5	12.9	2.2	0.2	0.0	2.1	1.2	0.0	0.0	0.2	0.0	0.0	0.2	0.3	5.0	0.5
DECR2	"PDCR, SDR17C1"	ENSG00000242612	"2,4-dienoyl-CoA reductase 2"	Q9NUI1	16	401858-412487	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 165.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 129.2;Proximal enterocytes: 81.3;Proximal tubular cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047631			Approved	Peroxisomes,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Peroxisomes	Microtubules	"HPA047631: "	"unprognostic (2.74e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.22e-3)"	13.0	34.8	5.5	1.6	5.7	5.8	11.8	5.5	8.1	9.6	5.4	18.5	20.6	10.0	2.0	12.0	9.2	2.1	12.4	6.0	6.6	35.8	165.1	6.8	1.2	5.6	5.5	8.6	21.2	1.7	8.4	2.4	5.5	11.9	2.8	0.5	9.5	7.1	32.3	10.5	17.4	1.5	5.5	6.8	13.8	11.4	6.1	1.8	6.3	7.2	1.0	10.7	8.1	6.1	2.4	22.5	3.4	14.7	4.1	6.3	7.7	7.0	5.7	6.0	6.7	16.2	16.2	6.1	12.2	7.5	3.7	3.5	2.1	6.4	1.3	12.4	5.7	2.3	10.3	37.6	17.7	4.9	11.1	9.1	4.8	4.2	5.5	6.1	6.9	9.5	4.3	7.9	5.5	27.7	3.2	10.2	8.0	9.0	7.5	5.8	1.3	12.2	6.9	6.3	4.3	8.5	11.3	15.9	8.8	1.3	21.9	10.1	10.8	5.1	5.8	7.5	5.6	6.7	7.1	2.6	7.0	10.2	16.1	0.0	3.8	0.1	2.7	5.1	1.5	1.8	1.1	1.5	5.1	1.7	2.6	1.5	0.2	2.9	2.5	7.8	0.9	2.6	5.5	5.7	5.5	8.1	6.0	6.6	5.6	5.5	5.5	5.5	6.1	6.1	9.6	12.8	16.2	5.2	4.3	3.8	7.3	5.6	10.2	2.0	14.9	15.6	8.3	20.0	7.4	20.2	0.0	34.3	5.7	53.8	39.2	37.3	2.6	7.1	8.1	9.4	12.5	29.5	2.3	38.9	7.1	9.9	38.7	9.6	12.7	15.8	7.5	129.2	12.9	3.3	2.7	30.6	6.1	7.3	5.7	6.3	6.5	6.0	5.4	0.0	10.0	7.0	5.2	3.0	2.8	25.3	37.2	6.8	3.8	6.4	81.3	159.1	7.7	3.0	0.0	7.7	8.3	3.8	6.3	12.6	6.0	12.6	3.5	25.8	38.8	5.1
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870592-6877936	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 1746.1;pancreas: 747.8;salivary gland: 1975.0"	"Cell type enriched"	"Detected in many"	6	"Distal tubular cells: 13300.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Group enriched"	"Detected in many"	4	"amygdala: 1.2;cerebellum: 1.5;hypothalamus: 1.0;midbrain: 2.4;thalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 43.3"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		2500000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favorable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	11.1	0.7	1.2	1.5	0.0	5.3	41.5	1.5	0.4	305.4	0.3	20.7	5.1	6.2	16.4	190.6	21.2	54.9	1.3	0.0	1.0	1746.1	248.4	5.7	0.0	0.0	2.4	0.5	747.8	6.9	12.7	2.1	0.2	37.9	11.5	1.9	1975.0	24.5	2.9	217.6	8.7	0.3	0.0	0.3	33.3	0.4	3.0	3.0	3.6	0.0	9.0	11.6	152.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.0	0.5	0.0	2.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	4.2	0.0	0.1	0.3	0.0	2.7	1.2	43.3	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	0.4	0.0	1.0	0.0	2.4	0.2	0.0	3.0	0.2	0.7	3.2	4.5	0.0	6.8	90.1	641.5	210.5	134.9	0.4	46.9	26.9	0.1	1976.0	57.2	982.1	0.0	11.8	0.4	117.6	13300.4	1860.0	0.0	339.5	223.6	8.8	15.7	0.0	0.0	295.4	0.9	19.0	1.5	1529.3	0.0	0.0	3.3	319.3	3.6	0.0	0.0	8.6	46.8	4.4	7.3	0.1	17.4	17.0	7.2	0.0	15.3	0.6	0.0	0.0	0.0	156.9	91.2	0.0	1.2	537.6	59.1	218.9	9.5	0.7	0.0	1.4	14.3	0.0	0.0	237.0	537.6	3.7	13.8	0.0	15.4	257.0
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.7;skeletal muscle: 41.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.1;Basal prostatic cells: 138.2;Glandular and luminal cells: 192.7;Squamous epithelial cells: 114.9;Suprabasal keratinocytes: 171.8;Urothelial cells: 340.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 11.8;U-266/70: 25.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029935, HPA054955"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA029935: AB_10601208, HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	0.9	0.5	0.8	0.3	0.8	1.0	1.9	0.9	0.9	4.2	2.2	0.6	0.7	1.5	0.8	17.7	0.9	1.2	1.1	1.1	0.4	0.6	2.0	1.5	0.4	0.6	0.6	1.1	1.2	1.7	0.6	0.1	0.7	1.4	0.6	1.5	2.7	1.4	41.6	12.4	0.6	1.1	0.3	0.4	0.9	5.5	0.6	0.4	1.4	1.7	3.4	2.6	7.0	0.5	2.1	0.0	0.1	1.4	1.7	1.8	0.4	0.6	1.1	0.7	1.1	0.3	0.0	0.1	0.9	4.1	1.4	7.4	1.4	4.6	0.7	0.1	1.8	1.2	0.4	0.1	0.5	0.0	1.8	1.8	4.4	2.7	2.3	0.1	0.2	0.5	0.2	0.3	2.4	6.0	0.2	0.1	0.9	0.0	1.1	0.0	6.2	0.1	0.1	5.7	0.0	0.0	4.5	0.1	0.5	1.1	0.9	0.3	0.3	1.0	1.5	11.8	0.2	25.4	4.8	0.0	1.0	0.0	0.8	3.0	0.0	0.9	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.8	0.8	0.9	0.9	1.1	0.4	0.6	0.6	0.7	0.3	0.6	0.5	6.6	28.9	2.2	3.3	3.3	109.1	138.2	32.5	60.3	20.4	5.2	5.3	8.7	11.5	21.3	7.3	20.9	0.1	1.9	1.1	0.0	7.2	29.5	100.3	15.7	8.6	0.0	0.0	2.8	7.5	0.1	6.9	5.6	192.7	2.5	8.1	15.4	11.7	0.3	0.0	0.8	0.9	4.1	2.2	9.3	12.9	5.0	14.0	7.2	9.4	1.1	2.3	1.0	5.0	3.5	33.0	0.2	2.2	17.6	79.5	0.1	0.8	46.8	10.3	0.0	21.7	6.6	47.9	59.7	114.9	171.8	0.0	3.7	1.3	1.5	340.4
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;gallbladder: 21.0;lymphoid tissue: 20.7;testis: 12.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: AB_2686534"	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.42e-4)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (3.08e-4)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.3	0.2	0.4	3.9	0.7	11.1	0.9	0.5	0.5	0.6	0.1	4.1	6.0	0.6	0.0	2.5	0.2	21.0	0.1	0.3	0.6	2.9	0.4	0.4	9.1	1.2	0.5	0.2	0.1	0.0	0.0	7.5	1.4	0.2	5.5	0.1	0.5	0.1	0.0	2.1	6.4	0.9	0.6	1.6	1.4	12.6	0.6	20.7	1.2	0.0	9.7	1.0	1.1	1.5	61.0	20.3	60.5	37.2	1.3	1.9	66.2	16.1	10.9	27.7	35.8	34.0	37.5	34.6	38.5	5.0	36.0	19.8	49.2	36.1	36.9	49.5	35.5	43.3	22.7	42.6	1.0	36.7	40.3	1.2	3.7	9.0	12.9	5.4	26.1	36.3	31.4	45.8	24.7	38.0	59.8	31.9	44.7	13.0	32.6	65.4	49.2	29.4	22.8	29.9	33.6	15.4	37.7	13.4	17.7	27.0	24.9	28.8	12.1	11.7	34.2	9.5	41.6	23.0	43.3	68.0	14.7	53.2	33.3	1.5	0.1	0.9	0.2	0.0	0.2	0.4	1.0	0.7	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	3.2	0.4	0.4	0.7	0.5	0.5	0.3	0.6	1.2	0.5	1.4	0.6	0.6	1.5	0.2	0.0	1.8	0.0	1.9	4.7	1.0	1.5	0.0	0.1	0.5	0.8	0.1	18.6	0.3	0.0	0.0	7.4	1.1	3.1	0.0	0.3	1.9	3.3	1.4	0.9	0.0	23.8	5.5	0.2	21.6	1.1	2.6	11.7	3.8	5.2	0.0	0.3	6.4	0.0	1.7	2.3	0.0	1.6	2.9	2.4	0.3	1.9	0.0	4.7	0.1	0.2	0.0	2.0	7.0	0.9	5.8	0.0	15.9	0.7	3.7	1.0	0.1	0.1	6.6	0.3	1.4	37.2	12.7	5.8	2.0	46.9	4.5	0.6	7.9	0.9
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015876-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 29.0;kidney: 19.6;liver: 74.0;testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 34.8;Early spermatids: 153.3;Extravillous trophoblasts: 47.0;Proximal enterocytes: 33.2;Spermatocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 53.7;RH-30: 40.1;SiHa: 37.3;SK-MEL-30: 34.4;U-2197: 34.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.8	2.5	1.9	3.2	1.8	0.9	2.9	3.7	2.8	2.7	4.6	24.6	1.0	2.2	4.4	0.9	4.4	1.1	2.6	2.7	19.6	74.0	0.9	0.7	3.2	2.7	1.6	3.8	2.3	0.8	1.5	3.0	1.9	5.1	0.1	2.0	1.5	4.9	6.0	29.0	1.7	2.8	0.3	3.0	28.2	2.7	2.9	0.5	0.9	1.5	1.2	3.4	4.9	9.4	5.2	7.3	3.3	3.8	3.6	4.9	16.2	5.4	9.8	13.0	13.5	0.9	0.0	3.7	16.2	4.5	9.4	10.8	3.8	11.5	0.0	14.9	2.5	16.1	19.3	3.2	9.1	10.9	4.6	5.7	5.7	4.2	5.3	0.0	0.0	6.2	0.0	53.7	1.0	0.0	14.6	4.8	7.7	0.0	0.0	40.1	0.1	3.2	1.3	1.6	4.2	37.3	6.6	34.4	5.1	1.7	4.7	0.0	6.3	10.4	34.1	10.6	0.0	0.0	0.1	2.3	0.0	31.5	4.1	0.5	6.7	0.2	0.1	0.0	0.0	0.4	0.2	3.2	0.0	1.9	2.1	0.0	2.4	0.0	1.2	0.0	0.4	2.5	3.2	2.9	3.7	2.6	2.7	3.2	2.7	3.0	2.8	2.7	4.9	0.2	0.0	0.0	1.0	0.0	34.8	12.8	4.5	12.5	0.0	0.2	0.6	0.1	1.5	0.9	0.0	0.0	0.5	0.5	6.0	3.9	0.9	153.3	0.2	0.2	0.3	3.5	3.2	0.1	0.6	47.0	1.6	0.0	0.1	2.5	0.1	1.4	22.6	3.1	0.0	0.4	2.4	0.0	0.6	9.5	16.3	1.5	1.7	1.8	3.7	1.2	0.0	0.0	3.5	10.4	0.8	0.6	1.2	0.1	2.4	33.2	18.4	0.9	0.0	0.0	4.5	1.4	42.3	6.5	6.6	7.4	1.5	0.7	0.2	2.4	1.6
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933699-48944969	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 17.3;kidney: 18.0"	"Group enriched"	"Detected in many"	11	"Proximal enterocytes: 213.7;Proximal tubular cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.2"	"Group enriched"	"Detected in many"	33	"granulocytes: 4.2;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"JURKAT: 3.2;U-266/70: 3.2;U-266/84: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Actin filaments"		"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.2	0.4	1.6	0.0	1.6	0.1	0.2	1.9	3.3	0.3	1.0	0.3	10.5	0.1	0.0	0.8	0.3	0.2	0.1	1.7	1.7	18.0	0.4	1.1	0.2	1.2	1.3	0.6	0.4	0.5	1.8	1.3	1.2	3.2	0.0	1.7	0.4	0.1	0.2	0.2	17.3	0.0	1.3	1.7	0.7	1.9	2.7	0.1	0.1	0.0	0.2	0.3	0.4	1.6	1.4	0.0	0.1	0.7	0.4	0.3	0.5	0.0	0.2	0.2	0.7	1.4	1.1	0.0	0.2	0.0	0.9	0.4	0.5	1.0	0.4	0.5	1.1	2.0	0.5	0.5	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.3	0.0	3.2	0.7	0.2	0.0	0.3	0.0	0.1	0.3	2.1	0.9	0.7	0.1	1.0	0.1	0.4	2.1	1.1	0.2	0.1	0.5	0.1	1.0	0.0	0.0	0.0	0.8	0.3	0.0	3.2	2.8	0.8	0.7	0.0	0.2	4.2	0.0	0.5	0.7	0.0	0.4	0.0	0.8	0.3	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	0.6	0.2	1.6	1.6	1.9	3.3	1.7	1.7	1.2	1.3	1.2	1.3	2.7	1.6	0.5	3.2	6.4	1.0	1.0	0.8	2.4	3.3	2.2	2.4	1.0	3.4	0.7	1.5	4.6	3.7	0.0	0.2	0.4	1.5	9.8	2.2	0.7	0.3	0.5	0.8	0.0	0.4	1.0	0.4	0.2	0.5	4.1	0.8	1.3	0.1	0.0	0.0	12.9	0.0	1.2	5.0	2.0	0.8	0.0	2.4	0.0	1.7	0.0	0.0	0.0	1.6	0.0	0.0	0.5	1.5	3.6	0.0	0.0	3.5	213.7	77.8	0.5	4.5	0.0	1.2	0.4	0.0	0.8	3.1	0.1	0.1	0.6	0.4	2.7	3.2
DHRS4	"FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2"	ENSG00000157326	"Dehydrogenase/reductase 4"	Q9BTZ2	14	23953734-23969279	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 235.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.21e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.55e-6)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.68e-2)"	34.1	45.8	8.6	10.4	9.2	6.9	34.5	8.8	9.7	30.5	10.1	43.5	34.0	27.1	5.2	45.8	23.6	5.9	49.1	8.3	8.6	92.0	109.7	28.0	10.2	9.2	8.6	33.0	40.3	8.8	19.3	5.3	9.2	31.9	13.5	3.9	31.2	8.4	62.2	44.7	38.6	8.3	8.6	32.2	33.7	37.9	9.0	9.6	25.4	14.0	8.5	30.5	33.1	9.5	15.1	29.6	10.4	17.2	16.6	18.5	0.1	27.4	15.3	11.5	9.1	6.5	16.5	13.3	14.3	14.6	7.6	18.1	8.6	12.3	10.1	34.6	16.5	7.8	23.5	36.6	9.5	11.6	45.2	18.0	14.8	9.2	20.8	12.3	14.4	19.6	11.8	30.4	15.8	52.3	21.1	10.7	9.9	18.9	30.3	33.8	18.0	41.4	12.1	17.1	19.9	16.1	27.7	17.6	13.8	6.8	16.0	14.6	25.5	13.3	13.8	13.9	9.0	22.8	22.8	3.5	11.8	12.6	13.6	5.4	54.4	6.0	18.0	45.8	21.4	21.5	20.3	18.2	47.4	18.5	20.1	19.5	2.3	18.1	25.5	39.4	19.4	36.2	8.6	9.2	8.8	9.7	8.3	8.6	9.2	8.6	9.2	8.6	9.0	9.5	16.6	16.0	30.5	6.2	12.5	12.5	10.4	15.7	55.2	5.1	22.2	31.9	35.4	17.2	21.3	14.7	0.0	9.6	17.8	34.2	78.2	6.4	50.4	13.1	11.6	14.6	19.2	20.8	2.6	9.8	6.0	23.7	34.7	7.8	13.9	10.5	20.0	68.1	30.4	6.7	2.1	50.1	8.2	29.2	13.5	66.1	11.1	35.9	5.4	3.7	33.2	18.1	47.4	4.0	5.0	5.3	22.3	17.3	24.6	11.2	51.8	235.4	23.2	1.8	6.6	13.5	18.1	59.4	1.9	61.6	13.4	3.8	18.1	22.9	71.8	9.0
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 136.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 204.2;Proximal enterocytes: 326.4;Proximal tubular cells: 581.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"	"Secreted - unknown location"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	27.2	39.5	28.8	14.6	29.6	11.5	30.5	28.3	38.4	26.9	30.8	34.7	34.4	19.7	12.8	38.4	18.6	10.6	45.9	28.5	27.8	122.5	136.2	22.5	14.6	29.3	28.7	25.2	34.0	24.5	16.7	10.0	28.7	32.5	26.6	6.7	24.7	20.7	50.7	37.1	42.0	18.4	28.6	29.3	27.9	41.4	29.4	16.9	21.5	28.5	16.5	26.0	26.1	29.9	18.7	29.0	4.9	24.4	46.2	47.9	0.6	17.3	34.3	24.8	18.4	8.4	22.5	12.6	11.5	35.3	16.0	20.6	22.3	29.1	20.6	43.3	13.3	3.1	24.8	52.4	34.0	15.3	47.9	50.0	36.4	16.3	23.7	17.0	29.5	40.0	10.1	44.9	26.7	61.5	40.4	16.5	9.7	45.9	31.8	64.9	19.9	38.2	35.6	23.7	26.0	15.7	24.5	21.5	15.0	10.3	25.2	24.5	20.8	12.9	13.4	15.4	8.8	25.5	21.1	3.8	11.1	23.7	18.8	4.8	56.3	6.9	19.4	47.2	20.1	21.9	20.9	22.2	45.4	17.4	21.0	19.1	2.6	17.2	29.3	37.4	21.8	33.6	28.8	29.6	28.3	38.4	28.5	27.8	29.3	28.7	28.7	28.6	29.4	29.9	39.3	16.0	29.6	10.4	17.8	27.8	46.1	56.8	27.9	9.9	45.5	54.4	17.2	47.1	34.3	25.8	2.1	21.2	22.9	37.9	127.2	40.0	20.7	20.6	20.1	32.0	37.3	24.2	7.3	55.7	7.3	36.4	13.3	16.5	17.7	31.8	50.0	204.2	146.1	11.8	6.7	61.7	42.7	55.9	42.8	35.4	43.8	41.9	51.6	10.3	65.0	79.5	35.0	10.1	8.5	30.4	54.9	37.2	10.8	32.5	326.4	581.7	28.6	8.3	32.9	24.2	32.7	17.2	1.7	42.1	40.2	13.0	21.3	37.5	78.1	42.4
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068954-12123221	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 129.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 227.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037949: AB_2675752, HPA037950: AB_10673650, HPA066098: AB_2685617"	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	10.7	8.4	8.1	6.8	10.4	3.8	8.4	12.6	8.5	8.8	11.9	10.1	7.6	6.2	6.8	7.5	6.1	5.3	13.2	7.6	8.5	42.7	129.5	5.4	8.5	9.5	8.6	10.0	18.0	12.7	5.6	7.7	9.5	12.9	10.8	7.5	13.1	5.7	18.7	5.6	6.9	5.7	8.8	7.8	10.9	4.7	9.1	10.5	11.6	23.1	9.7	6.3	6.1	11.4	27.0	20.4	29.8	23.8	18.2	10.8	35.9	13.3	8.6	23.4	20.6	13.1	15.7	19.3	4.3	8.4	10.8	37.4	31.6	10.4	26.6	10.9	14.2	10.6	7.7	10.1	17.8	4.2	3.8	13.3	7.9	13.7	5.5	9.2	13.0	23.1	16.7	15.1	6.3	52.3	14.4	7.7	16.7	24.9	4.7	24.3	9.7	16.5	15.2	6.4	7.7	34.9	26.3	46.3	15.4	31.7	102.2	15.2	5.8	7.5	5.4	15.8	9.9	13.4	10.3	12.6	9.7	7.4	12.8	23.8	6.8	15.4	4.2	9.2	4.5	13.0	3.2	2.7	11.9	9.9	3.1	4.1	19.4	14.3	17.0	17.3	5.7	4.9	8.1	10.4	12.6	8.5	7.6	8.5	9.5	8.6	9.5	8.8	9.1	11.4	6.9	12.8	38.8	21.5	21.3	5.2	6.7	5.3	10.2	13.3	13.7	8.3	31.1	28.6	7.8	16.5	10.4	35.4	23.2	14.6	19.6	10.9	3.5	8.8	17.3	8.1	11.3	21.9	12.8	11.1	25.1	8.1	21.9	20.8	8.8	45.2	11.0	227.4	10.3	26.9	17.3	18.0	4.1	15.3	10.1	4.2	12.5	13.5	5.4	17.8	13.4	10.4	8.2	15.6	20.5	12.4	9.6	12.0	22.6	9.6	9.4	62.5	5.2	19.2	13.1	10.6	7.4	6.7	3.8	16.2	6.0	13.5	8.4	21.8	16.6	7.8
DIO1	TXDI1	ENSG00000211452	"Iodothyronine deiodinase 1"	P49895	1	53891239-53911086	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	42	"kidney: 144.9;liver: 185.3;thyroid gland: 260.2"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 61.5;Proximal tubular cells: 115.7"	"Group enriched"	"Detected in many"	8	"liver cancer: 44.7;thyroid cancer: 43.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"Hep G2: 33.9;SK-BR-3: 79.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.91e-3)"	"unprognostic (6.96e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (3.59e-2)"	0.1	0.2	0.2	0.1	0.1	0.1	0.7	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.2	4.6	1.0	0.6	0.1	0.1	144.9	185.3	0.4	0.8	0.3	0.2	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.7	0.3	0.0	260.2	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	1.0	0.3	0.0	33.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.3	0.1	0.1	0.2	0.3	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	79.0	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.9	0.1	15.2	11.5	0.4	0.0	0.0	0.5	0.1	0.0	11.7	0.0	3.6	0.3	0.1	0.4	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	61.5	0.5	0.0	0.5	0.0	0.0	2.2	0.0	5.3	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.0	115.7	10.2	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	2.3	0.3	0.1	0.0	0.0
DIPK2B	"CXorf36, DIA1R, FLJ14103"	ENSG00000147113	"Divergent protein kinase domain 2B"	Q9H7Y0	X	45148373-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Adipocytes: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002806	Uncertain				"Secreted - unknown location"	NA	NA		940000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	40.8	5.3	14.4	6.1	15.0	0.8	36.9	11.7	13.9	19.6	7.8	9.1	2.6	20.5	6.9	6.5	18.0	8.8	27.3	11.4	13.1	7.0	1.4	14.1	5.7	14.4	14.2	6.9	3.5	4.6	3.3	40.5	14.1	11.3	3.8	1.4	6.8	7.2	16.6	7.4	7.7	20.7	12.4	3.1	6.3	1.5	14.8	2.7	18.5	16.6	3.4	14.3	13.9	15.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	81.7	0.1	0.0	0.5	0.0	0.1	0.0	0.3	0.1	1.4	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.4	15.0	11.7	13.9	11.4	13.1	14.4	14.2	14.1	12.4	14.8	15.4	96.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11956207-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1224.0"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 884.3;Muller glia cells: 1960.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		18000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	31.2	79.1	110.7	10.0	183.6	0.2	26.0	12.6	135.2	89.7	104.8	53.2	14.6	47.0	16.7	29.7	23.0	67.0	1224.0	147.7	80.2	17.0	5.6	123.7	8.5	95.1	54.3	38.1	18.2	34.2	38.2	25.0	46.8	59.4	13.0	204.1	30.9	78.1	7.8	29.7	24.6	43.1	83.9	33.2	31.7	30.9	99.9	4.7	16.4	18.8	5.4	40.9	48.3	121.6	1.5	13.1	18.1	0.1	15.3	29.7	0.6	418.9	643.0	182.4	205.5	9.6	3.2	0.0	44.8	614.4	96.8	64.4	1.5	181.9	69.5	0.1	0.5	0.0	1.7	0.0	113.6	0.0	0.3	45.3	60.0	61.9	151.3	370.2	195.3	0.0	0.2	0.4	256.4	0.0	0.1	0.4	8.6	0.0	0.5	0.1	1.2	0.1	62.5	0.6	0.5	53.2	2.0	0.0	0.2	47.9	0.2	0.5	349.7	107.5	82.8	11.2	110.3	0.1	0.0	0.3	18.1	0.0	103.5	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.6	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	110.7	183.6	12.6	135.2	147.7	80.2	95.1	54.3	46.8	83.9	99.9	121.6	5.8	3.2	3.0	94.3	0.1	45.6	59.5	70.3	93.4	31.6	3.2	103.2	884.3	0.0	12.8	0.0	12.5	0.5	0.4	0.0	0.0	0.8	104.3	0.7	8.4	32.9	1.8	0.0	90.4	0.2	0.8	106.1	7.1	0.6	1.3	17.0	66.8	0.4	20.4	13.5	83.7	0.1	0.0	1.3	12.5	88.5	20.5	1.4	64.0	38.4	0.0	1960.4	0.0	27.6	14.7	1.1	0.1	57.6	1.7	32.8	0.0	0.2	2.9	67.5	190.7	12.7	83.4	1.2	3.2	5.8	14.8	0.8	4.1	0.5	0.3	3.0
DLGAP2	"C8orf68, DAP-2, ERICH1-AS1"	ENSG00000198010	"DLG associated protein 2"	Q9P1A6	8	737628-1708476	"Nuclear receptors, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 2.6;testis: 12.2"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 645.0;Inhibitory neurons: 467.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030320	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA030320: AB_10600904"	"unprognostic (8.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.81e-1)"	0.2	0.0	0.1	0.0	1.0	0.0	0.1	0.0	3.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	12.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	16.0	0.0	0.4	0.3	0.0	0.0	4.1	0.7	0.9	1.7	0.0	1.8	0.0	16.7	0.0	0.0	0.0	1.9	0.1	64.1	0.1	0.0	0.6	0.0	0.0	645.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	40.4	467.8	0.0	0.0	0.0	0.3	31.9	0.9	0.2	1.8	35.6	0.0	1.9	0.0	12.1	9.1	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.7	2.5	0.0	0.3	0.2	8.2	6.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1
DLL4		ENSG00000128917	"Delta like canonical Notch ligand 4"	Q9NR61	15	40929340-40939073	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Angiogenesis, Differentiation, Neurogenesis, Notch signaling pathway, Sensory transduction, Vision"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.7;Distal enterocytes: 24.2;Endothelial cells: 48.6;Hepatic stellate cells: 30.4;Intestinal goblet cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BJ hTERT+: 59.4;HUVEC TERT2: 15.7;SCLC-21H: 32.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023392	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023392: AB_1847740"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (7.52e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.51e-3)"	25.2	2.6	6.9	2.9	6.1	0.3	21.2	6.5	7.0	8.0	4.9	7.6	4.0	8.8	1.0	3.7	7.6	3.7	23.8	5.8	6.0	10.0	3.5	22.5	5.0	7.1	6.5	4.1	2.9	2.9	5.6	19.8	7.5	7.9	3.0	0.9	4.3	2.7	10.0	5.5	6.8	4.2	6.6	4.6	4.8	1.5	8.4	5.0	15.4	10.6	1.7	8.7	7.6	6.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.9	59.4	0.2	0.3	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.7	0.0	0.4	1.1	0.1	0.1	0.0	0.6	0.0	0.9	0.0	1.4	0.5	1.6	0.0	0.1	32.5	0.0	0.3	0.7	0.0	0.0	0.0	3.5	0.9	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	6.1	6.5	7.0	5.8	6.0	7.1	6.5	7.5	6.6	8.4	6.2	70.7	0.0	2.7	0.0	1.7	1.3	0.2	0.2	4.0	4.9	1.6	2.8	3.2	1.5	0.9	0.0	0.0	1.5	0.2	24.2	0.0	0.2	0.2	1.9	0.7	48.6	17.4	0.0	0.9	0.2	0.6	3.1	13.3	2.6	2.5	0.0	30.4	0.1	0.2	0.0	0.6	36.3	6.1	1.6	0.8	0.3	0.0	0.8	1.8	11.2	0.0	0.2	0.0	0.5	0.5	0.2	16.7	0.0	3.5	2.3	9.2	0.0	0.2	1.4	0.0	0.9	3.8	0.8	2.0	1.0	1.6	1.9	0.4	0.4	12.0	0.6
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	16.3	14.7	11.8	5.3	12.5	0.6	16.8	0.2	14.2	7.1	7.1	38.0	5.4	18.1	11.2	9.1	16.8	21.5	37.8	15.5	0.5	5.4	50.0	7.2	4.7	1.1	0.6	13.9	52.9	4.3	4.4	15.1	0.4	13.4	8.4	80.0	30.2	30.7	73.4	11.5	9.4	22.0	0.0	2.3	15.5	8.3	4.8	3.3	7.3	67.4	6.4	21.1	7.2	9.9	0.3	0.2	27.9	0.3	0.3	0.3	7.6	6.1	0.6	2.8	3.1	13.3	0.6	0.4	0.2	12.5	2.3	8.5	10.5	15.0	4.2	7.4	8.6	3.3	10.5	30.3	14.7	1.2	3.7	3.3	9.5	4.6	17.1	15.3	6.1	2.0	2.9	0.4	8.3	0.5	4.4	0.6	13.3	0.1	9.8	0.3	25.0	0.1	0.3	3.3	0.5	8.5	0.1	2.3	2.8	27.7	2.2	0.1	1.6	0.3	0.5	1.1	4.6	0.4	23.8	0.6	1.0	2.3	14.4	0.8	0.1	2.0	0.1	0.1	0.1	1.1	0.1	0.1	0.3	0.9	0.1	0.1	4.3	0.1	0.1	0.4	0.2	0.1	11.8	12.5	0.2	14.2	15.5	0.5	1.1	0.6	0.4	0.0	4.8	9.9	8.5	28.9	25.3	164.9	6.7	20.1	7.0	6.3	3.4	78.0	26.5	50.0	452.8	7.2	15.0	3.7	308.6	33.7	0.7	0.8	3.9	3.8	22.4	22.5	1.4	9.9	8.4	0.0	1275.8	12.3	9.5	26.1	3.6	5.6	1.3	37.9	6.1	49.8	4.2	11.8	719.8	1.3	6.1	4.8	5.4	20.5	89.2	3.5	19.6	94.6	6.7	54.9	0.0	1161.6	610.2	6.0	0.1	118.8	0.2	3.6	3.6	2.1	60.4	375.9	118.3	95.2	50.3	4.0	8.8	1.8	11.5	5.1	1.0	33.1	4.2	4.8
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 169.4;liver: 283.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.4	1.6	1.4	3.0	1.3	0.2	2.8	12.2	1.4	1.3	2.1	1.9	1.5	2.4	169.4	283.8	0.4	0.2	1.5	1.9	2.2	1.8	0.6	2.9	0.1	2.0	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.4	0.1	1.0	2.3	2.9	0.3	4.8	1.5	0.3	1.2	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	1.6	1.5	2.4	1.5	1.9	2.0	1.4	2.9	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
DMRT2		ENSG00000173253	"Doublesex and mab-3 related transcription factor 2"	Q9Y5R5	9	1049858-1057552	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.2;lymphoid tissue: 20.9;parathyroid gland: 46.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 115.4;Ionocytes: 46.8;Skeletal myocytes: 22.7"	"Group enriched"	"Detected in many"	4	"lung cancer: 3.0;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.8;RH-30: 5.0;RPMI-8226: 19.4;SK-MEL-30: 5.2;THP-1: 3.6;WM-115: 3.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"HPA003498, HPA029297"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Vesicles,Centriolar satellite"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"	"Vesicles, Centriolar satellite"	"HPA003498: , HPA029297: AB_10600905"	"unprognostic (5.67e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.93e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.27e-3)"	4.7	0.1	1.7	0.1	3.4	0.0	5.3	3.1	2.7	0.1	0.2	1.6	0.0	0.1	1.1	0.3	0.6	0.0	0.1	1.9	1.9	41.2	0.0	3.1	0.2	3.0	3.1	0.0	0.0	46.4	0.5	0.2	2.9	0.3	0.9	0.4	1.3	1.4	13.3	0.3	0.1	0.0	1.7	0.0	0.0	0.8	2.8	20.9	0.1	2.5	0.1	0.0	0.2	8.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.8	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.0	19.4	0.0	0.8	2.9	0.0	0.0	0.0	5.2	0.3	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	3.1	2.7	1.9	1.9	3.0	3.1	2.9	1.7	2.8	8.5	0.5	0.0	0.0	0.3	0.2	0.5	0.6	1.8	0.0	0.1	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.1	0.1	1.8	115.4	0.0	4.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	4.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.0	46.8	0.0	1.1	0.4	0.6	0.2	3.6	0.0	0.0	0.3	0.0	0.5	11.1	0.0	1.9	0.0	0.4	0.2	0.0	0.4	0.6	2.4	0.0	22.7	0.7	4.0	3.0	0.2	0.1	0.1	0.1	0.0	1.8	0.4
DMRTA1		ENSG00000176399	"DMRT like family A1"	Q5VZB9	9	22446824-22455740	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 8.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 19.4;Distal tubular cells: 15.6;Glandular and luminal cells: 14.5;Hepatocytes: 30.8;Proximal tubular cells: 29.2;Squamous epithelial cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.3;hTERT-RPE1: 7.4;LHCN-M2: 2.9;RPTEC TERT1: 3.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"HPA044764, HPA062253"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles		"HPA044764: AB_10959788, HPA062253: AB_2684726"	"unprognostic (1.47e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.74e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.92e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.53e-3)"	1.8	0.0	0.4	0.2	0.4	0.0	0.4	0.3	0.3	1.6	2.4	0.4	0.6	0.3	1.2	1.7	0.3	0.9	0.3	0.6	0.3	3.4	8.4	0.9	0.4	0.4	1.6	0.2	1.4	2.2	0.7	0.0	0.4	1.4	0.3	0.1	3.5	0.4	0.7	0.2	0.5	0.1	0.4	0.2	2.0	0.1	0.7	0.5	1.8	1.1	0.8	0.4	0.1	0.4	0.2	0.3	0.0	0.0	0.2	0.1	0.1	0.0	6.3	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.2	1.2	1.7	0.2	0.0	0.4	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.1	7.4	0.4	0.0	0.0	2.3	2.9	0.6	0.0	0.0	1.2	0.3	2.1	0.0	0.1	0.9	3.0	0.0	0.1	0.0	0.8	0.5	1.4	1.4	0.0	0.0	2.1	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.6	0.3	0.4	1.6	0.4	0.4	0.7	0.4	0.1	0.0	2.7	2.0	0.1	0.0	4.8	7.2	19.4	0.5	1.9	1.0	1.9	5.7	5.6	5.5	0.0	0.0	0.0	1.1	15.6	6.9	0.1	10.7	1.4	0.3	2.4	0.0	0.0	6.7	0.0	0.8	10.2	14.5	0.0	0.6	0.0	30.8	0.3	0.0	0.0	0.7	8.2	0.3	0.3	0.1	0.3	0.4	0.0	1.0	0.0	5.4	0.0	0.0	0.0	7.8	0.2	0.0	0.1	6.3	4.1	29.2	5.9	0.1	0.0	2.9	0.6	0.2	1.2	26.5	0.4	0.1	0.3	0.0	1.9	8.2
DNAH17	"DNAHL1, DNEL2, FLJ40457"	ENSG00000187775	"Dynein axonemal heavy chain 17"	Q9UFH2	17	78423697-78577396	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 2.1;retina: 2.5;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 56.4;Cone photoreceptor cells: 87.6;Early spermatids: 43.7;Late spermatids: 36.6;Oligodendrocytes: 52.5"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.9;lung cancer: 1.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 5.7;MOLT-4: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA024354, HPA076261"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA024354: AB_1847911, HPA076261: AB_2732305"	"unprognostic (4.98e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.70e-3)"	"unprognostic (6.66e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.35e-3)"	"unprognostic (1.58e-10)"	"unprognostic (5.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.12e-1)"	"unprognostic (6.04e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	5.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	0.0	0.2	1.6	0.8	1.3	0.9	0.6	2.1	0.4	6.4	0.5	0.7	0.6	0.6	0.3	0.1	0.0	56.4	0.1	0.0	2.5	0.0	0.0	0.0	87.6	0.0	0.1	0.0	0.0	0.0	43.7	1.4	0.5	1.0	0.0	0.0	2.2	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.8	1.7	36.6	0.6	2.9	0.0	1.0	0.1	1.5	0.0	1.0	52.5	0.1	0.0	0.4	0.4	0.3	0.0	0.1	0.0	7.8	0.0	0.6	0.5	17.4	0.6	0.0	0.1	0.0	0.3	0.4	0.0	0.1
DNAJC12	JDP1	ENSG00000108176	"DnaJ heat shock protein family (Hsp40) member C12"	Q9UKB3	10	67796669-67838188	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 70.3;liver: 67.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 75.9;Enteroendocrine cells: 166.2;Hepatocytes: 74.5;Intestinal goblet cells: 98.0;Proximal tubular cells: 163.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 22.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 7.7"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 7.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 91.5;NB-4: 76.0;SCLC-21H: 72.0;U-698: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036289	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA036289: AB_10670794"	"unprognostic (1.52e-2)"	"unprognostic (3.65e-3)"	"unprognostic (4.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.97e-2)"	"unprognostic (7.31e-3)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (7.35e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.81e-3)"	"unprognostic (7.99e-2)"	2.0	70.3	23.3	2.3	26.3	1.5	30.2	36.5	28.5	6.0	12.8	9.1	3.2	7.3	5.9	1.2	3.4	5.4	6.6	26.3	29.1	29.5	67.5	1.6	0.6	22.5	50.1	15.0	37.0	6.6	41.1	0.1	29.0	7.6	14.2	13.6	5.4	4.8	10.9	0.3	4.7	6.0	19.7	1.2	6.6	7.0	23.2	2.1	1.5	9.9	0.7	4.4	3.3	23.4	0.0	32.9	5.3	0.9	7.5	6.1	0.1	0.1	2.0	1.1	6.8	0.5	0.0	91.5	13.4	0.1	0.4	0.0	0.9	1.2	0.3	4.4	36.9	21.9	26.9	8.5	7.9	41.7	0.5	19.3	7.6	3.2	1.9	0.1	11.4	2.6	40.5	1.2	3.2	1.8	2.0	76.0	1.5	0.4	36.4	1.2	3.0	48.2	0.8	0.0	72.0	41.1	0.5	14.4	1.3	0.3	0.7	0.4	0.0	3.5	1.0	0.8	1.0	8.6	1.0	68.2	6.6	49.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	23.3	26.3	36.5	28.5	26.3	29.1	22.5	50.1	29.0	19.7	23.2	23.4	1.5	0.0	1.1	2.9	2.1	0.3	2.2	1.4	0.6	31.9	75.9	35.6	9.3	1.5	13.0	5.5	6.2	0.1	0.6	7.2	9.8	1.5	5.6	2.2	24.8	2.3	166.2	9.1	12.3	55.9	0.1	8.7	6.1	1.6	0.0	2.0	1.4	74.5	0.6	38.7	14.8	98.0	8.2	2.6	0.4	4.2	16.1	3.1	0.0	1.0	3.7	13.5	0.0	11.6	13.6	43.4	4.1	21.4	0.4	26.3	1.1	163.2	20.3	5.5	0.0	4.6	5.3	2.8	0.7	0.2	0.1	0.0	0.9	21.6	4.4	1.3
DNAJC22	"FLJ13236, wus"	ENSG00000178401	"DnaJ heat shock protein family (Hsp40) member C22"	Q8N4W6	12	49346888-49357546	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 24.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 47.1;Distal enterocytes: 36.8;Exocrine glandular cells: 42.9;Hepatocytes: 44.6;Intestinal goblet cells: 26.9;Pancreatic endocrine cells: 27.6;Paneth cells: 26.2;Proximal enterocytes: 59.6;Undifferentiated cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.5;CACO-2: 19.1;EFO-21: 17.2;MCF7: 18.8;OE19: 18.6"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low region specificity"	"Detected in all"			HPA039953			Approved	Vesicles		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA039953: AB_2676770"	"unprognostic (5.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (4.56e-5)"	"unprognostic (4.77e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (7.54e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-2)"	1.2	0.2	0.5	0.4	0.7	0.2	0.3	1.5	0.8	1.1	0.6	4.0	5.6	0.6	0.3	0.0	0.7	3.1	0.1	0.5	0.5	3.7	24.1	0.1	0.1	1.7	1.4	0.0	5.6	2.0	0.2	0.2	1.8	0.2	2.2	0.2	1.4	0.1	0.0	0.4	5.0	0.2	0.7	0.2	3.0	0.6	0.8	0.0	4.4	0.0	0.0	0.1	0.7	1.1	0.9	5.6	0.0	10.5	0.0	0.0	2.4	0.0	1.9	0.5	1.3	19.1	4.0	0.0	17.2	0.5	0.6	0.2	1.2	0.0	1.5	0.0	3.5	0.2	0.4	6.3	1.1	0.1	1.2	0.2	0.1	0.6	0.1	2.8	0.5	0.1	0.1	0.2	0.6	18.8	0.0	0.1	0.1	18.6	5.8	0.0	3.6	0.1	0.3	0.1	2.6	0.6	0.1	0.3	2.4	0.1	6.7	0.0	0.2	0.6	2.1	0.1	0.6	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.5	0.8	0.5	0.5	1.7	1.4	1.8	0.7	0.8	1.1	0.2	0.0	1.1	1.0	0.3	0.6	1.5	3.0	0.0	0.3	5.9	3.7	0.5	47.1	2.0	1.8	0.0	0.1	0.3	36.8	0.0	16.0	4.1	6.2	4.5	0.6	21.0	0.0	0.5	42.9	0.3	3.8	10.2	5.9	1.3	4.7	1.4	44.6	0.1	3.3	0.2	26.9	0.0	0.8	0.4	1.9	0.0	0.4	3.6	0.0	0.6	0.6	0.0	0.0	5.7	27.6	26.2	0.7	0.0	0.7	59.6	18.6	5.7	0.5	0.0	0.5	2.1	1.9	1.9	0.0	0.3	0.4	0.5	1.0	26.2	0.4
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 34.5;kidney: 34.2"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 715.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		420000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	4.6	5.0	5.1	6.6	5.6	4.3	4.6	13.4	6.4	9.8	6.9	6.1	29.7	5.2	5.0	7.1	6.8	2.7	5.5	5.8	4.9	34.2	5.9	4.9	10.0	6.0	5.2	7.5	23.6	2.7	16.3	4.2	6.6	11.6	5.0	4.4	4.9	2.5	3.7	7.8	34.5	2.7	3.2	9.2	11.2	9.2	5.8	9.4	7.4	1.3	8.7	6.0	8.5	9.7	2.9	6.5	11.4	5.9	3.3	2.8	5.2	4.7	0.8	3.7	5.3	8.0	6.9	12.3	3.6	0.7	7.8	4.8	4.2	1.3	3.9	5.5	6.4	4.4	11.3	5.4	1.7	2.9	9.6	2.3	4.8	5.0	1.2	5.8	2.5	10.3	11.2	5.0	3.2	12.3	6.3	13.6	6.9	8.7	3.6	14.9	5.3	5.7	3.1	2.5	8.1	7.6	3.5	10.5	1.9	5.7	10.4	7.7	3.4	6.8	5.0	4.3	2.5	4.8	7.5	21.4	1.7	5.7	6.6	2.7	1.1	3.2	1.5	0.7	1.0	1.4	1.2	1.3	0.6	2.1	1.3	1.8	5.0	1.0	0.7	1.1	1.4	0.5	5.1	5.6	13.4	6.4	5.8	4.9	6.0	5.2	6.6	3.2	5.8	9.7	4.9	9.6	10.3	27.1	9.1	2.7	8.6	3.1	10.8	27.3	5.5	4.8	6.0	4.3	9.7	16.5	22.9	8.6	9.3	11.8	56.7	5.3	19.3	9.8	10.0	7.7	14.3	7.6	20.5	11.0	4.1	7.4	13.3	8.4	2.5	23.3	7.5	1.8	3.9	25.2	22.0	38.6	20.3	5.0	4.2	52.4	8.4	4.4	1.8	15.9	13.2	8.6	30.9	22.1	20.6	5.3	61.4	7.9	7.2	12.4	715.5	2.4	9.1	17.9	0.0	13.6	6.3	28.5	24.5	5.8	3.8	6.2	12.2	10.4	33.4	6.3
DNASE2	"DNL, DNL2"	ENSG00000105612	"Deoxyribonuclease 2, lysosomal"	O00115	19	12875209-12881466	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Developmental protein, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 226.7;Paneth cells: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066185	Enhanced				"Intracellular and membrane"	NA	NA		560000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA066185: AB_2685632"	"unprognostic (9.62e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.97e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.42e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.98e-1)"	27.0	26.7	17.1	24.0	17.5	9.6	23.3	17.2	19.1	22.7	19.7	24.7	23.7	25.1	29.5	18.9	25.3	25.3	22.7	16.5	17.6	19.2	36.0	37.7	42.2	18.7	18.2	26.1	41.7	43.1	23.8	20.6	19.4	27.7	19.2	5.6	33.0	26.1	19.7	29.2	22.7	22.0	19.3	26.2	30.0	5.9	17.8	20.8	38.7	13.1	26.5	24.3	19.9	23.0	63.7	36.3	2.9	80.8	86.8	46.2	55.0	34.4	87.2	33.2	79.6	3.8	43.6	27.9	97.3	54.9	73.0	71.8	30.7	33.2	16.2	89.8	41.0	13.1	36.8	17.5	68.3	26.5	119.8	46.5	74.5	24.8	36.7	80.2	50.2	42.4	14.0	112.1	20.3	82.7	27.3	14.1	6.1	66.3	60.8	17.1	14.2	64.3	32.9	29.7	17.3	28.6	46.1	65.8	123.5	11.8	98.5	23.4	32.5	67.8	21.4	70.3	31.1	139.9	153.6	35.7	112.9	24.6	34.4	73.5	71.0	10.9	64.5	95.8	53.5	31.1	56.1	68.8	14.0	35.6	49.0	53.7	40.6	70.9	114.2	28.3	85.8	66.4	17.1	17.5	17.2	19.1	16.5	17.6	18.7	18.2	19.4	19.3	17.8	23.0	18.7	25.6	22.4	7.5	25.5	14.5	23.6	56.9	14.2	6.7	22.7	18.5	10.6	28.6	31.0	36.8	4.2	60.0	23.5	17.3	3.9	67.1	0.5	24.1	15.1	21.4	16.4	5.7	1.3	58.3	96.2	27.9	13.7	25.4	22.2	23.8	28.9	26.4	226.7	5.0	1.7	15.0	83.4	87.5	6.8	2.5	32.0	55.5	46.2	2.8	28.4	32.2	33.0	3.0	1.7	39.5	125.0	33.4	36.6	15.1	10.8	6.8	29.9	3.3	13.1	16.5	16.9	0.6	4.8	12.4	12.4	48.0	23.9	23.0	26.2	18.5
DNMT3L	MGC1090	ENSG00000142182	"DNA methyltransferase 3 like"	Q9UJW3	21	44246339-44262216	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.9"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 20.8;Proximal tubular cells: 29.1"	"Cancer enriched"	"Detected in some"	90	"testis cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"BEWO: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055234, HPA066780"	Approved		Approved	"Nuclear speckles"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA055234: AB_2682750, HPA066780: AB_2685719"							"unprognostic (1.05e-4)"			"unprognostic (1.91e-1)"			"unprognostic (2.73e-9)"	"unprognostic (2.77e-1)"	"unprognostic (5.28e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	1.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	20.8	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229481	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 450.0;Proximal enterocytes: 818.0;Proximal tubular cells: 1091.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 547.1;RPMI-8226: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		540000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	46.1	103.3	42.7	29.1	45.1	23.2	37.2	40.2	66.2	45.2	66.7	68.7	104.0	50.2	8.3	62.3	57.8	13.2	46.5	41.7	45.7	172.4	136.8	31.8	33.0	39.9	42.5	40.3	100.7	75.8	37.2	9.2	41.5	42.0	17.9	6.0	45.8	18.7	89.5	42.2	88.3	11.4	43.2	61.6	57.5	10.2	46.1	17.0	35.8	44.7	18.8	39.1	39.8	42.3	189.4	135.3	20.7	86.2	14.4	44.5	64.1	44.9	16.1	29.8	38.9	55.8	67.2	134.9	69.4	15.3	1.5	95.1	16.2	35.7	8.6	72.4	318.7	63.7	127.4	161.2	34.1	54.3	40.3	28.1	44.3	9.0	26.7	12.0	39.6	96.8	147.1	232.0	24.5	311.8	52.3	135.3	41.5	547.1	81.5	87.0	27.7	347.3	52.1	63.6	79.8	96.2	41.4	108.5	95.7	6.6	149.2	177.9	49.7	22.6	39.2	51.6	90.2	160.7	79.6	109.5	14.3	71.6	36.0	1.2	109.7	4.8	42.4	237.9	78.5	219.8	138.8	74.6	178.2	194.6	122.2	83.8	4.1	42.0	176.6	135.3	269.7	92.3	42.7	45.1	40.2	66.2	41.7	45.7	39.9	42.5	41.5	43.2	46.1	42.3	16.4	28.9	38.2	5.5	73.9	61.3	91.3	147.6	68.3	11.9	138.4	181.0	91.0	163.0	80.9	115.8	2.1	53.4	12.9	164.0	450.0	201.6	0.6	159.5	66.4	30.8	64.8	78.8	4.1	107.2	66.5	60.1	88.7	39.1	33.7	108.4	28.5	231.2	308.3	6.7	4.9	216.6	93.6	75.8	62.3	3.1	67.1	63.4	110.3	1.0	36.7	78.4	10.3	5.5	5.1	157.2	155.3	59.8	81.8	112.6	818.0	1091.6	260.3	23.5	0.0	39.4	57.9	8.9	38.1	131.5	73.6	32.3	44.5	82.2	288.9	101.4
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206407	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.6"	"Group enriched"	"Detected in many"	4	"Astrocytes: 791.0;Excitatory neurons: 422.8;Microglial cells: 1568.3;Oligodendrocyte precursor cells: 434.3;Oligodendrocytes: 815.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 43.3;HUVEC TERT2: 75.5;TIME: 69.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	7.8	4.4	17.1	6.6	41.6	1.4	4.8	11.4	21.9	5.0	0.0	3.2	1.5	4.6	2.8	2.5	5.2	5.0	4.9	40.6	17.8	4.5	10.0	17.3	2.7	16.5	18.1	8.4	3.2	3.3	3.2	6.9	15.6	4.0	2.8	10.5	3.3	2.5	6.2	2.5	2.4	7.3	14.9	1.8	2.2	2.1	19.2	1.7	3.5	7.3	2.2	3.7	3.5	26.0	0.1	3.5	8.8	7.8	7.2	10.4	5.3	1.0	9.6	1.7	2.8	0.0	0.2	0.8	7.6	2.3	2.0	0.5	1.5	8.8	6.5	2.9	12.9	0.4	5.8	14.3	5.1	1.1	0.4	4.9	1.0	43.3	20.8	3.0	75.5	3.4	0.1	22.6	3.8	1.0	2.0	0.7	5.1	1.5	15.8	0.8	7.0	3.6	6.0	0.5	1.9	7.5	6.2	4.3	5.8	8.2	0.8	0.4	69.0	6.6	3.4	13.7	3.0	1.2	0.5	0.9	0.7	1.8	16.5	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.1	0.1	0.0	0.1	17.1	41.6	11.4	21.9	40.6	17.8	16.5	18.1	15.6	14.9	19.2	26.0	56.4	48.1	6.8	791.0	1.1	5.2	3.3	7.5	8.6	27.4	3.7	6.3	13.1	2.8	16.7	3.7	22.9	0.3	0.1	2.3	0.0	2.1	3.8	1.3	5.5	47.1	10.9	5.3	422.8	0.4	0.2	21.4	0.5	2.2	2.5	5.0	43.9	17.0	14.6	94.2	177.1	0.7	14.2	16.7	21.0	1.5	5.6	27.4	8.8	1568.3	6.1	5.4	0.0	434.3	815.3	1.2	8.0	8.2	0.2	8.2	0.0	1.8	12.2	11.4	13.1	4.2	5.8	0.6	1.9	2.3	2.7	0.0	0.6	26.2	1.5	1.8
DOCK6	"KIAA1395, ZIR1"	ENSG00000130158	"Dedicator of cytokinesis 6"	Q96HP0	19	11199295-11262524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.3;Cardiomyocytes: 185.4;Endothelial cells: 64.8;Hepatic stellate cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 68.2;TIME: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049423, HPA049424"	Approved		Supported	Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA049423: AB_2680760, HPA049424: AB_2680761"	"unprognostic (2.69e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.72e-3)"	"prognostic favorable (9.09e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.95e-1)"	31.2	9.9	7.4	5.4	6.3	0.4	27.5	4.5	9.7	15.4	3.6	16.8	14.2	14.7	4.6	16.8	11.6	12.0	29.6	4.6	5.1	26.3	13.2	46.3	4.9	7.8	7.1	12.0	14.4	5.4	11.9	15.0	6.9	14.8	6.2	1.8	11.4	7.5	15.1	25.2	15.4	7.1	5.7	14.5	15.8	5.8	11.4	2.1	29.0	9.3	2.6	14.2	16.6	5.6	14.6	8.9	9.9	8.1	7.3	10.5	15.9	4.2	6.9	4.1	6.3	16.9	11.2	0.9	25.4	7.1	3.9	8.3	4.3	22.3	2.5	12.4	7.0	2.8	2.2	12.8	11.8	4.3	13.7	8.1	13.0	7.5	17.0	7.9	68.2	0.3	15.7	0.0	9.1	32.7	0.1	14.7	12.5	13.2	16.6	0.9	6.7	14.0	6.8	20.0	0.6	17.6	4.2	4.2	7.6	6.5	4.9	7.6	68.8	7.5	7.8	17.1	7.6	1.2	0.2	14.1	6.3	3.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	6.3	4.5	9.7	4.6	5.1	7.8	7.1	6.9	5.7	11.4	5.6	70.3	3.2	12.6	6.8	0.9	6.5	6.2	8.5	4.6	1.4	4.3	3.8	185.4	5.7	11.3	25.8	0.0	0.3	0.9	15.6	1.9	5.4	3.5	3.9	8.9	64.8	12.1	0.0	2.9	6.8	1.3	19.6	35.2	7.2	5.1	4.7	55.3	5.6	4.6	0.0	5.9	15.9	8.2	2.5	4.4	1.3	22.4	1.6	3.6	35.6	0.0	4.6	0.0	7.1	3.5	11.9	10.9	9.4	1.9	8.4	11.9	1.9	9.2	2.6	19.7	8.4	30.8	1.5	4.3	7.4	11.5	0.5	1.2	7.8	9.7	9.0
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501904-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.6;lymphoid tissue: 118.4"	"Group enriched"	"Detected in many"	5	"B-cells: 31.6;granulocytes: 18.3;Hofbauer cells: 55.7;Kupffer cells: 51.1;Macrophages: 38.3;monocytes: 45.4;Plasma cells: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 133.6"	"Group enriched"	"Detected in many"	6	"B-cells: 37.2;granulocytes: 133.6;monocytes: 77.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.0;HMC-1: 87.5;REH: 148.6;U-698: 122.1;U-937: 88.0"	"Low region specificity"	"Detected in many"							HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	NA		240000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.0	6.1	5.2	30.2	6.2	93.6	4.4	6.5	7.9	3.2	6.3	8.2	6.5	3.4	1.7	5.5	7.8	4.3	4.1	6.0	7.0	5.0	6.5	27.1	31.5	11.3	6.8	2.1	4.5	0.8	3.4	7.0	10.5	5.5	3.5	2.1	6.6	2.0	3.6	2.6	28.9	4.5	6.7	118.4	5.9	8.9	9.9	4.3	4.4	4.1	32.3	7.1	4.0	8.1	5.2	7.8	5.4	6.3	3.2	0.4	13.0	4.4	1.1	14.0	12.9	11.0	2.2	124.0	3.2	4.0	6.8	8.9	12.2	7.6	6.9	26.1	14.6	21.3	21.4	2.5	1.0	46.1	87.5	1.6	4.5	16.2	1.6	1.5	1.9	11.4	14.8	50.2	5.1	12.9	2.7	52.5	12.2	1.5	12.9	148.6	9.3	1.2	4.4	5.2	7.4	4.9	2.0	2.1	6.2	4.8	11.7	63.4	2.7	12.3	11.3	6.5	5.4	11.1	15.0	122.1	2.7	88.0	2.2	16.8	62.4	57.0	0.3	61.3	0.6	37.2	0.1	0.3	14.5	19.6	0.1	0.1	133.6	0.5	77.6	1.2	0.0	28.7	5.2	6.2	6.5	7.9	6.0	7.0	11.3	6.8	10.5	6.7	9.9	8.1	1.4	0.0	5.6	1.6	31.6	0.3	0.1	0.4	1.8	0.8	1.0	0.9	0.4	0.0	0.2	0.0	0.0	0.5	0.3	0.2	0.0	0.2	0.0	0.4	0.4	1.9	0.0	6.3	4.1	0.2	0.7	1.2	0.5	0.8	18.3	0.2	7.1	0.8	55.7	0.0	3.5	0.3	0.0	51.1	2.3	0.4	0.6	38.3	1.8	3.7	45.4	0.3	2.1	0.5	0.5	0.0	0.7	1.2	38.3	0.2	0.2	0.1	0.1	0.6	0.0	1.8	0.4	3.0	1.9	0.7	0.3	1.0	2.2	0.3	0.8	0.1
DOK6	"DOK5L, HsT3226, MGC20785"	ENSG00000206052	"Docking protein 6"	Q6PKX4	18	69400888-69849087	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.8;parathyroid gland: 12.5;retina: 22.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 230.4;Excitatory neurons: 236.8;Inhibitory neurons: 259.1;Oligodendrocyte precursor cells: 178.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;Hep G2: 11.1;RPMI-8226: 10.5;SCLC-21H: 4.7;SH-SY5Y: 10.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041099, HPA063534"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 56: Bipolar cells - Visual perception"	"Focal adhesion sites, Cytosol"		"HPA041099: AB_2677299, HPA063534: AB_2685032"	"unprognostic (5.83e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.62e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.60e-3)"	"unprognostic (2.13e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.09e-3)"	1.1	0.7	8.8	0.7	10.3	0.1	0.5	0.9	14.0	1.8	0.0	0.6	0.3	1.5	0.5	0.7	0.7	3.2	6.2	17.8	10.6	4.9	2.4	2.4	0.5	10.9	11.6	2.2	0.2	12.5	0.7	5.9	9.7	1.3	0.5	22.3	0.8	2.1	0.1	0.5	0.5	2.5	4.1	0.9	0.7	1.5	6.5	0.1	2.2	0.6	0.5	3.1	1.1	5.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.0	11.1	0.3	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.5	0.0	0.0	4.7	10.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	4.0	0.6	0.0	1.5	0.3	0.0	0.0	3.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.3	0.9	14.0	17.8	10.6	10.9	11.6	9.7	4.1	6.5	5.8	0.5	0.0	0.0	9.8	0.0	0.3	0.1	0.0	0.0	230.4	0.1	0.0	9.1	0.0	1.3	0.0	14.6	0.0	1.2	0.0	1.9	0.0	45.3	0.4	13.3	1.5	0.0	0.0	236.8	0.0	0.0	6.7	0.0	0.3	0.0	17.2	0.0	0.9	0.0	10.1	259.1	0.0	0.0	0.3	0.8	30.6	1.5	2.1	0.0	8.4	0.1	6.9	2.1	178.4	6.4	0.0	0.0	6.8	0.7	0.1	0.0	9.6	0.0	14.6	0.0	0.4	5.5	0.9	1.1	0.1	0.6	0.0	1.2	4.9	0.0	0.1
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 377.4;kidney: 255.9;pancreas: 440.7"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 1217.5;Proximal enterocytes: 4683.5;Proximal tubular cells: 829.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;Hep G2: 33.1;HHSteC: 13.9;U-937: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		370000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.6	2.3	0.0	1.8	0.0	0.4	0.5	0.0	0.2	4.1	0.0	1.7	85.5	0.6	0.9	0.3	0.6	3.9	0.3	0.0	0.3	255.9	0.5	0.9	2.8	0.2	1.1	0.8	440.7	0.0	0.5	0.8	0.6	0.5	0.5	0.3	1.2	1.0	0.0	2.2	377.4	0.3	0.3	4.5	1.6	46.5	0.9	0.9	0.8	0.0	0.9	2.2	0.9	0.0	0.0	0.9	0.2	0.0	1.7	0.2	4.4	0.0	0.0	0.0	0.0	8.5	0.2	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.6	0.0	0.0	33.1	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.1	1.1	3.4	0.0	0.0	0.0	3.0	0.0	0.1	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	1.4	0.0	0.0	0.2	0.1	0.0	46.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.1	0.6	0.3	0.9	0.0	0.1	3.2	1.8	0.0	9.2	0.5	0.0	0.0	0.0	5.8	1.7	0.0	0.3	0.0	0.6	23.9	0.0	0.2	0.0	2.0	56.7	0.5	13.2	0.2	0.2	7.0	8.9	0.0	0.3	192.1	0.8	8.9	1.1	0.1	1.3	0.7	1.1	0.0	0.5	0.0	0.3	142.3	0.0	0.3	0.3	45.2	289.8	4.8	5.4	0.0	1.0	0.1	0.0	0.0	0.1	27.4	187.4	1217.5	61.2	0.0	4683.5	829.6	0.0	0.2	6.6	0.0	0.7	17.3	2.8	0.0	0.3	0.4	2.5	0.2	151.7	0.0
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;retina: 18.0;skeletal muscle: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.5;Cone photoreceptor cells: 108.4;Early spermatids: 58.5;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 115.7;Rod photoreceptor cells: 85.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;BJ hTERT+ SV40 Large T+: 12.2;HEL: 31.5;Karpas-707: 12.4"	"Region enhanced"	"Detected in all"		"cerebellum: 49.5"	"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA066790: AB_2685724, HPA070601: AB_2686284"	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.3	1.4	2.8	0.5	6.7	2.6	0.4	35.5	5.1	0.4	0.0	2.0	0.2	0.2	0.0	0.6	0.3	0.3	14.2	10.2	3.8	1.4	3.0	0.2	0.8	12.0	5.9	13.7	0.3	5.1	0.6	0.3	12.6	0.1	1.5	18.0	0.4	0.2	26.5	0.5	1.3	0.5	4.4	1.0	0.5	3.5	5.7	0.3	0.4	9.1	1.0	0.2	0.2	7.7	2.1	0.0	1.6	0.1	0.2	2.9	17.7	5.4	5.1	12.2	4.7	0.1	0.2	0.2	0.3	1.7	0.2	0.1	1.7	0.8	7.4	0.3	0.6	31.5	0.2	0.0	0.5	0.2	0.5	0.7	0.3	2.8	2.0	2.0	4.0	3.4	2.8	12.4	3.9	0.1	2.7	0.3	0.0	0.0	1.8	6.9	0.8	0.4	2.1	0.0	1.2	0.7	0.0	0.1	0.0	0.5	0.0	0.0	8.7	6.0	0.0	2.2	0.6	4.3	1.2	0.4	0.5	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.7	35.5	5.1	10.2	3.8	12.0	5.9	12.6	4.4	5.7	7.7	0.8	0.0	0.0	104.5	6.0	0.6	0.1	0.0	0.0	10.5	1.1	0.9	38.4	1.5	0.0	0.0	108.4	2.6	2.6	7.5	1.9	0.1	58.5	0.1	0.8	2.9	0.0	8.6	17.7	0.4	1.3	2.8	0.0	0.1	4.5	43.2	1.1	4.4	0.4	6.7	21.7	3.4	0.0	0.8	0.7	34.3	0.3	1.7	0.0	8.4	0.1	8.6	2.1	123.1	115.7	0.7	5.1	4.9	2.6	0.1	2.7	10.7	0.0	85.5	0.0	2.6	3.5	4.5	1.2	0.3	0.3	0.1	3.8	14.5	7.4	0.0
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 137.9;parathyroid gland: 155.7;placenta: 134.1;prostate: 107.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.3;Proximal enterocytes: 291.1;Proximal tubular cells: 101.4;Syncytiotrophoblasts: 172.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 55.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.3"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 194.4;ASC TERT1: 212.6;BJ hTERT+: 207.0;RPTEC TERT1: 263.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	NA	NA		190000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	13.3	3.1	0.2	5.3	0.2	0.6	8.4	0.1	0.6	10.9	0.1	14.6	107.0	3.6	4.0	3.0	7.4	6.7	3.4	0.2	0.1	94.9	57.2	16.0	5.8	0.2	0.2	3.5	3.5	155.7	0.1	134.1	0.3	107.3	16.9	0.1	84.5	23.5	1.5	5.7	137.9	3.0	0.1	11.2	7.6	1.3	0.8	12.4	5.0	3.9	4.4	5.7	3.5	0.4	0.2	0.2	1.0	0.0	194.4	212.6	0.6	37.7	207.0	10.9	37.2	38.0	1.0	0.0	13.6	71.0	30.2	1.1	0.4	0.0	6.2	12.3	0.0	0.0	0.0	57.1	77.0	0.0	0.0	22.0	0.1	66.3	0.5	9.1	6.6	0.7	0.0	0.0	3.6	0.0	3.6	0.5	2.0	1.3	72.7	0.0	0.0	0.6	263.3	0.0	0.1	0.4	0.0	0.0	0.0	4.4	0.0	0.3	37.0	21.8	1.1	0.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	52.3	0.2	16.2	10.7	1.2	0.0	15.7	6.6	0.4	5.3	0.0	4.0	2.0	4.7	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.2	0.3	0.1	0.8	0.4	10.8	6.4	26.0	0.3	2.1	4.1	0.4	0.1	0.0	1.8	0.2	0.8	3.3	12.8	2.8	14.7	10.4	140.3	10.4	27.4	1.9	3.0	15.0	2.3	7.1	9.4	55.2	0.4	31.6	0.0	59.1	35.3	2.0	68.0	13.9	5.3	9.3	34.5	14.5	0.0	6.3	16.4	0.0	0.9	7.6	7.9	0.0	4.8	5.4	3.7	1.1	0.0	1.0	2.5	0.7	1.4	23.8	0.0	2.1	32.7	291.1	101.4	2.2	0.1	0.0	2.1	1.5	4.0	1.1	0.1	4.1	172.0	25.8	29.2	29.1	0.3
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.0;endometrium 1: 58.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 673.4;Inhibitory neurons: 1195.9;Oligodendrocyte precursor cells: 1947.8"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	0.6	8.2	16.5	0.2	24.5	0.1	0.5	32.0	34.5	5.8	0.0	19.8	0.5	58.2	2.5	0.3	5.2	0.1	0.2	42.7	21.6	5.3	0.0	1.4	0.1	54.0	24.5	0.7	3.9	0.0	10.8	0.2	53.1	0.3	1.6	11.1	0.1	8.9	6.0	3.6	3.4	19.9	8.6	4.7	7.8	7.3	32.2	1.9	17.1	0.9	0.0	0.3	1.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	16.5	24.5	32.0	34.5	42.7	21.6	54.0	24.5	53.1	8.6	32.2	14.8	0.1	0.0	0.0	147.9	0.0	3.3	0.4	0.0	0.0	27.0	0.4	1.3	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.4	0.9	21.6	0.4	10.3	0.0	673.4	4.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	32.0	1195.9	0.4	0.0	0.0	0.0	18.4	1.2	0.2	16.0	22.5	0.0	17.1	0.0	1947.8	290.8	0.3	0.0	3.8	0.0	0.1	0.1	0.4	0.8	6.1	0.0	0.7	0.9	1.2	4.0	0.0	1.6	0.0	0.2	0.0	0.0	0.2
DPYD	DPD	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 68.5"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1712.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain					NA	NA		1600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (2.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.25e-1)"	22.2	13.2	7.2	22.6	12.8	10.3	16.7	5.7	10.4	18.8	2.4	11.9	21.9	14.9	8.4	17.1	14.3	25.7	8.9	7.4	12.9	12.6	68.5	29.6	16.6	12.4	9.4	24.0	11.8	9.2	6.2	4.5	12.1	9.9	10.1	3.3	15.0	13.4	5.8	7.1	19.4	18.2	6.9	24.7	8.4	3.7	12.9	17.0	10.3	10.1	12.0	18.2	14.2	24.4	22.2	6.2	7.8	0.2	42.4	72.5	0.1	35.2	31.9	32.1	23.6	0.0	9.2	11.7	50.6	32.9	5.1	5.2	0.0	8.3	58.7	11.6	7.3	10.0	11.1	0.2	18.8	4.5	0.6	57.5	3.0	25.7	29.3	67.7	26.8	6.8	0.4	36.4	17.0	0.0	23.6	6.4	0.9	0.2	7.5	0.1	37.1	18.6	39.4	0.1	11.1	8.8	30.1	2.5	0.3	0.8	0.0	10.2	30.9	69.2	5.0	56.4	70.6	3.0	0.1	0.2	10.2	12.6	56.2	18.2	61.1	4.1	11.6	29.5	14.8	2.2	13.3	11.0	32.7	4.9	12.5	11.1	59.8	13.3	27.1	0.9	15.8	21.9	7.2	12.8	5.7	10.4	7.4	12.9	12.4	9.4	12.1	6.9	12.9	24.4	25.5	16.0	39.1	23.8	15.4	7.6	8.8	9.4	18.8	2.5	8.4	8.3	5.3	40.0	11.5	7.3	0.0	0.2	19.2	3.3	5.9	2.5	7.0	1.5	15.2	14.7	3.0	13.3	258.6	6.4	0.2	30.0	10.7	1.7	9.5	4.5	17.2	54.2	17.1	0.0	30.5	5.5	6.1	130.4	27.0	4.0	33.5	73.7	3.6	105.9	98.1	4.8	27.8	34.2	1712.3	5.3	2.1	18.8	17.0	4.9	21.0	6.6	8.6	0.1	13.1	16.0	17.7	1.2	3.1	19.7	5.5	0.1	31.4	5.1	6.8	9.3
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467055	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 199.6;liver: 477.6"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 459.5;Proximal tubular cells: 518.8"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 57.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024785, HPA070814"	Enhanced					NA	NA		820000		"Cluster 85: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA024785: AB_1847856, HPA070814: "	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	8.6	2.8	0.6	0.1	0.6	0.0	0.4	0.2	1.7	1.2	0.2	0.2	0.0	0.1	0.6	0.1	0.7	6.5	0.1	0.6	0.5	199.6	477.6	0.6	0.3	0.5	0.7	0.2	0.1	0.6	0.2	0.6	0.6	4.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.9	1.2	5.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.2	1.7	0.6	0.5	0.5	0.7	0.6	0.3	1.2	0.5	0.1	0.0	0.0	1.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	40.0	0.0	20.2	0.0	0.0	0.0	0.0	27.4	0.1	12.8	0.3	0.1	1.0	0.0	16.0	11.2	0.0	0.0	1.8	0.0	0.3	0.0	0.4	11.7	459.5	1.4	0.0	4.6	0.0	0.0	11.1	0.3	13.5	0.9	10.6	0.0	14.0	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	518.8	0.0	0.1	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0
DTHD1	FLJ16686	ENSG00000197057	"Death domain containing 1"	Q6ZMT9	4	36281616-36347511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.8;fallopian tube: 13.7;lung: 3.5;lymphoid tissue: 4.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 37.9;Early spermatids: 87.2;Endometrial ciliated cells: 109.2;NK-cells: 53.5;Respiratory ciliated cells: 199.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (9.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.45e-5)"	"unprognostic (5.12e-3)"	"unprognostic (9.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.05e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.12e-3)"	0.2	0.1	2.5	1.2	1.8	0.5	0.1	1.0	0.4	0.5	1.5	0.1	0.4	0.6	0.2	0.3	13.7	0.6	0.1	2.1	2.5	0.0	0.3	3.5	4.0	11.8	11.2	0.0	0.1	0.0	0.0	0.0	6.3	0.1	0.3	0.0	0.2	0.1	0.0	0.0	0.5	0.1	10.6	2.2	0.5	1.2	1.6	0.3	0.2	0.0	1.3	0.3	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.6	0.0	0.3	1.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.4	2.5	1.8	1.0	0.4	2.1	2.5	11.8	11.2	6.3	10.6	1.6	4.9	0.4	3.2	4.1	0.7	1.4	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.4	0.0	24.2	0.0	0.0	0.0	37.9	0.0	0.0	0.1	87.2	109.2	0.6	0.1	0.0	0.8	0.2	0.0	0.0	0.4	3.1	1.7	1.3	0.0	0.0	0.1	0.1	0.0	0.2	0.0	8.2	0.8	0.0	24.1	0.3	1.2	0.0	1.9	0.1	0.0	53.5	0.0	2.9	0.1	0.0	0.0	12.4	0.1	0.0	0.2	199.1	0.0	0.0	0.5	0.9	1.8	0.3	0.5	0.1	0.0	27.4	0.0	0.0	0.1
DUSP26	"DUSP24, MGC1136, NEAP"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591330-33600023	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 421.3;tongue: 204.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7;pancreatic cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	0.7	27.4	44.2	1.2	45.2	0.2	0.4	47.4	49.6	1.2	18.4	2.8	3.5	1.3	5.6	5.0	3.6	1.2	70.8	45.0	53.0	1.5	0.2	3.3	0.4	39.8	42.1	33.2	3.0	2.0	61.4	0.0	55.2	4.2	1.1	34.1	4.6	0.8	421.3	0.3	2.6	2.7	38.3	0.7	3.9	3.6	44.4	0.8	0.9	204.4	0.8	1.2	1.7	41.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	97.7	23.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	3.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	45.2	47.4	49.6	45.0	53.0	39.8	42.1	55.2	38.3	44.4	41.1	0.0	0.0	0.0	1.3	0.9	0.0	0.2	0.0	0.6	76.8	0.0	0.3	59.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	21.5	0.4	7.8	0.4	0.1	0.8	25.7	0.0	11.3	0.4	0.0	3.5	0.5	0.1	0.0	1.0	0.4	0.0	0.0	25.2	14.7	0.5	0.0	0.0	0.0	5.2	0.0	0.1	1.8	2.8	0.0	22.8	0.0	12.1	12.0	1.1	0.0	6.0	5.3	0.3	0.0	2.5	0.0	75.2	0.0	10.8	5.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.1	0.1
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350684	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 32.2;stomach 1: 32.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 155.5;Ionocytes: 126.1;Pancreatic endocrine cells: 195.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.9"	"Immune cell enriched"	"Detected in single"	9	"T-reg: 6.7"	"Lineage enriched"	"Detected in single"	20	"T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"A549: 100.0;OE19: 91.7;SK-MEL-30: 157.2;WM-115: 122.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	15.2	5.2	2.3	5.4	1.4	6.2	23.7	5.0	9.0	6.0	0.4	1.2	1.2	4.5	0.1	2.5	1.9	11.3	2.3	20.9	1.2	2.8	0.7	5.7	2.6	1.6	1.1	0.4	32.2	0.6	5.3	7.5	1.1	5.2	1.4	5.9	16.1	10.1	4.2	5.6	2.0	1.2	0.3	1.0	32.4	2.8	2.9	4.2	1.2	0.9	2.7	13.8	2.8	1.1	38.0	100.0	57.9	2.8	7.2	0.0	4.9	7.7	42.0	22.8	10.1	1.1	18.8	0.0	20.5	3.6	16.0	12.0	0.7	25.7	13.5	1.0	1.9	0.3	3.7	0.7	0.2	0.5	47.3	4.6	16.7	7.1	42.1	49.7	18.9	0.4	0.3	4.5	46.0	42.9	0.1	7.1	10.1	91.7	60.5	1.2	1.9	8.1	52.3	19.7	0.4	32.0	10.8	49.5	157.2	1.1	10.7	1.1	53.3	16.7	0.3	0.0	5.7	11.6	1.4	0.1	50.2	8.9	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.7	0.0	2.3	1.4	5.0	9.0	20.9	1.2	1.6	1.1	1.1	0.3	2.9	1.1	11.1	0.0	2.8	0.0	33.5	12.1	98.3	27.3	4.0	43.2	80.4	62.2	2.6	51.5	51.1	0.0	12.5	3.2	24.0	1.9	0.0	74.3	7.6	64.7	13.3	16.3	97.8	0.0	3.8	78.6	40.9	9.6	121.8	155.5	6.3	0.0	21.8	0.3	25.0	43.7	8.2	8.5	126.1	4.0	102.8	25.6	0.3	47.4	65.8	0.0	75.6	0.8	0.0	1.5	0.3	195.2	0.0	0.0	31.0	30.9	0.4	0.2	43.6	3.4	13.1	18.9	17.8	1.4	8.2	2.3	11.9	17.8	115.6	0.1	4.6	102.7
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 226.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	113.9	24.7	12.0	63.7	12.9	178.7	50.8	10.0	28.5	39.4	29.8	47.3	24.8	26.2	14.2	34.8	36.6	75.5	30.9	19.8	11.6	58.9	143.3	88.2	42.3	12.6	12.1	14.2	17.9	34.6	17.8	74.1	12.4	18.8	56.1	6.8	226.2	22.9	8.5	17.4	52.1	43.2	12.7	71.0	28.7	6.9	16.0	47.7	77.4	40.2	27.2	76.4	13.8	13.6	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.9	10.0	28.5	19.8	11.6	12.6	12.1	12.4	12.7	16.0	13.6	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 56.9;placenta: 72.6"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Hep G2: 372.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.0	4.1	0.0	3.3	0.0	0.2	1.7	3.8	0.1	1.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	4.0	1.9	56.9	1.1	0.0	0.0	2.1	2.5	0.8	0.5	0.7	0.0	72.6	2.2	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	1.9	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.7	0.1	2.6	1.6	0.8	0.1	32.6	0.0	0.0	10.3	0.1	0.0	0.0	0.0	6.5	2.0	0.0	15.8	0.0	1.2	7.5	39.9	1.0	0.0	1.1	7.3	0.0	3.0	372.7	0.0	0.0	5.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	2.1	0.1	0.8	1.1	1.8	14.8	0.0	0.0	0.0	0.1	9.4	0.4	1.2	2.3	2.8	1.6	0.9	0.6	3.9	0.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.3	1.7	3.8	4.0	1.9	2.1	2.5	2.2	1.9	2.8	2.6	0.0	0.0	0.0	3.6	0.5	0.6	1.0	0.6	2.8	0.0	0.2	3.4	2.3	1.5	0.0	11.0	0.0	1171.5	0.0	0.0	727.8	0.1	0.0	0.1	0.1	3.1	0.0	0.0	0.7	0.0	84.0	6.1	0.0	0.0	0.0	3.8	0.0	0.9	84.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	3.2	0.4	0.0	0.0	0.0	0.4	0.8	8.9	0.2	0.0	1735.1	0.2	10.8	0.1	1.1
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 95.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Endothelial cells: 43.7;Excitatory neurons: 34.7;Hepatic stellate cells: 32.2;Kupffer cells: 27.1;Oligodendrocytes: 62.7;Syncytiotrophoblasts: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.0"	"Group enriched"	"Detected in many"	5	"hTERT-RPE1: 31.9;HUVEC TERT2: 85.5;LHCN-M2: 75.3;RH-30: 78.5;TIME: 58.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	10.1	1.7	1.0	11.5	1.1	31.6	4.3	4.1	7.7	1.9	0.7	7.0	2.0	2.3	0.5	7.4	3.2	4.6	16.8	0.2	3.8	3.6	6.5	8.3	3.7	14.8	5.1	1.3	1.5	2.3	1.5	21.1	13.7	3.3	2.5	0.5	1.3	4.8	95.3	1.2	3.1	10.2	2.0	21.4	2.5	1.1	10.2	2.3	4.6	32.3	0.9	6.9	1.8	1.8	1.1	0.0	3.3	3.0	0.0	0.0	6.1	0.1	0.8	2.2	1.5	0.4	1.0	0.0	12.1	0.1	3.4	2.5	0.0	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	1.5	0.0	2.3	10.6	31.9	85.5	0.2	8.4	0.0	75.3	0.0	0.0	5.8	8.1	0.0	0.9	0.0	78.5	0.0	2.6	0.2	0.0	0.0	4.1	0.7	0.1	7.9	0.3	0.8	58.1	0.3	3.8	0.2	1.1	0.0	0.0	0.0	0.0	13.3	0.0	0.0	4.1	0.1	0.5	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	27.0	0.4	0.1	0.0	0.0	1.4	1.0	1.1	4.1	7.7	0.2	3.8	14.8	5.1	13.7	2.0	10.2	1.8	30.5	3.2	8.1	1.0	1.0	2.4	0.0	0.1	0.0	1.1	0.3	0.6	24.0	0.0	1.3	0.0	0.0	8.1	0.7	0.1	0.0	0.4	4.8	0.7	1.3	43.7	0.0	2.7	34.7	0.2	3.8	2.2	0.0	9.3	2.5	0.3	32.2	13.4	11.4	0.0	13.0	0.2	0.0	27.1	3.0	6.0	0.6	10.2	0.0	16.9	5.8	0.1	0.0	2.5	62.7	0.1	0.0	0.7	0.1	0.2	0.0	2.1	0.7	0.2	6.6	5.2	5.5	0.6	1.1	0.1	1.6	66.2	1.1	0.9	0.0	0.1
EAF2	"BM040, TRAITS, U19"	ENSG00000145088	"ELL associated factor 2"	Q96CJ1	3	121835183-121886526	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 71.8;lymphoid tissue: 53.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 73.7;Plasma cells: 144.1;Proximal tubular cells: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"memory B-cell: 104.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 73.5;HL-60: 114.9;THP-1: 59.9;U-698: 93.5;U-937: 64.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA008411	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA008411: AB_1847950"	"unprognostic (3.43e-1)"	"prognostic favorable (2.25e-9)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (1.00e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.34e-2)"	4.3	2.6	2.3	19.5	2.0	71.8	10.0	2.1	3.1	5.5	1.5	10.3	8.9	2.0	4.9	2.7	1.4	5.0	1.7	2.7	2.4	30.2	3.5	4.3	53.6	2.1	2.4	1.0	4.2	3.1	3.3	2.9	2.2	21.0	11.6	1.7	7.6	8.4	0.8	1.0	7.7	3.5	1.4	16.9	8.2	4.6	3.0	7.7	1.7	1.3	43.4	7.8	1.4	2.0	3.5	3.0	2.0	2.5	0.7	2.1	6.0	1.3	0.8	2.4	4.4	5.8	2.0	73.5	1.5	0.3	7.7	5.7	5.0	3.0	6.0	35.8	2.9	42.4	3.0	11.1	1.0	114.9	44.7	1.0	6.9	2.8	2.6	0.0	2.3	10.0	5.0	14.2	1.1	1.0	16.3	15.1	2.9	13.8	2.5	17.1	6.4	11.2	2.4	4.3	2.5	0.6	2.1	2.0	5.7	5.5	1.8	59.9	0.7	1.5	2.4	1.4	3.4	25.4	12.2	93.5	2.8	64.0	4.7	11.9	18.8	42.8	1.4	41.2	2.8	104.4	2.2	1.5	22.5	97.4	2.9	1.6	3.5	1.8	54.7	30.5	2.7	13.1	2.3	2.0	2.1	3.1	2.7	2.4	2.1	2.4	2.2	1.4	3.0	2.0	4.5	3.2	4.2	48.0	73.7	2.4	6.9	25.0	6.2	1.3	5.9	6.6	4.3	0.0	16.5	1.8	4.2	15.5	15.3	2.9	17.6	4.4	36.4	4.3	2.0	2.5	1.2	10.3	17.3	17.6	2.2	4.9	7.7	7.7	10.1	2.5	3.9	1.6	16.5	0.0	28.6	5.7	16.2	32.4	15.7	4.6	5.0	29.8	16.0	8.4	29.5	9.4	6.2	12.1	7.7	4.2	4.7	3.0	144.1	11.1	2.4	128.0	9.1	5.3	0.0	4.5	4.6	37.6	18.1	2.3	2.4	7.7	11.1	2.2	3.5	5.9
EBI3	"IL27B, IL35B"	ENSG00000105246	"Epstein-Barr virus induced 3"	Q14213	19	4229523-4237528	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 147.6"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 485.6;monocytes: 505.7;Syncytiotrophoblasts: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 4.8;memory B-cell: 18.7;naive B-cell: 14.7;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	14	"B-cells: 18.7;monocytes: 6.3"	"Cell line enriched"	"Detected in some"	13	"HDLM-2: 218.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046635	Enhanced				"Secreted to blood"	NA	NA	203000	1400000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA046635: AB_2679729"	"unprognostic (7.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.25e-3)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.67e-2)"	4.7	4.7	3.8	14.6	3.3	1.2	1.7	3.4	5.3	1.5	3.2	3.0	4.3	1.1	0.1	1.0	2.4	5.4	1.4	3.8	3.7	2.1	3.3	2.9	20.2	5.7	4.2	1.3	2.5	0.4	1.7	147.6	5.2	1.8	1.6	0.1	1.8	1.4	0.2	0.6	8.4	2.1	4.5	34.0	3.7	0.9	5.8	9.4	0.9	0.4	7.3	4.8	1.0	6.1	0.1	1.7	0.1	0.0	0.0	0.0	7.3	0.7	4.2	0.4	0.2	1.3	1.2	4.2	16.4	0.0	2.0	0.1	0.0	0.0	0.0	218.8	0.0	0.0	0.1	0.2	0.3	0.0	7.7	0.4	0.0	2.1	0.6	1.6	0.1	0.0	0.4	0.5	0.1	0.1	0.0	3.0	0.4	0.0	0.0	0.0	0.6	0.3	2.6	0.0	0.2	0.4	0.0	0.0	0.0	2.7	0.2	0.2	0.9	0.3	5.1	0.0	0.2	0.4	0.0	0.2	0.3	0.0	0.6	0.0	0.1	0.0	0.0	4.8	0.0	18.7	0.0	0.0	0.8	14.7	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.6	3.8	3.3	3.4	5.3	3.8	3.7	5.7	4.2	5.2	4.5	5.8	6.1	0.5	0.0	0.5	0.3	8.4	0.4	0.0	13.3	0.0	0.0	0.2	0.6	0.1	1.5	10.7	0.0	0.0	10.6	0.5	0.0	0.0	2.8	0.0	0.3	0.4	1.3	0.0	0.0	0.6	0.9	485.6	0.7	0.0	0.3	11.4	0.0	1.1	0.1	9.6	0.0	0.4	0.0	6.1	102.6	11.3	0.0	0.0	19.0	0.0	5.6	505.7	0.1	0.0	0.0	0.1	0.6	0.0	0.0	2.6	0.1	0.0	0.6	1.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	336.4	1.0	0.1	0.0	0.1
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345572	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 29.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 673.8;TIME: 588.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					NA	NA		1300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	87.3	123.2	26.5	47.7	29.4	48.1	79.4	23.0	30.1	61.4	12.6	71.0	30.1	42.4	10.0	26.7	46.9	36.8	70.9	21.3	33.7	38.1	54.0	72.1	35.7	34.4	25.7	71.0	91.8	125.0	47.4	66.5	30.4	53.1	34.7	14.7	33.6	25.1	19.8	34.3	46.1	42.3	21.2	48.5	43.3	22.7	28.1	21.1	51.4	33.2	34.9	58.8	43.8	27.5	93.0	60.1	77.9	38.3	111.0	116.4	44.1	135.4	236.8	72.9	66.6	44.1	275.8	34.0	323.6	138.8	157.7	38.4	32.6	64.9	63.5	83.0	27.2	48.7	89.9	34.8	144.3	7.1	11.8	61.6	74.3	112.6	55.8	199.2	673.8	27.6	10.0	17.7	62.9	19.4	14.6	11.4	23.2	26.3	46.5	17.5	45.0	49.2	114.0	17.0	26.4	63.1	134.3	79.2	57.4	42.5	55.9	20.2	588.7	160.7	77.9	73.3	79.9	26.4	49.0	39.1	332.6	16.5	196.6	0.2	8.4	3.3	2.9	10.0	4.2	6.1	6.1	4.6	0.7	4.1	4.0	2.7	29.8	1.5	7.8	2.8	8.6	7.2	26.5	29.4	23.0	30.1	21.3	33.7	34.4	25.7	30.4	21.2	28.1	27.5	164.0	19.2	7.5	46.4	25.1	20.3	19.7	81.6	18.8	5.0	71.3	44.7	18.9	10.0	54.7	23.9	0.0	6.0	12.4	105.8	5.9	25.8	1.5	19.6	35.2	106.1	25.2	20.2	19.2	56.7	35.0	51.8	20.9	51.8	18.4	35.4	97.1	36.0	3.3	0.0	14.8	13.0	57.0	9.6	14.3	4.2	43.5	17.3	7.2	31.9	25.5	50.4	8.2	13.6	22.5	100.4	106.5	55.3	29.4	34.9	45.7	7.5	24.2	4.4	39.5	72.7	47.5	1.3	5.9	8.5	16.1	10.5	17.9	80.6	21.6	40.8
ECHDC3	FLJ20909	ENSG00000134463	"Enoyl-CoA hydratase domain containing 3"	Q96DC8	10	11742366-11764070	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.6;skeletal muscle: 128.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 81.2;Distal tubular cells: 144.8;Hepatocytes: 152.0;Proximal tubular cells: 209.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 35.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"eosinophil: 15.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"A-431: 52.9;BEWO: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038306	Enhanced					NA	NA		120000	"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA038306: AB_10672586"	"unprognostic (8.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (3.91e-4)"	71.7	29.3	2.6	3.2	2.4	7.0	52.8	2.5	2.5	15.9	17.5	6.7	1.8	11.0	2.2	22.9	11.1	1.8	67.0	2.6	4.3	63.0	161.6	17.5	3.7	3.0	2.7	10.5	29.7	1.8	10.8	7.9	2.9	13.7	3.6	2.0	28.6	13.7	128.4	21.7	6.0	4.4	2.9	15.7	26.6	14.3	3.8	2.8	17.9	60.1	5.5	9.3	17.8	3.3	52.9	7.6	0.1	0.0	0.0	0.0	28.7	6.3	0.0	4.6	4.0	19.1	0.4	0.0	5.8	14.1	1.3	12.5	11.9	1.9	2.0	0.1	0.5	0.0	7.6	0.0	20.5	0.0	7.4	14.1	11.8	4.8	0.0	0.4	9.3	0.0	19.6	0.0	1.4	7.3	0.0	0.2	13.3	0.1	0.0	16.3	0.0	0.0	3.6	0.0	5.5	8.4	0.0	13.1	0.0	16.5	20.5	2.6	2.8	0.0	5.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	3.6	2.9	1.7	15.4	0.0	0.6	0.0	0.2	0.1	0.5	1.7	1.7	0.3	0.0	3.6	0.5	0.7	0.6	0.0	0.3	2.6	2.4	2.5	2.5	2.6	4.3	3.0	2.7	2.9	2.9	3.8	3.3	2.7	19.2	11.8	0.0	3.6	4.5	13.8	2.7	0.0	0.9	16.7	27.2	42.2	17.2	6.4	16.5	2.1	81.2	0.1	1.3	144.8	33.6	4.0	2.3	5.9	3.5	0.0	1.7	0.3	29.8	32.9	6.0	16.3	4.6	0.0	49.5	4.6	152.0	13.1	0.0	0.2	0.6	6.1	14.1	2.2	6.3	2.8	10.6	8.8	1.0	6.8	13.1	0.0	0.0	0.5	13.6	1.2	3.4	6.4	26.1	0.9	209.9	0.4	2.7	19.7	12.0	12.0	22.1	9.6	0.4	5.7	28.9	1.5	4.9	1.9	6.8
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362485-133373354	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1128.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1476.3;Proximal tubular cells: 2336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	302.4	127.1	127.7	53.7	127.8	43.9	116.9	131.3	136.1	59.8	149.7	143.1	171.6	47.0	89.3	107.9	90.5	66.7	226.4	133.1	129.9	481.7	1128.7	48.5	52.4	129.4	129.9	71.3	96.8	98.7	74.3	73.6	128.8	102.0	104.6	39.8	163.4	123.2	294.3	68.2	153.6	59.4	130.3	48.4	84.5	52.6	134.6	40.0	88.5	271.6	59.0	87.4	57.8	136.0	185.1	229.2	120.4	303.4	173.0	111.4	110.5	132.2	175.9	183.2	154.1	509.5	174.0	139.2	111.9	151.4	94.4	167.7	160.2	136.1	132.0	107.4	281.2	138.5	128.1	367.2	145.0	180.4	93.5	124.5	115.9	121.2	153.6	160.8	165.1	98.3	127.8	117.4	181.6	443.9	90.7	352.0	84.4	289.8	272.1	152.8	146.4	74.6	227.8	236.0	78.1	123.4	137.0	224.1	178.9	69.4	174.8	171.5	132.1	81.3	115.9	169.9	177.4	87.0	58.8	159.8	192.4	98.8	68.7	96.1	184.7	86.8	105.5	212.2	137.6	178.7	117.8	115.8	242.6	148.9	119.3	115.8	19.8	166.0	168.1	104.9	123.0	233.0	127.7	127.8	131.3	136.1	133.1	129.9	129.4	129.9	128.8	130.3	134.6	136.0	99.2	44.8	82.7	16.3	60.5	68.2	86.9	271.8	62.6	57.0	98.5	119.6	255.2	210.1	161.5	174.7	6.2	470.2	34.0	298.6	565.4	162.8	29.9	148.9	92.7	71.4	131.7	72.2	11.6	101.1	163.5	92.5	87.7	226.4	91.2	120.0	88.5	1476.3	221.1	45.4	11.0	223.0	175.0	92.1	61.5	39.1	77.6	88.0	135.2	10.3	113.0	145.2	45.3	10.6	24.3	107.8	248.6	91.7	57.5	88.0	486.2	2336.5	93.2	55.2	85.5	57.0	98.8	52.9	66.1	125.2	76.3	299.1	62.5	220.0	317.2	127.8
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115693-4135597	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 422.7"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 293.6;Distal tubular cells: 428.4;Proximal tubular cells: 577.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	53.6	123.6	43.9	21.0	47.7	21.5	65.0	46.5	63.7	60.0	50.5	53.3	64.0	44.9	102.1	26.7	49.2	40.1	150.9	42.4	47.8	236.0	422.7	28.6	20.0	45.0	45.6	71.4	159.8	53.2	52.6	37.7	44.2	45.2	55.4	31.8	29.9	36.3	198.4	22.7	59.6	35.5	45.3	30.1	103.5	30.9	49.0	33.5	37.0	236.4	21.8	31.6	26.8	45.5	82.8	45.1	72.8	161.0	89.7	131.4	8.8	114.0	116.7	122.1	107.7	34.0	12.4	3.6	139.6	126.0	111.0	41.6	83.6	67.4	179.5	30.4	95.8	44.0	59.7	186.8	51.3	40.4	20.7	90.6	40.6	106.2	58.4	166.0	262.9	136.2	146.2	31.1	118.6	33.4	113.9	100.7	49.5	8.1	158.7	108.8	90.8	1.5	67.2	16.8	1.8	33.7	6.8	48.2	107.6	131.0	109.8	18.9	268.6	92.4	49.8	82.7	69.8	46.8	88.7	8.4	47.9	34.7	73.0	19.2	36.4	17.4	41.5	28.4	57.1	45.8	48.8	58.3	58.9	51.9	59.8	59.2	1.2	66.0	43.3	45.3	57.9	41.1	43.9	47.7	46.5	63.7	42.4	47.8	45.0	45.6	44.2	45.3	49.0	45.5	61.0	28.9	25.2	17.0	24.4	18.2	48.6	50.3	22.2	14.3	33.3	41.0	165.8	78.6	40.1	36.8	12.5	293.6	29.3	32.0	428.4	53.2	63.1	60.8	43.1	48.0	52.1	77.6	10.7	175.5	29.0	55.2	34.7	57.0	23.4	68.6	53.9	162.2	64.3	18.5	11.9	41.6	20.3	22.0	19.2	50.6	63.3	23.5	35.6	14.0	34.7	77.7	21.6	8.5	18.2	80.4	37.5	50.8	28.3	24.7	120.6	577.0	83.6	46.4	26.3	46.8	33.9	46.5	35.6	24.9	12.8	101.9	41.2	224.0	60.8	22.3
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 73.3;Hepatocytes: 49.3;Leydig cells: 122.1;Peritubular cells: 69.6;Skeletal myocytes: 43.6;Smooth muscle cells: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 19.1;ASC TERT1: 34.5;HSkMC: 36.8;hTCEpi: 42.8;hTERT-HME1: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035347, HPA035348"	Approved		Approved	"Mitotic spindle,Centrosome,Cytosol"	"Secreted to extracellular matrix"	Yes	NA		10000000		"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Centrosome, Cytosol"	"Mitotic spindle"	"HPA035347: AB_10669856, HPA035348: "	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	122.1	14.3	5.0	2.1	5.0	0.6	34.8	6.0	4.9	43.5	8.1	6.8	9.0	40.8	23.2	9.0	30.0	31.7	31.5	4.5	11.6	28.4	81.5	22.5	8.3	5.2	10.3	91.6	6.3	9.1	6.1	3.5	5.8	21.2	7.4	0.3	7.2	22.2	7.4	9.7	14.8	27.8	4.4	0.9	4.3	16.8	8.0	5.0	11.4	24.6	7.8	13.3	11.1	12.0	0.7	0.1	0.4	0.0	19.1	34.5	1.3	0.8	1.1	0.1	0.5	0.6	0.0	0.0	0.1	1.9	0.3	0.5	0.9	0.8	0.1	4.4	0.0	0.0	0.0	0.0	3.3	0.2	0.0	36.8	42.8	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.1	0.0	0.1	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	5.0	6.0	4.9	4.5	11.6	5.2	10.3	5.8	4.4	8.0	12.0	12.9	0.0	2.3	5.5	0.3	11.5	0.1	0.6	0.6	3.0	0.3	1.3	5.5	1.5	2.0	0.0	2.1	0.1	0.3	0.2	0.0	0.1	5.1	0.6	18.6	5.2	0.0	0.8	3.4	0.0	16.2	73.3	0.5	0.5	0.0	18.2	2.2	49.3	0.4	0.0	2.8	0.4	0.0	1.3	15.4	8.9	122.1	1.1	5.4	17.8	0.1	0.1	0.0	0.5	2.9	0.0	0.2	69.6	1.4	0.1	11.1	9.2	3.3	2.5	26.3	43.6	50.2	0.9	0.6	0.9	9.1	0.8	0.9	13.5	0.6	0.2
ECSCR	"ARIA, ECSM2"	ENSG00000249751	"Endothelial cell surface expressed chemotaxis and apoptosis regulator"	Q19T08	5	139448560-139462743	"Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Adipocytes: 235.8;Endothelial cells: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	122	"EFO-21: 172.1;HUVEC TERT2: 443.7;TIME: 330.9"									HPA063337			Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA063337: AB_2732701"	"unprognostic (5.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.91e-1)"	62.7	12.7	5.5	11.2	5.5	0.2	59.8	5.7	8.5	26.8	5.3	19.4	4.6	29.4	7.4	15.9	33.5	12.1	54.6	5.2	5.9	29.9	6.0	60.1	11.6	6.0	5.9	10.4	6.7	4.7	7.1	33.5	6.3	19.6	8.0	0.8	16.1	7.3	15.1	16.6	20.7	24.4	6.1	23.5	15.2	3.3	6.7	3.5	40.9	17.2	7.2	35.5	26.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.3	0.0	0.0	172.1	0.3	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	443.7	0.1	0.0	0.0	1.4	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	330.9	0.4	0.4	0.0	1.7	0.0	0.0	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.5	5.7	8.5	5.2	5.9	6.0	5.9	6.3	6.1	6.7	5.9	235.8	0.0	3.9	0.0	1.0	14.9	0.4	0.0	0.0	0.0	1.9	2.5	0.0	0.0	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.6	0.0	0.4	0.5	214.9	0.0	0.0	0.1	1.2	0.1	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	18.3	0.0	0.0	1.7	10.6	5.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	13.9	0.3	1.3	0.9	0.0	1.6
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290361-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 44.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 749.7;Ductal cells: 316.3;Glandular and luminal cells: 289.7;Pancreatic endocrine cells: 268.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 4.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 660.4;HUVEC TERT2: 446.8;T-47d: 137.5;TIME: 334.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	NA	Yes	9740		"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	44.6	1.8	14.7	7.3	13.8	4.7	23.6	13.6	18.2	6.2	9.7	10.6	10.4	7.0	6.3	12.1	9.4	13.5	7.8	12.6	12.2	7.7	3.1	36.6	5.6	15.1	13.6	2.6	9.6	1.4	1.1	18.5	15.2	5.5	14.5	1.0	12.1	8.9	7.6	11.8	9.8	11.3	13.1	12.3	10.4	4.7	15.7	1.7	3.4	6.4	2.4	9.9	5.9	14.2	10.3	57.6	1.1	0.1	0.3	0.2	0.2	18.2	16.0	15.0	12.4	74.6	8.6	0.0	660.4	7.2	9.2	5.4	0.0	10.6	11.0	0.8	0.0	0.0	2.1	2.3	0.8	0.0	0.0	0.4	6.2	3.0	2.1	4.7	446.8	0.0	0.0	0.0	56.8	1.6	0.2	0.3	0.6	10.4	0.7	0.2	5.1	0.1	35.3	9.4	0.6	0.0	1.8	53.1	0.1	117.2	137.5	0.8	334.3	37.1	30.1	0.7	23.5	0.3	0.4	1.3	0.3	0.0	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.0	0.0	14.7	13.8	13.6	18.2	12.6	12.2	15.1	13.6	15.2	13.1	15.7	14.2	190.7	173.1	23.8	2.9	0.8	189.9	749.7	99.9	151.4	0.2	68.7	26.8	2.2	8.6	110.6	38.6	0.0	1.8	0.8	189.7	3.9	316.3	13.3	187.2	16.3	236.8	15.6	2.7	3.6	218.9	0.4	9.0	22.4	289.7	1.3	0.8	169.2	1.8	1.8	1.7	3.0	43.8	12.2	5.0	6.7	19.8	5.6	5.3	8.8	6.5	10.9	0.3	0.0	3.5	0.6	268.5	145.7	0.4	0.4	185.8	119.6	8.3	27.4	0.4	6.6	1.8	21.8	1.0	0.6	53.7	64.5	0.8	9.7	0.1	196.6	141.8
EFEMP2	"FBLN4, UPH1"	ENSG00000172638	"EGF containing fibulin extracellular matrix protein 2"	O95967	11	65866441-65873592	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 122.8;Leydig cells: 93.5;Muller glia cells: 84.8;Peritubular cells: 107.2;Smooth muscle cells: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 125.8;BJ hTERT+: 159.7;fHDF/TERT166: 232.6;HSkMC: 155.3;hTERT-RPE1: 159.1;LHCN-M2: 134.5;U-138 MG: 114.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023270	Approved				"Secreted to extracellular matrix"	NA	NA		2600000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA023270: AB_1848019"	"unprognostic (3.13e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.89e-2)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (8.33e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.58e-2)"	38.4	18.0	19.8	13.8	21.1	2.8	29.5	18.8	26.7	46.6	22.1	39.6	9.3	55.2	8.3	12.8	35.8	33.5	61.6	19.1	20.4	26.8	7.0	32.1	9.1	24.9	20.0	47.0	19.9	26.8	15.2	22.4	21.4	31.1	6.5	5.9	17.4	35.2	21.2	14.9	16.2	32.3	20.3	16.1	20.6	8.2	21.4	5.6	39.1	22.0	5.0	33.1	30.7	19.1	0.5	0.2	2.1	47.3	54.3	108.0	0.8	125.8	159.7	48.1	44.8	0.0	4.3	0.7	9.3	232.6	0.7	0.9	0.0	1.3	12.1	5.4	0.1	1.1	3.2	8.0	89.1	0.0	0.4	155.3	0.4	18.9	1.0	159.1	28.5	1.0	0.3	8.0	134.5	0.4	0.2	20.7	1.6	0.2	0.6	0.4	0.3	3.2	1.6	0.6	0.7	14.1	0.2	1.3	1.5	6.6	1.5	10.0	64.6	114.2	24.7	52.6	0.6	10.9	0.7	0.3	42.6	0.8	19.7	0.0	0.1	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.7	0.0	0.0	0.0	0.2	19.8	21.1	18.8	26.7	19.1	20.4	24.9	20.0	21.4	20.3	21.4	19.1	30.8	35.3	7.4	29.0	1.5	13.5	38.9	33.9	8.6	7.7	10.2	27.6	46.0	15.7	11.4	18.4	0.0	2.4	2.3	0.3	7.9	28.7	15.6	3.4	57.1	27.9	0.0	0.4	1.1	0.2	3.9	122.8	2.6	4.1	0.0	74.3	42.8	1.8	9.8	6.7	2.9	0.3	4.1	3.5	19.1	33.3	93.5	3.0	24.9	9.4	0.7	84.8	2.1	9.5	1.6	2.6	0.1	107.2	1.4	30.1	0.2	21.2	9.0	4.8	39.5	41.1	113.2	35.9	3.3	1.1	10.1	5.9	2.4	78.5	0.3	14.2
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68829021-68842160	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.3;Granulosa cells: 134.5;Hepatic stellate cells: 143.5;Suprabasal keratinocytes: 120.5;Theca cells: 116.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 3.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 97.0;hTCEpi: 74.1;PC-3: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"		NA	NA		1300000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: AB_2685799"	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	47.0	23.7	9.3	8.2	9.5	2.3	41.2	8.7	11.8	27.1	8.7	27.6	19.1	19.4	10.7	32.0	19.6	18.3	32.5	9.1	8.9	44.0	11.6	41.6	4.3	9.4	9.1	14.3	7.6	16.5	10.3	25.4	8.9	19.8	13.2	1.2	11.2	16.2	9.1	52.5	20.6	8.8	9.6	26.1	18.1	6.3	9.7	5.6	19.6	9.5	4.8	25.9	27.9	9.3	10.4	5.3	41.9	15.6	21.7	13.4	21.9	8.7	9.5	3.8	2.8	4.8	19.0	2.5	56.7	3.3	5.0	54.3	40.0	97.0	2.1	4.3	10.2	2.6	2.3	8.5	20.0	1.9	21.3	25.0	74.1	9.4	42.4	3.4	29.3	5.3	2.8	0.2	3.3	8.5	4.2	2.0	29.0	63.5	70.9	18.6	4.4	16.6	15.9	36.1	15.6	7.5	6.7	2.0	2.6	31.7	1.6	3.6	49.7	7.2	8.9	19.6	3.3	0.1	2.3	2.5	3.6	11.3	4.7	0.0	0.6	0.3	0.4	1.7	0.3	0.3	0.4	0.4	3.5	0.2	0.3	0.2	0.1	0.7	1.1	0.5	0.2	0.5	9.3	9.5	8.7	11.8	9.1	8.9	9.4	9.1	8.9	9.6	9.7	9.3	81.1	3.2	1.1	2.6	3.2	117.3	66.2	60.7	93.4	3.3	3.6	11.2	8.2	20.0	12.8	22.0	0.0	11.4	5.9	59.4	0.0	16.4	0.4	2.6	7.6	42.4	8.4	2.7	1.0	15.6	75.9	20.5	21.4	4.5	4.5	134.5	143.5	4.8	12.4	1.7	1.0	27.6	8.2	9.1	23.8	1.3	27.4	8.6	21.4	2.8	5.9	12.5	2.1	0.5	0.6	46.3	52.6	8.2	2.3	40.2	28.6	5.7	2.8	1.3	13.1	8.7	12.5	2.0	3.8	76.2	120.5	11.2	4.7	116.2	29.8	93.6
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489745-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 239.7;Hepatic stellate cells: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 76.5;OE19: 45.5;SH-SY5Y: 42.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		940000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	20.7	6.1	3.8	4.3	5.9	0.2	17.1	1.3	6.2	11.0	0.0	22.1	7.9	10.2	0.7	12.1	8.8	4.2	15.5	5.5	4.9	11.2	4.8	23.4	3.2	0.1	0.1	7.2	3.9	3.2	6.3	15.4	0.3	12.5	9.9	3.2	14.0	10.6	6.5	17.2	14.4	5.5	0.1	7.4	15.0	5.4	1.6	3.6	11.9	8.0	3.2	6.5	14.1	4.3	23.3	1.8	76.5	0.1	0.2	0.7	0.3	10.8	5.4	8.2	4.7	19.1	28.7	0.0	11.0	2.5	0.6	28.4	2.9	10.9	8.9	0.0	24.3	0.1	6.0	0.0	1.5	6.9	0.6	3.5	19.0	0.4	16.1	4.1	10.4	0.2	0.1	0.0	9.1	3.3	0.2	0.1	4.7	45.5	5.0	21.9	3.3	0.1	11.9	2.5	5.8	42.7	3.6	1.7	0.1	21.4	1.0	0.2	9.6	16.3	0.0	0.5	23.8	0.4	0.0	0.0	34.5	0.4	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.9	1.3	6.2	5.5	4.9	0.1	0.1	0.3	0.1	1.6	4.3	239.7	6.4	35.7	38.8	4.4	83.2	52.9	15.4	13.1	10.4	39.8	45.3	8.8	5.7	13.2	25.8	0.0	1.4	8.6	114.6	0.0	6.8	0.4	24.7	69.8	106.5	50.6	0.0	49.3	1.4	3.1	15.4	69.3	42.1	17.8	11.8	187.4	1.3	1.1	6.7	29.7	59.8	26.4	5.8	11.9	1.0	0.3	4.0	32.0	48.7	0.0	89.1	0.0	3.5	13.9	46.3	64.3	0.4	1.0	25.1	15.9	0.2	8.7	3.4	0.0	33.1	22.8	0.7	3.3	41.1	86.0	1.9	7.9	6.4	71.5	72.0
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356403-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol		No	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001581: AB_2666367, HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	19.3	12.6	39.7	5.5	59.6	0.0	22.7	51.7	45.6	47.3	28.0	24.4	3.1	29.2	9.9	44.1	28.6	8.7	15.0	35.6	39.3	10.0	1.8	12.1	3.6	63.0	57.6	41.9	2.2	22.2	8.4	10.4	54.8	36.8	3.3	10.6	26.2	22.5	3.6	59.0	9.6	12.5	44.8	7.6	11.9	5.4	49.9	3.2	17.5	5.1	4.8	25.3	42.9	76.0	4.7	0.0	73.2	39.5	17.1	20.0	57.7	5.3	11.3	2.0	0.9	0.0	0.0	0.0	0.0	30.3	0.3	27.5	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	11.6	18.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	0.0	0.0	22.6	0.1	0.0	24.1	7.8	66.5	15.1	2.6	0.0	8.7	17.6	0.0	0.0	7.6	0.0	19.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	59.6	51.7	45.6	35.6	39.3	63.0	57.6	54.8	44.8	49.9	76.0	2.0	0.0	6.7	17.0	0.0	11.6	11.6	5.6	9.6	5.0	20.3	16.3	0.7	0.0	4.1	0.0	6.2	9.3	0.2	0.0	1.9	0.1	0.9	0.6	18.9	1.8	0.0	0.0	0.2	0.0	14.7	15.7	0.0	0.7	0.0	4.4	1.8	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.7	0.8	20.2	0.4	7.2	1.9	0.0	9.0	0.0	22.1	48.9	0.0	0.0	13.9	0.1	7.6	0.0	0.3	1.1	9.3	6.6	12.6	8.9	2.2	0.5	22.7	13.4	18.1	0.5	0.3	0.0	7.0
EGFL7	ZNEU1	ENSG00000172889	"EGF like domain multiple 7"	Q9UHF1	9	136658856-136672678	"Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 806.1;Endothelial cells: 436.5;Hepatic stellate cells: 511.5;Hofbauer cells: 290.3;Spermatogonia: 179.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.1;eosinophil: 3.5;intermediate monocyte: 6.2;non-classical monocyte: 5.5;plasmacytoid DC: 5.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 5.9;granulocytes: 3.5;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 183.9;HUVEC TERT2: 329.0;RPMI-8226: 136.8;TIME: 312.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050716	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA050716: AB_2732562"	"unprognostic (1.72e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.76e-3)"	"unprognostic (5.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.14e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.49e-2)"	195.6	50.2	108.8	13.4	90.4	14.4	192.3	85.0	144.3	112.9	74.4	49.1	13.4	104.3	9.8	39.8	98.5	27.4	243.3	89.8	86.5	144.3	56.1	204.2	20.8	102.0	96.9	37.8	28.2	18.5	51.3	181.6	100.9	74.9	3.5	1.0	39.4	13.2	60.5	47.8	51.4	13.4	89.9	191.7	40.7	43.3	111.7	5.6	105.5	25.2	2.9	87.5	86.3	85.2	0.1	45.7	14.6	52.7	1.2	1.0	33.4	12.9	2.3	7.3	2.3	16.2	42.4	0.3	183.9	4.3	11.9	6.5	3.7	8.3	0.3	77.2	14.1	28.8	3.4	1.3	11.4	0.0	40.1	1.5	3.2	3.7	0.0	2.5	329.0	2.1	104.9	0.1	2.5	83.5	0.5	0.7	21.1	64.3	2.6	91.4	5.9	136.8	4.6	1.1	9.3	31.0	6.3	5.9	12.2	4.2	15.5	43.6	312.6	1.8	37.2	4.4	2.5	0.4	0.1	0.5	0.2	0.1	38.4	0.0	2.1	3.5	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.8	0.2	5.5	5.9	0.0	2.4	108.8	90.4	85.0	144.3	89.8	86.5	102.0	96.9	100.9	89.9	111.7	85.2	806.1	0.0	26.5	2.3	6.2	11.9	5.6	5.5	9.6	2.0	5.9	6.7	23.7	5.7	4.2	3.7	0.0	3.1	5.9	1.4	7.9	19.4	2.7	1.4	3.4	436.5	1.2	58.9	15.0	2.0	17.8	18.5	0.5	1.9	20.3	2.0	511.5	20.5	290.3	3.3	10.1	4.6	2.0	24.5	14.2	9.2	8.7	18.7	19.6	102.1	1.2	1.9	0.0	3.5	1.8	5.8	3.7	6.0	4.0	19.1	22.5	25.2	0.2	2.3	13.1	13.0	18.4	18.9	179.8	2.7	9.5	6.0	2.9	4.8	0.5	3.5
EHD3	PAST3	ENSG00000013016	"EH domain containing 3"	Q9NZN3	2	31234152-31269451	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.7;esophagus: 43.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 24.3;Hepatic stellate cells: 120.3;Syncytiotrophoblasts: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 5.6"	"Lineage enriched"	"Detected in many"	7	"B-cells: 20.8"	"Cell line enhanced"	"Detected in many"		"BJ: 79.7;BJ hTERT+: 192.2;HEL: 77.4;U-266/70: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		15000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (3.44e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.88e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (4.92e-3)"	2.5	9.1	20.5	5.9	29.5	1.9	3.2	10.5	38.7	5.5	1.1	2.5	1.6	4.4	3.0	43.9	4.5	3.4	15.9	29.5	18.5	20.0	11.0	5.7	6.8	11.7	17.8	2.5	1.3	21.1	9.1	11.7	13.9	5.5	1.7	9.0	5.9	4.4	2.3	3.1	3.7	4.6	9.6	7.3	2.2	1.3	31.1	2.7	3.2	5.1	11.1	6.6	6.0	26.2	1.8	8.4	4.5	3.9	7.5	11.3	0.7	79.7	192.2	7.5	6.9	0.0	0.9	0.6	2.9	26.0	6.5	0.8	0.2	5.2	5.3	3.2	7.1	77.4	0.4	0.0	25.7	0.0	0.2	18.1	2.3	7.3	3.0	20.0	0.1	0.2	0.3	0.4	5.6	12.6	1.0	0.1	17.7	0.0	4.3	2.8	0.3	1.8	5.8	8.9	2.2	12.1	0.8	1.3	0.0	14.1	1.2	0.0	0.0	5.8	5.4	0.3	6.5	48.7	6.5	0.1	14.8	0.0	12.4	0.6	0.5	0.5	2.1	1.0	1.1	20.8	1.0	1.4	0.5	5.6	0.9	0.5	1.2	0.8	2.8	0.0	0.5	10.2	20.5	29.5	10.5	38.7	29.5	18.5	11.7	17.8	13.9	9.6	31.1	26.2	1.9	0.0	0.0	2.6	16.2	0.8	1.8	1.7	10.2	9.7	0.6	6.2	24.3	5.7	0.9	0.0	0.0	4.1	0.6	0.0	0.0	0.5	0.1	0.7	2.3	8.4	1.8	6.1	17.1	0.2	8.4	3.3	1.1	0.5	0.0	0.4	120.3	5.0	1.7	0.0	11.1	0.1	0.0	16.1	0.4	0.0	1.2	5.9	0.0	4.7	1.1	9.0	0.0	22.6	5.4	0.2	0.1	3.0	5.8	2.6	0.0	0.2	0.4	5.9	19.7	3.0	7.0	0.6	2.7	10.7	0.9	43.9	1.4	0.7	0.1	4.7
EHD4	PAST4	ENSG00000103966	"EH domain containing 4"	Q9H223	15	41895933-41972557	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 189.5;Urothelial cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 103.8;TIME: 172.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA052729, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		440000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.72e-1)"	21.6	4.6	3.1	11.8	3.2	10.9	16.4	7.5	3.5	9.4	5.3	12.1	5.5	9.6	10.5	15.0	9.8	15.2	27.8	3.3	3.8	14.3	9.6	15.0	12.8	4.8	4.0	5.6	14.3	12.8	5.8	8.3	4.8	9.5	10.2	6.1	10.4	9.7	4.4	14.3	12.4	12.9	5.2	7.4	9.9	2.8	4.0	5.3	18.4	4.7	8.8	23.8	9.0	6.6	28.7	9.8	9.3	9.6	4.6	6.5	8.1	14.9	31.4	25.9	36.1	41.4	16.1	5.9	39.2	18.8	51.6	28.4	13.9	32.6	19.0	35.7	11.7	8.7	13.5	7.1	11.3	4.0	24.4	5.5	12.6	26.3	28.8	9.9	103.8	8.7	9.2	6.6	21.1	12.2	4.2	4.5	7.1	27.8	33.5	0.1	24.5	9.4	23.4	57.0	15.4	6.5	10.9	23.2	17.0	9.0	22.9	5.6	172.8	8.1	15.7	30.5	73.1	18.1	30.9	12.4	10.3	9.4	71.6	1.1	14.0	9.0	4.0	12.4	6.1	2.1	6.2	5.0	14.9	2.6	2.6	3.8	2.3	4.4	5.2	2.5	7.9	8.0	3.1	3.2	7.5	3.5	3.3	3.8	4.8	4.0	4.8	5.2	4.0	6.6	94.9	6.4	44.2	3.9	20.0	81.6	189.5	68.1	34.1	4.9	31.4	20.1	36.6	30.0	69.0	44.1	31.3	10.1	22.2	96.0	7.9	71.3	16.1	66.1	9.7	114.9	22.6	5.7	1.2	62.6	20.4	21.3	25.5	72.4	61.6	16.2	54.7	8.7	89.0	1.7	0.7	22.5	28.5	35.6	52.7	34.7	7.5	46.3	19.6	12.2	53.5	37.5	4.1	26.7	2.7	75.1	70.9	4.9	31.5	49.9	71.4	4.6	60.8	27.8	13.1	8.0	29.0	5.4	8.2	29.3	79.8	17.4	27.8	21.2	37.3	200.1
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	11	"kidney: 144.3;liver: 344.5"	"Group enriched"	"Detected in many"	10	"Hepatocytes: 289.0;Proximal tubular cells: 147.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	10.8	4.3	2.1	3.0	2.9	1.2	4.1	3.9	2.7	3.5	9.2	14.2	21.5	2.8	3.5	5.5	3.6	4.4	10.7	2.1	3.1	144.3	344.5	4.3	2.1	3.2	4.1	2.6	9.9	7.8	1.5	3.2	3.0	6.3	10.8	1.6	5.7	2.2	1.7	4.5	12.9	3.7	2.5	3.7	10.4	2.7	3.1	2.1	6.5	5.6	2.8	3.6	2.1	2.8	12.3	5.0	1.4	0.0	7.3	6.1	1.5	5.7	1.8	3.7	4.1	21.9	7.5	0.0	22.1	5.7	1.4	5.8	0.0	4.8	7.6	16.2	5.2	8.6	1.3	22.5	4.7	1.0	0.2	8.7	6.0	3.7	3.4	5.0	5.5	0.0	5.7	6.1	7.2	6.4	0.2	5.1	3.0	4.3	6.3	0.0	9.9	0.5	15.4	6.8	4.4	6.4	11.2	6.4	10.5	12.1	23.7	10.1	2.6	2.4	3.6	1.9	0.5	1.7	5.6	0.5	0.8	3.9	4.0	0.1	0.9	0.0	0.6	0.8	0.4	0.5	0.4	0.9	2.4	0.0	0.6	1.0	0.0	1.2	0.8	1.0	0.6	0.4	2.1	2.9	3.9	2.7	2.1	3.1	3.2	4.1	3.0	2.5	3.1	2.8	4.9	16.0	10.9	20.9	4.5	1.5	1.4	1.9	1.2	0.7	3.2	2.3	19.2	17.2	3.9	20.2	4.2	8.9	0.4	17.8	19.6	2.1	0.2	6.5	5.1	3.9	7.7	9.7	4.9	6.8	2.9	1.6	8.6	3.1	0.0	6.1	13.6	289.0	4.4	0.0	5.7	12.8	0.0	10.5	1.0	0.7	0.6	2.7	3.6	4.7	9.4	1.9	0.0	3.5	8.0	3.7	9.3	0.4	0.8	2.5	15.0	147.1	4.0	1.2	0.0	1.1	2.4	3.7	4.2	4.9	0.4	1.4	2.2	3.6	10.8	1.8
ELF5		ENSG00000135374	"E74 like ETS transcription factor 5"	Q9UKW6	11	34478791-34525193	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 151.2;salivary gland: 147.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 40.3;Breast glandular cells: 143.2;Breast myoepithelial cells: 57.1;Collecting duct cells: 101.2;Cytotrophoblasts: 26.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"RT4: 30.2;T-47d: 56.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062706			Approved	Nucleoplasm		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm		"HPA062706: AB_2684841"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.41e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.93e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-1)"	0.2	0.0	0.1	0.0	0.1	0.2	151.2	0.2	0.2	0.9	0.4	0.0	2.1	0.0	0.0	1.3	0.1	0.2	0.0	0.1	0.0	17.0	0.2	7.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	1.4	0.0	2.5	0.0	0.0	147.6	30.4	0.0	6.2	0.0	0.0	0.0	1.1	0.6	0.2	0.1	0.5	0.0	0.0	2.5	5.7	2.3	0.2	0.1	0.0	0.0	0.1	0.0	0.5	3.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	30.2	0.0	0.0	0.0	5.1	0.0	0.1	56.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	1.0	3.2	40.3	0.0	1.1	0.3	1.9	0.9	0.0	0.0	143.2	57.1	0.4	0.0	9.7	101.2	0.0	26.9	1.4	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.0	1.9	0.4	0.1	0.0	0.5	17.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.4	4.8	0.0	0.0	0.2	0.9	2.5	0.2	0.0	0.1	11.5	0.6	0.0	0.0	6.5
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ETS transcription factor ELK3"	P41970	12	96194375-96269824	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 170.7;Endothelial cells: 148.0;Hepatic stellate cells: 160.6;Respiratory ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	37.1	14.4	5.4	34.2	6.1	18.4	28.4	14.4	5.8	28.0	11.7	15.6	9.2	35.2	9.3	38.1	16.9	30.2	23.9	4.7	7.2	14.0	10.8	27.5	38.0	9.1	7.9	10.2	9.0	11.6	5.8	27.0	7.9	13.1	13.9	2.9	15.3	15.3	11.2	12.5	13.5	37.9	7.0	41.8	14.8	8.6	8.3	19.7	21.8	22.2	37.5	29.2	24.5	6.6	50.3	29.5	29.7	15.8	73.7	137.3	7.6	62.3	118.5	48.6	37.3	1.7	36.6	8.0	20.9	70.4	36.4	17.6	3.3	99.8	85.0	21.7	11.4	2.5	12.2	11.2	22.3	24.2	5.7	81.3	18.4	100.4	75.4	98.5	117.8	6.0	6.0	32.3	166.4	7.6	4.8	16.4	36.3	7.1	38.8	39.7	49.8	9.1	41.7	13.0	1.4	31.4	20.5	9.1	32.0	44.7	5.0	13.3	73.2	132.4	52.2	82.5	54.8	61.7	55.0	1.8	47.0	28.2	94.1	7.1	23.5	0.5	11.1	13.0	42.5	23.2	25.7	15.0	17.7	19.0	15.4	11.4	7.4	20.1	12.1	7.1	45.4	12.8	5.4	6.1	14.4	5.8	4.7	7.2	9.1	7.9	7.9	7.0	8.3	6.6	170.7	6.4	22.3	3.9	22.3	32.6	44.6	15.0	10.8	0.7	7.1	8.1	6.6	2.8	39.4	5.5	4.2	1.2	27.5	2.1	5.9	21.8	1.0	49.0	19.7	148.0	1.2	12.4	4.2	15.6	3.9	35.2	3.1	44.0	17.1	1.3	160.6	4.3	24.5	0.0	1.9	3.4	2.0	32.0	39.7	2.5	11.5	31.4	12.4	39.4	23.6	5.8	9.2	5.5	5.3	56.8	3.4	10.5	29.5	45.7	0.5	0.7	103.1	0.6	13.1	27.7	19.9	0.2	12.6	24.4	27.0	1.1	32.6	10.6	3.0	79.0
ELMOD1	DKFZp547C176	ENSG00000110675	"ELMO domain containing 1"	Q8N336	11	107591091-107666779	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.8;pituitary gland: 21.7;retina: 32.6;skin 1: 28.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.5;Excitatory neurons: 126.1;Horizontal cells: 37.0;Inhibitory neurons: 103.9;Oligodendrocyte precursor cells: 80.9"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 14.9;RH-30: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038435, HPA066479"			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA038435: AB_10795575, HPA066479: "	"unprognostic (2.74e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.13e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.39e-1)"	0.4	2.6	17.2	0.3	27.1	0.1	2.4	13.2	32.8	0.5	0.0	0.5	0.2	0.4	0.1	0.1	2.1	0.1	4.8	24.6	23.5	3.1	0.3	0.4	0.1	15.1	24.8	0.1	0.1	0.9	21.7	0.0	11.8	0.8	0.2	32.6	0.1	0.1	2.6	28.9	0.2	0.3	14.3	0.1	0.1	1.6	18.8	0.4	0.1	1.8	0.0	0.0	0.1	10.7	0.0	0.0	5.6	0.1	0.0	0.1	0.2	0.2	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.2	4.4	0.5	2.8	0.4	0.5	0.0	2.3	0.1	0.0	0.1	1.5	0.1	0.0	0.5	0.1	0.0	0.0	0.1	14.9	1.9	0.0	0.1	1.1	0.1	0.0	0.1	0.6	0.0	2.2	0.1	33.9	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	1.6	0.0	0.9	0.2	0.0	0.0	4.5	0.0	2.7	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	17.2	27.1	13.2	32.8	24.6	23.5	15.1	24.8	11.8	14.3	18.8	10.7	0.0	0.0	3.9	24.2	0.2	0.0	0.4	0.1	0.0	33.5	0.0	0.1	12.8	0.0	1.3	0.0	16.7	0.1	0.0	0.0	0.0	0.0	11.4	2.2	1.0	1.6	0.0	0.0	126.1	0.0	0.1	0.5	0.0	0.2	0.0	0.1	0.4	1.1	0.1	37.0	103.9	0.0	0.0	0.3	2.2	13.6	0.3	0.4	0.0	7.5	0.0	10.0	0.0	80.9	5.9	0.0	0.0	0.4	0.0	0.3	0.0	4.2	4.8	18.3	0.0	0.7	0.8	5.0	1.5	0.0	3.1	0.0	0.2	0.0	0.0	0.2
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 70.4;Fibroblasts: 115.9;Leydig cells: 110.6;Peritubular cells: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 97.6;BJ: 143.7;fHDF/TERT166: 205.6;U-2197: 817.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	147.2	21.6	11.6	40.8	14.3	0.1	94.2	19.9	17.6	100.2	24.3	57.6	8.8	73.6	18.4	53.0	70.7	76.7	184.1	13.1	15.3	12.8	13.4	214.1	14.5	15.4	20.1	37.0	90.9	2.8	24.9	58.9	13.8	106.4	11.3	2.8	66.9	35.1	17.9	91.3	40.6	90.0	14.9	40.9	63.2	13.1	14.0	5.1	48.4	16.9	4.5	85.3	84.3	17.9	0.0	2.0	0.8	0.0	97.6	0.6	0.6	143.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	205.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.5	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.6	0.6	8.3	0.8	0.8	0.4	58.0	1.0	0.0	0.0	28.0	68.9	0.0	1.2	0.1	10.0	0.6	0.0	0.0	0.2	0.3	817.9	0.0	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	14.3	19.9	17.6	13.1	15.3	15.4	20.1	13.8	14.9	14.0	17.9	34.6	0.0	6.4	34.9	0.1	11.0	13.5	33.9	4.0	2.8	0.9	1.1	9.7	2.8	4.3	7.3	2.1	0.1	0.3	0.2	0.0	0.3	3.5	3.5	70.4	28.4	1.8	0.0	4.6	3.9	0.3	115.9	7.1	2.3	0.0	0.2	47.2	4.2	0.5	6.7	8.1	1.3	0.0	0.6	20.4	7.5	110.6	1.2	14.2	23.4	0.0	15.9	0.0	14.1	18.5	1.1	0.2	148.2	0.4	1.4	0.0	0.1	3.0	0.8	0.0	12.2	34.1	1.1	1.2	2.1	10.9	0.1	1.2	0.6	0.2	1.1
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914814-79947553	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, FDA approved drug targets, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 105.5;retina: 176.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 63.8;Cone photoreceptor cells: 148.0;Excitatory neurons: 55.3;Rod photoreceptor cells: 355.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"MAIT T-cell: 23.7"	"Lineage enriched"	"Detected in single"	238	"T-cells: 23.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 41.2;MOLT-4: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.27e-4)"	0.7	2.0	7.1	1.1	7.0	0.1	4.1	10.0	15.4	3.5	9.7	1.8	0.6	2.2	1.0	10.6	0.7	1.6	0.9	7.8	9.9	1.5	0.1	0.3	0.4	14.4	5.3	1.7	0.5	10.8	6.4	1.7	15.0	4.0	1.0	176.7	2.8	1.7	0.2	43.1	0.8	2.7	4.3	0.5	0.9	5.7	7.4	105.5	1.5	0.5	1.7	1.2	4.0	7.2	0.0	0.8	10.8	12.0	8.8	8.5	1.6	5.6	6.1	4.7	10.2	1.5	0.0	0.0	1.0	7.7	19.3	1.1	14.1	7.9	3.5	0.0	18.2	0.4	2.2	0.0	8.1	4.4	1.7	6.9	2.9	4.8	4.9	6.8	7.8	41.2	0.0	0.0	10.0	1.9	32.8	0.0	10.4	0.0	5.6	0.0	15.5	0.0	0.1	0.0	14.2	4.2	6.0	9.6	1.7	7.4	3.8	0.3	0.8	2.1	4.1	3.2	4.3	7.2	15.3	0.0	5.0	0.0	3.3	0.0	0.0	0.0	2.3	0.0	23.7	0.0	3.3	3.9	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.2	0.9	7.1	7.0	10.0	15.4	7.8	9.9	14.4	5.3	15.0	4.3	7.4	7.2	0.7	0.0	0.0	7.5	0.2	11.3	2.3	7.5	15.4	63.8	0.7	1.7	0.9	0.0	3.9	0.0	148.0	0.9	1.7	0.0	0.0	0.1	6.3	0.3	7.0	2.2	8.9	0.0	55.3	0.0	1.5	6.5	0.0	0.1	0.0	1.5	0.0	0.0	0.2	42.1	53.0	0.5	6.1	0.3	1.5	2.1	1.2	0.2	3.6	8.4	0.1	50.7	0.0	20.1	8.6	0.0	1.1	3.4	0.3	3.1	0.0	2.3	0.5	355.3	0.0	2.0	4.3	15.4	15.4	14.8	37.8	1.0	2.6	1.3	0.2	0.7
EMILIN1	"DKFZp586M121, gp115"	ENSG00000138080	"Elastin microfibril interfacer 1"	Q9Y6C2	2	27078615-27086403	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 64.5;Fibroblasts: 111.3;Hepatic stellate cells: 45.0;Leydig cells: 85.1;Peritubular cells: 167.3;Sertoli cells: 72.3;Smooth muscle cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 98.2;BJ hTERT+: 65.0;HHSteC: 99.0;HSkMC: 109.6;SH-SY5Y: 129.4;U-138 MG: 63.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002822	Supported				"Secreted to extracellular matrix"	NA	NA		4300000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA002822: AB_1078738"	"unprognostic (3.14e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (8.13e-9)"	"unprognostic (8.96e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.70e-3)"	55.5	55.7	6.9	47.0	7.1	1.9	43.6	6.4	7.1	139.8	4.6	223.5	24.9	206.3	7.4	23.3	129.2	35.4	68.9	5.9	7.5	55.5	42.4	100.7	11.7	13.0	7.6	172.4	21.2	1.4	26.9	16.2	9.5	96.4	7.9	0.3	17.5	52.1	10.3	19.1	72.0	50.3	8.3	118.1	87.6	16.9	10.4	2.4	29.7	2.6	2.2	142.9	70.2	8.6	0.9	0.7	5.9	0.9	35.8	49.0	1.1	98.2	65.0	20.7	29.7	0.5	0.8	0.6	0.9	56.6	0.1	0.9	0.2	0.2	3.8	3.1	1.3	1.8	0.5	43.9	99.0	1.5	27.0	109.6	0.1	14.2	0.0	0.2	0.2	1.3	1.0	0.9	4.3	1.1	0.9	28.8	3.2	0.5	0.7	15.6	1.3	1.2	0.0	0.4	1.6	129.4	0.3	0.5	1.1	0.4	0.4	2.5	11.9	63.6	2.0	7.6	0.4	1.7	1.8	1.1	0.7	1.3	17.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	6.9	7.1	6.4	7.1	5.9	7.5	13.0	7.6	9.5	8.3	10.4	8.6	5.2	0.0	0.5	6.5	0.4	3.3	0.2	0.0	0.0	0.6	0.8	7.1	2.9	1.5	0.0	0.0	0.0	1.6	0.6	0.2	0.0	0.4	0.6	1.9	64.5	6.3	0.0	4.0	0.2	0.4	1.5	111.3	0.5	1.3	4.5	0.2	45.0	1.0	6.4	0.0	0.3	0.3	0.0	2.5	5.8	10.0	85.1	4.1	10.6	8.4	0.5	3.6	0.0	0.5	0.3	0.8	0.1	167.3	0.8	0.2	0.5	1.0	0.0	1.1	72.3	35.3	52.4	0.6	0.4	0.4	3.1	2.9	1.3	10.7	0.1	0.1
EMP1	"CL-20, TMP"	ENSG00000134531	"Epithelial membrane protein 1"	P54849	12	13196723-13219941	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2255.1;vagina: 819.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 835.5;Basal keratinocytes: 694.1;Endothelial cells: 662.2;Squamous epithelial cells: 888.5;Suprabasal keratinocytes: 687.6;Urothelial cells: 1193.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1166.6;fHDF/TERT166: 861.7;HaCaT: 766.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 4.5;spinal cord: 16.0"	HPA046912			Approved	Vesicles		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA046912: "	"unprognostic (1.40e-2)"	"unprognostic (7.30e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (2.98e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (9.69e-8)"	536.6	42.0	18.6	63.9	20.2	20.7	166.7	18.2	28.4	463.2	14.2	100.7	39.5	61.6	12.5	2255.1	84.8	205.8	121.8	17.7	46.5	93.9	35.1	177.9	11.4	29.5	22.9	21.8	86.8	20.6	29.9	76.9	27.2	39.6	56.4	5.5	377.8	20.3	27.0	150.9	41.8	149.2	25.1	26.2	48.5	9.2	20.8	28.4	133.5	35.6	165.4	205.7	819.5	22.1	373.5	19.4	9.1	1.9	563.2	1166.6	1.5	269.6	489.4	135.7	172.3	2.7	612.6	2.2	187.3	861.7	60.0	766.6	10.8	35.7	182.9	7.2	0.8	1.2	61.9	0.2	135.6	2.6	2.1	369.8	50.9	432.7	126.4	107.3	316.8	0.2	2.0	6.2	325.4	1.6	0.8	8.3	6.6	69.8	62.3	1.0	37.1	3.4	396.4	4.4	0.3	0.3	120.1	17.4	211.9	69.9	3.1	2.2	349.8	302.2	106.7	287.0	146.8	1.5	4.1	2.5	441.2	2.2	363.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	18.6	20.2	18.2	28.4	17.7	46.5	29.5	22.9	27.2	25.1	20.8	22.1	835.5	205.1	88.5	8.1	3.7	694.1	362.3	34.8	223.7	0.1	316.5	91.7	12.9	27.1	166.8	18.4	0.0	1.2	7.6	481.5	15.6	28.7	0.8	76.0	167.6	662.2	47.6	0.0	0.9	4.4	1.8	470.5	62.2	160.3	50.4	0.1	157.1	2.2	39.8	0.0	0.4	13.5	6.1	37.1	481.2	2.1	69.6	105.8	473.2	7.5	7.0	2.4	0.0	0.5	0.2	62.2	343.0	109.4	12.7	413.0	48.6	0.5	60.2	0.4	6.6	202.1	170.1	1.1	0.9	888.5	687.6	1.1	23.0	5.1	26.6	1193.8
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;kidney: 36.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 55.2;Excitatory neurons: 13.0;Proximal tubular cells: 35.7"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 3.7"	"Region enriched"	"Detected in some"	10	"cerebral cortex: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 3.7;HEK 293: 8.3;HMC-1: 1.6;RPTEC TERT1: 1.4;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"amygdala: 2.7;cerebral cortex: 10.5;hippocampal formation: 7.8"	"HPA006230, HPA006421"	Approved		Supported	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA006230: AB_2667542, HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.1	0.1	0.0	1.3	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.8	0.0	0.7	0.1	0.0	0.0	0.0	1.3	0.0	36.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	13.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	55.2	0.0	0.1	0.0	1.2	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	1.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	35.7	0.0	0.0	0.0	0.0	0.0	1.5	5.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.6;kidney: 90.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					NA	NA		55000000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	11.6	2.2	0.4	1.5	0.5	0.1	4.8	0.4	2.5	1.6	1.8	1.2	36.6	12.9	4.1	1.7	2.3	4.4	4.3	0.6	0.5	90.0	29.0	4.6	0.8	0.9	0.8	1.2	1.3	45.2	1.2	15.5	0.7	1.8	0.8	0.0	1.1	1.2	2.3	0.7	163.6	10.6	0.5	9.2	1.2	0.5	0.4	4.4	5.0	8.9	0.3	2.6	1.6	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.8	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	2.5	0.6	0.5	0.9	0.8	0.7	0.5	0.4	0.8	10.7	0.0	2.0	1.6	1.1	1.7	0.1	0.0	0.0	0.0	0.2	0.1	3.9	0.0	0.3	11.0	0.0	37.0	0.0	1.5	17.6	0.0	0.5	3.1	40.7	2.2	1.8	0.0	7.3	0.0	3.5	15.4	0.0	2.3	0.0	0.0	1.4	31.4	2.7	0.0	2.9	28.4	2.0	1.0	1.9	0.2	0.6	1.1	0.0	1.0	0.0	0.0	1.0	0.0	0.8	0.0	31.6	0.4	0.1	0.2	663.2	177.6	1.7	0.0	157.8	0.8	54.1	0.0	0.2	0.1	1.0	58.6	1.9	0.5	42.1	0.1
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 32.1;intestine: 44.5"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 160.0;Glandular and luminal cells: 387.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	86	"basophil: 30.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 30.6"	"Group enriched"	"Detected in some"	18	"HEL: 4.4;Hep G2: 14.6;HMC-1: 6.2"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"spinal cord: 2.6"	HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		1100000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	1.2	6.2	0.4	1.1	0.4	0.1	6.6	0.9	0.5	32.1	0.2	9.3	16.2	3.8	1.2	0.5	2.3	1.3	0.1	0.3	0.5	10.0	5.0	0.9	0.5	0.5	0.6	0.5	0.1	0.3	0.1	0.1	0.5	2.4	8.4	0.3	18.1	15.6	0.1	0.6	44.5	0.8	0.4	0.3	0.5	0.8	0.5	9.6	0.3	0.2	0.4	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.4	0.0	14.6	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.5	0.3	0.5	0.5	0.6	0.5	0.4	0.5	0.4	0.4	0.0	1.1	5.2	0.2	0.0	2.6	0.7	1.2	0.2	1.0	0.6	0.3	0.0	2.5	0.0	0.0	0.0	0.2	9.2	1.9	0.0	1.6	160.0	46.3	1.4	0.0	2.1	2.1	0.0	0.1	0.5	0.0	387.2	36.0	0.1	0.7	1.7	0.1	0.0	4.1	1.5	0.0	0.6	1.1	0.4	1.2	1.5	1.8	2.8	0.0	0.1	1.0	3.5	0.9	0.0	1.9	0.7	0.3	2.7	53.3	9.1	5.4	0.1	0.0	0.2	1.0	2.5	0.8	0.0	0.6	0.1	2.2	0.1	4.9	1.1
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4;kidney: 30.6;ovary: 12.5"	"Cell type enhanced"	"Detected in some"		"Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042740, HPA069197"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		290000		"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA042740: AB_10793984, HPA069197: "	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.2	0.3	2.7	0.8	11.8	0.9	0.8	14.2	5.5	0.2	2.3	1.0	1.7	0.2	6.1	1.0	0.3	0.5	0.2	2.7	6.1	30.6	0.1	0.3	0.9	20.4	9.6	12.5	0.0	0.0	4.2	0.1	18.1	2.2	1.0	0.1	0.7	6.1	0.2	0.1	2.2	0.1	12.5	1.0	1.2	2.4	11.1	1.9	0.1	1.3	2.8	0.6	0.3	29.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	2.7	11.8	14.2	5.5	2.7	6.1	20.4	9.6	18.1	12.5	11.1	29.4	0.5	0.0	0.0	5.9	0.1	0.0	0.2	0.9	0.6	0.0	0.1	0.5	0.9	0.0	0.4	1.8	0.0	0.0	0.0	0.0	3.9	1.1	1.0	0.0	0.0	0.5	0.0	0.0	4.3	0.2	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.4	0.2	0.0	1.5	0.0	0.0	0.6	0.0	0.4	4.1	0.6	1.8	4.7	1.1	0.0	0.0	6.6	119.9	0.0	0.0	35.3	0.5	0.1	0.0	31.3	0.2	0.0	0.0	5.1	0.6	0.1	1.6	0.0	0.0	0.0	0.3	23.9	0.0	0.3
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730943-79742219	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 104.6"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 9.1;Proximal enterocytes: 22.7;Proximal tubular cells: 9.7"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.2;Karpas-707: 2.1;U-266/70: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024603	Approved				"Intracellular and membrane"	NA	NA		450000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	9.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
ENTPD4	"KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase"	ENSG00000197217	"Ectonucleoside triphosphate diphosphohydrolase 4"	Q9Y227	8	23385783-23457695	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA017655	Supported		Approved	Vesicles		NA	NA		82000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA017655: AB_1848181"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.72e-2)"	16.3	11.5	8.6	24.2	10.5	30.5	14.8	11.1	16.2	17.0	8.1	19.8	18.1	16.8	17.3	12.6	13.7	14.6	21.2	10.8	12.3	12.2	13.7	20.0	29.3	13.1	9.2	13.5	21.4	27.2	18.3	17.2	12.8	16.8	20.3	32.7	22.0	13.4	15.2	12.4	26.2	16.5	7.6	25.4	20.3	19.9	12.5	14.5	14.7	15.9	29.8	16.7	16.6	11.6	20.8	28.7	34.0	23.5	29.0	36.8	35.0	33.1	30.4	21.3	33.2	40.3	26.4	35.5	22.9	32.8	32.9	24.5	15.8	29.0	40.3	8.6	11.5	18.4	18.1	14.2	23.7	9.8	34.8	22.8	34.7	28.4	29.9	51.9	31.2	26.7	13.2	30.6	36.4	9.3	14.8	11.9	20.1	26.2	10.2	14.3	34.6	10.8	27.0	24.1	27.2	26.6	12.0	17.0	23.7	67.0	12.9	13.6	38.6	39.1	38.3	43.7	24.1	24.7	11.5	45.5	51.3	11.5	39.4	17.0	5.7	13.4	7.4	8.6	8.8	8.7	7.3	8.1	7.5	6.5	9.2	7.3	14.4	4.8	7.0	6.8	6.3	6.9	8.6	10.5	11.1	16.2	10.8	12.3	13.1	9.2	12.8	7.6	12.5	11.6	15.9	19.2	34.5	10.7	25.8	6.5	12.0	17.6	8.6	32.1	11.4	8.6	24.6	7.2	27.3	14.7	14.6	16.1	33.4	25.1	0.0	15.6	8.6	13.6	21.6	15.8	17.3	10.3	31.4	16.9	16.9	16.9	23.9	23.9	17.7	18.9	12.1	11.5	12.3	47.1	37.4	19.7	20.3	14.2	15.5	19.2	7.2	18.2	12.4	19.7	19.4	15.2	18.6	23.1	23.1	21.8	13.3	8.6	46.9	18.9	18.8	5.0	15.0	35.9	13.1	14.3	14.6	21.5	22.8	9.5	5.5	20.2	21.3	11.7	12.4	18.9
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)"	O75356	14	73958010-74019399	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 107.2;kidney: 95.2;liver: 263.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 18.2;prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;eosinophil: 9.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in all"		"RT4: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5900000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	8.2	7.7	5.0	11.4	7.3	8.0	12.4	7.1	6.7	7.3	7.1	94.6	72.1	6.3	7.7	11.3	5.7	12.1	7.7	5.1	6.3	95.2	263.7	6.5	5.5	7.6	7.3	6.7	4.9	7.7	5.0	5.6	7.8	37.7	107.2	9.4	10.7	4.4	15.0	8.1	68.4	9.7	6.5	6.0	42.3	8.6	7.3	4.6	6.1	9.1	5.6	16.9	7.2	9.0	9.5	7.8	8.2	15.1	16.5	15.5	9.4	9.6	7.9	6.4	7.1	5.6	10.9	10.6	4.7	12.8	6.0	10.8	8.5	14.1	7.2	8.8	4.0	7.9	5.7	30.9	15.5	4.7	8.8	12.9	14.0	8.7	18.2	8.8	13.1	17.1	8.8	15.4	9.7	13.6	5.4	5.6	2.5	8.5	15.7	6.0	8.0	5.2	11.4	57.1	5.8	6.0	16.6	12.9	9.2	6.4	18.7	4.1	10.8	12.6	12.7	7.5	7.2	10.1	16.9	8.3	8.0	8.8	11.5	18.3	1.2	9.4	2.5	2.3	1.3	1.4	1.3	1.8	1.7	1.5	2.1	2.1	0.1	0.5	1.4	0.9	1.6	1.3	5.0	7.3	7.1	6.7	5.1	6.3	7.6	7.3	7.8	6.5	7.3	9.0	8.0	16.0	6.7	8.1	4.9	3.7	6.2	8.9	5.2	6.6	15.0	7.9	5.2	10.0	11.3	7.3	4.2	8.2	4.3	209.3	25.4	6.9	19.5	10.0	13.6	7.0	16.2	36.6	5.9	12.9	6.7	7.9	23.0	25.8	1.3	9.6	9.7	134.8	6.2	10.1	8.2	77.1	14.2	9.7	1.9	12.7	2.8	5.2	5.4	11.2	5.4	4.9	8.2	2.0	11.3	9.1	58.4	5.7	3.6	28.5	87.0	63.1	6.4	12.2	13.1	6.0	5.9	27.2	19.1	8.5	3.4	3.3	4.9	10.3	60.9	39.0
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.4;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 8.4"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.0	0.6	0.2	3.2	0.1	1.8	0.6	8.4	0.4	0.4	0.4	0.7	0.4	0.8	0.8	0.3	0.4	1.6	0.3	0.2	0.3	0.4	2.4	2.2	15.0	0.2	0.3	0.5	0.3	0.1	0.2	0.4	0.6	0.5	0.8	1.6	0.9	0.1	0.1	0.2	1.4	0.4	0.3	12.8	1.3	0.4	0.2	1.5	0.5	0.1	5.4	1.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	1.3	0.0	7.4	1.1	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.3	0.0	8.3	0.2	0.0	0.0	2.0	2.0	0.0	0.2	0.2	0.9	1.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	16.5	0.0	26.2	0.0	3.0	19.5	0.0	0.0	0.2	11.9	0.2	33.0	0.1	0.1	0.0	2.9	0.2	0.1	8.4	0.4	0.2	0.3	0.2	0.3	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.8	1.5	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	16.8	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.3	1.3	1.8	1.0	1.1	0.1	93.7	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	2.0	0.0	0.1	0.0	31.5	0.0	0.0	0.0
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 171.9;Excitatory neurons: 306.8;Inhibitory neurons: 237.4;Late spermatids: 291.6;Oligodendrocytes: 159.2;Syncytiotrophoblasts: 214.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 12.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;HUVEC TERT2: 59.5;SCLC-21H: 65.5;TIME: 164.8;U-2 OS: 57.7;U-2197: 57.1;U-251 MG: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	27.6	28.1	5.8	27.4	5.3	4.1	11.7	17.9	49.9	6.4	0.0	17.7	49.6	7.8	5.6	10.7	13.6	9.3	6.5	7.1	24.8	33.9	4.8	13.9	7.9	59.6	14.7	11.4	6.9	59.6	10.4	21.1	53.3	5.8	13.1	45.8	4.0	7.3	6.1	4.0	47.7	13.4	7.7	12.2	3.2	62.3	29.1	6.5	4.6	10.7	3.9	10.3	5.7	29.8	0.3	0.9	3.9	0.0	54.5	62.8	43.7	12.8	0.0	0.0	0.0	0.7	0.1	0.1	0.1	39.8	23.2	0.2	38.6	0.0	0.0	0.0	34.2	0.1	0.4	0.0	0.2	0.1	4.6	33.3	0.0	12.3	0.1	16.2	59.5	0.0	0.4	0.4	0.1	0.0	0.5	0.7	7.9	0.2	12.5	0.3	0.0	0.2	0.4	4.8	65.5	0.5	0.1	0.5	25.9	31.2	0.7	4.8	164.8	0.3	57.7	57.1	71.6	0.1	0.1	0.0	0.2	5.4	6.8	0.0	4.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.7	0.0	12.4	0.0	0.0	0.7	5.8	5.3	17.9	49.9	7.1	24.8	59.6	14.7	53.3	7.7	29.1	29.8	18.2	19.2	6.4	28.7	1.3	15.9	4.1	0.0	3.4	75.6	5.3	1.7	3.5	2.8	1.9	7.3	77.2	98.6	0.2	44.0	15.6	0.4	171.9	2.2	10.1	21.9	9.1	3.2	306.8	0.7	44.2	27.7	0.0	2.1	0.0	0.0	7.1	0.8	58.8	3.3	237.4	10.0	0.0	82.2	66.7	291.6	22.4	81.9	10.6	103.0	50.9	3.3	2.1	44.2	159.2	0.8	8.3	7.9	1.6	3.8	91.2	68.4	1.6	14.7	0.0	3.0	13.1	2.7	11.5	2.3	8.4	214.0	2.6	0.2	12.3	1.7
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 198.8;dendritic cells: 53.7;Early spermatids: 42.2;Excitatory neurons: 47.9;Inhibitory neurons: 44.3;Late spermatids: 41.2;Oligodendrocyte precursor cells: 77.9"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"neutrophil: 24.0;plasmacytoid DC: 23.3"	"Group enriched"	"Detected in many"	33	"dendritic cells: 23.3;granulocytes: 24.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 63.9;HMC-1: 35.5;RPTEC TERT1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	1.0	0.6	4.7	0.8	18.7	0.7	3.2	40.6	12.8	1.8	0.0	3.2	1.4	2.2	0.9	1.9	1.3	1.7	0.3	7.0	5.1	1.3	1.6	0.3	1.9	5.0	14.4	0.7	0.3	0.2	1.0	0.2	5.5	1.7	0.5	4.2	2.2	2.7	4.9	4.8	0.7	0.7	0.9	1.9	0.6	10.8	12.0	0.7	7.0	10.3	1.7	1.5	1.0	4.2	0.0	0.0	8.4	0.1	0.2	0.0	0.0	6.6	0.1	0.3	0.1	0.1	0.0	1.1	1.6	3.4	0.6	0.1	5.5	0.0	1.2	63.9	0.8	4.8	0.0	0.0	0.0	0.0	35.5	0.1	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.3	4.7	0.2	0.0	0.3	2.4	1.2	0.1	0.0	0.9	0.2	16.5	0.0	1.1	0.2	0.0	0.1	0.0	1.1	0.1	0.7	0.5	1.1	3.4	0.7	7.9	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	23.3	0.0	0.2	4.7	18.7	40.6	12.8	7.0	5.1	5.0	14.4	5.5	0.9	12.0	4.2	1.9	0.0	0.0	198.8	1.0	3.7	0.0	0.0	0.0	1.9	0.8	12.3	1.6	0.0	0.0	0.0	10.4	0.0	53.7	0.0	0.0	0.8	42.2	0.1	0.5	2.8	0.0	0.0	47.9	0.4	0.1	0.4	0.0	0.1	0.0	3.3	0.4	7.0	0.4	0.0	44.3	0.0	0.0	0.0	0.8	41.2	0.6	0.8	1.8	8.4	0.1	16.9	0.0	77.9	5.6	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.3	0.8	0.5	1.6	0.0	5.8	0.0	0.2	3.0	0.3	0.2
EPHX2	ABHD20	ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490781-27545564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 333.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 180.0;Hepatocytes: 131.5;Proximal enterocytes: 399.0;Proximal tubular cells: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 35.0;naive CD4 T-cell: 106.7;naive CD8 T-cell: 50.4;T-reg: 29.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 106.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 139.4;K-562: 51.6;OE19: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Enhanced		Enhanced	Cytosol		NA	NA		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	19.3	74.0	14.5	9.1	15.0	1.9	30.1	14.4	14.1	21.0	42.2	61.4	112.8	17.7	27.2	38.6	41.6	9.4	29.1	13.2	15.3	166.3	333.2	11.2	17.2	16.1	17.3	38.0	64.5	54.8	35.8	8.5	15.9	64.6	57.6	21.5	36.5	27.2	16.2	43.4	128.4	15.4	15.8	10.8	23.4	9.0	15.8	65.9	22.6	13.8	20.8	19.7	23.4	15.7	15.3	10.1	6.3	8.1	0.4	0.0	4.8	1.3	0.9	0.7	0.2	8.0	10.1	0.1	5.9	4.1	3.2	10.7	1.1	2.6	0.5	0.0	4.7	22.5	1.1	24.8	3.4	0.1	4.5	8.6	10.7	0.1	1.1	2.5	0.5	139.4	51.6	0.2	0.0	4.7	14.9	0.5	10.1	102.4	17.2	0.1	0.1	0.4	8.7	2.2	5.1	16.0	12.1	14.2	15.0	4.6	21.8	4.2	0.2	0.0	3.8	1.8	0.1	12.5	10.1	0.2	0.4	0.1	0.1	0.1	0.1	0.0	7.8	0.0	11.3	4.5	35.0	12.7	0.1	2.5	106.7	50.4	0.2	4.6	0.1	0.2	29.6	20.0	14.5	15.0	14.4	14.1	13.2	15.3	16.1	17.3	15.9	15.8	15.8	15.7	6.3	6.4	17.0	16.3	6.1	11.9	18.6	10.1	29.6	34.1	17.2	18.4	23.7	20.0	9.7	27.6	79.2	22.8	1.0	82.7	180.0	8.8	7.5	6.9	4.8	9.4	23.4	3.8	3.0	6.4	2.5	12.1	15.8	1.5	5.7	17.4	17.5	131.5	2.2	33.7	7.2	63.4	2.0	4.6	1.2	4.8	29.8	3.6	5.4	2.8	2.6	91.5	3.1	7.5	5.1	3.1	83.7	18.8	4.5	20.5	399.0	259.3	24.1	52.4	0.0	11.5	10.2	1.3	13.9	39.2	18.3	8.2	11.9	78.5	101.3	10.8
ERG	"erg-3, p55"	ENSG00000157554	"ETS transcription factor ERG"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.4;Endothelial cells: 105.5;Hepatic stellate cells: 69.9;Microglial cells: 88.1"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 138.3;MOLT-4: 47.7;REH: 151.5;TIME: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018377, HPA046598"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	24.6	4.1	5.1	7.1	5.5	7.6	20.0	5.0	5.5	10.0	3.0	5.4	3.4	11.6	1.9	5.2	9.1	12.0	12.4	4.5	5.1	12.8	6.1	19.6	7.5	5.9	5.4	4.4	4.9	2.4	2.4	24.3	6.2	7.1	3.4	0.5	3.7	4.3	7.9	4.9	6.5	12.0	4.7	26.6	4.6	1.5	7.0	4.1	10.0	9.9	3.7	9.2	6.9	5.4	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.2	22.3	0.0	0.1	0.9	0.0	0.0	138.3	0.1	0.0	0.0	0.0	1.0	47.7	0.0	0.5	0.0	0.0	151.5	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	113.4	0.7	2.2	0.5	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	5.5	5.0	5.5	4.5	5.1	5.9	5.4	6.2	4.7	7.0	5.4	94.4	0.0	3.9	0.3	0.7	3.4	1.7	0.6	3.4	0.0	0.6	4.3	3.8	4.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.7	0.4	105.5	0.0	13.5	13.3	0.0	0.0	5.7	0.0	2.1	24.0	4.4	69.9	1.3	0.3	0.0	1.7	0.4	0.0	5.9	3.4	2.1	0.9	0.9	3.6	88.1	0.2	0.0	0.0	7.1	1.4	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.1	0.0	2.4	3.7	0.3	1.4	0.5	3.4	0.0	0.6	0.5	0.3	0.6
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443156-41444765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 42.5;kidney: 16.6"	"Group enriched"	"Detected in some"	10	"Proximal enterocytes: 189.7;Proximal tubular cells: 90.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 2.6;Hep G2: 6.2;THP-1: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.3	0.1	0.1	0.0	0.6	0.1	0.1	0.4	0.1	0.3	42.5	0.6	0.0	0.2	0.5	0.3	2.0	0.0	0.0	16.6	0.0	1.1	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.3	0.0	1.7	0.2	39.2	0.0	0.1	0.6	0.2	0.8	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.1	0.2	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	13.7	0.2	3.7	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	189.7	90.2	0.0	0.0	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.0	0.3	0.1	3.0	0.0
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064522-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2"	"Not detected"	"Not detected"							"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (9.38e-4)"	0.5	0.1	1.5	0.3	2.4	0.0	1.0	0.9	1.4	2.5	1.2	1.9	5.3	1.3	0.6	0.7	11.1	12.3	5.3	1.0	2.4	5.6	10.2	0.9	1.0	1.8	2.1	0.9	34.2	2.2	1.3	0.2	1.9	2.7	3.3	2.3	1.3	2.3	0.0	0.7	1.5	0.5	1.1	0.2	12.6	2.4	4.7	0.7	0.6	0.0	0.7	1.9	0.5	1.3	0.0	7.3	0.0	0.0	0.1	0.0	4.7	4.6	1.8	2.3	1.8	0.1	2.4	0.0	6.0	1.2	3.6	0.4	8.0	0.2	2.8	0.0	11.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.0	14.7	0.0	0.0	0.1	0.2	0.0	0.8	1.6	0.2	2.8	0.0	0.0	0.2	7.5	18.2	4.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.4	0.9	1.4	1.0	2.4	1.8	2.1	1.9	1.1	4.7	1.3	0.0	3.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	2.1	1.3	8.0	100.1	3.1	7.3	0.0	0.3	0.0	1.6	0.0	57.6	0.3	27.8	0.6	0.8	18.0	0.0	1.1	18.4	1.8	0.2	7.7	7.7	0.0	4.3	0.4	2.6	0.1	0.0	1.6	2.4	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.1	8.0	0.0	0.5	0.1	14.8	1.6	0.0	0.0	2.5	0.7	24.5	39.4	0.1	0.0	0.2	1.0	0.2	4.7	1.1	0.0	0.1	0.2	0.7	3.6	2.6
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 405.9;Endothelial cells: 301.0;Hepatic stellate cells: 138.1;Sertoli cells: 151.2;Smooth muscle cells: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.2;naive B-cell: 7.5"	"Group enriched"	"Detected in many"	9	"B-cells: 7.5;granulocytes: 8.2;T-cells: 2.2"	"Group enriched"	"Detected in many"	10	"HEL: 218.8;HUVEC TERT2: 277.9;TIME: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056293, HPA072563"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		82000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Cell Junctions"	Cytosol	"HPA056293: AB_2683089, HPA072563: "	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	97.5	17.7	38.4	9.0	37.7	1.9	79.4	38.8	46.9	33.3	30.1	20.0	7.0	36.2	7.8	21.8	34.2	20.0	83.0	35.2	38.7	63.6	11.5	112.5	8.7	40.9	38.9	14.4	13.6	13.2	14.8	106.9	44.0	19.8	7.8	2.5	15.6	15.6	27.1	18.2	20.9	29.4	37.3	17.3	23.4	4.3	45.4	5.4	95.9	49.8	8.3	30.8	30.2	37.8	1.2	1.6	0.4	1.2	0.0	0.3	5.1	0.1	0.1	0.0	0.1	2.7	14.1	1.2	3.2	0.0	0.2	0.0	3.7	0.0	0.0	1.8	1.3	218.8	0.1	8.0	0.6	0.4	3.6	0.0	0.0	0.0	0.0	0.2	277.9	0.1	0.2	5.9	0.5	1.8	0.0	0.0	0.6	20.8	2.1	0.0	1.0	0.9	0.0	2.4	0.2	0.8	0.1	16.1	0.0	7.5	3.3	0.8	142.0	0.4	0.4	0.5	0.0	0.2	0.2	0.2	0.1	0.5	0.4	8.2	0.6	0.0	0.1	0.3	0.0	2.1	1.5	0.1	0.4	7.5	2.2	0.8	6.5	0.0	0.0	0.4	0.4	24.8	38.4	37.7	38.8	46.9	35.2	38.7	40.9	38.9	44.0	37.3	45.4	37.8	405.9	38.5	56.0	2.0	4.5	15.2	0.5	0.2	2.8	18.5	2.5	3.2	11.2	0.0	3.0	14.7	4.2	1.8	2.5	3.5	5.9	7.6	5.0	1.1	1.5	301.0	0.0	5.3	1.5	2.4	18.7	13.8	3.6	1.4	3.8	0.1	138.1	1.7	1.1	0.0	0.4	0.4	0.0	5.3	22.1	26.3	0.9	25.7	12.4	20.6	1.2	0.7	0.0	0.5	0.4	46.5	2.1	0.4	2.8	1.8	0.1	0.1	1.9	1.3	151.2	4.6	89.4	0.1	0.9	0.8	10.9	37.1	2.0	2.4	1.6	2.3
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.4	0.2	0.0	2.4	0.0	8.5	0.5	0.0	0.0	3.5	0.0	1.5	3.9	0.2	0.0	15.4	0.2	0.4	0.1	0.0	0.0	0.9	0.6	0.4	4.4	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	1.4	0.0	2.0	0.1	0.0	2.6	4.3	0.7	0.0	1.0	0.9	6.2	0.1	10.7	0.1	0.0	4.9	0.6	5.9	0.0	27.8	23.6	27.6	21.1	0.6	1.9	17.5	15.9	8.6	28.8	19.2	15.8	22.7	49.9	9.5	6.8	17.4	20.2	32.6	9.9	14.3	13.7	32.8	30.6	24.1	11.1	0.1	19.5	25.2	0.6	0.6	15.5	7.6	2.8	15.4	22.2	42.6	41.0	9.1	29.2	30.6	16.4	22.5	14.5	12.9	29.3	30.2	21.4	4.2	11.6	18.9	15.8	11.9	20.4	10.1	13.0	36.9	12.7	8.2	14.5	27.2	11.9	25.5	32.5	29.7	31.9	8.2	19.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	0.6	0.9	0.3	0.5	0.6	0.0	1.0	1.3	0.9	0.0	0.4	3.7	0.0	1.9	0.6	2.7	0.0	0.2	0.8	0.2	0.8	1.0	3.5	1.3	0.7	0.0	2.3	1.1	3.6	0.7	0.0	4.4	0.7	6.8	2.6	0.0	0.4	2.7	22.4	0.6	2.1	1.2	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.5	1.5	1.3	0.4	2.1	0.4	22.6	6.6	0.2	0.0	0.0	0.4	0.9	5.5	4.1	7.4	0.6	0.3	0.4	0.1	2.8	0.4
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	Actin-binding	"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 129.1;retina: 117.8;testis: 145.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.4;thalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"HPA028674, HPA060220"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	5.7	0.4	2.6	1.0	28.0	9.2	13.4	1.0	30.3	0.2	28.2	90.4	2.4	39.9	34.3	18.6	0.3	0.9	0.4	1.7	63.4	129.1	3.2	0.3	0.6	1.3	0.4	0.9	26.8	42.1	0.9	1.1	10.0	6.8	117.8	9.4	6.2	0.8	91.7	89.5	0.8	0.3	0.9	2.7	145.3	6.1	1.6	0.4	0.0	1.7	1.3	22.3	0.5	14.1	0.7	0.6	0.1	0.0	0.0	48.9	0.0	0.0	0.2	0.0	29.9	1.5	0.5	6.5	0.0	0.1	32.6	2.3	0.1	0.0	2.0	0.7	0.4	0.7	81.5	0.0	0.6	2.7	0.1	0.6	0.0	0.0	0.0	0.0	1.0	17.6	0.0	0.0	28.2	0.2	1.0	0.6	3.8	12.2	0.0	0.4	10.9	0.2	0.1	21.0	0.7	3.7	160.1	5.0	0.3	53.6	7.4	15.6	0.1	0.8	0.6	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	13.4	1.0	0.4	1.7	0.6	1.3	1.1	0.3	6.1	0.5	0.2	0.0	0.6	0.0	0.8	7.8	2.4	4.5	12.5	5.6	10.7	3.9	1.4	11.5	3.8	9.2	68.8	3.0	0.2	175.5	13.7	0.2	137.5	19.1	0.9	0.8	6.0	8.2	0.2	3.1	0.5	0.3	5.6	12.4	0.0	0.0	3.9	109.4	0.2	0.0	0.2	36.3	8.2	3.2	0.9	461.6	3.7	1.5	0.0	0.0	0.0	272.5	0.0	0.0	0.1	0.1	186.3	2.2	0.0	1.6	512.1	102.2	9.0	72.5	0.0	0.0	0.2	12.3	3.9	17.6	22.7	6.6	1.5	0.0	35.3	2.9
ESRRB	"DFNB35, ERR2, ERRb, ERRbeta, ESRL2, NR3B2"	ENSG00000119715	"Estrogen related receptor beta"	O95718	14	76310712-76501837	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 36.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 13.7;Early spermatids: 14.1;Horizontal cells: 55.5;Late spermatids: 37.6;Rod photoreceptor cells: 40.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.3;K-562: 5.0;U-266/70: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA074772			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA074772: "	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.28e-2)"	"unprognostic (3.92e-5)"	"unprognostic (5.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-4)"	"unprognostic (4.40e-2)"	0.0	0.0	0.4	0.0	0.4	0.0	0.3	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.9	0.3	0.6	6.6	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	36.5	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.1	2.4	1.2	0.9	0.1	0.0	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.2	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.4	0.0	0.2	2.3	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.3	0.6	1.5	1.2	0.7	0.6	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.4	5.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	13.7	0.0	14.1	0.0	0.0	0.8	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.5	2.0	0.0	0.0	0.0	0.0	37.6	0.0	0.1	0.0	3.7	0.0	4.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.3	0.0	0.1	0.8	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein subunit alpha"	P13804	15	76215353-76311472	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 389.7;tongue: 493.5"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 402.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		680000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	93.0	112.3	33.8	55.0	36.0	63.0	70.4	36.0	54.6	38.7	40.3	131.4	135.6	27.0	30.6	85.1	30.1	44.7	243.0	34.2	37.6	180.0	389.7	39.0	60.9	35.6	35.7	25.6	81.6	71.0	13.9	70.9	36.0	42.2	123.5	34.3	49.3	38.2	300.8	40.1	116.3	65.7	35.5	38.8	67.7	28.4	38.2	54.5	38.7	493.5	65.9	74.0	33.1	36.9	122.4	196.7	128.2	134.8	141.7	149.1	201.0	144.4	166.2	183.0	162.8	175.3	221.3	203.5	141.3	144.3	138.5	304.6	502.7	200.2	211.9	245.8	98.0	222.2	131.4	205.2	114.7	214.5	158.7	112.7	185.9	93.1	153.5	100.0	187.8	64.7	214.1	205.2	190.3	191.2	44.9	178.2	99.9	225.3	58.4	192.8	158.6	272.8	202.1	386.9	133.3	67.2	218.2	492.2	205.0	294.4	254.1	223.4	111.4	178.2	119.5	157.0	177.4	99.0	221.0	255.9	127.8	281.1	128.5	50.0	120.3	82.7	65.4	110.3	61.7	77.3	60.6	67.6	159.4	67.3	48.8	60.1	30.2	122.9	96.1	63.4	95.8	141.9	33.8	36.0	36.0	54.6	34.2	37.6	35.6	35.7	36.0	35.5	38.2	36.9	65.7	57.7	41.6	45.1	54.3	53.4	110.8	151.5	44.9	13.1	47.2	46.4	352.9	65.8	84.5	36.8	22.9	277.4	61.1	250.9	209.4	106.5	11.7	29.5	45.1	51.8	65.4	117.8	26.0	84.1	180.8	66.8	90.2	37.0	38.6	53.1	48.9	348.8	132.3	53.8	31.5	141.6	89.5	79.0	84.5	7.9	59.4	103.0	56.9	28.1	129.0	26.7	85.5	37.2	46.9	92.1	176.2	58.3	87.8	92.4	231.1	402.9	50.2	20.4	46.0	44.0	113.7	66.4	40.5	79.5	57.1	300.2	55.5	123.4	187.3	162.0
ETFB		ENSG00000105379	"Electron transfer flavoprotein subunit beta"	P38117	19	51345169-51366388	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1105.3;Proximal enterocytes: 710.7;Proximal tubular cells: 1118.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 53.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1693.9;OE19: 770.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	159.1	171.5	121.1	44.0	134.4	70.2	115.3	134.8	145.5	55.7	123.0	97.6	136.3	48.9	16.9	140.7	53.3	62.7	387.8	112.8	120.6	144.5	493.6	50.4	58.2	129.8	124.8	55.2	81.9	106.3	73.1	39.0	125.7	55.2	41.2	24.1	172.2	37.9	280.7	79.0	129.7	31.7	119.9	64.5	90.0	53.6	132.4	81.4	70.3	280.3	36.9	65.6	69.0	137.0	118.9	304.3	41.3	113.9	129.4	150.4	65.6	82.4	61.0	63.5	63.1	257.3	192.1	121.5	80.2	129.8	33.8	104.0	83.3	171.1	19.2	182.0	323.3	98.1	188.9	1693.9	141.8	92.1	67.6	235.3	50.3	86.1	88.2	79.2	54.9	115.0	146.6	130.2	83.2	243.7	95.2	86.2	26.7	770.2	372.0	104.5	114.4	224.6	88.5	135.7	91.7	44.5	184.5	49.9	94.4	29.4	130.3	86.3	77.8	65.9	67.6	71.4	73.3	195.8	130.0	109.8	335.0	135.1	172.5	127.7	190.1	119.6	104.3	212.3	137.4	281.6	156.0	134.2	225.3	303.1	163.6	136.0	97.8	205.3	165.7	265.1	225.7	140.5	121.1	134.4	134.8	145.5	112.8	120.6	129.8	124.8	125.7	119.9	132.4	137.0	90.9	80.1	93.8	15.3	75.6	65.0	114.9	196.4	55.2	77.1	129.9	170.1	243.8	234.4	122.5	121.4	31.3	240.7	58.7	440.9	571.3	188.0	139.2	67.5	70.2	76.2	168.4	120.0	4.1	140.5	206.6	93.8	128.9	48.2	88.8	63.2	144.9	1105.3	217.5	43.7	4.2	335.2	158.7	147.7	73.4	354.4	107.5	86.9	286.4	5.6	95.2	158.8	50.4	7.1	18.9	155.4	339.4	114.3	69.9	74.9	710.7	1118.7	118.8	67.9	98.6	87.4	144.5	71.0	52.8	135.3	63.6	160.1	74.0	217.3	354.4	140.3
ETNK2	"EKI2, FLJ10761"	ENSG00000143845	"Ethanolamine kinase 2"	Q9NVF9	1	204131062-204152044	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 108.1;liver: 235.5;testis: 125.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 417.0;Late spermatids: 1337.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 53.8;MCF7: 55.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 22.6"	HPA057167	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA057167: AB_2683358"	"unprognostic (1.64e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.28e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (6.50e-4)"	"unprognostic (5.50e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.20e-1)"	14.4	6.1	12.8	2.1	12.5	2.8	17.4	7.9	12.0	18.8	28.3	5.7	1.9	10.8	29.9	23.9	13.1	5.3	6.3	10.6	14.0	108.1	235.5	3.3	2.1	10.5	13.4	36.1	9.5	18.5	25.6	4.3	11.1	13.7	2.1	5.7	27.7	16.2	2.0	20.3	3.7	6.5	8.5	7.2	4.9	125.0	15.1	3.7	10.6	4.1	9.3	10.0	26.0	7.5	11.3	3.8	11.0	20.9	4.0	1.3	10.9	11.4	25.2	15.6	6.8	19.2	5.4	0.4	18.4	2.8	18.2	9.9	19.7	15.9	10.7	0.4	17.3	0.2	2.5	30.6	16.2	0.5	0.7	5.4	53.8	3.2	0.7	8.0	11.1	11.9	1.6	0.4	2.0	55.1	3.2	0.3	23.0	0.4	8.4	0.8	13.0	0.4	13.4	4.3	2.9	15.4	7.2	33.6	5.4	35.1	32.5	0.7	0.7	4.4	23.8	1.0	8.4	0.5	0.2	0.5	0.3	0.6	6.3	0.0	0.1	0.0	2.2	0.0	2.1	0.0	0.5	1.3	0.0	0.1	1.3	1.6	0.1	0.8	0.0	0.0	0.3	0.6	12.8	12.5	7.9	12.0	10.6	14.0	10.5	13.4	11.1	8.5	15.1	7.5	1.3	0.0	0.0	1.3	1.0	4.1	13.8	8.2	1.8	4.2	12.3	11.6	1.1	4.3	2.5	3.7	4.2	6.1	1.6	0.1	39.2	9.5	417.0	4.5	1.9	2.1	1.2	13.5	1.2	6.3	9.2	6.4	1.1	3.2	8.9	47.4	6.8	196.9	0.8	0.0	2.9	0.1	2.0	6.5	1.1	1337.3	29.2	1.6	10.6	0.0	0.0	3.8	1.0	2.5	0.2	4.5	0.0	42.2	0.0	14.9	0.3	147.2	3.1	0.8	0.0	4.1	4.4	11.0	7.4	16.1	2.4	9.4	2.9	34.1	0.2	13.5
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805183-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 701.0;Basal squamous epithelial cells: 863.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 33.6;granulocytes: 37.0;monocytes: 32.4"	"Cell line enhanced"	"Detected in many"		"HEL: 309.0;hTCEpi: 269.6;hTERT-HME1: 210.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: AB_2666824"	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	109.9	29.7	51.4	95.5	43.3	167.1	87.7	31.6	72.5	89.6	61.4	119.3	131.3	77.5	27.9	90.6	72.5	132.1	68.0	50.9	43.2	66.1	230.7	185.5	38.0	50.0	39.9	65.7	37.5	61.9	56.6	73.6	45.0	80.1	146.5	7.5	50.3	45.7	149.7	248.3	179.7	78.0	47.9	201.0	72.7	7.6	54.0	43.7	62.5	42.8	34.8	210.2	103.6	44.4	120.1	26.2	16.6	5.6	18.8	61.3	49.2	27.4	154.1	36.2	46.5	23.0	35.1	24.7	13.3	25.0	48.5	35.7	28.0	71.2	63.8	24.5	12.0	309.0	152.6	62.2	196.9	18.4	28.2	39.8	269.6	49.6	210.2	22.0	28.3	17.2	31.3	0.2	14.4	20.1	54.1	22.2	56.0	39.3	18.2	189.6	10.2	25.2	50.2	74.4	14.2	18.4	78.4	32.8	6.2	5.7	1.9	36.3	30.8	83.0	13.0	55.3	60.5	0.5	0.3	25.2	20.7	69.4	70.8	21.0	19.5	7.0	3.2	24.9	3.9	0.4	3.0	4.7	33.6	0.4	3.2	3.2	37.0	0.3	32.4	8.1	0.3	8.9	51.4	43.3	31.6	72.5	50.9	43.2	50.0	39.9	45.0	47.9	54.0	44.4	253.0	51.3	156.6	6.2	10.8	427.4	701.0	150.8	863.4	2.1	84.2	69.7	25.6	51.5	141.9	51.5	0.0	58.4	17.5	150.7	11.7	73.7	4.0	241.1	127.4	312.7	91.8	36.4	39.6	108.5	109.3	98.7	161.1	497.9	51.3	0.9	242.0	262.4	62.1	0.0	10.7	266.0	79.3	150.8	291.7	2.0	18.0	253.4	67.6	74.0	41.0	1.5	3.1	4.0	3.1	127.6	175.1	24.8	21.0	184.0	162.2	47.2	107.9	1.6	52.6	81.8	108.8	0.6	3.3	522.6	486.4	177.6	28.8	8.2	243.3	338.7
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.9;prostate: 3.8;seminal vesicle: 2.9;urinary bladder: 3.3;vagina: 3.5"	"Group enriched"	"Detected in some"	33	"Early spermatids: 62.0;Late spermatids: 73.3"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.6"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"OE19: 25.2;RT4: 16.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Not detected"	"Not detected"			HPA055132			Approved	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.9	3.8	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.3	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.8	0.9	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	62.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	73.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	2.0
EXOC3L1	"EXOC3L, FLJ35539, FLJ35587"	ENSG00000179044	"Exocyst complex component 3 like 1"	Q86VI1	16	67184379-67190185	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 44.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.4;Endothelial cells: 19.6;Granulosa cells: 20.8;Hepatic stellate cells: 28.9;Leydig cells: 15.5;Peritubular cells: 18.4;Theca cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HUVEC TERT2: 3.5;SCLC-21H: 6.4;SuSa: 2.1;TIME: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029574	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA029574: AB_10602495"	"unprognostic (1.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.48e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.64e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.35e-1)"	6.4	4.6	0.5	1.8	0.5	0.0	4.1	1.0	0.8	2.6	0.0	1.6	0.9	2.8	0.1	1.3	1.8	1.1	5.4	0.5	0.5	7.3	2.1	10.0	1.4	0.8	0.2	3.6	1.6	0.8	2.0	5.9	1.1	2.4	0.4	0.2	1.6	0.6	2.1	1.2	1.7	0.9	0.1	44.7	1.5	2.1	0.4	0.1	7.1	0.8	0.2	1.7	1.3	0.1	0.1	0.0	0.7	0.2	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.8	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	3.5	0.4	0.3	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.4	0.8	0.7	0.1	0.0	0.1	6.4	0.8	0.8	0.1	0.0	2.1	0.6	0.0	2.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.5	1.0	0.8	0.5	0.5	0.8	0.2	1.1	0.1	0.4	0.1	26.4	0.0	0.0	0.3	0.3	0.9	2.1	2.8	5.7	1.5	3.0	5.2	1.6	0.0	0.4	3.7	0.0	0.6	0.2	4.6	7.9	1.0	2.0	0.1	0.3	19.6	1.2	2.7	0.1	3.7	4.3	2.6	1.5	0.4	0.0	20.8	28.9	1.4	0.8	3.3	0.3	3.4	2.0	1.9	0.2	5.5	15.5	1.8	0.0	1.0	4.0	0.3	0.0	1.0	0.0	0.6	3.1	18.4	0.0	0.4	8.9	0.2	0.3	0.9	0.0	0.3	1.1	4.0	8.6	1.2	2.0	0.8	0.2	32.5	2.7	1.6
EXOC3L2	"FLJ36147, XTP7"	ENSG00000283632	"Exocyst complex component 3 like 2"		19	45212370-45245407	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"kidney: 19.0;thyroid gland: 17.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 15.3;Endothelial cells: 17.7;Hepatic stellate cells: 51.4;Theca cells: 21.2"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 19.1;K-562: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041595, HPA061110"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Nucleoplasm, Golgi apparatus, Cytosol"	"HPA041595: AB_10794521, HPA061110: AB_2684431"																		4.3	8.3	0.3	2.1	0.6	1.6	2.9	0.5	0.4	4.0	1.6	2.7	2.4	4.9	0.4	1.9	2.8	2.3	2.3	0.4	0.3	19.0	2.7	2.7	1.1	0.7	0.5	0.9	2.7	3.3	5.0	0.4	0.5	5.2	0.7	0.1	1.8	2.2	0.9	2.1	3.2	1.9	0.3	8.3	2.9	3.3	0.4	0.4	17.9	0.3	0.5	3.2	2.4	0.7	0.1	0.3	2.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	2.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	19.1	0.6	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	16.6	0.2	0.0	0.2	0.0	0.0	0.1	0.1	0.5	1.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.0	0.1	0.3	0.6	0.8	1.5	0.2	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.4	0.4	0.3	0.7	0.5	0.5	0.3	0.4	0.7	15.3	0.0	1.3	0.7	0.7	0.4	0.3	0.0	0.0	0.7	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	17.7	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.2	0.0	0.4	51.4	0.3	0.0	0.0	1.1	0.6	0.0	1.6	0.0	0.0	1.8	2.8	0.0	0.0	0.1	0.2	2.1	0.5	0.7	0.0	0.0	1.9	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.6	0.4	6.2	0.2	0.9	0.0	0.1	21.2	0.0	0.3
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 243.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 27.6;Hepatocytes: 75.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.2	17.1	0.2	0.1	0.0	0.0	13.1	0.0	0.2	0.0	27.6	243.2	8.4	0.0	0.0	0.3	0.3	58.9	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.7	0.0	8.7	0.0	0.0	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	27.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	2.5	1.8	0.0	0.0	0.2	0.3	11.7	2.3	0.0	0.0	0.0	0.1	0.0	5.3	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.7	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402141-177409564	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"liver: 604.6"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 523.0"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;eosinophil: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.6;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	7000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.4	0.1	1.4	0.1	1.2	2.6	0.3	0.1	1.3	0.4	0.1	0.5	0.5	0.2	0.0	1.9	0.3	0.1	0.4	1.5	0.8	0.8	604.6	0.6	0.0	0.8	0.6	0.0	0.6	0.1	0.6	0.1	0.9	0.3	0.1	0.0	0.4	0.0	0.0	0.9	0.5	0.0	0.4	1.0	0.1	1.2	0.8	0.0	0.2	0.0	0.1	0.2	0.8	0.8	0.7	1.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.3	0.0	0.2	1.1	0.5	0.3	0.0	7.1	1.4	1.1	0.3	0.7	0.2	0.6	2.4	0.2	1.0	0.0	0.3	0.1	0.2	1.6	0.3	2.5	0.0	9.0	0.1	2.1	0.0	2.1	6.4	0.5	0.2	1.5	0.9	0.0	2.0	4.3	0.2	0.7	0.6	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.4	0.0	0.0	0.0	4.6	0.5	0.0	1.2	3.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.5	0.0	0.5	1.4	1.2	0.1	1.3	1.5	0.8	0.8	0.6	0.9	0.4	0.8	0.8	0.5	0.0	0.0	0.3	5.3	33.1	7.7	15.3	35.9	0.6	12.7	17.5	1.0	17.2	3.9	1.8	4.2	0.0	4.0	27.6	0.0	6.5	23.3	2.2	0.9	2.2	10.3	19.6	2.6	4.2	0.4	1.1	3.6	1.7	0.0	0.2	16.8	523.0	0.5	0.0	0.8	12.3	8.2	16.7	6.1	42.1	0.6	1.0	8.8	0.0	1.2	0.7	2.1	1.5	0.6	11.1	22.0	0.0	8.5	7.2	60.7	16.1	3.6	0.9	0.0	0.5	1.1	12.0	23.6	57.5	54.3	0.1	4.0	0.1	34.8	7.6
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 902.0;Exocrine glandular cells: 464.1;Pancreatic endocrine cells: 1755.7;Peritubular cells: 530.7;Urothelial cells: 497.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 1062.0;HaCaT: 490.7;HBEC3-KT: 1270.5;U-2197: 473.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	118.2	21.3	53.1	28.8	69.9	4.1	70.1	53.2	74.4	48.0	44.1	52.2	36.8	61.1	44.2	41.3	89.9	59.6	36.8	54.0	62.7	18.0	5.1	59.8	12.9	77.7	62.6	114.8	96.5	17.2	81.2	133.4	57.1	56.8	42.1	72.6	93.3	60.4	7.6	56.0	47.3	10.7	60.8	7.2	42.6	34.6	62.0	5.6	62.6	9.9	14.9	65.4	73.0	55.4	1062.0	1.8	2.2	0.5	108.0	53.1	57.2	147.0	87.6	155.4	167.9	18.6	220.6	0.0	73.3	183.5	33.4	490.7	13.2	1270.5	254.4	0.9	1.6	0.0	35.0	3.3	35.9	0.7	0.6	91.9	28.2	73.8	356.5	293.7	1.1	1.1	0.9	0.8	110.0	1.8	1.5	22.3	9.8	6.8	2.2	1.2	10.3	0.5	19.8	3.2	1.3	2.6	117.4	48.3	3.6	29.6	1.3	13.9	0.3	93.7	2.5	473.0	44.6	0.9	1.3	0.9	71.9	5.7	3.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	53.1	69.9	53.2	74.4	54.0	62.7	77.7	62.6	57.1	60.8	62.0	55.4	9.4	131.4	243.3	196.6	0.7	16.3	902.0	359.6	2.2	3.6	29.6	20.4	26.4	18.6	380.3	14.7	0.0	16.5	0.6	20.9	0.0	133.5	8.6	61.3	125.0	13.2	13.1	0.0	0.4	464.1	6.0	125.3	23.0	123.0	2.5	38.1	7.5	0.4	6.1	3.3	4.6	70.3	65.1	2.8	5.2	14.5	281.1	9.1	3.6	45.9	2.1	340.6	0.0	15.6	1.2	1755.7	15.5	530.7	1.2	121.6	10.1	0.4	92.0	16.1	6.6	39.3	76.7	1.7	4.4	6.4	7.5	7.7	7.3	7.9	14.3	497.9
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169511951-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 142.8;liver: 176.2;placenta: 46.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2"	"Group enriched"	"Detected in some"	23	"Hep G2: 32.8;OE19: 125.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4"	"Group enriched"	"Detected in all"	7	"amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.0	0.3	3.2	1.4	3.7	0.6	4.4	1.3	0.1	142.8	0.3	0.9	0.1	0.2	0.2	3.5	17.6	2.7	4.4	1.6	1.5	176.2	0.9	2.2	1.9	2.2	0.0	0.8	0.0	1.6	46.9	2.4	1.3	0.6	1.0	6.2	0.0	0.2	1.3	0.3	1.1	0.8	1.8	4.9	0.5	2.2	0.5	0.4	0.2	2.3	3.8	0.1	4.2	0.0	0.6	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	32.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	125.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	4.1	8.1	0.0	0.2	0.0	0.0	1.4	0.2	0.4	0.0	0.3	0.0	7.0	0.0	0.0	0.0	6.2	1.1	0.3	1.4	4.4	1.3	4.4	1.6	1.9	2.2	2.4	0.8	2.2	4.2	0.0	3.2	0.6	1.6	0.7	0.1	6.1	0.0	0.0	0.3	0.7	0.3	9.4	74.4	1.9	0.0	2.1	82.7	0.1	0.3	0.0	2.4	2.4	0.9	0.0	2.4	25.2	0.0	5.4	0.2	2.3	5.3	4.1	0.2	0.0	2.8	3.6	253.4	5.3	0.0	2.6	0.1	0.0	12.3	0.4	0.3	0.0	7.1	3.6	0.0	18.2	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.1	1.8	0.0	0.2	3.1	0.1	0.0	2.4	0.2	0.5	0.5	0.0	0.0	59.5	2.5	0.0	0.0	11.8
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Hemophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.2"	"Group enriched"	"Detected in many"	10	"Adipocytes: 118.6;Endothelial cells: 120.4;Hepatic stellate cells: 371.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 7.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB018777	Enhanced				"Secreted to blood"	NA	NA		25000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB018777: AB_640320"	"unprognostic (2.09e-1)"	"unprognostic (5.66e-4)"	"unprognostic (4.94e-2)"	"unprognostic (8.32e-5)"	"unprognostic (1.26e-1)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.44e-2)"	29.4	15.2	7.8	2.5	8.6	2.1	19.3	7.4	11.2	7.5	9.9	9.6	2.9	10.9	9.1	4.0	7.9	5.0	53.2	8.2	8.5	14.1	20.1	16.7	4.7	8.6	8.4	14.5	11.6	5.6	6.4	3.3	8.6	9.0	3.8	6.2	4.7	7.5	20.6	3.6	5.0	6.3	7.8	17.9	5.7	6.1	8.9	3.2	10.9	28.1	3.7	8.1	3.7	7.8	6.1	4.5	0.9	2.1	6.5	10.1	0.7	2.9	1.8	2.0	3.4	0.3	6.8	12.0	9.5	3.0	4.7	0.8	1.0	1.0	1.8	5.1	1.9	2.4	2.8	0.2	3.0	2.1	5.6	7.2	0.6	1.8	2.4	3.5	1.2	5.7	1.1	9.0	10.0	2.7	1.7	1.9	1.6	1.8	4.5	1.4	1.5	1.8	1.8	1.3	3.7	2.8	7.0	0.8	3.9	1.0	2.1	4.9	1.5	10.3	5.5	16.6	3.7	5.3	5.1	6.0	9.4	12.3	5.5	4.6	2.8	0.9	5.2	2.4	10.3	2.1	3.1	5.5	2.7	1.9	1.6	4.1	4.4	3.3	2.4	0.4	4.6	2.7	7.8	8.6	7.4	11.2	8.2	8.5	8.6	8.4	8.6	7.8	8.9	7.8	118.6	0.0	6.3	13.1	2.3	1.8	2.5	1.6	4.0	8.1	3.7	4.2	17.7	7.2	1.9	3.7	2.1	0.9	2.0	0.6	7.9	3.1	1.4	1.5	1.5	120.4	0.0	8.4	7.2	0.7	0.7	6.8	0.0	1.5	1.3	8.2	371.2	11.8	3.2	6.7	5.0	0.6	0.0	19.9	1.1	3.3	11.5	3.0	0.0	8.4	2.4	6.8	2.1	7.5	6.0	4.5	0.1	5.3	2.0	1.4	0.9	11.4	2.4	3.5	6.6	11.1	13.0	2.3	3.4	1.5	1.1	0.1	4.0	4.3	0.4	2.1
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5501.2;liver: 13065.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	160.2	0.6	0.0	10.7	0.5	1.8	0.7	0.4	5501.2	4751.8	13.0	0.0	2.6	3.9	0.5	0.8	0.6	0.7	727.6	13065.3	0.9	3.7	0.6	0.5	0.9	1.0	0.3	0.8	0.7	0.5	2.6	3416.4	0.1	0.5	8.4	0.9	0.5	4727.6	230.4	0.5	2.8	15.8	1.1	0.6	0.1	0.5	0.4	0.1	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.8	0.6	0.7	0.6	0.5	0.5	0.5	0.6	0.7	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365253-31376850	"Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"heart muscle: 5666.1;skeletal muscle: 2202.5;tongue: 1442.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 629.8;Cardiomyocytes: 2495.2;Distal tubular cells: 452.0;Proximal tubular cells: 703.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"ASC TERT1: 215.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"		NA	NA	1640000	3000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: AB_2682909"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	31.4	63.5	33.7	2.1	39.2	1.6	95.4	42.3	51.5	40.4	14.8	16.3	0.8	93.9	6.4	9.5	37.2	3.7	5666.1	52.0	37.3	229.8	6.6	26.4	3.4	50.5	38.3	20.3	2.2	0.3	9.0	2.8	55.2	48.9	4.8	17.8	46.5	52.2	2202.5	16.3	7.5	44.2	31.4	28.8	60.3	15.3	36.1	2.3	6.8	1442.4	1.4	12.5	32.5	36.8	1.0	0.4	8.8	1.1	50.6	215.0	2.0	2.6	17.3	0.3	6.6	1.3	1.9	1.6	17.8	5.2	0.3	2.1	2.5	0.0	0.5	0.8	3.7	1.8	2.7	5.3	2.2	1.7	0.5	16.9	0.0	3.9	0.0	2.5	0.0	1.4	2.2	0.5	2.2	0.5	0.7	1.5	11.4	0.9	3.1	0.4	5.7	0.6	4.1	0.7	2.1	0.5	1.5	0.7	28.4	13.2	0.9	3.1	1.7	1.0	1.0	6.0	1.3	1.0	2.3	1.3	2.9	1.5	1.7	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.3	0.1	0.2	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.1	33.7	39.2	42.3	51.5	52.0	37.3	50.5	38.3	55.2	31.4	36.1	36.8	4.9	0.0	1.7	2.9	7.7	3.6	1.5	0.4	0.0	6.1	629.8	13.2	2495.2	2.8	1.3	27.6	2.1	3.8	2.1	0.4	452.0	0.4	2.5	0.4	0.5	25.6	0.0	0.0	16.1	0.4	1.4	67.2	1.1	3.1	1.3	43.8	2.2	0.1	114.7	8.4	14.6	0.1	0.0	27.8	10.3	5.4	6.8	19.1	8.8	3.7	0.0	2.6	0.0	3.5	8.9	0.3	12.3	7.9	0.1	6.8	0.1	703.6	1.5	10.2	0.0	14.9	40.7	2.9	0.2	0.2	3.0	1.6	5.1	97.9	0.3	36.5
FADS6		ENSG00000172782	"Fatty acid desaturase 6"		17	74877302-74893781	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 10.7;epididymis: 18.2;intestine: 14.8"	"Cell type enriched"	"Detected in some"	13	"Proximal enterocytes: 72.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016802	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA016802: AB_2669448"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.98e-4)"	"unprognostic (3.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.79e-1)"	0.2	7.1	4.5	0.5	3.5	1.5	0.5	6.6	9.1	0.6	0.0	0.8	7.5	0.2	18.2	3.2	0.1	0.0	0.2	2.0	2.0	1.1	6.1	0.2	0.6	10.2	2.4	0.3	0.4	0.5	0.1	0.2	10.7	0.1	0.7	1.2	0.3	0.3	0.4	7.7	14.8	0.2	0.9	4.1	0.2	0.7	5.1	0.4	0.4	0.2	0.8	1.2	1.1	3.6	0.2	0.3	0.5	0.4	0.0	1.0	0.7	0.5	0.0	0.1	0.2	0.8	0.3	0.3	0.1	0.5	0.3	0.3	0.7	0.0	0.2	0.1	0.0	0.5	1.6	0.6	0.3	0.4	0.4	0.3	0.0	1.1	0.4	0.2	0.0	0.4	0.4	1.4	0.6	0.6	0.3	1.1	0.3	0.2	0.5	0.2	0.1	0.5	0.3	0.3	0.4	0.4	0.5	0.2	0.1	0.5	0.2	0.5	0.3	0.3	0.7	0.6	0.5	0.5	0.2	0.3	1.0	0.3	0.5	1.1	0.6	0.4	0.2	0.6	0.2	0.3	0.3	0.3	0.1	0.5	0.3	0.4	2.0	0.8	1.5	0.5	0.2	0.0	4.5	3.5	6.6	9.1	2.0	2.0	10.2	2.4	10.7	0.9	5.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	1.8	1.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	3.7	0.0	0.0	0.8	0.0	0.1	0.3	0.0	0.0	5.2	0.2	0.1	0.3	0.0	0.2	0.0	1.1	0.4	4.0	0.3	1.7	5.4	1.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	5.1	0.0	0.0	1.1	72.2	1.9	0.0	0.5	0.0	1.1	0.4	0.0	2.0	1.7	0.6	3.8	0.2	0.4	0.7	1.3
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 301.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	99.2	65.4	16.0	7.0	17.1	20.0	59.0	16.6	21.1	19.2	15.1	13.8	14.6	19.3	50.4	15.2	23.0	9.7	20.3	16.3	18.8	65.0	301.5	20.0	5.7	17.9	19.6	26.4	9.9	18.4	16.8	7.8	16.9	16.6	11.9	1.6	14.8	13.6	31.0	10.9	16.8	13.5	17.2	19.1	14.2	20.8	17.4	6.7	14.5	27.7	5.8	16.4	15.8	17.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	16.0	17.1	16.6	21.1	16.3	18.8	17.9	19.6	16.9	17.2	17.4	17.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.1"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 112.2;Proximal tubular cells: 210.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	12.3	21.4	9.1	8.5	9.4	10.0	9.4	9.3	11.1	8.3	9.2	22.6	36.1	9.7	8.0	19.3	6.9	12.1	19.9	10.9	11.1	64.1	58.5	7.1	7.4	10.7	10.0	8.0	15.8	12.1	9.5	7.5	10.1	9.4	14.2	6.7	11.2	10.7	30.7	17.1	27.1	8.7	8.8	8.4	21.0	10.1	9.4	7.9	7.8	24.7	6.4	11.3	11.1	9.9	20.1	44.6	20.9	36.9	27.0	19.5	12.9	32.4	16.0	21.1	22.9	28.6	20.4	12.8	26.6	20.2	32.7	40.5	16.4	25.8	19.0	19.3	39.0	11.5	38.7	67.0	26.2	20.0	21.2	25.8	33.3	19.3	12.9	17.8	27.8	15.3	12.1	12.8	26.8	92.5	10.9	30.1	12.4	18.4	33.0	24.6	28.3	36.4	76.8	24.9	40.4	33.6	42.3	33.5	52.0	13.8	49.4	13.4	41.1	34.4	24.6	20.5	17.8	18.6	42.3	15.1	22.0	14.5	15.1	15.8	40.8	16.5	25.1	51.5	22.5	37.2	24.7	27.3	42.6	32.7	27.0	24.8	3.5	38.1	38.4	33.1	28.4	24.3	9.1	9.4	9.3	11.1	10.9	11.1	10.7	10.0	10.1	8.8	9.4	9.9	14.6	25.6	16.4	2.9	11.2	14.0	13.3	29.6	13.1	19.8	12.4	15.7	42.9	27.1	17.2	42.3	27.1	22.6	10.9	50.8	50.9	57.2	89.8	16.8	19.8	16.3	29.3	36.4	8.0	39.2	14.2	15.5	17.3	18.2	5.1	13.8	9.7	35.5	30.5	18.5	8.6	25.6	24.4	9.1	14.2	45.0	14.6	13.7	16.0	4.7	18.9	17.4	20.6	3.0	6.4	34.9	36.7	15.4	4.0	11.2	112.2	210.9	14.4	24.2	13.1	12.7	16.5	9.9	9.1	27.2	24.0	15.3	9.8	30.3	52.7	9.6
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 359.4;parathyroid gland: 98.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 141.9;Early spermatids: 202.2;Excitatory neurons: 77.6;Horizontal cells: 232.2;Inhibitory neurons: 105.1"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 12.2;OE19: 16.7;SH-SY5Y: 6.7;U-87 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	4.7	41.6	180.7	4.9	189.0	0.0	1.8	107.7	359.4	6.7	0.0	8.5	2.2	9.9	8.0	4.2	14.2	10.2	41.9	205.6	161.0	2.1	0.4	2.2	3.7	223.0	129.4	3.9	2.4	98.1	42.0	0.2	206.5	14.2	3.5	72.3	2.6	9.0	1.2	0.9	6.3	12.2	106.8	1.9	4.2	30.5	175.3	1.9	1.8	1.2	2.8	9.5	10.5	223.0	0.0	0.5	0.5	0.7	2.7	1.7	0.1	0.7	3.6	0.7	0.4	0.4	0.0	0.0	0.1	5.1	0.2	0.3	1.5	0.0	0.4	0.0	0.0	2.9	0.0	0.0	12.2	0.1	0.1	1.1	0.2	2.7	0.0	0.0	0.0	0.3	1.6	0.4	0.7	0.0	0.1	0.0	0.1	16.7	0.0	0.0	0.2	0.0	0.0	0.0	4.4	6.7	0.0	0.2	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.1	0.1	0.4	0.0	0.0	38.5	0.0	0.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.1	180.7	189.0	107.7	359.4	205.6	161.0	223.0	129.4	206.5	106.8	175.3	223.0	0.2	0.0	0.0	31.0	0.0	0.3	0.3	0.7	0.6	141.9	2.3	2.3	1.1	0.0	0.4	0.0	2.1	0.0	0.3	0.1	0.0	0.1	202.2	0.1	0.5	0.7	0.0	0.0	77.6	0.2	0.1	16.7	1.1	0.0	26.1	0.0	0.0	0.0	0.4	232.2	105.1	2.2	12.2	0.0	0.4	52.0	5.0	0.5	0.0	13.1	0.0	35.6	0.0	45.2	55.5	0.1	0.0	5.3	0.3	0.5	0.0	0.4	0.0	20.2	0.0	0.9	0.7	4.8	5.8	0.5	0.3	0.1	0.5	0.4	0.7	0.3
FAM110D	"FLJ14050, GRRP1"	ENSG00000197245	"Family with sequence similarity 110 member D"	Q8TAY7	1	26159079-26163962	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Adipocytes: 82.7;Endothelial cells: 63.5;Hepatic stellate cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"TIME: 1.2;U-2 OS: 1.4;U-937: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA013664	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA013664: AB_1234332"	"unprognostic (7.53e-2)"	"unprognostic (4.45e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.16e-3)"	"unprognostic (7.67e-5)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (9.87e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-1)"	10.9	1.3	4.1	0.6	3.0	0.8	8.5	3.1	3.7	4.8	2.0	2.9	1.1	7.9	0.8	1.9	7.4	2.3	6.2	3.1	3.2	4.0	0.4	4.2	1.1	4.7	3.6	1.3	2.2	1.1	1.3	0.6	4.1	3.1	0.5	0.3	2.4	0.7	4.2	3.0	3.1	2.8	4.5	0.8	3.3	0.6	4.1	0.9	4.7	2.1	0.4	4.0	3.6	3.3	0.1	0.1	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.5	0.1	0.0	0.1	0.4	0.1	0.2	1.2	0.1	1.4	0.1	0.0	0.0	0.2	0.1	0.0	1.0	0.0	1.3	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.2	1.0	0.4	0.1	0.2	0.0	0.0	4.1	3.0	3.1	3.7	3.1	3.2	4.7	3.6	4.1	4.5	4.1	3.3	82.7	0.0	3.4	0.3	0.9	1.0	0.9	0.0	2.2	2.3	1.3	1.8	3.1	2.8	1.3	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.4	0.2	0.5	63.5	0.0	2.7	0.4	0.0	0.0	2.5	0.0	0.2	0.0	0.3	34.6	0.0	0.0	1.7	0.7	0.0	0.0	1.3	1.8	0.5	0.6	0.4	0.0	4.7	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	1.4	1.8	0.2	0.7	0.8	0.9	0.3	0.3	0.5	0.0	0.3
FAM117A		ENSG00000121104	"Family with sequence similarity 117 member A"	Q9C073	17	49710332-49789180	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.4;Erythroid cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 50.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 82.0;U-266/84: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022531	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA022531: AB_2101087"	"prognostic favorable (5.30e-5)"	"unprognostic (8.06e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.25e-7)"	"unprognostic (4.05e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.73e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.66e-2)"	13.5	7.3	7.6	14.8	6.8	76.5	12.5	10.0	5.9	12.6	37.4	22.8	10.6	20.4	9.6	9.4	16.7	10.4	18.9	9.6	4.8	9.0	11.7	12.1	22.9	6.3	4.6	21.6	16.0	18.6	14.6	5.4	6.1	10.0	8.5	8.0	13.5	11.3	4.0	19.1	18.7	16.7	3.3	34.2	13.3	19.0	6.7	23.5	14.5	6.3	17.4	20.2	10.5	5.0	7.2	1.7	11.4	0.2	5.0	1.0	20.2	2.4	4.0	4.3	7.1	51.2	11.8	34.4	12.4	1.4	19.1	4.1	9.0	8.5	3.3	2.4	14.5	37.9	0.1	16.6	5.6	5.8	29.1	4.9	7.1	7.1	3.9	4.4	7.8	28.9	46.9	28.1	4.1	18.6	37.5	31.1	17.0	10.0	5.7	11.6	9.6	18.4	6.7	6.4	11.1	7.5	2.4	1.1	8.5	11.1	16.7	21.5	0.7	4.2	3.4	4.6	2.0	82.0	60.2	23.0	3.6	8.4	3.5	50.4	1.7	9.1	8.5	1.1	9.2	23.6	5.5	7.2	1.3	15.3	4.5	6.2	3.6	12.8	0.3	3.6	5.9	3.4	7.6	6.8	10.0	5.9	9.6	4.8	6.3	4.6	6.1	3.3	6.7	5.0	15.5	6.4	9.3	5.2	19.5	9.1	1.3	2.1	7.4	15.1	14.6	21.7	22.2	1.5	4.1	7.3	14.6	1.1	56.4	2.2	5.9	2.0	4.1	4.2	5.9	9.9	10.7	104.4	4.5	3.5	1.9	9.3	9.2	7.9	2.5	2.9	7.1	8.6	1.2	5.0	4.0	4.9	6.1	2.9	4.5	5.6	14.3	7.6	7.2	1.9	13.0	3.5	37.0	2.0	2.3	3.8	1.0	15.4	34.9	2.6	0.5	3.6	1.5	4.0	0.0	14.2	10.2	15.5	14.5	8.8	14.1	0.8	27.9	5.5	2.7	1.1
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.1;Horizontal cells: 238.9;Inhibitory neurons: 172.8;Microglial cells: 132.1;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	2.6	2.8	2.5	4.8	3.6	1.3	2.5	8.1	3.3	4.9	0.6	10.7	13.6	6.3	2.5	29.8	4.1	7.0	4.1	3.2	2.1	4.9	2.4	4.2	3.8	2.4	2.3	6.3	6.0	9.7	1.9	4.0	2.4	16.1	11.1	8.2	4.5	3.5	2.6	9.6	11.5	3.7	1.2	3.5	10.7	10.1	2.2	2.9	3.8	6.5	6.4	4.9	7.1	3.7	7.9	4.8	9.5	6.1	4.5	3.2	8.9	2.5	5.0	2.6	4.3	8.9	6.2	14.3	18.1	1.9	12.6	7.3	9.6	5.6	4.6	6.8	8.2	6.2	4.6	8.0	5.5	12.3	6.4	2.9	13.8	5.0	13.4	3.1	7.2	4.4	10.6	6.8	3.1	0.8	2.2	5.5	6.4	9.2	3.9	6.8	31.3	6.8	9.8	4.0	10.1	3.1	2.9	2.6	3.0	6.3	1.8	5.2	3.6	2.2	5.7	2.2	5.8	8.5	10.3	5.5	1.6	10.4	4.2	1.8	2.3	0.1	0.8	2.0	0.9	1.6	0.7	0.3	3.5	2.0	1.1	0.7	0.6	2.7	3.3	0.5	0.9	0.9	2.5	3.6	8.1	3.3	3.2	2.1	2.4	2.3	2.4	1.2	2.2	3.7	12.0	28.9	12.5	85.8	10.8	15.9	12.9	8.3	31.3	20.8	4.5	4.1	11.5	17.2	8.9	20.2	29.2	2.9	4.7	49.9	5.9	6.7	30.4	13.9	15.6	13.0	23.4	1.7	170.1	12.4	1.5	10.2	45.9	21.4	8.8	13.5	9.7	6.5	5.6	238.9	172.8	29.2	16.2	10.6	15.5	23.8	15.5	11.9	5.4	132.1	11.9	13.8	4.1	219.2	121.3	18.4	31.7	13.2	6.4	35.4	24.0	10.0	9.9	26.4	6.6	11.6	9.3	33.2	10.5	71.4	33.5	8.2	4.6	10.9	25.5	15.8
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609181-54623556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 66.3;kidney: 174.5"	"Group enriched"	"Detected in some"	15	"Proximal enterocytes: 478.5;Proximal tubular cells: 294.8"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"CACO-2: 78.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved					NA	NA		10000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.6	0.3	0.5	0.6	1.5	0.2	0.1	1.6	0.9	0.0	5.9	2.4	2.4	0.1	0.0	0.3	0.0	0.1	3.0	0.6	0.5	174.5	16.7	0.0	5.3	2.7	2.8	0.3	0.6	0.0	0.1	0.0	1.5	0.1	1.3	0.3	0.5	0.0	1.0	0.1	66.3	0.0	0.4	0.8	0.7	0.6	2.2	0.2	0.4	0.0	1.8	0.1	0.0	0.6	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	78.9	0.9	0.0	0.3	0.0	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.7	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.5	0.0	0.0	0.8	0.0	0.0	1.6	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	1.6	0.9	0.6	0.5	2.7	2.8	1.5	0.4	2.2	0.6	0.0	0.0	0.0	3.6	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	9.3	13.7	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.4	16.8	0.0	0.3	0.0	14.3	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	25.0	0.0	0.0	0.0	478.5	294.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.1	18.1	0.0
FAM205C	FAM205CP	ENSG00000187791	"Family with sequence similarity 205 member C"	A6NFA0	9	34889066-34895764	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	38	"testis: 28.9"	"Group enriched"	"Detected in some"	91	"Early spermatids: 275.6;Late spermatids: 489.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	103	"THP-1: 14.8"	"Not detected"	"Not detected"													NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.29e-1)"				"unprognostic (1.90e-1)"	"unprognostic (3.64e-2)"		"unprognostic (8.64e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.73e-2)"		"unprognostic (1.85e-4)"	"unprognostic (1.48e-3)"				0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.1	28.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.9	0.0	275.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	489.3	1.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.0	0.0	2.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM217A	"C6orf146, MGC43581"	ENSG00000145975	"Family with sequence similarity 217 member A"	Q8IXS0	6	4049434-4087344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 14.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 246.0;Late spermatids: 418.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA035455	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA035455: AB_10669905"	"unprognostic (5.93e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.54e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.51e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	246.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	418.8	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	20.9	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109713825-109770495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 116.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA075616"	Uncertain		Approved	"Golgi apparatus,Cell Junctions,Midbody ring"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Cell Junctions, Midbody ring"	"HPA040181: AB_10796448, HPA075616: "	"unprognostic (8.59e-3)"	"prognostic favorable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	0.7	19.0	23.7	0.7	45.2	0.6	1.2	36.7	34.2	0.6	5.6	1.9	4.8	0.3	0.8	2.3	0.4	0.8	8.9	20.0	27.6	10.6	4.0	2.1	0.4	41.2	43.1	13.4	3.9	0.7	22.4	0.1	37.7	1.8	1.0	22.1	3.4	0.5	4.3	3.2	2.2	0.4	29.0	6.2	7.2	23.4	48.4	0.4	0.7	0.6	0.6	0.9	1.8	65.6	2.0	3.1	1.6	3.7	1.0	0.0	1.1	0.6	0.3	1.6	0.2	28.1	0.5	0.3	2.2	0.8	1.7	1.2	1.9	0.1	0.6	16.8	4.0	3.5	0.9	6.5	0.2	2.8	3.6	0.2	0.2	0.3	0.0	0.4	0.1	2.0	1.2	0.6	0.3	11.5	0.7	3.6	3.0	3.3	5.3	2.3	8.0	1.2	3.5	1.5	19.2	116.4	2.5	3.7	8.2	0.5	4.5	3.0	0.2	0.5	3.2	1.3	2.4	2.9	4.0	2.4	0.3	2.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	45.2	36.7	34.2	20.0	27.6	41.2	43.1	37.7	29.0	48.4	65.6	2.1	0.0	0.0	2.3	3.6	2.2	0.9	0.1	3.4	23.4	7.4	6.1	8.1	1.5	0.8	1.8	33.3	0.3	10.4	1.2	7.9	1.7	29.1	1.2	0.5	1.3	7.7	0.0	1.3	0.8	0.2	1.5	1.5	1.8	0.0	0.7	0.7	1.3	0.3	77.4	6.7	5.8	0.0	0.0	2.1	13.4	1.2	1.9	7.2	0.0	0.1	11.2	0.0	9.5	78.5	1.1	0.2	0.4	1.3	1.7	0.9	0.7	0.6	50.3	0.0	2.6	1.5	1.1	5.7	3.3	1.8	0.8	3.7	6.0	1.6	0.4
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145454-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 41.3;HUVEC TERT2: 28.0"	"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"		"HPA062443: AB_2684765, HPA069294: AB_2686111"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	16.7	4.1	7.7	5.3	8.6	7.2	11.2	16.6	15.5	2.8	0.5	2.8	2.9	3.8	3.8	4.3	2.3	5.1	7.2	6.7	1.7	4.5	4.6	5.1	5.2	1.6	2.3	2.8	2.2	3.9	1.5	10.8	2.9	3.8	2.8	10.5	8.8	2.9	6.0	6.3	3.4	5.1	0.4	5.0	7.3	6.0	3.9	3.2	4.2	5.0	4.1	5.1	2.5	13.7	6.3	2.4	2.5	2.1	12.5	7.1	3.7	5.3	1.2	1.0	1.6	1.9	7.9	41.3	4.9	2.9	3.5	3.1	3.9	5.5	1.8	19.7	6.6	4.4	6.4	3.4	7.4	10.3	2.7	7.8	8.7	1.5	9.1	2.0	28.0	5.8	8.4	19.6	3.1	6.5	3.8	7.4	3.2	10.3	5.9	8.6	4.2	8.5	4.2	6.1	4.6	3.8	5.0	9.0	2.7	3.6	6.5	4.4	17.9	3.2	9.7	2.1	1.9	8.2	11.3	19.1	7.3	5.1	4.1	2.8	0.6	0.6	0.5	0.5	0.4	0.6	0.5	0.4	0.3	0.9	0.5	0.6	1.5	0.6	0.6	1.0	0.6	0.3	7.7	8.6	16.6	15.5	6.7	1.7	1.6	2.3	2.9	0.4	3.9	13.7	272.0	60.9	69.9	0.0	4.9	0.0	0.0	0.0	0.0	0.0	87.0	42.2	0.0	0.0	36.5	33.1	0.0	1.6	9.2	0.0	7.9	12.0	0.0	4.6	3.9	44.0	0.0	0.0	0.0	17.3	2.8	13.8	0.0	12.0	32.8	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	28.2	0.0	0.0	4.0	0.0	0.0	3.5	42.3	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	2.5	9.8	1.3	0.0	0.0
FAM24B	"AC073585.2, MGC45962"	ENSG00000213185	"Family with sequence similarity 24 member B"	Q8N5W8	10	122849078-122879641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 50.9;Early spermatids: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"hTERT-HME1: 135.5;LHCN-M2: 181.8;TIME: 58.3"									HPA052490	Supported				"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA052490: AB_2681851"	"unprognostic (4.03e-2)"	"unprognostic (4.27e-2)"	"unprognostic (3.13e-3)"	"unprognostic (8.40e-5)"	"unprognostic (2.55e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.42e-7)"	"unprognostic (2.99e-1)"	"unprognostic (7.06e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.81e-3)"	2.1	1.3	4.9	2.6	5.0	2.6	3.0	4.9	6.4	2.8	3.7	2.8	2.3	2.3	2.9	2.4	2.2	2.1	1.5	5.2	6.3	15.0	0.9	2.4	5.9	5.3	5.0	2.9	7.8	1.0	10.9	0.4	5.2	3.0	4.0	5.9	1.9	1.4	0.9	4.2	3.6	1.6	4.9	3.8	3.1	9.2	5.2	4.9	2.4	0.2	4.7	2.6	2.3	5.8	8.1	12.8	3.1	0.1	1.9	3.7	4.0	11.8	11.1	4.8	4.4	14.2	16.6	3.0	3.6	6.5	1.4	5.2	0.0	7.1	13.1	14.0	5.3	23.8	18.4	7.6	10.4	0.0	13.8	4.3	0.9	10.4	135.5	0.9	12.6	15.5	9.5	6.0	181.8	7.3	13.9	13.9	5.0	8.1	13.3	0.0	18.5	2.8	8.6	7.2	8.6	3.7	5.5	2.9	15.0	7.7	4.7	14.1	58.3	1.4	6.7	5.0	1.2	6.5	7.1	18.0	9.7	23.3	0.0	2.2	1.5	1.0	1.7	1.5	0.6	4.2	3.4	2.4	2.1	2.3	3.5	2.1	1.0	2.1	1.5	8.1	3.6	1.2	4.9	5.0	4.9	6.4	5.2	6.3	5.3	5.0	5.2	4.9	5.2	5.8	2.5	0.0	0.5	0.0	7.1	6.6	1.6	4.2	14.2	3.6	3.7	5.8	0.2	2.8	1.2	9.2	0.0	0.1	7.7	1.6	50.9	4.3	28.2	0.5	0.7	1.9	4.8	6.5	0.0	7.3	0.2	3.8	2.0	0.6	8.9	0.5	1.8	0.8	1.2	1.7	0.0	3.5	12.2	4.1	2.9	4.1	3.7	3.3	1.8	0.0	3.5	2.9	8.2	0.0	0.0	8.7	2.7	4.1	2.7	2.0	2.3	1.8	1.2	4.3	0.0	1.7	2.3	12.9	4.6	5.5	5.4	0.0	6.7	0.2	3.5	1.2
FAM83A	"BJ-TSA-9, MGC14128"	ENSG00000147689	"Family with sequence similarity 83 member A"	Q86UY5	8	123178960-123210079	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 111.3;vagina: 55.8"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 71.2;Club cells: 58.2;Pancreatic endocrine cells: 28.7;Squamous epithelial cells: 19.3;Suprabasal keratinocytes: 15.2;Urothelial cells: 25.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 52.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 83.5;HBEC3-KT: 126.3;hTCEpi: 66.4;K-562: 206.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA052615			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA052615: AB_2797244"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.98e-9)"	"unprognostic (2.62e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.07e-2)"	0.2	0.6	0.0	0.1	0.0	0.2	0.3	0.2	0.1	18.9	0.1	0.1	1.0	0.0	1.3	111.3	4.3	1.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.7	0.0	0.1	7.5	6.4	0.1	10.2	2.4	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.4	0.0	7.4	3.8	55.8	0.0	83.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.6	0.7	10.6	0.0	0.0	25.9	0.0	126.3	0.0	0.0	0.1	0.8	9.2	0.0	0.0	0.1	0.1	0.0	66.4	0.0	16.8	0.0	0.0	0.1	206.3	0.1	0.0	0.3	0.0	0.1	0.0	4.2	0.1	0.0	0.0	0.1	0.0	18.4	0.1	0.0	14.4	9.7	0.1	0.2	1.5	0.2	0.6	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	4.0	71.2	1.2	0.0	4.4	0.9	1.1	0.0	58.2	1.8	0.0	0.1	0.0	1.0	0.0	0.3	1.0	0.0	0.1	0.1	0.0	0.0	0.6	0.7	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	10.2	0.0	0.4	1.6	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	28.7	0.2	0.0	0.1	0.7	1.1	0.1	9.6	0.0	0.0	0.1	1.4	2.2	0.6	19.3	15.2	0.0	0.1	0.0	0.8	25.0
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54945099	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 14.5;skin 1: 25.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 33.8;Basal prostatic cells: 32.5;Basal squamous epithelial cells: 43.3;Squamous epithelial cells: 31.9;Suprabasal keratinocytes: 41.1;Urothelial cells: 25.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.3;HaCaT: 18.1;HBEC3-KT: 9.8;hTCEpi: 19.7;hTERT-HME1: 23.8;RT4: 19.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031464, HPA031465"	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavorable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.86e-5)"	0.0	0.0	0.1	1.0	0.1	0.1	2.2	0.1	0.1	3.8	0.0	8.0	7.4	0.3	1.2	14.5	1.6	2.1	1.1	0.0	0.0	2.5	0.1	0.1	0.0	0.0	0.7	0.0	1.5	0.0	0.0	4.3	0.1	1.8	8.2	0.1	4.7	1.1	0.7	25.9	7.4	0.2	0.0	0.0	3.9	0.6	0.0	2.3	3.6	0.1	3.6	4.3	9.8	0.2	13.3	0.2	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	6.5	3.6	0.0	0.0	0.0	0.1	18.1	0.0	9.8	0.1	0.0	2.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	19.7	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.6	4.1	0.0	0.0	0.0	0.0	9.1	19.2	0.2	0.0	2.9	0.6	0.0	3.3	4.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	33.8	32.5	6.6	43.3	0.0	1.5	3.0	3.1	5.7	6.5	7.3	0.0	11.2	0.1	9.0	0.0	6.1	6.3	8.8	0.8	0.3	1.2	0.0	0.2	3.5	11.9	0.4	9.2	8.1	0.0	0.0	0.4	0.0	0.6	0.0	0.1	5.4	6.1	0.0	1.5	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	17.4	0.0	0.1	9.1	12.6	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.6	31.9	41.1	18.7	0.1	0.0	8.8	25.4
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659103-172666876	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.7"	"Group enriched"	"Detected in some"	14	"dendritic cells: 43.4;NK-cells: 79.3;T-cells: 28.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 58.1"	"Group enriched"	"Detected in many"	9	"NK-cells: 41.5;T-cells: 58.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054959	Approved				"Secreted to blood"	NA	NA	73600		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.3	0.8	0.1	1.0	0.2	2.8	0.6	0.1	0.2	0.4	0.1	0.8	1.9	0.5	0.7	0.3	0.3	1.1	0.3	0.2	0.1	0.3	1.1	2.0	5.7	0.3	0.2	0.3	0.1	0.0	0.1	0.2	0.2	0.5	0.9	0.0	0.9	0.3	0.1	0.4	1.4	0.3	0.0	4.1	1.5	0.2	0.1	0.6	0.2	0.0	1.8	0.8	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	58.1	0.2	35.5	0.0	11.5	31.4	0.1	0.0	2.2	25.0	1.9	41.5	0.1	0.0	0.2	14.9	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.1	0.4	0.4	0.0	2.5	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	43.4	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.6	1.8	0.0	0.9	0.0	79.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	28.8	0.0	0.0	0.1
FAT3	"CDHF15, CDHR10, KIAA1989"	ENSG00000165323	"FAT atypical cadherin 3"	Q8TDW7	11	92224818-92896473	"Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 19.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 265.8;Excitatory neurons: 512.9;Inhibitory neurons: 149.2;Oligodendrocyte precursor cells: 88.4"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.3;fHDF/TERT166: 2.2;NTERA-2: 2.5;SuSa: 2.2;U-2 OS: 2.1;U-251 MG: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026878, HPA074824"	Uncertain		Approved	"Cell Junctions"		NA	NA		4700		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"		"HPA026878: AB_1848430, HPA074824: "	"unprognostic (5.00e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.76e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.66e-4)"	"unprognostic (8.83e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.25e-1)"	0.5	0.0	5.5	0.0	19.3	0.0	0.1	1.3	9.0	0.6	0.0	0.2	0.0	0.6	0.6	0.1	0.6	0.0	0.2	4.0	15.5	0.2	0.0	1.2	0.0	0.5	4.7	0.5	0.0	0.0	2.9	0.1	1.9	2.0	0.1	1.3	0.0	3.8	0.1	0.2	0.0	0.1	0.8	0.1	2.2	0.7	7.5	0.1	0.0	0.2	0.2	2.3	1.0	1.0	0.0	0.3	7.3	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.4	0.0	0.0	0.0	1.4	2.2	0.0	1.2	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	2.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	19.3	1.3	9.0	4.0	15.5	0.5	4.7	1.9	0.8	7.5	1.0	0.0	0.0	0.0	265.8	0.0	0.1	0.3	0.9	0.0	20.8	0.1	0.5	1.8	0.0	0.1	14.7	0.0	0.1	0.0	0.1	0.0	0.7	4.8	0.1	0.2	0.2	0.0	0.0	512.9	0.0	0.1	1.9	0.0	0.0	0.0	3.7	1.4	0.0	0.1	0.0	149.2	0.0	24.4	0.0	0.0	3.8	1.2	0.3	0.0	13.1	0.0	0.8	0.0	88.4	7.0	0.2	0.0	7.5	0.0	0.6	0.0	0.0	0.0	1.7	0.0	2.5	4.4	1.0	6.5	0.1	0.0	0.0	0.0	44.8	0.0	0.1
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	359.3	123.1	17.3	72.3	29.5	1.7	318.2	27.8	27.5	1131.0	802.4	200.7	75.5	410.6	126.0	305.8	497.6	676.1	773.7	47.0	11.9	61.3	15.7	414.9	16.1	21.8	24.5	214.1	106.3	216.9	90.3	505.7	23.1	466.8	83.6	3.1	121.2	158.5	36.0	296.3	174.5	180.3	15.9	24.9	269.1	21.9	24.7	20.5	195.3	47.5	13.0	704.6	940.5	14.6	17.7	41.6	122.9	258.0	1839.4	809.8	559.8	1029.3	1615.9	89.8	33.8	179.2	5.2	0.4	42.8	38.6	2.5	90.9	78.0	2.7	10.8	0.9	21.0	0.4	209.4	121.5	243.2	1.0	1.0	1345.8	15.8	89.6	32.7	1.8	0.2	1.4	0.9	2.1	63.3	2.4	0.8	3.2	173.8	3.7	15.4	1.4	0.9	2.1	41.1	1485.2	8.7	162.7	127.5	589.6	0.6	344.3	3.7	5.4	8.0	17.4	109.3	465.8	1.0	1.6	0.8	1.4	1.2	1.0	43.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.0	2.4	1.2	0.0	0.1	17.3	29.5	27.8	27.5	47.0	11.9	21.8	24.5	23.1	15.9	24.7	14.6	34.4	6.4	1.3	34.3	1.2	170.9	113.4	54.8	21.1	0.1	5.3	11.6	20.1	10.0	28.3	1.8	0.0	666.3	1.6	0.1	0.0	1.3	10.5	61.5	628.2	34.5	0.0	0.0	0.5	0.2	651.6	1506.5	38.7	256.5	1.3	29.0	22.1	0.6	82.4	0.0	0.8	0.3	6.1	0.0	222.9	25.4	92.2	11.4	170.7	41.2	0.0	0.1	0.0	0.0	0.4	1.0	0.1	30.5	4.5	47.4	0.0	0.3	10.2	0.6	118.3	37.1	81.5	42.2	68.7	23.8	130.3	1215.9	18.2	2.3	0.4	86.9
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869411-91947987	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Group enriched"	"Detected in many"	19	"granulocytes: 6.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Uncertain	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		12000000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	182.2	73.4	10.7	17.7	12.8	7.5	110.4	7.4	12.5	124.9	15.7	80.3	19.1	178.4	40.0	26.8	143.0	130.2	211.1	9.4	8.6	108.4	29.3	164.8	25.5	15.5	10.9	107.3	46.4	16.8	14.5	67.0	14.2	49.0	20.6	0.6	55.8	70.9	30.4	66.9	52.7	88.7	13.1	130.9	68.9	35.6	12.7	21.8	79.5	36.0	15.7	117.5	93.3	7.5	0.0	1.6	0.2	0.0	457.1	234.6	22.5	202.0	202.5	5.8	4.5	4.7	0.0	0.0	4.2	394.6	0.6	0.1	9.8	1.0	1.0	0.0	2.3	0.4	4.7	0.0	74.2	0.0	0.1	216.6	0.4	3.9	14.1	2.8	10.4	0.1	0.0	0.1	25.3	0.4	0.5	0.5	0.5	0.0	0.5	0.4	30.2	0.2	1.2	0.1	0.2	0.1	12.3	0.7	2.6	7.0	2.9	0.3	1.9	3.2	6.6	3.8	0.1	0.1	0.0	0.2	0.4	0.0	0.0	6.6	0.1	2.2	0.8	0.2	0.5	0.0	0.3	0.1	0.0	0.1	1.1	1.8	2.5	0.0	0.2	0.0	0.1	0.4	10.7	12.8	7.4	12.5	9.4	8.6	15.5	10.9	14.2	13.1	12.7	7.5	31.4	83.3	13.1	0.0	2.1	9.2	2.4	7.1	1.8	0.0	11.2	9.3	5.2	0.0	11.5	5.5	0.0	2.5	2.5	0.1	5.9	4.7	5.9	13.3	67.4	15.2	0.0	0.4	2.6	4.7	2.5	209.4	2.0	12.0	2.5	1.8	34.2	0.4	7.8	0.0	3.6	0.1	18.3	2.5	18.4	27.5	626.6	5.8	21.4	15.9	1.6	0.0	8.2	5.0	2.3	2.2	0.0	794.8	0.7	1.3	0.0	32.5	21.4	0.0	6.6	28.0	14.5	3.0	2.8	1.3	8.7	3.7	15.5	3.5	0.4	1.2
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408313-48645721	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.9;placenta: 76.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		520000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	60.9	4.4	1.4	14.5	5.4	3.4	13.7	2.8	2.8	36.0	9.5	8.3	3.8	15.2	6.3	12.6	12.2	27.3	23.5	0.8	2.0	2.7	2.9	10.0	3.7	5.2	6.0	28.4	3.3	3.0	2.5	76.7	3.7	8.0	11.7	1.3	4.6	13.2	4.5	5.7	6.6	35.7	2.3	6.4	6.0	7.1	4.7	2.9	18.6	21.2	3.5	18.8	9.9	5.0	0.1	5.2	19.8	22.4	215.1	460.7	0.2	175.8	62.9	51.1	32.4	0.1	0.3	0.1	7.9	420.8	0.4	0.7	3.9	0.6	45.9	20.7	1.2	2.0	88.5	0.2	120.7	0.8	0.3	251.3	0.1	135.9	15.6	211.1	55.5	1.6	0.0	0.4	55.6	0.0	1.5	0.2	4.0	0.2	7.1	0.1	17.0	0.2	5.9	0.5	0.2	12.9	0.0	2.2	0.1	15.3	0.2	1.4	106.8	206.9	6.2	305.8	37.6	1.2	1.0	0.0	138.9	0.3	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	5.4	2.8	2.8	0.8	2.0	5.2	6.0	3.7	2.3	4.7	5.0	50.0	0.0	1.3	34.9	0.4	25.6	0.8	1.5	0.6	6.1	1.3	3.4	14.2	0.0	5.8	12.9	0.0	132.4	0.4	0.0	0.0	0.2	8.7	4.2	105.2	36.1	0.0	5.5	82.3	0.6	40.8	388.5	3.1	2.0	1.3	22.5	34.6	0.6	15.3	0.0	123.5	0.0	0.0	0.8	39.0	22.8	236.1	5.7	42.7	30.0	2.3	0.8	0.0	76.9	218.7	1.7	0.0	227.2	1.7	0.7	0.1	0.6	3.3	0.2	26.3	139.5	55.8	3.3	3.4	0.8	20.6	65.8	4.3	51.3	0.0	0.2
FBN3	KIAA1776	ENSG00000142449	"Fibrillin 3"	Q75N90	19	8065402-8149592	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.4;salivary gland: 4.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 2.4;Inhibitory neurons: 3.4;Oligodendrocyte precursor cells: 17.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 3.7;NTERA-2: 12.3;REH: 18.6;SuSa: 4.5"					"Not detected"	"Not detected"			HPA049482	Uncertain				"Secreted to extracellular matrix"	NA	NA		2400000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA049482: AB_2680786"	"unprognostic (9.66e-3)"	"unprognostic (5.15e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (4.14e-2)"	"unprognostic (5.14e-3)"	"unprognostic (6.26e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.17e-1)"	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.5	0.0	0.1	0.3	0.6	2.4	0.1	1.4	0.0	0.5	0.6	0.1	0.0	0.0	0.7	0.0	0.6	0.9	0.1	0.0	4.0	0.0	0.3	0.2	0.1	0.1	0.5	0.0	0.1	0.5	0.6	0.5	1.9	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.7	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	12.3	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.5	0.3	0.6	0.5	0.6	0.6	0.5	0.6	0.6	0.0	6.4	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 324.4;kidney: 297.8;liver: 893.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 500.4;Macrophages: 238.6;Proximal enterocytes: 1095.0;Proximal tubular cells: 864.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 404.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HaCaT: 75.2;MCF7: 243.4;OE19: 54.5;RT4: 157.0;U-698: 170.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		21000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	13.7	27.4	1.6	12.7	1.8	15.0	41.4	1.8	5.7	19.9	2.6	29.8	324.4	3.6	15.8	2.7	7.1	34.4	2.9	1.5	2.2	297.8	893.2	165.9	6.8	3.6	2.6	1.1	41.4	107.9	8.6	3.0	2.9	25.8	30.5	0.7	53.2	28.9	1.3	8.1	258.1	8.8	2.6	12.2	85.6	2.5	3.2	2.2	16.8	0.9	7.8	70.8	6.7	3.8	0.5	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.6	3.8	0.0	0.3	0.8	0.1	75.2	0.1	0.0	0.1	0.0	0.3	0.6	2.9	1.3	0.0	1.5	18.8	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.2	0.3	0.2	243.4	0.1	4.4	1.1	54.5	9.5	0.0	0.9	1.9	0.0	157.0	0.7	5.6	0.6	44.5	0.0	0.9	26.7	7.7	0.2	0.1	1.0	0.8	0.0	0.3	1.1	170.4	0.0	1.4	0.1	63.3	68.4	404.3	7.9	162.3	11.7	3.0	4.6	4.6	90.1	3.2	16.2	8.3	12.1	15.4	90.7	32.1	2.3	33.1	1.6	1.8	1.8	5.7	1.5	2.2	3.6	2.6	2.9	2.6	3.2	3.8	2.8	76.9	182.8	0.0	10.3	0.8	8.9	0.7	0.0	0.1	62.4	24.3	0.7	102.9	41.0	62.5	0.0	11.1	14.8	26.1	111.6	21.5	0.1	4.0	0.4	4.8	31.9	24.4	0.9	62.7	1.7	5.4	102.4	5.2	47.4	16.0	12.1	500.4	177.6	0.0	0.8	61.4	0.0	79.9	32.1	1.5	1.5	238.6	12.4	1.9	20.1	2.6	8.2	0.5	0.3	24.0	77.6	4.1	18.3	11.9	1095.0	864.1	9.1	0.2	6.6	0.6	2.0	0.6	1.3	0.8	1.0	10.1	12.1	0.5	90.4	68.1
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"kidney: 38.1;lymphoid tissue: 26.2"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 32.9"	"Group enriched"	"Detected in some"	5	"liver cancer: 2.4;renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056505	Enhanced					NA	NA		5300000		"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.2	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.1	7.9	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	26.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	32.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1
FCER1G		ENSG00000158869	"Fc fragment of IgE receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 441.6;lymphoid tissue: 470.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 726.6;granulocytes: 705.6;Hofbauer cells: 2318.6;Kupffer cells: 1950.8;Langerhans cells: 1526.3;Macrophages: 1971.3;monocytes: 808.9;NK-cells: 1037.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	11	"basophil: 1987.3;classical monocyte: 3240.2;intermediate monocyte: 5333.6;myeloid DC: 2386.3;neutrophil: 1831.0;NK-cell: 1750.9;non-classical monocyte: 6984.5;plasmacytoid DC: 3315.6"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 77.8;HMC-1: 301.7;THP-1: 276.1;U-266/84: 90.1;U-937: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported					NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.87e-2)"	251.7	86.5	34.0	275.6	33.8	441.6	62.9	35.5	66.0	52.5	47.5	82.7	44.9	30.7	38.7	30.6	72.0	101.5	53.1	33.7	42.0	40.3	177.3	286.6	160.9	53.4	48.7	19.9	22.3	26.8	26.9	211.0	50.1	31.0	113.2	8.3	42.9	38.8	11.9	21.0	60.6	160.3	41.5	470.1	39.4	14.5	49.9	62.7	25.5	34.6	82.5	254.6	21.7	65.4	0.2	0.0	0.7	1.3	1.8	0.7	0.4	0.5	0.2	0.5	0.8	2.2	0.1	0.5	0.7	0.0	0.3	0.2	0.5	0.0	0.4	0.3	1.5	77.8	0.6	14.0	0.3	16.1	301.7	6.0	3.3	2.3	0.2	0.7	0.4	1.8	0.1	7.3	2.4	0.5	1.4	37.9	1.6	0.0	0.0	0.1	6.7	0.2	0.5	0.4	0.3	1.0	0.6	0.1	2.7	1.4	0.2	276.1	0.4	1.8	0.4	0.9	1.1	3.0	90.1	0.9	1.7	87.1	0.5	1987.3	3240.2	307.3	13.6	5333.6	15.9	28.2	10.6	10.6	2386.3	9.0	17.3	45.0	1831.0	1750.9	6984.5	3315.6	21.8	4265.5	34.0	33.8	35.5	66.0	33.7	42.0	53.4	48.7	50.1	41.5	49.9	65.4	12.8	86.6	147.7	0.7	35.9	39.6	1.5	0.2	1.8	0.1	5.2	22.1	6.8	15.7	27.3	18.4	0.0	14.5	726.6	1.0	0.0	1.9	3.0	1.0	0.9	38.6	1.8	79.3	0.1	1.0	18.8	18.3	1.1	1.0	705.6	0.5	41.0	13.6	2318.6	0.0	0.2	0.5	0.0	1950.8	1526.3	9.4	5.3	1971.3	80.0	12.2	808.9	0.2	1037.1	0.0	0.1	1.0	1.4	1.2	10.1	1.3	0.4	5.4	15.3	2.3	72.3	3.8	11.2	1.0	2.5	1.4	35.9	23.7	133.3	0.4	0.6	1.8
FCGR1A	"CD64, CD64A"	ENSG00000150337	"Fc fragment of IgG receptor Ia"	P12314	1	149782671-149791675	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.3;lymphoid tissue: 41.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 283.3;Kupffer cells: 140.9;Late spermatids: 64.9;Macrophages: 94.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 131.5;intermediate monocyte: 54.7;myeloid DC: 35.6;neutrophil: 93.4"	"Group enriched"	"Detected in many"	53	"dendritic cells: 35.6;granulocytes: 93.4;monocytes: 131.5"	"Cell line enriched"	"Detected in some"	5	"THP-1: 191.6"					"Low region specificity"	"Detected in all"			HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (4.83e-8)"	"unprognostic (1.28e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.03e-2)"	12.2	7.2	8.4	41.3	8.9	17.9	3.6	8.8	12.8	4.2	8.4	2.3	1.1	1.6	93.3	1.7	1.8	8.2	2.2	8.6	9.4	2.8	4.2	28.6	14.4	14.6	10.6	2.3	4.3	2.7	2.5	32.6	13.0	1.6	2.1	2.3	1.9	2.4	0.3	0.4	1.3	19.1	13.2	12.5	2.1	3.7	12.2	1.4	1.4	0.8	0.8	14.7	0.8	18.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	13.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.3	191.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.4	0.0	2.0	131.5	1.6	0.0	54.7	0.7	1.6	0.0	0.3	35.6	0.0	0.0	0.1	93.4	0.0	11.8	0.9	0.3	48.5	8.4	8.9	8.8	12.8	8.6	9.4	14.6	10.6	13.0	13.2	12.2	18.9	0.3	0.0	3.1	0.0	0.8	0.1	0.0	0.0	0.6	1.5	0.2	0.8	1.7	1.5	1.3	0.0	2.1	2.7	0.0	0.0	0.0	0.0	30.8	0.1	0.1	9.3	0.0	2.7	0.1	0.0	1.3	1.0	0.0	0.1	0.0	0.2	1.8	0.5	283.3	0.0	0.1	0.0	0.0	140.9	6.0	64.9	0.3	94.9	0.0	7.5	34.7	0.3	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.7	1.3	6.6	0.2	0.3	0.6	0.4	0.1	0.0	4.1	0.6	0.1	0.1	0.0
FCGR1B	CD64b	ENSG00000198019	"Fc fragment of IgG receptor Ib"	Q92637	1	121087345-121097161	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 51.5;lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 86.5;Kupffer cells: 51.5;Late spermatids: 14.6;Macrophages: 36.6;monocytes: 16.4;Sertoli cells: 19.7"	"Cancer enriched"	"Detected in single"	4	"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 31.2;neutrophil: 36.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 36.3;monocytes: 31.2"	"Group enriched"	"Detected in some"	6	"NB-4: 19.8;THP-1: 73.9"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (3.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.24e-10)"	"unprognostic (8.99e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.93e-2)"	5.0	3.0	4.4	18.9	4.5	6.6	1.8	4.5	7.8	1.0	3.7	0.7	0.5	0.7	51.5	0.7	0.8	1.9	1.1	4.6	4.7	1.4	1.7	6.8	2.2	6.1	5.7	0.6	2.6	0.7	1.0	11.0	6.2	0.8	0.8	0.8	0.9	0.6	0.4	0.2	0.7	5.8	6.0	7.2	0.9	0.7	6.2	0.4	2.1	0.1	0.3	4.0	0.4	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.9	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	19.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.3	1.0	73.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	31.2	0.6	0.0	19.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	36.3	0.0	12.4	0.3	0.0	8.8	4.4	4.5	4.5	7.8	4.6	4.7	6.1	5.7	6.2	6.0	6.2	6.4	0.4	0.0	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.1	0.6	2.2	0.0	0.6	0.0	2.1	0.8	0.1	0.1	0.0	0.0	7.7	0.2	0.2	2.0	0.0	0.8	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.4	0.4	0.3	86.5	3.3	0.1	0.0	0.0	51.5	4.1	14.6	1.2	36.6	0.0	11.2	16.4	0.1	1.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.4	19.7	0.6	0.1	0.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.1
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 178.2;Kupffer cells: 159.1;Langerhans cells: 336.6;Macrophages: 305.0;monocytes: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cell line enhanced"	"Detected in some"		"HEL: 29.4;HMC-1: 56.2;K-562: 17.9;NB-4: 15.8;THP-1: 61.9;U-937: 26.7"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	68.0	24.8	7.3	101.7	6.6	48.6	13.3	8.0	12.1	18.1	13.9	16.0	8.1	7.3	4.3	11.7	14.6	36.8	11.5	6.5	11.5	12.7	12.3	77.5	16.1	15.1	11.4	7.2	12.7	8.5	7.6	107.3	13.3	6.1	21.0	2.3	9.9	9.6	2.6	3.5	10.8	40.9	11.9	61.8	10.1	4.4	13.8	9.8	6.4	10.2	7.7	68.3	5.2	21.8	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	29.4	0.3	0.0	0.7	8.6	56.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	17.9	0.5	0.0	0.0	0.4	15.8	0.0	0.0	1.1	0.2	1.2	8.1	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	61.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.4	26.7	6.6	2.4	358.3	421.8	0.7	268.4	1.0	3.2	0.5	0.4	89.9	1.7	0.4	0.7	2322.4	0.4	232.7	3.8	0.9	170.3	7.3	6.6	8.0	12.1	6.5	11.5	15.1	11.4	13.3	11.9	13.8	21.8	2.3	22.4	49.1	0.0	8.6	8.7	0.9	0.3	1.2	0.4	1.1	3.8	1.8	2.8	12.1	0.0	0.0	1.0	3.4	0.1	9.8	0.2	38.2	0.1	0.8	15.6	0.0	3.0	0.1	0.6	1.6	8.9	1.1	0.1	30.4	0.1	3.9	2.1	178.2	0.0	0.1	0.0	0.0	159.1	336.6	66.5	1.5	305.0	17.8	12.2	97.3	0.5	7.2	1.0	0.6	0.5	0.0	0.0	4.6	0.3	0.0	9.6	3.7	0.2	6.6	1.5	6.0	0.4	0.6	0.8	7.7	1.6	4.8	0.2	0.1	0.4
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 206.3;lymphoid tissue: 306.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 333.4;Hofbauer cells: 193.1;Kupffer cells: 807.9;Macrophages: 300.0;NK-cells: 579.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"intermediate monocyte: 1763.5;neutrophil: 1169.8;non-classical monocyte: 3948.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 1169.8;monocytes: 3948.7"	"Not detected"	"Not detected"											"CAB032435, HPA055431"	Supported				"Secreted to blood"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	52.9	41.9	18.4	99.8	20.4	27.3	14.7	19.3	27.2	8.2	26.5	12.5	5.8	5.9	5.9	4.9	9.1	24.5	22.3	16.9	22.0	7.9	111.5	206.3	37.1	37.7	27.9	6.6	7.8	13.6	11.3	71.0	30.6	6.9	12.6	6.9	14.7	7.6	3.3	2.2	5.7	68.4	31.7	306.8	6.8	7.7	28.8	9.3	7.0	4.3	3.9	32.5	3.5	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.5	26.2	9.6	513.6	1763.5	4.9	3.7	4.7	205.9	175.8	1.4	3.0	184.0	1169.8	136.2	3948.7	4.6	2.6	734.1	18.4	20.4	19.3	27.2	16.9	22.0	37.7	27.9	30.6	31.7	28.8	39.8	2.7	22.4	24.6	0.7	6.5	0.5	0.1	0.0	0.0	0.2	1.4	3.4	0.7	8.6	10.5	3.7	2.1	1.2	333.4	0.0	0.0	0.2	1.4	0.1	0.0	18.9	0.0	16.4	0.0	0.0	1.4	3.9	0.0	0.1	18.9	0.1	8.6	5.3	193.1	0.0	0.1	0.1	0.0	807.9	7.4	3.7	0.3	300.0	0.0	20.6	77.2	0.1	579.9	0.0	0.1	0.0	0.0	0.0	22.1	0.0	0.0	0.8	5.8	1.5	19.7	1.1	0.4	0.0	0.5	0.2	0.0	2.1	88.0	0.0	0.0	0.3
FCHO1	KIAA0290	ENSG00000130475	"FCH and mu domain containing endocytic adaptor 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	1.8	24.9	14.7	33.7	20.2	1.5	21.7	32.6	1.0	8.6	2.5	3.2	1.3	1.4	1.1	1.5	4.2	0.8	24.1	25.6	1.4	2.2	3.7	24.3	27.5	28.6	1.7	0.7	1.1	3.9	1.1	29.7	1.0	2.2	3.4	1.3	0.8	0.6	22.2	8.1	1.7	19.9	15.5	3.4	4.4	29.2	17.6	1.0	0.8	17.4	3.0	1.0	59.5	0.9	11.9	7.5	5.2	0.2	0.2	7.5	1.1	0.3	0.3	0.5	1.5	1.4	62.4	17.1	0.5	1.4	2.3	3.7	2.3	0.2	27.6	2.1	4.9	1.4	6.4	0.6	15.7	10.2	0.1	0.3	0.0	0.4	0.4	1.6	30.2	24.9	28.9	0.0	17.4	36.2	27.8	3.6	14.7	28.7	30.2	0.2	43.3	0.2	1.2	1.3	2.5	0.3	5.9	0.9	0.9	6.0	15.4	1.3	0.1	4.1	0.9	0.4	18.2	9.0	33.4	0.9	38.5	0.5	13.2	9.6	10.1	7.0	14.3	6.0	12.4	7.9	6.3	14.5	12.3	7.4	6.1	37.8	6.4	11.5	15.3	7.6	7.4	24.9	33.7	21.7	32.6	24.1	25.6	27.5	28.6	29.7	19.9	29.2	59.5	0.4	0.0	1.5	0.7	16.8	0.0	0.4	0.2	0.6	7.8	2.0	4.3	0.9	2.8	0.4	1.8	0.0	2.9	19.1	2.0	0.0	0.5	1.5	0.8	0.2	2.4	1.2	2.5	15.0	0.0	4.6	2.5	1.5	1.0	9.5	2.9	2.5	0.0	6.8	0.0	13.0	1.7	0.0	8.7	14.3	0.7	2.5	11.0	1.8	6.5	12.3	0.1	13.4	3.0	46.9	2.1	0.5	8.6	4.5	0.3	0.1	0.1	0.7	0.8	0.0	0.2	0.6	0.9	5.5	0.2	0.6	0.8	9.8	12.2	1.8	0.3
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700769	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 49.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 54.3;dendritic cells: 21.2;Early spermatids: 8.0;Late spermatids: 9.1;NK-cells: 30.9;T-cells: 12.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 35.3"	"Group enriched"	"Detected in many"	54	"B-cells: 35.3;NK-cells: 20.4;T-cells: 19.0"	"Cell line enriched"	"Detected in some"	7	"Daudi: 9.9"					"Low region specificity"	"Detected in some"			HPA048022	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA048022: AB_2732541"	"unprognostic (6.73e-3)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.74e-5)"	"unprognostic (1.09e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.46e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.69e-2)"	0.4	0.0	0.0	14.1	0.0	1.1	0.1	0.0	0.0	0.1	0.0	1.1	0.3	0.2	0.1	0.1	0.1	1.0	0.2	0.0	0.0	0.2	0.8	0.9	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.2	0.0	0.8	0.0	0.1	0.0	8.7	0.1	0.0	27.5	1.5	0.2	0.0	4.6	0.4	0.1	36.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	19.0	0.0	1.8	30.3	2.6	13.2	0.0	35.3	0.2	8.3	0.4	20.4	0.0	0.0	11.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	54.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	8.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.0	1.2	0.0	9.1	0.0	0.4	0.0	1.0	0.9	0.0	30.9	0.5	0.0	0.0	1.1	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 234.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 47.2"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	3600000000		"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.6	0.0	0.1	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.4	234.6	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.8	0.0	2.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.9	0.0	5.3	0.2	0.2	0.1	0.0	2.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.7	47.2	0.0	0.0	0.0	0.2	0.0	2.9	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0
FGD2	ZFYVE4	ENSG00000146192	"FYVE, RhoGEF and PH domain containing 2"	Q7Z6J4	6	37005646-37029069	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;dendritic cells: 29.7;Kupffer cells: 118.2;Langerhans cells: 49.3;Macrophages: 52.0;Microglial cells: 43.1;monocytes: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 22.3;intermediate monocyte: 64.8;memory B-cell: 23.2;myeloid DC: 35.0;naive B-cell: 18.6;non-classical monocyte: 70.5;plasmacytoid DC: 27.4"	"Group enriched"	"Detected in many"	18	"B-cells: 23.2;dendritic cells: 35.0;monocytes: 70.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;Daudi: 11.5;HDLM-2: 11.3;U-698: 9.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029145, HPA049692"	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA029145: AB_10601321, HPA049692: AB_2680852"	"unprognostic (3.54e-2)"	"unprognostic (1.40e-4)"	"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.10e-2)"	6.1	3.3	1.0	14.8	1.3	6.0	2.6	1.2	1.3	1.5	2.3	3.4	3.7	1.3	1.5	2.4	2.8	4.1	1.6	1.0	1.6	1.4	2.5	8.0	22.5	3.2	1.7	1.0	1.3	0.3	1.1	2.7	1.9	1.5	2.7	0.1	2.3	1.8	0.6	2.1	11.1	4.7	2.1	39.7	3.8	0.6	2.1	5.5	2.7	0.9	9.8	4.5	1.6	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	22.3	2.3	0.1	64.8	0.1	23.2	0.0	0.0	35.0	18.6	0.0	0.0	0.3	0.4	70.5	27.4	0.1	7.5	1.0	1.3	1.2	1.3	1.0	1.6	3.2	1.7	1.9	2.1	2.1	2.0	0.3	6.4	7.4	0.0	53.7	2.0	3.0	1.0	0.6	0.3	0.7	0.6	3.2	2.8	0.5	0.0	0.0	0.3	29.7	0.3	0.0	2.8	11.9	0.5	0.2	1.2	0.0	1.3	0.1	0.9	0.4	1.0	1.5	1.2	7.6	0.0	2.5	0.6	17.7	0.0	0.2	0.1	4.1	118.2	49.3	2.1	1.5	52.0	1.8	43.1	51.8	0.4	2.1	0.5	0.2	1.0	3.9	0.0	14.2	1.6	0.1	0.2	3.2	0.2	0.0	2.3	0.5	0.0	0.1	3.3	2.3	0.4	3.0	0.1	0.4	5.6
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 295.2;choroid plexus: 125.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.1;Cardiomyocytes: 62.4;Muller glia cells: 69.4;Oligodendrocytes: 119.8"	"Cancer enriched"	"Detected in many"	12	"glioma: 33.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.6;BJ hTERT+: 33.0;BJ hTERT+ SV40 Large T+: 35.9;BJ hTERT+ SV40 Large T+ RasG12V: 45.0;HBF TERT88: 64.3;hTEC/SVTERT24-B: 45.4;LHCN-M2: 30.6;U-2 OS: 33.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (1.25e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (2.59e-5)"	"unprognostic (3.72e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (3.45e-5)"	"unprognostic (3.01e-4)"	17.9	3.3	206.3	1.6	259.3	1.1	12.5	213.9	295.2	1.3	125.8	2.4	1.0	3.1	7.9	2.0	1.7	2.5	50.2	183.5	245.5	66.5	1.7	2.8	1.2	236.2	237.7	0.9	0.8	4.3	6.5	2.1	259.9	1.8	1.3	18.8	7.3	2.3	2.2	1.7	1.2	2.5	225.4	6.9	0.8	2.0	244.3	1.5	5.6	7.8	2.0	1.2	1.0	272.8	5.6	0.3	0.3	1.5	1.1	3.3	1.8	44.6	33.0	35.9	45.0	0.2	0.2	1.3	3.1	15.4	2.1	0.7	0.0	3.5	64.3	0.2	0.0	0.0	0.8	0.4	0.6	0.0	0.4	1.6	1.1	45.4	2.7	9.7	0.0	0.2	0.0	1.6	30.6	0.7	0.1	0.9	1.4	0.1	1.4	0.2	1.5	0.6	1.5	0.2	1.1	2.3	0.1	0.9	0.6	8.0	0.0	0.2	1.1	5.8	33.0	0.8	21.3	0.8	0.4	0.3	8.2	0.3	1.6	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.3	0.0	0.1	0.2	0.1	0.0	206.3	259.3	213.9	295.2	183.5	245.5	236.2	237.7	259.9	225.4	244.3	272.8	1.4	0.0	0.0	75.1	0.1	0.4	5.0	5.7	7.4	3.5	1.2	25.4	62.4	0.0	2.1	20.2	16.7	1.1	0.1	0.0	0.0	1.1	0.4	0.0	0.7	4.8	0.0	0.0	13.0	0.0	0.5	4.7	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	14.6	0.0	12.2	0.0	0.0	1.4	0.0	0.2	3.6	29.0	0.0	69.4	0.0	15.1	119.8	0.6	0.0	0.4	0.0	5.3	0.0	0.3	0.1	11.6	6.6	0.5	23.4	0.1	0.1	0.6	0.0	0.8	0.4	0.0	0.0	0.7
FGF10		ENSG00000070193	"Fibroblast growth factor 10"	O15520	5	44300247-44389706	"Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Disease variant, Ectodermal dysplasia, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 21.6;Fibroblasts: 14.6;Leydig cells: 8.4;Muller glia cells: 4.3;Peritubular cells: 10.5"	"Cancer enriched"	"Detected in some"	6	"breast cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"AF22: 27.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB010315	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB010315: AB_2262731"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.20e-1)"		"unprognostic (3.54e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.73e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.23e-4)"	13.9	1.6	0.3	2.6	0.9	0.0	15.2	0.5	0.7	14.6	1.1	7.0	0.4	2.4	4.4	1.4	8.5	2.8	0.7	0.6	0.7	0.7	0.1	2.6	0.6	1.3	1.9	17.3	4.8	0.0	2.1	5.5	1.1	4.6	1.5	0.3	5.4	3.0	0.7	0.9	2.9	1.3	1.6	0.0	4.3	0.8	1.7	1.1	5.3	3.8	0.2	5.0	12.0	0.4	0.0	0.0	27.9	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.5	0.7	0.6	0.7	1.3	1.9	1.1	1.6	1.7	0.4	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	21.6	0.9	0.0	0.0	3.0	0.5	0.0	14.6	0.0	0.3	0.0	1.6	0.4	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.5	8.4	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.3	0.0	10.5	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Human disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.7;gallbladder: 3.4"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 9.4;Microglial cells: 1.9;Proximal tubular cells: 4.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 11.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.1;BJ hTERT+: 120.0;fHDF/TERT166: 88.0;HBF TERT88: 88.0;LHCN-M2: 81.1;U-138 MG: 109.5;U-251 MG: 55.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: AB_2678001"	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.0	0.0	0.2	0.6	0.0	0.1	0.0	11.7	1.2	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	3.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	2.7	0.2	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	1.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.1	6.1	21.8	0.0	64.1	120.0	16.5	12.2	0.0	0.1	0.0	0.0	88.0	1.2	0.1	0.1	22.5	88.0	0.0	1.1	0.2	0.1	0.0	1.7	0.6	0.0	6.3	0.0	48.6	23.0	27.9	5.7	0.0	0.0	0.2	81.1	0.0	0.1	0.3	0.1	0.0	2.1	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.8	0.0	0.0	0.2	20.9	109.5	4.6	5.4	55.0	0.0	0.0	0.1	6.3	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.7	1.2	0.6	0.0	2.7	0.2	3.0	0.0	0.5	0.5	0.0	0.0	1.1	0.3	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.6	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38400215-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 176.7;Leydig cells: 192.0;Oligodendrocyte precursor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 508.7;BJ hTERT+: 278.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved					NA	NA		78000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"CAB033614: AB_783377, HPA056402: AB_2683118"	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	95.1	12.8	27.5	15.9	24.6	14.1	87.1	48.8	22.4	79.8	37.2	97.2	8.8	74.2	15.8	35.8	85.9	57.1	89.9	30.9	28.8	40.1	9.1	55.7	16.6	35.9	37.3	108.2	98.6	20.4	57.1	51.3	63.7	60.5	17.9	15.8	31.4	53.6	24.8	35.6	41.7	57.1	30.3	9.9	40.4	20.4	33.4	17.1	33.7	23.3	16.1	79.3	63.9	29.6	12.9	42.0	198.0	508.7	120.1	91.2	142.9	136.7	278.8	90.0	95.8	27.3	6.5	1.8	38.3	127.7	103.9	0.2	90.0	6.8	104.3	39.2	24.1	0.0	7.7	27.8	69.7	31.1	0.6	80.5	0.7	70.9	13.3	45.6	86.9	6.0	11.9	0.4	40.5	12.5	91.5	9.2	145.9	1.6	21.6	86.3	21.1	0.4	35.6	0.3	7.9	19.4	23.4	1.0	5.1	93.4	9.3	5.4	51.4	49.2	28.9	149.6	29.7	2.4	4.1	0.5	60.3	1.7	27.1	0.2	0.3	0.1	1.7	0.1	1.1	0.3	0.7	1.2	0.0	0.6	0.5	1.5	0.6	0.4	0.2	0.2	1.0	0.1	27.5	24.6	48.8	22.4	30.9	28.8	35.9	37.3	63.7	30.3	33.4	29.6	101.0	3.2	15.8	55.8	1.8	31.5	95.9	1.1	37.0	4.4	28.7	77.7	52.5	24.3	5.1	9.2	4.2	8.3	6.3	0.4	0.0	27.3	15.3	48.2	40.6	75.5	25.0	3.6	25.4	65.2	80.5	176.7	3.1	75.3	8.2	40.4	47.5	0.8	25.3	21.9	21.1	0.6	4.1	5.6	75.2	15.0	192.0	11.7	33.8	19.7	1.7	88.1	6.2	166.4	14.2	21.6	0.3	99.6	6.4	94.7	0.1	7.9	1.0	3.3	13.1	118.9	59.9	1.6	14.1	4.8	19.7	10.4	14.1	2.1	0.7	11.7
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 53.8;skeletal muscle: 35.8;tongue: 48.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	6.8	1.5	1.5	2.9	1.8	0.2	2.4	0.1	2.5	1.8	0.7	11.7	1.8	8.5	0.9	9.5	4.8	5.7	53.8	4.1	0.5	1.8	3.2	7.6	1.2	0.2	0.5	1.3	1.4	12.4	1.4	5.1	0.3	3.9	3.3	0.4	1.2	3.4	35.8	0.6	2.6	13.2	0.5	0.3	3.2	2.1	0.8	1.1	2.3	48.9	0.9	10.9	1.6	1.5	0.0	1.3	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.7	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	1.5	1.8	0.1	2.5	4.1	0.5	0.2	0.5	0.3	0.5	0.8	1.5	82.1	128.2	82.6	5.9	0.5	0.6	0.5	2.8	0.0	3.5	0.5	0.8	582.5	0.0	9.1	0.0	0.0	0.8	0.5	0.1	1.9	0.1	54.2	18.2	1.7	45.9	0.0	2.7	9.7	0.4	0.3	60.3	0.0	19.2	1.3	1.7	72.1	0.7	1.3	0.0	12.8	0.1	8.2	1.9	1.2	17.6	2.5	1.8	1.8	5.6	0.0	2.5	1.0	6.0	10.0	0.0	0.0	4.5	0.0	0.8	0.4	0.1	62.4	3.5	92.1	70.2	114.2	7.1	7.9	0.7	0.9	0.8	1.8	11.9	0.1	0.4
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 210.1;Early spermatids: 376.7;Sertoli cells: 256.4;Skeletal myocytes: 184.2;Smooth muscle cells: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.1;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 84.2;HDLM-2: 79.9;TIME: 145.8"	"Region enriched"	"Detected in many"	7	"olfactory bulb: 18.0"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	77.1	21.7	4.9	52.4	6.3	0.8	32.6	4.8	6.6	63.8	4.0	57.7	28.4	117.6	23.8	56.0	31.2	90.9	54.8	6.2	4.4	24.0	28.1	30.7	30.1	9.6	4.2	76.4	35.5	17.5	3.9	43.9	9.7	67.9	29.8	4.7	9.3	54.3	140.4	16.8	41.2	151.7	3.7	42.9	46.7	22.0	3.6	11.9	20.1	161.5	22.3	101.5	21.9	4.0	59.0	0.0	22.3	0.1	35.8	30.2	2.0	29.4	58.8	50.2	56.5	17.8	0.2	0.2	5.0	84.2	13.2	7.1	0.0	14.4	59.0	79.9	0.6	4.8	0.2	23.3	17.8	1.4	0.0	24.2	5.1	5.6	0.0	32.0	22.8	0.0	3.8	0.5	7.7	0.1	5.2	1.2	1.3	3.1	0.0	0.1	26.1	0.7	33.5	1.0	2.0	3.7	0.4	0.4	0.1	11.7	0.0	10.5	145.8	8.8	0.2	1.9	15.5	4.2	0.2	0.3	6.5	0.4	0.0	0.2	0.4	0.0	0.1	1.0	0.0	0.6	0.1	0.1	2.1	0.6	0.0	0.1	0.2	0.4	2.9	0.4	0.1	0.3	4.9	6.3	4.8	6.6	6.2	4.4	9.6	4.2	9.7	3.7	3.6	4.0	92.9	16.0	23.1	9.4	4.1	27.8	56.7	7.9	2.2	11.8	12.3	6.5	145.7	35.8	2.3	5.5	8.4	1.1	1.8	2.1	1.9	210.1	376.7	2.3	60.5	77.2	3.0	0.0	42.0	109.3	0.7	145.2	21.9	2.4	34.8	16.3	41.0	0.7	3.2	106.0	25.8	5.7	6.1	36.3	98.9	180.2	83.0	86.1	17.8	25.3	17.7	0.9	0.0	22.1	21.6	43.7	0.2	104.2	3.0	5.1	5.4	2.6	1.9	6.0	256.4	184.2	351.9	40.1	2.5	1.5	22.7	3.1	8.8	41.8	3.2	3.5
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FKBP prolyl isomerase 1A"	P62942	20	1368977-1393164	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 977.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 675.2;granulocytes: 974.2;monocytes: 1013.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 1749.2;TIME: 1929.6"									"CAB004639, HPA051798"	Uncertain					NA	NA		12000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	272.7	185.0	138.4	178.8	177.5	167.0	188.2	88.5	163.2	123.0	112.6	158.6	108.9	165.4	150.1	169.8	131.7	104.5	171.4	166.7	115.8	186.7	98.1	235.2	162.7	92.4	98.9	135.1	114.6	123.0	79.5	218.7	95.6	125.4	188.5	11.8	111.0	119.8	110.3	127.3	117.0	225.1	97.8	185.7	118.3	56.9	120.5	188.1	190.9	150.6	202.2	206.8	126.2	118.9	718.1	299.5	172.9	240.3	654.1	771.3	202.9	423.9	337.1	382.7	354.2	278.4	295.2	272.5	149.3	555.7	656.3	337.7	255.1	1007.2	419.7	68.8	170.5	284.2	113.9	473.3	406.4	390.5	168.0	484.7	332.0	410.3	412.6	513.3	1749.2	401.0	271.0	145.8	443.3	125.8	401.9	453.7	307.1	335.3	276.4	307.0	254.1	351.9	540.0	243.4	248.7	173.8	208.0	479.3	728.8	231.8	177.2	293.0	1929.6	1363.6	201.8	278.1	329.5	76.4	168.1	292.9	248.1	332.3	307.5	316.3	870.8	974.2	112.9	1005.8	104.3	128.1	135.5	133.2	675.2	136.2	140.1	132.6	805.0	160.6	1013.4	312.7	195.0	1153.8	138.4	177.5	88.5	163.2	166.7	115.8	92.4	98.9	95.6	97.8	120.5	118.9	779.1	86.6	77.2	0.0	160.6	263.1	211.2	393.3	152.0	17.6	175.6	156.5	59.7	170.1	179.5	172.9	0.0	281.8	148.3	456.2	238.7	432.4	47.7	98.7	183.8	814.8	330.6	196.4	0.0	337.5	702.0	212.2	160.0	122.5	143.5	95.3	623.6	113.5	746.7	35.3	0.0	245.9	329.6	541.8	436.5	52.2	200.0	428.8	241.9	0.0	527.4	52.2	152.4	0.0	0.0	483.6	977.5	162.9	214.8	221.1	210.8	332.1	123.0	11.7	138.1	87.4	224.7	169.3	141.8	329.4	299.3	231.5	150.1	347.3	318.0	245.7
FKBP7	FKBP23	ENSG00000079150	"FKBP prolyl isomerase 7"	Q9Y680	2	178463664-178478600	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.1;Endometrial stromal cells: 54.8;Fibroblasts: 67.6;Leydig cells: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 155.0;ASC TERT1: 96.7;fHDF/TERT166: 60.9;HSkMC: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008707	Approved	Supported	Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA008707: AB_1848624"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (4.61e-6)"	"unprognostic (3.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.10e-1)"	9.3	5.4	1.5	3.9	1.6	1.4	11.9	2.6	2.8	23.1	1.5	8.3	2.8	27.8	11.3	5.9	15.1	15.4	12.3	1.6	1.8	5.2	8.3	7.8	2.9	1.6	1.5	50.0	2.8	2.7	5.0	13.0	1.5	9.3	6.2	2.1	5.0	13.3	3.8	4.2	4.4	19.2	1.2	3.0	5.4	4.4	1.5	2.5	6.6	6.5	2.8	11.6	10.2	2.1	0.2	1.9	18.5	27.8	155.0	96.7	1.7	33.3	55.0	5.9	19.0	0.3	1.9	5.4	7.3	60.9	5.5	0.3	7.1	2.8	10.3	4.5	3.9	5.7	7.3	5.5	23.7	3.5	3.8	64.7	1.4	24.0	3.4	44.2	19.8	6.6	2.5	3.4	25.2	0.3	6.1	6.0	3.6	3.5	2.9	7.8	31.9	7.7	8.4	0.6	9.7	32.0	7.0	0.2	6.2	12.7	0.5	6.8	18.2	11.0	6.8	12.8	3.2	6.3	7.2	2.6	19.9	8.7	24.3	0.0	0.4	0.0	1.0	0.7	1.2	1.1	0.9	0.7	2.6	0.7	0.9	1.0	0.0	0.6	0.0	2.1	1.1	0.4	1.5	1.6	2.6	2.8	1.6	1.8	1.6	1.5	1.5	1.2	1.5	2.1	16.2	6.4	4.1	2.9	5.4	7.0	9.3	19.6	7.4	4.2	6.7	13.6	16.1	2.8	5.2	7.3	0.0	7.6	2.7	0.7	1.9	10.9	149.1	3.4	54.8	19.3	1.2	4.2	1.6	8.4	22.4	67.6	4.1	3.5	14.0	19.0	15.7	11.9	5.8	5.0	3.7	5.6	14.2	4.4	13.6	27.1	64.0	3.8	17.8	4.7	1.6	4.2	1.0	7.1	4.2	3.9	0.7	48.5	10.3	3.4	0.4	3.7	2.1	3.6	6.6	31.1	37.7	8.5	5.1	3.7	5.8	5.1	5.5	30.4	3.1	4.1
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FKBP prolyl isomerase 9"	O95302	7	32957404-33006930	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 108.6;Fibroblasts: 89.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 379.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"	No	No		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: AB_2682761"	"unprognostic (1.23e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavorable (5.80e-4)"	"prognostic unfavorable (2.02e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavorable (7.02e-6)"	80.7	44.8	23.9	16.8	24.0	2.3	59.1	26.5	25.3	65.9	28.1	44.8	19.7	55.7	22.4	35.6	50.6	44.4	77.1	21.4	32.1	38.2	21.1	49.6	13.6	28.9	30.2	46.3	40.8	25.1	34.8	77.4	29.3	42.3	45.3	11.7	36.0	52.1	35.0	64.4	31.0	74.4	28.0	23.7	41.0	11.4	34.2	8.2	40.8	49.7	15.8	43.3	52.2	27.9	38.9	71.4	27.6	113.4	254.1	290.2	36.4	202.6	209.9	65.5	103.9	31.6	89.2	0.2	80.7	379.5	105.1	73.3	40.8	100.0	75.2	0.1	11.9	6.6	72.3	31.6	105.6	0.4	10.8	191.8	59.6	59.0	56.9	156.3	83.9	0.1	15.0	7.7	137.3	37.1	0.2	19.4	5.8	76.6	37.3	0.3	73.7	0.3	73.0	13.0	25.7	62.4	115.6	58.4	73.4	69.6	41.1	18.7	112.8	107.0	99.8	67.4	46.8	23.9	48.9	0.2	104.4	0.3	218.5	0.9	2.2	0.5	0.0	1.6	0.0	0.2	0.0	0.0	0.8	0.1	0.1	0.0	4.0	0.1	0.4	0.1	0.0	0.6	23.9	24.0	26.5	25.3	21.4	32.1	28.9	30.2	29.3	28.0	34.2	27.9	108.6	12.8	21.7	22.9	0.6	34.3	12.7	31.4	10.2	8.2	15.7	16.5	46.1	17.2	10.3	18.4	10.4	18.8	0.6	23.2	5.9	19.5	0.5	22.6	25.8	80.1	12.2	1.7	9.8	41.5	27.7	89.1	17.9	23.0	5.7	81.0	60.0	18.0	7.6	11.8	10.2	25.4	10.2	8.6	23.5	3.2	36.7	5.4	60.5	15.0	2.9	30.5	0.0	8.5	8.8	36.5	22.1	55.3	4.4	8.1	18.8	8.1	11.0	5.2	46.0	21.2	45.8	1.0	1.3	12.1	28.6	13.1	3.1	12.3	27.7	10.5
FLRT1	"MGC21624, SPG68"	ENSG00000126500	"Fibronectin leucine rich transmembrane protein 1"		11	64103188-64119173	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 8.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.1;Excitatory neurons: 8.8;Inhibitory neurons: 16.1;Muller glia cells: 6.2;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 13.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.0;SCLC-21H: 5.4;SH-SY5Y: 13.5;THP-1: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054589	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA054589: AB_2682533"	"unprognostic (5.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.64e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.37e-2)"	0.3	4.4	7.0	0.3	8.4	0.0	0.4	1.6	6.8	2.9	0.0	3.9	0.5	1.5	0.0	0.8	0.6	0.5	1.2	7.1	3.0	2.5	0.9	0.2	0.0	1.5	4.3	0.5	1.0	0.0	1.2	0.1	0.6	1.2	0.3	1.6	0.7	0.9	0.2	1.0	0.9	0.5	1.6	0.3	1.1	0.3	8.5	0.0	2.2	0.1	0.0	0.7	1.1	7.4	0.4	0.7	2.7	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.4	0.0	1.1	0.6	3.7	0.0	0.0	0.7	0.2	0.0	0.9	0.1	0.0	2.1	0.3	4.0	0.0	0.5	0.1	0.6	1.2	0.1	0.2	0.8	0.2	0.1	0.0	0.3	5.4	13.5	0.3	0.3	0.4	0.0	0.4	11.3	0.1	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.2	3.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	8.4	1.6	6.8	7.1	3.0	1.5	4.3	0.6	1.6	8.5	7.4	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	6.2	0.0	32.2	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FLT4	"PCL, VEGFR-3, VEGFR3"	ENSG00000037280	"Fms related receptor tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 27.4;Endothelial cells: 27.1;Extravillous trophoblasts: 37.1;Hepatic stellate cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 12.4;HEK 293: 15.6;HL-60: 9.5;HUVEC TERT2: 9.9;JURKAT: 12.3;T-47d: 14.6;TIME: 15.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	20000000	290000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	17.2	11.3	3.5	4.7	4.6	0.8	14.7	2.6	3.4	9.0	2.6	4.9	2.8	8.0	3.0	4.4	9.8	3.8	9.7	5.1	2.6	20.1	6.2	16.9	5.5	3.4	3.0	4.5	2.0	2.3	7.8	6.4	3.6	5.6	1.3	0.3	2.0	2.5	4.7	4.0	7.2	4.1	2.8	17.6	3.5	3.1	4.2	1.0	25.7	4.1	1.4	5.6	5.5	2.7	0.1	2.5	3.2	10.1	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.4	0.3	0.3	0.9	0.1	0.6	0.4	3.4	0.2	0.3	0.1	15.6	1.2	0.5	0.5	0.1	9.5	0.3	0.2	0.1	0.2	0.4	0.3	9.9	12.3	0.4	0.4	2.1	5.6	0.1	0.5	7.0	0.3	0.6	8.2	0.1	0.1	0.1	0.3	0.3	1.1	0.1	0.2	0.1	3.1	14.6	0.3	15.7	0.2	6.9	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	3.5	4.6	2.6	3.4	5.1	2.6	3.4	3.0	3.6	2.8	4.2	2.7	27.4	0.0	1.7	0.7	0.7	0.9	0.2	0.0	1.2	0.2	1.4	1.4	4.5	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	27.1	0.0	0.0	0.2	0.0	37.1	0.8	0.0	0.1	2.5	2.4	64.6	0.6	1.2	0.0	0.1	0.0	0.0	3.3	0.8	0.7	0.3	0.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.7	0.7	0.1	5.2	0.1	1.1	1.0	1.8	0.2	0.0	0.1
FMN2		ENSG00000155816	"Formin 2"	Q9NZ56	1	240014348-240475187	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, Protein transport, Stress response, Transport"	"Actin-binding, Developmental protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.0;parathyroid gland: 19.7;retina: 16.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 758.1;Excitatory neurons: 537.5;Horizontal cells: 124.5;Inhibitory neurons: 366.7;Oligodendrocyte precursor cells: 154.3"	"Group enriched"	"Detected in some"	8	"glioma: 5.9;testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 70.8;BJ hTERT+: 39.4;fHDF/TERT166: 73.8;LHCN-M2: 87.9;U-138 MG: 48.9;WM-115: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050649			Approved	"Plasma membrane,Actin filaments"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Actin filaments"		"HPA050649: AB_2681202"	"unprognostic (1.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.11e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.40e-3)"	1.2	5.1	27.6	0.2	29.6	0.0	0.5	11.8	46.0	0.4	0.0	6.8	0.2	1.4	0.9	0.7	1.9	1.2	0.1	28.4	20.9	3.6	0.0	0.3	0.0	21.2	29.7	2.4	1.0	19.7	9.0	0.2	14.4	1.6	1.6	16.7	0.3	2.6	0.1	0.2	0.9	1.7	16.0	0.2	0.7	2.2	39.0	0.0	0.5	0.2	0.1	0.3	0.3	30.9	0.0	2.1	6.6	0.0	20.2	15.3	0.0	70.8	39.4	31.0	16.3	0.0	0.0	0.0	0.0	73.8	1.2	0.0	1.3	0.0	28.8	0.0	5.8	0.0	0.7	0.0	0.1	0.0	0.0	1.7	0.0	8.5	1.9	17.0	0.0	0.0	0.0	0.0	87.9	0.0	0.0	0.1	2.3	0.0	2.2	0.0	0.2	0.0	0.0	0.0	12.0	10.6	0.0	0.1	0.3	0.2	2.1	0.1	0.3	48.9	0.2	16.0	18.2	0.0	0.0	0.0	10.4	0.0	69.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	29.6	11.8	46.0	28.4	20.9	21.2	29.7	14.4	16.0	39.0	30.9	0.0	0.0	0.0	758.1	0.0	0.1	0.0	0.0	0.0	30.6	0.2	0.3	1.6	0.0	0.0	1.8	50.1	0.1	0.0	4.7	0.0	0.0	15.2	4.3	0.7	0.5	12.1	0.0	537.5	0.0	0.1	1.4	0.0	1.1	0.0	0.8	2.9	0.1	0.1	124.5	366.7	0.5	0.0	0.6	0.6	3.0	0.3	0.1	1.8	31.9	0.0	2.3	0.0	154.3	17.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.3	1.8	4.4	0.0	0.0	0.5	0.0	3.1	1.6	0.0
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247319	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 277.6;lymphoid tissue: 104.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.1;dendritic cells: 160.0;Kupffer cells: 77.4;Langerhans cells: 141.6;Macrophages: 115.5;monocytes: 132.8;NK-cells: 152.4;Plasma cells: 109.8;T-cells: 134.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 190.8;MOLT-4: 138.4;U-266/70: 158.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavorable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	22.9	7.4	14.2	68.5	11.3	277.6	13.4	10.1	21.5	10.4	9.0	12.5	11.5	5.6	2.3	8.9	14.1	18.5	12.7	20.8	9.0	8.4	8.5	54.6	69.4	16.2	11.2	3.4	6.5	6.8	16.3	12.2	15.5	10.4	7.3	1.3	16.2	3.3	4.7	9.5	36.7	8.2	11.1	104.9	13.7	4.2	17.2	49.7	9.0	6.2	38.7	21.4	10.5	16.3	16.9	32.2	0.3	1.7	0.3	7.0	1.7	2.0	4.3	11.8	8.8	1.5	7.2	51.4	16.2	0.6	12.4	2.7	0.0	0.4	3.9	91.1	4.4	29.8	51.0	2.7	32.6	78.6	100.6	5.4	1.4	15.6	6.7	16.4	0.3	55.8	2.7	190.8	8.8	10.9	138.4	80.7	1.6	2.1	1.0	86.2	11.3	92.7	3.3	2.1	10.0	4.8	9.9	1.7	4.0	2.6	9.2	62.7	4.0	0.7	11.1	1.9	73.3	158.9	75.7	52.2	1.4	62.8	2.5	11.1	6.5	11.3	8.6	7.4	5.7	4.5	6.6	9.4	5.6	5.1	4.4	5.8	28.4	7.2	5.9	3.3	8.1	5.3	14.2	11.3	10.1	21.5	20.8	9.0	16.2	11.2	15.5	11.1	17.2	16.3	7.2	3.2	3.0	0.0	108.1	6.1	2.9	0.9	2.2	4.9	3.3	4.7	2.5	1.5	1.1	1.8	0.0	0.6	160.0	0.7	0.0	1.5	2.5	0.7	4.3	5.7	1.2	34.9	12.8	0.9	1.2	12.9	4.6	1.2	22.9	0.2	6.1	1.5	45.3	3.3	10.3	0.4	0.0	77.4	141.6	0.7	5.3	115.5	44.4	9.4	132.8	0.9	152.4	0.5	1.0	0.5	0.1	0.0	109.8	1.9	0.2	0.8	1.0	1.6	6.6	9.3	2.4	0.8	3.5	0.6	6.1	2.5	134.6	0.2	0.5	1.4
FMO1		ENSG00000010932	"Flavin containing dimethylaniline monoxygenase 1"	Q01740	1	171248471-171285978	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"kidney: 199.0"	"Group enriched"	"Detected in many"	7	"Proximal enterocytes: 97.9;Proximal tubular cells: 196.9"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HSkMC: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078132	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA078132: "	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.49e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.37e-1)"	5.1	5.6	0.1	0.5	0.1	0.0	10.0	0.1	0.3	6.3	0.3	0.4	0.1	3.1	0.1	3.5	4.2	5.2	0.7	0.1	0.1	199.0	2.9	1.5	0.4	0.1	0.1	5.0	2.4	1.1	1.8	2.3	0.1	0.4	0.2	0.0	5.4	0.7	0.1	10.4	20.2	4.2	0.1	0.0	0.9	1.6	0.1	7.4	2.3	0.8	10.8	2.5	1.7	0.1	0.0	0.0	0.0	0.0	2.7	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.0	0.0	0.0	0.3	3.0	3.2	0.5	0.0	12.5	0.0	0.5	1.1	10.0	2.8	0.0	3.7	0.0	0.3	0.0	0.0	13.7	0.0	0.7	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.1	18.7	0.0	0.0	0.0	3.2	0.0	0.3	0.4	0.0	0.1	2.9	0.0	0.0	0.0	1.5	10.8	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	2.6	0.0	0.1	97.9	196.9	0.0	0.0	6.6	0.5	4.7	0.0	0.1	1.4	2.3	0.8	1.0	2.6	1.4	0.1
FMO4	FMO2	ENSG00000076258	"Flavin containing dimethylaniline monoxygenase 4"	P31512	1	171314183-171342084	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 48.6;liver: 61.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 29.4;Hepatocytes: 22.1;Oligodendrocytes: 18.5;Proximal enterocytes: 16.5;Proximal tubular cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 5.7;HSkMC: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049100, HPA072438"	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"HPA049100: AB_2680629, HPA072438: "	"unprognostic (1.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.27e-2)"	"unprognostic (4.13e-1)"	"prognostic favorable (1.09e-4)"	"prognostic favorable (7.45e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.95e-1)"	3.7	2.6	2.2	1.9	3.1	0.9	4.1	2.8	3.0	3.3	3.1	5.0	5.4	2.7	6.3	2.3	3.5	4.9	5.2	2.1	2.6	48.6	61.3	3.2	2.9	3.1	2.8	3.8	2.4	4.7	1.9	2.3	3.3	3.1	4.8	0.7	2.0	2.2	1.0	3.4	9.2	2.0	2.6	3.1	5.0	1.7	3.1	3.6	3.2	2.1	3.3	2.4	2.9	3.5	0.1	0.1	0.3	0.4	4.1	3.4	0.2	0.8	3.7	1.1	1.2	0.6	5.3	3.7	5.7	0.1	2.0	0.2	0.7	1.0	1.6	1.6	0.8	0.0	0.0	0.0	0.6	0.7	0.8	6.6	2.4	0.4	1.0	0.4	0.2	1.7	0.2	2.3	0.5	0.7	1.6	1.3	0.4	0.9	1.2	0.4	0.4	2.1	2.6	0.0	0.1	0.0	1.2	1.0	2.4	4.1	2.2	1.0	0.1	0.9	0.3	1.0	0.7	2.9	1.0	2.2	1.8	1.1	0.8	0.2	1.0	0.3	0.9	1.6	0.7	1.2	0.8	1.3	0.9	1.8	1.2	0.9	0.1	1.7	1.1	1.2	2.1	0.8	2.2	3.1	2.8	3.0	2.1	2.6	3.1	2.8	3.3	2.6	3.1	3.5	2.2	0.0	2.6	7.2	3.2	2.8	4.6	5.0	2.8	0.0	2.3	2.0	3.7	2.8	3.7	9.2	0.0	2.8	0.6	7.1	29.4	2.3	5.7	3.8	1.7	1.4	1.2	0.0	0.1	1.4	1.2	6.6	8.2	1.7	1.3	1.5	2.9	22.1	3.7	0.0	0.1	3.2	2.0	5.9	1.3	1.3	1.5	2.7	5.4	2.8	1.6	1.8	1.0	0.0	18.5	1.1	0.7	0.4	1.1	0.9	16.5	49.5	7.3	0.0	0.0	1.8	2.1	0.3	0.5	1.9	1.6	1.9	1.7	2.0	2.8	1.8
FMOD	SLRR2E	ENSG00000122176	Fibromodulin	Q06828	1	203340628-203351758	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 26.7;Fibroblasts: 52.5;Intestinal goblet cells: 80.2;Leydig cells: 28.0;Peritubular cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.6;CACO-2: 38.6;HHSteC: 11.8;HSkMC: 22.1;OE19: 45.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 71.7"						"Secreted to extracellular matrix"	NA	NA		2600000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (1.48e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (9.40e-3)"	"unprognostic (3.58e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (2.67e-4)"	122.7	13.6	1.3	31.1	2.3	0.1	64.4	1.5	3.9	100.1	9.0	39.4	49.6	105.8	17.2	19.1	85.8	123.6	149.0	1.0	1.5	24.3	11.0	60.2	28.6	2.4	0.9	125.1	33.1	28.0	21.7	81.2	1.5	58.4	62.1	9.9	49.6	49.2	12.6	25.9	21.2	106.5	2.1	18.2	135.6	6.3	1.5	9.6	71.3	25.6	33.8	45.4	60.0	1.4	0.0	0.1	0.0	0.0	10.6	0.7	0.2	7.1	8.1	0.0	1.1	38.6	0.0	0.0	0.8	7.7	0.0	0.3	0.0	0.6	0.5	0.0	0.0	0.0	0.9	0.0	11.8	0.0	0.0	22.1	0.1	0.0	0.4	5.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.3	0.0	45.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	1.0	0.3	2.0	0.0	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.3	1.5	3.9	1.0	1.5	2.4	0.9	1.5	2.1	1.5	1.4	9.3	0.0	6.3	0.0	0.0	6.9	5.0	1.5	6.2	0.2	10.3	26.7	1.6	2.8	2.1	7.3	0.0	1.1	0.4	2.9	0.0	1.9	0.1	1.1	12.1	8.3	6.1	0.0	0.1	0.7	0.7	52.5	12.8	1.6	0.0	0.5	19.2	0.1	1.2	0.0	0.0	80.2	0.0	0.3	9.3	0.4	28.0	0.6	12.4	7.5	0.6	11.9	0.0	0.0	0.0	1.5	2.2	28.6	0.0	11.7	0.7	0.2	0.7	1.0	6.6	1.3	15.5	0.0	0.3	0.6	4.3	3.1	1.2	2.0	8.6	1.6
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735615-82751196	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 79.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 90.1;Proximal tubular cells: 167.2;Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 34.3;Hep G2: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria		NA	NA		180000		"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA059151: AB_2683931, HPA061358: AB_2684490"	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favorable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	14.4	47.3	47.4	2.9	64.3	12.0	8.4	64.4	56.6	10.4	36.8	15.5	22.4	9.4	7.0	4.6	12.5	6.9	47.5	46.5	54.3	49.6	48.1	7.8	2.4	63.3	56.8	22.3	18.1	21.9	22.4	5.3	62.7	12.5	9.5	13.8	28.5	12.1	23.5	5.3	14.5	6.6	49.4	4.6	17.4	5.2	55.6	1.0	10.2	10.9	2.3	8.8	7.9	79.8	1.3	16.1	4.4	23.2	6.9	5.7	2.9	2.9	2.2	5.4	2.7	21.0	3.3	0.2	3.9	2.6	4.5	0.6	34.3	2.5	2.0	1.0	2.4	12.5	12.9	66.2	18.8	0.3	10.1	4.9	9.0	2.1	0.0	5.7	10.6	1.0	22.4	0.6	1.1	1.8	0.2	0.2	2.9	7.6	13.0	2.1	0.3	0.1	11.5	4.5	7.0	22.7	5.3	1.2	15.8	3.8	15.4	4.5	2.5	0.4	1.6	5.6	4.3	1.2	0.3	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	64.3	64.4	56.6	46.5	54.3	63.3	56.8	62.7	49.4	55.6	79.8	3.9	3.2	2.0	8.8	1.9	1.5	3.7	1.5	14.8	41.9	4.5	3.7	5.8	4.3	2.5	31.3	47.9	11.7	2.6	5.7	90.1	3.2	0.2	11.6	3.0	5.2	5.4	49.2	10.2	1.2	2.6	8.6	47.9	25.9	1.3	6.9	4.2	5.4	8.2	32.0	13.0	10.4	6.1	1.0	3.4	0.4	5.3	5.7	12.4	5.6	1.2	36.2	1.0	6.0	17.1	1.7	7.3	3.0	9.1	3.9	28.2	167.2	2.5	72.9	0.0	6.1	9.8	0.8	4.1	12.8	1.8	8.3	3.1	18.6	9.5	3.5
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49145092-49208638	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 266.4;prostate: 76.0"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 367.6"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;RPMI-8226: 1.7;SK-BR-3: 1.8;TIME: 1.3;WM-115: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.8	1.1	17.3	0.9	37.3	0.7	4.8	27.1	27.7	1.9	7.9	0.7	266.4	1.7	0.9	1.5	3.5	10.2	0.5	18.3	22.4	13.5	35.5	1.3	0.9	32.7	28.4	1.0	0.3	0.2	0.0	0.3	31.5	76.0	0.5	4.0	52.8	0.6	0.2	1.7	82.9	1.0	24.1	2.4	1.1	0.8	31.1	0.1	1.0	0.2	0.6	1.4	0.3	59.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.2	0.7	0.0	1.8	0.3	0.2	0.3	0.0	1.3	0.1	0.9	0.2	0.1	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.3	37.3	27.1	27.7	18.3	22.4	32.7	28.4	31.5	24.1	31.1	59.3	0.5	0.0	0.6	0.0	0.0	0.3	0.7	0.1	0.6	0.0	8.2	7.0	0.3	0.0	1.9	0.0	0.0	0.0	0.5	0.0	7.9	0.0	5.2	2.1	0.5	5.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	2.8	0.0	0.0	2.9	25.9	0.1	0.0	1.0	1.1	0.0	0.3	0.0	1.4	1.5	0.2	3.6	1.0	0.0	17.4	0.0	0.0	367.6	0.0	1.2	0.4	0.0	43.0	0.8	32.4	0.1	0.6	0.0	0.0	0.4	1.1	1.5	1.5	0.9	0.0	0.2	0.5	0.2	0.6
FOLR1	"FOLR, FRα"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 480.2;fallopian tube: 187.2;lung: 193.5;salivary gland: 219.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 444.2;RPTEC TERT1: 476.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA	448000	140000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.1	1.7	2.7	0.2	1.8	0.1	28.3	11.8	1.8	123.5	480.2	0.5	0.3	1.9	7.6	3.4	187.2	2.4	0.6	14.1	4.1	153.0	0.2	193.5	0.0	5.7	7.8	0.7	7.1	17.5	8.1	36.2	3.8	1.5	0.4	0.5	219.5	15.2	0.1	2.5	0.4	0.2	3.2	0.2	33.0	0.2	7.7	0.2	45.9	0.0	0.4	0.1	0.1	2.7	0.2	0.2	0.0	0.2	0.0	0.0	64.7	0.1	0.1	0.1	0.1	44.5	46.0	0.0	45.5	0.8	0.0	0.9	2.4	2.1	0.2	0.1	1.4	1.0	444.2	1.3	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.5	0.1	0.1	2.2	0.7	0.0	0.5	15.1	0.0	476.5	0.0	0.1	3.0	1.4	7.1	0.1	38.5	65.7	0.5	0.0	0.0	8.4	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.8	11.8	1.8	14.1	4.1	5.7	7.8	3.8	3.2	7.7	2.7	1.0	496.8	213.3	0.0	1.3	0.9	7.9	80.3	0.0	0.0	211.3	62.9	0.2	34.3	276.3	318.2	0.0	462.2	1.1	0.0	133.1	14.3	0.1	33.6	2.3	3.4	1.8	0.0	0.0	1.4	110.9	4.3	9.7	33.7	5.1	0.0	0.0	0.0	29.5	0.0	0.0	0.1	87.5	0.0	0.4	0.0	0.6	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.3	0.0	366.0	149.1	0.1	0.0	0.1	6.3	0.0	0.5	3.2	0.1	259.0	2.2	0.3	0.3	10.4
FOLR2	FRβ	ENSG00000165457	"Folate receptor beta"	P14207	11	72216601-72221950	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 168.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 1114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 64.2;intermediate monocyte: 50.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 18.7;monocytes: 64.2"	"Cell line enriched"	"Detected in some"	5	"U-698: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		15000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (2.03e-1)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.98e-3)"	119.1	55.0	10.7	28.2	11.0	10.8	31.7	8.2	18.6	27.9	13.8	36.0	19.5	13.5	12.4	31.6	16.8	80.1	38.6	10.9	9.5	10.8	44.8	39.7	78.5	9.3	10.7	16.0	7.1	7.9	6.1	168.4	11.4	6.1	46.7	0.2	12.8	16.7	5.9	9.8	29.6	46.3	9.3	27.7	21.0	13.0	16.2	28.7	9.1	26.3	29.0	81.3	6.3	16.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.0	0.2	0.0	18.6	0.5	0.8	0.0	0.0	64.2	0.0	0.3	50.6	0.0	9.5	0.0	0.0	18.7	4.0	0.0	0.0	1.1	1.8	13.7	0.2	0.0	20.4	10.7	11.0	8.2	18.6	10.9	9.5	9.3	10.7	11.4	9.3	16.2	16.1	3.4	0.0	0.6	0.0	8.0	7.9	0.1	0.0	1.2	0.0	0.1	1.1	2.2	1.5	0.0	0.0	0.0	7.6	0.6	0.0	0.0	0.0	0.9	0.3	0.1	2.3	0.0	0.0	0.0	0.0	6.0	2.4	0.0	0.5	2.5	0.0	2.2	1.7	1114.8	0.0	0.0	0.0	0.0	229.3	98.8	2.5	1.5	199.4	0.0	15.9	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.1	0.0	0.2	0.0	0.3	0.0	2.5	1.2	0.6	0.7	1.3	5.1	16.0	1.2	0.1	0.0	0.1
FOXD1	"FKHL8, FREAC4"	ENSG00000251493	"Forkhead box D1"	Q16676	5	73444827-73448777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.6;Microglial cells: 9.4;Muller glia cells: 20.9;Proximal enterocytes: 6.9;Spermatocytes: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 55.1;hTERT-RPE1: 63.9;U-138 MG: 74.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"spinal cord: 9.6"							NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (7.06e-4)"	"unprognostic (1.02e-3)"	"unprognostic (3.00e-5)"	"unprognostic (1.48e-4)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.61e-10)"	"unprognostic (3.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (9.65e-4)"	1.0	1.8	1.8	0.1	2.9	0.0	0.6	1.7	2.5	0.7	3.2	0.1	0.0	0.1	0.2	1.8	0.6	0.4	0.0	1.6	5.0	2.1	0.0	0.3	0.4	1.7	1.9	0.1	0.0	0.1	2.0	1.3	1.8	0.2	0.0	0.4	0.7	0.0	0.3	1.2	1.2	0.0	1.5	0.2	0.2	3.3	3.5	0.0	0.3	2.0	0.5	0.4	0.8	1.6	36.5	2.4	0.2	12.9	6.4	6.3	1.3	28.1	13.2	32.5	28.6	0.1	43.1	0.0	1.0	25.5	22.0	12.6	4.2	16.8	34.6	10.5	19.8	0.4	0.4	0.1	2.5	1.8	0.2	7.0	11.1	55.1	17.0	63.9	0.0	5.8	0.4	0.0	34.3	8.3	0.0	0.1	8.1	0.0	5.9	8.8	6.2	1.0	12.4	2.7	5.0	1.3	9.2	0.4	1.5	3.6	1.0	48.5	0.1	74.5	44.9	23.4	0.3	0.0	0.0	0.0	41.1	2.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.9	1.7	2.5	1.6	5.0	1.7	1.9	1.8	1.5	3.5	1.6	1.1	0.0	0.0	0.3	0.4	0.8	0.0	0.8	0.0	9.6	0.2	0.6	1.6	0.0	0.4	0.0	0.0	0.0	2.9	0.1	0.0	0.0	2.9	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.7	0.0	1.8	2.0	0.0	1.3	1.3	0.3	0.4	0.0	9.4	0.0	20.9	0.0	0.0	0.1	0.1	1.2	1.9	2.2	0.1	6.9	0.3	0.3	2.9	0.0	0.1	2.5	5.0	2.6	0.1	0.4	0.0	1.1	0.0	1.0	0.0
FOXD2	"FKHL17, FREAC9"	ENSG00000186564	"Forkhead box D2"	O60548	1	47438044-47440691	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.8"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 22.2;Enteroendocrine cells: 9.1;Intestinal goblet cells: 12.6;Paneth cells: 11.1;Sertoli cells: 6.6;Undifferentiated cells: 18.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 3.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 14.4;WM-115: 23.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"spinal cord: 4.0"							NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (5.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.79e-12)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (5.91e-2)"	0.4	0.8	0.3	0.6	0.4	0.0	0.3	0.3	1.0	1.1	2.1	5.8	0.3	0.3	0.2	0.1	0.3	0.0	0.1	0.2	0.6	1.9	0.6	0.3	0.1	0.1	1.4	0.1	0.1	0.1	1.1	0.2	0.2	1.3	4.6	0.2	0.3	0.2	0.2	0.2	0.4	0.1	0.2	0.6	0.7	0.4	0.3	0.1	0.2	1.0	0.0	0.2	0.4	0.2	0.8	0.4	0.0	14.4	0.1	0.1	0.4	0.4	0.1	0.0	0.1	1.0	0.2	0.2	0.6	0.0	1.2	0.2	0.6	0.0	0.0	1.8	2.3	0.5	0.3	0.1	0.0	0.2	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.8	0.4	0.1	0.1	0.4	0.2	0.6	0.0	0.4	0.5	1.9	1.1	0.7	0.0	0.9	2.0	0.0	0.6	0.8	2.0	0.4	4.0	1.1	0.3	0.5	1.5	0.1	0.7	0.4	0.2	0.3	0.6	0.9	23.2	0.2	0.1	0.4	0.5	0.1	0.4	0.2	0.2	0.4	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.3	0.4	0.3	1.0	0.2	0.6	0.1	1.4	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.3	0.1	1.3	0.0	0.2	0.0	0.0	0.0	1.4	22.2	0.0	0.2	0.4	0.1	1.1	0.3	9.1	0.0	0.0	0.7	0.0	0.8	1.1	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	12.6	0.0	1.4	0.8	1.1	0.0	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	11.1	0.7	0.0	0.0	1.3	0.2	0.4	0.2	6.6	0.2	2.0	0.7	1.5	0.0	0.1	0.0	1.0	0.0	18.1	0.0
FOXE3	"FKHL12, FREAC8"	ENSG00000186790	"Forkhead box E3"	Q13461	1	47416285-47418052	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cataract, Disease variant, Peters anomaly"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"Cardiomyocytes: 6.0;Spermatogonia: 2.3"	"Group enriched"	"Detected in some"	4	"cervical cancer: 0.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"SuSa: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA					"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (2.11e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.24e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-7)"	"unprognostic (2.41e-1)"	"unprognostic (5.46e-2)"		"unprognostic (3.60e-1)"	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109734	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 44.0;salivary gland: 11.4"	"Cell type enriched"	"Detected in some"	4	"Ionocytes: 132.2"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"MCF7: 1.4;SuSa: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Vesicles	"HPA071469: AB_2686403"	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.5	0.1	0.0	0.1	3.0	0.0	0.0	11.4	1.5	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.2	0.0	0.0	7.6	6.5	0.3	0.0	0.3	1.8	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	132.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0
FOXI2	FLJ46831	ENSG00000186766	"Forkhead box I2"	Q6ZQN5	10	127737185-127741183	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1.9;kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.2;Distal tubular cells: 3.9;Squamous epithelial cells: 1.4;Urothelial cells: 1.7"	"Cancer enriched"	"Detected in some"	6	"renal cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"			"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.12e-3)"	"unprognostic (4.71e-4)"	"unprognostic (6.78e-3)"	"prognostic favorable (4.23e-7)"	"unprognostic (6.31e-3)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.65e-2)"	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.3	1.9	0.2	0.1	0.3	0.0	0.2	3.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	0.8	0.3	0.1	0.5	0.1	0.2	0.1	0.5	0.2	0.0	0.3	0.3	0.0	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.7
FOXN3	"C14orf116, CHES1"	ENSG00000053254	"Forkhead box N3"	O00409	14	89124871-89619149	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 517.2;Oligodendrocyte precursor cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.2;U-266/84: 112.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059209	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Plasma membrane"	"HPA059209: AB_2683949"	"unprognostic (1.69e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (9.58e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.11e-1)"	46.5	27.0	17.8	23.6	17.9	83.7	22.8	76.2	15.1	24.9	33.4	28.8	36.7	26.5	9.2	39.4	23.2	22.9	38.2	12.2	15.8	12.8	30.8	23.9	29.1	20.5	18.3	50.6	24.8	46.9	5.1	22.7	21.5	20.2	21.8	16.5	18.4	22.1	79.6	41.4	35.2	35.1	19.3	21.6	29.0	16.8	21.5	41.6	9.5	72.6	30.9	25.5	20.6	18.3	0.5	7.7	19.7	11.3	78.1	24.8	14.2	15.7	15.4	13.8	22.7	7.8	6.3	24.0	7.8	25.0	9.5	5.6	33.5	22.3	20.4	109.2	6.2	8.3	14.6	25.0	25.3	16.6	14.1	59.4	12.6	1.3	9.4	16.6	30.2	34.1	10.0	69.0	22.9	9.4	32.2	16.6	21.2	14.2	13.8	51.4	67.0	22.8	1.7	26.6	10.7	35.1	23.0	21.9	6.4	64.8	12.8	45.3	55.0	23.5	32.1	23.6	23.6	58.4	112.6	44.6	8.5	28.2	13.8	48.8	23.8	35.8	41.9	25.7	33.3	13.5	27.8	35.9	35.2	16.4	35.8	34.6	9.6	32.2	17.3	7.9	35.9	31.2	17.8	17.9	76.2	15.1	12.2	15.8	20.5	18.3	21.5	19.3	21.5	18.3	108.7	32.1	33.9	229.5	65.4	89.3	22.4	27.4	41.5	123.2	21.0	21.7	103.2	47.1	53.4	9.2	0.0	36.9	105.9	37.2	21.5	11.5	86.2	38.8	36.3	67.3	59.3	52.5	125.6	20.9	21.3	75.2	45.9	36.4	12.7	112.4	55.6	92.9	43.5	79.1	195.2	37.5	30.5	100.3	174.9	38.5	96.3	87.9	32.0	517.2	65.3	38.6	94.7	291.6	143.8	15.5	32.1	85.4	71.3	16.8	77.4	12.2	16.0	9.9	39.5	133.6	57.9	4.3	11.6	51.4	147.6	29.6	85.0	37.2	46.6	29.1
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 195.3;lymphoid tissue: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 4199.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 4199.5"	"Group enriched"	"Detected in some"	5	"LHCN-M2: 17.2;U-87 MG: 67.1"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	69.6	10.0	3.8	166.0	4.4	195.3	5.3	4.1	8.7	8.2	5.7	4.6	3.1	3.7	0.5	8.9	15.4	28.6	7.5	3.6	8.1	4.5	21.4	50.8	12.7	15.2	8.2	2.4	11.2	5.1	3.5	45.1	11.9	3.1	3.3	2.6	4.1	2.3	1.8	1.3	5.2	42.9	8.6	129.2	5.4	2.2	9.9	8.4	3.1	22.8	10.3	66.9	2.7	18.2	0.5	0.8	0.3	0.4	1.0	2.1	0.5	0.2	0.0	0.5	2.0	0.3	0.7	1.2	0.6	0.0	3.9	0.4	0.0	0.0	0.1	0.1	0.0	0.7	0.9	1.0	6.0	0.3	0.5	4.8	0.2	1.8	1.8	9.2	0.0	0.3	0.1	0.6	17.2	0.9	0.1	0.3	0.4	0.3	0.7	0.3	0.7	0.0	1.5	0.5	0.2	0.3	0.6	0.1	0.5	0.2	1.0	1.1	1.0	2.0	0.4	0.1	3.5	0.2	0.0	0.5	67.1	1.7	0.1	317.1	759.9	204.9	1.6	319.7	1.5	0.7	1.0	0.7	174.1	1.0	1.0	1.2	4199.5	0.4	201.8	8.1	1.3	420.3	3.8	4.4	4.1	8.7	3.6	8.1	15.2	8.2	11.9	8.6	9.9	18.2	0.1	16.0	25.7	0.0	1.8	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.2	0.0	15.5	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.8	0.0	0.1	6.3	0.0	2.5	0.2	0.0	1.6	4.7	0.5	0.1	26.5	0.0	2.5	2.1	119.6	0.0	0.1	0.0	0.0	215.3	4.7	2.0	0.3	178.5	0.0	3.7	89.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	8.8	0.3	6.6	0.6	0.8	0.6	0.8	0.2	0.0	3.0	2.5	0.0	0.0	0.1
FPR3	"FMLPY, FPRH1, FPRL2, RMLP-R-I"	ENSG00000187474	"Formyl peptide receptor 3"	P25089	19	51795157-51826190	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.2"	"Group enriched"	"Detected in some"	15	"Hofbauer cells: 56.5;Kupffer cells: 97.4;Langerhans cells: 223.6;Macrophages: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"classical monocyte: 2.3;intermediate monocyte: 6.7;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	44	"dendritic cells: 2.4;monocytes: 6.7"	"Group enriched"	"Detected in some"	5	"HEL: 10.0;hTERT-RPE1: 2.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (1.96e-1)"	"unprognostic (4.28e-2)"	10.6	12.1	0.6	23.9	1.1	0.4	5.3	0.5	2.4	5.5	2.2	12.6	11.2	3.7	1.5	5.7	2.0	18.8	3.8	0.6	0.7	3.2	21.3	28.2	13.9	3.1	1.0	1.7	2.3	2.2	0.9	5.6	2.8	2.5	18.2	0.3	2.4	2.9	0.9	2.7	14.4	8.9	1.2	16.3	7.1	2.7	6.0	8.1	2.2	2.0	11.0	17.4	1.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.6	1.1	0.5	2.4	0.6	0.7	3.1	1.0	2.8	1.2	6.0	3.9	0.5	0.0	1.7	0.3	2.7	5.6	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.0	2.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.1	1.5	56.5	0.0	0.2	0.0	0.0	97.4	223.6	0.2	0.3	66.6	7.2	1.0	3.7	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.4	0.1	0.0	0.0	1.5	0.1	0.0	0.3	0.5	0.0	0.1	0.4	4.5	0.8	0.6	0.0	0.0	0.1
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FRMPD1	"FRMD2, KIAA0967"	ENSG00000070601	"FERM and PDZ domain containing 1"	Q5SYB0	9	37650954-37746904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 68.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 47.8;Cone photoreceptor cells: 152.2;Inhibitory neurons: 24.3;Rod photoreceptor cells: 79.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.2;NK-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042934	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA042934: AB_10960422"	"unprognostic (6.41e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.04e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.12e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.91e-2)"	0.4	0.5	3.1	0.8	3.8	2.9	0.9	2.9	4.1	0.3	0.4	0.5	0.7	1.0	0.6	1.6	0.8	1.6	0.7	2.6	2.9	0.5	0.5	0.7	1.3	3.1	4.8	0.3	0.9	0.7	0.8	0.4	2.6	0.5	0.5	68.9	4.1	0.5	4.2	6.4	1.1	0.4	2.2	0.4	0.6	9.4	5.5	0.2	1.0	1.2	1.1	0.5	0.1	4.5	0.2	0.3	1.2	0.1	0.0	0.0	1.5	0.5	0.0	0.1	0.1	0.6	0.5	0.3	0.2	0.3	0.5	0.9	0.9	0.5	0.3	0.4	0.3	0.1	0.5	0.3	0.0	0.0	0.2	0.6	0.0	0.5	0.2	0.6	0.0	0.9	0.5	0.2	0.2	0.3	0.1	0.2	0.7	0.1	0.6	0.6	1.0	0.1	0.0	0.9	2.5	1.7	0.0	1.6	0.8	0.4	0.8	0.3	0.0	0.3	0.5	0.5	0.4	0.4	0.7	0.6	0.4	0.3	0.4	3.2	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	1.0	1.3	0.4	0.3	0.2	0.1	3.1	3.8	2.9	4.1	2.6	2.9	3.1	4.8	2.6	2.2	5.5	4.5	0.2	3.2	10.5	11.1	0.3	0.1	0.3	0.0	0.0	47.8	0.5	0.3	1.1	4.3	1.8	0.0	152.2	0.2	0.0	0.4	0.0	0.1	4.8	0.2	0.1	1.4	0.0	0.0	3.7	0.2	0.5	0.8	0.0	0.4	5.1	0.2	0.7	0.8	0.1	1.7	24.3	0.3	0.0	1.3	2.1	1.3	0.9	0.8	0.0	1.0	0.3	9.0	0.0	13.6	6.7	0.1	0.1	0.4	0.1	0.2	0.0	0.0	1.5	79.8	0.0	0.8	0.2	0.4	1.7	0.0	0.4	0.7	1.0	0.1	0.1	0.3
FRMPD2	"MGC35285, PDZD5C, PDZK5C"	ENSG00000170324	"FERM and PDZ domain containing 2"	Q68DX3	10	48153088-48274696	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.7;choroid plexus: 5.2;retina: 24.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 50.0;Cone photoreceptor cells: 287.7;Early spermatids: 97.7;Endometrial ciliated cells: 70.6;Late spermatids: 118.5;Respiratory ciliated cells: 62.9;Rod photoreceptor cells: 90.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HBEC3-KT: 1.0;SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (1.53e-1)"	"unprognostic (3.08e-1)"		"unprognostic (7.88e-4)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.54e-3)"		"unprognostic (1.85e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.25e-12)"	"unprognostic (3.48e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.43e-5)"	0.0	0.0	2.4	0.0	2.0	0.0	0.4	2.7	1.3	0.2	5.2	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.9	2.1	2.7	0.1	0.0	0.2	0.0	4.7	6.7	0.0	0.0	0.0	0.1	0.0	4.1	0.3	0.1	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.3	3.5	0.0	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.0	2.7	1.3	2.1	2.7	4.7	6.7	4.1	4.0	3.5	3.4	0.0	0.0	0.5	36.6	0.0	0.1	0.4	1.6	0.0	50.0	1.1	0.4	5.0	0.0	4.6	3.7	287.7	0.2	0.0	0.1	0.0	0.1	97.7	70.6	0.5	0.3	3.0	0.0	2.0	0.0	0.3	0.8	0.0	1.6	0.0	0.0	0.0	0.2	0.1	3.3	0.9	0.6	6.1	0.0	0.0	118.5	0.3	0.2	0.0	0.0	0.0	5.2	0.0	0.5	0.3	0.2	0.1	0.4	0.0	0.4	4.2	0.5	62.9	90.8	0.0	0.2	0.6	2.1	1.0	0.0	0.3	0.0	0.1	0.1	0.7	0.4
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480626-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.7"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 700.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 351.1;HaCaT: 292.3;HBEC3-KT: 191.3;HMC-1: 206.5;PC-3: 558.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	"Cluster 32: T-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	26.1	6.2	0.8	3.0	0.5	0.4	15.2	0.4	0.7	7.7	0.7	9.8	1.8	4.2	3.7	6.5	11.8	7.2	9.4	2.0	2.0	2.9	68.7	8.2	1.6	1.8	1.0	9.9	2.6	0.5	5.9	24.1	0.9	15.5	3.0	0.3	11.3	10.8	9.2	18.0	8.8	4.7	0.5	0.3	11.1	5.0	1.1	2.3	4.0	7.7	12.9	40.4	7.5	0.7	20.0	1.8	33.7	0.0	38.6	13.5	55.4	76.3	351.1	46.4	45.4	0.3	0.2	0.0	0.6	19.9	2.3	292.3	0.0	191.3	32.7	0.8	0.2	4.0	1.7	31.3	20.4	0.3	206.5	31.0	0.5	84.5	55.0	31.3	40.0	0.0	0.0	0.6	29.7	0.1	0.1	1.6	52.1	0.0	558.2	4.2	43.6	0.0	0.0	31.9	0.5	0.1	3.1	0.2	2.0	83.9	0.3	0.3	0.2	124.1	35.3	13.2	11.1	0.4	0.1	0.1	14.8	4.1	116.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.4	0.7	2.0	2.0	1.8	1.0	0.9	0.5	1.1	0.7	5.2	0.0	1.1	0.0	1.0	20.0	31.5	64.4	13.1	0.0	0.9	23.4	11.4	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.4	0.1	3.4	2.9	0.0	0.0	0.1	4.6	14.8	107.7	3.6	0.1	0.0	700.1	1.1	57.2	1.8	0.0	0.7	0.0	2.0	0.8	16.4	1.5	3.1	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	11.3	0.2	37.1	0.0	0.1	1.6	0.0	13.1	29.6	33.3	0.3	12.2	4.0	4.7	6.0	2.0	0.3	0.0	51.8
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120450993	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 352.1;Fibroblasts: 521.9;Leydig cells: 327.4;Peritubular cells: 270.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"basophil: 12.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1782.4;BJ: 2156.3;fHDF/TERT166: 2692.9;HBF TERT88: 1741.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		34000000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: AB_2732489"	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	432.4	134.3	20.5	116.3	18.1	2.2	166.1	22.8	22.7	279.9	83.0	156.4	37.1	157.5	50.8	126.1	150.6	257.0	242.7	20.6	22.8	45.4	35.7	120.7	50.3	28.5	44.6	90.3	37.3	35.5	25.7	442.0	23.1	188.3	90.4	29.8	59.3	184.4	31.8	64.2	69.1	409.6	22.7	63.1	68.6	33.5	22.7	24.2	78.8	89.8	38.8	260.4	104.3	20.6	81.0	21.2	222.9	91.8	1304.4	1782.4	1.3	2156.3	1208.9	1374.5	1211.0	0.1	178.5	0.8	178.8	2692.9	112.8	20.5	68.6	270.0	1741.5	1.1	32.5	0.4	159.8	0.3	286.0	1.2	0.9	1362.7	8.5	884.5	192.7	612.1	811.6	11.2	0.5	0.3	227.6	0.5	22.6	2.0	181.3	0.4	181.9	0.7	92.7	1.0	150.4	1.7	39.2	93.5	764.6	13.6	76.5	462.6	23.5	6.2	986.8	507.4	479.8	268.0	323.8	1.0	1.1	2.3	177.4	0.9	67.0	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	2.6	20.5	18.1	22.8	22.7	20.6	22.8	28.5	44.6	23.1	22.7	22.7	20.6	76.9	64.1	9.4	56.5	1.1	64.1	31.9	36.4	10.2	2.3	25.6	24.6	127.5	8.6	42.5	23.9	0.0	114.4	2.5	0.9	0.0	62.6	2.3	44.4	176.7	111.4	3.0	3.6	9.6	5.8	352.1	521.9	3.1	23.0	1.3	66.5	142.5	17.4	20.6	1.7	16.2	0.2	8.2	10.8	91.6	9.8	327.4	11.5	110.3	30.0	9.9	116.1	0.0	9.5	0.9	117.8	0.7	270.8	0.9	108.4	0.0	5.5	74.9	4.3	59.2	62.5	129.3	1.5	4.4	2.2	48.2	54.7	7.1	47.5	0.9	65.3
FSTL4	KIAA1061	ENSG00000053108	"Follistatin like 4"	Q6MZW2	5	133196455-133612541	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 390.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 57.2;U-266/70: 19.3;U-266/84: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045920	Uncertain		Uncertain	Mitochondria	"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA045920: AB_10965844"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.02e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.25e-2)"	0.1	1.3	5.5	0.6	5.5	1.9	0.6	8.5	11.2	0.3	0.0	1.1	0.7	0.2	1.5	1.9	0.9	0.5	0.3	3.1	3.2	2.8	0.1	1.2	0.3	0.0	6.2	0.4	1.9	3.1	2.3	3.8	0.0	1.6	1.1	3.9	0.7	0.0	0.9	3.4	0.8	0.2	0.0	0.4	1.4	1.7	21.4	1.3	0.8	0.5	1.1	6.0	0.9	7.8	7.5	13.1	1.4	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	12.5	1.7	0.7	10.5	0.0	1.3	0.2	1.7	0.5	0.0	0.9	0.6	0.6	13.9	1.1	0.0	0.0	0.7	0.3	1.8	0.0	0.1	0.3	0.0	0.5	5.9	7.0	0.0	12.7	1.5	0.6	14.4	14.2	1.6	0.6	1.3	14.1	0.0	15.0	57.2	1.6	2.9	2.4	0.3	12.2	4.6	0.5	0.3	0.6	2.4	0.8	0.4	19.3	20.7	0.5	0.2	0.1	0.4	1.1	0.2	0.1	0.2	0.0	0.5	0.6	0.4	0.3	0.1	0.5	0.4	0.2	0.5	0.2	0.2	0.3	0.3	0.3	5.5	5.5	8.5	11.2	3.1	3.2	0.0	6.2	0.0	0.0	21.4	7.8	0.0	0.0	3.1	21.5	1.0	1.7	2.5	0.2	4.0	10.1	0.6	0.3	9.6	0.0	4.4	0.0	14.6	0.4	0.1	0.0	0.0	0.2	35.9	1.2	0.2	0.6	9.0	0.0	390.3	0.0	0.0	0.4	0.0	0.1	0.0	1.4	0.0	0.0	0.1	1.7	57.9	0.4	0.0	0.0	0.0	20.4	0.3	1.2	10.6	8.4	0.0	3.0	0.0	21.1	4.5	0.6	0.0	0.7	0.0	0.4	0.2	2.5	3.7	2.6	6.6	0.0	1.1	0.5	0.7	3.3	1.6	0.0	0.4	0.9	0.1	2.9
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 939.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 92.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		1600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.4	1.7	5.4	0.2	6.8	0.0	0.4	3.6	8.4	1.3	3.0	1.3	1.3	1.2	0.4	0.3	0.9	0.1	1.6	4.9	4.7	155.7	939.8	0.2	0.2	4.6	3.9	3.0	4.0	0.0	3.4	0.0	5.6	4.2	0.0	0.0	0.2	0.6	0.4	0.3	1.7	0.0	3.5	0.5	0.5	13.9	4.4	0.0	0.9	0.0	0.0	1.3	1.0	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.0	92.9	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.5	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.4	6.8	3.6	8.4	4.9	4.7	4.6	3.9	5.6	3.5	4.4	5.5	0.0	0.0	0.0	1.0	8.1	0.1	0.0	0.0	0.0	1.3	0.2	0.5	1.5	131.5	0.0	9.2	0.0	0.0	0.1	0.0	46.9	0.0	104.7	0.1	0.4	1.8	0.0	61.5	10.5	0.0	0.0	0.6	0.0	0.2	0.0	0.6	30.4	444.9	0.1	3.3	5.9	0.1	0.0	28.9	0.0	124.3	3.1	1.6	0.0	1.0	0.0	0.2	0.0	1.0	18.5	0.0	0.1	2.6	0.0	0.5	0.3	395.1	0.0	0.4	0.0	0.2	0.5	39.2	17.9	0.2	0.4	0.0	3.6	0.1	0.2	0.1
FTCDNL1	FONG	ENSG00000226124	"Formiminotransferase cyclodeaminase N-terminal like"	E5RQL4	2	199760544-199851192	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Excitatory neurons: 43.5;Oligodendrocytes: 115.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA065748			Approved	Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA065748: "	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (3.92e-2)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.21e-2)"	2.4	4.9	4.4	0.9	7.9	2.3	2.1	5.4	5.5	0.6	1.8	1.1	1.0	0.4	1.8	1.3	1.9	0.9	2.9	4.5	4.8	4.2	10.0	1.4	2.0	6.1	6.7	1.0	2.2	1.5	0.9	0.6	5.7	1.2	1.1	1.4	2.4	0.6	8.1	1.2	0.8	1.1	6.1	4.6	0.9	1.0	6.0	0.7	5.7	8.4	0.8	0.7	0.9	7.6	0.6	1.9	0.1	0.0	1.9	1.1	1.4	0.7	0.7	1.0	0.4	0.0	3.5	2.0	0.2	0.8	5.7	0.0	0.9	5.3	1.2	2.3	0.5	1.5	0.8	1.7	0.7	5.5	6.5	0.8	0.2	0.4	0.1	0.7	0.0	4.9	2.7	0.1	0.7	6.0	1.9	2.1	1.6	0.5	4.0	0.3	0.2	0.0	0.4	0.0	2.3	0.0	3.4	3.2	3.2	1.3	4.8	7.1	0.6	2.7	0.0	1.8	1.1	4.7	2.9	1.1	5.2	2.7	1.3	0.0	4.1	1.7	0.4	5.5	1.7	3.4	1.7	0.6	5.8	2.1	1.1	1.8	0.0	1.1	5.1	8.7	0.0	1.4	4.4	7.9	5.4	5.5	4.5	4.8	6.1	6.7	5.7	6.1	6.0	7.6	0.8	0.0	0.0	39.8	3.2	2.7	2.9	0.0	13.6	3.3	6.2	5.5	5.7	4.3	1.3	3.7	4.2	1.5	3.3	0.3	1.9	0.2	2.4	8.4	0.8	1.5	0.0	5.9	43.5	0.7	1.4	1.4	4.6	3.3	0.0	5.9	2.2	6.9	7.4	1.7	23.5	1.2	0.0	8.1	4.7	1.0	0.3	8.2	7.2	17.8	2.1	1.7	0.0	24.6	115.4	0.3	0.1	0.4	1.4	2.6	1.0	10.6	0.0	6.5	0.0	2.4	3.4	0.4	2.0	6.9	2.3	0.3	1.5	10.3	1.1	1.2
FTL	"MGC71996, NBIA3"	ENSG00000087086	"Ferritin light chain"	P02792	19	48965309-48966879	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Iron storage"		"Cancer-related genes, Cataract, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 14422.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 74983.4;Kupffer cells: 70127.1;Macrophages: 34584.5;Proximal tubular cells: 58047.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 125209.0;monocytes: 102128.9"	"Cell line enhanced"	"Detected in all"		"HHSteC: 24796.9;HSkMC: 20811.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020769, HPA041602"	Enhanced		Approved	Cytosol		NA	NA		170000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB020769: , HPA041602: AB_2677575"	"unprognostic (2.95e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	6778.7	3262.2	6806.2	2353.2	7172.4	4213.8	4226.0	6782.1	10053.2	2094.3	6429.7	2451.1	2427.0	1523.4	1010.8	1306.2	2169.9	4298.0	2537.3	6497.7	6998.4	8845.6	14422.9	7261.1	3353.2	7250.8	6998.4	2455.3	2166.2	931.7	1730.4	3423.2	7218.5	1946.5	1800.0	684.9	1663.5	1390.4	1345.9	1449.7	2806.6	1842.3	7149.5	6751.4	3204.5	455.9	7581.8	1168.9	3000.4	1072.0	1334.6	4239.9	1804.7	7334.0	869.7	12906.5	949.6	1457.0	16013.9	16478.6	1693.1	2194.1	12820.0	3090.7	6903.8	2852.3	3413.2	656.4	4104.3	13203.9	6755.6	505.8	788.2	1301.8	2765.6	8895.0	507.6	1740.0	3222.8	18949.7	24796.9	4133.3	5591.2	20811.1	1735.9	5272.5	2301.6	4590.4	4549.8	774.6	3284.9	1328.2	6198.4	213.0	1152.1	2402.8	1729.8	15140.6	1306.9	947.6	643.0	6763.9	1989.7	545.0	1209.9	701.5	5761.7	313.4	1239.5	5104.1	183.2	8493.4	3438.3	3353.4	1740.1	4364.3	3083.1	5690.2	13742.1	625.1	3563.9	4334.7	6017.7	64938.4	71067.8	77353.0	6560.6	102128.9	7527.7	17097.3	7247.4	7054.3	25176.6	15607.2	8656.4	7466.9	125209.0	4978.3	91398.0	10579.6	9634.4	94147.5	6806.2	7172.4	6782.1	10053.2	6497.7	6998.4	7250.8	6998.4	7218.5	7149.5	7581.8	7334.0	2757.2	1125.0	3379.9	88.5	3311.5	2793.9	6799.5	2785.4	2159.8	474.7	2597.9	3977.3	777.8	4398.0	2550.4	2021.2	177.2	941.5	2199.4	2314.2	10704.0	4251.2	290.2	504.9	1413.1	4867.0	1613.4	4331.2	60.6	6134.8	1447.8	5703.3	1715.1	617.4	2365.7	942.2	4598.0	23702.0	74983.4	533.3	113.8	2368.8	3039.4	70127.1	16939.0	1601.8	4175.9	34584.5	5085.3	129.3	22965.8	3161.9	2020.6	55.8	309.7	6905.5	5604.7	2010.8	4884.7	9790.5	21474.5	58047.8	1908.0	682.6	1341.1	1643.8	3455.6	82.1	311.2	1985.5	2226.7	1502.7	2590.4	1492.0	2816.8	13083.6
FUOM	"C10orf125, FLJ26016, FucM, FucU"	ENSG00000148803	"Fucose mutarotase"	A2VDF0	10	133355158-133358025	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 564.7;Hofbauer cells: 172.0;Proximal enterocytes: 690.7;Proximal tubular cells: 368.1"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 61.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039207	Approved					NA	NA		2000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA039207: AB_10795033"	"unprognostic (1.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.65e-1)"	12.9	8.8	4.2	11.3	4.4	6.6	13.0	4.0	7.2	7.3	8.2	12.0	52.0	5.5	3.2	8.7	7.9	9.6	17.4	4.2	4.6	46.7	228.3	14.1	16.8	5.3	4.7	7.3	18.3	8.0	6.0	5.2	5.7	7.0	5.4	0.3	28.8	3.6	3.0	7.4	46.8	3.6	4.9	23.7	8.5	5.6	5.1	6.1	6.6	2.6	8.0	7.9	7.7	4.8	23.3	7.2	13.6	28.4	3.8	9.2	24.8	18.3	20.7	6.5	8.1	46.4	12.4	0.0	20.7	13.8	0.0	1.2	4.9	6.3	0.5	8.4	4.9	22.3	10.3	50.7	20.1	25.2	14.8	9.6	0.2	2.6	1.4	3.0	9.2	22.9	22.2	29.7	13.9	23.0	3.9	33.6	9.5	13.5	3.2	21.8	0.4	13.0	7.5	0.0	1.4	11.0	6.7	20.6	25.3	6.8	0.2	38.3	18.7	0.1	18.4	0.0	0.1	15.5	2.7	16.7	5.5	10.2	7.1	0.1	68.9	6.5	16.0	73.2	14.7	36.0	14.0	13.4	57.2	34.5	14.9	13.1	3.3	17.1	15.7	79.0	10.4	28.6	4.2	4.4	4.0	7.2	4.2	4.6	5.3	4.7	5.7	4.9	5.1	4.8	20.4	6.4	10.0	0.0	32.7	12.1	9.2	8.5	6.2	0.1	12.2	25.7	10.9	22.8	11.4	9.2	0.0	10.3	25.1	79.2	31.3	13.6	3.7	3.8	9.7	14.1	3.0	24.4	0.6	12.7	9.0	25.6	8.6	7.7	27.3	15.5	25.0	564.7	172.0	0.0	1.2	49.7	6.1	103.0	55.4	10.3	10.2	68.7	26.6	1.9	85.6	3.5	13.4	0.0	1.0	12.5	119.5	3.8	29.6	17.8	690.7	368.1	4.0	1.1	13.1	11.6	14.9	20.2	23.7	10.0	9.9	6.6	21.5	4.1	61.1	12.1
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 158.7;intestine: 72.3;retina: 79.3;salivary gland: 84.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 154.7;Intestinal goblet cells: 78.7;Pancreatic endocrine cells: 49.0;Paneth cells: 88.9;Proximal enterocytes: 85.2;Undifferentiated cells: 65.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 46.3;hTCEpi: 6.9;OE19: 20.6;RH-30: 14.8;SK-BR-3: 7.1"									HPA046966	Supported					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046966: AB_2679879"	"prognostic unfavorable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.5	0.0	0.4	12.6	0.6	0.7	1.2	0.5	0.7	25.9	0.5	72.3	47.7	0.3	0.0	158.7	1.3	22.4	0.2	0.4	1.2	9.8	2.3	5.2	0.1	0.8	0.5	0.1	9.1	0.0	0.6	0.1	0.7	2.2	44.5	79.3	84.2	8.5	0.1	3.2	56.3	2.8	0.2	0.2	20.8	4.0	0.6	0.2	0.0	0.0	15.9	3.0	53.2	0.7	46.3	0.0	0.2	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.6	0.0	0.0	2.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	20.6	0.0	0.0	14.8	1.6	0.0	0.6	0.0	0.2	0.0	7.1	0.2	0.1	0.1	0.4	0.0	0.2	0.1	0.1	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.5	0.7	0.4	1.2	0.8	0.5	0.7	0.2	0.6	0.7	0.1	0.0	4.8	0.3	1.1	0.0	3.0	23.6	0.0	1.8	1.7	0.3	0.3	11.5	36.4	0.0	0.0	0.1	0.0	154.7	0.0	43.2	4.9	1.1	0.1	0.5	13.8	0.0	0.1	14.2	0.4	0.0	18.3	0.6	8.9	0.1	0.0	0.4	0.0	0.0	0.0	78.7	14.2	0.0	0.0	8.7	0.0	0.2	0.0	1.0	0.0	1.9	0.0	0.0	0.1	49.0	88.9	0.0	0.1	0.9	85.2	16.5	22.8	34.9	0.0	0.0	1.5	0.5	0.2	6.5	0.0	0.3	0.5	0.0	65.6	27.3
FUT5	FUC-TV	ENSG00000130383	"Fucosyltransferase 5"	Q11128	19	5865826-5870540	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.1"									HPA046966	Uncertain					NA	NA					"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA046966: AB_2679879"				"unprognostic (7.72e-2)"	"unprognostic (3.59e-1)"		"unprognostic (5.03e-2)"			"unprognostic (1.20e-1)"								0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830408-5839722	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.4;kidney: 36.1;salivary gland: 45.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"Hep G2: 10.5;RPMI-8226: 4.0"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		51000	"Cluster 10: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favorable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.1	0.0	0.1	2.6	0.1	0.4	1.7	0.2	0.1	17.3	0.4	17.3	28.6	0.3	0.0	79.4	0.6	9.3	0.0	0.1	0.1	36.1	12.4	0.2	0.1	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.2	11.6	2.0	45.7	2.5	0.0	0.1	27.0	0.4	0.1	0.1	4.8	0.2	0.1	0.0	0.0	0.0	6.7	0.0	26.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.2	10.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.7	4.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.5	0.0	0.7	0.0	0.4	3.5	0.0	0.4	3.7	1.9	0.3	18.6	15.7	1.8	0.0	0.2	0.3	35.6	3.9	6.8	0.3	0.6	0.7	0.3	4.9	0.0	0.1	0.4	0.1	0.3	0.0	0.7	0.0	0.2	0.7	5.1	0.1	0.0	0.1	39.4	8.2	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.5	0.1	2.7	21.5	0.0	0.0	0.2	101.4	45.3	6.4	11.5	0.0	0.3	0.7	1.0	0.6	3.6	0.1	0.0	0.5	0.1	29.0	1.7
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264433-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 44.9;Cholangiocytes: 45.8;Horizontal cells: 141.3;Peritubular cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.0;non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 24.8;HSkMC: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favorable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.4	4.4	2.4	2.7	2.5	1.1	10.7	5.8	2.4	9.9	11.1	5.9	5.1	8.6	4.3	5.2	5.5	5.7	12.7	4.7	2.9	9.6	2.5	10.7	1.3	2.5	6.2	10.1	4.7	2.4	3.9	10.0	2.3	10.3	3.7	2.0	9.0	16.4	1.9	10.4	5.1	5.3	2.3	3.2	4.6	1.6	3.4	1.8	20.5	2.4	1.3	6.4	11.2	2.0	0.8	2.5	24.8	2.6	19.8	17.0	4.5	9.2	5.8	3.3	2.3	1.1	4.3	0.0	2.2	5.9	4.2	4.7	3.9	2.0	2.2	0.0	4.9	0.2	4.6	1.3	1.4	4.2	1.0	32.3	3.6	7.6	2.4	12.6	0.7	2.8	1.5	3.6	9.7	6.2	0.8	1.1	6.4	1.3	4.2	5.1	15.3	0.4	5.3	11.8	3.4	6.5	7.0	5.6	1.6	5.7	3.0	3.8	3.8	13.9	10.4	15.0	3.8	3.3	2.5	0.4	15.0	3.5	16.5	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	2.4	2.5	5.8	2.4	4.7	2.9	2.5	6.2	2.3	2.3	3.4	2.0	5.7	3.2	1.5	4.6	1.1	4.2	44.9	7.0	10.8	1.6	27.7	29.5	18.5	45.8	4.6	12.9	2.1	3.4	0.6	7.4	0.0	4.3	0.3	12.0	13.1	4.5	3.5	0.8	0.6	2.0	2.2	18.5	2.0	15.7	12.7	1.8	15.4	0.9	3.5	141.3	1.0	3.0	4.1	17.4	16.2	1.1	33.2	14.3	17.8	1.9	4.6	3.0	1.0	1.0	0.2	1.9	4.8	45.1	0.4	11.7	6.0	11.6	2.4	2.9	0.0	6.2	10.3	0.5	3.7	9.1	5.1	2.1	0.6	2.6	4.6	7.3
G6PC	"G6PC1, G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42914438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 75.1;liver: 286.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 246.2;Proximal enterocytes: 176.2"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052324	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favorable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favorable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.4	0.2	0.0	0.2	0.1	19.7	0.0	0.1	0.0	0.0	4.1	0.0	0.2	0.1	75.1	286.7	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	30.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	1.8	0.0	0.0	0.0	0.0	1.9	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.5	246.2	0.1	0.0	0.0	2.1	0.0	3.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	176.2	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.2
GADL1		ENSG00000144644	"Glutamate decarboxylase like 1"	Q6ZQY3	3	30726200-30894765	"Enzymes, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 25.8;tongue: 11.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.4;Club cells: 1.3;Collecting duct cells: 1.8;Fibroblasts: 5.9;Late spermatids: 1.8;Skeletal myocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;TIME: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039160, HPA040229"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA039160: AB_10796222, HPA040229: AB_10796118"	"unprognostic (4.96e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (7.32e-2)"		"unprognostic (5.05e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.98e-5)"	"unprognostic (8.81e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.06e-1)"	0.3	0.4	2.2	0.4	2.1	1.2	0.4	2.6	2.5	0.1	0.1	0.2	0.2	0.3	0.6	0.6	0.2	0.3	0.6	1.8	0.8	0.7	0.3	0.3	0.4	0.9	0.5	0.6	0.4	0.2	0.2	0.3	0.9	0.6	0.2	1.7	0.4	0.1	25.8	0.9	0.2	0.2	0.1	0.6	0.3	0.5	1.0	0.1	0.9	11.3	0.3	0.2	0.0	2.3	0.4	0.0	0.2	0.4	0.3	0.1	0.5	0.2	0.1	0.0	0.0	0.5	0.5	0.4	0.2	0.0	0.2	0.3	4.7	0.1	0.1	0.6	0.1	0.5	0.8	0.2	0.0	0.3	1.3	0.1	0.1	0.2	0.1	0.4	0.1	0.3	0.5	1.7	0.2	0.3	0.2	0.5	0.5	0.1	0.1	0.7	0.9	0.4	0.2	0.6	0.5	0.3	0.2	0.3	1.3	0.3	0.4	0.3	2.4	0.6	0.5	0.8	0.2	0.6	0.3	0.3	0.2	0.2	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.0	2.2	2.1	2.6	2.5	1.8	0.8	0.9	0.5	0.9	0.1	1.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	1.8	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
GALM		ENSG00000143891	"Galactose mutarotase"	Q96C23	2	38666081-38741237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 86.5;kidney: 120.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 97.8;Proximal enterocytes: 161.1;Proximal tubular cells: 222.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 68.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 39.1;T-cells: 68.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;Karpas-707: 71.1;U-266/70: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035472, HPA035473, HPA064835"	Enhanced		Approved	Nucleoplasm		NA	NA		620000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA035472: AB_10669906, HPA035473: AB_2674642, HPA064835: AB_2732723"	"unprognostic (5.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.99e-3)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.45e-2)"	"prognostic favorable (9.06e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"prognostic favorable (1.32e-4)"	9.0	86.5	5.2	12.2	5.1	3.8	10.4	6.0	6.1	9.3	8.3	34.7	71.4	8.1	23.0	5.8	35.8	16.5	13.0	4.9	4.8	120.2	72.5	14.3	16.0	5.4	6.1	15.5	15.0	21.3	3.0	7.7	5.4	10.2	33.3	4.4	8.7	20.8	13.1	3.8	52.8	10.4	5.7	6.6	14.9	4.4	7.0	11.0	15.1	12.3	10.2	10.8	6.4	6.0	0.2	27.1	8.1	0.0	27.3	15.4	14.9	3.2	10.3	7.5	12.2	32.4	14.4	10.9	18.9	15.3	14.5	4.3	11.7	0.7	14.5	49.5	19.3	5.9	7.1	62.7	10.0	2.4	0.4	11.1	0.4	17.5	0.0	10.5	8.2	0.0	17.2	71.1	13.9	0.9	23.4	41.0	12.4	59.2	8.6	15.2	0.6	21.3	9.3	45.1	1.5	11.2	0.1	18.9	14.7	10.2	9.0	5.4	3.4	2.5	0.5	18.6	1.0	76.4	54.3	0.3	17.9	7.0	0.3	39.1	4.8	4.2	21.5	3.3	31.8	6.8	33.1	31.2	10.3	4.7	11.7	10.2	11.3	5.5	0.7	0.8	68.3	11.9	5.2	5.1	6.0	6.1	4.9	4.8	5.4	6.1	5.4	5.7	7.0	6.0	9.7	28.9	11.0	13.4	10.0	6.6	6.7	3.4	10.8	3.6	7.8	4.2	23.4	24.3	6.5	69.9	0.0	23.6	19.0	83.2	25.4	12.1	1.4	28.5	11.6	10.0	13.2	8.2	2.3	15.1	31.4	16.1	17.9	10.1	7.0	16.8	14.6	48.1	94.8	3.3	1.4	40.5	4.1	18.6	43.6	1.3	20.2	34.7	17.8	4.7	9.9	38.2	18.6	0.5	1.3	6.8	64.5	97.8	14.7	5.7	161.1	222.1	14.8	6.8	6.6	16.6	10.4	1.0	2.3	3.2	6.0	6.3	44.0	43.3	80.4	5.7
GALNT15	"GALNT7, GALNTL2, pp-GalNAc-T15"	ENSG00000131386	"Polypeptide N-acetylgalactosaminyltransferase 15"	Q8N3T1	3	16174680-16231992	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 157.4;brain: 141.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 103.9;Astrocytes: 34.6;Early spermatids: 26.6;Endothelial cells: 26.9;Hepatic stellate cells: 41.7;Muller glia cells: 47.4;Oligodendrocytes: 69.3"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 133.0;ASC TERT1: 128.8;HSkMC: 102.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017076	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		40000	"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Cytosol	"HPA017076: AB_1849458"	"unprognostic (3.87e-1)"	"unprognostic (4.84e-4)"	"unprognostic (6.39e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.40e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-6)"	"unprognostic (5.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.78e-3)"	157.4	4.9	45.1	1.7	55.8	2.7	87.2	62.5	49.3	12.3	14.4	21.7	3.0	11.4	11.9	12.4	24.9	5.6	18.1	47.9	90.8	11.8	4.0	9.4	4.1	137.6	60.4	22.3	3.6	2.4	3.5	32.3	130.8	6.0	3.9	13.4	25.5	4.7	36.3	41.7	21.2	7.0	102.4	12.3	15.3	9.1	62.8	4.0	18.3	35.3	1.3	33.0	22.8	141.7	0.4	1.3	0.9	1.0	133.0	128.8	0.3	3.4	2.5	0.4	1.3	0.0	0.5	0.5	1.9	7.8	2.3	0.8	0.5	1.4	2.0	0.6	1.4	1.1	1.9	0.0	7.4	1.5	0.4	102.8	0.0	1.2	1.8	2.4	2.8	0.7	0.2	3.0	1.1	1.9	0.0	2.1	0.5	0.8	1.1	0.3	1.1	24.1	0.5	0.5	0.4	0.3	0.4	1.0	0.6	0.6	0.7	1.8	3.9	0.6	4.3	26.8	0.6	1.4	5.1	1.4	2.5	0.4	0.4	0.5	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	45.1	55.8	62.5	49.3	47.9	90.8	137.6	60.4	130.8	102.4	62.8	141.7	103.9	0.0	1.7	34.6	0.1	0.5	0.4	0.0	0.0	3.8	1.1	0.9	2.8	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	26.6	0.5	3.3	26.9	0.0	0.0	4.9	0.0	0.1	24.7	0.0	1.0	1.3	0.1	41.7	1.8	0.1	0.0	3.9	0.0	0.0	0.8	2.1	16.7	1.8	0.5	0.0	22.5	0.1	47.4	0.0	5.0	69.3	0.2	0.0	0.7	1.8	2.1	0.0	0.1	0.0	3.2	0.0	7.3	2.1	25.5	0.5	0.1	0.9	0.0	0.2	0.3	0.0	0.3
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132144-71713600	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.0;choroid plexus: 46.0;heart muscle: 43.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Endometrial stromal cells: 7.4;Fibroblasts: 1.5;Granulosa cells: 1.7;Theca cells: 2.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.3;NTERA-2: 10.8;RPMI-8226: 12.6;SK-BR-3: 45.7;SuSa: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	3.2	8.7	30.5	1.9	37.9	0.0	2.0	35.9	51.2	4.0	46.0	16.6	0.3	16.6	3.1	9.3	8.7	2.5	43.5	55.0	3.2	5.7	0.4	9.3	0.0	2.1	3.8	31.6	10.1	1.2	13.3	0.2	3.0	14.7	1.0	3.3	3.3	8.2	4.7	2.2	3.9	8.3	0.0	3.4	2.4	5.0	11.2	2.6	10.1	2.9	1.5	21.2	3.3	24.8	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.7	0.0	0.0	45.7	0.0	14.1	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	37.9	35.9	51.2	55.0	3.2	2.1	3.8	3.0	0.0	11.2	24.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 615.1;skeletal muscle: 1234.9;tongue: 466.4"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 718.3;Proximal tubular cells: 417.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 176.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					NA	NA		420000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	14.0	26.6	69.4	4.5	74.5	8.8	15.6	68.6	79.1	16.5	53.4	10.9	3.2	10.0	141.9	23.0	14.7	9.9	98.1	67.3	67.1	72.0	615.1	8.1	7.7	71.8	68.3	22.8	229.8	37.8	37.4	4.9	70.4	36.5	2.2	15.0	42.6	17.5	1234.9	32.8	6.4	4.6	68.8	10.7	31.8	55.0	76.1	24.8	22.2	466.4	4.3	12.9	15.3	94.5	21.6	24.1	25.2	56.9	30.9	37.3	34.3	25.2	41.2	31.8	28.7	54.8	15.1	11.3	17.2	30.0	3.8	9.1	39.8	15.5	8.5	81.5	46.2	34.9	20.3	176.7	18.2	0.7	11.5	41.8	5.5	33.8	0.1	44.0	6.9	43.0	50.6	26.6	52.6	22.1	103.9	12.0	28.6	10.7	75.4	103.1	22.3	81.4	38.1	19.5	8.4	58.5	1.9	14.3	32.0	16.1	65.3	48.1	12.2	34.6	35.6	1.9	11.6	119.0	24.8	19.5	32.2	46.1	40.7	3.7	2.5	15.3	18.8	3.4	27.3	22.0	26.3	23.8	11.2	32.3	40.6	30.8	1.5	18.2	6.1	47.3	15.8	14.9	69.4	74.5	68.6	79.1	67.3	67.1	71.8	68.3	70.4	68.8	76.1	94.5	9.2	0.0	7.2	5.5	18.0	58.9	42.1	57.8	116.7	41.0	60.3	99.9	99.3	127.2	12.9	16.5	56.3	35.7	15.4	0.8	92.0	39.9	5.2	6.5	7.4	9.2	7.2	35.8	7.4	33.6	41.2	30.9	10.2	4.0	4.5	43.3	18.9	718.3	81.7	18.5	10.1	1.5	6.1	29.5	13.3	16.0	83.9	13.9	32.0	3.7	4.7	57.3	10.3	4.0	36.7	13.5	0.1	139.5	12.5	24.1	0.1	417.4	6.1	61.7	32.9	77.8	47.1	4.3	22.6	42.1	42.9	12.0	19.7	31.1	3.3	23.2
GARNL3	"bA356B19.1, DKFZp761J1523"	ENSG00000136895	"GTPase activating Rap/RanGAP domain like 3"	Q5VVW2	9	127224265-127393660	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 77.1;Excitatory neurons: 178.4;Inhibitory neurons: 184.7;Microglial cells: 48.7;Oligodendrocyte precursor cells: 45.2;Oligodendrocytes: 165.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 5.3;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028757, HPA074886"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA028757: AB_2294383, HPA074886: AB_2732270"	"unprognostic (3.15e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.22e-1)"	"unprognostic (3.23e-7)"	"unprognostic (6.39e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.78e-5)"	3.1	6.0	5.7	0.3	5.7	0.0	4.4	11.6	6.0	6.0	2.0	2.9	1.8	7.4	5.2	4.4	5.4	3.7	11.3	6.9	5.2	2.1	1.8	2.4	1.3	4.7	4.5	4.5	2.1	6.6	2.0	1.4	5.8	6.2	1.9	1.3	5.0	4.0	1.5	2.8	1.8	6.7	4.6	1.8	1.8	2.9	4.2	0.6	5.7	1.8	1.3	4.6	3.3	11.2	0.5	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	1.0	1.2	0.3	0.0	1.0	0.1	0.4	0.6	1.8	0.0	0.1	0.0	0.8	0.0	1.9	1.2	0.4	0.4	0.1	0.1	1.5	0.0	0.0	1.5	0.7	1.9	0.8	0.7	0.1	0.5	0.0	0.3	0.4	5.3	1.6	0.1	1.1	3.4	1.9	2.5	1.2	3.9	0.8	2.7	0.4	0.6	0.9	0.0	0.0	0.2	1.0	0.0	0.4	2.3	2.4	1.0	0.4	0.5	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	5.7	5.7	11.6	6.0	6.9	5.2	4.7	4.5	5.8	4.6	4.2	11.2	1.3	0.0	0.0	77.1	0.5	2.7	1.7	0.4	2.8	8.0	3.1	4.3	6.8	4.3	2.0	3.7	0.0	0.6	0.2	0.9	1.9	0.3	2.2	1.0	21.1	1.5	1.2	0.4	178.4	0.6	0.1	4.8	5.6	1.2	0.0	2.4	1.8	2.5	0.8	1.7	184.7	0.8	0.0	1.3	1.9	1.0	7.5	1.3	1.8	48.7	0.0	4.0	0.0	45.2	165.3	0.4	1.6	3.4	0.5	3.3	0.6	1.8	0.1	1.0	0.0	7.1	4.0	3.5	3.9	2.7	2.0	0.3	0.7	1.0	0.8	1.2
GASK1A	"C3orf41, DKFZP434B172, FAM198A"	ENSG00000144649	"Golgi associated kinase 1A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.4;Extravillous trophoblasts: 2.6;Fibroblasts: 1.8;Hofbauer cells: 3.9;Syncytiotrophoblasts: 2.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;RPMI-8226: 3.4;SK-BR-3: 2.6;T-47d: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"	NA	NA		600000		"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	5.5	2.1	4.9	2.5	6.4	0.0	4.2	6.3	3.8	10.6	4.9	3.4	0.7	9.8	2.2	1.8	11.3	5.3	1.7	4.1	5.9	1.0	13.1	3.1	0.7	8.8	7.7	6.8	2.0	0.1	3.0	2.0	7.6	2.6	1.0	3.9	2.6	2.2	1.4	1.7	2.1	6.0	6.3	0.9	3.4	2.9	10.0	0.6	2.1	0.8	0.3	3.2	3.9	5.2	0.0	0.0	0.0	3.1	0.1	0.0	1.1	0.2	0.3	0.0	0.0	0.1	0.9	0.0	1.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.6	0.4	1.2	0.8	0.0	0.4	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	3.4	0.0	0.5	0.1	0.3	0.0	2.6	0.0	0.1	6.7	0.9	0.0	0.4	0.6	1.4	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	6.4	6.3	3.8	4.1	5.9	8.8	7.7	7.6	6.3	10.0	5.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181144-89198942	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0"									"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	11.3	5.2	4.0	29.5	3.9	6.6	6.7	4.4	4.8	4.2	2.6	6.6	12.4	8.8	4.5	7.2	9.1	8.8	11.0	3.8	4.3	9.8	14.1	31.2	34.3	7.1	3.7	16.4	1.6	6.5	2.7	11.9	7.7	5.8	7.2	3.4	7.1	6.7	7.1	2.1	11.8	7.7	3.9	29.0	11.9	2.9	4.4	10.0	7.8	9.4	11.0	13.1	4.5	3.9	0.8	0.0	0.1	0.3	0.1	0.1	0.6	1.8	7.6	8.0	7.2	0.1	12.1	0.6	1.0	2.3	0.6	0.9	0.0	0.3	0.4	9.9	0.1	13.0	0.4	0.3	1.0	0.2	0.3	0.4	0.0	0.1	0.0	1.2	1.9	0.3	0.4	2.3	0.0	0.2	6.6	0.3	0.4	0.1	0.1	11.1	0.2	0.4	0.1	18.3	0.2	0.5	0.3	0.7	0.3	0.6	0.5	1.4	0.4	0.3	1.6	0.2	0.2	16.0	0.3	0.3	0.3	0.1	2.3	0.6	4.1	0.4	7.1	14.1	6.1	2.5	7.6	7.9	2.2	3.3	5.6	5.2	5.6	13.8	14.5	0.9	9.0	5.5	4.0	3.9	4.4	4.8	3.8	4.3	7.1	3.7	7.7	3.9	4.4	3.9	84.4	32.1	39.3	0.0	28.3	4.6	9.1	20.7	1.8	2.8	3.5	2.4	3.6	8.6	25.3	5.5	8.4	0.9	29.0	5.1	0.0	2.2	1.9	4.8	8.4	81.2	0.0	11.2	0.5	3.3	1.6	22.2	9.2	7.4	21.5	17.9	92.4	6.5	8.3	0.0	2.5	4.3	4.1	29.2	10.9	1.2	3.7	33.7	5.4	15.9	33.8	15.5	36.0	1.0	0.6	36.3	1.9	1.9	7.2	24.4	4.4	1.5	43.3	12.2	0.0	5.3	11.3	2.4	3.4	2.9	3.0	1.5	34.2	122.6	2.4	13.6
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 73.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.2;NK-cells: 75.2;Plasma cells: 22.9;T-cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 243.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.5;NB-4: 10.0;U-266/70: 20.7;U-937: 31.5"	"Low region specificity"	"Detected in many"							HPA028656	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.7	3.3	0.4	73.9	0.5	34.9	4.6	0.4	1.7	3.1	1.5	6.9	5.8	2.3	1.4	2.6	3.1	11.5	2.0	0.4	0.5	2.0	11.1	19.1	54.4	2.9	0.7	2.7	1.1	0.7	1.0	2.8	1.2	2.3	8.0	0.2	4.8	1.2	0.7	1.0	9.0	6.1	0.5	42.7	9.2	4.0	0.8	12.4	2.3	0.9	23.3	12.7	1.4	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.7	1.2	1.2	0.0	0.1	0.1	6.5	5.3	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.9	0.6	3.0	0.3	0.0	0.0	10.0	1.4	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.6	1.3	0.1	0.0	0.0	4.0	0.1	0.5	0.5	0.0	2.2	20.7	0.5	0.1	0.2	31.5	0.0	0.9	15.3	1.1	97.5	38.0	150.4	4.8	63.1	89.3	6.7	6.0	23.2	35.8	97.9	53.4	44.9	0.7	243.8	38.4	0.4	0.5	0.4	1.7	0.4	0.5	2.9	0.7	1.2	0.5	0.8	0.7	2.1	6.4	5.1	0.0	12.4	0.0	0.2	0.5	0.6	0.0	0.4	0.4	0.7	1.5	4.2	0.0	4.2	0.1	39.2	0.1	0.0	0.0	0.4	3.7	0.4	2.8	0.0	0.8	0.0	1.1	0.0	1.5	2.0	3.9	10.8	0.2	4.6	0.6	4.0	0.0	0.7	0.0	0.0	18.9	1.4	0.2	0.0	17.1	0.0	2.8	10.4	2.9	75.2	0.0	0.0	1.3	0.0	0.0	22.9	0.4	0.0	0.3	8.0	0.4	0.0	0.9	0.9	0.1	2.9	0.9	0.0	0.1	72.9	11.0	0.1	0.1
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GCHFR	"GFRP, HsT16933"	ENSG00000137880	"GTP cyclohydrolase I feedback regulator"	P30047	15	40764068-40767708	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 350.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 787.2;Hofbauer cells: 522.9;Proximal enterocytes: 620.8;Proximal tubular cells: 500.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 120.3;RPTEC TERT1: 146.6;SCLC-21H: 124.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.3;midbrain: 11.8;pons and medulla: 9.4"					HPA046258	Enhanced		Supported	Nucleoplasm		NA	NA		170000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA046258: AB_10967205"	"unprognostic (2.50e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.89e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.62e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.03e-3)"	"unprognostic (9.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.55e-1)"	37.4	20.1	13.6	8.9	13.3	19.5	34.5	17.4	20.1	16.1	18.5	18.7	38.8	6.5	2.2	57.2	15.8	10.0	10.9	13.1	14.5	73.5	350.1	46.4	24.7	18.2	67.3	19.2	15.3	9.8	12.2	6.6	33.7	19.4	6.9	4.2	22.3	3.2	4.5	31.1	60.7	1.7	13.5	13.0	16.4	3.3	15.9	23.0	12.8	7.4	19.5	12.2	17.6	12.2	0.3	7.7	6.2	33.3	9.5	3.4	16.7	2.2	7.8	3.7	7.4	90.7	49.7	46.0	31.1	1.9	2.4	6.1	16.4	3.1	0.8	36.2	26.2	45.5	65.3	120.3	7.7	29.9	15.2	7.8	3.8	1.6	0.6	2.9	14.4	3.7	23.2	13.2	1.1	17.2	7.9	60.4	16.0	8.2	56.5	64.7	0.5	28.8	146.6	24.2	124.6	1.9	20.1	87.7	10.4	8.1	25.3	30.0	0.0	0.6	1.2	2.2	0.3	0.9	6.0	28.9	4.9	66.3	4.0	18.0	73.3	102.4	76.8	23.6	129.0	48.2	67.1	71.1	48.7	31.2	68.3	44.7	11.7	132.6	22.4	90.4	144.4	109.0	13.6	13.3	17.4	20.1	13.1	14.5	18.2	67.3	33.7	13.5	15.9	12.2	24.3	3.2	54.0	0.3	24.9	14.5	21.6	72.2	8.6	2.5	81.4	48.0	0.1	84.4	87.0	64.4	12.5	161.9	25.9	75.7	76.3	52.5	0.6	46.2	4.9	13.7	60.6	24.4	1.6	32.7	37.0	10.1	16.3	35.7	44.4	12.2	31.4	787.2	522.9	0.0	1.7	74.4	111.9	56.1	18.5	0.5	17.7	71.9	67.6	0.0	29.0	26.1	102.0	0.0	0.4	18.7	161.8	8.6	12.8	25.6	620.8	500.2	58.3	22.4	0.0	4.7	12.4	2.9	12.5	79.7	14.9	36.5	49.2	1.7	125.3	40.8
GCSH		ENSG00000140905	"Glycine cleavage system protein H"	P23434	16	81081945-81096395	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 553.4;Extravillous trophoblasts: 1476.4;Proximal tubular cells: 655.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041368, HPA057079"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		50000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA041368: AB_10804001, HPA057079: "	"unprognostic (4.09e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.55e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (6.26e-6)"	"unprognostic (1.12e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.47e-2)"	28.7	20.1	58.9	6.9	66.5	6.3	24.2	62.9	113.8	18.2	50.8	16.0	7.2	17.5	68.9	15.5	19.8	11.7	38.1	55.8	60.9	78.2	118.9	10.8	6.7	60.1	66.0	18.4	19.7	31.0	14.3	26.0	61.1	18.7	13.0	15.6	15.6	16.7	59.3	10.1	9.5	11.8	61.7	6.3	17.5	7.4	63.7	10.4	96.4	63.6	9.3	18.3	15.2	67.8	63.6	28.3	82.4	37.0	40.4	30.9	175.5	35.9	26.4	43.3	20.6	37.0	57.2	17.2	32.3	15.9	31.9	33.3	64.5	36.5	71.6	4.7	86.7	21.8	34.9	114.6	45.7	70.3	24.1	32.0	47.8	26.8	53.7	13.0	22.3	45.1	86.3	3.4	42.9	67.7	45.9	138.8	113.0	49.6	57.5	72.7	44.1	25.5	98.4	56.4	43.7	45.3	53.3	32.9	70.8	63.9	48.3	33.2	19.8	27.6	49.3	44.0	37.8	14.7	31.8	102.1	18.2	41.3	22.6	3.6	1.3	1.3	2.8	2.1	4.6	3.5	2.6	4.0	3.9	2.5	4.4	5.9	1.7	7.0	1.7	10.8	2.2	2.4	58.9	66.5	62.9	113.8	55.8	60.9	60.1	66.0	61.1	61.7	63.7	67.8	31.1	3.2	5.9	16.3	24.8	29.1	94.6	73.6	52.3	43.7	97.9	115.6	12.9	44.3	31.4	80.9	37.5	553.4	13.8	15.3	295.4	70.0	32.4	34.8	128.3	31.9	26.4	71.1	12.6	42.5	1476.4	61.6	31.1	55.2	36.3	38.5	33.2	352.0	118.8	38.7	11.9	34.3	67.1	19.7	34.6	19.5	140.8	18.8	85.4	4.7	17.7	215.8	19.6	19.6	35.2	42.3	17.8	141.1	51.7	123.9	13.7	655.9	20.0	45.7	32.9	46.2	50.2	20.7	77.3	78.4	27.1	228.8	16.3	114.5	49.4	69.8
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GDF11	"BMP-11, BMP11"	ENSG00000135414	"Growth differentiation factor 11"	O95390	12	55743122-55757264	"Predicted secreted proteins"		"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 76.6;Cone photoreceptor cells: 77.2;Horizontal cells: 57.2;Rod photoreceptor cells: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HMC-1: 127.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060985, HPA069609"	Approved		Approved	Vesicles	"Secreted to blood"	No	No	46400	340000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA060985: AB_2684403, HPA069609: AB_2686159"	"unprognostic (5.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.48e-2)"	3.6	4.0	22.5	3.7	17.5	1.8	2.3	16.4	17.8	6.8	15.9	5.4	1.6	7.6	2.0	2.4	5.0	4.6	7.5	18.1	18.5	3.0	1.3	3.6	2.8	22.0	26.6	5.7	2.9	2.9	4.7	2.0	20.9	6.0	1.6	21.6	4.8	9.4	1.8	1.5	3.7	4.6	18.3	5.6	2.7	1.1	22.3	4.6	3.6	2.0	1.8	5.9	3.4	17.7	4.9	7.6	32.8	18.6	24.4	17.8	8.2	10.1	9.5	12.5	10.7	26.0	2.1	9.5	13.0	10.5	5.9	4.6	25.0	18.0	4.3	18.2	22.7	11.7	12.3	4.1	4.9	9.8	127.7	17.2	1.0	18.3	5.2	14.0	16.4	12.7	13.2	30.1	16.0	9.2	16.0	8.5	26.4	0.3	18.9	25.1	8.9	5.9	7.7	6.6	22.2	13.6	6.2	2.8	2.6	13.3	10.7	10.7	10.1	15.0	22.9	11.9	7.4	8.1	2.6	4.9	8.0	9.7	10.8	0.2	0.2	0.5	1.2	0.1	1.0	0.7	0.7	0.7	0.2	0.7	0.6	0.8	0.3	0.2	0.4	0.7	0.5	0.1	22.5	17.5	16.4	17.8	18.1	18.5	22.0	26.6	20.9	18.3	22.3	17.7	8.4	0.0	1.1	19.2	10.9	0.5	9.8	0.6	4.0	76.6	6.3	6.6	25.6	1.5	0.9	0.0	77.2	3.6	16.6	1.5	0.0	5.0	0.6	9.9	35.2	8.0	10.7	11.1	4.3	1.4	5.3	13.3	3.1	18.0	5.7	7.6	6.4	0.2	1.6	57.2	10.8	1.9	0.0	1.9	0.7	0.8	9.0	4.4	3.6	1.9	4.1	30.6	22.6	17.1	3.2	3.3	4.1	5.7	4.1	9.8	3.4	0.5	0.1	53.1	13.1	31.1	18.1	2.9	4.1	3.0	0.9	4.7	18.9	7.2	2.2	6.2
GDF3		ENSG00000184344	"Growth differentiation factor 3"	Q9NR23	12	7689784-7695775	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"kidney: 2.9"	"Cell type enriched"	"Detected in some"	25	"Granulosa cells: 30.2"	"Cancer enriched"	"Detected in some"	422	"testis cancer: 383.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"NTERA-2: 452.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018468	Uncertain				"Secreted to blood"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"			"HPA018468: AB_1849586"	"unprognostic (9.48e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.40e-2)"		"unprognostic (3.09e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	2.9	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	36.8	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.1	0.0	452.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	77.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92473043-92486925	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 53.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 14.2;Intestinal goblet cells: 12.4;NK-cells: 11.3;Plasma cells: 8.6;T-cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 61.9;HMC-1: 47.5;NB-4: 64.7;THP-1: 127.7;U-937: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favorable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.0	0.5	0.1	5.1	0.2	53.7	0.9	0.1	0.1	0.6	0.3	3.6	4.7	0.6	0.5	0.5	0.7	1.9	0.3	0.1	0.1	0.5	1.0	2.8	6.9	0.3	0.1	0.5	9.4	0.2	0.5	0.2	0.2	0.8	4.5	0.0	1.0	0.3	0.2	0.3	5.7	0.4	0.2	7.0	3.2	0.9	0.2	31.2	0.9	0.0	4.4	1.7	0.6	0.2	1.4	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.1	1.0	10.3	0.1	0.7	0.0	0.5	0.4	1.2	0.0	0.2	0.0	2.5	1.6	0.2	5.3	0.1	61.9	47.5	0.0	0.0	0.1	0.1	0.3	0.1	17.1	0.4	15.3	0.1	2.1	39.5	64.7	0.0	0.1	0.2	7.8	2.7	3.4	0.0	0.7	0.1	0.1	0.3	0.1	0.3	0.1	0.0	127.7	0.0	0.0	1.5	0.1	0.2	22.2	1.6	4.0	0.0	261.3	0.0	0.0	0.0	0.4	2.1	0.0	1.0	0.0	0.9	1.4	0.0	0.0	0.3	1.9	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.1	0.2	0.0	0.1	1.4	0.0	0.1	0.0	0.1	12.4	0.0	0.8	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	11.3	0.0	0.1	0.4	0.0	0.0	8.6	0.0	0.7	0.1	0.1	0.0	0.0	0.1	0.2	0.5	3.9	0.0	0.0	0.0	16.4	0.1	0.4	0.0
GFRA1	"GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1"	ENSG00000151892	"GDNF family receptor alpha 1"	P56159	10	116056925-116273284	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.5;Breast glandular cells: 33.1;Fibroblasts: 51.2;Hepatocytes: 42.2;Oligodendrocyte precursor cells: 91.0;Skeletal myocytes: 100.1"	"Cancer enriched"	"Detected in many"	11	"breast cancer: 40.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 44.7;BJ hTERT+ SV40 Large T+ RasG12V: 77.2;EFO-21: 46.5;fHDF/TERT166: 89.3;HBF TERT88: 63.2;MCF7: 59.5;U-251 MG: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043829	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		140000		"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"	Nucleoplasm	"HPA043829: AB_2678689"	"unprognostic (2.07e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.64e-2)"	10.9	3.4	7.2	4.2	14.9	0.0	23.2	2.6	9.5	9.9	0.3	18.3	1.7	4.9	20.5	6.9	17.2	5.6	4.8	9.7	18.0	6.0	16.0	2.8	4.0	7.8	28.5	4.5	6.6	2.7	3.2	0.0	7.2	4.5	3.9	3.2	6.0	5.4	4.3	7.2	8.2	4.8	6.2	3.9	8.2	3.1	7.6	4.1	2.8	13.9	6.4	7.0	9.2	6.1	0.1	3.7	12.2	0.0	0.0	0.1	0.0	7.9	0.4	44.7	77.2	0.0	0.0	0.0	46.5	89.3	0.0	0.0	0.1	0.0	63.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	11.5	0.0	3.9	0.0	9.1	0.0	0.0	5.6	59.5	7.6	0.0	5.0	0.0	0.0	0.0	1.9	0.0	5.0	0.0	1.6	0.1	0.0	0.0	0.1	2.1	0.4	0.0	0.4	0.0	0.4	0.1	53.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	14.9	2.6	9.5	9.7	18.0	7.8	28.5	7.2	6.2	7.6	6.1	6.1	0.0	0.0	40.5	0.5	5.7	0.0	0.0	1.8	4.1	33.1	11.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	13.2	0.0	0.2	3.2	6.0	0.0	5.1	13.5	0.0	51.2	3.1	0.0	6.3	0.1	0.4	42.2	0.0	0.0	6.6	0.0	0.0	1.0	9.6	12.8	8.1	1.0	5.4	1.9	0.0	12.6	0.0	91.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	100.1	16.7	0.1	10.4	0.7	4.5	0.0	0.7	0.1	0.0	0.2
GGACT	A2LD1	ENSG00000134864	"Gamma-glutamylamine cyclotransferase"	Q9BVM4	13	100530164-100589528	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"kidney: 75.5"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"SCLC-21H: 133.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065320	Enhanced					NA	NA		110000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA065320: AB_2685466"	"unprognostic (1.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.12e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.57e-1)"	5.8	6.0	3.4	3.8	4.1	1.6	5.0	3.9	4.7	2.6	3.5	7.6	8.7	3.2	2.1	2.7	3.0	2.9	1.6	3.1	4.0	75.5	16.7	3.0	3.4	4.4	4.1	2.8	15.2	3.0	1.5	3.0	3.9	3.4	4.9	6.8	8.9	3.1	2.3	4.8	6.1	2.4	4.3	4.1	7.1	6.6	3.8	3.6	3.5	4.2	5.8	3.4	2.5	4.7	14.2	1.7	11.3	12.2	9.4	14.3	4.9	8.8	2.3	1.5	3.8	0.2	12.6	1.4	4.9	6.4	0.2	0.7	1.8	2.6	0.5	20.1	7.6	6.0	1.1	0.7	13.4	8.6	19.1	17.3	9.8	0.2	0.8	0.1	5.7	6.6	3.1	0.3	2.3	0.9	1.4	1.1	0.6	27.4	3.8	0.9	2.8	1.8	14.1	2.4	133.3	5.0	2.8	6.2	6.6	10.5	5.9	28.0	5.5	0.0	0.1	3.0	2.4	7.3	4.4	0.5	0.7	6.4	6.2	0.0	4.1	0.8	5.8	5.9	5.5	3.9	4.8	6.4	3.3	4.3	2.9	4.3	0.0	7.0	6.2	2.4	5.4	3.4	3.4	4.1	3.9	4.7	3.1	4.0	4.4	4.1	3.9	4.3	3.8	4.7	3.2	0.0	1.5	7.5	7.2	2.7	3.0	1.1	5.2	1.7	4.4	3.2	0.9	1.5	2.1	7.3	14.6	13.4	2.6	4.6	7.9	8.7	4.7	2.6	2.1	3.4	7.8	1.7	2.7	10.0	11.8	3.6	3.1	4.2	5.7	4.1	4.2	14.0	12.1	1.7	3.2	4.7	2.0	9.8	1.4	10.3	2.8	6.2	0.0	4.7	10.0	6.8	19.6	3.5	8.0	9.1	4.5	3.8	2.1	2.3	10.5	152.0	0.1	3.3	6.6	4.3	1.8	22.5	10.9	3.9	2.0	4.4	6.1	12.4	7.7	2.5
GGH		ENSG00000137563	"Gamma-glutamyl hydrolase"	Q92820	8	63014881-63039407	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.7;liver: 188.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 510.3;Early spermatids: 471.0;Extravillous trophoblasts: 273.4;Proximal tubular cells: 340.8;Syncytiotrophoblasts: 754.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 30.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 30.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019296, HPA025226"	Approved				"Intracellular and membrane"	NA	NA		1200000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB019296: , HPA025226: AB_1849645"	"unprognostic (9.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	9.8	5.4	11.1	14.2	11.1	43.7	16.5	10.7	14.3	5.9	13.1	54.3	11.3	6.3	4.4	20.7	3.5	4.3	3.1	11.1	12.3	125.7	188.6	8.0	10.9	13.3	11.1	3.1	9.9	13.1	1.9	54.9	13.7	4.4	74.4	2.1	13.0	3.7	2.1	27.2	9.9	11.6	10.1	5.5	8.2	33.9	14.4	17.8	2.4	3.2	22.5	8.5	10.8	11.1	110.5	97.6	97.4	15.7	94.1	39.6	69.6	64.3	105.1	94.2	137.7	144.5	183.8	69.8	18.0	77.1	166.8	87.2	97.2	101.9	138.9	139.0	71.6	112.3	50.3	105.1	17.6	53.5	65.9	29.1	29.2	93.9	50.7	59.4	116.1	66.9	62.4	255.2	177.3	64.3	28.8	71.1	51.0	231.6	86.0	77.6	95.2	98.1	75.8	40.3	38.6	69.9	91.8	103.6	98.5	91.6	116.6	65.8	65.5	104.2	115.6	99.4	111.3	112.6	127.2	88.3	158.0	0.1	185.0	0.0	2.1	2.3	1.1	1.7	0.8	6.5	1.5	1.7	0.9	2.7	1.8	1.9	3.0	4.4	2.0	30.6	2.7	1.9	11.1	11.1	10.7	14.3	11.1	12.3	13.3	11.1	13.7	10.1	14.4	11.1	13.1	16.0	7.3	11.1	26.1	30.2	23.2	66.6	9.1	2.0	14.9	21.0	3.2	17.2	31.1	22.0	0.0	510.3	11.7	49.2	37.2	19.7	471.0	5.4	11.5	13.1	13.2	62.5	11.5	7.4	273.4	27.2	11.7	7.6	10.8	21.4	13.6	219.5	72.4	0.0	8.7	70.7	44.7	21.0	15.5	154.2	5.9	12.0	24.9	1.0	32.1	23.1	2.1	3.5	2.9	4.3	23.7	8.2	106.9	10.5	4.3	340.8	18.3	1.3	26.3	12.8	20.4	80.3	133.0	35.9	43.0	754.5	8.5	9.3	102.0	23.1
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245108	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 42.8;Fibroblasts: 58.3;Leydig cells: 36.4;Sertoli cells: 184.1;Smooth muscle cells: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.3;eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.9;ASC TERT1: 124.4;HHSteC: 234.7;HSkMC: 271.7;TIME: 110.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		22000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	137.6	60.5	39.0	18.6	39.3	1.4	90.6	37.6	41.7	73.2	32.8	27.8	19.4	54.4	12.9	19.6	70.6	37.2	93.4	35.0	45.1	78.2	55.2	37.7	48.0	52.2	46.3	26.6	25.8	13.2	41.1	11.9	46.9	49.3	12.0	2.1	37.1	20.9	23.1	40.1	40.8	32.2	41.9	36.1	40.0	9.6	45.3	10.4	110.2	16.6	18.3	45.1	64.2	38.2	0.0	1.8	0.6	0.0	164.9	124.4	1.1	2.9	0.2	0.1	0.0	0.1	0.1	0.2	3.4	0.2	0.3	0.3	0.1	0.1	0.0	2.2	0.9	6.7	1.0	24.1	234.7	3.0	6.4	271.7	0.1	3.4	3.2	0.4	45.8	0.7	0.4	1.2	44.1	0.4	0.0	22.4	3.6	1.1	0.0	0.1	4.0	1.0	6.1	0.0	0.4	5.9	0.1	7.3	0.1	22.7	1.0	1.7	110.8	0.1	2.3	0.1	0.0	0.3	1.5	0.2	3.9	5.7	0.2	2.3	0.5	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.2	39.0	39.3	37.6	41.7	35.0	45.1	52.2	46.3	46.9	41.9	45.3	38.2	27.2	3.2	16.0	1.0	0.3	7.0	3.3	3.2	0.0	0.0	7.2	4.2	4.4	0.0	17.9	0.0	0.0	0.2	0.4	0.0	0.0	0.6	0.8	0.3	8.3	42.8	0.0	2.7	0.1	0.2	0.2	58.3	1.1	0.4	1.3	0.0	33.5	0.1	2.1	0.0	0.1	0.0	0.0	1.0	12.5	3.3	36.4	1.8	3.6	22.5	3.3	0.3	0.0	0.5	0.0	0.4	0.0	23.7	0.3	2.2	0.0	0.1	2.2	1.0	184.1	33.9	85.6	0.6	0.4	0.3	4.4	0.3	1.1	2.1	0.0	1.4
GHRHR		ENSG00000106128	"Growth hormone releasing hormone receptor"	Q02643	7	30938669-30993254	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	351	"pituitary gland: 211.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Spermatocytes: 1.2;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"				"unprognostic (8.32e-2)"		"unprognostic (1.45e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.39e-1)"		"unprognostic (7.23e-2)"	"unprognostic (4.15e-1)"		"unprognostic (2.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.87e-3)"		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	211.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.1	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GIMAP4	"FLJ11110, HIMAP4, IAN1, IMAP4"	ENSG00000133574	"GTPase, IMAP family member 4"	Q9NUV9	7	150567369-150573953	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 127.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 182.3;Endothelial cells: 195.2;Hepatic stellate cells: 222.0;Kupffer cells: 197.2;Macrophages: 110.0;monocytes: 176.0;NK-cells: 344.0;T-cells: 186.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	26	"HUVEC TERT2: 326.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019135, HPA019137, HPA027198"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599"	"unprognostic (5.03e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.08e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-1)"	46.1	18.3	15.0	75.1	15.6	4.2	31.8	16.2	21.2	19.7	16.3	21.2	16.5	23.0	9.6	12.0	18.7	24.6	31.3	14.3	16.0	17.3	29.9	50.8	127.7	19.2	18.0	7.7	6.7	9.6	6.0	48.7	18.0	10.2	22.4	1.5	11.2	13.3	17.5	8.4	25.0	38.3	18.8	115.6	18.0	4.2	16.4	30.5	21.1	48.1	85.1	31.1	11.6	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	326.4	3.4	0.1	0.3	0.0	0.0	0.4	0.2	0.4	0.0	0.0	12.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	370.2	5.2	325.8	390.9	404.2	3.0	408.0	402.8	122.1	1.3	424.3	361.9	339.7	263.4	320.4	5.3	312.1	776.9	15.0	15.6	16.2	21.2	14.3	16.0	19.2	18.0	18.0	18.8	16.4	18.7	182.3	3.2	12.4	0.3	7.3	6.8	0.2	0.0	3.4	0.1	2.2	4.7	9.9	5.7	1.8	11.0	0.0	0.6	82.6	0.0	0.0	0.2	0.6	0.3	0.4	195.2	0.0	9.7	0.5	0.2	0.8	9.0	2.0	0.3	6.3	0.0	222.0	3.7	96.4	0.0	0.1	0.0	0.0	197.2	20.9	1.7	5.0	110.0	10.6	18.7	176.0	0.2	344.0	0.0	0.1	0.1	0.0	0.0	14.7	0.4	0.0	1.9	0.7	0.4	13.1	3.9	7.9	0.0	0.8	1.1	6.1	0.8	186.2	0.8	0.0	0.3
GIMAP5	"HIMAP3, IAN4L1, IAN5"	ENSG00000196329	"GTPase, IMAP family member 5"	Q96F15	7	150722253-150750033	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 106.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.1;Basal keratinocytes: 11.1;Endothelial cells: 29.7;Langerhans cells: 13.9;Suprabasal keratinocytes: 10.7;T-cells: 31.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 41.7"															NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.77e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.13e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.47e-2)"	34.4	13.6	13.3	44.8	14.2	5.2	25.5	13.7	16.8	15.9	12.7	16.6	10.6	17.1	8.8	12.4	18.9	17.9	24.2	12.8	13.2	12.7	23.3	39.7	106.2	15.2	14.1	5.9	8.7	9.1	4.1	26.4	14.8	6.6	16.5	0.8	7.2	9.0	12.4	7.2	22.1	30.5	14.2	64.2	15.6	3.5	14.7	25.1	18.3	43.9	66.4	26.7	6.7	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.3	0.0	1.4	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.4	0.0	3.6	70.5	1.1	260.4	106.3	337.2	1.1	436.3	334.0	8.0	0.6	521.5	280.6	8.3	188.3	43.6	1.6	176.9	510.2	13.3	14.2	13.7	16.8	12.8	13.2	15.2	14.1	14.8	14.2	14.7	13.8	22.1	0.0	1.7	0.0	1.4	11.1	0.3	0.0	1.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.1	5.8	0.2	0.0	0.0	0.1	0.0	0.1	29.7	0.0	0.4	0.0	0.0	0.4	2.6	0.5	0.1	2.5	0.0	8.9	0.6	3.1	0.0	0.0	0.2	0.0	5.3	13.9	0.1	0.0	7.1	3.6	0.0	2.2	0.0	9.2	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.1	0.1	0.0	0.1	0.0	0.7	3.2	0.2	0.1	0.1	10.7	0.3	31.5	0.1	0.1	0.1
GIMAP6	"FLJ22690, IAN6"	ENSG00000133561	"GTPase, IMAP family member 6"	Q6P9H5	7	150625375-150632648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.3;Endothelial cells: 83.5;Hepatic stellate cells: 92.1;Kupffer cells: 75.2;monocytes: 37.4;NK-cells: 91.6;T-cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"monocytes: 75.1;NK-cells: 217.3;T-cells: 127.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.4;HUVEC TERT2: 124.9;MOLT-4: 43.3;TIME: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026715, HPA050740"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA026715: AB_1849675, HPA050740: AB_2797239"	"unprognostic (8.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.56e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.91e-4)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.88e-2)"	"unprognostic (8.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.68e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.75e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	42.0	9.4	9.7	33.9	9.7	2.5	21.8	9.7	10.6	14.9	8.0	12.0	13.6	19.3	7.3	8.4	16.9	14.7	29.1	8.0	9.5	12.4	12.7	38.8	50.2	11.4	10.5	5.7	5.2	8.0	3.3	32.3	11.3	6.4	12.2	0.6	7.8	10.0	24.7	6.4	18.7	25.8	10.9	64.0	11.6	3.2	11.6	29.3	14.2	34.7	33.9	16.5	6.5	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	6.3	0.0	0.0	0.0	0.4	18.4	0.1	0.0	0.0	0.0	0.0	124.9	0.5	0.0	4.6	0.0	0.0	43.3	5.4	0.0	0.0	0.0	4.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.8	35.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	13.0	0.0	11.6	58.1	2.1	112.9	75.1	127.2	0.4	104.3	120.2	22.1	0.3	108.3	103.0	8.0	217.3	60.2	0.7	105.7	163.5	9.7	9.7	9.7	10.6	8.0	9.5	11.4	10.5	11.3	10.9	11.6	10.1	95.3	0.0	1.1	0.0	3.1	3.8	0.1	0.0	0.6	0.0	1.1	1.0	7.4	0.0	0.0	0.0	0.0	0.2	24.5	0.1	0.0	0.0	0.4	0.1	0.2	83.5	0.0	19.4	0.0	0.2	0.3	3.4	0.0	0.2	2.5	0.3	92.1	1.7	30.6	0.0	0.0	0.1	0.0	75.2	6.5	2.2	1.2	20.0	1.8	13.1	37.4	0.1	91.6	0.0	0.1	0.1	0.0	0.0	2.9	0.1	0.0	0.2	0.7	0.4	0.0	2.6	2.2	0.3	0.1	0.4	3.1	0.4	41.2	1.2	0.0	0.3
GIMAP8	"DKFZp667I133, hIAN6, IAN9"	ENSG00000171115	"GTPase, IMAP family member 8"	Q8ND71	7	150450630-150479393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.4;Endothelial cells: 66.0;Hepatic stellate cells: 86.0;Kupffer cells: 75.1;Microglial cells: 32.8;monocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 59.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014474, HPA017765"	Supported					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014474: AB_1849685, HPA017765: AB_1849683"	"unprognostic (7.86e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.31e-1)"	20.3	5.7	4.4	21.3	5.0	0.7	16.0	4.7	5.5	9.8	5.5	6.7	6.8	10.4	3.1	4.3	9.0	7.5	17.4	4.1	4.5	8.3	9.4	27.0	23.2	5.4	4.9	3.5	2.8	4.6	2.6	15.4	5.4	4.9	7.2	0.3	4.3	5.3	9.8	4.7	10.5	12.7	5.4	40.6	5.0	2.0	5.1	7.3	11.9	15.1	13.5	8.4	5.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	59.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.7	0.0	9.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.5	45.2	0.0	15.3	59.0	17.4	0.5	14.8	13.9	13.0	0.0	16.7	13.6	4.8	15.5	57.4	0.7	7.7	26.8	4.4	5.0	4.7	5.5	4.1	4.5	5.4	4.9	5.4	5.4	5.1	5.8	67.4	3.2	5.3	0.3	0.8	3.1	0.5	0.0	1.8	0.0	0.4	0.8	5.5	5.7	0.0	1.8	0.0	0.0	5.3	0.0	0.0	0.0	0.3	0.2	0.1	66.0	0.0	1.3	0.1	0.0	0.0	2.3	0.5	0.2	3.8	0.0	86.0	1.6	6.8	0.0	0.1	0.0	0.0	75.1	2.8	0.9	0.3	21.9	0.0	32.8	44.2	0.0	19.6	0.0	0.1	0.0	0.0	0.0	2.2	0.9	0.0	0.2	1.5	0.0	0.0	1.5	1.2	0.2	0.4	0.5	1.7	0.1	11.1	0.2	0.0	0.4
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138444	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.0;kidney: 41.4;lymphoid tissue: 27.9"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 122.1;Proximal tubular cells: 267.7;Undifferentiated cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.1;HaCaT: 6.0;Hep G2: 23.0;HUVEC TERT2: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	3.9	23.8	0.5	1.7	0.4	0.3	3.0	0.4	0.5	1.8	0.5	15.6	38.0	2.1	0.9	2.1	3.1	5.5	1.5	0.5	0.4	41.4	18.4	2.7	0.8	0.4	0.4	2.4	18.1	2.3	0.9	3.5	0.4	1.7	14.9	0.1	4.2	0.9	1.1	4.7	38.0	2.8	0.4	27.9	6.0	1.0	0.5	0.4	1.0	1.6	0.8	2.0	1.9	0.4	0.0	0.0	0.0	0.1	2.4	6.1	0.0	1.0	0.0	0.5	1.1	5.1	3.3	1.5	0.1	0.5	0.0	6.0	0.0	0.0	3.2	0.2	0.0	0.8	0.0	23.0	1.2	0.0	0.0	1.0	0.1	3.5	0.1	0.0	23.5	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.4	33.6	0.0	1.3	2.0	2.0	12.9	2.4	0.9	4.0	0.4	5.2	1.5	3.2	27.1	2.5	9.2	2.1	6.7	0.0	43.7	33.2	11.8	2.5	13.3	0.9	21.6	3.0	0.4	14.7	33.0	3.1	2.9	8.6	7.2	0.0	5.9	22.9	43.3	13.2	0.0	15.2	34.4	0.0	0.8	1.9	1.2	1.2	2.1	0.0	14.0	1.0	0.0	0.0	4.5	8.9	16.5	39.3	0.0	0.0	0.8	122.1	267.7	11.7	0.5	0.0	1.3	1.3	0.6	2.5	7.9	21.7	1.6	1.3	32.4	63.8	6.0
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161052	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 7.8;parathyroid gland: 4.0;placenta: 2.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 13.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.3;melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 7.7;HL-60: 6.6;U-266/84: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	7.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.1	0.0	1.0	0.0	0.2	0.0	4.4	0.2	0.0	3.7	0.1	1.1	0.0	0.5	3.5	0.6	0.7	0.4	7.7	0.0	0.1	1.3	1.2	0.1	2.5	2.1	0.5	0.2	1.9	1.8	0.0	0.0	0.0	6.6	0.0	0.2	1.2	0.1	0.3	0.0	0.0	2.8	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.1	1.5	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	3.7	0.1	0.8	1.4	0.0	0.0	0.0	1.5	0.2	1.7	4.7	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.2	0.0	0.0	0.0	13.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	2.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71212811-71225516	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 100.9;liver: 335.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 143.2;SK-MEL-30: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.1	0.0	27.1	3.7	63.2	0.0	6.4	76.5	37.6	8.8	12.7	33.9	44.0	1.7	22.5	0.3	27.4	41.5	0.0	27.3	40.9	42.9	335.7	2.4	0.0	90.6	64.4	0.1	83.0	0.0	0.1	0.0	76.0	11.6	23.8	0.0	37.7	7.5	0.0	0.9	34.4	1.8	50.0	0.1	16.4	10.2	56.9	0.0	0.1	0.1	0.0	0.4	0.1	100.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.3	0.0	5.1	0.2	0.0	0.2	0.0	0.0	155.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.1	63.2	76.5	37.6	27.3	40.9	90.6	64.4	76.0	50.0	56.9	100.9	0.0	0.0	4.8	0.3	0.8	0.6	0.7	0.5	0.0	0.0	7.7	2.4	0.1	114.4	2.7	9.2	0.0	0.0	0.1	50.2	9.8	34.1	0.3	8.2	3.4	0.6	9.6	8.0	0.2	58.9	0.0	0.1	15.8	29.0	4.5	0.0	3.3	286.4	0.0	0.0	0.2	29.4	2.0	4.8	0.4	0.4	0.3	0.8	23.2	0.0	0.6	0.0	0.0	1.0	51.3	32.3	53.4	0.4	0.0	2.6	118.8	68.9	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	1.0	0.0	66.1	2.8
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20192938	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 328.1;esophagus: 812.1;vagina: 519.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 69.8;Basal respiratory cells: 237.4;Basal squamous epithelial cells: 55.8;Ionocytes: 50.8;Squamous epithelial cells: 160.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 144.6;hTCEpi: 105.4;OE19: 76.9;RT4: 169.9"	"Low region specificity"	"Detected in all"							"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	2.0	0.7	1.3	6.7	1.2	3.8	3.7	2.4	3.1	328.1	5.3	20.8	12.9	2.9	3.4	812.1	0.9	14.0	0.4	1.1	1.7	9.8	47.5	0.7	0.4	1.8	1.7	0.3	1.3	0.1	4.1	0.2	1.7	1.2	17.4	0.0	145.2	0.3	0.4	73.0	10.6	2.6	1.7	0.2	8.1	1.2	7.6	12.5	1.7	1.2	90.4	27.9	519.8	1.6	8.7	0.6	0.0	0.2	0.0	2.9	1.7	0.0	0.0	0.0	0.0	1.3	144.6	0.0	0.7	0.1	1.1	28.9	5.3	14.4	0.1	12.6	1.8	0.1	0.1	0.3	0.0	0.0	5.1	2.4	105.4	1.9	19.5	0.0	0.0	2.1	0.1	10.7	0.2	1.4	1.3	0.0	0.3	76.9	14.4	0.2	0.0	8.3	0.2	169.9	0.1	0.0	0.3	0.1	0.3	1.9	2.2	0.4	0.0	0.2	0.0	2.5	22.2	8.7	9.6	0.0	17.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.4	3.1	1.1	1.7	1.8	1.7	1.7	1.7	7.6	1.6	0.1	3.2	0.0	2.0	0.6	69.8	16.1	237.4	55.8	0.0	1.3	1.3	0.5	4.3	37.3	1.8	0.0	0.1	0.0	28.0	0.0	4.4	1.5	5.0	1.5	1.3	4.2	0.0	0.0	9.8	0.2	1.7	4.1	19.1	0.0	0.0	0.0	25.2	0.6	0.0	0.0	6.1	50.8	0.6	13.3	1.3	0.0	3.9	1.8	0.0	4.6	0.0	0.0	0.0	0.0	9.2	13.3	0.0	2.7	8.6	10.7	17.5	7.5	0.0	0.0	0.1	4.7	0.8	2.1	160.9	28.7	0.1	0.9	0.0	25.0	21.7
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149930-228159826	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 51.3"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 12.5;Oligodendrocytes: 26.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.4;SCLC-21H: 2.9;TIME: 2.7"	"Region enhanced"	"Detected in all"		"white matter: 105.5"	"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.9	0.9	13.6	0.6	31.2	0.2	1.7	39.0	20.2	4.2	5.2	5.8	0.2	4.7	0.9	1.4	5.4	0.7	1.7	13.9	19.5	1.3	0.5	2.9	0.6	43.9	31.6	3.8	0.5	0.7	1.4	0.5	38.1	3.0	0.3	0.5	0.8	1.7	0.8	1.7	1.7	1.8	28.1	1.4	2.4	1.2	27.6	0.4	2.0	0.8	0.3	4.2	3.5	51.3	0.2	0.2	0.1	0.3	0.8	0.4	1.0	0.8	0.2	0.3	0.4	0.5	0.7	0.1	5.4	1.5	0.4	0.5	0.2	0.2	0.1	0.2	0.9	0.2	1.4	1.2	1.4	0.0	0.0	0.2	0.1	0.5	0.3	0.7	0.1	1.0	0.6	0.1	0.2	0.3	1.1	0.3	0.3	0.0	1.1	0.2	0.1	0.0	0.4	0.0	2.9	1.7	0.2	0.0	0.2	0.1	0.1	0.2	2.7	0.7	2.1	2.5	0.9	0.1	0.4	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.6	31.2	39.0	20.2	13.9	19.5	43.9	31.6	38.1	28.1	27.6	51.3	2.8	0.0	0.6	0.7	0.2	3.4	1.3	0.6	1.8	2.6	1.3	0.6	1.8	0.0	0.0	0.0	12.5	0.0	0.4	0.2	0.0	0.1	0.2	1.0	1.1	4.3	0.0	0.0	0.8	0.5	0.0	2.2	0.0	1.6	0.0	0.3	3.6	0.0	0.1	3.3	1.1	0.3	0.0	0.6	3.8	0.0	2.5	1.3	1.8	0.0	0.0	0.3	0.0	0.0	26.9	1.1	0.0	4.1	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.6	1.8	0.0	0.0	0.5	1.7	0.0	0.8	0.6	0.3	1.0
GJD2	"CX36, GJA9"	ENSG00000159248	"Gap junction protein delta 2"	Q9UKL4	15	34751032-34754998	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.9;pituitary gland: 7.5;retina: 21.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.2;Cone photoreceptor cells: 39.6;Horizontal cells: 6.7;Rod photoreceptor cells: 13.7"	"Cancer enriched"	"Detected in single"	32	"pancreatic cancer: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"								"unprognostic (4.30e-2)"						"unprognostic (2.87e-2)"			"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"			0.0	5.9	1.1	0.0	0.6	0.0	0.0	1.1	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.7	1.1	0.3	0.0	0.0	0.0	3.2	1.4	0.0	3.9	0.0	7.5	0.0	1.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.6	1.1	1.4	0.7	1.1	3.2	1.4	1.0	0.2	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.8	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731462	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.7;kidney: 107.7;liver: 79.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.2;Macrophages: 133.4;Proximal enterocytes: 144.2;Proximal tubular cells: 161.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"neutrophil: 178.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 178.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.4;Hep G2: 46.4"	"Low region specificity"	"Detected in all"							HPA060687	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"			"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	8.8	9.8	3.1	51.5	2.8	6.6	4.8	3.7	17.2	4.8	8.4	13.0	86.6	3.6	12.3	9.6	7.7	23.8	4.8	2.3	4.1	107.7	79.2	19.7	10.6	7.2	4.2	2.6	4.5	14.0	5.4	8.2	6.8	3.6	10.9	10.3	11.2	2.2	2.6	6.3	90.7	4.4	3.6	10.1	6.2	2.9	14.5	5.4	6.6	3.1	14.5	30.2	2.7	8.0	4.5	3.5	4.5	7.7	2.7	10.4	1.8	10.6	37.4	7.6	8.6	5.8	4.1	12.6	1.7	4.1	6.9	0.3	8.5	3.5	10.1	8.2	9.6	7.5	6.6	46.4	17.2	14.2	15.4	6.3	4.9	24.2	22.3	1.9	6.0	9.6	4.0	17.3	2.1	6.2	11.0	14.6	7.5	4.9	4.0	15.0	7.1	13.1	5.7	14.8	4.8	6.1	9.4	9.4	21.5	4.5	10.6	10.1	2.3	5.5	2.3	0.3	4.9	9.1	10.7	12.5	9.5	9.1	5.6	5.0	22.8	7.9	1.7	7.2	1.3	3.1	3.1	2.2	14.2	5.6	1.8	1.9	178.4	4.8	9.1	4.2	11.5	6.2	3.1	2.8	3.7	17.2	2.3	4.1	7.2	4.2	6.8	3.6	14.5	8.0	2.0	16.0	27.4	19.6	15.8	6.9	12.3	12.6	4.6	3.2	9.4	3.9	4.3	12.8	22.5	7.3	16.7	1.2	5.6	54.7	35.2	21.9	61.5	15.1	2.7	3.8	12.1	6.3	41.5	11.1	1.1	12.4	20.9	1.7	14.5	6.9	3.6	38.1	34.8	5.0	37.2	14.7	0.0	26.6	139.2	29.9	1.2	133.4	14.2	10.3	42.6	29.1	3.1	28.6	19.6	10.6	39.9	2.2	12.4	17.0	144.2	161.1	47.7	17.7	0.0	9.2	7.0	15.3	1.7	14.7	16.9	0.8	15.7	3.7	11.0	26.8
GLB1L2		ENSG00000149328	"Galactosidase beta 1 like 2"	Q8IW92	11	134331874-134378341	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 160.6"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 182.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 21.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;NK-cell: 3.1"	"Group enriched"	"Detected in many"	24	"NK-cells: 3.1;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.9;HaCaT: 52.6;OE19: 123.6;SCLC-21H: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054808, HPA059955"	Uncertain		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA054808: AB_2682608, HPA059955: AB_2684178"	"unprognostic (2.63e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.01e-1)"	1.5	2.1	3.0	2.6	2.1	0.3	7.0	0.1	7.7	5.9	14.7	27.6	5.7	33.9	2.1	3.5	25.6	2.8	1.2	8.5	0.3	20.7	0.6	3.6	0.6	1.0	0.8	13.7	10.6	25.0	14.1	1.5	1.0	34.5	11.7	160.6	9.1	25.2	1.0	9.4	4.0	4.4	0.1	0.6	9.0	8.3	0.7	0.5	22.7	0.2	0.6	6.7	5.0	1.3	16.0	1.6	8.2	4.7	0.0	0.0	5.5	0.0	0.0	0.0	0.0	13.3	49.9	0.0	16.3	0.0	6.8	52.6	25.2	0.4	0.0	0.0	23.9	0.0	6.7	0.6	2.2	0.0	28.4	0.3	0.7	0.0	0.0	0.0	0.1	7.6	26.3	0.0	0.0	15.3	4.4	3.0	4.7	123.6	18.2	0.0	0.0	1.5	14.1	11.0	34.9	13.1	11.4	14.2	0.0	1.2	18.4	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	4.1	0.0	3.1	0.0	0.0	0.0	3.2	0.0	1.2	0.0	0.6	1.2	0.0	0.1	0.9	1.4	0.0	3.1	0.0	0.0	0.0	0.5	3.0	2.1	0.1	7.7	8.5	0.3	1.0	0.8	1.0	0.1	0.7	1.3	0.2	0.0	1.8	0.3	0.4	2.2	5.2	1.0	1.8	6.2	7.2	7.9	1.6	1.5	2.5	0.0	41.7	0.2	3.4	19.5	0.0	2.5	2.1	7.9	22.1	1.2	9.0	0.0	1.6	2.4	1.0	3.6	4.1	2.2	0.0	41.9	0.0	0.2	0.2	5.0	1.2	5.9	0.0	0.0	0.3	6.8	1.2	0.3	5.4	1.0	0.0	10.8	1.0	1.0	0.3	2.2	6.3	0.7	2.2	8.1	3.0	8.4	10.1	182.0	0.0	3.7	2.3	2.6	4.6	1.9	0.9	0.1	2.5	3.4	11.5	2.7
GLB1L3	FLJ90231	ENSG00000166105	"Galactosidase beta 1 like 3"	Q8NCI6	11	134274245-134319564	"Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.0;prostate: 7.9;seminal vesicle: 4.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.8;Excitatory neurons: 39.5;Inhibitory neurons: 20.9;Oligodendrocyte precursor cells: 11.6;Spermatogonia: 7.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.0"	"Region enhanced"	"Detected in some"		"cerebral cortex: 4.0"	"Group enriched"	"Detected in many"	11	"gdT-cell: 1.2;memory CD4 T-cell: 3.1;memory CD8 T-cell: 1.9;naive CD4 T-cell: 2.4;naive CD8 T-cell: 1.9;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.5;JURKAT: 11.4;NTERA-2: 3.4;PC-3: 4.5;SCLC-21H: 6.8"	"Not detected"	"Not detected"							HPA039916	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA039916: AB_2676746"	"unprognostic (1.64e-3)"	"unprognostic (7.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.55e-2)"	"unprognostic (8.69e-3)"	"prognostic favorable (1.97e-4)"	"unprognostic (6.58e-3)"	"unprognostic (3.81e-1)"	"unprognostic (6.95e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.52e-5)"	"unprognostic (1.39e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.07e-1)"	0.0	1.0	0.9	0.4	1.0	0.1	0.3	2.3	4.0	0.4	0.0	0.9	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.2	7.9	0.0	1.6	2.7	4.3	0.0	3.3	0.1	0.0	0.0	0.1	0.0	1.3	0.2	0.1	1.3	0.0	0.1	0.1	0.8	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.2	0.0	2.1	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	2.2	0.0	3.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	6.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	3.1	1.9	0.0	0.0	2.4	1.9	0.0	0.0	0.0	0.0	1.5	0.6	0.9	1.0	2.3	4.0	0.4	0.1	0.5	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	1.3	0.1	0.5	0.1	1.3	0.0	0.5	0.4	1.3	0.7	0.0	0.1	0.0	0.0	1.3	0.3	0.0	0.0	0.0	9.8	0.1	0.3	0.3	0.0	0.0	39.5	0.0	3.4	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	20.9	0.0	0.0	0.0	0.0	1.2	0.6	0.1	0.0	1.9	0.0	0.3	0.0	11.6	0.9	0.1	0.0	0.0	0.3	0.4	0.0	0.5	0.0	0.7	0.0	0.0	0.1	4.3	7.5	0.0	0.1	1.2	0.3	0.0	0.0	0.1
GLDC	"GCSP, NKH"	ENSG00000178445	"Glycine decarboxylase"	P23378	9	6532467-6645729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 173.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 31.3;Cytotrophoblasts: 79.0;Extravillous trophoblasts: 41.6;Hepatocytes: 120.5;Oligodendrocyte precursor cells: 52.3;Proximal tubular cells: 31.6;Syncytiotrophoblasts: 46.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 41.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 235.7;CACO-2: 58.2;HMC-1: 45.6;RPTEC TERT1: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002318, HPA052887"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		740000	"Cluster 37: B-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA002318: AB_1849700, HPA052887: AB_2681980"	"unprognostic (6.73e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (5.24e-5)"	"unprognostic (1.50e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.17e-2)"	0.3	0.3	15.3	1.4	15.5	0.5	0.8	14.7	23.7	0.4	12.9	1.0	0.8	0.4	5.2	3.2	0.7	0.8	0.1	14.8	14.4	38.2	173.5	1.0	1.6	14.0	13.6	0.3	0.1	0.0	4.9	15.2	13.4	0.5	0.4	1.6	1.1	1.0	1.3	4.5	0.8	0.0	13.1	1.2	1.0	3.5	15.8	0.0	5.1	0.1	1.2	1.1	0.1	15.3	0.6	4.9	2.1	25.6	0.2	0.4	235.7	0.1	0.0	0.0	0.1	58.2	0.5	0.3	5.6	0.1	0.7	0.4	0.0	0.7	0.2	1.2	13.4	0.2	0.3	38.3	0.0	0.1	45.6	0.0	0.1	1.8	0.3	1.0	9.0	4.3	0.0	0.5	1.2	1.5	0.9	0.2	27.5	4.6	3.8	1.3	0.0	0.5	95.4	1.0	22.6	11.7	0.0	21.4	0.3	13.9	5.3	0.1	3.0	0.6	0.6	2.6	1.3	1.1	34.4	0.1	0.8	2.4	5.1	0.4	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	15.3	15.5	14.7	23.7	14.8	14.4	14.0	13.6	13.4	13.1	15.8	15.3	0.2	0.0	0.0	17.6	1.9	0.0	0.0	0.2	1.2	0.4	1.5	0.6	0.7	11.5	0.1	31.3	0.0	79.0	0.2	0.0	5.9	0.0	12.6	5.4	0.5	0.6	0.0	0.0	21.6	0.2	41.6	0.3	0.0	10.7	0.0	1.1	2.2	120.5	7.0	0.0	15.9	0.0	0.0	2.8	0.3	10.8	0.3	0.4	0.0	1.9	0.0	9.6	0.0	52.3	1.8	0.1	0.0	0.0	15.1	0.0	0.0	31.6	0.0	0.4	0.0	1.7	0.8	4.5	5.1	0.4	0.0	46.0	0.8	0.0	0.0	0.1
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57459785-57472268	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 11.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 6.5;Leydig cells: 29.5;Peritubular cells: 42.9;Sertoli cells: 13.1;Theca cells: 7.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.2;BJ hTERT+: 16.9;NTERA-2: 14.0;RH-30: 60.6;U-266/70: 16.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122"	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	2.4	1.2	1.3	1.7	1.6	0.5	1.5	3.5	1.9	11.1	0.4	3.0	2.5	9.5	6.6	0.6	3.7	5.5	2.1	1.0	2.1	1.4	0.8	1.6	0.7	1.9	2.4	1.5	0.8	0.0	1.0	0.5	1.7	4.2	4.1	0.0	1.5	2.8	0.6	1.7	3.3	2.4	1.7	0.9	1.9	4.7	4.2	0.3	2.3	1.8	1.0	4.4	3.1	1.1	0.1	9.8	3.2	24.2	0.7	0.1	0.3	0.9	16.9	2.1	2.3	0.3	0.7	3.1	0.0	0.5	2.3	1.7	1.8	1.1	0.4	2.7	0.3	0.1	1.2	0.2	2.7	0.7	1.4	0.8	0.4	3.1	1.0	4.2	0.3	2.2	0.4	7.8	1.0	0.0	0.7	0.5	14.0	0.8	0.9	1.2	60.6	1.7	2.7	0.0	0.1	0.1	0.2	0.1	0.4	2.4	0.0	0.3	0.1	2.2	7.7	0.6	0.3	16.7	1.0	5.7	2.0	1.3	3.8	0.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	1.9	0.0	0.0	0.1	0.2	0.0	1.3	1.6	3.5	1.9	1.0	2.1	1.9	2.4	1.7	1.7	4.2	1.1	0.4	0.0	0.0	2.0	0.7	0.1	0.4	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.1	3.5	0.5	0.0	0.0	0.1	0.0	0.1	6.5	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	2.5	29.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	0.1	0.2	0.0	1.3	0.0	0.0	13.1	1.9	1.6	0.3	1.1	0.2	0.6	0.1	0.5	7.8	0.1	0.1
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 10.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	1.6	1.0	1.9	0.9	2.2	0.0	1.4	1.4	1.3	4.3	0.6	3.4	0.4	4.7	1.2	0.8	2.8	2.1	2.3	1.1	1.9	1.4	0.4	2.0	0.3	2.1	2.1	10.9	0.3	0.1	1.8	0.8	1.8	2.9	0.6	0.0	1.4	1.1	0.9	2.7	1.6	1.9	1.6	0.8	1.6	2.4	1.8	1.3	1.0	0.4	0.3	3.1	2.4	0.9	0.0	10.3	20.1	5.5	3.2	4.0	0.0	5.8	1.8	2.4	2.4	0.0	0.5	0.0	0.9	5.2	0.9	0.3	4.3	0.2	1.9	0.0	2.1	0.4	6.1	0.2	3.8	0.0	1.2	2.3	0.0	13.1	0.0	2.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	1.6	4.3	0.1	2.2	3.5	0.0	0.0	2.0	2.1	3.8	0.0	0.2	4.3	0.1	0.0	5.1	0.0	17.9	2.5	0.0	0.0	0.1	0.0	7.4	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.2	1.4	1.3	1.1	1.9	2.1	2.1	1.8	1.6	1.8	0.9	0.3	0.0	0.0	39.5	0.0	2.0	0.1	0.5	0.6	0.0	0.1	0.9	1.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.1	0.3	6.1	0.5	0.0	0.0	0.7	0.2	0.1	10.4	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.5	2.1	25.1	0.1	0.0	2.8	0.0	0.0	1.0	3.0	0.3	1.0	0.0	30.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.0	3.4	0.1	3.6	0.1	1.7	0.0	0.0	7.9	0.0	0.1
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.1;seminal vesicle: 7.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.6;Excitatory neurons: 28.0;Inhibitory neurons: 13.3;Proximal tubular cells: 4.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.2;hippocampal formation: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.5;GAMG: 5.9;hTERT-RPE1: 4.7;PC-3: 7.3;U-138 MG: 5.1"	"Not detected"	"Not detected"							HPA001409	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.0	0.1	0.5	0.4	0.5	0.0	1.2	0.2	2.2	5.1	0.0	0.3	0.3	0.9	0.5	0.8	0.8	0.6	1.0	2.2	0.0	4.3	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.0	0.0	8.1	0.0	0.0	0.8	7.6	0.1	2.0	0.6	0.2	0.1	0.2	0.8	2.3	0.0	0.2	0.4	0.0	0.0	2.6	4.6	0.3	0.0	0.0	0.0	0.4	2.8	3.7	0.0	2.0	4.5	1.7	1.3	0.0	0.0	0.0	0.1	2.1	5.9	0.0	0.0	0.0	0.5	0.0	1.3	0.0	1.4	0.1	1.0	0.0	0.0	2.5	0.2	2.1	2.0	4.7	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.9	0.1	1.3	0.0	0.0	3.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	2.2	2.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	1.3	0.1	6.6	0.0	0.0	4.0	1.3	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.2	0.1	0.0	0.0	28.0	0.0	0.0	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	1.0	2.9	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	1.2	0.1	0.1	0.0	4.8	0.0	0.0	0.0	0.4	0.8	1.8	2.8	0.3	1.7	0.1	0.1	0.1	0.0	0.1
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761747-48773648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 5.8;intestine: 10.6;kidney: 11.2;liver: 8.2"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 45.2;Proximal tubular cells: 70.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA010667	Enhanced		Uncertain	Mitochondria		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.3	0.0	4.7	10.6	0.0	5.8	0.1	1.9	0.8	0.0	0.0	0.0	11.2	8.2	1.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.1	0.2	6.1	1.9	0.3	0.3	0.0	0.0	10.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	3.2	2.6	1.3	0.5	0.0	0.3	0.2	0.0	0.6	8.3	1.0	0.0	4.3	0.3	7.3	0.0	0.1	0.0	14.4	13.7	0.6	0.2	3.0	0.1	0.0	1.2	2.7	0.2	0.9	0.1	0.0	0.0	1.1	0.0	0.1	0.0	8.0	0.0	0.0	0.3	7.3	0.0	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.5	0.0	0.5	0.5	0.8	13.9	0.0	0.1	0.3	45.2	70.5	2.7	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	8.9	0.7
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95822726	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 777.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 723.9;Extravillous trophoblasts: 751.2;Proximal enterocytes: 968.3;Proximal tubular cells: 1165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 569.0;RPTEC TERT1: 462.1;U-87 MG: 441.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008634, HPA046431, CAB069419"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		6300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	82.1	101.4	32.5	80.0	34.9	173.7	37.2	46.3	52.4	28.2	29.0	57.2	194.7	12.7	10.1	13.6	17.2	50.8	102.7	47.3	37.1	247.4	143.6	71.9	61.5	52.0	42.1	10.9	10.9	82.4	23.7	102.0	39.8	28.5	47.4	6.9	59.2	25.6	777.4	38.3	170.3	25.7	34.3	64.9	40.2	4.9	43.6	75.6	18.9	55.9	80.4	53.1	20.9	37.9	22.2	97.1	8.4	18.0	211.3	310.4	1.6	326.5	569.0	35.9	62.9	31.2	10.2	86.2	45.7	99.0	83.0	9.7	12.9	156.4	100.5	75.7	24.1	62.8	63.5	248.1	386.6	67.2	182.8	184.4	23.2	219.7	21.3	81.1	75.3	179.3	8.2	51.3	262.3	7.9	121.4	133.0	22.2	3.3	111.6	186.1	66.8	107.9	462.1	16.8	23.6	12.5	85.3	47.8	39.4	22.0	13.0	66.0	78.0	91.9	101.9	74.6	14.4	37.1	202.0	70.4	441.3	170.6	19.7	48.9	727.2	901.6	222.9	483.8	313.6	142.9	205.0	166.7	459.8	107.8	201.4	186.1	783.8	113.4	411.2	166.6	457.7	781.7	32.5	34.9	46.3	52.4	47.3	37.1	52.0	42.1	39.8	34.3	43.6	37.9	77.5	22.4	28.4	3.6	74.1	17.2	62.9	330.5	8.6	2.2	57.9	31.5	154.9	65.8	183.6	93.8	0.0	47.4	130.0	173.8	723.9	60.4	0.3	83.4	49.0	47.1	31.7	63.1	8.7	96.0	751.2	63.1	35.7	118.0	31.6	3.5	46.4	206.9	271.5	0.0	8.0	89.9	65.1	304.9	276.1	2.3	19.0	232.3	69.4	12.2	340.0	7.8	302.8	2.0	2.4	113.5	291.3	13.9	200.2	89.5	968.3	1165.9	124.1	3.9	19.7	22.1	67.0	0.6	1.6	4.1	20.6	285.3	97.7	11.7	85.4	214.6
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880821-190965552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 907.3;RPTEC TERT1: 419.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		92000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	37.0	77.4	38.5	45.7	50.5	28.7	32.0	40.5	74.6	31.0	35.6	32.0	92.2	28.8	26.6	16.8	25.1	41.8	34.7	55.5	35.9	316.8	11.7	55.6	68.0	44.7	19.8	28.9	36.9	62.0	19.9	35.8	52.5	20.8	30.1	81.8	20.4	31.2	15.8	28.5	103.4	36.9	12.0	49.3	18.7	16.2	24.1	41.7	35.7	23.6	57.9	36.5	23.6	44.8	43.6	47.2	32.4	43.1	99.7	68.9	84.0	126.8	95.7	90.6	103.1	58.1	42.1	88.5	907.3	269.3	46.1	55.6	58.0	50.0	131.5	219.8	37.7	147.3	69.1	72.2	90.8	87.2	66.5	62.9	51.0	71.2	48.4	90.1	119.3	36.7	69.3	175.2	203.3	22.8	59.2	83.7	86.9	25.7	76.7	74.2	83.7	77.4	419.2	78.9	44.9	46.8	172.8	37.9	169.2	115.1	14.9	53.0	85.3	129.4	94.5	65.9	156.8	56.2	138.9	122.1	46.7	70.6	105.5	6.4	1.0	1.9	3.7	1.5	6.5	3.4	4.4	4.8	1.6	3.8	4.5	5.5	2.1	2.8	1.1	3.6	4.1	1.1	38.5	50.5	40.5	74.6	55.5	35.9	44.7	19.8	52.5	12.0	24.1	44.8	81.0	189.1	122.5	61.0	89.3	174.5	44.7	15.6	60.9	93.5	51.8	49.5	38.2	35.8	28.4	391.8	210.6	4.4	128.0	100.6	50.9	21.4	6.6	33.7	66.8	68.3	59.2	17.9	427.1	24.5	15.6	66.0	46.4	97.9	36.8	48.2	63.5	4.3	29.1	26.9	270.5	36.7	14.2	31.2	230.0	7.3	28.6	84.3	88.9	143.4	68.4	11.9	55.6	163.3	146.9	29.8	92.9	43.2	118.4	70.1	165.9	539.1	17.0	111.9	19.7	71.6	76.0	11.3	12.9	61.7	162.8	4.0	114.0	97.8	43.6	56.7
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788964-4790589	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 73.8"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 83.7;Proximal tubular cells: 135.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 3.4;CACO-2: 9.2;Hep G2: 13.7;MCF7: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		150000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.5	0.5	1.3	0.5	1.1	1.5	0.3	2.3	2.7	0.4	0.0	0.5	10.1	0.5	0.0	0.8	0.4	0.3	0.2	1.0	2.1	12.0	73.8	0.4	0.1	3.1	2.8	0.3	0.7	0.2	0.8	0.1	2.0	0.4	0.0	0.3	1.0	0.0	1.3	1.7	6.2	0.0	0.4	1.1	1.1	0.1	1.5	0.0	0.2	0.0	0.0	0.5	0.5	1.4	0.5	1.8	0.1	1.5	0.0	0.0	3.4	0.4	0.0	0.0	0.0	9.2	0.6	0.8	0.9	0.0	0.3	1.7	0.0	0.0	0.0	1.7	1.2	0.1	0.7	13.7	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.4	0.0	4.1	0.1	0.1	0.2	0.6	0.7	0.7	0.5	0.2	0.0	0.7	1.1	0.7	1.6	0.3	0.4	0.0	1.0	0.1	1.7	0.5	0.7	0.4	0.3	0.1	0.5	0.1	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.3	1.1	2.3	2.7	1.0	2.1	3.1	2.8	2.0	0.4	1.5	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.3	0.2	1.5	0.5	0.0	0.0	0.0	0.1	0.4	17.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.2	0.0	0.0	2.2	83.7	0.1	0.0	0.2	0.6	0.0	1.3	0.4	0.2	0.6	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.6	0.3	21.1	135.8	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.1	0.3	0.3	0.1	0.3	0.4
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050202-87094843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 816.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.1;Hepatocytes: 402.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 555.0"	"Low region specificity"	"Detected in all"							"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		23000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	70.1	93.0	217.2	44.8	219.0	29.2	96.4	180.4	216.8	50.2	135.8	63.4	80.9	48.1	30.0	77.0	47.4	53.3	75.6	193.3	223.2	249.2	816.4	57.7	42.9	220.9	222.9	71.6	66.2	39.0	37.1	58.8	202.3	110.5	61.5	90.2	55.6	53.2	51.1	84.2	88.6	53.3	223.2	46.4	57.0	22.3	254.6	44.8	68.1	64.4	59.2	68.1	55.6	202.3	127.1	100.3	77.1	131.5	143.0	174.5	84.0	97.7	167.8	92.4	100.5	233.0	120.6	141.5	77.8	143.4	53.0	194.7	101.4	98.5	98.0	102.7	79.8	69.0	55.9	555.0	318.1	163.2	95.5	121.3	181.5	103.2	304.9	140.3	112.0	109.3	70.7	124.0	101.0	92.1	148.1	145.7	88.2	136.9	79.8	110.4	98.3	93.1	267.4	101.8	39.7	73.9	87.8	68.8	126.1	73.9	94.3	112.8	112.4	47.8	42.5	98.2	101.0	73.6	81.4	167.5	115.3	182.8	29.3	9.1	14.2	9.7	8.3	11.1	10.3	9.8	11.2	10.1	15.9	11.3	9.9	8.0	1.2	13.6	16.0	5.9	12.6	6.5	217.2	219.0	180.4	216.8	193.3	223.2	220.9	222.9	202.3	223.2	254.6	202.3	49.3	22.4	23.9	294.1	56.6	106.0	57.5	32.2	105.3	22.5	83.3	38.2	60.2	57.2	47.3	60.7	37.5	95.7	45.6	56.1	156.5	32.5	14.2	37.3	44.0	54.1	39.4	52.6	35.8	33.8	63.8	89.0	86.2	59.7	43.2	33.6	50.7	402.3	69.1	15.2	38.0	49.5	36.7	74.1	184.5	26.0	88.0	81.4	104.9	42.2	50.6	140.0	39.1	48.7	42.9	50.2	38.3	90.7	75.7	103.4	124.2	175.5	21.6	68.9	65.7	41.3	55.9	11.4	8.6	189.5	122.3	47.6	84.6	70.9	49.6	107.3
GLYAT	"ACGNAT, GAT"	ENSG00000149124	Glycine-N-acyltransferase	Q6IB77	11	58640426-58731974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Detoxification	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"kidney: 571.8;liver: 698.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 346.7;Proximal tubular cells: 1261.0"	"Group enriched"	"Detected in some"	158	"liver cancer: 21.7;renal cancer: 25.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.4"	"Not detected"	"Not detected"							"HPA040251, HPA044094"	Enhanced					NA	NA		21000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA040251: AB_2676902, HPA044094: AB_2678807"	"unprognostic (2.15e-2)"				"unprognostic (9.38e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.65e-3)"		"unprognostic (1.83e-1)"		"unprognostic (1.60e-1)"		"prognostic favorable (1.31e-6)"	"unprognostic (2.69e-1)"				47.0	0.1	0.0	0.1	0.1	0.1	8.5	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	571.8	698.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	11.5	0.0	31.3	0.0	0.1	0.0	0.0	123.3	0.0	6.0	0.0	0.0	0.6	0.0	8.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	346.7	0.0	0.0	0.2	0.0	0.0	10.7	0.0	8.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1261.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 576.3"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 234.3;Proximal tubular cells: 797.1"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;Daudi: 4.9;RPTEC TERT1: 1.5;U-2197: 1.2"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.3	0.4	0.1	0.4	0.3	1.6	0.1	0.7	0.1	1.3	0.9	0.0	0.1	0.3	141.4	576.3	0.0	0.1	0.9	0.2	0.0	1.7	2.6	0.0	0.0	1.1	11.1	0.3	0.2	1.9	0.0	0.0	0.6	0.2	0.0	0.3	0.1	2.7	0.1	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.1	0.5	0.4	2.0	0.0	4.9	0.0	0.3	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.3	0.9	0.2	1.1	0.3	0.3	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.3	12.8	0.0	14.7	0.0	0.0	0.0	0.1	107.6	0.1	0.0	2.5	0.1	0.5	0.0	8.0	0.7	0.6	0.0	0.1	0.0	0.1	0.0	0.1	5.0	234.3	0.0	0.0	0.8	0.1	0.0	8.1	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	1.3	0.0	797.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.9	0.1	0.9	0.2
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52295257	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 275.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	14.8	8.3	1.0	4.5	0.9	6.7	9.3	0.5	1.5	2.9	0.9	11.4	22.4	3.2	0.6	3.8	2.7	2.2	4.4	0.9	1.2	24.9	275.1	4.2	4.6	1.4	0.9	2.4	5.9	2.5	2.9	2.2	1.2	3.7	3.6	0.6	3.1	1.0	3.6	1.9	21.7	1.6	0.4	8.9	8.5	2.3	1.2	2.3	4.1	1.0	3.2	3.3	2.5	1.2	2.9	5.8	3.4	1.2	15.7	2.4	1.8	2.4	2.6	4.6	3.9	12.1	2.4	6.7	1.6	2.7	3.7	1.6	1.7	7.8	0.8	2.0	1.8	9.3	7.5	16.2	1.7	2.8	5.0	2.4	3.5	7.6	3.2	2.1	10.2	5.2	2.4	4.5	3.6	1.9	5.9	2.7	1.5	14.2	4.2	1.9	2.5	11.1	5.8	3.9	1.9	1.9	2.6	1.4	3.0	1.0	3.2	1.7	3.8	3.5	4.1	2.4	6.1	5.1	3.9	5.4	2.7	4.9	2.2	2.2	5.2	6.6	5.6	2.8	2.6	4.4	4.2	4.9	5.6	2.6	3.3	4.3	4.4	3.6	3.5	3.4	6.6	3.7	1.0	0.9	0.5	1.5	0.9	1.2	1.4	0.9	1.2	0.4	1.2	1.2	5.4	6.4	3.2	0.7	8.2	0.4	3.2	4.1	1.8	1.6	2.1	1.4	1.6	18.6	3.0	9.2	0.0	7.9	9.2	18.4	19.6	5.4	0.3	4.4	2.7	8.3	23.4	26.5	0.6	6.2	5.3	2.9	27.0	8.6	1.3	3.4	14.6	183.0	13.2	0.0	0.4	15.8	2.0	16.6	2.4	0.0	1.2	9.1	3.6	1.0	7.7	1.2	9.2	0.5	0.7	4.0	40.6	0.0	13.5	2.8	105.2	83.0	2.4	1.5	0.0	2.7	2.7	1.8	8.3	2.1	1.3	11.1	9.3	7.7	24.9	4.3
GMNC	GEMC1	ENSG00000205835	"Geminin coiled-coil domain containing"	A6NCL1	3	190852737-190892429	"Predicted intracellular proteins"	"Cell cycle, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 2.8;fallopian tube: 8.1;liver: 4.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Endometrial ciliated cells: 5.9;Hepatocytes: 6.1;Proximal tubular cells: 11.5;Respiratory ciliated cells: 4.4"	"Cancer enriched"	"Detected in some"	5	"ovarian cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	45	"SCLC-21H: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA043663	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043663: AB_10959313"				"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"		"unprognostic (5.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.73e-2)"		"unprognostic (2.55e-3)"		0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.1	0.2	2.8	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.1	0.3	1.7	1.9	4.1	0.0	0.0	0.6	0.7	0.1	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.1	0.3	1.7	0.6	0.7	0.5	0.7	0.7	2.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	14.6	5.9	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.5	4.4	0.2	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GNA14		ENSG00000156049	"G protein subunit alpha 14"	O95837	9	77423079-77648322	"Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 219.1;Early spermatids: 50.2;Hepatic stellate cells: 61.4;Late spermatids: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	95	"basophil: 27.3"	"Lineage enriched"	"Detected in single"	95	"granulocytes: 27.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.3;HUVEC TERT2: 1.6;PC-3: 3.2;THP-1: 1.6;U-2197: 2.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048886	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA048886: AB_2680544"	"unprognostic (7.80e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-4)"	"unprognostic (2.48e-6)"	"unprognostic (6.35e-3)"	"unprognostic (3.34e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.03e-1)"	3.4	2.2	7.3	4.0	6.5	0.0	2.4	2.7	8.4	3.6	11.8	5.8	1.7	15.6	5.2	4.8	3.6	4.9	4.1	9.2	4.5	11.7	6.0	8.8	3.3	9.7	5.0	6.0	1.4	1.4	3.1	7.0	7.0	6.8	6.1	0.1	8.0	13.7	0.6	0.9	3.0	13.8	8.1	7.3	3.3	2.1	5.6	0.7	17.6	0.6	2.1	7.6	4.8	13.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.3	1.0	0.3	0.0	0.6	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.4	3.2	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.8	0.4	0.0	1.2	0.3	1.6	0.4	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	27.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.3	6.5	2.7	8.4	9.2	4.5	9.7	5.0	7.0	8.1	5.6	13.9	2.3	0.0	1.1	219.1	0.2	0.6	2.0	0.2	0.0	0.0	1.0	0.4	0.8	0.0	6.5	0.0	0.0	0.1	0.0	2.6	0.0	0.7	50.2	1.7	4.9	12.8	3.0	2.7	15.8	1.0	0.1	4.2	0.0	1.8	4.5	0.1	61.4	1.2	0.3	0.0	4.4	13.7	2.0	2.5	1.1	38.8	3.7	0.2	1.8	15.9	0.0	0.0	0.0	7.1	12.4	0.1	2.7	1.9	0.0	1.0	0.5	7.1	20.8	0.0	0.0	19.4	0.9	0.4	0.7	0.3	0.6	0.1	0.2	0.5	2.9	4.9
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136033-3163749	"Plasma proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 75.6;esophagus: 108.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 141.5;Langerhans cells: 190.6;Macrophages: 78.3;Suprabasal keratinocytes: 95.8;Urothelial cells: 173.8"	"Group enriched"	"Detected in all"	4	"cervical cancer: 39.9;head and neck cancer: 46.4;lung cancer: 17.3;pancreatic cancer: 11.9;urothelial cancer: 31.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 67.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 67.1;granulocytes: 19.4;monocytes: 29.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 65.4;HMC-1: 152.1;MOLT-4: 162.4;NB-4: 59.8;REH: 119.3;THP-1: 62.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043113	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA043113: AB_10967343"	"prognostic favorable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	6.8	3.1	4.0	12.4	3.8	75.6	4.6	4.0	7.3	13.3	4.7	2.5	1.7	1.3	0.4	108.8	2.4	4.6	1.9	4.1	4.1	2.0	1.4	13.1	4.2	5.4	4.5	0.8	1.2	0.4	1.4	7.6	5.1	11.6	1.8	0.1	19.5	2.5	0.6	50.8	2.5	3.1	4.9	8.8	4.3	1.4	6.6	32.0	1.2	0.9	12.1	28.1	41.6	6.4	44.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	18.7	0.1	0.1	0.0	0.1	36.2	0.0	65.4	0.0	0.1	0.0	19.1	0.1	0.0	0.0	27.2	152.1	0.0	40.0	0.2	26.2	0.0	0.0	16.6	0.1	0.3	0.0	0.0	162.4	59.8	0.1	2.9	0.0	119.3	0.0	0.2	0.0	23.6	0.2	0.0	4.6	0.2	0.2	0.0	0.0	62.1	0.1	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.3	29.8	0.1	19.4	29.1	14.3	0.0	21.8	1.1	0.0	2.0	0.3	28.8	0.0	0.0	0.0	6.9	4.4	15.5	67.1	8.7	13.3	4.0	3.8	4.0	7.3	4.1	4.1	5.4	4.5	5.1	4.9	6.6	6.4	1.0	9.6	8.8	0.0	2.2	67.2	141.5	65.5	9.1	0.2	7.4	3.7	0.5	0.0	39.0	3.7	0.0	0.5	27.6	0.5	0.0	0.7	0.5	1.4	0.5	3.1	6.6	21.0	1.3	0.0	0.8	2.5	3.6	3.9	34.3	0.0	0.7	0.0	66.5	0.0	0.4	2.2	57.0	36.2	190.6	0.8	0.0	78.3	21.4	7.5	32.0	0.0	0.0	0.0	0.2	13.2	0.3	0.0	3.6	69.3	0.0	0.1	21.7	0.1	19.7	0.3	3.3	4.0	2.0	38.0	95.8	0.4	19.6	0.1	1.4	173.8
GNG11	GNGT11	ENSG00000127920	"G protein subunit gamma 11"	P61952	7	93921735-93928610	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Adipocytes: 1903.6;Endothelial cells: 1236.2;Hepatic stellate cells: 994.2;Macrophages: 481.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 20.5;neutrophil: 9.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 219.9;HUVEC TERT2: 349.6;SK-MEL-30: 221.8;TIME: 201.1;U-87 MG: 187.1"	"Low region specificity"	"Detected in all"							HPA045255	Uncertain					NA	NA		3400000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA045255: AB_10794781"	"unprognostic (1.30e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.89e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.71e-3)"	75.5	16.8	14.4	8.1	14.6	2.5	64.4	14.7	22.0	24.9	13.7	23.5	6.7	26.8	10.9	10.9	33.5	15.5	48.3	14.1	14.7	34.9	12.1	39.8	7.8	14.9	14.6	56.7	8.8	4.4	9.3	85.9	15.3	15.8	6.4	1.5	9.1	17.9	15.4	11.4	16.1	16.7	15.1	39.0	16.0	3.3	16.1	19.0	29.1	18.6	3.5	27.9	18.4	14.9	0.2	34.2	67.2	31.0	51.2	40.0	0.0	34.8	67.7	19.0	26.7	0.1	2.9	0.0	219.9	17.5	79.9	0.5	0.5	3.2	23.8	0.2	2.0	11.0	35.9	0.0	81.8	0.0	0.1	13.4	0.1	61.0	6.0	78.7	349.6	0.0	0.1	0.2	85.9	0.0	0.1	0.1	5.8	0.0	10.4	32.5	7.6	0.1	41.3	0.0	0.1	67.2	0.0	0.2	221.8	8.6	144.4	2.4	201.1	93.4	10.4	68.3	3.9	0.0	0.2	0.7	187.1	0.0	81.8	20.5	0.7	0.3	0.1	0.1	0.2	2.3	0.0	0.0	1.0	2.0	0.2	0.0	9.8	0.0	0.1	3.7	0.1	50.2	14.4	14.6	14.7	22.0	14.1	14.7	14.9	14.6	15.3	15.1	16.1	14.9	1903.6	12.8	27.3	1.3	20.6	83.6	11.8	3.1	5.7	0.7	15.2	26.8	94.8	11.5	3.1	187.6	0.0	2.3	15.4	0.1	74.3	135.7	5.9	124.1	94.6	1236.2	0.0	40.6	0.0	5.7	12.9	207.3	0.5	236.4	2.5	12.7	994.2	11.1	17.0	0.0	0.0	0.3	18.3	55.9	89.5	17.0	82.3	481.1	188.5	26.2	49.6	9.2	41.2	0.5	0.2	4.3	0.0	86.9	8.0	11.0	0.0	12.9	1.7	4.7	151.2	115.5	165.0	1.9	7.6	2.7	65.8	23.8	15.9	109.9	0.0	4.5
GP2	ZAP75	ENSG00000169347	"Glycoprotein 2"	P55259	16	20309574-20327808	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	966	"pancreas: 35381.6"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 504.1"	"Cancer enriched"	"Detected in many"	14	"pancreatic cancer: 320.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015739, HPA016668"	Enhanced				"Secreted to digestive system"	NA	NA		41000	"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA015739: AB_1849905, HPA016668: AB_1849907"	"unprognostic (2.14e-2)"		"unprognostic (1.97e-2)"	"unprognostic (5.68e-2)"			"unprognostic (4.29e-2)"	"unprognostic (1.63e-1)"			"unprognostic (2.84e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"			7.1	1.9	0.2	0.9	0.2	0.7	3.8	0.6	0.4	2.5	0.4	3.9	36.6	2.1	0.2	3.9	1.4	18.7	6.5	0.3	0.2	33.4	5.0	1.5	2.1	0.2	0.6	15.4	35381.6	0.0	2.9	2.4	0.3	33.4	6.2	0.1	7.5	0.0	1.6	1.8	10.1	0.1	0.1	2.5	27.4	1.9	0.2	0.1	1.3	0.0	0.2	1.0	1.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.6	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.2	1.1	0.1	0.1	87.2	0.0	0.0	0.0	0.0	0.0	1.7	9.8	1.3	7.5	0.3	0.5	0.2	0.0	0.0	0.0	504.1	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.0	0.0	0.3	15.6	0.3	0.4	0.0	0.0	4.2	0.2	0.0	0.0	0.0	20.7	13.9	0.4	0.0	69.7	2.0	0.0	0.0	0.3	0.0	0.5	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	19.9	2.1
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in single"		"Paneth cells: 1.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HEL: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA072646			Approved	Cytosol		NA	NA		270000000	"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
GPC3	"DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1"	ENSG00000147257	"Glypican 3"	P51654	X	133535745-133985594	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 574.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.1;Extravillous trophoblasts: 61.0;Fibroblasts: 404.2;Muller glia cells: 88.9;Syncytiotrophoblasts: 148.6"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 269.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.8"	"Group enriched"	"Detected in some"	5	"HAP1: 514.3;Hep G2: 1825.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006316			Supported	"Plasma membrane"		NA	NA		27000	"Cluster 32: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA006316: AB_1078994"	"unprognostic (2.06e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.92e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	99.9	22.8	0.5	3.5	1.0	0.0	61.8	0.5	0.3	11.8	0.2	6.5	1.6	9.2	41.1	6.7	13.9	13.7	24.5	0.3	4.0	87.0	5.1	122.9	2.5	1.9	3.1	15.5	21.2	4.1	47.0	574.9	3.0	8.3	4.1	6.2	13.7	9.2	4.5	18.0	5.6	7.3	1.7	3.7	13.6	2.8	2.0	8.0	22.4	28.6	10.9	14.6	9.3	1.0	0.0	0.0	21.8	1.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	154.0	0.0	0.0	0.1	0.1	0.0	0.0	514.3	0.4	0.0	0.0	22.6	0.0	0.9	1825.2	0.3	0.0	0.5	12.9	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.5	0.1	132.1	0.1	0.0	0.0	0.0	0.1	122.4	6.1	15.3	40.3	0.0	0.0	0.4	233.8	0.5	23.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.8	1.2	0.0	0.7	0.0	0.0	0.0	0.1	0.5	1.0	0.5	0.3	0.3	4.0	1.9	3.1	3.0	1.7	2.0	1.0	28.5	0.0	1.7	0.3	1.0	10.5	4.8	17.0	0.0	0.4	5.0	10.4	0.5	1.5	20.0	5.5	0.0	65.1	0.8	0.5	19.6	0.3	0.9	0.2	0.4	1.8	1.8	0.0	2.5	1.6	61.0	404.2	0.5	1.5	0.0	1.0	2.2	0.0	26.7	0.0	2.5	3.1	2.0	0.0	6.1	2.4	10.5	1.0	3.6	23.4	0.0	88.9	0.0	3.5	1.4	1.7	2.6	3.0	0.4	2.7	1.2	40.7	24.3	3.1	0.0	21.7	21.3	6.9	7.1	0.2	4.0	148.6	1.1	7.6	4.1	0.6
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103982-50111313	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 609.9;skeletal muscle: 577.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 99.1;Proximal enterocytes: 247.0;Proximal tubular cells: 298.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 134.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044620, HPA058621"	Enhanced					NA	NA		4700000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044620: AB_10796803, HPA058621: "	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	609.9	4.7	9.1	1.6	16.8	0.2	229.2	22.7	12.8	0.3	5.5	6.4	76.4	0.2	5.3	4.9	0.5	16.6	9.2	10.1	14.2	149.3	147.6	18.4	1.0	32.6	18.3	0.3	7.2	13.0	1.3	0.0	26.5	1.3	3.3	1.0	33.0	1.3	577.1	10.2	76.9	1.3	32.7	0.4	3.3	0.8	18.4	1.5	2.7	215.7	0.4	4.1	1.0	49.4	0.1	0.2	0.1	0.1	134.0	0.0	0.3	0.1	0.0	0.0	0.0	27.0	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.1	0.6	25.2	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.7	0.7	0.3	0.0	0.2	0.1	0.4	0.1	3.7	0.0	0.2	0.2	30.2	0.2	0.0	0.6	0.2	0.0	1.5	1.0	0.0	1.8	0.0	0.0	0.0	0.3	0.2	0.1	0.6	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	16.8	22.7	12.8	10.1	14.2	32.6	18.3	26.5	32.7	18.4	49.4	3.4	3.2	3.2	0.0	2.4	0.0	0.2	0.3	0.6	3.2	3.4	3.7	5.8	11.5	1.8	5.5	8.4	0.0	0.0	3.0	43.0	0.9	0.1	0.5	0.1	0.2	1.2	5.3	0.2	0.7	0.0	0.8	4.1	0.2	0.0	0.1	1.1	99.1	2.3	3.3	0.2	9.7	0.0	1.0	0.4	0.0	0.0	5.2	1.8	0.0	1.0	2.8	0.0	0.0	4.0	0.6	8.0	0.0	0.0	0.1	247.0	298.4	0.4	1.7	0.0	7.0	1.1	0.0	0.0	0.8	0.4	0.0	1.2	0.0	10.6	0.2
GPHA2	"A2, GPA2, MGC126572, ZSIG51"	ENSG00000149735	"Glycoprotein hormone subunit alpha 2"	Q96T91	11	64934471-64935893	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pancreas: 360.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.5;Exocrine glandular cells: 17.4;Pancreatic endocrine cells: 2.4;Spermatocytes: 7.7;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 15.8"	"Region enhanced"	"Detected in single"		"cerebellum: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 21.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067068			Approved	Vesicles	"Secreted to blood"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA067068: "	"unprognostic (1.13e-1)"	"unprognostic (8.31e-3)"		"unprognostic (1.51e-2)"		"unprognostic (9.22e-4)"		"unprognostic (7.88e-3)"		"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.70e-1)"	0.0	0.1	0.3	0.2	0.6	0.1	0.1	3.6	0.6	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.4	16.9	0.0	0.3	0.3	0.8	0.7	0.3	0.6	0.4	0.3	2.7	360.5	0.0	28.0	0.0	0.6	0.7	0.0	0.1	0.3	0.5	0.0	0.5	0.5	0.0	0.2	0.6	1.1	10.8	0.4	0.1	0.3	0.0	0.5	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	21.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	3.6	0.6	0.3	0.3	0.4	0.3	0.6	0.2	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	17.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	7.7	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.2"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 12.3;Granulosa cells: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.7;HHSteC: 133.9;hTCEpi: 61.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	1.5	2.7	0.1	0.2	0.9	0.0	0.7	0.5	0.3	2.6	12.2	0.3	0.1	0.5	0.2	4.5	0.5	1.2	1.6	0.6	0.3	0.4	0.0	0.2	0.8	0.0	0.0	1.3	0.0	0.4	0.2	3.9	0.0	0.2	0.3	0.7	0.9	0.1	0.7	4.8	0.3	1.0	0.0	0.0	0.1	0.9	0.2	0.0	0.3	2.4	0.3	1.0	5.6	0.0	2.2	0.2	1.8	0.0	0.4	7.5	0.6	14.4	24.7	8.8	7.4	0.0	0.0	0.0	0.8	7.3	0.6	0.2	0.7	0.0	2.9	0.0	0.3	0.0	4.2	0.0	133.9	0.0	0.0	5.5	61.8	12.5	20.0	10.2	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	6.9	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.3	6.1	2.9	0.0	0.0	1.6	0.1	0.0	0.3	10.5	4.8	12.5	1.1	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	12.3	4.5	0.0	0.0	0.0	42.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.2	0.0	0.0	0.8	1.0	0.7	0.5	0.0	0.0	0.4
GPR155	"DEP.7, DEPDC3, FLJ31819, PGR22"	ENSG00000163328	"G protein-coupled receptor 155"	Q7Z3F1	2	174431571-174487094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 83.4;stomach 1: 52.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 14.6;WM-115: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036159, HPA057384"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Cytosol"		"HPA036159: AB_10671835, HPA057384: AB_2683424"	"unprognostic (3.91e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.11e-4)"	"unprognostic (5.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.54e-2)"	4.3	9.7	8.7	5.9	16.3	2.3	2.4	6.5	12.1	2.4	83.4	10.2	3.8	1.9	12.3	5.9	1.6	5.7	7.0	12.2	5.3	20.1	7.3	3.0	6.3	5.5	5.3	2.5	18.2	8.9	2.3	4.4	5.2	7.5	3.7	10.0	3.6	8.4	4.7	13.2	4.0	6.1	3.5	5.4	52.6	2.2	7.1	3.0	8.3	4.4	3.6	4.1	2.7	6.1	0.7	0.3	0.8	2.0	4.9	2.7	0.5	3.8	1.3	0.6	2.1	0.3	0.2	2.2	1.2	2.8	1.3	0.2	1.3	1.1	2.1	0.8	1.5	2.3	1.1	0.2	0.9	0.7	1.1	3.9	3.1	1.9	0.6	4.0	1.0	3.0	0.3	5.5	4.2	0.6	1.6	0.8	0.4	2.3	1.5	1.9	5.6	1.0	2.0	1.3	5.9	5.0	1.2	0.8	2.0	2.5	0.3	0.3	2.6	2.7	1.0	3.9	0.5	14.6	2.2	0.3	3.0	0.6	9.9	1.3	2.2	0.1	1.8	4.0	1.6	1.1	3.1	2.9	0.6	1.0	2.5	3.9	7.3	3.6	5.7	0.3	5.5	1.4	8.7	16.3	6.5	12.1	12.2	5.3	5.5	5.3	5.2	3.5	7.1	6.1	18.5	12.8	3.6	31.3	9.8	42.7	4.0	4.0	29.0	34.9	5.8	6.1	26.0	2.8	6.8	11.0	125.1	1.5	12.2	0.6	1.9	1.9	0.7	1.4	24.1	9.8	12.7	15.2	99.4	6.0	1.2	9.7	9.7	0.6	1.3	4.0	16.1	16.1	6.1	50.5	131.1	0.8	2.0	50.4	23.0	1.8	14.9	27.0	152.9	8.4	34.3	16.7	11.3	130.2	21.2	3.5	0.1	32.0	14.3	3.1	0.4	41.7	0.5	25.8	0.0	16.9	9.5	3.3	3.2	7.5	28.6	0.8	25.7	52.4	1.0	1.8
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 41.5;smooth muscle: 27.6"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 158.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		Yes	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	3.5	1.1	3.8	5.3	2.8	0.2	2.7	3.3	4.0	6.7	1.1	8.4	1.5	41.5	3.6	9.8	10.7	5.6	3.1	3.8	2.4	1.4	0.4	4.2	0.9	3.7	9.4	7.3	11.7	5.4	1.7	2.2	3.8	9.5	3.2	2.1	1.8	11.8	1.0	2.1	3.3	27.6	2.8	2.0	2.9	1.7	4.1	2.0	1.7	1.9	1.3	4.6	5.4	2.7	11.7	7.1	28.0	18.1	6.6	11.7	0.0	11.1	11.9	9.2	9.7	44.9	1.8	0.0	6.0	16.6	17.2	33.9	6.9	10.7	5.3	4.4	8.8	4.2	5.8	0.1	2.8	1.2	2.8	4.2	6.9	7.9	12.7	21.3	18.7	3.6	3.9	0.1	14.2	1.0	1.3	0.2	11.5	19.4	11.0	3.4	12.1	0.0	4.9	3.1	5.7	24.6	12.0	0.4	32.2	10.6	6.3	1.4	25.4	18.9	9.7	25.6	12.7	0.0	0.0	0.0	5.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	2.8	3.3	4.0	3.8	2.4	3.7	9.4	3.8	2.8	4.1	2.7	5.8	3.2	1.1	13.7	0.1	2.2	5.7	2.5	5.2	2.2	2.2	4.2	3.6	0.0	1.4	0.0	0.0	0.5	0.0	2.8	0.0	4.1	0.4	1.3	19.4	9.1	0.0	0.0	10.8	8.0	0.4	12.3	1.1	1.8	0.0	15.3	8.9	0.1	0.8	158.2	10.9	1.5	0.0	2.5	6.3	0.9	7.5	2.0	1.8	3.7	1.1	3.2	0.0	9.5	0.4	2.6	2.4	17.0	0.0	10.9	0.0	0.1	1.1	2.1	19.7	8.8	15.1	0.3	3.3	2.7	1.4	0.4	1.0	0.7	2.5	2.7
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203216	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.3"	"Cell type enriched"	"Detected in some"	4	"T-cells: 107.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 110.3"	"Lineage enriched"	"Detected in many"	15	"T-cells: 110.3"	"Cell line enriched"	"Detected in some"	25	"U-266/70: 27.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067323	Supported					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA067323: "	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	3.7	1.6	0.5	21.3	1.5	1.2	1.9	1.7	3.8	4.3	12.3	4.3	4.5	1.5	0.5	2.5	3.0	6.2	0.9	1.1	0.4	1.3	4.3	6.4	17.4	2.5	0.7	0.8	0.7	0.2	0.5	0.5	0.7	1.9	4.6	0.0	1.7	0.8	0.2	0.9	12.9	1.1	0.1	13.0	5.9	0.3	1.1	13.0	1.8	0.1	11.3	9.3	2.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.1	0.0	0.0	0.2	0.0	0.2	0.3	3.5	27.9	0.2	110.3	0.0	40.2	53.5	2.3	0.5	24.1	21.1	0.8	7.3	0.5	2.2	21.4	9.4	0.5	1.5	1.7	3.8	1.1	0.4	2.5	0.7	0.7	0.1	1.1	1.2	0.4	0.0	2.2	0.3	2.3	1.1	0.4	0.0	0.6	4.8	0.3	0.3	1.0	0.0	1.3	0.0	2.1	0.4	25.8	0.1	0.0	0.0	0.2	0.1	0.6	0.5	0.0	2.7	0.8	0.0	0.0	2.3	4.6	0.1	2.5	0.0	1.8	1.6	0.1	21.9	0.3	0.5	0.0	2.2	8.1	0.1	0.0	4.8	0.0	0.0	14.0	5.7	6.2	0.5	0.0	0.0	0.0	0.0	14.9	0.2	0.0	0.5	0.0	0.1	0.0	0.5	1.2	0.8	0.7	0.1	0.6	0.7	107.6	0.1	0.0	0.3
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144688-79175318	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.6;dendritic cells: 30.6;Plasma cells: 4.2;T-cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"JURKAT: 42.3;MOLT-4: 75.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041025, HPA058306"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"HPA041025: AB_10794260, HPA058306: "	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	0.8	0.4	0.5	6.9	0.3	2.5	0.9	0.6	0.6	0.4	0.3	1.0	2.0	0.5	0.6	0.3	0.3	1.1	0.3	0.4	0.4	0.5	1.0	1.9	15.2	0.7	0.5	0.2	0.1	0.1	0.1	0.2	0.7	0.7	1.6	0.2	1.5	0.1	0.2	0.2	3.6	0.3	0.3	8.1	2.1	0.1	0.4	16.9	0.9	0.1	10.4	1.4	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	1.2	0.0	0.0	75.1	0.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.2	0.0	0.0	0.0	6.5	0.0	3.6	3.6	2.0	1.2	2.5	4.8	6.1	0.1	2.6	4.2	4.9	0.3	4.6	5.5	1.0	4.8	1.6	0.5	0.3	0.6	0.6	0.4	0.4	0.7	0.5	0.7	0.3	0.4	0.5	0.7	0.0	2.4	0.0	6.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.6	1.8	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.5	0.1	0.0	0.0
GPR18		ENSG00000125245	"G protein-coupled receptor 18"	Q14330	13	99254732-99261744	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.7;lymphoid tissue: 38.9;testis: 13.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 172.6;Late spermatids: 190.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 65.3;NK-cells: 52.9;T-cells: 41.9"	"Group enriched"	"Detected in some"	4	"Daudi: 8.1;THP-1: 20.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013873	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA013873: AB_1849285"	"unprognostic (3.87e-6)"	"unprognostic (1.31e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.31e-6)"	"unprognostic (2.89e-1)"	"unprognostic (7.55e-4)"	"unprognostic (4.27e-5)"	"unprognostic (3.45e-3)"	"unprognostic (2.31e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.20e-6)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.92e-3)"	0.4	0.1	0.2	12.2	0.3	9.7	0.2	0.7	0.4	0.3	0.9	0.9	1.0	0.4	0.2	0.5	0.2	1.2	0.3	0.2	0.1	0.3	0.9	0.7	38.9	0.7	0.2	0.1	0.1	0.0	0.1	0.1	0.4	0.4	1.0	0.0	0.9	0.1	0.1	0.3	4.1	0.2	0.1	10.5	1.5	13.0	0.3	7.9	0.4	0.1	32.5	2.1	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.9	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	3.5	0.0	0.2	1.9	0.5	24.4	5.5	41.3	65.3	22.1	34.0	12.6	53.3	41.9	38.9	2.2	52.9	5.3	12.5	6.4	13.1	0.2	0.3	0.7	0.4	0.2	0.1	0.7	0.2	0.4	0.1	0.3	0.4	0.2	0.0	1.3	0.3	44.7	0.3	0.0	0.0	0.0	1.0	0.1	0.3	1.0	0.0	0.6	0.0	0.0	0.0	14.4	0.1	0.0	0.0	172.6	1.3	0.2	0.2	1.2	6.1	0.4	0.0	0.0	0.2	1.1	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.3	1.2	190.5	0.9	3.9	0.0	0.0	0.6	0.0	18.6	0.5	0.1	0.0	0.1	1.2	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.2	1.8	0.4	0.0	0.3	0.0	20.5	0.1	0.1	0.1
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697275	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 251.4;Kupffer cells: 173.3;Macrophages: 100.6;Microglial cells: 54.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 339.6;eosinophil: 117.9"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 339.6"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	28.2	17.1	5.2	15.1	5.2	0.9	21.5	6.1	5.8	14.0	5.6	12.0	6.5	6.7	2.7	8.2	7.8	17.0	8.3	5.0	7.6	5.0	8.5	10.9	20.0	10.6	7.9	7.3	5.4	5.3	1.4	42.7	11.4	3.2	13.1	0.6	3.6	8.8	0.8	1.0	14.6	16.3	9.9	15.6	7.8	2.7	9.7	6.9	3.7	4.6	16.7	13.3	1.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	339.6	9.7	117.9	0.0	12.9	0.4	1.5	0.4	0.1	2.0	1.2	0.1	0.3	1.1	14.3	7.0	0.3	0.6	2.8	5.2	5.2	6.1	5.8	5.0	7.6	10.6	7.9	11.4	9.9	9.7	18.8	0.9	0.0	2.8	1.0	2.0	0.6	0.2	0.0	0.0	0.0	0.5	2.3	1.2	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.1	0.1	5.0	1.2	0.4	0.7	0.0	1.6	1.0	0.5	0.0	37.3	0.0	2.9	0.8	251.4	0.0	0.9	0.0	0.0	173.3	13.6	1.9	0.9	100.6	1.8	54.4	7.1	0.1	1.0	3.5	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.1	0.0	0.8	19.7	0.6	0.3	0.0	0.2	0.4	1.0	2.5	7.2	0.1	0.1	0.0
GPR4		ENSG00000177464	"G protein-coupled receptor 4"	P46093	19	45589764-45602212	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.7;Endothelial cells: 26.4;Hepatic stellate cells: 24.7;Sertoli cells: 6.6;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HUVEC TERT2: 18.7;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014278	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA014278: AB_1849300"	"unprognostic (2.49e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (6.46e-3)"	"unprognostic (1.93e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.49e-3)"	40.6	6.9	7.0	3.3	6.2	0.5	22.1	6.0	8.8	4.9	6.2	4.2	0.9	7.4	0.7	2.6	6.0	3.3	23.8	5.6	5.9	24.6	3.6	28.6	0.9	8.0	7.5	3.5	3.7	1.4	5.9	4.0	8.6	5.8	0.7	0.9	2.9	0.9	5.7	2.9	5.1	2.5	6.5	4.1	5.6	1.7	10.7	0.5	18.2	2.5	0.6	7.0	4.9	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.1	0.0	0.1	0.0	2.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.0	0.3	0.3	0.0	18.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	31.3	0.1	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	6.2	6.0	8.8	5.6	5.9	8.0	7.5	8.6	6.5	10.7	6.3	26.7	0.0	0.5	0.7	0.1	2.4	0.2	0.0	1.2	0.1	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	0.3	26.4	0.0	0.0	0.1	0.0	0.0	1.5	2.0	0.2	0.0	0.0	24.7	0.1	0.3	0.0	0.2	0.0	0.0	1.2	1.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	6.6	0.6	16.8	0.0	0.2	0.1	1.3	0.0	0.1	0.3	0.0	0.3
GPRC6A	bA86F4.3	ENSG00000173612	"G protein-coupled receptor class C group 6 member A"	Q5T6X5	6	116792085-116829083	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Enteroendocrine cells: 1.8"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA					"Cluster 29: U-266 - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"						"unprognostic (9.16e-2)"									"unprognostic (2.48e-1)"			"unprognostic (4.38e-3)"			0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 179.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 176.9;Hepatocytes: 237.3;Paneth cells: 88.4;Proximal enterocytes: 139.7;Proximal tubular cells: 164.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;Karpas-707: 2.8;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					NA	NA		17000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	22.6	2.4	2.2	4.6	1.9	2.3	12.5	3.3	4.7	0.7	3.5	36.0	18.3	0.5	0.4	2.4	1.3	2.4	40.3	2.1	0.4	13.9	179.6	0.4	0.3	0.8	0.5	1.1	10.3	1.4	2.9	0.1	0.6	1.8	5.8	0.6	14.6	1.2	50.1	17.1	18.0	0.4	0.2	0.6	15.0	2.6	0.9	0.0	0.9	24.3	0.2	0.6	1.3	0.9	0.2	0.8	0.2	0.5	0.4	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.9	0.4	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.7	1.3	0.3	1.5	2.5	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.2	2.8	0.0	1.3	0.4	0.4	0.3	0.6	0.5	0.5	0.1	1.5	0.0	0.9	0.5	0.8	0.2	0.7	0.1	0.1	1.9	0.1	0.2	0.1	0.6	0.7	0.1	2.9	0.2	0.2	0.4	0.9	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	1.9	3.3	4.7	2.1	0.4	0.8	0.5	0.6	0.2	0.9	0.9	0.2	0.0	0.0	14.4	5.3	1.7	1.3	1.2	0.6	0.9	14.1	4.6	8.5	34.3	1.8	7.3	0.0	0.0	0.4	176.9	21.5	1.1	16.5	0.5	0.4	1.1	2.4	43.2	0.8	2.4	3.3	0.3	51.0	0.7	8.9	0.3	14.3	237.3	0.1	3.3	0.5	30.4	0.0	14.4	2.1	48.1	0.6	1.2	1.8	1.0	0.1	15.6	0.0	2.0	0.0	1.3	88.4	0.4	0.1	1.2	139.7	164.9	0.5	2.0	0.0	2.0	0.4	1.0	0.6	2.4	4.5	0.0	1.8	0.4	62.1	1.6
GPT2	ALT2	ENSG00000166123	"Glutamic--pyruvic transaminase 2"	Q8TD30	16	46884362-46931289	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 267.4;skeletal muscle: 176.4;tongue: 184.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 64.3;Hepatocytes: 123.9;Syncytiotrophoblasts: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 159.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051514	Approved		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA051514: AB_2681516"	"unprognostic (1.65e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.12e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.86e-1)"	"unprognostic (3.54e-3)"	"unprognostic (3.18e-1)"	56.8	10.4	51.6	4.0	49.9	3.8	17.0	49.1	56.9	5.2	38.4	7.7	1.7	3.7	31.4	77.8	7.6	9.8	7.9	51.3	45.7	23.5	103.7	2.1	4.3	69.8	45.9	2.3	267.4	8.3	13.0	3.1	63.9	24.2	4.9	6.9	48.8	10.9	176.4	37.8	3.9	3.1	60.2	2.3	58.6	15.0	54.9	7.7	7.6	184.5	13.4	2.7	7.7	64.5	42.6	19.0	23.8	90.6	32.7	7.0	43.1	28.9	10.9	30.7	19.2	65.3	17.6	29.9	24.7	20.7	15.6	33.6	43.3	42.8	20.4	14.0	21.1	10.5	10.8	159.9	22.4	75.6	9.5	15.2	37.0	30.0	46.3	20.3	15.1	56.1	8.7	23.3	10.3	75.8	15.1	62.9	25.3	52.2	54.2	0.3	26.3	71.1	12.4	21.0	73.7	37.7	14.9	76.4	39.0	9.4	19.6	67.6	11.3	21.1	40.9	14.2	23.4	110.2	36.9	87.1	32.6	48.3	11.7	0.4	0.2	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	51.6	49.9	49.1	56.9	51.3	45.7	69.8	45.9	63.9	60.2	54.9	64.5	1.3	6.4	3.4	54.9	4.8	15.9	4.9	6.8	64.3	14.5	6.7	8.4	14.9	8.6	9.1	18.4	22.9	9.2	0.3	10.2	11.7	7.0	9.6	12.2	7.2	2.3	13.1	5.2	16.7	30.2	44.8	7.5	37.2	37.5	3.8	14.9	5.0	123.9	3.8	6.7	18.8	13.4	6.1	3.2	7.3	22.9	4.7	2.3	8.8	1.0	1.1	42.5	1.0	13.6	26.0	25.6	5.2	15.4	7.9	12.4	2.0	38.6	5.4	5.9	0.0	5.2	3.6	2.5	17.3	53.1	16.3	83.3	1.4	2.6	6.3	4.2
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028992	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 11673.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 20125.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 605.6;thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 20.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 20.7"	"Cell line enriched"	"Detected in many"	12	"ASC diff: 7677.4"	"Region enhanced"	"Detected in all"		"hypothalamus: 239.5"	"Low region specificity"	"Detected in all"			CAB069456	Approved				"Secreted to blood"	NA	NA	5090000000	6200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	4524.7	443.8	57.8	75.4	68.3	7.9	3188.6	62.7	73.8	917.6	578.2	741.2	88.3	416.0	90.7	568.6	1038.4	136.4	2362.4	68.2	117.5	11673.5	986.3	2471.8	133.2	317.7	104.5	517.8	257.0	112.4	793.7	592.2	136.6	557.5	93.4	4204.9	481.4	140.0	847.9	669.7	720.6	61.0	67.5	555.7	641.1	80.4	135.8	26.8	3627.5	458.9	44.9	1196.7	891.7	70.3	2.2	10.0	8.5	2.7	7677.4	6.7	9.2	3.5	0.8	7.9	2.4	177.5	3.9	1.1	214.1	5.6	3.2	2.8	39.6	433.2	6.0	6.1	2.5	1.9	4.3	195.0	294.7	0.5	4.3	649.1	41.2	0.2	1.0	10.6	11.3	1.2	1.2	0.3	11.0	31.4	0.5	1.2	13.8	0.8	0.2	1.0	5.2	1.7	74.1	4.3	11.3	11.4	1.2	31.6	1.9	33.6	43.5	2.1	2.5	2.3	19.6	3.7	1.0	2.7	15.6	2.5	7.0	3.0	0.6	0.0	4.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	20.7	0.0	0.2	0.0	0.0	1.6	57.8	68.3	62.7	73.8	68.2	117.5	317.7	104.5	136.6	67.5	135.8	70.3	353.6	9.6	33.7	1.0	106.8	18.5	86.9	94.8	1.2	26.3	31.7	5.5	639.8	18.6	58.3	649.2	43.8	713.8	2.2	2.3	1772.6	5.5	2.9	48.1	71.1	144.6	45.6	24.0	4.0	48.2	1191.3	514.0	50.0	627.9	11.4	274.9	735.3	228.4	151.5	16.8	0.4	5.9	91.6	47.9	86.7	17.5	446.7	160.2	23.2	3.7	0.7	5019.8	0.0	0.0	0.3	9.9	13.8	41.0	2.2	141.8	0.5	20125.9	39.1	86.8	683.7	131.6	264.6	7.1	10.3	13.9	21.6	1767.7	68.3	1.0	1.3	34.3
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.8;choroid plexus: 91.8;retina: 96.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Inhibitory neurons: 102.8;Oligodendrocyte precursor cells: 95.0;Rod photoreceptor cells: 92.3;Theca cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 7.0"	"Group enriched"	"Detected in many"	4	"A549: 62.4;HDLM-2: 168.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008557, HPA075204"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum, Plasma membrane"	Vesicles	"HPA008557: AB_1079197, HPA075204: "	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.8	258.8	22.5	4.3	27.4	18.6	1.1	80.1	52.3	0.9	91.8	1.6	34.6	1.1	9.4	0.6	3.6	12.1	15.0	55.6	19.4	15.5	1.5	2.6	5.4	25.7	20.1	15.2	2.4	0.7	16.6	5.0	24.2	1.1	1.1	96.7	1.9	2.0	3.4	0.5	25.2	1.2	9.4	3.6	11.4	16.8	33.5	6.6	4.9	2.2	3.5	1.2	0.8	26.1	0.1	62.4	3.5	0.1	0.3	0.7	9.5	20.5	14.6	4.1	1.8	2.6	0.4	3.8	10.4	10.1	6.8	0.0	6.2	0.0	4.3	168.5	5.0	0.0	28.3	0.7	0.0	22.1	0.0	1.0	0.1	7.1	0.0	5.2	1.8	1.6	0.0	0.2	3.7	0.5	3.8	7.2	7.6	28.3	23.0	10.8	9.8	6.8	0.2	0.0	20.0	16.3	4.9	0.5	0.1	8.1	0.5	12.0	12.3	23.8	3.2	4.2	1.0	0.0	0.0	0.0	4.6	20.5	1.1	0.0	1.2	0.4	0.4	0.7	0.2	0.0	1.5	1.2	1.7	0.0	0.2	0.2	0.1	1.6	0.7	7.0	0.7	0.5	22.5	27.4	80.1	52.3	55.6	19.4	25.7	20.1	24.2	9.4	33.5	26.1	1.4	0.0	0.5	94.7	0.6	0.0	0.0	0.1	1.2	44.3	1.1	1.0	5.7	21.5	0.2	5.5	114.7	6.9	17.9	0.1	3.9	0.7	9.6	1.6	0.6	1.0	0.0	0.0	120.7	0.4	3.7	1.6	16.3	0.9	0.0	41.9	0.7	0.0	2.6	45.4	102.8	1.8	0.0	3.8	2.6	2.7	0.6	7.5	0.0	37.5	2.5	23.4	0.0	95.0	5.5	3.9	1.3	0.7	2.4	0.1	17.3	8.9	0.4	92.3	0.0	3.0	4.2	3.9	1.9	0.1	0.4	2.5	7.2	109.3	1.5	0.0
GRAP		ENSG00000154016	"GRB2 related adaptor protein"	Q13588	17	19020656-19047011	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.5"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.2;B-cells: 21.2;Endothelial cells: 19.8;Hepatic stellate cells: 30.7;Microglial cells: 9.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 99.7;T-cells: 133.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 87.1;HUVEC TERT2: 38.9;JURKAT: 30.1;REH: 47.8;TIME: 70.4;U-698: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046595, HPA066654"	Uncertain		Approved	Centrosome		NA	NA		1400000	"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Centrosome		"HPA046595: AB_10966385, HPA066654: AB_2685699"	"unprognostic (3.02e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.86e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-3)"	6.3	3.5	6.7	13.9	6.2	6.5	5.9	6.1	6.9	3.9	5.0	2.6	1.9	3.3	0.5	1.8	4.6	5.3	3.7	5.8	6.1	4.9	6.0	7.1	36.9	6.8	6.5	1.8	0.9	0.6	1.9	6.1	6.8	2.7	1.8	0.4	1.6	3.7	1.7	2.4	15.7	3.3	6.5	37.5	2.2	6.3	7.0	31.9	5.5	1.4	30.7	3.6	2.2	6.0	0.0	0.2	4.5	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.1	0.0	87.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	5.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	38.9	30.1	0.2	0.0	0.0	0.2	19.9	1.9	0.9	0.0	0.0	47.8	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	6.8	70.4	0.0	0.2	9.8	0.1	0.1	0.0	60.2	0.1	0.1	0.3	21.5	9.4	1.3	21.5	4.8	21.5	99.7	67.4	28.4	10.5	82.7	133.6	66.5	2.9	21.4	0.4	7.9	62.3	48.9	6.7	6.2	6.1	6.9	5.8	6.1	6.8	6.5	6.8	6.5	7.0	6.0	11.2	6.4	1.8	0.0	21.2	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.6	0.0	0.0	0.1	3.1	0.0	0.0	0.3	2.3	1.1	0.2	19.8	0.0	4.0	0.0	0.0	0.7	0.4	0.0	1.2	2.5	0.1	30.7	0.8	8.2	0.0	0.0	0.4	0.0	4.4	0.7	0.8	0.0	1.9	0.0	9.4	2.9	0.2	2.1	0.0	0.1	0.2	0.0	0.4	3.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.3	0.7	0.3	0.0	1.0	0.3	6.9	0.5	0.3	0.0
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 32.6;granulocytes: 146.9;Macrophages: 82.0;NK-cells: 59.8;T-cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Group enriched"	"Detected in some"	4	"HEL: 45.7;JURKAT: 175.8;K-562: 44.8;MOLT-4: 122.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.2	0.7	0.2	7.9	0.2	10.3	2.0	0.2	0.3	1.5	0.5	2.2	3.6	0.8	0.5	1.2	0.7	2.6	1.1	0.2	0.3	0.6	1.2	4.4	15.7	0.6	0.3	0.2	0.4	0.1	0.3	0.6	0.5	1.6	2.3	0.3	1.7	0.7	0.4	1.1	4.5	0.9	0.5	9.3	3.8	1.9	0.4	184.8	0.8	0.5	12.9	3.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	45.7	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.2	0.3	0.0	175.8	44.8	0.0	0.0	0.0	122.8	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	6.3	0.7	0.1	51.4	0.3	38.2	3.1	37.5	56.2	1.2	5.2	31.3	58.2	6.6	5.4	0.3	0.8	35.0	74.9	0.2	0.2	0.2	0.3	0.2	0.3	0.6	0.3	0.5	0.5	0.4	0.7	1.1	0.0	6.7	0.3	8.2	1.7	0.0	0.0	0.0	0.6	1.1	0.8	1.0	2.8	0.0	0.0	0.0	0.0	18.3	0.1	0.0	0.4	4.8	0.3	0.1	0.8	1.2	32.6	1.3	0.2	0.0	0.6	0.0	0.1	146.9	0.2	2.5	2.3	0.2	0.0	1.2	0.6	0.0	1.9	4.6	2.9	0.3	82.0	1.8	1.0	6.8	0.3	59.8	2.5	1.0	0.0	0.3	0.4	6.3	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.9	4.4	2.1	0.1	1.1	0.1	57.1	0.0	0.1	0.3
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.2;kidney: 61.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.1;Basal squamous epithelial cells: 104.7;Prostatic glandular cells: 79.0;Squamous epithelial cells: 124.7;Syncytiotrophoblasts: 98.6;Urothelial cells: 79.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"OE19: 1706.0"	"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Low region specificity"	"Detected in many"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	5.9	0.1	0.0	0.7	0.4	0.0	14.2	5.6	0.4	13.5	4.5	8.1	11.8	3.3	3.8	60.2	22.3	9.5	1.2	0.2	0.0	61.5	11.1	10.6	0.1	0.0	0.4	1.0	32.7	11.4	6.9	11.9	0.5	14.5	10.0	0.1	25.2	11.6	0.3	39.9	10.8	1.0	0.0	0.5	16.9	1.2	0.1	1.1	6.6	0.1	8.7	7.5	26.2	0.3	12.6	14.4	0.0	0.0	0.0	0.0	19.1	0.0	0.8	0.1	0.5	44.7	24.3	0.0	4.2	0.4	0.9	24.1	0.0	16.1	0.0	0.0	2.1	0.0	6.4	38.5	0.0	0.0	0.0	0.0	15.1	0.2	3.7	2.5	0.1	0.0	0.0	0.0	0.0	11.5	0.2	0.1	4.9	1706.0	3.4	0.1	0.0	18.6	18.5	14.0	9.5	0.1	18.4	370.7	0.1	17.3	14.0	0.0	0.0	0.0	1.1	0.2	0.0	0.2	0.1	1.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.6	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.5	22.4	15.1	0.0	0.9	38.2	77.1	20.0	104.7	0.2	48.2	30.5	2.5	17.2	18.2	22.0	0.0	35.7	0.7	25.6	9.8	35.6	0.0	30.2	5.3	2.6	14.4	0.0	0.3	19.4	27.4	3.1	27.0	41.8	1.3	0.5	0.4	5.1	2.8	0.0	0.0	19.7	40.7	0.0	2.3	0.0	2.8	1.3	5.4	0.0	1.6	0.4	0.0	0.0	0.0	26.7	26.0	1.2	0.3	79.0	28.3	13.8	20.9	0.1	0.0	0.9	2.1	0.4	0.3	124.7	41.9	98.6	1.4	0.0	21.1	79.7
GREB1	KIAA0575	ENSG00000196208	"Growth regulating estrogen receptor binding 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"ovary: 278.3"	"Cell type enriched"	"Detected in many"	9	"Granulosa cells: 545.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 40.3;Hep G2: 39.6;MCF7: 61.8;SH-SY5Y: 40.5;SK-MEL-30: 30.4;T-47d: 138.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	"Mitochondria, Cytosol"		"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.8	3.4	8.5	0.7	9.6	0.4	13.7	2.1	9.9	60.2	0.8	1.0	0.7	61.3	7.0	0.6	53.4	2.8	4.6	7.8	20.4	1.8	3.1	1.4	0.6	8.7	8.5	278.3	7.6	0.7	8.9	3.0	4.4	63.4	0.2	1.5	1.1	3.8	4.0	2.7	0.9	12.8	3.2	0.2	3.0	14.9	10.7	0.3	0.6	4.8	0.3	1.7	21.5	6.5	0.1	1.0	40.3	0.5	0.2	0.2	1.8	0.0	0.1	0.1	0.3	0.3	0.2	2.5	0.3	0.0	6.9	0.2	3.1	0.2	0.1	5.1	3.6	0.4	0.3	39.6	0.5	0.3	2.1	0.5	2.2	0.6	0.4	0.4	0.0	3.9	0.5	1.0	0.3	61.8	1.2	2.0	13.0	0.1	0.1	29.1	0.0	1.9	0.1	0.0	11.8	40.5	0.9	1.1	30.4	5.2	138.0	0.7	0.0	4.1	2.0	0.4	0.1	6.0	4.4	24.7	6.8	11.9	1.2	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.1	0.1	0.0	8.5	9.6	2.1	9.9	7.8	20.4	8.7	8.5	4.4	3.2	10.7	6.5	0.4	0.0	0.5	20.2	0.7	0.8	1.9	0.0	0.6	4.8	24.7	13.7	8.3	5.7	0.6	0.0	2.1	0.2	0.1	0.1	0.0	0.3	0.8	35.7	36.0	1.3	0.0	0.0	15.0	0.2	3.6	16.9	0.0	23.4	3.8	545.2	0.7	8.9	3.2	3.3	46.9	0.0	0.0	0.0	1.2	2.5	20.2	1.4	5.4	1.0	0.0	0.2	0.0	11.6	20.9	0.4	0.0	55.3	5.0	14.3	0.0	2.5	2.9	0.5	0.0	7.2	14.8	1.1	2.9	0.3	0.3	0.3	1.1	33.1	0.0	2.5
GREM2	"CKTSF1B2, DAND3, FLJ21195, Prdc"	ENSG00000180875	"Gremlin 2, DAN family BMP antagonist"	Q9H772	1	240489573-240612155	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Developmental protein, Heparin-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 31.4;liver: 26.3"	"Cell type enriched"	"Detected in many"	9	"Syncytiotrophoblasts: 298.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 32.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009920	Approved				"Secreted to blood"	NA	NA		12000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB009920: AB_2279266"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.07e-8)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.38e-2)"	0.8	1.7	2.1	9.7	2.9	0.1	3.4	0.1	6.1	0.9	0.0	17.1	10.8	9.6	2.2	17.1	1.4	31.4	0.0	1.3	1.8	2.3	26.3	1.2	0.2	2.1	1.7	6.6	0.2	22.9	2.1	4.0	1.9	2.6	20.1	5.8	4.2	1.8	7.3	3.6	14.9	6.4	1.3	3.2	9.3	0.3	2.8	0.3	0.5	0.7	0.2	3.8	0.5	2.0	0.0	0.0	0.1	0.0	1.9	2.4	0.0	6.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	2.8	1.3	0.0	0.0	3.9	0.5	0.8	0.4	1.0	0.0	0.0	3.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	2.9	0.1	6.1	1.3	1.8	2.1	1.7	1.9	1.3	2.8	2.0	0.2	0.0	0.0	0.3	0.2	4.7	0.0	0.0	0.6	20.8	14.0	0.1	0.6	0.0	0.0	0.0	12.5	7.4	0.6	0.6	0.0	0.0	0.0	2.3	1.2	0.6	1.2	0.0	28.6	0.0	1.7	17.4	0.0	13.7	0.0	0.1	0.7	20.4	1.5	0.0	30.5	0.1	0.0	0.3	6.2	0.2	0.0	0.2	1.8	3.7	0.0	0.4	1.0	1.5	1.2	0.1	0.1	4.5	0.1	0.6	0.0	0.0	0.7	6.7	0.0	0.2	1.4	2.4	2.7	0.6	3.7	298.0	1.6	2.3	0.6	0.1
GRIA3	"GluA3, GLUR3, GLURC, MRX94"	ENSG00000125675	"Glutamate ionotropic receptor AMPA type subunit 3"	P42263	X	123184153-123490915	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6;retina: 17.8"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 468.4;Horizontal cells: 198.5;Inhibitory neurons: 396.3;Oligodendrocyte precursor cells: 385.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 23.8;BJ hTERT+: 34.5;fHDF/TERT166: 45.9;U-2197: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058659, HPA073344"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058659: AB_2683791, HPA073344: "	"unprognostic (2.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.29e-4)"	"unprognostic (2.42e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	0.8	10.3	20.0	0.3	25.3	0.1	1.4	1.3	31.6	6.7	0.0	0.7	0.3	2.1	3.6	0.4	1.5	1.2	2.0	29.0	4.0	2.5	7.7	0.3	0.5	1.9	3.4	4.1	1.7	0.0	1.0	0.4	1.4	1.7	0.8	17.8	0.2	1.9	0.2	0.5	0.5	1.9	4.5	0.1	2.0	0.7	6.4	0.2	0.2	0.1	0.8	0.6	2.8	20.9	0.0	0.0	0.0	0.0	2.2	0.4	0.0	23.8	34.5	0.4	0.9	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	6.6	0.0	15.1	0.2	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	25.3	1.3	31.6	29.0	4.0	1.9	3.4	1.4	4.5	6.4	20.9	0.1	0.0	0.0	27.4	0.0	0.3	0.0	0.8	0.6	13.6	0.2	0.0	1.6	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.1	0.3	8.7	0.3	0.0	0.0	468.4	0.2	0.1	6.4	1.1	0.2	0.0	0.1	0.4	6.1	0.1	198.5	396.3	0.0	0.0	0.0	1.5	0.3	9.3	0.2	1.8	14.0	0.0	1.9	0.0	385.0	67.6	0.3	0.0	4.1	0.0	0.4	0.0	6.2	0.1	3.8	0.0	0.2	4.5	0.0	0.1	0.0	1.0	0.1	0.1	0.7	0.0	0.0
GRIK2	"GluK2, GLUR6, MRT6"	ENSG00000164418	"Glutamate ionotropic receptor kainate type subunit 2"	Q13002	6	101181257-102070083	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"brain: 93.3"	"Group enriched"	"Detected in some"	26	"Excitatory neurons: 724.6;Inhibitory neurons: 2376.0;Oligodendrocyte precursor cells: 1234.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.9"	"Region enhanced"	"Detected in all"		"cerebellum: 93.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 16.4;BJ hTERT+: 26.6;fHDF/TERT166: 20.8;HAP1: 10.2;SiHa: 11.1;WM-115: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014395, HPA014623, CAB022463"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305"	"unprognostic (1.43e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.34e-5)"	"unprognostic (1.94e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-4)"	0.2	1.8	18.7	0.4	20.3	0.3	0.2	93.3	25.2	1.4	0.0	0.5	0.6	0.4	1.1	0.4	0.3	0.5	4.5	20.7	28.4	0.8	0.1	0.1	0.1	1.0	6.8	0.4	2.6	0.0	1.6	2.4	7.9	0.9	0.4	4.2	0.7	1.2	0.9	1.6	0.6	0.3	1.6	0.4	0.3	0.7	19.8	0.0	3.4	0.1	0.0	0.5	0.4	7.6	0.1	0.1	3.1	0.2	3.6	0.1	0.0	16.4	26.6	0.8	0.5	0.0	0.3	0.1	0.0	20.8	0.0	5.1	10.2	0.0	0.3	0.0	0.0	1.7	8.5	0.0	0.9	0.0	0.2	0.3	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.4	6.2	0.0	0.0	0.2	2.7	0.0	0.2	0.1	0.4	0.1	0.7	0.0	3.3	7.0	11.1	0.0	0.5	0.5	0.0	0.8	0.0	2.1	0.5	0.1	1.3	0.1	0.0	0.1	1.5	0.0	24.6	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.0	18.7	20.3	93.3	25.2	20.7	28.4	1.0	6.8	7.9	1.6	19.8	7.6	0.2	0.0	0.5	54.9	0.0	0.6	1.0	0.1	0.6	11.4	0.1	0.0	5.9	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.8	3.4	1.9	0.4	1.8	0.0	724.6	0.6	0.0	1.8	0.0	0.5	0.0	13.0	0.0	0.0	0.1	0.0	2376.0	0.0	0.0	0.0	0.0	7.7	0.3	0.1	1.8	38.4	0.0	0.5	0.0	1234.0	40.5	0.1	1.1	0.4	0.0	0.8	0.1	0.0	2.2	1.1	0.0	0.7	4.6	0.0	0.5	0.1	0.6	0.0	0.0	4.3	0.1	0.9
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437601	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 27.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 215.5;Inhibitory neurons: 138.8;Rod photoreceptor cells: 124.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 27.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.0	0.0	3.3	0.0	3.6	0.0	0.0	27.6	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	7.3	2.3	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.6	27.6	6.8	7.3	2.3	0.0	3.1	0.9	0.0	7.7	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	3.7	0.0	0.0	1.8	16.7	0.0	0.0	0.0	1.9	0.0	8.5	0.1	0.0	0.2	0.0	0.0	215.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.6	6.7	138.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.7	0.0	4.0	0.0	8.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.9	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRPEL2	"DKFZp451C205, FLJ23713, Mt-GrpE#2"	ENSG00000164284	"GrpE like 2, mitochondrial"	Q8TAA5	5	149345430-149354583	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 44.9"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018173, HPA023211"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA018173: AB_1850358, HPA023211: AB_1850360"	"unprognostic (3.13e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.87e-5)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.16e-8)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-1)"	6.8	4.2	4.6	5.9	5.0	5.0	5.1	8.8	6.2	13.4	2.8	4.1	4.8	4.3	4.1	44.9	3.8	3.5	8.2	4.8	6.1	6.2	4.7	9.3	7.2	6.3	5.5	5.4	3.7	6.5	3.0	7.5	6.6	3.9	3.9	5.6	7.2	4.0	8.8	4.5	5.0	3.6	5.3	4.8	5.5	4.6	6.0	5.3	6.5	5.1	11.0	4.9	11.0	5.9	16.3	9.5	12.5	44.2	7.9	8.1	25.2	14.8	11.9	13.5	19.1	22.7	10.6	17.5	15.0	7.6	18.0	12.4	20.3	20.8	18.8	9.0	18.0	21.1	16.0	11.9	22.1	21.2	11.1	12.4	24.5	16.3	26.8	5.9	9.7	22.1	18.5	39.4	9.9	11.2	13.4	17.1	16.0	9.9	34.5	17.3	17.0	22.0	8.8	15.7	25.3	20.7	14.7	25.9	44.5	9.3	23.0	24.5	11.2	14.6	16.3	10.4	21.3	14.7	21.6	16.6	14.3	28.9	14.5	9.9	2.5	3.6	5.1	2.4	6.1	3.9	7.6	5.6	3.9	1.8	9.9	7.5	2.0	3.8	2.8	1.1	15.1	4.8	4.6	5.0	8.8	6.2	4.8	6.1	6.3	5.5	6.6	5.3	6.0	5.9	20.9	9.6	6.4	2.3	3.3	17.8	5.3	9.9	9.6	6.1	7.0	6.0	8.8	4.3	9.3	9.2	8.4	9.2	3.5	5.1	1.9	5.3	11.6	2.3	4.9	36.0	6.0	11.4	4.3	6.0	18.2	6.0	3.6	5.6	2.5	6.6	20.3	7.1	6.0	3.3	5.1	4.5	10.2	9.7	7.4	5.4	4.1	2.7	7.2	5.6	4.5	5.4	2.1	3.0	4.9	7.5	3.1	5.3	4.4	7.1	6.5	6.2	5.0	6.7	0.0	6.1	6.0	22.6	12.0	10.0	19.6	5.6	9.2	5.2	7.2	8.2
GRTP1	"FLJ22474, TBC1D6"	ENSG00000139835	"Growth hormone regulated TBC protein 1"	Q5TC63	13	113324163-113364148	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Proximal enterocytes: 70.2;Rod photoreceptor cells: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 60.4;T-47d: 54.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046201	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA046201: AB_2679584"	"unprognostic (5.31e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.07e-3)"	"prognostic favorable (1.50e-5)"	"unprognostic (4.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.50e-3)"	4.4	14.2	2.6	3.2	2.6	2.9	7.9	3.5	5.3	14.3	5.8	24.8	46.0	8.6	3.5	21.6	10.5	6.1	2.6	2.7	2.0	19.3	83.9	4.5	1.6	2.8	2.8	12.8	9.8	8.3	2.8	2.9	2.5	18.3	13.3	20.9	14.5	4.9	10.0	25.9	38.8	3.0	2.8	7.8	13.2	9.5	2.7	1.6	4.0	1.3	2.5	10.6	17.0	3.2	10.1	3.8	7.5	12.9	1.2	1.9	23.6	1.9	0.0	0.5	0.2	21.9	23.2	0.6	1.5	0.6	4.7	15.5	6.6	1.9	0.0	0.5	8.7	13.5	11.2	21.9	2.1	1.1	4.8	0.6	2.9	1.6	0.2	1.0	0.0	1.3	8.2	0.7	0.0	20.5	0.2	1.9	21.2	60.4	2.9	1.1	0.3	0.4	1.7	12.3	0.6	6.6	0.4	11.3	2.7	8.9	54.6	1.3	1.0	0.4	2.8	1.8	0.7	3.8	4.3	1.5	8.1	3.0	4.4	0.6	0.4	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.3	0.5	0.2	2.2	0.3	0.5	0.3	0.1	0.7	2.6	2.6	3.5	5.3	2.7	2.0	2.8	2.8	2.5	2.8	2.7	3.2	1.1	0.0	6.0	11.1	0.8	21.7	24.0	23.4	14.2	5.8	12.7	8.6	1.2	30.0	15.9	3.7	81.3	28.8	0.7	51.8	23.5	10.0	0.4	6.2	4.8	3.0	3.6	3.8	0.5	9.2	9.2	4.0	14.3	8.8	0.0	18.3	5.7	30.1	1.7	3.3	0.5	28.2	16.2	0.8	1.9	0.8	8.1	2.3	1.8	1.0	2.6	13.7	0.0	1.0	1.0	9.6	43.3	8.6	0.1	11.0	70.2	45.8	9.6	69.6	0.0	5.9	5.3	0.2	8.8	18.2	23.7	25.3	1.2	2.7	40.1	23.8
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 916.5;kidney: 943.1;liver: 2610.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	916.5	0.0	2.5	0.0	0.0	4.2	0.0	0.2	2.0	0.0	7.3	672.0	0.4	7.0	5.3	86.1	119.5	0.2	0.0	0.0	943.1	2610.5	12.2	0.5	0.0	0.0	78.9	148.6	0.0	0.2	0.5	0.0	18.7	8.1	0.0	21.5	0.6	0.1	1.2	674.6	0.3	0.0	0.2	135.5	336.8	0.3	0.1	0.1	0.0	11.5	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750087-52763475	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 696.0;liver: 2058.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 201.6;Distal tubular cells: 213.2;Exocrine glandular cells: 239.6;Pancreatic endocrine cells: 334.7;Proximal enterocytes: 367.0;Proximal tubular cells: 1186.6;Respiratory ciliated cells: 435.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 25.9;Hep G2: 20.0"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.4	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	149.5	0.0	0.7	0.1	2.5	109.4	0.0	0.0	0.0	696.0	2058.5	4.8	0.1	0.0	0.0	0.2	299.2	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.5	0.0	0.0	0.0	115.5	0.0	0.0	0.0	11.7	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.0	20.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.3	0.6	0.5	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	1.7	0.0	0.2	1.5	0.0	0.0	0.1	0.1	0.0	201.6	31.1	16.5	0.0	0.0	0.0	0.1	213.2	8.1	6.9	0.0	0.0	0.6	0.0	0.0	0.0	239.6	0.2	0.5	7.7	0.0	0.0	37.2	0.7	124.2	0.1	0.0	0.0	13.7	2.0	2.2	0.0	14.6	1.2	5.1	0.0	0.0	5.2	0.0	0.0	0.0	0.1	334.7	18.8	0.4	0.0	3.9	367.0	1186.6	435.5	0.0	0.0	0.0	1.5	1.9	0.7	0.0	0.0	0.0	2.6	10.4	30.1	1.3
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52840843	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"Smooth muscle cells: 23.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.0	0.0	0.0	23.6	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109711780-109775428	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"breast: 929.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 59.0;Leydig cells: 143.5;Muller glia cells: 213.3;Peritubular cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.9"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 21.6;HHSteC: 10.3;HSkMC: 10.9"									"HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 5: Breast - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	21.7	6.4	60.3	4.6	65.3	0.5	929.9	60.4	71.1	72.5	62.9	13.9	2.3	35.1	32.9	11.6	62.0	25.8	17.0	61.4	54.5	5.5	3.9	18.0	5.0	57.2	55.4	213.9	4.7	0.2	9.4	0.8	56.7	27.9	7.8	12.4	7.9	32.6	3.9	12.2	10.3	26.5	60.1	7.7	13.2	11.4	53.5	6.4	9.1	14.0	6.5	27.9	47.6	58.6	0.0	0.0	0.0	0.0	1.7	1.6	0.4	1.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	21.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	10.3	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.6	0.0	3.9	0.9	0.7	60.3	65.3	60.4	71.1	61.4	54.5	57.2	55.4	56.7	60.1	53.5	58.6	2.5	0.0	0.5	32.3	0.0	6.6	0.9	0.2	0.0	2.0	0.5	0.8	0.9	1.5	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	9.0	0.3	12.3	2.2	0.0	2.1	0.1	0.0	0.1	59.0	1.1	0.3	0.0	0.6	5.7	0.0	0.3	0.0	0.5	0.1	0.0	0.6	9.3	15.1	143.5	0.6	10.6	1.9	0.0	213.3	0.0	2.0	0.3	0.0	0.0	127.2	0.1	0.1	0.1	0.0	0.0	6.8	26.3	2.3	9.4	2.0	1.8	1.0	6.5	0.0	2.8	2.4	0.1	0.6
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	6.0	12.6	7.0	3.4	7.0	0.5	6.9	7.2	8.1	16.8	14.0	15.1	7.7	11.3	8.6	26.7	8.8	5.7	11.6	6.0	8.4	18.6	4.6	11.7	1.0	9.2	8.9	10.5	10.0	18.9	27.6	5.8	9.0	13.3	5.6	36.7	17.3	8.2	68.1	22.4	6.7	8.4	6.7	2.0	13.9	5.0	10.1	3.4	17.4	29.7	5.4	15.0	19.8	10.2	21.2	12.9	28.1	30.8	22.2	10.8	0.2	8.8	23.7	17.1	17.7	21.7	30.1	5.4	6.5	18.1	41.7	11.6	22.6	10.2	12.6	0.2	13.0	1.1	43.1	26.1	71.2	0.2	0.7	14.7	42.1	12.0	48.9	39.7	8.9	10.4	15.5	0.1	19.2	26.1	2.7	18.9	22.6	25.7	12.8	28.1	16.4	20.0	32.7	14.6	23.1	30.5	21.7	39.0	19.9	14.2	23.4	21.2	4.6	17.5	16.9	11.4	20.5	1.1	3.4	8.9	6.7	0.3	14.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	7.0	7.0	7.2	8.1	6.0	8.4	9.2	8.9	9.0	6.7	10.1	10.2	0.9	9.6	8.2	48.3	0.1	7.9	9.9	10.5	9.6	30.8	5.6	4.1	10.4	12.8	6.8	9.2	33.3	1.4	1.5	4.5	11.7	7.6	1.6	11.5	8.0	4.1	4.2	0.8	24.6	9.2	1.8	5.6	6.1	17.0	2.5	8.0	2.9	3.1	2.6	21.9	42.1	3.6	8.2	1.2	5.7	0.3	4.1	2.5	7.2	14.0	0.7	5.9	1.0	25.6	24.9	11.6	3.2	5.7	0.0	17.8	3.6	17.4	12.7	41.1	0.0	19.0	5.7	0.1	3.7	18.2	6.7	2.9	1.1	2.4	7.4	15.8
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 38.4;Alveolar cells type 2: 56.1;Breast glandular cells: 37.4;Breast myoepithelial cells: 24.9;Distal tubular cells: 19.6;Ductal cells: 21.8;Smooth muscle cells: 49.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.2;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.8;HEK 293: 5.5;Karpas-707: 9.7;MOLT-4: 18.5;RPTEC TERT1: 12.1;RT4: 14.2;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm		NA	NA		7100	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	14.4	7.8	10.1	17.0	24.1	1.2	15.4	2.8	14.0	14.5	0.1	27.1	8.7	16.1	6.2	7.5	9.5	12.6	33.7	12.7	8.0	15.6	8.0	21.0	8.5	5.3	10.0	5.6	13.1	31.4	3.9	25.9	4.5	25.8	10.3	17.0	5.3	13.9	5.1	2.5	9.2	28.9	8.7	14.1	8.6	1.2	10.2	7.5	7.2	18.7	9.2	7.3	6.6	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	6.8	0.0	0.0	0.0	5.5	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	3.6	0.0	9.7	0.0	0.0	18.5	0.0	0.0	0.0	0.2	4.1	0.0	3.0	12.1	14.2	2.5	8.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.1	8.2	10.1	11.5	0.0	1.0	10.1	24.1	2.8	14.0	12.7	8.0	5.3	10.0	4.5	8.7	10.2	8.5	38.4	9.6	56.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	37.4	24.9	0.0	0.0	6.8	11.0	0.0	0.4	1.7	0.0	19.6	21.8	0.0	5.5	9.7	10.9	0.0	0.0	0.0	2.0	0.3	8.3	0.0	15.2	3.8	3.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	12.9	2.2	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
GUCY1A2	"GC-SA2, GUC1A2"	ENSG00000152402	"Guanylate cyclase 1 soluble subunit alpha 2"	P33402	11	106674019-107018476	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;placenta: 17.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 353.8;Inhibitory neurons: 141.8;Oligodendrocyte precursor cells: 208.6;Sertoli cells: 105.2;Smooth muscle cells: 107.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.8;BJ hTERT+ SV40 Large T+ RasG12V: 13.4;HBF TERT88: 7.1;TIME: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009534	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB009534: AB_2279509"	"unprognostic (7.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.70e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.02e-5)"	"unprognostic (2.48e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.09e-2)"	3.4	2.0	5.3	0.6	18.4	0.0	1.9	1.6	13.8	12.7	0.0	0.7	0.2	12.3	3.1	0.4	5.9	1.5	2.7	7.1	3.9	1.8	1.7	4.6	0.7	4.7	2.6	1.2	4.3	0.6	0.5	17.9	4.9	1.8	0.5	3.5	0.6	6.8	1.8	0.6	0.4	13.1	0.4	6.0	0.3	1.7	8.6	0.2	1.4	3.6	0.3	0.9	2.8	7.4	0.0	0.2	4.0	0.0	0.2	2.4	2.2	0.3	11.8	1.5	13.4	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.1	0.0	7.1	0.0	1.1	0.0	0.1	0.0	0.2	0.0	1.6	0.6	0.0	1.8	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	3.6	0.0	0.7	0.5	0.8	0.2	4.6	3.7	3.0	0.8	1.2	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	18.4	1.6	13.8	7.1	3.9	4.7	2.6	4.9	0.4	8.6	7.4	29.5	0.0	0.5	20.2	0.5	1.7	2.2	0.0	1.2	24.0	0.4	0.9	5.1	0.0	0.0	3.7	12.5	0.1	0.0	0.1	0.0	5.8	2.5	0.9	24.2	12.5	0.0	2.7	353.8	0.2	0.0	8.2	0.0	1.1	0.0	42.7	2.2	0.2	0.4	18.5	141.8	0.0	0.0	0.8	1.5	6.5	24.5	1.1	3.6	18.7	0.0	29.3	0.0	208.6	10.7	0.3	0.0	25.2	1.2	2.4	0.0	0.1	0.0	4.8	105.2	20.7	107.0	1.6	1.5	0.7	1.1	0.3	0.5	19.6	0.0	1.5
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888046-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	6.0	3.8	2.6	5.2	5.3	1.8	4.0	4.3	3.2	5.7	2.6	3.7	0.6	5.6	2.5	3.2	5.1	10.1	13.6	2.0	2.4	0.9	0.3	3.8	1.5	6.2	5.8	16.5	4.2	2.4	1.9	4.0	4.1	3.3	2.0	0.4	5.3	4.0	0.8	1.7	1.2	5.5	5.3	0.7	1.3	5.8	4.6	6.7	8.8	1.5	1.0	5.7	3.6	6.9	0.2	1.8	0.1	11.2	9.9	19.3	1.7	1.8	4.2	4.0	9.8	0.5	1.2	0.0	3.1	4.9	22.3	0.1	1.0	2.2	3.8	0.0	1.3	0.0	7.2	12.4	12.6	4.9	0.0	18.8	1.1	9.7	1.6	6.0	0.0	22.1	5.8	0.1	2.4	2.7	36.5	0.1	6.6	0.1	2.2	0.2	9.5	0.0	1.3	1.7	1.1	5.0	9.8	0.5	1.3	2.0	3.7	1.5	0.1	4.3	13.5	13.3	6.5	1.0	0.1	0.2	11.1	2.3	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.3	0.0	2.6	5.3	4.3	3.2	2.0	2.4	6.2	5.8	4.1	5.3	4.6	6.9	1.6	3.2	2.6	7.2	0.1	1.9	1.9	5.3	0.0	0.6	1.5	7.6	14.6	2.8	2.3	0.0	0.0	0.2	1.5	1.4	0.0	0.1	47.9	5.7	45.4	0.6	3.5	0.0	8.3	1.1	0.3	23.0	0.0	7.5	0.0	8.0	0.7	0.0	0.4	0.0	9.0	2.9	0.0	0.0	4.0	27.1	8.1	0.5	0.0	12.2	0.0	2.5	0.0	3.0	61.3	0.8	0.4	7.2	0.0	2.0	0.6	0.5	2.1	0.4	0.0	40.0	3.9	2.5	4.2	0.2	0.4	0.8	0.4	22.9	1.6	0.4
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"bone marrow: 156.3"	"Cell type enriched"	"Detected in some"	350	"Erythroid cells: 1995.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	203	"HEL: 149.1;K-562: 37.7"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		15000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.1	0.1	0.0	0.1	156.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	1995.6	2.4	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.9	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102646-55110252	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.1"	"Group enriched"	"Detected in many"	24	"dendritic cells: 739.3;NK-cells: 1543.8;T-cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	15	"gdT-cell: 941.4;MAIT T-cell: 926.2;memory CD4 T-cell: 250.0;memory CD8 T-cell: 922.7;naive CD8 T-cell: 494.1;NK-cell: 718.8"	"Group enriched"	"Detected in all"	42	"NK-cells: 718.8;T-cells: 941.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.0;JURKAT: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054134, HPA076751"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054134: AB_2682395, HPA076751: "	"prognostic favorable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	5.6	6.0	0.9	16.7	0.9	35.3	7.2	0.9	2.5	7.6	1.2	14.7	29.2	14.7	8.8	4.8	4.6	14.0	4.0	0.8	1.0	3.2	15.2	21.9	68.1	1.6	0.9	4.5	1.0	1.3	1.0	3.1	1.1	3.1	17.8	0.0	7.1	3.0	1.7	1.6	27.6	7.2	1.1	51.1	11.7	2.0	1.1	12.4	2.9	1.3	19.2	13.5	2.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.5	3.8	941.4	2.3	926.2	3.4	250.0	922.7	3.1	1.3	48.5	494.1	19.9	718.8	4.0	3.2	33.1	712.7	0.9	0.9	0.9	2.5	0.8	1.0	1.6	0.9	1.1	1.1	1.1	1.1	5.1	3.2	18.1	0.0	12.3	0.4	0.1	0.0	2.8	0.0	2.7	2.4	1.6	5.7	3.1	0.0	0.0	0.4	739.3	1.4	0.0	1.6	0.0	1.7	2.7	2.8	0.0	36.2	0.0	0.0	0.2	7.8	20.4	2.1	7.6	0.0	17.9	2.8	0.3	0.0	0.1	1.5	0.0	25.8	2.6	0.0	0.0	12.3	3.6	0.0	12.6	0.0	1543.8	0.0	0.1	0.0	3.9	0.0	40.8	0.1	2.8	3.3	2.9	0.0	0.0	2.6	2.6	0.0	0.1	1.1	1.4	0.7	709.4	0.0	1.8	0.0
GZMH	"CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2"	ENSG00000100450	"Granzyme H"	P20718	14	24606480-24609699	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.9;lymphoid tissue: 25.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 575.2;NK-cells: 492.3;T-cells: 302.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 1678.5;memory CD4 T-cell: 490.7;memory CD8 T-cell: 1389.6;naive CD8 T-cell: 1214.0"	"Lineage enriched"	"Detected in all"	7	"T-cells: 1678.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.0"					"Low region specificity"	"Detected in many"			HPA029200	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA029200: AB_10602908"	"unprognostic (3.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (8.80e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.77e-3)"	3.4	5.2	1.2	3.1	1.3	33.9	4.6	1.3	2.4	2.6	1.6	2.7	2.4	2.0	5.0	3.6	3.5	7.0	2.5	1.1	1.3	1.2	6.7	15.9	25.2	2.0	1.2	2.8	0.8	0.7	2.4	1.6	1.5	1.4	2.5	0.0	7.9	2.1	1.9	0.6	2.8	3.4	1.3	24.4	4.7	0.8	1.4	3.8	1.5	0.6	4.5	7.5	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.2	31.6	3.4	1.7	1678.5	3.6	30.2	7.6	490.7	1389.6	3.3	4.6	155.1	1214.0	18.6	250.8	5.4	44.6	4.5	1436.5	1.2	1.3	1.3	2.4	1.1	1.3	2.0	1.2	1.5	1.3	1.4	1.3	2.9	0.0	4.6	0.0	3.3	1.1	0.1	0.0	0.0	0.0	1.7	1.5	1.4	8.6	0.0	0.0	0.0	0.1	575.2	0.0	0.0	0.1	0.1	0.3	0.3	1.5	0.0	8.6	0.0	0.0	0.0	1.2	1.1	0.4	1.3	0.0	7.5	1.2	0.1	0.0	0.0	0.0	0.0	9.3	3.4	0.2	0.0	4.5	3.6	1.9	3.1	0.0	492.3	0.0	0.1	0.0	0.0	0.0	43.7	0.2	0.0	2.6	0.7	0.0	0.0	1.9	1.3	0.1	0.0	0.4	1.8	0.0	302.2	0.0	0.1	0.1
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 22.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 385.8;NK-cells: 810.5;T-cells: 243.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 583.9"	"Group enriched"	"Detected in all"	33	"NK-cells: 194.9;T-cells: 583.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HDLM-2: 1.7;HMC-1: 2.1;JURKAT: 3.5;MOLT-4: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015624	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA015624: AB_2669245"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"	2.2	1.1	0.9	10.0	0.9	21.6	1.1	3.6	2.0	1.4	0.3	1.5	2.1	0.8	0.2	0.8	1.3	1.8	0.8	0.9	0.9	1.0	3.3	5.3	19.2	1.0	0.8	0.7	0.4	0.0	0.9	0.4	1.0	1.3	0.3	0.2	2.8	0.4	0.7	0.8	6.2	0.2	0.7	22.7	3.7	1.8	0.9	8.7	1.6	0.1	3.8	1.5	1.4	1.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.1	0.0	0.4	1.3	0.6	0.3	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.1	0.5	0.1	0.3	0.1	9.1	1.4	1.3	583.9	1.7	366.5	0.9	189.2	471.3	1.5	4.0	182.8	379.2	11.9	194.9	2.3	3.6	99.1	227.5	0.9	0.9	3.6	2.0	0.9	0.9	1.0	0.8	1.0	0.7	0.9	1.0	3.4	0.0	0.0	0.3	5.7	3.1	0.1	0.0	0.6	0.5	2.4	2.2	0.1	1.5	0.0	0.0	0.0	0.2	385.8	0.1	0.0	0.4	0.9	0.6	1.5	1.4	0.0	12.0	0.3	0.4	0.4	2.2	13.3	1.1	0.0	0.1	3.6	1.4	0.2	0.0	0.2	0.4	0.0	3.7	4.7	1.6	0.0	5.9	1.8	1.0	8.6	1.6	810.5	0.5	0.3	0.3	0.0	0.0	35.8	0.1	0.0	1.2	0.0	1.4	0.0	1.5	1.2	0.5	1.1	0.9	1.4	0.5	243.6	0.2	0.1	0.1
H2AC1	"bA317E16.2, H2AFR, HIST1H2AA"	ENSG00000164508	"H2A clustered histone 1"	Q96QV6	6	25726063-25726562	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"			Nucleoplasm		"HPA041189: AB_2677357"													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC1	"bA317E16.3, H2BFU, HIST1H2BA, STBP, TSH2B"	ENSG00000146047	"H2B clustered histone 1"	Q96A08	6	25726777-25727345	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"testis: 6.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011603, HPA042205, HPA043013"	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"					"CAB011603: AB_2118143, HPA042205: AB_2677900, HPA043013: AB_2678269"															"unprognostic (3.94e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 295.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 23.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					NA	NA		580000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	8.7	5.4	1.8	5.9	2.1	4.1	12.9	2.1	2.5	16.0	3.3	13.2	23.1	10.5	14.5	6.0	10.6	6.1	7.0	1.8	2.3	41.8	295.8	5.7	6.1	2.0	2.5	14.0	26.3	2.9	4.5	8.5	2.3	10.1	11.6	0.3	3.8	11.3	2.4	5.0	40.8	4.7	2.1	5.4	9.6	1.8	2.1	4.0	5.8	3.2	4.5	15.8	9.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	4.6	14.0	0.1	0.0	0.1	0.6	0.0	0.0	4.7	0.0	0.8	0.0	1.4	5.6	0.0	49.4	0.4	1.9	0.1	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.6	0.2	0.0	9.9	1.1	0.3	0.0	0.0	0.1	0.0	0.6	1.0	0.0	1.3	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	7.9	17.4	19.2	0.0	10.5	0.0	3.5	0.0	0.0	23.2	3.9	0.0	0.1	5.5	0.7	2.9	7.7	0.0	5.6	1.8	2.1	2.1	2.5	1.8	2.3	2.0	2.5	2.3	2.1	2.1	2.3	2.5	0.0	1.1	3.6	3.5	4.0	6.3	2.3	14.8	0.1	2.9	7.6	0.6	14.3	1.6	1.8	0.0	1.1	2.9	18.3	17.6	7.4	0.0	0.6	8.1	1.9	6.7	12.0	3.4	13.3	0.5	18.0	1.5	0.3	30.4	1.2	4.6	209.8	21.3	0.0	2.2	14.9	0.0	13.5	4.9	0.2	12.5	8.7	5.4	8.4	8.4	3.6	1.0	5.5	1.0	4.8	28.7	10.5	0.5	2.1	236.8	162.7	0.5	0.3	13.1	37.7	13.8	0.4	0.7	6.0	4.8	1.2	1.2	2.2	25.5	2.7
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035174	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Oxidoreductase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 280.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 272.4;Proximal enterocytes: 383.0;Proximal tubular cells: 318.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Enhanced		Supported	Mitochondria		No	Yes		1000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (1.73e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.05e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.83e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.18e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.88e-2)"	143.0	54.1	23.2	20.9	23.8	27.4	74.9	24.6	26.3	37.9	33.5	101.2	84.4	49.8	24.9	34.2	56.2	24.0	175.6	22.9	27.2	140.2	225.5	22.8	22.2	24.7	26.3	54.3	42.1	40.2	18.0	13.7	26.0	35.4	90.8	10.4	55.9	42.4	249.7	28.0	89.1	72.7	26.0	18.0	60.7	27.9	24.9	76.0	37.7	280.3	28.5	34.1	28.7	28.0	32.2	27.9	64.3	46.2	149.2	48.2	27.0	43.1	68.5	49.6	48.9	21.2	60.9	185.0	23.5	38.8	34.6	42.0	85.5	64.5	55.5	49.6	37.2	39.9	50.5	48.9	24.3	88.2	17.0	50.4	34.1	35.1	32.3	41.4	34.4	127.1	53.1	98.7	57.3	58.9	163.6	36.7	29.0	147.8	30.1	113.5	84.3	89.2	54.5	129.4	73.2	43.1	41.1	161.9	45.6	37.0	77.4	70.8	20.6	35.5	18.9	48.5	26.7	52.1	63.3	80.6	47.0	60.2	27.0	0.0	11.1	11.4	17.2	14.2	22.1	31.4	19.5	20.7	36.8	27.1	22.4	22.2	1.2	36.7	20.1	41.7	17.7	16.3	23.2	23.8	24.6	26.3	22.9	27.2	24.7	26.3	26.0	26.0	24.9	28.0	17.3	28.9	33.8	11.1	25.7	15.6	54.2	65.8	41.5	6.9	46.5	56.1	225.6	52.9	48.1	35.0	4.2	41.0	18.3	164.7	160.4	43.3	196.8	41.4	22.6	17.5	32.4	65.6	15.1	32.2	44.7	28.2	52.5	26.1	10.8	63.9	21.0	272.4	116.5	6.7	18.9	93.3	36.7	37.8	11.8	108.5	46.3	25.3	21.4	12.2	15.3	26.8	8.2	9.5	9.9	23.0	100.8	35.3	32.0	33.9	383.0	318.8	70.8	6.8	39.5	21.7	38.2	22.4	20.3	64.0	18.2	17.0	19.6	66.3	194.2	49.1
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827157	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 378.7;Proximal tubular cells: 501.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043041: AB_2678284, HPA061143: AB_2684439"	"unprognostic (3.11e-1)"	"prognostic favorable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favorable (5.19e-4)"	41.2	109.0	81.5	20.2	84.2	82.1	35.1	82.7	103.9	22.8	78.9	53.7	45.3	24.6	31.1	29.0	28.5	21.9	138.6	89.9	83.8	100.1	236.2	39.2	24.6	82.8	80.2	22.0	63.5	54.0	72.7	23.1	83.7	33.5	23.3	32.2	32.5	37.7	198.8	31.2	44.8	24.7	80.1	35.2	52.9	91.7	84.0	35.8	35.1	156.2	18.4	34.8	24.6	87.6	31.1	46.1	40.9	46.5	35.1	13.8	37.0	38.1	35.2	57.7	46.1	23.7	26.5	6.4	76.5	32.9	39.6	33.2	39.1	38.2	17.2	64.5	63.4	12.0	47.9	69.3	50.2	15.7	62.6	16.9	80.6	28.8	19.6	50.6	50.1	79.8	16.1	56.3	18.3	51.2	41.1	34.0	15.7	32.0	42.3	34.2	25.8	73.6	74.5	13.8	54.7	47.4	41.8	52.9	84.9	30.8	38.7	52.0	38.7	17.5	21.5	36.9	44.6	63.3	64.7	19.8	29.8	14.5	28.5	37.3	33.3	64.9	26.0	59.1	19.0	31.3	34.0	27.3	30.7	30.4	32.0	27.4	29.7	25.5	88.2	64.8	42.8	30.3	81.5	84.2	82.7	103.9	89.9	83.8	82.8	80.2	83.7	80.1	84.0	87.6	46.2	9.6	39.0	11.8	33.7	23.8	45.1	59.7	12.0	117.1	39.5	31.1	84.2	65.8	39.7	46.0	64.6	52.4	43.2	60.9	158.5	45.6	193.1	75.0	12.1	35.3	39.6	378.7	24.6	38.3	38.5	25.6	23.9	35.5	30.4	36.0	41.0	186.9	76.2	138.0	22.2	41.2	93.6	49.0	41.6	60.1	46.9	47.6	55.2	12.2	50.1	95.2	64.9	7.1	19.7	49.7	68.8	54.9	50.4	48.3	168.9	501.7	70.2	117.0	72.3	33.3	61.1	245.2	68.3	29.1	45.6	68.7	44.1	45.3	39.9	49.9
HAO1	"GOX, GOX1"	ENSG00000101323	"Hydroxyacid oxidase 1"	Q9UJM8	20	7882985-7940458	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	583	"liver: 607.8"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 301.4"	"Cancer enriched"	"Detected in some"	184	"liver cancer: 93.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049552, HPA072442"	Enhanced					NA	NA		240000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA049552: AB_2680814, HPA072442: "					"unprognostic (4.88e-2)"		"unprognostic (2.87e-3)"				"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	607.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	301.4	0.0	0.0	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"kidney: 303.7;liver: 425.6"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 256.8;Proximal tubular cells: 450.1"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050355			Uncertain	Vesicles,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA050355: "	"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.0	0.6	0.2	0.1	0.6	0.0	0.6	0.1	0.6	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	303.7	425.6	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.1	0.4	0.2	0.1	0.3	23.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.6	0.2	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	11.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.6	0.0	13.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	4.2	256.8	0.1	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	450.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0
HAPLN4	"BRAL2, KIAA1926"	ENSG00000187664	"Hyaluronan and proteoglycan link protein 4"	Q86UW8	19	19254756-19262804	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 107.1"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 16.0;Hepatocytes: 6.7;Inhibitory neurons: 19.9;Proximal enterocytes: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 3.5;NTERA-2: 8.3;SCLC-21H: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055856	Enhanced				"Secreted in brain"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055856: AB_2682946"					"unprognostic (3.36e-4)"													0.1	1.0	5.8	0.1	3.7	0.2	0.2	18.3	107.1	2.0	0.0	0.2	12.4	0.8	0.1	0.0	0.2	0.2	0.1	10.7	20.0	0.5	14.1	0.1	0.1	46.6	9.7	0.6	0.9	0.0	0.7	0.2	43.2	0.6	0.1	2.3	0.1	0.3	0.0	0.2	15.4	0.2	10.9	0.1	0.3	0.1	33.6	0.0	0.0	0.0	0.0	0.1	0.5	35.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	3.5	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.0	0.1	0.0	0.4	0.1	0.7	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.7	18.3	107.1	10.7	20.0	46.6	9.7	43.2	10.9	33.6	35.6	0.1	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.0	0.0	16.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.4	6.7	0.1	0.0	19.9	0.6	0.0	0.0	0.0	0.2	0.3	0.1	0.0	1.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	15.0	0.2	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0
HAVCR2	"CD366, FLJ14428, Tim-3, TIM3, TIMD3"	ENSG00000135077	"Hepatitis A virus cellular receptor 2"	Q8TDQ0	5	157085832-157142869	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.6;granulocytes: 80.6;Hofbauer cells: 148.3;Kupffer cells: 89.1;Langerhans cells: 67.8;Macrophages: 83.2;monocytes: 49.5;NK-cells: 70.0;Proximal tubular cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 53.8;intermediate monocyte: 57.9;myeloid DC: 137.9;NK-cell: 97.1;non-classical monocyte: 36.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 137.9;monocytes: 57.9;NK-cells: 97.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.8;Daudi: 6.4;HDLM-2: 26.3;HMC-1: 6.0;RPMI-8226: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB026003	Enhanced					NA	NA		9900000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB026003: "	"unprognostic (2.50e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.34e-1)"	14.2	8.2	9.5	19.7	11.1	13.9	5.3	11.1	13.3	4.9	10.4	5.4	4.0	3.2	6.0	3.7	3.3	12.8	2.5	9.1	11.8	26.8	9.8	22.6	32.1	18.0	13.7	1.7	3.0	2.8	1.8	16.9	16.9	2.1	6.8	1.2	2.9	2.9	1.7	2.2	4.9	7.9	16.1	24.1	4.7	2.0	17.5	9.1	1.6	2.1	14.0	13.1	1.2	27.2	0.0	0.2	0.1	0.2	7.8	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	6.4	0.3	0.0	0.2	0.1	0.0	0.0	0.0	26.3	0.0	1.1	0.1	0.0	0.0	0.0	6.0	0.4	0.4	0.0	0.2	0.0	0.0	0.7	0.1	2.3	0.0	0.1	0.1	3.9	0.2	0.0	0.0	0.1	3.0	21.5	0.3	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.2	0.3	0.0	0.9	0.3	0.3	0.0	0.3	1.8	0.2	0.1	0.7	0.1	16.7	53.8	0.1	14.6	57.9	3.0	1.2	5.9	7.9	137.9	0.5	7.0	9.5	2.5	97.1	36.1	16.4	11.5	43.1	9.5	11.1	11.1	13.3	9.1	11.8	18.0	13.7	16.9	16.1	17.5	27.2	1.2	6.4	6.5	2.0	5.9	1.0	0.2	0.1	0.0	0.9	0.7	1.5	1.1	0.0	1.9	0.0	0.0	0.6	87.6	0.3	7.9	0.1	11.1	0.1	0.1	3.7	0.0	1.3	2.1	0.0	0.8	0.9	0.5	0.1	80.6	0.1	1.1	0.5	148.3	0.0	1.7	0.3	0.0	89.1	67.8	7.8	0.3	83.2	3.6	31.9	49.5	0.1	70.0	1.0	4.8	0.1	0.1	0.0	16.3	0.5	0.1	57.7	0.0	0.2	6.6	0.7	0.5	0.3	0.4	0.1	1.3	1.1	26.3	1.5	0.2	0.3
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052197-32101856	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 112.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 150.7;Kupffer cells: 155.5;Langerhans cells: 89.2;Macrophages: 170.1;Microglial cells: 52.5;monocytes: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 575.0;eosinophil: 707.8;intermediate monocyte: 1059.1;myeloid DC: 336.3;neutrophil: 801.3;non-classical monocyte: 1251.7"	"Group enriched"	"Detected in all"	16	"dendritic cells: 336.3;granulocytes: 801.3;monocytes: 1251.7"	"Group enriched"	"Detected in some"	9	"THP-1: 69.3;U-937: 199.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB005195, HPA035534, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane, Cytosol"	"CAB005195: AB_631619, HPA035534: , HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	24.8	9.2	4.7	100.0	5.0	55.2	6.0	5.5	6.0	5.5	13.7	12.8	15.2	3.1	2.6	6.7	7.6	14.4	4.8	4.7	6.2	4.7	14.1	46.0	38.6	9.9	6.8	2.5	4.5	2.1	3.1	20.9	8.3	4.0	13.6	0.5	5.1	4.7	1.6	5.8	17.8	25.3	8.1	112.1	6.7	2.3	8.4	14.5	2.8	6.9	39.3	32.8	4.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.1	0.1	1.3	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	15.6	0.0	0.1	0.1	4.9	0.4	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.7	0.0	69.3	0.0	0.0	0.3	0.0	0.1	1.9	0.3	10.3	0.0	199.6	0.0	6.4	575.0	707.8	1.1	1059.1	1.3	48.4	1.1	1.1	336.3	43.0	1.1	0.9	801.3	11.0	1251.7	30.4	1.2	566.4	4.7	5.0	5.5	6.0	4.7	6.2	9.9	6.8	8.3	8.1	8.4	12.0	0.6	6.4	14.0	0.0	17.1	3.1	4.0	0.2	0.6	0.1	0.4	1.3	2.0	1.5	3.9	7.3	0.0	0.9	12.1	0.2	1.9	0.1	2.5	0.1	0.1	3.7	1.8	1.7	1.2	0.6	0.9	1.3	4.6	0.1	6.3	0.1	1.1	2.3	150.7	0.0	1.0	0.5	22.4	155.5	89.2	0.3	0.0	170.1	1.8	52.5	222.0	0.0	4.1	1.5	0.6	0.0	0.0	0.0	0.7	0.5	0.1	0.3	1.5	0.1	0.0	0.6	0.5	0.2	0.3	0.2	1.1	1.6	3.0	0.2	0.9	3.7
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA004775: AB_1850548"	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.65e-4)"	52.5	41.8	7.7	28.5	8.1	23.6	45.3	3.2	9.7	46.2	24.6	44.2	8.9	51.4	13.6	23.5	50.3	16.8	31.6	4.1	4.8	29.3	6.0	55.0	27.3	17.2	7.1	44.9	14.5	20.1	20.6	19.5	10.2	34.4	4.8	2.8	30.6	17.1	16.2	40.1	28.6	16.9	3.4	38.4	27.2	7.9	10.7	80.0	39.2	9.4	15.2	44.3	38.5	7.6	41.6	28.1	28.6	46.9	21.9	60.2	25.3	39.4	30.7	28.3	18.8	37.4	38.4	80.5	126.8	37.1	13.9	37.8	6.7	31.4	10.5	38.8	13.6	27.6	29.9	8.6	23.6	9.1	1.2	39.4	10.8	28.6	15.4	51.6	58.6	45.9	29.9	33.4	18.6	18.0	83.2	21.8	39.4	9.1	29.1	64.2	14.7	29.6	12.1	26.9	8.1	18.8	30.6	14.1	14.4	18.4	13.4	12.0	66.6	56.9	61.0	47.6	28.9	70.8	58.8	67.4	23.8	41.9	19.1	0.0	1.4	0.0	0.8	0.5	0.9	0.8	0.7	0.7	0.4	0.5	0.8	0.6	6.5	0.9	0.5	0.3	0.3	1.5	7.7	8.1	3.2	9.7	4.1	4.8	17.2	7.1	10.2	3.4	10.7	7.6	80.6	41.7	32.1	34.9	32.7	13.8	26.8	28.7	8.6	20.3	22.5	17.4	13.4	28.6	28.6	36.8	0.0	4.8	18.6	5.3	1.9	31.6	15.5	26.2	39.4	79.3	7.3	40.4	19.9	23.0	3.5	37.8	25.5	58.4	8.8	20.2	101.7	2.0	15.6	28.6	17.5	9.6	24.4	32.7	14.1	6.9	55.0	13.3	14.2	46.9	20.5	11.7	28.8	10.6	13.6	66.8	7.3	33.1	42.9	69.1	0.6	3.8	31.8	4.0	26.3	18.3	26.9	1.1	3.7	10.3	21.6	2.9	28.2	9.3	8.1	46.8
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50265965	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 102.9;epididymis: 46.1"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 596.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.9;testis cancer: 2.7"	"Region enriched"	"Detected in many"	6	"hypothalamus: 102.9"	"Immune cell enriched"	"Detected in single"	2140	"basophil: 686.2"	"Lineage enriched"	"Detected in single"	2140	"granulocytes: 686.2"	"Group enriched"	"Detected in some"	4	"HEL: 460.8;HMC-1: 1051.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 43.9"	"Group enriched"	"Detected in some"	10	"hypothalamus: 16.5;midbrain: 4.2"	HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	2.3	0.4	0.0	3.5	5.6	4.7	1.4	0.0	0.2	2.3	0.7	3.8	4.1	2.5	46.1	4.8	0.8	11.2	0.7	0.2	102.9	0.4	0.5	6.9	0.9	0.0	13.7	0.1	1.2	0.5	0.4	0.4	0.0	1.7	3.6	0.8	1.3	0.9	0.3	2.3	4.6	2.5	0.0	0.5	12.9	1.3	17.8	0.9	0.1	0.8	1.0	3.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	460.8	0.2	0.0	0.0	1.2	1051.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	181.8	0.3	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.4	686.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.0	5.6	0.0	0.2	0.2	102.9	0.0	13.7	0.0	0.0	17.8	0.1	0.0	12.8	47.5	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	10.9	0.3	0.0	0.0	2.3	9.2	0.0	596.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.4	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.1	0.1
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 214.0;Exocrine glandular cells: 156.4;Paneth cells: 208.6;Proximal enterocytes: 254.0;Proximal tubular cells: 275.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	12.2	156.4	16.8	11.1	18.0	8.4	19.5	16.2	19.3	19.9	14.5	59.7	82.9	13.4	14.9	42.1	16.5	17.8	22.4	15.8	17.7	56.3	122.8	10.2	10.2	15.7	17.0	19.9	53.0	68.4	23.1	5.0	16.2	30.4	35.9	8.0	52.2	16.1	8.8	28.3	68.5	7.7	15.7	17.6	50.1	7.0	18.5	6.7	38.7	5.7	7.6	17.6	21.1	15.5	7.4	20.8	4.4	12.3	10.7	4.7	37.0	5.4	10.1	8.6	9.3	38.3	36.1	16.2	6.6	3.0	17.0	28.3	7.0	8.3	2.9	22.9	16.1	22.4	12.5	24.1	12.5	1.4	16.6	7.4	17.4	7.0	19.7	9.9	4.5	14.9	18.0	4.0	4.1	48.3	10.4	6.5	9.9	73.7	16.1	8.5	0.0	13.2	11.0	15.4	11.1	7.0	9.3	39.4	14.0	9.5	24.8	4.7	4.5	1.7	0.1	1.4	1.9	9.7	20.2	6.8	2.1	0.1	1.3	0.2	3.7	8.2	12.4	2.1	14.0	14.8	14.2	11.5	6.1	16.6	14.5	11.1	2.4	8.2	0.2	14.1	17.1	8.5	16.8	18.0	16.2	19.3	15.8	17.7	15.7	17.0	16.2	15.7	18.5	15.5	4.1	9.6	10.1	24.5	19.7	9.9	20.6	26.6	10.8	10.3	38.6	31.2	15.8	80.1	32.6	23.9	10.4	29.4	11.7	214.0	86.1	84.8	0.2	20.9	6.4	9.4	40.3	15.4	9.2	156.4	16.5	8.6	112.7	22.3	7.6	122.4	9.7	85.4	20.6	1.7	10.4	80.4	28.5	6.5	3.7	2.0	14.3	6.9	10.6	6.5	13.7	12.1	15.5	5.5	4.9	104.8	208.6	9.1	9.3	23.7	254.0	275.1	33.3	13.8	6.6	5.5	11.1	0.3	6.0	42.9	14.6	31.6	14.0	26.0	94.6	51.4
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112629-43566001	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 16.4;kidney: 7.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 135.6;Excitatory neurons: 533.3;Inhibitory neurons: 157.3;Late spermatids: 72.0;Oligodendrocyte precursor cells: 277.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"cerebral cortex: 16.4"	"Group enriched"	"Detected in some"	4	"basophil: 4.9;neutrophil: 3.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.8;GAMG: 3.7;U-266/70: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.1	0.0	1.5	0.2	1.7	0.5	0.2	0.0	16.4	0.1	0.0	0.2	0.0	0.2	0.6	1.0	0.1	1.9	0.0	0.7	0.0	7.8	0.1	0.1	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.3	0.1	2.2	0.4	0.2	0.9	0.6	0.1	0.1	0.0	0.1	0.3	1.8	0.2	0.0	0.5	2.6	0.2	0.3	0.1	3.8	0.0	3.8	0.3	0.5	0.0	0.0	0.0	1.2	2.2	0.1	0.5	0.0	0.0	0.2	2.3	2.2	3.7	0.2	0.0	0.0	0.2	0.1	0.7	0.0	0.3	0.2	0.2	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	1.8	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.8	0.9	0.3	12.0	0.4	0.0	2.7	0.3	0.0	4.9	0.8	0.7	0.3	0.5	0.2	0.6	0.3	0.1	0.1	1.0	0.3	0.3	3.3	0.6	0.6	0.9	0.1	0.0	1.5	1.7	0.0	16.4	0.7	0.0	0.2	0.0	0.1	0.0	0.2	3.8	0.0	0.0	0.0	7.8	0.1	0.4	0.3	0.0	0.0	15.4	0.1	0.3	1.4	0.0	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	135.6	1.1	3.6	0.2	0.0	0.0	533.3	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.4	0.1	0.0	45.4	157.3	0.1	0.0	0.0	1.4	72.0	0.3	0.2	0.0	24.4	0.1	0.6	0.0	277.9	4.8	0.0	1.4	0.4	0.0	0.4	4.3	15.8	0.0	1.9	0.0	0.6	0.4	3.2	3.3	0.3	0.3	0.0	0.6	0.2	0.5	0.3
HELT	"bHLHb44, HCM1228, HESL, MEGANE, Mgn"	ENSG00000187821	"Helt bHLH transcription factor"	A6NFD8	4	185018841-185020804	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"kidney: 1.5"	"Cell type enriched"	"Detected in single"	7	"Distal tubular cells: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036188, HPA036189"	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA036188: AB_10672237, HPA036189: AB_2674997"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 72.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 58.7;Spermatocytes: 178.5;Spermatogonia: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 71.4;MOLT-4: 68.2;NB-4: 75.3;U-937: 98.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"cerebellum: 9.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	5.4	2.9	8.6	8.0	8.9	13.3	8.0	6.8	9.2	8.5	4.9	6.5	5.0	3.9	4.7	2.7	2.3	6.5	1.8	8.9	9.6	3.4	2.0	4.7	13.5	8.0	8.1	5.2	2.1	0.9	5.3	5.6	8.9	3.7	9.5	3.0	3.0	3.4	3.2	3.8	7.6	3.6	7.8	11.1	4.7	72.0	10.6	18.7	2.2	6.2	11.3	6.2	2.0	8.6	16.9	8.5	0.7	0.0	0.7	0.5	0.1	4.0	1.5	9.4	1.5	24.7	26.0	0.0	8.9	7.5	0.0	0.1	0.0	0.2	5.9	5.5	0.0	42.4	31.7	0.0	8.1	25.4	36.4	7.8	0.5	2.1	0.0	0.0	1.9	71.4	0.0	18.5	0.4	42.8	68.2	75.3	24.0	13.5	3.7	29.3	0.0	1.5	0.0	18.0	40.1	0.0	35.3	9.8	0.1	2.4	0.0	55.7	0.5	0.0	31.4	17.5	0.1	11.2	15.0	0.1	0.0	98.6	0.3	43.3	19.7	43.2	61.8	24.0	55.6	12.6	30.0	56.4	24.6	7.1	24.7	45.1	19.6	55.6	29.8	19.5	31.2	39.9	8.6	8.9	6.8	9.2	8.9	9.6	8.0	8.1	8.9	7.8	10.6	8.6	2.4	0.0	1.1	2.3	5.4	1.7	1.4	6.6	1.2	5.2	8.1	7.1	1.8	14.3	4.0	5.5	0.0	12.8	28.0	4.0	3.9	3.0	12.2	2.2	3.6	3.0	4.9	13.9	5.2	1.3	21.5	5.2	2.6	2.4	7.0	2.9	6.1	0.5	15.8	0.0	3.7	4.0	4.1	11.7	3.3	20.1	5.0	7.5	1.8	3.7	11.2	3.6	58.7	4.0	2.7	2.8	7.4	3.0	8.0	1.2	5.5	0.8	2.8	2.4	6.6	3.0	3.5	178.5	107.7	2.9	1.6	5.2	23.0	8.5	6.1	3.3
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188534-93226469	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 96.2"	"Group enriched"	"Detected in some"	11	"Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SCLC-21H: 172.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		210000		"Cluster 9: Intestine - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.1	0.0	2.3	0.0	2.5	8.9	0.0	0.1	0.0	0.0	64.3	30.1	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	15.2	0.0	0.1	0.0	0.1	0.1	0.0	4.3	0.4	7.3	0.2	0.0	0.8	96.2	0.0	2.6	1.4	0.0	0.0	48.0	1.5	0.1	0.1	10.1	3.2	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	172.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.4	0.3	1.1	0.7	0.0	0.0	15.1	6.6	0.2	0.0	0.9	5.5	0.0	0.0	0.0	17.2	9.8	0.1	2.5	0.0	0.0	0.1	218.2	18.7	0.5	0.0	0.0	0.1	27.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.6	387.5	349.9	0.0	0.0	2.4	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	2.2	0.0	318.1	0.0	0.1	0.9	11.5	0.0	0.3	0.0	0.0	0.0	0.1	5.6	1.2	0.0	0.1	0.1	0.1	0.0	19.7	0.3
HEPH	"CPL, KIAA0698"	ENSG00000089472	Hephaestin	Q9BQS7	X	66162549-66268867	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.9;smooth muscle: 82.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 78.0;Distal enterocytes: 211.0;Intestinal goblet cells: 95.6;Paneth cells: 96.9;Proximal enterocytes: 156.2;Undifferentiated cells: 72.4"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 37.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.5;HEL: 25.4;HSkMC: 36.0;K-562: 72.5;LHCN-M2: 28.5;SuSa: 68.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA005824	Approved					NA	NA		3700000		"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA005824: AB_1850603"	"unprognostic (3.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (3.08e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	8.2	19.1	18.2	14.7	25.0	0.0	8.3	20.8	19.2	23.8	8.7	81.9	79.0	34.7	14.4	11.9	14.2	38.7	36.0	16.7	21.2	8.1	3.5	12.3	3.6	22.3	24.4	22.1	2.3	1.4	3.7	1.3	20.4	24.3	77.6	15.0	7.6	31.8	0.8	4.8	81.6	82.7	18.8	11.1	12.4	3.5	21.7	1.3	5.1	3.2	2.6	19.5	10.1	21.0	0.0	0.0	28.5	2.3	0.0	0.1	0.8	7.3	0.4	0.0	0.0	17.4	0.0	0.0	0.1	15.1	0.0	0.0	0.0	0.0	0.0	8.3	0.0	25.4	0.0	0.0	0.3	0.2	0.1	36.0	0.0	0.0	0.0	9.9	0.0	0.0	72.5	0.6	28.5	0.0	0.0	0.6	14.1	4.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	68.6	0.0	0.0	0.7	16.2	1.2	0.1	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	25.0	20.8	19.2	16.7	21.2	22.3	24.4	20.4	18.8	21.7	21.0	2.5	0.0	0.0	78.0	0.5	0.9	0.0	0.0	0.0	1.0	0.9	6.0	24.1	0.0	0.0	0.0	0.0	0.0	0.1	211.0	0.0	0.3	0.6	1.3	15.1	4.1	40.8	0.0	0.3	1.1	0.0	12.6	0.0	1.2	0.0	1.1	6.4	0.0	0.2	0.0	2.9	95.6	0.0	0.0	1.9	1.5	11.5	0.3	0.0	6.5	0.0	26.1	0.0	3.5	36.2	5.0	96.9	29.7	0.0	0.3	156.2	0.0	0.7	1.3	6.6	4.4	9.8	0.0	0.3	0.3	0.6	0.0	0.5	6.9	72.4	0.2
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"Helicase for meiosis 1"	A2PYH4	1	91260766-91404856	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.3;testis: 13.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.4	0.3	1.0	0.1	1.0	0.2	0.4	5.1	1.0	0.9	0.0	0.5	0.3	2.3	1.1	0.1	0.8	0.2	0.6	0.7	1.6	0.7	0.1	0.2	0.1	1.7	1.6	3.9	0.7	0.1	9.3	0.5	1.1	0.6	0.3	4.5	0.5	1.1	1.5	0.1	0.2	0.9	1.1	0.4	0.2	13.8	1.6	0.1	1.6	1.1	0.2	0.4	0.3	1.3	0.0	0.1	5.2	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.7	1.4	0.0	0.5	0.0	0.0	0.5	0.5	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	5.1	1.0	0.7	1.6	1.7	1.6	1.1	1.1	1.6	1.3	0.2	0.0	1.1	50.9	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.3	3.1	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0	0.4	17.8	0.2	1.9	0.4	0.0	2.5	17.6	0.2	0.2	0.6	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	38.4	0.0	0.0	0.0	0.0	5.0	4.1	0.0	0.0	10.3	0.0	2.4	0.0	90.5	9.5	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	6.2	0.0	2.0	1.4	58.9	15.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628172-120682269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"kidney: 200.3;liver: 752.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 119.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.4	0.3	0.4	2.5	1.9	0.5	12.5	0.6	0.8	27.4	1.5	16.7	31.6	3.1	13.0	0.4	4.2	61.7	0.3	0.5	0.4	200.3	752.6	0.8	0.4	0.4	0.4	0.2	31.2	7.0	0.2	0.2	0.4	44.5	20.3	0.7	4.2	4.2	0.1	0.9	25.6	0.5	0.4	0.6	25.5	0.1	0.5	0.7	55.1	0.2	0.1	0.2	0.1	0.6	0.0	12.3	4.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	55.8	10.7	0.1	82.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	186.6	0.0	0.4	1.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.3	328.0	0.0	0.1	0.3	0.1	212.2	0.0	0.2	0.2	0.2	0.9	0.0	0.0	0.2	1.0	0.6	0.1	0.9	0.2	0.1	0.0	0.3	0.5	0.2	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.4	1.9	0.6	0.8	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.6	0.1	0.0	2.0	0.3	5.9	0.0	0.4	0.6	0.0	0.3	7.5	1.7	0.3	81.5	4.9	27.6	2.1	0.0	0.3	18.5	103.7	7.2	0.2	113.9	17.1	1.2	43.8	24.0	3.2	17.8	0.0	0.4	19.4	127.8	1.3	0.0	16.4	534.7	0.2	0.0	0.6	16.0	2.0	16.1	0.0	0.0	0.0	21.3	0.0	1.9	2.0	4.2	0.0	0.0	0.5	12.1	35.6	0.0	0.0	12.9	54.6	477.5	4.1	0.2	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	3.8	0.4	9.1	0.4
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699010-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"placenta: 311.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 23.8;Fibroblasts: 95.8;Hepatic stellate cells: 25.0;Muller glia cells: 36.2;Smooth muscle cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 94.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 171.6;HHSteC: 135.8;HL-60: 82.4;hTEC/SVTERT24-B: 87.4;Karpas-707: 240.7;U-87 MG: 62.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved				"Secreted to blood"	NA	NA	4110000	14000	"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804"	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	7.9	19.8	1.6	6.3	3.3	12.3	5.2	1.5	7.8	7.2	1.8	4.4	2.6	8.1	3.6	2.9	5.4	16.6	4.7	2.9	3.6	11.8	30.3	19.5	2.2	3.6	2.3	1.8	2.1	2.1	2.4	311.9	4.3	7.2	3.4	14.2	2.4	6.4	0.8	0.9	2.3	7.1	1.8	6.5	3.9	2.4	2.9	1.5	5.6	3.9	1.5	10.4	6.3	3.3	0.0	0.0	0.1	0.0	21.6	171.6	0.1	0.7	33.4	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	135.8	82.4	0.4	41.4	0.0	87.4	0.3	0.0	2.2	0.0	0.1	240.7	0.6	0.0	0.0	56.4	0.0	0.0	0.2	0.8	0.0	7.5	0.0	0.0	0.2	9.3	0.0	0.1	0.0	0.2	0.0	3.5	0.4	2.0	0.0	0.1	0.0	0.1	0.0	0.0	62.6	16.9	0.1	94.0	15.2	3.9	0.0	18.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	3.2	0.0	17.3	1.0	0.0	4.3	1.6	3.3	1.5	7.8	2.9	3.6	3.6	2.3	4.3	1.8	2.9	3.3	6.2	0.0	4.1	16.3	0.0	1.0	0.2	0.0	1.8	0.2	0.3	0.5	1.3	1.5	0.6	0.0	0.0	5.6	0.0	0.0	0.0	0.0	15.2	1.0	23.8	6.2	0.0	2.1	0.3	0.0	4.9	95.8	0.5	0.9	1.3	0.0	25.0	0.5	18.4	0.0	22.4	0.0	0.0	12.5	1.9	2.3	18.3	14.0	1.8	7.5	10.5	36.2	1.0	0.0	0.1	0.0	0.0	10.9	0.3	0.4	0.0	0.0	0.0	0.7	13.1	0.9	26.2	0.2	0.3	0.3	0.1	12.0	0.6	1.3	0.0	0.4
HHAT	"FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn"	ENSG00000054392	"Hedgehog acyltransferase"	Q5VTY9	1	210328252-210676296	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 25.8;Excitatory neurons: 47.7;Microglial cells: 20.6;Oligodendrocytes: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"B-cells: 1.8;dendritic cells: 3.7;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.6;LHCN-M2: 11.6;RH-30: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016462	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA016462: AB_2669360"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.89e-3)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-3)"	"prognostic favorable (8.47e-7)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.67e-2)"	2.1	6.5	1.1	0.6	1.1	0.4	3.3	0.3	1.6	3.4	3.6	2.3	1.1	2.5	3.1	2.8	2.8	2.2	2.4	1.0	0.4	4.0	2.7	2.1	0.8	0.7	0.8	2.1	2.3	1.7	3.2	1.3	0.6	4.0	1.3	1.7	4.4	2.0	0.3	3.4	2.5	1.1	0.9	2.2	1.8	2.5	0.6	2.0	4.6	0.2	0.8	3.1	2.9	0.9	0.8	0.9	2.3	1.3	1.0	1.3	4.8	1.2	1.1	1.9	3.1	0.2	0.9	0.0	1.2	0.9	3.1	0.6	0.5	0.5	2.2	1.7	1.2	0.0	0.1	1.1	0.2	0.3	13.6	1.2	2.7	1.6	1.2	3.2	0.3	1.2	0.0	0.0	11.6	1.2	0.6	0.0	0.6	0.7	0.1	1.3	12.4	0.0	7.5	2.6	1.9	7.8	2.1	0.0	6.0	5.9	4.0	0.7	1.7	2.8	8.5	1.6	4.7	3.8	0.2	0.0	1.1	0.8	2.3	0.0	0.3	0.0	0.7	0.4	1.3	1.5	0.9	0.8	0.4	1.8	0.0	0.2	0.0	0.1	0.1	3.7	0.2	0.4	1.1	1.1	0.3	1.6	1.0	0.4	0.7	0.8	0.6	0.9	0.6	0.9	2.0	0.0	2.4	25.8	5.3	2.2	5.7	2.8	6.8	0.5	5.8	2.4	2.4	4.3	1.2	9.2	0.0	4.6	13.9	1.9	3.9	2.6	1.2	8.8	2.6	2.0	0.0	0.4	47.7	0.7	3.6	3.0	2.6	5.8	0.0	4.6	3.6	2.5	1.9	0.0	11.8	2.7	4.1	2.9	0.5	0.5	1.2	1.5	0.0	20.6	1.0	15.6	0.0	17.1	26.0	1.2	2.1	0.4	2.2	3.7	2.3	0.6	12.9	0.5	0.0	1.7	1.7	0.3	1.3	3.1	2.6	2.2	2.8	0.4	2.0	5.2
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	16.2	18.5	5.0	22.2	5.4	84.7	11.2	5.6	8.8	7.1	5.1	7.8	6.4	6.4	3.5	4.1	6.1	27.4	6.1	4.8	5.2	7.0	91.2	16.9	39.1	6.3	5.4	3.0	38.1	1.9	2.2	14.6	6.4	4.7	6.5	0.3	3.5	4.0	2.9	4.6	19.0	5.8	6.2	39.9	5.2	2.4	6.0	4.4	102.1	6.3	30.4	12.7	5.0	6.7	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	5.4	5.6	8.8	4.8	5.2	6.3	5.4	6.4	6.2	6.0	6.7	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
HHIP	"FLJ20992, HIP"	ENSG00000164161	"Hedgehog interacting protein"	Q96QV1	4	144646156-144745271	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3;lung: 16.2"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 175.6;Leydig cells: 136.1;Oligodendrocytes: 413.3;Theca cells: 162.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 322.6;TIME: 376.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012616	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA012616: AB_1850687"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.66e-3)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.38e-1)"	2.3	2.3	10.4	0.4	25.4	0.8	0.3	10.7	19.6	1.3	0.0	3.2	2.6	1.6	3.8	0.0	0.1	1.1	0.2	17.1	11.0	0.8	6.8	16.2	0.0	20.0	20.2	0.6	2.6	0.0	0.3	0.0	13.6	4.7	3.2	0.9	0.3	2.6	0.4	0.2	3.7	0.1	9.4	0.0	5.9	1.5	18.1	2.7	0.6	1.3	0.0	5.0	0.3	37.3	0.0	0.1	4.9	0.1	0.3	1.9	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	3.0	0.2	0.3	0.0	2.2	0.0	2.0	0.1	0.0	0.1	0.1	0.0	0.0	10.4	7.8	17.2	322.6	29.1	0.1	0.0	4.8	0.0	47.7	0.0	4.4	0.0	2.8	0.4	65.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	376.7	0.4	3.9	0.3	2.5	2.2	0.0	10.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.4	25.4	10.7	19.6	17.1	11.0	20.0	20.2	13.6	9.4	18.1	37.3	0.3	12.8	175.6	3.9	0.4	0.0	0.0	0.5	0.0	42.7	0.0	0.0	1.2	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.5	6.0	0.6	0.0	0.0	17.6	0.4	0.0	38.9	0.0	0.4	16.5	0.1	9.3	0.1	0.1	0.0	13.9	0.0	2.0	0.0	0.4	4.5	136.1	1.3	1.8	1.0	0.0	0.3	0.0	8.5	413.3	0.1	0.0	44.0	0.0	0.0	0.0	0.0	4.4	3.3	0.0	1.7	0.9	0.3	0.5	0.0	0.6	0.0	1.0	162.7	0.0	0.0
HHIPL1	KIAA1822	ENSG00000182218	"HHIP like 1"	Q96JK4	14	99645129-99680569	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 33.3;Bipolar cells: 10.5;Excitatory neurons: 8.3;Inhibitory neurons: 12.2;Muller glia cells: 13.1;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;fHDF/TERT166: 5.6;SiHa: 3.7;THP-1: 3.9"	"Low region specificity"	"Detected in many"												"Secreted in other tissues"	NA	NA		120000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (6.16e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.49e-6)"	"unprognostic (2.52e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.12e-6)"	1.6	0.3	7.0	1.1	8.7	0.1	0.8	4.1	8.4	1.5	3.0	2.0	0.5	2.5	0.4	0.8	1.3	1.2	1.6	7.2	4.6	0.7	0.6	0.7	1.0	4.9	4.7	1.0	0.2	0.3	0.9	0.6	4.5	1.7	0.3	2.1	0.8	0.9	0.3	0.5	0.9	1.8	4.0	0.9	0.8	0.4	6.3	0.1	0.5	0.4	0.6	1.3	1.1	4.2	0.0	0.2	0.4	0.1	0.1	0.0	1.7	1.6	0.4	0.3	0.1	0.1	0.5	0.1	3.1	5.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.9	0.1	1.2	0.2	0.1	1.4	0.1	0.0	0.1	0.9	0.2	0.0	0.2	1.2	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.6	3.7	0.0	0.0	0.6	0.0	3.9	1.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	8.7	4.1	8.4	7.2	4.6	4.9	4.7	4.5	4.0	6.3	4.2	1.6	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.0	10.5	0.3	0.8	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	2.0	1.7	0.0	0.0	8.3	0.0	0.1	2.6	0.0	0.0	0.0	0.9	0.7	0.3	1.9	0.0	12.2	0.0	0.0	2.1	0.7	0.2	0.3	0.3	3.6	6.5	0.0	13.1	0.0	13.0	6.2	0.0	1.4	1.9	0.0	0.1	0.1	0.0	0.0	1.7	0.0	0.9	0.9	0.3	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.1
HHLA2	"B7-H5, B7-H7, B7H7, B7y"	ENSG00000114455	"HERV-H LTR-associating 2"	Q9UM44	3	108296490-108378285	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 129.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 274.7;Paneth cells: 64.2;Proximal enterocytes: 186.8"	"Group enriched"	"Detected in many"	12	"colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;HDLM-2: 4.0;Karpas-707: 2.8"					"Low region specificity"	"Detected in all"			HPA055478	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055478: AB_2682830"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.14e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-2)"	0.4	0.2	0.5	5.6	0.4	1.1	0.2	0.7	1.3	0.0	0.0	87.9	86.8	0.3	0.8	0.5	3.7	29.2	0.2	0.6	0.7	7.6	0.1	5.7	0.6	0.7	0.3	0.1	2.9	0.1	0.2	0.1	0.6	0.2	83.0	1.2	0.2	0.3	0.5	0.3	129.9	2.0	0.2	0.3	9.4	3.3	0.6	0.4	0.2	0.0	0.3	0.0	0.0	0.8	0.2	0.3	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.7	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.0	0.0	4.0	0.1	0.1	1.4	0.2	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.8	0.0	0.2	0.4	1.5	0.5	0.2	0.3	0.3	0.1	0.8	0.0	0.1	0.7	0.7	0.7	0.0	0.1	0.5	0.1	0.2	0.1	0.1	0.7	0.2	0.2	1.3	0.7	0.3	0.0	0.4	0.1	0.5	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.2	0.5	0.4	0.7	1.3	0.6	0.7	0.7	0.3	0.6	0.2	0.6	0.8	0.0	0.0	2.0	0.7	0.4	0.0	0.1	0.7	0.0	0.0	0.7	0.3	0.2	27.1	1.6	0.0	0.0	0.0	0.0	274.7	0.0	8.5	3.3	3.2	0.0	0.3	1.8	0.0	1.3	37.6	0.1	0.3	2.6	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.5	12.5	2.0	0.0	0.7	4.2	0.3	0.3	0.0	0.0	1.1	0.0	0.0	0.5	0.9	35.7	64.2	0.0	0.0	0.1	186.8	20.4	19.4	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.0	0.1	0.5	0.0	17.7	0.1
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2;Proximal tubular cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		74000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	34.0	60.1	40.6	17.4	49.2	14.5	28.5	40.5	60.3	33.4	51.0	37.5	55.9	28.1	29.1	34.9	22.5	22.3	28.7	40.7	47.7	142.2	129.0	13.9	20.5	43.9	43.1	18.6	27.2	58.2	19.1	18.6	44.9	25.5	40.9	38.4	20.9	23.2	49.2	58.7	33.9	18.3	45.0	17.8	25.6	21.7	43.3	16.8	31.7	38.5	21.9	23.7	26.6	72.6	23.5	16.1	37.0	23.8	29.9	27.6	16.9	23.1	11.4	20.8	22.1	46.8	20.2	33.3	36.1	18.1	17.0	44.4	33.2	30.7	29.5	47.0	25.1	44.5	37.7	41.4	10.7	31.8	16.7	19.8	17.8	24.3	4.8	32.3	31.6	30.4	55.2	30.3	20.8	18.2	34.3	33.6	11.1	30.2	30.2	42.4	24.8	83.8	43.8	68.4	27.9	24.0	18.0	27.2	66.8	47.2	32.0	21.3	26.5	22.8	20.8	16.1	15.8	18.7	45.2	30.9	20.7	27.4	18.6	27.8	11.9	26.4	19.5	14.2	21.3	43.5	21.8	21.0	20.9	34.7	22.9	29.6	6.0	32.0	11.3	26.7	37.0	12.7	40.6	49.2	40.5	60.3	40.7	47.7	43.9	43.1	44.9	45.0	43.3	72.6	23.3	22.4	25.8	129.3	29.8	56.0	131.4	74.9	34.1	35.3	39.1	24.1	28.6	42.9	51.3	36.8	102.2	53.6	18.8	53.5	115.4	27.4	230.2	48.0	21.4	33.3	37.8	13.0	46.4	29.4	22.3	27.7	29.6	39.3	10.2	41.1	89.3	117.4	35.3	25.2	51.5	31.4	71.2	15.7	11.7	62.9	34.8	15.9	46.2	52.5	14.1	35.5	39.1	104.0	141.1	15.6	26.6	45.5	23.3	27.9	32.4	376.2	47.6	50.5	39.5	29.9	26.2	18.0	29.4	45.5	40.6	20.0	30.7	61.7	62.7	67.8
HID1	"C17orf28, DMC1, HID-1"	ENSG00000167861	"HID1 domain containing"	Q8IV36	17	74950742-74973166	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 111.2"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 71.4;Intestinal goblet cells: 89.5;Paneth cells: 87.8;Proximal enterocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 115.9;OE19: 99.2;SH-SY5Y: 56.7;SK-BR-3: 172.6;T-47d: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031406	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"		"HPA031406: AB_2673866"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.47e-3)"	"unprognostic (6.79e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.34e-4)"	13.2	5.8	21.7	6.6	26.9	2.0	23.2	41.5	33.3	19.9	2.8	17.9	39.1	11.9	29.1	5.5	19.0	21.6	12.4	22.0	24.3	12.3	4.4	20.4	5.3	27.4	22.7	3.0	111.2	14.4	44.0	20.1	30.3	36.2	17.9	8.7	86.2	20.2	4.6	7.6	27.3	6.3	10.4	16.7	68.7	6.8	25.4	2.8	16.8	5.7	6.3	12.3	7.6	39.1	5.2	11.4	1.3	15.8	0.0	0.0	2.7	0.0	0.6	1.1	1.0	10.6	5.8	0.0	1.0	0.0	1.4	4.9	14.5	1.0	0.8	0.0	11.4	0.1	0.3	10.1	2.7	0.0	1.1	0.2	6.0	0.1	2.4	0.3	26.0	3.8	0.7	4.0	0.0	115.9	0.7	0.2	0.4	99.2	7.1	0.2	0.0	21.8	14.5	44.8	21.1	56.7	0.0	172.6	0.0	3.6	101.2	0.0	0.5	0.1	1.4	0.4	0.0	2.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.9	0.7	0.0	0.1	1.0	1.1	0.0	0.0	0.0	2.6	0.0	0.4	21.7	26.9	41.5	33.3	22.0	24.3	27.4	22.7	30.3	10.4	25.4	39.1	21.4	0.0	5.5	4.9	4.6	1.5	2.6	3.1	0.6	14.3	20.4	12.3	3.8	4.3	8.6	0.0	0.0	26.3	1.1	16.0	3.9	19.0	0.4	10.2	3.0	19.1	35.3	0.0	16.1	26.9	1.7	1.0	71.4	20.3	0.0	1.1	20.7	0.4	2.5	20.2	15.5	89.5	16.2	0.8	0.4	1.0	0.9	0.7	7.2	6.5	0.6	2.8	0.0	8.0	50.9	22.9	87.8	0.0	22.7	17.8	107.4	0.5	6.5	4.4	0.0	1.5	1.8	0.4	2.1	0.5	0.4	35.0	1.8	0.1	15.6	13.9
HIVEP3	"FLJ16752, KBP-1, KBP1, KIAA1555, KRC, Schnurri-3, SHN3, ZAS3, ZNF40C"	ENSG00000127124	"HIVEP zinc finger 3"	Q5T1R4	1	41506365-42035925	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.6"	"Group enriched"	"Detected in many"	5	"Astrocytes: 83.9;Excitatory neurons: 219.6;Inhibitory neurons: 271.9;Microglial cells: 163.9;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 196.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 18.8;hTEC/SVTERT24-B: 9.5;Karpas-707: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005728	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA005728: AB_10612117"	"unprognostic (2.87e-3)"	"unprognostic (2.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	1.6	0.6	0.8	2.1	2.1	1.6	1.4	1.4	1.6	0.4	0.0	0.5	0.4	0.4	0.3	1.9	0.5	0.7	0.8	2.0	0.0	1.0	0.3	1.9	1.7	0.7	0.4	0.5	0.8	0.4	2.1	0.6	1.0	1.4	0.5	0.6	1.6	0.3	0.6	4.6	0.6	0.8	0.1	1.1	0.7	0.3	0.5	6.6	1.5	0.4	2.1	1.8	0.5	0.3	1.9	0.6	0.2	1.8	2.2	1.0	0.0	0.9	0.2	2.3	4.0	0.1	0.3	4.0	0.6	1.0	1.5	2.7	0.4	0.4	3.1	18.8	0.5	0.2	0.9	0.0	0.4	0.3	0.3	5.6	0.4	9.5	1.1	0.6	0.5	1.3	0.0	11.0	1.8	1.2	3.0	0.8	0.6	0.6	2.3	2.0	2.9	2.2	1.5	0.4	2.0	0.6	2.6	0.7	0.5	1.1	0.9	3.4	3.4	2.0	2.2	0.6	4.6	3.3	1.4	2.6	8.1	0.2	7.5	0.0	0.5	0.0	0.6	1.1	0.1	0.1	0.2	0.3	0.4	0.4	0.0	0.2	0.0	0.0	1.0	0.1	0.1	0.4	0.8	2.1	1.4	1.6	2.0	0.0	0.7	0.4	1.0	0.1	0.5	0.3	5.9	6.4	10.5	83.9	9.6	23.7	26.5	4.3	17.6	16.4	15.1	11.0	6.9	5.7	8.2	1.8	2.1	0.4	17.6	3.5	1.9	3.1	9.9	1.2	7.7	7.5	3.6	4.4	219.6	2.7	4.4	11.1	1.5	2.8	1.3	0.2	11.4	2.5	6.2	25.2	271.9	1.2	2.0	6.5	17.3	31.9	8.7	15.0	5.4	163.9	9.1	16.0	27.8	83.9	196.0	3.1	0.1	4.1	3.3	15.5	1.9	3.2	1.1	3.5	6.6	23.9	7.4	11.3	8.6	23.7	8.7	0.8	14.5	10.0	0.9	11.1
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899346	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 129.3;lymphoid tissue: 76.6"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.1;Hofbauer cells: 34.5;Kupffer cells: 43.9;Macrophages: 38.8;monocytes: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 1.4;cerebral cortex: 1.6;thalamus: 2.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 569.7"	"Group enriched"	"Detected in many"	13	"granulocytes: 569.7;monocytes: 200.9"	"Cell line enriched"	"Detected in some"	5	"U-937: 20.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		2000000	"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	8.4	4.5	0.0	19.0	0.2	129.3	2.6	1.4	1.6	0.8	0.2	2.5	2.0	1.0	0.1	0.9	5.1	2.1	4.0	0.2	0.0	1.8	5.2	25.1	4.2	0.0	0.0	1.0	1.5	0.1	0.7	2.8	0.0	1.1	1.4	0.1	1.5	0.3	0.9	0.5	3.1	7.9	0.0	76.6	2.1	1.3	2.4	1.4	1.3	0.5	0.7	4.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	0.1	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.6	0.0	569.7	92.5	204.8	0.3	179.4	0.2	0.4	0.2	0.1	30.2	0.2	0.1	0.1	32.2	0.2	200.9	1.4	0.2	43.6	0.0	0.2	1.4	1.6	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.4	1.3	0.0	0.4	0.2	34.5	0.0	0.4	0.0	0.0	43.9	0.9	1.8	0.0	38.8	0.0	1.0	14.6	0.0	2.1	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.2	0.1	0.3	0.3	0.1	0.0	0.0
HMGCL	HL	ENSG00000117305	"3-hydroxy-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 322.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 172.4;Proximal tubular cells: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		34000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	27.5	63.0	26.3	16.8	27.5	7.5	25.8	27.5	28.3	27.5	33.0	53.3	45.7	20.2	47.2	32.8	35.6	26.3	42.5	24.6	26.9	115.5	322.5	23.6	21.7	28.0	26.2	21.6	33.4	60.2	26.3	19.9	27.7	31.7	52.9	16.1	30.3	27.9	63.7	25.5	40.0	23.3	27.4	26.8	40.9	17.9	30.1	23.4	40.5	70.2	25.1	28.6	24.2	29.6	28.5	16.0	17.7	13.4	70.6	53.5	6.8	22.0	38.3	23.3	28.2	10.2	53.7	14.8	44.3	34.6	19.0	22.4	21.3	35.7	25.2	30.4	16.1	19.8	13.8	23.5	90.9	7.8	12.7	62.4	52.0	30.8	58.5	62.5	32.2	27.4	20.6	20.3	43.3	29.3	12.2	15.3	4.6	77.4	22.1	17.2	14.5	27.9	55.4	14.5	14.8	13.2	28.6	10.8	49.3	23.3	33.9	19.3	24.3	19.3	11.6	35.5	9.7	28.7	15.2	13.3	47.7	28.7	23.0	103.5	67.0	66.0	36.3	66.0	39.8	45.9	39.1	42.1	58.0	51.2	39.6	37.7	25.5	54.4	77.5	43.9	45.5	61.7	26.3	27.5	27.5	28.3	24.6	26.9	28.0	26.2	27.7	27.4	30.1	29.6	19.9	12.8	25.7	14.0	16.3	5.9	29.9	54.3	9.6	24.6	19.9	17.1	33.7	41.5	30.6	49.7	18.8	43.0	10.0	48.1	119.3	57.7	2.3	25.0	17.5	22.5	9.0	18.7	4.3	24.0	27.3	20.8	30.5	23.1	17.7	29.7	30.4	172.4	61.6	35.3	5.3	49.5	28.5	23.5	7.7	3.6	21.8	23.5	21.4	8.4	41.4	37.1	24.7	6.0	12.5	31.2	53.8	24.5	8.3	29.4	70.9	216.8	31.5	25.5	6.6	17.1	21.6	6.6	5.4	13.8	6.5	41.3	15.2	65.6	48.9	24.3
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 612.2"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 327.1;Extravillous trophoblasts: 285.2;Hofbauer cells: 494.9;Kupffer cells: 954.1;Macrophages: 271.5;Syncytiotrophoblasts: 502.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 98.8;intermediate monocyte: 238.8;non-classical monocyte: 329.2"	"Lineage enriched"	"Detected in all"	7	"monocytes: 329.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 869.1;GAMG: 631.2;U-138 MG: 506.2;U-87 MG: 489.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		170000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	150.2	48.9	40.9	64.6	48.8	99.3	20.6	42.4	66.3	28.2	46.4	35.2	106.0	10.4	7.6	48.4	40.7	52.6	18.2	40.6	46.6	96.2	136.5	113.6	57.2	52.3	46.5	139.0	41.7	7.4	9.6	72.2	56.3	6.7	31.1	1.7	15.1	4.0	107.1	74.1	64.5	38.7	45.9	612.2	19.9	17.8	60.7	25.1	11.3	21.4	49.4	46.2	29.2	56.2	12.2	179.1	1.8	37.7	170.9	49.6	869.1	83.2	57.6	42.9	48.6	82.1	11.3	0.1	18.3	83.3	631.2	10.1	11.4	1.9	16.1	308.6	9.2	4.3	51.5	179.3	218.9	11.5	54.8	146.3	4.2	282.3	19.7	74.6	130.9	0.5	0.0	87.4	152.5	6.9	0.2	4.3	18.1	130.4	20.7	1.2	15.6	28.4	35.2	104.5	2.7	2.4	215.8	19.1	15.5	92.5	8.9	3.0	44.3	506.2	22.1	82.5	82.5	53.5	77.0	9.3	489.4	5.7	8.6	11.3	98.8	7.7	1.1	238.8	0.4	24.8	0.7	1.7	44.6	2.9	0.1	0.5	47.1	5.3	329.2	1.1	1.8	70.9	40.9	48.8	42.4	66.3	40.6	46.6	52.3	46.5	56.3	45.9	60.7	56.2	19.3	3.2	19.0	0.0	11.5	16.4	27.5	11.0	10.8	0.0	25.0	9.1	2.9	24.3	10.5	5.5	0.0	50.5	3.5	59.1	21.5	13.6	2.1	39.6	12.9	327.1	16.0	5.7	0.2	1.5	285.2	64.1	9.2	74.6	11.4	98.4	23.6	23.6	494.9	0.0	0.4	8.3	18.3	954.1	175.8	4.1	31.1	271.5	35.6	1.9	184.7	0.4	9.2	0.5	1.4	8.3	26.1	5.3	2.5	110.6	61.5	157.9	7.1	0.6	0.0	40.8	52.7	0.9	4.4	5.5	15.6	502.0	6.8	6.9	6.1	118.3
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"intestine: 15.4;kidney: 16.7;liver: 34.7;pancreas: 9.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.2	0.0	5.5	15.4	0.2	0.0	0.1	1.1	0.8	0.0	0.1	0.1	16.7	34.7	0.0	0.0	0.1	0.1	0.0	9.5	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.2	14.3	0.1	0.0	0.0	4.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.6	0.2	0.0	1.2	4.3	0.0	1.8	0.0	0.1	0.4	14.5	0.0	2.6	0.0	1.3	0.2	0.3	4.8	0.0	0.2	5.3	0.1	0.2	4.6	0.5	0.0	0.1	0.4	15.8	0.1	0.0	0.2	9.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.5	0.0	0.5	0.0	3.9	14.8	0.0	0.1	0.5	33.4	16.0	0.0	0.3	0.0	0.8	0.3	0.1	0.3	0.0	0.3	0.0	0.5	0.0	10.8	0.4
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.4;kidney: 43.3;liver: 117.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2;liver cancer: 38.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.1	0.1	5.9	0.2	0.1	0.1	0.2	0.2	0.0	8.4	58.6	102.4	0.1	0.0	0.1	1.0	5.9	0.0	0.4	0.0	43.3	117.1	0.1	0.1	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	44.1	0.1	0.0	0.1	0.2	0.0	82.6	1.8	0.0	0.0	22.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.4	6.0	0.1	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	114.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	42.2	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	35.8	0.0	12.9	0.0	0.0	0.0	232.6	15.6	7.8	4.0	2.5	0.1	0.4	35.9	2.7	0.5	22.1	0.0	0.1	38.2	0.1	4.5	0.0	3.6	186.8	0.0	0.0	0.3	69.8	0.0	5.3	0.0	18.7	0.3	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	21.0	120.0	0.4	0.1	0.3	153.9	170.1	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.8	136.1	0.2
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 114.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.2	2.5	0.5	0.0	1.0	0.2	0.3	2.3	0.1	20.6	100.5	0.4	1.2	0.3	1.0	12.1	0.0	0.3	0.3	17.4	12.9	0.2	0.1	0.4	0.5	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.6	0.0	0.4	0.4	0.0	0.0	114.6	0.9	0.4	0.1	8.1	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.3	0.3	0.4	0.5	0.3	0.4	0.3	0.3	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181157-27185232	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 44.8;endometrium 1: 96.7;smooth muscle: 41.2"	"Cell type enriched"	"Detected in some"	19	"Endometrial stromal cells: 116.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"spinal cord: 3.5"	"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	3.5	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	44.8	0.0	23.1	0.0	96.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	10.0	0.0	14.7	3.9	0.0	0.1	9.6	7.9	1.5	0.2	41.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	17.0	10.4	0.0	4.8	0.3	0.0	13.1	15.2	11.1	0.0	26.8	32.5	18.9	13.8	0.3	1.7	0.0	6.1	23.5	0.1	3.2	16.3	0.0	14.7	1.6	44.0	5.7	11.2	0.7	0.9	12.5	1.7	6.5	0.6	0.1	0.0	0.0	14.1	1.1	0.4	0.0	2.2	0.4	0.0	9.4	0.0	4.4	13.1	0.7	0.0	0.3	9.6	8.1	5.6	0.0	6.7	0.0	2.0	3.6	1.2	34.7	0.0	0.2	12.9	3.2	1.5	0.0	0.0	0.0	0.2	43.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.3	1.1	5.9	0.0	0.8	4.0	116.8	1.3	5.3	0.0	0.0	0.0	0.1	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.8	0.2	0.2	0.0	0.0	0.0	0.9	5.8	1.2	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.3
HOXA13	"HOX1, HOX1J"	ENSG00000106031	"Homeobox A13"	P31271	7	27193503-27200091	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 23.1;placenta: 17.1;prostate: 22.3;seminal vesicle: 23.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 41.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 26.9;HEK 293: 37.3;PC-3: 18.4;RT4: 42.1;THP-1: 18.2;U-937: 20.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046098, HPA069061"			Supported	"Nucleoplasm,Mitotic chromosome,Intermediate filaments"		Yes	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Mitotic chromosome, Intermediate filaments"	"HPA046098: AB_2679536, HPA069061: "	"unprognostic (7.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.04e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.22e-3)"	"unprognostic (7.30e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.42e-11)"	"unprognostic (2.58e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.36e-2)"	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.1	0.0	9.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	22.3	11.9	0.0	0.0	23.3	2.1	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	14.1	0.0	2.2	1.6	0.0	2.5	0.2	0.0	0.1	13.2	14.4	5.1	3.3	2.8	0.2	0.0	1.6	6.2	0.7	0.0	26.9	0.0	4.3	0.0	37.3	1.9	6.9	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	8.7	0.0	11.8	18.4	2.7	0.6	0.0	0.1	42.1	0.7	0.0	3.3	0.0	0.3	2.0	0.0	18.2	0.0	0.5	4.5	0.3	0.1	0.0	0.0	0.0	0.0	20.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.6	0.1	4.0	1.1	8.4	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.1	2.8	0.5	0.0	0.0	0.1	0.1	0.1	0.0	10.3	3.1
HOXD11	"HOX4, HOX4F"	ENSG00000128713	"Homeobox D11"	P31277	2	176104216-176109754	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.1;intestine: 3.8;kidney: 4.7;prostate: 3.3;vagina: 4.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 26.7;Collecting duct cells: 22.0;Distal enterocytes: 22.8;Endometrial stromal cells: 29.0;Enteroendocrine cells: 20.6;Urothelial cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 21.9;RPTEC TERT1: 2.6;SCLC-21H: 6.1;U-251 MG: 4.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	40	"spinal cord: 3.9"	HPA055155			Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA055155: AB_2682719"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.48e-1)"		"unprognostic (1.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (6.73e-2)"		"unprognostic (5.00e-2)"	"unprognostic (2.11e-8)"	"unprognostic (2.09e-3)"	"unprognostic (2.49e-2)"		"unprognostic (2.27e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	3.8	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.1	0.3	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.4	26.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.0	0.0	0.1	0.0	22.8	9.8	0.0	0.0	1.1	29.0	1.7	20.6	0.0	0.0	0.0	0.1	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.6	0.0	0.0	1.2	0.2	0.9	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	1.2	0.0	8.8	0.0	0.3	0.0	0.0	0.0	0.1	2.3	0.1	0.4	0.0	0.9	0.0	0.1	0.0	9.2	14.0
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2530.4"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1373.6;Proximal tubular cells: 2144.0"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 7.8"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 7.8"	"Cell line enriched"	"Detected in some"	31	"Hep G2: 516.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		26000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	2.3	5.3	0.6	0.7	0.4	0.9	4.6	3.2	0.6	2.0	119.0	1.2	0.1	4.1	0.7	0.7	6.4	1.1	3.5	7.8	0.5	531.0	2530.4	2.0	0.3	1.5	1.0	4.7	3.9	0.1	1.1	0.3	0.8	2.3	0.5	0.3	0.2	7.3	2.2	0.2	0.9	1.4	0.6	2.3	1.9	10.2	3.5	0.1	0.7	0.1	0.1	3.7	1.9	1.0	0.3	0.9	0.6	0.6	0.3	0.6	0.6	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.6	1.1	0.2	0.4	0.2	0.0	0.0	0.3	0.8	1.2	5.4	516.4	11.5	1.8	16.4	3.6	0.3	0.0	0.0	1.3	0.0	0.5	0.8	0.0	1.3	1.3	0.2	0.4	9.9	0.4	0.0	0.3	1.6	0.5	0.0	1.4	0.1	0.1	1.5	0.1	0.1	6.9	1.1	0.9	0.2	0.0	0.3	0.1	0.1	0.8	0.6	0.7	0.2	1.2	0.0	0.0	0.6	7.8	0.0	0.8	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	3.9	0.0	1.3	3.8	0.0	0.3	0.6	0.4	3.2	0.6	7.8	0.5	1.5	1.0	0.8	0.6	3.5	1.0	0.0	0.0	0.0	0.7	15.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	55.8	0.0	92.0	0.0	0.8	0.0	0.0	193.7	0.5	38.0	0.1	0.0	2.6	0.0	80.2	1.0	16.2	0.3	0.4	0.0	0.1	0.0	0.0	38.9	1373.6	0.3	0.0	1.0	0.0	0.0	37.8	0.3	121.0	2.5	10.8	0.0	0.0	0.4	0.0	0.0	1.5	0.7	0.2	0.0	5.3	0.0	0.0	0.0	2144.0	0.0	0.0	0.0	2.0	0.2	1.8	1.4	0.0	0.0	1.1	8.0	7.1	0.0	0.0
HPGD	SDR36C1	ENSG00000164120	"15-hydroxyprostaglandin dehydrogenase"	P15428	4	174490175-174523154	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 235.0;urinary bladder: 376.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 457.8;Extravillous trophoblasts: 701.7;granulocytes: 864.5;Proximal enterocytes: 500.6;Urothelial cells: 922.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 52.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 123.7;T-reg: 45.0"	"Group enriched"	"Detected in many"	73	"granulocytes: 123.7;T-cells: 45.0"	"Cell line enhanced"	"Detected in many"		"A549: 157.8;ASC diff: 110.6;HEL: 355.0;OE19: 102.1;RT4: 565.7;SuSa: 121.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004919, HPA005679"	Enhanced		Supported	Nucleoplasm,Cytosol		No	NA		20000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA004919: AB_1079081, HPA005679: AB_1079080"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (3.20e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.37e-4)"	"unprognostic (2.33e-2)"	9.2	16.5	1.0	11.4	0.7	2.7	159.9	0.5	1.2	32.2	8.7	60.9	152.2	45.5	36.5	81.6	13.4	24.9	1.6	1.2	2.8	60.2	210.8	91.0	5.5	1.4	2.0	1.1	2.6	85.3	2.1	99.1	1.0	10.2	57.4	1.0	7.7	4.0	2.5	39.8	117.3	63.7	0.8	10.3	235.0	1.6	2.2	12.2	1.7	3.0	26.6	376.0	83.0	0.7	0.0	157.8	0.0	0.0	110.6	5.4	0.4	0.0	0.0	0.0	0.4	45.1	0.2	0.1	0.0	0.0	0.2	14.2	16.0	0.0	0.0	0.3	2.9	355.0	10.8	0.3	0.0	2.1	0.9	5.6	2.6	0.0	0.1	0.1	0.0	22.6	0.2	0.0	0.0	0.3	1.2	0.3	1.4	102.1	7.4	16.3	0.3	1.3	36.2	565.7	0.9	0.4	0.0	1.3	3.5	121.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	28.4	0.0	0.1	0.3	0.2	0.0	123.7	0.3	16.6	9.9	0.0	15.6	0.4	5.2	4.5	0.7	0.2	1.6	4.0	1.3	1.1	0.0	0.0	45.0	3.0	1.0	0.7	0.5	1.2	1.2	2.8	1.4	2.0	1.0	0.8	2.2	0.7	3.4	16.0	33.0	0.0	4.3	17.3	80.8	6.9	45.5	3.3	14.5	6.7	0.8	35.8	23.6	22.0	0.0	48.5	38.5	457.8	21.5	7.4	1.4	5.7	5.4	18.2	8.4	17.2	0.8	94.5	701.7	25.3	196.7	36.4	864.5	1.5	13.9	245.7	21.4	0.0	9.7	60.7	0.0	14.8	19.5	0.5	19.9	29.2	76.5	5.6	2.9	0.0	10.3	0.0	4.1	42.4	254.7	0.0	50.2	76.8	500.6	131.1	4.4	0.8	0.0	2.4	3.7	0.5	1.0	53.4	22.4	56.6	42.7	65.0	58.9	922.8
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066573	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 200.5;liver: 866.2;pancreas: 272.1"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 442.2;Proximal tubular cells: 201.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 31.5;Hep G2: 47.8;T-47d: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	1.8	0.9	5.6	0.2	8.8	0.0	11.6	7.0	7.2	1.6	4.2	1.1	1.4	4.0	3.9	0.3	7.4	4.0	5.1	5.7	6.5	200.5	866.2	11.8	0.4	7.5	8.1	1.3	272.1	24.2	14.8	0.5	7.5	20.1	0.3	0.3	15.6	4.7	22.1	0.9	1.1	0.2	6.5	2.6	58.2	1.3	7.6	0.2	19.9	5.4	0.1	0.6	0.4	11.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.5	0.0	0.1	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.3	0.1	0.0	0.0	3.2	0.2	0.1	0.0	0.2	0.5	22.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.8	7.0	7.2	5.7	6.5	7.5	8.1	7.5	6.5	7.6	11.7	0.5	9.6	32.4	8.8	3.0	0.1	5.1	0.0	0.0	7.2	12.0	8.9	3.4	51.5	1.3	33.1	0.0	0.1	0.0	0.1	52.8	7.5	8.9	4.9	1.0	1.1	2.4	10.7	2.3	26.5	0.3	1.9	18.3	12.5	2.5	0.1	8.6	442.2	1.1	0.0	1.7	2.4	0.0	9.7	0.3	26.0	0.0	1.8	0.0	2.8	0.6	1.6	0.0	0.0	41.6	14.4	0.0	0.4	0.0	7.5	0.0	201.0	0.0	0.6	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.8	1.8	0.1	0.1	0.5
HRC	MGC133236	ENSG00000130528	"Histidine rich calcium binding protein"	P23327	19	49151198-49155396	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	50	"heart muscle: 718.3;skeletal muscle: 453.0;tongue: 244.7"	"Cell type enriched"	"Detected in some"	17	"Cardiomyocytes: 1182.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 5.8;HSkMC: 5.6;K-562: 8.0;THP-1: 13.9;U-266/84: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004833	Enhanced				"Intracellular and membrane"	NA	NA		100000		"Cluster 38: Heart - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA004833: AB_1079083"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.75e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.41e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-1)"	9.3	3.6	2.5	0.6	2.7	0.0	5.7	3.1	4.0	6.4	2.0	2.4	0.9	6.3	5.4	4.5	9.2	2.2	718.3	2.5	2.3	3.5	1.9	2.8	0.8	2.4	2.6	4.6	1.3	1.5	1.5	2.1	2.6	4.3	0.9	0.8	8.1	2.5	453.0	2.9	2.3	2.1	2.2	0.5	1.8	1.4	2.8	0.6	4.7	244.7	0.4	3.1	3.9	2.4	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	5.8	0.0	0.0	1.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	13.9	0.2	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.7	3.1	4.0	2.5	2.3	2.4	2.6	2.6	2.2	2.8	2.4	3.7	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	1.0	0.8	1.0	1182.5	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.3	1.7	11.0	1.2	0.0	0.0	0.2	0.0	20.9	0.0	0.5	0.0	0.0	0.7	0.6	0.1	3.3	0.1	2.8	0.0	0.0	1.1	0.4	8.4	0.3	3.6	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.4	8.2	0.1	0.2	0.5	0.0	0.0	0.2	65.7	8.7	44.2	0.0	0.2	0.1	0.1	0.1	0.2	2.8	1.5	0.2
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease variant, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"liver: 5433.2"	"Cell type enriched"	"Detected in some"	29	"Hepatocytes: 479.7"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.7;RH-30: 3.0;SiHa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	NA	NA	120000000000	28000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favorable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.4	5433.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	3.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.6	0.0	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	479.7	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;kidney: 13.9;ovary: 14.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.7;Excitatory neurons: 37.5;Inhibitory neurons: 44.2;Leydig cells: 62.7;Oligodendrocyte precursor cells: 54.3;Peritubular cells: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.2;HeLa: 28.1;RH-30: 66.1;RT4: 33.7;SH-SY5Y: 82.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034625	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA034625: AB_10612119"	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.03e-4)"	0.2	2.4	12.4	0.6	10.0	0.0	2.0	1.2	7.4	1.0	0.0	0.6	0.1	3.5	2.4	3.9	1.8	0.3	0.2	9.6	10.7	13.9	0.0	0.7	0.1	6.3	22.5	14.1	5.3	0.3	1.1	8.4	7.3	2.8	0.8	1.5	0.9	0.8	6.2	0.2	0.1	1.5	4.9	0.0	0.9	2.9	20.3	0.6	0.4	0.9	0.5	2.5	0.7	2.6	10.7	0.1	14.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.0	0.0	0.0	15.2	0.0	0.0	0.5	21.7	0.1	0.0	0.0	46.2	0.1	28.1	0.0	0.0	0.0	0.0	0.7	20.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	7.8	0.3	0.1	11.8	7.2	0.6	0.0	66.1	0.0	13.3	33.7	1.8	82.0	14.8	0.0	0.1	23.7	0.0	0.1	0.0	0.0	2.6	9.6	23.8	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	10.0	1.2	7.4	9.6	10.7	6.3	22.5	7.3	4.9	20.3	2.6	0.0	0.0	0.0	1.6	0.0	0.3	0.2	1.8	6.8	0.2	4.3	2.4	0.8	0.0	5.5	3.7	0.0	35.7	0.2	0.3	5.9	0.0	0.5	0.3	0.6	0.5	0.0	0.0	37.5	2.0	2.6	2.6	0.0	0.1	0.0	0.1	0.0	0.0	3.4	0.0	44.2	0.2	2.0	0.0	0.0	1.1	62.7	0.2	0.0	10.3	0.0	5.3	0.0	54.3	1.4	0.8	0.2	35.3	0.0	1.3	0.0	0.1	9.8	0.4	0.0	17.9	0.3	0.3	1.1	11.1	0.3	17.4	0.1	0.3	0.2	1.8
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734949	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 968.3"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 646.2"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 989.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					NA	NA		110000	"Cluster 35: T-regs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	22.4	7.7	9.8	14.6	15.4	0.3	12.0	23.0	22.0	2.8	8.1	4.2	1.2	4.2	15.7	2.1	5.1	8.0	7.5	11.0	16.0	24.3	968.3	39.9	4.3	14.3	21.4	59.9	3.2	0.2	8.8	72.5	16.3	27.8	3.3	0.6	2.5	13.0	5.5	33.8	5.0	12.9	9.4	7.3	7.1	7.2	12.8	0.6	5.2	10.6	1.9	27.9	6.3	17.5	0.4	0.0	0.0	0.0	989.2	102.8	0.0	0.1	36.0	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	206.6	0.2	0.1	5.4	0.0	6.9	0.4	0.9	0.0	0.0	0.0	51.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	16.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	34.9	8.4	4.0	0.2	0.2	0.3	1.4	0.3	0.3	5.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	5.6	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.7	0.4	9.8	15.4	23.0	22.0	11.0	16.0	14.3	21.4	16.3	9.4	12.8	17.5	0.4	3.2	0.0	1.3	0.8	0.1	0.4	4.8	0.6	0.5	0.2	0.0	1.4	30.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.9	0.6	1.0	0.0	5.3	3.3	0.0	0.1	66.4	0.5	2.8	0.0	0.0	7.5	646.2	8.3	0.0	2.8	0.0	0.0	7.9	2.3	2.8	29.2	3.7	0.0	28.1	0.6	16.2	0.0	0.5	55.7	0.4	0.0	7.9	0.0	0.9	0.0	0.2	0.1	0.5	0.0	2.6	5.5	0.0	0.2	0.1	0.1	0.3	1.1	0.3	0.0	1.7
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 249.9;kidney: 335.2;salivary gland: 260.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 191.3;Distal enterocytes: 476.1;Intestinal goblet cells: 288.8;Paneth cells: 226.2;Proximal enterocytes: 270.2;Syncytiotrophoblasts: 114.5;Undifferentiated cells: 170.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 62.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.4;OE19: 29.0;RPMI-8226: 13.9;RT4: 13.9;SCLC-21H: 14.9;SK-BR-3: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	2.1	5.4	1.6	13.4	4.6	0.1	14.0	2.8	2.8	15.5	0.7	249.9	40.0	11.8	4.0	10.9	10.4	6.8	1.9	1.6	1.3	335.2	5.5	3.2	1.0	2.7	1.3	9.3	7.4	3.6	0.5	13.0	3.3	12.9	102.2	0.0	260.2	6.2	0.9	66.1	141.8	18.3	1.5	7.0	9.8	2.5	2.0	0.4	11.1	0.2	0.9	5.3	23.6	2.4	3.6	1.1	0.4	1.4	0.1	1.7	3.6	0.0	0.0	0.1	0.1	6.1	1.3	0.0	2.7	0.1	0.1	7.8	5.1	0.5	0.0	0.0	1.8	0.0	0.7	6.6	0.6	0.7	0.0	1.7	3.0	0.3	0.1	0.0	0.0	4.6	0.4	0.0	0.0	3.8	0.2	0.2	11.4	29.0	1.0	0.0	0.2	13.9	0.5	13.9	14.9	1.0	0.8	13.4	0.6	1.3	6.5	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.6	2.8	2.8	1.6	1.3	2.7	1.3	3.3	1.5	2.0	2.4	0.7	0.0	0.5	0.0	1.1	1.5	7.2	1.3	1.2	0.0	4.8	2.2	0.5	30.0	2.3	191.3	0.0	1.2	0.3	476.1	45.0	2.1	0.2	17.4	25.2	0.5	26.9	0.0	1.1	3.0	0.7	7.1	7.1	43.5	8.9	43.4	1.1	1.2	1.4	0.0	0.8	288.8	4.1	0.3	0.5	0.5	25.4	0.7	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.6	226.2	6.8	0.2	13.5	270.2	16.3	0.4	0.0	13.1	0.3	3.9	0.2	1.6	3.5	3.4	114.5	1.2	16.7	170.9	10.5
HSD17B14	"DHRS10, retSDR3, SDR47C1"	ENSG00000087076	"Hydroxysteroid 17-beta dehydrogenase 14"	Q9BPX1	19	48813018-48836510	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 78.2;Hofbauer cells: 149.9;Proximal tubular cells: 434.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 3.7;NK-cells: 4.7;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"GAMG: 53.9;HHSteC: 49.5;hTERT-RPE1: 37.9;Karpas-707: 50.7;RT4: 40.5"	"Not detected"	"Not detected"							HPA021467	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA021467: AB_1847652"	"unprognostic (2.03e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (4.32e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (4.56e-1)"	"unprognostic (5.50e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.81e-2)"	9.2	39.5	38.1	3.2	36.3	1.2	11.2	42.8	47.7	34.1	72.5	10.5	3.3	31.6	5.6	4.2	22.7	11.6	8.1	37.2	38.2	58.2	78.8	13.1	8.0	35.6	41.2	56.2	6.2	46.7	24.1	7.3	35.3	15.0	1.9	10.0	6.4	9.2	1.3	7.7	8.2	8.5	35.8	8.7	8.6	4.8	43.6	9.6	25.3	2.2	3.8	15.8	14.6	37.0	0.1	14.0	14.1	2.4	15.8	2.6	0.3	2.6	19.9	1.1	1.2	13.4	0.2	8.0	14.2	0.6	53.9	0.1	1.3	0.1	1.3	0.5	1.0	4.1	0.3	1.8	49.5	0.0	20.9	19.0	0.5	1.2	0.5	37.9	18.1	4.8	0.1	50.7	0.1	0.5	1.1	0.4	1.2	8.2	9.3	7.9	0.1	1.5	0.0	40.5	3.5	9.0	0.0	1.8	10.9	6.0	0.4	0.5	0.0	0.3	5.2	0.5	0.1	8.9	18.9	0.6	11.9	1.2	0.1	0.0	0.0	0.0	0.9	0.0	1.5	3.7	1.5	0.7	0.0	2.5	3.1	2.3	0.0	4.7	0.0	0.5	0.5	0.8	38.1	36.3	42.8	47.7	37.2	38.2	35.6	41.2	35.3	35.8	43.6	37.0	3.3	3.2	11.5	21.5	6.0	2.5	3.6	1.7	0.0	5.5	1.3	5.0	2.0	1.5	4.4	7.3	0.0	1.4	0.3	0.0	78.2	1.9	0.4	0.3	3.5	8.2	13.2	5.3	5.0	1.1	3.0	14.1	2.0	0.7	7.0	7.4	28.5	32.0	149.9	11.8	5.0	0.3	8.2	13.4	9.5	1.4	4.1	17.3	21.4	6.5	8.0	53.5	1.0	4.5	0.8	2.6	0.0	7.2	0.1	3.8	2.2	434.5	0.7	1.6	0.0	2.4	2.9	5.6	15.7	0.3	1.8	2.2	2.8	7.5	0.2	2.9
HSD17B3	SDR12C2	ENSG00000130948	"Hydroxysteroid 17-beta dehydrogenase 3"	P37058	9	96235306-96302176	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.1;testis: 36.7"	"Group enriched"	"Detected in some"	6	"Leydig cells: 108.1;Oligodendrocytes: 93.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 2.3;HEL: 1.0;U-2 OS: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056833	Enhanced		Approved	Vesicles		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA056833: AB_2683252"	"unprognostic (2.78e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.26e-4)"	"unprognostic (3.45e-1)"	"unprognostic (5.48e-8)"	"unprognostic (8.47e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.11e-2)"	1.6	0.8	3.1	0.2	4.3	0.0	1.7	3.4	5.9	3.1	2.4	2.7	0.5	1.5	0.9	0.7	3.5	0.2	2.1	3.1	3.6	4.7	15.1	1.8	0.0	4.3	3.9	1.4	4.2	0.0	1.7	0.1	4.2	3.2	0.1	0.7	1.0	0.1	0.5	0.9	3.7	0.0	3.3	0.9	1.4	36.7	4.2	0.1	10.0	0.1	0.0	1.6	1.8	5.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	4.3	3.4	5.9	3.1	3.6	4.3	3.9	4.2	3.3	4.2	5.4	0.0	0.0	0.0	15.3	0.2	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.2	4.0	0.2	0.0	0.4	1.8	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.5	0.0	0.0	0.4	14.4	108.1	1.1	0.0	4.7	0.1	0.6	0.0	1.0	93.2	0.2	0.1	12.8	0.0	0.1	0.6	0.0	0.5	0.2	0.0	0.1	0.5	1.9	1.8	0.0	0.3	0.1	0.0	0.0	0.3	0.0
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"liver: 1804.3"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1969.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.4;U-266/84: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	8.5	2.5	13.1	6.9	16.2	0.5	0.7	13.4	18.9	28.0	9.4	24.7	3.2	20.9	1.6	9.9	6.5	9.1	0.8	12.3	12.6	2.5	1804.3	63.2	0.8	12.0	14.6	6.0	0.6	0.5	0.6	5.4	11.5	51.2	7.6	0.8	0.4	69.2	0.4	1.2	4.8	13.1	12.4	47.5	5.7	23.3	13.7	0.9	31.4	0.5	0.9	36.7	14.6	12.8	0.3	0.8	1.9	0.4	1.9	1.4	2.3	4.1	3.5	1.9	1.9	0.4	0.4	12.0	1.7	0.5	0.5	0.3	6.1	1.1	1.1	7.7	2.2	3.7	1.2	0.6	1.2	1.9	6.0	1.0	0.4	1.2	0.6	0.6	0.0	10.3	1.1	13.4	0.9	2.4	5.6	1.3	7.5	0.7	0.7	7.4	0.8	2.9	0.2	1.4	11.0	2.3	2.0	3.6	0.9	0.7	0.6	1.5	0.3	0.9	0.8	4.0	1.0	11.7	18.0	7.8	1.3	6.9	0.6	0.0	0.0	0.0	1.0	0.2	1.2	0.7	0.8	0.8	0.2	0.3	1.1	0.7	0.0	0.0	0.5	0.7	1.0	0.3	13.1	16.2	13.4	18.9	12.3	12.6	12.0	14.6	11.5	12.4	13.7	12.8	0.4	173.1	130.6	21.2	6.1	1.3	3.1	0.6	0.6	0.4	0.7	0.6	0.2	27.1	9.3	0.0	0.0	1.4	0.4	0.0	0.0	0.1	4.6	0.7	3.5	1.3	0.0	29.5	1.4	0.0	2.6	5.0	0.0	0.1	0.0	1.6	26.0	1969.3	0.4	0.0	2.1	0.4	0.0	40.2	0.3	4.5	12.5	0.5	0.0	1.0	1.0	1.3	0.0	3.0	5.5	0.1	0.0	1.5	0.8	16.1	0.0	0.3	1.5	0.6	13.1	0.6	3.5	16.4	11.4	1.2	1.6	0.4	2.2	36.0	0.7	1.1
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 108.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 436.6;Late spermatids: 901.8;Spermatocytes: 203.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"HAP1: 82.3"	"Low region specificity"	"Detected in all"							"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol		NA	NA		1000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: AB_2676366, HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (6.78e-4)"	1.3	11.3	12.0	1.0	10.5	3.0	3.5	21.7	30.6	3.5	13.5	2.6	2.3	1.0	1.2	13.7	7.0	3.7	6.4	10.6	32.7	13.3	7.4	1.5	0.3	15.2	17.7	3.8	4.0	11.1	8.0	2.9	21.5	4.1	3.5	26.9	5.7	4.9	1.5	8.4	1.2	3.0	12.9	0.9	2.1	108.7	17.7	4.0	3.9	3.6	4.7	2.8	7.7	15.9	20.6	26.5	14.0	22.1	9.5	9.5	16.2	9.1	3.7	8.6	9.5	19.7	9.2	0.1	16.4	2.6	7.0	4.7	82.3	32.9	11.7	38.7	24.7	11.0	33.5	23.7	3.5	42.3	17.9	8.7	29.7	5.7	20.3	8.9	11.3	9.4	19.8	12.2	10.9	14.9	13.6	3.7	3.3	21.5	21.6	0.1	1.5	2.0	29.1	9.2	25.7	9.4	16.4	28.2	1.5	8.3	21.7	7.1	3.2	3.0	0.1	3.7	22.1	23.6	29.3	6.4	11.7	28.3	9.4	0.6	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.0	10.5	21.7	30.6	10.6	32.7	15.2	17.7	21.5	12.9	17.7	15.9	2.7	3.2	9.3	17.6	1.1	28.4	91.9	31.3	40.9	57.7	7.7	9.4	18.1	12.8	27.6	9.2	104.3	10.0	0.8	3.4	19.6	6.8	436.6	17.8	1.6	6.8	18.4	0.0	47.1	2.9	2.1	8.1	2.6	5.2	15.8	2.5	1.8	9.7	1.2	40.4	70.4	3.5	24.4	2.5	9.7	901.8	10.2	4.7	8.8	7.5	3.0	16.6	2.1	19.6	9.3	2.8	0.3	9.8	0.4	26.2	0.3	24.6	52.0	66.8	0.0	18.7	12.5	203.1	13.5	47.5	42.5	16.7	4.2	2.8	5.3	65.2
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754566-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 2969.8;tongue: 1759.1"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		310000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	650.0	414.0	37.3	45.4	40.6	0.4	394.9	32.5	49.2	581.9	26.1	699.9	28.1	565.1	101.6	112.3	495.1	97.9	1463.9	30.0	43.6	69.0	42.3	126.6	5.7	76.7	48.5	455.2	50.5	4.2	17.5	40.2	73.7	271.2	44.0	21.1	115.9	194.7	2969.8	39.1	180.0	278.2	50.8	15.7	362.1	60.6	53.8	6.2	99.5	1759.1	2.7	537.3	290.6	49.3	0.6	0.7	2.1	2.5	1774.3	742.0	1.2	83.0	1.3	4.9	9.3	1.1	0.4	0.7	0.6	252.4	0.0	0.2	0.4	0.7	3.9	0.9	0.5	0.4	1.3	0.5	599.9	0.2	0.9	700.3	0.0	19.1	0.9	2.2	5.4	0.3	0.5	1.0	0.2	0.3	0.4	1.9	1.2	2.3	0.6	1.5	0.5	0.7	0.0	0.1	0.8	0.7	0.1	0.2	0.7	0.3	0.3	0.5	0.1	153.2	0.9	17.3	0.6	1.0	2.8	0.3	20.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	40.6	32.5	49.2	30.0	43.6	76.7	48.5	73.7	50.8	53.8	49.3	11.1	3.2	0.6	1.6	0.1	1.8	0.4	0.0	3.4	7.8	0.5	0.5	29.7	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	0.1	27.0	4.9	165.7	3.6	0.0	5.2	0.2	0.0	2.5	125.2	4.1	3.5	0.0	3.6	17.5	0.3	5.0	0.0	0.5	0.0	0.0	0.3	3.6	18.9	271.8	2.7	1.8	0.0	0.6	44.5	0.0	0.0	0.1	0.2	0.0	220.4	0.1	0.4	0.0	0.4	0.0	2.8	26.3	38.0	102.6	2.3	1.4	1.9	2.0	4.8	1.8	311.0	0.0	0.5
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	38.9	99.7	53.4	31.0	54.1	54.7	35.7	56.0	60.6	33.5	45.9	34.8	25.4	39.4	59.1	30.3	35.1	28.6	65.4	51.5	74.1	43.3	30.8	26.9	34.5	60.8	56.4	60.2	27.7	52.8	144.7	36.4	56.7	35.3	35.3	56.1	28.4	39.6	181.8	35.1	26.0	34.6	56.1	28.5	32.5	41.5	79.9	43.0	47.6	109.2	35.7	35.1	27.8	55.3	151.4	79.3	99.9	70.5	72.1	54.0	87.1	71.5	60.4	57.2	55.5	47.6	66.0	114.1	163.1	68.1	66.3	66.0	120.5	52.3	75.0	86.5	106.9	70.9	99.9	59.2	40.8	138.1	57.7	48.4	66.1	63.2	39.3	40.8	60.3	166.3	67.4	81.0	76.5	114.3	135.7	115.4	58.7	139.4	115.7	104.2	123.7	103.3	62.0	105.9	69.0	106.9	66.7	54.4	56.4	83.9	39.8	96.5	57.4	69.2	52.2	79.5	126.1	47.6	69.1	92.7	44.4	192.4	50.3	48.4	20.6	33.2	41.0	21.5	44.5	33.9	44.4	42.2	28.5	33.3	44.8	40.7	6.7	49.7	35.3	20.6	47.9	27.9	53.4	54.1	56.0	60.6	51.5	74.1	60.8	56.4	56.7	56.1	79.9	55.3	28.2	51.3	42.9	11.4	36.8	29.6	38.0	28.0	38.7	52.5	25.8	23.5	173.3	20.0	53.1	49.7	10.4	95.3	37.6	26.2	49.0	36.7	6.8	51.0	39.3	29.8	81.2	55.5	10.2	34.3	69.8	42.1	42.3	32.9	34.8	48.4	10.4	22.8	38.2	42.1	12.1	37.8	28.5	19.5	19.2	11.7	45.1	30.3	32.0	7.5	34.4	78.0	25.7	8.0	13.6	32.5	18.5	53.8	54.3	37.2	20.4	32.1	44.4	56.7	46.0	46.9	41.0	29.4	92.2	42.7	26.6	116.8	51.6	45.8	32.6	36.8
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125042	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 17.4;cervix: 21.5;endometrium 1: 18.8;smooth muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Endometrial stromal cells: 17.7;Endothelial cells: 4.1;Hepatic stellate cells: 5.7;Microglial cells: 4.7;monocytes: 6.2;Peritubular cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 1.8;T-reg: 1.0"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.8;T-cells: 1.0"	"Group enriched"	"Detected in some"	4	"HHSteC: 8.7;HSkMC: 16.5;SK-MEL-30: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA012867: AB_1856710, HPA063658: AB_2685079"	"unprognostic (1.86e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.42e-3)"	"unprognostic (7.44e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	0.9	17.4	0.4	1.5	0.4	1.2	0.8	0.9	0.6	21.5	1.2	9.0	1.5	18.8	11.8	0.7	2.4	1.2	4.7	0.4	0.6	3.4	3.6	0.9	1.0	0.5	0.4	0.8	0.2	0.6	0.3	4.1	0.5	0.3	2.1	0.2	0.5	1.4	0.1	0.1	4.8	16.8	0.2	0.4	4.5	0.4	0.4	1.2	3.2	0.3	0.8	2.2	0.8	0.6	0.2	0.3	0.0	0.1	0.5	4.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.7	0.1	0.3	16.5	0.0	0.0	0.0	0.0	3.2	1.4	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	32.7	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.6	0.4	0.6	0.5	0.4	0.5	0.2	0.4	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.2	1.5	17.7	4.1	0.0	0.0	0.7	0.7	0.1	0.8	0.0	3.4	0.0	0.1	5.7	1.5	3.4	1.7	0.9	0.0	0.0	0.8	0.0	0.2	0.6	2.2	0.0	4.7	6.2	0.0	1.0	0.5	0.6	0.2	0.0	5.3	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.2	0.3	0.0	0.2
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122458551-122514907	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	246.0	81.3	382.1	37.0	436.6	0.5	202.8	422.6	595.7	352.1	316.2	154.8	20.8	197.1	247.1	57.8	122.9	301.2	114.7	377.7	411.4	230.9	226.4	69.9	39.9	427.1	447.0	425.5	55.9	111.8	184.1	281.9	425.3	85.7	51.8	243.6	101.1	114.5	31.1	130.5	73.5	152.3	382.1	54.2	87.3	19.5	423.6	21.2	78.8	80.9	27.3	137.3	188.3	464.2	0.3	45.6	19.4	5.7	2417.8	889.4	0.8	108.3	196.8	44.4	23.6	0.2	0.6	0.0	29.0	862.3	68.6	12.8	7.6	124.4	6.2	0.1	4.9	0.1	65.4	0.3	123.7	0.1	0.9	1581.4	444.6	25.8	205.3	503.6	207.1	0.0	0.1	1.5	1238.2	22.3	0.1	0.7	20.9	0.2	67.6	0.2	1.3	0.4	282.6	2.2	1.2	3.9	272.1	0.2	122.2	91.4	8.6	0.2	136.0	309.9	4.5	141.3	94.1	0.2	0.1	0.3	1004.6	0.2	148.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	382.1	436.6	422.6	595.7	377.7	411.4	427.1	447.0	425.3	382.1	423.6	464.2	55.1	22.4	6.9	116.5	0.9	44.1	32.5	10.8	23.9	53.3	5.4	31.2	26.4	14.3	0.9	64.4	54.2	30.9	1.3	0.0	0.0	2.0	3.5	11.3	76.5	107.0	0.0	2.7	2.2	4.6	164.6	269.3	4.6	14.4	1.3	731.6	57.8	157.8	51.3	625.9	31.2	0.3	8.2	18.1	59.9	4.2	31.7	22.0	46.2	86.2	8.5	373.8	0.0	193.0	112.5	2.7	1.3	77.5	1.9	8.7	0.2	22.6	10.1	150.3	6.6	63.3	140.5	0.2	0.7	7.0	30.5	87.7	7.2	2.5	0.6	11.9
HVCN1	"Hv1, MGC15619, VSOP"	ENSG00000122986	"Hydrogen voltage gated channel 1"	Q96D96	12	110627841-110704950	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 162.1;lymphoid tissue: 72.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 178.4;Early spermatids: 87.3;Hofbauer cells: 57.0;Late spermatids: 76.4;Spermatocytes: 117.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NB-4: 286.4;U-698: 90.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039329	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA039329: AB_10674284"	"unprognostic (3.43e-2)"	"unprognostic (6.32e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.85e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-1)"	8.2	5.1	23.4	32.0	34.7	6.9	5.2	24.3	21.1	9.3	162.1	6.5	4.8	10.1	11.5	4.6	9.2	8.3	17.5	26.2	29.5	3.3	4.4	13.7	65.0	25.7	32.8	13.5	1.7	2.2	3.0	8.1	27.8	6.4	6.7	2.7	3.9	8.7	7.9	3.0	17.8	10.3	20.2	42.7	7.6	44.7	27.6	16.2	3.9	9.8	72.9	9.7	5.2	25.0	0.1	0.5	2.8	0.2	4.5	4.7	1.4	0.9	1.1	2.6	1.4	0.5	0.0	2.9	2.4	5.1	0.0	0.4	3.3	0.2	3.7	0.2	0.6	0.1	0.3	0.7	4.0	44.1	3.1	6.2	0.4	2.4	0.0	0.4	6.4	13.4	1.9	2.4	4.7	0.2	6.4	286.4	3.2	0.0	2.7	5.4	0.2	0.3	0.0	0.1	0.3	0.4	0.1	0.0	0.2	2.9	0.0	42.8	1.9	0.0	0.2	0.4	0.1	27.4	3.7	90.5	0.3	2.2	0.2	378.0	208.3	675.7	14.0	197.8	7.7	550.4	13.2	22.7	88.7	799.8	25.2	17.2	327.4	182.6	185.0	131.7	31.0	193.2	23.4	34.7	24.3	21.1	26.2	29.5	25.7	32.8	27.8	20.2	27.6	25.0	18.4	3.2	5.3	9.4	178.4	0.8	1.9	2.0	1.2	0.5	1.2	2.8	6.6	0.0	3.6	1.8	0.0	0.4	25.8	0.0	0.0	0.5	87.3	0.5	5.8	13.1	0.0	0.8	0.6	0.2	1.4	5.4	1.5	0.3	8.2	3.9	12.1	0.3	57.0	0.0	0.5	0.2	0.0	41.7	17.2	76.4	13.4	42.2	12.4	15.0	31.6	15.2	23.7	2.0	0.1	0.5	0.1	13.9	9.9	0.6	0.0	0.5	1.7	1.8	13.1	4.7	15.1	117.5	2.8	0.7	0.4	1.2	7.6	0.5	0.2	1.2
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 341.8;Endothelial cells: 180.8;Hepatic stellate cells: 128.5;NK-cells: 106.1;Plasma cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 1260.8;TIME: 319.0"	"Low region specificity"	"Detected in all"							HPA071155			Approved	"Plasma membrane,Cytosol"		NA	NA		730000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	97.4	11.3	39.6	30.4	39.6	20.7	78.7	40.3	48.3	20.3	34.6	26.3	14.1	24.4	6.7	12.1	22.2	18.8	99.7	38.2	40.5	44.3	14.6	84.5	60.5	42.1	40.9	12.7	15.4	9.0	12.4	79.3	42.9	16.1	18.2	1.2	16.0	8.6	37.9	16.3	34.2	29.5	41.4	168.1	18.8	3.5	44.6	31.5	33.6	55.9	41.8	33.0	21.4	40.6	0.0	0.0	0.0	0.0	11.3	10.8	3.2	1.1	0.7	0.3	1.1	2.7	52.2	92.9	16.6	0.0	0.3	0.4	1.2	0.0	1.7	22.3	0.0	82.9	4.4	10.0	1.8	14.2	0.3	0.4	0.0	0.8	0.2	0.0	1260.8	78.8	67.7	50.5	0.3	0.0	101.8	11.8	0.1	0.7	0.0	60.3	0.2	128.7	6.7	12.8	0.0	0.8	0.0	0.2	0.0	0.1	0.0	10.3	319.0	0.2	0.8	6.2	0.0	47.6	18.7	83.4	0.1	17.7	0.0	444.8	191.8	62.1	282.8	464.6	326.0	265.6	371.2	270.7	203.6	328.9	400.3	253.3	23.1	188.5	525.8	67.2	450.8	502.0	39.6	39.6	40.3	48.3	38.2	40.5	42.1	40.9	42.9	41.4	44.6	40.6	341.8	0.0	8.4	0.0	47.8	7.4	4.0	5.2	0.6	0.1	6.1	11.3	0.5	1.5	4.5	7.3	0.0	0.5	41.7	1.7	0.0	1.2	0.6	1.2	2.4	180.8	1.2	28.2	0.1	1.4	0.3	13.8	1.1	0.8	12.0	0.7	128.5	1.9	20.0	0.0	0.0	2.2	2.0	55.6	13.4	1.3	0.3	56.9	28.4	21.5	25.7	0.4	106.1	0.5	0.2	6.8	4.7	1.9	114.4	3.8	0.6	0.5	4.1	0.5	6.6	7.4	11.6	0.2	0.3	0.7	5.4	1.0	60.1	6.5	4.2	2.8
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339661	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 206.5;liver: 73.2;lymphoid tissue: 85.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 151.9;dendritic cells: 164.6;Hepatocytes: 168.8;NK-cells: 313.1;Plasma cells: 137.2;T-cells: 183.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1948.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 1948.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 324.6;NB-4: 222.3;RPMI-8226: 257.6;U-266/84: 188.8;U-937: 179.0"					"Not detected"	"Not detected"			"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA		390000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	18.9	7.4	4.8	50.4	4.6	206.5	10.0	4.5	6.4	4.9	4.4	16.1	15.1	3.6	2.8	7.6	6.2	9.0	18.1	4.5	4.6	11.9	73.2	16.0	72.2	4.9	5.0	2.9	15.2	2.9	1.0	4.6	5.0	6.8	11.0	0.9	15.2	2.9	18.0	4.3	28.1	4.4	5.2	85.8	19.5	2.1	5.2	48.6	6.8	11.9	50.6	14.1	4.4	4.6	12.4	5.8	4.2	13.1	6.8	5.3	7.3	7.5	5.1	5.9	5.2	5.3	8.1	0.2	24.9	6.2	0.1	5.4	0.2	5.5	2.0	106.2	3.7	23.8	5.4	22.6	3.4	96.7	102.1	4.8	4.4	7.0	2.6	6.4	2.9	57.1	13.0	324.6	6.9	24.0	13.9	222.3	3.2	31.7	38.3	11.1	2.7	257.6	6.2	11.2	1.3	5.6	6.5	20.4	17.3	1.9	17.7	23.9	4.6	28.0	3.0	31.2	7.6	20.7	188.8	37.3	20.2	179.0	22.1	193.6	395.4	872.4	362.7	287.8	436.2	280.1	343.0	331.7	327.5	271.7	301.5	283.9	1948.5	380.1	417.4	52.9	436.3	614.5	4.8	4.6	4.5	6.4	4.5	4.6	4.9	5.0	5.0	5.2	5.2	4.6	22.6	3.2	29.7	0.7	151.9	8.2	6.5	7.0	10.2	0.3	23.1	20.6	0.1	21.5	9.8	5.5	0.0	12.0	164.6	49.1	62.6	16.9	7.7	10.7	9.4	19.2	5.4	37.4	0.2	35.4	24.7	10.2	16.8	9.9	30.4	5.5	31.1	168.8	24.0	1.7	0.1	33.2	4.1	70.0	50.4	10.0	6.2	52.9	55.2	1.0	127.7	6.4	313.1	0.0	0.1	23.2	43.8	4.1	137.2	12.3	79.9	54.4	9.0	1.2	0.0	7.3	10.7	5.7	0.7	8.3	8.4	4.7	183.3	5.4	36.4	10.2
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.5;lymphoid tissue: 20.2"	"Cell type enriched"	"Detected in some"	12	"T-cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.1"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.1"	"Group enriched"	"Detected in some"	8	"HEL: 4.6;MOLT-4: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	0.5	0.1	0.0	7.7	0.0	16.5	0.3	0.0	0.0	0.2	0.0	0.7	0.7	0.2	0.1	0.5	0.3	1.4	0.2	0.0	0.0	0.2	0.4	2.6	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.2	2.3	0.4	0.0	3.3	1.3	0.2	0.0	20.2	0.4	0.0	16.2	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.2	0.0	15.1	6.8	0.0	0.0	15.7	7.2	0.1	0.5	0.0	0.0	29.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	3.1	2.9	0.0	0.0	0.0	0.0	1.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.2	6.3	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.8	4.7	0.1	0.0	3.1	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	1.8	0.1	81.2	0.0	0.0	0.1
IDNK	"bA522I20.2, C9orf103, hGntK"	ENSG00000148057	"IDNK gluconokinase"	Q5T6J7	9	83623049-83644130	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 80.3;Proximal enterocytes: 84.2;Proximal tubular cells: 224.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020378, HPA058429"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Mitochondria, Cytosol"		"HPA020378: AB_1845794, HPA058429: AB_2683716"	"unprognostic (1.49e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.10e-6)"	"unprognostic (1.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.86e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.11e-2)"	8.9	12.0	18.8	6.1	24.5	5.8	8.7	20.6	26.8	4.3	22.7	9.5	26.3	5.3	13.3	8.3	12.9	6.4	5.8	19.1	22.6	50.9	70.5	7.3	11.0	20.3	20.8	5.5	13.8	14.8	9.0	3.0	20.6	8.4	9.2	10.9	8.8	9.5	2.3	7.1	26.9	4.4	20.5	7.9	8.9	3.7	20.8	38.9	13.2	2.6	9.5	5.2	3.9	21.1	4.3	10.4	1.7	1.8	4.6	6.9	7.8	3.4	8.6	3.5	2.8	2.9	5.3	5.8	5.2	5.8	3.5	8.4	1.3	2.0	3.6	11.9	1.6	2.1	4.6	12.7	19.4	1.5	2.8	4.3	3.3	7.2	7.2	6.2	7.9	16.0	1.9	7.1	4.8	26.8	3.7	1.4	1.6	18.1	6.0	4.6	4.2	3.3	9.6	5.5	6.9	8.6	7.5	6.5	7.6	2.5	6.0	8.1	7.4	1.6	1.3	14.3	6.1	9.0	10.4	1.0	7.3	2.4	2.8	100.7	13.0	19.1	30.5	24.1	25.4	39.3	26.0	24.7	18.1	26.7	20.2	27.2	2.8	33.1	47.6	20.9	52.2	24.8	18.8	24.5	20.6	26.8	19.1	22.6	20.3	20.8	20.6	20.5	20.8	21.1	6.2	12.8	8.7	14.7	9.3	6.8	3.2	7.3	4.0	8.9	10.0	8.4	9.9	10.0	8.8	5.5	0.0	8.0	11.3	8.4	80.3	11.3	0.4	34.6	2.0	5.6	7.3	2.5	4.7	16.1	4.6	8.0	4.6	7.0	20.8	10.2	3.3	44.3	11.1	10.1	5.6	12.8	12.2	11.6	7.5	2.0	4.4	8.2	12.4	11.2	19.8	38.0	24.7	8.0	11.4	5.4	21.7	4.1	12.1	4.6	84.2	224.4	28.3	3.5	0.0	8.8	5.9	1.4	1.5	5.4	5.8	3.0	13.7	9.9	11.2	4.2
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA002134, CAB016293, HPA073514"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: "	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	95.7	37.9	13.5	114.5	17.5	35.5	72.8	14.3	14.1	56.8	9.1	38.3	23.8	76.5	22.7	63.6	54.2	100.6	35.0	13.7	20.3	30.1	27.7	68.2	140.6	29.9	22.7	76.8	16.7	9.7	9.3	66.7	27.0	26.5	45.0	7.7	63.7	32.0	16.8	58.8	47.9	87.3	23.6	107.8	30.7	18.8	23.8	116.8	37.4	32.6	133.1	113.6	52.8	26.2	43.5	3.2	14.4	0.6	97.4	319.5	0.4	89.9	238.0	245.7	324.2	0.0	54.1	251.7	75.4	55.3	79.2	122.2	2.2	91.1	97.7	78.4	1.1	64.9	17.2	0.1	181.8	22.8	4.2	302.4	159.5	126.5	177.8	117.8	262.8	218.1	1.4	179.4	138.6	0.0	302.2	21.1	38.4	0.0	32.5	140.6	91.4	295.0	34.4	16.1	6.6	0.1	117.7	1.0	259.5	56.9	0.4	26.3	150.2	63.1	29.7	179.9	38.2	165.8	82.8	235.5	181.2	72.7	155.7	9.1	67.7	0.4	57.5	66.4	51.9	88.4	54.3	59.4	68.3	94.6	33.9	43.3	164.4	91.6	65.3	51.1	82.1	63.8	13.5	17.5	14.3	14.1	13.7	20.3	29.9	22.7	27.0	23.6	23.8	26.2	378.4	38.5	54.6	4.2	217.8	95.0	110.7	197.6	174.8	0.4	47.8	43.8	10.7	37.1	130.7	42.3	0.0	3.4	278.3	7.9	1.9	38.0	4.9	41.9	219.1	286.8	12.1	38.7	1.3	47.8	2.9	207.8	9.7	68.0	138.3	27.7	137.4	3.0	214.2	0.0	2.2	19.9	79.3	163.8	135.0	9.8	117.4	187.2	83.6	116.2	202.4	30.8	329.6	37.2	20.7	47.1	23.5	53.0	143.3	32.6	7.9	4.9	76.6	1.4	85.5	185.3	132.7	2.4	13.2	92.6	68.2	3.3	219.2	70.6	26.4	107.5
IFI27	"FAM14D, ISG12, P27"	ENSG00000165949	"Interferon alpha inducible protein 27"	P40305	14	94104836-94116698	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 3792.9;Distal enterocytes: 2150.5;Endothelial cells: 1972.1;Exocrine glandular cells: 1603.8;Intestinal goblet cells: 1638.8;Pancreatic endocrine cells: 1678.1;Paneth cells: 2179.2;Proximal enterocytes: 3048.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 7.0"	"Group enriched"	"Detected in many"	6	"monocytes: 7.0;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 2026.8;BJ hTERT+ SV40 Large T+ RasG12V: 1782.5;EFO-21: 547.7;Karpas-707: 501.5;SK-MEL-30: 607.2"									HPA028875	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA028875: AB_10601434"	"unprognostic (1.15e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.78e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.10e-1)"	"prognostic favorable (8.80e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.65e-1)"	470.3	323.3	178.3	115.7	177.4	162.8	410.3	180.9	232.6	351.4	162.7	374.4	129.2	137.8	39.9	310.4	163.2	344.1	471.5	174.5	182.4	217.9	150.4	608.2	48.3	203.8	187.7	75.6	39.3	30.3	65.3	183.8	215.0	85.0	221.4	6.1	156.9	47.0	113.1	129.8	256.2	117.4	194.9	797.8	697.0	140.2	194.1	202.8	149.8	152.4	54.2	116.9	213.7	190.8	181.3	0.4	1.3	0.4	0.5	21.7	1.7	2.8	8.8	2026.8	1782.5	3.8	146.8	1.5	547.7	115.3	33.8	5.7	1.1	0.2	79.7	2.1	3.7	1.0	1.4	0.9	13.7	0.6	1.1	2.0	2.0	353.8	0.1	1.1	284.0	1.3	1.1	501.5	0.1	0.5	1.7	1.1	0.5	0.5	24.7	1.8	0.5	0.6	1.2	0.6	0.4	1.1	0.0	0.1	607.2	1.4	0.9	3.0	0.3	0.2	2.7	325.8	1.0	9.4	14.6	3.9	0.9	0.5	1.4	0.0	1.3	0.5	0.3	7.0	0.3	0.0	2.6	0.7	0.8	0.1	0.0	0.4	0.0	0.4	2.1	0.1	2.5	2.1	178.3	177.4	180.9	232.6	174.5	182.4	203.8	187.7	215.0	194.9	194.1	190.8	3792.9	391.0	82.7	1.3	26.8	171.2	6.5	126.9	91.6	4.9	23.4	38.2	45.9	151.5	237.4	12.9	8.4	7.3	14.9	2150.5	1.9	50.6	13.6	1035.5	188.3	1972.1	267.8	42.3	0.6	1603.8	221.2	330.8	892.5	838.5	45.1	1174.4	742.5	5.8	158.3	5.0	0.4	1638.8	107.8	106.9	163.5	36.7	172.1	59.6	350.4	84.3	26.1	8.3	0.0	0.0	0.7	1678.1	2179.2	417.5	6.3	11.1	3048.1	23.7	548.1	20.5	276.1	45.2	295.8	20.3	12.1	151.9	140.4	5.2	34.1	302.4	523.4	80.4
IGF2BP1	IMP-1	ENSG00000159217	"Insulin like growth factor 2 mRNA binding protein 1"	Q9NZI8	17	48997385-49056145	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 5.5;testis: 4.8"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 37.3;Spermatocytes: 30.4;Spermatogonia: 21.7"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 146.7;CACO-2: 238.7;Hep G2: 112.0;K-562: 124.4;NTERA-2: 117.6;REH: 140.0;SuSa: 111.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021367, HPA062273"	Enhanced		Supported	Cytosol		NA	NA		13000		"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA021367: AB_1851480, HPA062273: AB_2684733"	"unprognostic (6.79e-4)"	"unprognostic (2.76e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.30e-6)"	"unprognostic (1.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.80e-6)"	"unprognostic (2.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.47e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	59.5	146.7	0.1	5.2	7.6	105.0	8.5	0.2	12.1	20.1	238.7	4.0	12.4	0.9	1.0	3.6	0.0	91.4	0.0	21.1	0.0	52.9	91.3	33.6	112.0	6.9	48.8	23.6	10.4	0.0	2.9	0.2	4.1	24.9	16.6	124.4	0.0	16.6	0.9	0.1	42.9	117.6	0.2	0.2	140.0	48.3	0.0	0.0	0.1	0.0	0.0	5.1	0.1	3.6	111.4	0.2	13.5	0.5	0.0	1.4	12.5	0.0	0.1	0.1	80.7	0.1	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	1.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	5.5	0.0	0.6	0.0	0.0	3.5	0.2	0.0	0.0	0.0	5.3	0.1	0.1	3.9	0.0	2.7	0.2	0.0	37.3	3.7	0.0	0.1	1.3	0.0	0.0	0.0	6.9	0.0	0.2	0.0	0.0	0.0	0.8	4.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.1	0.0	0.0	0.1	0.0	5.3	0.7	0.0	0.0	1.1	1.1	30.4	21.7	0.0	0.1	2.9	0.3	0.1	0.0	0.3
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888360-45893660	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 1198.4"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 994.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	25000000		"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	2.6	0.1	0.2	0.0	0.2	0.0	2.4	0.2	0.3	0.3	0.1	0.0	0.3	79.6	0.1	0.0	4.1	0.3	0.5	0.2	0.3	1.6	1198.4	0.1	0.1	0.8	0.3	46.3	0.5	0.0	0.5	204.5	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.5	0.1	0.1	0.3	1.1	0.3	0.0	0.0	0.0	0.2	0.2	0.2	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.3	1.4	0.1	1.6	0.3	0.0	0.0	0.7	0.0	0.0	0.3	0.5	54.7	0.3	1.1	0.1	0.1	0.7	11.3	0.1	0.6	0.3	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.3	0.0	2.2	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.9	0.0	0.0	0.0	0.2	145.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.8	0.3	0.9	0.2	0.3	0.2	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	5.7	1.0	35.8	0.7	0.0	0.0	0.9	0.0	0.0	0.0	11.0	0.1	4.7	94.3	0.9	3.5	10.7	0.1	0.0	1.6	1.8	0.0	15.9	0.0	2.1	6.8	994.8	1.7	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.1	0.5	0.0	0.0	3.4	0.8	0.0	0.0	0.0
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 580.8;Fibroblasts: 1360.5;Leydig cells: 1030.8;Peritubular cells: 1495.9;Sertoli cells: 1170.1;Smooth muscle cells: 420.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 145.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 31.6;non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1163.6;BJ: 476.9;BJ hTERT+: 683.3;fHDF/TERT166: 1045.9;hTERT-RPE1: 468.5;U-87 MG: 631.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 120.2"	"HPA008005, HPA075088"	Uncertain				"Secreted to blood"	NA	NA	199000000	300000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA008005: AB_1851499, HPA075088: "	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	145.8	90.2	28.1	9.2	32.6	0.4	150.5	31.8	40.8	276.6	71.6	75.5	20.8	117.2	129.5	75.8	237.4	36.8	107.0	28.4	33.1	30.6	7.7	40.4	8.7	32.7	29.2	136.8	15.9	4.8	106.3	15.7	33.2	129.3	28.0	6.6	35.9	122.2	38.5	39.2	52.5	39.0	36.7	45.2	67.6	22.2	41.7	6.8	58.4	102.2	9.2	127.1	214.1	27.2	135.3	219.6	0.2	177.3	313.9	1163.6	0.8	476.9	683.3	126.9	69.0	23.2	294.7	0.0	68.5	1045.9	96.4	453.3	3.0	42.3	26.2	1.2	2.8	4.4	37.1	33.3	111.9	0.8	1.1	325.5	2.3	57.4	11.9	468.5	30.5	7.5	0.6	9.3	53.1	0.5	6.6	1.0	6.8	4.1	150.4	2.3	4.9	5.6	10.1	3.3	1.3	8.7	152.2	0.0	10.9	4.0	6.3	0.5	132.2	87.2	41.2	95.5	18.0	5.3	10.7	0.6	631.6	6.7	49.5	0.0	0.0	31.6	0.6	6.8	3.4	0.1	1.0	5.4	2.1	0.0	0.5	6.8	0.0	0.0	20.1	0.0	0.0	1.5	28.1	32.6	31.8	40.8	28.4	33.1	32.7	29.2	33.2	36.7	41.7	27.2	83.9	6.4	4.2	2.0	3.4	113.6	41.0	580.8	23.9	2.5	5.9	29.0	21.1	10.0	37.6	20.2	0.0	3.0	3.5	0.2	11.7	87.9	9.6	4.9	99.2	71.9	0.0	3.2	3.1	8.0	4.9	1360.5	30.5	2.5	0.0	2.3	116.4	0.8	7.6	0.0	3.6	0.3	50.8	6.8	122.8	32.6	1030.8	15.2	144.1	19.7	2.5	51.1	0.0	1.5	0.9	77.1	0.0	1495.9	9.6	94.9	0.0	15.2	13.9	2.8	1170.1	102.3	420.9	3.8	6.8	8.0	87.8	3.4	14.1	0.4	0.0	34.1
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 11440.4;Peritubular cells: 11731.6;Sertoli cells: 8184.6;Smooth muscle cells: 4434.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 21.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 693.6;BJ hTERT+: 643.1;hTERT-RPE1: 1471.3;RPTEC TERT1: 682.7;TIME: 1009.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	190000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	833.0	374.9	99.4	151.1	124.0	44.2	583.2	112.7	149.7	640.3	1299.1	473.1	105.6	653.2	260.4	115.3	618.1	405.7	1117.2	132.7	143.8	1298.6	283.2	532.4	133.1	185.2	138.7	359.1	270.1	77.2	246.0	66.6	146.4	506.0	83.2	4.7	193.7	659.0	185.6	193.6	259.6	334.9	136.8	436.9	267.4	259.2	187.9	48.9	995.3	91.8	81.9	546.4	494.0	132.6	1.3	4.8	1.1	0.0	134.8	50.4	4.7	693.6	643.1	59.2	19.0	2.8	0.1	0.3	433.7	33.5	35.3	70.2	0.7	111.1	15.7	1.3	5.4	2.5	78.7	0.5	207.7	17.1	17.9	234.7	55.8	96.8	26.2	1471.3	138.2	0.6	0.5	0.9	142.8	0.0	0.5	74.5	5.9	0.0	1.3	13.4	0.4	2.8	682.7	0.0	1.0	1.8	130.2	9.5	0.0	276.3	1.8	64.6	1009.4	60.5	46.4	7.8	114.8	41.1	0.4	1.4	159.2	58.3	1.8	2.0	3.9	21.7	0.1	4.1	0.1	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.3	10.8	4.5	0.4	0.1	1.7	99.4	124.0	112.7	149.7	132.7	143.8	185.2	138.7	146.4	136.8	187.9	132.6	2254.8	112.2	20.2	164.9	16.2	238.5	127.2	300.5	24.5	5.9	27.7	53.5	148.2	20.0	90.6	2087.4	22.9	6.6	76.9	1.4	516.5	2455.3	75.9	1235.5	702.2	2740.1	1.2	82.7	0.7	15.1	8.3	1435.9	29.0	381.3	15.8	1205.0	3079.4	16.4	26.5	0.0	3.7	1.0	61.1	101.9	375.7	335.4	11440.4	70.4	944.5	151.8	41.8	17.1	345.0	11.6	0.8	84.6	1.5	11731.6	11.0	113.3	0.0	692.2	731.0	12.5	8184.6	155.0	4434.0	36.6	38.6	9.9	179.1	5.7	51.3	759.1	2.5	64.0
IGHA1		ENSG00000211895	"Immunoglobulin heavy constant alpha 1"	P01876	14	105703995-105708665	"Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 7411.2;lymphoid tissue: 6397.6;salivary gland: 8904.9;stomach 1: 6664.9"	"Group enriched"	"Detected in many"	10	"B-cells: 17763.5;Plasma cells: 34095.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	203	"memory B-cell: 2571.8;naive B-cell: 1114.6"	"Lineage enriched"	"Detected in many"	284	"B-cells: 2571.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.4;RPMI-8226: 34.7;SH-SY5Y: 22.3;U-266/70: 78.2;U-266/84: 24.0"									"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	NA	NA		130000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001217: AB_1079120, HPA006013: AB_1079119"	"prognostic favorable (8.87e-5)"	"unprognostic (5.36e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (3.81e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.83e-7)"	"unprognostic (8.10e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	200.6	41.7	1.4	1121.1	1.0	918.5	953.5	0.7	6.5	214.3	4.2	5973.6	7411.2	79.9	3.5	641.9	203.5	662.9	73.8	0.6	1.3	278.5	327.7	1305.3	1420.6	3.5	1.1	40.6	115.1	3.5	38.3	6.7	1.1	202.5	1338.5	0.0	8904.9	69.0	10.8	56.7	3788.8	69.5	1.4	6397.6	6664.9	23.2	1.0	131.0	447.3	0.4	1949.0	1616.2	302.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.8	0.0	0.0	3.6	0.0	0.0	0.0	17.4	0.0	3.7	0.0	0.0	0.0	5.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	4.1	14.4	5.5	0.0	0.0	3.8	4.3	34.7	0.0	0.0	9.7	22.3	2.6	0.0	0.0	0.0	0.0	1.6	5.1	0.0	3.9	4.2	3.2	78.2	24.0	2.2	0.0	2.4	0.0	3.8	3.0	0.6	1.3	0.3	1.0	2571.8	0.7	1.1	1.5	1114.6	0.4	1.0	9.0	0.9	0.9	1.7	1.0	508.3	1.4	1.0	0.7	6.5	0.6	1.3	3.5	1.1	1.1	1.4	1.0	1.9	11.8	131.4	783.5	0.0	17763.5	0.0	26.0	0.0	1.2	0.0	22.4	4.6	4.7	22.8	46.4	0.0	0.0	0.7	55.5	20.8	0.0	0.0	0.0	0.1	0.1	26.5	28.4	167.0	0.0	0.0	0.5	56.5	99.4	0.1	584.8	0.0	353.8	225.1	1.6	0.0	0.0	13.6	0.0	57.8	0.0	0.0	0.0	34.6	0.0	0.0	6.7	0.0	11.3	0.0	0.0	0.0	12.8	0.0	34095.8	33.2	0.0	1.4	16.0	0.0	0.0	2.0	13.6	0.0	0.0	0.8	0.0	6.0	2514.2	0.0	27.9	1.2
IGHD3-22	IGHD322	ENSG00000211911	"Immunoglobulin heavy diversity 3-22"		14	105886031-105886061	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.6;lymphoid tissue: 2.7;stomach 1: 3.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 48.9"	"Lineage enriched"	"Detected in many"	7	"B-cells: 48.9"	"Cell line enriched"	"Detected in single"	13	"SH-SY5Y: 1.3"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"												"unprognostic (4.12e-1)"						"unprognostic (1.53e-1)"				0.0	0.0	0.1	0.9	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.2	3.1	0.0	0.0	0.7	0.0	0.0	2.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	48.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHG1		ENSG00000211896	"Immunoglobulin heavy constant gamma 1 (G1m marker)"	P01857	14	105736343-105743071	"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11451.9;urinary bladder: 3998.0"	"Group enriched"	"Detected in many"	16	"B-cells: 3900.5;Plasma cells: 9883.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 12.7"	"Immune cell enriched"	"Detected in some"	6	"memory B-cell: 766.8"	"Lineage enriched"	"Detected in many"	123	"B-cells: 766.8"	"Group enriched"	"Detected in many"	9	"Karpas-707: 157.8;U-698: 392.7"									"HPA001245, CAB008642"	Supported				"Immunoglobulin genes"	NA	NA		230000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008642: AB_1617595, HPA001245: AB_1079121"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.49e-9)"	"unprognostic (3.12e-1)"	"unprognostic (3.52e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.61e-2)"	526.0	696.8	0.7	1661.1	0.6	681.1	203.2	0.5	4.5	518.2	2.8	302.1	103.7	210.6	18.4	334.4	661.5	312.9	143.2	0.4	2.2	491.7	356.1	962.4	3281.1	4.7	3.2	407.0	38.5	7.9	35.8	2.3	2.3	209.8	85.1	0.3	391.6	250.8	13.1	28.5	1008.8	27.6	12.7	11451.9	608.9	172.8	1.2	1773.7	1277.9	0.1	5826.8	3998.0	267.2	1.8	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.7	0.0	0.0	2.3	0.0	0.0	0.0	8.4	0.0	5.3	0.0	0.0	0.0	22.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	157.8	0.0	0.0	1.7	2.1	2.6	0.0	0.0	2.9	15.1	3.7	0.0	0.0	18.2	17.0	3.1	0.0	0.0	0.0	0.0	0.2	10.8	0.0	3.2	3.3	4.5	4.9	0.3	392.7	0.1	3.7	0.0	0.2	0.3	0.1	0.3	0.0	0.2	766.8	0.6	0.3	0.4	134.9	0.0	0.1	6.2	0.1	0.1	0.1	0.2	96.2	0.7	0.6	0.5	4.5	0.4	2.2	4.7	3.2	2.3	12.7	1.2	1.8	2.9	73.7	378.5	0.0	3900.5	0.0	8.1	0.0	0.0	0.0	0.5	0.0	2.8	22.8	9.3	0.0	0.0	0.0	0.4	7.0	0.0	0.0	0.5	0.0	0.1	8.5	13.9	83.4	0.0	0.0	0.0	13.6	8.2	0.0	209.4	0.0	46.1	52.9	0.1	0.0	0.0	5.0	0.0	62.8	0.0	0.9	0.0	9.7	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	5.4	0.0	9883.3	9.1	0.0	10.9	1.5	0.1	0.0	0.0	1.5	1.9	1.0	0.0	0.0	0.0	415.6	0.0	13.6	0.1
IGHG2		ENSG00000211893	"Immunoglobulin heavy constant gamma 2 (G2m marker)"	P01859	14	105639559-105644790	"FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 4319.4"	"Group enriched"	"Detected in some"	8	"B-cells: 2050.1;Plasma cells: 2918.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	447	"memory B-cell: 339.0;naive B-cell: 119.3"	"Lineage enriched"	"Detected in single"	661	"B-cells: 339.0"	"Group enriched"	"Detected in some"	4	"RH-30: 9.6;RPMI-8226: 25.1"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		250000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"prognostic favorable (3.53e-4)"	"unprognostic (6.88e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (3.30e-6)"	"unprognostic (1.06e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (4.72e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.40e-2)"	109.5	11.0	1.3	170.0	1.4	34.8	56.0	0.2	4.1	59.9	0.8	202.8	7.5	55.8	0.8	90.2	51.5	20.7	15.2	0.2	1.1	157.5	98.2	171.0	65.4	0.9	0.2	16.3	8.0	0.1	8.2	0.0	0.5	64.2	9.4	0.0	201.2	1.2	3.5	13.3	330.7	1.0	1.5	4319.4	87.2	2.3	0.3	16.7	134.4	0.0	226.0	100.4	104.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	25.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	339.0	0.5	0.0	0.3	119.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	34.5	1.3	1.4	0.2	4.1	0.2	1.1	0.9	0.2	0.5	1.5	0.3	1.8	0.2	54.5	305.3	0.0	2050.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	2.8	13.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	4.1	0.0	32.5	0.0	0.0	0.0	3.1	0.0	0.0	126.1	0.0	8.2	5.1	0.1	0.0	0.0	0.9	0.0	12.4	0.0	0.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2918.6	0.7	0.0	3.5	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.1	305.5	0.0	0.7	0.0
IGHG3		ENSG00000211897	"Immunoglobulin heavy constant gamma 3 (G3m marker)"		14	105764503-105771405	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 1289.1"	"Group enriched"	"Detected in many"	7	"B-cells: 2548.4;Plasma cells: 4543.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	415	"memory B-cell: 211.0;naive B-cell: 64.4"	"Lineage enriched"	"Detected in single"	636	"B-cells: 211.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 23.8;Karpas-707: 18.7;U-698: 49.1"														"Immunoglobulin genes"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (8.49e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.92e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.46e-11)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.80e-2)"	"unprognostic (6.79e-2)"	63.6	17.6	0.1	90.8	0.3	65.4	23.8	0.1	1.5	37.9	1.0	30.0	11.6	22.8	0.3	32.2	104.4	8.4	6.7	0.1	0.6	72.8	42.4	194.9	346.3	2.8	0.1	13.4	6.3	0.1	6.8	0.1	0.4	41.4	8.8	0.0	69.9	12.7	1.9	2.3	100.9	1.6	1.2	1289.1	65.4	31.7	0.1	27.1	87.6	0.0	929.0	87.3	29.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.0	3.9	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	49.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	211.0	0.0	0.0	0.0	64.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.7	0.1	0.3	0.1	1.5	0.1	0.6	2.8	0.1	0.4	1.2	0.1	1.0	1.9	57.7	363.7	0.0	2548.4	0.0	9.7	0.0	0.0	0.0	0.5	0.1	1.9	18.6	11.2	0.0	0.0	0.0	2.0	7.0	0.0	0.0	6.5	0.1	0.2	5.3	13.2	24.5	0.0	0.0	0.0	9.1	2.6	0.0	195.5	0.0	22.9	64.2	0.1	0.0	0.0	7.4	0.0	62.8	0.0	16.4	0.0	7.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.0	4543.8	13.3	0.0	0.5	2.2	0.0	0.0	0.0	0.7	4.7	0.7	0.0	0.0	0.0	467.3	0.0	13.5	0.1
IGHG4		ENSG00000211892	"Immunoglobulin heavy constant gamma 4 (G4m marker)"	P01861	14	105620506-105626066	"FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 2478.2"	"Group enriched"	"Detected in some"	10	"B-cells: 964.5;Plasma cells: 2099.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	457	"memory B-cell: 122.7;naive B-cell: 73.7"	"Lineage enriched"	"Detected in single"	571	"B-cells: 122.7"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 339.7"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		170000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"unprognostic (7.29e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (4.58e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (9.09e-8)"	"unprognostic (2.84e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.72e-2)"	80.0	2.1	0.4	2478.2	0.6	42.2	5.8	0.5	1.0	33.9	0.3	40.6	85.5	10.8	0.2	401.2	28.5	101.3	19.2	0.3	0.4	44.0	43.7	49.4	136.5	0.6	0.4	3.9	4.2	0.5	1.9	0.2	1.3	31.2	44.3	0.1	16.4	4.1	0.8	4.7	186.2	1.8	1.1	831.6	57.4	2.2	0.4	49.9	108.3	0.0	872.5	588.7	29.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	43.2	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.6	339.7	0.0	0.0	3.5	3.7	0.3	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.3	1.5	0.6	0.1	57.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	122.7	0.0	0.0	0.1	73.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.6	0.4	0.6	0.5	1.0	0.3	0.4	0.6	0.4	1.3	1.1	0.4	0.3	1.3	6.4	118.8	0.0	964.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.0	8.6	3.7	0.0	0.0	0.0	0.3	11.5	0.0	0.0	0.2	0.0	0.4	2.5	27.8	26.7	0.0	0.0	0.0	4.3	0.0	0.0	50.4	0.0	16.4	36.7	0.0	0.0	0.0	10.5	0.0	51.9	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	0.0	2099.3	0.2	0.0	10.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	152.3	0.0	12.8	0.1
IGHJ3		ENSG00000242887	"Immunoglobulin heavy joining 3"		14	105864587-105864635	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"esophagus: 36.4;intestine: 57.9;pancreas: 61.6"	"Cell type enriched"	"Detected in single"	48	"Plasma cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basophil: 9.0;naive B-cell: 29.1"	"Group enriched"	"Detected in many"	7	"B-cells: 29.1;granulocytes: 9.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;RPMI-8226: 6.1;TIME: 8.0;U-251 MG: 2.6"															NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (8.67e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-2)"		"prognostic favorable (3.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.30e-1)"	16.2	3.0	0.6	0.0	0.9	0.0	0.0	0.2	2.5	1.9	0.5	0.0	0.0	0.0	0.0	36.4	0.7	9.1	0.0	0.6	0.9	0.9	10.2	17.3	0.0	1.5	0.4	11.3	61.6	0.0	0.0	0.0	1.7	7.5	57.9	0.1	0.0	4.3	0.0	2.4	0.0	0.0	1.4	0.0	0.0	0.3	0.7	0.0	2.4	0.0	0.0	5.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.2	0.0	0.9	0.0	0.7	1.1	2.6	29.1	1.5	1.2	0.0	0.4	0.7	0.0	1.2	0.0	0.6	0.9	0.2	2.5	0.6	0.9	1.5	0.4	1.7	1.4	0.7	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGHJ6		ENSG00000211900	"Immunoglobulin heavy joining 6"		14	105863198-105863258	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"cervix: 142.4;intestine: 38.6;lung: 47.0;testis: 151.4;urinary bladder: 113.5"	"Cell type enriched"	"Detected in single"	56	"Plasma cells: 39.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory B-cell: 316.2;naive B-cell: 112.7"	"Lineage enriched"	"Detected in many"	21	"B-cells: 316.2"	"Cell line enhanced"	"Detected in some"		"U-266/84: 1.3;U-937: 1.2"															NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"																					0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.1	0.9	142.4	0.0	2.6	38.6	1.0	0.0	0.0	2.1	0.5	0.9	0.3	0.0	3.0	2.4	47.0	0.4	0.4	0.1	0.0	0.0	3.7	0.0	0.0	0.3	3.6	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	151.4	0.3	0.0	0.7	0.0	10.7	113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	0.0	3.5	3.5	0.8	0.3	0.0	0.2	316.2	0.5	0.6	0.5	112.7	0.6	0.3	14.8	0.2	1.0	0.0	0.1	89.2	0.0	0.0	0.1	0.9	0.3	0.0	0.4	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV1-18		ENSG00000211945	"Immunoglobulin heavy variable 1-18"	A0A0C4DH31	14	106184901-106185394	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 223.2;lymphoid tissue: 486.7;salivary gland: 234.3"	"Cell type enriched"	"Detected in some"	259	"Plasma cells: 13773.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	21	"memory B-cell: 73.2"	"Lineage enriched"	"Detected in many"	21	"B-cells: 73.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HL-60: 3.0;RPMI-8226: 2.9;TIME: 1.6"														"Immunoglobulin genes"	NA	NA		4700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.47e-4)"	"unprognostic (2.53e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.56e-2)"	"unprognostic (9.67e-3)"	"prognostic favorable (8.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.84e-7)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.44e-2)"	22.0	3.5	0.0	0.0	0.3	0.0	22.9	0.0	0.6	54.6	0.0	223.2	0.0	8.9	4.5	162.5	24.3	7.7	2.3	0.0	0.0	16.2	14.3	58.3	0.0	0.6	0.1	8.5	3.2	1.9	1.3	0.2	0.4	10.8	0.0	0.0	234.3	0.0	0.4	1.3	103.2	2.6	0.0	486.7	84.0	0.5	0.1	0.0	33.9	0.2	0.0	156.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.6	0.5	0.8	0.0	0.0	1.1	1.2	2.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.4	1.0	0.5	0.0	0.3	0.0	1.4	0.0	3.4	0.0	0.1	0.0	0.0	0.1	73.2	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	53.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13773.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	3.2	0.0	0.1	0.0
IGHV1-24		ENSG00000211950	"Immunoglobulin heavy variable 1-24"	A0A0C4DH33	14	106276548-106277043	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 186.8;salivary gland: 76.3"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 231.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HL-60: 1.8;JURKAT: 1.3;RH-30: 1.4"														"Immunoglobulin genes"	NA	NA		3100000000	"Cluster 24: B-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (9.01e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.93e-3)"		"prognostic favorable (3.61e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.07e-7)"	"unprognostic (5.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.78e-2)"	6.8	1.4	0.1	33.7	0.0	0.0	8.5	0.0	0.3	56.3	0.1	30.5	0.0	5.7	0.0	46.2	6.5	4.6	1.8	0.0	0.1	7.0	6.4	17.7	0.0	1.2	0.1	19.6	1.4	0.1	0.4	0.3	0.0	3.1	14.0	0.0	76.3	0.0	0.1	0.8	24.0	2.1	0.0	186.8	37.0	14.2	0.0	0.4	14.5	0.0	18.4	63.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.8	0.1	0.0	0.0	2.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	3.6	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	19.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	231.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	5.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0
IGHV1-46		ENSG00000211962	"Immunoglobulin heavy variable 1-46"	P01743	14	106511117-106511856	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 67.9;lymphoid tissue: 125.7;salivary gland: 67.4"	"Cell type enriched"	"Detected in some"	201	"Plasma cells: 8432.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;RPMI-8226: 1.2;SH-SY5Y: 1.2;TIME: 2.3;U-266/70: 1.1;U-266/84: 1.2"														"Immunoglobulin genes"	NA	NA		2900000000	"Cluster 24: B-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.28e-4)"	"unprognostic (2.49e-2)"	"prognostic favorable (7.34e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-1)"	"prognostic unfavorable (1.56e-6)"	"unprognostic (6.19e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.13e-1)"	5.1	1.3	0.0	0.0	0.0	0.0	7.2	0.0	0.1	6.2	0.0	67.9	0.0	2.5	1.0	4.9	3.5	0.7	5.0	0.0	0.0	3.2	4.2	15.3	0.0	0.1	0.0	3.0	5.3	0.1	0.3	0.3	0.1	1.9	45.1	0.0	67.4	0.0	0.1	0.7	34.2	0.0	0.0	125.7	25.1	0.2	0.0	0.0	10.5	0.2	0.0	5.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.0	0.5	1.2	0.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.1	1.1	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.0	1.9	41.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8432.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
IGHV1-58		ENSG00000211968	"Immunoglobulin heavy variable 1-58"	A0A0C4DH39	14	106622357-106622855	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"urinary bladder: 204.7"	"Group enriched"	"Detected in some"	17	"B-cells: 2.4;Plasma cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 8.7;naive B-cell: 12.7"	"Lineage enriched"	"Detected in single"	58	"B-cells: 12.7"	"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.5"														"Immunoglobulin genes"	NA	NA		120000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (9.63e-3)"	"unprognostic (6.78e-2)"	"unprognostic (5.64e-2)"	"unprognostic (4.04e-2)"		"prognostic favorable (7.25e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (8.28e-5)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.36e-1)"	8.1	3.4	0.0	13.8	0.0	5.9	3.8	0.0	0.0	0.8	0.0	19.5	15.7	0.4	0.0	8.3	1.1	4.7	1.0	0.0	0.0	1.5	1.4	5.4	41.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	27.8	0.0	23.5	1.9	0.0	0.2	9.8	0.1	0.0	26.2	13.1	0.5	0.0	10.3	1.1	0.0	51.1	204.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV1-69	IGHV1-E	ENSG00000211973	"Immunoglobulin heavy variable 1-69"	P01742	14	106714684-106715181	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 139.1;lymphoid tissue: 170.2;urinary bladder: 162.6"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 231.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"medulla oblongata: 2.5;pons: 3.0"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HMC-1: 1.0;MOLT-4: 6.2;SCLC-21H: 1.1;U-698: 1.9"														"Immunoglobulin genes"	NA	NA		2700000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (3.51e-3)"	"unprognostic (7.03e-2)"	"prognostic favorable (9.56e-5)"	"prognostic favorable (8.32e-4)"		"unprognostic (1.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.95e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.82e-2)"	7.7	1.4	0.0	0.0	0.1	0.1	6.5	0.0	0.0	21.4	0.1	56.9	0.0	6.9	0.0	7.0	5.7	77.4	0.7	0.0	0.1	7.0	4.8	18.0	0.0	2.5	0.0	2.0	0.8	1.8	0.5	0.0	3.0	4.6	139.1	0.0	55.9	13.0	0.1	0.5	31.7	6.8	0.0	170.2	31.0	0.1	0.0	0.0	25.2	0.0	0.0	162.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.0	0.0	1.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	231.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0
IGHV1-69-2	IGHV1-F	ENSG00000281990	"Immunoglobulin heavy variable 1-69-2"	A0A0G2JMI3	14	106737110-106737547	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.1;lymphoid tissue: 47.1"	"Cell type enriched"	"Detected in some"	226	"Plasma cells: 10423.1"					"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.7;naive B-cell: 5.5"	"Lineage enriched"	"Detected in many"	6	"B-cells: 6.7"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 11.2"														"Immunoglobulin genes"	NA	NA		1100000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"																					6.3	0.3	0.0	5.8	0.0	2.5	3.6	0.0	0.0	1.5	0.0	12.0	22.1	1.1	0.2	2.1	1.2	14.5	1.6	0.0	0.0	2.7	0.9	4.5	13.5	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.5	14.4	0.0	16.4	0.9	0.0	0.0	18.0	0.2	0.0	47.1	9.9	0.2	0.0	3.7	1.1	0.0	36.5	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	6.7	0.5	0.9	0.0	5.5	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	1.4	23.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10423.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
IGHV1-69D		ENSG00000280411	"Immunoglobulin heavy variable 1-69D"	A0A0B4J2H0	14	106762092-106762588	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 2878.6;stomach 1: 989.1"	"Group enriched"	"Detected in some"	6	"Plasma cells: 5.8;T-cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	225	"memory B-cell: 184.5;naive B-cell: 433.4"	"Lineage enriched"	"Detected in many"	316	"B-cells: 433.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HL-60: 2.3;MOLT-4: 4.2;RPMI-8226: 2.5;U-266/70: 3.3;U-698: 7.9"														"Immunoglobulin genes"	NA	NA		1200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (3.32e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.49e-4)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.72e-8)"	"unprognostic (5.14e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.08e-2)"	26.1	95.3	0.1	462.7	0.1	113.1	146.7	0.0	0.7	37.5	1.0	628.2	491.2	15.0	16.8	98.6	16.0	78.0	20.2	0.0	0.1	17.5	46.6	149.6	2878.6	1.1	0.0	35.9	3.3	0.6	1.1	0.4	0.1	16.5	406.2	0.0	385.0	100.0	0.5	5.2	121.3	43.8	0.2	452.7	989.1	6.8	0.0	135.7	38.3	0.0	2219.2	295.4	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.2	0.3	1.3	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.6	0.4	3.3	0.1	7.9	0.0	0.7	0.0	0.8	0.3	0.1	0.0	0.0	0.2	184.5	0.3	0.0	0.2	433.4	0.4	0.1	0.4	0.2	0.4	1.3	0.2	33.5	0.1	0.1	0.0	0.7	0.0	0.1	1.1	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
IGHV2-26		ENSG00000211951	"Immunoglobulin heavy variable 2-26"	A0A0B4J1V2	14	106301396-106301862	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 128.8;lymphoid tissue: 98.5;urinary bladder: 227.1"	"Group enriched"	"Detected in some"	39	"B-cells: 8.3;Plasma cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	14	"memory B-cell: 13.9"	"Lineage enriched"	"Detected in single"	140	"B-cells: 13.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.3;RH-30: 1.4"														"Immunoglobulin genes"	NA	NA		190000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 57: B-cells - Immune response"				"unprognostic (9.39e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.94e-2)"		"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (6.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.09e-2)"	6.2	7.7	0.0	59.0	0.0	21.6	14.0	0.0	0.3	15.5	0.2	35.0	61.5	4.2	0.0	31.5	3.8	128.8	5.6	0.0	0.4	2.3	6.0	20.7	3.5	0.2	0.6	0.5	1.6	0.0	0.3	0.0	0.1	6.3	86.5	0.0	44.2	0.9	0.1	0.5	55.1	4.4	0.2	98.5	65.1	0.0	1.1	0.0	6.8	0.0	21.8	227.1	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.6	0.1	0.2	1.1	0.2	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGHV2-5		ENSG00000211937	"Immunoglobulin heavy variable 2-5"	P01817	14	106037902-106038365	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 465.8;lymphoid tissue: 1426.6;stomach 1: 707.9"	"Cell type enriched"	"Detected in some"	333	"Plasma cells: 9414.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"memory B-cell: 66.7;naive B-cell: 67.3"	"Lineage enriched"	"Detected in many"	22	"B-cells: 67.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.8"														"Immunoglobulin genes"	NA	NA		700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.38e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.62e-3)"		"prognostic favorable (1.41e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.56e-1)"	16.9	5.0	0.0	183.0	0.2	112.8	106.0	0.0	0.5	45.0	0.2	465.8	266.6	7.5	2.5	27.9	10.7	65.0	5.8	0.0	0.1	20.9	16.4	83.9	188.0	0.5	0.2	13.8	9.3	1.0	1.1	0.3	0.7	9.4	296.3	0.0	201.4	8.8	0.4	2.9	177.0	17.4	0.3	351.0	707.9	2.3	0.0	121.5	27.6	0.0	1426.6	249.3	12.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.6	0.4	0.0	0.1	1.2	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.4	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	66.7	0.0	0.0	0.1	67.3	0.1	0.1	3.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.0	0.5	0.0	0.1	0.5	0.2	0.7	0.3	0.0	0.4	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	27.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9414.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0
IGHV2-70D		ENSG00000211974	"Immunoglobulin heavy variable 2-70D"	A0A0C4DH43	14	106723574-106724093	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.8;lymphoid tissue: 90.8;stomach 1: 47.0"	"Cell type enriched"	"Detected in single"	10	"B-cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	68	"memory B-cell: 9.7;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	97	"B-cells: 9.7"	"Cell line enriched"	"Detected in single"	7	"MOLT-4: 1.7"														"Immunoglobulin genes"	NA	NA		110000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (5.57e-2)"	"unprognostic (9.48e-3)"	"prognostic favorable (3.34e-4)"	"unprognostic (4.34e-2)"		"unprognostic (8.37e-3)"		"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (6.70e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.11e-2)"	1.7	0.7	0.0	16.6	0.0	4.1	7.1	0.0	0.0	5.6	0.1	36.8	14.2	1.9	0.0	5.2	4.5	20.9	1.7	0.0	0.0	2.5	2.3	6.2	4.6	0.0	0.0	0.8	0.3	0.1	0.1	0.0	0.0	0.7	33.1	0.0	30.3	0.1	0.0	0.1	21.7	0.6	0.0	41.4	47.0	0.0	0.0	4.5	2.5	0.0	90.8	3.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-11		ENSG00000211941	"Immunoglobulin heavy variable 3-11"	P01762	14	106116635-106117204	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 220.1;lymphoid tissue: 613.1;stomach 1: 206.7"	"Cell type enriched"	"Detected in some"	142	"Plasma cells: 1655.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	445	"memory B-cell: 43.1;naive B-cell: 45.7"	"Lineage enriched"	"Detected in single"	458	"B-cells: 45.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;SH-SY5Y: 1.2"														"Immunoglobulin genes"	NA	NA		18000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (2.07e-3)"	"unprognostic (4.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (3.42e-5)"	"unprognostic (4.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.30e-1)"	9.3	25.9	0.0	175.0	0.0	38.0	66.0	0.0	0.5	34.7	0.2	220.1	193.4	6.8	12.3	38.6	6.6	43.7	8.6	0.0	0.0	6.8	10.5	29.1	123.7	0.8	0.0	7.8	2.0	0.2	0.8	0.0	0.1	4.0	167.9	0.0	119.7	3.7	0.3	0.7	116.8	11.2	0.1	219.2	206.7	1.3	0.4	44.9	17.0	0.0	613.1	109.4	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1655.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
IGHV3-20		ENSG00000211946	"Immunoglobulin heavy variable 3-20"	A0A0C4DH32	14	106210936-106211453	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.2;lymphoid tissue: 216.6;stomach 1: 122.5;urinary bladder: 81.9"	"Cell type enriched"	"Detected in some"	24	"Plasma cells: 142.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	242	"memory B-cell: 28.5;naive B-cell: 19.8"	"Lineage enriched"	"Detected in single"	286	"B-cells: 28.5"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.2"														"Immunoglobulin genes"	NA	NA		2200000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.45e-2)"		"prognostic favorable (2.93e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	2.8	2.1	0.0	36.3	0.2	22.6	23.7	0.0	0.1	17.4	0.2	64.8	99.2	1.8	0.0	10.1	2.2	20.7	3.1	0.0	0.0	1.5	4.7	10.5	58.0	0.1	0.0	2.7	0.4	0.1	0.2	0.0	0.0	1.2	62.5	0.0	43.1	1.4	0.0	0.3	37.7	2.0	0.0	59.6	122.5	1.1	0.0	16.6	2.8	0.0	216.6	81.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	142.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
IGHV3-21		ENSG00000211947	"Immunoglobulin heavy variable 3-21"	A0A0B4J1V1	14	106235064-106235594	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 209.7;lymphoid tissue: 398.1;salivary gland: 213.2"	"Cell type enriched"	"Detected in some"	86	"Plasma cells: 3885.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.1;NB-4: 2.1;NTERA-2: 1.2;RH-30: 2.3;TIME: 1.9"														"Immunoglobulin genes"	NA	NA		37000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.30e-4)"	"unprognostic (1.21e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.51e-2)"	"unprognostic (9.16e-3)"	"prognostic favorable (9.34e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-1)"	"prognostic unfavorable (9.31e-8)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-1)"	18.1	2.7	0.3	0.0	0.3	0.0	24.8	0.2	1.1	16.8	0.3	209.7	0.0	7.1	0.9	17.4	30.9	0.0	2.0	0.2	0.3	15.4	10.7	55.3	0.0	0.4	0.3	2.9	16.2	2.3	1.3	0.6	0.4	7.2	0.0	0.0	213.2	0.3	0.4	4.3	111.3	0.8	0.4	398.1	83.0	0.4	0.3	0.0	25.6	0.0	0.0	27.7	10.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.1	1.2	0.0	0.0	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.2	1.1	0.2	0.3	0.4	0.3	0.4	0.4	0.3	1.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.0	21.4	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3885.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGHV3-23		ENSG00000211949	"Immunoglobulin heavy variable 3-23"	P01764	14	106268606-106269140	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1683.1;lymphoid tissue: 2989.8"	"Cell type enriched"	"Detected in some"	139	"Plasma cells: 15979.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	406	"memory B-cell: 548.5;naive B-cell: 336.7"	"Lineage enriched"	"Detected in many"	503	"B-cells: 548.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;HL-60: 3.3;NB-4: 4.1;RH-30: 3.0;RPMI-8226: 9.0;SH-SY5Y: 5.8"														"Immunoglobulin genes"	NA	NA		42000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.34e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (3.26e-1)"	"unprognostic (4.79e-1)"	"unprognostic (7.26e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.79e-7)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.42e-2)"	66.5	189.3	0.4	912.2	0.4	185.5	343.1	0.1	2.1	80.1	1.5	1683.1	1640.8	37.0	9.8	342.6	30.1	231.2	46.4	0.1	0.3	27.3	56.4	248.7	859.5	0.8	0.1	42.6	31.0	1.5	2.7	0.9	0.4	35.3	1087.1	0.1	697.8	53.4	0.9	15.0	886.8	40.0	0.8	802.7	1058.8	35.0	0.2	197.5	52.3	0.1	2989.8	993.6	27.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	4.1	0.7	0.0	0.0	0.6	3.0	9.0	0.0	0.0	2.7	5.8	0.8	0.1	0.0	0.0	0.0	0.0	1.8	0.0	1.3	1.3	1.1	1.5	0.0	0.3	0.0	0.9	0.0	0.4	0.4	0.1	0.2	0.0	0.1	548.5	0.2	0.3	0.3	336.7	0.1	0.2	1.0	0.2	0.2	0.2	0.8	62.4	0.4	0.4	0.1	2.1	0.1	0.3	0.8	0.1	0.4	0.8	0.2	1.4	0.1	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	12.0	0.0	0.0	0.0	1.6	19.4	0.0	1.3	0.0	1.8	2.0	0.2	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15979.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.1	0.0
IGHV3-30		ENSG00000270550	"Immunoglobulin heavy variable 3-30"	"P01768, P0DP03"	14	106335082-106335613	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 534.0;lymphoid tissue: 1294.8;salivary gland: 459.9;stomach 1: 572.6;urinary bladder: 378.9"	"Cell type enriched"	"Detected in some"	184	"Plasma cells: 14426.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	409	"memory B-cell: 164.0;naive B-cell: 136.6"	"Lineage enriched"	"Detected in single"	446	"B-cells: 164.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Daudi: 1.7;NB-4: 2.3;RPMI-8226: 1.7;SCLC-21H: 1.7;SH-SY5Y: 3.0;U-266/70: 1.3"														"Immunoglobulin genes"	NA	NA		8500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (2.12e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.72e-2)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.96e-2)"	25.3	38.5	0.1	320.5	0.2	119.7	143.9	0.0	0.4	49.3	0.5	534.0	265.5	13.3	0.0	134.6	44.8	146.5	30.3	0.4	0.2	29.2	25.1	128.2	374.9	0.6	0.2	23.0	12.3	0.7	3.3	0.7	0.2	18.6	254.9	0.0	459.9	20.4	0.9	3.5	296.1	23.6	0.1	797.4	572.6	5.9	0.1	158.2	76.6	0.1	1294.8	378.9	34.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	1.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	164.0	0.2	0.0	0.1	136.6	0.3	0.1	0.3	0.0	0.0	0.2	0.0	24.4	0.1	0.2	0.0	0.4	0.4	0.2	0.6	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	78.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	5.4	16.3	0.0	1.3	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14426.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.4	0.0
IGHV3-33		ENSG00000211955	"Immunoglobulin heavy variable 3-33"	P01772	14	106359793-106360324	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1066.7;lymphoid tissue: 2371.2;stomach 1: 1778.8"	"Cell type enriched"	"Detected in some"	26	"Plasma cells: 556.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 4.0"	"Group enriched"	"Detected in many"	101	"memory B-cell: 378.9;naive B-cell: 364.1"	"Lineage enriched"	"Detected in many"	103	"B-cells: 378.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.4;HL-60: 5.3;RPMI-8226: 7.7;SH-SY5Y: 3.8;U-266/70: 8.1"														"Immunoglobulin genes"	NA	NA		7500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.04e-3)"	"unprognostic (2.38e-2)"	"unprognostic (8.95e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (6.84e-2)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.18e-1)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (6.23e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.92e-2)"	27.9	67.4	1.0	513.8	0.8	117.8	289.5	0.2	4.0	53.6	2.4	1066.7	882.1	16.2	14.5	127.5	18.9	141.9	32.9	0.2	0.4	15.7	41.8	210.1	795.2	1.4	0.2	110.0	29.4	1.9	1.7	0.8	0.4	23.2	775.6	0.0	619.6	39.5	0.5	3.6	343.9	37.3	0.5	476.1	1778.8	29.4	0.7	296.8	42.2	0.1	2371.2	379.8	18.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	5.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.1	0.8	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.8	2.9	7.7	0.0	0.0	1.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.7	8.1	0.0	0.2	0.0	0.8	0.0	0.2	0.6	0.1	1.1	0.0	1.9	378.9	3.6	0.9	0.3	364.1	1.4	0.6	1.0	0.2	0.1	0.2	0.5	44.6	1.0	0.8	0.2	4.0	0.2	0.4	1.4	0.2	0.4	0.5	0.7	0.7	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.0	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	556.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGHV3-35		ENSG00000211957	"Immunoglobulin heavy variable 3-35 (non-functional)"	A0A0C4DH35	14	106389392-106389858	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 14.1;lymphoid tissue: 12.8;salivary gland: 7.6;stomach 1: 16.7;urinary bladder: 20.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"memory B-cell: 3.7"	"Lineage enriched"	"Detected in single"	35	"B-cells: 3.7"	"Cell line enriched"	"Detected in single"	6	"MOLT-4: 1.3"														"Immunoglobulin genes"	NA	NA		19000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.39e-3)"	"unprognostic (9.98e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.60e-2)"		"prognostic favorable (2.53e-4)"		"unprognostic (1.06e-1)"	"unprognostic (4.74e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.21e-1)"	"unprognostic (4.29e-6)"	"unprognostic (4.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	0.1	0.1	0.0	12.8	0.0	3.3	1.1	0.0	0.0	2.8	0.0	10.3	14.1	0.4	0.0	0.5	1.1	1.1	0.5	0.0	0.0	0.1	0.7	2.4	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	11.1	0.0	7.6	0.5	0.0	0.2	6.0	0.6	0.0	5.3	16.7	0.0	0.0	0.0	0.0	0.0	2.2	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-43		ENSG00000232216	"Immunoglobulin heavy variable 3-43"	A0A0B4J1X8	14	106470264-106470800	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 211.9;stomach 1: 312.2;urinary bladder: 153.0"	"Cell type enriched"	"Detected in some"	28	"Plasma cells: 557.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	321	"memory B-cell: 29.4;naive B-cell: 39.0"	"Lineage enriched"	"Detected in single"	366	"B-cells: 39.0"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.8;SH-SY5Y: 2.3"														"Immunoglobulin genes"	NA	NA		4000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.31e-4)"	"unprognostic (2.22e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.87e-3)"		"prognostic favorable (8.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.63e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-2)"	9.3	2.3	0.0	23.7	0.3	11.5	43.7	0.0	0.3	46.0	0.0	101.8	102.5	2.0	0.0	10.2	3.5	10.7	0.4	0.0	0.0	2.7	9.8	10.8	4.3	0.7	0.0	4.2	2.2	1.0	0.3	0.1	0.2	2.7	66.1	0.0	58.1	5.4	0.1	1.0	48.3	4.4	0.0	83.7	312.2	0.2	0.1	0.0	3.8	0.0	211.9	153.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	557.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0
IGHV3-48		ENSG00000211964	"Immunoglobulin heavy variable 3-48"	P01763	14	106537810-106538344	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 516.4;lymphoid tissue: 858.8;stomach 1: 404.9"	"Cell type enriched"	"Detected in some"	100	"Plasma cells: 5878.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	527	"memory B-cell: 187.1;naive B-cell: 97.5"	"Lineage enriched"	"Detected in single"	693	"B-cells: 187.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.6"														"Immunoglobulin genes"	NA	NA		49000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (9.19e-3)"	"unprognostic (1.87e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (4.88e-8)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	8.7	22.9	0.0	232.6	0.0	81.2	56.4	0.0	1.3	25.9	0.2	434.1	516.4	8.1	0.1	33.4	12.1	38.6	6.9	0.0	0.0	10.8	18.6	32.3	125.3	0.3	0.0	12.2	8.8	0.9	0.9	0.1	0.7	6.8	253.2	0.0	164.6	16.0	0.6	1.6	134.4	17.7	0.1	271.1	404.9	27.9	0.0	36.3	16.0	0.0	858.8	248.6	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.4	0.0	0.0	0.0	0.8	0.9	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	187.1	0.0	0.0	0.1	97.5	0.0	0.1	0.1	0.0	0.0	0.0	0.2	22.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.7	17.9	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5878.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
IGHV3-53		ENSG00000211967	"Immunoglobulin heavy variable 3-53"	P01767	14	106592676-106593347	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.5;lymphoid tissue: 129.5;stomach 1: 43.3"	"Cell type enriched"	"Detected in some"	22	"Plasma cells: 176.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	99	"memory B-cell: 54.7;naive B-cell: 52.7"	"Lineage enriched"	"Detected in single"	101	"B-cells: 54.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.41e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-3)"	"prognostic favorable (5.66e-4)"		"prognostic favorable (3.95e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.04e-5)"	"unprognostic (1.79e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.72e-1)"	2.9	0.8	0.0	37.1	0.0	7.9	15.5	0.0	0.1	4.7	0.0	66.5	81.5	1.0	0.3	4.1	1.9	6.7	1.4	0.0	0.0	1.8	2.8	7.7	38.5	0.1	0.0	3.2	1.3	0.1	0.1	0.0	0.0	1.1	74.0	0.0	32.2	1.9	0.0	0.3	33.9	2.3	0.0	66.9	43.3	1.6	0.0	8.2	4.6	0.0	129.5	10.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	54.7	0.0	0.0	0.0	52.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGHV3-66		ENSG00000211972	"Immunoglobulin heavy variable 3-66"	A0A0C4DH42	14	106675017-106675544	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 47.3;intestine: 59.5;urinary bladder: 103.9"	"Cell type enriched"	"Detected in some"	107	"Plasma cells: 958.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	137	"memory B-cell: 39.7"	"Lineage enriched"	"Detected in single"	137	"B-cells: 39.7"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;U-2 OS: 2.3"														"Immunoglobulin genes"	NA	NA		7200000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.43e-6)"	"unprognostic (2.48e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.31e-3)"		"unprognostic (2.20e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.19e-1)"	3.8	0.9	0.0	0.0	0.1	11.1	3.9	0.0	0.4	15.3	0.3	59.5	0.0	1.4	1.2	27.0	3.2	47.3	0.3	0.0	0.0	1.3	3.5	13.1	41.1	0.2	0.0	5.6	0.4	0.0	0.1	0.0	0.0	3.9	32.3	0.0	16.1	5.7	0.0	1.5	10.1	1.3	0.0	31.8	6.3	0.6	0.0	0.0	2.5	0.0	39.7	103.9	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	39.7	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	958.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGHV3-7		ENSG00000211938	"Immunoglobulin heavy variable 3-7"	P01780	14	106062151-106062683	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 461.3;lymphoid tissue: 971.3"	"Cell type enriched"	"Detected in some"	255	"Plasma cells: 20463.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 18.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	147	"memory B-cell: 134.0;naive B-cell: 107.0"	"Lineage enriched"	"Detected in single"	163	"B-cells: 134.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9"														"Immunoglobulin genes"	NA	NA		39000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.29e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.37e-2)"			"prognostic favorable (1.47e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.70e-2)"	47.8	10.1	0.7	50.1	1.0	71.1	202.7	0.3	0.8	87.4	0.6	461.3	154.1	37.7	8.2	17.8	13.4	37.0	2.2	0.2	0.4	17.6	20.3	56.4	102.5	1.6	2.8	24.7	4.8	2.9	1.8	0.3	2.3	9.2	303.5	0.0	265.5	22.9	1.3	9.6	206.0	3.6	3.9	610.4	230.4	13.2	0.4	0.0	21.1	0.1	971.3	42.9	14.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.4	2.6	5.8	0.0	0.0	2.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	1.2	1.6	0.0	0.1	0.0	0.6	0.0	0.4	0.8	0.2	0.1	0.0	0.2	134.0	0.2	0.2	0.3	107.0	0.1	0.1	0.1	0.1	0.2	0.6	0.2	12.6	0.7	1.0	0.3	0.8	0.2	0.4	1.6	2.8	2.3	3.9	0.4	1.3	0.0	0.0	0.0	0.0	80.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.5	0.0	5.3	0.0	0.0	0.0	4.4	31.1	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20463.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.5	0.0
IGHV3OR16-13	IGHV3/OR16-13	ENSG00000271178	"Immunoglobulin heavy variable 3/OR16-13 (non-functional)"		16	33827214-33827661	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 32.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"stomach cancer: 4.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	28	"memory B-cell: 18.1"	"Lineage enriched"	"Detected in single"	181	"B-cells: 18.1"	"Cell line enriched"	"Detected in some"	818	"Daudi: 1604.0"															NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (7.59e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.47e-2)"			"prognostic favorable (3.23e-5)"		"unprognostic (1.34e-1)"		"unprognostic (2.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.26e-5)"	"unprognostic (6.83e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.04e-1)"	0.2	0.0	0.1	5.3	0.0	0.6	0.4	0.0	0.1	1.3	0.0	6.7	6.0	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.2	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.0	7.0	0.0	0.0	0.0	4.0	0.1	0.0	32.2	4.2	0.0	0.0	1.0	0.3	0.0	10.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1604.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3OR16-8	IGHV3/OR16-8	ENSG00000271130	"Immunoglobulin heavy variable 3/OR16-8 (non-functional)"		16	33009175-33009620	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 32.0;lymphoid tissue: 49.4;stomach 1: 32.9;urinary bladder: 40.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"memory B-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"B-cells: 7.3"	"Not detected"	"Not detected"																	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"						"unprognostic (2.58e-4)"	"unprognostic (3.25e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.56e-1)"		"unprognostic (2.43e-4)"		"unprognostic (1.31e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"		"unprognostic (2.60e-7)"	"unprognostic (2.24e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-2)"	2.3	0.8	0.0	13.8	0.0	5.9	4.5	0.0	0.0	2.7	0.0	30.1	32.0	0.2	0.0	1.9	0.7	5.3	0.0	0.0	0.0	0.1	0.9	3.2	3.6	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	14.8	0.0	10.0	0.0	0.0	0.0	9.0	1.8	0.0	5.8	32.9	0.1	0.0	3.0	0.7	0.0	49.4	40.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV4-28		ENSG00000211952	"Immunoglobulin heavy variable 4-28"	A0A0C4DH34	14	106324254-106324760	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 44.8;lymphoid tissue: 87.4;salivary gland: 39.9;stomach 1: 30.7;urinary bladder: 122.6"	"Cell type enriched"	"Detected in some"	230	"Plasma cells: 346.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"spinal cord: 1.3"	"Group enriched"	"Detected in some"	206	"memory B-cell: 28.7;naive B-cell: 12.5"	"Lineage enriched"	"Detected in single"	288	"B-cells: 28.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		2500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (3.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.64e-3)"		"prognostic favorable (2.63e-4)"	"unprognostic (1.58e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-1)"	1.8	11.3	0.0	40.9	0.0	6.0	12.9	0.0	0.2	3.3	0.1	44.8	44.8	1.0	0.0	12.5	1.9	7.7	1.2	0.0	0.0	1.8	2.4	8.9	10.0	0.0	0.0	3.5	0.4	0.0	0.2	0.0	0.0	0.8	44.1	0.0	39.9	1.7	0.0	0.5	30.2	2.0	1.3	42.3	30.7	0.5	0.0	5.8	4.3	0.0	87.4	122.6	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGHV4-34		ENSG00000211956	"Immunoglobulin heavy variable 4-34"	P06331	14	106373663-106374145	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 283.3;urinary bladder: 278.5"	"Cell type enriched"	"Detected in some"	197	"Plasma cells: 15696.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	602	"U-698: 5353.4"														"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (5.34e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.34e-3)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.77e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.61e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.51e-2)"	7.9	3.0	0.0	0.0	0.3	0.0	9.8	0.1	1.5	12.0	0.1	83.5	0.0	5.5	0.9	7.3	22.5	0.0	2.3	0.0	0.2	7.2	7.0	33.4	0.0	0.6	0.2	22.0	1.3	0.4	0.9	0.3	0.3	3.8	2.2	0.0	82.1	0.0	0.3	2.8	54.2	0.3	0.1	283.3	48.0	0.3	0.1	0.0	19.3	0.0	0.0	278.5	4.0	1.4	3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.5	2.6	3.2	0.0	0.0	1.4	0.0	4.1	0.0	0.3	0.0	0.6	3.7	0.0	0.1	8.8	0.4	1.8	0.0	0.8	5353.4	0.0	3.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.5	0.0	0.8	0.0	0.3	0.1	1.5	0.0	0.2	0.6	0.2	0.3	0.1	0.1	1.4	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15696.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0
IGHV4-59		ENSG00000224373	"Immunoglobulin heavy variable 4-59"	P01825	14	106627249-106627825	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 525.9;lymphoid tissue: 911.2;urinary bladder: 702.5"	"Cell type enriched"	"Detected in some"	301	"Plasma cells: 12374.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"spinal cord: 2.0"	"Group enriched"	"Detected in some"	37	"memory B-cell: 169.0;naive B-cell: 77.2"	"Lineage enriched"	"Detected in many"	51	"B-cells: 169.0"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.1;SCLC-21H: 2.0;SH-SY5Y: 4.2"														"Immunoglobulin genes"	NA	NA		5500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.62e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.25e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (9.18e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (6.04e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.76e-1)"	23.9	3.2	0.0	260.5	0.3	95.5	89.3	0.0	1.1	40.4	0.8	525.9	301.0	12.1	2.7	89.6	17.9	168.0	27.9	0.0	0.6	13.8	20.6	89.9	148.0	0.3	0.1	23.5	10.3	1.7	1.5	0.3	0.2	12.6	456.0	0.0	225.7	8.8	0.5	3.6	222.6	19.5	2.0	465.3	260.5	15.0	0.2	86.4	44.1	0.0	911.2	702.5	10.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	8.1	1.0	0.3	0.3	0.0	0.8	1.0	0.7	0.0	0.0	2.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.4	0.4	0.1	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	169.0	0.0	0.2	1.4	77.2	0.1	0.0	0.0	0.0	0.1	3.3	0.1	11.9	0.0	0.3	0.0	1.1	0.0	0.6	0.3	0.1	0.2	2.0	0.2	0.3	0.0	0.0	0.6	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.2	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12374.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.6	0.0	0.5	0.0
IGHV4-61		ENSG00000211970	"Immunoglobulin heavy variable 4-61"	A0A0C4DH41	14	106639119-106639657	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 206.7;lymphoid tissue: 385.2;stomach 1: 143.1"	"Cell type enriched"	"Detected in some"	98	"Plasma cells: 2432.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 25.5"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Cell line enriched"	"Detected in single"	11	"MOLT-4: 8.7"														"Immunoglobulin genes"	NA	NA		4400000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (2.11e-3)"	"unprognostic (6.59e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.12e-2)"		"prognostic favorable (3.71e-6)"	"unprognostic (6.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.72e-2)"	"unprognostic (9.95e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (3.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.32e-2)"	6.4	44.4	0.0	97.5	0.1	30.8	56.0	0.0	0.2	10.1	0.1	206.7	185.7	5.8	0.0	15.5	5.0	22.4	3.1	0.0	0.1	5.5	10.5	28.2	54.4	0.3	0.1	10.4	1.3	0.2	0.7	0.0	0.3	4.1	121.8	0.0	104.3	7.0	0.2	0.7	86.5	8.0	0.3	181.3	143.1	0.9	0.0	30.1	23.0	0.0	385.2	43.9	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.0	0.0	8.7	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	39.0	0.0	0.1	0.0	25.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	4.6	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2432.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
IGHV6-1		ENSG00000211933	"Immunoglobulin heavy variable 6-1"	A0A0B4J1U7	14	105939756-105940253	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 441.3;lymphoid tissue: 159.0"	"Cell type enriched"	"Detected in some"	175	"Plasma cells: 2295.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in single"	53	"B-cells: 19.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		930000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.35e-4)"	"unprognostic (9.66e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.26e-1)"		"prognostic favorable (1.85e-5)"		"unprognostic (1.84e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (3.69e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	13.0	2.1	0.3	0.0	0.1	0.0	7.5	0.0	0.4	4.2	0.2	441.3	0.0	1.2	0.0	17.9	4.3	1.5	2.7	0.0	0.1	3.2	6.2	13.6	0.0	0.3	0.1	0.9	11.5	0.0	0.3	0.0	0.1	1.6	0.0	0.0	56.7	8.6	0.1	2.0	40.9	11.2	0.3	159.0	19.5	0.3	0.2	0.0	6.8	0.0	0.0	3.7	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.1	19.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.1	0.3	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2295.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
IGKC	HCAK1	ENSG00000211592	"Immunoglobulin kappa constant"		2	88857161-88857683	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"intestine: 35196.7;lymphoid tissue: 63075.6"	"Group enriched"	"Detected in many"	12	"B-cells: 72318.1;Plasma cells: 96515.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	21	"memory B-cell: 39143.0;naive B-cell: 35081.5"	"Lineage enriched"	"Detected in all"	23	"B-cells: 39143.0"	"Group enriched"	"Detected in many"	6	"Daudi: 9909.1;U-266/70: 10337.6;U-266/84: 3927.9;U-698: 12154.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB015377	Uncertain				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB015377: AB_2251264"	"prognostic favorable (6.59e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.82e-3)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (2.17e-9)"	"unprognostic (1.85e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.59e-1)"	1025.4	2379.8	13.1	20500.0	13.3	6315.2	11287.7	11.3	33.6	3649.2	26.7	35196.7	24515.5	877.3	474.1	5708.4	1137.6	5995.3	810.4	11.4	16.7	1176.6	1580.5	5824.2	21356.1	25.1	18.2	2214.9	462.9	72.6	101.8	22.2	15.3	843.6	30618.3	4.0	19606.1	2123.2	32.9	250.8	17061.1	1259.7	43.5	26904.1	22740.5	1083.9	13.4	8576.0	2151.1	8.1	63075.6	24817.5	705.0	20.2	17.1	0.0	0.0	0.0	0.0	0.0	103.7	0.0	0.0	0.1	0.0	0.0	0.0	9909.1	15.3	0.0	1.0	22.2	0.0	0.0	0.0	510.2	0.0	30.9	0.0	0.0	0.0	67.8	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.8	0.4	0.0	0.0	18.3	83.2	28.8	0.0	0.0	16.7	56.4	1509.5	0.6	0.0	79.6	146.1	19.6	1.5	6.0	0.5	0.5	17.2	66.7	0.0	56.9	24.3	44.0	10337.6	3927.9	12154.4	0.0	28.9	0.0	47.5	55.6	31.6	24.6	11.2	21.7	39143.0	28.3	18.3	46.6	35081.5	15.2	16.8	65.2	24.1	29.1	1735.4	23.7	8567.0	13.1	13.3	11.3	33.6	11.4	16.7	25.1	18.2	15.3	43.5	13.4	20.2	58.6	336.5	1863.8	0.0	72318.1	0.0	189.2	0.0	2.2	0.0	8.8	7.0	5.7	163.0	88.5	0.0	0.0	48.0	452.1	39.8	3.9	0.0	2.8	0.7	0.3	72.8	77.8	1658.9	0.0	0.2	37.3	186.5	64.7	0.4	849.0	15.5	340.2	334.8	8.9	0.0	0.0	35.1	0.0	496.3	0.0	11.0	0.0	64.4	0.0	0.0	26.4	0.0	59.8	0.0	0.0	0.0	25.9	0.4	96515.7	193.2	0.3	45.2	12.4	0.0	0.0	3.7	38.4	0.3	0.2	5.9	0.0	49.4	6505.3	0.1	50.2	1.9
IGKJ1	J1	ENSG00000211597	"Immunoglobulin kappa joining 1"	A0A0A0MT89	2	88861886-88861923	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"intestine: 3082.3;lymphoid tissue: 3301.5;salivary gland: 1202.6;stomach 1: 2816.8;urinary bladder: 1106.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	418	"memory B-cell: 38345.4;naive B-cell: 32121.1;plasmacytoid DC: 14778.6"	"Group enriched"	"Detected in all"	390	"B-cells: 38345.4;dendritic cells: 14778.6"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 21925.7"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"																					70.6	227.2	1.9	3301.5	1.5	424.8	363.1	1.3	9.2	71.7	5.0	1960.8	3082.3	41.6	0.0	278.0	18.1	157.4	31.0	3.2	2.2	31.7	92.0	382.5	839.3	3.4	2.4	127.7	50.3	2.0	0.0	6.3	2.9	50.4	1743.7	0.2	1202.6	16.4	6.9	8.8	2231.5	61.2	3.4	1516.0	2816.8	31.2	2.1	115.3	6.2	0.0	2770.1	1106.5	0.0	2.9	22.9	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	7.4	0.0	9.9	2.5	0.0	0.0	14.6	0.0	0.0	0.0	851.1	0.0	10.1	0.0	0.0	0.0	34.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	10.3	12.1	11.8	0.0	0.0	23.1	0.0	4365.8	0.0	0.0	10.3	18.7	0.0	0.0	4.9	0.0	0.0	31.0	0.0	0.0	9.7	2.4	34.6	21925.7	5461.9	93.7	0.0	6.3	0.0	48.3	44.8	22.7	19.1	17.9	25.4	38345.4	27.2	13.8	57.2	32121.1	20.1	20.9	68.0	38.9	26.9	14778.6	29.9	3897.0	1.9	1.5	1.3	9.2	3.2	2.2	3.4	2.4	2.9	3.4	2.1	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ2	J2	ENSG00000211596	"Immunoglobulin kappa joining 2"		2	88861525-88861563	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 2670.6;lymphoid tissue: 2226.1;salivary gland: 1187.7;stomach 1: 1719.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	50	"memory B-cell: 22200.6;naive B-cell: 20663.6"	"Lineage enriched"	"Detected in all"	52	"B-cells: 22200.6"	"Group enriched"	"Detected in many"	7	"HDLM-2: 213.9;RPMI-8226: 179.1"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"																					67.9	154.0	0.6	1862.6	0.9	296.5	312.9	0.1	4.0	158.7	0.7	1762.7	2670.6	37.5	0.0	308.3	14.3	114.1	19.6	0.6	0.6	27.0	61.7	236.7	693.3	4.3	1.4	71.6	72.5	1.9	0.0	1.1	1.2	46.0	1364.3	0.0	1187.7	20.2	2.9	5.2	1974.3	28.2	1.5	1097.1	1719.7	44.8	0.9	73.5	5.1	0.0	2226.1	494.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	3.5	0.0	0.0	0.0	213.9	0.0	9.7	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	8.0	3.6	0.0	0.0	7.4	2.5	179.1	0.0	0.0	3.2	17.5	4.8	0.0	0.0	0.0	0.0	29.6	10.7	0.0	3.4	3.7	7.6	5.3	0.0	29.0	0.0	1.8	0.0	19.7	33.6	12.8	10.3	7.7	12.8	22200.6	15.0	8.1	23.3	20663.6	9.5	9.6	42.6	10.8	18.6	430.3	17.4	2451.2	0.6	0.9	0.1	4.0	0.6	0.6	4.3	1.4	1.2	1.5	0.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGKJ3		ENSG00000211595	"Immunoglobulin kappa joining 3"		2	88861221-88861258	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 1010.8;lymphoid tissue: 997.2;stomach 1: 710.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	12	"spinal cord: 18.3"	"Group enriched"	"Detected in all"	26	"memory B-cell: 8663.4;naive B-cell: 7153.9"	"Lineage enriched"	"Detected in all"	28	"B-cells: 8663.4"	"Group enriched"	"Detected in some"	6	"HDLM-2: 105.2;RPMI-8226: 89.2;U-698: 41.2"															NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"																						15.1	19.6	0.8	886.7	0.7	115.0	111.2	0.3	1.3	19.2	0.5	587.3	1010.8	7.6	0.0	68.8	7.9	44.8	9.3	0.9	0.6	14.3	41.1	101.9	490.2	1.2	0.5	31.1	0.0	0.0	0.0	1.9	1.5	18.2	546.6	0.6	362.3	12.6	8.7	2.5	726.3	19.9	18.3	548.6	710.1	9.7	0.9	53.9	5.1	3.9	997.2	236.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	105.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	89.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	0.0	0.0	41.2	0.0	0.0	0.0	17.0	8.6	57.9	1.9	1.1	9.2	8663.4	3.0	3.3	5.9	7153.9	5.7	5.1	61.8	7.1	15.2	309.9	7.8	660.0	0.8	0.7	0.3	1.3	0.9	0.6	1.2	0.5	1.5	18.3	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ4		ENSG00000211594	"Immunoglobulin kappa joining 4"		2	88860886-88860922	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 3282.9;lymphoid tissue: 2905.5;stomach 1: 2295.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	42	"memory B-cell: 36413.7;naive B-cell: 27723.7"	"Lineage enriched"	"Detected in all"	48	"B-cells: 36413.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.9;Daudi: 23.5;HDLM-2: 58.4;RPMI-8226: 43.3;SH-SY5Y: 27.6;U-698: 25.7"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"																						80.0	268.7	0.6	2905.5	0.7	407.6	414.6	0.3	4.1	110.0	0.5	1844.1	3282.9	29.5	62.5	433.0	33.3	138.1	34.8	0.6	1.1	48.2	104.6	481.3	932.6	2.9	0.7	117.5	29.3	1.7	0.0	1.3	1.3	56.4	1849.6	0.3	1142.3	54.8	3.9	17.3	2184.0	78.1	2.6	1246.0	2295.9	39.7	1.8	113.5	11.4	0.0	2661.5	645.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	9.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	2.0	10.4	0.0	0.0	0.0	0.0	9.1	43.3	0.0	0.0	6.7	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	7.3	8.5	3.3	0.0	25.7	0.0	0.0	0.0	114.4	64.9	20.3	24.9	9.5	16.8	36413.7	15.8	15.2	32.5	27723.7	22.7	16.1	60.0	21.5	25.4	759.9	22.8	3519.3	0.6	0.7	0.3	4.1	0.6	1.1	2.9	0.7	1.3	2.6	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ5		ENSG00000211593	"Immunoglobulin kappa joining 5"		2	88860568-88860605	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	4	"intestine: 1221.3;lymphoid tissue: 1365.8;salivary gland: 643.7;stomach 1: 1066.6;urinary bladder: 436.6"	"Cell type enriched"	"Detected in single"	13	"B-cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	24	"memory B-cell: 9254.1;naive B-cell: 8737.5"	"Lineage enriched"	"Detected in all"	25	"B-cells: 9254.1"	"Cell line enriched"	"Detected in some"	24	"U-698: 3392.4"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (4.92e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.30e-3)"		"prognostic favorable (1.83e-4)"		"unprognostic (1.12e-1)"			"unprognostic (3.22e-1)"		"prognostic unfavorable (5.49e-6)"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"		"unprognostic (2.02e-1)"	25.2	42.2	0.5	1365.8	0.7	164.5	236.5	0.6	4.5	73.7	0.3	1194.4	1221.3	13.4	5.8	130.7	8.8	78.5	26.1	0.9	0.7	18.0	30.8	157.6	529.7	1.6	0.6	63.3	29.2	6.6	0.0	4.1	1.2	22.8	1171.9	0.0	643.7	17.1	0.0	5.8	1078.7	40.6	4.9	672.7	1066.6	12.4	0.7	61.5	4.3	0.0	1213.5	436.6	0.0	0.9	17.7	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	142.3	0.0	0.0	0.0	0.0	0.0	7.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	58.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.3	3.5	11.4	3.2	1.9	3392.4	0.0	8.1	0.0	3.3	10.1	10.2	3.8	1.3	2.2	9254.1	18.4	3.5	7.4	8737.5	9.5	3.4	9.4	7.6	3.4	373.6	8.8	1167.3	0.5	0.7	0.6	4.5	0.9	0.7	1.6	0.6	1.2	4.9	0.7	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-12	"IGKV112, L19"	ENSG00000243290	"Immunoglobulin kappa variable 1-12"	A0A0C4DH73	2	89040224-89040745	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 395.8;lymphoid tissue: 788.8"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 12442.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	820	"memory B-cell: 259.8;naive B-cell: 164.2"	"Lineage enriched"	"Detected in single"	1005	"B-cells: 259.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		13000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (6.09e-4)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.74e-2)"		"prognostic favorable (3.85e-5)"		"unprognostic (5.89e-2)"	"unprognostic (5.74e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (6.59e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.71e-1)"	13.6	144.8	0.0	201.7	0.2	73.1	116.8	0.0	0.4	50.8	0.2	395.8	240.6	7.3	0.0	57.1	16.2	69.6	9.9	0.1	0.1	13.7	17.8	65.3	238.6	0.6	0.0	18.1	7.2	0.2	1.4	0.0	1.1	7.2	278.6	0.0	219.0	5.4	0.4	2.8	231.2	11.2	1.2	360.5	254.9	6.7	0.0	69.5	32.7	0.0	788.8	243.3	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	259.8	0.0	0.1	0.1	164.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	24.3	0.0	0.2	0.0	0.4	0.1	0.1	0.6	0.0	1.1	1.2	0.0	0.3	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12442.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.3	5.0	0.0	0.0	0.0
IGKV1-16	"IGKV116, L1"	ENSG00000240864	"Immunoglobulin kappa variable 1-16"	P04430	2	89099859-89100361	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 279.7;lymphoid tissue: 597.8;urinary bladder: 260.3"	"Cell type enriched"	"Detected in some"	559	"Plasma cells: 18463.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	523	"memory B-cell: 164.7;naive B-cell: 112.8"	"Lineage enriched"	"Detected in single"	621	"B-cells: 164.7"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		10000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.63e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.84e-2)"	"unprognostic (5.82e-2)"	11.8	4.7	0.1	159.1	0.1	40.0	75.9	0.0	0.8	76.0	0.6	279.7	199.4	6.3	0.5	34.3	6.6	99.0	11.4	0.0	0.1	9.2	14.9	40.5	155.0	0.2	0.0	17.7	2.0	0.1	3.6	0.1	0.1	5.6	235.6	0.0	126.9	30.9	0.8	0.7	143.6	11.8	0.1	315.4	158.9	2.0	0.1	45.7	18.4	0.0	597.8	260.3	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	164.7	0.0	0.0	0.1	112.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	16.9	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	21.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18463.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGKV1-17	"A30, IGKV117"	ENSG00000240382	"Immunoglobulin kappa variable 1-17"	P01599	2	89117342-89117844	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 375.0;lymphoid tissue: 454.4"	"Cell type enriched"	"Detected in some"	113	"Plasma cells: 4510.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	425	"memory B-cell: 105.7;naive B-cell: 82.2"	"Lineage enriched"	"Detected in single"	478	"B-cells: 105.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (7.72e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.08e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (3.12e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.28e-2)"	12.8	26.5	0.1	183.7	0.2	27.7	87.1	0.0	0.7	11.9	0.4	358.5	294.8	6.6	4.1	54.7	12.4	55.7	10.9	0.0	0.1	10.3	14.2	36.5	95.7	0.6	0.0	12.4	3.3	1.1	1.0	0.1	0.2	5.5	375.0	0.0	134.3	31.0	1.3	1.2	152.7	4.7	0.1	306.1	159.7	2.4	0.3	45.6	25.8	0.0	454.4	182.6	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.8	2.0	0.0	0.0	0.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	105.7	0.0	0.0	0.1	82.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	12.6	0.1	0.2	0.0	0.7	0.0	0.1	0.6	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4510.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0
IGKV1-33	"IGKV133, O18"	ENSG00000242076	"Immunoglobulin kappa variable 1-33"	P01594	2	89266494-89268506	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1727.5;stomach 1: 627.3;urinary bladder: 623.3"	"Cell type enriched"	"Detected in some"	131	"Plasma cells: 2044.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.5"	"Region enriched"	"Detected in many"	7	"spinal cord: 12.0"	"Group enriched"	"Detected in some"	378	"memory B-cell: 369.6;naive B-cell: 441.5"	"Lineage enriched"	"Detected in many"	411	"B-cells: 441.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (1.76e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.52e-2)"			"prognostic favorable (4.58e-5)"		"unprognostic (5.06e-2)"		"unprognostic (8.55e-3)"	"unprognostic (2.31e-1)"			"unprognostic (1.63e-2)"	"unprognostic (2.57e-1)"		"unprognostic (4.66e-1)"	50.5	21.9	0.1	266.2	0.5	139.5	320.5	0.6	1.0	129.8	0.4	471.5	296.2	20.7	2.8	106.2	33.4	187.2	23.2	0.2	1.6	36.7	37.9	130.4	529.5	0.4	1.0	37.0	8.3	1.9	2.7	0.4	0.7	18.7	511.9	0.2	476.4	127.7	0.7	2.5	175.9	14.5	12.0	820.8	627.3	13.5	0.2	381.9	53.9	0.2	1727.5	623.3	26.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	1.9	2.7	0.0	0.0	9.1	8.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.4	3.5	0.7	0.0	0.2	0.0	0.6	0.0	0.4	0.3	0.4	0.1	0.0	0.1	369.6	0.2	0.1	0.3	441.5	0.2	0.1	1.0	0.2	0.3	0.3	0.2	39.5	0.1	0.5	0.6	1.0	0.2	1.6	0.4	1.0	0.7	12.0	0.2	1.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2044.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0
IGKV1-39		ENSG00000242371	"Immunoglobulin kappa variable 1-39"	P01597	2	89319625-89320146	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.5;lymphoid tissue: 254.9;salivary gland: 151.2;stomach 1: 83.2"	"Cell type enriched"	"Detected in some"	151	"Plasma cells: 16225.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 13.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	388	"memory B-cell: 1069.8;naive B-cell: 935.1"	"Lineage enriched"	"Detected in many"	415	"B-cells: 1069.8"	"Cell line enriched"	"Detected in some"	21	"Daudi: 194.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.76e-4)"	"unprognostic (5.10e-3)"	"unprognostic (4.71e-2)"			"prognostic favorable (1.70e-5)"		"unprognostic (2.38e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"		"unprognostic (6.62e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.25e-1)"	10.9	9.1	0.0	54.7	0.1	14.2	17.7	0.0	0.1	21.8	0.0	108.5	70.5	5.7	0.0	11.6	12.5	14.3	1.5	0.2	0.0	10.9	6.8	27.2	36.5	0.0	0.0	1.8	3.2	0.0	0.5	0.0	0.2	4.2	13.3	0.0	151.2	0.9	0.2	1.3	74.4	1.2	0.0	254.9	83.2	0.3	0.0	5.9	31.0	0.0	42.5	17.5	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	1.8	0.0	9.0	0.0	0.0	0.0	0.9	1.0	0.7	0.3	0.3	0.3	1069.8	0.5	0.4	1.1	935.1	0.3	0.6	2.5	0.4	0.6	1.3	0.8	136.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.7	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16225.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	4.9	0.0	0.3	0.0
IGKV1-5		ENSG00000243466	"Immunoglobulin kappa variable 1-5"	P01602	2	88947301-88947957	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 777.1;lymphoid tissue: 1459.2;urinary bladder: 945.2"	"Cell type enriched"	"Detected in some"	240	"Plasma cells: 39194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	364	"memory B-cell: 859.0;naive B-cell: 860.5"	"Lineage enriched"	"Detected in many"	364	"B-cells: 860.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;HL-60: 2.4;RPMI-8226: 5.0;SCLC-21H: 2.9;SH-SY5Y: 4.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.19e-4)"	"unprognostic (1.26e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.59e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (7.60e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (4.36e-8)"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-2)"	35.8	82.0	0.2	639.7	0.2	115.4	233.9	0.1	1.6	115.8	0.6	777.1	528.7	17.1	2.0	146.2	86.9	124.8	18.7	0.1	0.5	36.2	32.0	125.3	387.2	1.0	0.2	60.8	10.8	0.5	3.0	0.4	0.3	16.7	745.0	0.0	392.2	34.8	0.9	3.2	429.7	24.4	1.3	915.4	456.3	11.5	0.2	155.3	58.4	0.0	1459.2	945.2	28.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	1.6	0.5	0.0	0.0	0.3	1.0	5.0	0.0	0.0	2.9	4.5	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.7	0.4	0.6	0.1	0.4	0.0	0.6	0.0	0.7	1.2	1.3	0.5	0.2	0.4	859.0	2.3	0.3	1.0	860.5	0.2	0.3	1.4	0.4	0.6	0.7	0.6	113.5	0.2	0.2	0.1	1.6	0.1	0.5	1.0	0.2	0.3	1.3	0.2	0.5	0.0	0.0	0.6	0.0	163.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	7.0	89.7	0.0	0.0	0.0	0.7	3.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39194.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	11.8	0.0	0.2	0.0
IGKV1-6		ENSG00000239855	"Immunoglobulin kappa variable 1-6"	A0A0C4DH72	2	88966262-88966767	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 155.5;lymphoid tissue: 606.3"	"Cell type enriched"	"Detected in some"	33	"Plasma cells: 877.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	801	"memory B-cell: 123.6;naive B-cell: 85.7"	"Lineage enriched"	"Detected in single"	946	"B-cells: 123.6"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		12000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (3.44e-5)"	"unprognostic (5.25e-3)"	"unprognostic (3.78e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.86e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (5.23e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.54e-1)"	8.2	1.7	0.1	84.1	0.1	37.0	50.3	0.0	0.4	16.5	0.1	155.5	110.5	4.0	4.1	23.5	5.0	18.1	5.3	0.0	0.0	7.7	6.3	20.0	82.3	0.1	0.1	4.0	1.8	0.0	1.1	0.0	0.0	4.3	145.9	0.0	95.0	2.2	0.2	0.6	59.1	5.1	0.2	209.5	130.3	0.7	0.0	22.7	16.4	0.0	606.3	144.8	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	123.6	0.0	0.0	0.1	85.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.1	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	877.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
IGKV1-8	"IGKV18, L9"	ENSG00000240671	"Immunoglobulin kappa variable 1-8"	A0A0C4DH67	2	88992409-88992931	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 29.7;lymphoid tissue: 55.0;salivary gland: 21.2;stomach 1: 18.6;urinary bladder: 41.7"	"Cell type enriched"	"Detected in some"	40	"Plasma cells: 622.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	311	"memory B-cell: 131.0;naive B-cell: 136.4"	"Lineage enriched"	"Detected in single"	317	"B-cells: 136.4"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		6100000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.64e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.41e-3)"		"prognostic favorable (5.13e-4)"	"unprognostic (6.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (4.14e-7)"	"unprognostic (6.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.98e-1)"	2.1	2.5	0.0	13.5	0.0	7.1	6.7	0.0	0.1	2.0	0.0	29.7	12.0	1.3	0.0	2.9	1.4	5.4	1.5	0.0	0.0	3.3	2.1	4.8	13.7	0.0	0.0	0.5	0.9	0.0	0.1	0.0	0.0	1.4	19.3	0.0	21.2	0.7	0.0	0.1	13.9	0.6	0.0	51.3	18.6	0.3	0.0	7.0	3.3	0.0	55.0	41.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	131.0	0.0	0.4	0.1	136.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	622.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0
IGKV1-9	"IGKV19, L8"	ENSG00000241755	"Immunoglobulin kappa variable 1-9"	A0A0C4DH69	2	89009982-89010515	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 428.1;lymphoid tissue: 671.3;stomach 1: 283.7"	"Cell type enriched"	"Detected in some"	116	"Plasma cells: 7178.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	705	"memory B-cell: 300.5;naive B-cell: 296.8"	"Lineage enriched"	"Detected in single"	709	"B-cells: 300.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;NB-4: 1.0;RPMI-8226: 2.9;TIME: 1.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.10e-7)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.70e-2)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.04e-8)"	"unprognostic (4.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.40e-1)"	12.6	12.6	0.2	184.3	0.4	53.6	202.8	0.0	1.3	15.8	0.4	428.1	267.0	8.3	0.8	52.9	78.3	30.0	13.9	0.1	0.1	15.4	17.9	40.1	201.8	0.3	0.1	20.7	2.5	0.5	1.3	0.1	0.2	12.8	348.6	0.0	221.3	13.3	0.5	1.6	182.8	13.3	0.4	313.1	283.7	35.1	0.1	85.1	34.2	0.0	671.3	187.5	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	1.0	0.3	0.0	0.0	0.0	0.9	2.9	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.1	300.5	0.1	0.0	0.3	296.8	0.0	0.1	0.3	0.2	0.2	0.1	0.3	34.5	0.2	0.4	0.0	1.3	0.1	0.1	0.3	0.1	0.2	0.4	0.1	0.3	0.0	0.0	0.0	0.0	61.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7178.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0
IGKV1D-13		ENSG00000276566	"Immunoglobulin kappa variable 1D-13"	"A0A0B4J2D9, P0DP09"	2	90154073-90154574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 103.7;lymphoid tissue: 317.6"	"Cell type enriched"	"Detected in some"	141	"Plasma cells: 6195.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	733	"memory B-cell: 480.8;naive B-cell: 331.6"	"Lineage enriched"	"Detected in single"	868	"B-cells: 480.8"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		370000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (4.68e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.71e-3)"		"unprognostic (3.01e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.60e-2)"	4.8	0.4	0.0	101.2	0.0	34.8	34.3	0.0	0.0	46.6	0.0	85.6	21.7	5.4	0.0	17.9	10.2	2.5	3.5	0.0	0.0	8.1	6.4	39.4	317.6	0.0	0.0	1.0	1.9	0.0	0.4	0.0	0.1	3.1	78.3	0.0	54.2	1.4	0.0	1.1	103.7	6.8	0.0	102.8	20.3	2.7	0.0	29.0	7.2	0.0	223.2	45.9	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.3	0.1	0.1	0.2	480.8	0.2	0.1	0.5	331.6	0.0	0.0	0.4	0.1	0.1	0.2	0.1	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6195.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-39		ENSG00000251546	"Immunoglobulin kappa variable 1D-39"	P04432	2	89862482-89862981	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2922.1;lymphoid tissue: 6491.8;stomach 1: 2259.8"	"Cell type enriched"	"Detected in some"	298	"Plasma cells: 7890.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 12.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	226	"memory B-cell: 470.5;naive B-cell: 733.0"	"Lineage enriched"	"Detected in many"	275	"B-cells: 733.0"	"Group enriched"	"Detected in some"	36	"Daudi: 731.4;U-698: 516.7"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.88e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.14e-3)"			"prognostic favorable (5.99e-5)"		"unprognostic (3.84e-1)"		"unprognostic (4.34e-2)"	"unprognostic (1.28e-1)"			"unprognostic (9.06e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-1)"	147.3	181.1	0.6	1609.8	0.8	466.1	990.4	0.5	4.2	369.0	2.1	2922.1	2055.2	80.0	52.5	611.3	132.1	629.8	87.5	0.4	2.0	82.3	171.8	685.1	1968.9	2.6	0.8	214.9	26.5	3.5	5.5	1.3	3.6	80.9	2261.1	0.4	1229.7	148.4	2.3	33.2	1255.9	88.7	4.2	1712.0	2259.8	27.6	1.3	770.5	209.3	0.0	6491.8	1816.1	46.9	2.5	0.3	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	731.4	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	5.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.3	6.6	2.4	0.0	0.0	1.0	2.9	10.3	0.0	0.0	11.1	17.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	2.5	0.0	0.1	516.7	0.0	1.6	0.0	0.5	0.4	0.8	0.6	0.2	0.4	470.5	0.3	0.3	0.4	733.0	0.5	0.2	2.6	0.8	0.4	0.4	0.3	47.6	0.6	0.8	0.5	4.2	0.4	2.0	2.6	0.8	3.6	4.2	1.3	2.5	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7890.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	14.0	0.0	0.0	0.0
IGKV1D-42		ENSG00000211633	"Immunoglobulin kappa variable 1D-42 (non-functional)"	A0A075B6H8	2	90190193-90190681	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.7;lymphoid tissue: 25.3"	"Cell type enriched"	"Detected in single"	93	"Plasma cells: 9.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"memory B-cell: 5.6;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	57	"B-cells: 5.6"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 2.6"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		41000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (8.08e-6)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-2)"			"unprognostic (2.51e-3)"		"unprognostic (1.84e-1)"			"unprognostic (2.10e-2)"		"unprognostic (1.66e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-1)"	0.1	0.0	0.0	7.6	0.0	6.6	10.8	0.0	0.0	0.8	0.0	18.8	7.5	0.2	0.3	1.4	0.2	1.7	0.1	0.0	0.0	0.0	0.3	2.8	2.6	0.1	0.0	4.1	1.1	0.0	0.0	0.0	0.0	0.1	47.7	0.0	8.5	0.0	0.0	0.1	7.9	0.0	0.0	4.2	13.9	0.0	0.0	0.6	0.3	0.0	25.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-43		ENSG00000242580	"Immunoglobulin kappa variable 1D-43"	A0A0B4J1Z2	2	90209873-90210529	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.9;lymphoid tissue: 4.8;stomach 1: 3.6"	"Cell type enriched"	"Detected in some"	86	"Plasma cells: 695.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	152	"memory B-cell: 13.3;naive B-cell: 17.0"	"Lineage enriched"	"Detected in single"	171	"B-cells: 17.0"	"Cell line enriched"	"Detected in single"	310	"RPMI-8226: 79.1"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		380000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (3.32e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-2)"		"unprognostic (4.57e-3)"		"unprognostic (1.37e-3)"		"unprognostic (3.15e-1)"	"unprognostic (2.67e-2)"		"unprognostic (3.82e-5)"	"unprognostic (3.96e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.06e-1)"	0.2	0.0	0.0	2.8	0.0	1.3	1.4	0.0	0.0	0.0	0.0	2.7	1.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	2.0	0.2	0.0	0.0	2.9	0.0	0.0	1.8	3.6	0.0	0.0	0.5	0.1	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	695.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGKV2-28		ENSG00000244116	"Immunoglobulin kappa variable 2-28"	A0A075B6P5	2	89221698-89222461	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1044.6;lymphoid tissue: 1735.3"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 1868.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 11.1"	"Lineage enriched"	"Detected in single"	13	"B-cells: 11.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;Daudi: 2.8;HL-60: 3.6;K-562: 2.0;NB-4: 2.7;RPMI-8226: 4.5;SCLC-21H: 2.1;SH-SY5Y: 1.7"														"Immunoglobulin genes"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.03e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.34e-1)"			"prognostic favorable (3.32e-4)"		"unprognostic (2.12e-2)"		"unprognostic (6.32e-3)"	"unprognostic (3.14e-1)"			"unprognostic (3.71e-2)"	"unprognostic (5.21e-2)"		"unprognostic (2.64e-2)"	36.2	40.2	0.2	402.4	0.2	180.2	425.2	0.1	1.1	56.6	0.9	1044.6	756.7	38.2	4.9	662.7	29.0	130.8	22.3	0.1	0.3	46.2	40.2	157.6	584.6	0.6	0.9	87.9	19.5	3.8	3.3	0.5	0.3	21.1	709.6	0.1	732.4	95.0	1.8	7.1	425.6	23.9	0.8	1207.7	530.0	161.9	0.2	167.6	84.8	0.0	1735.3	494.1	30.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	1.1	4.5	0.0	0.4	2.1	1.7	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	11.1	0.2	0.1	0.8	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.1	1.1	0.1	0.3	0.6	0.9	0.3	0.8	0.2	0.9	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1868.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.0	0.0
IGKV2-30		ENSG00000243238	"Immunoglobulin kappa variable 2-30"	P06310	2	89244781-89245596	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 631.0;lymphoid tissue: 670.2;stomach 1: 323.1"	"Cell type enriched"	"Detected in some"	365	"Plasma cells: 25365.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	316	"memory B-cell: 561.0;naive B-cell: 325.4"	"Lineage enriched"	"Detected in many"	400	"B-cells: 561.0"	"Cell line enriched"	"Detected in some"	388	"U-698: 8426.0"														"Immunoglobulin genes"	NA	NA		6800000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.84e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-1)"		"prognostic favorable (6.78e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.53e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.50e-1)"	15.0	9.4	0.1	160.7	0.2	75.9	237.0	0.1	1.3	19.6	0.7	631.0	394.3	5.6	0.8	37.8	11.5	35.0	17.9	0.1	0.1	15.1	29.6	67.3	176.7	1.4	0.1	15.8	7.8	0.1	2.3	0.2	0.2	7.8	324.5	0.0	220.5	23.3	0.6	2.0	260.2	19.1	0.6	670.2	323.1	21.2	0.1	40.9	18.8	0.0	600.3	207.5	21.5	1.1	5.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	13.1	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.1	2.7	1.9	0.0	0.4	0.0	0.9	3.8	0.0	2.6	0.0	0.0	5.6	0.0	0.0	21.7	0.1	2.6	0.3	1.7	8426.0	0.0	2.7	0.0	0.5	0.4	0.2	0.2	0.0	0.2	561.0	0.1	0.2	0.4	325.4	0.0	0.2	1.4	0.2	0.3	0.7	0.3	53.3	0.1	0.2	0.1	1.3	0.1	0.1	1.4	0.1	0.2	0.6	0.1	1.1	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	30.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25365.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.3	0.0
IGKV2D-29		ENSG00000243264	"Immunoglobulin kappa variable 2D-29"	A0A075B6S2	2	89947512-89948279	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 252.2;lymphoid tissue: 464.7"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 184.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	253	"memory B-cell: 360.5;naive B-cell: 489.4"	"Lineage enriched"	"Detected in many"	292	"B-cells: 489.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.5;HDLM-2: 1.2;TIME: 2.1;U-698: 2.2"														"Immunoglobulin genes"	NA	NA		1500000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.31e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.76e-2)"		"prognostic favorable (8.34e-4)"	"unprognostic (4.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.80e-2)"	11.3	1.0	0.0	73.7	0.1	29.4	49.4	0.1	1.3	12.6	0.8	252.2	97.0	3.9	0.0	9.5	6.5	14.2	3.8	0.1	0.2	3.6	8.4	41.4	139.4	0.3	0.0	9.8	2.8	0.2	0.3	0.0	0.2	3.6	110.9	0.0	106.8	10.3	0.4	3.0	67.9	2.9	0.4	170.2	126.0	1.0	0.1	38.0	7.8	0.0	464.7	35.1	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.2	0.1	0.0	2.2	0.0	0.1	0.0	0.3	0.4	0.2	0.1	0.0	0.2	360.5	0.2	0.1	0.6	489.4	0.0	0.1	1.6	0.2	0.4	0.2	0.2	42.2	0.0	0.1	0.1	1.3	0.1	0.2	0.3	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0
IGKV3-11		ENSG00000241351	"Immunoglobulin kappa variable 3-11"	P04433	2	89027171-89027731	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1373.3;lymphoid tissue: 2812.9;urinary bladder: 1822.6"	"Cell type enriched"	"Detected in some"	129	"Plasma cells: 27475.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"spinal cord: 19.8"	"Group enriched"	"Detected in many"	292	"memory B-cell: 1729.8;naive B-cell: 1401.2"	"Lineage enriched"	"Detected in many"	323	"B-cells: 1729.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;Daudi: 2.0;SCLC-21H: 3.7;SH-SY5Y: 4.6"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		18000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"unprognostic (3.97e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	45.8	60.5	0.4	733.2	0.3	189.1	385.3	0.2	2.1	136.2	0.6	1373.3	701.6	32.1	11.5	143.5	34.0	253.5	18.9	0.2	0.6	44.4	55.2	227.4	575.7	0.6	0.7	120.8	13.7	1.9	3.2	0.9	0.9	30.1	1090.9	0.1	496.0	60.9	1.2	14.2	536.0	59.5	19.8	1100.0	788.6	22.2	0.3	261.9	88.8	0.9	2812.9	1822.6	33.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.4	1.8	1.5	0.0	0.0	3.7	4.6	0.4	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.7	0.7	0.6	1.8	0.3	0.1	0.0	1.4	0.0	1.9	1.3	1.2	2.0	0.2	0.7	1729.8	0.8	0.6	1.6	1401.2	0.8	0.8	5.3	0.9	1.1	1.2	1.3	186.7	0.4	0.3	0.2	2.1	0.2	0.6	0.6	0.7	0.9	19.8	0.3	1.0	0.0	0.0	0.5	0.0	211.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	82.6	0.0	0.0	0.0	2.5	1.9	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27475.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	62.0	0.0	0.3	0.0
IGKV3-20		ENSG00000239951	"Immunoglobulin kappa variable 3-20"	P01619	2	89142574-89143160	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3080.6;lymphoid tissue: 5246.5"	"Cell type enriched"	"Detected in some"	138	"Plasma cells: 52154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	329	"memory B-cell: 1602.7;naive B-cell: 1222.4"	"Lineage enriched"	"Detected in many"	373	"B-cells: 1602.7"	"Group enriched"	"Detected in many"	215	"U-266/70: 3769.9;U-266/84: 1732.3"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		20000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.86e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (7.35e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-2)"	104.8	56.4	0.9	1791.2	0.9	380.3	736.4	0.5	4.2	326.9	2.6	3080.6	1714.2	59.0	7.8	302.1	105.2	637.2	55.7	0.5	1.6	106.2	113.5	454.0	2815.6	2.1	8.4	153.5	32.8	5.8	9.6	1.8	1.4	56.1	2731.8	0.2	1270.5	224.5	3.3	13.4	1355.8	82.8	10.4	2699.1	1412.9	24.7	1.2	671.5	224.3	1.8	5246.5	1644.0	70.0	1.5	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.5	0.0	2.1	0.0	0.0	0.0	6.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	2.0	5.9	2.8	0.0	0.0	3.0	6.0	10.4	0.0	0.0	7.7	12.8	1.4	0.0	0.1	0.0	0.0	0.8	4.4	0.0	2.0	1.5	4.3	3769.9	1732.3	1.8	0.0	2.3	0.0	4.0	1.2	0.7	0.7	0.4	0.8	1602.7	0.8	0.6	3.5	1222.4	0.4	0.7	4.2	0.8	1.0	0.9	0.8	196.9	0.9	0.9	0.5	4.2	0.5	1.6	2.1	8.4	1.4	10.4	1.2	1.5	0.1	3.2	1.3	0.0	376.9	0.0	0.0	0.0	5.2	0.0	0.1	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	9.4	0.0	0.0	0.0	55.3	124.4	0.0	1.3	0.0	3.6	5.0	0.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	52154.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	0.0	0.0	26.7	0.0	0.2	0.0
IGKV3D-11		ENSG00000211632	"Immunoglobulin kappa variable 3D-11"	A0A0A0MRZ8	2	90172802-90173414	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.6;lymphoid tissue: 58.5;stomach 1: 27.7"	"Cell type enriched"	"Detected in some"	34	"Plasma cells: 196.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	468	"memory B-cell: 152.5;naive B-cell: 146.1"	"Lineage enriched"	"Detected in single"	478	"B-cells: 152.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.1"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		6700000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.40e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.24e-3)"		"prognostic favorable (5.58e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (1.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.24e-2)"	1.3	0.7	0.3	35.9	0.2	8.9	6.4	0.0	0.1	1.7	0.0	38.6	32.2	0.8	0.0	2.4	2.1	2.7	0.5	0.0	0.1	2.1	1.3	12.4	13.0	0.1	0.3	1.5	0.5	0.0	0.1	0.0	0.1	0.7	26.6	0.0	18.8	0.3	0.0	0.1	23.6	0.7	0.2	29.9	27.7	0.2	0.0	4.2	2.3	0.0	58.5	17.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	152.5	0.0	0.0	0.1	146.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	30.2	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0
IGKV3D-15		ENSG00000224041	"Immunoglobulin kappa variable 3D-15"	A0A087WSY6	2	90114838-90115402	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 126.7;lymphoid tissue: 203.0;salivary gland: 54.1;stomach 1: 87.4;urinary bladder: 58.0"	"Cell type enriched"	"Detected in some"	622	"Plasma cells: 3673.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	191	"memory B-cell: 181.1;naive B-cell: 155.6"	"Lineage enriched"	"Detected in single"	206	"B-cells: 181.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;HL-60: 2.6;SiHa: 1.7"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		4800000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.11e-4)"	"prognostic favorable (7.46e-4)"	"unprognostic (9.16e-3)"	"unprognostic (1.74e-1)"		"unprognostic (1.90e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.93e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (8.99e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	3.1	4.4	0.1	93.5	0.4	11.1	17.1	0.1	0.5	5.9	0.3	111.6	63.0	1.0	0.0	16.4	5.2	10.1	2.3	0.1	0.2	3.6	2.0	18.0	43.6	0.4	0.2	17.9	4.0	0.3	0.1	0.0	0.2	1.7	126.7	0.0	54.1	1.1	0.1	0.6	46.7	4.3	0.3	56.3	87.4	0.2	0.1	13.0	4.5	0.0	203.0	58.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.0	0.6	0.0	0.1	0.8	0.0	0.0	0.0	0.0	181.1	0.0	0.0	0.1	155.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	27.5	0.1	0.4	0.1	0.5	0.1	0.2	0.4	0.2	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3673.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGKV3D-20		ENSG00000211625	"Immunoglobulin kappa variable 3D-20"	A0A0C4DH25	2	90038848-90039479	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 131.8;lymphoid tissue: 275.4"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 289.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	1042	"memory B-cell: 197.3;naive B-cell: 99.0"	"Lineage enriched"	"Detected in single"	1388	"B-cells: 197.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 19.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		11000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.82e-4)"	"unprognostic (4.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (7.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	4.0	6.3	0.0	81.2	0.0	16.0	32.4	0.0	0.6	12.2	0.1	131.8	55.9	2.7	0.0	15.3	4.2	16.2	6.4	0.0	0.1	3.0	6.4	20.6	73.5	0.2	0.1	7.1	3.3	0.0	0.3	0.1	0.1	3.7	88.1	0.0	64.0	3.3	0.1	2.6	77.7	6.0	0.3	88.4	82.5	1.2	0.0	16.2	5.2	0.0	275.4	38.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.5	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	197.3	0.0	0.1	0.1	99.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.1	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	289.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
IGKV3D-7		ENSG00000228325	"Immunoglobulin kappa variable 3D-7"	A0A0C4DH55	2	90234812-90235370	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.6;lymphoid tissue: 5.5;stomach 1: 4.4;urinary bladder: 5.5"	"Cell type enriched"	"Detected in single"	415	"Plasma cells: 207.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"memory B-cell: 2.8;naive B-cell: 4.3"	"Lineage enriched"	"Detected in single"	44	"B-cells: 4.3"	"Cell line enriched"	"Detected in some"	12	"RPMI-8226: 48.7"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		3700000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "		"unprognostic (2.74e-1)"				"unprognostic (8.62e-3)"		"unprognostic (6.59e-2)"			"unprognostic (2.14e-1)"			"unprognostic (3.05e-1)"	"unprognostic (4.02e-1)"			0.1	0.0	0.0	5.5	0.2	1.3	0.1	0.0	0.1	0.2	0.0	4.0	4.6	0.0	0.0	1.9	0.1	1.5	0.0	0.1	0.1	0.0	0.2	0.5	1.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.1	0.1	0.0	0.0	4.4	0.0	0.0	3.8	4.4	0.0	0.1	0.2	0.6	0.0	4.3	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV4-1	"B3, IGKV41"	ENSG00000211598	"Immunoglobulin kappa variable 4-1"	P06312	2	88885397-88886153	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1805.7;lymphoid tissue: 3169.0"	"Cell type enriched"	"Detected in some"	219	"Plasma cells: 46306.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	588	"memory B-cell: 3036.3;naive B-cell: 3070.9"	"Lineage enriched"	"Detected in all"	591	"B-cells: 3070.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.9;RPMI-8226: 10.4;SH-SY5Y: 6.9;U-266/70: 7.5"														"Immunoglobulin genes"	NA	NA		8500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.41e-5)"	"unprognostic (9.19e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.08e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.19e-1)"	55.9	296.3	0.4	1054.1	0.9	342.1	665.2	0.4	3.4	145.2	2.4	1805.7	1769.7	46.8	19.4	195.7	41.3	188.2	51.9	0.4	1.2	35.0	76.1	302.3	816.8	1.9	0.8	86.5	28.3	2.5	2.8	1.0	3.5	43.9	1318.2	0.1	701.8	89.6	1.0	8.6	1023.0	66.4	3.6	972.3	1125.7	125.7	0.7	405.1	51.0	0.1	3169.0	758.2	19.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	3.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.6	3.6	0.3	0.0	0.0	1.4	2.2	10.4	0.0	0.0	4.0	6.9	2.3	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.8	1.1	1.0	7.5	0.2	0.8	0.0	1.2	0.0	3.9	3.2	5.1	1.6	0.9	1.7	3036.3	1.9	1.1	2.8	3070.9	2.1	1.3	2.4	1.6	2.4	2.3	1.7	344.9	0.4	0.9	0.4	3.4	0.4	1.2	1.9	0.8	3.5	3.6	0.7	1.5	0.0	0.0	0.0	0.0	210.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.0	0.0	0.0	0.0	17.0	40.2	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46306.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	15.7	0.0	0.1	0.0
IGKV6-21	"A26, IGKV621"	ENSG00000211611	"Immunoglobulin kappa variable 6-21 (non-functional)"	A0A0C4DH24	2	89159751-89160366	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.3;lymphoid tissue: 141.0"	"Cell type enriched"	"Detected in some"	142	"Plasma cells: 1715.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	194	"memory B-cell: 28.8;naive B-cell: 9.8"	"Lineage enriched"	"Detected in single"	289	"B-cells: 28.8"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 10.5"														"Immunoglobulin genes"	NA	NA		250000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.82e-4)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.32e-2)"		"unprognostic (1.51e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.32e-2)"		"unprognostic (4.74e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	2.2	0.4	0.0	41.6	0.0	12.0	37.4	0.0	0.1	3.3	0.0	97.3	38.8	1.8	0.6	8.4	1.9	5.9	0.5	0.0	0.0	2.7	2.6	11.9	64.4	0.2	0.0	2.1	0.8	0.0	0.1	0.0	0.0	1.5	79.3	0.0	43.5	9.0	0.0	0.5	38.5	5.0	0.1	63.8	36.3	0.9	0.0	10.2	3.5	0.0	141.0	37.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1715.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGLC1	IGLC	ENSG00000211675	"Immunoglobulin lambda constant 1"		22	22895375-22895834	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 3264.2;lymphoid tissue: 5586.9;stomach 1: 2335.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 37.3;granulocytes: 15.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	743	"memory B-cell: 5729.2;naive B-cell: 5821.4"	"Lineage enriched"	"Detected in all"	749	"B-cells: 5821.4"	"Cell line enriched"	"Detected in many"	5	"U-266/70: 600.3"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"																					132.3	163.1	2.2	1208.8	1.9	641.9	903.4	1.7	7.0	190.8	4.4	3038.0	3264.2	63.1	2.1	535.0	113.2	640.0	104.5	1.7	2.2	148.2	114.7	470.6	2372.4	3.9	1.7	135.6	69.8	8.0	13.2	1.9	2.2	71.5	2133.6	0.7	2047.0	124.0	4.9	28.8	1389.9	78.0	2.6	3332.0	2335.3	23.7	2.3	873.2	224.5	0.0	5586.9	1948.8	79.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	1.0	0.0	1.9	0.2	0.0	0.0	6.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	9.1	0.0	0.0	1.1	10.2	2.0	0.0	0.0	2.3	8.9	33.4	0.0	0.0	6.3	11.1	1.4	0.0	0.0	0.0	0.0	0.3	2.5	0.0	1.3	4.3	2.6	600.3	119.9	36.5	0.0	3.5	0.0	4.2	7.7	2.0	3.7	1.7	2.9	5729.2	3.8	2.5	6.0	5821.4	0.9	2.2	7.6	2.8	4.8	5.2	3.4	897.2	2.2	1.9	1.7	7.0	1.7	2.2	3.9	1.7	2.2	2.6	2.3	3.4	0.0	6.4	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0
IGLC2	IGLC	ENSG00000211677	"Immunoglobulin lambda constant 2"	P0DOY2	22	22900976-22901437	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9734.6;lymphoid tissue: 19988.7;stomach 1: 10849.9"	"Group enriched"	"Detected in many"	40	"B-cells: 24632.2;Plasma cells: 18795.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	36	"memory B-cell: 11361.1;naive B-cell: 10650.3"	"Lineage enriched"	"Detected in all"	37	"B-cells: 11361.1"	"Group enriched"	"Detected in many"	190	"RPMI-8226: 62032.1;U-266/70: 102644.1;U-266/84: 83511.6"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (5.76e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.96e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.83e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (4.47e-9)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	386.6	782.7	7.7	3871.2	6.2	2741.4	2183.6	4.6	14.9	815.5	11.4	8217.0	9734.6	194.3	207.0	1690.0	231.5	2091.8	318.3	4.6	5.7	301.6	382.3	1442.8	5543.4	11.1	5.0	540.2	112.7	16.8	31.0	7.5	6.6	264.0	5055.4	0.7	5934.2	384.9	8.6	74.2	5290.6	306.2	6.6	7090.0	10849.9	256.0	5.4	2071.4	491.7	0.6	19988.7	6482.1	176.7	10.7	120.6	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	221.4	12.0	0.0	0.0	61.9	0.0	0.0	0.0	30.5	0.0	7.7	0.0	0.0	0.0	19.2	343.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	64.7	0.0	0.0	70.1	27.7	52.3	0.0	0.0	45.3	436.2	62032.1	0.0	0.0	46.7	45.7	5.6	43.0	17.3	0.0	17.7	57.2	11.7	0.0	38.9	23.4	78.2	102644.1	83511.6	298.8	0.7	21.9	0.7	9.9	18.6	5.6	5.8	3.0	5.7	11361.1	5.8	4.5	10.9	10650.3	3.5	4.7	118.0	5.8	8.7	303.3	6.5	2385.6	7.7	6.2	4.6	14.9	4.6	5.7	11.1	5.0	6.6	6.6	5.4	10.7	4.1	32.1	121.0	0.0	24632.2	0.0	0.3	0.0	1.2	0.0	16.1	3.0	3.9	44.3	8.1	0.0	0.0	0.3	8.0	28.0	0.0	0.0	0.0	0.0	0.1	86.3	62.5	222.4	0.0	0.0	0.3	42.5	14.8	0.0	65.6	0.0	222.8	539.9	2.1	0.0	0.0	21.5	0.0	134.5	0.0	0.0	0.0	8.5	0.0	0.0	11.4	0.0	15.5	0.0	0.0	0.0	20.6	0.0	18795.5	0.0	0.0	1.4	1.5	0.0	0.0	0.2	10.2	0.0	0.0	2.8	0.0	0.1	538.6	0.0	23.7	0.0
IGLJ1		ENSG00000211674	"Immunoglobulin lambda joining 1"	A0A0A0MT76	22	22893692-22893818	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"intestine: 95.1;lymphoid tissue: 50.0;salivary gland: 32.5;stomach 1: 40.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"memory B-cell: 19.6;naive B-cell: 11.0"	"Lineage enriched"	"Detected in single"	31	"B-cells: 19.6"	"Group enriched"	"Detected in some"	6	"Daudi: 274.6;U-266/70: 310.0;U-698: 88.7"														"Immunoglobulin genes"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"					"unprognostic (4.18e-4)"							"unprognostic (4.80e-3)"						"unprognostic (6.97e-2)"	"unprognostic (4.68e-1)"			2.3	0.6	0.1	43.3	0.1	9.8	1.8	0.2	0.6	0.0	0.4	17.1	95.1	0.8	0.0	2.0	0.4	5.1	0.2	0.0	0.1	0.2	0.1	2.7	50.0	0.5	0.1	0.5	0.0	0.0	0.0	0.2	0.3	0.6	13.5	0.0	32.5	0.0	0.0	0.0	43.4	2.6	0.2	31.5	40.8	1.3	0.2	5.2	0.0	0.0	34.5	4.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	274.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	3.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	310.0	37.0	88.7	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	19.6	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.1	0.1	0.2	0.6	0.0	0.1	0.5	0.1	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV1-40		ENSG00000211653	"Immunoglobulin lambda variable 1-40"	P01703	22	22409766-22410282	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1291.5;stomach 1: 1287.4"	"Cell type enriched"	"Detected in some"	358	"Plasma cells: 43406.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Group enriched"	"Detected in some"	496	"memory B-cell: 666.4;naive B-cell: 576.7"	"Lineage enriched"	"Detected in many"	532	"B-cells: 666.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.5;RPMI-8226: 2.2;SH-SY5Y: 3.4;TIME: 2.3"														"Immunoglobulin genes"	NA	NA		2300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.64e-3)"	"unprognostic (4.68e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.37e-3)"	"unprognostic (9.60e-3)"	"prognostic favorable (5.74e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	43.4	13.0	0.8	203.5	0.5	114.3	138.5	0.1	3.0	68.1	1.1	553.8	551.6	14.8	0.6	125.4	21.5	236.0	15.2	0.2	0.2	28.8	28.3	115.4	282.5	0.3	0.2	56.6	10.0	1.1	3.4	0.6	0.6	46.1	336.7	4.2	413.8	19.7	1.2	3.1	287.2	14.3	0.2	1029.8	1287.4	7.2	0.3	179.2	61.2	0.0	1291.5	464.8	19.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	1.0	1.1	0.0	0.0	0.2	0.8	2.2	0.0	0.0	1.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.4	0.7	0.7	1.1	1.1	0.8	0.0	0.3	0.0	0.4	0.7	0.2	0.3	0.1	0.6	666.4	0.3	0.3	0.6	576.7	0.1	0.2	1.2	0.3	0.3	0.6	0.4	53.7	0.8	0.5	0.1	3.0	0.2	0.2	0.3	0.2	0.6	0.2	0.3	1.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.2	8.0	0.0	0.0	0.0	28.6	64.2	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43406.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	7.4	0.0	0.1	0.0
IGLV1-47		ENSG00000211648	"Immunoglobulin lambda variable 1-47"	P01700	22	22357739-22358260	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 706.6;lymphoid tissue: 1804.0;stomach 1: 625.5"	"Cell type enriched"	"Detected in some"	114	"Plasma cells: 10777.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	638	"memory B-cell: 1518.1;naive B-cell: 819.6"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1518.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.1;RH-30: 2.1;RPMI-8226: 4.2;SCLC-21H: 2.7;SH-SY5Y: 2.4;U-698: 7.1"														"Immunoglobulin genes"	NA	NA		3000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (5.19e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.12e-8)"	"unprognostic (5.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.15e-2)"	36.0	216.0	0.6	323.0	0.4	162.3	200.5	0.4	2.3	82.1	0.7	706.6	704.7	23.8	3.0	163.7	21.3	112.7	27.2	0.2	0.5	23.2	31.8	126.7	689.2	2.6	0.4	43.5	8.9	4.9	2.1	0.5	1.2	22.5	531.5	0.2	526.6	70.2	0.7	4.7	332.8	34.7	0.5	813.7	625.5	9.8	0.4	260.1	34.1	0.0	1804.0	367.0	10.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.7	2.1	4.2	0.0	0.0	2.7	2.4	0.5	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.6	0.0	7.1	0.0	0.9	0.0	0.7	1.2	0.5	0.7	0.1	0.5	1518.1	0.7	0.6	1.0	819.6	0.3	0.6	0.6	0.5	0.5	1.8	0.6	159.6	0.6	0.4	0.4	2.3	0.2	0.5	2.6	0.4	1.2	0.5	0.4	2.4	0.0	0.0	0.0	0.0	94.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	1.7	29.0	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10777.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0
IGLV10-54		ENSG00000211642	"Immunoglobulin lambda variable 10-54"	A0A075B6I4	22	22038643-22215270	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"breast: 121.9;intestine: 324.6;lymphoid tissue: 329.7;salivary gland: 253.6;stomach 1: 194.5"	"Cell type enriched"	"Detected in some"	17	"Plasma cells: 358.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.2"	"Group enriched"	"Detected in some"	32	"memory B-cell: 60.0;naive B-cell: 35.2"	"Lineage enriched"	"Detected in many"	41	"B-cells: 60.0"	"Cell line enhanced"	"Detected in single"		"TIME: 2.3"														"Immunoglobulin genes"	NA	NA		54000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (9.35e-5)"	"unprognostic (2.65e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.30e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (3.33e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.86e-1)"	3.6	1.9	0.1	96.4	0.3	33.8	121.9	0.1	2.2	2.0	0.8	324.6	294.8	1.5	0.0	22.5	24.3	21.9	12.0	0.1	0.3	2.5	7.0	22.3	64.7	1.4	0.1	2.6	11.6	0.0	0.4	0.4	0.2	6.4	155.1	0.0	253.6	2.3	0.1	1.0	138.9	12.7	0.2	155.3	194.5	0.4	0.1	22.9	2.5	0.0	329.7	21.8	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	60.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	0.3	0.1	2.2	0.1	0.3	1.4	0.1	0.2	0.2	0.1	0.7	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	358.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGLV2-14		ENSG00000211666	"Immunoglobulin lambda variable 2-14"	P01704	22	22758700-22759218	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2622.2;lymphoid tissue: 5374.9;stomach 1: 2530.1"	"Cell type enriched"	"Detected in some"	179	"Plasma cells: 58316.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	50	"memory B-cell: 3655.3;naive B-cell: 2657.4"	"Lineage enriched"	"Detected in all"	58	"B-cells: 3655.3"	"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 22672.4"														"Immunoglobulin genes"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.23e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.69e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	83.9	192.1	0.8	754.9	1.7	357.8	749.8	0.5	6.4	119.7	3.8	2622.2	2470.7	47.8	20.7	245.2	49.0	442.1	45.2	0.6	1.0	54.3	102.1	399.3	3320.0	1.6	0.6	75.3	52.1	4.5	5.6	1.2	1.0	71.0	1074.1	0.1	797.3	119.4	2.7	21.3	1262.7	62.0	1.4	1580.6	2530.1	13.9	1.3	586.1	116.5	0.5	5374.9	1165.2	35.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.4	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4453.2	0.0	0.0	8.7	8.0	1.7	0.0	0.0	4.9	3.7	22672.4	0.0	0.0	11.8	11.1	0.4	17.3	0.0	0.0	7.1	0.0	5.1	0.0	4.1	5.7	1.1	20.4	37.7	1.4	12.1	1.7	5.0	3.9	5.3	1.7	47.1	1.0	28.8	3655.3	9.6	53.9	3.3	2657.4	1.4	12.7	11.6	62.5	2.4	2.2	2.1	451.3	0.8	1.7	0.5	6.4	0.6	1.0	1.6	0.6	1.0	1.4	1.3	2.1	0.0	0.0	0.0	0.0	324.1	0.0	0.0	0.0	1.2	0.0	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	14.7	0.0	0.0	0.0	9.9	121.8	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	58316.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	36.6	0.0	0.8	0.0
IGLV2-18		ENSG00000211664	"Immunoglobulin lambda variable 2-18"	A0A075B6J9	22	22734607-22735089	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 271.5;lymphoid tissue: 224.4"	"Cell type enriched"	"Detected in some"	210	"Plasma cells: 2488.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	44	"memory B-cell: 321.2;naive B-cell: 126.9"	"Lineage enriched"	"Detected in many"	64	"B-cells: 321.2"	"Group enriched"	"Detected in some"	7	"RPMI-8226: 13.4;U-266/70: 22.3;U-266/84: 7.2"														"Immunoglobulin genes"	NA	NA		570000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.06e-5)"	"unprognostic (2.81e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.13e-2)"		"prognostic favorable (7.75e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (1.95e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-2)"	3.4	0.3	0.0	73.0	0.0	23.7	67.1	0.0	0.3	6.7	0.1	271.5	262.0	4.2	0.0	39.6	10.8	36.3	12.5	0.0	0.0	2.0	2.8	12.6	37.6	0.1	0.0	4.1	1.1	2.1	0.2	0.1	0.4	1.7	138.6	0.0	64.3	4.9	0.1	0.3	150.2	6.5	0.0	95.8	72.5	0.5	0.0	22.1	2.8	0.0	224.4	18.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	13.4	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	22.3	7.2	0.1	0.1	0.1	0.0	0.2	1.8	0.0	1.6	0.0	0.8	321.2	0.3	1.3	0.1	126.9	0.7	0.6	0.5	5.0	0.1	0.2	0.1	69.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2488.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGLV2-23		ENSG00000211660	"Immunoglobulin lambda variable 2-23"	P01705	22	22697789-22698407	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 691.1;lymphoid tissue: 1598.0;stomach 1: 672.8"	"Cell type enriched"	"Detected in some"	132	"Plasma cells: 12487.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	369	"memory B-cell: 2072.7;naive B-cell: 2596.0"	"Lineage enriched"	"Detected in all"	410	"B-cells: 2596.0"	"Cell line enriched"	"Detected in some"	10	"Karpas-707: 85411.7"														"Immunoglobulin genes"	NA	NA		540000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.43e-5)"	"unprognostic (7.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (8.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.42e-2)"	16.0	38.9	0.7	306.7	0.3	103.6	184.7	0.1	1.5	45.2	0.6	634.1	691.1	16.2	1.3	78.7	25.5	66.8	19.9	0.2	0.1	18.6	26.2	160.8	623.2	1.0	0.1	16.3	8.2	0.6	1.7	0.6	0.4	10.8	457.1	0.0	356.7	38.1	0.5	2.1	517.3	16.1	0.3	530.5	672.8	5.9	0.2	277.6	39.1	0.4	1598.0	274.5	11.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	65.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	82.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	85411.7	0.0	0.0	2.2	4.2	0.5	0.0	0.0	0.7	1.9	8843.9	0.0	0.0	2.1	4.5	0.0	4.7	0.0	0.0	1.9	0.0	1.0	0.0	1.1	3.4	0.7	213.9	81.1	0.5	92.6	0.2	35.5	1.8	3.1	1.0	1.6	0.9	1.3	2072.7	1.6	0.8	2.6	2596.0	0.6	0.9	6.3	1.6	1.7	0.9	1.3	231.7	0.7	0.3	0.1	1.5	0.2	0.1	1.0	0.1	0.4	0.3	0.2	0.3	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.7	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12487.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.5	0.0	0.2	0.0
IGLV2-8		ENSG00000278196	"Immunoglobulin lambda variable 2-8"	P01709	22	22822658-22823289	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1141.8;lymphoid tissue: 1012.4"	"Cell type enriched"	"Detected in some"	80	"Plasma cells: 5288.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	125	"memory B-cell: 1439.0;naive B-cell: 2097.3"	"Lineage enriched"	"Detected in all"	149	"B-cells: 2097.3"	"Group enriched"	"Detected in many"	617	"U-266/70: 64161.5;U-266/84: 56786.5"														"Immunoglobulin genes"	NA	NA		1500000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.92e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.07e-5)"	"unprognostic (2.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.62e-1)"	18.7	7.0	1.1	325.0	0.6	96.0	155.2	0.3	2.4	26.0	1.7	1141.8	977.0	9.4	3.5	91.4	7.9	132.4	30.5	0.3	0.3	15.4	24.3	59.2	228.2	0.8	0.3	57.2	30.3	1.4	1.4	0.2	0.7	9.0	250.6	0.0	255.5	60.3	0.6	1.9	451.5	20.1	0.8	437.7	433.9	3.4	0.3	90.6	23.7	0.0	1012.4	259.0	10.3	1.0	62.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.6	0.0	0.0	23.1	0.0	0.0	0.0	22.3	0.0	0.5	0.0	0.0	0.0	0.7	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	11.3	1.9	14.8	0.0	0.0	97.9	0.9	10.1	0.0	0.0	1.4	2.8	0.2	0.0	9.3	0.0	0.0	29.5	0.9	0.0	9.8	0.6	38.9	64161.5	56786.5	20.4	0.0	10.1	0.0	1.2	2.4	0.6	2.1	0.7	0.9	1439.0	1.3	1.5	1.9	2097.3	0.4	1.0	14.1	1.3	1.4	0.6	0.7	174.0	1.1	0.6	0.3	2.4	0.3	0.3	0.8	0.3	0.7	0.8	0.3	1.0	0.0	3.2	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.5	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5288.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.2	0.0
IGLV3-1		ENSG00000211673	"Immunoglobulin lambda variable 3-1"	P01715	22	22880706-22881396	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1234.9;lymphoid tissue: 3325.7;stomach 1: 1460.4"	"Cell type enriched"	"Detected in some"	321	"Plasma cells: 56277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	725	"memory B-cell: 779.5;naive B-cell: 1038.5"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1038.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (9.70e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.13e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (9.06e-9)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	44.5	70.9	0.3	485.2	0.2	332.4	317.1	0.2	2.0	192.0	0.9	1234.9	643.4	39.2	0.0	217.7	19.2	310.4	28.1	0.1	0.4	26.3	70.1	176.2	1117.0	1.0	0.3	34.1	7.6	2.7	2.0	0.7	1.5	21.9	684.4	0.2	627.3	19.6	1.2	4.1	481.7	37.2	0.4	654.2	1460.4	56.0	0.3	335.5	35.9	0.0	3325.7	679.7	30.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.0	0.0	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.2	2.4	0.8	0.0	0.0	0.5	3.0	4.5	0.0	0.0	9.1	9.9	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	1.7	1.8	1.2	2.8	0.0	0.3	0.0	0.7	1.1	0.5	0.3	0.4	0.4	779.5	0.6	0.2	1.2	1038.5	0.2	0.3	0.6	0.4	0.8	0.5	0.5	52.3	0.3	0.2	0.2	2.0	0.1	0.4	1.0	0.3	1.5	0.4	0.3	0.9	0.0	3.2	0.0	0.0	111.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	10.7	174.8	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56277.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.7	0.0	0.2	0.0
IGLV3-10		ENSG00000211669	"Immunoglobulin lambda variable 3-10"	A0A075B6K4	22	22811747-22812281	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 317.0;lymphoid tissue: 707.7;stomach 1: 288.7"	"Cell type enriched"	"Detected in some"	52	"Plasma cells: 1090.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.3;medulla oblongata: 1.8"	"Group enriched"	"Detected in some"	786	"memory B-cell: 548.7;naive B-cell: 315.0"	"Lineage enriched"	"Detected in single"	998	"B-cells: 548.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;HL-60: 1.0;RH-30: 1.6"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		2000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"unprognostic (6.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (7.40e-3)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (9.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	33.3	112.9	0.5	144.0	0.4	65.5	111.1	0.1	3.3	41.3	0.6	308.0	176.3	7.6	4.5	56.3	7.9	43.5	20.5	0.1	0.2	12.2	20.8	48.0	230.5	1.8	0.2	14.6	10.8	0.9	0.8	0.4	0.6	11.0	317.0	0.0	139.7	10.8	0.2	8.1	94.9	5.8	0.1	217.1	288.7	97.4	0.2	25.9	8.6	0.0	707.7	140.2	7.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.2	0.0	0.2	548.7	0.1	0.2	0.2	315.0	0.0	0.2	0.3	0.1	0.1	0.3	0.1	43.2	0.5	0.4	0.1	3.3	0.1	0.2	1.8	0.2	0.6	0.1	0.2	0.2	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.1	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1090.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0
IGLV4-60		ENSG00000211639	"Immunoglobulin lambda variable 4-60"	A0A075B6I1	22	22162199-22162681	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 193.1;lymphoid tissue: 116.3;urinary bladder: 185.2"	"Cell type enriched"	"Detected in some"	152	"Plasma cells: 1125.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	78	"memory B-cell: 79.4;naive B-cell: 48.9"	"Lineage enriched"	"Detected in single"	96	"B-cells: 79.4"	"Group enriched"	"Detected in some"	4	"Daudi: 7.8;HEL: 13.3;U-698: 3.9"														"Immunoglobulin genes"	NA	NA		120000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.57e-4)"	"unprognostic (5.46e-3)"	"unprognostic (9.43e-3)"	"unprognostic (1.26e-2)"		"prognostic favorable (1.89e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.60e-1)"	1.8	1.9	0.0	32.9	0.0	18.1	36.6	0.0	0.2	3.3	0.1	70.7	193.1	1.5	0.0	12.3	1.9	3.4	11.4	0.0	0.0	3.1	3.9	43.5	116.3	0.0	0.0	4.6	1.1	0.4	0.2	0.2	0.1	1.1	73.3	0.0	37.9	0.8	0.1	0.1	86.8	2.1	0.0	80.3	37.7	1.7	0.0	18.3	1.7	0.0	112.0	185.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	3.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.1	0.0	0.0	48.9	0.0	0.0	0.8	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1125.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGLV4-69		ENSG00000211637	"Immunoglobulin lambda variable 4-69"	A0A075B6H9	22	22030934-22031472	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 430.3;lymphoid tissue: 461.2;salivary gland: 116.6;stomach 1: 285.6;urinary bladder: 204.0"	"Cell type enriched"	"Detected in some"	140	"Plasma cells: 4593.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	4	"medulla oblongata: 1.1"	"Group enriched"	"Detected in some"	302	"memory B-cell: 331.7;naive B-cell: 224.0"	"Lineage enriched"	"Detected in single"	361	"B-cells: 331.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;NB-4: 1.0;REH: 1.3;RPMI-8226: 5.4;SH-SY5Y: 1.3"														"Immunoglobulin genes"	NA	NA		320000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.02e-4)"	"unprognostic (1.32e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.34e-3)"	"unprognostic (2.67e-2)"	"prognostic favorable (4.04e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (9.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.08e-2)"	15.6	9.7	0.0	172.4	0.1	43.2	64.1	0.1	0.2	27.9	0.1	325.8	430.3	5.7	0.2	52.2	5.5	44.1	15.1	0.0	0.0	6.2	14.5	72.1	450.4	1.1	0.0	10.6	8.5	0.3	1.1	0.1	0.2	6.3	209.5	0.0	116.6	6.3	0.2	0.7	219.6	3.4	0.0	305.9	285.6	1.4	0.2	82.1	9.8	0.1	461.2	204.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	1.3	0.0	5.4	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.1	331.7	0.2	0.1	0.2	224.0	0.0	0.1	0.9	0.1	0.1	0.1	0.2	32.3	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	11.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4593.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0
IGLV5-45		ENSG00000211650	"Immunoglobulin lambda variable 5-45"	A0A087WSX0	22	22375986-22376505	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 40.5;intestine: 43.5;lymphoid tissue: 97.5;salivary gland: 49.0"	"Cell type enriched"	"Detected in some"	116	"Plasma cells: 6697.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"memory B-cell: 1.2;naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.2"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		160000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (4.62e-4)"	"unprognostic (6.18e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.58e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (6.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.36e-2)"	2.2	0.3	0.0	0.0	0.0	0.4	5.5	0.0	0.4	3.3	0.0	43.5	0.0	0.7	0.0	40.5	2.0	0.0	0.2	0.0	0.0	2.5	3.1	9.6	0.0	0.1	0.0	0.6	0.6	0.0	0.2	0.0	0.1	1.1	0.2	0.0	49.0	0.0	0.1	0.7	42.1	0.0	0.0	97.5	14.1	0.4	0.0	0.0	4.0	0.0	1.4	14.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.8	57.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6697.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0
IGLV6-57		ENSG00000211640	"Immunoglobulin lambda variable 6-57"	P01721	22	22195799-22196276	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1814.6;urinary bladder: 675.2"	"Cell type enriched"	"Detected in some"	72	"Plasma cells: 10791.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 353.9;naive B-cell: 292.4"	"Lineage enriched"	"Detected in many"	13	"B-cells: 353.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 148.0;RPMI-8226: 40.6;U-266/70: 21.6;U-698: 47.3"														"Immunoglobulin genes"	NA	NA		1900000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.92e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.30e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	15.6	9.1	0.0	220.8	0.1	191.7	215.5	0.0	0.6	82.3	0.4	485.0	351.3	19.1	4.4	171.4	38.2	75.8	39.2	0.1	0.0	10.7	26.8	97.0	237.6	0.6	0.1	20.3	7.7	17.8	1.1	0.4	0.5	17.2	318.8	0.0	249.6	12.7	0.3	3.2	174.3	11.5	0.1	276.6	437.6	15.9	0.1	139.7	15.3	0.0	1814.6	675.2	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	148.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.2	1.0	40.6	0.0	0.0	2.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.2	0.4	21.6	15.2	47.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.3	353.9	0.1	0.1	0.2	292.4	0.1	0.1	27.9	0.1	0.1	1.2	0.2	27.6	0.0	0.1	0.0	0.6	0.1	0.0	0.6	0.1	0.5	0.1	0.1	0.3	0.0	0.0	0.6	0.0	148.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	1.8	26.7	0.0	0.0	0.0	4.4	67.8	0.0	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10791.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	6.2	0.0	0.5	0.0
IGLV7-43		ENSG00000211652	"Immunoglobulin lambda variable 7-43"	P04211	22	22395018-22395489	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 161.9;lymphoid tissue: 238.7;stomach 1: 115.9"	"Cell type enriched"	"Detected in some"	57	"Plasma cells: 1304.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	325	"memory B-cell: 132.0;naive B-cell: 54.2"	"Lineage enriched"	"Detected in single"	461	"B-cells: 132.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;RPMI-8226: 1.4;U-698: 1.5"									HPA003182	Approved				"Immunoglobulin genes"	NA	NA		130000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003182: "	"prognostic favorable (6.49e-6)"	"unprognostic (7.85e-3)"	"prognostic favorable (7.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.62e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (7.63e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	8.0	0.8	0.0	31.2	0.1	15.8	45.7	0.0	0.5	4.9	0.0	161.9	132.8	3.6	0.5	7.9	3.3	22.1	3.5	0.0	0.1	3.1	4.2	13.0	59.0	0.0	0.0	4.1	2.2	0.0	1.0	0.2	0.1	2.3	129.3	0.0	72.5	4.7	0.1	0.5	57.1	17.7	0.0	168.6	115.9	0.5	0.0	31.3	6.4	0.7	238.7	31.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	132.0	0.0	0.0	0.0	54.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.2	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1304.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.2	0.0
IGLV7-46		ENSG00000211649	"Immunoglobulin lambda variable 7-46"	A0A075B6I9	22	22369614-22370087	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 400.6;lymphoid tissue: 459.1;stomach 1: 250.7;urinary bladder: 444.0"	"Cell type enriched"	"Detected in some"	180	"Plasma cells: 6758.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.6"	"Group enriched"	"Detected in some"	377	"memory B-cell: 183.6;naive B-cell: 82.3"	"Lineage enriched"	"Detected in single"	521	"B-cells: 183.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;RPMI-8226: 2.8;U-698: 6.6"									HPA003182	Approved				"Immunoglobulin genes"	NA	NA		270000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003182: "	"prognostic favorable (3.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.25e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.02e-1)"	15.1	3.8	0.0	59.8	0.3	44.2	171.7	0.1	0.9	4.1	0.1	400.6	162.4	4.4	0.0	43.7	3.0	56.0	5.2	0.0	1.6	5.7	7.7	44.9	82.2	0.4	0.0	9.0	6.2	0.1	0.8	0.1	0.2	2.5	298.6	0.0	107.2	5.2	0.5	0.8	133.1	12.1	0.1	248.1	250.7	0.7	0.2	57.3	8.7	0.0	459.1	444.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.3	0.0	6.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	183.6	0.1	0.0	0.1	82.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	15.2	0.0	0.3	0.1	0.9	0.0	1.6	0.4	0.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6758.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0
IGLV9-49		ENSG00000223350	"Immunoglobulin lambda variable 9-49"	A0A0B4J1Y8	22	22343187-22343732	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 125.5;lymphoid tissue: 118.0"	"Cell type enriched"	"Detected in some"	20	"Plasma cells: 46.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	672	"memory B-cell: 70.3;naive B-cell: 88.1"	"Lineage enriched"	"Detected in single"	747	"B-cells: 88.1"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		43000000	"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.04e-5)"	"unprognostic (4.30e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.61e-2)"		"prognostic favorable (2.00e-5)"	"unprognostic (6.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.12e-8)"	"unprognostic (1.66e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.16e-2)"	2.4	125.5	0.0	14.7	0.0	9.8	6.1	0.1	0.5	3.3	0.0	33.6	36.5	2.2	0.0	6.0	3.2	1.1	1.2	0.2	0.0	1.2	4.4	43.8	118.0	0.2	0.0	3.3	1.4	0.0	0.1	0.1	0.2	0.9	15.1	0.0	29.7	1.0	0.1	0.1	28.2	0.4	0.0	65.9	46.3	2.0	0.0	14.0	3.4	0.1	97.9	39.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.1	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.1	0.5	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.3;ovary: 16.2;retina: 50.6;testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.9;Early spermatids: 257.9;Inhibitory neurons: 139.1;Late spermatids: 334.0;Oligodendrocytes: 283.2"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;HEL: 5.9;SK-MEL-30: 35.1;U-266/70: 11.9;U-266/84: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	0.3	7.8	19.5	0.4	34.0	0.0	0.2	26.9	22.2	0.8	1.5	4.1	0.2	0.5	1.1	1.2	0.6	0.8	2.2	19.3	18.6	8.2	0.1	0.1	0.1	30.5	28.0	16.2	3.7	1.3	1.7	0.1	29.9	0.7	0.8	50.6	0.6	0.8	3.9	1.5	0.9	0.5	23.3	0.1	1.6	35.7	25.6	0.3	3.4	5.0	0.2	0.6	0.8	46.3	0.0	8.0	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	2.7	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.7	0.6	0.0	0.1	35.1	2.1	0.7	0.1	0.0	0.0	1.4	0.0	0.1	11.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	34.0	26.9	22.2	19.3	18.6	30.5	28.0	29.9	23.3	25.6	46.3	0.1	0.0	0.0	133.9	0.6	0.4	0.1	0.3	2.8	9.1	0.3	0.1	1.3	0.0	0.5	0.0	75.0	0.2	0.1	0.0	0.0	0.9	257.9	4.2	0.8	0.3	0.0	0.0	77.8	0.7	0.0	2.0	0.0	7.2	0.0	26.8	0.0	0.0	0.0	16.8	139.1	0.0	6.1	0.0	0.4	334.0	3.7	0.4	3.6	4.7	0.0	22.3	0.0	43.2	283.2	0.2	0.0	1.9	0.2	0.1	0.0	5.9	0.4	25.7	0.0	0.8	0.9	22.4	6.0	0.7	0.0	0.1	0.2	6.8	0.0	0.4
IGSF21	"MGC15730, RP11-121A23.1"	ENSG00000117154	"Immunoglobin superfamily member 21"	Q96ID5	1	18107798-18378483	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 177.8;Excitatory neurons: 82.2;Microglial cells: 74.9;Oligodendrocyte precursor cells: 141.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		23000		"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.85e-4)"	"unprognostic (3.76e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	2.2	4.8	29.6	0.4	35.8	0.4	3.0	41.4	51.7	1.7	9.2	1.0	0.0	1.0	0.4	0.9	1.0	0.8	1.0	37.4	17.6	1.1	0.4	1.5	0.2	26.9	23.4	0.6	1.9	10.4	1.6	1.4	27.0	3.8	0.3	9.4	1.1	1.1	0.3	0.8	0.4	0.3	21.6	13.0	0.6	0.8	24.5	0.8	0.6	0.4	0.7	3.9	1.1	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	35.8	41.4	51.7	37.4	17.6	26.9	23.4	27.0	21.6	24.5	33.5	0.1	0.0	0.0	3.6	0.6	0.3	0.2	0.0	0.0	177.8	9.2	2.7	0.6	1.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.9	0.0	0.0	1.8	3.0	0.0	82.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	28.9	0.1	0.0	23.6	4.0	12.8	0.6	12.8	0.0	74.9	0.0	6.3	0.0	141.3	2.4	0.1	1.3	0.0	0.0	0.9	0.0	0.0	0.0	13.0	6.6	4.5	0.2	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.2
IL15RA	"CD215, IL-15RA"	ENSG00000134470	"Interleukin 15 receptor subunit alpha"	Q13261	10	5943639-5978187	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 39.1;Exocrine glandular cells: 55.2;Fibroblasts: 37.6;Hepatic stellate cells: 36.0;monocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;EFO-21: 41.3;HDLM-2: 78.5;HHSteC: 42.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	8	"cerebellum: 7.1"	CAB026215	Approved				"Secreted to blood"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"CAB026215: "	"unprognostic (2.86e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (2.67e-6)"	"unprognostic (5.09e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (1.27e-12)"	"unprognostic (4.43e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.75e-2)"	19.3	7.5	3.3	20.4	3.7	11.7	18.3	3.0	4.6	21.5	3.6	12.3	16.2	15.0	4.6	11.5	18.8	23.2	17.8	2.8	4.4	14.1	19.5	44.5	21.3	5.7	3.9	3.7	11.5	2.2	4.6	16.1	4.6	10.4	10.9	0.3	8.0	5.3	7.1	11.2	15.7	12.1	4.8	15.1	16.3	3.2	4.6	5.7	12.1	10.2	11.6	25.7	12.7	3.5	16.8	2.4	0.0	0.7	21.5	4.9	4.3	8.6	18.4	10.7	11.4	0.3	70.8	1.9	41.3	16.0	6.0	15.6	2.0	12.1	2.4	78.5	3.5	2.0	4.9	1.2	42.7	0.9	0.6	4.1	4.2	6.0	0.2	4.4	29.1	1.3	20.5	23.5	0.3	9.3	3.6	8.9	0.4	6.7	6.8	10.0	0.0	13.4	2.8	1.3	0.1	0.1	12.9	1.4	0.6	0.2	6.1	8.0	10.8	0.5	1.3	30.1	11.2	20.5	6.2	0.4	4.9	12.4	0.7	10.2	26.0	6.6	18.9	32.8	29.1	10.8	14.7	19.7	7.1	6.4	6.1	11.0	7.5	11.5	21.0	0.1	17.7	12.8	3.3	3.7	3.0	4.6	2.8	4.4	5.7	3.9	4.6	4.8	4.6	3.5	25.2	6.4	5.0	1.3	6.0	5.7	5.7	9.9	4.6	0.0	4.4	3.0	5.8	22.8	3.3	0.0	0.0	0.6	4.2	5.8	0.0	39.1	1.7	5.1	23.0	21.0	5.4	19.8	3.3	55.2	1.6	37.6	9.7	6.7	3.8	0.1	36.0	8.7	6.6	0.0	0.9	6.8	2.0	14.7	5.5	2.1	5.0	7.3	3.6	12.2	55.0	0.0	4.1	1.0	0.3	35.5	13.3	0.7	22.2	20.1	9.3	0.1	3.4	0.0	0.0	7.1	6.4	0.2	0.4	4.6	6.5	0.1	7.8	0.0	9.3	6.8
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846568-53865794	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.9;kidney: 59.8;liver: 33.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Enteroendocrine cells: 29.2;Oligodendrocyte precursor cells: 37.7;Proximal tubular cells: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.2;Hep G2: 59.5;OE19: 46.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005482	Enhanced		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Plasma membrane"		"HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	0.9	2.0	20.2	2.3	21.4	0.5	5.7	22.7	28.9	18.1	16.6	6.8	5.8	5.1	0.7	1.7	3.3	2.4	2.7	19.4	20.2	59.8	33.3	3.8	2.5	18.7	19.9	1.5	7.8	1.1	4.2	0.9	19.0	2.4	6.9	4.8	4.9	0.6	1.3	2.2	5.9	0.8	18.9	1.2	3.6	2.5	23.2	0.3	2.9	0.2	0.7	0.8	1.3	23.6	1.5	3.1	4.5	3.4	0.1	0.0	7.1	3.1	0.1	0.1	0.0	20.2	1.4	4.6	1.0	1.0	1.7	0.8	12.2	0.0	0.0	1.6	3.5	6.0	6.1	59.5	0.0	5.6	3.2	0.0	0.0	0.0	0.0	3.8	0.0	1.6	4.9	2.1	0.1	4.2	0.9	2.3	12.1	46.2	2.6	1.7	1.9	5.3	1.4	5.3	6.4	3.7	10.1	2.4	1.9	3.3	9.2	2.0	2.5	3.0	3.3	2.6	3.9	4.7	5.6	2.9	2.7	3.3	1.7	1.3	0.2	0.0	0.2	0.2	0.1	0.1	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.3	0.9	0.1	20.2	21.4	22.7	28.9	19.4	20.2	18.7	19.9	19.0	18.9	23.2	23.6	0.2	0.0	4.1	48.3	0.2	0.3	2.0	0.0	0.0	0.1	8.2	4.4	4.1	17.2	1.3	0.0	0.0	1.4	0.3	4.3	9.8	4.8	1.0	0.5	1.0	0.2	29.2	0.0	0.5	1.6	1.0	0.6	4.6	1.7	2.5	0.4	0.4	13.1	0.1	0.0	2.5	8.7	2.0	0.0	1.1	0.7	1.2	1.2	0.0	1.9	0.0	4.4	0.0	37.7	4.3	1.8	3.0	0.4	0.0	4.4	2.9	78.0	0.0	0.1	0.0	0.3	0.5	0.4	1.0	0.0	0.1	0.4	0.9	0.0	10.2	0.6
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1400000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	137.3	68.0	7.1	69.5	8.3	18.0	77.5	7.5	11.0	161.1	16.2	39.3	20.7	33.5	105.2	32.1	52.0	92.0	58.3	7.6	9.0	45.7	75.5	115.5	17.1	16.2	8.4	31.1	43.3	126.7	13.1	120.8	8.9	66.7	30.5	8.5	34.2	47.4	18.6	40.1	40.3	49.9	10.0	41.0	43.9	20.6	14.9	21.7	52.5	16.0	19.7	87.4	40.2	7.7	2.0	12.8	0.3	10.8	624.9	276.8	4.4	27.4	123.8	19.2	28.7	5.7	3.4	0.0	19.8	55.0	33.9	5.5	0.2	2.2	16.1	55.5	0.1	0.7	2.9	31.3	196.3	0.1	0.3	770.6	2.3	21.7	5.2	8.4	8.7	0.0	3.5	1.1	28.1	5.6	0.0	1.2	0.7	5.6	0.9	0.3	2.0	0.4	18.3	13.4	0.1	0.3	12.5	7.7	0.0	3.6	11.1	0.8	0.3	54.7	3.6	92.1	2.2	0.1	0.0	0.1	21.3	0.6	3.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	7.1	8.3	7.5	11.0	7.6	9.0	16.2	8.4	8.9	10.0	14.9	7.7	99.3	25.6	73.2	1.3	1.8	31.1	46.8	8.2	5.2	0.1	19.4	13.7	5.2	28.6	68.6	5.5	0.0	6.1	2.5	0.7	3.9	31.7	7.0	127.1	280.2	103.6	1.2	14.3	0.5	21.8	82.8	79.1	2.0	315.4	1.3	0.3	146.7	47.1	5.4	0.0	3.0	0.5	10.2	12.0	188.2	12.6	28.0	26.0	19.6	23.4	7.0	9.0	0.0	0.5	0.5	12.0	0.3	1.5	1.8	65.9	0.0	8.3	28.6	1.0	6.6	37.7	34.3	1.3	1.2	4.5	38.6	23.9	8.5	4.0	0.8	23.6
IL22RA1	"CRF2-9, IL22R"	ENSG00000142677	"Interleukin 22 receptor subunit alpha 1"	Q8N6P7	1	24119771-24143140	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 199.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.8;Exocrine glandular cells: 12.0;Pancreatic endocrine cells: 11.3;Paneth cells: 33.4;Proximal enterocytes: 44.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 11.3;Hep G2: 8.1;OE19: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.68e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.78e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.64e-2)"	0.7	0.4	0.0	1.2	0.0	0.0	2.0	0.3	0.3	4.0	0.0	11.4	20.0	0.2	0.1	17.8	1.5	2.6	0.3	0.5	0.1	2.1	7.0	0.8	0.0	0.1	0.0	0.3	199.3	0.0	2.1	0.1	0.1	0.7	10.0	0.2	2.9	0.4	0.4	40.1	28.3	0.4	0.1	0.0	3.5	0.4	0.0	0.0	2.3	0.0	2.4	0.3	7.0	0.1	2.9	2.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	1.3	1.5	11.3	4.8	0.0	0.9	0.3	4.7	5.0	0.6	3.0	0.4	3.7	0.0	0.0	1.4	8.1	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	0.1	18.7	1.0	0.0	0.0	0.1	0.0	0.6	0.1	0.1	1.4	0.0	1.6	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	4.2	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.4	0.7	2.8	0.0	0.1	0.3	0.3	1.5	0.2	0.0	0.0	0.0	0.0	34.8	0.0	1.1	0.3	0.5	0.1	0.0	0.0	0.0	0.2	12.0	0.0	0.3	3.6	0.5	0.0	0.5	0.0	5.8	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.0	0.0	0.1	11.3	33.4	0.0	0.0	0.2	44.0	1.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.3	1.1	0.0	0.0	0.0	7.0	0.2
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125843-37175054	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 50.2;placenta: 36.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.1;Extravillous trophoblasts: 85.5;NK-cells: 388.3;T-cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 50.8;NK-cell: 186.4"	"Group enriched"	"Detected in many"	22	"NK-cells: 186.4;T-cells: 50.8"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 525.8"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Low region specificity"	"Detected in some"			HPA062657	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (6.76e-4)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	3.2	1.3	2.0	22.4	1.6	36.8	1.9	0.8	2.3	2.2	1.5	5.1	5.5	7.6	2.9	3.5	2.9	6.8	1.9	2.2	1.0	1.0	8.5	12.4	35.7	2.4	2.2	1.6	0.8	0.4	0.6	36.3	1.9	2.3	5.2	0.0	4.3	3.2	0.7	8.9	8.3	2.5	1.7	50.2	6.4	1.5	3.3	14.9	1.8	0.7	24.0	8.0	1.0	1.8	0.4	0.0	1.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	525.8	0.6	1.0	0.0	0.1	0.0	0.0	24.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.0	0.7	0.1	4.2	3.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	2.3	0.0	0.9	0.0	0.0	13.2	0.0	0.6	36.2	66.0	0.1	0.4	0.4	0.5	5.4	0.1	0.5	50.8	0.6	27.4	0.4	11.4	28.6	0.1	1.9	3.6	15.0	1.2	186.4	0.5	0.3	24.4	37.3	2.0	1.6	0.8	2.3	2.2	1.0	2.4	2.2	1.9	1.7	3.3	1.8	1.5	3.2	6.8	0.0	3.6	3.2	0.7	0.1	5.7	0.0	1.0	0.8	1.7	0.0	0.6	1.8	0.0	0.6	130.1	0.2	0.0	0.3	2.2	0.5	1.2	1.0	0.0	16.8	0.1	0.2	85.5	1.4	5.6	1.2	10.1	0.1	7.1	1.8	2.3	0.0	0.1	0.1	0.0	5.3	1.7	1.6	0.3	3.7	5.4	0.0	2.0	0.0	388.3	0.0	0.1	0.0	0.0	0.0	18.6	0.2	0.1	0.2	0.7	0.0	0.0	0.2	0.9	0.0	0.3	0.5	1.6	1.2	103.6	0.0	0.3	0.1
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 118.0;lymphoid tissue: 346.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 186.1;dendritic cells: 199.0;Distal enterocytes: 202.0;NK-cells: 310.0;Paneth cells: 133.2;Plasma cells: 221.2;T-cells: 289.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"Karpas-707: 2316.2"									"HPA046641, HPA049691"	Enhanced		Approved	Vesicles		NA	NA		13000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Vesicles		"HPA046641: AB_2679733, HPA049691: AB_2680851"	"unprognostic (2.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (8.25e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.28e-7)"	"unprognostic (1.73e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.54e-2)"	12.8	6.2	2.7	132.2	2.4	87.3	14.1	2.5	6.3	10.2	4.0	98.9	50.4	7.5	7.5	15.1	6.8	28.2	4.6	2.3	2.8	7.1	20.6	51.7	235.6	3.6	2.7	4.9	4.1	1.9	1.5	16.9	4.2	7.8	118.0	0.5	19.0	5.9	2.6	15.4	82.8	12.3	3.1	119.4	41.4	2.2	3.0	346.4	5.8	6.3	306.9	46.4	5.5	3.8	1.2	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	4.7	9.1	187.3	13.5	0.0	0.7	1.7	0.4	0.0	0.0	160.3	0.2	23.6	0.3	0.3	0.2	99.3	4.0	0.0	0.0	0.0	0.1	0.1	0.0	220.5	43.3	2316.2	0.0	0.0	356.4	193.7	0.4	0.9	0.1	79.5	0.8	20.0	0.0	0.7	0.2	0.3	2.3	0.1	0.5	0.0	0.0	3.5	0.4	0.0	1.0	0.0	0.5	132.1	242.2	119.6	2.1	397.4	0.9	540.5	102.2	169.7	1204.7	239.5	1179.9	604.7	1086.3	1250.7	243.5	603.0	742.0	943.1	773.0	1190.3	177.0	368.9	1422.2	1494.0	2.7	2.4	2.5	6.3	2.3	2.8	3.6	2.7	4.2	3.1	3.0	3.8	3.3	3.2	11.2	0.0	186.1	8.2	8.1	13.1	1.2	0.0	1.5	1.7	0.9	4.3	4.2	0.0	0.0	0.5	199.0	202.0	0.0	1.2	0.1	0.8	0.7	5.8	77.7	27.1	0.0	2.3	0.3	4.2	13.7	0.7	39.3	0.4	6.1	2.1	31.1	0.0	0.0	24.5	4.1	25.2	116.7	0.0	0.0	45.4	42.7	1.0	91.1	0.1	310.0	0.0	0.1	28.0	133.2	0.4	221.2	4.3	88.8	1.1	2.3	0.4	0.0	1.3	2.6	0.0	0.1	1.8	6.8	0.3	289.5	0.0	18.6	8.9
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.0;dendritic cells: 137.5;Endothelial cells: 83.2;Langerhans cells: 47.6;monocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 2665.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 2665.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.8;NB-4: 24.9;RPMI-8226: 54.1"									"HPA003539, CAB018374"	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favorable (9.78e-4)"	"prognostic favorable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	25.2	2.9	7.1	15.8	13.6	25.0	20.6	16.1	11.7	6.4	0.2	8.1	5.5	8.7	1.6	5.4	8.0	11.3	13.0	5.9	8.1	9.2	1.8	25.0	25.1	11.7	10.6	8.8	5.4	3.4	2.8	6.2	11.1	7.0	6.6	22.0	9.5	3.2	12.1	12.7	9.2	12.3	7.5	11.1	6.9	3.5	10.1	4.4	10.3	8.6	13.0	12.4	6.3	20.5	0.2	9.4	3.6	1.3	0.1	0.0	1.1	1.2	0.3	0.0	0.1	0.9	1.5	1.2	7.2	0.2	0.6	9.6	0.0	0.0	0.0	128.8	3.9	0.6	2.1	0.4	0.0	0.8	15.6	0.0	0.0	0.0	0.0	4.1	8.2	0.9	0.3	6.1	0.0	1.4	0.7	24.9	3.1	0.8	0.5	1.4	4.2	54.1	0.0	1.4	0.6	0.4	0.6	0.3	2.8	1.8	1.2	17.8	0.4	0.5	1.5	0.5	0.3	12.5	3.9	1.1	9.8	2.8	0.1	2665.0	5.6	83.9	0.6	31.7	1.0	2.5	0.9	0.5	14.9	8.9	0.7	0.7	4.6	14.2	42.5	628.5	0.5	12.0	7.1	13.6	16.1	11.7	5.9	8.1	11.7	10.6	11.1	7.5	10.1	20.5	79.0	3.2	1.8	11.8	6.8	5.9	0.7	0.9	1.2	2.3	0.5	0.9	2.2	1.5	1.0	0.0	10.4	0.1	137.5	4.7	0.0	0.4	0.2	2.7	1.4	83.2	0.0	3.0	7.3	0.2	0.1	4.3	0.5	1.5	11.4	0.4	24.3	0.7	4.6	0.0	14.3	7.3	0.0	2.8	47.6	0.1	0.3	32.9	8.8	13.1	72.6	0.6	1.0	6.0	18.2	0.1	3.4	0.7	4.0	0.7	0.2	0.0	0.4	3.2	0.0	3.6	3.2	0.1	0.7	0.7	5.5	0.3	1.6	1.3	0.6	2.1
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;granulocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 78.1"	"Group enriched"	"Detected in all"	5	"B-cells: 78.1;granulocytes: 31.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.2;HBEC3-KT: 115.0;HDLM-2: 110.6;U-698: 119.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	38500	110000	"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	49.4	45.2	22.7	82.3	19.7	103.4	34.1	19.2	22.0	39.7	21.4	97.0	27.3	35.8	5.9	70.8	42.3	41.2	34.2	18.7	21.0	50.8	116.0	119.2	117.1	29.4	22.2	14.3	29.8	31.7	14.9	39.3	24.0	49.9	35.6	2.4	20.5	25.6	9.3	24.4	55.7	37.3	25.5	90.0	55.0	15.5	25.3	22.3	24.2	6.6	89.6	63.2	45.4	23.8	39.9	10.1	6.4	13.1	3.1	14.1	14.3	24.7	27.3	9.3	7.7	20.4	105.2	124.2	30.1	38.5	18.3	39.7	7.3	115.0	8.2	110.6	4.0	22.6	6.6	31.6	40.8	6.1	61.7	23.5	45.0	44.2	26.5	48.7	50.7	6.8	10.5	9.8	15.0	17.3	0.7	18.8	8.0	34.2	9.1	0.4	47.5	10.2	42.9	43.2	1.9	0.6	3.7	24.7	5.0	15.6	8.2	23.5	81.0	21.0	9.8	19.0	17.6	6.1	2.1	119.7	2.1	21.1	0.3	1.4	7.2	13.0	4.2	3.1	3.4	25.8	6.9	4.4	4.1	78.1	10.0	5.0	31.1	8.2	1.8	4.8	5.3	5.8	22.7	19.7	19.2	22.0	18.7	21.0	29.4	22.2	24.0	25.5	25.3	23.8	30.5	28.9	49.2	0.7	92.0	13.3	43.3	34.9	26.2	0.3	9.4	14.2	2.4	34.3	33.4	1.8	0.0	17.6	29.8	60.0	0.0	39.5	0.3	6.6	2.2	39.0	23.4	5.2	1.7	32.3	3.8	17.2	32.1	17.2	110.8	0.7	62.8	45.9	27.2	0.0	0.6	35.5	8.2	30.6	29.9	0.8	0.3	34.3	14.2	38.4	39.3	0.0	7.2	0.5	0.7	49.3	28.7	0.0	13.4	37.7	24.0	1.2	28.5	0.2	39.5	16.4	20.0	0.8	3.3	23.8	14.9	24.9	38.3	0.2	16.7	46.9
INSRR	IRR	ENSG00000027644	"Insulin receptor related receptor"	P14616	1	156840063-156859117	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.5;kidney: 3.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.9;Cardiomyocytes: 2.3;Early spermatids: 2.8;Spermatocytes: 4.1;Spermatogonia: 5.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"medulla oblongata: 14.5;pons: 13.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 4.6;SH-SY5Y: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA025285	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA025285: AB_1851814"	"unprognostic (1.19e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (6.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (9.07e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (3.66e-2)"	0.5	1.4	0.0	0.0	0.5	0.0	0.2	1.2	1.9	1.3	0.2	0.1	0.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.5	3.8	0.0	0.0	0.0	14.5	0.6	0.0	0.2	0.0	0.6	0.0	13.4	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	1.9	0.0	0.5	14.5	0.6	13.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
INSYN1	"C15orf59, LOC388135, MGC131524"	ENSG00000205363	"Inhibitory synaptic factor 1"	Q2T9L4	15	73735458-73753351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.6;heart muscle: 48.5"	"Cell type enriched"	"Detected in single"	24	"Cardiomyocytes: 14.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041563	Approved		Approved	Nucleoplasm,Cytosol		No	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA041563: AB_10794670"	"unprognostic (2.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.67e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (5.38e-9)"	"unprognostic (4.98e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.20e-3)"	3.5	2.6	32.6	0.9	30.1	0.1	1.9	27.2	42.8	7.9	1.6	6.6	0.8	4.2	3.4	12.0	7.8	1.9	48.5	38.9	28.8	15.5	0.4	2.7	0.2	26.9	56.6	13.5	1.4	2.9	5.2	0.5	27.7	10.6	0.6	3.9	3.3	11.0	4.6	13.3	2.4	3.2	22.8	0.7	3.7	4.5	46.3	0.2	2.1	2.6	0.9	6.4	16.9	34.7	0.0	0.0	1.8	1.2	8.7	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.8	1.0	2.1	1.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.4	4.7	0.4	1.3	2.0	0.1	0.0	1.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.6	30.1	27.2	42.8	38.9	28.8	26.9	56.6	27.7	22.8	46.3	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IQSEC3	"KIAA1110, MGC30156"	ENSG00000120645	"IQ motif and Sec7 domain ArfGEF 3"	Q9UPP2	12	66767-178455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 39.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.8;Excitatory neurons: 81.6;Horizontal cells: 114.4;Inhibitory neurons: 76.2;Spermatocytes: 48.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 7.1;U-266/70: 9.1;U-266/84: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039025			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA039025: AB_10672768"	"unprognostic (2.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.83e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-2)"	4.0	0.8	6.6	0.5	8.2	0.7	1.4	17.0	39.1	2.2	0.0	0.6	0.4	2.4	0.3	0.3	3.3	1.5	1.3	9.8	5.6	2.0	0.2	2.0	0.4	5.4	2.3	1.6	0.8	0.0	8.7	0.9	1.7	1.2	0.2	7.5	0.3	2.9	1.0	0.2	0.5	1.2	4.7	0.4	0.5	1.4	8.3	3.2	0.4	0.4	0.1	0.9	1.6	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	2.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	6.6	8.2	17.0	39.1	9.8	5.6	5.4	2.3	1.7	4.7	8.3	15.9	9.9	3.2	0.0	1.6	0.0	0.3	0.0	0.0	0.6	50.8	0.1	0.1	2.2	0.0	0.0	0.0	8.4	0.0	2.1	0.1	0.0	0.0	0.8	0.1	0.9	3.3	0.0	0.0	81.6	0.0	0.0	1.3	0.0	0.2	2.5	0.1	2.2	0.4	1.6	114.4	76.2	0.0	0.0	0.8	0.6	4.3	0.6	1.4	0.0	7.5	0.1	6.6	1.0	4.5	1.4	0.2	0.0	0.0	0.0	0.1	0.7	5.2	0.0	16.1	0.0	0.5	1.1	48.6	21.8	0.1	0.1	0.0	0.5	0.1	0.2	0.1
IRAG1	"IRAG, JAW1L, MRVI1"	ENSG00000072952	"Inositol 1,4,5-triphosphate receptor associated 1"	Q9Y6F6	11	10573091-10693988	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 7.4;Hofbauer cells: 11.1;Smooth muscle cells: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 24.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 20.8;BJ: 15.3;BJ hTERT+: 17.6;fHDF/TERT166: 6.9;REH: 6.8"	"Region enriched"	"Detected in many"	5	"thalamus: 7.6"	"Low region specificity"	"Detected in all"			HPA008704	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA		220000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nuclear bodies"	"HPA008704: AB_1079413"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.30e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-3)"	29.7	8.0	64.6	18.2	85.8	1.5	16.1	50.4	53.4	55.4	17.7	67.6	8.5	60.8	16.1	37.5	45.6	33.2	10.1	54.5	54.3	9.3	2.1	13.3	3.7	65.8	71.4	20.2	2.9	2.7	3.8	11.8	54.4	37.9	17.3	1.7	4.1	39.5	6.7	9.3	22.0	69.1	55.2	7.1	33.7	8.2	89.8	2.3	10.2	8.1	1.8	43.8	21.9	48.8	0.1	0.0	4.2	0.0	20.8	4.1	0.2	15.3	17.6	0.0	0.0	0.4	1.7	0.0	0.1	6.9	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.0	0.2	4.8	0.4	0.0	0.1	0.0	1.2	0.0	0.6	0.1	0.3	0.0	0.1	0.3	0.5	0.0	0.1	6.8	0.0	0.3	0.0	0.0	0.0	3.1	0.0	2.6	0.0	4.4	0.0	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	6.0	0.0	0.7	2.2	1.7	0.0	3.9	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	24.0	0.0	5.7	0.1	0.0	0.7	64.6	85.8	50.4	53.4	54.5	54.3	65.8	71.4	54.4	55.2	89.8	48.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0
IRAG2	"JAW1, LRMP"	ENSG00000118308	"Inositol 1,4,5-triphosphate receptor associated 2"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fertilization, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 60.3;lymphoid tissue: 202.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.1;B-cells: 6.2;dendritic cells: 42.9;Hofbauer cells: 14.1;Plasma cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 210.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Daudi: 634.3;REH: 221.9;U-698: 722.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA002967, HPA007356, HPA018505"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA		6700	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum, Plasma membrane"		"HPA002967: AB_1079161, HPA007356: , HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	9.6	1.9	8.5	47.2	5.4	60.3	6.5	2.3	5.6	2.4	3.2	10.1	8.7	2.5	2.8	5.2	5.1	7.8	2.4	6.6	2.6	9.4	6.2	7.7	171.7	6.0	4.4	5.7	30.7	1.5	2.4	4.4	6.1	3.4	9.2	1.1	3.6	4.4	1.1	5.8	19.1	4.5	3.6	37.5	10.1	1.0	2.8	95.1	4.9	1.6	202.8	14.5	8.3	4.6	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	634.3	0.3	0.0	0.0	0.2	0.0	2.4	0.0	22.1	0.0	37.8	0.0	0.1	0.0	49.7	54.2	0.0	0.0	0.7	0.0	0.1	0.0	31.5	7.8	40.6	0.0	0.0	54.5	91.2	0.1	0.0	0.0	221.9	0.3	63.8	0.7	29.7	0.2	0.1	0.2	0.3	0.2	0.1	0.0	36.7	0.5	0.0	1.5	0.0	0.1	40.4	7.8	722.4	0.2	21.8	0.0	80.2	21.0	210.1	23.6	40.8	20.2	66.1	14.9	24.2	22.4	51.0	25.5	25.4	151.3	49.0	51.5	20.8	2.7	20.2	8.5	5.4	2.3	5.6	6.6	2.6	6.0	4.4	6.1	3.6	2.8	4.6	13.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0
IRX3	IRX-1	ENSG00000177508	"Iroquois homeobox 3"	P78415	16	54283304-54286787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 89.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 66.7;Breast glandular cells: 133.8;Breast myoepithelial cells: 84.6;Endometrial ciliated cells: 73.0;Glandular and luminal cells: 88.2;Respiratory ciliated cells: 67.3;Squamous epithelial cells: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 119.4;NB-4: 204.4;RPTEC TERT1: 236.4;T-47d: 122.9;THP-1: 201.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA066576			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA066576: "	"unprognostic (4.21e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.25e-1)"	8.2	6.8	3.4	0.4	3.0	0.1	75.6	6.3	1.2	29.7	2.7	0.3	0.4	2.2	36.5	33.0	10.9	0.3	63.1	1.2	5.1	42.6	2.2	36.5	2.0	7.5	8.1	0.9	4.0	27.2	7.2	1.9	6.2	23.2	0.0	1.2	43.2	31.3	22.7	89.3	0.6	1.2	6.2	0.1	22.5	0.5	7.5	1.0	9.3	8.8	4.5	4.8	17.5	5.0	1.1	1.1	15.6	15.1	8.4	3.3	1.7	6.6	14.5	13.9	3.4	4.2	6.8	0.0	2.2	10.0	5.5	29.0	12.6	3.6	18.5	14.3	9.8	0.0	22.2	14.6	0.6	16.7	4.1	2.5	59.7	26.5	12.0	9.8	0.0	19.1	0.0	0.0	119.4	7.7	30.9	204.4	1.1	0.0	0.0	23.2	19.2	0.0	236.4	6.2	10.6	1.9	20.4	51.3	2.6	1.7	122.9	201.8	3.4	57.9	6.4	10.6	5.3	0.0	0.0	0.1	38.0	53.7	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.0	6.3	1.2	1.2	5.1	7.5	8.1	6.2	6.2	7.5	5.0	2.6	19.2	66.7	0.0	0.4	25.0	47.4	25.3	45.5	1.3	133.8	84.6	14.1	0.0	43.2	5.5	0.0	0.1	1.3	0.1	1.9	5.2	0.0	73.0	8.1	5.8	0.0	0.0	0.0	0.2	0.1	18.3	2.0	88.2	0.0	5.5	8.2	7.1	0.3	0.0	0.0	0.0	36.7	1.2	2.7	0.0	0.0	9.0	10.6	0.0	0.2	10.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	25.8	0.0	6.5	67.3	1.2	0.0	32.1	6.4	0.4	1.0	72.8	41.3	0.0	1.1	0.1	0.0	34.0
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173710-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 118.0"	"Region enriched"	"Detected in all"	5	"spinal cord: 124.7"	"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		130000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	89.3	17.5	4.4	5.5	11.8	0.0	66.9	1.7	10.4	216.2	5.4	75.1	5.7	181.4	18.9	17.1	78.7	38.6	63.3	4.6	5.2	20.9	8.2	37.7	9.9	2.8	3.2	170.9	10.1	2.1	44.6	10.2	2.8	51.4	5.2	0.3	33.6	22.9	18.5	46.7	31.3	26.3	2.3	33.0	32.5	14.9	4.5	3.3	63.4	19.7	5.3	63.5	111.9	5.0	0.0	1.5	0.1	0.0	62.7	33.5	0.2	10.2	0.1	0.0	0.0	0.0	4.0	0.0	0.6	148.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	25.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.5	5.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.4	7.6	0.1	0.1	1.1	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.8	1.7	10.4	4.6	5.2	2.8	3.2	2.8	2.3	4.5	5.0	10.3	0.0	1.3	0.7	0.1	11.7	0.1	0.2	0.0	0.1	4.8	3.9	3.9	1.5	0.7	0.0	0.0	1.3	0.8	0.0	0.0	0.2	2.4	7.2	193.5	14.0	0.0	0.0	1.9	0.2	1.4	154.5	2.0	4.2	0.0	0.0	7.5	0.0	3.8	0.0	0.2	0.0	0.0	0.0	16.2	6.1	214.9	2.6	12.4	34.7	0.0	0.2	0.0	0.5	0.7	0.8	0.0	159.9	0.0	0.1	0.0	0.1	1.5	0.5	26.3	7.0	49.8	0.7	0.7	1.3	8.8	1.0	2.6	7.0	0.0	0.2
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"intestine: 37.5"	"Group enriched"	"Detected in some"	32	"Distal enterocytes: 24.2;Enteroendocrine cells: 19.4;Intestinal goblet cells: 16.0;Paneth cells: 19.4;Proximal enterocytes: 32.7;Undifferentiated cells: 23.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 1.6;Hep G2: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA060328: AB_2684254"			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	37.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.0	0.0	0.0	0.0	0.0	0.0	27.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.2	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.1	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.8	0.0
ITFG2	"FGGAP1, MDS028"	ENSG00000111203	"Integrin alpha FG-GAP repeat containing 2"	Q969R8	12	2812622-2859791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038664, HPA038665"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA038664: AB_10672722, HPA038665: AB_2676138"	"unprognostic (5.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.24e-1)"	"unprognostic (5.89e-1)"	"unprognostic (4.35e-2)"	"unprognostic (7.43e-2)"	12.8	15.6	6.0	11.4	8.1	14.4	14.0	10.2	8.1	17.7	10.7	14.2	12.4	18.7	14.5	13.1	17.1	8.9	12.1	5.9	9.2	16.4	12.2	15.0	15.9	7.7	7.9	28.9	22.1	28.1	14.1	14.5	8.1	13.9	15.0	8.1	17.9	15.6	8.3	11.7	14.5	13.4	6.2	19.6	16.1	5.1	8.0	18.1	26.7	9.7	15.8	14.7	14.9	11.8	7.3	10.6	11.9	9.7	10.2	11.6	11.0	15.9	9.0	18.9	13.8	22.7	17.6	16.5	4.4	15.0	9.4	9.1	18.5	15.9	14.1	14.7	10.6	23.1	12.7	9.1	18.8	21.7	12.0	15.7	18.4	17.3	26.4	15.5	13.1	15.6	12.8	17.3	10.9	21.9	31.3	12.6	24.6	16.5	8.0	15.6	13.3	9.5	11.3	12.3	5.7	18.3	19.5	17.1	7.2	16.2	10.6	9.9	13.4	12.4	7.4	12.0	30.8	2.2	1.4	25.0	8.0	12.4	12.8	4.0	16.6	8.4	19.2	22.2	18.0	25.8	14.7	19.0	19.6	24.2	19.8	18.6	1.9	23.4	35.6	14.6	13.2	16.5	6.0	8.1	10.2	8.1	5.9	9.2	7.7	7.9	8.1	6.2	8.0	11.8	11.1	12.8	17.9	12.7	35.9	3.3	9.8	9.3	10.2	39.8	16.5	15.6	17.1	18.6	12.1	12.9	64.6	28.1	27.6	13.0	11.7	9.2	46.3	13.0	19.1	10.5	9.5	17.9	13.6	7.2	8.9	15.0	23.0	13.2	6.3	18.7	12.1	11.3	13.4	32.0	15.2	15.2	8.2	12.0	5.1	12.1	16.8	11.0	1.8	8.4	16.8	10.0	42.2	10.1	25.8	7.2	14.4	13.2	19.6	9.1	20.5	6.1	8.7	56.0	6.6	11.7	16.9	13.2	20.0	14.3	4.0	17.4	24.3	22.2	19.5	5.9
ITGA11	HsT18964	ENSG00000137809	"Integrin subunit alpha 11"	Q9UKX5	15	68296532-68432163	"Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.3;endometrium 1: 53.1;smooth muscle: 25.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.8;Excitatory neurons: 13.4;Fibroblasts: 30.1;Microglial cells: 18.7;Peritubular cells: 13.5;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 119.5;hTERT-RPE1: 174.5;U-138 MG: 80.6;WM-115: 45.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 7.3;spinal cord: 2.1"	HPA051813	Uncertain					NA	NA		260000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA051813: AB_2681622"	"unprognostic (4.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.22e-7)"	"unprognostic (8.38e-3)"	"unprognostic (2.28e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.33e-2)"	6.5	3.4	0.2	1.1	1.5	0.2	3.2	0.7	1.1	26.3	0.4	2.1	0.8	53.1	13.5	1.5	12.0	2.4	12.7	0.2	0.3	6.5	0.7	1.7	0.5	0.2	0.2	4.6	0.8	0.4	1.8	1.5	0.1	5.2	1.3	0.4	1.2	7.4	2.1	2.7	1.6	25.0	0.1	3.2	1.6	0.9	0.1	0.2	2.0	2.4	0.1	3.9	8.2	0.5	0.0	0.2	0.4	0.9	3.7	0.1	0.1	7.9	15.1	1.6	0.5	0.1	0.2	0.1	0.6	119.5	2.1	0.2	0.0	0.0	0.4	0.0	0.2	0.5	6.8	0.0	10.8	0.2	7.0	1.5	0.0	3.1	0.3	174.5	0.0	0.1	0.2	0.3	20.9	0.1	0.1	0.4	0.7	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	5.5	0.1	0.1	18.5	0.1	0.5	5.0	80.6	0.7	2.1	0.1	0.2	0.0	0.1	13.5	0.2	45.4	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	1.5	0.7	1.1	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.5	2.9	0.0	0.0	0.3	0.3	0.8	0.5	0.0	0.6	3.9	1.0	7.0	13.8	0.0	0.0	1.8	0.0	0.0	0.3	0.1	1.9	0.3	0.3	0.2	0.8	1.1	0.0	0.0	13.4	0.0	0.1	30.1	1.5	0.3	0.0	0.2	2.2	0.5	0.3	0.0	0.7	0.0	0.0	0.6	1.2	0.5	6.8	0.6	0.0	18.7	0.0	0.3	0.0	0.0	0.5	0.2	0.0	13.5	0.2	0.3	0.1	0.3	0.0	1.6	19.7	2.7	5.4	0.0	0.2	0.2	0.4	0.1	0.6	0.2	0.0	0.3
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 111.9;Exocrine glandular cells: 105.1;Pancreatic endocrine cells: 245.6;Urothelial cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 647.2;hTERT-RPE1: 572.8;RPTEC TERT1: 562.0;U-87 MG: 920.8;WM-115: 570.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"		NA	NA		170000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	17.5	29.8	5.3	9.9	5.4	0.4	17.3	6.0	6.1	14.8	5.2	25.4	30.4	21.3	11.7	24.1	24.5	17.9	13.2	5.0	10.9	68.9	2.2	65.8	3.0	7.5	6.6	12.8	15.9	17.7	21.1	26.7	11.9	19.5	15.5	4.4	19.4	15.7	9.0	30.8	26.7	15.6	4.2	11.1	24.5	2.1	7.8	5.9	43.5	4.1	6.2	46.7	17.1	4.0	181.8	234.9	1.4	7.5	4.3	17.5	37.3	83.4	177.9	123.1	93.2	5.3	276.2	0.4	507.9	59.5	400.4	126.8	2.2	647.2	73.9	22.9	3.5	0.1	56.8	1.6	105.1	0.3	5.0	21.6	313.5	123.2	540.7	572.8	91.6	9.1	0.1	2.6	236.0	52.9	0.7	0.5	5.5	81.2	141.0	0.4	12.1	13.7	562.0	311.1	9.7	3.9	89.8	12.2	205.0	56.2	21.1	2.4	200.8	541.8	169.4	5.6	329.5	8.1	14.2	5.9	920.8	1.9	570.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	5.4	6.0	6.1	5.0	10.9	7.5	6.6	11.9	4.2	7.8	4.0	8.5	54.5	30.1	3.6	3.4	57.4	63.5	63.5	48.3	18.0	17.1	32.0	5.3	27.1	26.2	77.3	25.0	2.8	1.3	91.2	0.0	111.9	0.5	26.4	3.1	14.7	14.5	0.0	24.3	105.1	3.2	5.3	47.4	20.7	3.8	3.4	8.9	0.3	1.1	3.3	20.0	25.1	16.2	1.2	8.2	0.6	1.8	2.0	17.8	8.4	4.3	3.1	2.1	3.0	0.8	245.6	26.7	4.1	4.5	72.6	69.6	4.4	21.7	16.2	13.1	5.6	23.4	0.5	1.6	17.0	23.2	1.8	3.8	0.9	44.7	104.2
ITGA5	"CD49e, FNRA"	ENSG00000161638	"Integrin subunit alpha 5"	P08648	12	54395261-54419266	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 398.8;smooth muscle: 361.9;urinary bladder: 386.5"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 101.5;Extravillous trophoblasts: 391.9;Hepatic stellate cells: 88.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 89.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 615.4;HUVEC TERT2: 1360.8;TIME: 1277.7;U-87 MG: 623.6"	"Region enriched"	"Detected in many"	5	"basal ganglia: 10.4"	"Low region specificity"	"Detected in many"			"HPA002642, CAB009008"	Enhanced					NA	NA		26000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB009008: AB_647474, HPA002642: AB_1078469"	"unprognostic (7.51e-3)"	"prognostic unfavorable (4.07e-6)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (8.51e-3)"	"prognostic unfavorable (2.91e-4)"	"prognostic unfavorable (2.23e-5)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.76e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.99e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.11e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (2.18e-3)"	114.4	47.1	8.7	136.2	9.2	46.4	69.1	9.2	13.8	64.0	9.7	398.8	15.3	106.1	5.0	72.3	71.1	50.8	113.9	8.5	9.0	26.6	48.6	121.7	17.5	11.3	9.9	39.3	20.9	14.9	10.5	91.6	11.3	141.9	40.6	1.3	24.5	114.9	29.1	50.5	87.6	361.9	10.6	16.3	90.8	4.0	17.1	13.2	40.5	25.7	12.5	386.5	76.9	9.8	65.4	23.9	43.6	0.6	130.8	278.7	113.5	286.0	308.2	300.9	220.6	17.1	15.3	0.5	206.9	308.5	149.1	10.1	12.5	81.4	197.4	0.4	12.2	28.1	31.3	1.1	179.5	88.7	44.4	206.8	39.2	351.9	258.3	615.4	1360.8	15.6	25.6	0.8	165.4	6.4	13.7	99.2	18.1	4.2	19.1	13.7	29.2	6.2	46.9	1.1	0.1	0.6	57.7	4.3	2.2	93.8	7.1	79.9	1277.7	353.0	62.3	85.9	121.5	0.3	3.6	0.7	623.6	83.0	118.5	16.4	64.9	0.5	14.2	27.3	11.2	0.1	10.9	10.9	62.6	0.3	7.7	6.6	89.1	26.4	24.0	3.4	4.9	42.9	8.7	9.2	9.2	13.8	8.5	9.0	11.3	9.9	11.3	10.6	17.1	9.8	58.3	3.2	4.4	1.6	2.7	14.3	3.4	11.3	4.0	1.1	6.1	2.8	16.3	14.3	4.9	0.0	0.0	5.4	19.6	0.0	0.0	34.0	0.3	1.7	32.1	101.5	0.0	3.4	1.4	3.4	391.9	45.0	0.5	3.0	19.7	5.1	88.9	27.1	28.4	0.0	1.2	0.0	2.0	22.8	58.5	0.5	6.5	38.5	10.6	14.0	24.6	0.0	21.6	0.0	0.2	8.8	0.0	4.5	8.7	3.6	0.0	0.2	1.8	1.1	13.1	11.1	30.7	0.2	0.7	1.3	10.7	34.6	14.3	2.4	0.0	2.0
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.6;monocytes: 36.8;NK-cells: 152.4;Plasma cells: 46.6;T-cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 121.7"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 608.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced					NA	NA		1600000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favorable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"	4.2	1.4	0.3	36.7	0.5	36.8	2.3	0.3	1.0	2.4	0.5	5.5	6.0	2.3	1.0	2.5	3.0	7.0	1.4	0.3	0.4	2.6	10.6	22.0	62.4	1.6	1.1	1.3	1.0	0.5	1.2	3.0	1.4	2.4	8.6	0.0	5.3	1.4	0.9	1.4	19.7	3.6	0.7	64.9	8.6	1.0	1.6	55.2	3.5	0.9	46.4	6.9	2.3	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.1	0.0	1.1	608.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	134.3	0.0	0.0	43.3	3.5	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	26.0	0.0	0.0	0.0	0.0	0.0	36.6	12.5	0.0	0.1	3.8	0.0	5.3	24.4	17.0	56.6	48.0	27.7	4.8	21.4	42.7	22.3	1.7	9.4	29.7	14.3	24.2	121.7	6.0	15.6	43.6	0.3	0.5	0.3	1.0	0.3	0.4	1.6	1.1	1.4	0.7	1.6	2.1	1.2	6.4	10.5	0.7	19.1	0.8	0.3	0.0	0.0	0.4	1.2	1.0	1.9	0.0	1.9	1.8	0.0	0.2	118.6	0.3	0.0	0.1	0.5	4.1	0.6	2.3	0.0	4.8	3.6	0.0	0.6	1.4	1.1	0.9	5.1	0.1	5.3	4.9	19.3	0.0	2.8	0.2	0.0	30.0	3.4	0.7	0.0	31.5	1.8	15.9	36.8	0.1	152.4	0.5	1.6	0.0	0.0	0.0	46.6	0.1	0.9	0.3	6.7	0.9	0.0	1.2	0.7	0.2	0.2	0.1	0.3	0.7	84.9	0.1	0.0	0.2
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 87.5"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 106.1"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871"	Enhanced					NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	12.9	2.3	6.0	42.7	8.1	48.1	4.3	8.8	33.7	2.2	8.4	2.9	2.3	2.8	0.8	2.0	5.9	10.8	3.5	6.2	9.3	2.9	6.3	58.1	23.2	14.6	11.8	1.0	2.9	1.4	2.9	4.6	14.3	3.2	4.3	0.6	4.5	1.5	1.3	2.1	5.5	4.7	13.0	67.5	4.8	0.6	18.4	4.0	2.8	3.2	12.3	9.2	2.1	24.8	0.1	0.6	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	9.0	0.0	0.3	0.1	0.0	0.3	0.1	18.6	0.1	0.1	0.3	0.4	0.0	1.1	106.1	0.1	0.1	1.7	0.2	0.7	1.0	0.0	0.1	0.4	0.0	0.0	0.1	8.8	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.1	0.0	3.3	0.8	0.0	1.6	0.0	0.1	0.1	0.0	0.2	4.9	1.8	0.3	12.8	29.1	27.1	4.8	50.3	0.4	2.1	0.1	0.7	34.7	1.0	0.1	0.7	87.5	41.4	61.0	0.6	0.1	11.5	6.0	8.1	8.8	33.7	6.2	9.3	14.6	11.8	14.3	13.0	18.4	24.8	0.8	12.8	51.1	0.0	9.8	2.8	0.3	0.0	0.0	0.1	0.6	1.3	1.5	0.0	10.5	0.0	0.0	0.4	33.6	0.0	0.0	0.3	0.0	0.4	0.5	4.8	0.0	3.4	0.2	0.0	0.6	4.4	0.0	0.5	74.0	0.0	1.1	0.1	45.1	0.0	0.3	0.0	0.0	51.5	77.3	0.0	0.0	141.7	1.8	56.2	35.3	0.1	68.0	0.5	0.3	0.2	0.0	0.0	5.5	0.2	0.0	0.3	1.5	0.1	0.0	0.6	1.0	0.0	0.2	0.0	1.1	0.4	16.5	0.1	0.0	0.1
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 376.2;lymphoid tissue: 175.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"THP-1: 812.4;U-937: 615.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		3300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	54.5	23.2	8.2	175.2	9.5	376.2	15.4	13.1	9.3	15.5	11.7	25.2	23.8	8.5	2.8	16.2	17.0	36.4	11.8	7.7	14.2	8.4	23.4	78.0	169.1	29.5	19.9	7.2	11.3	5.1	4.6	44.4	28.1	8.8	13.9	1.1	19.5	9.2	6.8	9.3	32.8	46.4	23.9	137.2	29.1	5.9	26.2	87.2	7.3	7.6	68.4	46.3	5.9	50.4	1.9	4.8	0.0	0.0	0.0	0.3	1.7	0.0	2.7	0.1	0.0	0.4	0.4	17.9	128.1	0.2	0.6	0.5	0.0	0.2	0.0	1.5	1.4	18.2	0.0	3.2	0.1	106.6	27.5	1.6	0.1	0.5	0.3	0.1	0.3	58.0	0.7	1.4	7.0	4.0	117.8	126.1	0.4	0.4	2.4	1.5	23.2	64.6	4.7	0.0	0.6	1.3	3.4	2.5	1.7	0.0	0.4	812.4	2.5	0.2	6.6	0.4	3.7	0.8	5.9	2.9	0.1	615.0	0.9	186.6	1848.8	1224.1	726.7	1144.9	326.6	86.1	349.7	506.5	1031.4	115.2	233.1	396.5	1386.1	585.5	1183.5	165.5	288.0	3034.2	8.2	9.5	13.1	9.3	7.7	14.2	29.5	19.9	28.1	23.9	26.2	50.4	7.1	16.0	29.6	0.3	81.7	5.5	0.5	9.6	0.6	0.0	4.1	6.5	4.0	14.3	18.6	5.5	0.0	4.0	417.6	0.3	0.0	3.4	1.0	0.6	0.5	16.8	0.0	19.6	0.5	0.4	4.8	5.3	2.6	0.7	24.1	8.2	9.7	8.6	652.4	0.0	0.3	0.2	2.0	485.9	259.1	2.8	0.6	527.4	5.4	27.2	463.8	0.4	959.9	0.0	0.2	0.6	0.1	1.5	50.5	0.6	1.8	4.2	3.6	0.8	6.6	2.1	3.2	0.2	1.0	0.9	5.1	5.6	254.5	0.0	0.3	0.7
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255185	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 57.9"	"Group enriched"	"Detected in some"	6	"dendritic cells: 51.7;granulocytes: 31.8;NK-cells: 42.2;Plasma cells: 34.0;T-cells: 115.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	23	"gdT-cell: 39.6;MAIT T-cell: 26.4;memory CD4 T-cell: 55.6;memory CD8 T-cell: 54.9;naive CD4 T-cell: 78.2;naive CD8 T-cell: 65.0;NK-cell: 29.3;T-reg: 73.2"	"Group enriched"	"Detected in many"	23	"NK-cells: 29.3;T-cells: 78.2"	"Group enriched"	"Detected in some"	10	"JURKAT: 62.2;MOLT-4: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043670			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA043670: "	"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	1.0	0.3	0.0	15.9	0.0	3.7	0.9	0.0	0.0	1.0	0.0	1.4	0.7	0.4	0.0	1.4	0.4	4.2	0.2	0.0	0.0	0.3	1.6	3.1	29.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	1.5	0.0	0.3	0.1	0.0	0.2	4.0	0.5	0.0	10.5	3.1	0.5	0.0	57.9	0.5	0.0	24.6	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	3.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	39.6	0.0	26.4	0.0	55.6	54.9	0.1	0.0	78.2	65.0	1.3	29.3	2.3	0.1	73.2	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.0	4.0	2.7	0.6	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.6	1.8	0.0	0.1	51.7	0.1	0.0	0.1	8.5	0.2	0.3	0.8	0.0	1.7	0.2	0.0	0.0	1.1	7.7	0.4	31.8	0.1	1.8	1.0	0.0	0.0	0.2	0.0	0.0	1.6	5.1	6.7	0.0	2.9	1.8	1.0	2.8	0.0	42.2	0.0	0.1	0.0	0.0	0.0	34.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.2	3.4	0.1	115.7	0.0	0.1	0.6
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 472.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 7.4;thalamus: 2.4"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.0	0.4	0.6	0.3	0.3	0.5	0.6	0.6	0.1	0.2	6.4	18.1	0.2	0.6	0.0	0.0	8.9	0.5	0.3	0.1	26.6	33.6	0.7	0.5	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.2	6.5	0.2	0.1	0.0	0.0	0.2	19.6	0.2	0.0	0.1	2.0	0.2	0.5	0.0	472.7	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.5	0.3	0.2	0.4	0.2	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.9	0.7	0.2	0.3	0.2	1.3	0.4	0.3	0.6	0.6	0.3	0.1	0.5	0.4	0.6	0.0	0.5	0.5	0.7	3.2	7.8	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.3	0.4	0.8	14.3	8.9	0.0	0.0	0.1	0.0	23.7	1.9	0.3	0.0	0.9	0.3	0.4	3.6	2.7	0.1	0.2	0.0	0.7	0.0	2.2	1.3	0.1	1.1	25.1	0.1	0.0	0.1	21.8	0.0	0.0	1.2	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	22.5	0.0	0.0	1.0	89.1	35.4	3.6	1.3	0.0	1.7	0.3	0.1	0.1	0.0	0.4	0.3	0.9	0.4	11.5	0.7
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged canonical Notch ligand 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 211.1;Endometrial ciliated cells: 197.4;Smooth muscle cells: 190.1;Squamous epithelial cells: 343.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 219.2;hTERT-HME1: 131.1;U-251 MG: 187.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		25000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	44.2	10.1	10.3	13.0	9.5	21.8	30.3	8.4	12.0	44.0	8.9	23.7	13.8	27.3	19.5	52.4	27.0	21.6	20.7	12.8	9.8	21.7	6.2	23.9	8.4	12.4	14.2	20.3	22.0	20.9	8.2	67.9	10.0	25.9	23.0	22.1	15.8	26.7	9.8	57.2	13.6	23.6	9.7	23.3	25.1	4.5	12.1	9.3	19.9	22.8	15.6	28.5	50.0	8.5	4.1	20.6	63.1	78.1	11.8	11.3	2.3	2.4	11.9	3.3	1.8	18.5	11.2	0.7	59.0	2.4	17.7	85.8	9.4	219.2	2.7	0.2	4.5	7.0	2.2	87.9	5.8	28.4	0.5	4.6	63.7	10.6	131.1	12.5	21.1	0.3	0.1	8.8	6.0	0.2	0.0	20.2	18.2	68.7	20.3	5.3	3.9	13.1	29.9	25.6	2.8	2.1	6.3	4.4	26.2	49.8	0.3	3.3	80.5	14.2	9.9	11.8	187.9	3.6	0.6	0.9	9.1	10.3	11.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	10.3	9.5	8.4	12.0	12.8	9.8	12.4	14.2	10.0	9.7	12.1	8.5	73.0	41.7	15.4	5.9	1.1	104.6	54.9	76.3	211.1	9.7	13.2	29.1	20.6	30.0	34.4	16.5	43.8	16.9	6.8	64.3	1.9	31.6	5.0	197.4	22.2	102.5	5.3	0.0	6.9	30.4	1.0	41.9	76.0	96.4	7.0	2.7	60.0	1.8	4.2	21.9	9.2	12.8	20.3	5.9	33.9	9.6	21.5	9.1	14.2	22.5	2.8	11.9	2.1	24.6	1.3	97.3	18.3	33.8	4.3	24.5	7.8	2.3	30.2	69.1	85.5	46.7	190.1	0.9	3.2	343.9	106.8	2.2	4.3	107.2	39.1	33.7
JAKMIP2	"JAMIP2, KIAA0555"	ENSG00000176049	"Janus kinase and microtubule interacting protein 2"	Q96AA8	5	147585438-147782775	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8"	"Group enriched"	"Detected in many"	6	"Astrocytes: 195.5;Excitatory neurons: 250.7;Horizontal cells: 85.8;Inhibitory neurons: 229.4;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 198.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.3;MAIT T-cell: 5.3;memory CD4 T-cell: 2.8;memory CD8 T-cell: 5.5;naive CD8 T-cell: 4.6;NK-cell: 7.0"	"Group enriched"	"Detected in many"	6	"NK-cells: 7.0;T-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.9;Karpas-707: 47.5;RH-30: 47.8;RPMI-8226: 16.0;SCLC-21H: 22.4;SH-SY5Y: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046929, HPA065023"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA046929: AB_2679867, HPA065023: AB_2685407"	"unprognostic (3.69e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-8)"	"unprognostic (1.54e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	0.2	3.3	11.4	1.0	12.5	0.5	0.1	24.8	14.3	0.5	0.1	2.2	0.4	1.0	0.2	1.3	0.1	1.4	0.4	11.4	12.1	0.3	2.6	2.0	0.9	11.7	11.8	0.1	0.8	1.0	8.3	0.1	12.4	0.6	0.5	5.3	0.2	0.4	0.0	0.3	0.6	1.5	10.4	0.8	1.8	2.9	13.0	7.0	0.1	1.6	0.9	0.7	0.2	16.6	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.1	0.0	0.0	4.8	0.1	0.0	0.0	0.0	3.1	6.9	2.0	0.0	0.0	0.3	0.0	5.7	2.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	47.5	0.0	0.1	5.1	0.0	11.4	0.1	0.1	2.0	47.8	16.0	0.0	0.1	22.4	15.4	0.0	0.3	0.1	2.5	0.0	0.0	0.0	3.5	4.0	0.0	1.1	3.3	2.0	4.6	8.9	0.0	0.0	0.0	0.0	0.4	7.3	0.0	5.3	0.7	2.8	5.5	0.1	0.3	0.7	4.6	0.5	7.0	0.2	1.1	1.3	1.5	11.4	12.5	24.8	14.3	11.4	12.1	11.7	11.8	12.4	10.4	13.0	16.6	0.2	0.0	1.5	195.5	1.5	0.0	0.0	0.0	0.0	23.2	0.0	0.1	0.7	0.0	1.3	0.0	2.1	0.0	13.3	0.0	0.0	0.8	11.3	0.2	0.5	0.3	1.2	3.0	250.7	0.0	0.0	1.2	0.5	0.1	29.1	10.3	0.7	3.1	1.3	85.8	229.4	0.8	0.0	0.9	0.0	8.4	0.0	4.2	0.0	11.2	0.4	24.4	23.7	159.3	198.5	0.2	0.0	0.0	3.1	0.0	0.1	0.1	1.5	7.9	0.0	0.4	0.7	7.8	2.0	0.1	0.1	0.3	13.8	18.9	0.0	0.3
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 28.0"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	13.9	4.5	0.9	68.7	1.0	20.9	5.6	2.4	2.1	5.6	2.3	16.8	17.8	3.5	1.5	8.5	4.3	20.4	3.2	0.7	0.9	3.4	9.8	43.3	31.1	1.3	0.9	1.8	2.9	1.0	1.6	7.8	1.0	4.4	22.7	0.3	2.9	3.6	1.2	4.6	32.1	15.3	1.0	60.0	9.4	1.5	1.0	24.3	2.9	7.8	31.6	24.9	3.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	3.1	0.4	3.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	137.4	1023.8	3529.6	60.1	616.5	386.5	7.1	107.4	113.7	1017.6	2.9	124.7	103.1	2121.1	24.3	310.3	765.1	191.3	844.1	0.9	1.0	2.4	2.1	0.7	0.9	1.3	0.9	1.0	1.0	1.0	1.1	1.2	6.4	34.2	0.0	6.9	0.0	0.2	0.0	0.0	0.3	0.9	1.3	0.0	2.8	5.6	1.8	0.0	0.3	136.9	0.9	0.0	0.1	1.0	0.4	0.2	1.3	0.0	5.0	0.0	0.4	0.4	1.8	2.6	0.6	15.2	0.0	5.7	2.8	31.0	0.0	0.0	0.2	0.0	125.8	0.0	1.1	0.0	166.6	0.0	0.0	204.7	0.0	9.2	0.0	0.0	0.1	0.1	0.0	6.3	0.1	0.6	0.8	2.2	0.2	0.0	0.4	0.5	2.2	5.9	0.2	0.0	0.4	56.0	0.0	0.1	0.2
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 3028.0;intestine: 7979.6;stomach 1: 5916.2"	"Cell type enriched"	"Detected in many"	16	"Plasma cells: 101294.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	121	"memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1"	"Group enriched"	"Detected in all"	137	"B-cells: 4173.0;dendritic cells: 3578.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	130.2	76.6	0.7	1089.0	0.8	76.3	3028.0	0.4	3.0	205.2	3.1	7979.6	6145.8	94.2	25.0	654.4	115.0	492.4	45.6	0.4	1.4	43.3	116.8	620.2	1033.5	1.9	1.0	183.5	78.3	2.1	2.0	2.4	0.8	90.2	6426.5	0.3	2420.5	258.4	4.2	13.2	4277.1	200.3	7.0	819.4	5916.2	40.0	0.8	155.3	19.4	0.8	1746.7	1059.4	11.6	2.8	8.9	0.0	0.0	0.0	0.0	0.0	15.5	8.2	1.5	0.1	0.1	0.0	0.0	3953.8	3.3	12.7	0.1	6.6	0.0	0.0	0.6	2.1	0.0	3.3	0.0	0.0	0.0	3.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.4	2117.6	0.1	0.0	6.1	14.9	4.9	0.0	0.0	4.8	2.6	4469.2	0.0	0.0	3.3	15.7	3.7	2.6	2.7	0.0	0.8	6.8	3.9	9.9	11.8	4.9	6.3	8794.0	3519.2	4949.0	2.1	5.2	1.2	25.1	7.5	2.6	4.0	1.5	19.1	4173.0	2.5	3.8	6.6	2555.1	2.1	2.1	28.3	4.5	2.5	3578.1	2.6	1310.4	0.7	0.8	0.4	3.0	0.4	1.4	1.9	1.0	0.8	7.0	0.8	2.8	3.0	22.4	101.3	0.0	6154.9	0.0	28.2	0.0	8.6	0.0	11.7	1.9	2.2	15.7	8.1	0.0	0.0	0.1	700.0	5.1	0.0	0.0	0.5	0.0	0.1	38.1	7.3	139.0	0.0	0.0	0.1	48.8	228.8	0.0	79.5	0.1	66.4	24.6	0.3	0.0	0.0	5.3	0.0	35.8	0.0	0.3	0.0	42.0	0.0	0.0	3.9	0.0	6.2	0.0	0.0	0.0	5.1	0.0	101294.9	32.7	0.0	5.4	3.6	0.0	0.0	0.6	88.4	1.4	0.3	24.3	0.0	0.3	1487.8	0.0	3.5	0.6
JDP2	JUNDM2	ENSG00000140044	"Jun dimerization protein 2"	Q8WYK2	14	75427716-75474111	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.7;Kupffer cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 11.8;granulocytes: 7.7;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 167.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059511	Supported		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear speckles"		"HPA059511: AB_2684046"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (8.58e-5)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.30e-3)"	53.5	20.0	23.2	29.3	22.0	78.6	40.2	22.8	28.2	31.6	22.0	31.6	22.5	22.7	3.7	25.4	28.5	27.7	39.1	23.5	24.2	18.9	20.5	47.2	13.1	24.6	22.9	21.6	23.1	8.1	17.3	17.5	22.6	21.8	11.3	16.4	24.2	15.0	21.9	29.1	30.1	20.9	22.6	66.8	23.3	4.7	25.4	4.8	25.1	16.7	10.6	25.3	31.6	21.8	15.5	13.5	2.5	26.8	81.5	60.2	90.5	47.5	51.0	30.4	38.1	33.0	13.5	12.4	23.5	90.7	5.6	59.5	16.7	16.2	13.1	16.7	1.9	17.0	26.0	11.9	167.1	24.1	1.3	106.5	95.2	12.4	30.6	11.9	1.5	13.8	2.2	23.0	27.7	76.4	1.4	39.8	9.1	30.4	8.7	8.2	0.3	34.0	14.8	8.6	2.1	10.4	48.9	69.4	55.1	29.7	66.4	52.1	6.2	38.1	57.5	2.4	7.0	18.7	6.0	28.8	11.5	90.0	19.1	0.1	4.5	4.4	0.0	8.1	0.0	11.8	0.2	0.0	2.4	5.1	0.0	0.0	7.7	0.1	13.2	2.1	0.2	1.4	23.2	22.0	22.8	28.2	23.5	24.2	24.6	22.9	22.6	22.6	25.4	21.8	70.7	12.8	33.5	26.8	9.9	16.4	6.0	5.8	19.9	21.8	26.2	18.2	17.7	12.8	8.1	9.2	10.4	1.4	1.2	20.0	0.0	2.4	0.3	21.6	18.4	21.2	5.4	0.8	18.9	6.6	5.6	49.5	10.2	23.9	2.5	10.1	10.4	8.5	9.7	8.4	20.8	14.9	4.1	87.7	25.7	1.5	18.0	47.3	12.4	14.0	13.8	38.6	2.1	18.1	3.0	8.5	8.2	16.6	9.8	2.6	17.7	3.0	7.4	31.1	6.6	47.2	19.5	0.1	0.9	19.7	8.9	0.3	2.2	5.3	8.7	11.5
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321540	"Human disease related genes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 237.4;tongue: 106.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	0.3	0.2	2.9	0.5	7.5	0.0	0.7	7.6	5.3	0.7	13.2	3.3	0.7	3.2	0.8	2.8	0.3	0.3	8.4	5.9	1.5	0.8	0.4	3.7	0.1	3.0	1.5	0.1	6.5	0.8	0.5	1.4	2.4	2.8	5.0	0.4	2.8	0.5	237.4	0.6	1.0	1.9	1.9	0.1	0.9	1.0	1.9	3.2	1.4	106.0	1.1	2.3	1.4	3.6	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	1.1	1.1	0.5	0.2	4.4	0.0	1.5	0.0	1.0	6.4	5.6	4.3	1.4	0.0	8.3	0.0	5.2	0.0	0.7	2.9	0.3	0.8	3.7	0.0	4.0	0.0	0.0	10.9	0.8	0.0	0.4	4.1	15.1	0.0	9.7	17.7	2.9	7.6	5.4	0.0	0.2	12.7	7.3	1.0	0.1	34.4	1.8	1.6	24.2	0.2	0.0	1.6	2.3	0.6	1.4	0.0	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.5	7.6	5.3	5.9	1.5	3.0	1.5	2.4	1.9	1.9	3.6	1.1	38.5	12.9	3.9	0.2	2.8	32.8	3.0	6.2	0.4	2.4	1.5	35.7	0.0	10.8	1.8	6.2	0.0	0.1	7.1	0.0	0.3	2.4	2.9	8.9	1.7	12.6	0.0	82.2	1.4	0.0	2.6	7.7	3.7	0.0	0.0	0.0	0.0	0.1	0.0	50.3	9.9	2.0	0.0	0.4	0.5	0.9	0.4	1.8	3.7	0.0	0.4	0.0	14.1	4.6	3.4	6.2	0.0	0.0	32.8	0.0	1.0	6.2	0.1	0.0	25.0	1.4	0.1	4.3	7.4	2.0	0.0	0.2	0.1	6.7	25.6
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 196.2;Endothelial cells: 83.8;Hepatic stellate cells: 55.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 7.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.1;TIME: 14.8;U-266/70: 5.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory bulb: 16.2"	HPA051153	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favorable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	25.6	7.6	12.0	2.3	9.7	0.6	26.1	9.6	12.2	8.2	5.8	6.2	2.9	10.2	0.7	5.1	11.2	2.5	32.9	8.7	8.9	22.2	4.2	33.4	2.8	12.5	11.5	3.6	3.9	1.5	6.9	14.6	11.5	7.6	0.5	0.3	4.1	1.8	13.7	6.7	7.3	2.4	9.7	35.5	6.2	2.4	13.2	0.7	15.5	6.0	0.8	7.9	6.8	8.9	0.1	0.6	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.0	2.3	0.0	0.0	0.1	0.5	2.6	0.0	0.7	1.4	0.3	0.3	0.4	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	8.1	0.6	0.0	0.3	0.0	0.4	0.0	0.4	0.5	0.5	0.2	1.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.5	0.0	14.8	0.0	1.3	0.3	0.1	5.9	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	1.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.2	0.4	0.2	1.2	0.0	0.0	0.4	0.2	12.0	9.7	9.6	12.2	8.7	8.9	12.5	11.5	11.5	9.7	13.2	8.9	196.2	6.4	3.2	2.0	0.3	2.5	0.4	0.6	0.6	0.3	1.5	2.5	2.2	0.0	0.8	0.0	4.2	0.4	3.8	0.1	5.9	0.1	6.6	0.5	0.7	83.8	0.0	2.7	0.6	1.8	0.3	6.4	1.5	0.8	0.0	0.2	55.3	1.0	0.5	0.0	0.9	0.0	0.0	1.3	2.1	8.1	0.6	0.9	5.4	18.7	0.0	0.4	12.3	0.5	1.6	0.6	0.1	0.4	0.4	1.0	0.0	0.4	0.7	0.7	19.7	8.3	12.9	6.5	3.6	1.1	1.3	0.3	2.8	4.0	0.1	0.8
KAZALD1	"FKSG28, FKSG40"	ENSG00000107821	"Kazal type serine peptidase inhibitor domain 1"	Q96I82	10	101061989-101068131	"Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 23.0;Gastric mucus-secreting cells: 44.4;Intestinal goblet cells: 53.5;Proximal enterocytes: 78.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 30.8;T-47d: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA011800	Uncertain				"Secreted to extracellular matrix"	NA	NA		65000		"Cluster 64: Macrophages - Immune response"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA011800: AB_1852082"	"unprognostic (3.34e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.11e-1)"	2.9	0.6	0.3	0.6	0.2	0.3	2.8	0.3	0.4	7.1	0.1	1.9	2.8	2.0	1.3	0.6	2.1	0.6	8.1	0.5	0.2	2.0	0.5	1.2	0.7	0.4	0.3	0.5	0.9	0.8	3.6	0.8	0.4	5.2	1.6	0.4	6.9	2.2	4.1	1.7	3.2	1.5	0.2	18.0	6.6	1.9	0.4	1.0	2.5	3.1	0.3	3.6	2.9	0.2	3.3	1.6	1.8	30.8	1.8	7.4	2.0	5.2	5.6	1.0	1.0	6.2	2.0	0.2	2.8	4.6	0.5	0.7	1.9	0.1	0.3	3.1	0.8	0.4	6.5	6.7	0.5	0.4	2.3	1.1	0.4	0.1	0.9	0.4	0.0	0.9	0.7	3.2	0.9	5.3	0.1	1.9	0.5	7.2	11.7	12.4	9.1	0.4	0.6	1.6	0.3	1.2	0.5	0.8	1.7	0.7	36.7	0.5	0.1	0.7	2.1	0.5	1.2	0.9	2.6	2.5	1.3	3.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.4	0.5	0.2	0.4	0.3	0.4	0.2	0.4	0.2	8.3	0.0	1.5	0.7	0.3	2.0	0.9	1.6	0.6	1.5	2.5	3.0	3.4	1.5	1.6	0.0	2.1	0.3	0.3	23.0	1.9	0.5	0.1	4.1	1.3	5.1	2.4	2.7	0.1	2.1	0.6	16.9	44.4	7.2	0.0	0.2	3.6	0.3	0.8	0.0	0.1	53.5	4.1	4.8	1.9	0.1	9.9	0.9	1.8	0.0	0.0	0.8	0.0	0.0	0.1	1.5	12.8	0.4	0.2	5.0	78.1	0.4	0.7	2.2	0.0	10.4	6.1	3.9	1.4	0.7	2.8	0.5	0.6	0.2	8.1	0.4
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5990927-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 50.3;Excitatory neurons: 67.8;Hofbauer cells: 63.6;Inhibitory neurons: 49.2;Kupffer cells: 86.2;Macrophages: 51.3;Melanocytes: 64.0;NK-cells: 51.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 278.8;JURKAT: 142.7;U-937: 289.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	12.8	7.7	69.2	28.6	94.1	63.8	8.0	7.4	188.3	5.6	0.0	8.8	5.4	7.2	2.3	5.0	8.6	11.2	22.1	141.6	12.8	26.0	10.1	31.1	43.6	78.7	5.3	5.6	4.0	1.5	20.3	5.9	77.5	6.2	4.6	17.8	6.4	3.4	12.6	12.3	23.9	6.3	1.5	65.8	6.5	5.6	18.9	27.0	6.2	15.8	24.7	8.8	5.1	89.7	11.3	27.0	2.5	4.5	1.5	5.0	10.3	6.3	40.0	6.3	7.8	10.6	4.1	62.0	23.3	6.1	7.7	5.4	2.7	1.0	3.2	84.6	9.6	71.1	25.3	21.1	6.0	278.8	1.9	6.5	1.3	3.4	7.5	6.3	3.6	142.7	2.7	114.2	3.1	9.8	61.9	115.9	1.1	3.9	15.4	13.8	9.7	78.9	0.1	0.2	20.6	6.2	5.3	6.4	101.0	2.7	5.4	117.3	1.1	1.3	9.4	14.4	7.5	84.4	122.4	100.4	12.7	289.2	1.9	4.4	34.3	18.6	29.8	27.2	26.8	7.5	18.2	28.0	31.0	8.7	18.7	20.6	14.4	19.4	25.0	12.7	19.1	43.2	69.2	94.1	7.4	188.3	141.6	12.8	78.7	5.3	77.5	1.5	18.9	89.7	3.0	0.0	6.6	7.5	23.0	4.8	1.7	1.8	1.8	24.0	1.2	2.3	15.7	7.2	1.5	1.8	6.2	0.5	50.3	0.3	0.0	0.3	5.8	3.4	1.9	3.1	0.0	11.1	67.8	1.4	2.3	3.5	2.0	0.6	8.8	2.9	3.9	1.0	63.6	6.7	49.2	0.5	2.0	86.2	19.0	5.2	3.7	51.3	64.0	5.6	26.6	4.9	51.5	8.5	6.1	0.6	0.1	2.6	23.4	0.4	0.1	40.8	8.7	11.8	0.0	2.1	3.1	3.2	2.9	0.7	2.8	0.8	44.3	2.5	0.3	0.6
KCNG2	"KCNF2, Kv6.2"	ENSG00000178342	"Potassium voltage-gated channel modifier subfamily G member 2"	Q9UJ96	18	79863668-79900184	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.2;Horizontal cells: 114.4;Inhibitory neurons: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hippocampal formation: 10.3"	HPA048628	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 62: Horizontal cells - Visual perception"			"HPA048628: AB_2680466"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.78e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.18e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.63e-2)"	0.1	0.0	0.9	0.0	1.2	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.7	0.3	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.0	2.7	3.2	1.7	0.1	1.5	0.1	0.8	0.6	0.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	6.9	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	19.2	0.0	8.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	114.4	31.3	0.1	0.0	1.5	0.0	0.0	0.3	0.8	0.0	6.5	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.9	0.0	0.0	0.0	1.2	2.1	0.0	0.0	6.3	0.0	0.1	0.2	0.0
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.8;kidney: 7.0;pituitary gland: 5.3;prostate: 3.9;retina: 4.4"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 44.8;Cardiomyocytes: 25.6;Cone photoreceptor cells: 31.3;Enteroendocrine cells: 34.6;Proximal enterocytes: 40.3;Proximal tubular cells: 14.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 3.3;SH-SY5Y: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.1;olfactory bulb: 2.4;spinal cord: 2.5"	HPA061704	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA061704: "	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.98e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.15e-2)"	0.0	0.1	0.9	0.0	1.1	0.2	0.0	0.9	1.1	0.0	0.3	0.2	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.6	7.0	0.0	0.3	0.0	1.6	1.5	0.0	1.3	0.0	5.3	0.1	1.7	3.9	0.2	4.4	0.0	0.0	0.1	0.1	4.8	0.0	1.1	0.1	0.8	1.2	1.5	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.9	1.1	0.6	1.6	1.6	1.5	1.7	1.1	1.5	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	44.8	0.0	0.3	25.6	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.0	0.0	3.0	0.6	0.1	1.3	34.6	0.0	1.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	3.8	0.0	0.0	0.0	3.4	0.0	0.1	1.8	0.0	0.0	1.1	0.0	0.5	0.1	0.1	1.2	0.0	0.0	1.4	40.3	14.1	0.0	3.1	0.0	0.2	1.0	0.0	0.7	0.0	0.1	0.1	0.1	0.0	0.8	0.1
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728606-21948772	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.5;retina: 18.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9816.7;Inhibitory neurons: 1982.4;Oligodendrocyte precursor cells: 5175.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	0.6	2.2	11.9	1.3	16.4	0.0	0.6	13.8	24.5	11.0	0.0	6.9	1.2	6.2	0.6	4.0	2.5	1.1	0.5	17.8	12.8	8.2	0.2	0.5	0.0	7.0	7.9	1.3	0.5	0.0	4.2	1.0	13.7	0.5	4.1	18.1	0.5	0.3	0.3	0.5	3.8	6.0	4.3	0.3	0.8	0.4	9.0	0.0	6.4	0.0	0.0	1.0	1.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	16.4	13.8	24.5	17.8	12.8	7.0	7.9	13.7	4.3	9.0	10.6	0.0	0.0	0.0	148.2	0.1	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.5	0.0	0.0	14.7	0.0	0.1	0.0	0.3	62.6	0.1	9.8	0.2	2.1	1.6	0.0	0.0	9816.7	0.0	0.0	3.1	0.0	0.2	0.0	12.3	1.1	0.2	0.2	0.0	1982.4	0.6	0.0	0.0	0.0	4.2	0.0	0.5	3.6	119.9	0.6	45.9	0.0	5175.8	91.4	0.0	7.8	0.0	0.0	0.0	0.4	15.2	0.0	12.6	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.1	0.1	14.5	0.7	0.1
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium inwardly rectifying channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	117	"kidney: 198.0"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 195.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	39	"RPTEC TERT1: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.2	0.1	1.0	0.1	1.6	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.5	0.1	198.0	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.1	0.3	0.5	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.6	0.0	0.0	0.1	0.0	195.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium inwardly rectifying channel subfamily J member 10"	P78508	1	159998651-160070160	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 100.7;kidney: 28.0;retina: 36.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 93.0;Muller glia cells: 75.7;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 93.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.7;SK-MEL-30: 2.1;U-266/70: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	0.1	0.3	56.7	2.1	86.3	0.0	0.1	100.2	58.4	0.2	8.7	0.5	0.2	0.1	0.0	0.1	0.1	0.1	0.1	51.4	78.7	28.0	2.1	0.1	7.3	92.7	94.7	0.1	0.1	0.1	0.4	0.0	87.5	0.2	0.2	36.7	0.3	0.2	0.1	0.4	0.5	0.0	71.8	10.5	0.9	0.6	83.6	0.4	0.2	0.1	1.9	0.1	0.1	100.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	1.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	2.1	0.5	0.0	0.3	0.1	0.0	0.2	0.5	0.0	2.0	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	56.7	86.3	100.2	58.4	51.4	78.7	92.7	94.7	87.5	71.8	83.6	100.7	0.1	0.0	0.0	93.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	3.7	4.2	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	13.0	0.0	1.1	0.0	1.1	0.0	3.7	0.0	75.7	0.0	35.7	93.7	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	3.5	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 241.6;thyroid gland: 129.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 197.9;Cholangiocytes: 88.6;Proximal tubular cells: 236.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	20	"neutrophil: 395.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 68.7;GAMG: 103.6;HBEC3-KT: 69.6;RPTEC TERT1: 67.5;RT4: 80.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	8.7	0.5	0.8	20.7	0.7	14.1	2.8	0.9	6.7	12.7	0.5	0.9	1.5	0.5	11.0	8.5	1.2	30.4	0.8	0.8	0.6	241.6	2.8	42.2	1.2	0.9	0.6	0.3	57.8	0.7	0.4	4.6	1.8	2.6	0.4	0.5	25.5	14.6	0.5	3.0	0.7	2.4	0.3	11.7	40.5	1.8	5.4	1.9	129.5	3.0	1.9	25.1	8.1	1.1	1.6	0.0	0.3	0.6	13.7	68.7	0.6	1.0	4.8	0.0	0.0	0.0	0.6	0.2	0.0	7.5	103.6	23.5	0.0	69.6	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.1	21.0	7.2	17.8	3.8	1.5	3.2	0.1	0.2	0.7	31.6	0.0	0.1	0.2	0.0	0.1	0.7	1.5	0.3	0.7	67.5	80.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.4	3.5	0.2	1.7	0.4	0.1	5.6	4.3	0.4	0.3	19.3	0.1	0.0	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.3	395.3	0.0	0.0	0.4	0.0	4.6	0.8	0.7	0.9	6.7	0.8	0.6	0.9	0.6	1.8	0.3	5.4	1.1	2.9	60.9	197.9	0.0	1.1	2.8	10.4	20.7	13.6	0.0	0.5	0.0	1.6	88.6	33.1	31.3	0.0	0.1	0.0	0.0	17.6	27.8	1.9	0.0	0.0	4.6	0.0	0.0	0.3	8.6	0.8	1.5	15.8	0.1	6.3	0.0	0.7	0.4	0.4	0.0	0.1	0.0	2.0	2.9	3.0	2.2	0.6	5.9	1.8	0.0	2.1	0.0	0.0	0.0	0.1	44.7	0.0	0.0	0.1	0.7	0.0	236.9	7.0	0.0	0.0	1.5	0.8	1.1	1.1	16.8	1.6	0.1	1.7	0.1	0.0	9.0
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;SH-SY5Y: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.5	1.4	5.7	0.1	8.7	0.1	0.3	32.7	17.0	1.6	4.7	0.8	10.7	0.1	1.1	0.1	0.4	1.3	15.1	14.6	3.7	10.5	3.1	0.2	0.0	2.2	4.3	0.1	2.1	10.4	6.8	0.0	2.4	6.5	0.8	5.0	0.0	11.3	5.3	0.1	9.5	0.2	1.6	0.4	0.7	0.4	4.1	0.0	0.1	0.2	0.0	0.4	0.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.1	5.7	8.7	32.7	17.0	14.6	3.7	2.2	4.3	2.4	1.6	4.1	6.4	0.3	0.0	0.0	38.8	0.0	0.8	5.3	0.0	0.0	10.9	3.7	1.7	49.0	5.7	0.0	20.2	14.6	0.0	0.0	0.1	5.9	0.1	0.3	0.0	0.0	1.3	31.1	0.0	309.6	3.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.3	0.1	124.5	431.3	7.0	0.0	0.0	2.1	0.0	6.2	0.6	1.8	5.6	0.0	0.7	0.0	32.6	6.8	0.0	1.2	4.1	0.0	6.1	16.2	8.7	0.0	3.9	0.0	8.0	1.6	0.4	0.3	0.0	1.8	0.0	0.8	1.9	8.4	4.7
KCNJ8	Kir6.1	ENSG00000121361	"Potassium inwardly rectifying channel subfamily J member 8"	Q15842	12	21764955-21775600	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 71.3"	"Group enriched"	"Detected in many"	4	"Sertoli cells: 197.2;Smooth muscle cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"BJ: 11.1;CACO-2: 58.4;SH-SY5Y: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031066	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	28.6	17.3	4.9	3.2	5.4	0.0	22.1	4.8	5.7	17.0	11.6	15.6	1.2	18.8	0.7	3.6	14.8	1.8	71.3	4.7	5.0	13.9	41.9	13.8	2.5	5.2	5.3	16.8	42.4	1.8	7.8	3.0	5.1	13.0	0.3	0.8	6.4	8.4	17.1	5.8	5.9	5.5	5.2	8.0	12.7	1.0	7.2	0.6	16.1	4.5	0.4	15.1	11.5	4.7	0.0	0.1	0.9	0.0	1.4	3.2	0.0	11.1	4.4	6.5	1.9	58.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	4.3	2.9	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.2	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.6	2.7	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.4	4.8	5.7	4.7	5.0	5.2	5.3	5.1	5.2	7.2	4.7	18.7	3.2	29.5	2.9	0.0	1.3	0.4	0.0	0.6	0.0	9.2	3.0	28.3	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	10.8	12.8	1.2	0.0	3.6	1.3	0.0	9.8	0.0	0.9	0.0	1.0	2.9	23.0	0.3	0.0	0.2	0.0	0.0	0.8	1.5	0.1	0.3	0.3	1.8	0.0	0.0	13.2	0.0	0.5	0.4	1.2	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.0	197.2	3.3	61.6	0.0	1.0	0.1	0.9	0.3	0.3	0.5	0.2	0.6
KCNK10	"K2p10.1, PPP1R97, TREK-2, TREK2"	ENSG00000100433	"Potassium two pore domain channel subfamily K member 10"	P57789	14	88180103-88326907	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;intestine: 5.1;stomach 1: 2.6"	"Group enriched"	"Detected in some"	4	"dendritic cells: 12.5;Excitatory neurons: 43.8;Inhibitory neurons: 17.0;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 11.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	62	"plasmacytoid DC: 10.0"	"Lineage enriched"	"Detected in single"	100	"dendritic cells: 10.0"	"Cell line enhanced"	"Detected in some"		"OE19: 1.5;REH: 1.7;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030462	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA030462: AB_10601919"	"unprognostic (9.52e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.26e-3)"	0.0	0.3	4.0	0.4	3.6	0.2	0.0	5.1	4.1	0.2	0.0	1.3	5.1	0.0	0.0	1.1	0.0	0.0	0.0	4.4	2.9	2.4	0.0	0.1	0.1	4.2	2.9	0.0	1.4	0.0	0.5	0.0	3.5	0.0	0.7	0.1	0.2	0.0	0.0	0.0	2.6	0.1	2.3	0.1	2.6	0.5	2.4	0.0	0.0	0.0	0.4	0.0	0.2	4.6	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.1	1.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.1	4.0	3.6	5.1	4.1	4.4	2.9	4.2	2.9	3.5	2.3	2.4	4.6	0.0	0.0	0.0	0.7	0.1	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	12.5	2.1	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	43.8	0.6	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.0	1.6	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	37.7	11.9	0.1	0.3	0.0	0.0	0.0	1.5	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.2	0.0	0.0	0.1	0.0	1.6	0.1
KCNK5	"K2p5.1, TASK-2, TASK2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188971-39229475	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.4;kidney: 37.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Distal enterocytes: 55.6;Gastric mucus-secreting cells: 31.6;Proximal enterocytes: 66.5;Proximal tubular cells: 45.4;Syncytiotrophoblasts: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 34.9;HEL: 36.1;HMC-1: 31.8;K-562: 34.3;OE19: 27.4;T-47d: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	4.0	3.7	0.1	2.2	0.1	9.6	5.3	0.0	0.1	4.4	0.1	14.2	28.4	2.1	0.2	6.1	2.3	18.8	1.7	0.0	0.2	37.2	23.5	6.1	2.7	0.2	0.2	6.4	20.4	1.9	1.2	8.6	0.1	3.5	8.5	0.1	27.1	2.4	0.2	29.4	35.4	1.3	0.1	2.2	16.7	0.7	0.3	1.8	10.0	0.1	1.9	3.2	6.7	0.0	6.6	5.9	7.7	2.9	0.0	0.0	6.6	0.0	0.0	0.0	0.0	34.9	14.3	0.0	10.2	0.0	0.8	13.2	6.0	0.2	0.0	0.0	4.5	36.1	3.1	0.2	0.0	7.5	31.8	0.0	0.1	0.2	0.0	0.0	0.0	7.8	34.3	0.1	0.0	11.4	16.7	8.1	14.4	27.4	0.0	0.0	1.4	13.6	5.3	5.4	1.9	1.5	5.7	7.3	0.0	2.9	25.9	12.1	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.3	0.0	2.3	0.0	19.2	0.0	0.1	3.7	2.5	1.5	5.7	0.0	4.2	3.2	0.6	48.6	7.7	1.8	0.0	28.8	0.8	55.6	5.9	14.5	0.1	2.6	0.3	6.9	0.0	6.1	0.0	11.8	5.3	3.2	31.6	5.3	0.0	2.2	0.0	27.5	2.1	0.0	0.0	15.3	8.2	0.6	3.5	0.7	0.6	0.8	1.8	0.0	0.6	0.0	0.0	0.0	0.0	12.1	25.1	0.0	0.4	2.6	66.5	45.4	1.0	0.0	0.0	2.4	0.6	0.0	1.1	8.2	2.7	45.6	3.5	1.4	11.1	10.4
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 27.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 74.8;TIME: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		11000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear membrane"	"CAB004028: AB_2212507, HPA073577: "	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	41.6	11.7	2.7	4.3	3.8	0.0	26.1	2.8	4.1	14.8	10.4	6.3	2.2	39.5	2.9	4.0	17.9	5.6	20.6	2.1	2.8	15.7	9.2	23.5	2.8	3.2	3.6	5.2	6.2	8.6	11.0	30.9	3.5	11.7	1.0	16.4	5.3	10.0	6.5	5.9	7.5	7.5	3.3	4.4	8.4	1.8	4.5	1.0	34.4	4.6	1.0	8.6	7.5	3.4	0.0	0.0	4.4	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.5	0.0	0.0	0.9	0.0	0.0	0.4	0.2	74.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.8	2.8	4.1	2.1	2.8	3.2	3.6	3.5	3.3	4.5	3.4	157.8	0.0	4.9	0.0	1.4	2.5	0.5	0.1	1.8	11.7	1.3	2.5	9.4	1.5	18.4	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.8	0.4	2.6	143.8	0.0	2.7	0.1	0.0	0.1	8.3	0.0	0.8	2.5	0.0	158.1	3.3	0.4	0.0	1.3	0.0	0.0	10.6	2.1	0.9	0.0	1.2	7.2	7.5	0.0	206.6	0.0	0.0	6.1	0.5	0.0	0.4	1.3	0.5	0.0	0.0	3.9	7.9	0.0	0.9	7.5	0.3	0.9	0.8	2.7	0.1	0.6	1.6	0.0	1.4
KHDRBS2	"MGC26664, SLM-1, SLM1"	ENSG00000112232	"KH RNA binding domain containing, signal transduction associated 2"	Q5VWX1	6	61679961-62286225	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;retina: 4.0;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 1423.1;Inhibitory neurons: 720.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.8"	"Group enriched"	"Detected in some"	13	"memory B-cell: 5.9;naive B-cell: 6.9;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.9;dendritic cells: 1.9"	"Group enriched"	"Detected in some"	7	"AF22: 4.7;NTERA-2: 1.6;THP-1: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000500, HPA029392"	Supported					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA000500: AB_1079184, HPA029392: AB_10600816"	"unprognostic (6.98e-2)"			"unprognostic (1.21e-1)"	"unprognostic (3.06e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-5)"	"unprognostic (5.52e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.15e-1)"	0.1	0.9	1.0	0.3	2.0	0.1	0.0	0.0	5.8	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	2.3	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.0	0.1	0.1	4.0	0.0	0.1	0.2	0.0	0.7	0.0	0.0	1.0	0.1	0.1	0.5	0.6	4.1	0.0	0.5	0.2	0.0	2.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.1	0.3	1.9	0.0	0.3	1.0	2.0	0.0	5.8	0.9	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	38.5	3.3	17.6	24.3	0.0	0.0	0.0	0.6	41.4	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.7	1423.1	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.4	0.0	0.1	35.3	720.1	0.0	0.0	0.3	0.0	0.0	0.3	1.4	0.0	117.1	0.3	30.5	0.0	238.8	99.4	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.0	3.1	0.0	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127438406-127459389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.6;skeletal muscle: 28.3"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 93.0;Alveolar cells type 2: 27.1;Skeletal myocytes: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.4;SCLC-21H: 33.3;SH-SY5Y: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	16.8	2.3	16.9	0.9	18.4	0.0	3.7	20.1	32.6	4.3	8.0	9.7	0.9	2.9	1.8	6.2	2.0	1.6	2.1	18.2	17.4	1.2	0.7	13.2	0.3	16.7	16.9	2.5	0.8	0.0	13.9	0.3	17.2	4.3	3.6	8.7	1.8	1.1	28.3	1.0	4.3	1.8	18.0	2.0	5.4	4.0	17.7	0.3	0.9	10.4	0.2	6.0	3.6	19.6	0.0	2.1	10.4	0.0	0.8	1.7	0.0	0.2	1.3	1.1	2.7	0.0	0.0	0.0	0.0	0.2	7.0	0.0	1.0	0.0	1.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	4.3	0.0	0.9	0.0	1.2	0.0	0.0	1.2	0.0	4.7	0.0	4.8	0.0	0.0	0.0	2.6	0.0	0.2	0.0	33.3	17.8	0.0	0.0	0.2	0.0	0.0	1.1	0.0	5.3	0.8	0.0	1.9	0.0	0.0	0.0	4.7	0.3	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	18.4	20.1	32.6	18.2	17.4	16.7	16.9	17.2	18.0	17.7	19.6	0.4	93.0	27.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.7	0.0	0.3	8.4	0.0	0.0	0.0	0.3	0.3	0.6	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	3.6	1.1	0.0	34.3	0.5	1.0	0.1	0.0	0.0	0.1	0.1	3.4	0.0	0.0
KIAA1191	"FLJ21022, p33MONOX, p60MONOX"	ENSG00000122203	KIAA1191	Q96A73	5	176346062-176361807	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 304.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044701, HPA048145"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA044701: AB_2679053, HPA048145: AB_2680283"	"unprognostic (7.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.39e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (5.02e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.73e-2)"	41.7	44.3	40.6	26.7	43.8	30.8	46.0	33.4	43.2	50.9	44.3	46.3	49.6	49.4	52.5	61.2	66.8	42.9	86.7	45.1	47.4	199.3	70.4	47.9	29.2	39.1	39.6	90.0	57.3	87.0	33.1	38.2	45.1	55.2	44.5	58.6	72.3	64.8	70.9	44.2	51.0	55.1	32.7	34.0	62.0	12.8	46.3	36.6	60.8	63.2	37.5	49.7	34.3	33.9	61.5	63.4	105.1	142.7	95.6	72.8	82.6	86.8	86.2	96.6	106.1	118.2	60.2	24.0	111.9	105.5	145.2	53.8	67.6	157.6	113.1	125.0	81.4	27.9	41.4	63.1	111.0	24.0	47.2	73.9	115.2	83.2	70.8	109.6	120.7	39.1	43.1	51.2	108.6	81.7	34.7	14.5	47.1	65.6	81.2	25.2	66.1	21.1	92.6	60.0	82.8	91.6	92.3	45.7	103.6	94.6	66.9	27.1	106.5	88.4	40.2	65.7	107.5	33.7	49.7	27.7	69.0	46.5	71.3	33.8	23.8	32.9	28.7	28.6	32.1	25.1	27.3	27.6	23.1	18.3	28.4	29.7	10.4	27.4	29.0	18.2	40.2	28.6	40.6	43.8	33.4	43.2	45.1	47.4	39.1	39.6	45.1	32.7	46.3	33.9	26.8	54.5	41.0	16.6	31.3	34.0	40.6	29.1	39.3	31.3	40.8	35.6	61.2	34.3	35.9	33.1	25.0	25.0	35.8	38.7	93.9	37.2	2.5	27.5	24.5	30.2	43.2	17.4	19.6	27.4	13.7	29.6	28.1	35.6	17.7	20.6	26.0	45.8	15.8	48.8	22.7	28.3	30.5	21.4	27.1	7.9	31.1	19.8	21.4	12.2	29.5	33.5	13.4	12.5	16.0	37.9	37.5	38.4	28.6	45.0	50.1	304.3	35.1	30.8	13.1	23.8	26.0	7.2	6.0	38.7	31.7	33.4	30.3	20.0	30.6	47.5
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF7	JBTS12	ENSG00000166813	"Kinesin family member 7"	Q2M1P5	15	89608789-89655467	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein, Repressor"	"Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.4;Oligodendrocyte precursor cells: 10.1;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 33.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043145	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA043145: AB_10969200"	"unprognostic (9.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.74e-3)"	"prognostic unfavorable (3.80e-5)"	"unprognostic (1.81e-1)"	"unprognostic (3.67e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.39e-8)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.66e-1)"	6.8	3.2	2.0	1.3	1.7	0.2	5.4	1.4	1.7	8.3	3.3	5.6	0.6	7.0	0.5	1.9	7.6	1.2	5.4	1.6	1.7	2.4	0.9	2.2	1.2	1.9	2.0	9.1	1.1	2.2	4.2	1.0	1.8	6.6	0.4	0.2	2.5	2.4	1.3	2.3	3.0	1.4	1.5	2.2	3.4	1.8	2.0	1.0	4.9	0.4	0.3	7.0	4.9	1.1	0.4	2.7	3.9	9.8	9.8	3.6	6.9	15.5	4.9	8.4	6.8	5.4	3.4	0.0	4.0	11.2	2.2	3.7	3.8	0.0	2.0	0.0	15.5	3.5	10.4	6.0	9.3	0.0	0.1	6.7	1.9	5.1	0.0	1.5	3.6	7.9	2.7	0.1	2.9	0.8	5.3	0.5	9.4	0.1	2.4	0.1	0.3	0.0	0.1	1.5	2.2	5.7	16.5	0.2	6.1	2.1	1.8	1.1	7.6	13.5	11.0	33.9	7.3	6.7	2.5	0.0	13.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.7	1.4	1.7	1.6	1.7	1.9	2.0	1.8	1.5	2.0	1.1	0.5	0.0	0.0	14.4	0.0	0.3	1.0	0.5	2.2	0.9	1.8	1.8	5.4	0.0	0.2	0.0	0.0	0.3	0.3	0.7	0.0	0.1	0.5	0.5	4.0	2.1	0.0	0.8	2.9	0.4	0.2	4.3	1.5	0.6	0.0	4.8	1.4	0.1	0.1	0.0	4.5	0.4	0.0	0.0	0.4	0.4	5.6	0.1	0.0	5.6	0.0	1.2	0.0	10.1	0.3	0.1	0.1	4.1	0.0	1.3	0.0	0.3	0.1	0.2	6.6	3.2	3.7	0.7	1.4	0.3	0.4	0.3	0.4	4.2	0.4	0.8
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867136	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 70.0"	"Cell type enriched"	"Detected in some"	9	"Bipolar cells: 58.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HMC-1: 33.0;JURKAT: 19.5;U-937: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"		"HPA071587: AB_2732182, HPA074326: AB_2732251"	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.5	0.0	0.5	0.2	1.4	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	1.1	0.0	0.0	0.8	0.4	0.4	0.0	70.0	0.0	0.9	0.1	0.4	0.0	0.1	11.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.5	0.6	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.7	1.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	1.1	0.7	0.0	0.1	0.0	3.6	0.1	2.9	0.0	0.1	21.5	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.2	0.0	0.0	0.0	0.0	0.0	19.5	0.2	0.3	0.0	0.2	0.6	0.1	0.2	0.1	0.0	5.5	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.8	1.3	0.3	0.0	0.0	0.0	0.4	0.0	7.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.3	1.0	0.8	0.1	0.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	1.8	0.1	0.2	0.1	0.0	0.0	0.4	6.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016423-33066143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 47.1;kidney: 128.7;parathyroid gland: 135.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 123.3"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 2.4;SK-BR-3: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2"						"Secreted to blood"	NA	NA	510000			"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	3.3	1.4	0.9	0.8	3.1	0.1	2.5	0.8	1.5	1.8	47.1	2.1	2.7	1.2	8.8	1.1	0.8	1.3	1.1	4.2	1.1	128.7	0.4	3.5	1.0	0.5	0.5	0.1	1.2	135.2	0.3	30.4	0.5	8.0	0.9	0.0	0.8	2.5	0.7	0.6	2.6	1.2	0.6	2.4	2.0	0.5	0.8	0.5	1.3	1.5	0.5	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.1	0.8	1.5	4.2	1.1	0.5	0.5	0.5	0.6	0.8	0.5	15.8	0.0	0.5	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.7	12.9	0.0	0.2	0.0	0.4	5.9	0.0	1.8	0.1	2.5	10.2	16.3	0.4	1.2	0.0	0.1	1.6	0.0	0.1	0.0	0.1	1.1	0.2	2.8	0.0	0.5	1.1	0.0	0.9	1.0	0.8	0.3	1.9	0.0	6.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.6	1.8	123.3	0.7	0.0	0.0	1.1	2.3	1.4	0.5	0.0	0.1	0.1	1.1	0.1	1.9	0.1
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.2;Oligodendrocytes: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003423, HPA030490"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA003423: , HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	19.9	8.2	8.2	13.8	15.0	40.3	15.0	19.3	9.1	8.9	0.0	11.4	4.6	16.9	5.9	9.7	10.0	11.8	10.1	8.3	13.4	7.9	7.1	15.2	7.7	20.2	17.0	14.2	5.1	3.0	4.9	5.8	20.9	8.2	5.3	4.7	7.4	7.4	4.9	6.8	10.3	20.9	12.1	10.3	9.1	6.8	17.4	14.3	8.8	7.4	7.3	9.8	9.8	20.3	8.8	6.1	16.3	1.1	5.6	14.4	3.4	10.0	8.0	15.3	6.7	0.1	7.1	0.1	6.3	20.6	26.5	21.5	13.9	46.2	8.2	6.0	0.8	0.2	18.5	3.5	9.7	4.6	6.7	19.3	15.3	10.7	35.0	22.0	18.1	4.6	0.0	8.2	11.8	0.2	5.6	1.7	9.7	0.9	3.0	2.4	4.3	6.4	3.7	6.8	25.0	30.5	8.6	12.0	7.8	13.0	2.0	6.9	35.9	30.3	14.5	12.9	12.0	6.2	4.5	0.0	26.7	3.8	6.1	28.9	9.4	12.3	1.6	12.1	0.6	5.7	8.4	1.6	5.3	7.7	14.3	9.9	40.8	22.9	22.7	2.4	7.7	6.1	8.2	15.0	19.3	9.1	8.3	13.4	20.2	17.0	20.9	12.1	17.4	20.3	95.2	41.7	6.7	74.4	15.8	21.9	23.1	35.0	6.2	9.0	9.9	11.4	17.6	14.3	15.1	9.2	12.5	0.5	6.9	0.4	1.9	22.7	10.2	13.9	33.7	65.8	6.0	2.5	46.4	51.5	0.8	22.0	11.7	17.3	12.0	3.6	79.9	14.7	15.6	11.8	31.1	2.6	34.6	50.0	22.9	5.2	13.7	37.6	3.6	61.8	28.3	7.1	8.2	68.9	160.5	79.9	1.4	10.1	4.3	9.2	14.1	4.3	9.8	8.7	46.0	38.6	42.0	0.8	14.8	8.1	15.3	1.1	7.6	7.9	4.3	9.3
KLHL3	KIAA1129	ENSG00000146021	"Kelch like family member 3"	Q9UH77	5	137617500-137736089	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.1;Excitatory neurons: 91.9;Inhibitory neurons: 56.1;Late spermatids: 60.7;Muller glia cells: 46.2;Oligodendrocytes: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 5.8;RT4: 6.1;TIME: 13.5;U-266/70: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051291	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051291: AB_2681423"	"unprognostic (4.31e-2)"	"unprognostic (5.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.39e-3)"	"unprognostic (3.28e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.50e-4)"	4.4	7.1	8.5	2.3	10.6	1.0	3.9	26.7	9.9	5.2	3.4	2.8	1.8	3.3	1.8	2.5	3.7	4.0	16.5	9.5	7.4	8.5	2.5	3.0	3.9	6.8	7.2	5.8	2.4	0.4	8.5	2.3	7.1	3.2	1.6	7.7	2.1	1.5	1.9	2.1	2.9	2.4	5.2	4.2	3.5	6.5	8.3	3.9	9.2	1.6	2.9	3.3	4.7	12.6	0.3	0.3	1.4	0.0	0.8	1.1	0.9	0.3	0.4	0.1	0.2	0.5	5.3	1.3	2.8	0.0	0.0	0.1	0.3	2.5	0.2	1.4	0.6	0.6	1.1	0.0	0.3	0.0	1.0	1.0	0.2	0.6	0.0	2.2	5.8	3.7	0.2	1.1	0.2	0.0	3.0	0.8	2.4	0.0	0.8	2.4	0.0	0.0	0.9	6.1	1.6	0.9	0.3	0.0	0.5	3.8	0.0	0.5	13.5	0.4	0.3	0.0	0.4	7.9	4.7	0.0	5.0	0.1	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.9	0.5	0.0	0.7	0.0	0.4	0.4	0.2	8.5	10.6	26.7	9.9	9.5	7.4	6.8	7.2	7.1	5.2	8.3	12.6	13.3	0.0	2.2	20.2	1.9	1.1	1.7	1.4	1.2	15.6	1.8	1.5	36.4	1.5	1.4	7.3	22.9	0.6	5.6	0.5	1.9	0.8	44.1	7.1	1.8	14.1	15.6	2.7	91.9	0.9	0.1	3.9	9.2	7.1	1.3	6.6	24.7	3.7	0.6	5.0	56.1	1.0	0.0	1.3	1.2	60.7	2.5	0.7	1.8	7.5	1.0	46.2	5.2	30.7	66.4	1.3	0.3	1.9	1.0	0.8	0.5	0.3	2.3	6.6	0.0	3.7	3.9	9.2	8.5	1.8	0.9	0.1	3.2	6.8	1.9	1.2
KLHL5		ENSG00000109790	"Kelch like family member 5"	Q96PQ7	4	39045039-39126857	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 186.3;Microglial cells: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 323.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013958	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013958: AB_1852590"	"unprognostic (6.02e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.24e-3)"	41.4	22.4	53.9	32.3	53.8	9.0	18.7	44.8	56.5	17.0	29.4	44.4	12.7	19.1	13.5	32.0	9.4	23.1	14.4	49.8	50.0	25.0	42.3	20.2	33.7	53.5	50.2	18.4	11.3	12.9	7.5	28.0	53.0	35.9	16.1	11.8	10.2	66.0	10.7	6.1	13.2	46.1	56.7	21.0	13.1	11.0	55.2	14.6	21.5	18.9	38.9	34.8	9.5	52.6	56.7	78.2	40.9	30.2	22.9	58.5	59.1	44.2	323.1	36.6	35.4	64.6	40.4	86.4	52.4	45.5	192.7	3.3	50.7	112.3	46.6	8.8	10.1	36.8	71.4	46.5	195.6	10.9	11.9	74.5	61.9	55.5	137.7	134.1	73.7	13.8	28.2	17.0	87.1	23.8	11.5	19.6	12.6	14.3	75.5	20.9	53.7	2.1	31.3	23.0	2.8	29.7	25.0	8.0	21.8	49.0	19.3	22.9	94.2	96.8	65.4	25.5	53.8	19.3	18.7	79.0	78.6	28.3	22.9	5.4	2.2	0.4	0.7	3.2	1.1	5.1	1.4	0.8	2.5	3.7	1.1	0.5	2.3	1.0	1.4	0.9	0.2	0.8	53.9	53.8	44.8	56.5	49.8	50.0	53.5	50.2	53.0	56.7	55.2	52.6	74.9	16.0	1.1	45.7	38.0	3.7	9.4	22.9	7.4	18.8	16.5	11.2	4.5	17.2	33.7	11.0	4.2	1.0	6.3	0.3	17.6	39.3	2.8	4.0	11.1	43.6	1.2	10.9	46.1	21.0	57.9	12.6	3.1	5.3	2.5	9.5	22.9	35.6	13.3	70.7	186.3	0.4	12.2	25.4	25.8	6.6	8.1	28.6	17.8	190.2	27.5	12.1	7.2	69.9	79.0	24.3	0.1	13.9	43.0	31.5	2.0	21.8	32.7	3.4	0.0	14.2	17.3	9.8	5.6	3.3	3.4	5.7	10.7	32.4	0.7	14.1
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 253.0;esophagus: 94.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 23.9;Breast myoepithelial cells: 16.1;Collecting duct cells: 11.0;Oligodendrocytes: 87.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 575.5;CAPAN-2: 1346.5"	"Region enhanced"	"Detected in all"		"pons and medulla: 167.8"	"Region enhanced"	"Detected in many"		"spinal cord: 371.7"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		10000000		"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.2	0.0	71.8	0.0	135.8	0.0	7.2	170.8	119.8	53.1	45.6	0.1	0.2	1.5	0.4	94.2	28.9	3.5	0.0	72.9	94.3	20.4	0.0	0.0	0.0	213.8	130.8	0.8	0.0	0.0	0.7	0.0	182.1	0.1	0.0	0.0	15.8	2.2	0.0	9.9	0.0	0.0	123.6	5.8	0.1	0.9	118.1	1.5	0.0	0.0	36.4	0.0	27.4	253.0	575.5	0.0	0.0	1.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	67.7	1346.5	0.0	8.1	0.0	0.6	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	131.0	2.2	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	5.6	18.2	1.0	1.9	0.0	1.1	46.3	0.0	1.3	0.0	0.4	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.8	135.8	170.8	119.8	72.9	94.3	213.8	130.8	182.1	123.6	118.1	253.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	0.0	23.9	16.1	0.3	0.0	1.7	11.0	0.0	0.1	0.4	0.0	0.0	0.1	2.3	0.6	7.5	0.4	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	87.9	7.8	0.0	0.0	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	1.6	0.0	0.3	0.1	0.0	0.0	2.4
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976468-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 94.7;skin 1: 201.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Basal keratinocytes: 5.0;Basal squamous epithelial cells: 4.6;Breast glandular cells: 9.4;Breast myoepithelial cells: 10.4;Squamous epithelial cells: 5.9;Suprabasal keratinocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 8.0;HaCaT: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		3700000	"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	7.1	0.1	8.4	0.1	9.2	0.3	11.2	0.9	7.4	19.7	1.0	0.1	0.5	0.7	0.2	94.7	16.3	1.3	0.2	6.5	1.4	12.1	0.1	3.1	0.0	4.3	1.4	0.1	0.1	0.3	0.7	0.0	4.9	0.1	0.0	0.1	21.6	0.2	1.0	201.2	0.0	0.2	2.1	0.8	0.3	0.3	7.4	0.9	0.2	0.0	10.9	0.0	30.9	3.0	5.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	8.0	0.0	1.1	0.0	0.1	31.7	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	8.4	9.2	0.9	7.4	6.5	1.4	4.3	1.4	4.9	2.1	7.4	3.0	0.0	6.4	1.1	0.0	0.0	5.0	0.1	0.5	4.6	0.0	9.4	10.4	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	5.9	10.7	0.0	0.1	0.0	0.1	2.7
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607916	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 36.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 642.3;NK-cells: 1855.8;T-cells: 790.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 2177.1"	"Group enriched"	"Detected in all"	140	"NK-cells: 756.7;T-cells: 2177.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"	3.1	1.7	0.7	17.8	0.8	47.4	5.1	0.3	0.8	4.2	0.2	7.7	10.7	1.6	1.4	3.2	1.5	10.7	0.7	0.6	0.7	1.4	11.3	6.7	20.1	0.6	0.6	1.0	0.4	0.2	0.3	1.4	0.6	2.1	8.1	0.1	0.8	1.0	0.7	0.8	20.1	1.6	0.6	28.9	10.1	0.6	0.6	5.7	1.3	0.9	36.4	10.6	1.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.4	0.2	9.5	2.2	1.1	519.7	2.1	2177.1	1.6	307.4	346.1	1.9	1.5	17.1	98.0	10.5	756.7	3.6	3.9	77.9	285.3	0.7	0.8	0.3	0.8	0.6	0.7	0.6	0.6	0.6	0.6	0.6	0.8	6.1	0.0	8.9	0.0	19.0	9.7	0.9	0.0	1.2	0.0	5.2	2.5	1.0	4.3	1.3	0.0	0.0	0.4	642.3	1.7	0.0	0.6	0.0	1.9	1.5	6.2	0.0	118.1	0.4	0.0	0.1	7.9	12.2	2.4	0.0	0.0	45.3	10.1	0.9	0.0	0.6	1.0	0.0	36.2	15.8	0.0	0.0	13.2	24.9	0.0	28.1	0.0	1855.8	2.5	0.1	0.0	3.3	0.0	23.0	1.1	0.9	2.0	0.0	0.0	0.0	1.6	4.1	0.0	0.1	1.2	8.8	1.0	790.5	0.0	2.0	1.3
KLRC4	NKG2-F	ENSG00000183542	"Killer cell lectin like receptor C4"	O43908	12	10407382-10409757	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 22.2;NK-cells: 8.2;Plasma cells: 4.7;T-cells: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"gdT-cell: 8.2;memory CD8 T-cell: 5.9;naive CD8 T-cell: 6.7;NK-cell: 4.7"	"Group enriched"	"Detected in many"	59	"NK-cells: 4.7;T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.5;SuSa: 1.8;U-698: 1.7"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.60e-1)"		"unprognostic (7.00e-2)"	"unprognostic (1.55e-4)"		"unprognostic (1.89e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.51e-3)"	0.8	0.7	2.0	2.3	2.1	1.7	1.5	0.9	2.0	0.6	0.2	1.2	1.3	0.8	0.6	0.8	0.5	2.2	0.3	1.6	2.0	0.2	1.2	1.8	4.7	2.2	1.6	0.4	0.1	0.0	0.1	0.5	1.8	0.4	1.3	0.1	1.1	0.1	0.0	0.1	2.6	0.5	1.2	9.4	2.3	0.6	1.9	0.6	0.7	0.0	3.2	0.6	0.5	2.8	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.3	0.0	0.0	5.9	0.0	0.0	0.0	6.7	0.1	4.7	0.0	0.0	0.0	1.8	2.0	2.1	0.9	2.0	1.6	2.0	2.2	1.6	1.8	1.2	1.9	2.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.4	0.0	0.0	0.4	0.0	8.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.2	0.0	0.1
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.1;lymphoid tissue: 42.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.2;NK-cells: 6.2;Plasma cells: 4.5;T-cells: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 335.8;T-cells: 287.4"	"Cell line enriched"	"Detected in some"	9	"U-698: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	5.5	2.1	1.7	12.6	1.9	22.1	4.1	1.7	2.8	2.2	1.2	3.9	4.7	2.5	2.3	2.2	2.8	7.3	1.8	1.7	2.0	2.0	5.5	12.1	37.0	2.0	1.7	2.4	1.1	0.5	1.1	1.4	1.8	2.5	4.5	0.4	4.4	0.9	0.8	1.3	12.2	1.8	1.7	42.9	7.2	2.5	1.7	9.9	3.6	1.5	19.0	4.5	3.2	2.4	0.3	0.0	0.7	2.8	0.2	7.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.2	0.2	0.0	0.7	1.4	0.0	0.3	0.0	0.4	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.8	0.3	0.1	0.1	0.0	2.0	0.2	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	64.2	0.2	0.0	0.3	0.4	0.5	0.2	287.4	0.6	111.5	6.2	1.7	261.2	0.6	6.1	2.3	258.8	4.8	335.8	1.3	1.9	0.7	127.9	1.7	1.9	1.7	2.8	1.7	2.0	2.0	1.7	1.8	1.7	1.7	2.4	0.0	0.0	1.3	0.0	2.4	0.0	0.1	0.2	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.5	1.8	0.0	0.5	0.0	6.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	22.2	1.0	0.0	0.0
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 31.5;liver: 91.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.8;Hepatocytes: 46.9;Langerhans cells: 49.4;Macrophages: 33.0;Proximal tubular cells: 63.2;Syncytiotrophoblasts: 180.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 1.6;liver cancer: 3.3;renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	79	"classical monocyte: 11.0;intermediate monocyte: 32.3;memory B-cell: 36.1;myeloid DC: 11.3;naive B-cell: 42.0;non-classical monocyte: 33.8;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	97	"B-cells: 42.0;dendritic cells: 24.3;monocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.2;RPMI-8226: 9.1;RPTEC TERT1: 21.9;SK-BR-3: 10.9;U-698: 9.4"	"Region enriched"	"Detected in single"	4	"thalamus: 1.1"	"Low region specificity"	"Detected in many"			"HPA031115, HPA056942"	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 57: B-cells - Immune response"			"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	1.4	0.8	0.1	5.1	0.2	1.4	5.3	0.1	1.0	0.6	0.5	0.9	0.6	5.4	0.2	0.2	0.2	1.6	0.4	0.3	0.0	31.5	91.7	5.0	8.8	0.0	0.0	0.2	0.1	0.1	0.2	6.8	0.1	0.3	1.1	0.2	0.3	0.2	0.1	0.2	1.2	0.7	0.0	8.4	1.2	1.3	0.8	1.6	0.2	0.0	11.2	5.6	0.1	0.3	0.2	1.8	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.2	0.4	0.0	0.2	6.2	0.4	0.0	0.2	2.5	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.2	0.7	0.1	0.2	0.5	0.0	0.4	0.1	0.9	0.0	0.2	0.0	2.4	1.0	0.9	0.4	1.6	0.1	9.1	21.9	4.5	0.3	0.1	0.0	10.9	0.1	2.1	4.3	2.1	0.0	0.0	0.1	0.1	1.6	0.4	0.6	9.4	0.2	2.7	1.8	0.1	11.0	0.2	0.0	32.3	0.0	36.1	0.0	0.0	11.3	42.0	0.0	0.1	0.3	0.0	33.8	24.3	0.0	6.1	0.1	0.2	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.1	0.0	0.5	0.0	33.8	1.0	0.1	13.3	2.2	0.0	1.8	0.8	0.4	2.8	11.1	0.0	0.0	3.6	5.5	0.1	5.9	4.8	4.9	9.5	1.5	0.3	0.0	5.2	6.6	0.2	2.3	0.4	2.0	26.6	0.0	0.1	0.7	46.9	7.0	0.0	30.0	0.0	4.1	22.7	49.4	1.8	0.0	33.0	0.0	0.0	5.5	0.0	1.0	1.0	0.6	1.5	0.0	0.0	11.7	0.2	0.2	63.2	2.3	0.0	0.0	0.1	1.3	1.6	0.3	3.1	1.4	180.1	1.6	0.1	0.0	0.1
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717348-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 3195.2"	"Group enriched"	"Detected in some"	25	"Distal tubular cells: 655.4;Hepatocytes: 1816.9"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;Hep G2: 1.7;RH-30: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	NA	NA	90000000000	47000000000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	464.1	3195.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	48.6	0.0	33.1	0.0	0.0	0.0	1.8	655.4	0.0	0.4	0.0	0.0	1.5	0.0	40.2	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	30.0	1816.9	0.1	0.0	0.8	0.1	0.0	47.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.5	0.1	1.1	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.7	0.0	0.1	0.1
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KRT85	"Hb-5, KRTHB5"	ENSG00000135443	"Keratin 85"	P78386	12	52360006-52367481	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"skin 1: 172.7"	"Group enriched"	"Detected in some"	12	"Early spermatids: 6.2;Late spermatids: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"A549: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049778	Supported					NA	NA		110000000		"Cluster 61: Skin - Cornification"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA049778: AB_2680877"	"unprognostic (1.36e-2)"	"unprognostic (3.93e-1)"				"unprognostic (7.27e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.36e-1)"		"unprognostic (4.72e-2)"			"unprognostic (9.22e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.38e-1)"		3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	172.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
KRTAP5-8	"KRTAP5-2, KRTAP5.8, UHSKerB"	ENSG00000241233	"Keratin associated protein 5-8"	O75690	11	71538025-71539209	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 6.0;skin 1: 7.6"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (9.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.92e-2)"		"unprognostic (2.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.14e-1)"		"unprognostic (3.62e-2)"	"unprognostic (2.21e-3)"	0.1	0.1	0.4	0.0	0.5	0.0	0.1	0.3	0.8	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.4	0.4	6.0	0.2	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.1	7.6	0.1	0.0	0.3	0.1	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.8	0.4	0.4	0.4	0.4	0.5	0.3	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877657-143055833	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.4;urinary bladder: 51.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7"	"Group enriched"	"Detected in many"	19	"B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7"	"Cell line enhanced"	"Detected in many"		"A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		590000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	5.2	4.0	2.4	24.4	2.1	10.8	30.8	2.7	4.5	4.0	3.6	2.4	1.1	2.5	1.3	6.7	1.2	9.8	1.2	2.0	1.6	18.6	88.4	13.5	15.0	2.8	1.7	0.4	0.9	0.8	1.2	7.3	3.3	0.9	2.9	1.5	1.8	0.7	0.7	1.3	3.0	4.8	0.5	8.9	5.8	16.6	6.6	3.9	2.3	0.3	28.9	51.5	3.4	2.1	0.2	185.2	0.3	0.4	0.4	0.6	0.5	0.4	5.1	0.2	0.2	3.3	2.7	11.9	0.5	0.1	298.5	0.7	0.1	0.2	0.2	0.6	0.2	4.3	195.5	128.3	2.4	0.4	0.8	17.3	15.0	106.5	0.6	0.2	0.2	0.3	0.5	1.1	1.7	96.7	0.2	11.8	0.7	0.2	0.9	0.2	0.9	0.4	3.2	96.0	0.5	0.3	102.2	15.2	1.0	1.0	50.9	26.5	1.5	5.9	0.5	89.1	0.3	0.7	0.3	0.3	314.5	22.2	0.6	0.7	109.4	2.4	0.5	142.7	0.4	73.6	0.6	0.3	111.2	51.3	0.5	0.3	5.8	1.8	123.4	77.7	0.6	49.2	2.4	2.1	2.7	4.5	2.0	1.6	2.8	1.7	3.3	0.5	6.6	2.1	3.0	3.2	2.7	0.7	46.8	4.0	0.5	136.1	0.0	0.5	5.8	0.9	1.6	7.2	109.6	3.7	4.2	3.3	16.1	0.7	5.9	14.5	46.3	1.5	1.1	5.1	0.0	2.5	1.3	9.5	2.3	1.8	20.4	15.7	0.0	0.0	2.5	49.1	38.8	10.1	0.9	0.0	114.0	64.7	190.5	42.8	1.8	122.9	1.8	29.0	248.0	0.2	1.0	0.5	0.8	59.6	1.1	0.4	5.1	1.1	0.0	44.4	21.1	0.6	6.6	0.5	3.9	47.8	8.0	1.5	3.1	104.7	2.2	0.1	1.0	22.6
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312229	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	4.6	2.5	2.9	2.2	2.9	2.7	3.7	6.1	5.5	2.3	1.3	4.3	4.7	2.4	3.0	5.1	3.1	2.0	5.2	2.7	2.5	19.6	12.6	1.8	2.6	1.2	2.4	2.5	3.9	6.1	2.3	1.7	1.1	3.3	5.0	11.4	2.8	3.2	15.5	5.1	3.6	2.5	1.2	1.3	4.3	3.9	2.4	3.0	4.8	14.7	3.4	2.4	2.3	4.1	24.3	16.6	6.8	6.6	3.3	2.2	19.1	7.9	4.4	12.2	14.3	26.8	10.8	19.0	9.0	3.2	9.7	17.4	20.6	8.2	13.5	15.2	11.9	41.1	10.9	3.7	3.1	14.7	13.7	2.0	5.2	8.1	7.0	3.1	5.3	19.3	14.7	11.6	3.2	29.0	16.7	6.7	9.9	20.6	17.6	15.6	22.0	14.8	11.4	28.0	13.8	9.9	23.3	17.5	10.4	9.0	22.9	4.0	5.0	7.7	21.5	9.0	10.6	10.5	25.6	26.3	4.3	7.3	8.8	8.6	0.4	0.9	0.9	0.1	2.2	0.8	1.1	1.0	0.6	0.6	1.3	1.7	0.5	1.7	0.1	1.0	1.6	0.5	2.9	2.9	6.1	5.5	2.7	2.5	1.2	2.4	1.1	1.2	2.4	4.1	1.9	41.7	19.2	16.6	5.1	3.7	2.7	2.1	8.6	15.5	3.9	2.2	14.7	2.8	20.4	12.9	56.3	6.4	6.1	4.8	15.6	3.8	35.1	5.2	2.8	4.6	7.8	7.4	60.5	4.2	6.6	5.3	7.7	5.6	18.9	6.0	2.9	14.2	2.1	11.8	61.4	4.3	0.0	2.7	0.6	8.8	2.5	3.3	1.8	13.1	2.4	6.1	7.2	20.6	18.9	2.5	3.6	4.5	3.3	2.7	6.0	21.7	18.4	40.3	0.0	5.8	3.9	14.3	12.6	10.5	6.3	4.9	5.0	4.6	7.6	2.1
LACTB2	CGI-83	ENSG00000147592	"Lactamase beta 2"	Q53H82	8	70635318-70669185	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 286.3;Proximal tubular cells: 325.7;Spermatocytes: 263.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 437.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044391, HPA053040"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		37000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA044391: AB_10965168, HPA053040: AB_2682022"	"unprognostic (6.33e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (3.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.93e-2)"	20.4	39.3	6.4	12.9	8.0	3.2	18.4	8.4	9.0	10.8	8.7	21.9	38.8	9.6	11.5	10.2	9.3	28.7	29.8	5.8	8.3	77.0	96.0	20.1	15.6	8.1	7.9	10.0	14.8	21.0	8.3	10.6	8.9	15.4	21.3	12.7	15.0	9.2	28.2	12.4	33.8	15.7	8.1	11.5	16.0	63.2	7.6	14.5	20.2	32.1	13.5	13.2	7.9	10.6	65.7	66.4	20.8	8.6	35.6	53.7	12.5	36.0	20.7	37.7	28.2	32.3	72.3	0.1	14.4	17.4	75.7	45.9	25.0	38.0	30.2	38.8	26.6	30.5	8.1	18.0	74.0	30.1	25.5	64.6	44.8	18.6	28.2	18.0	10.0	23.2	53.4	60.1	50.6	19.6	17.1	5.5	22.3	88.2	60.3	15.2	12.1	14.0	146.3	33.8	29.6	10.3	79.7	437.8	41.0	27.0	72.7	40.1	16.0	3.0	20.8	67.4	29.4	47.7	38.1	0.2	21.1	50.6	28.7	15.8	13.8	13.0	8.5	16.8	10.6	12.6	8.8	8.4	17.3	11.7	8.3	9.2	5.8	11.0	16.7	11.9	13.4	5.9	6.4	8.0	8.4	9.0	5.8	8.3	8.1	7.9	8.9	8.1	7.6	10.6	15.1	57.7	45.1	3.6	16.0	16.4	22.1	58.9	12.5	15.4	12.1	15.1	38.4	18.6	43.9	18.4	8.4	25.1	12.0	27.2	76.3	51.2	286.3	29.4	11.7	15.3	12.1	19.6	3.9	117.2	15.3	15.1	20.4	31.5	9.5	8.7	19.2	76.1	48.0	8.4	4.6	25.8	34.6	34.5	11.2	40.9	20.5	24.2	16.0	3.7	19.4	35.3	8.2	2.5	10.3	70.2	25.1	15.1	18.3	16.0	59.8	325.7	44.9	14.7	6.6	9.6	14.4	263.1	25.0	12.4	16.8	19.4	13.9	34.2	34.7	11.0
LAIR1	CD305	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.1;lymphoid tissue: 46.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 106.6;granulocytes: 109.3;Hofbauer cells: 190.9;Kupffer cells: 100.9;Macrophages: 128.9;NK-cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 7.5;Karpas-707: 19.4;THP-1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011155	Enhanced		Supported	"Plasma membrane"		NA	NA		350000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.01e-5)"	"unprognostic (1.72e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.52e-2)"	"unprognostic (5.22e-2)"	23.3	11.6	0.5	3.0	0.3	4.4	12.3	1.6	1.3	4.1	0.5	6.9	0.4	3.8	0.2	2.6	5.5	0.9	3.8	0.4	0.6	4.6	3.5	28.1	5.8	1.0	0.8	2.2	3.8	0.1	4.4	1.0	1.0	5.4	0.2	0.1	5.8	0.2	1.3	2.1	14.3	2.0	0.4	46.3	5.0	1.7	1.1	3.9	3.3	0.1	0.9	6.3	3.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	3.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	19.4	0.0	0.0	2.6	1.8	0.0	0.0	0.0	2.6	0.2	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	22.9	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	3.2	0.3	13.1	4.2	11.7	7.7	9.8	4.8	2.1	2.3	4.1	0.1	5.8	3.4	4.4	0.7	6.3	11.0	11.2	1.7	3.8	0.5	0.3	1.6	1.3	0.4	0.6	1.0	0.8	1.0	0.4	1.1	0.9	1.9	16.0	25.6	0.3	26.1	0.6	0.6	0.2	0.0	5.6	1.1	2.9	1.5	1.5	11.2	0.0	37.5	5.3	106.6	0.2	0.0	0.1	32.2	0.6	0.7	5.0	0.0	10.9	0.4	0.0	5.2	2.5	0.0	0.7	109.3	0.6	3.6	1.2	190.9	1.7	0.5	0.0	0.0	100.9	17.7	26.1	0.3	128.9	0.0	13.1	22.5	0.9	98.9	0.0	0.6	0.1	0.0	0.0	5.1	0.7	0.3	0.3	11.0	15.4	0.0	0.9	1.3	2.9	1.0	0.4	1.1	10.0	32.1	0.2	0.2	0.9
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689453-23956222	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 171.0;Gastric mucus-secreting cells: 138.1;Pancreatic endocrine cells: 585.5;Paneth cells: 170.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 40.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"HBEC3-KT: 1237.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		1800000		"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	10.0	1.2	8.3	8.5	3.6	0.1	20.3	2.8	5.9	15.4	5.4	13.6	17.8	15.6	4.7	14.5	12.0	7.4	4.2	4.1	3.5	3.2	1.7	20.9	4.1	3.8	5.9	5.7	4.7	10.9	3.0	24.8	3.6	12.2	8.4	3.7	21.3	13.5	2.0	32.1	19.7	6.9	3.5	0.8	31.8	3.3	4.3	9.5	2.3	1.7	4.1	12.2	23.1	2.9	140.5	15.7	0.1	0.1	6.9	1.3	0.3	2.6	1.8	1.3	1.7	5.4	159.5	0.1	17.3	1.8	0.4	248.5	0.2	1237.9	0.9	0.2	8.8	0.0	5.6	2.8	1.2	0.0	0.6	1.6	139.1	0.8	140.0	0.9	5.2	0.2	0.0	0.2	1.6	0.4	0.1	0.1	1.4	42.6	14.4	2.6	0.1	0.2	51.8	15.4	0.6	2.5	4.9	2.0	0.4	0.3	4.5	1.8	12.3	0.9	1.0	6.7	0.6	0.2	0.1	0.6	2.9	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.3	3.6	2.8	5.9	4.1	3.5	3.8	5.9	3.6	3.5	4.3	2.9	28.8	115.4	26.4	13.1	0.7	31.4	104.2	117.1	100.7	6.0	21.8	41.8	2.3	4.3	20.4	1.8	0.0	0.6	0.5	171.0	0.0	30.2	3.9	21.5	4.3	7.5	8.3	0.0	8.3	34.4	0.4	3.6	138.1	24.0	5.7	9.5	2.5	0.9	0.2	0.0	18.5	23.7	4.1	0.0	1.5	4.5	5.9	2.0	1.8	68.4	0.6	0.2	0.0	1.0	2.0	585.5	170.1	3.4	0.2	45.6	39.5	0.0	15.6	2.2	6.6	1.5	22.1	4.5	4.0	28.2	9.9	0.1	1.5	5.9	28.4	18.2
LAMC3	DKFZp434E202	ENSG00000050555	"Laminin subunit gamma 3"	Q9Y6N6	9	131009174-131094473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 48.7"	"Group enriched"	"Detected in many"	4	"Leydig cells: 118.4;Peritubular cells: 364.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;EFO-21: 17.3;Hep G2: 6.1;SiHa: 6.7;U-2 OS: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022814	Enhanced				"Secreted to extracellular matrix"	NA	NA		1100000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA022814: AB_2670960"	"unprognostic (9.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.55e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.83e-2)"	1.5	13.5	1.3	0.3	1.8	0.0	1.5	1.3	2.4	22.3	1.9	1.6	0.4	3.3	3.5	1.7	1.1	2.7	1.2	1.4	1.2	9.2	4.9	23.3	0.0	1.4	1.3	1.7	3.5	0.9	11.6	48.7	1.2	4.2	0.1	0.0	1.4	3.8	0.3	8.6	0.3	0.3	1.2	11.3	0.5	19.0	1.7	0.2	1.2	1.1	0.0	15.0	8.2	2.0	0.0	0.5	4.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	17.3	0.0	0.3	0.0	0.3	0.0	0.0	0.0	2.2	0.0	1.5	6.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	2.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.4	0.1	6.7	0.0	2.6	0.4	0.0	0.7	0.0	0.0	5.3	0.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	1.3	1.8	1.3	2.4	1.4	1.2	1.4	1.3	1.2	1.2	1.7	2.0	1.5	0.0	0.0	1.0	0.0	6.8	0.0	0.0	0.0	0.0	0.4	0.4	1.3	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.1	1.9	1.6	48.5	1.7	0.0	0.0	1.7	0.0	0.8	20.7	0.0	1.1	0.0	27.8	3.6	0.1	1.5	0.0	4.1	0.2	0.0	0.0	10.2	12.6	118.4	0.5	10.6	36.5	0.1	0.0	0.0	0.0	1.0	0.1	0.0	364.1	0.0	0.2	0.0	0.2	0.0	0.0	46.0	0.1	10.0	1.0	3.5	0.0	4.4	1.0	0.8	38.1	0.0	0.1
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.3;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 90.6;granulocytes: 171.6;Hofbauer cells: 82.7;Kupffer cells: 71.1;Langerhans cells: 81.9;Macrophages: 89.1;monocytes: 89.6;NK-cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 871.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 192.2;REH: 205.7;RPMI-8226: 73.3;THP-1: 186.5;U-937: 177.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	6.8	5.4	9.7	37.7	11.1	61.3	3.8	11.8	12.8	3.7	9.1	6.5	6.3	2.9	2.5	3.6	4.2	9.1	2.3	10.3	12.2	3.3	4.8	19.2	51.6	18.4	13.6	1.7	3.0	2.2	3.0	7.4	17.7	7.1	7.7	1.2	4.5	3.5	3.3	3.0	13.6	8.8	16.5	47.0	6.5	2.0	15.3	12.2	2.8	2.4	56.6	10.1	2.5	20.1	1.7	1.1	1.1	3.1	0.3	0.0	1.1	1.4	1.2	0.6	0.7	2.3	28.9	19.6	0.4	0.5	6.1	1.2	0.4	1.1	0.6	31.4	1.2	8.6	1.8	1.8	0.1	56.1	55.6	0.4	0.8	2.1	0.6	1.2	0.3	1.1	1.6	9.3	0.5	1.7	1.3	192.2	0.9	5.5	2.0	205.7	1.1	73.3	0.2	1.7	0.9	0.8	0.6	1.2	1.2	0.9	1.1	186.5	2.1	2.1	19.9	0.8	1.8	0.9	6.2	32.2	9.4	177.6	1.5	871.6	276.6	46.0	8.8	159.0	0.9	169.3	2.3	1.4	225.2	191.1	1.0	2.9	491.0	73.9	93.9	8.9	4.9	214.7	9.7	11.1	11.8	12.8	10.3	12.2	18.4	13.6	17.7	16.5	15.3	20.1	1.3	3.2	16.2	0.7	90.6	3.4	0.7	0.0	0.6	0.3	1.0	1.9	1.1	5.7	3.1	3.7	0.0	0.6	47.8	0.2	0.0	0.3	2.4	1.3	0.6	3.9	7.8	16.6	1.7	0.2	1.1	1.7	1.1	2.1	171.6	0.4	3.9	4.5	82.7	0.0	1.4	0.8	0.0	71.1	81.9	3.4	0.0	89.1	1.8	20.6	89.6	0.2	70.0	0.5	0.9	0.6	0.1	0.7	18.7	1.2	0.1	0.2	5.9	1.3	0.0	1.9	0.9	0.4	1.4	0.1	2.6	1.2	27.7	0.3	0.8	0.4
LAYN	"FLJ30977, FLJ31092"	ENSG00000204381	Layilin	Q6UX15	11	111540280-111561745	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Prostatic glandular cells: 233.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"myeloid DC: 11.2;T-reg: 13.4"	"Group enriched"	"Detected in many"	123	"dendritic cells: 11.2;T-cells: 13.4"	"Cell line enhanced"	"Detected in many"		"BJ: 150.7;BJ hTERT+: 153.7;BJ hTERT+ SV40 Large T+ RasG12V: 96.7;fHDF/TERT166: 95.1;HSkMC: 88.8;hTERT-RPE1: 94.0;U-138 MG: 108.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040087	Approved		Approved	Cytosol		NA	NA		340000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA040087: AB_10793927"	"unprognostic (2.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-2)"	10.7	2.0	15.6	5.7	21.4	1.0	8.5	15.7	19.6	15.6	13.7	29.2	3.8	15.8	10.1	4.7	17.7	17.0	7.0	16.6	17.1	5.7	0.9	11.3	7.1	17.4	19.7	39.1	2.0	6.4	6.2	14.1	16.3	14.6	3.3	0.8	5.5	17.0	6.1	2.6	10.6	22.5	14.2	8.2	13.1	4.4	18.0	10.3	27.4	6.1	5.0	8.8	12.2	23.7	0.4	3.9	0.8	0.0	25.4	48.0	7.6	150.7	153.7	71.0	96.7	0.2	0.1	0.0	1.4	95.1	18.7	3.2	9.9	0.7	74.2	0.2	0.5	0.8	0.0	0.2	41.7	0.0	0.2	88.8	0.0	30.8	0.2	94.0	0.9	0.0	0.0	0.1	29.4	0.0	0.1	0.1	4.8	0.0	0.0	0.0	11.4	0.2	0.6	0.0	4.9	18.9	0.5	0.2	0.4	34.9	0.1	0.7	0.6	108.8	81.2	1.0	74.3	0.0	0.0	0.2	14.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.4	0.4	15.6	21.4	15.7	19.6	16.6	17.1	17.4	19.7	16.3	14.2	18.0	23.7	22.2	19.2	2.8	0.3	0.3	2.2	48.8	44.8	0.6	0.4	0.7	15.0	2.7	2.8	23.3	0.0	0.0	1.6	2.6	0.0	0.0	6.5	2.5	3.9	7.7	50.9	0.0	2.7	0.3	0.2	2.1	13.1	0.0	0.9	1.3	9.6	6.8	0.1	0.7	0.0	1.4	0.0	6.1	0.6	13.6	1.8	22.7	1.2	0.0	2.8	0.6	0.2	0.0	4.0	30.1	0.8	0.0	55.3	2.8	233.0	0.0	0.2	32.0	0.2	32.9	2.6	17.3	0.1	2.3	0.1	2.3	0.5	14.5	11.2	0.0	50.3
LBH		ENSG00000213626	"LBH regulator of WNT signaling pathway"	Q53QV2	2	30231534-30323730	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 210.6;Pancreatic endocrine cells: 298.9;Smooth muscle cells: 435.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 112.4;MAIT T-cell: 110.2;memory B-cell: 92.0;memory CD4 T-cell: 83.8;memory CD8 T-cell: 86.1;naive B-cell: 123.0;naive CD4 T-cell: 140.2;naive CD8 T-cell: 124.6;T-reg: 89.2"	"Group enriched"	"Detected in all"	7	"B-cells: 123.0;T-cells: 140.2"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 302.4;hTERT-RPE1: 150.6;U-2 OS: 95.1"	"Low region specificity"	"Detected in all"							HPA034669	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA034669: AB_10600820"	"unprognostic (2.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.77e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.67e-1)"	35.2	10.3	8.4	57.4	7.9	28.6	32.0	13.7	22.4	45.6	18.4	27.4	14.4	83.0	27.0	17.0	41.7	44.9	119.3	15.2	33.9	39.3	15.0	130.7	117.8	23.0	17.4	63.3	14.4	84.8	16.7	54.5	18.4	27.3	18.1	70.8	63.9	26.3	14.3	30.3	41.2	48.2	11.2	83.5	22.8	9.8	14.4	125.7	68.9	20.4	100.9	35.5	22.7	11.8	0.1	11.4	14.0	2.5	3.6	2.2	1.1	14.5	19.1	3.8	0.6	59.4	15.2	28.6	33.3	302.4	3.8	19.5	81.1	0.8	0.6	41.3	3.4	4.6	12.2	0.2	10.9	0.4	4.0	13.0	1.1	5.0	0.3	150.6	0.7	19.0	14.6	0.2	14.2	0.2	32.3	0.4	84.6	2.6	0.6	33.1	75.4	9.7	2.6	5.0	3.9	10.0	23.7	2.3	1.0	49.7	0.1	1.2	18.9	26.8	95.1	52.0	1.8	53.8	3.3	2.7	11.9	1.8	8.4	0.7	0.7	1.1	112.4	1.2	110.2	92.0	83.8	86.1	0.8	123.0	140.2	124.6	4.0	18.9	3.2	12.1	89.2	110.4	8.4	7.9	13.7	22.4	15.2	33.9	23.0	17.4	18.4	11.2	14.4	11.8	46.9	109.0	20.0	0.7	167.3	12.4	64.5	51.7	16.5	41.2	13.0	125.0	65.1	12.8	40.8	25.8	210.6	18.3	152.2	6.0	13.7	85.4	39.4	110.5	18.0	81.8	23.8	85.9	2.2	56.9	10.8	54.7	23.4	45.2	15.8	2.3	23.6	1.2	33.2	8.4	16.4	9.3	30.5	10.0	23.1	144.5	10.5	14.3	23.2	14.0	6.7	13.1	163.7	9.5	0.7	298.9	8.7	26.7	26.3	95.3	0.7	21.7	67.8	45.4	177.5	36.3	435.6	0.7	6.6	9.1	10.7	9.3	205.3	8.8	6.3	56.8
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346482-38377013	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 1338.5"	"Cell type enriched"	"Detected in some"	30	"Hepatocytes: 458.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 10.7;HSkMC: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	58.2	0.5	0.0	24.2	0.1	0.5	6.6	0.0	0.2	4.6	0.0	0.5	0.0	2.6	0.0	0.1	0.6	0.2	3.3	0.0	0.0	8.7	1338.5	1.2	2.8	1.1	0.1	0.2	1.7	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.4	0.0	22.8	0.6	0.6	1.5	0.0	0.5	0.6	0.7	0.4	0.1	3.9	2.0	0.3	0.7	0.2	0.3	0.0	0.1	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.6	0.7	0.0	0.0	0.1	0.0	0.0	7.9	0.8	1.0	0.1	0.2	0.5	0.0	10.7	0.3	11.0	0.1	0.8	0.0	0.7	0.0	0.0	9.7	458.3	0.3	0.0	0.3	0.0	0.0	8.5	0.0	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	15.2	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0
LCE2D	"LEP12, SPRL1A"	ENSG00000187223	"Late cornified envelope 2D"	Q5TA82	1	152663380-152664659	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"skin 1: 152.1"	"Group enriched"	"Detected in some"	8	"Melanocytes: 1.8;Suprabasal keratinocytes: 4.7"	"Group enriched"	"Detected in some"	42	"head and neck cancer: 1.2;melanoma: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 28: Keratinocytes - Keratinization"									"unprognostic (3.94e-2)"			"unprognostic (5.63e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	152.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 343.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 143.9;NK-cells: 272.9;T-cells: 255.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	12	"gdT-cell: 1109.8;MAIT T-cell: 1034.8;memory CD4 T-cell: 1123.8;memory CD8 T-cell: 1201.7;naive CD4 T-cell: 1260.7;naive CD8 T-cell: 1168.7;NK-cell: 641.5;T-reg: 1682.7"	"Group enriched"	"Detected in all"	12	"NK-cells: 641.5;T-cells: 1682.7"	"Group enriched"	"Detected in some"	6	"JURKAT: 365.7;MOLT-4: 536.9;U-698: 302.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favorable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	3.4	2.2	0.4	50.6	0.5	13.7	2.3	0.4	0.5	2.2	0.7	6.9	7.6	1.7	13.0	3.9	2.1	9.4	1.9	0.5	0.4	3.8	3.8	11.4	111.0	0.8	0.5	1.6	0.9	0.5	0.8	1.1	0.6	2.8	6.5	0.0	4.8	1.4	1.3	1.9	23.1	2.3	0.6	39.9	12.1	1.1	0.5	343.0	3.7	1.4	79.6	13.2	2.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.7	64.1	3.5	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.6	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	365.7	0.2	0.0	0.0	0.0	536.9	0.2	5.9	4.6	0.3	20.6	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.3	0.3	0.4	0.6	0.4	0.0	0.0	1.7	0.1	0.1	0.7	0.3	302.7	0.0	0.1	0.0	12.8	5.2	6.0	1109.8	4.9	1034.8	62.0	1123.8	1201.7	5.2	98.9	1260.7	1168.7	33.6	641.5	6.0	7.7	1682.7	1836.9	0.4	0.5	0.4	0.5	0.5	0.4	0.8	0.5	0.6	0.6	0.5	0.6	4.9	0.0	9.3	0.0	23.4	4.6	1.2	0.4	0.0	0.0	3.5	5.2	1.8	4.3	1.6	3.7	0.0	0.3	143.9	0.9	0.0	0.6	0.1	1.0	0.5	3.4	2.4	10.1	0.2	0.5	0.2	3.1	7.7	0.7	5.1	0.0	4.6	1.5	0.3	0.0	0.2	0.3	0.0	7.8	7.3	0.0	0.0	8.1	3.6	0.0	8.7	0.0	272.9	0.5	0.1	4.7	0.0	0.4	15.7	1.0	0.0	1.4	1.8	0.0	0.0	1.5	2.4	4.5	2.0	0.5	3.1	0.4	255.5	2.9	1.3	1.1
LCNL1	FLJ45224	ENSG00000214402	"Lipocalin like 1"	Q6ZST4	9	136981904-136986410	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 71.2;dendritic cells: 24.9;Leydig cells: 53.4;Muller glia cells: 30.2;Peritubular cells: 127.5"	"Cancer enhanced"	"Detected in some"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.39e-1)"	"unprognostic (4.60e-3)"	"unprognostic (1.08e-3)"	"unprognostic (5.14e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.03e-5)"	"unprognostic (6.46e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.34e-9)"	"unprognostic (4.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.93e-1)"	0.0	0.1	0.9	0.0	1.0	0.0	0.0	0.9	3.4	0.5	0.8	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.7	0.8	1.0	0.4	0.0	0.1	0.1	1.1	0.9	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.8	0.3	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	1.0	0.9	3.4	0.8	1.0	1.1	0.9	1.1	0.8	1.1	1.1	0.0	0.0	0.0	71.2	0.0	0.1	0.0	0.0	0.0	8.3	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.1	24.9	0.0	0.0	0.0	2.0	0.3	3.9	1.5	0.0	0.0	2.6	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	14.2	0.0	0.0	0.0	0.0	6.0	53.4	0.1	0.0	7.5	0.0	30.2	5.2	3.5	11.9	0.0	0.0	127.5	0.3	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.2	0.4	0.8	0.0	0.0	0.1	0.4	0.0	0.0	0.1
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	58.9	15.5	13.7	8.0	19.8	0.4	52.2	3.3	45.9	43.5	7.6	12.7	6.5	65.5	23.4	15.8	28.0	31.2	33.7	23.3	7.3	28.0	26.0	58.2	11.5	4.4	10.9	18.2	7.6	17.0	9.0	58.8	4.7	18.0	8.5	5.3	10.8	13.7	14.0	9.4	12.8	53.8	7.1	50.4	11.5	5.0	7.9	8.3	31.3	24.3	4.8	22.5	22.8	19.7	0.0	0.0	18.3	0.1	10.5	16.9	0.0	10.2	8.0	1.2	2.7	0.0	0.0	0.0	0.0	19.0	0.0	0.0	34.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	9.5	0.0	12.5	0.0	2.7	65.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.7	0.0	0.1	8.8	0.0	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.0	4.9	0.0	0.0	17.1	25.7	0.1	1.2	0.0	8.3	0.1	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.2	13.7	19.8	3.3	45.9	23.3	7.3	4.4	10.9	4.7	7.1	7.9	19.7	236.5	0.0	5.5	44.7	1.5	8.7	0.3	0.0	2.8	27.1	1.7	2.2	8.7	2.8	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.4	1.3	1.4	36.5	194.4	0.0	8.0	1314.4	0.2	0.2	44.4	4.1	1.1	5.7	0.1	364.8	3.1	0.4	0.0	196.5	0.0	0.0	16.4	13.2	2.6	38.2	1.4	8.8	117.1	0.0	10.4	3.1	120.6	36.7	0.2	0.0	50.4	0.0	0.3	0.0	0.1	0.7	2.1	6.6	2.8	19.3	0.2	0.7	1.3	6.8	0.1	4.9	39.7	0.0	0.5
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116780	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.6;liver: 135.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 37.3;Distal enterocytes: 80.2;Distal tubular cells: 37.2;Hepatocytes: 88.6;Proximal tubular cells: 118.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 11.1"	"Group enriched"	"Detected in many"	45	"granulocytes: 11.1;monocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.4;HMC-1: 14.4;T-47d: 29.1;U-266/70: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	24.9	14.4	17.7	2.1	19.7	0.7	11.7	20.5	22.6	5.4	34.1	27.2	8.8	3.5	1.1	10.8	5.5	3.0	85.6	16.1	18.9	36.1	135.5	4.9	0.8	20.8	20.2	16.4	18.7	17.0	11.8	0.7	22.4	8.1	9.7	1.3	21.3	3.2	68.7	5.8	5.7	1.2	17.0	1.1	23.1	1.7	19.3	0.5	10.6	52.7	0.6	2.6	3.7	17.5	0.7	2.1	0.0	0.2	1.6	1.4	6.1	0.2	0.1	0.2	0.2	2.8	2.6	0.1	2.1	0.9	1.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.8	11.4	2.6	0.0	14.4	2.0	0.3	0.0	0.0	0.6	0.1	0.4	0.7	2.5	0.0	5.3	0.1	0.8	1.4	2.7	1.3	0.0	0.0	7.8	1.4	0.1	0.0	0.0	0.2	5.2	0.3	0.7	29.1	3.3	0.0	0.0	0.2	0.0	0.0	11.5	0.6	0.0	1.9	0.1	0.0	11.1	2.2	0.6	0.0	3.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	17.7	19.7	20.5	22.6	16.1	18.9	20.8	20.2	22.4	17.0	19.3	17.5	1.6	0.0	6.7	7.8	1.0	0.6	1.8	2.2	0.6	0.5	6.5	2.4	37.3	11.5	2.3	11.0	0.0	2.1	0.1	80.2	37.2	2.3	0.4	2.2	0.3	1.7	3.0	2.7	1.0	6.2	1.2	2.3	32.6	3.8	10.2	2.1	4.2	88.6	7.2	1.7	1.4	11.0	0.0	6.0	1.0	0.6	0.0	3.0	5.4	1.9	2.0	12.0	0.0	1.0	3.2	3.0	28.3	0.0	0.8	2.1	2.4	118.1	2.0	1.4	0.0	4.1	1.3	0.0	0.7	3.6	0.3	3.1	1.0	1.8	15.7	1.5
LDLRAP1	"ARH, ARH2, DKFZp586D0624, FHCB1, FHCB2, MGC34705"	ENSG00000157978	"Low density lipoprotein receptor adaptor protein 1"	Q5SW96	1	25543606-25568886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Atherosclerosis, Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"NK-cells: 39.5;T-cells: 107.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB003705, HPA050358"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules		"CAB003705: AB_425923, HPA050358: AB_2681103"	"unprognostic (2.52e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.49e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.79e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-3)"	"unprognostic (9.96e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.24e-1)"	11.0	19.7	14.2	18.8	25.0	8.6	11.7	28.4	17.7	11.3	25.5	18.2	11.3	8.8	8.0	19.4	9.8	8.0	12.6	14.4	17.5	14.4	27.2	15.7	37.2	30.6	25.0	9.3	39.6	14.7	19.4	21.1	27.6	21.5	16.4	5.5	30.9	9.8	13.1	21.2	16.8	10.4	21.4	58.1	15.8	5.6	22.7	14.2	17.2	9.3	22.0	9.7	15.4	37.9	32.2	12.5	17.5	18.5	10.7	12.3	14.1	20.0	19.5	30.0	20.8	5.1	26.0	7.1	14.2	27.4	20.9	33.3	11.9	20.3	15.1	8.5	18.5	11.4	14.5	9.8	17.0	13.1	16.4	13.4	28.6	24.2	9.0	7.3	26.1	7.1	16.0	68.1	10.0	18.6	0.2	22.4	22.2	25.7	13.2	1.9	19.7	57.6	11.2	6.6	8.7	4.9	27.8	43.9	32.3	14.1	20.0	22.2	15.7	13.1	19.1	25.0	14.1	64.8	81.6	20.2	44.2	10.9	16.3	0.0	7.0	0.3	23.6	5.7	27.1	10.5	55.2	43.4	9.4	5.4	107.3	89.8	3.1	39.5	5.9	1.3	49.7	50.6	14.2	25.0	28.4	17.7	14.4	17.5	30.6	25.0	27.6	21.4	22.7	37.9	9.8	0.0	11.0	2.6	11.5	8.3	20.6	21.5	15.4	4.0	10.3	13.3	3.6	5.7	21.1	7.3	18.8	35.2	13.3	33.6	3.9	9.7	0.2	2.9	4.1	10.8	6.7	3.8	2.3	17.8	8.6	8.9	4.6	5.4	2.5	8.6	12.1	25.6	11.0	70.7	1.2	23.9	10.2	6.0	3.5	0.0	10.2	23.7	17.8	11.2	6.9	4.0	22.6	2.0	50.1	12.9	23.4	8.6	19.3	19.1	11.9	5.9	6.1	19.5	26.3	16.9	9.1	3.2	10.1	12.4	5.7	23.7	28.7	9.7	22.0	20.0
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	1.2	1.0	3.4	1.1	3.6	5.3	0.7	5.7	4.9	1.6	2.9	0.7	0.8	1.4	1.1	1.1	1.4	1.2	0.8	3.2	2.8	2.3	0.7	2.0	1.3	2.3	2.9	2.1	0.7	1.6	1.3	1.8	3.1	1.1	0.8	4.2	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	23.8	2.6	2.4	1.0	0.3	1.4	1.9	0.6	4.2	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.4	3.6	5.7	4.9	3.2	2.8	2.3	2.9	3.1	2.0	2.6	4.2	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570248-37582616	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 335.5;intestine: 198.0;kidney: 153.0;pancreas: 211.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 779.2;Distal enterocytes: 695.4;Langerhans cells: 982.8;Proximal enterocytes: 2724.7;Proximal tubular cells: 1764.8;Undifferentiated cells: 749.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	27	"classical monocyte: 1464.7;intermediate monocyte: 553.8;myeloid DC: 1207.2"	"Group enriched"	"Detected in all"	50	"dendritic cells: 1207.2;monocytes: 1464.7"	"Group enriched"	"Detected in many"	4	"CACO-2: 109.4;Hep G2: 62.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	7.5	1.4	0.6	23.5	1.4	19.2	5.4	0.2	1.1	1.8	0.2	55.0	41.2	3.6	1.0	5.2	4.4	335.5	1.6	0.5	1.0	153.0	5.0	8.6	60.7	1.6	1.2	0.9	211.5	0.2	0.1	1.7	1.4	2.2	81.1	0.1	2.1	0.7	1.9	9.9	198.0	5.2	0.4	59.2	10.7	0.6	1.1	41.3	1.0	0.7	64.0	8.2	0.5	3.4	2.8	1.5	0.9	1.0	0.0	0.0	1.1	1.7	0.0	0.0	0.0	109.4	0.1	0.4	0.3	0.0	0.3	1.7	0.0	0.0	0.0	0.2	1.1	0.0	0.0	62.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	2.8	0.0	1.0	0.4	21.2	0.3	0.0	0.9	1.3	0.0	0.0	0.0	0.3	1.7	1.9	2.4	0.5	1.6	1.7	6.4	2.0	1.0	4.3	0.8	0.0	0.2	0.3	2.7	0.2	1.3	7.7	1464.7	8.7	1.8	553.8	3.3	9.9	1.8	2.1	1207.2	2.3	2.3	1.9	26.8	2.3	39.7	9.6	3.0	981.5	0.6	1.4	0.2	1.1	0.5	1.0	1.6	1.2	1.4	0.4	1.1	3.4	1.6	6.4	3.9	0.0	16.4	17.1	0.1	0.5	0.0	0.0	13.2	7.5	0.3	779.2	1.4	29.5	0.0	0.2	7.0	695.4	127.2	26.3	0.1	0.1	0.3	2.3	73.7	4.8	0.1	206.7	0.3	3.2	5.6	0.2	2.5	0.0	0.7	1.9	26.4	0.0	0.1	413.0	0.0	100.8	982.8	0.3	0.6	150.8	24.9	0.0	164.8	0.0	4.1	0.0	0.1	291.6	331.6	0.0	0.9	0.3	2724.7	1764.8	2.1	0.0	0.0	0.3	2.3	0.0	0.4	0.1	12.4	0.3	8.6	0.0	749.3	0.3
LGALS3BP	"90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B"	ENSG00000108679	"Galectin 3 binding protein"	Q08380	17	78971238-78979947	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 629.8;Paneth cells: 584.1;Proximal enterocytes: 931.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"monocytes: 27.2;T-cells: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 862.9;SK-BR-3: 2270.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000410, HPA000554"	Uncertain				"Secreted to blood"	NA	NA		7100000000	"Cluster 32: T-cells - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA000410: , HPA000554: AB_1079246"	"unprognostic (1.23e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	192.8	218.6	51.2	75.0	91.4	48.6	109.5	95.6	62.3	188.8	159.8	210.8	312.9	121.4	45.2	114.2	155.6	240.8	311.4	46.6	81.4	103.1	68.5	182.8	52.7	145.6	88.3	155.6	79.1	107.8	134.9	147.0	116.8	114.3	92.6	10.0	498.7	154.2	20.0	54.0	260.9	80.2	104.3	76.8	315.6	70.1	89.8	48.8	102.0	20.4	25.3	125.0	119.0	152.5	499.0	255.3	7.2	11.2	157.3	181.4	147.9	55.7	49.0	371.3	725.7	107.5	862.9	2.8	372.7	33.5	361.7	200.1	53.6	203.7	11.5	1.2	319.0	33.8	206.0	481.0	387.7	0.4	31.6	305.8	111.5	197.5	12.6	83.8	9.9	68.7	3.4	1.5	87.7	62.8	151.2	6.0	13.0	163.7	170.7	100.1	209.9	4.8	155.5	352.6	235.1	267.4	52.7	2270.3	754.5	14.0	57.5	16.1	16.3	245.5	169.8	7.1	225.8	0.8	2.2	3.7	332.1	96.8	263.7	0.8	17.7	4.9	12.0	27.2	25.0	4.7	43.3	17.9	7.6	2.4	68.4	33.0	1.2	9.4	14.7	0.6	26.0	25.1	51.2	91.4	95.6	62.3	46.6	81.4	145.6	88.3	116.8	104.3	89.8	152.5	88.0	189.1	144.3	9.8	5.6	31.1	146.8	462.5	60.3	37.2	60.5	43.1	180.7	127.2	306.2	139.8	6.2	179.1	3.4	629.8	17.6	275.0	7.2	77.4	118.7	26.8	168.2	4.4	0.3	136.5	336.0	284.6	257.9	126.9	13.3	316.5	46.8	45.8	88.3	74.0	5.3	328.7	309.3	36.8	23.7	37.1	282.7	36.0	81.8	8.4	27.9	80.8	2.1	11.6	33.9	132.4	584.1	266.3	3.5	72.4	931.4	49.2	123.9	24.3	177.5	80.5	119.6	4.5	2.1	83.8	27.3	108.9	15.4	228.3	400.5	128.2
LGALS8	PCTA-1	ENSG00000116977	"Galectin 8"	O00214	1	236518000-236552981	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 322.8;Late spermatids: 222.6;Syncytiotrophoblasts: 176.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 118.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012734, HPA030491"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"		"HPA012734: AB_2668720, HPA030491: AB_10602345"	"unprognostic (2.03e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.93e-2)"	"prognostic favorable (9.40e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.93e-7)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.21e-2)"	28.6	14.3	10.8	26.5	11.3	44.4	23.3	12.4	14.1	17.2	11.5	19.9	21.6	16.7	19.6	21.2	13.8	24.8	55.0	12.5	12.6	23.4	49.5	27.0	24.0	12.9	10.9	21.6	21.8	35.0	12.7	41.0	13.5	22.2	19.9	22.9	22.1	21.3	6.8	32.4	24.1	21.8	11.7	42.6	18.9	57.1	11.4	26.3	17.2	9.4	22.8	32.8	15.3	11.7	52.3	27.5	3.6	20.8	46.6	39.0	55.6	38.0	45.4	49.0	59.3	37.6	63.3	1.5	34.8	33.7	26.8	60.3	11.0	54.7	43.2	31.1	7.3	35.5	20.7	68.1	56.9	46.9	78.9	39.6	45.6	41.0	13.8	42.4	52.5	26.4	40.7	25.1	35.7	33.3	23.2	8.4	12.5	4.1	18.5	27.2	0.8	3.0	35.4	80.8	13.1	25.7	24.4	82.3	13.7	2.1	59.0	33.7	39.1	1.0	22.0	29.9	47.7	10.0	7.4	1.0	50.4	65.7	30.9	118.5	37.4	18.7	12.5	32.9	17.8	10.7	18.4	14.1	31.7	6.8	12.2	12.7	16.1	14.2	24.0	14.2	22.5	24.8	10.8	11.3	12.4	14.1	12.5	12.6	12.9	10.9	13.5	11.7	11.4	11.7	44.0	76.9	54.7	12.1	19.3	32.5	28.5	64.9	44.9	28.1	31.7	22.7	55.2	34.3	68.1	14.7	25.0	64.4	33.9	25.3	5.9	61.8	322.8	18.7	21.9	39.9	18.1	19.0	31.5	39.2	53.5	35.2	23.0	20.8	109.4	38.0	46.1	27.1	57.5	38.7	37.0	18.8	57.0	100.5	23.6	222.6	23.6	45.1	7.2	24.4	38.7	6.5	17.5	18.1	16.7	44.0	36.0	13.9	15.1	20.6	26.4	14.5	53.1	19.4	26.3	22.5	19.6	46.8	8.7	21.3	37.1	176.2	34.4	22.8	17.1	24.4
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146830-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 112.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 22.2;Excitatory neurons: 17.7;Inhibitory neurons: 23.7;Melanocytes: 40.9;Oligodendrocytes: 58.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;melanoma: 14.3;thyroid cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;SCLC-21H: 1.6;SK-MEL-30: 1.6;WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	0.3	3.4	44.2	0.1	79.7	0.1	0.2	81.1	84.6	2.9	5.2	0.8	0.3	1.2	0.3	6.5	1.6	0.1	2.2	43.4	70.4	0.4	0.1	15.9	0.0	85.8	72.4	0.2	0.8	0.3	2.8	0.0	90.7	1.3	0.1	3.9	1.7	2.8	0.2	15.0	0.5	0.6	57.1	0.1	0.9	0.8	86.3	0.3	13.0	0.1	0.3	0.2	2.5	112.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	79.7	81.1	84.6	43.4	70.4	85.8	72.4	90.7	57.1	86.3	112.6	0.0	0.0	22.2	2.0	0.0	2.3	0.0	0.0	0.0	2.7	0.1	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.8	0.0	17.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.4	0.0	0.3	0.1	40.9	2.8	0.0	1.2	0.0	6.6	58.4	0.1	0.0	7.2	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.6	0.1	0.1	1.4	0.6	0.0	0.0	0.9	0.0	0.0
LGMN	"LGMN1, PRSC1"	ENSG00000100600	Legumain	Q99538	14	92703807-92748679	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1448.9;Macrophages: 346.1;Syncytiotrophoblasts: 416.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"plasmacytoid DC: 209.2"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 209.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 898.6;U-266/70: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001426	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001426: AB_1079247"	"unprognostic (1.19e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.18e-3)"	"unprognostic (7.24e-2)"	173.7	44.4	37.6	82.2	38.6	20.6	69.7	31.7	60.8	52.6	51.2	102.5	110.4	30.8	36.8	64.5	36.6	145.8	85.3	40.0	40.3	205.9	111.1	107.3	177.0	35.6	37.3	33.0	37.9	247.0	24.9	262.1	42.4	51.9	105.9	19.7	56.4	32.2	50.4	32.7	97.6	65.0	35.9	202.2	107.0	29.8	62.8	52.8	93.2	50.4	54.9	144.7	52.1	49.4	33.2	47.5	30.8	57.4	94.3	76.0	108.4	70.3	67.0	71.7	84.2	36.9	58.6	18.2	101.5	116.5	44.3	81.5	0.0	60.8	33.7	1.6	36.2	1.2	24.4	42.8	27.7	1.0	2.7	54.2	29.1	68.4	39.4	21.3	82.1	33.7	7.4	150.9	5.2	45.2	8.9	1.2	15.1	208.2	32.1	8.4	27.1	898.6	59.2	129.1	33.6	23.2	97.9	59.4	53.0	66.8	43.9	0.6	47.2	35.3	44.8	64.5	21.8	462.5	58.0	25.0	20.0	0.2	69.1	1.9	1.6	0.1	0.8	3.1	1.6	17.0	5.1	1.3	19.3	14.5	15.2	9.0	1.6	3.7	1.0	209.2	9.7	7.0	37.6	38.6	31.7	60.8	40.0	40.3	35.6	37.3	42.4	35.9	62.8	49.4	34.9	57.7	128.0	8.8	33.9	23.1	37.5	36.0	22.2	10.6	31.2	37.6	29.8	42.9	48.1	31.3	93.8	181.8	24.5	64.2	9.8	61.3	1.3	79.4	23.5	38.3	36.5	22.7	19.2	50.6	140.2	63.8	73.4	177.7	8.8	17.6	276.3	46.4	1448.9	13.5	41.0	31.1	95.6	317.6	89.0	3.3	30.4	346.1	48.0	27.2	37.5	23.6	2.1	10.6	15.2	50.5	57.1	57.9	24.7	44.6	163.4	220.4	20.9	19.8	19.7	40.4	62.1	19.9	17.6	22.3	17.5	416.3	8.2	15.1	48.3	44.7
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319983	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 2.0;liver: 3.8;placenta: 1.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.5;Inhibitory neurons: 3.7;Late spermatids: 4.4;Oligodendrocytes: 5.9;Proximal tubular cells: 5.6;Respiratory ciliated cells: 3.0"	"Cancer enriched"	"Detected in some"	4	"lung cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;BEWO: 3.3;CACO-2: 1.6;HeLa: 1.8;Karpas-707: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	2.0	3.8	0.2	0.0	0.3	0.1	0.0	0.3	0.0	0.0	1.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	2.2	0.0	1.1	1.9	0.1	1.2	2.0	0.0	0.1	0.0	0.0	3.5	0.2	0.5	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.3	0.0	3.7	0.7	0.0	0.3	0.0	4.4	0.3	0.1	0.0	1.9	0.0	0.0	0.0	1.5	5.9	0.0	0.3	0.0	0.1	0.2	0.1	5.6	3.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	0.1	0.1	0.8	0.2
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5;lymphoid tissue: 57.4"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 22.0;Kupffer cells: 79.9;Macrophages: 39.1;monocytes: 48.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 31.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 31.6;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.7;REH: 2.0;THP-1: 4.0;U-937: 9.1"														"Secreted to blood"	NA	NA		140000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	5.2	3.2	0.9	2.8	1.0	15.5	1.8	1.0	1.5	0.9	0.9	1.5	0.2	1.0	0.2	0.9	4.0	0.4	1.9	1.0	1.0	1.4	3.4	10.3	0.2	2.0	1.2	0.8	1.4	0.1	0.8	0.1	2.0	1.4	0.2	0.2	1.7	0.1	0.5	0.7	1.7	0.4	1.1	57.4	1.6	0.8	1.6	0.2	0.8	0.2	0.3	2.2	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	5.3	7.6	3.0	0.1	11.6	0.1	0.1	0.1	0.1	3.3	0.3	0.1	0.1	31.6	0.4	11.3	0.7	0.1	6.1	0.9	1.0	1.0	1.5	1.0	1.0	2.0	1.2	2.0	1.1	1.6	1.8	0.2	3.2	3.0	0.0	0.3	0.3	1.6	0.0	0.0	0.9	0.4	0.1	0.5	1.5	1.8	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.8	0.0	0.2	0.2	0.6	0.0	0.1	6.3	0.1	0.4	0.4	22.0	0.0	0.0	0.0	0.0	79.9	5.9	0.6	0.0	39.1	0.0	8.4	48.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.0	0.1	1.5	0.6	0.0	2.1	0.3	0.3	0.3	0.0	0.1	0.4	1.4	0.0	0.0	0.6
LILRA6	"CD85b, ILT8, LILRB6"	ENSG00000244482	"Leukocyte immunoglobulin like receptor A6"	Q6PI73	19	54236592-54242791	"Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 9.0;lymphoid tissue: 16.9"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 13.8;Kupffer cells: 31.7;Macrophages: 30.6;monocytes: 19.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.4;intermediate monocyte: 3.9;neutrophil: 8.2"	"Group enriched"	"Detected in many"	26	"granulocytes: 8.2;monocytes: 3.9"	"Not detected"	"Not detected"											HPA026985			Approved	"Plasma membrane,Cytosol"		NA	NA		21000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"HPA026985: "	"unprognostic (1.00e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.47e-5)"	"unprognostic (7.76e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-2)"	3.3	1.1	0.0	1.3	0.0	1.6	1.1	0.0	0.1	0.4	0.0	1.0	0.1	0.5	0.0	0.3	2.2	0.2	1.1	0.0	0.0	0.7	1.3	9.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.9	0.0	0.4	0.3	0.8	1.4	0.0	16.9	0.8	0.2	0.1	0.0	0.5	0.0	0.0	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.2	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	5.3	0.0	0.0	0.2	0.4	0.0	0.1	3.8	0.0	0.7	0.9	13.8	0.0	0.0	0.0	0.0	31.7	5.2	0.0	0.0	30.6	0.0	1.0	19.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1
LILRB2	"CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10"	ENSG00000131042	"Leukocyte immunoglobulin like receptor B2"	Q8N423	19	54273812-54281184	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 35.0;lung: 15.0;lymphoid tissue: 51.2"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 150.7;Langerhans cells: 61.8;Macrophages: 147.3;monocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"classical monocyte: 61.6;intermediate monocyte: 132.3;neutrophil: 62.9;non-classical monocyte: 153.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 62.9;monocytes: 153.4"	"Not detected"	"Not detected"																	NA	NA		65000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (1.23e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.45e-7)"	"unprognostic (1.90e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.72e-1)"	"unprognostic (9.73e-2)"	6.5	2.6	0.0	12.2	0.0	35.0	2.2	0.0	0.5	1.1	0.6	2.3	3.2	1.2	0.1	1.0	3.7	0.0	2.5	0.1	0.1	2.2	3.9	15.0	0.8	0.9	0.5	0.8	1.3	0.0	1.3	0.5	0.6	1.7	0.8	0.0	1.6	0.4	0.6	0.6	3.0	0.4	0.0	51.2	1.8	0.3	1.0	0.2	1.1	0.1	0.0	2.3	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.0	61.6	16.2	0.1	132.3	0.3	0.0	0.0	0.0	18.8	0.1	0.1	0.0	62.9	0.0	153.4	8.0	0.3	29.7	0.0	0.0	0.0	0.5	0.1	0.1	0.9	0.5	0.6	0.0	1.0	0.2	0.5	3.2	10.9	0.0	5.5	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.8	1.5	3.1	0.0	0.0	0.1	10.3	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.3	1.0	1.1	0.0	5.1	0.0	2.2	1.5	27.2	0.0	0.0	0.0	0.0	150.7	61.8	0.1	0.0	147.3	3.6	1.0	75.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.3	2.2	0.0	6.6	0.4	0.2	0.0	0.0	0.0	0.6	0.1	2.9	0.0	0.0	0.1
LILRB4	"CD85k, HM18, ILT3, LIR-5, LIR5"	ENSG00000186818	"Leukocyte immunoglobulin like receptor B4"	Q8NHJ6	19	54643889-54670359	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.7;lymphoid tissue: 18.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 76.9;Hofbauer cells: 127.6;Kupffer cells: 118.9;Macrophages: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 37.3"	"Group enriched"	"Detected in many"	44	"dendritic cells: 37.3;monocytes: 10.8"	"Cell line enriched"	"Detected in some"	32	"Karpas-707: 407.8"									HPA052807	Approved					NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA052807: AB_2681958"	"unprognostic (4.09e-2)"	"unprognostic (5.75e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	8.6	4.6	2.2	10.9	2.5	2.0	3.6	2.7	4.2	1.1	2.2	4.1	1.6	0.9	0.3	1.0	4.0	1.7	2.3	2.2	2.8	2.2	2.9	13.7	11.4	3.8	3.2	0.7	1.6	0.1	2.2	1.4	3.5	1.9	2.3	0.1	3.6	0.3	0.5	0.5	6.3	0.7	3.2	18.8	1.7	0.3	3.0	0.6	2.4	0.0	2.1	6.1	0.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	407.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.4	12.8	0.0	0.2	0.0	0.4	0.0	7.8	0.0	0.0	10.8	0.0	0.2	0.0	0.0	11.7	0.5	0.0	0.0	0.1	0.1	8.9	37.3	0.0	3.8	2.2	2.5	2.7	4.2	2.2	2.8	3.8	3.2	3.5	3.2	3.0	3.3	0.6	0.0	4.1	0.0	13.4	0.4	0.0	0.0	0.0	0.2	0.3	1.7	1.0	1.5	1.3	0.0	0.0	0.3	76.9	0.1	0.0	0.0	0.2	0.0	0.0	4.2	0.0	7.8	0.1	0.0	0.9	0.5	0.0	0.0	1.3	0.0	2.2	0.8	127.6	0.0	0.2	0.0	0.0	118.9	12.6	0.6	0.0	104.0	1.8	14.0	29.3	0.2	1.0	0.0	0.0	0.1	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.2	6.6	0.2	0.1	0.0	0.4	0.1	0.1	0.8	2.2	0.0	0.2	0.1
LILRB5	"CD85c, LIR-8, LIR8"	ENSG00000105609	"Leukocyte immunoglobulin like receptor B5"	O75023	19	54249421-54257301	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.9;lymphoid tissue: 49.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 61.1;Kupffer cells: 103.4;Macrophages: 40.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012069	Approved					NA	NA		58000000	"Cluster 17: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA012069: AB_1852873"	"unprognostic (3.55e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.86e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.02e-5)"	"unprognostic (6.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	17.9	10.3	0.2	1.7	0.5	0.9	7.2	0.3	1.0	1.6	1.3	6.1	4.6	1.1	0.8	1.8	4.4	2.8	5.1	0.2	0.2	1.6	7.1	5.3	1.8	0.5	0.3	1.3	0.8	0.3	0.7	4.8	0.4	0.6	4.8	0.1	2.9	0.6	1.8	2.3	6.8	2.4	0.2	49.1	2.5	1.1	1.0	1.0	1.4	1.3	0.7	4.2	1.2	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.5	0.3	1.0	0.2	0.2	0.5	0.3	0.4	0.2	1.0	1.1	0.5	0.0	1.1	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	1.7	0.0	0.1	0.2	0.0	2.7	0.0	0.0	0.4	0.7	0.0	0.1	0.0	0.1	8.6	0.9	61.1	0.0	0.0	0.0	0.0	103.4	9.8	1.8	0.0	40.1	1.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.5	0.0	0.1	0.3	1.1	0.8	0.4	0.5	0.0	0.0
LIME1	"dJ583P15.4, FLJ20406, LIME"	ENSG00000203896	"Lck interacting transmembrane adaptor 1"	Q9H400	20	63736283-63739103	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 242.8"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 210.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 314.8;MAIT T-cell: 285.2;memory CD4 T-cell: 437.6;memory CD8 T-cell: 412.5;naive CD4 T-cell: 289.4;naive CD8 T-cell: 319.4;plasmacytoid DC: 749.3;T-reg: 689.4"	"Group enriched"	"Detected in all"	8	"dendritic cells: 749.3;T-cells: 689.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 33.9;MOLT-4: 37.9;RPMI-8226: 144.4;U-266/70: 71.1"	"Low region specificity"	"Detected in many"							CAB015363	Approved				"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB015363: AB_629890"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (5.04e-5)"	"unprognostic (2.39e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (6.92e-6)"	8.9	5.6	2.2	5.6	5.6	4.7	5.8	2.6	7.0	8.8	0.8	11.8	2.2	5.9	0.0	11.2	6.8	0.0	5.1	2.9	1.4	54.5	242.8	9.0	10.7	2.8	1.8	9.6	5.1	0.1	11.3	0.1	2.5	13.4	0.3	0.0	12.5	0.4	3.9	13.2	18.7	0.0	1.0	43.2	18.3	5.9	3.5	6.1	11.2	0.0	1.2	7.6	9.2	4.8	2.0	0.6	0.1	0.4	0.0	0.0	4.9	2.6	0.2	0.3	0.0	1.1	2.1	5.7	3.8	0.1	0.0	5.1	0.0	0.3	0.3	2.5	4.8	1.1	2.3	25.4	0.0	1.5	2.1	0.2	0.7	0.0	0.0	0.0	0.0	16.4	2.1	33.9	0.0	1.1	37.9	10.7	2.0	1.3	6.6	25.9	0.8	144.4	0.4	0.3	2.0	2.9	1.3	1.3	2.8	0.0	1.1	0.8	0.5	1.8	2.8	1.9	1.5	71.1	3.0	12.7	1.5	1.1	0.7	1.9	1.5	1.8	314.8	1.0	285.2	76.4	437.6	412.5	2.4	37.2	289.4	319.4	10.6	85.5	1.7	749.3	689.4	193.8	2.2	5.6	2.6	7.0	2.9	1.4	2.8	1.8	2.5	1.0	3.5	4.8	0.0	0.0	0.0	21.5	7.2	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	7.7	0.0	0.0	0.3	22.4	0.0	0.0	0.0	0.4	3.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.6	0.1	0.0	0.0	9.0	9.6	0.0	0.0	0.0	210.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.8	0.1	0.0	36.7	0.0	0.1	0.0
LIN52	C14orf46	ENSG00000205659	"Lin-52 DREAM MuvB core complex component"	Q52LA3	14	74084796-74201235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.5;Inhibitory neurons: 65.4;Oligodendrocyte precursor cells: 60.3;Oligodendrocytes: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000900, HPA001777"	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA000900: AB_2135058, HPA001777: AB_2666431"	"unprognostic (2.34e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.90e-3)"	"prognostic favorable (6.60e-4)"	"prognostic unfavorable (6.08e-5)"	"unprognostic (2.48e-3)"	"unprognostic (9.34e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.20e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-1)"	8.0	7.8	8.4	5.4	8.4	3.5	6.3	8.8	10.1	5.8	7.8	4.5	6.5	7.0	5.7	4.9	5.5	4.9	10.2	8.3	10.0	19.3	6.6	5.0	6.1	9.2	8.9	8.5	3.4	6.8	5.7	5.0	9.3	6.4	5.7	10.7	3.9	5.6	5.6	3.8	5.8	6.8	7.9	5.1	4.3	7.5	8.9	10.7	5.1	10.0	6.3	5.8	3.9	8.5	10.5	7.7	26.8	12.8	15.5	6.6	10.5	17.5	16.7	23.0	25.7	14.0	9.6	5.9	5.3	8.6	9.2	9.2	20.4	6.9	35.1	49.1	8.1	9.1	8.9	20.0	16.6	9.4	12.7	8.2	7.7	12.2	15.9	6.3	11.0	18.6	9.7	27.8	11.4	13.4	14.9	12.3	7.7	13.8	12.3	19.0	25.1	9.6	6.0	6.2	19.0	15.5	16.4	12.0	13.7	9.9	16.3	13.5	6.3	10.8	20.3	11.5	14.8	18.2	41.8	13.2	12.5	10.7	18.4	6.2	6.4	20.6	10.7	6.6	16.6	8.7	9.3	10.7	8.6	9.4	13.7	12.5	3.2	11.4	4.8	7.9	13.9	10.1	8.4	8.4	8.8	10.1	8.3	10.0	9.2	8.9	9.3	7.9	8.9	8.5	5.6	9.6	9.0	39.8	10.4	4.8	3.2	3.2	11.4	8.8	7.6	5.3	10.0	10.0	6.6	5.5	8.4	6.3	8.8	3.5	7.9	3.1	0.8	5.9	6.6	7.4	3.0	16.4	47.5	2.4	5.2	8.1	6.1	6.7	2.5	9.0	6.4	12.2	6.3	16.8	65.4	6.0	4.1	4.3	3.7	1.6	5.3	4.5	0.0	26.2	6.6	10.8	10.3	60.3	60.4	2.4	5.0	9.8	27.3	3.3	10.9	22.4	6.2	7.5	6.6	8.1	6.4	16.3	10.4	10.3	5.5	8.8	8.2	3.7	4.7	1.4
LMO2	"RBTN2, RBTNL1, RHOM2, TTG2"	ENSG00000135363	"LIM domain only 2"	P25791	11	33858576-33892076	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.2;Endothelial cells: 144.6;Erythroid cells: 103.7;Hepatic stellate cells: 167.4;Kupffer cells: 65.0;Microglial cells: 64.6"	"Cancer enhanced"	"Detected in all"		"glioma: 30.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.9;granulocytes: 1.5;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HEL: 71.8;HL-60: 72.7;K-562: 60.9;NB-4: 27.3;THP-1: 81.6;U-937: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016258, HPA029285, HPA070901, HPA070910"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: "	"unprognostic (1.60e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.73e-3)"	"unprognostic (8.95e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	15.0	5.9	14.9	11.4	13.0	27.7	12.5	14.2	16.6	8.4	13.4	5.0	4.6	6.5	0.7	6.8	8.3	5.4	4.4	14.7	16.0	13.1	2.3	18.2	19.4	19.9	16.3	3.5	2.6	2.3	8.6	6.5	18.5	5.7	1.5	0.6	5.3	2.4	23.4	4.9	6.6	4.8	18.7	19.0	3.9	1.7	19.0	1.8	12.3	4.6	8.4	5.8	7.3	13.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	2.2	1.3	12.8	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	71.8	0.0	0.0	0.3	72.7	18.5	0.0	0.0	0.0	0.0	0.0	10.2	0.0	60.9	0.0	0.0	0.3	5.1	27.3	0.9	0.0	0.0	15.3	0.8	0.2	0.0	0.8	4.3	0.0	0.3	0.5	0.1	0.2	0.0	81.6	0.9	0.0	0.2	1.7	0.0	0.0	0.2	0.6	4.7	29.2	0.3	0.6	0.5	1.5	0.0	1.4	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	1.7	0.1	0.0	0.2	14.9	13.0	14.2	16.6	14.7	16.0	19.9	16.3	18.5	18.7	19.0	13.3	109.2	3.2	7.1	8.5	6.6	8.4	7.9	8.0	0.6	1.6	2.8	9.5	2.8	8.6	1.7	5.5	2.1	0.4	1.0	0.8	0.0	3.0	0.5	40.5	11.0	144.6	0.0	103.7	1.3	2.0	3.2	9.8	0.0	39.6	7.6	0.9	167.4	1.7	39.1	0.0	3.8	0.2	2.0	65.0	56.8	1.2	4.1	54.1	10.6	64.6	47.5	1.1	4.1	5.0	1.0	1.0	1.9	0.0	3.0	5.4	0.0	8.8	5.0	2.6	0.0	17.3	3.6	0.3	7.9	0.8	6.0	21.5	1.9	12.4	0.5	25.1
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896456-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 513.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Leydig cells: 125.6;Peritubular cells: 275.3;Rod photoreceptor cells: 70.2;Sertoli cells: 197.2;Smooth muscle cells: 224.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.8;BJ: 21.3;BJ hTERT+: 34.4;fHDF/TERT166: 17.4;HSkMC: 14.5;hTERT-RPE1: 54.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	157.7	52.5	7.8	28.5	9.7	0.0	75.4	5.7	9.1	161.9	5.5	513.9	25.1	309.5	49.7	135.8	194.7	85.5	31.7	6.2	8.0	11.8	5.1	44.3	7.3	13.6	6.5	72.2	8.4	18.2	5.8	35.3	6.8	165.2	46.9	48.0	21.2	242.5	137.5	43.2	115.5	206.6	5.4	18.5	218.6	17.9	9.1	2.5	39.8	45.7	1.6	368.7	111.9	7.2	0.0	0.1	0.4	1.2	15.8	2.0	1.3	21.3	34.4	1.3	1.5	0.1	0.2	0.0	0.7	17.4	0.2	0.3	0.5	0.0	0.4	0.0	1.4	0.0	0.1	0.0	1.5	0.1	0.1	14.5	0.0	1.0	0.0	54.4	0.1	0.0	0.2	0.2	0.7	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.4	0.1	0.3	0.0	0.5	0.4	9.5	0.7	0.0	0.0	0.1	0.8	0.3	0.0	0.7	0.6	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.7	5.7	9.1	6.2	8.0	13.6	6.5	6.8	5.4	9.1	7.2	16.1	0.0	1.1	8.5	0.3	1.3	1.0	0.3	0.0	4.8	1.6	40.8	25.1	0.0	0.0	0.0	135.5	1.7	0.0	0.1	0.0	0.0	2.1	2.6	64.5	5.8	0.0	0.0	0.5	0.6	0.3	20.4	0.5	1.2	0.0	0.7	9.3	0.4	1.0	3.3	1.0	0.0	0.0	0.0	2.3	8.2	125.6	0.9	3.6	3.7	0.0	7.3	0.0	4.0	1.0	0.0	0.0	275.3	0.0	0.9	0.0	0.1	0.9	70.2	197.2	5.2	224.3	1.2	0.5	0.8	2.3	1.2	1.3	2.1	0.0	0.4
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126613928-126701032	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;salivary gland: 18.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 5.0"	"HPA073716, HPA075656"			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA073716: AB_2686630, HPA075656: "	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	0.6	0.0	0.1	0.0	0.1	0.1	4.1	0.1	5.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	1.0	3.6	0.0	0.1	0.0	3.8	9.2	0.0	0.2	1.1	0.2	0.0	3.3	0.0	0.0	0.0	18.5	0.0	0.1	2.1	0.1	0.0	6.8	0.0	0.1	1.4	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.2	0.6	0.3	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.3	0.0	2.5	0.6	3.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	10.4	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.2	0.1	8.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.6	1.0	1.0	3.8	9.2	3.3	6.8	2.6	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.6	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 76.7"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 80.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 1.0"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	1800000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.0	0.1	2.0	0.0	1.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.8	0.0	0.0	0.8	6.3	0.5	76.7	0.1	0.0	1.8	1.9	0.2	0.6	0.0	0.0	0.0	1.3	0.6	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.2	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	0.0	1.1	0.8	6.3	1.8	1.9	1.3	0.2	4.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.2	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	80.7	0.0	0.0	1.3	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3
LRCOL1		ENSG00000204583	"Leucine rich colipase like 1"	A6NCL2	12	132603150-132610582	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"epididymis: 50.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 33.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;liver cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"		"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (5.09e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-6)"	"unprognostic (1.46e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.00e-3)"	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.2	50.1	0.1	0.4	0.0	0.0	0.0	0.1	0.2	2.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.6	1.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.1	3.3	33.2	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	1.5	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Endocytosis	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 109.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		180000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	109.2	14.1	21.3	29.0	36.3	8.2	40.0	30.2	19.7	32.3	8.0	24.1	23.2	36.9	6.2	19.3	30.3	31.5	35.5	16.7	21.9	5.7	35.0	34.0	4.9	46.0	31.5	71.0	10.7	7.8	10.2	39.8	27.9	13.8	11.2	9.9	20.3	20.2	13.0	20.4	18.4	28.9	27.1	13.6	15.1	7.3	48.9	5.6	17.6	23.5	2.7	25.5	29.3	27.6	7.7	14.5	30.4	24.2	484.8	488.4	91.2	85.3	109.0	27.5	26.7	26.9	12.4	0.4	10.4	222.2	6.0	33.6	5.3	8.7	9.7	0.7	1.3	0.4	17.9	56.4	66.5	0.5	14.6	318.5	3.1	61.8	7.2	248.7	1.7	1.1	0.4	1.3	87.2	1.7	0.2	0.4	34.8	11.0	8.8	3.2	171.0	1.6	1.9	2.2	1.4	16.4	19.0	0.6	13.2	42.0	2.9	1.2	1.2	96.0	35.0	53.9	5.2	1.1	0.1	0.2	167.4	0.1	18.7	0.0	4.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	1.6	21.3	36.3	30.2	19.7	16.7	21.9	46.0	31.5	27.9	27.1	48.9	27.6	24.6	12.8	8.4	113.6	3.2	24.0	11.9	28.7	19.9	29.2	4.9	19.3	14.8	15.7	14.7	1.8	0.0	87.5	1.1	81.7	0.0	7.4	1.9	9.7	111.4	13.0	4.2	0.8	39.3	1.8	53.0	273.4	49.5	4.2	6.3	36.9	11.0	188.4	73.8	8.4	41.6	14.1	6.1	145.3	28.6	8.4	233.3	102.9	28.4	89.9	48.8	154.7	1.0	173.4	6.6	14.7	27.2	184.3	4.4	5.5	86.0	2.1	15.1	7.3	39.5	129.7	77.0	1.6	2.4	35.4	16.1	125.9	4.2	11.4	25.0	12.3
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362534	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.5;kidney: 34.8;parathyroid gland: 44.7;retina: 29.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 29.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 39.4;CACO-2: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA		74000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.5	0.0	5.5	0.0	23.4	0.1	9.6	18.9	13.5	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.2	7.5	14.6	34.8	0.3	1.2	0.0	30.5	17.5	0.0	0.0	44.7	0.1	7.5	31.9	0.0	0.0	29.3	0.9	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.0	0.2	18.7	0.0	17.3	0.0	0.0	0.0	0.0	70.5	0.0	0.0	39.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	23.4	18.9	13.5	7.5	14.6	30.5	17.5	31.9	14.5	18.7	70.5	0.2	6.4	43.7	1.0	3.0	0.3	0.2	0.0	0.0	2.8	22.9	15.1	2.1	2.8	2.5	3.7	87.6	63.2	0.2	0.0	17.6	0.0	3.1	0.1	0.1	0.5	0.0	0.0	1.8	0.0	2.2	1.8	0.0	0.1	2.5	0.0	0.0	0.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	2.5	0.0	1.9	0.0	33.1	0.0	1.5	300.1	0.0	0.0	0.0	0.0	0.0	0.0	283.9	2.2	19.5	0.0	0.0	0.3	0.1	0.8	0.0	0.0	23.1	1.7	0.0	0.0	0.2
LRP2BP	DKFZp761O0113	ENSG00000109771	"LRP2 binding protein"	Q9P2M1	4	185363872-185395924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 28.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.5;Cone photoreceptor cells: 33.3;Early spermatids: 62.1;Inhibitory neurons: 34.2;Late spermatids: 42.3;Oligodendrocyte precursor cells: 40.2;Oligodendrocytes: 34.9;Rod photoreceptor cells: 34.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036664, HPA036665"	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036664: AB_10672361, HPA036665: AB_10673660"	"unprognostic (2.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.15e-5)"	"unprognostic (2.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-4)"	"unprognostic (2.17e-2)"	"unprognostic (9.76e-3)"	"unprognostic (2.15e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-4)"	1.7	2.1	6.7	0.7	6.9	0.4	1.6	15.0	7.9	2.7	9.8	3.6	0.3	1.8	2.3	1.0	6.9	0.9	3.6	6.5	7.5	4.8	1.6	4.4	0.7	11.4	10.0	8.5	3.2	0.2	17.4	0.6	8.7	3.7	0.4	28.9	1.5	0.5	3.0	1.5	1.9	0.3	9.8	2.7	1.7	10.7	8.1	0.2	3.5	0.7	0.1	2.1	1.7	10.8	0.5	0.4	0.5	1.1	0.3	0.1	1.0	1.5	0.4	0.0	0.3	0.5	0.5	1.8	0.1	0.1	0.5	0.3	0.3	0.2	0.2	1.7	0.9	0.4	1.5	1.6	0.2	0.3	0.5	0.3	0.2	0.7	0.2	1.5	0.4	1.3	0.6	1.4	0.4	0.1	0.6	1.2	0.6	0.0	0.2	0.3	0.3	0.4	0.4	0.3	1.2	0.8	0.3	0.4	1.0	0.7	0.4	0.1	1.4	0.8	0.6	0.2	0.8	5.3	0.5	0.3	1.3	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.2	0.0	0.5	0.3	0.2	0.1	0.1	0.1	0.5	0.2	0.0	6.7	6.9	15.0	7.9	6.5	7.5	11.4	10.0	8.7	9.8	8.1	10.8	3.1	9.6	2.6	57.5	3.5	2.4	4.1	1.3	2.8	28.8	3.0	2.4	5.5	0.0	1.8	0.0	33.3	1.2	3.3	1.7	0.0	1.5	62.1	17.6	3.1	3.2	7.8	0.0	28.0	0.9	2.5	2.1	2.6	4.4	0.0	1.9	1.4	0.3	0.5	26.9	34.2	2.4	4.1	1.2	1.4	42.3	2.8	1.9	5.4	3.7	0.8	10.4	0.0	40.2	34.9	1.0	0.2	3.8	2.5	4.3	2.6	1.6	14.1	34.0	0.0	5.4	2.8	8.4	1.9	0.8	3.1	1.6	3.1	2.1	1.0	2.1
LRP3	"hLRp105, LRP-3"	ENSG00000130881	"LDL receptor related protein 3"	O75074	19	33177603-33208864	"Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.2;Muller glia cells: 29.9;Peritubular cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"THP-1: 61.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041658			Approved	"Lipid droplets"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Lipid droplets"		"HPA041658: "	"unprognostic (3.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.32e-1)"	28.1	28.2	44.7	5.1	47.2	18.7	23.8	15.2	61.2	27.0	0.0	25.7	7.1	27.0	8.5	8.5	21.4	8.4	19.1	53.2	22.6	11.0	39.3	13.0	2.6	21.4	25.8	69.8	17.6	16.7	26.9	3.5	20.8	25.9	3.0	2.4	16.8	12.0	28.7	14.2	10.2	10.3	17.0	6.8	17.3	8.6	31.6	1.7	20.4	17.6	0.9	24.3	15.6	25.7	0.1	48.6	13.1	47.9	32.2	12.1	9.0	12.4	12.0	11.1	4.3	14.0	0.6	0.0	31.6	15.4	16.0	0.0	12.6	1.3	0.9	0.2	23.8	0.0	10.7	49.1	12.3	17.8	1.6	18.2	11.1	3.1	1.7	1.9	9.3	0.0	0.1	0.0	14.4	45.2	0.1	19.6	27.0	9.7	2.0	0.0	6.0	0.1	0.0	19.4	28.8	43.3	20.0	0.1	3.5	1.4	20.0	61.5	0.0	23.5	20.4	35.6	7.1	0.0	0.0	0.2	0.0	30.0	7.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.1	44.7	47.2	15.2	61.2	53.2	22.6	21.4	25.8	20.8	17.0	31.6	25.7	4.4	0.0	3.6	18.9	1.1	3.3	2.6	1.4	4.0	30.2	12.8	13.7	0.5	14.3	3.5	5.5	4.2	0.2	0.4	1.3	0.0	5.8	2.7	5.4	17.6	3.0	1.8	5.7	19.5	7.8	0.7	24.9	0.5	10.7	0.0	19.2	6.1	28.3	10.3	23.5	19.4	6.4	0.0	8.8	2.7	6.4	26.1	5.0	3.6	4.7	5.8	29.9	0.0	15.1	1.7	5.9	1.0	32.7	0.1	8.2	0.7	0.6	0.3	4.2	6.6	6.8	13.7	0.2	2.8	2.3	2.6	0.0	0.6	9.8	6.0	1.9
LRRC19	FLJ21302	ENSG00000184434	"Leucine rich repeat containing 19"	Q9H756	9	26993136-27005672	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 36.2;kidney: 42.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 152.3;Paneth cells: 36.0;Proximal enterocytes: 82.1;Proximal tubular cells: 57.0;Undifferentiated cells: 36.0"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 6.0;renal cancer: 5.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA		190000		"Cluster 87: Intestine & Kidney - Transmembrane transport"		"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.21e-5)"	"unprognostic (1.87e-2)"	"unprognostic (4.48e-2)"	"prognostic favorable (7.08e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	0.0	0.1	0.1	2.7	0.1	0.3	0.0	0.4	0.1	0.0	1.0	36.2	23.4	0.1	0.0	0.0	0.0	5.9	0.0	0.1	0.1	42.8	1.4	0.2	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	32.6	0.2	0.0	0.1	0.2	0.2	31.4	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.4	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	18.6	0.0	23.9	0.0	0.0	0.1	152.3	9.8	0.1	0.1	0.4	0.4	0.2	6.0	0.0	0.7	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	3.7	0.0	0.0	0.7	20.3	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	36.0	0.4	0.0	0.0	82.1	57.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	36.0	0.0
LRRC25	"FLJ38116, MAPA"	ENSG00000175489	"Leucine rich repeat containing 25"	Q8N386	19	18391137-18397622	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 32.4;lymphoid tissue: 61.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 47.0;Kupffer cells: 123.6;Macrophages: 90.0;monocytes: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.6;eosinophil: 356.2;intermediate monocyte: 512.1;myeloid DC: 229.3;neutrophil: 573.0;non-classical monocyte: 706.7"	"Group enriched"	"Detected in all"	60	"dendritic cells: 229.3;granulocytes: 573.0;monocytes: 706.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;HMC-1: 1.8;THP-1: 1.7;U-937: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029459	Approved		Approved	"Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		630000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Endoplasmic reticulum, Microtubules, Cytosol"		"HPA029459: AB_10610005"	"unprognostic (2.72e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-2)"	"unprognostic (9.15e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-3)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.14e-1)"	9.4	9.4	2.4	21.8	2.5	32.4	3.1	3.3	2.9	1.8	3.2	3.3	3.7	1.6	0.7	2.3	3.9	5.3	2.5	2.3	3.1	2.4	5.9	11.5	9.9	4.6	4.0	1.5	2.0	0.7	1.2	5.4	4.2	2.0	2.8	0.3	2.6	1.2	3.7	1.0	4.8	6.7	2.8	61.2	2.3	1.2	5.4	3.0	1.2	8.7	4.0	7.0	1.3	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	1.0	0.8	0.4	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.7	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.2	1.5	0.1	55.4	320.6	356.2	0.9	512.1	1.9	7.3	0.6	0.7	229.3	8.4	0.5	0.6	573.0	4.6	706.7	32.1	1.3	229.2	2.4	2.5	3.3	2.9	2.3	3.1	4.6	4.0	4.2	2.8	5.4	4.7	0.7	0.0	1.3	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.3	1.0	0.3	0.0	0.7	0.0	0.0	0.1	2.9	0.1	5.9	0.1	1.9	0.2	0.1	0.9	0.0	2.1	0.1	0.0	0.4	0.5	0.0	0.4	10.2	0.0	1.8	0.5	47.0	0.0	0.1	0.0	0.0	123.6	12.5	0.5	0.0	90.0	1.8	1.0	74.9	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	2.4	0.2	0.0	0.2	0.0	0.1	0.4	1.1	0.2	0.1	0.1
LRRC32	"D11S833E, GARP"	ENSG00000137507	"Leucine rich repeat containing 32"	Q14392	11	76657524-76670747	"Predicted intracellular proteins, Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 78.0;Endothelial cells: 88.3;Extravillous trophoblasts: 164.2;Hepatic stellate cells: 95.3;Sertoli cells: 39.5;Smooth muscle cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 115.0;ASC TERT1: 70.3;HSkMC: 44.0;HUVEC TERT2: 51.4;U-2197: 108.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055775, HPA058434"			Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		98000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA055775: AB_2732600, HPA058434: AB_2732622"	"unprognostic (3.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (7.99e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.22e-3)"	"prognostic unfavorable (2.64e-4)"	104.5	34.3	12.6	10.5	12.6	2.4	63.6	11.2	11.8	56.2	8.4	23.2	8.9	36.4	6.2	10.3	31.6	29.0	55.7	9.6	10.6	64.7	11.3	109.0	4.3	12.2	13.8	13.5	12.0	7.5	16.7	53.0	13.0	24.9	6.1	1.3	12.8	11.0	23.6	26.6	21.4	15.2	10.9	28.9	21.3	3.6	15.0	2.0	42.3	6.2	1.5	36.7	28.8	11.5	0.0	0.0	1.3	0.0	115.0	70.3	1.4	0.4	0.8	0.1	0.1	0.0	0.0	0.2	3.1	1.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	11.8	0.6	0.0	2.2	0.0	0.1	44.0	0.0	4.1	0.2	0.9	51.4	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	7.6	0.2	0.0	13.8	7.5	0.8	108.3	0.0	0.1	0.0	1.9	5.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	4.3	12.6	12.6	11.2	11.8	9.6	10.6	12.2	13.8	13.0	10.9	15.0	11.5	78.0	0.0	4.3	0.0	1.7	14.5	0.3	0.0	1.8	0.0	0.6	0.6	10.4	0.0	1.3	0.0	0.0	1.9	0.1	0.2	0.0	0.3	1.3	0.1	1.9	88.3	0.0	5.3	0.0	0.0	164.2	26.4	0.5	0.3	2.5	0.5	95.3	0.6	3.6	0.0	0.1	0.4	0.0	3.1	19.0	1.9	9.0	2.9	17.8	14.0	0.0	0.4	0.0	0.0	0.1	0.0	2.2	9.1	0.2	1.4	0.0	0.4	0.7	0.1	39.5	2.1	47.6	0.4	4.7	0.6	12.5	8.3	1.6	0.4	0.1	1.2
LRRC39	"MGC14816, myomasp"	ENSG00000122477	"Leucine rich repeat containing 39"	Q96DD0	1	100148448-100178273	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 107.0;retina: 117.9;skeletal muscle: 431.0;tongue: 172.9"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 96.4;Cone photoreceptor cells: 60.5;Early spermatids: 204.8;Hofbauer cells: 76.4;Inhibitory neurons: 62.2;Rod photoreceptor cells: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA077159	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA077159: AB_2732333"	"unprognostic (7.68e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.38e-4)"	2.2	9.8	3.5	1.5	3.6	1.5	1.9	2.8	4.7	1.6	1.1	1.8	1.0	1.4	1.4	4.2	1.7	1.1	107.0	2.8	3.7	1.7	2.6	1.7	2.4	3.8	2.9	1.6	1.6	5.3	2.3	4.2	2.5	4.2	0.6	117.9	2.9	0.5	431.0	3.8	1.7	0.7	1.8	2.3	1.6	6.5	4.2	1.1	1.9	172.9	0.9	1.7	1.3	3.6	0.4	0.5	1.8	2.4	0.4	0.8	1.5	0.8	0.3	0.3	0.7	0.1	1.1	2.0	0.9	0.3	0.4	1.1	0.2	0.2	0.7	0.3	1.7	0.9	2.4	0.4	0.2	0.6	1.1	1.5	0.3	0.3	0.1	0.5	0.3	1.5	0.9	1.7	0.5	0.3	1.0	2.4	0.8	0.5	0.6	1.0	0.8	0.8	0.3	0.6	0.7	2.5	0.5	0.7	6.7	0.6	0.6	1.4	0.5	1.0	0.9	1.3	1.6	3.2	1.6	0.7	1.7	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	2.8	4.7	2.8	3.7	3.8	2.9	2.5	1.8	4.2	3.6	0.3	0.0	1.3	6.8	0.4	0.1	0.1	0.0	0.0	13.1	0.3	0.1	96.4	0.0	0.0	0.0	60.5	0.5	0.3	0.3	0.0	0.2	204.8	0.2	0.5	1.8	0.0	0.0	14.6	0.6	0.6	3.8	0.0	0.5	1.3	0.2	0.7	0.2	76.4	18.5	62.2	0.0	0.0	0.3	0.0	21.7	2.1	8.0	0.0	1.9	0.8	8.1	1.0	5.5	10.2	0.3	0.1	0.4	0.5	0.1	0.0	0.0	0.7	74.2	0.0	8.6	1.4	9.9	1.2	0.0	0.1	0.7	0.4	0.4	0.0	0.0
LRRC4	NAG14	ENSG00000128594	"Leucine rich repeat containing 4"	Q9HBW1	7	128027071-128032107	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5"	"Cell type enhanced"	"Detected in many"		"Club cells: 33.2;Cone photoreceptor cells: 27.1;Horizontal cells: 55.5;Respiratory ciliated cells: 53.0;Rod photoreceptor cells: 35.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 38.5"	"Immune cell enriched"	"Detected in some"	5	"neutrophil: 13.1"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 13.1"	"Group enriched"	"Detected in some"	6	"AF22: 15.9;NTERA-2: 35.4;REH: 33.5;SCLC-21H: 18.2;SH-SY5Y: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051100			Approved	"Golgi apparatus"		NA	NA		2100000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA051100: AB_2797241"	"unprognostic (7.98e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.98e-4)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-3)"	2.3	6.7	8.4	2.7	11.4	10.9	0.6	7.8	38.5	1.6	0.0	0.9	0.6	3.2	0.3	4.1	6.6	3.2	2.6	14.4	0.0	3.2	1.9	6.0	1.8	0.0	0.0	4.8	0.4	6.8	1.8	4.4	0.0	0.7	0.5	4.3	1.5	2.8	0.8	0.4	0.8	1.6	0.0	4.7	1.9	6.2	0.0	5.1	0.5	1.8	2.1	1.5	2.8	11.9	0.0	0.2	15.9	0.0	0.6	0.0	0.0	0.9	0.0	1.4	0.4	0.0	0.0	0.0	1.1	1.5	0.0	1.4	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	35.4	0.0	0.0	33.5	0.0	0.3	0.2	0.0	18.2	10.9	0.0	0.0	1.3	2.5	0.0	3.7	0.4	1.1	0.2	0.1	0.9	0.0	0.0	0.0	0.2	0.0	2.3	0.5	0.2	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	0.0	0.6	0.0	0.0	0.1	8.4	11.4	7.8	38.5	14.4	0.0	0.0	0.0	0.0	0.0	0.0	11.9	1.8	16.0	14.3	5.5	0.6	0.1	1.6	5.7	0.6	11.3	0.5	0.4	1.4	0.0	33.2	1.8	27.1	0.2	0.7	0.2	0.0	0.1	6.6	11.6	5.2	5.1	0.0	0.0	18.3	0.0	0.3	1.2	0.0	18.7	1.3	1.8	11.0	0.1	19.8	55.5	22.6	0.0	2.0	11.2	0.7	0.9	0.0	1.6	1.8	9.4	0.6	0.8	0.0	11.6	2.1	0.0	0.5	0.7	0.9	4.5	0.1	0.6	53.0	35.1	0.0	2.4	2.0	6.2	4.6	5.6	0.0	0.4	0.5	0.7	0.3	19.0
LRRC70	"LOC100130733, SLRN"	ENSG00000186105	"Leucine rich repeat containing 70"	Q7Z2Q7	5	62578819-62581446	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 3.6;Endothelial cells: 4.9;Erythroid cells: 1.7;Fibroblasts: 1.8;granulocytes: 3.8;Hepatic stellate cells: 3.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"HUVEC TERT2: 17.6;TIME: 9.6"					"Low region specificity"	"Detected in all"			HPA013409	Uncertain					NA	NA		17000	"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA013409: AB_10601911"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	4.7	0.8	0.5	1.4	0.4	3.6	4.7	0.5	1.2	3.9	0.6	1.4	0.8	1.9	1.0	1.7	3.3	3.6	1.8	0.4	0.4	1.9	1.4	1.9	1.9	0.7	0.8	2.9	0.9	1.2	1.4	4.6	0.6	2.0	1.4	1.0	1.2	0.5	0.7	2.7	1.4	3.4	0.6	4.1	1.1	1.7	0.5	1.0	4.0	0.6	0.7	1.7	2.8	0.8	0.2	0.0	0.2	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	17.6	0.3	0.2	0.7	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	9.6	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.5	0.4	0.5	1.2	0.4	0.4	0.7	0.8	0.6	0.6	0.5	0.8	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.1	0.1	4.9	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.1	3.8	0.1	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.4	0.3	0.0	0.3	0.0	0.0	0.0
LTBP1		ENSG00000049323	"Latent transforming growth factor beta binding protein 1"	Q14766	2	32946953-33399509	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 161.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.4;Fibroblasts: 116.1;Leydig cells: 90.4;Peritubular cells: 161.0;Skeletal myocytes: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 569.4;HSkMC: 185.3;HUVEC TERT2: 194.5;U-2197: 181.1;U-87 MG: 255.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB025428	Approved				"Secreted to extracellular matrix"	NA	NA		96000000	"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025428: "	"unprognostic (1.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (4.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.62e-4)"	22.9	13.1	7.8	22.1	9.4	11.5	14.5	7.1	7.5	161.4	10.5	27.2	10.2	58.9	37.8	21.2	37.0	73.0	89.0	8.8	9.1	38.6	18.6	27.5	6.9	12.1	10.6	30.2	7.9	2.4	9.0	73.2	9.2	46.9	16.5	0.7	14.6	73.6	15.7	10.8	15.0	96.7	9.1	8.3	32.8	17.9	8.8	8.2	6.5	28.4	18.7	53.9	28.3	13.4	0.3	12.5	31.3	0.3	26.1	569.4	13.5	46.5	95.7	6.4	9.3	25.3	4.6	41.3	1.0	6.0	8.8	2.4	0.7	1.5	22.0	0.6	15.3	135.6	15.0	4.1	118.6	0.5	15.7	185.3	4.4	141.2	6.9	61.8	194.5	6.3	8.7	0.3	51.1	19.9	5.5	0.2	22.4	1.0	39.2	4.7	65.8	0.6	0.4	22.4	6.3	3.4	9.5	72.1	0.8	49.1	27.9	0.4	126.4	6.4	26.2	181.1	37.6	74.8	80.0	58.8	255.9	5.2	10.8	3.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	5.3	7.8	9.4	7.1	7.5	8.8	9.1	12.1	10.6	9.2	9.1	8.8	13.4	33.6	0.0	0.6	108.4	0.4	13.5	5.6	13.0	10.2	0.0	6.9	6.6	80.9	4.3	3.6	1.8	0.0	45.2	0.3	12.9	0.0	9.6	6.3	7.3	18.3	28.1	1.2	30.3	30.4	6.5	23.4	116.1	10.2	10.5	0.0	11.8	20.3	11.0	7.6	0.0	54.3	2.8	2.0	0.3	18.1	7.1	90.4	12.0	19.6	39.4	0.4	0.2	0.0	70.4	52.4	19.1	3.3	161.0	1.3	19.1	0.7	0.3	6.3	0.3	59.2	85.8	67.9	0.7	11.9	6.9	9.8	43.5	2.0	2.6	4.1	33.4
LTBP2	"C14orf141, LTBP3"	ENSG00000119681	"Latent transforming growth factor beta binding protein 2"	Q14767	14	74498183-74612378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Heparin-binding"	"Disease variant, Dwarfism, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 60.6;Fibroblasts: 59.5;Peritubular cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 240.8;HUVEC TERT2: 129.1;LHCN-M2: 129.4;TIME: 564.5"	"Group enriched"	"Detected in some"	10	"cerebellum: 5.3;olfactory bulb: 2.4"	"Region enhanced"	"Detected in many"		"olfactory bulb: 15.4"	HPA003415	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		14000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003415: AB_1079284"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.94e-4)"	34.2	4.0	1.1	15.2	2.9	0.6	24.4	4.1	5.6	66.2	9.5	6.6	3.1	22.5	23.9	10.7	11.7	33.1	45.4	1.2	1.1	4.1	2.1	64.9	8.3	2.2	1.1	39.4	8.7	9.6	7.3	28.0	1.4	15.7	2.6	2.3	26.7	19.6	13.6	12.6	6.9	16.0	2.2	3.9	8.5	5.4	1.9	3.1	53.0	21.4	6.1	14.2	21.6	1.0	2.5	4.9	1.2	0.2	36.9	67.7	0.2	47.4	16.2	9.2	5.7	0.0	17.4	0.4	13.8	240.8	4.1	4.8	0.2	17.7	3.8	0.2	0.8	0.8	2.2	2.1	8.8	0.1	0.6	70.2	7.7	50.7	29.1	68.9	129.1	0.1	0.2	0.1	129.4	1.1	0.1	0.3	0.3	0.2	4.5	0.5	1.1	0.1	11.3	6.7	1.0	3.3	33.1	0.1	1.1	3.4	1.1	0.2	564.5	3.3	54.0	17.0	18.0	0.7	0.7	0.1	13.1	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	2.9	4.1	5.6	1.2	1.1	2.2	1.1	1.4	2.2	1.9	1.0	3.8	0.0	2.2	2.3	0.1	5.6	15.1	13.0	13.1	2.1	1.9	60.6	6.4	0.0	6.1	0.0	0.0	0.5	1.2	0.1	5.9	1.4	1.2	0.5	7.9	6.5	0.0	5.7	1.1	0.4	0.3	59.5	1.5	0.9	1.3	1.9	9.3	0.4	4.2	3.3	0.7	0.0	20.3	0.3	5.8	5.8	16.4	3.7	0.0	22.5	0.1	0.4	0.0	1.0	0.3	4.4	0.0	82.4	0.3	10.7	0.0	0.0	0.3	1.0	6.6	3.2	10.8	2.8	3.8	5.2	1.0	1.2	0.9	2.2	0.1	2.1
LTBP3	LTBP2	ENSG00000168056	"Latent transforming growth factor beta binding protein 3"	Q9NS15	11	65538559-65558930	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Amelogenesis imperfecta, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 61.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 293.8;U-87 MG: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.50e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	65.4	80.1	44.0	21.4	46.1	11.2	68.0	42.0	56.1	120.0	42.2	103.7	16.8	130.8	36.7	36.7	112.6	39.9	131.2	37.6	41.4	84.5	48.8	72.2	24.7	57.0	49.0	155.5	70.1	44.7	111.0	25.5	45.4	109.0	8.5	12.8	64.2	56.3	54.6	39.6	55.8	35.7	51.7	58.1	62.0	20.3	46.9	17.6	114.0	31.0	12.1	84.9	88.0	54.0	16.5	65.9	8.7	43.2	60.7	97.0	8.5	64.7	43.6	8.2	5.3	25.3	85.5	2.0	53.6	64.2	20.4	71.9	11.8	12.2	3.7	9.5	26.4	15.9	25.2	26.2	40.3	2.2	13.4	109.9	4.9	12.1	1.5	293.8	31.9	5.2	4.9	12.7	6.0	39.4	10.9	5.9	7.6	14.6	81.2	29.3	1.1	32.1	6.7	5.5	2.9	41.8	17.3	24.9	35.3	3.7	46.0	5.8	107.0	24.8	32.2	42.5	17.6	13.9	27.1	1.4	157.8	2.6	52.3	0.2	7.3	2.9	8.8	11.2	14.1	61.2	12.6	10.4	8.9	47.6	10.5	11.2	2.9	10.8	13.2	17.8	14.2	7.8	44.0	46.1	42.0	56.1	37.6	41.4	57.0	49.0	45.4	51.7	46.9	54.0	47.1	12.8	11.7	64.0	26.8	73.8	27.7	22.0	50.7	55.7	42.2	43.1	16.7	35.8	16.2	40.5	2.1	24.7	24.4	19.7	21.5	28.1	1.1	19.3	37.5	29.8	30.6	11.2	21.3	12.0	10.5	86.1	14.8	25.3	24.1	92.5	37.5	61.6	20.7	28.6	17.9	15.1	8.2	11.0	34.4	4.3	86.6	14.6	30.2	17.8	11.5	71.4	24.7	29.7	20.2	18.1	15.0	123.8	20.9	35.8	25.3	15.7	8.2	14.3	39.5	89.4	44.0	9.5	37.5	46.9	79.3	16.3	24.4	26.0	20.4	26.5
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 327.1;Leydig cells: 972.3;Peritubular cells: 624.4;Skeletal myocytes: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 120.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"	NA	NA		9700000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	138.5	48.5	11.3	22.3	10.9	8.3	98.8	1.7	13.3	334.6	9.6	144.5	59.2	309.6	44.7	100.6	246.8	39.3	401.9	10.7	14.2	64.7	37.4	242.5	24.8	16.2	10.3	315.2	37.2	22.6	75.9	38.3	16.4	253.6	38.2	3.7	82.8	126.3	63.0	73.0	135.4	74.4	11.3	80.5	125.3	78.5	14.2	12.9	173.2	156.7	14.0	188.6	374.5	15.3	19.8	21.3	41.7	56.5	15.1	16.0	6.6	7.7	24.9	7.8	6.4	6.4	43.8	22.4	34.9	13.1	12.4	26.3	10.6	26.8	2.6	61.0	3.3	7.3	53.7	2.4	49.4	3.0	23.1	19.9	21.7	15.6	27.8	41.0	4.9	21.6	46.7	120.3	1.9	19.7	3.1	1.3	4.9	56.1	24.9	51.9	1.1	35.6	3.9	1.7	1.8	17.4	28.3	21.5	7.4	6.4	11.9	11.3	20.4	1.3	81.4	2.6	16.7	26.8	24.9	7.1	35.1	28.5	20.4	0.0	1.5	0.4	8.1	2.4	5.5	3.5	7.7	6.5	2.7	2.0	3.2	3.4	0.3	3.0	1.3	5.0	5.5	2.3	11.3	10.9	1.7	13.3	10.7	14.2	16.2	10.3	16.4	11.3	14.2	15.3	84.7	6.4	14.1	2.0	11.6	57.6	30.9	62.8	56.3	60.4	13.0	18.2	15.5	17.2	18.5	22.0	0.0	1.5	12.7	38.2	1.9	6.3	11.1	14.8	154.7	29.9	4.2	12.4	8.1	4.7	2.6	327.1	37.2	24.2	10.2	13.5	102.4	3.3	7.5	40.4	11.3	42.2	6.1	6.4	39.6	39.0	972.3	13.9	58.7	15.0	9.5	3.5	16.5	2.0	14.0	6.9	16.6	624.4	16.5	23.6	97.7	0.3	7.1	3.2	59.2	229.2	52.8	50.7	36.3	38.2	29.1	2.6	24.9	10.2	36.4	27.2
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111494	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 739.0;placenta: 535.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 966.4;Fibroblasts: 2136.1;Leydig cells: 401.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	122	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 1991.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"spinal cord: 149.2"	"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	NA	NA		29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	161.5	133.5	0.6	68.1	0.7	0.3	153.2	0.6	5.6	199.8	4.2	85.0	56.1	301.0	88.3	75.7	59.2	739.0	183.8	0.7	0.9	85.0	34.6	211.4	41.3	0.9	0.8	92.9	72.9	26.3	5.3	535.9	0.8	115.2	133.0	5.7	14.3	67.4	9.6	20.0	90.6	354.5	0.7	4.8	47.1	17.5	1.3	13.4	30.8	73.0	80.3	486.0	39.2	0.8	0.0	0.3	6.9	0.0	237.4	115.9	0.7	400.8	1991.0	16.0	24.3	0.0	0.1	0.0	0.0	339.9	0.0	0.6	0.0	0.0	5.4	0.0	0.0	0.0	21.5	0.0	183.7	0.6	0.1	160.5	0.0	33.7	1.0	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.2	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.3	14.9	0.1	0.0	10.8	16.3	0.0	0.0	0.0	17.0	4.5	14.3	0.0	0.2	0.0	0.0	8.8	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	5.6	0.7	0.9	0.9	0.8	0.8	0.7	1.3	0.8	77.5	12.8	30.9	0.0	0.6	97.6	1.2	0.8	3.4	0.2	9.4	8.6	15.2	0.0	5.0	0.0	2.1	44.9	4.0	0.1	0.0	0.7	3.5	27.0	966.4	27.2	0.0	0.0	0.0	0.0	38.9	2136.1	8.6	15.2	18.3	0.0	55.0	0.3	63.6	0.0	0.2	0.3	0.0	0.3	143.5	8.7	401.7	9.5	117.4	16.9	1.0	86.9	0.0	0.0	0.0	2.1	0.0	44.8	6.3	4.9	0.4	0.3	0.8	3.0	0.0	39.1	165.5	0.2	0.9	5.9	100.2	84.0	14.5	27.4	0.0	4.1
LY6K	"CT97, FLJ35226, HSJ001348"	ENSG00000160886	"Lymphocyte antigen 6 family member K"	Q17RY6	8	142700111-142705127	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.5;testis: 36.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 186.7;Prostatic glandular cells: 105.2;Spermatocytes: 404.4;Spermatogonia: 105.8;Urothelial cells: 131.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 125.2;BJ: 131.9;HeLa: 142.4;SiHa: 206.3;U-2197: 273.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017770, CAB075742, CAB075743, CAB079929"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 71: Testis - DNA repair"	"Cluster 18: U-2197 - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB075742: AB_2665748, CAB075743: AB_2665749, CAB079929: , HPA017770: AB_1853414"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.17e-5)"	"unprognostic (4.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.61e-2)"	5.4	0.2	0.6	0.2	0.6	0.3	4.4	0.9	1.7	3.3	0.0	0.5	0.3	0.5	0.2	12.5	1.2	0.4	1.5	0.8	1.0	3.0	0.2	0.8	0.2	1.7	0.8	0.7	0.3	0.0	0.4	2.4	2.0	1.1	0.0	2.4	1.7	0.8	5.4	6.8	0.3	0.1	1.1	0.2	1.1	36.0	0.7	0.6	1.0	1.3	0.6	1.0	5.1	1.1	125.2	2.0	0.0	6.3	2.4	7.9	1.5	131.9	15.3	39.9	24.0	0.2	0.5	0.0	10.9	15.0	14.3	10.8	0.0	7.5	33.5	1.2	0.2	0.1	142.4	0.3	1.9	0.0	0.0	11.7	21.1	29.7	38.0	0.1	3.7	0.0	0.0	0.6	76.2	1.0	0.2	0.3	4.2	4.1	2.0	0.3	0.5	0.2	6.7	1.7	3.7	0.5	206.3	2.7	41.3	6.6	0.5	0.2	5.4	1.9	11.8	273.2	0.2	0.2	0.1	0.3	0.6	0.1	13.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.9	1.7	0.8	1.0	1.7	0.8	2.0	1.1	0.7	1.1	25.6	3.2	0.5	0.0	0.4	38.9	54.2	4.3	21.6	0.6	15.1	49.8	0.2	5.7	9.8	25.8	0.0	13.5	0.3	0.0	0.0	0.8	7.7	3.1	8.5	9.2	0.0	0.0	0.0	0.0	186.7	8.0	0.0	9.0	0.0	0.0	3.3	0.1	6.0	0.0	0.0	0.0	6.1	0.3	28.7	14.8	4.1	4.6	12.4	0.0	0.0	0.5	0.0	0.0	0.1	6.7	1.1	3.0	0.0	105.2	0.0	0.2	3.6	0.6	0.0	17.8	13.1	404.4	105.8	32.2	44.9	25.3	0.7	0.1	0.0	131.4
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Group enriched"	"Detected in many"	9	"B-cells: 124.9;Hofbauer cells: 191.7;Kupffer cells: 199.1;Langerhans cells: 118.6;Macrophages: 149.8;Microglial cells: 105.9;monocytes: 155.6"	"Cancer enhanced"	"Detected in all"		"glioma: 22.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 426.6;myeloid DC: 426.1"	"Group enriched"	"Detected in all"	43	"B-cells: 335.1;dendritic cells: 426.1;monocytes: 426.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.5;NB-4: 44.7;RPMI-8226: 245.0;THP-1: 103.8;U-937: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		77000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	9.7	10.3	14.0	30.9	13.5	29.2	7.4	14.7	22.0	8.2	14.2	7.6	4.9	3.8	2.8	3.1	4.3	14.6	2.9	13.5	15.8	3.1	13.3	29.7	72.1	17.8	15.4	3.3	3.0	3.4	2.3	14.5	18.7	3.8	11.1	1.2	5.5	6.2	0.7	3.4	16.8	11.1	17.8	52.7	6.2	1.8	18.0	15.1	1.5	1.1	78.4	15.6	1.1	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	44.7	0.0	0.0	0.0	8.0	0.0	245.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	103.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	30.3	0.0	45.8	0.0	4.1	426.6	3.5	1.0	234.9	0.7	335.1	1.1	1.1	426.1	248.8	4.7	2.7	9.1	5.3	88.3	16.3	1.8	221.1	14.0	13.5	14.7	22.0	13.5	15.8	17.8	15.4	18.7	17.8	18.0	24.8	1.2	0.0	15.0	1.6	124.9	2.0	0.0	0.0	0.0	0.0	0.9	3.7	1.5	1.5	1.3	0.0	0.0	1.4	9.8	0.0	0.0	0.0	3.4	0.4	0.1	5.4	0.0	3.8	3.8	0.0	1.8	2.1	0.0	0.0	1.3	0.0	4.2	1.3	191.7	0.0	0.6	0.3	0.0	199.1	118.6	15.4	0.3	149.8	0.0	105.9	155.6	0.0	4.1	0.5	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.7	0.4	6.6	0.4	0.2	5.3	0.2	0.3	2.4	1.9	3.6	0.0	0.2	0.2
LYPD5	FLJ30469	ENSG00000159871	"LY6/PLAUR domain containing 5"	Q6UWN5	19	43785874-43827206	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"skin 1: 50.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.0;Late spermatids: 81.8;Melanocytes: 17.8;Syncytiotrophoblasts: 21.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.0;HaCaT: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042511, HPA054670"	Approved		Approved	Nucleoplasm,Cytosol		No	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA042511: AB_10794279, HPA054670: AB_2682567"	"unprognostic (4.27e-3)"	"prognostic favorable (5.84e-4)"	"unprognostic (4.63e-2)"	"unprognostic (8.42e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.91e-3)"	"unprognostic (3.96e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.83e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.53e-3)"	"unprognostic (4.08e-2)"	1.1	0.6	2.6	1.4	2.5	0.1	2.9	1.8	6.0	9.3	0.0	2.3	0.1	0.9	1.4	11.4	0.8	1.1	1.5	3.0	2.9	3.0	0.4	4.0	0.7	6.8	3.2	0.4	0.3	0.6	1.6	1.0	6.6	1.3	0.8	2.0	3.1	0.8	0.2	50.6	1.2	1.1	1.7	4.8	1.0	3.8	4.1	0.9	1.4	0.4	1.7	1.9	9.0	4.1	3.5	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.5	0.6	0.4	1.2	0.2	0.7	0.4	1.4	5.2	0.0	0.7	0.3	0.6	0.0	0.1	0.4	0.0	1.5	0.1	0.0	1.7	1.5	0.2	0.7	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.3	1.9	1.2	0.0	0.0	0.0	0.3	0.6	0.2	0.1	0.7	0.7	0.0	1.1	0.4	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.1	2.6	2.5	1.8	6.0	3.0	2.9	6.8	3.2	6.6	1.7	4.1	4.1	0.5	0.0	0.0	4.6	0.0	3.6	2.6	1.6	4.0	1.4	1.8	1.5	0.7	0.0	0.4	0.0	0.0	1.6	0.1	3.7	3.9	0.6	33.0	0.2	0.1	3.1	0.0	0.0	7.7	0.9	8.4	1.2	0.0	0.2	0.0	0.5	0.7	0.0	2.4	0.0	8.8	1.9	0.0	0.6	0.8	81.8	0.3	0.5	17.8	1.0	0.0	0.9	0.0	9.5	7.8	0.3	2.3	1.2	0.0	1.4	0.2	0.0	1.4	0.9	0.0	1.0	0.2	9.9	2.6	3.7	2.8	21.6	0.1	0.1	0.8	6.2
LYPD6	MGC52057	ENSG00000187123	"LY6/PLAUR domain containing 6"	Q86Y78	2	149329985-149474138	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;placenta: 15.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Early spermatids: 59.7;Inhibitory neurons: 65.9;Late spermatids: 230.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.6;fHDF/TERT166: 48.2;HBF TERT88: 25.0;LHCN-M2: 46.2;RT4: 39.9"	"Low region specificity"	"Detected in all"							HPA042805	Enhanced		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA042805: AB_10794159"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.64e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.49e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.14e-3)"	"unprognostic (6.75e-2)"	"unprognostic (7.33e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.72e-4)"	1.4	0.3	8.0	0.6	4.6	0.0	9.3	4.5	5.5	0.9	1.2	1.5	1.7	2.1	0.1	0.5	1.6	11.1	0.6	4.7	9.8	2.0	0.3	0.2	0.2	6.8	24.0	0.6	1.9	1.4	0.3	15.7	6.7	1.4	2.5	7.0	0.2	1.3	0.1	0.6	1.4	2.9	5.6	0.6	3.9	6.8	16.1	0.3	0.2	0.1	1.3	2.6	0.4	4.2	0.2	0.0	6.8	37.6	0.0	0.1	0.5	15.0	6.6	18.9	11.7	0.2	3.0	0.0	0.8	48.2	9.1	3.8	5.3	0.1	25.0	0.0	1.7	0.1	9.6	0.0	0.2	0.0	0.0	0.0	0.4	0.0	11.0	0.4	0.3	0.0	0.0	0.0	46.2	6.7	0.0	3.6	5.4	3.2	4.3	0.0	20.1	0.0	2.3	39.9	1.5	6.7	10.1	11.2	1.2	12.2	1.5	0.8	0.0	0.4	5.7	0.5	8.2	0.0	0.0	0.0	3.5	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	4.6	4.5	5.5	4.7	9.8	6.8	24.0	6.7	5.6	16.1	4.2	0.1	0.0	0.0	40.8	0.0	0.1	0.6	1.0	1.2	2.7	11.7	6.6	0.4	10.0	2.0	0.0	0.0	0.0	0.0	0.4	3.9	2.6	59.7	1.7	0.4	0.9	0.0	0.0	0.3	0.9	0.2	1.4	10.7	2.5	0.0	0.7	0.4	0.0	0.3	0.0	65.9	2.8	0.0	0.0	0.0	230.4	3.1	0.0	0.0	1.0	0.0	4.1	0.0	13.6	1.0	4.5	0.4	0.4	0.1	2.1	1.7	0.0	0.8	3.4	0.0	0.1	0.2	1.0	5.2	0.7	0.0	0.3	0.1	0.0	2.0	1.7
LYVE1	"LYVE-1, XLKD1"	ENSG00000133800	"Lymphatic vessel endothelial hyaluronan receptor 1"	Q9Y5Y7	11	10556966-10611689	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 126.4;placenta: 149.3"	"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 238.8;Hofbauer cells: 807.4;Kupffer cells: 338.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HUVEC TERT2: 81.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.8"	"CAB025860, HPA042953"	Supported					NA	NA		3300000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB025860: , HPA042953: AB_2678238"	"unprognostic (9.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	126.4	68.9	2.7	19.3	3.5	0.9	37.3	2.0	5.1	17.6	8.9	19.9	13.3	8.1	5.7	26.2	23.0	20.2	13.5	2.9	2.4	8.1	44.2	23.8	8.4	3.0	2.2	11.8	4.9	2.3	2.7	149.3	3.1	4.0	20.0	0.3	5.4	11.2	5.0	7.1	17.6	67.1	2.1	61.6	10.5	4.3	3.3	1.7	13.5	27.4	3.0	35.1	6.8	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	81.6	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	3.5	2.0	5.1	2.9	2.4	3.0	2.2	3.1	2.1	3.3	3.2	5.7	0.0	2.8	8.1	2.1	3.7	0.1	0.0	0.0	0.0	0.5	0.3	4.6	8.6	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	1.0	0.0	0.2	102.7	0.0	5.3	0.8	0.0	5.7	3.4	0.0	0.0	1.3	0.0	238.8	4.5	807.4	0.0	0.4	0.0	0.0	338.1	10.7	2.3	3.7	86.0	7.2	12.2	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.4	2.7	0.2	0.0	0.0	1.5	0.0	13.1	3.4	6.8	0.0	0.0	1.4	3.3	11.1	1.4	0.7	0.0	0.2
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
MACROD1	LRP16	ENSG00000133315	"Mono-ADP ribosylhydrolase 1"	Q9BQ69	11	63998558-64166113	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 290.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 137.0;Proximal tubular cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.8;RPMI-8226: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	14.9	14.1	6.4	1.3	5.9	2.8	17.3	6.8	12.7	15.6	5.9	21.3	5.7	13.8	0.9	18.6	15.3	2.2	111.6	6.4	8.2	55.1	50.2	10.4	1.1	8.6	7.9	21.6	49.5	4.1	11.8	1.6	8.8	19.6	1.4	1.2	30.1	5.5	290.1	26.0	10.7	1.1	6.6	6.5	27.2	4.7	9.1	1.0	32.0	58.9	0.5	17.4	16.8	7.4	12.7	5.7	1.9	10.2	1.7	1.0	10.9	7.5	3.2	5.3	5.1	5.3	33.2	44.9	25.4	0.6	2.6	29.8	1.9	0.1	0.6	3.6	21.9	16.8	23.3	29.7	6.1	13.8	1.8	2.5	3.4	0.6	1.7	4.5	1.8	14.7	15.2	8.5	1.1	73.8	20.1	45.1	5.5	4.3	24.4	18.7	11.5	145.4	1.8	0.7	15.7	31.2	5.7	40.3	41.4	0.2	29.8	1.0	2.9	4.9	7.4	7.0	0.8	17.8	3.1	7.4	3.4	13.4	4.6	0.0	0.0	0.0	0.4	0.2	0.4	0.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.4	5.9	6.8	12.7	6.4	8.2	8.6	7.9	8.8	6.6	9.1	7.4	19.4	0.0	4.6	6.8	7.1	28.0	39.8	7.5	57.5	15.1	46.2	45.0	32.5	30.0	8.6	42.3	0.0	35.6	1.3	34.6	137.0	20.8	7.1	19.0	13.3	11.9	22.9	8.0	7.1	40.4	16.1	15.9	20.9	22.7	0.0	41.6	9.7	45.3	11.7	11.8	12.4	55.2	8.2	6.9	5.1	26.8	24.8	7.2	39.2	4.7	2.4	16.9	1.0	13.6	6.9	19.2	35.2	14.3	12.9	37.6	23.0	333.4	3.1	20.6	19.7	55.7	19.1	8.2	32.5	46.3	37.1	23.9	6.1	18.8	67.9	49.8
MACROH2A2	H2AFY2	ENSG00000099284	"MacroH2A.2 histone"	Q9P0M6	10	70052544-70112282	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.1;Fibroblasts: 1.7;Hofbauer cells: 4.9;Syncytiotrophoblasts: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 12.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 12.6;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 173.9;AN3-CA: 111.5;SCLC-21H: 137.0;SH-SY5Y: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035865, HPA041189"	Enhanced		Supported	Nucleoplasm		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA035865: AB_10672099, HPA041189: AB_2677357"	"unprognostic (1.62e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.17e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.66e-2)"	3.8	3.2	5.3	5.6	4.5	1.9	10.2	7.3	6.3	14.7	3.3	10.8	9.5	18.3	11.6	17.4	16.5	8.7	13.5	4.1	4.9	15.2	5.2	5.6	4.9	3.8	3.9	13.3	7.8	14.9	14.0	2.1	3.7	13.1	10.5	3.2	10.9	14.4	6.5	10.7	10.1	15.3	3.6	2.7	8.6	11.8	4.2	7.4	10.2	8.6	7.2	13.2	11.8	4.4	4.7	31.1	173.9	111.5	2.5	5.1	0.1	8.6	0.3	16.2	11.0	0.5	55.8	0.0	23.5	2.8	9.1	27.4	15.3	44.8	5.1	81.1	63.4	0.0	0.2	59.1	11.2	1.9	0.8	8.1	30.4	6.4	8.5	23.4	0.0	6.3	0.1	0.6	15.7	37.5	0.2	0.9	74.8	0.2	44.9	0.4	0.5	0.6	30.7	34.0	137.0	132.4	28.6	0.2	0.0	35.2	41.5	20.3	0.0	0.3	32.3	12.4	6.2	0.4	0.1	0.3	0.0	0.2	0.3	1.6	2.4	0.8	0.6	5.4	1.1	0.3	0.9	0.8	12.6	0.3	0.8	0.9	1.4	1.1	3.0	0.2	0.5	1.6	5.3	4.5	7.3	6.3	4.1	4.9	3.8	3.9	3.7	3.6	4.2	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0
MAF	c-MAF	ENSG00000178573	"MAF bZIP transcription factor"	O75444	16	79585843-79600737	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, Mental retardation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 407.6;Hofbauer cells: 273.6;Inhibitory neurons: 378.7;Kupffer cells: 394.7;Proximal enterocytes: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 38.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 38.1"	"Group enriched"	"Detected in some"	13	"Karpas-707: 207.0;RPMI-8226: 355.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010296, HPA028289"	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB010296: AB_638562, HPA028289: AB_10602024"	"unprognostic (6.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (4.54e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.56e-3)"	27.8	15.4	14.6	20.7	14.5	4.0	17.3	10.3	13.5	35.0	14.2	11.4	70.3	23.5	6.0	22.6	20.1	16.7	6.8	13.7	13.0	48.2	25.7	18.8	30.9	19.0	22.6	39.2	3.2	50.8	5.3	36.1	17.6	18.4	10.7	4.7	11.8	15.4	49.6	57.8	83.0	17.8	18.7	26.0	13.0	10.0	28.7	17.9	23.1	19.8	23.9	17.7	30.5	29.8	0.0	0.0	22.4	0.0	0.8	0.0	0.5	2.2	0.1	0.0	0.0	0.3	0.0	0.1	0.0	1.2	0.0	0.8	0.7	0.4	0.0	7.2	8.3	0.0	0.0	0.2	1.0	0.1	14.3	0.1	6.4	0.0	0.2	0.0	0.0	0.3	2.4	207.0	1.5	0.1	0.2	0.4	13.5	0.0	0.0	0.1	6.2	355.1	0.0	1.9	0.5	0.3	0.9	0.2	0.6	8.7	0.2	0.0	4.5	0.0	6.9	0.5	0.9	0.0	0.0	0.0	0.9	0.0	1.4	38.1	0.3	0.0	1.1	1.1	8.6	0.0	3.2	2.7	0.1	0.0	0.2	0.5	0.0	0.9	0.3	0.0	4.7	0.6	14.6	14.5	10.3	13.5	13.7	13.0	19.0	22.6	17.6	18.7	28.7	29.8	40.2	9.6	14.6	24.8	10.4	88.3	3.7	30.1	51.2	9.7	8.5	33.1	8.2	57.2	7.7	3.7	0.0	1.7	71.5	18.2	11.7	1.7	1.1	8.1	114.1	42.7	3.0	8.4	5.1	0.8	3.0	73.0	12.8	6.6	22.1	73.0	407.6	63.7	273.6	0.0	378.7	8.9	16.2	394.7	57.9	9.0	149.8	127.2	44.4	122.7	2.7	78.1	40.2	67.3	20.0	4.0	9.9	115.1	48.1	33.9	288.9	146.6	3.0	2.7	13.1	42.7	40.0	1.1	2.0	107.4	141.2	4.2	122.2	28.0	10.1	5.4
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689236	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 273.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 88.3;non-classical monocyte: 121.4"	"Lineage enriched"	"Detected in many"	15	"monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0"	"Low region specificity"	"Detected in many"							HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	35.3	13.8	4.8	37.3	4.9	59.2	27.3	4.4	10.5	16.5	6.9	9.5	7.8	9.3	5.4	33.0	11.3	24.4	10.7	3.7	5.7	17.5	29.3	20.9	27.8	14.3	6.3	6.8	15.8	273.1	3.1	13.2	7.2	8.3	7.2	0.6	18.3	4.7	15.8	85.3	13.2	14.2	9.0	96.3	11.0	3.9	13.1	6.7	50.1	16.7	12.7	13.9	21.9	15.8	0.0	0.0	0.0	2.6	1.5	0.2	0.4	0.3	0.1	0.3	0.1	0.4	0.2	0.0	1.9	0.4	0.0	3.8	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.2	0.9	0.0	0.1	28.6	61.2	0.2	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.3	7.4	2.6	6.2	0.0	0.0	0.0	0.0	0.5	0.4	16.7	1.4	15.6	1.5	3.9	5.4	1.5	0.3	0.5	16.4	0.3	24.4	0.0	0.0	0.0	0.0	16.0	0.6	0.0	0.4	24.3	0.0	0.0	88.3	0.0	0.0	0.0	0.1	7.9	0.1	0.0	0.0	2.1	0.0	121.4	0.1	0.0	10.6	4.8	4.9	4.4	10.5	3.7	5.7	14.3	6.3	7.2	9.0	13.1	15.8	70.0	22.4	37.9	1.6	7.8	68.6	50.5	17.1	264.0	12.0	112.2	217.8	208.9	7.2	16.8	51.5	25.0	9.8	7.6	117.1	1.9	2.3	0.8	15.7	64.4	39.1	57.7	4.0	0.8	3.4	2.8	172.7	49.5	27.6	10.8	0.9	34.6	36.1	377.6	3.3	25.4	50.7	6.1	672.8	91.7	2.8	29.5	456.7	21.4	6.5	65.3	21.9	3.1	2.0	1.3	4.9	30.9	24.5	5.6	29.7	89.5	1.3	2.4	8.3	13.1	160.6	102.4	0.8	1.7	361.5	88.2	12.4	9.5	114.6	39.0	19.2
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530702-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026820: , HPA060841: AB_2684377"	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	40.9	31.0	37.0	13.0	34.8	19.5	34.4	26.8	34.8	30.9	38.2	61.1	18.2	34.7	1.8	30.1	33.6	11.6	80.5	26.8	28.0	50.3	32.8	60.0	9.4	35.5	33.3	21.7	39.7	4.2	25.6	25.4	32.2	49.2	4.7	2.4	25.6	10.7	78.6	38.6	31.1	6.7	30.2	21.0	37.2	9.7	35.6	22.9	27.3	13.1	4.9	39.4	35.7	43.2	50.0	35.0	1.2	5.2	3.9	4.8	26.2	32.3	18.3	7.7	5.4	25.2	13.4	11.6	11.7	8.2	51.8	38.1	2.9	9.2	3.3	17.9	25.2	6.8	50.8	18.7	8.7	16.2	20.7	4.8	11.8	12.9	9.6	9.5	7.1	35.7	17.8	6.2	3.6	32.7	18.2	57.6	11.2	12.2	35.2	27.1	1.2	19.5	7.3	20.2	14.8	5.4	19.5	56.4	14.6	7.5	22.0	21.3	16.8	11.8	82.3	59.5	17.9	11.8	3.9	19.8	15.5	22.0	17.1	0.5	0.4	1.2	0.6	0.2	0.6	0.3	0.3	0.7	0.2	0.5	0.7	0.5	0.6	0.5	0.5	1.5	0.7	0.4	37.0	34.8	26.8	34.8	26.8	28.0	35.5	33.3	32.2	30.2	35.6	43.2	33.0	41.7	17.6	2.0	8.8	63.9	52.2	21.3	37.0	2.2	33.7	20.2	2.8	11.5	25.7	31.3	2.1	11.0	13.2	45.8	1.9	15.2	2.9	57.3	13.3	24.6	23.2	8.2	8.8	14.9	9.0	16.6	20.4	94.3	9.5	6.6	9.7	14.8	10.9	11.8	3.7	24.4	16.2	13.2	27.9	6.0	4.7	18.0	19.6	9.4	8.7	7.1	8.2	0.5	3.1	46.2	38.9	3.0	6.0	60.8	27.4	2.5	29.6	1.6	13.1	33.2	27.1	0.9	4.0	25.8	57.7	78.0	11.0	2.0	19.8	73.5
MAG	"GMA, S-MAG, SIGLEC-4A, SIGLEC4A"	ENSG00000105695	"Myelin associated glycoprotein"	P20916	19	35292125-35313807	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"brain: 731.4"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 267.8"	"Cancer enriched"	"Detected in some"	7	"glioma: 20.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enriched"	"Detected in some"	22	"WM-115: 36.6"	"Region enhanced"	"Detected in all"		"white matter: 2742.2"	"Low region specificity"	"Detected in all"			"CAB009345, HPA012499"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB009345: AB_670104, HPA012499: AB_1854238"	"unprognostic (2.70e-3)"	"unprognostic (2.70e-2)"		"unprognostic (8.06e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.18e-4)"	"unprognostic (6.29e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-1)"	0.3	1.3	121.5	0.0	366.4	0.0	0.3	314.0	237.4	0.3	4.2	0.1	0.0	0.2	0.0	0.0	4.2	0.0	0.5	157.7	195.2	0.3	0.2	0.3	0.1	459.9	317.3	22.4	0.1	0.0	0.5	0.3	417.5	0.3	0.0	0.0	0.2	0.3	0.1	0.2	0.1	0.0	247.8	1.1	0.1	0.6	303.0	0.0	1.0	0.0	0.0	0.2	0.5	731.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	121.5	366.4	314.0	237.4	157.7	195.2	459.9	317.3	417.5	247.8	303.0	731.4	1.2	0.0	0.0	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.3	4.4	4.1	0.0	0.0	0.0	0.0	0.2	4.0	0.0	1.9	0.0	0.1	0.0	0.0	4.2	0.0	0.4	0.5	0.5	5.4	2.7	0.0	0.0	4.5	21.0	12.8	0.0	1.0	0.0	0.6	0.0	0.0	0.6	0.0	0.1	1.8	1.2	0.0	1.0	0.1	0.0	0.0	0.5	267.8	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	4.3	0.0	0.0	0.3	0.4	11.0	0.0	0.0
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452127-55453566	"Predicted membrane proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"epididymis: 515.9"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011324, HPA011971"	Uncertain		Supported	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"		"HPA011324: AB_1853499, HPA011971: "	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	20.2	29.9	46.8	17.6	48.2	5.1	18.4	40.9	59.3	29.6	59.4	21.0	10.2	30.9	515.9	10.0	45.3	18.1	24.1	47.1	60.0	25.5	19.6	23.5	22.7	41.9	47.7	36.3	28.1	25.5	54.1	20.9	45.7	48.8	11.5	22.0	18.6	44.3	12.9	11.3	17.1	27.3	45.5	20.4	25.3	33.8	50.3	32.0	28.6	16.9	17.0	17.9	16.7	48.8	0.1	5.7	32.6	0.0	51.5	31.0	0.4	36.0	32.9	9.7	26.0	0.1	7.4	0.0	48.2	36.4	18.4	4.9	12.5	13.5	15.2	42.5	2.0	11.4	0.0	4.6	17.0	0.6	14.1	25.8	1.2	5.6	4.1	9.1	15.0	12.0	6.5	43.8	10.8	22.0	30.8	9.8	9.3	0.0	6.8	19.1	4.1	24.0	17.9	0.0	0.2	24.5	0.0	9.5	15.5	24.4	4.7	8.5	17.7	13.3	15.4	8.2	1.9	25.9	35.1	4.9	24.8	15.8	17.2	14.0	9.0	20.5	21.5	14.3	19.4	18.9	35.4	24.6	13.7	17.9	48.2	30.5	1.2	18.9	18.5	28.5	52.1	19.0	46.8	48.2	40.9	59.3	47.1	60.0	41.9	47.7	45.7	45.5	50.3	48.8	24.9	6.4	14.4	4.9	18.3	8.0	7.8	20.0	5.2	36.7	8.0	14.1	10.4	18.6	12.5	12.9	10.4	2.8	15.7	1.9	13.7	32.2	1.6	2.8	33.5	29.0	15.8	3.0	14.2	10.7	2.0	42.9	3.1	1.9	12.7	11.1	32.9	14.0	15.0	37.0	17.5	8.4	4.1	3.8	11.2	4.0	47.2	6.2	21.4	6.5	9.3	56.8	23.7	18.6	28.4	4.7	8.8	63.9	39.8	13.7	0.8	20.1	6.7	19.6	26.3	44.5	35.0	1.4	2.7	3.3	6.3	1.6	19.9	19.7	4.6	4.8
MAIP1	"C2orf47, DKFZp666A212, FLJ22555"	ENSG00000162972	"Matrix AAA peptidase interacting protein 1"	Q8WWC4	2	199955317-200008540	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 30.0;Distal tubular cells: 37.2;Ductal cells: 31.4;Exocrine glandular cells: 28.0;Extravillous trophoblasts: 33.8;Proximal tubular cells: 84.2;Syncytiotrophoblasts: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064013, HPA072231"	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA064013: AB_2685175, HPA072231: AB_2732196"	"unprognostic (4.89e-2)"	"unprognostic (7.36e-2)"	"unprognostic (7.40e-3)"	"prognostic unfavorable (2.14e-4)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.02e-3)"	"unprognostic (7.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.70e-2)"	11.1	16.1	7.0	8.3	7.2	18.7	11.3	10.1	8.4	7.3	6.5	14.4	21.1	7.8	7.4	11.7	9.0	8.1	16.6	7.5	6.5	31.1	46.2	7.4	8.8	6.7	6.5	7.5	10.3	12.2	5.8	9.3	7.3	9.1	13.1	7.2	9.6	9.0	22.2	9.7	16.8	7.5	7.1	8.5	12.6	4.9	6.8	9.3	9.7	16.8	10.4	9.2	8.2	8.6	23.9	21.8	19.3	15.2	16.8	16.9	44.5	21.1	20.2	30.7	29.3	59.5	21.0	15.7	29.6	14.6	25.4	25.8	28.7	22.7	28.8	24.7	32.9	26.4	18.5	54.7	22.6	36.7	18.0	18.1	18.3	20.3	21.9	17.6	19.7	29.9	35.2	19.8	20.2	31.4	27.8	34.0	24.7	25.2	51.6	26.4	22.9	31.6	36.6	30.5	21.8	15.1	21.7	24.4	40.1	24.3	21.6	22.1	17.6	17.9	25.6	15.6	23.7	18.8	23.6	33.7	27.0	21.1	18.7	9.9	12.9	9.4	10.8	12.8	13.3	13.8	10.6	7.7	16.8	14.1	10.0	8.6	2.0	8.9	12.6	13.5	13.9	8.2	7.0	7.2	10.1	8.4	7.5	6.5	6.7	6.5	7.3	7.1	6.8	8.6	11.7	9.6	14.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	10.8	14.1	0.0	0.0	5.0	3.7	0.0	30.0	7.0	0.0	37.2	31.4	0.0	10.0	10.2	6.1	0.0	0.0	0.0	28.0	33.8	6.2	0.0	11.9	3.8	12.2	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	21.2	0.0	0.0	1.3	0.0	0.0	84.2	5.8	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	32.0	4.0	18.3	0.0	0.0
MAJIN	C11orf85	ENSG00000168070	"Membrane anchored junction protein"	Q3KP22	11	64937517-64972108	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 22.5"	"Group enriched"	"Detected in some"	8	"Distal tubular cells: 3.9;Proximal tubular cells: 9.5"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.0"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.6"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.3"	"Group enriched"	"Detected in some"	10	"CAPAN-2: 7.5;SiHa: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.37e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.69e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-2)"	0.0	0.2	0.2	0.2	0.6	0.1	0.2	2.6	0.6	0.1	0.0	0.1	0.0	0.0	2.0	0.1	1.1	2.9	0.0	0.1	0.1	1.4	1.2	0.2	1.4	0.5	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.2	0.2	0.1	0.6	0.0	1.2	0.4	0.0	0.2	0.6	0.2	22.5	0.1	0.1	0.9	0.0	1.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	2.6	0.6	0.1	0.1	0.5	0.2	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MALL	BENE	ENSG00000144063	"Mal, T cell differentiation protein like"	Q13021	2	110083870-110116022	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 368.5;intestine: 235.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 857.8;Ductal cells: 299.2;Pancreatic endocrine cells: 354.9;Paneth cells: 374.4;Proximal enterocytes: 742.2;Urothelial cells: 426.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 8.4;neutrophil: 2.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"A-431: 267.4;A549: 269.9;CAPAN-2: 347.7;fHDF/TERT166: 380.9;HaCaT: 276.4;PC-3: 158.3"	"Not detected"	"Not detected"							HPA051410	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA051410: AB_2681474"	"unprognostic (5.17e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.50e-3)"	17.2	2.9	3.9	17.2	3.7	2.4	13.4	3.6	3.8	58.2	4.7	114.1	235.4	6.3	5.7	368.5	8.4	20.3	18.6	3.6	4.9	7.0	3.1	79.9	6.1	4.1	4.2	2.0	4.4	97.8	2.6	9.3	4.6	18.9	95.1	0.4	40.8	4.2	6.3	43.7	218.8	14.4	4.9	5.0	9.2	9.7	6.9	3.1	28.6	10.8	55.0	98.6	148.1	4.2	267.4	269.9	0.2	0.9	0.1	0.1	0.8	48.5	2.1	0.2	0.2	44.3	347.7	0.6	127.6	380.9	0.1	276.4	0.0	12.6	0.1	0.7	0.2	1.8	7.3	0.1	1.9	0.1	0.6	4.8	13.9	1.2	0.0	0.0	111.9	0.0	0.1	0.4	0.0	10.0	0.0	1.0	0.2	117.8	158.3	0.1	0.1	1.2	30.4	15.3	0.7	0.2	0.2	9.3	0.7	0.4	0.3	1.4	130.9	0.4	0.9	0.7	0.8	0.3	0.4	31.7	0.4	0.4	0.2	8.4	0.4	0.6	0.2	0.2	0.2	0.5	0.5	0.4	0.2	0.5	0.3	0.5	2.5	1.2	0.1	0.4	0.3	0.3	3.9	3.7	3.6	3.8	3.6	4.9	4.1	4.2	4.6	4.9	6.9	4.2	45.1	41.7	185.9	0.3	2.0	16.4	107.2	38.6	3.4	0.0	10.9	6.1	3.2	2.8	64.6	1.8	0.0	0.3	0.4	857.8	0.0	299.2	26.3	3.2	1.8	50.6	17.5	0.0	0.8	66.1	0.1	8.2	2.6	7.6	7.0	0.4	33.9	0.5	8.2	0.0	0.1	51.2	30.5	0.9	3.8	9.7	2.5	2.9	14.2	2.8	1.0	0.1	0.0	0.0	0.0	354.9	374.4	1.2	0.0	187.4	742.2	14.6	19.4	0.1	0.0	1.1	5.6	27.2	1.3	57.9	13.2	0.5	2.4	0.6	97.4	426.0
MANSC4		ENSG00000205693	"MANSC domain containing 4"	A6NHS7	12	27762427-27780236	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 2.1;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA039454, HPA039682"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"		"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA039454: AB_2676515, HPA039682: AB_10805483"	"unprognostic (1.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.25e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.50e-3)"	"unprognostic (7.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.10e-2)"	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.6	0.3	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.4	0.0	0.2	0.5	0.3	0.1	0.2	0.2	0.0	0.7	0.5	0.1	0.1	0.0	0.5	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	1.5	0.3	0.1	0.1	0.1	0.3	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0
MAP1LC3B	ATG8F	ENSG00000140941	"Microtubule associated protein 1 light chain 3 beta"	Q9GZQ8	16	87383953-87404779	"Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB037216, HPA042824, HPA052474, HPA052484, HPA053767"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"CAB037216: AB_796155, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846, HPA053767: AB_2682253"	"unprognostic (4.70e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.21e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.98e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (2.77e-7)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	92.0	82.9	108.4	37.5	112.9	245.6	72.9	123.7	135.3	46.1	110.7	46.2	25.5	52.6	44.7	45.0	48.2	57.0	102.7	105.2	130.1	71.3	50.3	50.9	52.5	131.5	132.0	43.3	37.1	74.2	51.1	75.6	140.8	43.6	47.1	125.9	49.2	49.3	195.2	62.5	36.9	66.6	120.5	44.4	42.3	51.8	126.5	54.9	63.5	176.7	51.4	57.3	42.0	123.8	56.9	33.7	63.8	59.2	188.5	145.3	41.9	111.4	130.1	88.0	59.9	56.0	42.4	37.7	82.0	155.7	97.5	50.8	95.2	72.3	125.3	49.9	81.0	39.4	40.2	94.4	313.4	28.3	40.0	194.9	234.8	137.0	326.0	131.1	101.1	57.2	107.4	79.0	150.4	61.5	48.4	64.0	66.1	27.7	81.2	76.2	42.2	37.6	119.0	28.4	53.0	60.3	174.8	29.4	230.8	85.2	48.0	34.0	134.1	94.7	59.7	86.4	65.3	99.4	131.5	137.7	133.9	68.3	69.6	312.5	86.8	198.1	78.6	81.6	80.5	72.5	75.8	81.1	69.2	58.2	58.4	62.0	214.3	104.7	85.3	75.1	108.2	109.2	108.4	112.9	123.7	135.3	105.2	130.1	131.5	132.0	140.8	120.5	126.5	123.8	523.1	89.8	90.5	15.7	185.3	221.0	203.1	176.2	301.7	70.4	183.9	227.3	180.7	72.9	117.2	77.3	52.1	130.6	242.7	309.1	262.2	310.9	222.1	283.6	235.9	191.7	132.2	364.2	29.2	134.8	140.2	177.7	96.4	530.5	131.1	49.3	80.7	70.1	206.4	87.5	41.4	137.3	238.0	150.9	268.5	269.7	90.7	262.2	188.5	19.7	207.0	194.3	143.2	14.6	26.9	322.8	407.6	89.1	202.0	209.3	217.4	236.9	133.5	124.0	59.2	129.5	168.2	361.2	206.7	221.8	213.5	631.5	221.6	85.7	122.4	294.5
MAP3K15	"ASK3, bA723P2.3, FLJ16518"	ENSG00000180815	"Mitogen-activated protein kinase kinase kinase 15"	Q6ZN16	X	19360056-19515261	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 10.8;choroid plexus: 13.1"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Cone photoreceptor cells: 4.2;Granulosa cells: 7.5;Theca cells: 29.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;HAP1: 4.9;HEK 293: 4.1;JURKAT: 2.5;REH: 2.6;SuSa: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA004006			Approved	Vesicles		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA004006: AB_1079358"	"unprognostic (2.87e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.56e-8)"	"unprognostic (3.47e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.98e-2)"	"unprognostic (8.20e-2)"	0.0	10.8	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.6	1.1	0.0	0.3	0.0	0.0	0.3	0.4	0.5	0.7	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	4.9	0.0	0.0	0.8	4.1	1.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.1	0.0	1.1	1.3	0.0	0.5	2.6	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.6	0.0	0.3	0.4	0.0	0.2	0.0	0.2	0.0	3.1	0.3	0.0	0.1	0.5	0.0	0.0	1.0	0.2	0.6	2.9	0.0	0.0	5.5	4.2	0.0	0.1	0.2	3.9	0.0	0.4	0.3	0.3	0.1	0.0	0.4	2.6	0.0	0.3	0.4	0.0	0.3	0.0	7.5	0.4	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	1.0	0.0	0.3	0.0	0.5	1.1	0.1	0.0	1.2	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.3	0.2	0.6	1.4	0.0	0.0	0.1	0.2	29.8	0.1	0.0
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.1;lymphoid tissue: 56.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 42.6;dendritic cells: 42.6;Langerhans cells: 27.8;Plasma cells: 30.4;Rod photoreceptor cells: 77.9;T-cells: 43.6"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.2"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 45.2;HDLM-2: 46.4;Karpas-707: 46.9;REH: 25.5;RPMI-8226: 29.8;U-266/70: 36.0;U-266/84: 38.2;U-698: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	2.7	1.5	0.6	14.6	0.7	9.2	1.7	0.7	1.2	1.6	0.7	5.0	2.7	1.3	0.8	2.8	1.8	2.3	1.7	0.7	0.8	2.7	3.0	6.2	32.2	1.0	0.8	0.9	1.2	0.2	1.8	1.8	0.9	2.5	2.3	16.1	2.8	0.5	0.8	1.9	30.1	0.9	0.8	56.9	3.1	1.5	0.9	13.1	3.2	0.2	29.3	2.9	2.1	0.9	0.2	0.3	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	45.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	46.4	0.3	9.8	0.1	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	21.3	0.2	46.9	0.1	0.3	11.0	12.0	1.4	0.3	0.1	25.5	0.1	29.8	0.0	0.0	0.4	0.1	0.1	0.2	0.1	0.3	0.2	10.8	0.1	0.1	0.3	0.1	0.1	36.0	38.2	57.8	0.0	13.5	0.1	2.9	4.9	2.0	18.9	9.4	17.4	22.7	15.8	20.1	23.9	15.5	8.6	12.1	0.5	6.1	5.7	22.2	22.2	12.1	0.6	0.7	0.7	1.2	0.7	0.8	1.0	0.8	0.9	0.8	0.9	0.9	0.7	3.2	4.9	0.3	42.6	2.3	0.2	0.4	1.2	6.7	0.7	1.0	0.9	0.0	0.6	0.0	12.5	0.2	42.6	0.1	0.0	0.0	0.0	0.3	0.2	1.6	0.0	5.5	0.7	0.2	0.3	1.5	2.0	0.3	15.8	0.4	1.1	1.1	2.6	1.7	1.0	0.1	0.0	8.8	27.8	0.2	0.0	11.6	3.6	1.9	10.3	11.5	15.5	1.0	0.5	0.0	0.0	0.0	30.4	0.3	0.0	0.2	0.0	77.9	0.0	1.0	0.4	0.7	6.4	0.6	1.0	0.1	43.6	0.3	0.3	0.1
MAP4K4	"FLH21957, HGK, NIK"	ENSG00000071054	"Mitogen-activated protein kinase kinase kinase kinase 4"	O95819	2	101696850-101894689	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 472.1"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 337.3;Oligodendrocytes: 1134.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008476	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA008476: AB_1079362"	"unprognostic (6.40e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.22e-3)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (3.62e-6)"	"unprognostic (6.67e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.14e-3)"	54.1	9.1	272.6	42.9	316.1	72.5	32.2	208.8	252.5	23.9	95.0	21.1	10.6	27.4	12.1	35.2	19.7	34.5	44.8	219.4	256.3	15.0	32.8	29.2	54.1	317.5	286.1	23.1	16.1	15.0	10.0	49.4	273.1	13.9	17.8	22.7	19.3	10.2	37.4	21.1	17.7	28.7	246.7	24.2	22.0	40.1	348.5	44.3	15.8	30.6	60.1	33.1	25.6	472.1	112.7	83.8	175.2	84.3	162.4	288.6	219.5	139.8	114.3	122.2	100.1	139.5	145.6	163.1	118.3	210.3	36.0	45.5	56.0	123.2	121.1	219.8	38.0	122.4	62.5	367.7	136.7	59.1	5.5	261.3	55.3	301.9	133.5	122.1	322.5	90.3	80.9	0.4	325.4	61.3	137.8	36.5	89.2	42.5	131.5	164.1	120.0	0.6	81.2	38.8	68.5	113.6	96.5	0.4	104.0	160.8	22.4	105.1	409.1	240.5	102.9	70.6	168.6	0.3	0.4	96.7	155.2	73.2	180.1	8.8	3.2	0.0	2.3	3.2	1.6	3.4	2.9	1.5	1.1	5.0	2.2	2.5	13.5	1.1	3.1	6.0	3.7	1.5	272.6	316.1	208.8	252.5	219.4	256.3	317.5	286.1	273.1	246.7	348.5	472.1	104.3	19.2	23.9	283.0	64.5	30.0	41.9	17.4	12.5	109.1	14.3	17.4	71.0	28.6	29.6	18.4	50.1	13.1	38.4	12.0	0.0	57.4	31.5	67.2	77.1	84.2	17.4	48.0	197.5	53.2	23.4	49.7	26.5	101.0	24.0	151.8	67.1	39.2	38.8	35.3	122.4	13.6	14.2	26.9	245.9	46.0	55.0	54.7	19.6	337.3	88.0	49.2	10.3	228.7	1134.5	128.1	12.0	17.3	18.0	72.1	5.3	6.3	22.9	10.4	52.6	65.2	73.3	29.0	82.1	24.3	24.6	7.8	38.4	17.2	14.4	40.4
MAP6	"FLJ41346, KIAA1878, MAP6-N, STOP"	ENSG00000171533	"Microtubule associated protein 6"	Q96JE9	11	75586918-75669038	"Predicted intracellular proteins"	Transport	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 76.8;retina: 96.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 81.2;Cone photoreceptor cells: 158.4;Excitatory neurons: 75.8;Horizontal cells: 50.5;Inhibitory neurons: 43.3;Late spermatids: 41.9"	"Cancer enhanced"	"Detected in many"		"glioma: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 37.8;CACO-2: 38.1;HDLM-2: 21.5;SCLC-21H: 62.4;SH-SY5Y: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015442, CAB022600, HPA039061, HPA039062"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"CAB015442: AB_2140997, CAB022600: , HPA039061: AB_2676325, HPA039062: AB_2676326"	"unprognostic (3.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.99e-2)"	"unprognostic (7.99e-2)"	"prognostic favorable (3.41e-4)"	"prognostic favorable (9.15e-4)"	"unprognostic (2.43e-2)"	"unprognostic (3.96e-3)"	"unprognostic (8.09e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	4.8	19.0	68.3	2.0	68.0	0.0	3.5	50.7	70.6	10.6	64.4	23.0	1.7	18.1	21.0	4.2	40.7	6.4	8.6	67.7	71.5	17.0	1.2	7.8	0.7	70.2	64.6	8.0	3.6	22.0	76.8	1.5	70.8	17.8	3.5	96.1	3.6	21.1	1.0	8.1	4.8	13.1	52.9	2.4	10.7	18.6	68.5	0.8	7.9	1.3	0.5	7.1	8.4	59.7	0.2	0.7	37.8	0.1	0.1	0.0	0.0	3.8	0.2	0.3	0.0	38.1	0.1	0.6	1.4	6.3	1.3	0.0	3.4	0.5	0.0	21.5	0.5	0.0	0.0	0.0	1.0	0.0	0.0	2.1	0.5	0.1	0.2	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	5.9	0.0	2.9	0.0	0.0	0.1	0.1	0.5	62.4	31.7	4.6	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.1	0.1	0.5	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.3	68.0	50.7	70.6	67.7	71.5	70.2	64.6	70.8	52.9	68.5	59.7	1.2	3.2	3.7	25.8	0.1	0.8	1.7	0.7	0.0	81.2	0.8	1.8	8.4	1.5	3.1	11.0	158.4	0.2	0.2	0.0	1.9	0.1	27.7	28.2	4.6	1.6	13.1	0.0	75.8	0.2	0.0	2.9	0.0	0.8	0.0	0.8	2.2	0.3	0.1	50.5	43.3	0.0	6.1	0.0	1.1	41.9	7.5	0.3	5.4	1.9	0.0	18.7	0.0	13.0	13.3	0.2	0.0	18.4	0.1	1.4	0.0	1.2	25.4	10.2	0.0	1.9	5.7	23.5	4.3	0.1	0.4	0.0	0.3	0.1	0.0	0.4
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.6;epididymis: 36.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.2	2.8	11.6	0.3	15.3	0.7	0.4	12.5	66.6	0.3	0.0	0.7	0.7	0.6	36.4	0.2	2.3	0.5	0.4	13.9	16.3	3.5	0.1	0.2	0.2	35.8	7.0	0.3	1.1	0.0	3.9	7.6	28.9	0.8	0.8	14.6	0.2	2.0	0.5	0.9	1.2	0.4	3.0	0.1	8.7	9.6	17.1	2.3	0.1	0.1	0.3	0.1	0.3	20.0	0.0	13.3	1.1	0.1	0.1	0.3	0.0	1.4	0.0	0.2	0.1	19.3	0.5	2.3	2.0	0.0	0.2	0.0	0.0	0.0	0.1	1.0	25.0	0.0	21.4	11.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	5.0	1.0	0.0	0.3	0.0	0.0	1.5	0.0	29.1	5.0	12.8	4.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	1.4	0.1	1.4	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	11.6	15.3	12.5	66.6	13.9	16.3	35.8	7.0	28.9	3.0	17.1	20.0	0.2	3.2	0.0	4.6	0.6	1.8	0.3	7.2	0.6	29.1	0.9	1.1	1.2	0.0	2.5	0.0	2.1	93.0	0.8	2.2	3.9	1.3	16.4	0.6	0.2	0.7	9.6	0.0	45.5	0.9	9.2	1.1	28.1	0.7	0.0	12.3	0.0	0.2	6.1	18.5	55.2	0.6	2.0	0.0	0.7	17.8	0.6	0.7	0.0	6.5	0.0	2.8	0.0	11.1	3.6	0.8	4.8	1.9	0.9	1.0	3.5	18.8	6.9	8.1	0.0	0.6	0.8	57.8	134.9	0.9	1.6	30.6	0.4	0.9	1.3	0.5
MAPRE2	"EB1, EB2, RP1"	ENSG00000166974	"Microtubule associated protein RP/EB family member 2"	Q15555	18	34976928-35143470	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 163.3;Oligodendrocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016738, HPA016739"	Enhanced		Uncertain	Nucleoplasm		NA	NA		13000000	"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016738: AB_1853571, HPA016739: AB_1853570"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-3)"	22.4	58.7	54.2	29.1	65.2	22.1	16.6	58.5	89.4	19.3	1.9	24.5	15.0	14.0	18.9	17.4	12.7	41.1	89.1	68.8	56.9	18.4	33.4	27.2	35.8	74.0	61.0	24.9	12.8	19.2	16.3	28.3	70.6	16.1	24.6	49.1	20.2	17.2	50.4	26.1	19.6	23.8	70.0	27.8	30.6	6.4	68.2	74.4	21.7	91.9	32.6	27.2	14.4	109.0	0.8	26.3	28.9	15.4	17.1	15.9	2.0	18.7	44.7	22.3	37.2	2.0	9.9	87.8	21.3	41.1	23.5	35.0	22.8	15.2	39.8	51.5	21.3	88.9	26.9	52.8	12.6	49.5	72.3	19.6	4.0	30.4	10.5	21.2	124.0	61.4	28.3	37.7	28.8	1.7	104.6	16.4	22.5	28.8	5.2	41.6	35.2	20.0	11.9	0.4	35.9	23.9	14.0	0.7	15.5	27.2	3.2	29.0	21.0	24.1	13.4	14.2	12.7	19.9	50.8	50.8	41.4	65.1	38.2	69.0	30.0	46.7	63.8	37.7	49.5	60.8	44.4	58.3	33.4	55.5	50.6	61.5	21.5	74.4	51.6	47.3	52.9	76.9	54.2	65.2	58.5	89.4	68.8	56.9	74.0	61.0	70.6	70.0	68.2	109.0	27.0	22.4	18.3	104.8	73.0	23.7	5.1	2.0	38.1	109.6	18.9	19.7	105.6	12.8	4.8	5.5	25.0	0.6	107.9	13.3	5.9	9.8	12.4	11.9	12.6	29.4	29.3	25.0	163.3	12.8	9.7	28.5	42.3	14.6	27.3	4.6	33.5	26.1	26.1	52.2	141.7	25.8	4.1	44.7	38.3	6.8	19.3	44.6	30.2	70.3	17.1	40.3	52.5	97.5	435.9	10.1	15.6	21.1	31.6	2.9	12.0	5.1	6.5	12.5	78.9	25.4	74.9	1.9	10.6	9.1	27.6	0.8	76.1	15.0	11.1	3.5
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894527-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skeletal muscle: 79.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.4;Bipolar cells: 314.4;Early spermatids: 199.9;Excitatory neurons: 189.2;Horizontal cells: 361.7;Inhibitory neurons: 153.7;Late spermatids: 416.6;Muller glia cells: 145.7;Oligodendrocytes: 163.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.5;glioma: 13.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"HDLM-2: 69.0;SCLC-21H: 21.1;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"	"Secreted to blood"	NA	NA		7100	"Cluster 35: T-regs - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	4.7	4.3	26.2	0.3	27.1	0.0	9.1	8.3	67.7	2.4	0.0	8.4	0.5	1.0	0.2	8.4	1.0	0.8	9.4	30.0	20.4	14.7	0.6	0.8	0.3	11.6	11.4	0.6	1.5	2.9	29.5	3.4	22.4	5.4	0.3	17.6	8.5	3.4	79.0	6.3	1.8	0.3	2.7	0.4	1.7	20.3	14.8	0.4	0.9	27.4	0.2	10.2	2.3	19.7	2.9	0.5	0.3	6.4	0.3	0.9	1.8	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.6	0.4	0.5	0.1	2.3	0.3	0.0	69.0	3.4	0.0	0.3	4.2	0.0	0.1	0.1	0.0	0.5	0.1	0.3	0.1	0.0	4.4	0.7	3.6	0.0	7.7	1.0	0.2	0.2	0.7	2.0	0.0	4.0	8.5	0.0	9.1	21.1	9.1	2.5	0.0	1.8	1.0	34.7	0.1	0.1	0.3	0.8	1.7	0.3	0.9	0.3	0.0	0.6	2.0	0.5	0.1	0.0	0.0	0.2	0.7	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.3	0.2	0.1	1.7	0.0	0.7	0.0	26.2	27.1	8.3	67.7	30.0	20.4	11.6	11.4	22.4	2.7	14.8	19.7	1.9	0.0	9.8	142.4	1.0	1.0	1.4	0.2	1.2	314.4	26.7	21.2	35.2	0.0	0.1	1.8	64.6	0.2	0.4	0.1	7.9	0.5	199.9	0.4	1.7	1.8	0.0	0.0	189.2	0.4	9.1	3.7	0.5	1.3	4.5	1.6	1.1	0.5	0.3	361.7	153.7	0.0	2.0	0.6	1.7	416.6	2.8	0.8	5.4	8.4	0.7	145.7	0.0	129.7	163.8	0.6	0.0	2.6	0.1	2.5	0.1	76.1	0.0	28.3	0.0	28.2	6.0	18.4	8.1	22.7	3.3	0.3	1.5	0.8	0.3	0.6
MARCHF10	"FLJ35757, MARCH-X, MARCH10, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 137.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;EFO-21: 4.7;HSkMC: 2.1;SCLC-21H: 8.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.1	0.2	1.3	0.2	1.6	0.0	0.1	1.2	0.9	1.4	10.5	1.1	0.0	0.4	7.5	0.1	12.8	0.1	0.1	1.1	1.3	1.5	0.0	2.7	0.0	3.6	5.0	0.1	0.2	0.3	12.7	0.0	2.6	0.6	0.0	0.1	0.3	0.1	0.0	0.2	0.4	0.0	3.6	0.1	0.4	137.6	1.3	0.2	0.1	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.1	0.0	0.0	0.1	2.5	1.1	0.1	0.8	0.2	0.0	0.0	0.0	4.7	0.3	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.8	0.6	0.0	1.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.7	0.0	8.3	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.1	1.3	1.6	1.2	0.9	1.1	1.3	3.6	5.0	2.6	3.6	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MARCHF3	"MARCH-III, MARCH3, MGC48332, RNF173"	ENSG00000173926	"Membrane associated ring-CH-type finger 3"	Q86UD3	5	126867714-127030558	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 43.8;Syncytiotrophoblasts: 98.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 10.5;naive B-cell: 12.1"	"Lineage enriched"	"Detected in many"	4	"B-cells: 12.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 40.4;HUVEC TERT2: 27.4;TIME: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043406	Uncertain		Supported	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA043406: AB_10793947"	"unprognostic (5.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.75e-3)"	"unprognostic (9.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.60e-6)"	"unprognostic (7.74e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-1)"	5.6	2.8	6.1	2.9	5.6	3.7	2.6	5.3	4.1	0.9	1.9	5.3	0.9	1.4	0.0	1.4	1.5	5.2	7.8	3.9	5.7	0.8	0.7	2.4	2.5	11.5	7.1	1.1	2.4	0.3	2.4	1.7	7.9	0.6	5.6	7.4	4.6	0.2	6.5	5.8	2.4	2.9	8.3	1.6	2.4	5.6	7.8	1.3	1.4	3.3	2.1	7.6	0.7	8.5	0.4	1.8	3.9	2.1	3.4	3.2	1.2	14.2	5.9	11.1	16.3	1.9	0.8	3.8	1.3	1.9	2.4	1.1	4.9	2.5	15.3	0.8	4.7	12.2	3.2	1.9	5.6	5.0	3.0	2.4	0.7	40.4	4.8	2.6	27.4	0.6	5.1	0.7	9.3	1.3	0.5	2.3	3.3	3.0	4.6	1.5	15.5	1.2	0.9	2.0	1.3	0.9	3.3	0.5	1.6	1.9	2.9	5.0	33.5	2.2	1.8	12.6	1.6	1.9	2.3	2.3	8.3	3.8	2.0	0.0	0.2	2.8	0.5	0.4	0.1	10.5	0.6	0.3	0.1	12.1	2.3	0.5	0.8	2.3	0.3	0.7	2.9	0.8	6.1	5.6	5.3	4.1	3.9	5.7	11.5	7.1	7.9	8.3	7.8	8.5	3.8	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	43.8	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	98.6	0.6	0.0	0.0	0.0
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942194-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 94.9;lung: 199.6;lymphoid tissue: 87.9"	"Cell type enriched"	"Detected in many"	6	"Kupffer cells: 1269.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 21.6"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 4.1;thalamus: 12.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 33.7;intermediate monocyte: 56.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 56.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		30000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"	Vesicles	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	64.7	31.1	0.4	87.9	1.4	3.4	7.4	0.7	4.1	0.7	4.4	5.7	2.0	0.7	1.3	2.4	25.5	2.4	19.0	0.9	1.0	1.6	94.9	199.6	17.7	1.2	1.7	7.5	0.8	0.3	1.5	2.8	1.9	1.8	2.1	0.0	4.4	2.3	1.5	2.5	3.1	29.8	1.2	37.1	3.5	2.0	12.6	1.3	1.5	5.0	1.1	25.2	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	2.6	0.4	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	33.7	0.0	0.0	56.5	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.7	0.0	7.2	1.0	0.0	9.2	0.4	1.4	0.7	4.1	0.9	1.0	1.2	1.7	1.9	1.2	12.6	0.7	0.7	25.6	45.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	3.4	1.8	0.4	1.5	16.7	3.7	0.0	0.7	1.4	0.1	0.0	3.9	0.0	0.0	0.0	5.2	0.0	8.0	0.0	0.2	1.1	2.6	0.0	0.0	12.6	0.0	11.4	3.4	169.6	0.0	0.0	0.0	0.0	1269.8	46.4	0.1	0.0	199.3	0.0	2.8	23.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.5	0.1	0.0	0.2	13.1	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.9	1.9	4.1	0.0	0.0	0.1
MARVELD1	"bA548K23.8, FLJ22343, FLJ23440, GB14, MGC4415, MRVLDC1"	ENSG00000155254	"MARVEL domain containing 1"	Q9BSK0	10	97713173-97718150	"Predicted membrane proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.2;intermediate monocyte: 2.7;myeloid DC: 3.1"	"Group enriched"	"Detected in many"	18	"dendritic cells: 3.1;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 141.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (3.28e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.82e-2)"	"unprognostic (7.40e-3)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (1.54e-2)"	"unprognostic (7.44e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (8.89e-7)"	"unprognostic (3.92e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.86e-3)"	35.9	8.9	4.7	12.6	5.4	5.2	26.7	4.5	5.5	56.8	24.5	57.1	7.7	60.0	16.7	19.7	48.1	20.4	24.8	4.6	7.5	12.4	5.6	29.7	6.9	6.4	5.7	40.5	7.0	11.3	20.0	25.0	5.5	44.3	24.5	2.0	19.1	48.5	6.1	30.8	22.3	47.7	5.8	16.0	23.7	6.8	6.6	5.3	15.9	7.0	6.0	46.5	41.3	5.9	42.0	30.7	26.1	99.9	97.8	94.0	27.0	56.4	141.3	51.6	34.5	13.5	70.4	0.0	44.5	105.1	7.3	50.3	22.4	53.5	25.9	3.2	28.0	20.3	24.6	0.0	40.9	28.6	0.0	82.7	137.5	33.2	38.3	95.3	65.0	17.6	5.7	0.1	57.7	24.1	3.8	9.9	19.5	4.5	30.6	26.1	22.4	7.0	27.4	8.9	16.9	17.8	34.0	0.3	59.7	16.0	13.4	33.7	65.8	51.9	21.2	50.7	21.4	0.0	3.1	0.1	26.5	0.1	40.2	0.0	3.2	0.0	0.0	2.7	0.1	0.0	0.0	0.1	3.1	0.0	0.0	0.1	0.0	0.0	0.7	0.8	0.0	1.0	4.7	5.4	4.5	5.5	4.6	7.5	6.4	5.7	5.5	5.8	6.6	5.9	7.0	9.6	6.3	10.7	0.9	7.6	31.4	13.4	9.6	2.5	7.1	21.0	4.4	11.5	5.7	12.9	6.2	10.5	0.1	31.9	0.0	8.3	0.7	3.1	32.3	10.5	3.0	4.6	2.3	0.9	21.0	29.9	2.0	6.3	2.5	86.6	12.8	0.6	12.9	0.0	2.8	28.9	4.1	32.6	13.4	2.9	23.0	15.6	12.4	7.5	11.7	13.7	0.0	2.5	0.6	1.9	7.0	38.7	0.3	4.0	2.0	0.2	0.7	3.2	0.0	10.0	31.9	0.3	1.6	1.0	5.4	3.4	1.2	13.1	9.4	6.9
MATN2		ENSG00000132561	"Matrilin 2"	O00339	8	97868840-98036724	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033879	Approved				"Secreted to extracellular matrix"	NA	NA		1500000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"CAB033879: AB_2141502"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (6.65e-2)"	54.4	51.0	24.3	30.2	22.5	1.8	43.6	17.6	23.2	194.4	19.3	67.5	58.5	147.0	101.6	32.8	46.9	40.1	110.2	20.0	23.4	39.3	24.6	15.2	18.0	24.1	30.5	116.4	11.3	28.0	9.9	177.9	26.3	104.9	57.8	45.7	42.6	171.9	4.0	62.8	80.6	98.1	18.3	5.9	23.7	31.2	23.4	4.9	271.4	28.5	15.4	103.0	139.2	30.8	24.1	10.8	23.3	2.5	60.7	3.6	15.0	72.5	17.6	78.6	106.7	13.0	8.4	0.1	7.0	29.2	3.5	114.4	2.3	4.4	100.6	0.0	2.9	0.8	6.1	0.9	14.0	0.0	0.0	13.6	9.5	16.1	0.8	22.1	0.5	1.3	0.1	0.2	4.1	11.2	0.0	0.7	7.1	0.3	3.7	0.0	2.4	11.4	5.7	5.3	16.0	1.5	11.5	0.2	19.8	67.3	10.9	1.4	0.6	5.2	31.5	16.1	11.0	0.9	0.2	0.2	18.8	0.4	5.9	0.0	0.1	0.1	0.2	0.4	5.2	0.0	0.7	0.9	0.8	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	24.3	22.5	17.6	23.2	20.0	23.4	24.1	30.5	26.3	18.3	23.4	30.8	27.8	3.2	1.3	11.1	0.3	37.3	10.1	6.2	80.2	6.3	3.8	45.8	29.1	18.6	3.0	16.5	54.2	1.2	0.2	20.6	0.0	9.9	86.0	4.2	22.6	32.4	23.4	3.2	6.4	0.0	1.1	113.1	5.1	5.0	0.0	43.5	201.0	11.0	1.6	0.0	11.5	25.4	0.0	5.0	7.7	108.6	103.5	0.9	28.4	19.7	2.0	8.1	0.0	86.0	59.8	3.2	18.2	258.8	0.0	6.5	118.7	3.4	1.6	52.9	13.1	97.2	17.1	2.5	2.6	7.3	8.5	2.5	2.0	297.5	27.4	1.8
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528962-31530232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	73	"kidney: 81.8"	"Group enriched"	"Detected in some"	44	"Distal tubular cells: 401.1;Proximal tubular cells: 414.8"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;endometrial cancer: 0.8;liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favorable (1.73e-4)"					0.0	0.0	0.1	0.0	0.2	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	81.8	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.3	0.4	0.1	0.4	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	401.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1
MCF2L	"ARHGEF14, DBS, KIAA0362, OST"	ENSG00000126217	"MCF.2 cell line derived transforming sequence like"	O15068	13	112894378-113099742	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 134.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 138.3;Bipolar cells: 70.4;Cone photoreceptor cells: 127.2;Endothelial cells: 69.7;Microglial cells: 92.8;Oligodendrocytes: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 35.9;SCLC-21H: 65.3;SH-SY5Y: 29.0;SK-BR-3: 43.9;WM-115: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.56e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (6.01e-4)"	"unprognostic (9.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (1.17e-1)"	"prognostic favorable (9.14e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (2.63e-5)"	44.1	7.6	39.0	6.3	35.1	0.9	39.5	134.5	76.1	16.5	0.4	17.5	11.3	19.4	5.1	14.1	17.8	13.4	52.8	32.3	27.7	17.5	7.7	19.0	6.8	51.3	40.6	4.8	18.8	10.3	44.4	8.4	57.6	17.0	13.7	20.0	32.7	8.5	16.5	24.8	18.7	7.1	29.1	3.6	18.1	2.0	49.3	7.1	27.6	16.3	6.0	15.0	16.9	47.7	0.0	1.6	14.9	4.8	0.5	0.9	2.1	0.0	0.0	0.0	0.0	3.8	2.2	0.1	3.7	1.5	2.5	0.3	3.8	0.0	0.0	0.0	7.4	4.3	0.2	9.1	0.5	0.2	3.1	1.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	14.4	5.6	0.5	2.6	4.0	35.9	0.0	0.2	15.0	7.9	5.9	23.6	65.3	29.0	0.0	43.9	0.1	2.4	26.0	0.1	0.6	0.1	12.5	5.4	0.0	7.5	0.4	2.3	23.9	1.0	60.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.4	39.0	35.1	134.5	76.1	32.3	27.7	51.3	40.6	57.6	29.1	49.3	47.7	138.3	0.0	8.4	4.6	2.6	5.5	3.4	1.5	8.0	70.4	12.9	10.0	44.3	12.8	4.6	9.2	127.2	0.0	1.2	10.8	7.9	5.6	0.4	9.9	1.6	69.7	26.5	0.0	58.5	2.6	0.2	7.1	23.0	18.7	1.3	11.2	13.6	3.4	1.4	38.7	60.9	54.6	8.2	2.2	4.6	1.5	0.6	2.5	8.8	92.8	0.1	5.4	0.0	40.7	75.0	1.7	9.8	1.2	3.0	4.2	4.0	10.4	7.2	23.9	0.0	5.2	11.9	0.7	2.7	4.2	9.1	0.1	2.1	0.5	7.4	4.1
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1349.1;tongue: 1843.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	274.6	213.6	235.9	86.7	249.7	79.1	137.9	245.9	353.6	89.6	230.2	167.7	154.7	82.0	161.3	125.3	114.5	87.2	1349.1	253.2	261.5	371.6	266.3	89.8	131.9	248.5	218.3	80.4	69.9	411.8	107.2	92.5	253.3	125.5	190.9	240.7	122.0	142.0	792.5	87.7	133.1	171.5	215.7	71.6	192.6	70.5	259.1	170.4	125.5	1843.8	165.4	131.5	62.8	237.7	268.2	219.5	257.8	173.2	369.6	280.9	282.3	215.1	295.9	300.6	304.1	252.5	215.4	355.2	112.8	264.1	358.8	214.3	303.0	355.0	425.5	207.6	253.1	337.0	173.2	376.8	202.1	384.1	223.9	277.7	241.3	271.5	152.7	236.2	235.3	308.1	183.7	217.3	395.1	157.8	300.6	317.5	158.0	376.3	266.5	235.2	349.7	310.5	460.9	251.0	249.9	153.6	182.5	257.7	384.1	205.6	191.9	341.9	149.6	220.3	211.9	187.1	252.9	264.6	264.8	407.6	266.2	312.2	184.1	271.3	186.3	200.2	202.7	267.8	218.8	258.5	236.6	224.6	241.0	258.5	230.3	221.6	28.1	214.6	253.4	184.3	320.9	321.2	235.9	249.7	245.9	353.6	253.2	261.5	248.5	218.3	253.3	215.7	259.1	237.7	44.4	60.9	54.3	54.9	78.7	81.6	109.4	562.9	50.7	165.4	81.0	86.7	1926.9	95.8	227.2	134.3	70.9	248.7	78.4	128.4	630.0	186.2	12.4	116.1	72.6	61.0	62.8	62.9	120.2	108.1	257.0	134.7	112.7	68.8	80.5	95.0	36.0	153.2	397.0	122.8	130.0	115.9	380.5	85.2	65.8	15.1	100.0	98.4	177.9	43.1	155.0	136.3	73.2	51.3	58.8	91.3	99.8	109.1	82.1	48.8	177.4	1428.3	224.5	164.1	59.2	68.3	167.8	58.0	65.6	82.7	84.0	149.5	84.3	137.4	167.8	102.6
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 555.4;tongue: 246.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 471.5;Excitatory neurons: 735.7;Inhibitory neurons: 759.5;Microglial cells: 730.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 29.7;basal ganglia: 58.6;cerebral cortex: 75.3;hippocampal formation: 55.7"	"Group enriched"	"Detected in many"	4	"classical monocyte: 72.0;intermediate monocyte: 82.6;memory B-cell: 141.6;myeloid DC: 95.2;naive B-cell: 187.9;non-classical monocyte: 71.5;plasmacytoid DC: 100.3"	"Group enriched"	"Detected in many"	5	"B-cells: 187.9;dendritic cells: 100.3;monocytes: 82.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 103.6;HEL: 229.3;Karpas-707: 121.6;REH: 261.8;WM-115: 145.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 70.0;cerebral cortex: 253.1;hippocampal formation: 220.0;olfactory bulb: 66.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	28.9	26.8	29.7	39.2	58.6	11.1	17.5	0.0	75.3	18.8	0.0	15.9	6.9	25.9	7.3	13.6	17.3	28.5	35.2	55.7	0.0	10.4	10.5	21.3	62.9	0.0	0.0	34.9	5.6	9.3	6.3	45.5	0.0	20.0	15.4	34.2	9.0	17.7	555.4	4.9	11.2	31.5	0.0	43.8	12.7	9.4	0.0	12.8	21.7	246.8	77.7	21.3	7.6	11.0	1.6	0.0	7.1	0.0	7.7	4.6	0.2	2.2	4.5	0.3	1.0	0.2	1.0	103.6	0.6	12.0	2.5	3.1	9.6	9.1	0.2	31.7	12.5	229.3	12.3	0.0	2.8	10.4	0.6	21.6	0.0	0.3	0.0	1.4	35.1	0.0	12.3	121.6	9.0	0.0	0.3	0.1	2.2	0.1	8.4	261.8	63.1	50.5	0.0	1.2	0.0	8.3	0.0	0.7	29.5	3.9	0.3	58.0	40.4	5.6	1.0	0.6	5.4	92.0	11.5	62.0	1.5	70.1	145.2	0.6	72.0	0.2	0.2	82.6	0.1	141.6	0.2	0.1	95.2	187.9	0.2	0.2	24.3	16.7	71.5	100.3	0.5	34.4	29.7	58.6	0.0	75.3	55.7	0.0	0.0	0.0	0.0	0.0	0.0	11.0	367.4	32.1	52.0	117.5	471.5	10.7	4.2	0.0	7.4	22.6	5.2	26.5	86.4	10.0	21.7	1.8	214.8	0.8	138.6	9.2	27.4	0.8	11.0	0.8	13.4	197.5	1.2	59.1	735.7	12.7	1.2	26.8	2.0	1.0	5.1	107.5	283.4	3.4	171.1	5.0	759.5	1.5	0.0	205.8	127.5	8.6	29.8	205.1	67.6	730.7	202.7	61.8	8.2	119.6	18.7	0.4	3.0	71.8	314.7	2.1	0.2	0.8	3.7	202.9	335.2	72.7	257.6	4.0	29.5	2.5	8.4	1.6	12.2	58.6	6.3	2.3
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77650274-77927028	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 4.0;testis: 3.7;thyroid gland: 2.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 86.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.9;testis cancer: 1.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 43: Testis - Unknown function"		"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.1	0.7	0.4	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.2	0.6	4.0	0.8	0.0	0.0	1.0	0.5	0.0	2.0	0.1	1.0	0.0	1.2	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.7	0.6	0.0	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.2	0.2	0.6	1.0	0.5	1.2	0.5	0.6	0.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.1	0.0	0.0	0.1	0.0	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	21.3	0.3	0.0	0.0	9.4	0.0	0.6	0.0	2.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEIS1		ENSG00000143995	"Meis homeobox 1"	O00470	2	66433452-66573869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	Transcription	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Endometrial stromal cells: 117.2;Horizontal cells: 82.4;Oligodendrocytes: 227.5;Rod photoreceptor cells: 121.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6;plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.5;HeLa: 29.3;HHSteC: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011521, HPA056000, HPA058641"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 51: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB011521: AB_776272, HPA056000: AB_2683004, HPA058641: AB_2683784"	"unprognostic (6.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (2.45e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.01e-2)"	21.8	52.0	7.0	12.0	10.4	2.5	13.1	33.1	8.7	89.8	4.0	72.2	5.7	84.0	23.0	23.0	82.7	15.7	13.8	4.1	8.0	9.5	3.8	34.1	2.3	14.0	10.5	43.6	45.0	6.9	1.6	15.3	18.1	33.8	12.2	43.0	39.0	35.4	5.6	11.7	19.7	50.0	11.3	18.4	31.7	2.9	8.8	4.7	5.8	3.4	6.9	39.2	55.9	19.4	0.3	1.6	12.4	2.7	16.3	10.9	1.6	17.0	43.5	14.4	15.2	1.5	12.3	0.0	4.2	13.5	0.8	2.0	7.7	7.5	14.1	0.0	6.9	20.3	29.3	3.1	31.3	0.0	5.8	9.6	8.8	6.0	2.4	11.5	6.7	3.3	1.8	0.0	0.6	0.7	1.8	0.4	0.3	1.6	1.8	0.0	3.3	3.6	1.2	4.0	3.8	26.2	3.0	1.0	1.3	9.4	1.3	2.5	2.1	3.1	4.8	2.3	4.8	3.4	1.1	0.1	2.3	18.2	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.5	1.6	0.0	1.3	0.1	2.1	7.0	10.4	33.1	8.7	4.1	8.0	14.0	10.5	18.1	11.3	8.8	19.4	0.6	0.0	0.5	55.5	0.2	3.2	11.9	10.1	15.4	19.8	2.5	1.4	18.7	1.5	8.3	0.0	110.5	5.7	0.4	2.1	0.0	21.6	10.3	36.8	117.2	4.4	1.2	5.9	6.5	17.5	1.6	19.4	7.1	27.9	0.0	0.2	16.1	1.8	2.2	82.4	5.8	0.7	10.2	1.4	1.9	14.1	34.5	10.3	3.6	15.9	0.5	21.4	1.0	54.3	227.5	20.1	67.3	28.2	0.0	2.4	0.6	3.2	6.8	121.0	19.7	6.7	12.5	2.7	2.0	17.9	2.3	1.9	2.0	6.3	1.2	18.8
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772119	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 293.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA020914: AB_1853830, HPA050450: AB_2681130"	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	13.6	23.2	8.9	9.8	9.2	11.0	12.8	8.7	11.9	9.8	9.9	8.4	4.0	10.8	20.8	13.1	10.2	5.5	10.3	9.2	9.4	22.0	17.5	9.3	8.1	9.2	9.3	11.3	28.0	9.1	12.7	8.7	9.0	13.4	10.8	3.7	10.6	7.1	15.5	11.7	6.9	12.3	8.9	9.0	9.8	9.9	9.6	4.8	14.3	6.9	9.3	16.5	9.4	9.0	24.7	44.1	17.7	14.9	22.6	15.7	23.4	24.8	23.1	41.9	24.7	32.0	32.6	28.8	45.7	33.0	23.1	27.9	27.4	39.8	38.0	17.2	32.6	34.9	17.4	35.0	17.9	39.0	17.4	14.7	32.7	47.8	33.5	18.9	22.2	17.8	34.1	28.2	23.1	47.0	26.1	39.6	40.6	29.1	41.5	23.0	293.1	43.1	33.6	29.8	18.7	16.2	26.9	29.6	22.9	16.0	38.5	32.0	17.1	17.4	18.0	29.6	34.0	13.2	9.3	32.6	24.4	25.3	34.5	0.0	7.1	0.0	8.0	10.8	27.4	6.9	10.0	9.6	16.3	10.5	13.4	13.2	1.1	12.9	1.8	19.3	5.1	7.5	8.9	9.2	8.7	11.9	9.2	9.4	9.2	9.3	9.0	8.9	9.6	9.0	6.3	9.6	3.3	0.7	8.3	10.5	17.1	14.8	13.6	3.7	12.2	12.4	4.3	10.0	14.1	5.5	0.0	18.7	3.1	6.3	25.4	16.8	12.1	5.3	13.2	8.2	6.6	6.3	0.8	24.1	25.3	11.3	10.2	8.9	12.7	8.7	3.3	7.9	22.7	3.3	0.6	8.4	12.2	2.2	9.8	10.9	11.1	6.4	7.2	0.0	16.7	2.6	3.1	3.5	1.1	12.3	2.3	4.9	14.9	15.4	1.1	60.4	2.6	5.4	0.0	9.7	13.0	8.0	17.7	12.1	10.4	9.7	4.1	14.0	10.7	11.3
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681678-55684611	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1;heart muscle: 124.2;liver: 284.3"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 83.9;Hofbauer cells: 72.7;Proximal enterocytes: 192.4;Proximal tubular cells: 55.6"	"Cancer enhanced"	"Detected in many"		"glioma: 97.9;liver cancer: 97.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.5;myeloid DC: 7.0;naive B-cell: 1.7;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	45	"B-cells: 1.7;dendritic cells: 7.0;monocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 28.4;CAPAN-2: 56.6;EFO-21: 41.3;Hep G2: 28.7;LHCN-M2: 47.0;OE19: 32.5;THP-1: 42.2;U-87 MG: 41.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038644	Enhanced		Approved	Vesicles,Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Microtubules	Vesicles	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (2.43e-1)"	2.1	1.7	5.5	1.8	5.9	1.2	0.9	4.9	10.8	0.4	5.9	28.5	59.6	0.4	133.1	0.1	3.1	11.7	124.2	13.1	5.9	52.1	284.3	1.6	2.3	8.4	5.5	0.1	2.9	0.2	3.1	10.9	5.0	0.3	23.6	1.3	0.5	0.8	7.4	0.9	55.3	2.1	5.7	4.3	4.2	0.7	11.6	0.2	3.3	10.0	0.5	1.3	0.1	7.7	0.4	21.8	0.1	0.5	4.3	15.3	0.3	0.8	3.2	0.2	1.4	28.4	56.6	11.6	41.3	1.2	1.1	0.1	4.1	0.3	0.8	0.0	5.4	1.2	3.2	28.7	0.0	0.6	0.0	4.0	0.0	1.0	0.0	4.2	0.0	0.0	0.2	0.0	47.0	20.2	0.0	0.4	5.7	32.5	2.7	0.0	1.5	2.7	0.5	0.1	0.1	0.3	2.2	0.0	3.9	0.2	3.8	42.2	0.0	3.1	3.5	0.4	2.9	0.0	0.6	3.5	41.9	9.9	0.2	0.0	0.8	0.0	0.0	4.5	0.0	0.5	0.0	0.0	7.0	1.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.4	5.5	5.9	4.9	10.8	13.1	5.9	8.4	5.5	5.0	5.7	11.6	7.7	0.0	0.0	1.5	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.1	26.5	22.8	0.6	0.0	0.0	0.5	0.0	29.0	3.9	3.9	0.0	0.1	0.0	0.5	1.2	4.0	0.7	5.1	0.5	2.0	2.6	0.2	0.0	0.8	1.1	83.9	72.7	0.0	0.1	14.0	0.0	17.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	4.6	20.7	1.2	0.0	0.1	192.4	55.6	0.0	0.0	0.0	7.8	0.6	0.0	0.1	0.0	0.0	0.7	0.3	0.1	22.2	0.1
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980632	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 81.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 197.8;Fibroblasts: 75.8;Granulosa cells: 93.3;Leydig cells: 53.7;Peritubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 249.4;ASC TERT1: 249.6;HUVEC TERT2: 263.1;SH-SY5Y: 212.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA007354	Enhanced				"Secreted to extracellular matrix"	NA	NA		210000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	36.6	4.2	0.4	13.3	0.6	0.1	22.7	0.5	1.1	81.8	1.6	15.0	5.0	61.4	22.1	6.1	19.0	73.2	13.8	0.5	0.6	9.4	1.6	20.1	4.2	0.7	0.9	35.8	18.8	4.5	13.2	42.4	0.7	22.1	4.8	4.9	16.5	12.1	2.6	27.6	12.1	30.6	0.5	2.7	8.3	11.2	0.7	1.6	9.5	3.0	2.3	22.5	36.7	0.6	0.0	0.2	93.2	0.3	249.4	249.6	6.2	26.3	102.5	39.7	73.7	24.1	1.1	0.0	82.6	89.7	0.1	0.1	7.2	7.7	15.9	0.1	78.0	0.0	37.1	2.1	23.4	0.1	0.1	104.4	18.8	109.4	42.7	113.1	263.1	0.0	0.2	16.2	19.2	12.5	0.1	0.1	108.8	0.5	0.8	1.5	0.0	4.0	0.9	0.3	5.0	212.1	9.0	36.6	9.6	71.1	11.9	13.0	75.6	65.6	128.4	51.7	2.8	0.1	0.3	0.2	53.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.5	1.1	0.5	0.6	0.7	0.9	0.7	0.5	0.7	0.6	5.5	0.0	1.7	0.0	0.1	6.6	7.8	28.7	8.0	0.2	2.1	3.9	0.9	2.8	10.7	3.7	0.0	4.5	0.0	0.1	0.0	1.3	12.9	5.6	28.7	7.1	10.1	0.0	0.0	0.8	197.8	75.8	2.0	8.3	0.0	93.3	1.4	0.0	7.4	0.0	0.0	0.4	12.2	0.0	7.7	7.6	53.7	0.6	17.8	2.8	0.0	27.7	0.0	0.0	0.0	1.9	0.0	63.9	0.5	1.5	0.0	0.0	1.9	0.8	0.0	3.3	14.7	3.2	8.7	0.6	6.3	29.0	0.9	0.5	0.2	1.2
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 903.5;Peritubular cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	271.8	81.9	6.5	74.0	10.0	2.7	197.7	7.0	9.5	326.1	13.1	287.5	102.0	237.3	289.0	293.2	227.5	646.2	273.2	6.1	8.3	61.4	45.6	634.7	65.7	7.7	9.0	325.8	71.3	7.0	87.5	156.7	6.6	226.7	139.1	17.3	108.1	129.8	41.6	144.7	187.6	262.7	6.9	59.8	176.1	31.8	8.1	42.4	114.5	249.7	78.6	488.8	244.6	6.9	0.3	0.7	0.6	0.1	394.8	597.9	0.8	44.8	160.0	4.6	3.2	0.2	0.0	0.2	0.1	284.0	0.1	0.2	0.1	0.0	0.8	0.3	1.2	0.0	0.3	0.0	275.4	14.4	0.2	417.8	0.0	2.6	0.1	4.7	0.0	3.9	0.1	0.0	0.4	0.0	375.8	33.8	7.1	0.1	0.4	26.4	24.9	0.7	0.0	0.2	35.8	350.2	0.4	0.2	0.3	2.4	0.4	82.4	0.2	50.9	3.3	2.3	0.1	0.4	0.5	0.1	48.9	15.4	0.1	0.0	0.1	1.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.5	10.0	7.0	9.5	6.1	8.3	7.7	9.0	6.6	6.9	8.1	6.9	35.1	3.2	12.1	0.0	0.3	47.5	0.7	0.2	5.7	0.7	2.3	4.2	10.7	0.0	3.1	1.8	0.0	7.2	1.3	0.0	0.0	0.2	0.7	0.3	21.4	15.9	0.0	0.0	0.0	0.0	3.6	903.5	6.1	0.4	1.3	0.1	15.4	0.2	9.4	0.0	0.0	0.0	0.0	0.0	62.9	6.3	78.3	3.9	67.6	14.0	0.0	80.2	0.0	0.5	0.1	0.1	0.0	240.0	2.6	2.2	0.0	0.0	2.9	3.3	19.7	38.6	103.1	0.4	0.5	8.8	41.1	19.4	6.9	0.2	0.0	2.2
MFGE8	"BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10"	ENSG00000140545	"Milk fat globule EGF and factor V/VIII domain containing"	Q08431	15	88898683-88913381	"Cancer-related genes, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 407.0;Cone photoreceptor cells: 385.7;Rod photoreceptor cells: 978.7;Sertoli cells: 1084.7;Smooth muscle cells: 476.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 5.3;NK-cells: 7.7;T-cells: 14.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1784.6;ASC TERT1: 918.2;fHDF/TERT166: 660.4;HSkMC: 935.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002753, HPA002807"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	2830000		"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"	Cytosol		"CAB002753: , HPA002807: AB_1078072"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.99e-1)"	"prognostic unfavorable (6.06e-9)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (4.85e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.41e-3)"	237.2	95.2	44.2	45.2	49.6	3.7	226.7	56.4	61.8	272.8	52.4	113.7	21.2	444.7	77.0	67.6	361.8	120.2	485.8	41.6	47.2	69.0	15.6	137.2	47.4	55.9	47.4	228.5	36.5	18.9	49.3	79.6	55.6	129.3	29.3	68.7	97.1	195.8	264.3	118.9	106.9	162.7	47.0	40.7	124.9	38.3	46.5	18.8	90.6	124.1	36.9	163.6	223.4	55.6	19.7	85.4	78.7	98.7	1784.6	918.2	6.9	482.7	142.4	95.4	110.3	90.5	23.5	0.0	147.5	660.4	144.6	10.2	27.6	95.8	31.1	82.3	64.7	138.1	4.6	10.2	469.8	0.2	50.1	935.7	251.8	73.5	122.5	205.3	37.0	35.3	23.4	41.1	185.1	6.2	22.6	3.2	405.4	8.3	38.4	22.7	74.4	26.4	32.6	7.3	8.2	42.9	28.0	2.5	226.1	165.6	2.4	11.1	42.0	233.2	127.8	62.3	36.3	145.3	30.5	15.9	31.6	12.2	91.5	5.3	0.2	0.4	1.3	0.0	4.2	1.2	4.2	2.9	0.0	0.9	4.3	3.3	0.0	7.7	0.1	0.1	14.9	2.1	44.2	49.6	56.4	61.8	41.6	47.2	55.9	47.4	55.6	47.0	46.5	55.6	72.1	12.8	5.4	39.2	4.0	48.7	32.2	116.3	24.5	22.1	407.0	190.4	92.8	8.6	25.5	3.7	385.7	4.5	13.1	1.6	0.0	15.7	11.0	33.3	202.2	66.9	44.8	3.8	5.1	4.3	18.6	220.0	12.8	29.7	5.1	30.1	22.1	15.5	8.1	16.8	0.4	6.4	36.7	32.9	39.7	27.9	187.0	12.9	119.2	15.0	1.8	75.9	9.2	5.5	9.6	28.3	0.2	109.1	8.8	15.8	0.1	0.2	8.3	978.7	1084.7	51.8	476.0	3.3	9.0	21.7	35.9	5.3	12.5	25.8	2.0	10.2
MFSD4A	"DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064"	ENSG00000174514	"Major facilitator superfamily domain containing 4A"	Q8N468	1	205568885-205602918	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 66.7;stomach 1: 132.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.3;Collecting duct cells: 9.2;Distal tubular cells: 13.7;Endometrial ciliated cells: 9.9;Glandular and luminal cells: 40.5;Proximal tubular cells: 7.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"amygdala: 11.4;basal ganglia: 8.4;cerebral cortex: 18.4;hippocampal formation: 14.1;white matter: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 59.8"	HPA055407	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA055407: "	"unprognostic (7.15e-4)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (2.27e-13)"	"unprognostic (1.58e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.75e-3)"	"unprognostic (8.78e-2)"	2.2	0.4	11.4	1.1	8.4	0.0	2.7	0.6	18.4	8.5	0.0	13.8	1.9	1.0	9.2	1.4	2.5	16.8	0.9	14.1	0.0	66.7	0.2	6.8	0.4	0.0	0.0	0.6	1.4	0.4	1.5	6.2	0.0	1.4	18.2	14.0	17.1	0.6	0.3	5.1	1.4	0.8	0.0	0.6	132.6	0.5	0.0	0.6	0.4	0.7	1.3	0.7	0.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	8.4	0.6	18.4	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	11.3	6.4	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	2.9	0.0	0.0	6.2	9.2	0.0	0.5	0.7	0.0	13.7	1.4	0.0	9.9	6.0	2.5	0.0	0.0	0.0	6.2	0.1	0.5	0.0	40.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	7.7	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 25.5;intestine: 87.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 156.4;Proximal enterocytes: 521.4"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.5"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 13.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;BJ hTERT+: 1.6;HL-60: 2.8;U-937: 4.3;WM-115: 1.0"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			HPA002270	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	2.6	0.1	0.2	2.5	0.4	18.1	0.2	0.2	2.3	0.4	0.3	0.5	58.9	0.1	25.5	0.3	1.2	0.4	0.3	0.1	0.3	18.7	0.5	3.2	0.1	0.5	0.4	0.1	0.2	0.0	0.1	0.3	0.6	0.1	0.2	0.0	0.1	7.1	0.1	0.1	87.6	0.4	0.2	12.6	1.8	1.3	0.6	0.4	0.1	1.0	0.0	0.5	0.1	0.4	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.3	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	2.3	0.1	0.3	0.5	0.4	0.6	0.2	0.6	0.4	0.0	0.0	2.5	3.3	0.1	0.0	0.0	0.6	0.0	0.2	0.5	0.1	1.4	0.0	3.2	12.9	0.0	0.0	2.8	1.8	1.9	0.1	59.7	0.1	0.2	0.3	1.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.7	17.8	0.0	0.0	2.5	156.4	0.6	1.1	0.0	0.0	0.7	0.6	5.2	1.5	0.6	0.2	16.3	0.4	0.0	0.1	521.4	24.4	6.7	0.0	0.0	0.5	0.1	1.8	1.2	0.0	0.0	0.0	0.4	0.0	7.3	0.3
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1096.9;adrenal gland: 1137.3;liver: 3104.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1205.9;Club cells: 1308.7;Hepatocytes: 4345.6;Proximal tubular cells: 1265.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 170.2;myeloid DC: 123.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 123.5;monocytes: 170.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 5391.4;ASC TERT1: 2078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA		19000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	1096.9	1137.3	139.2	76.1	143.9	79.3	574.8	131.4	200.7	69.7	111.9	315.5	128.9	32.7	43.9	195.3	78.4	200.8	135.1	133.9	165.4	392.9	3104.7	177.2	3.5	156.5	155.7	11.4	131.3	0.8	52.6	14.2	166.6	161.2	212.8	7.0	155.3	55.8	25.5	88.8	119.5	44.7	146.4	7.3	131.4	20.2	147.5	14.0	272.3	43.3	7.7	267.9	114.7	132.9	1.4	495.2	115.6	139.4	5391.4	2078.4	1.5	408.5	418.5	220.6	339.1	186.0	838.6	0.4	48.5	535.8	694.2	2.4	317.0	663.5	202.9	1.1	41.4	175.7	256.6	664.8	1252.0	350.4	1.2	1375.9	714.7	671.2	710.5	540.4	393.1	0.1	126.7	0.6	486.3	101.2	0.3	137.0	987.6	0.7	391.2	0.4	69.3	229.3	503.3	982.1	21.8	17.1	645.8	411.8	17.5	630.1	442.5	190.8	248.0	226.1	30.5	447.3	541.1	0.6	1.7	1.5	748.1	538.5	7.1	11.3	170.2	1.8	0.1	26.3	0.5	1.0	0.2	0.1	123.5	0.0	0.1	0.1	5.9	0.2	5.9	34.1	1.1	55.9	139.2	143.9	131.4	200.7	133.9	165.4	156.5	155.7	166.6	146.4	147.5	132.9	39.6	266.0	651.3	130.2	14.0	25.6	130.2	1205.9	91.0	0.0	383.8	262.6	5.1	574.7	1308.7	71.7	0.0	2.9	9.8	288.1	181.9	26.9	25.4	299.9	198.2	19.6	45.6	92.8	4.4	434.1	218.1	404.5	153.9	947.9	34.1	26.3	67.5	4345.6	160.2	0.0	0.5	280.5	740.6	176.4	52.0	17.9	33.2	75.7	39.2	6.5	224.4	1.0	5.2	1.0	0.8	322.7	175.0	113.2	6.0	467.2	209.5	1265.6	526.1	1.3	0.0	11.3	124.3	0.7	2.3	510.3	17.6	7.9	22.1	152.4	534.1	883.3
MIA2	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI"	ENSG00000150527	"MIA SH3 domain ER export factor 2"	Q96PC5	14	39230231-39388513	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 125.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	12.1	26.6	5.6	16.8	6.9	23.6	22.1	5.8	7.9	29.7	58.0	30.8	80.4	15.7	40.2	26.9	22.2	30.3	16.6	9.4	6.5	78.4	138.9	15.5	16.2	5.6	4.7	9.6	43.6	40.5	15.5	11.2	6.4	21.1	34.6	12.8	52.5	19.2	54.5	9.9	78.4	12.3	4.1	14.5	45.3	21.0	5.1	14.3	46.7	20.7	19.8	16.2	17.2	7.1	23.0	25.1	10.4	18.5	20.6	23.2	14.5	13.3	13.9	9.3	9.6	19.7	125.4	27.5	40.1	15.0	18.9	34.1	12.7	15.0	11.0	21.4	10.6	17.2	11.5	106.1	48.2	23.2	30.7	14.4	83.7	9.2	69.2	59.0	15.3	31.8	16.6	68.3	14.0	22.1	14.9	18.9	12.0	87.2	20.8	15.2	18.3	34.9	42.7	24.7	8.7	5.1	31.0	32.5	20.4	13.1	31.2	24.8	24.3	14.1	9.2	10.4	8.8	38.7	35.7	27.2	7.9	14.5	12.0	40.9	16.3	25.9	15.4	18.0	14.0	11.7	11.6	14.4	17.8	13.1	14.2	13.2	34.5	14.6	21.0	12.3	11.8	11.8	5.6	6.9	5.8	7.9	9.4	6.5	5.6	4.7	6.4	4.1	5.1	7.1	26.7	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	33.1	19.9	0.0	5.7	0.0	44.1	0.0	5.6	35.9	0.8	7.9	42.9	0.5	78.7	30.7	7.1	0.0	0.0	0.1	42.7	5.0	4.6	0.0	93.5	0.0	10.3	0.0	3.8	7.6	0.0	0.1	1.8	0.0	0.0	0.0	0.6	0.0	12.7	0.0	0.0	23.8	0.0	1.0	0.0	0.0	41.3	0.0	0.0	8.1	0.0	6.6	61.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.0	13.6	20.0	0.2	0.0
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 129.3;Basal squamous epithelial cells: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 156.1;AF22: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002878, HPA003715"	Approved		Uncertain	"Golgi apparatus,Centriolar satellite,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Centriolar satellite"	"Golgi apparatus, Cytosol"	"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	5.9	2.5	6.9	5.0	7.7	1.7	5.3	17.2	5.0	7.0	6.5	17.3	5.7	8.9	4.9	7.0	6.4	6.8	9.3	7.0	4.9	7.3	4.2	6.5	2.2	3.6	10.4	4.4	3.5	2.8	4.2	6.2	4.9	10.4	10.6	12.3	4.9	12.9	0.7	2.9	5.8	12.3	2.1	1.0	3.8	3.6	8.2	2.3	4.2	2.2	3.1	11.7	6.2	4.4	33.2	156.1	132.5	16.7	8.1	9.2	14.6	16.2	17.8	19.7	20.7	31.0	9.7	10.6	6.5	21.9	58.4	22.5	11.0	15.1	23.0	1.3	11.0	2.7	24.3	1.1	2.8	0.3	1.2	12.1	7.0	16.1	15.8	20.4	23.1	5.1	2.1	3.2	9.6	8.0	5.3	0.5	32.7	5.1	10.0	3.9	28.9	0.4	18.7	36.2	7.1	3.5	7.4	23.5	10.1	42.7	19.2	0.2	13.7	7.2	1.0	34.1	17.0	2.8	1.2	0.4	13.5	0.3	31.3	0.5	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.7	0.0	0.1	0.4	0.0	0.1	6.9	7.7	17.2	5.0	7.0	4.9	3.6	10.4	4.9	2.1	8.2	4.4	16.5	35.3	20.7	129.3	0.7	21.4	31.5	24.7	82.6	10.7	8.5	13.2	4.8	8.6	19.6	23.9	18.8	9.1	1.3	22.6	1.9	13.4	2.2	39.8	8.9	25.4	12.1	2.7	15.5	8.7	26.9	16.2	10.7	38.5	1.3	13.4	69.9	4.0	1.5	69.0	44.3	9.0	2.0	2.5	5.8	7.9	30.1	1.2	3.6	23.4	0.0	37.0	0.0	66.4	59.2	7.3	17.2	41.3	0.2	8.2	11.3	1.5	19.3	2.9	6.6	3.7	3.3	0.3	2.4	36.1	10.1	20.0	0.8	9.7	20.0	49.2
MINAR2	KIAA1024L	ENSG00000186367	"Membrane integral NOTCH2 associated receptor 2"	P59773	5	129748094-129766732	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	22	"skeletal muscle: 35.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA013760	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA013760: AB_1852363"				"unprognostic (1.77e-1)"										"unprognostic (5.13e-1)"				0.2	0.1	1.1	0.0	1.0	0.1	0.2	1.1	1.4	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	1.0	1.2	0.0	0.1	0.2	0.1	1.1	1.0	0.0	0.1	0.0	0.0	0.4	1.0	0.1	0.0	0.2	0.0	0.1	35.9	0.1	0.0	0.1	0.7	0.4	0.1	0.5	1.6	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.3	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.4	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.4	0.5	0.3	0.0	0.4	0.1	0.1	0.1	0.0	0.2	0.2	1.4	0.0	0.9	0.2	0.0	0.3	0.1	0.0	0.5	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.7	1.3	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.6	0.1	0.2	0.8	0.1	0.0	1.1	1.0	1.1	1.4	1.0	1.2	1.1	1.0	1.0	0.7	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MIOX	ALDRL6	ENSG00000100253	"Myo-inositol oxygenase"	Q9UGB7	22	50486784-50490648	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	48	"kidney: 700.9"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 4564.6"	"Cancer enriched"	"Detected in many"	16	"renal cancer: 56.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.9;Hep G2: 5.7;Karpas-707: 12.8;U-266/70: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039451, HPA039562"	Enhanced					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039451: AB_2676513, HPA039562: AB_2676574"	"unprognostic (2.11e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.83e-2)"	"prognostic favorable (2.60e-6)"	"unprognostic (1.77e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.23e-2)"	0.2	0.1	0.1	0.3	0.2	0.2	0.0	0.8	0.5	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	5.3	0.0	0.2	0.2	700.9	0.4	0.0	0.7	0.2	0.2	0.0	1.2	0.0	0.1	0.1	0.3	0.5	0.0	0.1	0.3	0.1	0.0	0.3	0.2	0.0	0.1	0.2	1.1	0.2	0.2	0.2	14.7	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.1	2.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.6	0.4	0.0	0.2	0.2	0.0	0.0	24.9	0.0	0.2	0.4	5.7	2.8	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.1	12.8	0.0	1.2	0.0	0.1	0.2	0.5	0.4	0.1	0.1	0.1	2.6	0.1	0.1	0.3	0.0	0.0	0.6	0.5	0.1	1.4	0.0	0.0	0.5	0.1	0.1	7.8	0.7	0.3	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.8	0.5	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.0	1.7	0.0	13.0	0.8	0.9	0.1	0.0	0.6	0.7	0.8	0.1	1.5	0.0	99.3	0.0	0.0	0.3	0.3	424.6	0.0	0.0	0.1	0.2	0.2	1.2	0.0	0.0	0.9	0.1	0.3	0.0	0.2	0.0	0.1	0.4	0.3	0.1	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	23.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	4564.6	0.0	0.5	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.3	7.8	0.0	0.1	0.9
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751112-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 196.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 793.4;Intestinal goblet cells: 230.9;Paneth cells: 646.7;Proximal enterocytes: 1115.2;Undifferentiated cells: 220.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 121.4;HaCaT: 90.2;hTCEpi: 82.6;MCF7: 63.2;OE19: 76.9;SK-BR-3: 134.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"		No	No				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	1.3	0.0	0.3	12.1	0.3	0.0	0.9	0.5	0.4	4.4	0.1	95.5	171.0	0.7	0.0	0.3	9.8	11.3	0.0	0.4	0.3	8.8	0.1	9.3	0.1	0.5	0.5	0.3	1.7	0.0	8.1	1.2	0.5	5.6	48.4	0.0	1.0	0.5	0.0	0.6	196.6	3.3	0.2	0.0	22.9	0.5	0.3	0.3	0.1	0.0	0.0	9.0	0.6	0.2	30.4	121.4	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	42.1	44.2	10.8	11.5	0.0	0.1	90.2	0.0	37.7	0.0	0.0	0.1	0.0	47.0	13.3	0.0	0.0	1.9	0.0	82.6	0.3	4.5	0.0	0.0	0.0	0.0	0.4	0.2	63.2	0.1	0.7	0.1	76.9	24.6	0.2	0.4	1.0	30.1	33.7	1.4	0.4	42.9	134.3	0.1	0.1	29.3	0.0	0.0	0.0	14.8	1.8	0.2	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.4	0.4	0.3	0.5	0.5	0.5	0.2	0.3	0.2	0.1	38.5	8.0	0.3	2.9	0.1	4.5	22.5	0.0	0.0	4.7	2.3	0.5	10.0	39.7	11.0	0.0	0.6	0.0	793.4	1.9	39.9	0.6	40.5	1.5	0.8	58.0	0.0	0.2	46.0	6.0	2.4	56.6	14.3	8.9	0.0	0.0	0.0	0.1	0.0	0.3	230.9	28.5	0.0	0.0	0.9	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.2	157.7	646.7	0.0	0.1	41.6	1115.2	27.5	41.3	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.3	2.1	1.6	0.0	220.7	62.1
MIXL1	"MILD1, MIXL"	ENSG00000185155	"Mix paired-like homeobox"	Q9H2W2	1	226223618-226227060	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 18.5"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 6.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.7;Hep G2: 9.0;SuSa: 1.9;U-698: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005662			Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA005662: AB_2667382"	"unprognostic (4.09e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.66e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.71e-13)"	"unprognostic (1.54e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.47e-2)"	0.1	0.1	0.3	1.0	0.2	0.2	0.2	1.2	0.3	0.1	0.2	0.7	1.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	2.4	0.3	0.2	0.2	0.1	0.6	0.0	0.2	0.3	0.1	0.6	0.1	0.2	0.2	0.0	0.2	0.7	0.1	0.1	1.0	0.8	0.4	0.2	0.2	0.1	0.0	3.4	0.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.1	0.2	9.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	49.7	6.5	13.0	6.4	10.0	12.6	11.3	7.3	7.3	7.2	10.4	9.6	9.7	18.2	19.6	19.5	11.0	10.3	6.2	0.3	0.2	1.2	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.4	0.6	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.5	0.1	0.1	0.1	0.0	0.5	0.0	0.3	0.1	0.1	1.5	0.0	0.0	0.3	0.1	0.1	0.0	0.1
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 609.7"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 84.4;Enteroendocrine cells: 90.1;Hepatocytes: 286.6;Proximal enterocytes: 108.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 46.5;K-562: 15.2;SCLC-21H: 25.5;T-47d: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	72.3	85.1	5.5	0.7	4.1	0.2	51.2	16.3	9.4	3.0	0.2	7.8	58.8	0.6	16.3	3.4	12.9	5.5	3.5	4.5	1.4	36.2	609.7	2.7	0.0	5.6	1.4	4.9	23.1	6.3	13.4	0.0	6.1	3.7	1.5	0.7	8.7	0.8	58.1	4.5	46.8	0.5	1.3	0.3	4.7	30.9	2.2	0.9	7.3	13.8	0.0	2.0	2.7	2.1	0.2	2.5	0.0	5.9	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.3	0.0	0.6	1.2	0.0	0.0	0.0	0.2	6.1	0.0	4.8	46.5	1.3	0.2	1.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.1	6.3	0.1	0.0	0.7	8.2	1.0	0.0	0.0	1.2	0.0	0.1	25.5	0.7	1.0	4.4	0.0	0.1	11.4	6.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	4.1	16.3	9.4	4.5	1.4	5.6	1.4	6.1	1.3	2.2	2.1	0.6	0.0	16.2	2.3	1.6	1.1	4.8	0.6	0.6	9.9	1.4	1.3	3.4	84.4	4.7	3.7	20.9	0.1	0.3	3.2	1.9	2.9	3.2	0.7	0.2	2.5	90.1	16.0	33.4	1.0	0.1	6.5	4.6	0.8	0.0	0.1	12.8	286.6	0.4	1.7	29.1	19.6	0.0	11.2	1.5	1.2	2.8	2.8	7.2	30.9	0.2	2.0	1.0	2.0	0.9	1.4	13.9	1.2	0.1	2.2	108.9	14.1	3.2	6.5	0.0	23.9	1.0	5.1	1.1	0.5	0.9	0.5	1.7	0.0	31.9	4.0
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183704	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 333.5;kidney: 302.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 273.3;Proximal enterocytes: 372.4;Proximal tubular cells: 125.7;Syncytiotrophoblasts: 126.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 17.3;medulla oblongata: 9.3;pons: 10.9;thalamus: 4.6"	"Immune cell enriched"	"Detected in some"	122	"neutrophil: 139.4"	"Lineage enriched"	"Detected in many"	122	"granulocytes: 139.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 684.4;BJ hTERT+: 1116.9;HSkMC: 651.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 28.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 32.3;olfactory bulb: 8.5;spinal cord: 15.9"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		320000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	103.9	1.0	0.7	4.5	17.3	11.5	38.5	1.5	1.9	22.7	0.3	1.9	333.5	13.3	22.5	2.3	1.9	13.4	4.3	0.1	0.6	302.5	56.1	27.6	10.3	9.3	2.3	0.9	1.2	0.5	0.6	73.0	10.9	79.6	3.4	0.1	6.1	44.5	20.3	1.9	289.7	1.5	0.9	7.9	1.6	1.3	4.6	16.6	1.2	23.5	12.3	6.0	7.6	0.4	0.1	0.0	0.9	0.3	280.1	684.4	1.6	160.3	1116.9	82.2	209.8	0.0	0.3	172.9	0.1	130.1	107.4	0.5	5.2	6.1	201.3	0.0	0.8	0.0	0.1	0.2	229.6	0.0	0.0	651.1	1.0	40.4	308.1	89.4	59.5	0.4	0.2	0.3	135.1	0.7	0.4	1.0	6.1	0.5	1.1	303.3	139.9	1.6	5.2	1.9	0.5	1.5	0.1	0.5	31.9	68.3	0.2	0.2	165.8	356.4	0.8	115.7	27.9	0.1	0.0	217.3	42.5	0.1	7.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	139.4	0.0	0.0	1.1	0.0	0.0	0.7	17.3	1.5	1.9	0.1	0.6	9.3	2.3	10.9	0.9	4.6	0.4	5.9	9.6	13.0	0.3	2.3	0.8	74.1	2.5	0.0	0.0	1.5	64.1	1.6	21.5	11.2	22.0	0.0	82.1	6.9	0.0	9.8	0.2	0.5	6.2	273.3	6.6	0.0	0.0	2.2	0.0	57.8	40.6	0.0	5.7	2.5	0.0	2.9	53.2	8.9	0.0	8.1	9.9	2.0	3.1	1.2	0.5	4.1	10.7	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.6	13.8	1.2	0.1	40.0	372.4	125.7	1.6	0.0	0.0	17.4	11.1	0.2	0.5	0.1	0.3	126.0	2.5	0.1	12.6	33.6
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 1062.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 222.4;Extravillous trophoblasts: 467.9;Fibroblasts: 815.9;Leydig cells: 340.2;Peritubular cells: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5619.3;ASC TERT1: 1623.2;hTERT-RPE1: 6400.4;U-87 MG: 1812.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	220000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	518.9	68.3	3.9	135.1	4.0	1.2	328.9	4.9	7.8	514.1	9.4	173.8	57.4	453.6	192.6	121.5	190.6	1062.9	212.8	3.6	5.3	43.7	15.6	279.7	28.1	7.6	4.9	271.1	42.8	13.8	14.7	225.0	5.4	116.8	171.3	11.4	124.1	137.5	60.8	455.6	177.3	468.5	6.7	58.3	134.0	49.6	8.6	19.8	113.5	66.1	30.3	660.8	238.1	10.0	6.5	3.9	192.0	2.4	5619.3	1623.2	312.7	501.4	1146.1	99.4	79.0	0.2	2.1	0.5	391.7	891.0	37.0	54.2	1.2	4.6	57.0	0.7	0.9	0.7	12.9	3.0	530.6	0.4	14.8	1396.8	1.7	512.4	4.4	6400.4	651.1	0.5	0.7	2.4	334.7	0.0	0.4	8.2	152.4	0.5	1.6	0.4	46.1	0.9	16.1	7.6	3.2	345.0	93.3	0.8	2.1	849.0	1.6	36.0	924.6	1546.0	144.9	300.5	66.9	1.0	0.6	2.2	1812.3	28.3	289.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.0	4.9	7.8	3.6	5.3	7.6	4.9	5.4	6.7	8.6	10.0	38.4	0.0	0.5	0.0	0.0	122.1	14.1	48.8	9.1	30.5	3.1	16.8	4.4	0.0	3.1	11.0	0.0	5.6	0.5	0.1	0.0	2.5	12.5	7.7	222.4	46.9	28.2	0.0	0.0	0.4	467.9	815.9	12.2	5.4	0.0	0.0	13.2	0.1	28.2	1.7	0.2	0.1	2.0	1.6	180.7	40.2	340.2	11.8	128.1	27.2	0.0	7.7	0.0	5.0	0.0	9.3	0.0	419.0	2.8	5.6	0.0	0.2	1.1	2.5	13.1	80.0	65.3	1.2	2.8	6.6	102.3	17.2	10.3	35.2	0.0	4.4
MMRN2	"EMILIN3, EndoGlyx-1, FLJ13465"	ENSG00000173269	"Multimerin 2"	Q9H8L6	10	86935540-86969481	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Adipocytes: 229.3;Endothelial cells: 127.1;Hepatic stellate cells: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 89.2;HUVEC TERT2: 196.6;TIME: 237.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020741			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		84000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA020741: AB_1848154"	"unprognostic (4.17e-1)"	"unprognostic (7.87e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.66e-1)"	63.2	13.9	14.0	10.1	12.7	1.5	54.5	11.5	12.5	20.6	11.0	14.2	10.5	28.1	13.8	16.9	22.7	16.6	38.8	11.4	11.9	22.0	8.6	32.1	9.7	13.6	12.4	23.1	10.5	10.6	7.6	73.8	13.7	14.1	8.9	3.0	26.6	28.7	26.8	38.9	13.8	27.3	13.2	34.6	11.9	15.3	15.8	6.5	25.8	32.5	13.3	32.3	19.1	12.0	11.4	2.9	0.4	0.2	1.2	6.3	7.1	4.1	11.1	4.8	6.8	6.4	89.2	0.1	39.5	7.6	11.6	21.9	0.0	5.2	6.4	8.1	0.0	2.3	10.2	0.2	0.9	0.0	4.6	1.5	26.4	5.7	38.6	13.0	196.6	2.4	2.1	35.0	1.8	7.1	0.4	4.4	2.0	0.4	4.9	0.2	0.1	0.1	2.0	17.5	4.8	0.0	3.1	3.7	1.4	0.9	14.9	1.2	237.1	1.9	11.0	1.9	0.1	2.6	4.0	0.1	5.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	12.7	11.5	12.5	11.4	11.9	13.6	12.4	13.7	13.2	15.8	12.0	229.3	0.0	5.8	1.6	0.3	9.4	0.9	0.0	4.6	0.2	1.4	2.0	13.2	5.7	0.7	1.8	0.0	0.7	0.4	0.0	0.0	0.1	1.0	0.3	0.4	127.1	0.0	2.7	0.9	0.0	0.1	8.1	0.0	0.5	0.0	0.2	182.0	4.1	1.7	0.0	1.2	0.0	0.0	6.5	4.4	2.8	2.5	0.7	3.6	15.9	0.0	0.7	0.0	1.0	0.1	0.0	0.0	3.0	0.1	0.6	0.5	0.2	0.0	0.6	6.6	3.9	9.4	1.8	2.3	2.2	7.7	0.3	0.8	3.6	0.2	1.0
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717838-75732958	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 48.2;liver: 25.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 73.8;Hepatocytes: 79.6;Intestinal goblet cells: 36.2;Proximal enterocytes: 159.6;Undifferentiated cells: 32.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 4.5;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028834	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.0	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.1	0.1	0.0	13.9	44.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	25.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.6	0.0	0.2	0.2	0.0	0.6	48.2	0.7	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.3	1.5	0.2	0.0	0.0	0.0	0.0	73.8	0.0	0.0	0.0	0.1	0.0	0.0	2.4	2.7	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.4	79.6	0.0	0.0	0.0	36.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.3	0.0	0.0	0.6	159.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.1
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401475	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 64.2;smooth muscle: 78.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Basal squamous epithelial cells: 153.1;Early spermatids: 70.2;Endometrial stromal cells: 57.8;Excitatory neurons: 36.0;Oligodendrocyte precursor cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 3.1;naive B-cell: 1.7;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in many"	41	"B-cells: 3.1;dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.8;ASC TERT1: 131.7;BJ: 106.1;fHDF/TERT166: 196.5;HBF TERT88: 120.6;U-2197: 310.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035740	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	2.8	36.5	18.0	5.7	10.6	0.1	2.5	3.1	11.7	25.7	3.5	13.4	5.2	64.2	11.0	23.5	3.4	28.7	5.4	10.9	4.0	37.0	1.8	25.3	6.2	3.5	3.8	0.8	2.2	0.5	4.5	1.4	3.9	32.0	8.8	5.0	12.2	39.6	0.3	14.4	7.5	78.6	3.6	4.7	5.2	1.8	6.7	2.1	1.8	0.5	15.6	19.1	12.8	10.8	0.1	0.9	4.1	0.0	164.8	131.7	0.2	106.1	71.0	37.7	65.8	0.2	1.2	0.4	0.1	196.5	30.9	0.1	1.4	0.5	120.6	0.0	19.3	0.0	0.1	0.0	1.5	0.1	0.1	31.8	0.0	76.6	2.5	46.6	0.0	0.0	0.0	7.8	22.4	0.0	0.1	0.2	3.5	0.0	0.7	1.1	0.4	0.2	46.3	0.4	2.8	0.2	0.0	0.4	2.4	9.6	0.1	5.9	0.5	17.4	15.9	310.0	56.1	4.1	0.0	0.0	43.9	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	18.0	10.6	3.1	11.7	10.9	4.0	3.5	3.8	3.9	3.6	6.7	10.8	0.4	0.0	1.3	92.7	5.4	28.0	0.4	0.1	153.1	0.3	0.4	0.6	0.7	0.0	2.5	1.8	0.0	0.9	2.7	0.0	0.0	0.6	70.2	1.0	57.8	0.6	0.0	0.0	36.0	0.0	1.5	23.9	0.5	1.2	3.8	0.0	0.0	0.0	0.4	0.0	8.6	0.0	0.0	0.3	4.7	11.8	0.3	0.3	7.2	4.7	0.0	16.4	0.0	33.7	1.1	0.4	0.0	0.4	9.5	1.5	0.0	0.3	0.0	0.8	0.0	6.2	3.3	0.5	0.8	14.6	6.8	0.0	0.5	0.1	0.1	0.0
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029821	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 390.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 553.6;Hepatocytes: 578.6;Paneth cells: 621.4;Proximal enterocytes: 1322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		2900000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (5.89e-4)"	58.0	57.3	25.3	10.0	32.3	36.5	51.0	29.0	31.0	40.9	29.8	102.4	106.5	34.7	0.6	91.5	42.9	16.6	64.2	22.9	23.4	71.4	390.7	43.5	8.8	34.0	27.5	81.7	106.4	4.8	14.7	9.1	29.7	45.3	17.0	0.5	43.5	9.6	89.7	82.3	93.0	7.0	26.0	22.1	70.3	51.7	31.4	4.5	24.8	23.1	6.0	48.3	62.3	35.1	44.0	50.4	24.2	50.0	27.8	17.2	38.1	23.4	20.6	24.8	33.2	48.6	18.9	68.7	33.0	16.7	16.7	29.9	20.9	33.8	3.6	41.4	119.2	26.5	21.3	115.6	87.5	29.0	35.6	30.0	64.2	16.1	15.1	22.8	50.6	33.1	48.0	19.3	7.0	33.8	2.6	97.5	45.7	56.7	52.2	73.6	28.8	51.9	25.5	14.0	12.4	92.9	15.6	23.9	46.6	12.2	26.0	45.6	39.8	21.3	60.1	23.9	16.0	33.3	16.8	21.0	7.7	34.7	11.1	48.5	71.9	54.7	31.0	27.5	42.4	24.9	20.1	26.4	104.0	25.0	2.7	10.4	21.9	87.8	12.7	16.3	44.3	35.4	25.3	32.3	29.0	31.0	22.9	23.4	34.0	27.5	29.7	26.0	31.4	35.1	21.3	35.3	61.9	14.7	25.1	81.6	80.4	120.3	70.6	4.5	81.4	83.4	29.4	243.1	70.0	60.7	0.0	61.9	20.3	553.6	133.1	146.4	191.1	38.5	46.8	42.6	108.6	122.6	1.1	148.3	119.1	52.8	87.1	72.5	17.2	140.3	108.5	578.6	77.5	3.3	1.9	363.1	85.5	84.6	77.6	115.1	91.0	62.7	58.7	3.7	60.7	24.8	56.7	4.5	14.9	117.9	621.4	84.7	65.7	77.7	1322.1	469.8	13.4	2.8	46.0	34.4	36.0	101.3	11.5	133.7	152.9	50.1	26.6	57.7	397.5	110.6
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253416-118264536	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 222.5;urinary bladder: 155.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 38.8"	HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	28.6	4.7	2.5	11.9	2.1	0.7	19.6	2.3	4.8	56.7	5.2	31.1	17.0	16.9	38.5	222.5	46.4	33.5	7.2	2.3	2.6	26.4	23.2	47.0	2.3	3.2	3.0	3.8	13.5	27.1	10.7	1.7	3.2	48.6	30.8	0.9	58.0	69.5	4.7	38.8	11.3	14.7	3.6	4.6	37.0	0.9	3.4	18.1	30.3	1.0	52.6	155.9	120.5	2.8	65.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.0	120.9	0.3	130.4	0.0	0.6	166.9	0.0	38.9	0.0	0.2	9.5	0.1	1.7	35.8	0.0	0.0	0.4	0.0	90.2	0.0	3.0	0.0	86.8	0.8	0.0	0.2	0.0	51.3	0.2	0.2	1.6	34.2	0.1	0.0	0.0	6.4	14.9	321.7	0.1	0.0	5.8	61.4	0.0	0.5	26.1	0.7	351.9	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	2.3	11.6	3.0	0.1	9.2	1.3	0.0	0.6	0.4	17.0	0.0	0.8	0.9	13.2	0.4	1.4	0.3	0.2	3.8	2.5	2.1	2.3	4.8	2.3	2.6	3.2	3.0	3.2	3.6	3.4	2.8	5.9	83.3	123.3	0.0	0.2	332.5	504.4	289.1	127.5	0.0	29.0	17.4	3.4	30.0	221.1	128.8	0.0	1.7	0.5	52.0	0.0	39.4	0.0	91.6	18.8	33.6	5.3	3.6	0.0	51.1	0.2	8.2	29.6	194.0	7.0	0.0	45.3	16.5	0.8	0.0	0.0	6.3	81.4	6.4	27.0	0.3	0.0	7.8	21.4	1.9	4.9	0.0	1.0	0.0	0.0	68.2	20.8	0.0	1.2	186.3	3.3	6.9	65.2	0.0	0.0	0.3	9.2	0.2	0.7	336.4	467.4	17.8	5.4	0.0	33.4	489.7
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809348-17911164	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 122.3"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 128.9;Hepatic stellate cells: 397.7;Hofbauer cells: 176.1;Kupffer cells: 361.4;Macrophages: 316.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 4.8"	"Group enriched"	"Detected in some"	19	"MOLT-4: 19.3;TIME: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004114, HPA045134, CAB068203"	Enhanced					NA	NA		170000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	54.4	28.7	0.8	24.0	1.7	0.7	16.3	0.3	3.5	17.2	9.2	16.1	9.9	7.2	1.7	13.1	11.9	27.7	10.2	1.1	0.7	7.6	40.9	122.3	15.2	1.4	0.9	6.2	8.1	4.6	1.5	54.3	1.1	2.2	18.5	0.1	4.9	8.0	1.8	2.8	17.5	30.3	0.7	50.6	9.7	7.5	2.8	8.0	5.5	8.7	3.0	29.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.3	0.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	1.7	0.3	3.5	1.1	0.7	1.4	0.9	1.1	0.7	2.8	1.3	4.0	32.1	43.5	1.3	3.5	0.4	0.0	0.0	0.0	0.0	128.9	1.7	3.6	11.5	7.4	0.0	0.0	0.9	1.0	1.4	0.0	0.1	27.3	0.0	0.1	39.0	0.0	3.2	0.8	0.4	1.4	2.5	0.0	0.1	13.9	0.1	397.7	13.1	176.1	0.0	1.3	0.9	0.0	361.4	46.8	19.4	1.5	316.5	0.0	60.9	0.5	0.0	0.0	0.5	0.5	0.1	1.5	0.0	1.0	0.0	2.2	0.1	5.8	0.0	32.9	3.0	2.2	0.4	2.3	1.2	0.4	2.1	4.7	1.7	0.8	0.1
MRC2	"CD280, CLEC13E, ENDO180, KIAA0709"	ENSG00000011028	"Mannose receptor C type 2"	Q9UBG0	17	62627670-62693597	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 93.9;Endometrial stromal cells: 65.2;Fibroblasts: 141.6;Late spermatids: 82.8;Leydig cells: 71.7;Peritubular cells: 102.3;Theca cells: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 210.9;fHDF/TERT166: 164.9;HSkMC: 148.6;hTERT-RPE1: 150.6;U-138 MG: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041991	Enhanced					NA	NA		36000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA041991: AB_10794166"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (7.70e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (5.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	24.5	8.6	4.8	13.7	7.9	5.3	16.2	5.6	5.3	39.3	22.5	12.3	6.6	31.3	9.6	21.2	26.3	32.4	45.2	4.3	5.1	18.1	2.8	35.0	4.5	9.3	9.1	45.8	7.5	1.2	17.4	9.6	8.9	25.7	3.2	0.7	9.0	20.8	12.2	28.8	10.9	21.3	9.9	16.3	9.0	16.2	6.0	4.5	7.0	6.5	2.0	17.9	28.2	11.2	0.1	35.1	23.3	29.7	64.1	115.4	3.1	210.9	138.8	34.3	40.8	2.1	0.4	0.0	15.2	164.9	15.1	17.8	4.0	19.0	8.8	26.7	5.4	17.6	27.2	0.0	97.2	22.9	0.2	148.6	9.5	29.6	3.4	150.6	15.4	10.6	9.3	0.0	47.8	6.3	6.6	70.6	4.9	0.0	2.4	22.3	15.4	0.2	3.2	0.4	2.9	52.2	14.1	0.4	0.3	14.3	0.6	97.1	68.5	216.6	83.9	36.2	43.6	0.2	0.0	0.0	66.8	22.6	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.8	7.9	5.6	5.3	4.3	5.1	9.3	9.1	8.9	9.9	6.0	11.2	8.6	3.2	35.9	5.9	0.4	11.3	5.8	20.7	25.0	11.1	1.6	11.4	4.4	0.0	2.3	1.8	0.0	0.7	0.6	0.1	0.0	0.3	93.9	22.6	65.2	5.2	0.0	28.4	3.3	0.2	2.7	141.6	2.0	2.9	2.5	13.8	5.3	0.0	6.8	0.0	0.9	0.1	0.0	9.2	11.1	82.8	71.7	7.0	5.4	57.1	0.6	0.8	1.0	3.5	0.9	0.6	0.0	102.3	0.3	2.1	0.0	0.0	1.4	0.6	0.0	31.4	23.3	11.7	9.3	34.6	7.7	1.9	2.7	71.0	0.2	1.4
MRLN	"Linc-RAM, LINC00948, M1, MLN, MUSER1"	ENSG00000227877	Myoregulin	P0DMT0	10	59736692-59756041	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 269.3;tongue: 147.3"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 118.8;Proximal tubular cells: 25.8;Respiratory ciliated cells: 35.7;Rod photoreceptor cells: 37.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enriched"	"Detected in some"	4	"cerebellum: 4.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"RH-30: 13.3"	"Region enriched"	"Detected in many"	11	"cerebellum: 21.6"											NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 49: Ciliated cells - Cilium organization"					"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.54e-1)"	"unprognostic (3.17e-3)"		"unprognostic (9.77e-2)"		"unprognostic (1.09e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	0.1	0.2	0.4	0.1	0.4	0.3	0.2	4.5	0.7	0.5	0.4	0.2	1.0	0.5	0.8	1.2	5.1	0.7	0.1	0.4	0.2	8.1	0.2	0.7	0.1	0.5	0.3	0.3	2.8	0.0	12.0	0.1	1.0	1.3	0.1	30.6	7.0	0.1	269.3	0.6	1.1	0.1	0.1	0.5	1.0	0.8	0.3	0.3	0.3	147.3	0.1	0.0	0.1	0.6	0.0	0.8	0.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.6	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.7	0.2	1.8	1.1	0.1	0.0	0.6	1.0	0.0	0.6	0.0	0.1	0.0	0.1	0.1	1.0	0.0	1.1	0.0	1.0	0.2	0.2	0.8	0.5	13.3	0.0	0.0	0.2	0.6	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.3	0.6	0.2	0.5	0.1	0.1	0.4	0.3	0.0	1.7	0.3	0.4	0.6	0.1	0.4	0.5	0.3	0.3	0.2	0.6	0.2	0.5	1.2	0.3	0.3	0.4	0.3	0.0	0.4	0.4	4.5	0.7	0.4	0.2	0.5	0.3	1.0	0.1	0.3	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.1	1.0	0.0	1.8	0.0	2.1	0.0	0.1	1.5	0.0	0.2	5.6	118.8	0.8	0.7	0.0	0.0	1.3	0.2	6.4	0.4	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.5	0.6	0.3	0.0	0.4	0.0	0.1	0.0	25.8	35.7	37.8	0.0	10.1	0.2	2.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
MRO	"B29, C18orf3, FLJ30140"	ENSG00000134042	Maestro	Q9BYG7	18	50795120-50825402	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 44.7;kidney: 24.1;testis: 28.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 30.0;Granulosa cells: 11.3;Hepatic stellate cells: 37.5;Kupffer cells: 13.0;Proximal enterocytes: 20.0;Proximal tubular cells: 16.0"	"Cancer enriched"	"Detected in some"	7	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 2.4;ASC TERT1: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022011	Approved					NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022011: AB_2670880"	"unprognostic (9.21e-5)"	"unprognostic (5.22e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.99e-3)"	"unprognostic (6.06e-4)"	2.3	2.5	36.6	0.5	42.7	0.2	0.6	32.5	33.1	0.3	18.4	0.2	8.0	0.2	3.1	0.5	0.3	1.0	3.0	33.3	44.7	24.1	7.2	0.2	0.3	35.9	38.5	3.3	1.8	5.3	1.3	0.7	34.4	0.2	0.2	1.6	0.3	2.2	2.0	0.1	4.7	0.3	33.8	2.2	1.3	28.9	40.8	1.2	6.0	1.3	0.1	0.4	0.2	31.0	0.0	0.0	0.0	0.2	2.4	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.3	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	36.6	42.7	32.5	33.1	33.3	44.7	35.9	38.5	34.4	33.8	40.8	31.0	0.2	0.0	0.0	30.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.8	1.5	0.0	0.0	2.1	0.0	0.0	0.2	5.9	0.0	0.8	0.2	0.0	0.9	0.0	0.0	1.5	1.0	0.8	0.8	1.1	0.1	0.0	11.3	37.5	4.7	8.4	0.0	1.1	0.1	0.0	13.0	0.3	3.3	1.2	1.8	0.0	3.7	0.0	3.9	1.0	5.0	0.3	0.1	0.0	0.7	0.0	0.1	20.0	16.0	0.0	0.2	0.0	0.4	0.1	1.2	0.5	0.0	0.0	0.1	0.1	4.3	0.6	0.1
MROH2A	HEATR7B1	ENSG00000185038	"Maestro heat like repeat family member 2A"	A6NES4	2	233775679-233833423	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 1.7;thyroid gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 3.4;Early spermatids: 1.3;Hepatocytes: 1.0;Late spermatids: 1.7;Spermatocytes: 1.5"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RT4: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052107	Uncertain		Uncertain	Cytosol		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA052107: AB_2681729"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.06e-9)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	3.4	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.3
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098467	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.6"	"Cell type enriched"	"Detected in some"	20	"granulocytes: 967.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	908	"basophil: 275.5"	"Lineage enriched"	"Detected in single"	1467	"granulocytes: 275.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;THP-1: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 15.3"	HPA059967	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	2.6	0.2	0.3	2.4	0.3	0.9	2.7	0.5	0.5	6.3	0.6	4.9	5.5	4.2	3.7	4.8	0.9	8.2	0.6	0.3	0.3	0.5	0.4	12.6	1.1	0.4	0.3	0.1	0.5	0.3	0.1	0.3	0.4	3.0	5.4	0.0	1.8	2.4	2.9	2.5	6.7	4.1	0.3	0.2	5.3	1.0	0.3	1.2	0.1	1.2	1.8	3.8	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	275.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.3	0.3	0.5	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.3	0.5	0.1	0.0	30.9	0.0	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.1	0.5	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.0	46.7	0.1	0.0	0.1	1.1	0.0	0.1	967.4	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.7	0.4	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.2
MS4A4A	"CD20L1, MS4A4, MS4A7"	ENSG00000110079	"Membrane spanning 4-domains A4A"	Q96JQ5	11	60185657-60318080	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 63.1"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 376.8;Kupffer cells: 445.0;Macrophages: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 61.2;myeloid DC: 27.6;non-classical monocyte: 82.9;plasmacytoid DC: 27.7"	"Group enriched"	"Detected in many"	30	"dendritic cells: 27.7;monocytes: 82.9"	"Cell line enhanced"	"Detected in some"		"HEL: 35.6;HMC-1: 45.8;K-562: 154.9"									HPA029323	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"			"HPA029323: AB_10601866"	"unprognostic (7.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.56e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.21e-2)"	42.8	24.7	3.5	16.5	3.6	6.1	12.3	3.7	8.6	14.1	4.4	14.0	5.2	4.9	3.4	8.9	11.6	25.8	8.4	3.5	3.9	4.8	15.4	28.0	31.3	4.2	3.4	4.1	4.0	3.3	3.3	63.1	3.6	3.4	16.1	2.0	7.6	4.9	2.3	2.9	13.5	20.0	2.5	33.3	6.6	3.0	5.5	11.5	3.7	10.4	7.5	28.0	3.3	4.3	0.3	0.1	0.1	0.6	0.0	0.2	0.7	0.6	0.0	0.2	0.4	0.3	0.9	0.8	0.4	0.0	0.4	0.3	0.5	0.1	0.6	1.6	0.0	35.6	0.7	0.6	0.1	1.2	45.8	0.4	0.3	0.2	0.8	0.2	0.0	0.4	154.9	4.2	0.6	0.7	0.6	0.9	0.7	0.3	0.1	0.7	0.0	2.5	0.1	1.5	0.5	0.5	0.3	0.3	0.1	0.7	0.7	8.9	0.8	1.5	0.6	0.4	0.2	6.0	0.7	0.5	0.2	0.8	0.2	0.1	9.9	0.0	0.1	61.2	0.2	1.0	0.1	0.1	27.6	0.3	0.2	0.1	0.9	1.8	82.9	27.7	0.1	6.0	3.5	3.6	3.7	8.6	3.5	3.9	4.2	3.4	3.6	2.5	5.5	4.3	2.3	0.0	7.9	0.0	3.0	1.8	0.1	0.0	0.6	0.0	0.3	2.2	3.4	2.8	2.5	0.0	0.0	1.8	7.5	0.0	0.0	0.0	0.7	0.0	0.0	5.7	0.0	13.0	0.1	0.0	2.0	1.6	0.0	0.0	7.6	0.0	47.5	4.6	376.8	0.0	0.1	0.0	0.0	445.0	24.9	1.0	0.9	264.6	3.6	10.3	8.3	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	13.1	1.2	1.1	0.1	0.2	0.7	1.8	3.6	1.5	0.1	0.0	0.1
MS4A4E		ENSG00000214787	"Membrane spanning 4-domains A4E"	Q96PG1	11	60200270-60243137	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.4;Erythroid cells: 1.3;Kupffer cells: 3.4;Macrophages: 5.4;Microglial cells: 1.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 17.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.1"									HPA040075	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA040075: AB_10793915"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.16e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.97e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.05e-2)"	5.9	4.0	5.4	3.5	5.1	7.7	3.7	8.1	6.7	1.1	6.5	2.8	3.3	1.8	2.8	1.6	1.5	3.0	1.3	6.0	4.7	1.8	5.5	2.9	2.8	5.4	4.1	1.6	1.5	1.3	0.0	1.8	4.6	2.0	2.7	4.5	1.7	1.2	4.4	4.2	4.5	2.9	2.6	4.7	2.7	2.9	5.3	1.1	1.2	0.8	1.9	1.5	0.0	5.8	4.2	1.7	0.9	2.2	0.7	0.4	3.2	1.7	0.2	0.2	0.3	1.2	1.8	1.3	1.7	0.1	1.2	3.4	0.3	0.2	0.3	5.0	1.1	2.3	3.5	2.0	0.6	1.3	8.1	0.5	1.5	0.5	0.7	0.9	0.2	1.8	2.4	4.2	0.2	1.6	1.9	2.6	1.8	2.0	1.3	1.6	1.7	1.8	0.5	2.1	1.3	2.2	4.9	1.8	2.4	2.0	2.4	2.4	1.1	1.7	7.8	4.8	1.6	5.6	4.7	1.9	0.9	2.8	1.5	17.8	1.4	0.2	0.4	1.6	0.3	0.5	0.3	0.2	2.5	0.7	0.3	0.4	2.7	0.9	1.4	1.4	0.2	0.3	5.4	5.1	8.1	6.7	6.0	4.7	5.4	4.1	4.6	2.6	5.3	5.8	0.1	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	5.4	0.0	1.9	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A6A	"CD20L3, MS4A6"	ENSG00000110077	"Membrane spanning 4-domains A6A"	Q9H2W1	11	60172014-60184666	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 580.8;Hofbauer cells: 376.8;Kupffer cells: 1649.6;Langerhans cells: 470.0;Macrophages: 675.9;monocytes: 429.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 406.4;classical monocyte: 1095.3;intermediate monocyte: 345.6;myeloid DC: 638.8;plasmacytoid DC: 454.4"	"Group enriched"	"Detected in all"	74	"dendritic cells: 638.8;granulocytes: 406.4;monocytes: 1095.3"	"Cell line enriched"	"Detected in some"	8	"THP-1: 47.9"									"HPA011391, HPA076623"	Approved		Approved	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA011391: AB_10603876, HPA076623: AB_2686809"	"unprognostic (1.17e-1)"	"prognostic favorable (6.33e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.97e-2)"	72.6	42.3	10.7	57.5	10.9	33.5	40.0	10.8	22.5	28.1	14.7	41.0	27.8	14.3	9.6	25.7	16.8	61.4	22.8	10.0	11.8	11.5	108.6	56.4	109.1	15.8	13.7	12.3	7.8	8.7	9.8	65.2	14.8	12.4	54.9	1.4	16.0	18.3	5.3	7.3	45.1	52.6	12.4	121.5	24.5	7.8	13.6	32.2	10.0	17.7	47.6	59.9	8.6	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.1	0.0	406.4	1095.3	8.2	1.6	345.6	3.4	9.6	2.2	1.4	638.8	1.5	1.0	1.0	72.8	2.1	24.4	454.4	1.9	752.8	10.7	10.9	10.8	22.5	10.0	11.8	15.8	13.7	14.8	12.4	13.6	17.6	5.3	6.4	22.9	0.0	16.1	9.3	0.6	0.0	1.2	0.3	2.2	8.0	3.3	17.2	2.5	3.7	0.0	2.0	220.6	0.3	0.0	0.0	2.2	0.4	0.2	12.8	0.0	43.9	0.1	0.0	2.7	4.3	2.6	0.2	13.9	0.1	580.8	20.5	376.8	0.0	0.1	0.1	0.0	1649.6	470.0	5.1	1.5	675.9	14.2	40.3	429.2	0.0	11.3	0.5	0.1	0.0	1.2	0.0	2.0	0.2	0.0	0.5	1.5	0.6	46.0	3.0	4.4	0.5	1.1	2.4	8.0	2.1	10.4	0.1	0.2	0.3
MS4A7	"CD20L4, CFFM4, MS4A8"	ENSG00000166927	"Membrane spanning 4-domains A7"	Q9GZW8	11	60378485-60395951	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 196.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 311.4;Kupffer cells: 1060.3;Macrophages: 567.5;monocytes: 184.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 747.4;non-classical monocyte: 1486.0"	"Lineage enriched"	"Detected in many"	12	"monocytes: 1486.0"	"Cell line enriched"	"Detected in some"	25	"THP-1: 114.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA017418, CAB026387"	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB026387: , HPA017418: AB_1854137"	"unprognostic (1.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.24e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	46.9	37.6	6.3	50.9	5.0	10.7	30.7	4.5	13.7	18.2	13.9	21.4	17.6	7.6	4.1	12.7	6.6	46.8	9.9	4.2	8.7	8.0	66.5	75.7	23.2	12.8	10.4	6.0	6.0	9.0	4.7	43.9	11.4	4.9	23.3	1.2	6.7	9.0	1.9	2.3	25.1	15.9	7.4	196.6	14.8	4.7	17.1	18.2	7.3	4.1	18.6	41.2	3.9	18.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	0.0	0.1	1.1	0.1	0.1	0.0	2.8	0.0	0.1	0.1	0.8	0.5	0.0	0.0	114.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	3.0	0.0	3.1	0.0	8.3	188.0	2.5	0.8	747.4	1.1	22.3	0.6	0.5	120.9	19.7	0.8	0.4	9.3	0.8	1486.0	3.2	0.9	137.8	6.3	5.0	4.5	13.7	4.2	8.7	12.8	10.4	11.4	7.4	17.1	18.3	5.0	12.8	31.4	0.0	30.6	2.7	0.8	0.0	0.6	3.6	14.7	9.9	2.1	0.0	3.7	9.2	0.0	1.0	1.4	0.3	0.0	0.0	2.4	0.1	0.0	12.2	0.0	10.1	0.1	0.2	1.7	3.9	1.5	0.1	13.9	0.1	11.0	4.7	311.4	0.0	0.2	0.0	0.0	1060.3	93.4	1.2	1.2	567.5	1.8	59.0	184.8	0.4	4.1	0.0	0.3	0.1	1.1	0.0	1.8	1.1	0.0	0.7	7.3	0.5	19.7	2.2	1.2	0.0	0.4	0.9	1.8	1.9	5.3	0.3	0.1	1.0
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lung: 120.1"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 137.3;Kupffer cells: 322.8;Langerhans cells: 86.0;Macrophages: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 16.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.9"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 105.2;REH: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000272, CAB032491"	Enhanced					NA	NA		67000	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (8.19e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.69e-2)"	25.9	18.4	4.2	17.5	5.4	13.0	9.7	5.5	10.6	11.6	13.6	8.5	6.6	8.0	6.3	6.2	5.6	29.8	8.7	3.8	6.5	6.7	24.9	120.1	7.0	15.0	7.5	6.1	11.4	6.3	2.6	27.4	10.8	3.6	10.6	5.9	6.3	6.4	2.3	3.5	9.4	17.9	6.9	16.0	6.2	6.2	16.9	4.4	5.2	1.4	2.9	17.4	1.9	22.9	1.5	2.1	3.0	1.5	1.4	1.3	1.4	0.7	105.2	0.3	0.6	3.7	0.4	3.4	5.1	1.0	0.7	0.7	0.7	1.0	2.0	0.4	4.3	4.6	5.1	4.2	0.9	2.4	2.5	0.7	0.8	0.8	1.5	1.8	0.2	1.9	1.7	2.9	1.9	4.3	1.4	1.4	0.5	1.6	1.3	40.7	2.3	1.0	2.0	5.8	2.8	1.2	1.0	2.8	0.2	5.0	0.4	1.2	2.4	2.8	0.9	10.8	2.8	9.5	8.6	7.4	1.1	1.5	2.2	1.7	3.3	0.6	1.0	16.9	0.4	1.1	0.7	0.7	1.1	1.5	1.3	0.9	3.2	0.4	8.8	0.5	0.7	0.8	4.2	5.4	5.5	10.6	3.8	6.5	15.0	7.5	10.8	6.9	16.9	22.9	2.0	22.4	35.9	0.0	2.7	2.7	0.0	0.0	0.0	1.6	0.5	1.4	2.0	2.8	8.1	3.7	25.0	0.5	0.1	0.0	1.9	0.0	2.9	0.0	0.0	6.3	0.0	2.7	0.3	0.0	1.0	2.1	0.0	0.0	17.7	0.1	4.6	1.7	137.3	0.0	3.0	0.1	0.0	322.8	86.0	3.6	1.8	172.5	0.0	28.1	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.4	6.6	0.7	19.7	1.0	0.7	4.2	1.3	0.1	2.0	0.8	2.6	0.2	0.0	0.3
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054292-10428891	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 86.0;liver: 64.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 625.8;Inhibitory neurons: 318.6;Oligodendrocyte precursor cells: 268.9;Proximal tubular cells: 666.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"cerebellum: 28.4"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.3"	"Low region specificity"	"Detected in all"							"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		55000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"	"Plasma membrane, Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	17.0	20.4	2.2	1.1	3.0	13.5	16.1	28.4	5.4	9.1	0.0	13.9	1.1	10.7	0.1	11.6	7.4	0.4	29.0	3.8	0.0	86.0	64.0	12.2	0.6	0.0	0.4	6.4	14.5	0.7	9.2	0.8	1.8	9.2	0.6	0.6	10.5	1.0	14.5	9.5	20.1	0.8	0.0	18.6	14.2	15.2	0.3	1.5	9.6	1.3	0.6	11.6	8.2	2.8	0.1	0.9	1.3	4.3	1.2	1.4	0.5	2.5	0.2	0.3	1.7	0.6	2.1	0.0	0.6	2.5	5.8	2.3	0.4	0.1	1.3	0.2	0.0	0.3	1.5	2.2	4.3	0.8	12.3	0.4	3.2	0.3	0.0	1.4	0.6	0.3	0.4	0.2	4.9	0.1	0.0	0.3	0.6	3.3	0.8	1.6	1.3	2.0	1.1	1.1	2.5	1.5	4.6	0.2	0.5	0.4	2.3	2.8	2.6	1.7	2.0	0.4	1.2	0.2	0.1	0.7	4.8	0.8	3.1	0.5	1.9	5.6	0.4	1.2	0.3	0.6	0.4	0.3	1.2	0.1	0.3	0.2	2.2	0.7	0.9	0.2	0.3	0.2	2.2	3.0	28.4	5.4	3.8	0.0	0.0	0.4	1.8	0.0	0.3	2.8	44.1	0.0	7.4	152.8	21.4	16.4	29.3	10.8	14.2	10.1	21.2	21.8	21.6	25.8	7.2	25.8	31.3	7.7	12.4	26.4	92.0	32.3	80.6	13.6	8.7	30.3	9.6	3.4	625.8	47.1	4.6	13.1	14.8	11.8	80.7	13.7	19.6	97.2	47.0	16.8	318.6	20.8	4.1	33.6	48.3	167.9	9.3	38.0	30.2	85.3	22.3	14.6	11.3	268.9	60.7	51.1	37.8	9.8	16.2	33.8	195.5	666.1	5.6	6.2	13.1	11.3	16.9	39.3	26.5	20.1	14.1	8.3	18.0	14.1	24.5	31.1
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938229-1943293	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 234.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1414.9;neutrophil: 3051.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 3051.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	28.1	15.1	26.2	31.8	27.3	96.3	21.3	27.8	28.4	17.5	25.8	36.7	29.4	29.5	11.2	45.3	33.5	23.2	47.3	25.6	26.8	80.3	234.2	30.4	17.7	29.3	28.0	16.4	149.6	14.8	14.5	13.2	27.1	32.0	17.4	2.7	16.5	29.2	76.0	31.1	27.5	36.8	27.5	67.0	33.3	17.7	28.5	13.7	12.5	93.6	12.2	40.8	20.1	27.1	23.6	59.1	21.3	50.4	39.9	17.0	36.4	27.8	36.0	41.2	35.6	96.2	25.5	22.7	90.6	33.5	36.0	37.9	36.3	25.2	12.8	127.7	41.1	17.5	20.5	154.9	36.1	49.3	40.3	32.0	21.9	29.6	6.0	12.9	41.9	28.8	28.2	12.3	22.3	131.2	28.2	82.7	29.2	42.7	33.5	40.3	29.3	106.0	66.0	37.2	20.5	26.9	32.3	35.6	17.3	13.9	38.7	87.9	24.8	12.3	33.7	24.3	16.7	32.0	53.4	42.4	12.5	47.4	22.0	493.5	412.0	1414.9	31.9	194.8	32.2	28.0	26.5	26.7	171.2	28.3	20.5	22.7	3051.8	42.2	182.9	73.2	45.9	226.7	26.2	27.3	27.8	28.4	25.6	26.8	29.3	28.0	27.1	27.5	28.5	27.1	24.9	9.6	13.4	3.9	10.0	6.5	9.1	21.5	8.0	6.5	27.9	21.3	36.1	32.9	14.9	33.1	4.2	33.3	12.3	69.1	93.9	65.9	5.9	23.9	13.4	15.4	60.3	21.5	0.8	111.2	121.4	13.7	11.7	17.0	4.5	12.2	20.7	275.6	63.5	8.4	1.2	38.6	34.6	59.2	21.2	13.9	9.3	37.9	16.0	2.8	178.7	22.5	25.7	1.5	2.9	66.0	62.8	23.0	13.0	16.3	97.3	496.8	37.9	4.2	0.0	8.1	22.8	28.9	8.7	11.1	9.5	38.6	10.6	14.8	33.5	21.9
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 2801.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 41.6"	"Lineage enhanced"	"Detected in many"		"granulocytes: 41.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	44.9	10.7	12.9	20.9	13.6	21.2	26.3	12.5	12.8	29.5	18.8	108.0	11.9	85.8	20.1	63.0	41.4	33.2	90.8	11.9	18.3	10.1	3.8	30.6	5.7	15.9	15.2	16.9	5.8	3.2	6.8	25.2	13.8	52.7	27.8	12.5	10.8	103.0	104.0	9.7	25.6	123.9	14.6	13.6	36.2	5.8	18.2	4.1	14.5	69.2	3.9	60.9	23.7	11.8	8.8	19.2	16.4	75.9	71.6	63.0	0.5	87.0	92.9	33.2	19.8	0.7	1.0	0.0	18.3	126.1	10.5	1.9	7.7	22.1	30.0	0.2	15.9	0.0	16.7	0.9	46.6	47.1	0.3	33.4	11.9	28.1	39.0	110.6	68.2	0.1	0.3	0.3	76.8	2.9	0.0	11.0	5.4	0.2	10.4	0.2	22.0	0.5	7.5	1.0	0.4	7.9	30.0	1.8	21.9	16.8	14.1	44.5	78.9	42.3	22.8	19.5	34.2	8.0	6.7	0.2	11.5	106.7	26.9	15.0	0.6	41.6	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	6.8	8.3	0.4	10.8	0.1	1.4	12.9	13.6	12.5	12.8	11.9	18.3	15.9	15.2	13.8	14.6	18.2	11.8	55.3	12.8	3.4	76.7	0.8	6.4	16.4	11.4	4.0	22.7	2.2	45.3	2801.7	4.3	1.2	3.7	0.0	0.4	8.3	0.0	0.0	9.3	5.7	0.9	16.7	154.2	0.0	17.4	37.1	1.0	0.4	108.8	1.1	0.4	2.5	7.4	28.2	0.2	0.5	21.9	56.6	0.0	0.0	0.0	13.7	2.2	12.5	4.0	10.6	62.8	1.6	44.4	2.1	37.7	1.4	1.6	0.0	116.6	0.3	14.8	0.0	0.4	6.8	10.6	105.2	37.7	218.7	4.2	4.7	0.8	4.5	0.7	2.4	10.3	0.0	2.9
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	10	"liver: 927.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 362.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.6;NB-4: 17.3;U-266/70: 21.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	29.3	28.0	8.1	1.0	8.3	6.3	8.2	8.8	14.0	12.6	8.1	5.1	50.6	8.9	11.3	7.3	10.5	7.4	4.9	8.1	8.4	96.9	927.9	5.9	3.6	8.4	8.4	12.5	16.4	9.4	29.3	5.8	8.3	12.9	2.1	5.3	8.1	5.1	3.6	14.8	31.1	2.1	8.1	13.9	8.8	34.9	8.2	2.2	36.4	2.9	1.7	6.0	6.9	8.3	0.2	0.4	1.2	2.0	3.7	7.6	3.7	1.1	1.4	0.6	0.8	3.9	1.2	0.3	2.6	1.3	0.5	0.8	0.6	1.5	0.6	1.3	0.7	0.6	2.6	84.6	5.8	0.0	1.6	10.2	2.6	0.7	2.1	14.1	1.4	3.5	0.7	9.9	1.9	0.6	0.5	17.3	0.2	1.1	1.0	0.4	0.5	2.2	4.2	0.6	0.2	2.8	0.0	1.6	0.4	2.5	1.5	5.7	0.9	1.9	0.6	0.1	0.2	21.8	2.9	0.5	2.2	3.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	8.3	8.8	14.0	8.1	8.4	8.4	8.4	8.3	8.1	8.2	8.3	3.1	6.4	3.9	10.1	3.5	2.9	4.6	5.8	6.8	8.2	6.1	10.2	2.2	45.8	5.4	27.6	8.4	4.8	1.0	5.1	62.6	6.9	7.6	2.3	3.5	3.4	8.3	29.7	1.1	3.9	19.7	5.2	9.2	3.2	1.3	36.9	10.0	362.8	1.4	1.7	2.0	8.9	6.1	10.7	1.4	2.6	3.1	1.2	3.6	2.8	0.1	8.9	0.0	3.0	2.9	2.1	7.2	1.9	1.6	1.3	57.0	61.9	6.7	6.9	0.0	2.3	10.9	21.8	9.2	2.6	4.7	5.1	2.1	22.8	13.7	3.4
MSX1	"HOX7, HYD1, OFC5"	ENSG00000163132	"Msh homeobox 1"	P28360	4	4859665-4863936	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 57.0;choroid plexus: 98.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 118.4;Endometrial ciliated cells: 364.0;Glandular and luminal cells: 462.0"	"Cancer enriched"	"Detected in all"	17	"endometrial cancer: 246.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 47.9;EFO-21: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026198, HPA063895, HPA073604"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB026198: , HPA063895: AB_2685145, HPA073604: AB_2686617"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (1.64e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.16e-3)"	"unprognostic (4.07e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.18e-5)"	"unprognostic (4.35e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.33e-2)"	18.4	6.0	12.2	0.7	11.8	0.2	12.8	12.2	16.9	57.0	98.0	1.8	0.5	17.5	0.3	0.9	9.6	1.3	10.3	18.8	12.2	2.9	0.5	4.3	0.6	17.2	11.8	3.5	2.3	0.4	21.1	4.1	11.8	5.5	0.1	0.6	8.8	3.6	20.1	5.2	1.1	3.2	15.1	4.5	2.0	0.7	13.0	0.2	9.2	2.0	0.4	11.2	14.5	12.3	2.5	1.5	0.5	2.8	8.0	5.1	8.9	6.1	2.8	3.5	1.7	47.9	15.3	0.3	21.4	4.4	17.0	0.1	10.6	0.0	1.2	2.0	12.2	0.1	8.0	17.4	0.6	0.1	1.4	1.0	0.8	2.6	0.9	1.1	0.8	4.1	7.9	0.3	1.9	1.2	1.3	2.4	0.2	0.7	11.1	6.4	6.4	0.6	0.2	1.5	0.4	0.3	5.4	0.3	4.0	0.8	0.9	2.1	2.0	4.1	9.1	13.0	9.9	1.0	0.9	5.7	2.6	3.1	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	12.2	11.8	12.2	16.9	18.8	12.2	17.2	11.8	11.8	15.1	13.0	12.3	118.4	0.0	0.0	17.3	0.5	7.1	2.4	0.3	4.6	0.8	8.6	24.3	5.5	0.0	0.0	0.0	4.2	0.3	1.6	3.9	0.0	0.2	0.4	364.0	35.7	48.1	0.0	0.0	1.1	0.9	0.1	34.8	1.1	462.0	0.0	1.1	5.7	0.2	0.5	0.0	1.2	2.5	0.0	0.6	8.8	0.0	1.2	4.4	16.0	3.7	0.0	0.7	0.0	1.0	0.3	0.3	0.1	0.4	1.6	3.3	0.6	0.5	0.0	0.7	0.0	13.6	18.2	0.8	1.5	2.6	4.7	0.3	4.8	14.6	2.6	2.0
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666730-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 3543.0;liver: 6959.4;thyroid gland: 2886.6"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 77919.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"U-937: 1103.8"														"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	250.2	21.5	434.9	105.8	515.9	2.9	28.1	469.3	912.6	21.9	396.7	821.1	513.8	8.4	2.4	255.4	75.5	12.0	9.3	430.3	455.6	3543.0	6959.4	49.9	5.6	494.0	474.4	3.2	1806.7	0.3	21.7	2.1	465.6	425.3	516.5	42.6	44.2	5.9	8.4	58.4	1096.4	76.3	431.0	3.9	1262.3	4.0	466.6	0.9	2886.6	0.9	2.6	14.2	25.8	430.1	0.4	0.0	0.0	0.0	0.0	0.0	4.4	8.6	1.7	1.1	0.4	0.0	0.0	0.1	16.2	0.0	0.1	1.8	0.2	1.2	0.9	0.8	0.0	4.3	0.0	3.5	4.5	1.0	0.6	1.7	0.0	11.4	0.0	0.1	0.0	0.0	0.3	1.2	0.7	0.0	3.7	251.3	0.5	0.0	0.0	0.0	0.8	70.8	40.8	0.0	21.8	3.0	0.5	1.3	1.1	10.8	0.0	107.8	0.0	0.0	0.8	1.7	0.3	0.6	1.9	0.6	2.0	1103.8	0.0	0.2	0.3	0.1	0.3	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.1	0.7	0.5	434.9	515.9	469.3	912.6	430.3	455.6	494.0	474.4	465.6	431.0	466.6	430.1	10.6	28.9	8.7	38.5	338.7	57.9	26.0	4.5	46.1	0.0	87.0	116.2	11.7	330.3	9.1	2302.6	0.0	3.9	9.8	3657.8	6849.7	74.4	0.3	2960.7	777.1	49.2	246.7	878.6	0.1	283.4	403.2	50.7	443.9	8167.8	17.2	16.8	310.2	16307.3	26.3	0.0	0.1	3688.0	0.0	379.5	4.9	0.9	23.3	765.6	30.2	2.8	10.6	0.0	2.1	2.0	0.1	339.8	10431.2	2.2	26.3	823.7	8631.3	77919.3	3.9	0.0	0.0	25.1	42.9	0.3	0.8	42.2	77.9	132.7	247.5	4.7	3786.7	21.1
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 845.2;liver: 1137.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 18797.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 3.6;SuSa: 8.9"															NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	7.6	0.2	40.8	6.8	56.1	0.0	0.8	41.0	98.2	3.7	38.0	119.2	51.2	1.7	0.7	29.2	2.0	1.1	0.7	42.1	43.9	845.2	1137.0	1.9	0.8	50.0	46.7	0.1	204.5	0.0	0.4	0.9	47.2	22.0	61.3	5.6	4.0	0.0	0.2	6.5	298.0	8.0	40.1	0.4	76.3	0.3	40.4	0.1	325.4	0.0	0.6	3.4	2.6	43.8	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.9	0.6	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	40.8	56.1	41.0	98.2	42.1	43.9	50.0	46.7	47.2	40.1	40.4	43.8	0.1	0.0	0.0	1.0	73.2	12.2	1.4	0.9	1.2	0.0	0.4	0.5	2.2	42.9	0.7	535.2	0.0	3.1	0.0	1181.8	1668.9	1.8	0.0	668.1	153.9	9.3	43.6	133.7	0.0	47.9	543.9	2.7	28.5	1793.8	4.5	0.4	54.7	3439.8	19.3	0.0	0.0	767.4	0.0	55.1	0.8	0.0	0.3	195.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	43.3	3282.6	0.0	0.1	27.8	3229.9	18797.6	0.0	0.0	0.0	1.6	5.5	0.1	0.4	5.5	18.9	66.9	55.5	0.0	851.8	1.3
MT1X	"MT-1l, MT1"	ENSG00000187193	"Metallothionein 1X"	P80297	16	56682470-56684196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 4031.0;skeletal muscle: 6099.6"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 12792.4;Proximal tubular cells: 14889.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 1069.7;HBEC3-KT: 1964.6;NTERA-2: 670.6;U-87 MG: 720.2"															NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (8.15e-2)"	"unprognostic (9.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.18e-3)"	"unprognostic (7.05e-3)"	"unprognostic (7.26e-3)"	"unprognostic (9.49e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.85e-3)"	"unprognostic (3.84e-1)"	"prognostic unfavorable (1.82e-10)"	"unprognostic (1.56e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.37e-3)"	1445.8	168.5	452.1	105.1	574.1	28.3	1082.7	533.4	587.3	486.3	353.3	359.0	107.8	126.6	98.7	1045.3	379.7	96.5	389.8	426.4	474.5	798.8	4031.0	556.9	44.9	514.5	537.0	186.3	1598.7	32.0	251.0	16.0	519.9	505.2	209.2	75.7	584.9	51.6	6099.6	1768.6	214.8	126.9	496.4	43.0	671.7	58.6	575.1	82.4	1025.4	2145.7	116.2	213.7	911.9	483.8	45.0	47.9	1.9	95.2	1069.7	237.5	37.1	142.3	91.7	39.2	43.8	9.0	41.0	35.4	36.6	35.1	47.6	397.4	131.4	1964.6	46.4	135.0	80.7	46.3	26.7	16.4	152.4	298.1	105.2	238.8	375.9	94.7	98.4	35.8	9.1	34.4	8.0	13.1	135.1	124.5	60.9	317.6	670.6	2.8	314.3	62.9	5.5	90.8	394.0	5.7	95.6	33.3	429.1	107.6	30.7	35.1	12.4	75.0	21.0	81.3	97.5	82.4	99.3	14.3	12.3	14.8	720.2	488.8	48.0	73.1	58.0	19.1	75.3	26.9	86.1	15.6	83.5	94.4	58.5	11.7	78.9	98.4	3.1	24.8	11.7	20.1	90.1	52.3	452.1	574.1	533.4	587.3	426.4	474.5	514.5	537.0	519.9	496.4	575.1	483.8	1563.0	67.3	22.1	47.7	116.0	1747.7	967.7	2932.2	1361.9	0.0	367.7	963.0	158.0	290.2	957.0	581.2	0.0	8.7	162.5	1163.7	2111.0	120.5	2.8	784.0	199.0	256.6	143.9	320.4	2.2	100.3	642.6	621.1	481.2	1883.3	38.7	133.1	307.3	12792.4	67.1	0.0	0.8	1150.7	321.4	327.1	150.8	12.6	495.5	382.8	241.9	4.7	66.7	0.0	41.2	7.5	1.4	174.4	2750.0	118.1	162.8	956.5	3283.6	14889.1	180.0	0.0	72.3	2927.3	670.4	1.6	2.7	1963.3	2398.1	68.4	196.6	77.2	1288.2	265.7
MTCH2	SLC25A50	ENSG00000109919	"Mitochondrial carrier 2"	Q9Y6C9	11	47617315-47642607	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 569.2;Proximal tubular cells: 508.1;Spermatocytes: 435.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038390	Approved		Approved	Mitochondria		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038390: AB_10669723"	"unprognostic (4.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.12e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	28.8	40.3	13.2	14.1	14.1	12.6	25.3	14.3	15.7	20.5	12.7	41.7	38.9	26.8	19.4	50.3	18.9	11.9	41.0	13.8	15.1	57.3	115.3	20.0	14.7	13.3	14.0	13.6	22.6	21.2	18.5	9.9	13.7	18.3	32.7	16.2	29.8	11.9	81.8	28.7	37.6	21.4	12.8	19.6	22.6	69.8	14.7	14.6	21.6	47.5	23.0	23.2	26.1	14.9	47.8	51.2	42.9	57.9	49.7	45.8	31.6	50.5	46.1	66.7	62.6	40.9	47.2	65.4	26.8	62.3	71.7	58.5	77.7	66.4	80.9	33.0	73.4	37.5	69.3	82.5	68.2	79.1	36.1	52.1	51.5	44.3	65.8	38.6	61.1	55.1	70.9	38.0	82.9	69.3	61.1	59.5	46.4	92.4	77.0	56.1	65.4	47.0	78.5	60.6	51.0	35.7	69.1	68.8	37.1	40.3	99.2	36.4	51.2	60.9	52.9	102.4	65.8	40.5	49.3	73.2	50.4	67.7	55.7	13.3	33.8	14.1	20.3	37.6	19.6	25.1	17.7	19.2	44.0	19.5	15.1	17.6	3.2	22.2	31.5	28.9	24.0	34.1	13.2	14.1	14.3	15.7	13.8	15.1	13.3	14.0	13.7	12.8	14.7	14.9	28.4	22.4	35.9	54.9	39.2	47.0	56.0	169.3	44.9	0.0	50.7	41.3	67.8	71.4	84.0	53.3	0.0	82.8	41.2	98.1	181.9	153.3	569.2	48.8	37.5	31.6	79.8	74.6	47.0	109.4	119.1	40.0	46.4	40.1	37.3	29.3	33.2	289.4	164.2	0.0	50.9	97.0	150.5	65.7	40.3	166.5	28.9	67.5	81.8	22.5	103.9	0.0	30.9	58.8	58.6	93.0	69.7	58.3	70.9	84.9	213.3	508.1	79.0	0.0	32.9	30.0	141.3	435.4	104.4	129.8	54.1	127.8	34.5	74.4	165.5	65.2
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 365.5;Late spermatids: 792.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 107.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: AB_2683043"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (8.25e-2)"	9.9	15.2	4.4	6.2	6.1	4.9	10.0	4.7	6.9	9.8	4.6	11.3	12.4	8.4	12.0	10.2	6.3	6.6	7.6	4.3	4.9	31.8	34.9	5.9	4.7	5.2	5.5	6.2	8.8	11.6	3.9	7.6	5.1	7.3	12.0	34.0	8.4	8.5	9.7	8.2	12.5	9.5	4.5	4.0	14.7	19.7	5.3	4.6	11.5	7.3	6.8	8.9	7.6	6.6	34.3	25.1	19.7	22.7	25.7	25.6	15.7	22.3	20.3	26.8	27.9	21.5	34.5	19.0	7.0	21.7	26.6	21.9	44.3	30.0	35.6	6.9	24.0	23.6	16.8	43.1	32.7	6.2	10.9	17.5	31.1	34.7	107.9	15.2	33.1	13.8	32.8	19.0	30.8	30.9	21.1	14.2	20.5	74.9	22.5	10.7	26.9	15.9	32.5	30.2	8.6	12.9	21.9	36.7	29.6	19.6	40.5	13.3	25.8	15.9	22.4	38.8	19.6	18.4	12.9	13.6	19.8	25.0	21.6	1.3	0.8	0.3	0.5	0.6	0.7	0.4	0.7	0.6	0.8	0.3	0.6	0.7	0.2	0.2	0.3	0.5	0.7	0.4	4.4	6.1	4.7	6.9	4.3	4.9	5.2	5.5	5.1	4.5	5.3	6.6	6.8	19.2	9.8	5.9	6.1	16.8	12.3	13.5	10.2	0.0	9.7	4.8	7.4	18.6	12.2	11.0	0.0	25.0	6.9	11.9	56.7	22.6	365.5	7.5	10.0	10.0	4.8	12.6	13.1	24.1	29.0	10.1	14.3	8.2	5.1	9.2	8.9	39.9	9.7	0.0	16.4	12.6	20.3	6.3	7.0	792.9	16.8	6.5	14.2	11.2	3.8	0.0	4.1	18.6	42.4	20.0	9.6	12.0	10.7	20.6	20.0	112.7	16.1	0.0	6.6	7.5	13.1	93.0	35.9	18.4	19.5	39.1	4.5	20.6	15.7	16.6
MTHFS	HsT19268	ENSG00000136371	"Methenyltetrahydrofolate synthetase"	P49914	15	79833585-79897379	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 253.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 205.5;monocytes: 150.8;Proximal tubular cells: 201.6;Syncytiotrophoblasts: 253.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 134.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 134.1;monocytes: 49.1"	"Low cell line specificity"	"Detected in many"											"HPA008067, HPA054177"	Approved		Supported	Cytosol		NA	NA		13000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA008067: AB_1078882, HPA054177: AB_2682405"	"unprognostic (4.57e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (9.13e-3)"	"prognostic favorable (1.29e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.90e-1)"	21.9	19.8	8.0	4.6	8.2	5.0	19.0	9.6	12.7	9.9	6.9	12.0	13.7	9.0	10.3	10.1	9.4	7.0	19.0	8.0	9.2	53.1	253.4	17.8	6.4	8.7	9.3	8.6	32.8	26.3	21.5	8.3	9.1	19.5	6.4	5.9	13.6	5.5	20.2	6.2	14.5	6.2	8.8	14.9	19.5	12.1	8.7	10.6	15.9	11.1	10.8	12.4	9.9	9.1	12.6	35.8	5.0	2.6	15.8	12.0	11.9	8.8	13.0	16.4	10.5	34.5	22.4	15.1	25.1	15.5	15.0	19.5	31.9	10.7	15.4	14.7	28.4	14.8	22.9	39.8	25.3	7.8	0.8	17.5	27.8	8.1	23.0	19.6	7.4	16.0	28.8	12.0	17.4	36.0	10.2	36.1	15.6	51.4	17.0	10.8	17.2	25.8	35.1	34.3	8.9	4.8	25.1	14.2	43.8	20.0	17.3	13.0	3.3	5.7	11.1	3.6	7.1	6.8	20.2	17.8	3.3	25.9	6.2	17.5	25.7	73.5	9.4	35.3	12.4	13.5	13.7	12.9	12.3	11.1	16.5	12.6	134.1	17.8	49.1	13.3	15.7	19.1	8.0	8.2	9.6	12.7	8.0	9.2	8.7	9.3	9.1	8.8	8.7	9.1	11.3	19.2	44.0	0.0	20.7	10.7	9.9	63.0	35.9	0.0	25.5	32.5	0.7	58.6	34.3	22.0	0.0	68.1	10.1	10.0	64.6	55.8	2.2	11.9	7.8	10.5	17.6	36.6	0.0	75.7	37.1	13.5	39.8	11.0	8.8	7.2	21.8	205.5	45.7	0.0	0.0	18.7	24.4	22.1	34.8	3.8	13.7	29.3	21.4	0.0	150.8	0.0	35.0	0.0	0.0	75.3	35.9	15.8	13.3	13.3	101.7	201.6	29.9	0.0	13.1	8.4	10.5	6.7	8.5	21.1	8.1	253.8	22.2	9.2	24.9	7.7
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186533655-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.0;intestine: 1.2;kidney: 2.1;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"						"unprognostic (7.99e-2)"			"unprognostic (2.27e-1)"		"unprognostic (2.16e-1)"		"unprognostic (3.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.20e-2)"	"unprognostic (8.81e-2)"				0.0	0.0	0.0	0.6	0.1	0.0	0.0	1.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS I-BAR domain containing 1"	O43312	8	124550784-124728473	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 208.2;Oligodendrocyte precursor cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 168.3"	"Group enriched"	"Detected in all"	5	"B-cells: 50.3;monocytes: 168.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 81.4;HDLM-2: 98.7;HEL: 337.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: AB_2686756"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	24.5	36.2	16.8	13.2	23.2	12.5	14.0	46.1	23.4	12.5	22.3	11.0	6.4	8.4	9.9	45.2	12.5	9.2	17.1	16.3	27.7	24.2	72.9	16.5	16.0	27.5	20.6	10.4	28.5	3.7	11.0	35.7	25.3	10.1	9.1	15.0	13.9	6.3	32.3	30.8	7.9	9.6	20.5	34.5	12.0	22.3	26.4	18.4	6.0	24.4	17.2	15.5	24.3	39.5	3.6	1.1	51.6	1.0	81.4	41.7	0.1	2.1	14.2	1.1	0.5	4.8	0.4	1.6	4.9	0.2	0.4	0.8	0.4	29.2	1.1	98.7	1.2	337.8	0.9	27.0	18.4	0.0	34.5	66.4	65.4	15.9	41.0	2.1	31.5	0.3	0.5	0.3	5.6	2.7	0.8	4.0	1.8	54.8	0.4	0.4	0.1	0.5	11.6	11.3	36.3	2.8	7.9	6.3	26.6	2.5	1.3	1.1	16.7	2.7	1.0	0.2	0.7	0.5	0.3	5.4	29.1	0.4	10.7	3.1	13.1	0.1	22.7	88.1	2.6	44.9	4.8	8.7	11.8	50.3	2.2	6.8	2.2	2.2	168.3	0.2	0.5	29.2	16.8	23.2	46.1	23.4	16.3	27.7	27.5	20.6	25.3	20.5	26.4	39.5	33.0	0.0	26.9	15.7	92.0	35.8	81.4	41.2	9.6	0.0	8.0	19.9	34.9	22.8	30.9	66.2	0.0	36.0	51.4	10.7	21.5	17.6	54.2	25.5	0.9	32.2	44.2	17.2	40.4	5.2	2.3	30.5	26.5	9.7	46.3	0.9	70.3	78.1	74.2	0.0	208.2	17.1	61.1	167.1	116.2	62.1	3.7	96.7	26.6	114.3	90.2	0.0	78.2	360.4	178.4	32.6	15.9	4.5	12.6	71.9	1.2	19.9	42.0	0.0	39.5	25.2	17.3	2.5	10.7	86.1	63.4	94.4	22.7	1.8	15.8	59.2
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99564081-99623997	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 275.2;liver: 266.6"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 244.2;Proximal enterocytes: 605.4"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.8;Hep G2: 12.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		640000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.3	0.1	0.9	0.2	0.9	0.0	0.2	0.8	0.9	0.1	0.3	1.3	243.2	0.1	1.0	0.1	0.6	1.3	0.9	0.8	1.5	12.9	266.6	0.3	0.3	1.1	1.6	2.0	0.0	0.0	0.5	0.0	1.3	0.5	0.3	5.6	0.1	0.2	0.4	0.1	275.2	0.5	1.2	0.0	0.8	9.6	1.2	0.2	0.1	0.3	0.1	0.9	0.0	1.9	0.0	0.2	10.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.2	0.1	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.5	0.1	0.2	0.1	0.1	1.0	0.0	0.0	0.7	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.8	0.9	0.8	1.5	1.1	1.6	1.3	1.2	1.2	1.9	0.1	0.0	0.0	4.6	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.8	4.3	0.1	1.8	0.0	0.2	0.2	0.2	0.0	0.0	44.2	1.0	0.1	0.1	0.0	2.7	1.6	0.0	0.0	0.8	1.5	0.2	0.0	30.1	3.6	244.2	0.1	0.0	0.7	16.7	2.0	3.5	0.0	12.0	0.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.2	12.5	0.4	0.1	0.0	605.4	23.5	1.0	0.0	6.6	0.5	0.5	32.1	5.7	0.0	0.0	0.0	0.4	12.0	21.0	0.0
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 614.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 853.2;Intestinal goblet cells: 418.5;Paneth cells: 641.9;Proximal enterocytes: 422.5;Undifferentiated cells: 207.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"OE19: 220.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045163, HPA079663"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA045163: AB_10960396, HPA079663: "	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.8	0.8	0.0	62.0	0.0	0.1	0.5	0.0	0.1	0.8	0.0	304.6	614.6	1.5	0.0	0.8	2.8	47.9	0.1	0.0	0.0	17.5	3.7	0.3	0.4	0.2	0.0	0.0	4.5	0.0	0.1	0.0	0.3	2.1	301.3	0.0	0.0	0.8	0.0	0.1	503.8	10.9	0.0	0.1	35.3	0.3	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.1	6.4	13.6	0.0	0.8	0.2	0.1	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	1.0	0.0	220.9	1.1	0.0	0.1	2.7	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	25.8	0.8	0.0	0.0	0.0	0.0	853.2	0.0	24.7	0.9	120.0	1.5	0.4	153.8	0.0	0.1	31.4	0.0	0.0	36.7	6.1	8.9	0.0	0.0	0.0	0.0	0.0	0.2	418.5	0.0	0.3	0.0	4.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.8	641.9	0.7	0.0	1.5	422.5	7.7	10.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	1.5	0.0	207.9	1.4
MUC15		ENSG00000169550	"Mucin 15, cell surface associated"	Q8N387	11	26559032-26572263	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"epididymis: 1949.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 109.0;Respiratory ciliated cells: 168.3;Syncytiotrophoblasts: 665.9"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 56.7"	"Region enriched"	"Detected in single"	7	"basal ganglia: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;K-562: 11.7;SK-BR-3: 18.0;SuSa: 12.0;U-266/70: 7.8;U-266/84: 21.1"	"Group enriched"	"Detected in some"	4	"cerebellum: 1.2;thalamus: 1.4"	"Low region specificity"	"Detected in many"			"HPA026110, HPA073304"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA026110: AB_1854200, HPA073304: "	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"		"unprognostic (7.71e-5)"		"unprognostic (5.09e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.54e-3)"	0.1	0.3	0.4	0.0	4.5	0.0	15.4	0.0	0.6	6.5	1.1	0.0	0.0	0.4	1949.7	17.4	6.7	0.1	0.0	0.3	0.0	24.1	0.1	12.3	0.1	0.0	0.0	0.0	7.8	0.0	1.4	14.8	0.1	0.9	0.0	0.0	52.2	6.8	0.0	29.4	0.0	0.0	0.0	0.0	1.0	0.2	0.0	3.6	75.7	0.0	7.7	2.5	11.6	0.1	0.6	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.7	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.6	0.0	18.0	0.0	12.0	0.2	0.0	0.0	0.0	3.1	0.0	0.0	7.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	109.0	32.5	0.0	0.1	3.4	12.5	7.5	4.6	0.0	43.0	6.9	0.0	0.0	55.1	49.7	0.0	68.7	0.0	0.0	31.3	4.6	0.6	39.8	5.4	0.7	0.0	0.0	0.2	0.0	19.2	1.3	0.0	53.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	8.2	0.0	0.6	0.2	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	168.3	0.0	0.0	0.0	2.2	0.2	0.2	26.5	29.7	665.9	0.4	0.0	0.0	12.6
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 149.5;Extravillous trophoblasts: 259.9;Fibroblasts: 183.3;Leydig cells: 176.1;Peritubular cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"naive CD8 T-cell: 6.4"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.0;BJ: 143.6;BJ hTERT+: 66.9;fHDF/TERT166: 71.9;HSkMC: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	103.6	11.7	2.9	8.2	2.5	0.6	70.0	1.1	2.9	100.4	1.7	58.2	6.3	117.2	2.6	17.6	57.4	19.4	42.8	4.0	2.4	26.4	7.4	53.9	2.5	5.9	4.5	81.9	8.7	1.1	21.7	11.6	2.6	39.0	1.7	0.8	32.4	11.4	16.6	41.6	29.5	6.4	2.3	26.4	28.9	14.7	3.2	0.6	46.6	5.0	0.8	52.8	59.3	3.0	4.1	0.8	1.2	1.0	16.5	46.0	42.3	143.6	66.9	16.6	19.9	8.0	3.3	1.7	0.6	71.9	0.1	3.0	1.0	0.0	3.2	3.2	1.3	1.2	3.1	12.8	43.4	0.2	1.6	54.8	0.0	6.2	0.0	32.4	0.0	0.9	17.3	1.4	21.5	0.4	0.4	0.5	14.0	0.3	4.7	0.6	0.3	0.4	0.0	0.7	3.2	8.9	0.5	1.4	0.1	10.4	11.1	0.7	1.3	0.7	23.1	21.8	0.6	3.3	0.3	0.2	5.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	2.9	2.5	1.1	2.9	4.0	2.4	5.9	4.5	2.6	2.3	3.2	3.0	22.2	3.2	0.0	7.5	0.5	10.7	1.1	0.7	2.2	0.7	7.0	47.9	3.5	0.0	0.0	9.2	0.0	9.5	1.1	0.0	0.0	5.7	1.7	4.3	149.5	5.1	0.0	0.0	0.3	0.0	259.9	183.3	2.6	3.7	0.0	0.5	6.4	0.1	9.3	0.0	0.4	0.0	0.0	0.0	19.7	11.4	176.1	1.7	10.6	6.5	0.7	50.7	0.0	0.0	0.1	1.1	0.0	183.6	1.4	0.6	0.0	1.4	0.0	1.5	13.1	65.8	74.7	0.7	5.4	1.3	10.5	29.4	2.2	0.8	0.0	0.3
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 11.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 127.3;NK-cells: 107.1;Plasma cells: 40.2;Spermatocytes: 35.8;T-cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.9;MAIT T-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 82.5;BJ hTERT+ SV40 Large T+ RasG12V: 69.4;Daudi: 87.7;HBF TERT88: 113.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008791	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	1.0	0.7	1.1	6.1	2.2	2.5	1.7	2.0	1.7	0.7	0.3	1.0	1.3	1.1	0.5	0.7	0.8	2.3	3.4	1.0	1.3	0.4	2.0	2.3	20.1	2.9	1.7	0.6	0.2	0.4	0.4	0.9	3.2	1.2	1.4	5.9	0.5	1.6	0.9	1.2	1.9	2.3	1.9	7.6	1.3	11.8	1.6	2.5	0.6	0.8	16.1	1.1	0.8	3.7	35.4	11.9	3.7	10.1	1.0	2.1	2.6	47.7	21.8	82.5	69.4	1.6	34.9	87.7	4.2	40.4	31.0	10.0	3.5	4.0	113.0	10.6	5.5	1.8	13.4	1.6	0.2	0.8	3.4	0.7	0.4	22.7	19.0	14.8	2.7	6.4	0.4	28.3	51.0	3.1	5.8	1.3	2.8	3.3	15.8	1.9	14.1	2.2	19.4	1.2	8.2	3.3	8.4	3.0	8.6	5.6	50.6	2.3	14.5	49.4	11.3	11.1	44.2	8.2	12.1	25.7	13.0	5.3	20.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	1.1	2.2	2.0	1.7	1.0	1.3	2.9	1.7	3.2	1.9	1.6	3.7	3.0	0.0	2.3	3.3	4.0	1.8	0.4	0.3	1.8	10.4	4.7	6.6	9.1	2.8	0.1	0.0	2.1	2.0	127.3	0.5	0.0	0.5	3.9	0.8	2.4	1.7	0.0	6.6	3.9	0.0	0.7	2.7	3.1	1.4	0.0	5.6	4.2	0.9	0.7	5.0	2.7	0.4	0.0	1.6	3.2	4.2	0.9	5.1	1.8	8.4	1.6	10.3	107.1	5.5	12.4	0.2	1.1	0.0	40.2	0.3	0.0	0.5	1.5	9.1	0.0	2.5	4.5	35.8	6.8	3.2	0.4	1.5	89.1	1.4	0.8	0.3
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.6"	"Group enriched"	"Detected in some"	5	"Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"eosinophil: 30.7"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 30.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 124.6;TIME: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	26.6	3.2	6.8	5.2	6.9	1.2	21.4	6.9	10.2	9.0	5.2	6.1	3.5	10.1	4.5	4.6	9.2	10.5	17.1	6.3	7.1	6.6	13.1	15.6	6.2	7.7	6.9	3.6	2.7	4.3	2.2	20.7	8.6	4.4	5.8	1.0	3.7	3.8	12.8	4.7	5.6	12.4	6.8	49.6	4.5	1.8	10.0	2.5	12.2	20.5	3.0	8.1	7.3	7.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	17.7	0.1	0.0	0.2	0.0	0.1	0.0	23.0	0.3	0.0	0.7	0.1	0.1	0.0	0.2	0.2	0.3	0.0	124.6	0.0	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	104.4	0.5	0.8	1.5	0.0	1.1	0.0	15.6	0.0	0.0	0.0	0.9	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.6	6.8	6.9	6.9	10.2	6.3	7.1	7.7	6.9	8.6	6.8	10.0	7.5	123.0	0.0	5.2	0.7	0.8	7.1	0.2	0.1	2.8	0.2	0.4	0.9	3.1	2.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	1.3	0.2	141.3	0.0	13.7	0.1	0.2	0.0	4.0	0.0	0.1	1.3	0.0	230.6	2.1	0.1	0.0	0.1	0.0	0.0	7.3	7.3	3.7	0.3	13.3	14.2	30.9	0.1	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.5	0.0	0.0	17.7	0.0	0.0	1.5	2.2	0.1	0.1	0.5	5.5	0.0	0.9	0.5	0.0	0.7
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474207-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 171.9;Excitatory neurons: 221.3;Inhibitory neurons: 151.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		28000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	27.3	16.9	12.6	6.1	18.9	13.4	14.7	7.0	29.0	19.6	12.6	12.2	2.3	27.8	16.8	6.6	25.2	26.1	38.9	17.9	8.0	32.5	18.9	66.9	6.5	9.6	7.3	25.9	9.8	13.8	17.7	53.4	9.6	17.7	3.8	22.5	6.6	26.6	4.9	7.9	5.8	22.1	0.5	4.6	9.5	7.4	11.0	5.8	13.6	8.2	4.0	10.5	10.3	13.2	54.1	35.1	216.3	72.7	27.7	33.1	97.1	44.2	39.7	52.2	55.8	94.5	8.0	0.5	28.6	43.9	28.4	5.2	108.7	53.0	58.1	1.2	88.3	62.3	21.7	83.0	64.7	5.4	4.2	47.3	18.9	67.7	26.1	32.1	85.3	70.9	88.1	0.2	32.9	21.6	67.2	1.7	102.1	3.6	7.7	105.9	64.2	0.2	59.1	22.3	17.7	96.8	69.2	3.4	68.1	165.0	18.3	3.6	2.8	48.7	35.6	0.3	38.5	8.3	10.8	13.4	0.3	5.0	111.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	12.6	18.9	7.0	29.0	17.9	8.0	9.6	7.3	9.6	0.5	11.0	13.2	43.0	22.4	14.1	43.1	1.1	4.7	9.5	11.2	9.6	37.1	18.7	16.4	33.5	12.8	11.5	101.2	50.1	171.9	1.0	0.8	17.6	13.7	49.1	28.1	37.6	30.6	2.4	43.5	221.3	1.7	88.6	58.0	3.1	28.5	1.3	41.6	55.6	15.3	15.8	35.3	151.1	1.9	6.1	2.7	3.7	28.6	3.7	1.3	1.8	15.9	0.7	25.9	2.1	96.5	15.5	1.9	0.7	39.9	0.6	7.6	0.0	14.0	21.7	39.4	0.0	12.4	23.6	15.6	27.8	9.5	4.0	76.5	2.0	28.0	2.2	4.4
MYH8	"MyHC-peri, MyHC-pn"	ENSG00000133020	"Myosin heavy chain 8"	P13535	17	10390322-10421950	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"esophagus: 15.9;lymphoid tissue: 10.7;skeletal muscle: 16.7;tongue: 10.0"	"Group enriched"	"Detected in some"	8	"Proximal tubular cells: 84.8;Skeletal myocytes: 52.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"HSkMC: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001349, CAB016527"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		53000000		"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Focal adhesion sites"		"CAB016527: AB_2147291, HPA001349: AB_1079437"	"unprognostic (5.87e-2)"					"unprognostic (5.13e-3)"		"unprognostic (4.12e-2)"	"unprognostic (1.25e-2)"		"unprognostic (2.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.02e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.61e-1)"		"unprognostic (3.56e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	16.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	10.7	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	0.0	0.0	52.0	0.1	0.5	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 1700.3;smooth muscle: 2137.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		1500000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	143.6	57.4	37.6	188.7	64.8	3.3	163.4	72.1	42.4	281.3	14.1	551.5	110.9	669.2	232.9	420.6	289.8	250.4	33.6	33.6	46.7	64.4	67.2	85.2	33.6	104.6	64.8	95.9	15.3	11.6	2.6	70.2	99.3	907.6	299.1	13.6	140.1	1700.3	10.0	20.1	125.1	2137.7	55.6	89.5	122.7	50.5	52.2	8.0	22.2	14.9	19.1	505.7	84.8	112.1	14.4	38.4	10.8	7.8	10.8	1.9	4.7	200.0	298.2	137.3	92.1	8.1	7.4	0.6	42.5	260.2	67.0	4.8	5.2	1.8	149.0	0.2	0.7	102.4	0.9	28.9	56.1	0.6	9.8	36.9	3.5	24.4	34.4	202.7	8.9	1.3	1.2	0.5	90.9	1.7	0.2	2.5	12.0	0.5	5.1	13.5	6.8	36.7	291.9	8.5	1.4	6.4	21.8	1.9	3.1	25.0	1.0	0.3	33.4	39.5	13.9	10.3	30.7	3.4	4.2	0.3	104.0	1.0	9.6	7.4	1.6	0.4	0.1	0.2	0.0	0.2	0.0	0.0	3.5	0.1	0.2	0.1	5.0	0.0	0.0	3.3	0.2	20.9	37.6	64.8	72.1	42.4	33.6	46.7	104.6	64.8	99.3	55.6	52.2	112.1	45.9	16.0	38.3	43.4	2.5	20.5	27.2	24.8	1.2	2.9	19.9	728.5	25.2	37.1	5.7	27.6	125.1	0.8	3.5	88.1	3.9	6.0	40.7	45.9	46.6	56.9	11.4	3.2	25.2	3.9	0.8	40.1	3.1	54.4	2.5	3.2	45.3	208.7	4.9	3.3	3.4	3.9	8.2	7.9	37.0	33.8	104.7	20.8	19.6	8.4	1.2	4.7	0.0	5.5	37.0	4.0	18.7	690.5	3.3	8.6	14.2	17.2	17.6	19.9	276.1	5.6	448.7	4.7	4.6	1.3	20.2	2.5	3.2	4.5	4.2	3.7
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46702282-46790407	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 103.4;skeletal muscle: 46.5;tongue: 72.6"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 169.0;Endometrial ciliated cells: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.9;HEL: 40.2;K-562: 6.5;SK-BR-3: 7.9"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.6;hippocampal formation: 5.1"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 3.5"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	1.9	0.1	1.7	0.3	0.1	1.1	2.3	0.4	1.7	0.0	0.1	0.3	0.8	4.3	1.7	0.2	103.4	2.5	2.8	1.1	0.1	0.4	0.2	9.8	12.2	0.3	0.1	0.0	0.4	0.5	8.2	2.2	0.1	0.2	2.1	0.1	46.5	0.1	0.1	0.2	5.9	0.1	0.1	6.0	1.9	0.1	0.1	72.6	0.1	0.0	0.0	3.0	0.0	0.1	0.1	0.1	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	2.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	6.5	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	7.9	0.2	3.5	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	1.9	1.7	1.1	2.3	2.5	2.8	9.8	12.2	8.2	5.9	1.9	3.0	0.2	0.0	3.3	0.7	0.5	0.0	0.7	0.0	0.0	0.9	1.3	0.0	169.0	0.0	3.7	0.0	2.1	2.0	0.2	0.0	0.0	0.0	8.1	44.8	7.1	1.7	0.0	0.0	0.9	0.2	0.5	6.7	0.0	2.2	1.3	1.6	0.7	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	7.2	0.6	0.8	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.8	0.0	0.2	8.7	1.3	0.0	4.9	2.7	1.0	0.7	0.0	0.0	0.3	0.8	0.7	0.0	0.8
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750922	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 30.1;tongue: 72.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.8;Inhibitory neurons: 7.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 8.0;Proximal tubular cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	1.2	0.5	0.6	0.3	0.6	0.8	1.0	0.6	0.9	0.6	0.7	0.4	0.3	0.6	0.7	1.3	0.5	0.4	1.4	0.7	0.7	3.0	0.5	1.2	0.4	0.4	0.5	0.4	0.9	0.9	1.3	0.6	0.4	0.7	0.3	0.8	2.4	0.6	30.1	1.4	0.6	0.3	0.4	0.6	0.6	0.4	0.6	0.3	0.8	72.1	0.7	0.6	0.8	0.6	0.1	0.1	0.3	0.6	0.5	0.6	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.6	0.9	0.4	0.1	1.0	0.1	0.2	0.3	0.1	0.3	7.2	0.4	0.0	0.2	0.2	0.3	0.8	0.3	0.0	0.6	0.3	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.4	0.1	0.5	0.3	0.1	0.1	0.3	0.5	0.2	0.5	0.4	0.2	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.9	0.7	0.7	0.4	0.5	0.4	0.4	0.6	0.6	0.5	3.2	1.1	1.6	0.5	0.1	0.1	0.5	0.6	1.0	0.6	0.3	1.9	1.5	1.0	0.0	0.0	0.3	0.1	0.2	0.0	0.3	0.4	0.1	0.7	0.6	1.2	0.0	7.8	0.2	0.0	0.5	0.0	0.2	0.0	0.6	1.1	0.2	0.3	1.7	7.2	0.0	0.0	0.8	1.2	0.2	0.3	0.4	0.0	4.7	1.1	0.3	0.0	8.0	2.9	0.0	0.0	1.5	0.0	0.2	0.1	4.5	0.3	0.3	0.0	0.8	0.3	0.0	0.3	0.3	0.9	0.3	0.2	0.4	0.3	0.2
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979088	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.6;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 81.3;Langerhans cells: 65.1;Macrophages: 74.2;monocytes: 392.2;NK-cells: 252.4;T-cells: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.6;HEL: 64.1;HL-60: 39.9;JURKAT: 85.9;MOLT-4: 97.3;NB-4: 52.1;THP-1: 68.6;U-937: 57.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.2	0.8	0.4	16.6	0.3	43.6	1.0	0.3	0.6	0.8	0.3	2.0	3.3	0.7	0.3	1.5	1.2	3.5	0.9	0.3	1.0	0.9	1.3	12.0	25.1	1.4	0.7	0.3	0.7	0.1	0.5	1.2	0.6	1.1	1.8	0.0	2.3	0.7	0.3	0.9	7.8	2.8	0.6	19.0	3.3	0.4	1.6	27.2	1.6	0.4	14.8	6.1	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	52.6	0.0	64.1	2.7	0.0	0.0	39.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	85.9	0.0	0.0	0.0	0.0	97.3	52.1	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	57.3	0.0	41.5	58.3	18.5	61.5	95.5	38.4	27.7	40.5	55.6	42.7	18.9	14.1	29.6	6.0	23.9	129.8	4.5	79.9	79.9	0.4	0.3	0.3	0.6	0.3	1.0	1.4	0.7	0.6	0.6	1.6	0.8	0.9	3.2	7.7	0.0	55.7	2.8	0.4	0.0	0.0	0.2	1.2	1.3	1.1	1.5	1.3	0.0	0.0	0.2	81.3	0.2	0.0	0.3	0.6	0.3	0.5	1.0	0.0	6.3	0.1	1.1	0.3	2.3	2.0	0.6	30.4	0.4	2.2	1.4	10.5	3.3	0.0	0.2	0.0	58.7	65.1	1.6	0.0	74.2	3.6	0.0	392.2	0.3	252.4	0.5	0.0	0.2	0.1	0.4	33.4	0.4	0.0	0.6	0.7	0.2	6.6	2.0	1.4	3.8	1.2	0.2	1.7	0.1	87.1	1.2	0.1	0.2
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 14.1;kidney: 5.3;parathyroid gland: 8.8;retina: 5.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 85.5;Early spermatids: 34.2;Inhibitory neurons: 18.3;Late spermatids: 29.6;Rod photoreceptor cells: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HDLM-2: 11.2;HEL: 8.8;RT4: 11.7"	"Region enriched"	"Detected in some"	5	"basal ganglia: 5.2"	"Not detected"	"Not detected"			HPA045483	Approved					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	14.1	0.4	0.6	0.1	0.0	0.0	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.3	0.0	0.0	0.0	0.0	5.8	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.4	1.3	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	11.2	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.1	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.3	0.6	0.5	0.3	0.0	3.1	0.2	0.3	0.7	0.0	0.5	3.7	85.5	0.0	0.6	0.1	13.7	0.3	34.2	5.3	0.4	0.3	1.8	0.0	1.8	0.0	0.0	0.8	0.0	1.7	0.0	0.1	0.0	0.2	0.0	0.0	18.3	0.6	0.0	0.3	1.1	29.6	0.3	0.2	0.0	1.9	0.0	3.0	0.0	5.5	2.9	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.2	51.0	0.0	1.7	0.5	1.5	0.8	0.3	0.4	0.1	0.3	0.3	0.0	0.1
MYO7A	"DFNA11, DFNB2, NSRD2, USH1B"	ENSG00000137474	"Myosin VIIA"	Q13402	11	77128246-77215241	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 41.9;choroid plexus: 53.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.9;Cytotrophoblasts: 42.3;Hofbauer cells: 30.1;Kupffer cells: 17.8;Rod photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.6;intermediate monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.8;CACO-2: 9.0;RH-30: 19.5;RPMI-8226: 13.8;SK-BR-3: 10.5;U-937: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB034059	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB034059: AB_2148626"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.03e-2)"	5.2	41.9	2.5	3.0	2.9	1.0	3.1	2.2	2.7	1.9	53.2	2.8	2.2	1.5	1.2	1.0	2.7	2.8	2.5	4.0	8.6	4.3	23.3	2.3	2.9	5.0	8.3	5.2	5.4	0.5	19.1	16.0	8.4	2.4	1.2	27.4	1.5	0.8	1.4	0.8	2.8	2.2	3.5	15.8	2.2	24.5	5.1	1.4	2.0	0.7	1.1	2.0	1.6	4.4	0.0	1.3	0.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	9.0	2.0	0.0	2.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.3	5.7	0.2	0.4	0.0	0.1	0.0	0.0	0.5	0.0	3.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.3	0.0	19.5	13.8	0.0	0.3	2.9	0.9	0.1	10.5	0.1	2.2	1.3	1.3	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	2.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	2.5	2.9	2.2	2.7	4.0	8.6	5.0	8.3	8.4	3.5	5.1	4.4	1.7	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	14.2	0.5	0.5	4.4	4.3	0.0	0.0	47.9	42.3	0.3	0.2	0.0	0.6	1.9	0.1	0.5	2.2	1.2	0.0	0.7	1.7	10.5	1.4	5.6	0.3	0.0	0.8	16.4	16.1	30.1	0.0	0.8	0.7	0.0	17.8	0.9	6.4	3.1	7.3	0.0	6.5	0.8	17.0	0.0	3.0	0.1	0.7	0.2	0.4	0.1	0.1	1.7	2.7	0.1	31.4	0.0	5.2	0.3	0.4	0.6	0.1	0.3	16.1	1.4	3.2	0.6	0.2
MYO7B		ENSG00000169994	"Myosin VIIB"	Q6PIF6	2	127535802-127637729	"Predicted intracellular proteins"	Differentiation	"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 113.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 127.7;Intestinal goblet cells: 48.3;Paneth cells: 74.9;Proximal enterocytes: 151.4;Undifferentiated cells: 45.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 17.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.7;naive B-cell: 5.9"	"Group enriched"	"Detected in many"	22	"B-cells: 5.9;dendritic cells: 2.6;monocytes: 5.7"	"Cell line enriched"	"Detected in some"	10	"MOLT-4: 286.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039131	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA039131: AB_10672771"	"unprognostic (4.10e-3)"	"unprognostic (3.81e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.80e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.88e-1)"	0.1	0.0	0.2	4.9	0.2	6.5	0.1	0.2	0.3	0.0	0.0	35.9	113.2	0.0	6.7	0.3	0.4	13.0	0.2	0.7	1.8	8.5	0.3	1.0	4.0	0.5	1.1	0.0	0.2	0.0	0.0	1.7	1.1	0.1	25.3	0.0	0.1	0.2	0.8	0.3	84.4	1.2	0.5	11.3	0.4	1.4	0.3	9.0	0.2	0.0	1.6	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	14.5	5.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.2	0.0	28.1	0.0	0.0	0.2	0.0	286.1	0.8	0.0	0.5	1.7	0.5	1.9	0.3	0.5	0.0	0.1	0.1	0.0	2.4	0.0	0.0	0.1	0.5	0.1	0.6	8.6	0.4	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.7	0.1	0.0	2.2	0.0	0.8	0.0	0.0	2.6	5.9	0.0	0.2	0.1	0.0	1.4	0.7	0.0	2.4	0.2	0.2	0.2	0.3	0.7	1.8	0.5	1.1	1.1	0.5	0.3	0.8	2.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	12.8	0.0	5.5	0.0	0.1	1.5	127.7	1.9	0.2	0.1	0.0	0.0	1.0	25.8	0.0	0.2	0.2	2.0	0.1	1.5	0.0	0.0	0.1	2.9	0.2	0.1	0.0	0.4	48.3	0.0	0.0	0.3	0.4	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	1.6	74.9	0.0	0.0	0.0	151.4	9.9	0.0	0.0	0.0	2.8	0.1	0.6	1.1	0.0	0.1	0.3	0.6	0.0	45.7	0.1
MYOM3	FLJ35961	ENSG00000142661	"Myomesin 3"	Q5VTT5	1	24056035-24112135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 222.5;skeletal muscle: 321.5;tongue: 255.9"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 198.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 4.6;Hep G2: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028132, HPA028340"			Approved	"Golgi apparatus,Vesicles,Cytokinetic bridge"		Yes	No		830000		"Cluster 38: Heart - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles	"Golgi apparatus, Cytokinetic bridge"	"HPA028132: AB_10599293, HPA028340: "	"unprognostic (8.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.66e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.73e-4)"	"unprognostic (2.09e-1)"	"prognostic favorable (4.28e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.68e-1)"	0.4	0.2	0.0	0.2	0.0	0.0	0.7	0.3	0.1	0.2	0.0	0.6	1.1	0.3	0.0	6.0	0.9	0.4	222.5	0.1	0.1	31.4	0.2	0.3	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.1	4.5	0.7	1.2	7.1	0.0	321.5	2.2	5.2	0.2	0.0	0.0	0.2	9.0	0.0	1.7	0.3	255.9	0.1	0.1	0.4	0.2	0.1	4.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.3	0.0	1.9	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.8	18.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.2	0.1	1.0	0.2	0.5	0.6	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.0	0.6	0.2	0.1	0.6	0.0	0.1	0.6	198.3	0.0	0.0	3.7	0.0	0.0	0.1	3.6	1.9	0.1	16.2	0.4	0.0	1.6	1.2	0.0	0.4	0.4	0.0	6.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.7	10.3	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.5	2.4	0.0	0.0	0.2	13.0	33.2	0.0	2.5	6.6	10.0	1.3	0.0	0.2	0.0	0.6	0.0	0.3	2.3	2.2	0.3
MYORG	"KIAA1161, NET37"	ENSG00000164976	"Myogenesis regulating glycosidase (putative)"	Q6NSJ0	9	34366666-34376898	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 55.5;Exocrine glandular cells: 11.8;Pancreatic endocrine cells: 10.3;Proximal tubular cells: 9.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 35.4;SK-BR-3: 56.8;T-47d: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060533, HPA067487"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA060533: AB_2684311, HPA067487: AB_2685848"	"unprognostic (6.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (2.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.20e-1)"	"prognostic favorable (1.20e-13)"	"unprognostic (4.08e-3)"	"unprognostic (3.68e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.00e-3)"	8.1	6.2	30.6	3.4	30.3	2.0	3.4	27.1	31.5	1.7	16.8	19.0	27.3	2.7	1.9	5.3	4.5	6.1	3.9	28.4	28.2	14.5	41.5	3.2	1.5	34.0	33.5	1.0	11.1	1.5	5.5	19.8	28.7	3.2	16.2	3.4	5.6	5.2	84.2	3.7	25.8	4.4	24.5	1.4	15.0	1.3	31.8	1.1	1.9	39.2	1.8	3.1	2.4	24.2	8.1	5.5	9.2	5.6	3.8	1.2	19.7	1.4	1.1	0.8	1.3	13.9	8.3	4.4	15.9	1.4	4.0	16.4	6.7	15.5	1.1	1.4	3.6	0.8	24.6	35.4	0.5	0.8	2.7	1.8	7.2	2.6	3.0	4.3	3.8	3.3	1.1	4.2	2.0	13.4	2.5	1.2	5.5	27.4	4.4	4.0	4.6	1.3	4.9	2.9	1.3	13.0	10.8	56.8	0.9	7.8	52.8	1.3	3.2	1.8	11.0	1.6	3.5	2.8	6.5	1.6	1.6	3.1	1.6	0.4	0.1	0.2	0.7	0.1	0.5	0.2	0.4	0.4	0.0	0.2	0.2	0.3	0.3	0.4	0.1	0.1	0.6	0.1	30.6	30.3	27.1	31.5	28.4	28.2	34.0	33.5	28.7	24.5	31.8	24.2	3.9	9.6	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	0.0	2.5	3.7	0.0	55.5	0.3	0.0	1.9	5.7	0.0	3.4	0.7	2.1	0.0	0.0	0.0	11.8	3.6	1.1	0.0	2.0	1.3	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	9.2	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	17.4	0.3	0.1	0.0	0.0
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387467-139390081	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.8;lymphoid tissue: 272.2"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 4000.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 160.4;plasmacytoid DC: 569.3"	"Group enriched"	"Detected in many"	116	"B-cells: 160.4;dendritic cells: 569.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 581.5;RPMI-8226: 2193.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		350000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favorable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	4.4	9.1	0.0	87.4	0.1	33.0	21.0	0.0	0.7	18.3	0.2	70.1	89.8	1.8	0.4	10.1	5.7	14.3	2.3	0.0	0.0	5.9	5.8	15.9	123.2	0.1	0.0	4.9	1.3	0.0	0.7	0.0	0.1	5.1	39.9	0.0	56.7	4.9	0.1	0.4	47.8	2.1	0.4	272.2	66.6	2.4	0.1	147.3	9.1	0.0	117.8	58.7	3.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	256.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	144.6	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	128.5	0.5	581.5	0.0	0.0	227.8	2.2	0.0	0.0	0.0	90.1	0.3	2193.9	0.0	0.0	0.3	0.8	0.0	11.4	0.0	0.0	3.1	0.1	0.6	0.0	1.8	0.1	0.0	262.0	16.7	223.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.1	3.0	160.4	0.6	1.1	0.5	75.6	0.1	0.2	3.1	2.7	0.0	569.3	0.2	26.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.3	0.4	6.4	10.1	0.0	665.7	2.5	1.3	0.1	0.0	0.0	3.7	3.2	1.1	4.3	2.0	0.0	0.0	0.1	235.0	0.9	0.0	0.1	0.1	1.8	0.4	2.0	1.2	49.3	0.0	0.0	0.1	2.0	6.1	0.4	2.5	0.1	11.4	14.0	0.1	0.0	0.0	1.1	0.0	7.1	3.4	1.1	0.0	4.7	540.7	0.0	1.0	0.0	4.1	0.0	0.0	0.1	0.4	0.0	4000.1	3.0	1.2	1.9	1.2	0.0	0.0	1.7	2.1	0.1	0.1	0.4	2.4	2.2	100.7	0.5	9.7	0.4
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lung: 1075.5"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 3072.3"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 8.7"	"Group enriched"	"Detected in many"	7	"B-cells: 4.3;dendritic cells: 8.7"	"Cell line enriched"	"Detected in some"	31	"U-698: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"	NA	NA		1500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 19: Lung - Lung function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favorable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.4	0.9	0.8	1.6	0.9	0.1	0.5	0.9	0.9	0.7	0.7	0.6	0.4	0.5	2.0	0.4	1.0	0.1	0.4	0.8	0.9	106.3	1.2	1075.5	1.2	0.9	0.8	2.1	1.0	0.2	0.6	0.4	0.9	1.0	0.4	0.4	0.6	1.0	0.2	1.1	1.5	0.1	0.8	1.1	0.9	1.8	1.0	0.4	1.7	0.0	0.5	0.4	0.7	1.1	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.4	1.3	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.7	0.2	0.5	0.2	0.3	0.4	0.6	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	1.0	0.0	0.2	0.4	42.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	4.3	0.2	0.3	2.6	1.7	0.4	0.4	0.5	0.4	0.7	8.7	0.0	1.1	0.8	0.9	0.9	0.9	0.8	0.9	0.9	0.8	0.9	0.8	1.0	1.1	0.3	522.4	3072.3	0.3	3.8	0.1	0.5	0.2	0.0	1.3	0.8	0.9	0.4	1.5	45.9	46.0	4.2	0.5	0.4	0.8	9.8	0.6	47.2	12.6	0.4	6.2	0.0	0.4	0.5	0.8	0.3	5.8	0.5	1.5	69.4	1.0	0.4	0.4	0.3	0.0	0.5	1.0	0.0	1.6	5.3	9.1	0.9	7.9	0.0	1.9	0.2	1.5	1.0	0.0	1.4	0.1	2.3	0.4	0.6	0.4	2.0	276.1	16.4	0.9	0.0	0.3	0.3	1.4	1.4	0.0	0.6	0.1	12.9	0.4	0.9	0.1
NAT8	"ATase2, GLA, Hcml1, TSC501"	ENSG00000144035	"N-acetyltransferase 8 (putative)"	Q9UHE5	2	73640723-73642422	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 732.4"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 2565.5"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 242.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"Hep G2: 10.7"					"Low region specificity"	"Detected in all"			"HPA067855, HPA074519"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"HPA067855: AB_2732774, HPA074519: AB_2686699"	"unprognostic (4.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.36e-5)"	0.1	0.3	1.1	0.1	0.5	0.1	0.2	0.1	0.7	0.2	0.0	1.1	4.6	0.1	0.0	0.0	1.2	0.6	0.1	0.8	0.8	732.4	82.7	0.2	0.0	0.6	0.3	1.3	0.2	0.0	0.6	0.0	0.1	0.2	0.1	1.8	0.1	0.1	0.0	0.0	7.2	0.1	0.4	1.1	0.6	0.5	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.1	0.7	0.8	0.8	0.6	0.3	0.1	0.4	1.0	0.8	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	36.8	0.0	0.0	0.0	0.3	187.9	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	22.9	51.1	0.0	0.0	0.0	1.1	0.0	1.0	0.4	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	61.3	2565.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.6	0.1
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.5;brain: 99.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.5	0.7	56.1	0.1	46.4	0.0	1.6	42.9	99.0	0.0	0.6	0.2	0.1	0.3	1.3	0.1	0.9	0.1	0.8	45.8	29.0	5.3	0.0	0.0	0.2	52.3	46.4	0.2	2.3	0.9	1.8	0.1	57.5	1.0	0.1	3.7	2.3	1.6	5.7	1.0	0.2	0.2	33.0	0.3	0.4	9.0	88.8	0.2	0.3	2.5	0.0	0.0	0.0	38.9	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	56.1	46.4	42.9	99.0	45.8	29.0	52.3	46.4	57.5	33.0	88.8	38.9	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
NAV1	"DKFZp781D0314, FLJ12560, FLJ14203, KIAA1151, MGC14961, POMFIL3, steerin-1"	ENSG00000134369	"Neuron navigator 1"	Q8NEY1	1	201622885-201826969	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 169.1;Inhibitory neurons: 161.7;Oligodendrocyte precursor cells: 713.8;Oligodendrocytes: 224.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.4;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.1;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"TIME: 187.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012302, HPA018127, HPA027887"	Enhanced		Approved	Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Microtubules		"CAB012302: AB_776716, HPA018127: AB_1854317, HPA027887: AB_10601040"	"unprognostic (2.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (9.10e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.68e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (3.45e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	19.6	2.7	17.4	8.2	18.3	1.6	15.2	8.0	17.7	11.7	0.0	12.3	3.7	10.1	4.3	8.6	7.2	7.5	26.6	17.5	20.3	4.6	1.9	11.1	4.1	24.6	17.9	3.7	4.4	5.2	5.2	11.8	15.1	7.5	5.4	5.4	7.8	6.7	4.8	7.7	6.2	10.3	9.9	3.6	5.3	4.4	21.8	2.8	9.4	6.7	3.7	14.9	12.6	32.5	1.6	2.9	29.0	3.8	84.3	69.5	51.7	44.6	43.0	35.5	30.9	0.0	15.7	0.6	0.7	61.4	19.4	21.5	22.0	14.9	28.4	2.5	3.2	1.4	5.6	0.0	22.5	0.2	19.1	30.6	5.4	62.4	36.0	94.9	80.7	1.8	0.8	2.6	29.8	0.4	0.0	0.1	42.4	0.7	1.7	3.9	65.0	9.3	4.8	4.3	21.9	4.5	11.1	47.6	14.5	19.2	0.4	1.2	187.8	54.5	11.1	54.7	39.4	8.1	2.3	0.2	59.2	5.9	47.5	3.4	0.5	0.1	0.2	0.3	0.1	0.3	0.2	0.0	2.1	0.3	0.2	0.1	0.0	0.1	0.3	0.5	0.0	0.3	17.4	18.3	8.0	17.7	17.5	20.3	24.6	17.9	15.1	9.9	21.8	32.5	77.4	3.2	1.5	169.1	3.1	11.0	2.2	5.9	8.0	34.6	4.8	4.3	29.2	1.5	4.8	12.9	0.0	14.9	0.9	4.7	0.0	13.0	3.6	1.6	6.4	39.3	52.8	1.7	98.2	8.3	54.1	45.8	8.2	4.4	17.7	54.5	21.0	0.7	14.5	25.2	161.7	3.4	6.1	18.3	15.8	3.8	10.8	15.1	23.2	69.3	60.6	11.8	1.0	713.8	224.6	21.7	4.2	0.7	4.9	2.3	0.9	0.6	3.5	4.0	6.6	119.3	18.8	0.6	2.6	16.9	7.0	15.7	2.0	6.6	5.0	3.2
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 290.1;heart muscle: 145.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 530.8;Excitatory neurons: 461.4;Inhibitory neurons: 441.2;Oligodendrocyte precursor cells: 939.0;Oligodendrocytes: 1013.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"NK-cell: 53.7"	"Lineage enriched"	"Detected in many"	15	"NK-cells: 53.7"	"Cell line enhanced"	"Detected in many"		"HEL: 61.3;RH-30: 132.5;SCLC-21H: 107.4;SH-SY5Y: 52.7;U-138 MG: 72.8;WM-115: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA	1200000	2300000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	4.6	65.7	124.0	3.9	169.1	1.5	2.7	118.1	140.3	35.1	0.0	47.8	4.6	62.7	3.5	7.0	40.4	4.8	145.5	135.6	179.1	3.2	2.9	1.8	1.3	140.4	134.2	43.8	2.6	0.0	22.2	0.5	147.4	14.9	6.6	117.7	3.6	17.7	31.2	2.1	18.3	46.9	129.7	4.7	23.0	5.0	137.0	0.4	30.2	29.5	1.0	34.8	24.3	290.1	0.1	0.0	20.8	0.3	0.2	0.5	0.3	1.0	0.0	0.7	1.2	0.3	0.3	3.1	18.2	20.1	0.8	0.3	0.1	0.0	0.0	0.4	12.1	61.3	0.1	0.0	2.1	0.0	9.5	12.4	0.1	0.1	18.6	0.1	0.0	0.1	0.0	1.0	20.8	0.0	0.2	5.2	1.8	0.0	0.4	0.1	132.5	10.0	0.0	0.0	107.4	52.7	0.1	0.5	0.1	2.0	0.2	0.8	0.2	72.8	33.4	0.3	31.8	0.1	0.5	0.1	8.3	28.4	79.0	0.0	0.2	0.0	3.6	0.0	1.2	0.0	0.1	0.5	0.1	0.0	0.0	1.4	0.7	53.7	0.0	0.0	0.2	1.9	124.0	169.1	118.1	140.3	135.6	179.1	140.4	134.2	147.4	129.7	137.0	290.1	13.7	0.0	0.0	530.8	0.4	1.7	0.5	0.0	0.0	123.5	5.7	0.6	131.7	0.0	0.0	0.0	37.5	0.6	27.7	0.1	1.9	18.3	6.7	0.3	2.4	2.8	5.4	0.0	461.4	0.0	0.2	12.8	5.1	0.5	1.3	11.7	7.1	0.7	0.4	175.0	441.2	0.0	8.2	4.7	3.8	5.9	15.2	1.8	0.0	35.6	1.2	216.6	59.8	939.0	1013.5	1.3	0.0	10.1	5.6	0.4	0.0	0.2	0.7	98.0	0.0	107.5	4.8	1.0	2.8	0.4	1.7	0.1	13.4	5.6	0.0	0.2
NCCRP1	"FBXO50, LOC342897, NCCRP-1"	ENSG00000188505	"NCCRP1, F-box associated domain containing"	Q6ZVX7	19	39196964-39201884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 453.4;skin 1: 273.2;vagina: 181.7"	"Cell type enriched"	"Detected in some"	12	"monocytes: 563.9"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.8;head and neck cancer: 48.5;melanoma: 28.3;urothelial cancer: 33.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 30.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.6"	"Low region specificity"	"Detected in some"			HPA052812	Approved					NA	NA		400000	"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"HPA052812: AB_2681960"	"unprognostic (3.56e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (4.59e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.37e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	0.3	0.2	1.3	2.1	0.9	1.0	6.3	1.9	1.8	97.0	0.0	0.4	2.0	0.6	0.8	453.4	1.1	0.8	0.4	1.0	0.8	2.8	0.2	0.4	2.7	1.0	0.9	0.4	8.8	1.4	0.4	1.1	1.3	1.4	1.9	1.7	54.0	1.2	0.9	273.2	0.7	0.5	0.9	1.4	0.5	0.5	1.0	4.1	0.6	0.0	124.9	5.2	181.7	1.4	0.2	0.2	1.1	0.2	0.1	0.7	2.4	0.1	0.0	0.1	0.2	0.5	0.5	0.7	2.3	0.4	0.2	1.0	1.7	0.7	0.5	0.0	0.4	0.2	0.9	0.1	0.2	0.5	0.3	0.5	0.5	0.1	0.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.2	0.2	0.7	0.2	0.2	0.2	0.4	0.4	0.1	0.6	0.6	1.0	2.9	30.8	0.2	0.9	0.4	0.9	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.6	0.6	0.2	0.5	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	1.3	0.9	1.9	1.8	1.0	0.8	1.0	0.9	1.3	0.9	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	1.6	8.5	0.0	0.3	4.7	2.4	0.3	0.0	30.8	3.7	0.0	0.4	0.2	0.1	0.0	2.7	0.0	0.7	0.4	0.2	0.0	0.0	0.0	2.3	3.1	1.0	0.0	2.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	6.1	0.0	4.7	0.2	0.0	0.7	1.8	0.0	563.9	0.3	0.0	0.0	0.0	4.2	0.7	0.0	1.2	1.1	0.0	0.1	1.6	0.0	0.0	0.1	2.0	0.1	0.5	7.3	7.1	11.1	0.2	0.1	0.0	46.4
NCF1	"NCF1A, NOXO2, p47phox, SH3PXD1A"	ENSG00000158517	"Neutrophil cytosolic factor 1"	P14598	7	74773962-74789376	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.4;lymphoid tissue: 97.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 293.0;dendritic cells: 157.3;Kupffer cells: 119.9;Macrophages: 153.4;monocytes: 329.9;Plasma cells: 205.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1165.0;classical monocyte: 673.5;eosinophil: 1467.3;neutrophil: 2128.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 2128.0;monocytes: 673.5"	"Group enriched"	"Detected in some"	5	"Daudi: 96.2;HMC-1: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004524, HPA047836, HPA052095"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721"	"unprognostic (4.93e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.55e-3)"	"unprognostic (7.60e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.23e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-1)"	7.5	3.8	1.9	38.7	2.2	86.4	2.7	4.6	2.9	1.7	0.9	7.2	7.6	1.3	0.5	3.3	3.2	5.5	3.0	2.8	2.0	2.9	5.0	17.7	56.8	5.0	3.4	1.1	1.5	0.7	1.2	5.0	4.5	2.1	4.5	1.6	4.2	1.4	1.5	1.8	26.6	4.0	2.4	97.5	6.6	0.8	2.3	7.5	2.6	4.8	37.5	7.6	1.8	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	96.2	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.6	2.9	1.4	0.9	0.0	0.8	130.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.0	0.1	16.8	0.3	0.0	0.0	1.6	0.0	3.4	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	20.6	0.2	0.1	0.3	0.2	0.0	0.6	0.3	16.5	0.2	8.1	0.2	1165.0	673.5	1467.3	4.2	242.3	9.8	257.0	10.0	6.7	77.7	276.6	15.4	9.4	2128.0	10.7	60.2	280.9	11.1	514.1	1.9	2.2	4.6	2.9	2.8	2.0	5.0	3.4	4.5	2.4	2.3	6.6	5.0	0.0	2.8	0.0	293.0	3.1	1.1	29.6	5.2	0.2	3.1	3.2	0.6	4.3	10.9	3.7	0.0	0.6	157.3	0.0	0.0	1.3	8.7	0.8	1.0	3.6	0.0	6.1	0.0	0.6	12.2	1.5	10.2	2.5	14.5	0.1	3.9	3.6	39.3	3.3	0.1	0.3	2.0	119.9	23.4	6.4	0.0	153.4	10.6	1.0	329.9	0.3	10.3	0.0	0.1	1.2	4.2	0.4	205.7	1.0	0.4	1.9	17.6	0.5	0.0	1.4	1.5	0.2	0.7	5.0	1.7	4.5	63.6	0.1	0.3	2.2
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671788-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 34.8;lung: 11.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 262.8;Astrocytes: 478.6;Oligodendrocyte precursor cells: 774.6;Oligodendrocytes: 2156.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: AB_2679114"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	1.9	1.0	9.6	0.5	31.3	0.0	3.0	18.6	12.3	1.2	2.5	1.2	2.2	0.4	0.6	4.0	0.4	0.7	2.6	9.5	14.5	4.1	3.9	11.4	1.3	23.4	28.6	2.4	0.9	0.6	0.6	2.6	22.9	0.8	1.0	4.7	2.1	0.3	0.5	2.1	3.2	0.4	10.1	1.7	1.7	1.1	28.6	0.8	1.1	0.6	1.0	0.5	2.0	34.8	0.0	2.2	46.2	0.0	0.1	0.4	0.2	0.7	8.3	0.7	0.8	0.0	0.1	3.6	0.0	0.5	0.5	0.2	0.3	0.7	2.5	0.0	0.3	0.0	7.1	0.0	0.0	0.0	0.0	0.5	3.8	4.4	0.6	7.2	0.8	0.0	0.0	0.0	1.3	0.5	0.0	0.0	1.1	0.3	1.4	0.4	0.0	1.9	1.1	1.1	0.2	1.4	0.0	1.7	2.4	0.4	0.7	0.0	2.4	0.3	0.4	6.7	0.1	0.2	0.0	1.3	0.4	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	31.3	18.6	12.3	9.5	14.5	23.4	28.6	22.9	10.1	28.6	34.8	6.0	262.8	13.3	478.6	0.6	8.9	0.7	1.4	15.4	179.6	14.5	10.8	16.8	0.0	28.6	1.8	41.7	0.1	0.1	5.3	3.9	0.3	6.8	1.1	1.1	2.9	3.6	0.0	16.4	0.2	0.2	6.8	7.7	1.4	1.3	0.0	0.7	6.3	0.6	33.7	41.3	5.4	10.2	7.9	32.2	3.3	26.4	6.2	1.8	147.1	4.1	56.9	0.0	774.6	2156.8	1.0	5.2	7.5	0.0	0.5	20.7	14.0	1.2	7.8	6.6	8.7	24.7	0.1	1.3	15.5	2.8	0.0	0.7	0.0	1.6	1.5
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687305	"Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 236.4;Peritubular cells: 207.6;Theca cells: 121.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 55.0;ASC diff: 52.9;HSkMC: 71.3;NTERA-2: 44.0;SuSa: 57.4;U-2 OS: 80.4;U-266/70: 51.7;U-266/84: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA074457: AB_2686691"	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	46.8	49.4	43.3	11.1	40.5	1.2	35.1	26.0	39.7	70.5	30.4	35.9	11.1	63.7	24.0	16.8	47.2	23.8	34.6	36.7	89.6	13.0	4.5	19.6	10.9	36.0	41.3	69.8	11.8	8.7	56.3	32.6	46.2	27.3	10.7	20.8	12.7	39.3	14.7	11.9	20.8	33.5	36.7	19.1	20.3	18.5	69.6	6.8	17.4	22.4	6.6	31.4	40.4	32.3	0.1	0.0	55.0	0.0	52.9	20.1	0.1	35.4	0.0	0.8	9.6	0.0	0.0	0.0	0.1	10.6	8.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.3	0.0	31.8	71.3	0.0	10.2	0.0	0.0	0.0	21.7	1.2	0.0	18.0	0.0	27.6	0.1	44.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.1	0.4	0.0	0.4	0.0	57.4	9.4	0.0	0.0	2.6	80.4	0.0	0.1	51.7	51.7	0.0	5.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.0	0.0	43.3	40.5	26.0	39.7	36.7	89.6	36.0	41.3	46.2	36.7	69.6	32.3	24.1	25.6	11.0	6.8	0.3	13.0	13.8	0.3	27.9	66.0	2.3	19.8	36.8	15.7	1.4	12.9	20.9	1.9	2.9	18.5	23.5	17.9	2.5	1.4	60.8	18.7	6.7	4.2	7.8	10.7	1.4	103.1	4.1	1.1	0.0	83.9	38.9	0.2	7.3	50.5	21.8	4.3	0.0	7.6	13.3	8.6	236.4	2.8	39.2	9.4	0.7	88.7	0.0	9.5	16.4	4.5	2.6	207.6	0.0	6.9	8.1	1.1	4.1	51.0	98.6	91.4	94.0	28.5	21.8	13.4	8.2	2.5	1.4	121.8	7.1	4.1
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Disease related genes, Predicted secreted proteins"	Neurogenesis		"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 106.5;placenta: 60.1;retina: 57.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8;Bipolar cells: 69.8;Early spermatids: 217.1;Late spermatids: 221.7"	"Cancer enriched"	"Detected in many"	4	"lung cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 48.5;U-266/70: 20.8;U-266/84: 85.8"	"Group enriched"	"Detected in all"	4	"basal ganglia: 11.1;olfactory bulb: 34.0"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	4.8	2.6	1.1	0.9	1.7	0.0	3.2	4.7	1.2	14.2	9.3	6.5	2.9	6.0	4.3	7.7	20.4	9.4	5.2	1.8	2.6	27.1	0.4	106.5	0.3	8.8	12.9	42.5	0.5	0.7	5.3	60.1	15.2	16.7	8.3	57.4	2.2	4.4	4.3	1.7	4.7	3.5	7.6	0.3	4.1	10.4	3.7	2.4	1.3	14.0	0.2	9.0	1.9	5.4	0.2	0.0	10.6	0.0	13.9	11.3	0.2	0.2	0.5	0.2	0.5	1.6	0.0	0.0	0.0	48.5	0.8	0.0	0.0	0.0	1.1	0.9	1.7	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.6	0.0	0.0	0.0	14.3	1.0	0.0	0.2	0.1	0.9	7.4	2.1	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.6	0.2	0.0	0.0	11.5	0.0	0.2	0.5	20.8	85.8	0.0	3.9	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	4.7	1.2	1.8	2.6	8.8	12.9	15.2	7.6	3.7	5.4	10.9	246.8	48.3	1.6	0.0	1.1	0.0	0.0	0.0	69.8	0.2	0.1	1.6	8.6	28.6	12.9	18.8	0.3	0.0	5.3	0.0	0.0	217.1	0.9	4.7	11.7	1.8	0.0	0.0	0.2	0.0	14.9	0.0	0.1	2.5	0.1	2.9	0.0	0.1	1.7	8.0	0.8	0.0	0.0	0.8	221.7	3.4	0.4	5.4	6.5	0.0	12.2	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.0	12.5	20.0	0.0	1.2	3.6	6.4	5.0	0.3	0.9	0.5	0.3	13.0	1.2	0.1
NDRG2	"KIAA1248, SYLD"	ENSG00000165795	"NDRG family member 2"	Q9UN36	14	21016763-21070872	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1885.3;salivary gland: 2081.6;skeletal muscle: 1828.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 379.0;Distal tubular cells: 485.2;Muller glia cells: 548.0;Sertoli cells: 598.2"	"Cancer enhanced"	"Detected in all"		"glioma: 78.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"myeloid DC: 204.4"	"Lineage enriched"	"Detected in all"	11	"dendritic cells: 204.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 57.0;HMC-1: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002896, HPA003590, CAB017491"	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"CAB017491: AB_2298331, HPA002896: AB_1079459, HPA003590: AB_1079458"	"unprognostic (9.27e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.43e-12)"	"unprognostic (1.46e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.19e-2)"	192.0	400.6	1613.1	27.4	1885.3	2.8	321.6	1623.2	1666.4	395.4	1189.8	198.3	72.1	229.7	260.3	229.5	305.0	130.7	327.2	1551.7	1590.0	150.1	544.4	115.5	48.6	1690.6	1686.1	476.1	93.7	278.5	88.5	45.3	1581.9	171.3	111.0	134.1	2081.6	208.0	1828.7	220.3	125.4	127.7	1584.5	152.0	130.9	33.3	1752.7	40.1	99.9	1591.4	100.4	158.0	265.8	1597.9	10.9	2.3	6.8	12.6	1.1	0.0	1.0	0.2	4.5	3.9	2.2	15.1	20.0	0.6	4.0	0.3	6.2	17.6	30.3	6.3	5.4	0.1	10.9	14.3	2.2	57.0	1.3	1.3	39.0	11.8	13.1	0.9	1.9	6.3	0.0	12.6	29.0	1.2	0.6	9.4	5.0	4.0	17.9	35.2	0.8	14.6	0.7	3.7	7.6	27.4	0.1	19.4	3.0	3.3	14.4	17.3	26.6	8.2	0.0	1.2	20.8	0.4	0.4	6.1	4.8	0.3	1.8	0.3	4.7	0.0	6.5	0.7	8.3	1.5	11.4	6.4	12.6	11.9	204.4	4.4	18.7	14.0	1.4	3.0	0.1	7.0	9.4	15.3	1613.1	1885.3	1623.2	1666.4	1551.7	1590.0	1690.6	1686.1	1581.9	1584.5	1752.7	1597.9	98.0	0.0	11.9	379.0	6.7	28.7	83.7	86.4	12.0	6.3	240.7	201.2	180.2	151.5	110.9	40.5	10.4	11.5	9.1	81.4	485.2	104.9	6.3	33.3	11.0	53.9	33.5	8.4	1.1	21.7	0.7	62.3	18.8	40.2	48.8	79.0	164.2	214.9	20.7	3.3	3.9	77.4	57.0	30.8	137.6	14.4	348.6	30.4	321.9	47.8	8.7	548.0	1.0	42.7	71.0	16.3	37.9	166.3	1.2	68.5	18.5	41.3	70.8	15.5	598.2	167.7	162.8	1.7	5.5	21.6	30.4	21.6	11.9	66.8	118.9	155.9
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 4.8;liver: 1.3;lymphoid tissue: 2.9;retina: 2.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 299.6;Inhibitory neurons: 128.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"MOLT-4: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.0	0.5	1.2	0.0	4.8	0.0	0.0	3.3	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	1.0	0.1	1.3	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.4	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.8	3.3	2.8	1.5	1.0	0.6	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	20.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	299.6	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.6	0.1	6.7	128.6	0.2	0.0	42.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	12.1	18.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1
NECAB2	EFCBP2	ENSG00000103154	"N-terminal EF-hand calcium binding protein 2"	Q7Z6G3	16	83968244-84002776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 106.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Hepatocytes: 10.7;Inhibitory neurons: 22.2;Late spermatids: 49.2;Muller glia cells: 17.8;Proximal tubular cells: 27.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	66	"neutrophil: 55.4"	"Lineage enriched"	"Detected in single"	66	"granulocytes: 55.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.1;MCF7: 6.8;SCLC-21H: 37.6;U-87 MG: 12.2"	"Low region specificity"	"Detected in all"							"HPA013998, HPA014144, CAB068211"	Enhanced	Supported				NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017"	"unprognostic (5.27e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.48e-5)"	"unprognostic (3.45e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (8.89e-3)"	"unprognostic (3.48e-1)"	"unprognostic (8.61e-3)"	"unprognostic (3.75e-2)"	0.9	0.5	67.8	0.6	73.0	0.5	0.7	20.3	106.4	2.0	24.9	1.3	1.2	1.2	0.3	0.1	0.4	0.5	1.2	80.5	62.0	11.1	26.0	0.5	0.2	32.1	50.7	0.5	1.9	6.7	16.2	0.3	80.2	0.3	0.2	3.1	0.1	0.1	0.2	0.2	1.2	0.4	24.9	1.6	1.8	10.5	59.4	0.2	0.5	0.2	0.0	0.3	0.2	31.4	0.2	4.4	10.1	0.0	0.0	1.4	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.0	1.6	0.2	0.8	0.0	1.9	0.0	0.0	0.1	2.9	0.0	0.0	0.5	0.1	0.0	1.7	0.5	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.0	6.8	0.0	0.0	5.0	0.4	0.6	0.1	0.0	0.6	0.0	0.0	37.6	1.5	0.0	0.2	3.1	1.4	5.2	1.4	0.3	0.2	2.8	0.4	0.0	0.1	0.0	0.0	12.2	0.5	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.1	67.8	73.0	20.3	106.4	80.5	62.0	32.1	50.7	80.2	24.9	59.4	31.4	0.1	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	16.6	0.0	0.1	0.1	7.2	0.0	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	10.7	3.4	0.0	22.2	0.0	0.0	0.0	0.0	49.2	0.3	0.3	0.0	3.7	0.2	17.8	0.0	4.0	0.6	0.0	0.0	0.7	0.0	0.0	0.3	27.8	0.0	0.3	0.0	0.1	0.0	2.1	3.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395943-72282539	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 29.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 1968.8;Inhibitory neurons: 1254.4;Oligodendrocyte precursor cells: 726.3;Oligodendrocytes: 442.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.7;TIME: 28.5;U-2 OS: 22.9;U-251 MG: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"		NA	NA		380000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	16.5	5.8	12.8	3.6	15.9	1.2	5.9	4.4	15.7	7.1	0.0	17.5	2.7	5.2	4.1	10.5	7.2	10.7	11.2	15.1	9.1	6.8	0.3	5.5	1.6	1.9	5.6	6.0	4.5	0.7	3.9	2.9	2.7	7.3	7.8	29.8	2.4	5.4	3.3	5.8	5.1	6.4	3.7	0.6	7.4	3.2	12.4	5.6	3.5	5.1	0.8	13.3	6.6	6.5	0.4	0.1	0.8	0.2	26.7	21.0	0.2	19.4	7.2	10.4	12.7	0.1	0.2	0.3	0.1	21.5	0.2	0.6	0.0	0.0	22.4	0.2	0.1	0.1	3.4	0.1	2.2	0.2	0.4	10.2	0.1	8.9	1.5	15.4	12.5	0.3	0.1	0.8	19.5	0.1	0.2	0.2	3.2	0.3	11.0	13.7	20.4	0.3	1.7	0.3	1.5	1.7	6.8	0.1	0.0	0.4	0.1	0.3	28.5	2.3	22.9	0.9	24.5	0.4	0.2	0.1	5.2	13.0	8.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	12.8	15.9	4.4	15.7	15.1	9.1	1.9	5.6	2.7	3.7	12.4	6.5	6.0	0.0	0.5	170.7	0.0	5.0	0.6	0.1	0.0	51.4	0.2	0.5	4.2	1.5	2.5	0.0	27.1	0.0	4.4	0.1	0.0	2.4	6.2	0.1	1.3	2.6	0.0	0.8	1968.8	0.0	0.0	88.7	0.5	0.1	0.0	0.2	0.0	0.0	0.2	1.7	1254.4	0.6	0.0	0.0	16.7	12.5	210.3	2.4	8.8	58.1	3.1	12.2	0.0	726.3	442.7	0.5	0.0	44.8	0.5	1.3	0.0	1.5	7.1	58.7	32.9	8.3	8.5	0.7	2.5	0.3	3.4	0.0	1.1	0.2	0.1	0.7
NETO2	"FLJ10430, NEOT2"	ENSG00000171208	"Neuropilin and tolloid like 2"	Q8NC67	16	47077703-47143945	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;lymphoid tissue: 22.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.5;Inhibitory neurons: 176.6;Oligodendrocyte precursor cells: 79.4;Theca cells: 98.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013180	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA013180: AB_1854383"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (5.53e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.32e-1)"	2.7	7.2	6.1	6.4	19.8	2.4	2.8	3.6	9.3	1.6	1.0	8.5	1.6	2.2	0.6	6.1	0.8	4.8	2.6	4.1	8.3	2.7	0.7	5.9	6.3	6.9	0.8	1.6	2.5	10.7	1.2	3.4	6.4	1.1	2.4	7.5	2.7	1.2	4.4	1.8	2.8	1.6	1.7	22.7	2.2	8.0	3.5	5.4	8.8	2.2	6.2	4.9	2.9	4.2	86.8	94.4	133.9	0.3	19.3	111.6	22.2	84.0	13.2	72.9	39.3	19.9	54.0	21.3	50.4	18.0	70.2	37.9	86.4	83.6	89.0	0.3	55.7	17.2	32.8	21.3	23.9	55.8	43.7	67.9	54.7	29.5	41.2	70.5	49.2	50.5	25.9	25.7	47.4	23.5	31.9	30.4	64.7	25.8	68.8	0.1	26.2	43.0	51.4	18.3	87.8	63.5	110.9	8.6	12.5	21.8	1.7	40.3	24.1	0.1	0.3	0.1	0.5	27.5	24.7	47.6	58.9	38.9	59.6	0.3	0.9	0.0	0.0	0.5	0.3	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.1	6.1	19.8	3.6	9.3	4.1	8.3	6.9	0.8	6.4	1.7	3.5	4.2	4.9	0.0	4.5	4.6	6.5	7.8	0.6	10.4	13.1	2.2	5.2	8.9	1.3	0.0	3.6	0.0	0.0	1.4	2.1	15.9	0.0	0.4	3.1	2.1	4.0	10.6	10.8	0.4	96.5	3.1	0.5	4.9	1.5	0.9	2.5	18.0	2.9	0.4	6.6	0.0	176.6	2.6	6.1	11.4	14.6	5.7	0.6	16.6	3.6	8.4	7.3	39.9	1.0	79.4	3.1	1.3	1.5	0.0	13.7	4.9	2.9	0.1	2.4	1.6	6.6	5.3	3.6	17.9	22.2	18.8	3.3	0.8	5.2	98.7	2.8	1.4
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241809065-241817413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 75.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 74.6;Enteroendocrine cells: 34.4;Hepatocytes: 124.4;Intestinal goblet cells: 38.5;Oligodendrocyte precursor cells: 50.3;Paneth cells: 58.0;Proximal enterocytes: 76.0;Undifferentiated cells: 38.4"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"Hep G2: 57.7;HMC-1: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037394	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.9	0.2	2.3	0.1	2.5	3.5	0.2	2.2	4.4	0.5	0.6	15.5	10.7	0.2	0.0	0.0	0.7	0.4	0.3	2.1	2.5	1.8	75.8	0.4	0.0	5.0	2.8	0.3	0.1	0.0	1.1	0.0	2.7	0.4	2.2	0.1	0.8	0.0	9.0	0.1	9.2	0.0	2.6	0.3	0.1	0.7	2.7	0.0	0.3	0.8	0.0	0.1	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	57.7	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.5	2.2	4.4	2.1	2.5	5.0	2.8	2.7	2.6	2.7	2.9	0.2	0.0	0.0	1.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.6	1.5	0.7	1.8	0.0	0.0	1.1	74.6	3.9	0.0	0.1	0.0	0.1	0.3	34.4	0.0	0.4	0.0	0.0	0.2	0.5	0.0	1.3	0.1	1.1	124.4	1.5	0.0	0.4	38.5	2.0	4.2	0.7	0.2	0.6	4.0	0.0	0.0	0.0	26.2	0.0	50.3	0.1	0.0	58.0	0.7	0.4	0.0	76.0	23.6	0.2	1.3	0.0	3.6	0.4	0.5	0.5	0.0	0.0	0.0	1.3	0.0	38.4	0.1
NFIA	"KIAA1439, NFI-L"	ENSG00000162599	"Nuclear factor I A"	Q12857	1	60865259-61462788	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.9"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 777.3;Oligodendrocyte precursor cells: 606.7;Peritubular cells: 438.5;Skeletal myocytes: 513.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006111, HPA008884"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA006111: AB_1854422, HPA008884: AB_1854421"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.20e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (2.03e-4)"	23.0	12.4	28.4	5.2	37.7	10.0	15.1	75.9	24.6	18.3	31.8	14.2	7.2	8.9	11.7	18.8	15.6	14.3	16.9	28.4	31.3	10.8	40.5	8.4	5.1	51.5	33.4	15.7	13.5	10.9	5.4	4.3	34.9	15.0	9.1	4.2	17.5	11.6	13.8	8.7	6.4	13.2	37.3	9.4	9.7	5.8	33.6	8.6	27.4	15.8	6.8	13.8	10.3	27.1	5.0	6.8	1.0	74.2	31.8	20.2	0.2	1.6	5.1	1.6	2.4	0.4	4.8	10.9	4.8	2.7	0.7	7.2	3.1	15.4	0.9	23.4	6.6	0.4	15.2	4.8	7.3	1.2	1.8	25.7	14.9	6.8	27.6	5.5	19.1	3.0	5.1	16.9	1.5	3.6	0.3	0.3	2.9	6.9	6.6	1.1	6.9	18.2	4.3	13.1	4.8	5.7	4.1	28.2	10.3	0.8	30.2	0.5	15.5	1.3	8.5	15.2	3.1	1.2	3.1	0.1	1.7	0.2	1.7	3.2	2.7	1.5	1.9	1.9	2.9	0.6	2.3	3.0	1.3	0.3	2.2	2.7	0.1	0.5	2.5	1.0	0.1	1.8	28.4	37.7	75.9	24.6	28.4	31.3	51.5	33.4	34.9	37.3	33.6	27.1	232.1	35.3	44.7	777.3	4.4	85.0	68.8	72.1	220.9	42.6	140.7	107.4	192.9	148.7	68.1	47.8	2.1	5.7	8.1	28.4	27.4	38.0	28.9	85.8	69.8	132.7	25.2	163.7	142.3	47.8	1.1	265.6	30.5	68.2	27.3	11.6	197.0	304.5	14.8	42.1	125.7	46.8	36.7	60.8	42.6	26.4	408.8	19.2	46.2	259.5	14.9	150.2	5.2	606.7	431.3	20.8	37.6	438.5	8.0	53.0	19.1	109.9	82.6	6.9	144.7	513.1	133.7	5.0	13.5	148.4	76.3	1.6	15.0	34.9	69.7	57.1
NFIX	NF1A	ENSG00000008441	"Nuclear factor I X"	Q14938	19	12995475-13098796	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 145.2;Oligodendrocytes: 140.9;Skeletal myocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 149.5;fHDF/TERT166: 211.3;U-138 MG: 191.5;U-2197: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007533	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA007533: AB_2667855"	"unprognostic (3.32e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (4.66e-4)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-2)"	76.4	14.9	30.4	19.7	80.2	14.9	48.0	99.8	97.7	67.2	4.0	60.4	20.9	88.5	10.9	72.4	69.5	53.9	60.9	54.0	15.0	8.9	20.3	50.0	6.2	50.9	45.1	73.8	23.8	13.2	18.9	11.8	39.4	85.0	19.7	11.7	150.4	60.0	410.3	99.2	24.3	67.8	45.6	11.3	37.3	16.0	46.9	11.6	31.0	138.2	6.2	45.0	52.7	105.2	39.2	16.2	1.0	119.9	111.7	149.5	1.3	48.1	68.6	45.7	31.8	1.3	3.3	0.6	13.4	211.3	31.4	17.5	12.8	37.4	20.1	25.8	19.7	20.2	7.6	17.2	53.8	8.5	10.3	99.0	10.9	44.1	24.6	80.3	12.4	8.6	6.7	6.2	29.3	12.1	14.9	5.7	0.5	8.6	132.3	43.5	22.2	23.1	0.4	8.5	17.9	47.6	34.5	0.3	43.0	0.0	22.7	17.3	12.2	191.5	23.5	185.1	68.5	4.5	1.7	0.3	49.9	12.1	62.0	0.1	0.1	0.0	0.5	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	30.4	80.2	99.8	97.7	54.0	15.0	50.9	45.1	39.4	45.6	46.9	105.2	19.5	12.8	59.3	62.7	6.8	58.8	45.5	22.4	134.9	13.3	57.9	74.2	33.2	27.1	15.9	14.7	4.2	0.2	3.7	16.5	1.9	24.3	64.0	12.1	40.1	20.0	12.1	145.2	69.0	12.7	0.3	89.7	32.6	3.0	3.8	4.3	17.9	33.9	1.0	0.0	38.1	25.8	2.0	4.1	15.2	43.1	112.2	5.8	26.6	17.8	1.9	93.7	0.0	52.3	140.9	15.2	12.0	126.0	2.5	60.3	8.4	10.0	19.0	3.0	6.6	174.7	38.3	15.6	13.2	99.4	51.4	0.3	3.8	56.0	29.5	31.8
NFYB	"CBF-A, HAP3, NF-YB"	ENSG00000120837	"Nuclear transcription factor Y subunit beta"	P25208	12	104117086-104138241	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Syncytiotrophoblasts: 433.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 132.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004211, HPA065646"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB004211: AB_628018, HPA065646: "	"unprognostic (5.82e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.62e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.81e-3)"	32.9	40.8	34.0	15.2	34.3	14.7	27.2	30.5	50.8	28.6	26.8	60.4	15.0	30.5	33.1	16.1	30.1	18.5	37.4	31.0	31.2	24.0	30.6	29.0	24.7	32.9	34.0	23.2	21.3	21.7	17.4	23.6	32.0	39.0	18.4	21.2	20.6	67.9	36.2	18.4	21.7	21.1	34.7	19.4	26.3	22.6	32.1	26.3	22.7	36.3	22.8	38.1	23.9	36.2	30.1	25.3	55.3	35.7	34.2	35.6	48.6	31.5	27.2	37.2	25.6	21.2	14.0	44.4	15.1	30.3	22.9	22.0	46.5	20.9	37.4	28.9	14.7	27.4	31.0	19.7	31.0	35.0	17.6	49.3	25.6	14.5	25.5	62.0	24.0	40.1	27.1	16.2	31.6	29.6	53.2	40.5	52.8	22.1	26.0	43.5	30.9	18.8	27.3	25.3	31.3	26.2	58.0	132.5	19.3	36.8	53.1	42.9	15.2	21.3	13.1	17.5	24.0	28.5	29.5	42.0	12.5	23.7	22.8	18.0	5.7	18.5	12.1	7.8	16.6	12.3	12.1	12.5	5.7	8.5	13.0	13.7	7.2	13.5	9.0	5.0	16.9	9.1	34.0	34.3	30.5	50.8	31.0	31.2	32.9	34.0	32.0	34.7	32.1	36.2	42.5	54.5	26.7	8.8	21.1	37.3	106.8	42.9	15.9	22.7	24.3	31.8	39.5	12.8	30.3	18.4	4.2	58.8	24.5	13.3	37.2	24.2	6.2	20.4	36.4	36.5	12.0	39.4	13.1	18.3	86.3	43.0	11.2	17.5	21.5	30.8	77.1	31.2	23.1	15.2	13.7	15.4	30.5	14.4	29.8	5.4	34.2	19.2	28.4	8.4	20.2	43.3	22.6	11.1	25.3	27.3	16.9	30.5	17.1	54.5	12.6	42.5	26.7	27.2	19.7	35.4	40.0	90.0	32.4	18.0	37.1	433.2	25.6	18.8	18.3	55.7
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878701-233013256	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 56.2;brain: 129.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.0;Excitatory neurons: 105.9;Proximal enterocytes: 66.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 129.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 53.9;HDLM-2: 45.3;HeLa: 21.6;PC-3: 57.0;T-47d: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 167.6;cerebral cortex: 133.8;hippocampal formation: 73.0"	HPA008160	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	1.1	56.2	16.3	2.2	129.6	0.1	1.9	0.0	59.4	4.1	0.0	14.2	42.7	5.0	4.1	10.3	4.8	3.1	2.2	19.8	0.0	7.0	35.5	0.7	0.2	0.0	0.0	2.0	6.0	11.9	2.7	0.3	0.0	1.8	10.5	1.4	2.0	0.7	0.9	30.3	31.3	6.7	0.0	0.4	10.7	3.7	0.2	0.0	0.9	0.7	0.3	1.8	5.2	29.4	53.9	15.4	0.6	0.2	0.2	8.2	0.9	0.9	0.1	0.4	0.0	0.7	5.2	0.0	15.2	10.9	5.5	6.9	11.6	3.0	0.4	45.3	3.8	0.1	21.6	16.7	0.2	0.0	0.3	0.0	0.2	3.5	0.6	0.2	1.9	0.2	0.2	0.2	0.5	4.0	0.0	0.1	1.3	0.2	57.0	0.0	0.0	0.1	1.0	1.4	1.9	0.4	6.6	3.3	0.1	2.0	32.2	0.4	0.0	0.5	4.5	0.3	1.0	0.5	0.2	0.0	3.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	129.6	0.0	59.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	10.4	0.0	9.9	1.2	1.2	2.8	0.3	2.1	1.4	2.4	4.3	0.5	0.0	0.0	0.1	0.0	38.0	0.0	3.9	0.7	9.1	0.9	0.4	4.9	0.0	105.9	10.5	0.3	0.7	17.3	2.0	0.0	0.3	0.4	20.4	0.1	1.7	12.8	14.6	0.0	0.3	0.6	2.0	0.0	0.3	1.8	6.5	0.0	5.5	0.0	4.5	6.0	12.1	23.5	1.2	0.1	0.5	66.7	9.8	2.5	0.2	0.0	0.2	0.3	1.1	0.8	3.8	7.5	0.0	0.2	0.5	20.2	1.1
NHLRC4		ENSG00000257108	"NHL repeat containing 4"	P0CG21	16	567005-569495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 11.7;kidney: 10.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 23.9;Endometrial ciliated cells: 23.3;Erythroid cells: 11.8;Leydig cells: 8.1;Respiratory ciliated cells: 18.1;Theca cells: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 3.3;HMC-1: 9.6;REH: 2.6;RPMI-8226: 4.3"	"Low region specificity"	"Detected in single"							HPA077301			Approved	Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA077301: "	"unprognostic (7.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.60e-1)"	0.8	5.4	0.6	0.7	0.5	2.9	1.2	0.8	0.5	1.8	2.1	0.9	1.0	1.1	2.1	0.3	11.7	0.9	0.9	0.7	1.0	10.5	0.2	2.0	1.9	2.8	3.3	3.0	0.2	3.2	1.1	0.6	1.7	1.4	0.2	0.0	2.2	2.4	0.5	0.3	1.5	0.3	2.3	3.8	0.6	2.7	0.8	2.4	0.4	0.2	0.6	0.7	0.6	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.1	3.3	0.0	0.8	0.7	0.2	9.6	1.9	0.0	0.1	0.2	0.0	0.2	0.6	1.0	1.1	0.0	0.0	0.3	2.5	0.2	0.0	0.0	2.6	0.0	4.3	0.2	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.4	0.5	0.5	0.0	0.0	0.0	0.0	1.5	1.4	0.7	0.0	0.1	0.2	0.0	0.2	2.3	0.1	0.0	0.2	0.4	0.5	0.2	0.2	0.2	0.5	0.3	0.0	0.3	0.1	1.7	0.5	0.3	0.6	0.5	0.8	0.5	0.7	1.0	2.8	3.3	1.7	2.3	0.8	0.6	1.6	0.0	0.0	0.3	1.2	0.0	0.5	0.8	0.6	0.1	1.9	1.4	0.2	0.0	2.2	23.9	0.0	0.2	1.8	0.1	0.0	0.0	0.0	23.3	1.1	1.0	0.0	11.8	0.1	0.2	0.0	2.3	0.0	1.0	0.0	0.4	1.1	0.0	1.7	0.0	0.5	0.2	2.0	0.6	0.9	0.4	8.1	0.5	0.0	1.0	0.2	1.5	1.0	0.0	0.0	0.0	0.0	4.5	0.9	0.3	0.3	0.1	18.1	0.1	6.6	0.1	2.0	0.1	0.1	0.0	0.1	0.0	0.7	12.7	0.2	0.3
NIPSNAP1		ENSG00000184117	"Nipsnap homolog 1"	Q9BPW8	22	29554808-29581327	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 291.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 116.7;Proximal tubular cells: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059227	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA059227: AB_2683951"	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (8.82e-6)"	"unprognostic (2.81e-2)"	"unprognostic (8.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.72e-1)"	10.7	43.9	35.4	17.5	37.8	15.5	31.5	31.8	38.5	21.5	33.4	37.4	67.0	19.4	24.9	25.8	26.8	19.8	21.8	37.6	41.7	117.8	291.8	17.8	23.3	37.1	36.5	32.3	24.4	68.0	36.5	17.3	39.3	23.9	38.5	46.2	26.0	27.2	4.4	20.6	49.2	17.8	30.7	19.1	29.3	11.9	36.7	36.7	32.9	5.4	28.3	20.1	18.3	31.7	69.1	81.1	165.3	206.9	29.2	59.4	30.7	39.5	70.7	53.2	68.7	55.5	90.6	48.8	76.8	56.9	56.0	68.2	87.7	100.7	65.1	98.8	90.5	16.8	37.0	173.5	44.1	36.5	23.0	59.5	50.8	44.1	55.0	129.0	73.4	105.3	31.8	78.9	49.2	156.4	59.3	50.1	140.0	106.2	67.5	115.9	51.7	142.6	128.3	59.1	203.9	179.5	46.1	83.2	92.1	79.5	137.1	57.7	34.7	23.2	79.6	28.6	31.9	106.4	56.5	45.6	62.1	57.3	39.4	10.8	9.4	15.9	34.2	17.4	41.2	29.0	34.4	36.2	21.6	27.3	32.6	39.5	13.8	39.5	10.7	11.0	44.9	22.1	35.4	37.8	31.8	38.5	37.6	41.7	37.1	36.5	39.3	30.7	36.7	31.7	7.4	25.6	15.7	6.8	16.3	4.8	12.6	15.8	18.8	22.6	25.5	18.5	22.9	28.6	18.6	42.3	10.4	44.4	9.2	14.4	68.4	45.8	2.1	6.2	13.7	10.1	41.9	24.6	16.9	18.5	14.6	14.2	25.5	12.0	26.0	33.5	11.7	116.7	14.4	10.1	19.9	31.5	26.4	8.7	4.3	6.1	11.1	8.1	5.4	3.7	21.3	38.7	28.8	6.6	10.3	17.8	20.2	14.3	7.3	6.8	35.2	134.7	9.8	24.4	13.1	7.2	12.3	1.4	8.3	20.5	8.1	14.8	20.5	48.1	47.4	8.8
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334739-100361635	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.4"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 705.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		1700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	5.1	3.9	1.3	1.4	2.4	3.5	6.8	1.4	1.9	3.4	1.7	3.8	2.7	4.1	5.5	4.4	4.1	3.4	5.2	1.6	1.3	18.5	26.4	3.2	2.4	0.7	0.8	3.3	3.7	3.9	2.7	2.4	0.9	3.6	3.4	3.6	3.8	4.9	10.1	5.0	2.8	3.0	0.9	2.2	4.1	1.2	1.2	2.5	5.9	7.6	3.7	5.2	3.6	1.4	12.3	12.1	1.4	6.2	10.3	14.1	7.4	4.9	7.3	11.5	10.9	10.4	13.7	12.3	7.4	7.2	4.9	9.1	5.4	13.2	13.7	3.8	2.8	9.0	4.1	5.3	12.6	5.9	5.8	8.8	19.9	6.1	10.1	6.0	7.4	6.9	4.2	9.8	14.2	11.9	3.9	5.3	5.4	15.3	18.0	4.3	5.0	12.0	19.4	7.7	8.2	3.8	6.8	11.6	7.3	3.7	8.6	5.4	5.5	7.2	2.9	3.5	4.4	5.9	7.0	10.6	11.4	9.9	9.3	0.2	0.7	0.4	1.0	0.7	1.4	1.5	1.0	0.8	2.0	1.5	1.2	1.1	0.4	1.1	0.5	0.6	1.2	0.3	1.3	2.4	1.4	1.9	1.6	1.3	0.7	0.8	0.9	0.9	1.2	1.4	22.3	12.8	17.2	8.5	31.5	32.6	51.7	92.0	37.0	12.8	43.7	56.1	56.4	45.8	53.5	58.8	16.7	92.5	26.1	14.6	187.9	73.6	3.1	53.6	47.2	16.7	24.0	17.0	12.0	52.7	73.7	38.0	29.6	42.3	21.0	55.3	15.0	183.6	63.5	13.5	8.8	22.0	65.1	23.5	39.9	4.1	44.1	26.9	49.8	4.7	89.9	15.4	22.6	12.1	8.0	62.1	20.6	37.6	20.8	54.3	24.1	705.6	60.5	24.9	39.5	23.9	51.6	2.7	17.5	53.7	41.6	59.2	27.7	118.1	36.7	53.0
NKAIN4	"bA261N11.2, C20orf58, FAM77A"	ENSG00000101198	"Sodium/potassium transporting ATPase interacting 4"	Q8IVV8	20	63240784-63272694	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 68.1;choroid plexus: 20.3;kidney: 52.2"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 80.8;Oligodendrocyte precursor cells: 76.4;Proximal tubular cells: 264.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 45.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.9;MOLT-4: 42.8;SK-MEL-30: 9.3;SuSa: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029876	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA029876: AB_10602038"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-1)"	"unprognostic (6.07e-5)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.44e-4)"	"unprognostic (5.66e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.01e-1)"	0.1	0.8	41.3	0.2	41.0	0.1	0.1	28.7	68.1	2.3	20.3	1.7	0.3	0.4	0.4	0.0	0.3	0.1	0.0	45.7	44.7	52.2	0.0	0.1	0.0	39.1	40.3	0.1	0.1	0.0	2.4	2.8	39.9	0.1	0.1	3.1	0.1	0.1	0.0	0.4	0.4	0.0	37.5	0.1	0.3	2.2	40.3	1.2	0.8	0.1	0.0	0.1	0.6	36.1	0.1	2.0	7.5	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	1.3	0.8	0.0	3.9	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	42.8	0.0	5.2	0.0	0.1	7.8	0.0	0.7	0.3	0.0	0.0	0.0	0.5	0.1	9.3	29.5	0.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.5	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	41.0	28.7	68.1	45.7	44.7	39.1	40.3	39.9	37.5	40.3	36.1	0.0	0.0	0.0	23.8	1.9	0.3	0.0	1.7	0.0	2.6	0.0	0.1	0.3	0.0	0.1	11.0	0.0	3.3	0.0	0.0	5.9	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.6	3.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.9	5.3	1.5	0.0	1.0	0.0	80.8	0.0	76.4	0.1	4.2	0.0	0.0	0.0	0.0	0.0	264.8	0.1	1.9	0.0	0.0	0.3	0.4	6.0	0.0	0.0	2.3	0.8	0.1	0.0	0.1
NKG7	"GIG1, GMP-17"	ENSG00000105374	"Natural killer cell granule protein 7"	Q16617	19	51371606-51372701	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 602.6;lymphoid tissue: 154.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3163.4;NK-cells: 7721.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 6827.0;MAIT T-cell: 2871.2;memory CD8 T-cell: 4295.0;naive CD8 T-cell: 3114.2;NK-cell: 4796.8"	"Group enriched"	"Detected in all"	44	"NK-cells: 4796.8;T-cells: 6827.0"	"Group enriched"	"Detected in some"	5	"NB-4: 180.8;THP-1: 54.5;U-937: 46.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071454			Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA071454: AB_2686399"	"unprognostic (1.56e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (7.42e-6)"	"unprognostic (1.27e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.89e-3)"	"unprognostic (3.39e-1)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (7.62e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.44e-3)"	12.5	7.9	3.7	23.2	3.6	602.6	7.7	3.6	6.3	5.9	4.2	9.5	11.0	12.5	6.1	7.2	7.9	21.4	6.7	3.5	3.6	6.5	23.5	49.2	136.4	4.9	3.9	4.2	2.2	2.2	3.2	7.9	4.2	4.9	7.3	0.4	9.6	4.5	6.5	2.7	14.6	7.7	4.1	154.6	10.6	3.3	4.3	9.4	6.6	3.3	21.9	16.7	4.4	4.2	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.9	7.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.6	0.6	2.0	0.8	0.2	0.0	20.1	3.6	0.0	0.0	0.3	0.0	0.2	0.0	2.5	0.5	0.8	0.0	0.0	2.4	180.8	0.0	0.2	0.3	4.4	9.4	0.4	0.0	0.0	0.1	0.2	0.4	0.1	0.1	0.3	0.0	54.5	0.4	0.1	0.2	0.6	0.1	2.6	0.9	0.9	0.1	46.6	0.0	76.9	34.1	15.2	6827.0	131.7	2871.2	37.9	811.1	4295.0	87.1	15.4	261.0	3114.2	111.7	4796.8	104.8	67.1	17.5	4929.2	3.7	3.6	3.6	6.3	3.5	3.6	4.9	3.9	4.2	4.1	4.3	4.2	17.2	3.2	8.0	0.0	24.5	5.0	0.1	0.0	0.0	0.0	5.7	3.7	0.7	28.6	1.3	5.5	0.0	1.0	3163.4	1.9	3.9	1.0	0.2	2.7	3.6	7.1	0.0	186.5	0.0	0.0	0.8	5.2	17.3	4.2	24.1	0.2	55.3	9.9	15.0	0.0	0.0	0.5	0.0	132.9	10.2	0.3	0.0	55.5	17.8	1.0	49.4	0.0	7721.0	0.0	0.2	0.0	1.2	0.0	120.4	0.0	0.6	9.2	0.7	0.0	0.0	6.4	4.7	0.0	0.5	1.1	6.5	1.1	1321.5	0.0	1.1	0.1
NLRP6	"CLR11.4, NALP6, PAN3, PYPAF5"	ENSG00000174885	"NLR family pyrin domain containing 6"	P59044	11	278407-285388	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 39.9"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 9.9;T-cells: 2.6"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 0.9;liver cancer: 1.2;renal cancer: 1.5;stomach cancer: 1.8"	"Region enhanced"	"Detected in single"		"cerebral cortex: 3.6"	"Group enriched"	"Detected in many"	4	"neutrophil: 15.4;non-classical monocyte: 4.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.4;monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"REH: 2.0;U-266/70: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043681, HPA048500"	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA043681: AB_2678614, HPA048500: AB_2680422"	"unprognostic (6.37e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (4.23e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.69e-2)"	0.7	0.0	0.1	2.2	0.2	0.5	0.2	0.1	3.6	0.1	0.2	0.6	39.9	0.2	0.1	0.1	0.6	0.3	0.1	0.1	0.5	1.3	2.6	0.9	1.2	0.9	0.3	0.0	0.5	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.0	0.1	38.0	0.1	0.3	3.6	0.3	0.2	0.3	0.3	0.1	0.1	0.3	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.2	0.2	0.4	0.1	0.0	0.0	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	1.4	0.3	1.6	1.1	0.1	0.1	1.8	2.3	15.4	1.0	4.6	0.0	0.0	0.7	0.1	0.2	0.1	3.6	0.1	0.5	0.9	0.3	0.6	0.3	0.3	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.7	0.0
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NOD1	"CARD4, CLR7.1, NLRC1"	ENSG00000106100	"Nucleotide binding oligomerization domain containing 1"	Q9Y239	7	30424527-30478784	"Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Microglial cells: 26.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074367			Approved	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA074367: AB_2686683"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (6.62e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (2.64e-1)"	10.6	2.9	3.0	8.8	3.2	6.8	9.5	2.5	2.6	5.3	4.6	5.3	2.2	6.1	2.6	4.7	6.5	5.4	7.3	2.4	3.2	3.9	2.2	11.9	6.1	7.6	4.9	10.3	1.8	2.7	2.9	12.2	4.7	4.0	4.3	0.6	6.2	3.2	4.0	5.9	5.4	7.3	3.6	11.1	4.8	1.9	5.6	3.5	10.8	4.0	5.0	7.3	5.0	2.8	4.8	2.5	3.5	10.5	2.2	10.3	5.3	3.3	2.3	5.5	7.0	2.2	5.7	6.9	3.8	4.2	6.1	11.2	3.5	5.8	3.7	3.6	3.0	9.7	7.7	2.2	2.8	4.3	7.0	9.6	2.5	3.5	3.0	4.9	18.3	10.1	5.2	2.4	5.0	2.8	6.2	7.7	4.1	5.3	4.5	7.4	4.0	6.3	1.8	3.8	0.6	12.4	4.2	10.7	3.7	4.8	3.6	9.6	7.7	4.8	7.6	6.0	4.5	2.2	8.0	0.3	3.5	15.1	5.1	13.7	3.7	13.5	8.1	5.0	8.9	7.5	5.5	5.3	3.3	10.9	4.9	4.0	2.8	8.5	6.6	8.0	4.8	2.6	3.0	3.2	2.5	2.6	2.4	3.2	7.6	4.9	4.7	3.6	5.6	2.8	19.3	3.2	15.1	7.2	6.6	0.8	0.5	1.0	5.2	2.4	2.9	2.9	4.9	1.5	5.0	5.5	0.0	5.0	6.7	4.5	0.0	1.3	0.2	4.4	1.7	12.0	0.0	3.4	5.3	2.1	2.3	8.2	1.1	4.6	2.5	7.8	13.6	1.3	4.6	0.0	1.4	5.5	2.0	3.1	3.7	0.0	0.6	4.3	5.4	26.2	4.0	0.6	6.2	2.5	1.1	1.7	1.7	1.9	3.1	0.2	1.6	0.5	2.9	0.2	0.0	2.5	5.6	0.0	0.6	5.4	1.8	1.5	5.3	1.0	5.6	0.8
NOS2	"HEP-NOS, iNOS, NOS, NOS2A"	ENSG00000007171	"Nitric oxide synthase 2"	P35228	17	27756766-27800529	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 21.1;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 40.3;Extravillous trophoblasts: 27.7;Granulosa cells: 57.3;Proximal enterocytes: 10.7;Undifferentiated cells: 10.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 16.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 16.5;SCLC-21H: 13.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002014	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB002014: "	"unprognostic (1.95e-3)"	"unprognostic (3.08e-3)"	"unprognostic (4.75e-3)"	"unprognostic (4.42e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.13e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.03e-2)"	0.9	0.5	0.2	14.4	0.5	0.0	0.3	0.1	2.1	0.3	0.0	6.8	12.1	0.2	0.0	0.7	0.4	0.4	0.4	0.7	0.2	1.6	0.1	1.8	0.8	0.3	0.1	0.6	0.3	0.1	1.3	0.6	0.5	0.6	8.9	0.2	0.1	0.2	0.8	0.2	21.1	1.8	0.1	0.1	0.1	0.3	1.0	0.1	0.4	0.7	0.1	3.6	0.2	0.9	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.9	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	2.1	0.7	0.2	0.3	0.1	0.5	0.1	1.0	0.9	1.2	0.0	0.0	1.3	0.6	0.0	0.2	3.6	0.0	0.5	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.2	0.0	40.3	0.0	0.0	0.2	0.0	0.0	0.7	2.4	0.0	4.1	0.0	27.7	0.2	0.0	0.1	0.0	57.3	0.0	0.0	0.7	0.0	2.2	3.8	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.9	0.4	0.0	1.4	10.7	0.1	0.5	0.1	0.0	0.3	1.2	0.0	1.5	0.0	0.0	0.5	0.3	0.1	10.2	1.0
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150991017-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 62.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.4;Early spermatids: 81.9;Endothelial cells: 32.6;Hepatic stellate cells: 29.3;Late spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.1;HUVEC TERT2: 44.7;K-562: 16.6;TIME: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	19.3	6.3	8.4	5.8	6.8	0.8	13.2	5.7	6.7	7.3	3.4	5.9	2.6	9.7	0.4	5.8	8.1	4.7	20.6	5.7	6.1	24.2	4.3	11.2	2.7	9.2	7.7	3.2	2.9	1.2	7.2	4.8	8.6	7.6	1.2	0.8	4.4	1.7	3.9	4.2	6.7	3.7	7.5	62.4	5.4	7.2	11.0	0.6	9.1	3.5	1.2	9.7	7.4	6.0	0.4	0.1	1.3	4.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.3	2.2	0.4	2.1	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.4	2.2	0.3	6.4	0.6	0.5	10.4	0.1	0.2	0.0	0.0	0.1	44.7	5.1	16.6	3.6	0.0	0.0	0.2	0.5	1.7	0.7	0.1	3.0	0.0	1.8	0.0	0.3	0.5	0.4	0.2	1.4	0.0	0.4	0.1	1.4	82.5	0.2	0.7	0.4	0.1	2.4	8.9	2.2	0.0	7.5	0.0	0.2	0.1	0.1	1.1	0.2	0.7	0.3	1.7	0.9	0.2	0.5	2.3	0.9	0.3	0.2	0.2	0.2	2.1	0.5	8.4	6.8	5.7	6.7	5.7	6.1	9.2	7.7	8.6	7.5	11.0	6.0	20.4	9.6	2.2	0.3	0.7	0.9	0.1	0.1	0.0	0.2	0.2	0.3	3.1	0.0	0.7	0.0	0.0	0.2	0.7	0.1	0.0	1.0	81.9	4.9	0.7	32.6	0.0	0.0	0.2	0.0	0.1	2.9	0.5	3.2	5.7	0.7	29.3	0.7	0.4	0.0	0.2	0.4	0.0	0.6	0.5	29.3	0.9	0.4	0.0	7.5	0.0	0.3	0.0	0.0	0.0	0.8	0.0	1.2	1.5	0.4	0.1	0.2	2.2	0.3	0.0	0.6	2.6	6.9	5.3	0.2	0.6	3.6	1.6	0.9	0.1	0.9
NOSTRIN	MGC20702	ENSG00000163072	"Nitric oxide synthase trafficking"	Q8IVI9	2	168786539-168865514	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 167.0;Endothelial cells: 129.6;Hepatic stellate cells: 172.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.1;HEL: 41.9;K-562: 31.8;OE19: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044384, HPA076885"	Approved		Approved	Vesicles,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Vesicles	"HPA044384: AB_2678922, HPA076885: "	"unprognostic (4.74e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.02e-6)"	"unprognostic (4.89e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.98e-2)"	32.6	20.4	6.1	4.6	5.8	0.3	31.4	5.0	7.6	17.5	4.2	15.3	14.0	14.9	4.3	5.1	16.4	14.0	16.1	4.9	5.6	32.6	7.3	30.8	4.6	6.6	6.0	10.6	22.6	3.8	3.8	25.4	6.5	13.3	16.4	0.8	48.9	6.8	5.1	7.3	14.3	12.8	5.5	5.5	23.0	14.4	6.6	1.9	13.5	3.6	3.0	8.1	11.3	5.0	0.0	3.6	1.1	0.0	0.0	0.0	10.1	0.4	0.0	0.0	0.0	6.3	6.5	0.1	4.3	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	41.9	1.8	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	31.8	0.0	0.0	0.1	0.1	0.1	0.1	20.5	0.3	0.4	1.9	0.0	3.4	1.6	0.0	0.1	0.2	1.9	0.0	0.2	0.5	0.0	0.0	0.0	0.7	0.2	0.6	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	5.0	7.6	4.9	5.6	6.6	6.0	6.5	5.5	6.6	5.0	167.0	9.6	10.3	2.0	1.6	1.0	0.6	0.3	0.6	0.1	20.0	11.0	7.1	15.7	3.3	3.7	0.0	18.9	0.4	57.3	13.7	8.0	26.6	16.3	3.3	129.6	11.4	2.7	0.4	21.8	7.0	6.1	41.3	23.2	0.0	72.4	172.5	1.0	1.6	0.0	0.5	35.9	0.0	6.3	0.9	60.9	8.7	1.2	24.9	55.3	0.7	1.6	0.0	2.0	0.0	17.7	53.4	5.7	0.2	3.3	43.1	59.0	1.5	0.3	72.3	1.3	11.3	13.7	1.8	0.4	0.4	26.3	0.9	71.9	20.7	1.2
NOTCH1	TAN1	ENSG00000148400	"Notch receptor 1"	P46531	9	136494433-136546048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.2;Astrocytes: 67.3;Hepatic stellate cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 47.0;HDLM-2: 32.3;HMC-1: 39.7;MOLT-4: 72.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		29000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	18.2	4.2	10.4	4.9	16.1	4.3	15.0	12.1	9.3	14.3	0.0	19.8	4.3	12.7	0.2	16.3	11.9	0.9	14.9	8.6	5.5	11.8	9.2	22.2	3.0	13.5	12.3	5.1	14.0	0.7	6.3	2.6	9.8	15.4	0.6	0.6	10.7	3.1	5.0	24.2	14.2	1.3	9.7	24.8	10.0	2.5	13.9	4.0	11.2	1.2	0.9	14.2	16.5	14.0	8.8	10.6	4.0	2.6	0.0	0.4	17.7	3.3	0.4	1.4	0.4	1.8	0.9	13.3	10.3	1.3	1.6	47.0	1.0	8.6	0.1	32.3	2.0	5.5	6.1	0.6	2.1	6.9	39.7	0.3	16.7	1.4	1.9	0.7	9.0	3.7	3.6	1.1	0.0	9.0	72.3	13.1	8.4	2.9	7.7	15.7	9.2	19.3	0.6	4.2	0.0	0.7	6.1	4.3	3.4	1.0	3.2	10.4	22.7	5.0	9.3	5.9	4.3	2.4	2.6	4.1	3.7	5.0	26.1	0.2	0.4	0.6	0.3	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.3	2.3	0.7	0.1	0.1	0.1	0.5	10.4	16.1	12.1	9.3	8.6	5.5	13.5	12.3	9.8	9.7	13.9	14.0	56.2	9.6	21.9	67.3	8.4	24.9	12.3	35.1	23.9	0.8	10.7	12.4	11.0	5.7	16.3	1.8	2.1	1.1	14.2	11.8	0.0	5.1	0.3	12.3	9.9	53.2	2.4	5.2	0.3	4.0	2.2	6.4	1.1	17.3	34.9	1.0	68.2	7.7	9.3	1.7	0.4	14.8	18.3	10.1	17.5	0.3	1.2	15.2	7.2	18.7	14.3	46.6	24.7	33.7	19.6	2.1	11.5	0.7	5.7	8.4	4.1	3.4	3.8	2.0	6.6	14.7	18.4	0.2	3.3	20.6	29.8	1.1	15.0	1.4	28.8	15.6
NOTCH4	INT3	ENSG00000204301	"Notch receptor 4"	Q99466	6	32194843-32224067	"Human disease related genes, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 24.2;breast: 19.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 263.8;Endothelial cells: 121.0;Hepatic stellate cells: 188.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA		6400000		"Cluster 82: Adipose tissue - ECM organization"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.13e-1)"	24.2	4.0	0.0	0.5	0.0	0.0	19.8	0.0	0.0	5.8	0.0	3.6	0.5	7.2	3.2	2.7	5.8	0.0	15.8	0.0	0.0	8.5	2.5	18.5	0.4	0.0	0.1	2.8	2.6	0.0	3.0	1.4	0.0	6.0	0.1	0.0	2.6	0.0	5.6	2.8	3.9	0.0	0.0	2.6	3.9	0.9	0.0	0.0	9.6	0.0	0.1	5.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	263.8	0.0	6.1	0.0	6.0	5.2	32.1	9.9	13.6	2.7	2.6	6.6	8.7	0.0	4.2	5.5	4.2	0.4	11.9	0.6	0.0	2.6	46.0	2.6	3.1	121.0	6.0	12.0	0.2	1.1	0.3	4.7	0.0	1.0	0.0	1.8	188.8	2.3	1.7	6.7	0.2	0.8	4.1	9.3	5.2	35.6	7.2	6.8	3.6	10.3	1.6	21.0	0.0	0.0	0.5	0.4	0.3	5.3	0.7	18.0	1.0	0.9	3.1	3.6	0.0	7.8	9.3	5.5	1.9	1.9	1.6	0.3	3.6	3.7	0.9	5.6
NOVA2	"ANOVA, NOVA-2, NOVA3"	ENSG00000104967	"NOVA alternative splicing regulator 2"	Q9UNW9	19	45933734-45974044	"Human disease related genes, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045607	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"HPA045607: AB_10962628"	"unprognostic (9.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.42e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.31e-2)"	6.7	1.9	12.4	0.7	15.1	0.0	5.7	0.5	16.7	3.2	0.0	1.8	0.6	3.4	0.6	1.4	2.9	1.4	6.7	16.0	5.8	4.7	1.0	9.3	0.5	4.6	3.0	1.2	1.1	1.0	6.2	3.9	3.6	2.3	0.5	5.6	1.1	0.8	2.3	1.1	1.7	2.0	0.6	1.5	1.5	2.0	4.6	0.4	4.5	2.5	0.2	2.5	2.0	9.8	0.0	0.1	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	1.3	0.0	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	15.1	0.5	16.7	16.0	5.8	4.6	3.0	3.6	0.6	4.6	9.8	39.4	0.0	0.0	5.9	0.1	0.6	0.2	0.0	0.6	56.7	0.1	0.5	3.4	1.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.1	32.0	0.0	0.0	21.8	0.2	0.0	1.2	0.0	0.1	0.0	0.1	42.5	0.5	0.1	21.9	20.9	0.0	0.0	1.6	1.5	3.5	0.0	0.1	0.0	9.4	0.0	1.3	0.0	11.6	9.5	0.2	0.0	0.4	1.2	0.3	0.0	0.0	0.0	3.3	0.0	0.6	0.6	2.4	2.3	0.3	0.1	0.0	0.5	0.4	0.0	0.3
NOX4	"KOX, KOX-1"	ENSG00000086991	"NADPH oxidase 4"	Q9NPH5	11	89324353-89498187	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 138.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 164.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 14.3;HUVEC TERT2: 27.7;TIME: 70.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (8.95e-3)"	"unprognostic (3.80e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.99e-4)"	"unprognostic (9.71e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.03e-3)"	7.8	0.7	0.7	0.7	1.2	0.2	3.8	0.7	1.2	1.5	0.0	1.2	0.2	4.9	0.4	0.4	1.3	2.4	7.6	0.4	0.6	138.0	0.3	1.5	0.2	1.0	0.7	0.8	0.3	3.6	0.9	3.1	0.9	1.0	0.3	17.1	3.0	1.3	1.7	1.4	0.6	3.4	0.8	0.4	0.5	0.3	0.7	0.1	2.1	3.5	0.5	1.4	1.1	1.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.5	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.7	0.1	0.0	0.1	14.3	27.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	6.1	0.0	0.0	0.3	7.1	0.4	0.0	70.6	0.2	5.0	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	1.2	0.7	1.2	0.4	0.6	1.0	0.7	0.9	0.8	0.7	1.7	4.4	0.0	0.0	2.9	1.0	0.6	0.1	0.4	0.0	7.5	0.2	0.3	1.0	0.0	0.0	11.0	6.2	2.2	0.2	0.1	15.6	0.0	0.8	1.0	1.4	5.9	0.0	0.0	30.0	0.0	0.8	9.2	0.0	3.0	0.0	0.6	2.5	0.1	0.2	0.0	21.1	0.0	0.0	0.0	0.5	0.7	0.3	1.3	0.0	6.5	0.1	4.5	0.0	7.1	28.4	0.1	0.0	1.2	0.3	0.1	0.0	164.0	0.0	27.1	0.0	1.2	1.0	0.6	0.7	0.1	0.3	2.5	1.1	0.1	0.0	0.1
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541330	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 54.2;liver: 48.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 12.3;Hepatocytes: 44.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 6.8;Hep G2: 17.9;SCLC-21H: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB070127, CAB070128"	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.6	0.1	0.4	0.0	0.7	0.0	0.4	0.9	1.1	0.6	0.3	1.6	54.2	0.4	0.0	0.4	0.5	5.8	0.1	0.7	0.2	0.9	48.1	0.2	0.0	0.3	0.4	0.6	0.6	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.1	0.1	0.1	0.3	50.5	0.1	0.3	0.0	1.5	1.1	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.9	1.1	0.7	0.2	0.3	0.4	0.4	0.3	0.3	0.6	0.2	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.8	0.8	5.7	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.3	12.3	0.3	0.1	0.2	1.8	2.7	0.3	0.5	0.0	0.2	0.0	0.5	0.0	0.0	1.4	44.7	0.0	0.0	0.1	0.3	0.0	1.0	0.3	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.2	3.4	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3	0.1	0.3	0.7	0.2	0.1
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1 adhesion molecule, nephrin"	O60500	19	35825372-35869287	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 41.5;pancreas: 22.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;JURKAT: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.3	0.0	0.4	0.6	0.9	0.2	0.0	0.8	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	41.5	0.1	0.0	3.9	0.4	0.4	0.0	22.8	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.6	0.7	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.8	0.4	0.4	0.2	0.4	0.4	0.5	0.1	0.6	0.7	0.3	0.0	0.5	0.0	0.2	0.8	0.8	0.0	0.6	5.0	0.3	0.3	1.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.3	13.5	4.5	0.4	0.7	0.0	0.0	0.7	2.4	0.0	5.1	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.1	6.9	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.4	0.5	0.8	0.4	0.1	0.4	0.0	0.3	0.0	0.1	0.3
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2 stomatin family member, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"kidney: 255.0"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 20.2;Early spermatids: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"NTERA-2: 1.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB037267, HPA049486"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
NPL	"C1orf13, DHDPS1, NPL1"	ENSG00000135838	"N-acetylneuraminate pyruvate lyase"	Q9BXD5	1	182789293-182830384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 52.3;placenta: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.1;Cytotrophoblasts: 123.1;Hofbauer cells: 481.5;Kupffer cells: 148.8;Microglial cells: 125.5;Proximal tubular cells: 141.0;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 423.2"	"Group enriched"	"Detected in many"	34	"granulocytes: 423.2;monocytes: 128.4"	"Cell line enhanced"	"Detected in many"		"HEL: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028345, HPA075808"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		190000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Plasma membrane"	"HPA028345: AB_10610145, HPA075808: "	"unprognostic (2.43e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.05e-4)"	"unprognostic (4.41e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (6.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.44e-2)"	12.7	5.8	16.7	19.2	20.8	18.9	5.5	19.3	22.9	4.3	11.1	6.9	2.8	1.7	29.9	10.0	3.3	13.0	2.6	12.7	15.6	52.3	20.8	14.5	32.5	19.6	20.1	1.4	2.8	3.3	1.7	45.2	18.9	2.3	9.1	1.9	4.2	6.2	1.7	8.4	4.4	7.5	15.8	28.7	5.0	5.1	27.0	6.2	2.6	2.8	14.7	15.5	5.1	22.0	3.4	0.6	1.0	0.0	2.8	2.8	0.9	1.1	2.1	1.2	0.6	0.0	1.4	9.0	1.5	0.0	0.0	1.3	1.9	2.4	0.3	0.0	1.5	14.2	0.4	0.1	1.5	5.4	8.1	2.2	9.1	0.2	0.0	0.1	0.1	10.1	10.9	13.8	2.1	1.1	0.3	3.5	11.0	7.0	1.1	1.4	0.7	11.0	0.2	7.4	3.1	4.6	5.0	0.3	4.7	1.1	2.9	8.7	0.2	1.1	2.4	0.7	0.1	9.8	12.7	9.0	2.4	9.5	3.6	25.5	128.4	104.1	5.5	118.2	4.8	1.8	4.5	4.9	7.6	6.3	3.5	4.9	423.2	0.3	96.6	1.5	8.1	65.4	16.7	20.8	19.3	22.9	12.7	15.6	19.6	20.1	18.9	15.8	27.0	22.0	2.9	0.0	5.5	170.1	4.9	6.1	4.0	8.6	1.8	7.6	1.5	4.4	2.9	2.8	4.8	7.3	2.1	123.1	2.2	2.3	19.6	1.2	19.1	0.4	0.6	3.5	1.8	45.5	7.5	2.4	6.1	2.5	3.1	0.2	5.7	0.5	72.8	3.9	481.5	6.7	13.5	1.4	6.1	148.8	11.5	27.0	0.9	91.7	10.6	125.5	40.1	2.8	5.2	22.1	21.0	1.3	0.3	0.4	0.7	1.6	0.9	141.0	1.7	2.8	0.0	1.7	1.7	16.5	8.9	16.5	7.1	107.4	3.1	3.4	1.6	4.3
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 137.0;thyroid gland: 234.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	22.8	6.3	9.7	5.6	7.9	0.2	27.0	4.7	8.0	32.4	5.7	24.5	56.1	20.9	22.2	10.9	22.4	30.5	5.2	7.5	14.6	105.0	4.0	137.0	4.5	6.1	31.8	10.9	40.1	1.0	47.4	3.4	9.2	82.9	25.2	2.4	8.9	18.7	4.9	8.2	74.1	14.1	4.4	14.8	14.9	3.1	10.5	14.2	234.5	11.5	5.4	9.7	22.1	6.6	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	7.9	4.7	8.0	7.5	14.6	6.1	31.8	9.2	4.4	10.5	6.6	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	84.6	95.7	81.4	75.9	104.4	32.7	82.6	52.1	176.7	112.4	72.4	133.0	134.9	180.7	150.9	133.9	135.0	97.2	196.4	122.6	65.6	126.5	74.0	110.5	48.7	42.9	42.2	79.1	96.6	167.2	47.1	123.1	39.8	170.8	142.0	135.5	101.0	204.4	51.2	68.1	124.9	298.4	28.5	71.8	96.4	69.2	60.4	42.6	112.4	70.1	69.4	140.6	84.9	87.9	101.9	179.1	100.9	74.5	201.6	180.7	141.1	229.1	373.5	258.3	228.4	122.4	317.7	58.7	133.0	331.2	319.2	411.1	164.4	191.3	147.6	105.6	109.3	46.7	83.3	110.2	143.1	72.6	124.9	149.1	165.2	167.4	100.7	254.8	139.5	52.0	26.7	65.2	187.2	81.2	32.4	45.3	93.5	127.3	63.3	52.1	115.8	49.9	353.7	148.3	61.6	19.2	222.4	122.4	151.3	249.6	110.9	97.7	159.0	199.7	133.8	116.0	135.8	56.5	113.8	51.4	185.8	111.0	140.0	5.9	13.5	13.8	6.4	18.5	5.2	3.8	3.6	5.9	5.3	2.9	3.6	4.2	28.0	3.9	14.8	5.5	4.3	13.6	81.4	104.4	52.1	176.7	122.6	65.6	42.9	42.2	39.8	28.5	60.4	87.9	67.1	76.9	66.0	72.1	18.3	65.0	27.0	43.3	51.2	93.0	50.5	45.7	106.9	48.6	60.6	82.8	50.1	7.0	28.8	133.8	1.9	18.1	3.7	73.4	46.7	44.6	103.0	7.4	216.6	24.0	9.2	64.5	41.3	92.1	28.4	33.9	50.0	43.1	25.0	38.7	162.7	90.9	42.7	77.4	46.6	9.9	15.2	61.8	42.7	86.2	43.4	41.2	12.3	63.8	67.4	41.4	66.7	38.4	20.2	26.9	52.3	20.7	92.1	49.7	19.7	35.5	74.0	11.7	10.8	61.9	54.6	6.8	23.9	35.3	52.6	30.7
NPY1R	NPYR	ENSG00000164128	"Neuropeptide Y receptor Y1"	P25929	4	163323962-163344832	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 119.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 32.8;Excitatory neurons: 39.8;Hepatic stellate cells: 160.6;Sertoli cells: 46.0;Smooth muscle cells: 34.1"	"Cancer enriched"	"Detected in many"	13	"breast cancer: 65.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HEL: 128.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"prognostic favorable (7.68e-5)"	"unprognostic (9.14e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.21e-1)"	30.5	31.0	10.4	2.9	13.1	0.0	32.4	0.0	13.7	7.8	0.0	5.8	1.0	7.3	10.2	1.8	8.4	4.5	4.8	9.1	19.7	32.3	14.7	2.1	17.3	0.3	0.8	2.8	28.7	3.6	3.0	5.2	0.4	2.5	4.5	4.4	21.4	8.3	2.9	9.8	1.5	5.7	5.7	119.6	1.8	4.1	2.2	1.1	7.9	2.6	0.9	1.8	4.9	9.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	7.0	0.0	0.0	0.0	0.0	128.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.9	0.0	0.1	0.4	0.0	0.0	1.2	0.0	4.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.4	3.0	0.0	0.0	0.1	1.2	0.0	0.6	0.1	0.0	0.0	1.4	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	10.4	13.1	0.0	13.7	9.1	19.7	0.3	0.8	0.4	5.7	2.2	9.0	2.1	0.0	0.5	1.3	0.7	2.8	0.7	0.0	3.4	11.6	19.2	3.3	0.9	1.5	0.0	0.0	2.1	0.0	0.0	3.4	13.7	12.5	5.0	0.0	0.4	10.8	32.8	0.0	39.8	0.0	0.0	5.1	0.0	0.1	0.0	3.7	160.6	0.9	0.1	0.0	18.8	1.6	0.0	7.2	0.9	2.4	11.5	0.1	5.4	4.7	0.0	1.1	0.0	2.0	1.4	0.1	15.9	0.4	0.0	0.5	0.1	0.1	0.0	2.1	46.0	1.1	34.1	0.5	0.6	0.1	1.7	0.0	0.6	0.5	2.1	0.3
NPY5R	NPYR5	ENSG00000164129	"Neuropeptide Y receptor Y5"	Q15761	4	163343892-163351934	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 7.2;lymphoid tissue: 8.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.6;Granulosa cells: 1.4;Inhibitory neurons: 3.5;Smooth muscle cells: 3.1;Spermatocytes: 3.0"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 64: Macrophages - Immune response"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (4.63e-6)"		"unprognostic (3.00e-1)"		"unprognostic (2.79e-1)"		"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"			"unprognostic (3.74e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-1)"	7.2	3.3	0.9	0.3	2.2	0.0	1.7	0.0	1.5	0.7	0.0	0.3	0.0	0.7	1.0	0.2	0.8	0.5	0.7	1.1	2.8	4.6	1.0	0.3	2.4	0.2	0.4	0.2	1.0	0.7	0.3	2.9	0.2	0.2	0.3	0.2	3.7	0.9	0.1	0.8	0.1	0.7	1.1	8.8	0.2	5.1	0.8	0.1	0.7	0.4	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.0	1.5	1.1	2.8	0.2	0.4	0.2	1.1	0.8	0.6	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.5	0.0	0.0	4.6	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	3.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3019755	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 202.5;Proximal tubular cells: 730.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 240.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	60.0	121.5	48.1	27.0	48.8	72.1	45.0	61.1	65.4	32.6	64.3	28.2	35.3	25.8	32.9	32.8	30.0	31.5	76.5	48.5	49.6	190.3	124.2	30.4	19.5	61.8	47.9	29.8	42.6	33.5	21.2	28.6	61.4	28.1	19.6	31.1	61.9	28.9	123.6	50.7	35.6	19.8	42.9	39.3	36.1	18.2	51.5	18.3	26.8	144.9	18.2	31.8	29.0	53.2	45.7	75.7	42.1	95.3	73.0	42.9	45.4	40.5	51.2	37.1	40.9	80.0	16.1	36.9	144.7	71.1	86.4	33.7	45.4	28.5	28.9	95.9	37.1	23.6	83.0	77.3	59.7	24.4	73.9	27.8	34.2	44.9	40.9	53.4	36.8	47.9	142.3	24.1	30.8	95.5	27.0	44.4	54.9	87.6	59.8	49.3	50.1	108.2	56.6	24.0	11.4	15.9	59.5	25.9	128.9	75.0	35.4	16.9	60.7	34.8	14.4	45.9	18.1	45.4	116.7	12.3	43.3	69.5	72.7	25.2	91.8	52.8	33.1	64.2	24.4	12.1	29.6	29.8	61.7	9.1	17.8	19.6	240.2	30.0	60.8	6.5	37.2	43.2	48.1	48.8	61.1	65.4	48.5	49.6	61.8	47.9	61.4	42.9	51.5	53.2	30.3	9.6	16.1	9.8	16.3	35.2	41.5	32.7	12.5	34.8	34.2	32.1	72.8	47.1	21.3	25.8	10.4	42.6	18.2	21.2	162.4	29.1	51.6	15.1	21.4	28.0	4.8	43.8	47.0	63.4	53.9	51.5	33.1	9.0	13.9	11.0	25.7	202.5	76.6	42.1	46.7	23.3	30.5	44.7	105.7	62.8	35.8	75.4	67.6	19.7	148.6	54.0	20.6	10.6	9.1	55.8	18.3	41.0	15.0	38.6	103.7	730.3	28.7	22.5	26.3	35.0	42.9	24.8	11.4	35.4	41.2	31.2	20.8	21.9	25.4	41.8
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913975	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Receptor, Repressor"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.9;liver: 142.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 97.2;Distal tubular cells: 52.8;Exocrine glandular cells: 42.4;Gastric mucus-secreting cells: 90.2;Hepatocytes: 173.4;Proximal enterocytes: 49.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 52.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"Hep G2: 78.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.7"	"Not detected"	"Not detected"			HPA003983			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm	Vesicles	"HPA003983: "	"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.0	21.4	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	76.9	0.0	0.0	0.0	0.0	10.1	12.9	0.0	0.0	33.8	142.4	2.4	0.0	0.0	0.0	0.0	30.6	1.6	0.3	0.0	0.1	0.0	0.4	0.2	0.0	0.0	2.7	0.0	26.5	0.0	0.0	11.5	26.4	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	78.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.3	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	15.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	8.4	97.2	0.7	12.9	0.0	0.0	0.0	0.9	52.8	31.3	0.4	0.1	0.0	0.2	24.4	8.0	0.0	42.4	0.0	0.3	90.2	0.0	0.0	3.0	2.5	173.4	0.1	28.6	0.0	7.6	16.2	3.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.2	0.3	0.0	0.2	0.0	49.8	0.1	0.0	0.4	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.3	0.1	11.0	0.2
NR1I3	"CAR, CAR1, MB67"	ENSG00000143257	"Nuclear receptor subfamily 1 group I member 3"	Q14994	1	161229666-161238244	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 169.9"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 134.8;Proximal tubular cells: 47.1"	"Cancer enriched"	"Detected in single"	67	"liver cancer: 17.6"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA051365			Approved	Nucleoplasm		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA051365: AB_2616454"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.92e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.62e-2)"	0.1	0.1	0.2	0.0	2.2	0.6	0.0	0.4	1.0	0.1	0.0	0.1	2.4	0.1	0.0	0.2	0.1	0.0	0.4	0.1	0.0	10.0	169.9	0.2	0.2	0.2	0.1	0.1	0.2	0.0	1.7	0.0	0.3	0.1	0.0	1.0	0.0	0.0	1.5	1.2	3.6	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.1	0.4	0.4	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.8	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.9	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.2	0.0	0.3	0.1	0.2	0.7	0.7	0.5	0.4	0.3	0.2	0.0	0.7	0.8	0.6	0.1	1.2	0.1	0.5	0.8	0.5	0.8	0.2	0.3	0.6	0.1	0.6	1.0	0.5	0.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.4	1.0	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.6	0.8	22.4	11.7	0.0	1.3	0.6	1.2	0.1	0.0	0.7	0.2	0.1	0.5	5.7	5.0	3.7	0.0	0.1	0.2	0.2	3.9	0.1	1.7	0.1	0.2	2.3	0.0	8.0	0.4	0.0	0.2	1.9	0.0	0.1	13.3	0.1	3.9	134.8	0.3	0.0	0.6	0.0	0.0	4.1	1.1	3.1	0.3	1.8	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.1	0.0	0.4	0.8	0.5	5.0	47.1	4.4	1.6	0.0	2.4	0.5	0.2	0.2	0.0	0.0	0.0	1.6	0.1	0.3	0.9
NR2F1	"COUP-TFI, COUPTF1, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1"	ENSG00000175745	"Nuclear receptor subfamily 2 group F member 1"	P10589	5	93583222-93594611	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 294.1;Hepatic stellate cells: 171.4;Leydig cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 232.4;AN3-CA: 92.9;HHSteC: 174.1;hTERT-RPE1: 155.1;PC-3: 194.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019281, HPA058974"			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	Cytosol	"CAB019281: , HPA058974: AB_2732629"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.75e-1)"	"unprognostic (7.68e-3)"	"unprognostic (3.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.24e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (1.47e-4)"	42.2	40.3	41.8	5.0	39.0	0.2	20.4	32.9	50.7	65.1	12.8	11.3	2.6	29.4	25.2	10.4	77.9	34.3	16.1	44.7	25.6	32.8	13.0	44.4	8.3	31.6	41.1	62.7	7.6	1.6	21.6	52.6	23.8	44.9	3.0	8.7	6.9	40.3	0.3	2.0	7.4	11.8	31.5	7.2	28.8	3.8	42.4	2.1	16.9	3.6	3.8	49.1	40.6	30.8	20.1	9.5	232.4	92.9	48.3	14.8	11.0	11.6	4.7	6.9	7.1	1.3	3.6	0.1	0.7	4.7	2.8	5.0	5.7	0.4	3.0	24.7	45.2	9.2	61.9	15.1	174.1	1.9	0.9	69.7	0.1	3.3	1.3	155.1	26.3	0.1	0.1	0.1	21.4	0.1	0.0	2.7	0.1	1.4	194.2	2.8	1.9	0.1	1.4	0.8	23.9	48.4	5.2	0.0	0.6	4.0	1.9	3.7	26.7	39.3	1.8	20.6	29.4	0.0	0.0	0.1	64.2	0.8	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.8	39.0	32.9	50.7	44.7	25.6	31.6	41.1	23.8	31.5	42.4	30.8	16.1	0.0	1.7	68.2	1.5	1.3	0.2	0.4	1.8	32.8	3.8	2.4	37.3	1.5	3.5	14.7	54.2	0.6	0.0	0.2	7.9	4.0	3.8	10.1	294.1	70.1	0.0	0.0	23.3	1.6	0.6	69.1	0.5	5.7	0.0	29.7	171.4	5.0	1.3	0.0	47.1	0.0	0.0	15.8	0.4	5.9	93.5	1.9	0.0	59.0	0.0	69.0	0.0	13.0	1.7	3.6	0.0	10.5	0.0	0.5	0.1	37.3	10.8	3.7	13.1	2.9	51.6	4.8	4.4	2.8	0.6	1.1	2.2	11.8	0.0	0.6
NR2F2	"ARP1, COUP-TFII, COUPTF2, COUPTFB, NF-E3, SVP40, TFCOUP2"	ENSG00000185551	"Nuclear receptor subfamily 2 group F member 2"	P24468	15	96325938-96340263	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 292.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 542.2;Hepatic stellate cells: 395.5;Leydig cells: 510.4;Peritubular cells: 610.5;Sertoli cells: 486.4;Smooth muscle cells: 385.7;Theca cells: 572.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058974			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA058974: AB_2732629"	"unprognostic (9.28e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.28e-2)"	95.5	43.1	32.7	18.8	19.2	0.1	59.7	15.0	19.6	128.6	23.5	52.6	21.5	120.9	61.8	22.1	101.5	65.7	44.4	20.0	24.8	79.8	32.1	56.8	42.4	16.2	21.9	292.4	20.0	30.7	20.3	74.7	18.2	60.6	26.7	2.5	22.9	126.4	33.1	24.1	32.1	81.8	12.5	106.2	82.3	26.7	49.3	7.8	46.2	31.5	15.1	46.3	74.5	10.7	154.7	39.1	125.6	78.5	249.1	85.5	41.9	109.1	83.2	111.1	94.3	134.8	153.4	0.1	86.8	55.2	44.1	90.4	22.3	78.3	138.8	0.5	86.5	49.9	48.7	24.6	69.5	38.7	18.0	61.3	26.5	92.5	19.8	130.5	207.3	0.1	135.3	0.4	71.2	105.5	0.1	27.6	1.2	59.6	52.7	0.1	30.9	0.2	244.7	165.7	15.8	0.2	12.3	3.7	17.5	55.0	61.1	2.8	215.3	119.9	39.7	28.3	38.8	0.1	0.4	0.4	67.0	18.9	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	19.2	15.0	19.6	20.0	24.8	16.2	21.9	18.2	12.5	49.3	10.7	133.4	28.9	18.1	0.7	1.1	14.4	24.9	71.7	39.3	7.5	51.9	50.8	46.4	203.0	34.6	62.5	25.0	126.2	2.0	35.7	46.9	22.0	3.2	70.9	542.2	166.1	26.4	5.3	0.1	10.9	50.3	125.8	80.0	68.9	0.0	41.5	395.5	51.6	10.3	3.3	24.8	35.5	32.6	12.2	20.1	22.9	510.4	5.0	26.6	36.5	0.6	30.2	0.0	0.0	0.5	15.6	23.9	610.5	2.8	22.3	14.3	65.5	37.3	13.8	486.4	27.8	385.7	6.4	7.9	20.5	10.4	35.3	5.8	572.5	27.1	21.3
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027614-200177420	"Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 17.8;liver: 38.6;pancreas: 61.1"	"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 276.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	5.4	0.4	0.5	2.6	0.2	0.9	3.7	0.5	0.3	3.4	0.2	11.9	17.4	3.3	1.4	0.9	2.2	8.0	1.0	0.3	2.8	0.7	38.6	2.7	2.1	0.7	0.6	1.0	61.1	0.4	0.1	0.4	0.8	1.6	13.1	0.2	0.5	0.8	1.1	1.1	17.8	4.3	0.4	0.2	1.3	0.8	0.8	0.5	0.9	0.7	1.4	1.8	1.2	0.7	0.0	25.0	0.0	0.1	0.0	0.2	0.6	0.0	0.4	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.7	0.7	14.9	0.0	0.0	3.3	1.1	0.0	0.3	2.7	0.5	0.1	6.4	0.1	0.0	0.0	0.1	0.0	20.4	0.1	0.0	0.3	0.0	0.6	0.0	0.4	0.9	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.7	4.7	0.3	0.1	1.0	0.2	0.1	0.2	3.4	2.3	2.6	0.3	0.2	0.1	3.2	0.4	0.4	0.2	0.2	0.2	0.3	0.3	0.3	0.1	0.4	0.4	0.3	1.5	0.5	0.2	0.5	0.4	0.1	0.5	0.2	0.5	0.3	0.3	2.8	0.7	0.6	0.8	0.4	0.8	0.7	23.7	0.0	1.7	0.3	0.2	1.9	0.1	0.0	0.0	0.2	0.2	0.0	9.9	32.9	0.0	0.0	0.0	0.0	0.3	37.5	0.0	38.2	0.4	0.3	0.3	32.4	4.9	2.7	0.4	54.5	0.0	0.8	0.0	0.2	13.3	276.2	38.6	38.5	0.1	0.0	0.6	13.8	0.0	4.9	1.5	0.3	0.6	0.6	0.0	0.0	3.1	0.0	0.0	1.0	0.3	22.0	21.8	0.0	1.2	0.3	49.9	0.0	0.8	0.3	0.0	0.5	6.1	0.1	0.1	0.0	1.4	0.0	0.3	0.1	32.3	0.2
NRIP3	C11orf14	ENSG00000175352	"Nuclear receptor interacting protein 3"	Q9NQ35	11	8980576-9004049	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.9;retina: 24.5;testis: 43.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 545.3;Horizontal cells: 242.3;Late spermatids: 478.6;Spermatocytes: 189.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 13.1"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 51.4;SiHa: 34.3;U-87 MG: 47.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058827, HPA072961"	Approved		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA058827: AB_2683829, HPA072961: "	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.03e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.88e-3)"	"unprognostic (1.30e-1)"	1.1	10.2	16.7	1.6	13.4	13.8	3.9	23.2	42.1	3.4	0.0	1.5	0.5	3.2	3.1	0.8	2.2	1.6	1.2	72.9	20.8	1.4	0.2	0.8	0.8	20.5	18.4	0.5	0.4	5.4	1.5	0.8	23.6	0.7	0.6	24.5	0.6	0.9	0.3	0.6	0.6	2.3	25.1	0.5	2.5	43.5	31.6	0.9	0.9	0.2	0.6	1.3	0.7	17.2	0.0	0.9	1.9	0.3	0.7	2.7	0.1	20.3	8.0	16.2	16.9	3.1	1.8	0.1	3.0	5.9	9.6	0.2	5.5	0.5	28.0	1.7	8.5	2.2	1.2	0.2	1.4	26.5	51.4	3.7	0.3	16.7	0.1	17.1	13.3	4.4	4.2	0.2	15.0	0.0	1.3	8.6	6.6	0.1	0.0	0.0	2.8	0.0	0.3	1.2	5.4	1.7	34.3	0.9	5.3	1.4	3.5	2.5	16.6	24.7	11.8	1.4	0.1	0.1	0.0	0.0	47.9	3.1	12.3	13.1	0.1	2.0	0.1	0.3	0.2	0.1	0.5	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	1.1	0.3	16.7	13.4	23.2	42.1	72.9	20.8	20.5	18.4	23.6	25.1	31.6	17.2	4.0	0.0	1.3	1.0	1.7	2.2	5.7	0.5	0.0	19.6	12.1	8.9	1.6	0.0	0.4	0.0	10.4	0.4	7.4	0.6	5.9	0.4	545.3	3.7	4.1	2.5	5.3	2.7	11.5	1.1	0.5	2.5	7.1	6.6	15.8	2.4	0.0	0.0	12.1	242.3	96.3	0.5	8.2	3.1	17.2	478.6	6.8	12.8	3.6	0.0	0.6	4.4	0.0	4.5	1.6	8.2	0.1	5.7	1.2	3.5	0.1	0.0	0.1	10.6	0.0	6.0	3.6	189.8	44.0	0.9	1.0	1.0	5.5	5.6	0.2	4.2
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822539-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.1;ovary: 32.5;placenta: 24.2"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 79.4;Leydig cells: 113.4;Syncytiotrophoblasts: 67.9;Theca cells: 70.2"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	11	"cerebellum: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 58.1;HSkMC: 10.6;RH-30: 12.8;RPTEC TERT1: 34.8;SuSa: 40.5"	"Region enriched"	"Detected in single"	28	"cerebellum: 14.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.6"	HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Cytosol"		"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	0.8	16.1	0.0	0.9	0.0	0.0	0.7	7.0	0.3	1.8	0.0	1.4	0.1	1.7	4.6	0.6	0.9	10.1	3.5	0.0	0.1	6.2	0.1	0.2	0.0	0.1	0.6	32.5	0.4	0.1	0.3	24.2	0.5	4.9	0.3	0.1	1.1	0.9	0.2	0.1	0.3	1.7	0.1	0.0	0.5	3.3	0.0	0.1	0.2	3.3	0.0	1.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	10.6	0.0	0.1	0.0	3.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.8	0.0	34.8	0.7	0.0	0.2	0.0	1.8	0.0	40.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.1	0.1	0.6	0.5	0.1	0.0	0.4	3.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.0	1.2	1.0	4.8	0.0	0.0	0.0	0.0	79.4	0.0	0.2	19.6	0.2	1.3	0.0	3.2	0.7	0.0	0.0	0.9	0.0	10.1	8.9	0.0	0.0	0.0	2.1	0.0	0.0	7.1	0.0	0.9	0.0	0.0	0.0	0.0	2.6	113.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.5	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.7	1.6	1.7	0.1	0.0	67.9	0.0	70.2	0.2	0.1
NRN1	NRN	ENSG00000124785	"Neuritin 1"	Q9NPD7	6	5997999-6007605	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.9;parathyroid gland: 81.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 262.9;Endothelial cells: 115.3;Excitatory neurons: 71.9;Extravillous trophoblasts: 64.7;Hepatic stellate cells: 160.3"	"Cancer enhanced"	"Detected in all"		"glioma: 38.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"MAIT T-cell: 2.6;neutrophil: 2.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.2;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 140.0;ASC TERT1: 107.6;fHDF/TERT166: 147.5;JURKAT: 134.8;REH: 196.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		23000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (6.24e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.37e-3)"	66.4	5.1	49.1	6.4	44.9	0.5	64.2	46.0	80.8	16.2	17.0	21.3	3.7	9.4	4.0	8.2	13.6	11.2	19.7	98.9	27.7	8.2	4.4	15.6	9.6	30.4	29.9	4.7	2.9	81.0	12.3	42.1	32.5	10.1	4.7	23.4	8.7	7.4	17.3	18.8	10.8	10.5	22.1	15.7	10.3	0.6	60.1	3.6	9.4	16.1	3.5	13.8	17.0	45.9	16.7	0.6	1.4	0.1	140.0	107.6	19.1	2.6	0.0	11.8	16.1	0.2	0.1	0.0	2.5	147.5	25.0	0.5	43.3	0.0	11.4	26.1	21.2	13.7	0.0	0.0	0.0	58.0	43.7	17.3	0.0	10.5	0.0	0.1	57.4	134.8	0.2	0.6	42.5	0.1	89.7	2.6	0.1	0.0	0.0	196.3	47.7	0.4	0.2	0.2	24.9	9.2	0.0	0.8	13.9	0.2	0.4	16.4	12.1	56.4	1.6	21.4	36.5	0.1	2.2	0.9	85.8	0.2	8.9	0.0	0.1	0.0	0.1	0.1	2.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.2	0.0	0.1	49.1	44.9	46.0	80.8	98.9	27.7	30.4	29.9	32.5	22.1	60.1	45.9	262.9	0.0	1.3	7.2	1.6	10.5	0.1	0.0	1.2	6.7	1.4	2.4	2.5	1.5	0.0	0.0	2.1	1.5	1.0	0.0	0.0	0.1	0.1	0.0	0.1	115.3	0.0	0.0	71.9	0.5	64.7	15.9	0.0	0.1	0.0	0.0	160.3	0.9	1.8	3.3	3.0	0.0	0.0	4.1	21.5	0.4	0.9	1.4	16.0	8.4	0.5	4.5	0.0	13.6	8.3	0.2	0.0	0.0	1.4	0.4	0.0	0.0	0.0	20.2	0.0	4.4	18.3	0.4	0.3	0.6	11.2	1.4	1.9	0.1	0.0	0.7
NSG1	"D4S234E, NEEP21, P21"	ENSG00000168824	"Neuronal vesicle trafficking associated 1"	P42857	4	4348140-4419058	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.7;pituitary gland: 135.1;skin 1: 120.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 222.4;Cytotrophoblasts: 120.2;Granulosa cells: 128.8;Melanocytes: 291.7;Suprabasal keratinocytes: 178.2"	"Cancer enriched"	"Detected in many"	4	"melanoma: 61.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 45.2;MAIT T-cell: 61.9;memory CD4 T-cell: 42.2;memory CD8 T-cell: 37.1;naive CD8 T-cell: 27.6"	"Lineage enriched"	"Detected in many"	57	"T-cells: 61.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 84.7;SCLC-21H: 168.6;SH-SY5Y: 82.5;SK-MEL-30: 80.9;TIME: 204.6;U-698: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"				"unprognostic (3.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (9.49e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.41e-2)"	5.0	25.3	29.0	4.2	33.1	1.0	6.0	59.6	50.7	17.1	5.3	7.9	6.8	7.8	2.1	30.7	20.1	1.3	5.9	18.4	95.7	4.4	0.5	1.5	3.2	57.1	64.8	46.3	1.8	0.1	135.1	18.3	58.8	22.8	7.1	32.3	6.7	18.2	0.7	120.9	5.8	6.9	24.2	2.2	8.0	16.0	45.4	9.5	0.5	3.0	3.5	13.3	30.1	24.2	0.2	0.1	0.8	0.5	0.0	0.0	14.6	0.3	0.0	0.2	0.0	1.3	0.4	0.0	10.4	0.5	3.3	2.4	84.7	5.5	0.4	0.0	3.0	0.0	0.2	0.0	4.1	0.0	0.0	0.1	12.0	0.0	2.3	0.0	14.6	22.3	0.0	0.1	1.3	0.0	6.8	0.5	10.1	0.1	0.4	0.1	0.0	0.4	0.0	4.8	168.6	82.5	0.6	0.2	80.9	7.0	0.9	0.3	204.6	0.0	13.0	0.2	0.3	0.1	0.4	75.9	0.1	0.2	0.4	0.2	0.1	0.1	45.2	0.1	61.9	0.1	42.2	37.1	0.1	0.1	10.4	27.6	1.0	0.9	0.2	0.1	4.5	15.7	29.0	33.1	59.6	50.7	18.4	95.7	57.1	64.8	58.8	24.2	45.4	24.2	1.6	9.6	0.0	5.9	0.4	86.8	83.4	47.9	31.3	222.4	0.7	24.3	0.0	0.0	13.2	0.0	4.2	120.2	6.0	0.0	0.0	0.0	31.2	10.3	1.4	2.1	2.4	0.0	16.6	0.0	15.2	24.9	0.0	16.4	1.3	128.8	1.8	0.0	8.2	8.4	32.2	0.0	4.1	0.0	13.6	44.2	3.1	1.3	291.7	6.5	0.4	6.4	20.6	1.5	4.0	0.1	0.2	5.7	0.7	19.9	0.0	20.4	1.7	24.3	0.0	0.2	10.8	2.9	14.4	44.8	178.2	76.8	17.0	96.0	0.3	77.0
NTF3	NGF2	ENSG00000185652	"Neurotrophin 3"	P20783	12	5432108-5521536	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.5;Basal prostatic cells: 36.6;Basal squamous epithelial cells: 89.4;Prostatic glandular cells: 20.5;Sertoli cells: 32.9;Smooth muscle cells: 24.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Group enriched"	"Detected in some"	5	"cerebellum: 3.4;cerebral cortex: 1.3;hippocampal formation: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 11.4;BJ hTERT+ SV40 Large T+: 14.8;BJ hTERT+ SV40 Large T+ RasG12V: 19.7;HBF TERT88: 18.0;RT4: 8.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 4.7;cerebral cortex: 2.0;hippocampal formation: 2.2"	HPA032001	Uncertain		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"HPA032001: AB_2674106"	"unprognostic (3.04e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.33e-3)"	"unprognostic (4.66e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (7.77e-4)"	"unprognostic (4.02e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.06e-3)"	"unprognostic (4.51e-3)"	4.2	1.8	0.2	0.7	0.4	0.0	2.7	3.4	1.3	6.6	0.2	1.8	1.9	1.9	2.0	3.4	2.9	1.8	3.1	1.2	0.3	2.6	7.7	1.6	0.3	0.4	0.2	11.1	0.2	0.1	1.0	1.9	0.3	3.6	1.0	0.1	3.1	2.4	1.8	3.2	2.5	0.9	0.3	4.5	2.5	0.8	0.1	0.4	0.9	1.0	0.4	4.6	7.0	0.2	1.9	0.0	6.7	0.0	0.0	0.0	0.0	4.5	11.4	14.8	19.7	0.1	0.2	0.0	6.7	7.3	0.0	2.4	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	4.5	4.7	8.5	0.3	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.2	0.1	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.4	1.3	1.2	0.3	0.4	0.2	0.3	0.3	0.1	0.2	1.0	0.0	0.0	0.0	0.0	18.5	36.6	0.7	89.4	0.0	0.2	10.3	0.9	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.2	0.2	1.4	0.0	0.0	0.1	0.0	0.1	6.1	0.0	0.1	0.0	0.0	5.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	2.1	0.1	8.4	0.3	7.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.9	0.0	20.5	0.2	0.0	0.8	0.0	32.9	6.8	24.0	0.5	0.8	5.0	3.3	0.1	0.5	0.5	0.2	6.9
NTNG1	"KIAA0976, Lmnt1"	ENSG00000162631	"Netrin G1"	Q9Y2I2	1	107140007-107484923	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 75.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 59.7;Excitatory neurons: 122.1;Inhibitory neurons: 162.5;Oligodendrocyte precursor cells: 425.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"thalamus: 75.1"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 48.7;fHDF/TERT166: 25.0;RPTEC TERT1: 27.4;U-138 MG: 21.8;U-251 MG: 16.9;U-87 MG: 24.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"hippocampal formation: 19.7;midbrain: 61.3;pons: 56.0;thalamus: 76.4"	HPA065954			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA065954: AB_2685585"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.38e-5)"	"unprognostic (1.93e-3)"	"unprognostic (9.87e-3)"		"unprognostic (3.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-5)"	3.1	4.4	17.2	0.2	3.8	0.0	0.2	6.3	6.7	3.2	0.0	2.2	0.0	0.6	0.0	0.1	0.4	0.6	0.1	7.8	15.2	8.8	0.0	3.8	0.4	5.8	28.3	0.4	0.1	0.1	2.5	1.1	4.6	3.4	0.4	10.3	0.2	4.7	0.0	1.3	0.4	0.1	3.2	0.3	0.2	0.4	75.1	0.5	0.1	0.2	0.6	4.0	1.8	2.7	0.0	0.0	2.8	0.0	5.0	48.7	0.0	13.9	2.1	1.2	1.1	0.0	0.0	0.0	0.6	25.0	0.0	0.0	0.0	1.5	2.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	13.9	0.3	3.5	1.8	14.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.0	0.0	6.1	0.0	3.1	0.0	27.4	0.0	0.3	0.4	0.0	0.0	0.0	0.8	0.0	0.1	0.2	21.8	4.3	8.1	16.9	0.1	0.0	0.0	24.8	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	17.2	3.8	6.3	6.7	7.8	15.2	5.8	28.3	4.6	3.2	75.1	2.7	0.2	0.0	0.0	46.4	3.1	0.5	6.5	0.4	0.0	59.7	0.1	0.0	0.9	0.0	0.2	7.3	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.1	0.8	0.9	0.0	0.0	122.1	0.0	0.0	2.8	0.0	0.4	0.0	6.1	0.4	0.0	0.0	0.0	162.5	0.0	6.1	0.0	1.3	1.8	8.1	0.0	1.8	18.7	0.0	1.0	0.0	425.3	2.5	0.3	0.0	0.0	1.0	1.1	0.0	0.0	0.0	2.9	6.6	0.2	2.7	0.2	1.1	0.1	0.6	0.0	0.1	7.2	0.0	4.3
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 7.0;brain: 21.7"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.5"	"Lineage enriched"	"Detected in single"	768	"granulocytes: 94.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 82.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.1"	"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		79000	"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	0.8	7.0	0.7	0.4	1.8	0.7	0.2	1.8	7.6	0.7	0.7	0.8	0.5	1.0	0.0	0.1	0.5	0.4	1.0	0.3	2.8	3.0	0.0	0.5	0.1	19.8	1.5	0.1	0.2	0.0	0.7	0.2	21.7	1.4	0.0	1.9	0.5	0.3	0.4	0.1	0.3	0.6	0.2	0.1	0.5	1.6	0.4	0.3	0.2	0.2	0.0	0.3	0.5	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	11.9	0.0	14.0	0.0	0.0	0.0	0.0	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	1.6	0.0	0.2	0.0	2.4	0.2	0.0	1.5	2.5	0.0	0.2	0.0	0.5	1.5	18.2	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	1.1	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.1	94.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.7	1.8	1.8	7.6	0.3	2.8	19.8	1.5	21.7	0.2	0.4	0.6	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	4.2	0.7	0.0	0.0	4.3	0.0	0.1	55.9	0.0	0.0	0.0	0.1	57.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.9	3.2	2.7	0.0	0.1	0.0	1.0	0.1	0.0	0.0
NTSR1	NTR	ENSG00000101188	"Neurotensin receptor 1"	P30989	20	62708836-62762771	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 11.2;intestine: 11.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.4;Cardiomyocytes: 1.1;Excitatory neurons: 1.6;Inhibitory neurons: 1.3;Kupffer cells: 2.9;Microglial cells: 1.0;monocytes: 1.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Region enriched"	"Detected in many"	7	"midbrain: 11.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"PC-3: 57.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050299			Supported	"Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA050299: "	"unprognostic (4.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.87e-4)"	"unprognostic (9.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.16e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	0.0	0.0	1.1	0.0	1.5	0.6	0.0	0.0	1.4	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	2.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	2.8	0.2	2.7	0.3	1.1	57.7	1.8	0.0	9.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.8	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	1.4	1.4	0.4	0.4	11.2	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	4.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.9	0.3	0.0	0.0	0.5	0.0	1.0	1.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242226-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol		No	No		21000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	19.1	8.0	13.7	23.8	16.6	77.6	15.0	14.6	18.0	16.9	10.9	19.1	16.2	12.4	5.4	29.1	12.0	10.5	18.7	15.4	13.6	8.9	6.3	12.4	37.1	16.1	14.1	9.3	9.1	3.2	4.4	10.5	15.6	11.3	11.0	4.3	12.4	7.0	21.3	33.8	16.8	9.2	15.0	23.6	12.2	65.5	14.5	59.4	7.6	13.5	31.5	14.6	18.5	17.9	98.4	155.2	83.3	111.0	30.0	41.3	61.0	42.3	36.5	57.0	65.8	84.2	72.1	102.8	33.7	47.0	115.5	117.1	63.8	64.3	33.1	46.2	109.4	80.6	136.3	72.7	7.2	63.2	78.0	27.4	16.7	82.3	29.0	18.6	31.0	147.1	65.0	111.6	64.5	250.2	119.1	245.3	179.5	48.5	94.7	163.5	123.4	86.4	31.7	54.9	83.5	115.6	43.7	126.9	20.8	59.8	83.9	165.8	29.1	54.2	205.1	126.8	102.3	85.2	70.6	108.9	54.6	155.1	199.8	31.5	60.2	44.4	42.8	78.6	34.3	71.0	49.6	45.6	94.3	65.1	48.9	42.3	16.2	39.4	66.8	211.5	75.5	45.7	13.7	16.6	14.6	18.0	15.4	13.6	16.1	14.1	15.6	15.0	14.5	17.9	13.0	6.4	7.5	1.0	34.2	40.1	26.5	22.6	14.8	11.2	25.3	39.0	16.8	10.0	13.7	11.0	4.2	38.5	46.1	39.6	19.6	24.3	54.7	14.9	24.3	12.8	7.8	111.7	0.5	37.4	80.0	29.6	13.7	10.7	61.0	32.4	7.9	5.2	89.4	0.0	0.5	35.7	32.6	46.2	86.7	121.2	22.1	52.6	46.2	0.0	47.1	27.4	47.4	1.0	4.3	20.4	18.4	18.8	33.1	21.5	17.3	14.1	13.0	7.9	32.9	27.5	32.4	70.2	54.8	41.0	37.1	23.7	37.3	13.7	45.1	27.3
NUGGC	"C8orf80, HMFN0672, SLIP-GC"	ENSG00000189233	"Nuclear GTPase, germinal center associated"	Q68CJ6	8	28021964-28083936	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"liver: 20.6;lymphoid tissue: 22.9"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 15.7;Plasma cells: 35.1;Proximal tubular cells: 7.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 3.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 116.5;Karpas-707: 38.6;U-698: 84.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (6.23e-2)"	"unprognostic (2.17e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.83e-4)"	"unprognostic (2.08e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.14e-2)"	0.4	0.3	1.2	6.2	0.6	0.9	0.8	1.2	1.8	0.1	2.7	1.9	1.9	0.2	0.2	0.4	0.3	0.4	0.2	1.1	1.1	5.1	20.6	0.8	18.7	1.8	1.2	0.5	0.2	0.0	0.0	0.1	1.7	0.3	1.5	0.3	1.3	0.2	0.3	0.5	2.3	0.1	0.1	2.7	2.6	0.4	0.7	0.5	2.1	0.0	22.9	1.6	0.1	3.7	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	1.0	0.3	116.5	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.2	0.3	1.1	0.0	0.2	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	38.6	0.0	0.1	2.4	0.2	0.1	0.3	0.0	1.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.6	0.0	0.1	0.3	0.1	0.1	15.2	1.4	84.8	0.2	0.2	0.0	1.0	0.4	0.2	4.0	0.3	0.5	1.6	1.8	2.6	0.1	0.6	0.3	1.0	0.8	0.5	0.1	0.3	0.1	0.5	1.2	0.6	1.2	1.8	1.1	1.1	1.8	1.2	1.7	0.1	0.7	3.7	0.2	0.0	2.2	0.0	5.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.7	0.0	3.7	1.8	0.0	0.0	2.2	0.0	1.9	0.0	1.1	0.1	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.5	3.1	0.1	1.3	0.0	0.0	15.7	0.0	0.0	0.5	0.0	0.0	0.6	1.1	1.5	0.0	0.4	0.0	0.0	0.1	0.1	2.1	0.5	0.2	0.0	0.0	0.0	35.1	0.2	0.0	7.8	0.0	0.3	0.0	0.4	0.3	0.1	0.0	0.0	1.0	0.0	4.6	0.1	0.0	0.3
NUTM2F	"DKFZp434I1117, FAM22F"	ENSG00000130950	"NUT family member 2F"	A1L443	9	94318196-94328644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"testis: 1.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.4;Excitatory neurons: 42.9;Inhibitory neurons: 29.0;Microglial cells: 11.2;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 31.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"NTERA-2: 1.3"									HPA064635			Approved	"Nuclear bodies"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"		"HPA064635: "	"unprognostic (1.40e-1)"	"unprognostic (4.93e-3)"	"unprognostic (4.16e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.03e-1)"		"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.72e-3)"	"unprognostic (8.48e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.14e-1)"		"unprognostic (1.83e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	27.2	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NXF3		ENSG00000147206	"Nuclear RNA export factor 3"	Q9H4D5	X	103075810-103093143	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 25.0;testis: 57.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Early spermatids: 2.4;Endometrial ciliated cells: 8.4;Hepatic stellate cells: 2.9;Kupffer cells: 2.6;Late spermatids: 4.2;Paneth cells: 3.9;Undifferentiated cells: 2.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 48.6;HL-60: 46.6;NB-4: 43.0;THP-1: 33.0;U-2197: 135.9;U-937: 101.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003132, HPA046757"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003132: AB_1079514, HPA046757: AB_2679789"	"unprognostic (1.20e-3)"	"unprognostic (6.72e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.86e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-10)"	"unprognostic (1.90e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	0.6	0.8	0.0	0.1	0.0	3.9	0.2	0.0	0.1	1.4	0.1	0.3	0.6	0.1	10.9	0.1	25.0	7.2	0.4	0.0	0.0	1.1	1.1	4.9	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.9	0.0	1.1	0.1	0.0	0.1	3.0	0.0	0.0	0.6	0.1	57.8	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.2	0.0	0.0	0.1	0.5	0.2	0.0	48.6	0.5	0.0	0.0	46.6	0.0	0.0	0.0	1.9	0.0	0.6	0.0	2.2	0.0	8.6	1.0	0.0	0.2	43.0	0.0	0.4	0.2	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.0	0.0	0.0	0.1	135.9	0.1	0.1	0.0	0.0	0.7	101.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	2.4	8.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.9	0.0	0.5	0.0	0.1	0.9	0.0	2.6	0.0	4.2	0.3	1.4	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.1	0.8	1.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88534033-88584274	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.4;Endometrial ciliated cells: 39.1;Glandular and luminal cells: 13.9;Granulosa cells: 13.2;Proximal tubular cells: 18.6;Theca cells: 12.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 7.2"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045526	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA045526: AB_10961044"	"prognostic favorable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	6.5	0.7	4.3	1.2	3.4	4.2	2.8	6.0	5.5	4.0	1.8	0.5	0.9	2.0	1.3	0.4	4.3	1.0	0.7	3.4	3.4	2.3	4.5	0.7	0.9	0.7	1.2	1.1	0.4	0.3	0.1	0.6	1.4	0.9	0.4	4.8	1.6	0.7	1.3	1.5	0.9	0.4	0.4	1.1	0.8	1.3	3.6	0.5	1.3	0.1	0.5	0.4	0.3	5.1	1.5	2.6	1.0	1.0	0.1	0.7	0.7	2.6	0.7	0.3	0.5	0.6	1.0	0.6	1.1	0.3	0.7	1.3	0.4	0.1	0.9	0.4	0.8	1.3	4.0	1.0	0.4	0.7	1.1	0.5	0.2	0.3	0.2	0.4	0.0	0.9	0.9	2.7	0.7	0.7	0.7	1.2	1.4	0.5	0.7	0.5	0.5	0.9	10.4	0.8	0.6	0.4	1.6	0.8	0.5	0.7	1.2	0.6	0.9	0.9	1.9	1.5	0.6	0.9	0.8	0.7	0.7	0.9	0.7	2.1	0.3	0.8	0.6	0.1	0.6	0.2	0.3	0.7	0.0	0.3	0.6	0.7	0.8	0.5	0.1	0.3	0.6	0.3	4.3	3.4	6.0	5.5	3.4	3.4	0.7	1.2	1.4	0.4	3.6	5.1	0.2	0.0	0.0	1.3	0.1	0.0	1.9	0.7	1.2	0.2	7.5	3.2	0.3	4.3	0.1	1.8	0.0	0.2	0.0	0.0	1.9	0.8	11.4	39.1	4.3	0.8	0.0	0.0	1.2	0.2	1.3	0.8	0.0	13.9	0.0	13.2	0.0	0.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	4.4	0.9	0.2	0.0	0.0	0.0	0.5	0.0	1.0	0.7	0.2	0.0	2.2	0.1	0.4	0.0	18.6	0.2	0.8	0.0	0.3	1.3	0.4	1.6	0.0	0.1	1.1	0.3	12.7	0.0	2.2
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138669157-138780390	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.1;kidney: 4.1;ovary: 8.1"	"Cell type enriched"	"Detected in some"	6	"Inhibitory neurons: 156.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	6	"medulla oblongata: 11.7;midbrain: 7.6;pons: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.4;SiHa: 3.0;SuSa: 2.1;U-2 OS: 4.7;U-251 MG: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"	NA	Yes				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.2	0.0	1.8	0.1	1.7	0.0	0.1	1.0	1.8	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.0	0.4	4.1	0.0	0.0	0.0	11.7	7.6	8.1	0.0	0.0	0.1	0.1	13.1	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.6	3.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.7	1.0	1.8	1.0	0.4	11.7	7.6	13.1	1.9	1.1	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	156.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NYX	"CLRP, CSNB1, CSNB1A, CSNB4"	ENSG00000188937	Nyctalopin	Q9GZU5	X	41447343-41475710	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 13.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"HDLM-2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA					"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"							"unprognostic (3.27e-2)"	"unprognostic (6.72e-2)"				"unprognostic (4.21e-2)"	"unprognostic (4.10e-4)"			"unprognostic (1.83e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.80e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 155.4"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 1277.4;Proximal enterocytes: 702.0;Proximal tubular cells: 1384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 325.2;U-251 MG: 399.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	9.2	20.4	14.1	22.1	13.1	16.3	23.4	10.3	15.3	19.8	14.1	54.7	122.3	20.7	46.9	25.8	22.4	32.4	14.3	17.8	15.6	155.4	129.5	19.0	34.6	13.1	13.2	8.7	26.9	44.4	33.6	8.6	11.7	23.8	49.9	26.9	40.2	29.2	4.4	20.0	88.4	15.0	11.6	12.6	85.0	6.3	13.7	53.6	37.4	3.9	40.3	28.1	12.0	12.7	208.9	108.5	1.6	0.0	0.0	0.0	2.7	53.3	23.9	28.4	26.9	0.0	249.4	35.7	230.1	30.5	248.0	65.5	29.7	325.2	29.1	83.8	22.6	0.1	78.6	0.1	25.6	101.7	0.3	14.7	150.8	0.1	61.1	81.4	115.5	140.2	0.1	17.6	30.3	78.3	172.2	70.2	102.5	234.2	145.2	38.5	0.1	59.4	288.7	135.0	230.3	69.5	75.4	25.5	5.4	0.8	26.2	25.2	195.6	0.2	215.1	1.2	399.5	49.5	59.6	113.3	163.0	0.3	0.4	208.4	3.5	69.1	101.6	1.5	136.9	168.0	191.0	147.3	18.1	156.7	247.2	165.0	11.2	156.0	1.3	122.4	338.7	137.7	14.1	13.1	10.3	15.3	17.8	15.6	13.1	13.2	11.7	11.6	13.7	12.7	135.9	28.9	70.6	2.0	102.5	109.0	146.6	401.4	81.4	17.6	152.7	190.6	39.2	194.5	224.2	176.6	29.2	46.2	66.3	359.7	217.2	510.5	1.4	197.5	22.9	103.3	306.4	38.9	10.1	570.2	11.4	14.9	157.5	190.8	36.8	75.3	31.1	193.9	44.3	1.7	11.6	301.3	341.8	6.4	27.0	2.5	5.0	21.7	65.8	5.6	15.9	49.9	82.4	2.5	1.8	1277.4	311.6	21.4	53.5	180.1	702.0	1384.9	171.4	77.6	0.0	3.7	41.8	2.6	3.2	105.2	131.4	15.3	129.8	52.1	188.6	239.2
OCSTAMP	"C20orf123, dJ257E24.3"	ENSG00000149635	"Osteoclast stimulatory transmembrane protein"	Q9BR26	20	46540946-46550654	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Langerhans cells: 1.9;Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HMC-1: 2.2;Karpas-707: 1.3;NB-4: 2.5;RPMI-8226: 1.2;U-266/84: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031116	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA031116: AB_10600758"	"unprognostic (2.77e-1)"		"unprognostic (3.04e-1)"		"unprognostic (8.80e-2)"	"unprognostic (5.02e-2)"		"unprognostic (2.42e-1)"	"unprognostic (2.71e-1)"					"unprognostic (2.65e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.08e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ODF2L	KIAA1229	ENSG00000122417	"Outer dense fiber of sperm tails 2 like"	Q9ULJ1	1	86346824-86396342	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 335.7;Respiratory ciliated cells: 361.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028020, HPA028095, HPA028333"	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028020: AB_10601670, HPA028095: AB_10611385, HPA028333: AB_10601007"	"unprognostic (4.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.80e-3)"	"unprognostic (5.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (4.69e-7)"	"unprognostic (2.40e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.04e-3)"	22.6	20.2	14.0	14.0	15.8	17.1	23.0	16.8	20.0	21.7	14.3	18.4	8.3	18.1	23.3	17.6	23.7	15.2	13.4	14.2	12.7	24.5	7.1	22.9	16.6	13.2	14.8	18.8	11.4	7.2	28.1	10.1	8.1	20.0	14.8	41.2	15.5	10.5	5.2	11.9	22.8	9.7	9.0	36.5	8.7	13.3	15.2	21.9	22.1	3.7	13.2	15.3	17.6	16.8	30.0	7.9	19.7	15.1	21.0	35.8	20.6	28.6	17.4	27.6	32.0	6.2	16.3	0.7	26.3	15.3	35.2	15.3	8.1	16.7	23.6	14.1	12.8	7.3	24.5	0.6	15.9	13.1	9.3	16.5	20.2	41.7	11.4	19.9	45.3	19.8	10.2	6.8	16.4	4.0	15.7	13.8	24.1	6.5	14.5	21.0	14.8	3.2	27.7	40.0	19.5	14.1	25.8	26.2	54.9	30.7	8.5	12.6	41.7	23.0	21.4	31.8	29.4	1.9	1.0	12.3	5.4	6.7	26.5	5.6	2.2	13.6	26.1	3.4	51.5	20.9	30.2	21.0	2.4	21.2	19.3	18.8	6.3	14.8	4.1	12.7	31.8	4.9	14.0	15.8	16.8	20.0	14.2	12.7	13.2	14.8	8.1	9.0	15.2	16.8	72.9	93.0	76.2	22.5	54.0	25.0	54.6	49.0	15.4	139.3	67.0	49.3	12.0	21.5	133.2	80.9	141.8	7.3	73.9	23.1	23.5	61.9	48.5	335.7	57.3	78.7	41.3	16.6	119.1	27.1	35.1	52.5	13.3	70.6	36.7	55.9	72.8	3.9	15.5	57.2	107.2	68.5	42.7	21.2	19.7	10.3	24.8	18.6	56.9	38.4	21.8	28.8	80.3	29.1	49.9	55.9	28.1	28.6	38.9	16.5	9.3	23.1	361.9	120.3	19.7	24.3	32.1	64.0	27.4	19.2	17.3	2.9	106.4	60.6	28.2	67.3
OIT3	"FLJ39116, LZP"	ENSG00000138315	"Oncoprotein induced transcript 3"	Q8WWZ8	10	72893584-72933036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 110.8"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 372.3"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 4.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 2.3;Hep G2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		52000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.42e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.98e-4)"	"unprognostic (9.26e-2)"	"unprognostic (9.47e-4)"	"unprognostic (3.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.19e-1)"	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.3	0.5	0.0	0.1	0.3	5.3	0.0	0.0	0.0	0.0	0.3	2.8	0.1	0.0	1.5	110.8	0.3	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	6.1	0.0	0.0	7.8	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	14.6	0.0	10.7	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	372.3	10.6	0.0	0.0	0.9	0.0	0.0	31.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121180	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 555.7;choroid plexus: 246.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 193.1;Hepatic stellate cells: 78.1;Inhibitory neurons: 70.0"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.8;myeloid DC: 2.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 2.6;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"HeLa: 96.0;MCF7: 84.1;NTERA-2: 104.9;OE19: 78.9;SCLC-21H: 155.6;SiHa: 131.8;T-47d: 200.2;U-2197: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"	NA	NA		200000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: AB_2683443"	"unprognostic (6.77e-2)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	36.7	25.4	410.4	13.0	427.0	0.2	36.8	309.6	555.7	29.9	246.9	24.0	5.0	29.0	70.4	12.1	30.3	8.6	20.7	474.7	309.0	20.3	4.8	15.0	14.5	296.6	301.7	19.4	12.3	4.9	82.8	1.0	293.9	19.3	13.8	47.3	14.0	18.1	17.5	15.3	16.5	17.9	279.9	35.1	15.4	6.8	317.0	11.5	17.5	23.0	19.1	25.0	26.7	372.3	0.0	6.1	12.1	0.2	1.7	1.4	0.5	3.6	0.0	0.0	0.0	0.1	2.7	0.1	0.8	5.2	49.2	2.3	2.6	0.0	0.0	14.4	0.9	0.2	96.0	0.0	0.5	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.3	84.1	0.5	0.3	104.9	78.9	0.0	0.1	0.3	48.3	0.0	0.1	155.6	20.5	131.8	0.4	8.6	7.9	200.2	0.0	0.1	7.7	16.6	87.1	0.2	0.2	0.1	0.3	0.7	0.1	4.3	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	410.4	427.0	309.6	555.7	474.7	309.0	296.6	301.7	293.9	279.9	317.0	372.3	44.2	0.0	7.9	43.8	0.1	9.7	3.3	0.0	3.4	21.6	3.1	3.0	5.9	11.5	1.8	0.0	43.8	0.0	0.1	2.4	0.0	9.7	5.8	0.5	20.4	50.0	2.4	0.0	193.1	2.7	0.0	17.3	0.0	0.7	2.5	14.4	78.1	1.1	0.4	38.7	70.0	2.5	0.0	3.2	7.3	11.9	44.4	2.8	21.4	32.8	2.7	38.6	0.0	48.7	17.3	2.5	2.5	29.3	0.4	5.1	0.0	0.1	0.0	15.7	0.0	13.3	8.8	0.6	3.7	1.3	6.3	0.0	0.7	12.9	4.2	1.4
OLFML1	UNQ564	ENSG00000183801	"Olfactomedin like 1"	Q6UWY5	11	7485388-7511377	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 52.3;Leydig cells: 39.7;Peritubular cells: 39.5;Sertoli cells: 26.3;Smooth muscle cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 31.2;U-2197: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058824	Approved				"Secreted - unknown location"	NA	NA		260000	"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058824: "	"unprognostic (3.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (3.13e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.72e-3)"	21.6	6.2	1.4	5.2	1.8	0.3	12.5	2.2	1.9	27.2	7.5	8.4	5.0	19.0	21.3	8.2	17.5	23.8	14.8	1.8	1.9	6.4	10.8	18.9	9.3	2.0	1.5	48.6	2.8	2.3	3.1	7.3	1.7	14.1	10.2	0.2	5.6	18.3	5.2	8.3	7.2	18.0	1.2	14.7	5.4	4.1	2.1	3.2	8.2	12.1	5.6	14.9	17.7	2.0	0.0	0.0	0.4	0.0	1.9	1.9	31.2	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.2	0.1	0.1	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.2	0.1	20.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.8	0.1	0.0	0.0	1.4	1.8	2.2	1.9	1.8	1.9	2.0	1.5	1.7	1.2	2.1	2.0	6.1	0.0	0.0	1.0	0.4	5.2	0.0	0.0	1.2	0.1	0.2	0.3	1.0	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	13.3	2.9	0.0	0.0	0.1	0.0	2.0	52.3	0.0	0.4	0.0	0.0	5.0	0.9	0.6	0.0	0.1	0.0	0.0	0.0	6.1	0.7	39.7	0.4	7.2	2.8	0.0	0.0	0.0	0.5	1.4	0.1	0.0	39.5	0.2	0.1	0.0	0.3	0.0	0.0	26.3	9.4	16.3	0.3	0.1	0.2	3.7	0.3	0.7	5.0	0.0	0.1
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 136.6;Fibroblasts: 246.9;Leydig cells: 73.3;Theca cells: 126.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 577.3;ASC TERT1: 312.6;BJ hTERT+: 374.8;HSkMC: 581.6;LHCN-M2: 602.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		3000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	85.6	42.6	5.7	24.9	7.4	0.9	89.7	7.2	12.4	170.6	8.2	71.9	15.1	124.7	42.6	26.6	96.3	95.0	56.6	5.4	6.7	34.1	36.3	55.4	12.0	9.8	7.7	177.4	35.2	9.9	17.9	111.8	8.6	42.9	34.5	0.2	16.7	73.8	10.3	37.6	32.3	94.6	9.2	9.9	48.4	9.3	9.7	8.9	21.8	38.2	14.9	71.1	98.8	11.2	0.0	19.7	9.7	0.1	577.3	312.6	0.6	77.1	374.8	26.5	85.3	25.2	0.2	0.0	4.1	222.4	0.2	0.0	3.2	0.3	4.0	0.0	0.0	0.0	0.1	19.3	149.6	0.2	0.0	581.6	0.0	37.2	0.5	10.7	2.1	0.0	0.0	0.1	602.3	0.3	0.2	0.4	45.8	0.0	0.7	0.1	142.6	0.3	0.0	0.0	0.3	5.4	0.1	0.2	10.5	143.3	224.6	0.9	1.8	14.9	27.6	5.9	0.0	0.2	0.1	0.0	7.3	0.0	94.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	7.4	7.2	12.4	5.4	6.7	9.8	7.7	8.6	9.2	9.7	11.2	13.6	0.0	3.7	0.0	0.4	13.0	0.2	0.0	0.6	0.0	2.1	2.9	1.4	4.3	0.8	1.8	0.0	6.8	1.1	0.2	0.0	0.8	2.9	6.2	136.6	9.5	6.0	0.0	0.0	0.0	4.9	246.9	5.6	3.5	1.3	0.3	45.7	0.5	33.3	0.0	0.0	0.6	0.0	5.9	22.7	1.7	73.3	15.5	12.4	16.9	0.6	0.0	0.0	0.0	0.1	0.3	0.1	33.1	0.2	0.7	0.0	0.5	0.0	0.1	0.0	44.8	28.0	0.3	0.4	1.2	11.5	12.4	2.6	126.1	0.2	0.2
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92412380-92424471	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 66.8;Hepatic stellate cells: 26.4;Leydig cells: 97.9;Peritubular cells: 110.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"ASC diff: 6.1;ASC TERT1: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		21000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: AB_2732144"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	13.9	6.9	2.4	0.3	3.2	0.2	12.6	3.0	6.0	15.5	4.1	4.8	0.8	7.6	7.5	4.3	9.4	8.1	20.0	2.4	2.3	1.9	1.1	4.6	0.9	2.3	2.4	12.0	1.7	0.8	3.9	2.8	2.5	5.0	1.9	0.1	2.2	3.4	1.3	3.3	3.2	8.4	2.3	0.4	4.4	3.1	2.4	0.9	8.9	11.3	2.8	5.5	3.9	2.2	0.0	0.0	0.0	0.0	6.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.4	0.4	0.4	0.0	0.3	0.6	0.5	0.2	0.2	0.1	0.3	0.5	0.4	2.4	3.2	3.0	6.0	2.4	2.3	2.3	2.4	2.5	2.3	2.4	2.2	4.4	0.0	0.0	0.0	0.3	2.7	0.4	0.1	0.0	0.9	0.1	0.1	1.3	4.3	0.6	1.8	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.3	11.4	7.8	0.0	0.0	1.7	0.0	0.2	66.8	2.0	0.3	0.0	0.1	26.4	0.0	0.3	0.0	1.5	0.0	0.0	0.3	3.3	3.2	97.9	0.2	1.8	9.4	0.0	0.0	0.0	1.0	1.6	0.0	0.0	110.2	0.8	0.2	0.0	0.1	0.0	1.6	0.0	2.2	2.9	0.2	0.1	0.3	2.7	0.0	0.4	0.1	0.0	0.2
OPN1SW	"BCP, BOP, CBT"	ENSG00000128617	"Opsin 1, short wave sensitive"	P03999	7	128772485-128775794	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	84	"retina: 41.0"	"Cell type enriched"	"Detected in some"	12	"Cone photoreceptor cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"LHCN-M2: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013562, HPA014083"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytokinetic bridge, Cytosol"	"HPA013562: AB_2668850, HPA014083: AB_2668938"	"unprognostic (2.88e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (8.50e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (5.98e-8)"	"unprognostic (2.53e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (9.33e-4)"	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	41.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRD1		ENSG00000116329	"Opioid receptor delta 1"	P41143	1	28812142-28871267	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.7;Excitatory neurons: 11.8;Inhibitory neurons: 15.7;Skeletal myocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 16.4;SCLC-21H: 6.4;SH-SY5Y: 6.5;WM-115: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070831	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070831: AB_2732167"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-3)"	"unprognostic (6.28e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.95e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-7)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-3)"	0.1	0.5	1.4	0.1	1.6	0.4	0.0	0.0	3.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.1	4.4	0.1	0.1	0.3	0.0	0.1	0.1	4.7	0.1	0.1	0.5	0.2	0.0	1.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.2	1.0	0.0	0.0	0.0	16.4	0.1	0.0	0.1	6.4	6.5	0.0	0.1	1.1	0.3	0.1	0.1	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.4	22.0	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.0	0.2	0.0	0.0	1.4	1.6	0.0	3.2	1.9	0.0	4.4	0.1	4.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	3.7	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	11.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	2.6	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	1.2
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402893	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.8;tongue: 20.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 281.4;Excitatory neurons: 314.2;Inhibitory neurons: 404.2;Oligodendrocyte precursor cells: 134.2"	"Cancer enhanced"	"Detected in many"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 48.8;hTERT-HME1: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	1.3	1.5	4.1	1.0	6.1	0.2	1.7	3.7	16.3	1.1	0.0	1.0	0.7	0.8	0.7	2.4	1.0	1.1	3.8	6.1	8.0	2.7	5.6	4.0	1.1	5.7	6.9	1.4	1.2	0.8	6.7	0.6	5.3	3.1	1.0	8.4	2.2	1.5	33.8	8.7	3.5	1.4	1.7	1.0	0.8	1.3	7.5	1.6	2.3	20.3	0.8	1.0	1.5	8.3	0.0	1.1	8.3	16.9	6.8	7.5	6.3	13.9	7.2	12.0	14.6	1.4	0.2	0.0	0.5	12.9	6.6	0.3	19.6	11.4	20.2	0.2	10.2	48.8	2.9	0.0	4.4	8.0	0.3	5.0	17.6	26.4	50.8	4.3	5.8	6.2	0.9	5.8	15.9	7.0	0.1	0.0	10.0	0.0	10.2	0.0	16.9	3.2	0.9	0.0	6.3	3.8	6.2	1.8	13.7	9.2	2.4	0.1	11.4	13.7	8.5	9.3	16.3	31.8	13.4	0.0	16.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	4.1	6.1	3.7	16.3	6.1	8.0	5.7	6.9	5.3	1.7	7.5	8.3	0.7	0.0	7.2	281.4	0.0	13.3	2.1	1.3	7.4	59.4	2.1	1.7	15.2	4.3	6.5	0.0	25.0	0.2	0.0	0.1	1.9	0.6	1.0	4.4	1.0	1.7	1.8	0.0	314.2	0.8	4.9	4.3	0.0	0.4	7.0	2.0	0.0	6.2	3.9	1.7	404.2	6.0	4.1	3.5	1.0	1.1	0.0	0.7	5.4	62.8	0.0	10.6	0.0	134.2	10.3	0.2	0.0	1.5	1.5	2.2	9.5	6.2	78.2	6.9	0.0	25.4	5.8	0.1	2.1	6.4	20.9	0.1	0.9	14.5	1.4	0.5
OSCAR		ENSG00000170909	"Osteoclast associated Ig-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 13.6;lung: 28.4;lymphoid tissue: 29.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 35.6;Kupffer cells: 27.8;Macrophages: 42.9;monocytes: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	36	"classical monocyte: 43.0;eosinophil: 26.6;intermediate monocyte: 28.8;myeloid DC: 20.3;neutrophil: 40.0;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	79	"dendritic cells: 20.3;granulocytes: 40.0;monocytes: 43.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.9;HHSteC: 9.4;hTERT-HME1: 5.0;NB-4: 5.9;U-937: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	3.7	1.8	0.9	2.3	0.7	13.6	1.8	0.1	1.6	2.2	0.0	1.5	0.0	1.3	0.0	1.5	3.2	1.3	1.9	0.1	0.7	1.5	2.4	28.4	0.3	1.3	0.7	1.1	1.3	0.1	1.0	0.6	0.9	1.7	0.3	0.0	2.2	0.3	0.5	2.1	1.6	1.7	0.7	29.8	1.2	0.9	0.8	0.2	1.1	0.6	0.6	2.2	2.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	13.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.4	0.6	0.0	0.0	0.2	0.6	5.0	0.8	0.0	0.0	0.0	0.4	0.1	0.1	0.0	5.9	0.3	0.1	1.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.5	17.9	0.0	0.0	43.0	26.6	0.3	28.8	0.1	0.0	0.2	0.4	20.3	0.0	0.1	0.0	40.0	0.0	27.0	0.8	0.2	16.8	0.9	0.7	0.1	1.6	0.1	0.7	1.3	0.7	0.9	0.7	0.8	1.7	0.2	3.2	5.9	0.3	0.3	0.8	0.6	0.7	0.6	0.0	0.7	0.4	0.3	1.5	2.1	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.1	0.3	0.9	0.0	1.7	1.9	0.0	0.4	0.6	0.0	0.1	1.3	0.3	0.0	0.0	35.6	0.0	1.0	0.3	0.0	27.8	11.6	0.2	0.0	42.9	0.0	1.0	66.4	0.0	1.0	0.0	0.3	0.4	0.0	0.0	0.4	0.3	0.1	0.2	3.7	0.4	0.0	0.2	0.1	0.6	0.5	0.4	0.1	0.3	0.7	0.4	0.1	0.3
OSR2	FLJ90037	ENSG00000164920	"Odd-skipped related transciption factor 2"	Q8N2R0	8	98944403-98952104	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 166.1;endometrium 1: 155.1;fallopian tube: 155.3"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 243.1;Leydig cells: 784.1;Peritubular cells: 758.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	16	"ASC diff: 542.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052425, HPA063486"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Plasma membrane"	Nucleoplasm	"HPA052425: AB_2681826, HPA063486: AB_2685022"	"unprognostic (1.72e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.73e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-7)"	"unprognostic (1.37e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.54e-3)"	45.0	9.9	0.0	2.4	0.0	0.6	26.0	0.2	0.2	166.1	0.0	9.2	0.6	155.1	53.7	15.1	155.3	12.9	4.2	0.0	0.0	1.3	0.3	3.6	2.4	0.0	0.0	93.2	4.2	3.0	2.7	8.2	0.0	40.2	3.8	0.0	6.8	72.2	5.6	27.9	24.9	47.1	0.0	0.2	5.1	35.6	0.0	0.8	5.6	5.1	1.1	27.2	83.8	0.0	32.3	4.5	0.0	4.4	542.4	17.2	4.3	17.6	33.1	13.7	13.6	3.4	3.9	0.0	2.9	26.7	0.8	12.4	2.7	4.7	6.7	1.5	13.0	0.6	3.3	1.6	8.9	0.9	0.6	17.0	9.8	2.3	1.6	0.8	0.0	4.8	4.0	0.4	0.6	14.6	2.9	5.7	0.0	2.6	2.8	13.8	1.6	1.1	1.1	2.7	1.4	0.1	1.9	7.5	0.4	0.3	4.3	7.5	0.2	2.1	0.1	13.9	1.0	0.7	0.5	0.3	0.9	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.9	14.1	6.6	3.4	1.2	0.0	7.9	5.3	0.7	0.0	3.3	0.0	0.0	17.2	0.9	0.7	0.0	0.0	5.8	7.8	243.1	3.7	0.0	0.0	0.0	0.0	138.4	71.7	0.5	5.9	0.0	0.2	0.0	0.0	9.3	0.0	0.0	18.4	10.2	1.9	21.9	24.1	784.1	2.7	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	758.3	4.6	3.6	103.9	0.1	1.7	0.0	32.9	8.8	21.3	5.1	4.5	0.3	9.1	24.2	2.3	95.6	22.3	2.2
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380880	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 1.9;kidney: 5.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-87 MG: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.1	0.0	0.5	0.0	0.7	0.0	0.1	0.0	1.0	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.1	1.9	0.3	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.1	0.2	0.0	0.0	51.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	42.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1
OXER1	"GPCR, GPR170, TG1019"	ENSG00000162881	"Oxoeicosanoid receptor 1"	Q8TDS5	2	42762481-42764261	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 56.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.3;Proximal enterocytes: 16.1;Skeletal myocytes: 12.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 67.0;eosinophil: 144.5"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 144.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.6;Hep G2: 7.6;HMC-1: 6.1;REH: 3.2;THP-1: 2.8"									HPA051433	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA051433: AB_2681485"	"unprognostic (6.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.46e-2)"	2.1	1.8	1.2	1.5	1.2	2.4	1.9	0.3	1.8	6.9	1.1	3.9	5.0	3.1	2.3	2.4	3.6	1.4	2.4	1.3	0.6	8.4	56.3	1.9	1.2	0.9	0.9	9.1	7.2	0.3	3.8	1.7	0.7	6.6	1.8	0.3	1.5	1.7	0.9	3.1	8.5	0.8	0.4	4.9	2.3	1.2	1.0	1.0	2.2	0.4	1.1	6.0	4.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	6.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.3	2.2	0.0	7.6	0.0	0.1	6.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.4	0.0	0.0	3.2	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.6	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	67.0	1.8	144.5	0.1	0.6	0.0	0.2	0.0	0.0	1.4	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.8	1.2	1.2	0.3	1.8	1.3	0.6	0.9	0.9	0.7	0.4	1.0	0.6	0.1	0.0	0.5	0.7	0.1	0.5	0.6	0.2	0.6	1.6	0.4	0.6	0.4	2.8	0.2	1.8	0.0	0.1	0.0	1.9	1.9	0.6	0.0	0.1	2.0	0.1	1.2	0.0	0.0	2.0	0.1	2.0	0.0	0.1	2.5	0.4	0.4	8.3	1.0	0.0	0.0	3.4	0.0	1.3	1.2	0.3	3.4	1.5	3.6	1.0	3.0	0.9	0.0	0.0	0.0	0.6	5.3	1.9	0.0	0.5	16.1	4.9	0.2	0.0	0.0	12.9	1.1	0.3	0.2	0.3	0.1	0.3	1.1	0.3	5.1	0.3
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"Extravillous trophoblasts: 49.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"myeloid DC: 1.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in some"		"RT4: 3.3;SK-BR-3: 1.4;U-2 OS: 1.6"	"Not detected"	"Not detected"							HPA067673			Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA067673: AB_2685883"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	1.3	0.0	1.0	1.3	0.8	0.1	4.2	0.5	1.5	1.0	0.5	2.0	0.2	0.5	2.5	2.1	1.6	0.1	0.2	0.8	2.1	4.0	0.0	0.4	0.1	1.2	1.3	0.1	0.5	0.3	0.3	0.9	1.0	0.5	1.6	0.0	3.0	0.4	0.2	2.6	0.4	0.5	0.7	0.4	0.2	0.1	2.6	0.3	0.5	0.3	0.8	1.7	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.1	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	1.0	0.8	0.5	1.5	0.8	2.1	1.2	1.3	1.0	0.7	2.6	1.3	0.8	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.7	1.4	0.2	0.0	0.0	0.0	0.0	2.4	0.1	0.2	1.9	0.0	0.2	0.7	0.1	0.8	1.2	0.0	0.6	0.0	49.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.5	0.0	0.0	0.4	0.1	0.0	0.3	3.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	2.2	0.0	3.7	0.0	0.0	1.2	0.0
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"brain: 1167.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.0;Hepatocytes: 41.2;Late spermatids: 66.3;Proximal enterocytes: 15.7;Proximal tubular cells: 36.5"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in many"	141	"hypothalamus: 1167.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;HMC-1: 1.1"	"Region enriched"	"Detected in many"	6	"hypothalamus: 179.3"	"Group enriched"	"Detected in some"	903	"basal ganglia: 794.6;hypothalamus: 1854.1"	HPA071892	Supported	Supported			"Secreted to blood"	NA	NA	1500000		"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA071892: AB_2732190"	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	3.2	1.7	8.3	0.0	0.8	0.1	1.7	0.5	0.9	0.9	0.7	0.4	1.0	0.4	0.0	0.2	0.3	0.0	0.5	0.2	1167.9	4.1	19.3	0.2	0.1	0.2	0.7	0.3	0.1	0.0	15.9	0.0	0.2	0.7	0.0	0.0	0.5	0.1	0.2	2.3	1.0	0.0	1.3	0.2	0.2	2.6	7.8	0.0	0.6	0.0	0.0	0.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.4	0.2	0.5	2.1	0.8	0.5	0.4	1.6	1.4	1.7	0.5	0.2	0.0	0.7	1.3	0.3	8.3	0.8	0.5	0.9	0.2	1167.9	0.2	0.7	0.2	1.3	7.8	0.2	0.6	0.0	1.8	0.3	3.5	0.8	0.7	0.1	1.2	0.0	1.2	1.7	0.2	0.0	1.3	5.5	0.0	0.0	2.3	0.1	1.9	0.1	30.0	0.2	2.4	0.3	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.0	41.2	0.2	0.0	0.1	1.8	0.0	0.3	1.6	66.3	0.9	0.6	3.6	0.0	0.0	0.0	1.0	0.5	0.0	0.2	1.7	1.2	1.2	0.4	15.7	36.5	0.9	0.0	0.0	1.8	0.7	1.1	7.8	0.3	1.0	0.0	1.1	0.0	2.0	0.3
P2RY10	P2Y10	ENSG00000078589	"P2Y receptor family member 10"	O00398	X	78945332-78963727	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 79.3;granulocytes: 29.2;Langerhans cells: 38.5;monocytes: 32.5;Plasma cells: 32.6;T-cells: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 256.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 121.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036757, HPA065766"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA036757: AB_10696786, HPA065766: AB_2685556"	"unprognostic (3.02e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-6)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-4)"	"unprognostic (3.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.99e-2)"	0.8	0.5	0.4	14.6	0.5	8.2	0.9	1.4	1.1	1.0	0.0	2.7	3.1	0.8	0.3	1.1	0.4	3.2	0.4	0.4	0.1	0.4	1.6	2.4	27.4	0.2	0.0	0.4	1.5	0.0	0.1	0.3	0.2	1.3	3.6	0.6	1.2	0.2	0.2	0.6	6.4	0.7	0.0	16.6	3.9	0.3	0.2	10.3	0.6	0.1	25.8	5.4	0.4	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	121.8	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	9.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.1	0.0	26.5	0.1	1.4	0.2	0.3	0.1	256.1	0.2	158.1	12.6	0.9	11.4	73.1	28.0	25.5	4.0	74.1	25.7	19.5	27.9	18.1	10.9	2.8	41.7	13.2	0.4	0.5	1.4	1.1	0.4	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.7	0.0	1.7	0.0	79.3	1.8	0.0	0.0	0.0	0.0	0.3	0.3	1.2	0.0	0.6	0.0	0.0	0.0	15.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.5	0.1	29.2	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.6	38.5	0.0	0.0	3.6	8.8	0.0	32.5	0.0	9.2	0.0	0.0	0.0	0.0	0.0	32.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.0	0.0	55.1	0.0	0.0	0.3
P2RY13	"FKSG77, GPR86, GPR94, P2Y13"	ENSG00000181631	"Purinergic receptor P2Y13"	Q9BPV8	3	151326312-151329549	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.1;lymphoid tissue: 36.9"	"Group enriched"	"Detected in some"	9	"Kupffer cells: 124.4;Macrophages: 53.2;Microglial cells: 66.5;monocytes: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 581.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 581.5;monocytes: 185.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049047	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA049047: AB_2680611"	"unprognostic (1.09e-3)"	"unprognostic (7.51e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (7.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.46e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.78e-1)"	4.8	3.8	1.6	20.6	1.6	25.1	4.2	1.6	2.2	2.6	2.7	4.5	4.6	1.9	0.8	3.2	3.1	3.9	1.4	1.9	2.0	1.6	8.2	7.6	18.2	3.1	2.4	1.6	1.2	1.6	0.5	3.3	2.8	1.4	6.2	0.1	2.9	3.2	0.7	2.1	11.0	5.3	3.7	36.9	3.1	0.7	4.2	4.5	1.3	3.8	8.4	4.1	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	152.5	137.2	0.3	155.4	0.3	1.5	0.2	0.2	66.4	0.6	0.2	0.3	581.5	0.1	185.6	1.1	0.2	77.6	1.6	1.6	1.6	2.2	1.9	2.0	3.1	2.4	2.8	3.7	4.2	4.0	0.9	0.0	6.1	0.0	1.3	0.0	0.1	0.0	0.0	0.8	0.6	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	3.6	0.3	0.0	0.2	0.6	0.5	0.0	2.5	0.0	0.7	0.4	7.7	1.7	0.2	0.0	0.0	124.4	4.5	0.0	0.0	53.2	0.0	66.5	63.3	1.1	2.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.0
P2RY8	P2Y8	ENSG00000182162	"P2Y receptor family member 8"	Q86VZ1	X	1462581-1537185	"Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 31.2;lymphoid tissue: 40.1"	"Group enriched"	"Detected in some"	4	"B-cells: 42.0;dendritic cells: 56.2;monocytes: 26.1;NK-cells: 56.7;Plasma cells: 49.3;T-cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 119.2;MOLT-4: 60.6;NB-4: 59.6;RPMI-8226: 74.3;THP-1: 73.7;U-266/70: 96.8;U-698: 192.8;U-937: 60.6"					"Low region specificity"	"Detected in single"			HPA003631	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA003631: AB_1079543"	"unprognostic (4.32e-2)"	"unprognostic (3.22e-5)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.80e-5)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.27e-3)"	"unprognostic (5.76e-3)"	"unprognostic (5.52e-3)"	"prognostic favorable (6.54e-4)"	"unprognostic (4.29e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.80e-1)"	3.5	4.6	0.4	19.2	0.5	31.2	2.4	0.8	1.1	0.7	0.8	3.4	3.4	0.8	0.9	1.3	0.7	3.8	4.9	0.2	0.7	3.6	1.9	3.0	40.1	1.5	0.5	1.1	2.1	2.1	2.1	1.2	0.9	1.5	3.2	0.7	3.4	1.1	2.6	1.8	7.5	1.4	0.5	20.0	5.1	0.4	1.4	16.4	7.9	1.4	33.4	4.4	0.5	1.8	0.6	0.5	0.5	1.5	0.0	0.0	1.3	0.2	0.1	0.0	0.1	0.4	0.7	119.2	0.6	0.0	0.5	0.5	0.0	0.1	0.0	4.7	0.4	1.0	1.3	6.1	0.1	53.2	12.3	0.1	0.1	0.1	0.0	1.1	0.0	35.1	1.1	48.9	0.1	0.1	60.6	59.6	0.7	0.1	1.3	54.1	0.6	74.3	0.1	0.9	0.2	0.8	0.4	1.1	0.3	1.1	0.6	73.7	0.3	1.0	1.1	0.5	0.3	96.8	19.6	192.8	0.2	60.6	0.2	49.9	18.9	31.1	58.6	12.7	53.6	34.2	44.5	55.8	13.6	38.3	34.7	36.4	11.3	37.5	5.2	3.6	37.6	53.3	0.4	0.5	0.8	1.1	0.2	0.7	1.5	0.5	0.9	0.5	1.4	1.8	5.9	0.0	1.8	0.3	42.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	1.2	0.0	0.6	1.8	0.0	0.0	56.2	0.1	0.0	0.0	0.0	0.1	0.1	5.2	0.0	9.9	0.7	0.2	0.0	0.4	2.6	0.1	1.3	0.3	3.9	0.3	1.9	0.0	0.7	0.0	0.0	11.2	1.8	0.0	0.0	8.7	1.8	1.9	26.1	0.0	56.7	1.0	0.4	0.0	0.0	0.0	49.3	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.4	0.0	40.7	0.9	0.2	0.0
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828407-6839847	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.2;Cone photoreceptor cells: 100.1;Horizontal cells: 43.7;Leydig cells: 49.7;Peritubular cells: 38.4;Rod photoreceptor cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 39.6;hTERT-RPE1: 27.3;NTERA-2: 27.5;U-251 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		740000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.5	2.6	1.2	1.5	0.7	0.3	3.9	3.7	2.7	11.9	5.6	5.4	0.8	19.2	0.5	1.6	9.9	1.7	4.5	1.1	1.2	2.0	0.6	3.7	0.3	1.3	0.2	12.4	2.9	4.5	15.4	1.3	0.3	6.0	0.3	4.1	6.5	3.7	0.8	3.0	2.8	3.8	0.2	1.3	3.8	1.2	0.9	0.1	4.3	0.3	0.3	7.8	6.4	0.5	0.0	1.6	7.1	14.0	8.4	10.2	0.3	39.6	22.4	12.2	13.5	0.6	0.0	0.0	0.5	14.9	0.5	0.0	4.4	0.4	2.7	0.1	18.8	1.0	4.2	1.9	5.9	1.0	0.0	11.1	0.4	6.0	3.3	27.3	13.1	1.2	3.7	0.0	5.7	0.0	0.1	0.4	27.5	0.0	1.1	0.0	6.9	0.2	0.6	0.0	2.8	10.5	0.1	0.0	4.8	3.4	0.2	0.2	23.2	12.0	17.5	18.6	27.7	0.1	0.3	0.3	10.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	3.7	2.7	1.1	1.2	1.3	0.2	0.3	0.2	0.9	0.5	2.3	0.0	0.0	3.3	0.5	0.0	4.9	0.0	2.2	47.2	5.3	5.5	11.1	1.5	1.8	5.5	100.1	0.5	0.1	0.1	1.9	1.4	0.9	0.9	19.6	3.9	1.2	0.0	13.1	2.7	0.5	24.1	2.0	0.4	0.0	0.8	7.9	0.0	1.4	43.7	13.7	2.7	0.0	0.0	0.0	2.2	49.7	0.5	0.0	2.8	1.1	5.3	0.0	5.5	1.3	1.3	0.1	38.4	3.1	5.1	0.4	0.4	1.5	28.8	6.6	7.8	11.9	0.7	0.8	0.8	0.0	1.0	0.9	3.2	0.6	1.5
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132190147-132295315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 115.6;Endometrial stromal cells: 96.9;Skeletal myocytes: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 324.2;U-87 MG: 323.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No		13000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	17.4	11.7	11.9	16.1	12.1	2.4	12.3	11.4	28.4	29.5	42.2	28.7	22.6	31.1	76.7	19.6	29.6	19.9	40.6	14.4	17.2	80.0	10.5	31.5	2.5	11.4	14.3	8.6	70.7	10.9	19.9	35.1	19.1	10.8	32.7	7.8	32.5	17.1	13.0	16.7	26.8	52.6	10.0	8.7	20.5	9.7	16.8	11.3	20.7	22.9	8.3	22.9	22.3	12.2	57.0	34.9	11.2	57.2	149.2	173.7	61.1	261.9	223.7	108.9	265.0	78.9	50.3	1.5	71.8	283.3	120.5	70.2	33.2	136.5	172.7	41.5	11.9	0.6	48.1	49.0	324.2	0.0	33.9	104.6	193.1	128.8	117.4	162.7	59.1	0.1	21.2	3.6	134.0	23.2	0.2	0.5	3.0	53.7	27.2	0.9	3.6	9.8	31.1	11.0	5.4	15.8	67.7	22.3	47.9	84.1	28.4	3.7	88.9	171.7	63.5	51.0	57.1	24.4	28.1	11.8	323.4	0.4	48.3	0.0	0.4	0.0	0.8	0.3	0.7	0.0	0.4	0.1	0.2	0.0	0.0	0.1	1.0	0.9	0.0	0.3	0.0	0.2	11.9	12.1	11.4	28.4	14.4	17.2	11.4	14.3	19.1	10.0	16.8	12.2	13.0	35.3	10.3	7.5	1.1	16.8	43.6	115.6	23.9	11.6	9.5	9.5	13.3	8.6	36.9	11.0	22.9	2.6	0.3	43.2	5.9	68.3	1.4	26.7	96.9	12.2	15.0	0.0	7.7	71.8	70.2	61.6	12.8	28.0	5.7	11.1	9.3	7.8	7.6	0.0	7.7	18.6	32.6	1.3	5.5	2.0	8.1	4.4	30.2	2.8	2.6	6.8	0.0	1.5	1.2	81.9	41.0	5.3	3.0	19.6	41.4	44.6	71.9	5.2	26.3	109.4	47.6	23.0	29.1	6.8	9.8	7.5	4.8	10.4	13.8	15.3
PACC1	"C1orf75, FLJ10874, PAC, TMEM206"	ENSG00000065600	"Proton activated chloride channel 1"	Q9H813	1	212363928-212414901	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 13.1;Extravillous trophoblasts: 7.0;Hofbauer cells: 28.2;Syncytiotrophoblasts: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008540	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"			"HPA008540: AB_10794083"	"unprognostic (2.18e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.10e-2)"	"unprognostic (6.98e-2)"	2.9	2.5	15.0	4.0	24.5	5.8	2.6	24.4	22.9	3.0	10.1	2.0	2.0	2.7	1.9	3.9	1.7	2.8	2.4	15.5	18.8	10.2	1.5	3.8	8.0	26.1	22.3	1.7	3.3	3.6	3.4	4.2	25.3	2.9	2.1	6.0	2.7	1.5	2.1	2.3	3.0	2.9	23.0	5.4	1.8	5.6	20.9	8.6	2.0	1.4	5.2	4.4	3.0	35.1	11.6	8.8	13.0	21.6	7.5	4.0	12.9	6.6	5.2	10.8	9.5	7.4	8.4	13.6	5.3	3.3	10.5	10.1	12.5	6.0	10.7	10.3	13.5	12.8	5.8	9.2	10.7	20.8	19.5	3.6	6.2	9.9	7.2	10.8	12.3	19.7	11.8	7.8	7.5	4.6	23.2	21.4	17.3	5.4	11.5	18.9	14.5	13.1	5.5	5.7	20.1	31.2	7.7	11.3	30.2	12.8	16.8	25.2	10.9	7.0	8.0	16.8	17.3	10.2	17.3	19.1	9.4	18.9	19.9	21.3	8.7	5.3	5.3	11.8	7.0	8.5	4.1	6.2	14.4	8.2	5.8	6.4	0.7	7.0	11.0	20.4	6.4	6.2	15.0	24.5	24.4	22.9	15.5	18.8	26.1	22.3	25.3	23.0	20.9	35.1	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	13.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.2	0.5	0.0	0.0	0.0
PACRG	"FLJ32724, Glup, HAK005771, PARK2CRG"	ENSG00000112530	"Parkin coregulated"	Q96M98	6	162727132-163315492	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.7;testis: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 310.9;Excitatory neurons: 124.3;Inhibitory neurons: 174.9;Late spermatids: 369.8;Respiratory ciliated cells: 118.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066293	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA066293: AB_2685652"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.93e-3)"	0.8	2.5	13.6	1.1	15.2	5.7	2.0	5.9	14.2	2.3	13.2	1.2	1.4	5.3	9.7	3.0	35.7	5.1	13.0	11.9	12.5	10.2	4.8	3.8	1.4	15.1	15.7	4.2	4.3	2.0	23.7	0.4	10.9	3.4	2.4	7.5	2.2	3.6	2.1	4.6	0.8	2.1	9.4	1.8	2.3	29.5	13.5	0.7	4.0	1.3	1.0	4.4	0.9	24.2	0.5	1.7	0.7	1.0	0.0	0.6	1.2	0.4	1.6	0.0	0.3	3.5	0.4	3.2	0.4	0.0	0.3	1.4	0.8	0.0	1.7	0.0	1.1	0.0	1.9	0.0	0.0	0.4	0.5	1.0	0.0	0.5	0.0	0.6	0.0	1.1	0.5	0.7	0.3	0.1	0.2	1.2	0.0	2.8	2.9	0.6	0.0	0.0	3.6	3.6	6.9	3.1	0.0	0.0	0.0	0.2	0.0	1.1	1.2	0.7	0.3	0.0	0.2	1.3	0.5	1.2	0.3	0.8	1.3	2.3	0.7	0.7	0.7	0.2	0.5	0.3	1.1	0.4	0.1	0.6	1.4	0.6	2.5	0.0	0.1	0.5	0.5	0.2	13.6	15.2	5.9	14.2	11.9	12.5	15.1	15.7	10.9	9.4	13.5	24.2	0.3	0.0	1.7	61.0	0.1	0.3	4.2	8.7	2.8	1.3	1.3	3.0	41.0	0.0	8.9	5.5	8.4	0.1	0.0	0.1	54.8	3.4	310.9	67.0	3.1	1.2	6.6	0.0	124.3	7.1	0.1	1.2	0.0	1.9	0.0	0.7	0.7	3.9	0.1	0.0	174.9	0.3	10.2	0.6	0.3	369.8	3.7	0.4	0.0	11.2	0.0	6.0	0.0	59.3	20.0	1.6	1.2	2.6	0.1	3.2	0.0	6.3	118.4	8.1	0.0	1.1	2.2	53.4	6.1	1.1	0.3	0.3	0.3	2.9	0.4	2.7
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535229	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 149.3;retina: 64.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	0.2	0.7	40.9	1.2	72.9	0.8	0.2	0.0	149.3	0.3	0.0	0.8	0.5	0.5	0.1	0.1	0.6	0.3	5.4	64.4	0.0	1.4	0.2	0.2	3.6	58.8	10.0	0.6	5.1	1.7	6.3	0.0	55.4	0.7	0.2	64.3	1.0	0.4	0.2	0.3	1.4	0.1	0.0	1.3	1.3	0.8	3.9	1.3	0.2	0.1	2.2	0.4	0.3	59.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.1	0.0	12.1	0.7	0.0	2.8	0.1	0.1	0.1	0.0	14.0	0.0	0.4	4.2	0.3	0.0	2.2	0.0	0.4	21.5	2.4	0.0	0.0	0.3	0.0	0.0	3.5	16.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	15.8	0.0	0.1	40.9	72.9	0.0	149.3	64.4	0.0	58.8	10.0	55.4	0.0	3.9	59.5	0.2	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	76.1	0.2	0.1	4.5	0.0	0.0	0.0	81.3	0.1	24.9	0.1	0.0	0.3	0.2	1.3	0.2	0.6	0.0	0.0	49.9	0.7	0.0	0.1	0.5	2.0	0.0	0.2	0.0	0.0	0.0	69.0	47.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	6.5	0.0	12.7	1.0	1.0	2.0	0.1	0.0	0.0	0.2	0.1	0.0	2.3	0.0	89.4	0.0	0.2	0.2	0.4	1.7	0.0	0.0	0.0	0.6	0.1	0.1	0.1
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119451	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 240.6;skeletal muscle: 311.8;tongue: 492.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 95.9;Distal enterocytes: 178.7;Intestinal goblet cells: 77.3;Oligodendrocytes: 117.1;Paneth cells: 72.3"	"Cancer enhanced"	"Detected in many"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 43.3;neutrophil: 100.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 100.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.6;RPTEC TERT1: 33.1;SK-BR-3: 50.7;T-47d: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	0.9	85.9	9.3	161.5	23.7	41.1	164.3	103.9	3.3	33.5	89.8	1.4	0.8	0.6	6.1	2.7	1.6	0.6	82.2	165.1	12.7	0.7	4.4	1.0	205.8	167.0	0.2	1.5	2.1	3.7	1.4	212.0	2.6	92.3	50.5	44.4	1.6	311.8	9.6	8.4	5.8	189.3	13.4	2.2	0.8	144.3	2.1	0.6	492.3	1.3	2.5	1.0	240.6	0.0	11.6	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	4.9	0.2	1.5	0.5	0.1	1.6	0.4	0.1	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	3.8	0.6	1.4	1.6	3.9	0.0	0.0	0.0	0.4	33.1	0.0	2.1	0.2	0.0	50.7	0.0	2.7	13.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	0.0	1.3	16.2	43.3	0.0	0.9	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	100.6	0.0	0.2	0.4	0.0	6.4	85.9	161.5	164.3	103.9	82.2	165.1	205.8	167.0	212.0	189.3	144.3	240.6	0.2	0.0	1.3	28.4	1.0	0.3	0.4	0.6	0.0	2.2	31.2	32.5	0.4	0.0	3.3	1.8	95.9	0.2	0.7	178.7	11.7	0.6	6.1	0.0	0.0	8.2	3.6	0.0	1.5	0.0	0.5	0.6	0.0	0.1	17.1	0.5	0.7	0.0	7.2	0.0	1.4	77.3	2.0	4.8	25.8	10.3	0.3	9.2	28.4	15.9	33.8	33.6	0.0	13.6	117.1	0.0	72.3	0.7	0.4	0.5	15.0	0.3	0.2	29.6	0.0	5.6	1.3	0.2	0.4	0.0	0.4	0.1	0.4	0.0	51.8	0.2
PAGR1	"C16orf53, GAS, MGC4606, PA1"	ENSG00000280789	"PAXIP1 associated glutamate rich protein 1"	Q9BTK6	16	29816152-29822489	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 166.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Plasma cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041440, HPA043608"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"			"HPA041440: AB_10795541, HPA043608: AB_10797144"	"unprognostic (2.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.09e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.39e-2)"	23.5	27.8	10.2	5.5	10.8	6.5	23.2	18.4	12.3	120.8	8.9	48.9	8.7	55.3	7.1	25.7	68.4	6.1	32.0	10.1	9.9	30.4	28.1	23.0	8.7	10.9	10.7	166.5	26.3	7.4	128.9	3.7	10.8	69.3	5.7	6.8	21.4	8.8	24.6	18.0	30.8	4.7	10.5	23.6	26.4	31.2	10.6	9.3	30.2	9.0	6.8	50.7	73.8	12.5	16.7	24.1	13.9	8.7	7.0	6.7	11.8	12.7	11.5	14.5	12.7	17.1	16.9	33.4	12.7	9.1	7.2	15.4	15.2	19.1	9.2	14.8	31.1	14.8	16.4	16.1	7.3	23.6	26.9	7.5	15.1	10.2	10.0	13.4	12.1	31.0	20.1	10.4	9.9	45.2	18.6	27.6	19.3	14.2	20.4	35.4	24.5	24.9	10.8	7.8	34.9	13.2	9.6	22.4	9.7	10.5	20.9	15.0	9.2	12.0	10.9	15.2	12.9	19.4	21.3	13.1	15.8	24.2	15.0	22.5	16.9	33.0	19.7	17.0	22.1	19.7	16.8	20.0	21.3	19.5	21.7	20.1	11.0	13.9	19.6	21.5	12.7	15.2	10.2	10.8	18.4	12.3	10.1	9.9	10.9	10.7	10.8	10.5	10.6	12.5	1.3	0.0	9.8	66.6	15.2	0.0	0.3	0.1	18.2	3.5	4.7	2.9	0.6	14.3	6.9	1.8	0.0	5.6	5.3	5.9	0.0	27.9	0.5	1.0	1.3	3.8	14.6	10.7	16.2	21.7	8.2	4.4	13.3	0.8	7.6	0.3	6.1	2.0	7.5	5.0	16.5	11.1	0.0	5.6	0.0	0.6	0.9	7.7	0.0	9.4	22.5	1.9	4.1	11.6	8.6	13.5	15.8	3.4	34.5	0.7	20.7	2.1	3.0	3.3	0.0	0.9	5.0	3.1	1.6	16.7	0.4	6.7	10.9	0.2	13.2	0.2
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836889-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 496.6;liver: 1408.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 250.2;Hepatocytes: 807.7;Proximal tubular cells: 344.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"Hep G2: 238.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		No	NA		40000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.2	6.4	2.1	0.0	1.9	0.0	0.2	1.8	3.4	0.1	1.1	0.3	0.1	0.1	0.5	0.0	0.1	79.4	0.0	2.2	2.3	496.6	1408.4	0.0	0.1	2.8	2.3	0.1	9.2	0.8	3.0	0.0	2.3	1.5	0.0	2.4	0.1	0.1	0.0	0.0	0.1	0.0	2.6	0.3	0.4	3.3	2.5	0.7	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	238.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.2	1.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.9	1.8	3.4	2.2	2.3	2.8	2.3	2.3	2.6	2.5	2.8	0.0	0.0	0.0	1.0	2.7	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.5	250.2	0.0	5.5	0.0	0.0	0.0	0.0	21.5	2.4	66.8	0.0	0.1	1.1	1.8	21.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	807.7	0.0	3.3	2.3	0.0	0.0	22.2	0.0	15.7	0.6	1.8	0.0	0.0	0.0	0.6	0.0	4.5	0.0	0.0	0.0	1.2	0.0	0.4	0.0	344.4	0.0	0.2	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.1
PAIP2B	KIAA1155	ENSG00000124374	"Poly(A) binding protein interacting protein 2B"	Q9ULR5	2	71182738-71227103	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 181.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 86.0;Early spermatids: 95.1;Hepatocytes: 67.1;Proximal tubular cells: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 15.8;SCLC-21H: 23.1"	"Low region specificity"	"Detected in all"							"HPA046784, HPA072371"	Approved		Approved	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA046784: AB_2679804, HPA072371: AB_2686514"	"unprognostic (8.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (8.17e-5)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.96e-12)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.61e-2)"	2.4	1.6	131.5	1.8	159.1	1.3	4.5	108.3	176.8	3.1	66.3	3.8	3.7	2.9	1.8	6.1	7.2	1.1	23.0	94.7	116.5	10.3	18.1	2.7	2.1	134.9	136.6	11.5	54.2	6.0	2.2	0.6	143.0	4.8	3.7	27.7	37.9	3.5	48.5	16.4	2.7	1.7	132.8	2.2	10.5	2.2	130.3	2.4	11.6	26.7	4.6	2.8	4.0	181.5	2.5	0.6	1.0	3.6	0.4	0.5	4.4	0.3	0.1	0.3	0.2	0.9	1.0	3.2	0.6	0.0	2.4	2.0	6.1	3.7	1.2	1.7	5.0	3.1	0.4	0.1	1.6	0.8	0.2	0.6	3.3	0.2	3.6	0.9	0.6	7.2	5.5	3.0	0.2	3.2	1.0	1.7	2.6	5.8	2.3	0.0	10.5	15.8	1.9	1.7	23.1	1.3	2.6	1.7	1.1	5.5	7.5	0.2	0.1	0.3	1.9	1.9	1.0	6.1	5.5	3.9	0.2	1.1	0.5	0.5	0.3	0.5	1.0	0.4	1.2	2.5	1.3	1.0	0.4	2.6	2.1	1.9	0.2	0.8	0.4	2.3	0.6	0.6	131.5	159.1	108.3	176.8	94.7	116.5	134.9	136.6	143.0	132.8	130.3	181.5	3.3	3.2	4.5	5.2	9.9	7.8	7.0	4.0	5.7	11.3	14.8	8.8	86.0	12.8	2.7	7.3	6.2	3.2	13.2	2.7	21.5	4.9	95.1	18.4	3.9	3.9	41.5	15.6	4.2	41.3	9.2	4.7	11.2	17.5	1.3	7.5	7.1	67.1	1.9	6.7	4.6	6.3	14.2	3.2	1.6	30.0	5.3	2.6	14.2	2.8	2.4	12.3	4.1	2.5	31.9	10.4	4.0	5.3	29.9	9.4	1.3	56.9	15.5	43.3	0.0	9.3	4.0	32.9	7.7	17.3	20.0	6.3	4.7	4.3	8.1	6.0
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537370-9839076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 12.0;retina: 4.7"	"Group enriched"	"Detected in some"	4	"Breast myoepithelial cells: 6.5;Glandular and luminal cells: 2.0;Granulosa cells: 5.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 4.6;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.0	1.9	3.6	0.0	4.8	0.0	0.4	12.0	8.4	0.1	0.0	0.0	0.0	0.2	0.6	0.2	0.0	1.2	0.0	5.5	0.7	0.2	0.7	0.0	0.0	0.3	1.4	0.0	1.3	0.0	1.2	0.0	0.4	0.4	0.0	4.7	0.3	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.2	2.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.8	12.0	8.4	5.5	0.7	0.3	1.4	0.4	0.2	2.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497052-168928457	"Disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 527.9;Cardiomyocytes: 591.7;Peritubular cells: 399.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 304.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Mitochondria,Cytosol"		No	No		27000	"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"	"Plasma membrane, Mitochondria, Cytosol"	"CAB070159: AB_1726016, HPA035905: AB_2674854"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.28e-4)"	65.0	35.5	31.7	49.7	27.3	0.9	43.6	11.1	19.9	146.1	0.0	303.3	29.0	301.5	21.9	122.6	118.4	71.0	180.4	27.9	36.2	42.1	12.4	71.7	16.9	29.8	25.9	62.1	13.2	55.6	11.3	62.1	25.1	137.0	74.9	12.8	40.8	205.7	127.7	34.7	64.1	303.1	21.4	60.5	94.8	35.1	24.7	23.3	38.7	47.3	16.6	280.2	85.3	22.7	82.1	39.6	87.9	53.4	77.2	83.9	123.6	53.7	137.6	47.2	66.7	1.1	4.6	36.6	14.4	23.7	29.0	17.0	54.1	138.8	60.5	73.9	16.6	0.8	112.5	10.4	135.5	0.4	1.0	132.8	84.4	85.5	125.4	115.0	20.8	19.7	0.1	0.5	304.5	3.8	23.8	1.4	24.9	20.8	24.1	8.3	81.4	0.8	5.3	16.4	9.0	46.4	102.8	8.1	7.3	151.2	48.6	0.5	64.4	50.3	192.1	20.7	90.1	47.8	0.7	1.7	41.6	1.0	14.2	13.7	3.1	0.0	4.6	1.8	0.2	0.1	0.5	2.4	2.1	0.1	0.6	1.6	0.7	0.6	1.2	0.2	0.8	1.8	31.7	27.3	11.1	19.9	27.9	36.2	29.8	25.9	25.1	21.4	24.7	22.7	22.7	32.1	9.4	167.8	1.5	93.6	527.9	56.8	76.8	6.0	46.0	107.9	591.7	20.0	58.7	44.1	18.8	52.1	8.1	20.9	1.9	27.6	133.1	52.8	181.2	27.7	44.8	0.8	27.8	51.3	115.6	130.5	59.7	51.0	52.6	21.0	47.8	11.2	24.5	26.9	108.4	30.7	18.3	28.9	23.8	146.4	130.1	36.7	23.2	16.9	52.9	55.1	17.5	182.4	6.5	83.0	18.6	399.4	2.6	167.6	9.8	23.4	85.2	4.0	177.5	115.4	227.8	81.0	7.6	34.1	49.3	22.3	9.2	13.4	29.3	113.0
PANK1	"MGC24596, PANK, PANK1a, PANK1b"	ENSG00000152782	"Pantothenate kinase 1"	Q8TE04	10	89579497-89645572	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 45.2;liver: 109.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 37.5;Distal tubular cells: 70.5;Hepatocytes: 149.8;Proximal tubular cells: 53.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.00e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.55e-4)"	"unprognostic (4.61e-2)"	"prognostic favorable (1.55e-10)"	"unprognostic (3.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	"unprognostic (6.64e-2)"	2.1	4.6	2.8	2.1	3.1	0.5	2.5	7.2	4.2	5.3	9.7	13.9	20.4	1.8	3.8	5.3	3.0	1.7	8.6	3.1	2.7	45.2	109.7	2.2	1.8	3.5	3.4	2.3	1.8	6.5	1.5	2.7	3.8	1.9	17.3	2.0	2.1	2.3	11.4	9.6	17.2	2.3	2.0	1.6	4.6	2.8	4.0	5.2	10.4	28.0	2.6	1.9	3.5	2.8	8.0	5.2	28.1	19.4	14.9	10.8	14.2	4.6	5.0	4.3	5.7	8.2	8.1	5.8	3.0	3.6	3.2	7.9	12.9	2.9	4.6	2.0	5.7	3.9	5.6	16.2	4.4	12.3	2.1	6.6	12.7	6.5	5.1	9.2	5.1	4.9	6.8	0.7	6.3	6.2	13.6	12.5	22.1	21.0	3.1	11.9	5.6	3.8	13.2	3.8	8.7	10.4	5.8	6.9	4.6	16.6	7.5	8.9	2.2	2.6	2.5	5.2	5.7	6.5	12.7	7.2	3.4	9.7	1.8	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	2.8	3.1	7.2	4.2	3.1	2.7	3.5	3.4	3.8	2.0	4.0	2.8	0.6	6.4	3.7	7.8	1.6	2.3	0.7	2.2	1.8	4.7	2.1	2.0	12.9	10.0	2.5	11.0	2.1	4.7	0.5	37.5	70.5	1.1	0.5	2.5	2.6	1.7	11.4	7.8	21.1	0.7	4.5	1.8	2.0	3.3	0.0	8.4	3.3	149.8	2.4	13.5	32.1	14.8	0.0	3.8	0.7	0.7	1.2	2.2	0.0	7.5	0.4	1.0	0.0	12.1	3.0	0.1	17.9	2.2	1.4	0.5	31.4	53.2	1.5	1.3	0.0	2.2	5.1	0.7	0.8	5.6	2.8	1.8	1.8	1.4	25.1	0.5
PARD6G	"PAR-6G, PAR6gamma"	ENSG00000178184	"Par-6 family cell polarity regulator gamma"	Q9BYG4	18	80157232-80247514	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 39.6;Oligodendrocyte precursor cells: 25.6;Squamous epithelial cells: 25.3;Suprabasal keratinocytes: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.4;hTCEpi: 34.0;RT4: 27.9;U-2 OS: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047017	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA047017: AB_2679904"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.80e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.85e-1)"	"unprognostic (2.72e-1)"	3.4	1.7	5.8	1.4	5.7	0.6	5.3	3.8	7.9	9.6	6.8	6.0	1.8	6.5	2.7	18.0	6.2	3.3	2.9	9.3	7.8	7.0	3.5	2.9	2.5	6.3	5.8	6.2	2.1	2.1	3.8	5.5	5.5	5.7	2.0	1.8	4.5	5.9	1.9	38.1	3.0	5.4	4.6	2.0	2.7	2.1	8.3	5.3	18.0	1.0	4.3	5.6	12.0	5.9	3.0	4.3	17.7	13.4	0.6	0.7	12.9	3.3	0.7	2.9	0.4	1.2	1.2	0.0	1.4	1.5	5.1	13.4	6.4	19.2	2.8	0.5	5.7	0.2	3.5	10.4	0.8	4.0	36.4	5.7	34.0	0.3	1.8	2.2	1.4	4.2	1.4	0.8	4.3	5.0	3.6	0.4	5.3	1.4	5.2	0.1	11.7	1.5	0.5	27.9	7.4	7.7	4.1	2.2	20.0	8.6	2.6	3.4	1.1	5.9	28.8	2.2	1.6	0.9	1.2	0.3	1.9	0.9	11.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	5.7	3.8	7.9	9.3	7.8	6.3	5.8	5.5	4.6	8.3	5.9	3.3	3.2	0.6	7.5	0.7	39.6	13.7	11.0	18.8	1.3	4.1	10.3	2.8	1.5	2.3	3.7	0.0	0.6	9.7	0.4	0.0	0.4	0.5	9.8	10.1	8.2	0.0	0.0	6.5	0.2	9.5	4.1	0.5	3.3	0.0	3.1	10.8	1.5	0.8	0.0	8.5	0.7	8.2	0.9	6.5	0.7	1.8	0.8	12.4	15.9	0.0	2.0	0.0	25.6	4.8	0.8	0.0	1.9	3.6	6.6	0.0	7.6	2.6	2.5	19.7	1.9	13.6	1.5	6.0	25.3	63.9	0.4	8.0	2.0	0.6	13.4
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.9;Distal enterocytes: 398.3;Intestinal goblet cells: 109.7;Paneth cells: 132.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 56.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"memory B-cell: 8.1;myeloid DC: 4.0;naive B-cell: 5.6"	"Group enriched"	"Detected in many"	15	"B-cells: 8.1;dendritic cells: 4.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.6;Karpas-707: 44.9;U-266/70: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	45.1	51.8	4.1	27.7	5.4	0.4	29.3	0.0	19.3	43.3	2.1	91.3	7.0	34.7	14.0	13.5	23.3	28.6	103.6	10.4	26.0	55.9	1.3	33.7	18.2	1.3	3.9	19.6	34.1	73.1	41.0	40.7	21.2	83.8	113.4	6.0	39.4	64.5	21.0	11.1	15.7	48.2	0.0	15.3	13.4	12.0	4.1	17.3	123.7	18.1	20.9	44.9	25.0	0.0	1.1	1.9	1.7	0.0	44.6	0.3	0.2	0.0	0.2	0.0	0.0	3.9	0.3	0.0	0.2	0.0	0.1	0.1	15.1	0.0	0.0	0.2	3.3	0.0	0.0	0.0	7.4	0.0	1.3	1.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	44.9	0.8	0.5	5.2	0.2	4.3	0.0	2.7	0.0	4.1	11.8	0.2	9.5	2.8	0.1	0.1	0.3	0.0	1.8	0.0	0.0	0.0	2.7	2.9	0.3	4.2	49.8	5.1	12.9	4.7	0.0	0.7	0.0	0.1	0.0	0.0	0.3	0.0	8.1	0.0	0.0	4.0	5.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	4.1	5.4	0.0	19.3	10.4	26.0	1.3	3.9	21.2	0.0	4.1	0.0	44.8	16.0	84.1	2.9	11.6	3.2	27.2	6.5	4.0	7.0	4.0	3.4	181.9	31.5	10.4	0.0	0.0	0.3	0.1	398.3	3.9	0.5	10.1	3.0	73.5	6.4	19.9	2.7	51.3	49.2	0.7	13.2	2.0	2.8	1.3	61.9	2.9	0.0	1.5	0.0	77.8	109.7	14.2	0.3	34.7	28.6	36.7	4.9	8.8	1.0	0.7	0.1	0.0	6.0	3.6	23.5	132.1	74.4	42.9	32.6	2.5	27.7	7.2	1.7	46.0	5.4	61.5	1.6	3.2	0.3	1.8	0.8	1.9	14.9	81.6	9.1
PARP14	"ARTD8, KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680839-122730840	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 246.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 74.7;BJ hTERT+ SV40 Large T+ RasG12V: 113.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	14.0	12.6	4.3	24.3	5.1	20.1	11.3	3.6	2.7	11.4	5.5	11.5	15.3	8.2	2.4	9.0	10.7	15.2	11.1	2.8	5.1	14.9	24.5	33.5	24.0	15.1	5.9	9.2	7.8	7.3	7.6	17.8	8.6	13.0	8.7	1.1	11.7	7.2	5.0	5.3	17.5	10.2	10.9	37.4	11.7	2.2	8.9	15.4	14.7	8.3	26.8	13.7	9.4	7.8	15.6	13.0	8.0	8.3	9.1	26.2	0.0	6.1	40.1	74.7	113.1	6.9	28.7	0.0	24.2	13.4	41.8	11.5	11.9	11.6	15.0	24.0	1.5	14.6	5.8	8.7	20.4	6.4	6.8	14.7	4.7	13.0	4.8	16.4	32.2	12.3	7.0	22.7	2.1	7.9	24.8	1.5	1.1	2.1	11.1	34.2	8.3	4.3	9.5	16.2	0.6	0.0	15.3	3.1	14.1	0.8	5.7	9.3	22.0	4.0	9.4	2.3	5.5	8.7	1.6	2.7	12.0	13.8	7.2	13.1	10.8	5.8	8.6	13.7	7.2	12.8	4.5	5.6	5.6	20.3	3.6	4.1	29.5	9.5	14.7	0.7	9.9	4.3	4.3	5.1	3.6	2.7	2.8	5.1	15.1	5.9	8.6	10.9	8.9	7.8	111.5	246.8	98.4	17.3	115.3	16.8	17.0	35.9	13.1	2.1	19.6	15.6	14.6	24.3	65.9	25.8	4.2	14.1	64.9	43.0	3.9	36.0	0.3	118.8	59.8	94.7	10.7	18.5	0.5	41.2	28.4	37.2	24.5	149.8	32.2	69.6	67.1	32.5	36.5	0.0	3.0	18.2	26.4	61.6	39.9	2.1	28.0	83.9	16.0	124.6	132.2	15.1	58.7	47.3	1.1	44.0	20.2	17.3	50.9	31.8	29.5	11.5	73.0	1.0	13.1	32.7	30.3	1.9	1.1	13.7	10.5	4.8	51.4	42.8	16.0	25.9
PARP15	"ARTD7, FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577628-122639047	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 23.1;intestine: 42.1;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 19.2;B-cells: 88.4;dendritic cells: 38.6;granulocytes: 19.6;NK-cells: 21.6;Plasma cells: 18.6;T-cells: 31.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.6;JURKAT: 5.1;REH: 3.5;THP-1: 3.7;TIME: 8.9"					"Low region specificity"	"Detected in single"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	Mitochondria		"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	3.7	1.2	3.1	25.7	2.7	23.1	1.8	4.2	3.8	1.7	1.2	3.8	2.6	1.9	1.3	2.0	2.0	4.4	1.7	2.1	1.2	1.7	3.2	9.0	44.4	1.8	2.3	0.7	0.8	0.2	0.7	2.5	1.7	1.8	4.8	2.2	2.2	1.1	6.0	1.2	42.1	1.9	0.7	67.2	4.1	2.5	2.0	8.3	3.0	1.9	50.3	4.5	1.6	3.6	0.3	0.2	0.3	0.3	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.2	0.7	0.3	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.1	7.6	0.5	0.3	0.1	0.5	0.3	1.5	0.1	0.3	0.1	0.2	1.7	5.1	0.2	1.3	0.0	0.3	2.3	0.4	0.4	0.1	0.1	3.5	0.2	0.3	0.0	0.6	0.5	0.3	0.1	0.1	0.1	0.3	0.5	3.7	8.9	0.2	0.6	0.3	0.2	0.6	0.4	1.6	0.4	0.2	0.1	1.8	0.2	0.1	7.2	0.3	5.8	9.4	4.4	5.4	0.8	9.3	3.8	4.8	0.5	3.9	0.7	1.0	4.2	2.2	3.1	2.7	4.2	3.8	2.1	1.2	1.8	2.3	1.7	0.7	2.0	3.6	0.8	19.2	15.9	0.0	88.4	0.5	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.0	2.1	0.0	0.0	0.1	38.6	0.1	0.0	0.0	0.2	0.3	0.1	1.2	0.0	7.4	0.1	0.0	0.1	2.7	2.6	0.3	19.6	0.0	2.2	0.6	8.3	0.0	0.2	0.0	0.0	5.1	1.4	0.2	0.0	6.4	1.8	6.5	4.7	0.0	21.6	0.0	0.1	0.1	0.0	0.0	18.6	0.0	0.0	0.1	10.5	0.0	0.0	0.7	0.4	0.1	1.6	0.4	0.0	0.3	31.1	0.0	0.0	0.0
PATL2	Pat1a	ENSG00000229474	"PAT1 homolog 2"	C9JE40	15	44665732-44711316	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.7;lymphoid tissue: 17.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 29.2;dendritic cells: 19.1;NK-cells: 51.5;Plasma cells: 15.7;T-cells: 29.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 21.6;memory CD4 T-cell: 6.0;memory CD8 T-cell: 17.7;naive CD8 T-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 21.6"	"Cell line enriched"	"Detected in some"	28	"U-266/70: 124.9"	"Not detected"	"Not detected"													NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (3.30e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-4)"	0.9	1.1	0.8	7.7	1.1	7.7	1.3	0.6	0.8	0.3	1.5	2.1	2.4	1.1	1.7	0.6	1.4	2.3	0.7	0.7	0.8	0.5	1.7	3.9	17.2	1.8	1.1	0.9	0.6	0.4	0.2	1.0	1.1	0.8	2.5	0.1	2.5	0.6	0.3	2.7	3.2	0.8	0.9	13.9	3.2	0.5	1.2	3.6	0.7	0.0	10.8	2.1	0.2	1.4	0.2	0.0	0.0	0.1	0.0	1.1	2.8	0.1	0.4	0.9	0.9	0.6	1.2	0.9	0.1	0.3	1.8	1.3	0.1	0.2	0.5	2.1	0.0	1.2	0.0	0.1	0.5	0.5	0.7	1.2	0.1	0.5	0.3	0.2	0.0	1.4	0.2	4.5	0.3	0.3	0.1	1.4	0.4	0.1	0.1	1.8	0.0	0.5	0.1	0.4	0.1	0.0	0.0	1.3	0.1	0.2	0.1	0.9	0.6	0.3	0.0	0.8	0.0	124.9	4.3	0.4	1.2	3.1	0.4	1.5	0.3	2.6	21.6	0.7	3.2	3.3	6.0	17.7	0.7	3.5	3.6	12.8	1.6	2.7	0.5	0.6	0.9	3.7	0.8	1.1	0.6	0.8	0.7	0.8	1.8	1.1	1.1	0.9	1.2	1.4	1.4	3.2	1.7	1.6	29.2	0.9	0.6	0.5	0.6	0.0	0.6	0.6	11.7	0.0	0.4	0.0	0.0	0.2	19.1	2.0	0.0	0.4	0.3	2.4	1.0	1.8	0.0	3.0	0.3	0.6	0.5	1.9	8.2	0.8	0.0	1.2	1.4	1.0	2.0	0.0	0.4	1.4	0.0	4.8	2.3	0.0	0.3	5.6	0.0	3.7	5.2	0.0	51.5	0.5	1.3	0.4	0.3	0.0	15.7	0.6	2.2	0.4	8.5	0.0	0.0	1.0	2.6	0.1	0.4	1.4	0.9	0.3	29.8	1.8	0.9	1.3
PBLD	"FLJ14767, MAWBP, MAWDBP"	ENSG00000108187	"Phenazine biosynthesis like protein domain containing"	P30039	10	68282660-68333049	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 171.5;kidney: 270.0;liver: 335.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.5;Distal tubular cells: 109.5;Hepatocytes: 216.9;Proximal enterocytes: 380.2;Proximal tubular cells: 426.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 16.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038035, HPA038036"	Enhanced		Approved	Vesicles		NA	NA		1100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA038035: AB_10672470, HPA038036: AB_10675625"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.25e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.68e-2)"	8.9	11.2	2.9	8.4	5.5	9.3	4.5	5.3	5.3	3.9	4.2	33.2	171.5	5.9	3.8	3.4	7.2	9.4	6.2	3.0	4.6	270.0	335.2	3.9	5.5	4.9	4.1	3.6	63.0	5.6	2.3	4.2	4.2	5.6	27.6	8.7	4.5	5.1	5.6	5.6	146.4	5.0	3.0	4.6	54.8	3.8	4.4	2.1	5.5	3.1	2.2	5.4	2.1	8.9	3.8	7.5	7.1	4.9	6.4	3.6	3.3	15.1	9.5	5.6	5.8	6.9	9.5	4.2	5.6	10.6	2.3	5.8	3.3	3.9	4.8	2.0	5.4	3.3	9.3	6.4	3.0	5.0	3.3	6.4	4.0	3.4	4.2	10.1	3.5	4.0	3.1	9.2	8.9	5.9	4.7	8.7	2.1	3.0	3.2	8.0	9.4	7.1	11.3	5.4	4.1	5.5	10.1	5.8	7.0	2.0	20.0	5.9	10.9	5.5	3.9	2.7	2.5	5.5	4.3	6.3	6.6	2.7	1.4	2.6	2.8	1.5	0.4	1.4	0.8	0.8	0.6	0.4	2.8	0.6	1.1	0.7	3.3	1.8	0.9	1.2	1.1	1.2	2.9	5.5	5.3	5.3	3.0	4.6	4.9	4.1	4.2	3.0	4.4	8.9	1.6	3.2	4.2	3.6	4.5	1.9	1.7	2.2	1.2	5.0	6.2	2.8	3.5	24.3	4.3	55.2	10.4	3.9	3.7	97.5	109.5	8.8	1.2	17.9	5.7	3.4	7.2	6.6	1.8	31.8	2.0	3.2	33.1	6.5	1.3	8.2	6.4	216.9	3.1	10.1	2.8	42.6	2.0	10.4	4.4	0.4	4.1	5.5	1.8	3.7	5.0	5.5	3.1	3.0	7.5	12.5	46.4	3.0	1.5	2.0	380.2	426.5	12.9	17.2	0.0	2.0	6.6	1.6	1.4	1.8	0.6	3.1	2.8	9.6	57.3	3.0
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	60.9	23.7	35.7	2.9	35.5	3.5	28.4	36.6	35.8	3.7	17.5	4.7	6.5	3.8	1.8	9.3	3.2	2.8	4.3	32.4	41.0	23.3	148.0	2.6	1.3	43.4	40.1	5.1	4.9	18.2	8.6	4.4	37.6	7.2	2.8	2.4	35.3	9.3	12.1	4.7	7.7	1.4	37.8	1.5	9.1	10.7	49.0	2.0	4.6	6.6	2.0	2.9	4.4	37.0	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	35.7	35.5	36.6	35.8	32.4	41.0	43.4	40.1	37.6	37.8	49.0	37.0	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCARE	"C2orf71, FLJ34931, RP54"	ENSG00000179270	"Photoreceptor cilium actin regulator"	A6NGG8	2	29060976-29074523	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"retina: 28.5"	"Cell type enriched"	"Detected in single"	20	"Cardiomyocytes: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (2.28e-3)"	"unprognostic (1.23e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.88e-1)"		"unprognostic (5.88e-3)"	"unprognostic (6.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.81e-2)"		"unprognostic (2.37e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-4)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.5	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.5	0.2	0.3	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888565	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 429.5"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 453.9;Hepatocytes: 603.7;Proximal tubular cells: 877.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 527.8;Hep G2: 527.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	77.3	102.9	115.0	31.0	111.8	21.8	67.9	111.9	140.7	58.0	114.1	83.9	54.4	48.2	91.2	54.3	111.5	47.4	152.3	109.3	136.9	165.1	429.5	57.9	31.1	125.4	138.5	64.2	174.9	135.1	61.5	33.4	139.4	73.8	88.3	48.6	49.9	78.4	109.7	25.7	64.0	75.6	119.7	25.6	84.8	20.0	131.8	25.8	86.3	109.1	35.8	69.3	39.2	118.9	158.3	374.3	21.4	223.8	80.9	76.0	29.4	50.0	84.5	77.7	61.6	527.8	270.3	32.2	141.4	56.3	57.9	101.7	138.9	81.3	53.2	86.2	251.9	28.6	57.5	527.1	84.9	28.5	99.2	74.1	88.5	76.5	35.8	114.1	212.3	19.9	57.1	2.8	55.2	270.2	3.5	94.7	30.1	420.5	346.0	15.1	29.7	103.6	328.6	164.7	94.0	158.8	41.5	277.1	111.5	59.9	81.1	53.8	86.2	12.7	102.9	18.9	123.8	1.1	6.7	1.1	68.3	93.1	19.5	0.2	24.8	8.7	19.6	47.1	15.3	25.7	25.8	28.3	49.6	10.9	8.4	17.1	1.6	19.6	34.4	35.8	41.1	18.7	115.0	111.8	111.9	140.7	109.3	136.9	125.4	138.5	139.4	119.7	131.8	118.9	25.5	41.7	91.5	8.5	25.9	49.8	169.1	88.2	103.0	39.0	197.9	249.6	151.5	138.7	86.0	187.6	6.2	124.6	18.5	113.8	453.9	185.0	2.3	138.7	49.3	40.8	176.4	36.2	4.9	169.9	81.6	82.2	86.6	175.3	31.1	64.6	37.9	603.7	180.3	35.3	8.5	313.3	65.1	79.9	55.7	11.2	67.4	73.1	78.2	5.6	68.0	153.0	22.6	9.0	4.6	154.8	164.7	95.5	35.1	212.7	232.1	877.7	78.4	33.2	85.5	57.2	63.3	4.4	12.3	147.8	45.7	77.6	32.6	95.9	230.2	187.5
PCDH12	VE-cadherin-2	ENSG00000113555	"Protocadherin 12"	Q9NPG4	5	141943581-141969741	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.2"	"Group enriched"	"Detected in some"	4	"Adipocytes: 38.5;Endothelial cells: 40.0;Hepatic stellate cells: 41.0;Hofbauer cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	8	"non-classical monocyte: 4.6"	"Lineage enriched"	"Detected in single"	41	"monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 25.9;Karpas-707: 66.5;U-937: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051242	Uncertain				"Secreted to blood"	NA	NA		14000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA051242: AB_2681402"	"unprognostic (6.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.37e-2)"	"unprognostic (9.33e-2)"	13.4	5.0	0.8	2.5	0.9	0.5	4.9	2.5	1.7	2.7	1.2	2.0	2.0	2.8	0.4	2.1	2.1	4.0	10.8	0.6	0.8	6.0	4.0	15.5	2.6	0.5	0.3	1.7	1.4	2.9	3.6	30.2	0.6	1.9	1.3	1.6	1.4	2.3	4.0	1.7	2.1	5.2	0.3	18.6	2.0	1.1	1.4	0.8	6.5	5.1	1.0	3.2	1.9	0.3	0.1	0.1	1.9	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	5.0	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.6	1.4	0.2	0.1	0.2	0.5	0.2	0.0	0.0	0.4	0.0	0.4	25.9	0.3	0.0	66.5	0.0	0.4	0.1	0.3	0.5	0.0	0.3	0.5	0.2	3.0	0.0	0.1	0.3	0.7	0.1	0.1	0.3	0.2	0.0	1.8	1.8	0.6	0.1	0.9	0.1	0.4	0.4	0.1	0.4	11.7	2.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.8	0.9	2.5	1.7	0.6	0.8	0.5	0.3	0.6	0.3	1.4	0.3	38.5	0.0	1.1	0.0	0.5	0.6	0.0	0.0	1.2	1.3	0.1	0.1	4.0	0.0	0.0	0.0	2.1	0.3	0.3	0.0	3.9	0.1	1.7	0.1	0.1	40.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.1	1.3	0.0	41.0	0.5	34.6	0.0	0.2	0.0	0.0	8.5	0.3	2.5	0.0	1.5	1.8	6.5	0.3	0.5	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.4	0.0	0.7	1.0	0.0	0.2	0.2	0.3	0.5	0.2	1.4	0.0	0.2
PCDH15	"CDHR15, DFNB23, USH1F"	ENSG00000150275	"Protocadherin related 15"	Q96QU1	10	53802771-55627942	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Hearing"		"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 19.0;brain: 21.2;retina: 61.7"	"Cell type enriched"	"Detected in some"	13	"Oligodendrocyte precursor cells: 2965.2"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.1;U-266/70: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074437		Supported			"Intracellular and membrane"	NA	NA		22000		"Cluster 77: Retina - Visual perception"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA074437: "	"unprognostic (1.38e-1)"	"unprognostic (3.39e-1)"		"unprognostic (8.15e-5)"	"unprognostic (3.07e-3)"	"unprognostic (2.79e-1)"		"unprognostic (9.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-3)"		"unprognostic (1.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.66e-3)"	0.2	19.0	13.4	0.3	9.5	0.1	0.0	3.1	10.3	0.2	0.0	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.5	16.6	19.6	8.0	0.0	2.5	0.4	13.8	13.7	0.0	0.0	0.5	4.7	0.2	12.6	0.2	0.0	61.7	0.1	0.0	0.0	0.1	0.2	0.0	9.7	0.7	0.3	3.3	21.2	0.1	0.0	0.0	0.5	0.5	0.0	6.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.1	0.0	0.0	3.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	9.5	3.1	10.3	16.6	19.6	13.8	13.7	12.6	9.7	21.2	6.2	0.0	0.0	0.0	14.4	0.0	0.3	0.0	0.0	0.0	5.1	0.6	0.0	4.8	0.0	0.0	0.0	87.6	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	0.3	0.0	0.0	27.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	216.2	0.1	0.0	0.0	0.0	7.5	0.0	0.1	0.0	3.7	0.0	4.4	0.0	2965.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	92.8	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631744-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;lymphoid tissue: 25.1"	"Group enriched"	"Detected in many"	4	"Adipocytes: 57.6;Astrocytes: 77.1;Early spermatids: 60.7;Endothelial cells: 126.7;Excitatory neurons: 125.2;Hepatic stellate cells: 79.6;Inhibitory neurons: 67.9;Oligodendrocyte precursor cells: 193.0;Oligodendrocytes: 101.1;Spermatocytes: 68.3"	"Cancer enhanced"	"Detected in many"		"glioma: 9.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 14.7;HEK 293: 9.3;U-87 MG: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA		690000		"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Cytosol"	"Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	1.6	1.8	15.8	1.8	20.6	0.0	0.8	7.9	13.9	2.2	0.1	1.2	0.8	2.1	0.8	0.6	2.0	3.2	2.2	11.7	25.5	1.9	1.0	14.0	0.6	9.3	15.8	0.5	6.0	1.6	0.9	4.4	11.4	1.0	0.8	1.0	0.7	0.7	1.7	0.3	0.8	2.1	7.6	25.1	1.5	8.8	27.9	0.2	2.9	1.3	0.5	2.7	0.8	10.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	9.3	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.3	0.0	2.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	1.2	0.0	1.0	0.0	0.0	0.0	5.3	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	20.6	7.9	13.9	11.7	25.5	9.3	15.8	11.4	7.6	27.9	10.5	57.6	0.0	4.3	77.1	0.1	2.7	0.1	0.0	1.2	7.1	0.4	0.6	6.0	1.5	8.6	1.8	0.0	0.2	0.5	0.1	0.0	11.1	60.7	2.6	2.0	126.7	0.0	0.0	125.2	8.3	0.1	11.7	0.0	19.8	0.0	20.5	79.6	0.3	0.6	0.0	67.9	0.0	0.0	1.9	2.5	19.0	1.8	0.5	10.6	12.2	1.6	2.3	0.0	193.0	101.1	1.3	0.0	1.2	1.2	0.3	0.0	0.0	5.1	0.0	6.6	1.9	10.7	68.3	10.6	0.4	1.0	0.0	1.1	1.6	0.0	0.4
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.2"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		5900000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	22.2	5.2	2.6	7.9	3.0	0.1	13.5	2.8	3.2	25.3	2.6	12.2	9.3	30.4	11.2	6.4	11.7	22.5	6.5	2.5	4.8	7.1	2.1	7.2	1.7	4.1	5.8	21.0	1.5	2.0	2.4	44.2	3.8	17.5	13.8	2.1	6.5	13.5	2.6	4.1	8.7	18.4	3.2	6.4	6.7	4.5	3.9	3.6	5.1	23.2	1.4	10.8	8.4	3.0	0.0	0.3	148.2	0.0	175.0	190.8	0.1	27.4	86.8	5.0	7.7	0.3	0.0	0.0	0.1	143.3	0.4	0.4	34.2	0.7	2.6	0.2	1.0	0.0	0.0	0.0	129.4	0.0	0.1	195.9	0.3	9.4	3.8	4.7	1.0	0.7	0.0	0.6	2.8	0.0	3.9	0.1	0.3	0.0	2.7	11.7	4.1	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.2	38.3	0.9	0.0	0.0	69.3	4.2	13.9	0.5	0.2	0.0	0.0	3.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	2.8	3.2	2.5	4.8	4.1	5.8	3.8	3.2	3.9	3.0	3.4	0.0	0.5	1.3	0.0	4.1	0.4	0.1	2.2	2.5	1.1	1.7	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	1.9	72.3	3.0	0.0	0.0	0.2	0.0	0.3	56.3	0.0	1.7	0.0	6.4	2.5	0.0	3.1	0.0	9.0	0.0	0.0	0.0	7.8	1.3	37.9	0.9	1.8	10.3	0.0	6.8	0.0	0.0	0.6	0.0	0.0	58.6	0.1	0.0	0.0	0.1	0.0	0.2	19.7	6.6	25.5	0.6	0.1	1.2	2.6	0.8	0.7	18.5	0.0	0.1
PCDHB4	PCDH-BETA4	ENSG00000081818	"Protocadherin beta 4"	Q9Y5E5	5	141121818-141125623	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.7;Endometrial stromal cells: 8.2;Fibroblasts: 9.5;Horizontal cells: 8.4;Peritubular cells: 6.4;Skeletal myocytes: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 8.7;SH-SY5Y: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014466	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	"Intermediate filaments"	"HPA014466: AB_1855058"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.03e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-4)"	"unprognostic (5.18e-3)"	3.2	2.1	2.7	0.7	3.0	0.0	3.4	3.3	3.7	3.6	0.3	2.0	0.6	5.4	3.8	1.5	4.0	2.4	2.3	3.2	4.2	1.5	0.3	2.1	0.4	5.0	3.7	4.2	8.5	1.4	2.7	0.1	5.7	2.4	0.9	1.6	2.1	1.9	1.6	1.3	0.9	3.3	5.0	0.7	1.3	0.5	2.7	0.4	1.5	2.1	0.2	2.1	2.1	6.7	0.0	0.0	0.3	1.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.7	5.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	3.0	3.3	3.7	3.2	4.2	5.0	3.7	5.7	5.0	2.7	6.7	9.7	0.0	0.5	0.0	0.0	1.1	0.4	0.2	0.6	4.9	2.6	3.8	1.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	8.2	4.3	0.0	0.0	0.0	1.7	0.0	9.5	0.0	0.3	0.0	0.1	3.6	0.0	0.1	8.4	0.0	0.0	2.0	0.0	1.1	0.0	1.5	0.1	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.6	0.0	6.4	0.0	0.7	0.0	0.0	2.5	0.6	0.0	8.7	4.0	1.4	0.5	0.0	2.0	0.0	0.0	0.5	0.0	0.4
PCDHB7	PCDH-BETA7	ENSG00000113212	"Protocadherin beta 7"	Q9Y5E2	5	141172644-141176383	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Early spermatids: 38.4;Late spermatids: 27.3;Spermatocytes: 24.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.9;EFO-21: 4.8;U-138 MG: 3.2;U-2197: 9.6;U-87 MG: 3.3;WM-115: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059271	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA059271: AB_2683962"	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.69e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.78e-4)"	1.7	0.7	0.5	0.9	0.6	0.0	2.0	0.6	1.6	2.9	0.0	1.5	0.4	4.5	1.6	0.3	2.6	1.5	1.6	1.0	0.7	1.0	0.3	2.0	0.2	1.7	1.2	2.3	0.4	0.3	2.4	0.2	1.2	1.1	0.4	1.4	0.6	1.0	0.4	0.7	0.8	3.1	0.9	0.7	0.7	2.0	0.6	0.2	1.0	0.6	0.2	1.3	1.5	1.0	0.0	0.0	0.4	0.4	3.9	1.9	0.0	0.2	0.5	0.1	0.1	0.0	0.1	0.0	4.8	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	1.4	1.0	0.3	0.0	0.8	0.0	2.1	0.0	0.7	3.2	0.6	9.6	0.1	0.0	0.0	0.0	3.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	1.6	1.0	0.7	1.7	1.2	1.2	0.9	0.6	1.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	4.9	0.2	0.5	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	38.4	0.3	2.4	1.1	0.0	0.0	0.0	0.4	0.0	2.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.0	6.1	0.0	0.0	27.3	0.9	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.3	6.6	3.4	2.1	24.5	0.7	0.0	0.9	0.1	0.0	0.3	0.0	0.0
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568121	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Kinase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 432.1;liver: 681.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 703.8;Distal tubular cells: 588.9;Hepatocytes: 1184.0;Proximal enterocytes: 2209.9;Proximal tubular cells: 3547.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"ASC diff: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006277, HPA006507, CAB017027"	Approved					NA	NA		840000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	59.2	1.1	0.8	1.7	0.8	0.0	29.8	0.7	1.6	0.0	0.6	57.8	110.4	1.2	0.2	0.4	0.9	5.0	1.0	0.7	1.4	432.1	681.4	0.2	0.3	0.7	0.9	1.6	0.4	0.0	21.1	0.3	0.8	0.2	79.8	0.5	1.1	0.2	0.4	0.9	143.9	2.9	0.6	0.3	0.9	0.0	1.3	0.1	0.8	6.5	0.0	0.8	0.1	0.8	0.0	0.0	0.0	0.0	20.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.6	0.7	1.4	0.7	0.9	0.8	0.6	1.3	0.8	0.7	0.0	0.0	0.0	21.3	0.1	0.0	0.0	15.9	0.3	0.7	0.6	1.0	61.5	0.6	90.1	0.0	0.1	0.1	703.8	588.9	0.6	0.1	1.3	1.5	2.7	53.9	40.2	0.0	0.0	0.0	2.3	19.9	8.5	8.9	0.1	29.6	1184.0	0.0	3.3	0.0	293.6	0.0	22.6	0.0	0.0	0.0	12.8	0.0	1.9	0.0	9.9	0.0	0.0	0.0	0.1	285.5	0.0	0.0	0.0	2209.9	3547.9	0.0	0.4	0.0	0.3	6.0	0.0	0.1	10.3	0.3	0.3	10.2	1.5	348.5	0.1
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 196.1;kidney: 99.1;liver: 374.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	25.5	10.7	3.2	8.0	3.9	4.5	21.1	3.8	3.3	6.8	3.4	44.8	196.1	5.8	3.1	20.0	5.9	4.5	5.8	3.1	3.9	99.1	374.1	16.5	8.7	4.6	4.2	3.0	34.8	17.4	8.0	2.8	4.1	9.1	19.2	2.7	18.6	7.1	2.6	12.6	136.3	3.8	4.0	21.7	16.0	19.7	3.9	3.7	18.9	1.2	7.5	10.8	10.0	4.3	17.6	9.8	2.7	18.1	11.0	10.5	46.0	21.5	25.6	17.4	28.4	16.1	19.9	44.6	2.6	33.4	5.6	25.4	18.0	28.1	13.8	22.8	0.8	8.0	5.0	84.2	104.7	15.8	33.4	12.9	104.7	10.6	26.5	5.0	14.0	50.6	23.4	79.3	6.4	74.6	4.0	7.6	3.1	39.4	13.0	8.7	10.5	26.0	5.3	26.7	11.3	18.2	16.5	21.2	103.9	2.6	28.5	24.1	2.7	3.8	19.7	5.6	6.0	53.2	18.6	11.0	10.6	24.5	9.6	0.3	11.6	3.5	4.0	21.6	4.1	11.4	4.5	4.5	15.3	7.3	2.7	2.5	1.3	2.2	22.0	2.5	9.1	6.1	3.2	3.9	3.8	3.3	3.1	3.9	4.6	4.2	4.1	4.0	3.9	4.3	4.8	12.8	28.5	1.3	17.9	3.3	10.2	12.3	5.7	4.7	8.6	5.2	1.8	18.6	8.0	18.4	0.0	4.7	4.3	91.2	35.2	18.9	60.1	1.6	5.2	5.6	9.1	24.4	0.5	76.3	14.3	7.4	16.8	4.5	1.3	1.6	13.2	309.3	63.8	0.0	0.9	60.8	18.3	25.8	5.7	30.8	3.4	16.4	7.2	1.0	22.9	5.8	7.2	0.0	0.1	29.0	87.8	3.0	13.3	7.6	752.6	237.1	4.8	5.5	0.0	3.4	18.7	19.8	1.0	9.1	4.8	3.0	7.6	6.8	72.0	15.0
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889206	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 87.6;heart muscle: 123.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 138.0;Extravillous trophoblasts: 63.1;Fibroblasts: 225.8;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.5;RPMI-8226: 36.8;U-2197: 77.9;U-266/70: 68.6;U-266/84: 34.3"	"Low region specificity"	"Detected in many"							HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		580000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	87.6	2.8	0.8	4.0	0.9	14.9	29.1	0.4	1.0	21.5	0.8	6.9	0.1	4.2	2.2	7.8	3.9	1.5	123.2	1.3	1.9	17.9	18.3	16.4	2.3	0.7	1.1	3.9	1.4	0.7	23.7	48.1	0.6	21.5	5.1	0.7	3.1	8.9	2.4	5.3	2.8	8.7	0.5	3.0	3.4	2.4	1.5	0.7	6.4	22.1	1.9	25.7	26.0	0.8	1.4	11.0	3.4	0.0	65.5	18.1	0.0	1.0	0.2	2.9	3.6	0.7	1.2	0.0	3.3	4.9	14.8	0.1	13.7	0.0	3.4	0.0	21.0	2.5	6.8	0.0	0.0	1.5	0.0	6.9	0.0	6.9	1.7	14.5	0.2	2.2	0.5	0.0	1.4	2.0	4.5	1.2	5.5	0.2	21.9	0.0	8.1	36.8	3.2	0.1	7.6	4.6	17.8	0.0	6.5	4.7	0.0	4.5	0.0	5.8	12.8	77.9	6.0	68.6	34.3	0.0	16.6	1.9	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	1.3	1.9	0.7	1.1	0.6	0.5	1.5	0.8	17.3	0.0	3.2	0.7	0.2	7.4	0.7	0.9	0.6	18.0	0.5	0.6	37.3	0.0	0.9	12.9	25.0	138.0	0.2	0.2	0.0	0.0	0.6	2.1	2.2	4.5	0.0	0.0	1.6	0.0	63.1	225.8	0.5	3.7	1.3	29.0	0.4	11.8	15.3	6.7	2.2	0.2	0.0	0.6	12.4	1.0	0.6	6.7	3.6	1.9	0.0	13.8	0.0	29.7	1.6	0.5	0.4	0.0	0.0	2.1	0.0	0.0	0.0	12.6	0.0	6.1	16.9	25.8	47.7	1.0	7.4	241.6	1.1	19.1	0.0	0.4
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.4;retina: 33.3;testis: 112.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4139.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 53.4;white matter: 16.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 8.4;Karpas-707: 4.2;NB-4: 17.7"	"Region enriched"	"Detected in many"	44	"cerebellum: 2160.4"	"Region enriched"	"Detected in all"	28	"cerebellum: 552.9"	HPA057428			Approved	"Nuclear speckles,Vesicles"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"	Vesicles	"HPA057428: AB_2683436"	"prognostic favorable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favorable (2.76e-5)"	0.4	1.6	0.4	1.1	0.6	3.7	5.5	53.4	2.3	2.1	0.0	0.6	1.4	0.9	3.3	2.0	2.4	2.3	2.2	0.5	0.0	8.0	3.7	2.2	3.0	0.1	3.5	0.1	5.4	1.1	1.4	0.4	5.5	5.9	0.3	33.3	16.3	1.9	0.2	7.0	1.6	0.0	0.1	3.0	3.1	112.4	0.0	3.1	5.7	0.0	1.4	0.9	1.6	16.8	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.6	0.7	1.1	0.0	0.0	1.3	0.0	0.2	0.0	0.8	0.6	2.6	2.8	0.1	0.0	0.3	8.4	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	4.2	0.0	0.3	0.3	17.7	0.4	0.3	0.0	0.8	0.2	0.7	0.8	0.1	0.1	0.0	1.4	1.4	0.0	0.4	3.7	3.4	0.2	0.0	0.5	0.4	0.0	1.4	0.7	0.2	0.0	2.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.1	0.2	0.3	0.2	0.3	0.8	0.2	0.0	0.6	0.0	1.7	0.4	0.6	53.4	2.3	0.5	0.0	0.1	3.5	5.5	0.1	0.0	16.8	0.1	0.0	2.3	0.0	0.2	0.8	1.1	1.4	0.0	734.7	7.7	5.8	0.0	2.8	1.8	5.5	22.9	0.2	2.7	0.7	9.8	0.8	836.5	1.0	0.1	2.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.5	1.3	1.3	0.0	0.5	0.4	23.5	0.0	0.4	0.0	0.8	1.3	4139.3	10.5	7.1	1.8	1.0	1.5	40.7	2.1	0.0	0.0	0.4	0.1	13.2	0.3	1.0	1.3	0.5	0.4	100.3	19.7	0.0	0.1	14.5	9.0	0.0	1.1	0.0	1.0	0.0	0.6	0.6
PCSK6	"PACE4, SPC4"	ENSG00000140479	"Proprotein convertase subtilisin/kexin type 6"	P29122	15	101289784-101525202	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 153.6;liver: 160.0;lymphoid tissue: 81.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 231.6;Horizontal cells: 196.9;Oligodendrocytes: 561.9;Theca cells: 106.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.2;CACO-2: 35.7;HEK 293: 60.3;Hep G2: 53.8;OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004774	Uncertain				"Secreted to extracellular matrix"	NA	NA		480000	"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA004774: AB_1079583"	"prognostic favorable (9.99e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.06e-7)"	"unprognostic (2.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	5.3	2.2	17.5	3.0	67.3	1.1	11.2	57.8	37.0	2.2	4.2	16.5	6.8	2.0	3.3	9.0	2.8	3.1	20.0	19.3	34.1	3.2	160.0	3.6	2.5	113.0	64.5	6.1	2.6	0.6	5.1	32.0	95.6	3.1	14.8	7.6	2.8	0.6	11.4	10.1	10.1	3.6	42.9	81.4	9.8	13.0	54.0	20.9	2.2	16.3	1.8	3.7	2.6	153.6	19.7	14.6	2.6	0.9	0.2	0.4	47.2	0.7	2.5	0.0	0.1	35.7	8.3	0.4	2.4	0.6	1.1	11.4	12.5	1.5	0.0	2.8	60.3	33.5	8.4	53.8	1.6	4.5	0.4	0.3	7.5	0.2	0.2	0.2	0.1	4.3	24.5	0.2	0.0	8.8	0.1	4.7	9.3	65.9	6.5	0.2	0.4	4.4	4.4	25.4	7.3	8.6	26.2	1.5	9.1	6.6	2.2	21.9	0.2	0.3	1.2	0.3	0.2	0.5	0.6	0.7	0.2	0.6	7.3	0.8	0.2	0.9	0.2	0.4	0.3	0.5	0.4	0.2	0.1	1.0	0.6	0.5	0.4	3.3	1.3	0.4	0.1	1.2	17.5	67.3	57.8	37.0	19.3	34.1	113.0	64.5	95.6	42.9	54.0	153.6	1.7	3.2	0.6	2.9	1.3	0.4	0.3	0.9	0.6	1.7	15.4	6.6	2.0	8.6	1.4	1.8	20.9	6.7	0.6	22.6	0.0	0.6	1.6	4.7	21.6	4.9	0.0	3.2	19.4	0.8	24.3	15.5	1.5	6.9	0.0	4.2	12.5	231.6	1.4	196.9	30.8	3.7	0.0	5.2	1.1	2.4	10.5	1.7	0.0	5.6	1.0	1.7	3.1	25.6	561.9	7.3	8.2	0.0	0.0	1.7	2.3	0.1	1.2	1.6	0.0	2.0	1.0	4.7	2.4	0.9	0.1	3.3	1.0	106.5	8.5	0.2
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510531-5571282	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 17.9;Langerhans cells: 13.1;Microglial cells: 12.2;monocytes: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 71.4;BJ hTERT+: 111.6;HDLM-2: 88.1;TIME: 49.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	NA	NA		31000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	4.4	0.8	0.4	6.9	0.6	0.3	4.3	0.5	0.5	2.5	0.3	1.7	0.7	2.2	1.2	2.0	2.4	3.4	2.7	0.4	0.8	1.2	4.2	7.1	10.4	1.1	0.6	1.6	0.6	0.4	0.2	4.8	1.1	1.0	2.1	0.0	1.3	1.4	1.5	1.4	1.5	3.1	0.9	15.1	1.4	0.6	0.7	5.0	1.0	2.2	6.2	4.2	2.2	1.3	6.0	0.0	0.0	0.0	4.7	5.4	0.1	71.4	111.6	33.7	40.4	0.0	0.3	0.0	0.2	29.2	4.8	0.5	0.1	9.7	33.3	88.1	0.0	0.0	0.0	0.0	26.5	0.0	0.0	5.0	0.1	15.8	18.5	9.7	22.4	0.0	0.0	8.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.7	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	0.0	0.1	49.7	24.0	1.4	11.8	20.1	1.2	0.1	0.1	13.6	0.0	3.0	1.5	0.3	0.0	0.5	1.4	0.6	0.2	0.7	0.3	0.3	0.1	0.0	0.3	0.7	0.0	0.1	0.0	1.1	0.3	0.4	0.6	0.5	0.5	0.4	0.8	1.1	0.6	1.1	0.9	0.7	1.3	6.1	6.4	0.5	1.6	0.4	1.0	0.1	0.7	1.8	0.0	0.2	1.5	0.1	0.0	0.7	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.0	0.0	1.6	0.2	17.9	6.7	0.5	0.0	3.8	0.2	6.8	0.0	2.9	0.0	1.4	0.0	0.0	5.3	13.1	0.0	5.9	2.5	1.8	12.2	26.4	0.0	0.0	1.0	2.4	3.7	0.0	2.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	2.2	3.1	0.0	0.0	0.3	1.0	0.8	1.1	0.1	0.0	0.1
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32428131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 68.9;heart muscle: 58.5"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 1071.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.4;fHDF/TERT166: 148.3;hTERT-RPE1: 44.9;U-251 MG: 77.9;WM-115: 105.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.4	1.8	19.2	2.5	43.0	0.0	4.3	21.4	39.9	0.7	0.0	3.0	1.4	2.4	6.0	6.4	10.5	1.5	58.5	18.9	24.2	4.2	0.1	4.9	0.6	29.4	27.9	3.8	2.6	0.3	1.3	3.2	27.7	2.0	1.8	7.4	1.8	3.2	0.6	0.4	3.3	5.0	16.4	0.6	4.0	3.8	28.6	1.6	3.1	4.0	0.1	9.8	1.4	68.9	0.3	5.8	15.5	0.0	0.6	0.4	0.2	44.4	18.3	20.8	17.1	0.0	0.0	0.0	0.2	148.3	0.0	1.2	0.0	0.0	27.1	0.0	0.0	1.3	1.4	0.0	0.1	0.0	31.9	1.9	0.0	4.3	0.2	44.9	7.1	0.0	0.1	0.1	1.7	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	22.5	0.0	6.8	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	22.8	8.6	0.4	77.9	0.4	0.0	0.0	2.4	0.5	105.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	43.0	21.4	39.9	18.9	24.2	29.4	27.9	27.7	16.4	28.6	68.9	1.2	0.0	0.0	7.5	0.1	0.0	0.7	0.1	1.2	69.5	2.8	17.1	136.0	0.0	0.7	1.8	52.1	0.0	0.1	0.0	0.0	4.8	53.4	0.2	0.1	3.9	0.0	0.0	70.8	0.4	0.0	8.7	0.0	0.4	8.8	0.2	0.0	0.0	0.1	3.3	169.2	0.0	59.0	0.0	0.2	50.3	0.3	0.5	0.0	15.9	0.0	0.9	0.0	196.6	1071.4	0.2	0.0	0.4	0.1	0.2	0.0	0.0	2.2	4.7	0.0	0.9	9.4	1.3	1.2	0.2	0.0	0.0	0.1	1.2	0.0	0.0
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 197.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 114.9;Endothelial cells: 58.5;Enteroendocrine cells: 34.4;Excitatory neurons: 70.1;Hepatic stellate cells: 118.2;Inhibitory neurons: 35.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 75.1;basal ganglia: 84.7;cerebral cortex: 102.1;hippocampal formation: 84.4;white matter: 48.3"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.8;T-cells: 7.3"	"Cell line enriched"	"Detected in some"	8	"HeLa: 513.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"amygdala: 83.5;basal ganglia: 146.9;cerebral cortex: 90.5;hippocampal formation: 94.0"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB009752: AB_2268159, HPA031192: AB_2673781"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	89.2	44.1	75.1	5.1	84.7	4.7	83.6	0.0	102.1	38.1	0.0	34.6	6.0	27.2	8.3	18.6	39.3	22.7	41.1	84.4	7.0	32.5	19.4	12.6	6.7	6.4	5.1	11.6	6.9	5.5	11.8	12.0	10.1	20.7	8.9	3.0	9.2	10.7	16.8	18.1	18.7	18.5	0.0	197.0	17.1	7.4	17.9	3.8	24.1	28.9	3.5	28.8	27.1	48.3	0.3	0.2	0.7	0.2	0.2	0.1	0.3	0.1	0.2	0.2	0.4	0.4	2.5	0.8	12.2	0.2	1.9	0.2	0.9	0.1	0.1	0.1	0.1	0.0	513.6	0.8	0.9	0.0	7.8	0.1	1.1	2.7	20.5	1.1	11.3	0.5	0.8	0.9	0.1	0.0	0.2	0.2	7.4	0.2	14.0	0.0	0.2	1.4	0.1	0.3	44.5	2.4	0.4	0.2	2.2	0.7	0.3	0.1	65.2	0.1	9.4	3.5	0.4	0.4	0.2	0.1	3.9	0.1	0.6	0.0	0.6	0.0	7.3	0.8	4.2	2.8	4.3	4.3	1.0	1.8	2.7	2.3	0.1	0.0	0.4	0.0	1.8	1.5	75.1	84.7	0.0	102.1	84.4	7.0	6.4	5.1	10.1	0.0	17.9	48.3	114.9	0.0	0.5	2.0	0.7	2.5	0.1	0.0	0.0	4.9	0.6	1.0	7.8	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.6	0.0	0.1	58.5	34.4	5.3	70.1	0.0	0.3	2.1	0.0	0.1	1.3	0.1	118.2	2.1	0.5	1.7	35.6	1.2	0.0	9.4	8.2	2.5	0.3	4.9	1.8	11.2	0.0	0.0	0.0	9.0	5.7	0.1	0.0	0.4	1.5	0.1	0.0	0.1	0.0	0.4	0.0	1.8	6.6	4.8	2.5	0.5	2.8	0.0	0.6	0.2	0.1	0.3
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20368537-20688583	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.2;Bipolar cells: 38.4;Cardiomyocytes: 131.3;Horizontal cells: 52.2;Inhibitory neurons: 78.8;Smooth muscle cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.6;HEL: 15.3;HeLa: 42.5;HUVEC TERT2: 7.4;SH-SY5Y: 17.9;U-138 MG: 11.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 18.8"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		37000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	6.5	1.0	1.6	3.1	1.3	0.2	3.8	3.1	1.3	6.7	1.8	15.0	1.9	4.2	1.4	2.2	4.1	4.7	43.4	1.3	1.5	3.3	1.3	3.9	1.0	1.9	2.3	3.4	6.2	0.6	2.1	11.3	1.2	5.4	7.6	5.7	2.7	3.5	2.2	1.3	9.6	5.2	1.6	2.2	5.1	0.4	2.5	0.6	2.8	1.8	0.5	2.5	3.1	1.4	0.0	0.2	8.6	0.0	1.9	1.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.3	42.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.1	0.0	0.0	0.0	2.7	0.0	0.1	17.9	0.0	0.0	0.1	3.3	0.0	0.0	0.3	11.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	3.1	1.3	1.3	1.5	1.9	2.3	1.2	1.6	2.5	1.4	2.7	0.0	0.0	98.2	0.0	0.3	0.2	0.0	0.6	38.4	0.2	0.3	131.3	4.3	0.6	0.0	0.0	0.0	0.0	28.4	0.0	5.8	0.7	0.5	1.6	3.9	4.2	0.0	4.1	0.5	0.0	11.3	0.0	1.4	17.1	0.0	2.2	0.0	0.7	52.2	78.8	7.0	0.0	0.0	0.7	0.6	1.5	3.1	1.8	27.2	0.5	4.4	0.0	27.6	3.9	0.4	26.9	0.7	0.0	0.5	33.4	3.1	0.0	2.8	6.6	3.6	49.9	0.3	0.9	0.9	0.3	0.0	0.6	0.5	16.4	0.2
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9"	"Group enriched"	"Detected in all"	4	"prostate cancer: 7.0;thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		850000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	15.4	11.3	0.9	10.9	3.5	2.1	9.6	4.9	3.7	32.7	12.6	37.0	15.5	14.4	41.5	41.3	22.9	10.4	12.8	1.4	3.6	5.9	1.5	22.1	6.4	4.9	8.2	5.4	12.4	8.3	3.5	13.2	5.2	59.8	25.9	9.6	9.8	49.8	6.9	5.0	18.9	11.4	0.0	5.8	9.6	9.4	3.4	3.7	16.8	5.6	3.5	14.6	15.8	1.9	16.7	0.8	11.0	1.2	3.7	5.5	1.9	10.7	47.5	0.5	1.0	1.0	1.3	1.6	0.5	13.4	3.0	5.8	3.5	1.7	1.3	0.4	7.4	18.5	2.6	0.9	65.9	3.9	1.7	6.1	3.3	1.1	0.1	24.6	1.4	3.7	2.0	2.9	1.6	0.9	5.0	0.6	2.3	1.8	2.8	0.7	5.9	4.3	4.1	4.9	4.3	8.8	13.0	15.3	1.3	8.1	2.7	2.1	2.5	6.2	5.2	3.4	1.5	4.1	2.0	1.5	5.9	1.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.3	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.1	0.1	1.2	0.9	3.5	4.9	3.7	1.4	3.6	4.9	8.2	5.2	0.0	3.4	1.9	7.8	6.4	3.9	19.9	1.3	3.4	2.8	1.1	5.7	8.1	11.0	8.4	5.5	14.3	3.7	1.8	14.6	0.4	0.9	15.5	0.0	15.8	30.6	5.0	12.6	7.8	2.4	0.0	66.1	2.9	0.3	28.1	1.1	3.9	1.3	1.6	0.7	0.9	0.3	5.0	58.3	9.5	2.0	0.0	3.5	11.5	20.8	11.3	5.4	40.3	1.3	28.5	2.1	56.8	41.1	3.9	10.3	104.9	1.4	3.6	7.9	0.5	0.8	5.8	19.7	5.5	80.9	5.4	6.3	3.5	2.4	0.3	1.7	7.0	11.1	2.6
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69326913-69330588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Erythroid cells: 4.6;Gastric mucus-secreting cells: 8.6;Plasma cells: 14.7;Squamous epithelial cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	5.9	8.7	1.0	0.9	1.3	1.4	5.5	1.9	1.8	4.4	1.5	5.6	2.1	5.8	0.4	10.2	4.7	0.5	5.3	2.2	0.8	19.0	27.8	4.4	1.1	1.4	0.8	3.1	8.8	1.6	4.3	0.6	1.0	5.0	0.8	0.3	7.2	0.6	12.4	7.7	5.2	0.4	0.8	5.1	5.6	4.8	0.9	0.6	5.9	0.8	0.7	4.8	4.8	1.5	6.3	4.8	1.3	4.1	1.1	0.8	7.7	6.0	1.0	2.9	2.4	8.6	5.7	13.1	6.2	1.6	2.2	11.5	1.8	2.1	1.3	3.5	23.3	6.6	5.3	12.6	1.8	10.8	5.7	1.7	4.3	2.5	1.2	0.8	1.5	7.2	16.1	2.4	1.9	7.6	9.2	8.3	6.4	2.6	7.1	20.8	2.1	11.0	2.2	5.4	9.3	7.1	10.8	2.9	5.2	0.3	11.0	3.3	4.6	3.9	6.4	5.8	6.8	12.1	9.4	15.2	3.1	6.9	5.9	1.4	0.7	1.0	0.4	0.3	0.9	1.2	1.0	1.2	0.6	4.1	1.5	0.7	0.0	0.4	0.4	1.3	0.9	0.3	1.0	1.3	1.9	1.8	2.2	0.8	1.4	0.8	1.0	0.8	0.9	1.5	0.2	3.2	0.0	0.0	3.0	0.0	0.1	0.0	8.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.5	0.3	0.6	0.0	4.6	0.0	0.2	0.3	1.2	8.6	0.5	0.0	0.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	14.7	0.1	0.4	1.1	0.0	0.0	0.0	0.1	0.8	0.2	0.1	17.7	0.4	0.3	1.4	0.1	0.0	0.1
PDGFB	"SIS, SSV"	ENSG00000100311	"Platelet derived growth factor subunit B"	P01127	22	39223359-39244982	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.0;Endothelial cells: 60.6;Langerhans cells: 44.3;Macrophages: 25.5;Pancreatic endocrine cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 10.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.0"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;EFO-21: 69.2;HUVEC TERT2: 52.6;SK-BR-3: 53.5;TIME: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011604, HPA011972, CAB018341"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	4390000	950000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134"	"unprognostic (4.96e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.46e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.12e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.03e-1)"	32.6	6.4	14.7	7.1	10.7	0.4	24.0	10.3	22.2	7.5	4.8	20.6	4.9	8.9	5.2	6.2	7.2	11.7	31.2	12.0	9.8	17.0	3.7	28.1	7.4	13.6	12.4	3.8	8.8	8.9	4.0	40.2	12.0	7.6	3.5	0.8	10.6	5.2	18.7	10.3	9.1	9.2	10.6	6.6	7.9	3.4	16.0	2.1	16.1	11.0	1.6	8.5	6.6	9.4	33.8	2.6	8.4	0.0	0.0	0.0	9.9	0.1	0.4	0.2	0.0	13.0	10.3	0.0	69.2	0.0	3.1	12.4	0.5	2.8	0.0	0.1	0.2	0.7	1.1	4.8	4.3	0.0	18.1	0.0	0.3	0.0	0.4	0.9	52.6	0.0	1.3	6.1	1.9	13.7	0.1	0.1	3.2	8.1	3.4	0.0	0.3	22.8	27.7	0.1	0.2	0.0	0.6	53.5	0.2	6.0	24.3	0.1	68.1	0.1	6.4	0.1	7.5	0.1	0.4	0.3	0.1	1.5	31.3	0.0	0.0	0.0	7.3	0.1	10.0	0.0	4.3	5.6	0.0	0.0	3.6	1.9	0.1	0.0	0.4	1.3	2.3	2.1	14.7	10.7	10.3	22.2	12.0	9.8	13.6	12.4	12.0	10.6	16.0	9.4	75.0	0.0	1.1	0.0	0.6	2.8	1.2	3.8	1.2	0.7	5.1	7.1	3.1	0.0	1.3	7.3	0.0	7.3	4.0	0.1	0.0	20.0	1.3	4.0	0.7	60.6	1.8	0.0	2.8	3.6	6.5	1.6	0.0	5.6	0.0	13.1	16.8	1.4	7.7	0.0	0.9	0.7	4.1	2.6	44.3	0.1	0.6	25.5	1.8	14.0	1.1	0.3	0.0	0.0	0.2	54.7	0.0	0.0	0.0	2.7	0.1	1.9	0.9	0.1	6.6	4.7	9.6	0.3	1.6	1.1	1.4	4.5	2.0	1.2	0.1	0.6
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 190.2"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		300000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	46.0	28.9	13.9	40.4	13.7	1.6	40.1	8.1	12.8	50.8	18.1	37.7	22.4	44.3	21.8	22.5	50.9	38.5	32.1	11.9	11.0	26.5	16.0	37.9	8.5	16.7	11.9	190.2	13.4	3.0	3.7	62.7	15.1	15.0	35.2	5.3	16.6	18.9	9.6	14.8	31.3	48.1	12.1	46.2	29.4	13.6	8.9	7.6	16.5	41.9	7.2	63.9	38.0	20.0	0.1	0.0	1.0	0.8	468.1	216.1	0.5	25.4	279.4	0.1	0.7	67.6	0.5	0.5	0.5	195.9	0.8	0.6	19.6	0.2	0.1	2.6	1.0	0.7	0.7	1.2	156.3	0.3	0.4	392.0	0.0	31.4	0.0	5.4	0.0	0.7	0.6	0.9	1.1	0.1	0.4	1.2	3.5	0.3	1.1	0.5	0.1	0.1	0.0	0.4	0.6	37.9	0.0	0.5	0.2	2.0	0.7	0.1	0.8	84.9	3.2	93.9	0.2	0.4	0.1	0.8	2.6	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	13.7	8.1	12.8	11.9	11.0	16.7	11.9	15.1	12.1	8.9	20.0	11.1	0.0	0.5	0.3	0.6	17.1	0.6	2.4	1.2	5.5	4.3	3.2	4.8	0.0	0.8	0.0	0.0	1.4	0.9	0.1	1.9	4.2	2.2	11.7	423.9	5.7	0.0	0.0	1.1	6.7	2.0	256.4	5.1	9.0	0.0	2.6	26.0	1.0	3.1	0.0	19.5	0.2	10.2	0.6	27.3	17.2	449.8	5.4	23.2	39.4	4.7	17.5	0.0	499.6	0.4	20.0	0.0	408.9	0.2	0.9	0.0	0.1	0.5	0.6	0.0	25.7	13.9	1.0	3.4	8.1	15.8	1.4	2.5	49.6	0.0	1.0
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 1288.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC diff: 1350.1;ASC TERT1: 462.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		39000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	171.2	25.1	25.4	27.5	27.2	0.7	106.3	20.5	33.3	155.9	43.5	41.6	11.9	101.1	24.2	24.1	89.6	124.5	75.7	22.1	23.2	49.7	13.4	98.3	27.5	22.1	24.6	105.5	20.8	21.9	23.0	113.3	22.8	56.2	14.1	6.3	34.5	43.3	38.1	65.0	37.9	68.9	19.4	41.4	27.9	18.4	27.7	8.7	66.5	44.1	13.8	58.3	98.6	21.6	0.1	0.3	8.3	0.4	1350.1	462.7	3.0	48.9	202.3	33.5	56.4	5.4	0.0	0.0	6.4	142.0	19.0	0.1	0.1	0.4	15.8	0.0	0.0	0.1	3.3	3.5	190.7	0.0	0.4	210.0	0.0	46.3	0.6	106.6	0.1	0.1	0.1	5.5	5.5	0.0	0.1	0.6	9.0	0.2	0.2	3.7	2.5	0.2	0.0	0.0	0.1	24.8	0.5	0.1	0.0	38.2	0.1	0.6	0.4	53.7	17.2	23.1	2.8	0.4	0.0	0.3	33.4	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	25.4	27.2	20.5	33.3	22.1	23.2	22.1	24.6	22.8	19.4	27.7	21.6	50.8	0.0	1.1	81.9	0.5	24.0	0.5	0.0	2.2	6.6	1.4	3.3	17.3	1.5	0.0	1.8	4.2	0.6	6.0	0.3	0.0	0.8	1.6	2.8	99.5	32.2	0.0	0.0	7.9	0.0	1.1	123.5	2.0	2.3	0.0	2.5	6.4	1.9	1.5	0.0	1.3	0.7	0.0	0.0	35.6	10.9	165.3	3.1	24.9	45.0	0.7	50.7	23.7	10.1	3.3	0.1	0.1	203.8	2.3	0.7	0.3	0.1	0.7	2.9	1288.5	6.6	288.3	1.9	1.6	0.8	15.3	0.8	4.8	4.0	0.4	1.1
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067025-123225227	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	17.9	23.6	0.3	15.2	0.3	17.9	13.8	0.2	1.4	14.5	2.7	20.1	13.9	12.4	30.2	6.1	14.0	19.6	9.9	0.6	0.8	14.5	80.2	17.7	11.1	0.5	0.6	11.5	26.6	10.7	12.7	47.4	0.4	32.3	25.0	4.2	13.7	7.9	4.2	8.8	12.8	17.0	0.3	10.1	33.4	15.3	0.9	4.5	30.8	4.3	12.0	17.9	9.5	0.7	24.0	14.6	17.7	21.5	80.3	71.9	95.0	44.9	74.5	24.5	66.9	47.8	21.6	0.0	57.6	69.9	15.7	12.5	7.8	27.4	25.7	1.1	8.8	10.4	3.9	56.7	33.2	26.5	1.4	62.3	40.2	16.6	34.5	26.1	84.0	10.1	13.6	60.4	16.9	29.6	7.2	31.3	13.1	54.5	15.6	6.7	13.0	67.5	20.7	13.9	19.3	11.4	22.0	24.0	40.4	28.7	21.4	32.3	47.2	6.2	19.5	29.4	12.3	18.1	5.0	10.8	20.2	21.0	21.5	0.0	9.3	0.3	1.4	2.4	2.3	3.5	1.0	0.8	5.5	1.1	0.6	0.6	0.2	0.5	0.5	12.8	0.0	2.3	0.3	0.3	0.2	1.4	0.6	0.8	0.5	0.6	0.4	0.3	0.9	0.7	17.2	19.2	30.7	2.6	5.6	5.0	6.0	6.4	3.4	13.1	6.9	4.7	2.7	35.8	11.3	5.5	39.6	41.8	3.1	5.4	0.0	32.2	1.6	5.4	13.1	24.3	8.4	5.5	9.6	28.6	133.6	20.7	30.5	21.1	3.8	7.3	37.5	50.1	12.1	0.0	7.1	36.9	0.0	7.8	5.5	2.0	24.2	4.4	8.8	5.6	5.0	2.3	0.0	1.0	2.5	11.9	7.6	22.2	40.1	18.1	3.5	5.3	6.4	28.4	13.1	3.6	17.6	1.3	1.5	3.4	4.1	50.2	3.1	23.3	15.1	4.5
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 135.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Basal respiratory cells: 98.5;Fibroblasts: 123.1;monocytes: 116.3;Muller glia cells: 97.7;Peritubular cells: 62.8"	"Group enriched"	"Detected in many"	4	"glioma: 83.2;head and neck cancer: 40.2;testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 149.5;EFO-21: 356.4;HAP1: 253.3;HHSteC: 216.0;NTERA-2: 116.0;SuSa: 119.0;TIME: 242.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	61.5	3.3	8.9	55.9	9.3	0.0	20.9	13.7	8.1	43.1	23.5	16.6	3.8	25.9	11.3	15.8	33.4	42.1	20.3	8.0	14.6	3.4	0.6	32.4	9.8	24.9	15.6	29.4	6.4	1.1	3.3	135.6	19.1	14.0	10.6	22.7	9.1	14.1	30.0	20.0	15.9	34.5	16.4	0.3	24.7	4.5	22.5	10.3	6.2	11.3	18.5	96.1	25.2	21.2	0.1	0.0	149.5	0.1	0.5	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.2	356.4	9.0	0.1	0.7	253.3	44.7	0.0	1.0	46.1	0.1	0.0	0.0	216.0	0.0	0.2	29.5	82.9	18.6	21.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	116.0	0.0	0.6	0.3	0.2	0.1	0.0	4.0	0.1	0.1	0.2	0.0	0.3	119.0	0.1	0.6	242.2	41.8	34.6	0.6	0.1	0.1	0.3	1.0	88.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.9	9.3	13.7	8.1	8.0	14.6	24.9	15.6	19.1	16.4	22.5	21.2	2.4	105.8	11.2	3.9	0.2	14.5	30.4	98.5	14.8	1.4	0.5	19.9	8.4	2.8	18.8	0.0	4.2	2.0	0.1	0.0	0.0	0.5	0.7	1.6	37.6	22.4	0.0	0.0	2.6	0.0	2.1	123.1	0.0	2.8	1.3	3.4	6.4	0.0	6.5	0.0	3.5	0.0	8.2	0.0	14.0	1.8	20.2	5.3	7.2	5.6	116.3	97.7	0.0	19.6	0.2	0.4	0.0	62.8	0.0	15.8	0.0	0.0	5.4	3.4	0.0	17.0	8.4	1.0	8.2	3.9	7.0	2.9	1.3	0.9	0.0	3.4
PDSS1	"COQ1, COQ1A, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697701-26746798	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.1;lymphoid tissue: 13.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 32.5;Proximal enterocytes: 29.8;Undifferentiated cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA038032: AB_10670650, HPA042741: AB_2678139"	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	2.1	1.4	0.8	5.3	0.9	5.8	2.3	2.6	1.4	1.8	0.6	14.1	19.1	1.9	1.3	4.3	1.5	1.6	2.8	0.8	0.8	6.2	3.6	2.2	4.0	0.8	0.9	1.7	1.3	2.2	0.8	2.4	0.9	1.5	15.1	1.9	1.8	1.3	5.7	1.4	15.3	2.9	0.8	1.8	2.8	2.8	0.9	13.8	1.2	9.5	4.7	3.1	2.2	1.1	15.6	11.8	8.9	16.3	2.9	5.4	12.2	14.0	3.6	20.0	13.7	18.3	8.4	35.0	7.2	7.0	7.6	19.2	28.6	21.8	16.7	14.7	23.6	30.4	9.9	13.6	4.3	20.3	11.6	6.8	9.2	19.0	5.0	3.5	10.7	22.8	28.4	9.3	14.4	24.9	64.6	14.7	17.9	24.9	11.3	29.6	25.1	25.5	12.0	7.3	25.7	15.8	13.5	27.6	15.9	9.2	9.9	23.7	6.8	11.1	17.9	22.9	22.5	3.6	14.1	25.6	10.9	51.3	8.7	0.0	2.8	0.5	0.4	2.3	1.0	0.2	0.8	0.6	2.6	2.4	1.6	0.7	0.1	0.4	1.2	0.7	0.0	0.7	0.8	0.9	2.6	1.4	0.8	0.8	0.8	0.9	0.9	0.8	0.9	1.1	3.6	0.0	0.0	18.9	4.8	6.9	3.6	5.7	8.0	2.9	4.4	5.1	2.2	5.7	3.9	3.7	4.2	7.7	4.9	11.7	7.9	6.1	12.0	2.1	3.8	2.7	10.8	8.4	16.9	3.9	12.4	3.4	10.2	3.3	0.0	3.7	1.8	4.5	8.8	1.7	32.5	13.0	6.1	5.3	2.7	4.1	2.1	7.7	1.8	5.6	6.2	1.2	1.0	6.6	6.5	5.6	9.8	2.6	9.1	3.7	29.8	26.3	2.1	4.9	0.0	4.1	6.5	12.5	9.4	13.6	3.1	6.3	4.8	4.6	29.8	3.3
PDZD3	"FLJ22756, IKEPP, PDZK2"	ENSG00000172367	"PDZ domain containing 3"	Q86UT5	11	119185457-119190223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 19.3;kidney: 17.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 93.4;Gastric mucus-secreting cells: 30.5;Paneth cells: 74.8;Proximal enterocytes: 79.1;Proximal tubular cells: 29.5;Undifferentiated cells: 21.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.3;renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077887	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA077887: "	"unprognostic (2.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.58e-3)"	"unprognostic (9.00e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-3)"	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	17.1	0.0	0.0	0.0	1.0	2.8	0.1	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.3	8.6	0.0	0.0	6.2	0.0	0.0	93.4	3.9	0.1	0.0	0.2	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.4	30.5	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	8.5	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	74.8	0.0	0.2	0.1	79.1	29.5	0.7	0.7	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	21.0	0.1
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 595.8"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8"	"Group enriched"	"Detected in many"	4	"liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 14.7"	"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.2"	"Group enriched"	"Detected in many"	4	"RPTEC TERT1: 250.0;T-47d: 653.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.6	3.5	0.7	0.5	0.9	0.6	19.6	14.7	2.0	2.4	1.9	4.7	74.8	0.7	15.8	0.2	1.0	22.0	0.4	1.0	0.5	595.8	128.1	0.3	0.7	1.4	0.8	0.3	16.6	0.0	0.6	0.5	1.8	0.3	8.2	3.0	0.4	0.8	0.3	2.6	124.9	0.8	0.4	0.7	2.8	0.6	0.8	0.3	0.3	0.1	0.2	0.2	0.3	1.5	7.6	1.2	0.8	0.8	0.3	0.4	3.0	1.2	0.3	0.2	1.0	106.6	1.0	0.7	1.3	5.9	0.5	3.4	0.2	0.6	0.6	10.3	2.0	0.9	2.8	45.7	0.0	1.1	0.9	0.3	0.7	0.4	0.2	0.8	0.0	0.4	0.8	1.6	0.8	6.0	0.7	1.4	1.2	1.5	3.6	0.4	7.3	1.6	250.0	0.3	0.6	6.7	1.7	1.8	0.2	6.4	653.8	0.9	0.5	1.3	1.3	0.9	1.1	8.8	1.2	0.6	1.0	0.6	0.5	0.1	0.1	0.0	0.7	0.1	0.2	0.6	0.2	0.8	0.0	0.4	0.2	0.3	0.1	4.2	0.0	0.5	0.0	0.3	0.7	0.9	14.7	2.0	1.0	0.5	1.4	0.8	1.8	0.4	0.8	1.5	0.2	0.0	0.0	2.0	4.1	0.1	0.0	0.1	0.0	0.4	20.2	3.3	0.5	72.9	0.0	57.0	0.0	0.0	0.9	27.4	138.9	1.2	8.6	1.1	0.5	0.4	6.6	0.0	2.8	2.0	0.1	0.5	0.5	4.9	0.0	0.2	1.1	47.9	0.2	0.0	1.9	7.8	0.0	0.9	0.3	9.0	0.0	4.9	0.0	1.9	0.0	0.3	2.1	3.0	0.7	1.5	7.4	0.0	0.0	0.1	280.0	1113.8	0.1	0.5	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.1	4.1	4.3	6.5	0.1
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183582-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 1047.0"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 5516.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 148.8;RPTEC TERT1: 501.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	20.9	8.2	0.6	24.6	0.8	43.2	36.4	0.4	1.2	29.9	0.7	44.4	21.6	10.7	2.9	205.9	25.7	197.6	1.4	0.5	0.7	1047.0	6.8	29.5	0.4	0.4	0.5	0.7	99.9	0.0	1.1	3.9	0.7	12.1	30.9	0.0	203.4	8.6	1.6	153.1	66.4	3.1	0.4	3.7	63.4	1.4	0.9	1.9	1.5	0.6	60.2	20.0	66.6	0.4	54.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	41.5	0.0	148.8	0.0	0.0	0.7	0.0	0.5	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.6	501.3	0.0	0.0	0.0	0.5	4.3	0.0	0.0	1.4	0.0	0.0	0.1	1.2	0.1	0.4	0.3	0.6	0.3	0.1	0.1	0.0	0.0	3.4	0.3	0.6	1.1	0.2	0.0	0.0	0.0	1.7	0.4	0.2	0.0	6.6	0.7	0.1	1.5	1.1	144.5	0.6	0.8	0.4	1.2	0.5	0.7	0.4	0.5	0.7	0.4	0.9	0.4	1.6	76.9	47.4	0.0	31.2	14.1	13.3	489.8	7.4	0.0	152.9	105.5	0.1	303.1	413.3	233.6	0.0	0.1	1.7	118.8	414.8	1175.8	0.0	6.1	3.3	4.5	39.6	148.4	0.0	760.0	0.0	6.6	36.7	38.1	10.8	0.2	5.0	1.7	0.3	0.0	0.0	143.3	52.9	0.3	2.1	0.0	3.4	59.3	8.8	0.0	13.6	0.6	2.1	0.0	0.0	1115.2	91.0	0.0	0.1	38.9	106.2	5516.6	147.6	0.0	0.0	0.1	28.7	0.0	0.1	30.7	54.0	0.8	22.0	0.0	150.5	68.5
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205380-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1106.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 246.3;monocytes: 267.6;Muller glia cells: 315.8"	"Cancer enhanced"	"Detected in all"		"glioma: 466.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 78.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	Nucleoplasm	"HPA028356: AB_10602814, HPA070820: AB_2732166"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	190.2	82.2	863.3	121.7	900.6	16.6	142.7	908.1	949.4	110.1	612.5	146.5	31.7	124.5	83.4	119.2	104.2	88.2	241.9	884.6	939.2	112.0	41.2	147.9	75.5	1028.2	1010.2	80.4	39.6	85.4	80.0	102.3	981.5	112.2	58.5	461.4	80.8	119.4	61.1	105.6	64.8	194.6	933.0	103.2	75.8	80.5	915.2	40.7	83.5	84.5	96.9	133.4	110.2	1106.4	139.2	46.8	190.5	82.5	344.5	191.5	63.6	593.2	503.3	471.6	328.5	103.7	72.3	63.4	210.9	729.4	226.6	146.4	71.5	181.7	365.3	34.4	40.2	52.4	32.5	26.7	423.9	17.8	62.0	161.8	100.7	260.2	328.5	259.6	360.7	45.7	55.1	111.8	640.6	68.3	21.0	41.1	127.0	160.9	134.3	34.4	200.6	43.8	173.0	71.0	38.0	100.0	310.4	207.6	179.9	409.4	128.1	122.6	487.7	311.3	246.4	234.4	254.5	88.1	59.5	118.7	287.1	33.2	450.8	1.3	39.3	5.2	8.4	78.2	6.5	18.9	6.2	6.9	56.7	13.5	3.8	4.2	1.8	7.9	38.7	25.0	7.9	14.9	863.3	900.6	908.1	949.4	884.6	939.2	1028.2	1010.2	981.5	933.0	915.2	1106.4	137.8	16.0	29.9	40.5	38.6	80.2	124.2	21.8	33.6	172.1	76.9	60.2	246.3	11.5	24.7	5.5	73.0	21.8	13.7	12.7	29.4	74.7	65.4	36.4	33.7	125.1	12.0	7.4	24.8	46.3	61.1	81.5	17.9	85.9	31.1	17.2	89.3	6.5	63.3	92.5	19.1	12.0	8.2	42.6	234.6	55.4	66.8	68.9	74.7	14.0	267.6	315.8	8.2	12.1	48.3	102.5	4.7	109.9	14.8	119.4	5.4	18.3	13.8	129.2	46.0	69.4	78.3	16.5	4.1	42.7	73.3	45.3	19.4	18.5	12.8	178.8
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"	P16284	17	64319415-64413776	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 455.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.9;Endothelial cells: 468.2;Hepatic stellate cells: 275.3;Macrophages: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 702.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 773.0;TIME: 537.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004690, HPA004871"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA		110000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoli	"HPA004690: AB_1078462, HPA004871: "	"unprognostic (2.79e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.68e-2)"	"prognostic unfavorable (8.98e-5)"	"unprognostic (9.72e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.16e-2)"	195.6	21.4	20.3	78.9	21.4	35.5	128.5	21.9	25.3	54.9	21.7	37.9	29.7	51.1	9.2	54.3	45.1	88.6	70.3	18.0	22.2	43.6	22.4	204.9	68.0	24.7	23.1	10.7	21.3	29.9	9.7	455.1	24.1	23.5	37.7	4.0	33.4	24.5	35.7	36.2	39.4	83.5	26.3	94.9	30.9	5.0	28.1	62.4	69.8	97.0	60.4	84.0	35.7	22.2	0.1	0.3	1.3	0.1	1.1	1.5	0.4	0.2	0.3	0.0	0.1	4.7	0.1	4.2	121.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	95.0	1.8	2.2	3.7	0.5	0.3	0.3	0.0	0.8	0.2	1.6	773.0	34.1	2.3	57.8	0.1	0.4	33.3	8.1	0.1	0.0	9.1	1.4	15.3	3.8	0.0	0.1	0.4	0.3	1.8	0.0	0.1	0.2	0.0	48.5	537.8	0.8	0.5	0.9	0.2	3.4	6.3	6.8	1.6	6.7	0.1	54.8	263.9	219.2	19.8	419.6	18.9	26.7	2.2	46.6	154.0	32.7	36.3	68.6	392.0	40.3	702.3	88.6	2.1	224.2	20.3	21.4	21.9	25.3	18.0	22.2	24.7	23.1	24.1	26.3	28.1	22.2	672.9	16.0	37.9	0.7	24.4	0.0	0.5	0.0	4.0	0.0	4.8	4.6	23.3	1.5	3.1	9.2	0.0	0.5	50.1	0.0	0.0	0.8	0.9	1.1	1.1	468.2	0.0	17.9	1.2	0.2	4.0	22.0	0.0	1.6	8.8	0.0	275.3	3.0	45.8	0.0	1.2	0.0	0.0	110.4	0.0	1.1	2.5	143.9	0.0	47.8	93.8	0.3	26.8	0.5	1.3	0.1	0.0	1.9	109.1	1.3	0.0	0.5	7.3	1.2	0.0	6.9	15.8	0.1	0.5	1.6	0.0	0.8	21.2	4.3	0.1	1.0
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144420	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 228.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.1;Plasma cells: 318.8;Squamous epithelial cells: 208.0;Suprabasal keratinocytes: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 76.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 76.9;monocytes: 23.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 58.8;U-698: 146.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Approved		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	27.6	7.9	10.2	28.1	14.4	228.5	25.7	11.9	13.5	17.9	9.2	18.6	17.6	17.3	8.6	42.9	12.7	26.1	11.8	13.8	11.2	10.6	13.5	31.0	24.7	12.2	11.2	5.5	9.3	37.9	15.8	15.6	12.2	8.9	20.1	5.1	18.9	7.7	7.1	29.7	23.2	13.9	12.6	21.8	18.1	10.7	10.9	28.3	9.7	10.0	29.0	22.4	23.7	15.6	3.6	2.8	36.5	24.6	4.2	3.2	8.3	4.8	5.4	4.3	6.8	58.8	4.1	48.3	11.3	1.7	1.6	5.8	11.1	10.5	8.6	12.2	8.9	4.4	1.7	9.5	12.4	4.8	8.3	4.2	8.1	6.4	21.6	4.5	24.3	18.2	2.7	11.7	3.7	0.3	10.6	6.9	23.8	11.1	1.7	13.2	12.6	28.1	17.7	10.8	16.7	23.3	3.6	5.5	12.9	11.3	3.0	3.3	17.5	4.0	5.7	4.0	7.1	27.0	2.8	146.7	2.1	4.3	10.9	15.0	15.6	15.0	0.9	14.1	1.7	8.5	4.8	1.9	5.4	6.6	5.6	2.5	76.9	3.0	23.2	0.5	11.6	6.6	10.2	14.4	11.9	13.5	13.8	11.2	12.2	11.2	12.2	12.6	10.9	15.6	94.5	28.9	49.2	4.6	84.4	224.1	74.6	48.2	105.9	1.7	60.9	50.3	5.7	15.7	52.0	5.5	0.0	1.7	16.9	57.9	1.9	5.3	10.6	34.6	26.4	52.1	25.7	3.4	23.4	26.7	8.6	24.5	75.4	58.7	15.2	6.3	37.5	7.5	22.8	3.3	19.1	23.4	30.5	67.6	103.7	11.2	1.5	107.0	112.1	119.9	30.6	5.5	3.1	82.9	67.9	20.9	45.9	1.9	318.8	44.7	32.7	9.6	43.6	2.0	0.0	10.1	51.9	8.4	9.6	208.0	217.5	4.0	49.4	3.2	32.4	145.8
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 83.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.1;Cardiomyocytes: 79.0;Late spermatids: 158.2;Rod photoreceptor cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 20.8;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 23.8;granulocytes: 20.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	4.3	6.8	13.2	8.3	14.5	23.5	6.4	8.6	15.2	9.1	42.5	22.2	32.2	5.0	11.6	9.6	5.7	5.8	36.0	13.9	11.4	29.7	4.0	13.3	7.0	13.3	13.8	5.2	16.0	15.3	23.1	3.9	12.2	4.8	24.1	83.3	7.6	4.1	49.5	8.1	22.2	5.0	9.7	15.0	15.5	7.0	19.3	20.2	51.7	42.7	6.7	4.2	4.2	18.4	15.0	6.5	4.2	7.3	8.4	4.1	6.9	2.1	2.5	3.6	2.0	16.0	21.1	2.7	3.3	3.3	10.8	20.8	3.1	7.9	2.1	0.6	3.2	21.1	17.4	5.9	7.0	0.0	14.2	5.9	11.7	3.5	19.1	4.3	0.8	8.7	14.6	0.1	2.0	4.5	3.6	0.6	5.8	7.2	9.7	0.0	0.0	0.4	4.9	15.3	6.6	4.0	13.7	22.8	17.4	4.5	15.6	1.8	0.4	0.0	7.6	11.0	1.9	6.6	7.0	1.4	8.8	0.0	3.9	1.6	1.2	20.8	0.3	2.6	0.4	1.9	0.2	0.4	1.1	2.3	0.5	0.6	3.5	1.6	1.9	23.8	0.0	0.7	13.2	14.5	8.6	15.2	13.9	11.4	13.3	13.8	12.2	9.7	19.3	18.4	1.0	6.4	54.8	105.1	5.0	15.2	3.8	5.0	10.2	7.0	3.7	4.2	79.0	4.3	8.7	16.5	0.0	0.7	24.6	53.8	25.4	5.0	51.0	18.0	3.7	4.2	6.0	0.8	14.5	7.6	0.4	4.6	14.8	21.3	9.5	2.3	2.5	5.8	5.6	3.3	13.0	20.1	8.2	13.6	4.9	158.2	2.8	8.5	21.4	11.2	5.4	9.8	5.2	4.5	10.6	16.6	26.2	3.0	3.8	13.5	45.4	32.8	15.3	110.5	0.0	3.3	3.1	5.1	3.2	9.9	11.6	1.5	1.6	7.5	36.9	11.5
PFN3		ENSG00000196570	"Profilin 3"	P60673	5	177400109-177400661	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 25.7"	"Group enriched"	"Detected in some"	176	"Early spermatids: 666.2;Late spermatids: 1589.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA038274			Approved	Vesicles,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA038274: "										"unprognostic (1.03e-2)"					"unprognostic (1.13e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	666.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1589.2	6.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PGM5	PGMRP	ENSG00000154330	"Phosphoglucomutase 5"	Q15124	9	68328308-68531061	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell adhesion, Glucose metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 269.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107.2;Endothelial cells: 36.6;Hepatic stellate cells: 39.3;Microglial cells: 124.6;Sertoli cells: 52.6;Smooth muscle cells: 35.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.8"	"Group enriched"	"Detected in some"	5	"hTERT-RPE1: 28.7;PC-3: 56.5;RH-30: 38.8;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034397, HPA046329, HPA067102"	Enhanced		Uncertain	Cytosol		NA	NA		450000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: AB_2732758"	"unprognostic (3.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (1.83e-5)"	"unprognostic (3.04e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.73e-2)"	28.9	61.0	3.7	12.6	4.1	0.0	21.0	5.8	3.8	51.7	3.3	269.4	15.4	154.0	40.8	98.6	96.5	19.6	126.1	3.1	4.1	11.5	5.1	14.6	5.8	4.6	4.0	19.8	2.7	5.0	4.3	5.8	4.3	159.0	34.2	8.0	6.7	214.0	37.5	11.1	72.0	132.5	4.7	10.8	65.2	3.0	4.6	2.9	13.1	30.5	2.9	216.7	40.6	4.6	0.2	0.2	0.0	0.0	0.7	0.0	0.3	8.2	6.3	3.8	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	9.2	0.0	9.4	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.1	0.0	4.1	0.1	0.7	0.0	0.0	56.5	0.0	38.8	1.8	1.5	0.0	0.0	0.2	0.1	47.8	2.8	1.2	0.0	0.0	0.1	0.0	5.7	0.3	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	3.7	4.1	5.8	3.8	3.1	4.1	4.6	4.0	4.3	4.7	4.6	4.6	21.6	0.0	1.7	0.7	0.2	2.3	5.6	0.0	0.6	25.3	0.2	1.5	107.2	2.8	1.8	12.9	4.2	0.0	0.1	0.1	1.9	0.1	1.8	3.7	2.8	36.6	0.0	4.0	1.4	0.0	0.2	12.4	0.0	1.1	0.0	18.7	39.3	0.1	0.1	0.0	1.7	2.7	0.0	4.0	2.8	0.5	8.1	2.1	3.6	124.6	1.0	8.3	0.0	1.0	2.3	0.1	0.1	4.9	0.0	2.1	0.8	1.2	0.8	1.9	52.6	1.7	35.9	0.1	0.2	0.4	2.4	0.0	0.6	30.0	1.6	1.5
PGS1	DKFZP762M186	ENSG00000087157	"Phosphatidylglycerophosphate synthase 1"	Q32NB8	17	78378649-78425114	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022526	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA022526: AB_1855271"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.46e-3)"	"prognostic favorable (7.33e-5)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (9.94e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.72e-2)"	16.1	10.0	12.6	17.9	14.9	39.6	15.4	13.3	25.3	14.2	15.8	13.0	11.7	14.9	6.0	10.8	14.0	13.2	11.1	13.0	16.6	13.8	7.0	23.5	16.9	18.0	15.4	13.9	10.9	11.5	11.5	19.7	15.6	12.4	7.8	6.6	11.9	10.8	13.5	11.5	14.7	10.3	12.9	19.8	11.4	8.9	18.8	14.0	16.4	7.6	11.6	14.5	12.0	18.1	19.9	16.7	17.8	13.5	14.6	23.0	18.8	18.3	17.2	19.3	21.2	17.8	15.8	20.2	10.8	10.8	19.4	15.5	19.8	12.5	15.1	30.3	24.1	22.2	25.0	17.5	15.2	17.7	16.9	23.6	16.1	14.6	12.6	19.1	37.8	15.9	26.0	14.2	13.2	10.8	39.5	19.5	17.4	8.5	15.9	19.4	29.6	16.8	21.0	19.5	21.4	33.2	15.4	16.4	18.5	17.8	17.4	23.8	22.8	24.9	16.6	13.5	15.4	16.0	9.5	15.2	19.1	19.0	18.7	2.1	17.7	19.3	11.0	15.0	13.6	10.3	11.6	11.7	20.6	11.9	14.5	10.6	33.9	11.2	7.2	9.4	15.1	12.0	12.6	14.9	13.3	25.3	13.0	16.6	18.0	15.4	15.6	12.9	18.8	18.1	25.9	12.8	16.8	10.1	11.6	4.5	12.0	16.3	7.4	13.0	6.4	8.8	5.8	4.3	12.0	12.9	2.1	20.2	11.2	7.7	3.9	5.8	20.0	9.0	8.7	21.5	4.2	5.5	14.8	7.0	8.1	9.7	12.2	6.7	7.6	13.3	15.0	3.9	15.4	20.2	15.0	6.1	6.1	13.9	8.3	10.8	10.5	19.2	5.4	17.8	12.1	11.0	10.3	11.6	20.4	7.2	15.6	8.6	9.4	9.2	8.0	5.2	14.4	11.4	32.9	6.8	10.8	17.9	18.4	5.8	3.8	19.3	10.8	14.7	8.5	10.9
PHYH	"PAHX, PHYH1, RD"	ENSG00000107537	"Phytanoyl-CoA 2-hydroxylase"	O14832	10	13277796-13302412	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 667.8;skeletal muscle: 483.6;tongue: 412.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 258.6;Proximal tubular cells: 414.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007598, HPA011796"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA007598: AB_1855334, HPA011796: AB_1855335"	"unprognostic (5.78e-2)"	"unprognostic (3.83e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (7.28e-12)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.19e-1)"	57.9	66.5	22.9	9.5	23.7	8.2	32.2	23.5	28.3	28.8	31.7	46.5	58.7	22.1	16.7	22.9	16.7	28.2	126.5	21.7	24.1	191.4	667.8	17.3	7.5	21.6	24.4	36.8	48.2	56.7	20.9	19.3	22.8	22.5	37.2	28.2	33.7	25.4	483.6	17.5	55.8	23.2	22.7	12.8	44.2	15.1	26.0	5.6	56.0	412.7	5.4	27.0	14.8	23.6	17.2	35.2	15.6	22.5	110.7	69.9	12.4	17.2	23.9	19.4	19.1	9.1	30.3	0.9	12.9	29.0	47.0	7.8	20.5	20.2	11.8	41.4	10.7	14.9	9.3	36.6	54.8	2.5	26.8	50.3	28.9	21.0	8.4	22.7	18.7	16.8	8.4	32.2	45.5	16.3	9.2	12.1	14.4	49.4	12.6	15.7	24.1	5.8	40.6	21.9	5.3	16.8	64.8	1.4	32.9	12.5	64.8	44.2	6.4	29.5	10.6	36.4	11.8	36.6	26.3	3.3	38.3	18.9	11.6	16.3	18.7	8.2	8.0	14.2	17.6	11.0	9.9	10.4	15.8	5.6	12.5	12.7	0.8	4.4	11.2	14.4	10.5	12.3	22.9	23.7	23.5	28.3	21.7	24.1	21.6	24.4	22.8	22.7	26.0	23.6	53.6	12.8	19.2	8.5	14.5	11.9	27.6	19.1	6.2	47.0	22.6	24.5	258.6	77.2	19.7	35.0	22.9	137.8	20.5	72.9	144.8	40.6	33.1	18.5	29.0	29.7	31.8	15.2	7.1	19.6	34.3	41.3	41.8	26.8	30.4	28.3	25.0	145.5	55.4	21.9	5.6	57.4	46.8	21.0	22.0	45.4	25.4	25.3	17.8	4.7	10.3	69.3	7.2	2.5	2.4	16.7	46.0	37.6	15.1	11.9	141.9	414.6	19.6	41.8	19.7	30.2	37.5	12.5	1.6	7.3	13.4	83.9	25.2	103.3	46.9	18.1
PHYHIP	"DYRK1AP3, KIAA0273, PAHX-AP"	ENSG00000168490	"Phytanoyl-CoA 2-hydroxylase interacting protein"	Q92561	8	22219703-22232101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 217.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.9;Basal squamous epithelial cells: 14.8;Excitatory neurons: 48.5;Inhibitory neurons: 15.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3;thyroid cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 9.3;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 101.1;basal ganglia: 300.5;cerebellum: 251.7;cerebral cortex: 256.5;hippocampal formation: 296.8"	"HPA068030, HPA069318"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria	Nucleoplasm	"HPA068030: AB_2685944, HPA069318: AB_2686117"	"unprognostic (1.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-5)"	"unprognostic (8.62e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.09e-3)"	11.3	33.1	106.0	1.5	183.9	0.0	9.3	98.1	217.1	11.6	0.0	14.1	1.3	14.5	2.8	9.8	25.6	6.7	5.2	210.3	21.9	9.4	0.7	2.5	0.2	63.7	11.5	7.1	1.6	0.2	35.7	2.5	58.1	11.9	0.6	2.2	1.8	5.9	0.9	55.8	5.1	8.1	2.0	11.5	3.7	10.7	30.7	0.2	3.9	0.3	0.2	12.1	15.1	137.4	0.6	1.6	0.3	0.0	0.2	0.5	0.8	0.2	0.9	0.2	0.2	0.1	1.4	0.0	1.5	0.5	1.0	2.6	0.0	0.4	0.0	0.0	0.1	0.0	3.0	1.0	1.1	0.0	0.0	0.6	0.0	0.6	0.0	2.5	1.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.0	0.2	9.3	0.0	0.0	2.9	3.5	2.0	0.0	2.4	0.2	0.0	0.2	0.7	0.0	1.4	1.1	0.5	0.6	0.1	0.0	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.0	183.9	98.1	217.1	210.3	21.9	63.7	11.5	58.1	2.0	30.7	137.4	1.1	0.0	0.0	7.2	0.0	18.9	5.5	5.6	14.8	1.5	0.7	1.3	1.4	1.5	1.9	3.7	0.0	0.1	0.1	0.2	0.0	0.2	0.8	0.4	3.6	1.5	0.0	0.0	48.5	2.1	0.4	5.6	0.5	0.2	0.0	0.0	1.4	1.0	0.2	0.0	15.4	0.7	0.0	0.0	1.4	1.8	3.1	0.1	1.8	5.6	0.0	0.6	0.0	7.5	5.8	0.8	0.0	3.8	0.0	1.3	2.6	3.5	0.3	1.1	0.0	0.2	8.0	0.4	0.4	8.2	10.9	2.2	0.2	0.1	0.1	5.0
PID1	"FLJ20701, NYGGF4"	ENSG00000153823	"Phosphotyrosine interaction domain containing 1"	Q7Z2X4	2	228850526-229271287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Inhibitory neurons: 142.2;Langerhans cells: 210.4;Microglial cells: 179.9;Oligodendrocyte precursor cells: 543.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 71.1;intermediate monocyte: 79.4;myeloid DC: 83.6"	"Group enriched"	"Detected in many"	53	"dendritic cells: 83.6;monocytes: 79.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.5;hTEC/SVTERT24-B: 86.1;LHCN-M2: 57.3;REH: 62.3;RH-30: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036103	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA036103: AB_10602144"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.91e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-6)"	31.2	29.5	18.8	13.9	20.8	2.9	25.8	9.0	21.2	30.2	9.0	37.6	5.5	22.9	8.9	12.0	33.9	12.7	17.0	20.6	15.5	5.6	62.2	24.4	4.4	14.8	30.5	31.0	13.8	1.5	8.8	26.1	13.6	19.2	21.5	3.8	10.2	14.8	13.1	20.0	25.1	16.7	11.8	20.3	25.5	5.5	21.4	3.4	16.6	20.8	3.6	30.9	27.0	13.8	0.0	1.9	0.0	0.0	54.5	10.5	0.1	9.2	34.7	5.8	7.1	0.7	0.0	0.0	0.2	13.0	18.0	1.7	0.0	1.7	7.8	0.0	0.0	0.0	4.0	0.1	22.3	0.0	0.1	19.8	15.5	86.1	14.0	16.1	0.0	0.0	0.0	0.1	57.3	0.1	0.1	0.0	0.9	7.6	5.2	62.3	90.7	0.1	1.1	0.0	1.8	2.3	19.4	1.8	0.1	0.7	0.2	0.0	0.0	22.3	8.3	21.1	8.8	0.1	0.0	0.0	29.3	0.1	3.7	0.0	71.1	0.0	0.0	79.4	0.4	0.2	0.0	0.2	83.6	0.0	0.0	0.0	1.5	0.0	16.7	0.4	0.3	28.4	18.8	20.8	9.0	21.2	20.6	15.5	14.8	30.5	13.6	11.8	21.4	13.8	4.0	6.4	70.9	53.8	1.6	15.6	6.1	13.5	6.8	5.7	0.9	1.7	2.6	8.6	11.1	0.0	0.0	1.9	0.2	75.7	0.0	2.5	0.1	1.4	37.8	4.1	4.9	0.4	121.0	4.0	31.5	107.3	1.1	4.4	6.3	7.8	4.2	135.0	3.3	0.0	142.2	11.9	4.1	42.5	210.4	1.9	88.0	50.1	21.4	179.9	35.2	14.0	1.0	543.4	3.5	1.6	24.2	75.2	0.5	21.9	39.5	0.3	2.5	1.3	0.0	4.8	8.7	0.4	2.1	1.4	14.5	4.8	2.4	41.0	36.0	1.4
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319452-15335554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 83.5;Suprabasal keratinocytes: 55.0;Urothelial cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 22.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"			"HPA001174: AB_2666220"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	2.1	2.9	2.2	2.9	2.7	9.2	3.1	2.0	3.6	2.8	0.8	3.7	1.9	3.0	3.5	5.1	2.8	3.7	2.0	1.6	1.8	3.8	4.5	6.7	3.5	2.8	2.7	2.4	4.0	3.3	0.6	3.6	2.2	2.7	3.7	4.5	4.6	1.7	1.3	1.4	2.4	2.5	2.2	2.0	2.8	2.6	2.3	4.0	4.4	1.3	4.7	10.3	1.9	5.8	14.5	8.3	9.1	5.0	2.6	2.8	7.0	3.7	5.7	7.4	7.3	9.2	6.5	6.6	2.9	2.9	9.0	5.8	14.3	11.4	12.6	6.1	9.5	5.5	11.0	5.8	4.5	8.8	2.9	3.3	8.1	10.0	16.0	2.4	5.0	5.2	6.4	7.0	5.1	9.2	9.0	3.4	4.7	5.5	8.2	3.0	12.4	10.7	5.6	9.4	6.2	9.4	6.9	6.8	14.4	8.7	6.6	7.4	4.2	6.2	2.4	14.0	7.3	5.4	7.2	9.9	9.4	5.6	7.9	22.9	3.8	4.3	2.6	6.3	3.7	3.0	4.1	2.6	3.9	2.1	3.8	2.9	5.2	1.8	8.6	2.6	4.1	2.7	2.2	2.7	2.0	3.6	1.6	1.8	2.8	2.7	2.2	2.2	2.3	5.8	6.4	19.2	83.5	6.8	7.2	29.6	41.9	10.6	13.6	3.5	13.2	10.5	6.9	5.7	20.1	3.7	0.0	6.3	7.4	8.4	11.7	7.6	5.4	30.8	9.8	7.9	10.7	9.3	2.2	5.8	10.2	12.7	17.9	45.6	33.6	3.0	3.6	4.4	8.8	3.3	2.0	5.0	2.0	8.4	43.4	4.4	3.1	18.1	28.4	2.8	3.6	4.2	4.1	1.0	7.7	8.3	5.1	3.0	5.5	32.0	2.1	6.6	19.8	3.0	13.1	10.6	16.3	2.7	3.7	35.5	55.0	28.0	11.7	2.9	6.0	62.2
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057216	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"kidney: 146.0;liver: 506.6"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 225.4;Proximal tubular cells: 163.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 73.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 36.7;Hep G2: 120.2;NTERA-2: 68.4;RH-30: 90.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		380000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.4	0.6	14.3	0.6	17.5	0.3	0.3	17.5	15.6	0.7	11.4	3.6	13.6	1.6	24.4	1.8	8.8	3.4	0.4	13.8	15.3	146.0	506.6	1.2	0.9	15.1	16.3	0.9	0.7	1.7	0.8	4.2	14.7	2.0	1.1	4.4	0.5	3.4	0.3	0.7	4.3	2.0	13.0	1.0	0.9	0.3	16.3	0.4	0.2	0.1	0.5	1.3	0.5	14.2	0.0	0.0	36.7	0.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.8	0.0	0.1	0.2	0.6	0.0	0.1	0.5	0.5	0.5	0.2	120.2	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	1.1	0.0	0.2	0.0	0.7	68.4	2.4	0.0	0.3	90.7	2.2	0.0	0.1	11.2	3.8	0.3	0.2	0.5	5.9	0.2	4.4	0.0	0.1	0.2	0.1	4.3	0.9	11.4	0.4	0.0	0.6	3.6	1.0	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.4	1.8	0.2	0.1	0.8	1.4	0.3	0.1	0.1	0.4	0.3	14.3	17.5	17.5	15.6	13.8	15.3	15.1	16.3	14.7	13.0	16.3	14.2	0.4	0.0	0.6	12.4	1.4	0.3	0.3	0.2	0.0	2.9	0.2	0.3	0.5	5.7	0.1	0.0	4.2	0.2	0.7	0.2	9.8	0.0	1.5	0.2	0.3	0.8	1.2	5.3	0.2	0.2	7.7	0.7	1.5	0.2	5.7	1.3	5.3	225.4	1.2	0.0	0.5	0.0	0.0	6.0	2.1	2.1	0.3	2.2	0.0	1.0	2.2	29.0	0.0	1.0	0.1	0.0	0.0	1.2	0.2	0.3	1.9	163.7	0.0	1.4	0.0	0.7	0.4	0.1	1.0	0.0	0.1	0.4	1.2	0.1	0.1	0.1
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1255.9;Inhibitory neurons: 330.9;Oligodendrocyte precursor cells: 281.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: AB_2673808"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favorable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	25.7	8.9	27.2	5.6	30.1	3.8	18.6	23.5	26.9	8.7	13.2	7.6	1.5	7.8	3.8	9.8	10.9	3.8	13.3	22.7	31.2	21.8	9.8	15.1	8.8	38.4	41.0	15.2	23.1	1.8	13.7	6.0	28.2	11.9	2.2	15.0	14.1	4.4	5.4	4.9	8.7	3.5	28.7	9.4	12.6	2.5	42.7	8.4	9.0	5.0	7.4	12.0	9.2	20.1	4.2	1.0	4.5	6.8	2.8	5.1	3.9	6.0	2.9	0.8	0.4	0.0	6.4	4.6	1.4	3.6	1.7	2.0	6.7	6.0	1.1	9.3	3.0	0.7	7.6	3.4	0.7	1.4	9.8	3.6	2.2	0.9	2.5	0.5	3.2	6.5	0.3	16.9	2.3	7.0	10.9	2.8	6.6	1.8	7.7	15.2	0.9	4.2	9.7	5.4	4.7	13.0	1.7	3.3	4.1	4.8	3.0	4.7	3.7	1.8	1.0	2.4	2.9	13.2	6.2	3.7	14.4	4.6	1.6	0.7	1.4	10.3	11.1	2.6	5.7	0.5	6.9	9.2	0.9	1.3	8.2	8.3	1.7	5.2	4.1	0.1	2.8	4.1	27.2	30.1	23.5	26.9	22.7	31.2	38.4	41.0	28.2	28.7	42.7	20.1	102.6	9.6	1.1	1255.9	9.6	5.4	55.6	4.6	8.0	15.2	7.7	4.1	6.9	21.5	4.6	0.0	2.1	7.9	84.0	5.8	21.5	43.3	0.2	13.7	5.7	59.8	6.0	4.0	88.4	49.1	13.6	18.9	8.2	30.9	5.1	7.7	21.4	10.1	13.8	74.0	330.9	1.3	4.1	21.4	22.3	1.4	5.0	17.7	10.6	103.0	20.2	34.6	84.5	281.5	9.7	38.7	4.4	14.7	28.0	32.9	0.1	21.2	3.4	21.8	26.3	66.5	25.7	0.4	3.8	9.0	4.3	3.4	75.7	2.7	3.8	54.3
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 19.6;kidney: 25.1;liver: 92.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 22.1;Hepatocytes: 16.3;Late spermatids: 23.0;Proximal enterocytes: 14.8;Proximal tubular cells: 48.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"K-562: 107.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	Cytosol		No	NA		5200000		"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.0	0.0	0.0	0.0	0.1	19.6	0.0	0.7	0.1	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	25.1	92.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.2	7.2	0.0	0.0	0.1	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.5	0.2	0.2	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1.5	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.2	0.3	0.1	0.0	22.1	1.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.7	16.3	0.2	0.0	1.2	0.9	0.0	0.0	0.0	23.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	14.8	48.9	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	3.6	3.3	2.6	2.0	5.8	0.0	1.2	1.4	12.7	3.2	8.1	2.8	0.9	3.3	2.7	1.4	6.1	1.8	7.3	4.8	0.6	3.0	0.5	10.0	1.4	3.0	0.3	14.9	3.9	0.9	5.6	8.4	1.3	6.3	1.4	2.8	2.5	5.1	15.0	2.4	1.7	2.6	2.6	2.3	2.3	4.8	0.8	3.1	12.1	36.3	1.1	3.1	2.7	3.1	0.0	0.0	39.1	9.6	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	3.9	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	6.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.8	1.4	12.7	4.8	0.6	3.0	0.3	1.3	2.6	0.8	3.1	0.6	0.0	0.0	31.3	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	1.4	46.8	0.0	1.1	0.5	0.0	0.0	132.9	0.2	0.0	3.1	0.0	0.0	0.0	12.2	1.8	0.0	0.3	8.4	137.4	0.0	0.0	0.0	0.3	9.6	5.0	0.0	8.8	22.5	0.0	2.9	0.0	85.5	3.8	0.1	0.0	17.7	0.0	1.9	0.0	0.1	0.0	0.3	6.6	8.8	2.9	1.2	0.4	0.0	0.4	0.1	0.0	6.9	0.0	0.0
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72934762-72954806	"Metabolic proteins, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;kidney: 14.4;liver: 71.0"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 52.2;Proximal enterocytes: 70.0"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 9.1;Hep G2: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"	NA	NA		2300000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.2	27.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	14.4	71.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.3	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.1	1.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.8	52.2	0.0	0.0	0.3	2.4	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	70.0	13.4	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	6.3	0.0
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062615	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 39.1;thyroid gland: 41.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Excitatory neurons: 34.6;Inhibitory neurons: 43.5;Muller glia cells: 33.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.5;ASC TERT1: 19.5;BJ hTERT+: 16.2;hTERT-RPE1: 26.3;TIME: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		960000		"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.7	2.9	0.7	1.4	0.8	0.0	14.9	9.7	2.2	6.9	1.7	3.1	3.9	8.8	2.9	4.7	5.4	9.3	2.5	0.5	1.5	20.8	1.4	2.6	1.9	2.0	2.7	10.8	0.6	19.7	2.2	3.8	2.1	3.1	3.2	5.6	39.1	2.9	0.5	10.9	6.1	6.9	1.4	5.1	1.6	1.0	2.5	0.6	41.9	1.3	2.7	3.9	6.0	1.0	0.2	1.6	0.6	0.0	14.5	19.5	0.1	6.8	16.2	1.3	1.8	0.0	3.4	0.0	0.4	7.2	1.4	3.3	0.1	5.0	1.4	0.0	0.0	0.0	11.8	0.0	1.2	0.0	0.0	7.9	5.4	1.9	2.1	26.3	9.3	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	1.4	0.7	0.0	0.0	11.8	2.2	0.0	1.7	2.6	0.2	47.3	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.7	0.8	9.7	2.2	0.5	1.5	2.0	2.7	2.1	1.4	2.5	1.0	11.1	6.4	2.8	20.9	0.1	9.4	2.7	18.1	21.6	2.7	22.1	14.5	4.1	5.7	11.3	33.1	0.0	7.3	0.5	1.7	0.0	0.6	0.1	5.6	22.0	4.0	1.2	0.0	34.6	2.0	1.3	14.8	0.0	9.4	1.3	9.6	8.6	0.0	0.6	16.8	43.5	7.2	4.1	0.0	2.1	1.4	16.1	0.5	7.2	25.3	0.0	33.5	0.0	5.5	1.8	5.1	11.3	16.6	0.1	2.6	15.6	2.3	8.1	1.4	6.6	3.4	4.8	0.1	1.0	9.3	5.4	1.5	0.6	6.3	7.5	3.0
PLAAT2	"FLJ20556, HRASLS2, PLAAT-2"	ENSG00000133328	"Phospholipase A and acyltransferase 2"	Q9NWW9	11	63552770-63563379	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 67.9"	"Cell type enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.3;naive B-cell: 8.2"	"Lineage enriched"	"Detected in many"	10	"B-cells: 17.3"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 128.9"									HPA058997	Approved		Approved	Mitochondria		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.3	0.0	0.6	0.8	0.6	0.1	9.1	0.5	0.9	0.9	0.3	11.2	67.9	0.3	1.2	1.5	4.7	0.6	0.2	0.5	0.5	8.6	4.6	3.6	0.3	0.7	0.6	0.2	0.0	0.0	0.2	0.2	0.6	0.4	13.7	0.0	0.9	0.5	0.0	0.3	42.5	0.3	0.5	0.7	12.4	0.5	0.6	0.3	0.9	0.0	0.3	1.3	0.2	1.1	0.4	1.7	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.1	0.3	15.6	0.0	0.9	0.0	0.4	1.0	0.6	0.2	0.1	0.2	0.0	0.1	1.0	0.1	0.2	0.0	0.1	0.1	1.2	0.3	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.3	0.1	8.7	1.9	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.1	4.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.1	0.0	128.9	16.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.9	17.3	0.2	1.0	0.1	8.2	0.2	0.7	0.1	1.6	0.0	0.9	0.0	3.9	0.6	0.6	0.5	0.9	0.5	0.5	0.7	0.6	0.6	0.5	0.6	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
PLAAT5	"HRASLS5, HRLP5, iNAT, PLAAT-5"	ENSG00000168004	"Phospholipase A and acyltransferase 5"	Q96KN8	11	63461404-63491194	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adipose tissue: 16.5;pancreas: 13.6;testis: 53.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Syncytiotrophoblasts: 1.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	64	"basophil: 5.4;eosinophil: 16.4"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 16.4"	"Group enriched"	"Detected in some"	5	"HAP1: 11.4;NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042493			Uncertain	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA042493: AB_10797499"	"unprognostic (3.16e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.83e-3)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (7.11e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.57e-3)"	"unprognostic (4.50e-4)"	16.5	0.2	1.2	0.3	0.9	0.1	3.3	0.7	0.8	0.1	0.0	0.7	0.2	0.5	0.2	0.8	0.9	0.6	0.6	1.0	1.3	0.1	0.0	0.6	0.1	1.5	0.5	0.6	13.6	0.0	0.0	0.0	1.0	0.4	0.2	0.5	0.8	1.3	0.1	0.2	0.3	1.4	1.1	0.1	0.5	53.4	0.8	0.0	0.1	0.1	0.0	0.5	0.1	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.7	0.8	1.0	1.3	1.5	0.5	1.0	1.1	0.8	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42174718-42207709	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 246.0;urinary bladder: 181.4"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 763.3;Urothelial cells: 992.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 604.7;HMC-1: 425.2;hTERT-RPE1: 344.9;LHCN-M2: 298.2;U-2197: 441.2;WM-115: 806.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	58.9	44.0	14.0	35.6	13.7	0.1	35.1	14.6	17.4	21.8	10.3	55.3	29.9	49.6	16.8	33.7	49.8	40.4	19.3	12.5	16.6	91.9	5.3	41.3	2.3	15.4	15.4	21.5	16.0	246.0	13.3	44.4	16.6	54.0	25.0	2.1	15.6	29.1	8.8	6.2	34.6	32.9	16.0	2.0	41.8	11.9	18.8	4.4	30.9	9.8	2.7	181.4	33.1	14.0	4.2	1.4	29.0	9.1	43.1	61.9	0.9	125.8	216.4	54.2	43.4	1.4	604.7	0.0	4.4	17.1	28.4	14.5	0.3	23.9	78.5	64.6	8.4	0.7	1.0	0.6	253.9	0.2	425.2	65.6	0.4	140.3	6.0	344.9	103.9	0.2	4.6	0.8	298.2	0.0	0.6	0.5	42.3	0.3	48.2	0.2	103.5	0.3	12.6	0.4	0.3	7.4	0.2	0.4	158.7	39.7	1.0	0.3	189.3	11.6	43.1	441.2	15.6	0.2	1.1	0.2	9.7	0.2	806.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.0	13.7	14.6	17.4	12.5	16.6	15.4	15.4	16.6	16.0	18.8	14.0	63.5	0.0	13.7	0.0	2.9	10.8	763.3	155.9	7.4	4.7	103.9	66.3	7.4	1.5	19.1	0.0	4.2	0.6	0.9	0.1	0.0	9.3	0.9	4.8	104.2	98.2	0.0	0.0	1.6	0.6	1.3	136.5	2.0	5.1	164.0	89.7	36.4	0.8	1.9	1.7	4.0	0.0	4.1	1.0	17.7	1.5	3.7	4.7	23.2	25.3	1.6	2.1	1.0	42.7	0.3	52.0	0.0	2.6	2.8	193.3	0.2	0.3	4.0	3.8	13.1	10.8	48.3	1.1	0.6	13.6	13.5	0.7	6.0	0.5	0.5	992.1
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28644142	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 39.0"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 112.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.0;eosinophil: 3.0;intermediate monocyte: 4.4;myeloid DC: 5.7;neutrophil: 8.8;non-classical monocyte: 5.0"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.7;granulocytes: 8.8;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;OE19: 7.8;RT4: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	1.8	5.7	3.4	1.8	3.3	5.0	1.8	1.0	3.0	1.9	2.2	1.5	0.7	1.6	1.7	1.0	1.3	1.5	1.2	2.7	2.6	0.7	0.5	1.6	0.4	2.4	2.3	0.9	0.6	0.3	1.6	2.1	2.0	2.1	1.8	0.1	1.4	1.5	2.0	7.9	39.0	2.7	2.5	4.1	0.9	2.6	2.9	0.6	2.0	0.6	0.3	1.7	1.3	1.6	0.4	0.0	2.4	0.0	0.5	0.3	3.6	0.1	1.0	0.2	0.2	2.5	0.2	0.2	0.2	0.4	1.0	0.5	0.0	1.9	0.2	0.1	0.0	0.2	0.4	0.4	0.8	0.4	0.1	0.4	1.1	0.4	0.5	0.4	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	7.8	0.5	0.0	0.4	0.0	1.1	2.7	1.0	0.2	0.1	0.1	0.2	0.2	0.0	1.3	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.8	1.8	0.0	0.0	3.0	3.0	0.0	4.4	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	8.8	0.0	5.0	0.3	0.1	1.1	3.4	3.3	1.0	3.0	2.7	2.6	2.4	2.3	2.0	2.5	2.9	1.6	0.6	0.0	0.6	0.7	0.3	0.4	1.0	0.6	0.6	0.1	1.6	1.5	1.6	0.0	1.5	0.0	0.0	0.5	2.1	6.5	1.9	1.6	27.0	2.4	1.0	1.5	1.2	0.0	3.2	0.9	23.2	0.6	0.0	1.1	5.7	0.1	1.1	0.0	12.5	0.0	3.4	5.4	0.0	17.4	10.1	18.3	1.2	12.5	0.0	15.0	4.8	0.3	0.0	1.5	0.4	1.0	2.6	0.7	0.5	0.4	112.6	0.0	1.5	0.0	0.0	1.1	0.3	1.0	0.9	0.3	0.4	8.2	1.5	0.6	2.5	1.6
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.4;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 22.6;granulocytes: 26.6;Hofbauer cells: 30.3;Kupffer cells: 46.6;Macrophages: 41.7;Microglial cells: 39.4;monocytes: 20.9;NK-cells: 26.8;T-cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 78.6;HMC-1: 93.4;THP-1: 28.1;U-937: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	5.9	4.0	3.8	29.2	3.9	52.4	2.5	3.8	5.4	3.3	3.4	5.1	6.1	2.7	1.4	3.0	4.5	9.7	3.0	4.0	5.6	1.9	6.3	16.8	28.7	8.4	7.1	1.5	1.3	1.3	2.1	7.0	7.3	2.6	8.0	0.5	5.4	4.0	1.2	1.9	10.4	7.3	6.2	40.7	5.5	1.3	7.7	20.5	2.2	1.7	22.2	7.3	1.8	9.6	0.4	0.0	0.6	0.0	0.0	0.0	10.5	0.0	0.1	0.0	0.0	0.1	19.1	1.5	17.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	78.6	0.0	0.0	0.0	16.9	93.4	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.7	4.3	0.0	0.0	4.7	9.2	0.9	0.0	0.2	13.7	2.0	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.2	5.1	0.0	28.1	10.1	0.0	9.1	0.0	0.0	0.0	0.0	3.7	0.0	53.2	0.0	1.7	2.6	5.3	1.8	2.7	1.2	0.4	0.9	0.9	2.7	0.5	0.9	1.0	4.2	1.2	2.7	1.0	1.9	1.5	3.8	3.9	3.8	5.4	4.0	5.6	8.4	7.1	7.3	6.2	7.7	9.6	0.9	6.4	16.8	0.3	9.6	0.9	0.1	0.1	0.6	0.1	1.9	2.5	3.3	1.5	3.2	1.8	0.0	0.5	22.6	0.2	0.0	0.1	2.2	0.2	0.5	1.7	0.0	8.0	1.8	0.0	0.5	1.9	0.0	0.2	26.6	0.1	1.1	0.4	30.3	0.0	0.8	1.7	0.0	46.6	15.5	0.6	0.3	41.7	3.6	39.4	20.9	0.0	26.8	0.5	0.2	0.4	0.3	0.0	5.7	0.0	0.0	0.9	4.4	0.2	0.0	0.4	0.7	0.5	2.3	0.3	0.6	0.4	20.8	0.3	2.0	0.0
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	93993931-94332823	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.8	2.6	4.5	2.8	4.1	0.2	2.7	3.1	5.6	8.0	7.0	12.6	4.0	9.0	5.3	1.7	4.4	2.5	12.4	3.9	4.7	8.4	0.7	7.3	0.7	3.9	4.8	3.9	14.7	0.8	4.4	2.9	4.0	3.8	7.5	7.3	2.3	5.4	4.1	1.1	5.2	4.2	3.2	6.2	8.3	2.0	5.4	0.5	9.8	6.3	0.6	5.6	5.6	4.2	4.0	6.7	1.8	1.1	0.7	3.2	1.9	2.8	0.6	0.3	0.4	5.3	1.3	0.8	1.3	2.3	1.3	2.6	2.2	0.4	0.6	0.4	2.3	0.5	4.0	0.5	0.0	0.9	0.3	1.8	0.0	1.1	0.0	6.8	0.0	0.4	0.5	0.3	4.2	0.3	0.8	0.9	0.7	7.9	5.0	0.1	3.9	0.2	0.2	10.3	0.9	1.5	3.3	3.6	0.7	4.1	3.5	0.6	0.6	3.0	5.9	2.0	4.4	0.6	0.3	0.4	3.5	1.1	2.2	0.1	0.1	0.0	0.3	0.2	0.2	0.5	0.3	0.2	0.1	0.7	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.1	4.5	4.1	3.1	5.6	3.9	4.7	3.9	4.8	4.0	3.2	5.4	4.2	8.2	70.5	5.4	69.5	7.0	8.2	9.7	6.8	2.2	12.2	3.6	3.6	34.7	4.3	12.3	0.0	0.0	3.7	2.9	79.6	1.9	1.1	20.7	26.7	18.4	9.7	1.8	0.0	3.1	6.4	2.5	15.3	29.6	10.6	0.0	7.2	4.2	1.6	0.7	6.7	83.9	9.7	4.1	2.4	5.2	5.3	12.2	1.3	7.2	5.6	1.2	82.7	4.1	123.1	2.4	4.2	54.8	23.3	0.9	7.5	11.0	2.5	10.6	18.7	6.6	30.8	37.7	3.7	8.0	1.7	7.4	1.9	4.3	3.7	41.1	10.5
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600404-171810950	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 519.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004527, HPA042396, HPA066938"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.8	26.4	9.2	6.6	24.7	7.8	7.5	18.4	13.6	10.4	4.5	14.6	46.9	6.2	2.8	33.0	6.4	86.8	24.4	10.5	14.3	12.0	33.7	4.7	9.1	24.8	22.0	24.2	21.2	1.6	2.3	10.7	23.5	3.4	14.7	0.5	13.8	6.0	2.5	29.2	43.9	4.8	14.7	15.7	8.2	5.0	19.0	4.1	3.7	6.8	10.8	5.1	12.4	41.4	4.5	7.2	3.7	1.4	11.2	12.6	7.7	2.3	9.9	3.5	4.3	1.1	6.4	0.0	17.0	0.9	24.0	15.2	0.6	2.0	5.7	3.6	3.2	4.2	11.5	26.1	4.9	7.3	18.9	4.9	10.9	4.2	2.0	10.0	57.5	1.2	2.8	0.0	0.9	1.3	0.0	6.4	0.8	11.9	5.1	0.2	1.5	0.1	8.9	1.8	0.1	0.1	7.9	4.7	31.1	5.1	9.0	9.7	50.7	1.5	5.7	4.0	2.5	9.6	8.2	0.1	6.7	8.6	1.9	8.3	1.8	2.3	0.3	1.1	2.6	0.0	0.2	0.6	0.6	0.0	0.0	0.1	1.0	2.2	0.4	0.0	0.8	0.6	9.2	24.7	18.4	13.6	10.5	14.3	24.8	22.0	23.5	14.7	19.0	41.4	7.7	0.0	4.7	2.0	0.9	7.1	3.4	11.0	10.8	0.4	4.9	5.6	33.6	57.2	11.1	1.8	0.0	3.0	1.9	37.5	3.9	8.4	13.1	1.0	4.8	7.4	4.2	6.3	8.9	3.4	3.7	15.7	27.0	1.3	27.9	10.4	6.4	15.9	20.0	0.0	12.1	23.6	6.1	13.2	2.4	9.5	10.5	10.2	12.4	98.4	5.4	0.0	1.0	12.5	519.6	2.4	18.3	4.5	3.4	0.7	38.3	48.0	9.9	0.1	19.7	3.8	8.4	6.1	5.3	93.5	34.9	2.3	2.3	12.1	17.8	4.7
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	15.1	1.6	9.8	9.4	12.3	2.4	13.7	15.5	8.9	7.5	3.9	5.9	4.9	5.6	10.8	9.4	8.7	7.9	6.9	5.8	8.7	7.7	4.9	10.4	14.7	19.5	16.2	3.1	2.7	6.7	3.6	14.2	18.3	2.7	5.9	4.7	3.5	4.9	3.5	7.4	6.6	5.6	18.2	31.2	4.5	6.3	19.1	22.4	5.7	5.0	13.9	9.1	5.3	21.5	0.0	0.2	17.6	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	10.1	4.4	7.2	6.8	0.0	1.6	2.5	26.4	2.4	0.0	11.4	2.9	0.4	1.4	0.0	0.0	0.0	1.9	1.1	6.7	0.0	0.2	0.0	11.0	5.9	0.0	23.4	0.0	0.3	2.3	0.1	1.3	7.0	0.7	1.2	0.0	0.0	5.1	11.9	0.5	0.1	0.1	3.1	2.2	1.9	0.0	0.1	11.2	0.1	2.4	0.0	4.9	0.0	0.0	16.6	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.7	23.9	0.4	0.6	0.0	22.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.7	9.8	12.3	15.5	8.9	5.8	8.7	19.5	16.2	18.3	18.2	19.1	21.5	91.2	0.0	6.2	98.6	50.3	4.2	0.5	5.5	2.8	0.9	2.0	3.3	2.1	1.5	6.8	7.3	0.0	5.5	0.7	7.2	3.9	2.6	3.8	20.7	6.2	58.4	5.4	5.0	12.8	1.1	1.6	11.8	7.1	19.2	0.0	7.9	35.0	4.3	0.6	0.0	5.8	8.2	8.2	5.9	3.8	1.6	0.3	2.0	5.4	131.2	4.7	11.3	0.0	14.1	168.5	9.4	12.4	0.4	5.2	1.1	3.9	3.6	9.6	0.7	0.0	2.0	3.0	0.7	1.5	6.2	3.7	2.9	5.1	1.1	5.5	3.6
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2666.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1772.7"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	45000000000		"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.4	0.4	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	0.2	0.0	0.1	2.4	0.5	0.1	0.2	0.3	240.9	2666.4	0.4	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.9	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	30.0	0.0	1.8	0.0	0.0	0.3	0.0	19.6	0.0	0.2	3.0	0.1	1.2	0.0	24.0	0.6	0.0	0.0	0.0	0.0	0.1	1.3	0.0	28.5	1772.7	0.1	0.0	0.5	0.0	0.0	35.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	235.7	1.5	0.1	0.0	0.4	0.2	0.4	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	168.4	53.0	93.9	33.6	94.2	13.1	139.8	87.3	105.9	294.6	50.7	56.7	24.0	107.2	56.2	51.3	122.5	66.3	84.6	88.3	90.6	91.4	182.0	87.0	22.4	107.5	108.1	81.9	36.8	130.2	23.1	225.5	87.7	102.8	41.8	19.0	76.2	169.7	50.9	82.1	45.8	65.6	86.8	23.3	66.0	37.3	113.2	29.8	327.6	63.0	19.9	139.2	142.8	88.6	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	93.9	94.2	87.3	105.9	88.3	90.6	107.5	108.1	87.7	86.8	113.2	88.6	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 209.3;Alveolar cells type 1: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 3.7;plasmacytoid DC: 12.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 12.2;NK-cells: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	120.8	32.4	33.2	36.3	40.6	1.4	71.4	44.3	43.6	83.7	22.1	46.4	21.8	120.5	76.2	117.8	68.3	83.1	57.9	30.7	34.9	113.2	202.0	139.8	24.2	43.5	40.1	101.5	31.4	12.7	11.7	78.4	42.2	43.6	31.8	11.9	46.8	103.2	31.4	119.5	25.0	119.4	38.4	99.8	37.7	22.3	39.5	27.2	175.0	48.8	41.9	75.4	88.5	47.9	206.2	207.1	176.8	51.5	174.3	161.7	269.3	208.2	233.1	194.5	233.9	225.0	167.2	0.8	590.0	171.9	140.6	256.7	190.5	339.1	314.2	2.9	235.8	19.4	234.6	95.0	157.5	0.1	9.6	103.1	159.5	302.7	211.1	315.3	429.5	16.8	0.5	0.3	188.9	59.7	0.4	2.3	234.6	88.0	243.2	0.4	117.8	4.9	233.1	109.1	0.6	36.9	436.8	107.9	89.7	253.7	60.2	3.0	474.3	314.5	53.9	324.6	422.8	7.8	30.5	4.2	137.6	0.8	133.4	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.1	0.0	0.1	3.7	0.0	12.2	1.4	0.2	33.2	40.6	44.3	43.6	30.7	34.9	43.5	40.1	42.2	38.4	39.5	47.9	209.3	211.5	88.6	26.8	2.0	124.9	121.4	79.6	48.9	0.2	5.6	25.4	17.9	24.3	79.4	99.3	0.0	4.0	1.6	3.5	13.7	59.0	8.4	33.0	39.4	130.5	13.2	4.4	12.3	53.8	105.3	74.3	31.1	64.1	0.0	60.5	64.2	92.1	3.9	0.0	47.6	6.9	38.7	5.0	21.7	8.0	51.9	3.0	56.9	40.3	0.6	26.4	0.0	1.5	97.9	68.6	6.5	82.8	1.6	80.7	2.2	22.0	31.2	1.5	52.6	19.8	132.3	1.2	17.7	65.5	134.1	4.5	3.6	131.1	11.1	100.6
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544856	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Host-virus interaction"	"DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.6	23.0	11.4	86.7	12.5	64.4	45.9	12.7	17.6	25.9	11.9	65.0	39.8	28.2	31.0	47.9	40.0	66.1	24.3	12.1	13.5	71.9	49.2	49.3	40.6	17.4	14.2	34.9	38.3	16.8	15.4	56.3	15.3	23.7	59.5	9.8	49.1	49.6	10.8	13.6	45.4	41.9	16.2	64.5	44.0	17.1	14.7	30.0	27.8	17.6	39.4	68.1	29.5	14.0	106.2	41.5	26.4	12.1	40.9	65.0	40.5	32.6	88.4	319.8	418.6	34.0	88.1	8.4	75.6	20.6	245.9	86.2	21.2	32.7	56.6	32.9	21.6	66.1	12.5	25.2	292.9	40.3	35.4	106.3	53.3	36.6	182.3	52.6	49.4	19.1	44.7	104.0	66.9	41.0	30.6	16.1	25.8	71.6	37.6	27.4	28.1	2.9	95.9	29.6	16.3	0.0	42.6	20.9	569.9	35.8	20.7	46.8	30.6	26.9	22.7	59.1	55.8	79.2	15.6	0.4	27.0	29.0	23.3	41.1	157.6	44.3	20.8	159.6	30.0	25.2	13.5	18.5	105.8	19.7	9.3	13.9	100.0	57.8	94.8	28.5	8.3	79.3	11.4	12.5	12.7	17.6	12.1	13.5	17.4	14.2	15.3	16.2	14.7	14.0	191.4	35.3	43.0	12.7	28.2	37.0	106.5	92.1	26.2	0.7	36.0	22.6	7.3	124.4	110.4	95.6	0.0	53.7	25.4	134.2	74.3	291.6	2.0	56.1	24.5	135.2	33.1	18.3	7.1	217.4	114.1	74.8	47.9	58.2	28.4	60.5	100.6	29.7	139.9	0.0	9.0	71.5	79.3	86.2	162.9	6.8	114.9	185.5	48.0	35.6	72.3	64.3	32.0	7.1	0.3	157.6	110.3	45.9	18.2	79.6	40.7	75.0	133.5	1.6	39.5	63.4	59.2	1.5	2.4	21.8	28.6	44.5	25.9	42.6	69.4	211.9
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351450-17377342	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 436.2"	"Group enriched"	"Detected in many"	4	"Adipocytes: 439.2;Endothelial cells: 344.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 35.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 35.2"	"Cell line enriched"	"Detected in some"	27	"EFO-21: 549.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	283.0	51.1	2.7	54.6	3.1	1.7	210.5	2.9	4.2	102.7	18.2	95.7	86.7	90.0	5.1	48.9	83.3	139.2	92.5	3.3	3.1	153.0	6.9	31.0	50.5	3.7	3.5	16.7	96.1	98.6	64.3	48.8	3.6	68.4	22.3	0.0	77.9	38.0	32.7	58.9	103.3	50.5	3.6	166.7	116.6	4.4	3.5	18.9	436.2	12.9	16.2	104.4	80.8	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	549.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	9.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.1	20.0	0.0	2.3	0.1	0.3	0.5	2.2	2.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	35.2	0.0	0.6	2.7	3.1	2.9	4.2	3.3	3.1	3.7	3.5	3.6	3.6	3.5	4.1	439.2	6.4	0.0	0.3	0.7	22.9	1.0	0.0	8.0	0.0	2.7	3.3	3.7	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	3.6	0.4	0.3	344.9	0.0	0.4	0.4	2.5	0.1	48.9	0.0	0.3	0.0	0.4	79.6	0.2	1.8	0.0	0.3	0.0	0.0	3.5	28.8	0.8	0.0	5.5	23.2	6.5	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	7.6	1.5	0.0	0.0	0.0	0.1	0.0	1.4	6.1	0.5	0.7	2.9	16.8	0.1	1.4	0.7	0.0	2.3
PLXDC1	"TEM3, TEM7"	ENSG00000161381	"Plexin domain containing 1"	Q8IUK5	17	39063313-39154394	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 299.3;Fibroblasts: 63.8;Sertoli cells: 46.0;Skeletal myocytes: 96.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;MOLT-4: 3.0;U-87 MG: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012805	Approved				"Intracellular and membrane"	NA	NA		17000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 56: Bipolar cells - Visual perception"			"HPA012805: AB_1857893"	"unprognostic (4.28e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.07e-3)"	"unprognostic (6.07e-3)"	"unprognostic (4.62e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (9.15e-8)"	"unprognostic (9.37e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.33e-2)"	6.3	2.8	6.7	3.3	7.9	1.1	8.3	10.0	11.6	5.3	4.6	5.2	1.8	12.6	3.8	12.2	11.5	14.3	21.7	6.0	6.1	5.5	0.6	4.2	5.4	6.8	10.4	14.9	3.5	6.7	2.8	2.2	7.8	5.4	2.9	48.4	4.1	5.1	8.1	4.2	5.3	10.8	5.1	1.8	4.5	5.7	8.3	23.1	3.1	18.4	5.3	4.0	4.6	8.0	0.1	0.0	0.1	1.4	0.2	0.0	0.2	0.1	9.2	0.6	0.4	0.1	2.2	0.1	0.2	0.3	0.0	0.2	0.2	0.1	0.5	0.0	0.7	0.2	0.6	0.1	0.2	0.3	0.1	0.3	0.1	0.4	0.1	0.1	0.0	0.9	0.0	0.6	0.0	1.1	3.0	0.3	0.3	0.1	0.0	0.3	0.4	0.4	0.0	0.1	1.4	0.1	0.0	0.2	0.0	0.1	0.2	0.2	0.0	1.1	0.6	0.4	0.2	0.1	0.0	0.1	5.9	0.4	0.1	0.3	0.1	0.1	1.8	0.0	1.5	0.1	0.5	0.6	0.0	0.1	2.1	2.2	0.4	1.1	0.0	0.9	0.0	0.8	6.7	7.9	10.0	11.6	6.0	6.1	6.8	10.4	7.8	5.1	8.3	8.0	3.4	0.0	14.9	2.9	0.7	5.2	0.9	0.2	2.8	299.3	1.6	1.8	6.9	0.0	1.9	0.0	20.9	0.1	5.4	0.1	0.0	0.0	2.2	0.2	2.4	14.4	0.0	2.7	16.6	0.2	0.1	63.8	2.0	0.3	1.3	0.2	0.4	0.2	0.1	6.7	16.3	0.0	2.0	1.3	6.9	9.1	0.6	7.9	7.2	35.6	5.2	12.2	18.6	3.0	1.4	0.1	0.0	1.2	2.0	0.9	0.0	0.1	1.5	24.2	46.0	96.1	29.3	0.7	0.7	1.2	4.4	0.0	12.1	0.4	0.0	0.5
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Microglial cells: 1508.4;Oligodendrocytes: 470.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3"	"Group enriched"	"Detected in many"	13	"dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.4;U-2197: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"		No	No		720000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: AB_2686313"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	12.4	9.4	13.3	7.3	14.1	5.2	11.5	9.6	13.3	12.7	16.8	5.3	4.2	10.7	3.5	7.5	10.1	17.4	10.2	11.3	25.6	10.7	3.1	17.1	2.4	18.0	17.3	9.4	3.6	16.2	3.3	4.7	19.2	7.6	4.6	18.2	6.2	7.7	5.0	15.5	7.1	16.2	16.2	9.4	3.8	5.9	22.3	2.5	6.8	10.0	2.8	8.5	8.9	29.1	0.0	0.0	5.8	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.7	2.2	1.8	0.0	0.0	0.7	2.8	8.6	0.4	19.4	0.0	0.0	7.7	0.6	0.0	2.3	8.9	0.0	0.0	0.1	1.7	0.9	1.1	0.6	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.2	2.4	0.4	0.0	1.8	0.8	0.9	0.0	7.6	3.9	45.9	0.0	0.1	0.0	0.0	3.5	0.1	0.0	10.7	57.5	11.8	1.3	33.4	2.7	0.0	0.0	0.3	36.0	0.0	0.0	0.0	81.6	4.4	37.3	1.6	0.0	17.7	13.3	14.1	9.6	13.3	11.3	25.6	18.0	17.3	19.2	16.2	22.3	29.1	101.4	16.0	8.9	131.9	2.6	36.8	23.8	12.3	41.5	44.2	14.4	45.3	10.9	15.7	10.9	5.5	8.4	0.9	2.9	7.1	0.0	6.9	2.9	16.5	7.6	45.3	3.0	10.5	190.9	0.0	8.1	97.2	1.1	19.4	31.6	80.9	82.1	4.2	94.3	1.7	59.9	27.3	8.2	91.3	46.3	2.1	19.3	147.7	7.2	1508.4	94.5	25.5	5.2	158.3	470.2	1.0	16.6	57.2	3.8	5.5	16.0	22.2	3.0	73.6	19.7	110.1	12.7	1.6	1.2	35.5	38.1	1.2	4.2	71.4	8.8	11.7
PM20D1	"Cps1, FLJ32569"	ENSG00000162877	"Peptidase M20 domain containing 1"	Q6GTS8	1	205828025-205850132	"Enzymes, Predicted secreted proteins"		"Hydrolase, Lyase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"pancreas: 78.0;skin 1: 33.8"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 20.9;Gastric mucus-secreting cells: 7.1;Proximal tubular cells: 7.1"	"Cancer enriched"	"Detected in some"	32	"urothelial cancer: 30.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enriched"	"Detected in single"	9	"Karpas-707: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to digestive system"	NA	NA		3300000	"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.83e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.50e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-2)"	0.8	0.0	0.2	0.1	0.2	0.0	1.2	0.0	0.3	0.1	1.2	0.1	0.1	0.1	0.5	0.0	0.4	0.0	0.3	0.2	0.3	6.3	0.2	0.2	1.1	0.3	0.3	0.3	78.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.0	0.0	33.8	0.1	0.0	0.2	1.0	2.9	0.0	0.3	0.1	0.1	0.0	0.4	2.2	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.5	0.1	0.4	1.3	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	2.2	0.3	0.2	0.2	0.0	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.8	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.6	0.5	0.0	0.0	1.5	0.0	0.0	0.0	2.1	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.4	3.2	20.9	0.3	0.5	7.1	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.5	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.0	1.5	1.5	0.6	0.0	0.0	1.8	0.2	0.0	7.1	0.0	0.8	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.9	2.4	0.0	0.1
PMAIP1	"APR, NOXA"	ENSG00000141682	"Phorbol-12-myristate-13-acetate-induced protein 1"	Q13794	18	59899996-59904305	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 803.1;Endometrial ciliated cells: 463.6;Glandular and luminal cells: 529.8;Squamous epithelial cells: 474.5;Suprabasal keratinocytes: 691.2;Urothelial cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 169.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 169.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 207.5;U-138 MG: 202.1"									HPA051063	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA051063: AB_2681330"	"unprognostic (1.35e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.12e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.09e-1)"	2.0	0.7	2.8	8.0	2.7	88.1	3.9	2.6	5.1	6.5	3.0	2.5	3.7	5.4	0.2	13.7	2.9	8.0	0.9	2.6	2.8	2.3	2.1	3.8	14.7	2.8	2.7	0.7	1.2	14.8	16.7	13.4	3.0	3.6	3.4	2.0	3.6	1.3	1.5	24.1	3.9	1.9	2.7	4.6	2.5	3.1	3.7	12.1	2.1	1.5	14.2	17.3	7.9	2.4	26.6	17.4	5.2	1.6	8.8	69.0	19.8	125.4	84.1	71.5	70.7	1.7	32.5	104.6	17.0	23.5	207.5	38.4	21.0	11.8	70.4	33.7	154.5	19.4	26.0	4.6	87.6	67.1	28.2	28.7	30.8	93.8	48.5	26.1	24.0	46.7	26.7	17.5	24.1	2.6	53.8	20.1	151.7	2.7	32.7	54.1	28.8	39.1	41.9	24.2	39.7	32.7	6.1	3.2	71.5	56.1	5.3	54.6	90.6	202.1	54.0	10.3	141.4	2.8	0.3	92.1	16.8	37.6	48.5	169.8	16.7	103.6	10.9	26.2	9.6	33.8	5.0	6.8	12.1	25.0	4.1	5.9	53.5	6.3	32.1	10.2	25.2	15.1	2.8	2.7	2.6	5.1	2.6	2.8	2.8	2.7	3.0	2.7	3.7	2.4	29.2	32.1	25.7	0.7	175.3	803.1	316.2	236.4	415.4	0.2	111.8	82.0	4.7	12.8	129.6	3.7	2.1	120.3	125.3	141.1	0.0	54.7	0.8	463.6	48.8	48.5	133.4	5.5	0.0	67.0	14.7	32.9	168.2	529.8	31.8	11.8	7.9	0.5	89.5	0.0	0.0	146.8	181.0	37.2	363.3	1.1	0.9	140.6	74.7	7.5	142.4	0.3	34.0	0.0	0.2	100.1	123.6	1.2	63.1	265.7	94.7	0.5	101.5	0.7	0.0	10.8	32.0	0.3	19.8	474.5	691.2	315.2	117.0	19.8	122.2	569.2
PNMA6A	"MGC15827, PNMA6C"	ENSG00000235961	"PNMA family member 6A"	P0CW24	X	153072454-153075019	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 27.0;Distal tubular cells: 11.7;Horizontal cells: 23.5;Muller glia cells: 21.1;Proximal tubular cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.5;HMC-1: 6.7;SK-MEL-30: 6.9;U-2 OS: 14.7;U-698: 8.5"									"HPA045007, HPA052115"	Uncertain		Uncertain	Nucleoli,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria	Nucleoli	"HPA045007: AB_2679181, HPA052115: AB_2681734"	"unprognostic (2.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.76e-4)"	"unprognostic (5.75e-3)"	"prognostic favorable (1.93e-5)"	"unprognostic (4.61e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.22e-2)"	1.9	1.8	17.3	0.2	16.8	0.4	1.1	8.8	26.5	3.1	3.4	1.7	0.6	2.4	5.9	0.4	3.0	1.0	2.1	16.5	16.7	8.2	10.2	0.6	0.4	16.4	13.1	5.1	0.9	2.2	11.9	0.2	16.1	0.5	0.2	3.5	1.0	0.6	0.5	1.1	0.9	0.7	8.9	0.9	1.2	1.7	17.3	0.2	3.1	0.7	0.3	0.4	0.7	16.7	0.0	5.3	0.1	1.5	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.5	0.0	1.8	0.4	0.9	0.0	2.8	0.0	0.0	0.0	0.6	0.0	0.3	0.2	7.5	3.3	6.7	1.1	0.0	0.1	0.0	0.2	0.2	5.6	1.4	0.0	0.1	0.4	1.1	0.0	3.3	5.9	0.0	0.0	0.0	0.0	0.3	0.0	3.2	1.9	0.4	0.0	6.9	0.3	0.0	4.2	0.0	0.0	14.7	0.0	0.0	5.7	4.6	8.5	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	16.8	8.8	26.5	16.5	16.7	16.4	13.1	16.1	8.9	17.3	16.7	0.2	0.0	0.0	4.6	0.5	0.0	0.3	0.0	0.0	27.0	0.3	0.5	2.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	11.7	1.5	0.0	0.4	3.4	0.4	0.0	0.0	8.1	0.2	0.0	2.4	0.0	0.8	0.0	6.5	0.7	2.9	4.0	23.5	9.6	0.0	0.0	0.8	0.4	0.7	2.8	0.8	0.0	1.9	0.0	21.1	0.0	4.5	1.4	0.3	0.0	3.0	0.7	0.1	0.0	27.0	0.0	8.7	0.0	0.8	1.9	1.0	2.8	0.0	0.0	0.0	0.7	0.9	0.0	0.1
PNMA8B	"KIAA1183, PNMAL2"	ENSG00000204851	"PNMA family member 8B"	Q9ULN7	19	46486906-46495879	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 14.7;brain: 41.6"	"Group enriched"	"Detected in some"	4	"Adipocytes: 8.3;Granulosa cells: 5.3;Theca cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;AN3-CA: 1.8;SH-SY5Y: 1.4"	"Low region specificity"	"Detected in all"							HPA054810	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA054810: AB_2682609"	"unprognostic (1.31e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (4.26e-4)"	"unprognostic (7.30e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.32e-2)"	2.7	14.7	32.8	0.3	31.1	0.0	2.4	0.0	41.6	1.9	0.0	1.5	0.3	1.7	0.5	0.5	1.6	1.0	1.9	20.1	25.3	0.7	0.4	0.7	0.4	22.5	15.0	3.9	0.9	0.2	7.3	0.3	27.3	1.6	0.1	2.1	1.5	1.0	0.5	2.3	0.9	0.6	2.1	1.9	0.9	0.8	18.5	3.5	0.8	0.4	0.1	1.1	1.6	19.0	0.0	0.0	1.4	1.8	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	31.1	0.0	41.6	20.1	25.3	22.5	15.0	27.3	2.1	18.5	19.0	8.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.3	0.0	0.5	0.9	0.8	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.1	0.0	5.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0
PNPLA1	"dJ50J22.1, FLJ38755"	ENSG00000180316	"Patatin like phospholipase domain containing 1"	Q8N8W4	6	36243203-36313955	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 23.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.9;granulocytes: 4.5;Oligodendrocyte precursor cells: 1.5;Proximal enterocytes: 1.5;Proximal tubular cells: 3.8;Suprabasal keratinocytes: 3.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 69.8;eosinophil: 18.9"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 69.8"	"Cell line enriched"	"Detected in some"	4	"U-937: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.57e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-2)"	0.1	0.2	0.1	0.6	0.2	4.3	0.6	0.3	0.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	4.7	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	23.9	0.9	0.2	0.1	0.7	1.7	1.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	17.6	0.0	69.8	4.0	18.9	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.2	6.2	0.1	1.1	0.0	0.0	1.1	0.1	0.2	0.3	0.4	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.2	4.5	0.7	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.3	1.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.1	1.5	3.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	3.7	0.1	0.0	0.4	0.2	0.2
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 16.7;LHCN-M2: 19.3"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.6	0.2	0.6	0.5	0.8	0.1	1.6	0.1	1.2	0.6	5.9	0.1	0.8	0.3	0.1	0.2	0.9	0.4	0.2	1.2	0.7	4.5	31.0	0.8	0.3	1.7	1.8	0.3	0.0	0.2	0.0	0.3	2.0	0.0	0.1	6.4	0.7	0.0	1.7	5.8	0.5	0.0	0.2	0.4	0.2	0.4	1.3	0.1	0.1	0.1	0.2	0.0	0.3	0.6	5.1	1.6	16.7	6.8	4.6	5.2	0.5	3.1	1.8	4.1	8.8	5.0	9.0	0.0	2.5	5.2	2.4	4.3	10.6	5.0	3.4	0.0	0.9	0.3	4.5	9.4	7.5	0.0	0.3	6.0	3.8	13.2	0.6	7.0	0.5	0.2	0.0	0.0	19.3	0.7	0.3	0.0	11.5	0.6	0.0	0.1	8.9	0.2	1.7	0.2	1.5	0.1	3.4	1.4	4.8	2.9	5.3	5.8	0.6	1.6	4.9	0.1	0.1	0.1	0.0	0.0	14.3	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.1	1.2	1.2	0.7	1.7	1.8	2.0	0.2	1.3	0.6	0.4	0.0	0.0	4.2	0.2	0.4	0.5	2.4	0.0	35.9	0.5	0.1	1.3	10.0	1.4	0.0	18.8	0.0	0.2	0.2	0.0	0.4	0.0	1.5	0.5	0.4	1.8	0.0	1.9	0.0	0.1	0.5	0.0	3.6	0.0	1.9	0.7	42.3	0.7	0.0	1.2	0.8	0.0	2.8	0.3	0.3	0.3	0.9	1.8	0.0	0.0	1.1	0.0	0.0	0.8	2.6	0.0	0.7	0.0	0.7	0.4	5.0	0.1	37.3	0.0	1.0	0.8	0.6	0.6	0.0	0.1	0.0	0.2	1.6	0.4	0.4
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Hepatocytes: 53.4;Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	7.3	15.8	16.5	6.2	15.9	3.5	10.6	16.7	22.0	7.0	12.9	8.8	10.2	5.0	11.6	10.7	10.1	6.6	13.2	16.0	21.9	35.1	88.8	6.4	6.9	19.1	21.2	5.8	10.9	26.6	9.2	7.0	20.6	8.0	8.6	5.4	10.4	7.8	21.1	6.7	9.6	6.1	16.5	7.2	8.6	6.6	20.6	5.8	17.8	19.6	7.7	6.7	7.3	14.3	37.9	30.9	2.4	5.8	15.3	11.7	0.0	12.2	7.7	14.0	11.9	51.1	27.6	35.2	57.4	12.7	5.5	22.0	19.4	34.7	20.3	43.4	16.4	24.6	13.9	53.6	16.3	22.6	16.6	15.4	26.9	25.8	32.7	13.1	18.0	26.1	24.4	12.2	16.5	28.3	25.3	7.8	4.5	37.4	37.1	18.8	10.4	26.2	40.2	19.5	12.1	9.5	11.2	18.6	10.7	8.5	32.4	9.1	19.1	22.6	12.8	22.2	26.2	27.8	34.0	19.0	18.4	19.2	11.7	2.5	12.3	2.8	7.2	17.7	8.2	6.7	6.3	7.6	13.5	5.3	8.2	8.1	1.1	7.9	11.9	9.8	7.0	10.3	16.5	15.9	16.7	22.0	16.0	21.9	19.1	21.2	20.6	16.5	20.6	14.3	7.6	12.8	13.9	7.5	3.9	1.5	6.7	5.0	5.7	1.1	16.2	14.4	1.9	18.6	6.8	12.9	4.2	8.4	7.8	7.3	62.6	18.2	0.8	11.2	6.4	5.9	3.6	7.4	4.2	15.6	1.9	5.3	4.6	13.3	12.7	8.8	6.4	53.4	17.2	3.3	6.2	11.6	2.0	11.4	2.4	0.9	9.9	10.6	1.8	2.8	8.6	7.1	3.1	2.5	3.2	15.0	8.9	6.0	4.9	9.0	20.2	86.3	5.9	1.9	0.0	4.1	3.8	0.7	1.3	7.2	2.3	6.3	4.7	19.5	15.4	5.0
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 165.8;Cone photoreceptor cells: 87.6;Endothelial cells: 181.1;Glandular and luminal cells: 121.3;Microglial cells: 92.8;Rod photoreceptor cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 295.8;NTERA-2: 509.7;SuSa: 640.8;TIME: 474.0;U-251 MG: 226.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA		33000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	20.8	6.8	27.7	8.9	26.5	0.3	21.9	25.2	34.4	26.0	19.0	8.4	5.1	27.5	5.6	8.1	49.0	14.5	29.1	25.2	25.3	96.2	3.0	31.8	5.6	29.2	28.1	6.1	26.0	18.9	1.1	29.3	29.5	8.7	8.6	67.8	16.1	18.9	15.3	4.8	6.2	28.9	22.0	5.6	5.6	2.4	42.0	3.7	28.5	26.1	6.1	9.6	1.0	22.0	50.9	18.9	42.6	16.3	0.5	0.0	2.6	5.4	4.2	16.9	6.1	121.4	83.1	0.3	109.7	295.8	57.1	34.9	34.3	0.7	15.3	5.4	17.3	0.2	115.0	2.7	1.1	4.2	4.0	0.2	0.4	50.5	0.8	9.4	146.3	1.5	10.5	1.8	16.9	18.0	0.5	1.3	509.7	10.0	43.6	16.2	73.1	15.8	1.6	16.6	34.3	8.9	34.7	7.0	0.2	640.8	4.1	2.2	474.0	6.8	26.6	72.5	226.1	2.5	4.5	1.2	27.1	20.1	48.4	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	26.5	25.2	34.4	25.2	25.3	29.2	28.1	29.5	22.0	42.0	22.0	165.8	6.4	9.9	3.6	2.4	5.2	0.9	14.0	0.6	9.7	33.3	20.7	22.9	4.3	25.4	27.6	87.6	0.8	1.0	1.0	0.0	4.6	0.8	44.8	13.0	181.1	2.4	2.7	9.4	18.3	0.4	9.2	1.1	121.3	2.5	2.2	65.0	1.0	0.4	5.0	3.3	12.9	4.1	0.9	9.6	1.3	4.7	2.6	5.4	92.8	0.7	10.6	0.0	7.1	3.1	42.7	0.8	0.4	4.3	3.6	0.7	0.8	10.3	188.4	0.0	6.3	8.4	0.3	1.1	1.3	3.1	0.7	3.3	1.9	2.7	5.8
POGLUT3	"KDELC2, MGC33424"	ENSG00000178202	"Protein O-glucosyltransferase 3"	Q7Z4H8	11	108472112-108498384	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.8;Cardiomyocytes: 13.1;Cytotrophoblasts: 27.6;Extravillous trophoblasts: 14.5;Fibroblasts: 14.7;Hofbauer cells: 18.0;Syncytiotrophoblasts: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039315, HPA039817, HPA066134"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624"	"unprognostic (1.29e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.00e-3)"	"unprognostic (4.08e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (6.27e-5)"	24.6	13.2	5.0	17.3	5.0	7.6	16.2	4.6	5.4	33.6	7.0	16.8	9.4	35.0	27.3	21.0	23.0	21.7	15.2	4.2	5.9	15.6	13.2	16.0	10.4	5.5	6.1	36.5	8.3	25.2	5.4	32.7	5.4	28.4	16.9	5.8	13.9	28.4	5.5	13.7	11.2	37.1	5.3	12.4	11.3	5.8	5.5	16.4	12.1	13.9	9.5	22.5	18.8	6.0	10.9	12.4	46.5	47.8	76.5	88.5	44.8	47.0	43.7	66.0	71.1	58.9	78.1	0.1	28.6	61.6	73.1	7.9	35.6	1.2	69.3	19.4	27.4	18.1	12.1	27.2	30.8	47.7	0.2	51.1	14.6	35.0	1.0	40.1	56.6	0.3	41.5	0.3	101.0	7.9	30.9	27.2	20.3	11.5	34.8	1.5	72.5	0.2	12.3	30.3	9.7	29.5	89.1	6.2	13.3	21.4	42.3	18.0	56.8	127.0	24.9	10.8	49.7	0.4	0.1	0.3	32.6	48.9	103.1	0.1	0.1	0.0	2.0	0.7	1.7	0.2	1.0	1.7	0.5	0.3	1.0	1.5	0.1	1.9	0.4	1.0	0.9	0.5	5.0	5.0	4.6	5.4	4.2	5.9	5.5	6.1	5.4	5.3	5.5	6.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	27.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	21.2	0.5	0.0	0.0	0.0
POLR3GL	"flj32422, MGC3200"	ENSG00000121851	"RNA polymerase III subunit GL"	Q9BT43	1	145964690-145978848	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 196.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA027288	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA027288: AB_10602119"	"prognostic favorable (2.96e-4)"	"unprognostic (3.58e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (6.52e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	50.3	42.0	33.4	26.5	33.9	28.7	41.9	32.7	42.9	29.8	33.9	41.2	19.8	30.2	27.7	20.1	31.4	21.0	67.7	32.6	35.9	31.7	55.2	31.7	40.5	34.9	33.8	36.2	21.1	31.4	33.3	19.8	33.6	28.7	25.0	28.3	26.2	24.6	139.8	26.9	36.7	24.4	33.1	46.6	33.6	19.8	34.4	41.1	33.7	66.1	41.6	32.7	25.1	33.9	28.5	12.6	28.6	26.4	70.3	78.8	6.9	28.3	43.9	19.0	28.6	3.9	31.0	60.9	41.4	39.6	15.4	8.6	14.1	27.7	28.8	66.8	15.5	40.6	10.6	19.8	43.2	41.1	55.3	60.1	18.1	31.2	36.0	55.5	50.5	64.2	68.9	51.5	73.1	30.5	33.6	51.4	5.9	42.9	27.8	27.8	35.3	92.8	30.6	6.5	15.5	28.8	40.0	2.6	58.3	23.2	24.8	65.5	52.7	17.7	11.7	35.0	19.3	83.9	27.4	47.4	32.1	48.5	16.4	225.8	53.8	266.1	124.2	73.3	119.0	118.4	125.3	123.2	56.0	110.0	126.7	130.6	41.2	116.2	79.0	44.1	179.5	103.5	33.4	33.9	32.7	42.9	32.6	35.9	34.9	33.8	33.6	33.1	34.4	33.9	69.8	28.9	52.8	12.1	63.0	27.9	27.5	52.4	15.9	32.3	34.8	37.8	83.7	52.9	35.7	20.2	8.4	19.9	76.0	35.1	123.3	35.2	38.8	21.9	24.7	51.4	21.1	46.7	6.5	38.6	26.5	40.1	21.9	15.5	85.4	35.6	60.7	84.3	70.2	57.2	7.9	31.1	63.1	70.0	46.6	11.2	45.1	54.9	58.7	10.3	73.1	84.9	196.7	4.0	9.3	38.6	33.8	47.0	48.2	20.1	31.6	41.2	42.7	20.9	26.3	32.6	40.5	22.9	29.4	25.2	30.0	9.4	94.6	50.0	33.1	24.6
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 207.2;stomach 1: 174.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 87.9"	HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		660000000		"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	71.4	5.2	4.5	23.8	0.1	0.3	84.0	0.0	4.4	20.3	2.9	61.3	5.1	53.2	13.0	20.5	83.5	64.3	83.2	3.0	0.0	28.1	13.0	45.1	12.8	0.9	0.0	3.6	2.2	21.6	2.4	60.9	2.0	16.1	84.9	0.0	17.7	44.8	10.6	207.2	15.0	66.6	0.0	1.1	174.6	3.4	0.1	5.8	19.1	29.9	3.9	91.4	10.7	0.4	0.0	0.0	71.0	1.6	85.0	51.0	0.2	23.1	0.0	5.5	0.7	0.0	1.4	0.1	0.0	18.7	0.1	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.1	90.8	0.0	490.2	1.9	15.9	0.7	0.0	0.0	0.0	11.8	0.0	0.3	0.4	4.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.6	0.0	440.5	0.9	0.0	0.0	619.3	0.3	427.2	3.4	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	4.4	3.0	0.0	0.9	0.0	2.0	0.0	0.1	0.4	46.7	6.4	10.6	0.7	0.3	295.7	1.3	51.5	0.0	0.0	2.9	158.1	22.8	0.0	18.7	0.0	0.0	2.5	1.0	0.0	0.0	0.0	0.5	0.5	9.8	134.6	0.0	0.0	1.5	0.0	0.2	191.5	0.0	0.3	3.8	0.0	22.5	0.6	3.7	0.0	36.8	0.0	24.4	0.0	27.0	1.1	6.5	0.8	30.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	0.4	0.4	0.0	0.0	5.6	0.0	0.0	0.7	151.5	1.3	0.9	0.2	48.4	3.4	2.3	49.3	0.0	0.3
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.8;heart muscle: 22.0;skeletal muscle: 18.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 12.7;Cardiomyocytes: 35.3;Excitatory neurons: 36.9;Inhibitory neurons: 31.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 58.8;cerebral cortex: 37.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 8.0;hTERT-RPE1: 13.1;RH-30: 13.6;U-266/70: 8.5;U-87 MG: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053419: AB_2682143, HPA054132: AB_2682393"	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.5	0.6	9.5	0.4	4.2	1.0	0.6	58.8	37.4	3.5	0.0	1.4	0.5	2.3	2.4	1.1	1.0	1.7	22.0	7.6	0.0	5.3	0.3	0.8	0.2	2.2	0.0	0.9	0.1	0.4	1.6	2.8	1.5	1.0	0.2	7.2	1.4	0.6	18.9	2.0	0.8	1.2	0.0	1.6	0.8	3.2	2.5	0.4	0.5	12.0	0.2	0.6	2.0	3.1	8.0	0.0	0.1	1.9	0.0	0.3	0.3	0.4	0.9	0.7	3.2	0.4	0.3	0.4	1.6	1.8	0.2	0.9	0.6	1.5	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.5	0.1	0.4	0.0	13.1	0.0	1.6	0.1	0.3	6.5	1.1	0.6	1.0	0.9	0.0	0.3	1.4	13.6	2.3	0.0	0.0	2.6	3.3	0.8	0.2	1.1	1.2	0.2	0.6	0.0	4.8	2.8	0.1	0.1	8.5	0.2	0.1	12.4	0.7	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	4.2	58.8	37.4	7.6	0.0	2.2	0.0	1.5	0.0	2.5	3.1	0.1	0.0	0.0	12.7	0.1	0.0	0.1	3.7	0.6	5.1	0.5	0.3	35.3	0.0	0.9	0.0	6.2	0.1	0.1	0.0	0.0	0.9	2.7	0.4	0.3	0.6	0.0	0.0	36.9	0.0	0.4	1.7	0.0	0.7	0.0	1.8	0.7	0.0	0.3	6.7	31.9	0.1	0.0	0.0	0.0	3.6	0.3	0.7	0.0	4.7	1.9	1.5	1.0	5.5	1.9	0.4	0.1	1.9	0.0	0.1	0.0	0.1	1.0	1.5	0.0	1.1	0.8	0.6	1.4	0.3	0.0	0.3	0.1	0.1	0.0	0.0
PPP1R14D	"CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016"	ENSG00000166143	"Protein phosphatase 1 regulatory inhibitor subunit 14D"	Q9NXH3	15	40815451-40828709	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 111.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 334.5;Paneth cells: 338.1;Proximal enterocytes: 412.4;Undifferentiated cells: 108.9"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 45.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;RPMI-8226: 3.1;RT4: 1.9;SK-BR-3: 1.2;T-47d: 1.1;U-266/84: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041846	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041846: AB_10794307"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.26e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.11e-2)"	0.1	0.0	0.1	9.6	0.1	0.0	0.5	0.5	0.1	0.3	0.1	107.1	111.1	0.2	1.9	0.2	0.3	15.6	0.1	0.1	0.0	3.8	0.1	0.2	0.2	0.1	0.2	0.0	0.3	0.4	0.1	0.1	0.1	0.7	92.5	0.2	0.7	0.4	0.0	1.0	82.3	3.6	0.1	0.0	1.7	0.2	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	3.1	0.0	1.9	0.4	0.3	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.3	0.0	0.0	0.5	0.9	0.0	5.7	0.3	1.8	0.0	0.4	0.1	334.5	0.0	1.3	0.0	0.1	0.0	0.0	61.3	0.0	0.1	5.3	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	0.2	58.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	338.1	0.0	0.0	0.1	412.4	52.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.9	0.0	108.9	0.2
PPP1R16B	"ANKRD4, KIAA0823, TIMAP"	ENSG00000101445	"Protein phosphatase 1 regulatory subunit 16B"	Q96T49	20	38805697-38923024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.6;lymphoid tissue: 41.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 119.4;Inhibitory neurons: 46.8;Oligodendrocyte precursor cells: 49.8;Oligodendrocytes: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 57.3;HMC-1: 59.2;HUVEC TERT2: 35.6;U-266/70: 96.7;U-266/84: 41.8;U-698: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049571, HPA079512"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	"Nuclear speckles"	"HPA049571: , HPA079512: "	"unprognostic (2.62e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (2.67e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.87e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.90e-2)"	13.2	2.9	36.5	19.3	71.6	17.7	8.2	26.1	61.1	3.2	5.1	4.6	3.6	3.4	1.5	3.1	5.8	5.3	5.2	49.3	22.3	27.7	2.4	7.9	37.7	27.8	34.7	1.1	1.5	0.8	2.2	3.7	27.1	1.6	5.1	3.7	2.0	1.9	3.6	1.5	18.0	7.2	24.3	18.1	5.6	0.7	35.7	18.2	3.4	5.7	41.9	6.0	1.6	52.1	0.1	0.7	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	57.3	0.8	0.0	0.9	0.1	1.0	0.1	0.0	1.4	0.2	4.4	0.0	0.0	0.0	0.2	59.2	0.0	0.1	0.0	0.0	0.0	35.6	7.6	1.0	11.9	0.0	0.0	7.4	9.7	7.9	0.1	0.0	5.0	0.0	0.0	0.0	0.0	17.7	19.7	0.0	0.0	0.0	0.7	0.0	3.1	5.5	0.0	0.9	0.0	0.0	96.7	41.8	38.3	0.0	0.0	0.1	0.0	0.2	2.5	3.4	0.5	1.8	5.3	2.3	3.3	0.7	3.3	1.3	1.8	0.0	2.9	0.9	3.3	2.6	1.1	36.5	71.6	26.1	61.1	49.3	22.3	27.8	34.7	27.1	24.3	35.7	52.1	29.3	3.2	3.0	1.3	33.6	1.0	0.0	0.8	0.6	2.3	0.5	0.5	23.5	1.5	4.0	0.0	0.0	0.0	34.0	0.3	0.0	0.0	1.9	0.2	0.2	18.7	0.0	2.7	119.4	0.0	0.0	1.6	4.1	0.3	3.8	0.0	38.6	0.3	0.1	37.0	46.8	0.1	0.0	3.1	3.6	1.5	0.0	3.8	8.8	23.4	20.5	0.3	11.3	49.8	238.0	0.0	0.1	0.0	29.3	0.0	0.0	17.4	3.6	0.3	0.0	0.3	1.0	0.0	0.3	0.3	1.3	0.0	37.4	0.0	0.2	0.3
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984553-43012342	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	23.2	20.2	29.9	17.5	32.5	18.3	20.2	25.7	38.1	30.9	17.2	27.2	29.7	28.7	4.3	24.3	28.5	15.2	30.3	33.1	26.8	18.2	20.8	18.7	19.9	31.0	26.6	28.6	19.1	24.5	15.9	18.1	30.8	24.8	23.5	29.7	19.8	21.2	40.6	27.8	35.8	30.6	21.1	18.7	22.3	28.6	29.6	44.4	18.3	41.2	24.0	24.7	27.4	31.2	71.3	38.0	72.6	88.2	61.0	63.6	32.6	38.3	39.9	108.5	86.6	58.7	24.9	55.8	36.3	71.8	67.3	38.6	108.6	66.4	94.6	45.3	67.5	62.9	51.2	81.8	33.5	51.4	43.6	45.6	47.3	88.5	35.1	54.1	87.2	68.7	67.4	41.1	63.0	44.0	114.9	40.0	26.2	228.1	36.3	86.3	73.8	37.3	45.3	39.0	77.9	45.7	56.2	38.7	47.3	63.2	47.9	55.5	57.1	57.2	50.9	55.8	61.4	39.6	54.6	109.0	21.2	48.0	51.6	18.4	13.8	21.9	18.4	11.6	19.2	10.1	16.9	21.2	13.7	9.2	12.8	15.6	8.1	14.3	8.9	14.4	23.9	20.1	29.9	32.5	25.7	38.1	33.1	26.8	31.0	26.6	30.8	21.1	29.6	31.2	6.2	9.6	6.7	6.8	7.6	8.4	2.9	5.1	13.1	12.9	6.9	6.6	4.9	4.3	6.3	7.3	10.4	7.5	10.1	15.7	5.9	6.9	6.4	7.7	19.9	7.4	9.0	12.4	10.5	7.8	11.0	9.7	7.1	9.5	8.2	10.8	6.4	11.3	9.2	3.3	10.3	8.3	8.2	6.2	5.2	7.0	9.6	6.9	10.6	3.7	6.8	8.1	3.1	3.0	5.3	9.8	9.0	14.7	7.7	3.7	35.7	5.2	5.1	7.5	6.6	8.7	10.8	8.3	10.2	13.3	9.5	4.5	11.1	6.1	13.0	2.5
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40072710-40097260	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1082.7;THP-1: 1449.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		240000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	69.8	59.4	92.9	92.7	95.6	117.5	95.7	100.4	135.9	70.1	106.1	50.5	32.1	72.7	60.1	45.1	55.4	57.1	45.3	93.6	101.2	75.8	54.1	128.5	93.9	97.0	96.7	68.6	42.6	79.2	39.0	74.8	99.6	73.4	58.8	89.4	56.8	63.2	21.3	40.3	39.2	95.3	101.6	177.0	45.1	37.6	99.1	78.0	60.0	37.1	75.1	79.1	34.7	113.5	115.6	62.5	93.7	81.0	106.5	92.1	209.8	68.4	127.9	153.0	183.3	350.1	270.5	140.1	118.1	65.2	112.2	209.5	154.9	112.7	163.6	186.4	151.4	100.3	127.2	155.5	137.5	233.7	158.9	103.1	107.5	108.7	126.4	79.7	190.9	108.8	167.7	247.0	80.6	168.1	109.8	88.3	258.3	163.9	93.8	116.0	263.7	226.1	89.2	152.0	114.1	96.9	247.9	1082.7	298.6	111.7	199.3	1449.6	85.2	100.7	147.1	70.7	174.9	161.2	383.8	133.9	109.4	408.7	155.5	85.7	1254.3	624.2	122.2	1006.3	137.9	118.8	171.5	131.3	1091.1	118.6	227.0	168.3	683.9	100.3	815.7	101.8	204.1	1586.9	92.9	95.6	100.4	135.9	93.6	101.2	97.0	96.7	99.6	101.6	99.1	113.5	45.2	28.9	47.7	19.9	33.3	39.6	77.1	30.8	34.7	46.6	55.3	37.5	15.7	41.5	40.0	38.6	16.7	51.7	28.9	4.7	5.9	59.0	64.8	13.8	46.4	49.6	19.9	40.1	28.4	42.1	66.5	56.6	14.8	18.2	84.9	34.6	47.5	9.3	251.9	25.2	39.2	8.1	20.3	315.8	328.8	87.6	31.4	271.3	67.6	31.9	227.2	120.3	28.8	27.6	22.7	22.2	6.0	39.5	34.2	42.4	3.2	18.5	32.3	37.0	19.7	30.5	49.3	17.5	33.0	19.1	27.3	41.2	43.5	39.4	11.4	35.6
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347368-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 1135.4;liver: 675.2"	"Cell type enriched"	"Detected in some"	9	"Proximal enterocytes: 17736.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 348.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 34.2;Hep G2: 128.3"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	NA	NA		210000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.6	0.5	0.7	4.2	0.7	0.5	0.3	0.4	0.7	0.2	6.5	74.6	1053.8	0.8	0.1	0.4	0.7	2.6	0.3	0.6	0.4	145.4	675.2	0.2	1.5	1.2	0.7	0.4	0.1	0.1	0.8	0.1	1.1	0.3	35.7	0.0	1.7	0.3	0.2	1.3	1135.4	1.7	0.4	0.8	2.7	12.2	0.6	0.3	0.2	0.3	0.1	0.3	0.2	0.8	0.2	0.5	0.1	1.2	0.1	0.0	14.6	0.0	0.0	0.0	0.0	34.2	0.6	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.5	128.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	3.5	0.4	5.0	0.0	0.2	0.9	2.9	0.0	0.0	0.9	4.6	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.4	1.3	0.0	1.4	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.4	0.7	0.6	0.4	1.2	0.7	1.1	0.4	0.6	0.8	0.0	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.6	0.0	9.2	0.0	0.2	0.0	773.7	33.2	0.1	1.9	0.6	0.0	0.6	18.4	13.5	0.1	0.2	0.2	0.2	1.5	0.1	8.9	0.0	12.5	1021.3	0.2	0.0	0.0	676.2	0.0	20.9	0.0	7.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1815.7	1.5	0.0	0.1	17736.9	412.0	0.1	0.0	0.0	0.0	0.1	140.2	38.2	0.0	0.0	0.3	3.5	0.0	607.1	0.1
PRDM7	ZNF910	ENSG00000126856	"PR/SET domain 7"	Q9NQW5	16	90056566-90092072	"Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 1.0"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 6.3;Spermatocytes: 14.3;Spermatogonia: 5.1"	"Cancer enriched"	"Detected in single"	30	"melanoma: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"REH: 3.8;SK-MEL-30: 2.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059944	Approved		Uncertain	"Nuclear speckles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"		"HPA059944: AB_2684174"	"unprognostic (3.98e-1)"	"unprognostic (8.89e-2)"		"unprognostic (8.02e-3)"	"unprognostic (8.26e-2)"		"unprognostic (9.01e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.46e-1)"		"unprognostic (5.73e-1)"	"unprognostic (5.52e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.03e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	14.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475806-203491352	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 206.6;Leydig cells: 100.6;Melanocytes: 192.1;Muller glia cells: 152.4;Peritubular cells: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 18.0;BJ: 7.7;fHDF/TERT166: 11.7;SuSa: 5.2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 82.4"	HPA059225			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		450000	"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA059225: "	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (1.02e-4)"	114.8	23.4	12.6	4.2	14.2	0.5	77.5	7.7	20.2	126.7	20.0	136.4	6.6	147.7	7.6	41.3	108.6	40.4	212.0	11.6	10.0	25.3	15.6	124.7	8.0	10.2	8.2	128.2	13.1	2.5	22.6	12.0	9.4	73.6	8.9	21.5	32.7	77.1	35.6	56.4	61.0	51.4	8.3	44.2	41.3	7.2	10.3	3.2	60.4	36.9	15.9	147.8	92.9	9.4	0.2	0.2	0.5	0.1	18.0	0.5	0.4	7.7	1.0	0.2	0.2	0.0	0.1	1.2	0.6	11.7	0.1	0.6	0.2	0.3	0.3	0.0	0.1	0.2	0.5	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.2	2.1	0.0	0.4	0.2	0.4	1.3	0.1	0.1	0.5	0.4	0.3	0.1	0.4	0.2	0.4	0.0	0.3	1.0	0.2	0.2	0.2	0.8	5.2	0.2	0.1	0.6	0.5	0.2	0.3	0.1	0.2	0.3	1.2	0.1	0.2	0.5	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	12.6	14.2	7.7	20.2	11.6	10.0	10.2	8.2	9.4	8.3	10.3	9.4	8.8	0.0	5.8	5.2	0.9	18.2	1.0	0.0	2.2	3.6	4.2	5.1	7.4	1.5	0.6	0.0	2.1	0.1	0.3	0.1	0.0	0.0	1.1	0.6	1.7	15.6	0.0	2.7	1.6	0.0	0.1	206.6	4.6	1.6	5.1	0.2	22.9	0.3	0.3	1.7	0.2	0.0	0.0	0.3	19.2	5.3	100.6	0.9	192.1	22.5	0.0	152.4	0.0	7.5	0.5	0.0	0.0	199.7	0.4	0.6	0.0	0.1	1.5	8.9	26.3	9.6	38.3	3.1	2.4	1.6	9.9	0.3	1.6	0.1	0.0	1.3
PRICKLE1	"EPM1B, FLJ31937, RILP"	ENSG00000139174	"Prickle planar cell polarity protein 1"	Q96MT3	12	42456757-42590355	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8;Excitatory neurons: 307.7;Inhibitory neurons: 122.2;Microglial cells: 64.6;Oligodendrocyte precursor cells: 114.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	4	"B-cells: 11.5"	"Cell line enriched"	"Detected in many"	18	"HBEC3-KT: 1015.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001379, HPA050037"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA001379: AB_1855703, HPA050037: "	"unprognostic (2.44e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.29e-4)"	"unprognostic (1.12e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.33e-4)"	6.3	3.0	3.7	5.2	5.0	1.7	5.0	0.0	7.2	12.5	0.0	4.2	2.6	12.1	1.6	2.4	6.4	10.0	13.8	4.2	0.0	5.0	1.7	9.5	4.6	0.1	1.3	12.5	2.0	1.4	2.0	5.3	0.0	5.1	2.2	4.2	7.8	5.6	3.9	4.7	2.4	12.7	0.0	14.8	2.9	6.0	3.9	1.6	7.9	4.6	3.4	5.5	6.3	1.0	7.7	4.4	17.0	0.5	12.4	13.1	0.5	11.0	5.2	3.0	5.1	0.5	16.0	0.5	31.4	1.6	0.0	2.9	12.5	1015.4	3.5	0.6	6.4	17.5	0.9	0.4	1.7	0.3	0.2	19.3	7.5	12.7	1.7	1.8	39.7	0.3	1.8	3.1	2.9	0.3	0.1	0.5	56.1	0.1	18.0	0.2	0.7	0.1	21.1	0.7	4.4	3.0	0.3	0.7	0.7	13.7	0.3	35.1	2.9	0.9	13.4	14.0	14.2	0.9	0.6	6.1	0.2	10.7	0.6	2.6	1.8	0.4	0.2	1.0	0.7	7.6	0.2	0.2	1.0	11.5	0.4	0.2	2.4	0.5	0.6	1.6	0.2	0.9	3.7	5.0	0.0	7.2	4.2	0.0	0.1	1.3	0.0	0.0	3.9	1.0	6.9	16.0	8.2	8.8	13.2	2.7	5.3	7.3	4.0	13.5	4.0	2.2	5.7	14.3	2.6	1.8	2.1	0.6	0.2	0.0	0.0	3.8	72.8	5.2	43.0	8.1	0.0	0.4	307.7	2.6	0.2	19.2	3.6	8.6	1.3	59.1	14.6	0.1	0.6	8.4	122.2	0.0	2.0	0.9	2.3	25.4	9.9	1.2	7.2	64.6	1.1	2.7	0.0	114.6	5.3	3.9	0.1	24.8	3.1	1.0	0.0	3.3	0.3	4.5	0.0	3.8	7.9	5.1	4.8	1.9	1.4	0.7	1.1	18.6	0.0	0.8
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646850	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 30.6"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 70.3;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.00e-5)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	4.3	3.3	3.9	6.6	4.6	15.0	6.9	6.0	4.3	5.6	6.9	6.9	6.0	7.2	6.9	4.3	6.2	4.3	3.3	3.9	5.6	3.9	5.0	4.8	10.6	4.2	4.7	7.2	4.0	3.9	1.9	7.5	4.4	30.6	8.4	4.0	4.2	5.6	2.3	5.8	5.2	8.0	2.8	5.5	4.8	6.5	4.5	15.3	4.4	2.4	11.8	5.8	4.1	7.1	44.8	17.7	34.1	37.6	16.8	29.5	27.3	53.1	48.8	57.0	74.7	26.6	21.1	39.4	27.7	66.6	39.6	27.9	30.2	29.2	71.6	35.1	24.2	47.6	22.7	43.0	7.3	43.5	27.4	12.1	12.0	61.0	20.3	14.2	26.9	44.1	46.2	38.9	48.3	28.2	49.8	37.6	22.0	37.1	17.2	34.7	46.9	31.2	21.0	20.7	24.5	19.2	31.5	15.9	21.3	38.9	33.3	47.4	17.9	54.7	55.5	106.2	44.2	14.4	29.3	47.2	26.6	50.5	30.4	0.7	1.9	1.8	4.1	3.7	4.3	3.5	3.5	5.4	3.0	4.0	2.8	5.7	1.4	5.2	4.2	5.1	4.7	2.1	3.9	4.6	6.0	4.3	3.9	5.6	4.2	4.7	4.4	2.8	4.5	7.1	5.9	0.0	2.7	30.0	11.2	4.0	6.7	4.1	11.4	5.6	6.2	4.2	1.1	2.8	4.6	3.7	12.5	17.0	15.1	4.3	3.9	5.1	10.3	4.9	7.1	5.0	1.2	26.5	38.0	5.2	22.0	6.9	4.1	6.0	12.0	13.7	4.2	3.5	9.3	6.7	32.6	6.5	10.2	6.6	6.4	3.7	6.5	7.0	0.0	70.3	7.3	4.8	17.5	56.8	54.5	4.9	5.3	6.8	12.7	7.1	4.4	1.8	4.1	5.6	19.7	4.9	6.8	10.1	11.2	8.7	3.0	5.7	13.6	8.0	8.6	5.3
PRIMPOL	"CCDC111, FLJ33167"	ENSG00000164306	"Primase and DNA directed polymerase"	Q96LW4	4	184649667-184694963	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 24.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 24.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054372	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Nucleoplasm	"HPA054372: AB_2682466"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.02e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.05e-1)"	7.2	8.0	4.0	6.0	4.9	5.5	8.9	7.6	4.2	8.5	4.4	7.9	4.7	10.7	8.2	7.0	8.9	6.9	7.0	3.6	4.1	5.7	6.8	7.5	7.9	4.3	4.1	12.1	4.8	6.8	4.6	6.6	4.3	7.1	8.6	7.2	4.7	8.2	4.7	6.6	6.7	9.2	4.2	8.6	5.9	5.5	4.3	8.6	7.6	5.3	6.4	6.4	5.3	5.6	13.1	5.7	13.2	15.0	17.5	23.2	8.9	13.8	21.8	22.9	19.9	4.4	13.3	7.5	5.0	10.6	12.6	7.9	11.3	14.6	24.0	15.9	5.3	7.8	7.8	5.3	11.4	6.4	11.5	14.5	11.4	21.2	13.7	13.4	12.6	20.7	16.5	24.0	16.5	4.4	13.3	5.4	4.3	5.8	4.6	12.3	9.4	9.0	11.8	7.8	9.4	11.9	8.3	2.1	15.2	10.4	6.6	12.3	6.8	7.5	9.7	5.9	8.9	13.4	10.2	3.8	11.1	8.5	18.6	11.2	2.5	24.0	3.8	2.4	5.6	3.6	3.6	3.9	3.2	3.7	3.0	3.0	1.2	4.7	5.6	2.7	4.6	3.1	4.0	4.9	7.6	4.2	3.6	4.1	4.3	4.1	4.3	4.2	4.3	5.6	7.7	6.4	8.6	23.5	6.7	9.6	9.5	10.0	9.1	6.2	10.1	6.3	2.6	7.2	10.4	5.5	0.0	14.3	8.1	5.9	5.9	7.7	5.5	9.0	11.1	7.3	6.7	17.5	13.9	5.2	10.0	9.7	8.2	6.3	15.2	12.0	8.9	7.5	9.7	8.4	26.9	58.8	6.1	14.8	6.4	5.7	12.5	9.5	8.8	19.7	6.5	11.1	6.2	27.2	28.1	3.7	10.4	9.1	8.6	4.0	7.2	5.7	15.4	8.2	13.1	11.1	9.0	18.8	13.1	6.9	9.8	4.9	8.9	5.7	8.0	5.4
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8"	"Group enriched"	"Detected in all"	14	"NK-cells: 117.1;T-cells: 137.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0"	"Group enriched"	"Detected in all"	6	"basal ganglia: 28.0;thalamus: 17.9"	"Low region specificity"	"Detected in all"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	26.6	7.8	21.1	21.9	30.2	24.2	21.9	12.4	15.7	20.6	9.5	8.9	9.5	14.5	10.9	30.0	13.6	19.7	19.2	13.2	13.9	14.5	10.3	35.3	55.2	19.3	21.7	5.9	8.4	14.2	15.0	32.5	19.4	15.8	8.8	3.1	28.3	11.4	14.2	23.7	16.6	18.1	18.6	38.5	9.6	7.5	29.9	65.8	21.1	18.1	38.5	25.3	21.7	15.5	18.1	6.3	0.8	4.9	2.8	0.6	81.8	0.3	1.5	0.8	0.8	1.9	10.5	0.3	12.4	0.1	1.6	12.3	0.6	13.5	1.4	2.2	7.9	0.1	2.0	0.7	1.2	0.0	2.4	2.2	13.8	0.7	9.4	1.2	108.7	35.4	0.2	0.4	6.2	32.7	75.8	0.7	1.4	12.9	8.4	6.3	3.2	0.2	0.2	46.4	3.2	5.1	2.1	16.2	10.2	14.5	15.9	1.4	72.0	2.1	14.0	2.1	0.9	1.4	0.2	0.6	3.1	1.1	3.6	0.8	3.0	2.4	116.5	1.9	91.3	2.2	88.0	137.0	9.2	1.4	106.9	105.5	5.9	117.1	1.1	3.0	79.8	84.0	21.1	30.2	12.4	15.7	13.2	13.9	19.3	21.7	19.4	18.6	29.9	15.5	59.7	6.4	11.4	2.0	6.6	18.7	16.4	8.3	15.9	0.4	15.0	9.3	9.0	10.0	15.5	0.0	0.0	27.6	128.4	0.6	3.9	6.0	32.6	10.3	2.1	70.8	11.9	18.1	1.7	6.8	21.2	5.0	7.1	20.9	1.3	15.4	68.9	2.0	6.0	0.0	3.1	2.7	2.0	14.4	6.9	6.0	1.8	15.4	16.0	267.9	8.9	7.0	229.6	4.5	1.8	5.4	4.3	6.8	26.6	14.7	4.6	1.2	9.2	0.5	0.0	4.4	5.2	0.1	2.4	18.1	26.7	48.3	130.5	1.6	1.3	26.0
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	29.0	11.5	7.2	23.6	7.3	29.4	29.3	5.4	7.7	26.6	12.5	20.3	17.1	21.8	4.7	27.5	24.1	11.2	13.8	6.1	6.0	19.2	13.8	34.3	31.1	10.0	6.3	21.8	19.1	8.3	24.0	11.1	6.8	23.9	7.1	4.4	24.7	10.0	8.0	46.8	29.9	6.0	6.0	54.3	20.3	6.6	7.7	25.6	28.9	4.8	21.2	19.5	26.9	6.6	19.6	34.5	12.8	16.6	7.3	6.4	15.1	11.5	13.2	19.6	19.7	19.7	21.0	22.3	16.3	13.2	13.2	27.5	9.5	26.0	5.9	19.8	17.5	25.9	11.5	10.2	12.8	21.2	34.7	11.0	15.8	12.7	9.8	12.8	30.1	21.5	14.6	35.4	7.0	23.8	32.7	53.1	9.7	27.4	17.4	25.8	5.8	37.5	11.4	32.7	7.7	22.4	18.8	18.8	4.6	10.6	11.6	7.5	17.6	8.7	18.8	7.1	10.0	31.8	149.1	13.5	8.5	17.7	11.0	0.6	0.7	2.6	3.9	0.7	3.3	4.3	3.9	4.3	0.3	4.1	3.3	3.3	5.3	2.2	0.5	0.0	2.9	1.5	7.2	7.3	5.4	7.7	6.1	6.0	10.0	6.3	6.8	6.0	7.7	6.6	37.8	9.6	9.9	5.9	46.5	22.0	32.0	13.2	22.8	6.4	13.9	11.3	17.2	12.8	13.0	9.2	0.0	13.8	17.5	43.6	7.9	18.6	1.2	15.3	6.7	37.2	21.6	4.0	6.5	28.2	13.8	9.6	23.4	15.0	14.5	14.1	37.1	8.5	9.0	1.7	2.8	21.7	4.1	12.3	11.4	3.1	11.8	8.3	12.4	11.2	9.3	6.5	42.2	4.0	3.1	29.5	35.1	6.8	47.0	22.9	34.1	9.3	15.6	4.4	13.1	6.1	7.6	2.9	17.9	21.2	26.7	29.7	31.9	6.6	15.3	30.2
PRLR		ENSG00000113494	"Prolactin receptor"	P16471	5	35048756-35230487	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"choroid plexus: 781.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 78.3;Endometrial stromal cells: 113.8;Granulosa cells: 96.4;Proximal tubular cells: 53.0;Syncytiotrophoblasts: 48.3"	"Cancer enriched"	"Detected in many"	9	"breast cancer: 20.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"T-47d: 382.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 36: Stromal cells - Cell proliferation"				"unprognostic (3.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.84e-4)"	"unprognostic (2.50e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.84e-5)"	"unprognostic (1.24e-1)"	0.6	12.2	9.0	0.5	12.1	1.1	23.1	5.4	3.7	20.8	781.5	5.4	6.6	20.0	9.4	0.7	2.2	0.8	0.2	27.7	24.0	30.7	10.9	0.6	0.1	3.3	5.3	2.3	5.4	82.6	4.3	50.2	2.3	1.1	5.7	0.1	1.7	8.1	0.1	3.1	8.1	10.8	4.2	0.2	6.2	0.6	40.7	0.2	0.1	0.7	0.1	0.8	4.8	0.5	0.0	0.0	0.7	3.1	0.0	2.7	0.6	1.7	1.5	3.2	1.2	0.4	0.2	0.0	0.0	1.9	1.2	0.0	4.3	0.0	3.3	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.2	0.7	10.4	0.3	0.0	0.7	0.8	0.0	0.1	0.0	0.1	0.3	0.7	0.1	0.2	0.0	21.1	0.0	0.7	382.8	3.0	0.0	1.9	2.2	0.6	1.4	0.0	0.0	0.0	3.7	0.2	1.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.0	12.1	5.4	3.7	27.7	24.0	3.3	5.3	2.3	4.2	40.7	0.5	0.2	0.0	2.0	0.7	0.2	2.9	0.3	0.0	3.4	0.0	78.3	31.8	0.8	4.3	0.0	3.7	0.0	32.9	0.5	13.1	7.9	1.3	0.0	7.1	113.8	1.1	8.5	0.0	2.0	5.3	2.4	13.8	11.2	10.5	0.0	96.4	0.7	11.4	8.9	0.0	1.9	16.1	0.0	1.9	0.7	0.2	8.7	3.4	0.0	1.0	7.6	0.0	0.0	0.0	0.6	1.8	15.2	12.8	0.0	1.4	26.4	53.0	0.0	0.0	0.0	0.5	4.6	0.1	0.5	2.2	5.1	48.3	0.7	6.0	23.8	0.1
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 598.5"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 432.9"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.7"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 156.1"					"Low region specificity"	"Detected in all"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	NA	NA		5200000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.2	0.0	0.6	0.1	1.1	1.1	0.1	0.6	1.0	0.4	0.0	1.0	0.8	0.1	0.1	0.1	0.2	0.6	0.1	0.6	1.0	14.8	598.5	0.2	0.6	1.6	0.8	0.2	0.3	0.0	0.3	0.1	1.5	0.2	0.6	0.2	0.2	0.1	0.2	0.6	0.8	0.0	0.4	0.4	2.6	0.1	0.8	0.6	0.2	0.0	0.3	0.4	0.2	1.1	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.1	0.0	0.9	0.1	0.4	9.5	0.0	0.3	0.0	0.0	0.2	0.1	7.8	156.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.6	0.4	2.3	0.7	0.0	0.1	0.0	0.0	0.9	0.4	0.0	1.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	59.7	0.0	0.3	0.6	1.1	0.6	1.0	0.6	1.0	1.6	0.8	1.5	0.4	0.8	1.1	0.0	0.0	0.0	0.3	4.1	0.8	0.4	11.2	0.0	0.0	0.1	0.0	0.4	47.1	1.2	0.0	0.0	0.0	24.0	3.9	5.9	0.5	0.1	3.4	0.1	0.6	10.3	18.7	0.1	0.2	0.0	0.7	2.0	0.2	0.0	0.0	12.1	432.9	3.7	0.0	0.5	9.3	0.0	9.3	4.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.1	0.0	0.0	0.0	3.8	84.8	3.4	0.0	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.1	1.1	0.0	1.8	0.3
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"kidney: 140.1;liver: 173.6"	"Group enriched"	"Detected in some"	13	"Hepatocytes: 157.6;Proximal tubular cells: 559.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 28.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"Hep G2: 33.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.1	173.6	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	1.5	0.0	12.9	0.0	0.0	0.0	0.0	27.4	0.0	2.8	0.3	0.0	0.3	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	157.6	0.1	0.0	0.1	0.0	0.0	4.7	0.0	0.9	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	559.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274449-95291308	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.1;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Club cells: 39.9;Collecting duct cells: 33.1;Squamous epithelial cells: 37.2;Urothelial cells: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 79.5;CAPAN-2: 135.9;HaCaT: 73.2;hTCEpi: 78.4;MCF7: 62.1;RT4: 83.8;SK-BR-3: 117.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.7	0.3	1.1	1.5	1.3	0.3	10.3	1.0	2.1	16.6	0.2	11.4	10.5	1.9	27.9	88.1	5.5	27.0	1.1	0.9	0.6	32.4	0.8	1.7	0.1	1.4	0.7	1.1	10.2	25.5	1.5	4.5	1.2	24.7	9.8	0.4	35.2	27.7	0.7	60.0	4.8	0.8	0.3	0.6	26.3	0.6	1.4	2.0	11.9	0.2	7.9	25.7	37.9	2.1	79.5	0.1	0.2	0.8	0.3	0.1	38.5	0.1	0.2	0.3	0.4	0.8	135.9	0.0	0.0	0.1	0.1	73.2	0.0	42.4	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	78.4	0.1	0.4	1.9	0.0	0.1	0.0	0.1	0.0	62.1	0.4	0.5	0.1	3.7	0.5	0.2	0.0	0.1	0.2	83.8	0.6	0.2	0.0	117.7	0.1	0.9	37.2	0.1	0.0	0.2	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.0	2.1	0.9	0.6	1.4	0.7	1.2	0.3	1.4	2.1	0.4	3.2	4.2	1.3	0.1	6.6	25.2	27.6	14.2	0.4	29.1	14.9	1.7	37.1	39.9	33.1	4.2	19.0	0.1	8.0	11.7	15.6	0.5	2.7	0.6	0.9	3.6	0.0	0.6	11.0	3.5	0.6	25.5	5.5	0.0	0.7	0.0	0.0	2.4	0.0	1.2	10.4	12.2	0.0	0.8	1.4	0.3	0.2	7.2	0.0	0.6	0.1	0.0	1.5	3.2	17.5	12.4	0.7	0.0	14.1	0.7	0.1	12.3	1.1	0.0	0.4	2.2	0.6	0.1	37.2	12.8	11.2	0.2	0.8	17.4	37.5
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;liver: 86.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	1.6	10.0	11.0	1.4	21.4	0.0	1.8	24.6	18.2	1.0	0.0	2.6	2.1	1.1	1.2	0.6	2.2	1.9	15.7	23.1	12.4	4.7	86.8	1.2	2.8	18.7	17.3	7.4	15.5	0.1	4.0	0.4	13.9	0.5	2.7	21.2	0.3	0.4	3.6	0.7	2.6	0.8	10.6	7.1	2.1	5.4	30.0	0.2	7.6	2.1	0.7	1.0	0.7	38.2	0.0	0.0	0.6	0.0	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.3	0.2	2.3	0.0	0.1	0.0	1.0	0.6	0.0	31.4	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.1	3.5	2.3	5.7	0.0	0.4	0.0	0.4	0.0	1.7	2.0	1.3	0.0	15.9	2.5	0.2	0.5	2.3	77.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.2	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.4	24.6	18.2	23.1	12.4	18.7	17.3	13.9	10.6	30.0	38.2	14.3	0.0	2.3	1.3	1.9	5.9	1.1	0.3	5.7	196.4	4.8	4.7	105.9	102.9	1.3	9.2	2.1	0.0	0.1	3.2	15.6	34.7	52.7	0.1	1.0	36.5	66.9	5.3	2.9	2.7	0.1	8.7	8.6	0.3	0.0	9.3	11.0	285.9	0.9	523.3	66.8	16.5	12.2	4.4	6.6	10.4	1.2	2.2	10.6	8.4	0.0	36.0	0.0	27.2	114.0	3.4	130.6	1.2	0.1	3.9	3.3	0.4	0.9	11.7	0.0	113.6	3.7	2.9	0.4	0.4	4.5	0.0	1.9	29.6	10.5	0.9
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158648-113172386	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 109.2"	"Group enriched"	"Detected in some"	52	"Hepatocytes: 63.5;Proximal tubular cells: 20.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;Hep G2: 3.6"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	NA	NA	1720000000	650000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.3	0.1	0.3	0.0	0.1	0.0	0.7	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.0	14.4	109.2	0.1	0.3	0.0	0.0	0.1	0.7	0.0	1.2	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.5	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.3	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.4	1.1	0.4	1.6	3.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	0.5	0.3	0.4	0.8	1.4	0.1	0.6	0.1	0.1	0.0	0.5	1.3	0.0	0.0	0.1	0.6	0.7	0.0	0.4	0.3	0.3	0.0	0.3	0.1	0.7	0.4	0.3	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	63.5	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	20.5	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRR33	"C11orf89, LOC728008"	ENSG00000283787	"Proline rich 33"		11	1888078-1891895	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.4;lymphoid tissue: 28.3;skeletal muscle: 35.2"	"Cell type enriched"	"Detected in single"	14	"Cardiomyocytes: 2.9"					"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.4"	"Group enriched"	"Detected in some"	5	"Daudi: 3.0;HDLM-2: 8.6;Karpas-707: 6.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"																					4.8	23.4	0.0	6.1	0.0	9.7	3.0	0.0	0.2	6.1	0.1	3.0	1.3	2.8	0.0	3.1	3.1	1.5	7.2	0.0	0.1	0.5	1.1	2.7	6.3	0.2	0.1	0.5	0.6	0.0	0.6	1.4	0.2	1.3	0.0	0.0	3.3	0.0	35.2	11.0	6.1	0.0	0.2	28.3	2.9	1.2	0.2	0.0	1.7	4.0	0.0	6.9	4.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852730-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.6;salivary gland: 26.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 221.0;Club cells: 343.9;Ionocytes: 207.5;Pancreatic endocrine cells: 380.6;Urothelial cells: 479.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 17.3;MCF7: 14.6;RT4: 10.4;SK-BR-3: 22.9"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	23.4	0.0	0.5	0.3	0.7	0.4	79.6	1.3	0.8	0.0	0.0	0.0	16.7	0.5	2.9	0.0	0.0	0.0	0.0	5.8	1.5	2.4	1.1	0.0	6.0	0.5	0.0	26.9	0.3	0.0	3.2	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.3	0.0	2.2	2.5	23.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	17.3	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	22.9	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	4.2	0.0	0.2	23.2	221.0	128.8	28.5	0.0	42.8	23.7	0.3	38.6	343.9	16.5	0.0	36.7	1.9	18.5	1.9	113.1	0.0	28.4	4.6	1.8	3.6	0.0	0.0	98.3	37.1	1.3	52.5	56.6	0.0	0.0	0.0	0.1	2.3	0.0	0.0	7.5	207.5	0.0	1.4	0.0	0.0	0.9	7.2	0.0	1.0	0.0	0.0	0.0	0.0	380.6	32.3	0.0	0.3	75.4	0.6	0.2	108.0	0.0	0.0	0.0	13.7	0.1	0.2	22.7	27.6	10.5	2.7	0.0	6.9	479.5
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 249.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.1;Endothelial cells: 502.1;Granulosa cells: 347.3;Hepatic stellate cells: 591.8;Theca cells: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 104.6"	"Group enriched"	"Detected in many"	25	"NK-cells: 34.2;T-cells: 104.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 1093.7;hTERT-RPE1: 1296.9;TIME: 1138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030591	Uncertain				"Secreted to blood"	NA	NA		440000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	55.0	21.4	7.8	35.3	7.8	2.1	43.2	7.1	8.7	249.1	12.9	103.6	19.2	103.4	13.4	22.1	24.9	83.8	28.3	7.9	8.0	42.4	15.0	63.3	21.8	14.0	13.9	26.8	29.8	36.0	16.4	61.7	8.8	61.3	50.3	2.7	52.4	128.2	79.6	19.4	29.0	115.5	7.1	18.0	54.2	31.8	14.1	17.5	40.9	18.7	10.2	99.6	79.1	7.4	62.7	153.3	161.1	1.0	70.4	172.3	0.7	269.0	244.4	293.2	232.6	368.1	484.7	0.2	208.2	414.7	1093.7	126.2	2.6	205.0	70.9	0.7	13.0	21.1	74.7	1.4	36.3	0.1	0.9	137.4	26.8	143.2	162.1	1296.9	604.8	0.9	1.3	0.3	223.4	87.7	0.2	0.3	9.8	211.7	16.8	0.0	0.0	0.7	111.5	82.3	1.5	1.0	59.9	4.5	18.7	397.6	6.0	0.6	1138.2	174.0	2.3	351.7	154.5	1.3	1.3	0.8	124.2	0.5	176.3	0.2	0.2	0.1	104.6	0.1	0.2	0.2	17.8	60.0	0.2	0.0	4.7	50.4	1.6	34.2	2.7	0.2	0.0	39.9	7.8	7.8	7.1	8.7	7.9	8.0	14.0	13.9	8.8	7.1	14.1	7.4	95.8	28.9	14.5	14.0	3.2	15.4	96.2	367.1	2.8	1.6	44.7	78.0	4.3	37.1	231.3	53.3	2.1	18.4	53.4	154.8	7.9	162.6	3.1	10.3	130.3	502.1	13.8	20.4	26.3	83.5	15.7	117.1	22.4	7.0	2.5	347.3	591.8	5.2	5.0	0.0	16.5	30.6	85.5	36.6	18.2	6.6	14.3	5.4	72.9	39.4	1.5	0.8	180.2	11.6	2.3	257.7	80.1	7.5	5.8	100.1	5.2	5.7	90.1	0.9	39.5	14.4	105.9	3.0	7.3	1.7	9.8	4.5	24.0	445.1	11.1	60.2
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512534-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 50.5"	"Cell type enriched"	"Detected in some"	36	"Muller glia cells: 410.9"	"Group enriched"	"Detected in some"	4	"glioma: 2.8;testis cancer: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in single"	195	"T-cells: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	1.3	2.4	2.9	0.1	3.8	0.0	0.3	1.7	6.8	2.9	1.5	0.1	0.3	1.3	1.1	0.3	1.4	4.2	4.4	3.2	2.1	3.1	0.4	1.3	0.7	1.8	1.9	10.2	0.3	0.3	1.1	3.6	1.8	1.1	0.3	50.5	0.3	0.4	0.1	0.2	0.1	1.5	1.8	0.7	0.3	3.1	2.6	0.1	0.4	0.1	0.1	1.3	0.5	2.2	0.0	0.5	1.9	0.0	0.1	0.0	0.0	0.3	10.4	1.0	2.0	86.3	0.0	0.0	0.1	0.4	0.0	0.0	12.8	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	0.4	8.2	0.0	0.0	0.0	24.6	0.0	0.0	1.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.5	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.8	1.7	6.8	3.2	2.1	1.8	1.9	1.8	1.8	2.6	2.2	0.3	3.2	0.5	8.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	1.5	0.0	0.0	1.8	0.0	0.3	0.0	0.1	9.8	0.1	0.1	0.0	0.3	0.8	1.8	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.4	6.7	0.2	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	1.0	0.0	410.9	0.0	1.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	11.4	6.6	0.1	3.7	0.1	0.5	0.0	0.0	0.1	0.7	5.1	0.0	0.0
PRSS36	FLJ90661	ENSG00000178226	"Serine protease 36"	Q5K4E3	16	31138926-31150083	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.6"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 11.7;Distal enterocytes: 13.2;Hofbauer cells: 18.7;Paneth cells: 15.4;Proximal enterocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"HeLa: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA036079	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA036079: AB_10602290"	"unprognostic (3.74e-2)"	"prognostic favorable (2.97e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.31e-5)"	"unprognostic (4.18e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-1)"	1.4	0.8	0.4	0.3	0.6	0.4	0.5	0.4	0.8	0.2	0.3	0.7	1.0	0.1	0.0	0.3	0.3	0.1	0.3	0.5	0.5	0.2	0.3	0.7	0.1	0.5	0.4	0.1	0.2	0.1	2.6	0.7	0.5	0.1	0.2	0.0	0.5	0.1	0.2	1.0	0.7	0.3	0.4	0.1	0.3	0.4	0.6	0.8	0.3	0.0	0.2	0.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.8	2.6	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.0	0.1	0.0	0.2	0.0	0.0	0.4	0.6	0.4	0.8	0.5	0.5	0.5	0.4	0.5	0.4	0.6	0.5	0.3	0.0	1.1	0.7	0.2	1.9	2.6	8.9	1.8	0.5	5.9	11.7	1.1	2.8	3.5	0.0	0.0	0.8	1.2	13.2	0.0	1.7	1.7	0.9	0.6	0.6	0.0	0.4	0.6	2.8	1.2	1.3	1.1	0.9	0.0	0.5	3.3	3.3	18.7	0.0	0.8	4.1	2.0	3.2	3.8	0.9	2.8	4.2	0.0	0.0	5.4	0.6	4.1	0.0	0.1	1.8	15.4	2.6	0.0	1.7	46.9	1.9	1.2	0.0	0.0	0.4	0.4	0.6	4.4	1.5	2.6	0.5	0.5	1.1	3.9	1.9
PRSS51		ENSG00000253649	"Serine protease 51"	A0A1B0GVH4	8	10482878-10547585	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	17	"brain: 22.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 3.2;Late spermatids: 3.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	12	"cerebellum: 22.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted in brain"	NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (2.52e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.33e-3)"	"unprognostic (2.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	0.0	0.1	0.3	0.1	0.5	0.2	1.1	22.6	1.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.7	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	22.6	1.9	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS55	"CT153, T-SP1, UNQ9391"	ENSG00000184647	"Serine protease 55"	Q6UWB4	8	10525532-10554166	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	58	"testis: 27.7"	"Group enriched"	"Detected in some"	46	"Early spermatids: 260.4;Late spermatids: 85.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"							"unprognostic (3.64e-1)"	"unprognostic (8.44e-3)"					"unprognostic (6.10e-2)"	"unprognostic (7.40e-2)"		"unprognostic (6.23e-5)"	"unprognostic (6.62e-2)"				0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	260.4	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	85.4	1.5	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.6	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297125-78330093	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 175.0;liver: 267.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 115.5;Glandular and luminal cells: 145.9;Hepatocytes: 161.7;Proximal tubular cells: 304.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 15.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1170.1;SK-MEL-30: 752.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 22: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	7.8	65.8	123.3	7.3	124.6	2.0	5.1	130.5	175.0	5.1	92.8	5.9	5.4	4.3	61.6	33.2	34.7	1.7	2.7	122.4	126.5	136.7	267.9	5.1	9.3	130.2	122.4	5.6	129.1	9.7	7.6	3.0	129.9	10.0	5.5	6.2	19.2	4.0	0.6	57.2	4.5	3.3	133.6	6.0	19.4	10.4	120.3	30.0	30.3	0.5	12.4	7.3	11.2	161.6	222.8	146.0	121.1	215.6	35.1	41.2	284.7	184.3	130.4	91.8	170.6	38.2	41.9	143.2	79.8	416.9	82.9	215.3	209.1	203.6	136.4	141.2	73.9	49.2	60.8	293.3	322.0	277.6	84.6	131.1	1170.1	122.0	322.9	22.6	85.0	548.3	53.8	358.2	77.1	83.2	95.8	44.3	278.2	415.1	158.4	46.5	78.6	173.4	126.6	50.9	54.9	127.0	51.1	87.7	752.3	75.9	42.0	344.1	19.9	23.2	73.5	85.9	151.5	242.0	242.7	0.8	268.9	215.6	112.1	0.0	0.0	0.0	5.2	0.0	5.9	3.1	5.0	7.0	0.3	1.3	8.1	7.5	0.3	0.0	0.1	0.0	15.1	3.3	123.3	124.6	130.5	175.0	122.4	126.5	130.2	122.4	129.9	133.6	120.3	161.6	0.4	0.0	0.0	70.2	11.0	41.9	8.8	18.9	115.5	0.9	1.8	3.9	0.6	1.5	4.7	11.0	0.0	32.0	2.2	2.0	62.6	11.5	1.7	77.7	10.3	3.7	3.6	29.9	7.3	48.4	13.7	4.2	6.6	145.9	0.0	0.5	3.6	161.7	5.3	5.0	6.0	4.8	18.3	4.4	2.9	3.8	5.0	3.4	19.6	5.6	3.8	26.7	0.0	48.2	78.8	22.7	0.1	1.9	29.1	16.0	0.3	304.1	3.8	1.1	0.0	33.5	14.3	1.6	3.7	35.5	50.7	9.3	8.6	68.2	4.2	11.8
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 56.6;lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 60.0;Enteroendocrine cells: 60.0;Hofbauer cells: 42.5;Kupffer cells: 41.8;Macrophages: 41.8;monocytes: 51.1;NK-cells: 91.6;T-cells: 68.4;Theca cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 55.1;HL-60: 14.4;NB-4: 20.9;THP-1: 14.7;U-937: 59.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010116, HPA010600, HPA072744"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA010116: , HPA010600: AB_1855870, HPA072744: "	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	2.6	2.8	11.7	2.7	56.6	2.3	2.7	3.1	2.0	3.4	3.3	2.5	1.6	0.1	2.0	3.1	2.9	2.4	2.7	2.8	3.4	3.4	10.4	13.5	3.1	3.1	1.0	1.3	0.2	1.6	1.8	3.0	2.9	0.8	0.1	2.4	1.0	1.5	1.8	9.4	1.4	3.1	33.9	2.9	0.7	3.6	4.2	2.9	1.0	5.5	4.3	2.7	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	55.1	0.0	0.0	0.0	3.3	0.0	14.4	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	20.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	4.0	0.6	0.0	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.1	0.0	0.0	1.3	2.4	0.1	59.8	0.0	4.8	71.5	71.4	39.9	33.5	30.8	13.3	27.2	32.7	59.0	18.5	14.3	22.3	85.3	41.6	38.3	5.2	27.0	42.2	2.8	2.7	2.7	3.1	2.7	2.8	3.1	3.1	3.0	3.1	3.6	3.1	1.1	0.0	5.1	1.0	19.2	9.3	1.2	0.4	0.0	1.1	0.9	1.1	1.9	0.0	2.5	0.0	0.0	0.3	60.0	3.1	0.0	0.0	9.6	0.3	0.3	0.8	60.0	4.8	0.4	0.2	0.7	1.9	0.0	0.3	2.5	0.1	2.2	0.9	42.5	0.0	0.1	6.1	2.0	41.8	36.5	18.6	0.9	41.8	7.2	0.0	51.1	0.2	91.6	5.5	1.0	0.1	2.5	2.6	8.5	0.3	0.3	0.4	0.0	0.4	0.0	0.8	3.1	0.2	1.2	0.2	4.8	0.5	68.4	78.1	0.3	1.2
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267698-52276724	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Mast cell degranulation"	"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 7.9;lymphoid tissue: 6.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 50.6;NK-cells: 187.4;T-cells: 31.4"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 68.0;NK-cell: 90.3"	"Group enriched"	"Detected in many"	33	"NK-cells: 90.3;T-cells: 68.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA049668	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA049668: "	"unprognostic (9.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.60e-8)"	"unprognostic (1.14e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.89e-2)"	2.0	0.5	0.2	2.1	1.7	1.4	1.2	0.8	0.7	2.1	2.6	5.6	0.7	1.5	1.0	0.4	1.3	1.6	1.9	0.1	0.3	0.5	1.1	1.7	3.2	2.4	0.6	0.8	0.3	0.4	2.1	0.2	0.4	0.8	7.9	0.0	1.1	0.4	0.6	0.6	1.4	0.8	1.5	6.3	1.3	0.2	0.4	0.9	1.1	0.4	1.1	0.9	1.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	68.0	0.0	33.5	0.1	9.0	40.9	0.1	0.0	1.4	22.5	2.3	90.3	0.4	0.2	0.2	12.9	0.2	1.7	0.8	0.7	0.1	0.3	2.4	0.6	0.4	1.5	0.4	0.1	2.9	3.2	0.0	0.0	0.9	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	50.6	3.2	0.0	0.0	0.0	0.2	0.1	2.0	1.2	2.7	0.2	0.0	0.0	1.5	1.1	0.1	1.3	0.2	2.2	0.5	0.1	0.0	0.2	7.5	0.0	1.9	0.4	0.0	0.0	4.6	1.8	1.0	0.4	0.0	187.4	0.0	0.1	0.0	2.8	0.0	4.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	5.5	0.0	0.0	0.1	0.1	0.0	31.4	2.2	14.6	0.0
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Mast cell degranulation, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 4898.3;testis: 3242.2"	"Group enriched"	"Detected in many"	11	"Leydig cells: 38051.3;Peritubular cells: 65156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	27	"plasmacytoid DC: 1386.8"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 1386.8"	"Group enriched"	"Detected in some"	6	"HHSteC: 518.7;HSkMC: 252.0"									"HPA004938, CAB009916, HPA067456"	Uncertain				"Secreted to blood"	NA	NA		2500000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"CAB009916: AB_2174617, HPA004938: AB_1855745, HPA067456: "	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	391.1	297.1	1849.2	247.1	2423.8	9.9	121.1	2440.1	2559.6	1675.5	1508.4	84.8	31.5	320.4	735.9	172.5	492.1	396.7	4898.3	1760.9	2034.8	466.5	80.2	607.8	824.1	2339.4	2228.2	66.8	113.2	9.1	398.4	227.8	2318.0	727.0	17.7	146.1	97.8	813.1	108.3	164.9	205.9	99.7	1999.6	317.5	93.0	3242.2	2264.9	127.4	55.1	60.0	306.0	230.3	1181.0	2580.3	0.1	0.0	0.1	0.0	5.4	16.7	8.8	0.3	0.0	0.0	0.0	0.0	0.2	0.6	4.0	24.0	0.0	0.8	0.6	0.2	0.0	0.0	0.0	0.0	1.4	0.3	518.7	0.3	1.3	252.0	0.1	0.0	0.0	1.8	0.0	0.0	0.6	1.0	0.2	0.0	0.0	6.6	0.9	8.2	0.0	0.1	0.2	1.6	0.0	0.0	1.6	2.0	0.0	0.6	0.0	0.1	0.6	68.3	0.7	0.2	0.2	2.1	0.1	0.3	0.0	0.1	3.9	0.0	0.9	0.0	0.3	0.4	50.5	1.0	3.4	0.3	4.3	6.3	1.8	0.2	0.9	9.9	2.3	3.8	0.2	1386.8	1.4	11.2	1849.2	2423.8	2440.1	2559.6	1760.9	2034.8	2339.4	2228.2	2318.0	1999.6	2264.9	2580.3	29.3	0.0	0.6	665.0	1.5	70.4	3.2	0.1	5.7	46.8	6.6	14.7	333.6	8.6	0.1	138.0	52.1	14.4	1863.6	0.2	68.4	0.3	215.9	29.7	1156.5	167.8	0.0	13.5	4.0	0.0	55.0	1584.0	1.1	20.1	1.3	0.3	46.1	1.6	57.3	21.9	12.8	0.0	0.0	3.4	161.8	1230.9	38051.3	57.0	209.9	176.1	4.6	4625.8	583.9	63.3	850.4	1.7	0.0	65156.8	6.0	20.7	0.0	1.1	0.0	130.3	164.3	787.4	124.8	130.7	111.1	12.0	80.1	35.4	61.3	0.1	0.0	14.5
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599893	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 278.5;liver: 594.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 791.5;Proximal enterocytes: 1230.1;Proximal tubular cells: 581.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 5.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.9"	"Cell line enhanced"	"Detected in many"		"OE19: 909.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					NA	NA		2400000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	44.9	87.7	14.6	11.5	16.3	3.0	37.2	15.4	21.6	35.9	16.7	37.4	232.9	32.4	39.1	112.0	71.5	75.3	29.2	22.6	16.0	234.3	594.1	22.1	7.3	13.0	14.4	25.1	16.7	43.9	23.3	15.3	13.4	60.4	33.9	22.6	47.5	31.1	13.0	31.0	278.5	38.1	11.8	7.9	86.0	8.3	16.4	6.4	27.9	29.0	31.6	88.8	44.4	14.4	49.1	207.1	60.6	0.1	220.1	220.4	45.1	79.4	121.8	74.4	81.2	52.9	67.4	0.1	22.9	78.0	153.9	60.7	47.5	83.4	90.3	0.1	15.4	12.5	129.3	279.0	50.4	7.4	25.6	157.3	127.3	99.8	51.1	88.2	201.0	0.0	8.7	0.1	148.5	16.1	0.4	2.0	22.8	909.3	49.8	0.2	17.1	1.4	82.8	152.8	68.4	3.4	98.9	30.0	31.7	59.6	94.6	34.8	161.8	15.4	29.3	169.7	15.0	0.1	0.5	0.3	72.0	0.1	18.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.3	14.6	16.3	15.4	21.6	22.6	16.0	13.0	14.4	13.4	11.8	16.4	14.4	28.9	19.2	28.3	16.6	4.3	38.6	57.6	135.5	66.6	18.7	43.7	41.4	37.4	271.7	78.4	141.6	25.0	47.0	6.4	34.4	150.6	73.4	4.2	100.3	36.2	26.1	26.5	18.7	38.4	178.3	32.5	48.6	174.3	89.3	1.3	35.0	49.6	791.5	53.4	0.0	31.2	76.1	59.0	26.8	16.7	3.6	33.2	15.9	35.6	12.2	22.6	47.0	0.0	17.1	16.1	139.6	86.3	39.5	0.5	63.8	1230.1	581.3	80.3	46.4	13.1	17.4	61.8	15.2	5.3	242.9	30.5	20.5	5.8	46.8	145.9	156.5
PTN	"HBGF8, HBNF, NEGF1"	ENSG00000105894	Pleiotrophin	P21246	7	137227341-137343774	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 280.4;parathyroid gland: 383.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 672.0;Extravillous trophoblasts: 416.0;Horizontal cells: 526.6;Muller glia cells: 548.5;Oligodendrocyte precursor cells: 322.7;Squamous epithelial cells: 439.9"	"Cancer enriched"	"Detected in all"	11	"glioma: 514.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"AF22: 1717.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017685, HPA073913"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	167000	1400000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Endoplasmic reticulum"		"CAB017685: AB_1128556, HPA073913: "	"unprognostic (1.51e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-2)"	26.2	18.2	212.9	4.1	206.4	0.1	82.3	217.0	280.4	100.0	182.0	31.4	5.4	76.8	55.3	78.2	19.2	55.9	87.7	209.6	205.2	38.4	8.5	18.4	7.4	220.3	200.5	19.0	8.4	383.5	126.1	36.2	196.3	116.1	21.6	63.4	37.4	52.5	2.2	9.1	10.1	54.0	204.2	40.4	15.7	53.8	207.6	21.4	18.9	18.8	11.4	24.8	65.1	209.1	1.2	0.0	1717.6	21.2	0.4	0.9	140.6	45.3	134.3	25.1	34.3	0.4	0.2	0.0	0.2	60.0	15.6	1.0	0.0	0.0	18.9	0.0	1.4	0.0	0.0	0.0	7.7	0.0	0.5	1.9	0.0	16.6	0.2	24.6	0.0	0.0	0.0	8.2	7.0	0.0	0.0	0.6	133.5	0.0	1.1	0.1	2.8	0.4	0.7	0.0	8.0	116.5	0.0	0.0	0.2	24.1	0.2	0.2	0.0	37.4	32.9	1.8	99.4	0.7	0.0	0.0	119.7	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	206.4	217.0	280.4	209.6	205.2	220.3	200.5	196.3	204.2	207.6	209.1	10.1	0.0	0.0	303.3	1.3	23.2	1.7	85.0	209.5	27.7	244.6	117.3	14.6	2.8	20.9	1.8	6.2	220.0	2.2	0.0	9.8	1.1	24.5	53.4	672.0	32.0	0.0	0.0	4.9	0.0	416.0	248.8	0.5	24.6	0.0	1.1	7.1	0.3	20.4	526.6	18.1	0.0	0.0	0.3	20.6	14.0	172.7	4.0	44.4	102.1	0.0	548.5	0.0	322.7	218.4	0.3	0.0	185.5	2.5	18.6	0.0	7.5	7.2	32.3	59.2	3.0	91.4	4.0	2.4	439.9	13.9	193.3	4.4	144.7	0.0	2.2
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase non-receptor type 12"	Q05209	7	77537295-77640069	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		770000	"Cluster 40: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	60.5	30.1	24.2	43.9	26.6	69.9	50.3	29.2	31.6	40.9	25.9	48.9	18.9	38.6	18.6	38.5	39.6	40.2	39.0	25.1	27.3	36.1	30.9	65.0	27.5	28.5	27.8	34.6	20.1	21.0	21.9	74.7	30.5	26.4	27.7	30.9	23.8	33.2	24.6	36.9	29.7	40.2	26.7	52.7	27.1	30.1	32.7	33.9	31.0	44.5	27.5	46.7	39.6	30.2	72.4	43.5	100.6	51.8	69.1	71.7	54.2	73.3	93.0	56.6	80.0	21.6	109.9	8.6	23.2	86.3	123.6	50.2	34.2	73.4	113.3	21.2	19.2	44.9	44.2	88.4	67.7	25.8	28.8	59.0	80.3	123.2	157.6	101.0	121.6	2.1	54.9	12.2	182.6	49.4	3.6	71.9	81.7	97.6	49.2	15.1	80.6	4.5	97.6	38.5	12.5	66.6	90.4	81.5	73.4	172.2	39.5	93.9	89.3	121.4	73.1	45.0	141.3	12.6	7.4	22.2	71.6	65.9	215.7	3.6	4.1	6.8	3.1	2.8	1.3	2.3	1.1	2.6	3.8	1.0	0.6	3.3	9.5	13.3	5.3	0.3	1.6	2.7	24.2	26.6	29.2	31.6	25.1	27.3	28.5	27.8	30.5	26.7	32.7	30.2	139.3	70.5	56.2	30.0	18.2	68.8	60.0	55.9	23.9	16.7	40.9	26.3	41.3	28.6	46.4	20.2	8.4	40.0	89.0	31.2	3.9	42.1	3.5	43.9	62.4	114.4	12.1	16.6	65.8	39.6	58.7	54.6	21.4	87.2	14.5	21.7	119.2	24.6	50.1	35.3	58.0	21.7	28.5	82.0	121.3	6.7	46.6	96.1	35.6	93.7	54.9	66.9	163.7	70.4	67.3	75.0	21.4	47.0	17.6	62.0	10.9	19.2	23.2	15.2	65.7	127.9	66.8	51.2	71.4	29.8	101.4	72.1	27.3	24.4	23.3	104.8
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase receptor type D"	P23468	9	8314246-10612723	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.8"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 4579.7;Inhibitory neurons: 1152.9;Oligodendrocyte precursor cells: 1170.2;Oligodendrocytes: 3151.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.1;HAP1: 4.3;HSkMC: 6.3;RH-30: 8.1;SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.1	0.6	10.8	0.3	24.7	0.1	0.9	12.2	26.2	5.6	0.0	3.3	1.8	2.4	0.2	0.6	2.2	1.0	2.5	14.4	7.2	6.6	3.6	4.6	0.0	14.6	10.1	12.1	1.3	18.7	4.3	5.3	19.1	1.9	2.5	6.4	0.5	0.6	0.9	0.7	5.0	1.0	10.4	0.4	0.9	1.6	17.6	0.7	3.4	0.8	0.0	2.2	3.4	70.8	0.0	0.1	21.1	0.0	0.3	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.7	3.6	0.5	0.0	0.0	0.0	0.1	6.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.6	0.0	3.4	0.0	3.2	2.3	8.1	0.0	1.8	0.0	4.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.7	12.2	26.2	14.4	7.2	14.6	10.1	19.1	10.4	17.6	70.8	0.5	0.0	3.2	199.2	0.1	0.5	0.4	3.2	6.2	134.2	0.3	0.1	6.5	27.1	1.8	5.5	16.7	0.3	0.0	16.4	0.0	3.6	15.8	0.8	15.0	1.2	35.4	0.0	4579.7	0.0	0.3	15.5	0.5	1.0	0.0	9.2	1.4	13.5	1.3	5.0	1152.9	13.2	0.0	0.8	0.0	6.5	15.8	1.6	0.0	85.3	0.1	36.1	0.0	1170.2	3151.1	0.2	9.2	0.0	2.7	2.1	18.3	26.3	0.2	7.8	0.0	4.0	5.8	2.4	3.2	0.4	0.9	0.3	0.8	6.0	8.7	0.1
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase receptor type O"	Q16827	12	15322257-15602175	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.8;kidney: 36.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 193.6;Inhibitory neurons: 231.1;Oligodendrocyte precursor cells: 126.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;NTERA-2: 5.8;SH-SY5Y: 6.1;THP-1: 2.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 175.9"	"Low region specificity"	"Detected in all"			HPA034525	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	1.8	0.8	8.7	3.0	9.4	0.2	0.8	0.0	10.3	1.3	0.1	10.4	1.7	4.8	1.4	0.4	1.0	1.2	0.5	9.8	8.9	36.3	1.3	6.8	3.1	2.2	3.3	0.4	0.4	0.3	2.4	4.4	5.3	0.5	26.8	7.5	0.5	0.8	0.3	0.4	2.0	6.6	0.9	3.4	0.8	0.5	9.5	1.2	0.3	0.5	3.2	1.5	0.4	2.9	0.0	0.1	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.8	1.2	0.0	0.0	0.0	0.0	0.1	0.2	1.5	6.1	0.9	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.0	0.1	1.2	0.0	6.0	0.0	0.0	12.3	0.0	8.9	1.7	0.4	8.5	8.6	2.8	1.2	0.1	0.1	12.7	10.9	1.4	3.2	8.7	9.4	0.0	10.3	9.8	8.9	2.2	3.3	5.3	0.9	9.5	2.9	0.2	0.0	0.5	7.5	7.0	0.3	1.3	0.5	0.0	25.2	0.0	0.1	0.7	0.0	1.8	16.5	0.0	0.2	4.0	3.9	0.0	0.4	0.0	0.8	0.2	1.1	3.6	0.0	193.6	0.0	0.2	0.9	0.0	0.6	0.0	0.0	1.1	0.2	26.1	25.2	231.1	8.3	0.0	21.1	10.6	0.6	0.6	10.5	0.0	17.8	13.8	0.6	1.0	126.7	6.3	0.1	9.8	0.4	1.0	0.1	0.1	0.2	0.0	4.8	0.0	2.1	0.7	0.6	1.1	0.1	0.4	0.3	1.0	0.1	22.4	0.8
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase receptor type Q"		12	80402178-80680273	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"kidney: 7.1;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Club cells: 4.4;Early spermatids: 10.9;Excitatory neurons: 11.2;Late spermatids: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;BJ: 3.9;HBF TERT88: 2.6;RH-30: 2.9;RT4: 3.4;SiHa: 1.9;U-2197: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	3.2	0.0	0.3	0.0	2.0	0.0	0.4	0.0	0.7	0.5	0.0	0.1	0.0	0.0	1.9	0.1	1.6	0.2	1.1	0.2	0.4	7.1	0.0	2.3	0.9	1.0	0.7	0.3	0.3	0.1	0.1	0.1	0.6	0.6	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.8	0.0	0.1	2.7	0.3	0.2	2.9	0.0	0.3	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	3.9	0.8	1.2	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.4	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.7	0.2	0.4	1.0	0.7	0.6	0.8	0.3	0.0	0.0	16.0	1.1	2.0	0.0	0.0	1.9	0.3	0.0	0.1	0.0	0.0	3.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.9	0.0	2.5	1.3	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7
PWWP3B	"FLJ33516, MUM1L1"	ENSG00000157502	"PWWP domain containing 3B"	Q5H9M0	X	106168305-106208956	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"ovary: 189.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 12.2;Cytotrophoblasts: 1.9;Endothelial cells: 1.7;Fibroblasts: 4.0;Syncytiotrophoblasts: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;HHSteC: 1.6;HSkMC: 2.9;LHCN-M2: 5.5;NTERA-2: 2.1;SuSa: 1.5;T-47d: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000168, HPA020464"	Enhanced					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA000168: AB_1079431, HPA020464: AB_1854209"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.12e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (3.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.11e-5)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.53e-2)"	3.5	3.7	4.5	0.0	3.8	0.0	1.0	0.1	7.4	13.7	0.2	0.1	0.0	15.8	9.3	0.3	13.5	1.2	4.3	4.5	12.2	1.4	1.5	0.5	0.0	2.6	8.1	189.9	28.1	0.7	6.1	0.5	5.5	2.4	0.1	0.1	0.2	3.5	10.9	0.2	0.1	3.1	0.5	0.0	1.2	18.0	9.1	0.0	10.3	9.2	0.0	0.3	2.2	3.1	0.0	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	1.5	1.9	0.0	0.0	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	3.8	0.1	7.4	4.5	12.2	2.6	8.1	5.5	0.5	9.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0
PXDNL	"FLJ25471, PMR1"	ENSG00000147485	"Peroxidasin like"	A1KZ92	8	51319577-51809445	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Endonuclease, Hydrolase, Nuclease, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"heart muscle: 45.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 42.2;Early spermatids: 43.8;Excitatory neurons: 25.2;Inhibitory neurons: 68.8;Microglial cells: 16.9;Muller glia cells: 18.6;Spermatocytes: 24.2"	"Group enriched"	"Detected in some"	4	"breast cancer: 1.7;glioma: 0.7;renal cancer: 0.8;testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 7.7;Daudi: 5.9;SH-SY5Y: 6.1"									HPA007919			Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA007919: AB_1855966"	"prognostic unfavorable (3.27e-5)"	"unprognostic (4.59e-4)"	"unprognostic (5.57e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.97e-4)"	1.6	0.1	0.2	0.2	0.1	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.1	9.4	0.2	0.0	0.1	45.3	0.2	0.3	1.6	0.0	0.2	0.3	0.5	0.6	0.1	0.0	0.2	0.0	0.0	0.8	0.2	0.1	2.9	0.3	0.0	1.4	0.2	0.2	0.0	0.1	0.4	0.0	5.0	0.2	0.5	0.3	2.1	0.5	0.0	0.0	0.4	0.5	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.6	0.2	0.3	0.5	0.6	0.8	0.1	0.2	0.4	0.3	0.0	0.0	10.7	0.0	0.1	0.1	0.0	0.0	1.2	3.7	0.1	42.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.9	0.0	43.8	0.0	0.0	0.3	0.0	0.0	25.2	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	68.8	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	16.9	0.0	18.6	0.0	14.1	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.8	24.2	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
PXMP2	"MPV17L3, PMP22"	ENSG00000176894	"Peroxisomal membrane protein 2"	Q9NR77	12	132687587-132704985	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 312.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.3;Hepatocytes: 577.4;Proximal enterocytes: 333.3;Proximal tubular cells: 303.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 85: Liver - Metabolism"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.84e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.04e-1)"	24.8	14.7	23.7	7.5	24.3	23.4	18.7	24.5	29.8	14.3	37.7	49.5	52.1	14.9	22.3	16.2	18.7	15.4	62.9	28.5	24.1	58.2	312.0	12.9	11.5	24.1	24.2	23.0	42.5	14.5	9.3	8.1	22.9	19.8	39.2	7.5	18.6	9.7	42.3	16.8	55.1	9.5	23.0	13.1	98.2	9.1	24.9	25.9	14.7	30.5	10.7	15.9	12.8	23.5	60.5	24.8	36.6	34.1	21.5	16.6	21.4	21.0	19.4	44.7	39.6	30.3	22.4	37.2	24.9	30.0	15.7	42.0	49.1	26.6	24.3	21.3	77.8	33.2	43.9	33.8	41.7	24.8	14.4	21.7	21.8	18.6	14.7	31.2	12.1	56.2	58.2	28.4	23.8	54.2	78.9	39.2	35.7	70.0	33.9	80.1	39.2	30.6	32.9	25.2	69.0	22.5	45.6	23.6	29.6	28.1	63.2	56.0	14.3	21.9	51.1	19.1	35.6	25.7	26.7	60.6	24.6	34.9	17.7	0.0	1.2	2.9	2.3	0.6	2.1	2.5	1.8	2.4	2.1	2.7	1.8	1.5	0.7	1.5	0.6	6.3	3.1	1.2	23.7	24.3	24.5	29.8	28.5	24.1	24.1	24.2	22.9	23.0	24.9	23.5	10.9	3.2	7.2	8.1	8.2	8.4	20.0	10.6	15.4	6.1	50.3	51.1	35.8	138.7	6.0	25.8	4.2	60.1	7.3	187.3	166.3	16.5	18.7	11.8	16.9	14.1	18.7	55.9	5.9	10.3	36.6	17.0	65.7	17.4	4.5	32.4	46.8	577.4	34.9	0.0	7.1	85.1	2.0	19.2	9.4	38.8	31.1	8.1	12.4	5.6	2.7	45.5	13.4	4.5	1.0	10.2	143.4	35.0	20.9	28.1	333.3	303.7	2.1	7.3	19.7	7.5	14.8	44.9	30.2	31.2	10.7	28.5	8.1	12.4	158.6	23.2
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 169.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: AB_2681436"	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (1.09e-4)"	"prognostic unfavorable (3.72e-5)"	"prognostic unfavorable (7.12e-5)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	83.1	60.9	28.7	49.1	30.8	81.4	74.4	27.6	30.5	64.5	33.7	69.0	55.7	56.3	18.7	30.9	72.3	38.2	84.2	28.0	28.5	70.2	29.5	84.6	29.3	37.1	30.8	28.5	34.5	27.8	29.5	73.3	30.3	58.9	49.9	61.8	49.4	40.6	119.2	45.6	61.1	44.5	31.8	72.5	47.5	26.5	36.6	25.9	58.1	46.1	18.4	75.8	53.2	29.2	182.4	87.5	31.3	30.1	60.4	158.1	206.1	151.8	128.6	118.9	61.5	102.5	108.9	12.2	94.6	154.9	115.1	126.0	21.7	272.0	93.0	9.9	18.6	2.3	63.8	37.9	86.8	2.7	3.6	76.5	176.2	125.3	143.9	139.7	211.6	32.2	32.4	19.5	239.3	119.6	11.1	4.1	43.5	77.1	300.8	26.2	51.0	10.8	121.4	171.9	48.7	14.5	133.2	40.3	81.7	72.1	96.1	14.8	289.9	78.9	86.7	103.6	183.9	20.4	12.3	4.6	228.9	27.0	159.2	40.8	44.2	49.2	84.5	15.7	45.3	1.7	38.4	56.0	26.2	1.1	29.5	40.3	169.6	51.8	0.8	4.1	31.4	60.6	28.7	30.8	27.6	30.5	28.0	28.5	37.1	30.8	30.3	31.8	36.6	29.2	93.6	57.7	27.9	11.8	3.0	42.3	40.6	32.8	15.4	7.8	20.3	22.9	14.7	22.8	33.3	42.3	33.3	40.8	61.6	83.1	19.6	31.6	2.1	26.0	16.7	71.0	54.6	6.1	5.1	40.2	152.4	29.7	37.2	28.8	18.3	6.2	62.2	17.2	34.2	11.8	7.7	52.7	24.4	42.3	23.7	2.8	24.2	23.5	26.6	19.7	36.8	9.1	99.9	13.0	9.2	84.8	51.6	18.8	14.5	41.7	56.6	14.6	40.0	33.6	6.6	16.7	12.1	3.5	9.1	8.1	19.5	25.0	34.4	11.3	35.8	42.6
PYGM	GSD5	ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64759974	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	65	"skeletal muscle: 8468.3;tongue: 3594.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.7;Cardiomyocytes: 47.5;Late spermatids: 49.2;Peritubular cells: 44.0;Skeletal myocytes: 64.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 8.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.7;NB-4: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					NA	NA		10000000	"Cluster 10: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	15.2	3.0	35.4	2.1	30.1	1.2	7.7	55.5	29.4	5.8	15.5	25.5	1.5	10.4	6.4	92.2	14.6	3.8	70.8	26.8	26.1	2.4	1.2	2.7	2.2	48.8	30.4	4.0	1.6	0.3	1.7	1.4	39.6	25.6	3.6	2.9	50.0	26.3	8468.3	4.2	7.0	14.7	44.9	3.3	6.9	6.7	47.3	1.3	5.2	3594.2	1.2	16.7	5.2	38.1	0.1	0.0	0.7	0.1	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.6	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.3	0.4	0.1	3.7	0.2	0.2	0.1	0.0	0.0	1.1	0.7	0.6	0.0	1.1	0.7	2.2	0.7	0.1	0.1	0.4	0.7	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.4	0.4	0.3	0.4	0.3	0.0	0.4	0.1	0.0	1.0	1.4	0.4	0.0	0.1	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	1.1	0.0	0.1	0.1	1.3	0.0	0.2	0.2	0.1	35.4	30.1	55.5	29.4	26.8	26.1	48.8	30.4	39.6	44.9	47.3	38.1	2.4	0.0	2.3	29.7	3.0	0.8	0.6	0.2	5.2	3.5	2.9	4.7	47.5	0.0	0.8	0.0	4.2	0.6	1.9	1.0	0.0	0.1	11.7	1.6	5.2	2.0	0.0	0.0	0.2	0.0	0.2	5.1	1.1	4.0	0.0	0.8	1.8	0.0	0.5	0.0	0.2	0.9	0.0	0.6	1.3	49.2	16.4	2.3	0.0	1.0	0.5	9.9	4.1	0.5	0.4	0.3	0.2	44.0	0.3	1.3	0.6	0.0	0.1	1.3	6.6	64.3	12.8	1.2	0.9	2.5	0.6	0.1	2.9	0.9	1.1	0.3
PYGO1		ENSG00000171016	"Pygopus family PHD finger 1"	Q9Y3Y4	15	55538884-55588947	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 23.5;Endometrial stromal cells: 18.2;Inhibitory neurons: 30.4;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-698: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042248	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA042248: AB_10794272"	"unprognostic (5.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-6)"	"unprognostic (3.36e-4)"	"unprognostic (4.84e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.80e-2)"	1.8	2.3	2.6	0.9	3.0	0.2	1.7	7.3	2.3	3.7	2.9	3.2	0.4	5.6	2.0	1.8	2.5	2.3	1.3	2.6	4.6	0.9	0.1	1.9	0.5	3.3	4.5	6.1	1.4	13.2	3.0	2.0	3.1	4.5	1.0	4.5	0.9	4.8	11.7	0.7	0.9	4.7	3.3	0.3	1.4	3.2	4.9	0.4	6.8	9.1	0.4	2.2	1.7	2.4	3.7	6.3	12.2	6.2	4.4	10.0	4.6	7.8	8.9	6.2	7.1	4.5	0.0	0.0	2.4	5.3	8.9	0.0	12.4	0.1	8.3	0.0	3.9	1.8	1.8	0.4	5.9	6.6	0.0	5.5	6.2	5.5	0.9	6.9	3.2	1.0	0.1	0.0	10.3	0.1	0.3	0.0	3.3	0.9	3.4	0.0	14.8	0.0	2.1	2.7	6.5	7.3	7.6	0.0	5.6	1.7	2.3	2.1	0.0	15.8	6.9	0.3	9.5	0.2	0.2	33.6	4.9	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	7.3	2.3	2.6	4.6	3.3	4.5	3.1	3.3	4.9	2.4	0.6	9.6	6.3	23.5	0.0	1.7	5.9	0.1	4.6	5.6	2.4	3.6	6.1	0.0	1.9	9.2	0.0	1.5	0.1	0.0	0.0	0.5	2.9	1.6	18.2	1.1	0.0	0.0	1.8	0.0	0.2	9.3	0.0	1.9	0.0	7.1	1.1	0.0	0.5	0.0	30.4	0.0	0.0	0.6	1.4	2.6	9.9	0.3	7.2	4.7	0.0	7.0	0.0	59.8	1.9	0.5	0.0	12.0	0.0	5.7	0.0	0.2	1.8	4.5	0.0	12.7	6.1	11.6	2.8	1.4	0.9	0.3	0.6	2.0	0.0	0.7
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 23.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 165.9;NK-cells: 324.4;T-cells: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 36.8;T-cells: 97.3"	"Cell line enriched"	"Detected in some"	6	"U-698: 49.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	2.3	0.6	0.2	8.3	0.3	5.5	1.2	0.2	0.4	1.0	0.4	1.7	1.6	1.1	0.8	0.8	0.9	3.8	0.6	0.3	0.4	0.7	3.2	3.7	23.1	0.7	0.3	0.8	0.3	0.2	0.3	0.9	0.6	1.0	2.1	0.1	1.6	0.5	0.3	0.5	5.4	0.7	0.2	13.9	2.7	0.4	0.5	3.7	1.4	0.6	12.5	3.3	0.8	1.2	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.1	0.1	0.0	0.0	0.9	0.0	49.1	0.0	7.7	0.0	1.5	0.3	0.4	97.3	0.4	56.3	14.8	40.8	74.7	0.3	8.7	13.5	45.1	3.5	36.8	0.5	0.6	67.3	21.0	0.2	0.3	0.2	0.4	0.3	0.4	0.7	0.3	0.6	0.2	0.5	1.2	1.3	12.8	2.8	1.0	17.0	0.4	0.6	0.0	0.0	0.5	1.2	0.9	0.6	0.0	2.0	3.7	0.0	0.1	165.9	0.1	0.0	0.1	0.3	0.5	0.3	1.2	0.0	7.4	0.5	0.0	0.0	2.7	2.6	0.2	2.5	0.1	3.9	1.2	2.7	0.0	0.5	0.0	0.0	5.0	1.5	0.3	0.0	3.5	1.8	6.5	2.3	0.5	324.4	0.0	0.2	0.0	0.0	0.0	37.9	0.6	0.0	0.6	5.3	1.1	0.0	0.7	0.7	0.1	0.2	0.1	0.6	0.1	104.7	0.0	0.2	0.4
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease variant, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 752.2;choroid plexus: 301.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 337.6;Muller glia cells: 387.2;Oligodendrocytes: 481.3;Proximal tubular cells: 527.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria		NA	NA		2500000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favorable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	66.6	74.3	515.1	10.2	720.1	15.1	26.4	696.9	571.9	15.8	301.8	21.2	25.6	16.5	40.1	15.6	17.3	17.7	43.4	457.6	578.5	110.1	197.2	23.3	11.9	663.0	752.2	18.3	28.8	49.9	32.7	11.8	688.6	28.7	17.0	40.1	36.3	19.5	108.6	16.2	23.9	17.9	524.9	14.3	23.7	12.4	602.6	13.6	22.1	61.2	13.3	14.5	15.1	663.7	33.1	62.5	30.2	35.8	66.1	32.3	41.5	43.2	22.3	47.5	41.6	52.2	46.4	12.2	28.0	30.3	50.8	18.4	40.3	58.4	33.7	35.3	7.3	34.8	33.4	128.3	37.3	46.2	2.9	40.8	35.6	31.6	40.3	25.9	24.5	33.2	37.0	29.0	50.6	19.2	65.0	77.8	44.8	36.7	45.4	27.0	21.0	52.2	48.2	17.5	47.1	64.3	31.9	6.7	156.6	35.0	15.7	19.0	37.7	23.6	41.1	26.5	38.2	43.1	67.7	85.3	52.0	43.1	41.7	0.3	38.9	3.0	31.3	61.3	29.8	18.6	33.1	32.3	48.3	18.3	37.4	32.6	1.1	29.8	48.4	115.1	20.3	34.4	515.1	720.1	696.9	571.9	457.6	578.5	663.0	752.2	688.6	524.9	602.6	663.7	20.3	28.9	31.5	10.7	14.8	20.0	21.3	32.2	18.8	36.2	37.6	28.3	74.4	50.1	19.5	38.6	8.4	69.6	22.8	13.7	109.5	41.1	1.0	11.8	19.1	17.2	174.3	30.1	23.1	23.4	34.2	27.1	27.5	17.8	25.4	42.3	20.7	337.6	80.3	82.4	21.9	31.1	34.6	38.1	23.9	4.8	22.7	32.2	152.9	12.2	23.4	387.2	16.5	15.1	481.3	16.9	11.6	38.0	23.6	23.2	41.4	527.2	6.2	31.4	26.3	27.5	25.4	3.3	58.9	29.7	16.1	18.3	18.5	90.0	35.7	17.3
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29663279-29698699	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 119.4;liver: 183.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 404.7;Extravillous trophoblasts: 315.1;Hepatocytes: 367.4;Proximal tubular cells: 598.8;Syncytiotrophoblasts: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.2;intermediate monocyte: 5.3;myeloid DC: 5.8;non-classical monocyte: 9.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.8;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 597.1;Hep G2: 258.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011887, HPA076010"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		780000	"Cluster 7: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA011887: AB_2668555, HPA076010: "	"prognostic unfavorable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	8.4	89.4	20.6	4.3	20.2	4.8	6.7	25.8	19.8	50.6	19.4	19.2	61.6	26.1	95.2	4.0	43.6	10.2	26.8	18.5	22.2	119.4	183.5	9.2	6.8	28.6	26.6	31.0	34.5	16.2	5.8	27.3	32.4	7.0	15.2	7.5	13.4	26.1	5.1	5.1	30.3	13.7	23.6	17.2	7.1	4.1	22.8	8.2	6.5	1.2	5.2	10.5	11.5	23.3	0.6	1.4	51.8	56.4	8.8	21.6	167.8	6.0	5.2	8.6	11.0	145.9	91.9	2.3	597.1	10.8	10.0	1.0	18.5	0.6	4.5	0.8	16.7	27.1	2.2	258.0	52.5	4.1	10.4	69.8	1.4	4.8	0.2	12.8	0.2	28.2	75.1	2.9	0.4	154.6	17.6	100.3	162.1	1.9	0.2	89.3	16.3	58.5	47.9	4.2	48.6	103.5	0.0	142.1	118.8	85.1	106.5	112.8	0.6	2.5	24.9	0.9	0.5	1.8	4.9	18.8	4.4	10.4	8.1	0.0	4.2	0.3	0.8	5.3	0.9	0.1	0.6	0.7	5.8	0.0	0.1	0.4	0.8	0.4	9.0	3.1	0.9	1.9	20.6	20.2	25.8	19.8	18.5	22.2	28.6	26.6	32.4	23.6	22.8	23.3	3.1	9.6	24.8	5.2	10.1	3.6	11.7	0.5	1.8	3.3	5.0	2.0	43.2	8.6	3.0	64.4	0.0	404.7	5.8	84.5	50.9	1.2	0.0	93.8	49.5	5.5	28.3	10.5	1.3	55.2	315.1	35.8	0.5	81.0	5.1	6.7	9.7	367.4	147.5	6.7	5.6	47.3	0.0	21.2	18.3	0.5	29.2	19.8	42.7	12.2	4.4	20.8	3.1	11.1	0.5	11.5	78.5	27.1	8.7	4.2	161.0	598.8	1.5	5.0	6.6	3.3	16.2	0.5	3.0	0.2	2.0	215.6	5.7	36.5	104.7	8.3
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44337043-44351238	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"intestine: 2.4"	"Cell type enriched"	"Detected in single"	5	"Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	5	"colorectal cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;OE19: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA070264	Enhanced				"Secreted - unknown location"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"				"HPA070264: AB_2686244"	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425649-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 151.1"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	27.9	32.3	18.0	5.3	18.9	7.0	19.5	21.3	22.6	29.6	7.6	35.1	9.0	31.3	5.5	12.3	27.5	7.4	31.4	21.7	14.0	151.1	37.3	25.2	5.8	14.4	15.8	33.8	47.4	15.9	41.5	6.5	15.2	29.9	3.1	6.1	19.3	7.8	52.2	19.5	27.5	7.1	12.7	26.4	22.2	34.6	16.8	5.3	24.8	15.8	3.2	31.7	19.9	19.0	5.9	14.9	14.6	11.9	20.2	13.2	10.0	10.6	11.6	10.7	7.6	11.5	3.0	15.3	11.0	18.7	8.9	5.5	8.9	13.4	3.9	10.8	14.9	7.9	14.8	31.7	20.9	9.5	8.6	12.7	8.8	11.6	9.9	11.7	17.3	10.7	3.5	6.0	14.4	22.5	10.2	15.9	11.7	5.0	6.8	22.8	10.8	4.6	11.3	4.0	13.8	12.0	11.5	13.6	7.5	5.0	7.6	13.9	29.9	14.8	8.8	13.6	7.0	6.9	6.7	18.8	6.5	5.8	11.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	18.0	18.9	21.3	22.6	21.7	14.0	14.4	15.8	15.2	12.7	16.8	19.0	9.4	3.2	1.7	36.9	3.8	3.7	0.7	1.1	2.2	7.7	3.5	4.3	12.4	7.2	4.3	5.5	6.2	1.0	5.7	5.9	27.4	1.6	1.2	6.4	8.7	7.1	3.0	1.7	73.5	1.2	0.2	5.5	2.0	13.1	1.3	8.4	17.9	15.9	0.8	21.9	60.3	3.0	0.0	3.7	1.6	2.6	0.6	4.7	0.0	19.7	0.6	7.2	2.1	46.8	40.7	1.4	3.9	1.9	3.4	0.9	8.1	384.2	3.1	7.6	6.6	5.3	5.4	4.0	2.8	0.3	2.3	0.8	4.4	6.1	5.9	0.3
RAB27A	"GS2, HsT18676, RAB27, RAM"	ENSG00000069974	"RAB27A, member RAS oncogene family"	P51159	15	55202966-55319113	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Exocytosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 119.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 147.1;Intestinal goblet cells: 252.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 261.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 208.7;K-562: 238.0;Karpas-707: 179.4;SK-MEL-30: 188.3;U-937: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001333, CAB034046"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB034046: AB_2176724, HPA001333: AB_1079730"	"prognostic favorable (2.56e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.23e-2)"	"unprognostic (4.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.32e-1)"	17.5	27.8	3.5	40.2	3.9	100.2	13.9	4.4	4.4	12.9	5.6	53.0	30.0	12.8	5.0	20.6	12.3	17.6	7.7	3.4	6.7	19.2	43.6	42.4	46.0	5.8	5.0	8.0	29.2	11.4	31.4	17.6	5.9	61.2	66.1	4.2	18.3	11.8	3.2	12.8	40.9	25.8	5.0	30.8	119.9	10.0	5.9	19.3	30.5	7.0	46.2	37.5	13.9	5.7	23.0	10.0	9.7	11.3	8.3	38.8	9.5	29.4	32.5	19.2	26.4	7.0	15.6	0.9	22.3	16.0	38.9	16.0	15.7	27.0	18.3	84.9	9.7	5.4	37.6	18.1	56.0	208.7	26.5	34.3	44.2	29.0	71.6	80.7	46.9	26.4	238.0	179.4	20.7	27.7	1.5	57.6	3.6	38.9	14.7	32.4	27.3	50.3	28.7	17.7	14.9	7.1	31.4	15.2	188.3	24.3	13.3	162.2	25.3	52.5	20.3	33.1	33.6	72.0	88.2	6.0	70.2	185.1	19.0	261.3	72.4	99.8	59.2	30.1	58.2	8.0	28.6	61.9	39.0	13.4	13.9	37.4	114.9	34.1	24.0	2.1	36.2	48.9	3.5	3.9	4.4	4.4	3.4	6.7	5.8	5.0	5.9	5.0	5.9	5.7	27.5	76.9	147.1	12.7	18.6	14.1	25.7	19.2	6.2	3.0	16.3	18.3	7.4	15.7	50.1	11.0	2.1	6.3	81.0	18.5	13.7	24.6	2.8	10.1	15.6	32.1	74.3	12.8	12.5	87.6	18.7	16.9	93.3	16.7	31.7	8.8	41.7	41.7	15.6	0.0	12.2	252.0	12.2	33.3	15.2	2.2	7.5	31.1	71.2	10.3	71.9	2.4	104.0	10.1	7.1	62.9	15.9	13.9	38.6	32.3	14.6	6.7	31.3	4.4	19.7	9.4	15.8	9.3	4.6	7.1	15.5	7.5	81.4	4.6	18.4	23.4
RAB29	"RAB7L, RAB7L1"	ENSG00000117280	"RAB29, member RAS oncogene family"	O14966	1	205767986-205775482	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.3;monocytes: 76.4;NK-cells: 129.8;Proximal tubular cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020822, HPA026303"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"CAB020822: , HPA026303: AB_1856016"	"unprognostic (5.38e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (9.50e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.42e-1)"	13.5	14.4	12.5	20.4	14.1	7.1	14.1	14.3	12.1	8.7	10.5	12.6	10.6	8.3	23.8	7.8	6.2	16.9	13.1	12.3	14.3	73.1	19.4	13.5	35.1	15.9	12.9	7.9	9.2	25.5	5.9	7.2	15.8	13.8	10.1	6.8	19.8	13.9	6.4	5.5	12.4	14.8	14.3	24.3	10.4	4.6	15.3	12.1	33.4	6.0	28.0	15.7	5.7	17.0	20.4	18.6	2.8	13.1	52.5	29.8	9.7	14.1	43.2	28.9	34.4	5.6	28.7	21.6	13.6	24.3	34.6	11.2	32.8	37.3	26.4	88.3	15.3	16.4	7.3	9.5	25.4	16.1	23.2	29.0	24.6	23.3	32.8	24.0	37.2	19.8	16.2	24.2	41.2	7.6	17.7	8.3	13.1	25.4	14.0	3.7	43.1	17.5	33.6	27.7	4.4	12.5	10.0	45.0	37.8	10.3	22.0	13.2	38.7	29.7	15.0	43.5	20.6	39.4	87.0	11.5	30.1	26.3	22.5	92.4	22.6	62.3	92.2	43.8	86.9	50.8	51.0	79.5	33.4	45.8	37.2	63.5	8.8	94.1	53.9	10.4	53.3	51.3	12.5	14.1	14.3	12.1	12.3	14.3	15.9	12.9	15.8	14.3	15.3	17.0	16.3	19.2	17.7	11.1	61.2	0.0	6.3	0.0	13.6	2.1	19.5	16.0	19.3	21.5	6.2	31.3	0.0	12.0	82.3	1.9	29.4	18.7	5.1	2.0	6.3	18.6	4.9	10.8	7.8	10.1	6.4	11.2	10.7	3.5	13.3	9.2	14.6	33.7	32.8	0.0	10.2	3.7	0.0	30.1	0.0	4.1	14.3	34.0	0.0	10.3	76.4	26.5	129.8	10.6	9.8	8.3	4.8	20.7	34.8	10.7	9.5	187.7	2.9	2.0	6.6	10.0	6.7	3.8	11.8	9.3	0.0	2.9	51.7	19.7	5.5	6.9
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990700	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 31.0;pituitary gland: 10.6;prostate: 11.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Alveolar cells type 2: 103.2;Enteroendocrine cells: 293.8;Pancreatic endocrine cells: 92.8"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 125.8;BJ hTERT+: 48.4;fHDF/TERT166: 45.8;TIME: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.0	3.0	11.3	0.6	8.6	0.2	0.7	2.9	14.9	0.0	0.0	1.6	0.7	0.1	0.2	0.0	0.2	1.3	0.0	10.9	23.0	0.5	0.7	0.0	0.1	11.4	17.5	1.5	1.0	0.0	10.6	1.6	31.0	11.0	2.3	1.7	0.2	0.1	0.5	1.9	0.9	0.3	2.3	0.1	1.2	0.3	19.5	0.2	0.0	0.0	0.1	0.1	0.1	3.4	1.8	8.5	1.2	1.3	0.2	2.3	0.2	125.8	48.4	24.8	12.0	10.4	3.7	0.6	2.0	45.8	3.6	0.1	15.4	13.0	41.7	0.0	1.1	0.1	0.6	3.4	2.1	0.0	0.1	1.1	0.4	41.1	9.4	15.4	7.8	1.1	0.4	0.4	27.9	0.3	0.1	0.1	19.9	2.4	1.2	0.3	0.2	0.2	4.0	0.8	4.3	1.1	0.1	0.3	0.1	24.6	0.2	0.3	97.9	24.0	8.8	0.5	41.5	0.2	0.6	0.4	21.9	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	11.3	8.6	2.9	14.9	10.9	23.0	11.4	17.5	31.0	2.3	19.5	3.4	1.4	147.4	103.2	0.3	1.1	2.4	6.2	0.3	0.0	5.0	2.2	3.4	0.7	12.8	27.9	0.0	2.1	0.5	0.4	2.0	3.9	4.0	2.4	1.5	1.3	8.2	293.8	0.0	6.6	18.4	0.3	13.9	3.6	1.4	7.6	27.9	0.7	2.7	0.3	0.0	48.1	14.7	14.2	1.3	1.2	1.3	0.6	3.7	1.8	1.0	1.0	31.2	1.0	1.5	1.5	92.8	1.4	1.2	2.3	18.8	1.4	0.2	29.5	3.7	0.0	4.1	4.8	10.4	4.3	0.0	1.4	4.0	3.3	1.1	1.6	2.7
RAB6C	WTH3	ENSG00000222014	"RAB6C, member RAS oncogene family"	Q9H0N0	2	129979666-129982738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;breast: 2.5;parathyroid gland: 3.6"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 10.3;Oligodendrocytes: 3.3"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;prostate cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.5;HMC-1: 2.2;REH: 5.4;T-47d: 3.2;U-266/70: 2.1"									HPA059131	Uncertain		Uncertain	"Golgi apparatus"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 6: T47d - Mammary gland"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (3.84e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.78e-1)"	0.1	0.6	1.4	0.1	2.2	0.0	2.5	0.7	1.9	1.9	0.7	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	1.3	1.6	0.1	0.0	0.0	0.0	1.2	1.2	0.1	0.0	3.6	0.2	0.3	1.3	1.7	0.0	0.3	0.0	0.4	0.1	0.0	0.1	0.0	0.7	0.5	0.0	0.9	1.6	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.5	3.2	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.7	1.9	1.3	1.6	1.2	1.2	1.3	0.7	1.6	3.6	0.1	0.0	0.0	0.3	0.1	0.8	0.3	0.3	0.0	0.0	0.9	0.1	10.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.1	1.7	1.0	0.0	0.0	0.7	0.0	1.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.4	0.0	0.3	0.4	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.0	0.6	0.7	0.0	0.1	0.0	0.0	0.6	1.4	1.4	1.3	0.0	1.1	0.5	0.1	0.1	0.1	0.3
RADIL	"FLJ10324, KIAA1849, RASIP2"	ENSG00000157927	"Rap associating with DIL domain"	Q96JH8	7	4797055-4883716	"Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.1;Early spermatids: 9.2;Horizontal cells: 13.5;Microglial cells: 14.0;Spermatocytes: 17.0;Spermatogonia: 11.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;HEK 293: 6.5;NTERA-2: 7.3;SCLC-21H: 8.9;SH-SY5Y: 19.0;U-2197: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051776	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA051776: AB_2681605"	"unprognostic (6.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.89e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-4)"	"unprognostic (5.10e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.28e-3)"	3.4	0.5	2.2	0.2	1.9	0.0	3.3	11.0	3.6	4.1	0.4	3.4	0.2	3.2	0.2	0.8	3.7	0.7	4.8	1.8	4.0	0.4	0.1	4.5	0.1	3.3	3.7	1.5	3.3	0.3	2.9	2.6	3.4	2.0	0.2	0.3	1.1	1.2	2.8	1.2	1.3	1.0	2.8	0.5	1.3	8.2	2.7	0.2	2.5	2.0	0.1	2.3	2.9	1.7	0.0	2.1	4.4	7.8	0.2	1.9	0.0	1.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.8	1.5	0.0	3.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.7	4.2	0.0	0.4	1.9	0.0	0.0	7.3	0.1	1.6	5.0	0.5	0.0	0.0	0.0	8.9	19.0	0.0	0.0	0.0	1.8	3.2	0.6	0.0	0.0	0.0	6.1	1.9	0.2	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	11.0	3.6	1.8	4.0	3.3	3.7	3.4	2.8	2.7	1.7	1.8	3.2	1.5	10.1	0.0	0.8	0.0	0.0	0.6	2.1	3.4	1.8	2.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.2	1.1	2.6	2.2	0.0	0.0	2.6	1.7	0.0	3.9	0.0	0.1	0.0	0.2	0.4	0.0	0.1	13.5	3.6	0.3	0.0	0.6	1.2	5.1	3.4	1.0	7.2	14.0	0.0	4.7	0.0	7.1	3.5	0.3	0.1	3.8	0.0	0.4	0.0	0.0	1.5	0.9	6.6	4.7	4.1	17.0	11.7	0.0	0.6	0.1	2.1	0.3	0.0	0.0
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 21.9;esophagus: 62.8;skin 1: 21.6;vagina: 27.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 12.4;Early spermatids: 10.0;Late spermatids: 5.6;Respiratory ciliated cells: 14.6;Squamous epithelial cells: 17.2;Suprabasal keratinocytes: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 19.6;HeLa: 24.4;hTCEpi: 19.1;SiHa: 9.9;U-87 MG: 7.7"									HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Focal adhesion sites"	Cytosol	"HPA054022: AB_2797250"	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	3.7	0.8	0.6	0.1	0.4	0.1	1.9	1.0	0.7	21.9	0.8	0.2	0.1	0.3	0.0	62.8	0.8	0.1	0.5	0.5	0.5	2.2	0.1	0.3	0.1	0.4	0.3	0.1	0.1	0.0	0.2	0.5	0.5	0.3	0.3	0.1	12.9	0.3	1.6	21.6	0.1	0.5	0.1	0.9	0.3	0.4	0.4	0.1	0.3	0.2	11.6	1.9	27.5	0.5	1.8	1.0	0.0	0.0	0.2	1.3	0.0	0.1	0.9	0.1	0.3	0.0	4.3	0.0	2.6	4.4	1.4	1.7	0.0	19.6	0.2	0.3	0.0	0.1	24.4	0.0	0.0	0.0	0.0	0.4	19.1	1.0	3.9	0.4	0.1	0.1	0.0	1.3	0.8	0.0	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.3	0.4	0.9	0.2	0.0	9.9	1.5	0.0	0.0	1.2	0.0	1.8	0.8	0.3	0.2	0.9	0.0	0.0	0.0	7.7	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	1.0	0.7	0.5	0.5	0.4	0.3	0.5	0.1	0.4	0.5	1.0	0.0	0.0	0.3	0.0	2.2	1.1	12.4	1.8	0.6	0.3	0.6	0.3	1.5	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	2.5	0.1	1.0	0.0	0.0	0.9	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.3	5.6	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.5	1.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.4	0.0	0.3	0.4	0.0	0.2	17.2	6.5	0.0	0.2	0.1	0.2	1.6
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 19.8;brain: 68.1;kidney: 19.2"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 2828.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			0.1	19.8	31.9	0.2	35.2	0.2	0.1	68.1	40.2	0.0	0.0	0.7	0.3	0.1	0.7	0.0	0.6	5.0	2.3	27.0	27.5	19.2	0.3	0.1	0.1	12.3	17.3	0.0	2.3	0.0	6.1	1.2	22.7	0.2	0.4	9.0	0.6	2.0	0.2	0.2	0.6	0.1	7.6	2.4	0.5	0.4	26.5	0.0	0.1	0.3	0.1	0.1	0.1	28.5	0.1	0.0	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	31.5	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	35.2	68.1	40.2	27.0	27.5	12.3	17.3	22.7	7.6	26.5	28.5	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	38.5	1.0	0.6	5.0	21.5	0.0	7.3	2.1	0.0	0.0	0.0	178.1	1.0	2.2	0.0	0.0	0.9	1.8	0.0	2828.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	33.7	531.4	0.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	68.4	0.0	32.8	0.0	495.6	36.3	0.1	0.0	0.0	0.0	0.0	11.7	19.4	0.0	5.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	4.0	0.1	0.1
RAMP3		ENSG00000122679	"Receptor activity modifying protein 3"	O60896	7	45157791-45186302	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 144.6"	"Group enriched"	"Detected in many"	12	"Adipocytes: 287.8;Endothelial cells: 366.0;Hepatic stellate cells: 555.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"Karpas-707: 2.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 62.2;cerebral cortex: 49.2;thalamus: 174.9;white matter: 60.0"	"Low region specificity"	"Detected in all"			HPA075527			Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA075527: "	"unprognostic (1.62e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (4.85e-2)"	"unprognostic (6.88e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.44e-3)"	"prognostic favorable (2.50e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.21e-2)"	86.9	32.6	17.7	23.0	19.7	0.2	71.7	26.9	22.7	33.5	21.3	24.4	10.2	25.9	3.9	18.9	22.8	28.7	91.3	19.2	25.8	84.1	23.9	144.6	55.0	37.3	25.7	7.4	19.7	28.1	22.3	8.6	34.2	29.7	8.6	1.1	22.1	12.9	19.3	22.8	30.0	24.4	31.6	11.4	25.7	6.3	23.5	7.3	71.9	26.9	30.3	28.5	30.5	42.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	17.7	19.7	26.9	22.7	19.2	25.8	37.3	25.7	34.2	31.6	23.5	42.4	287.8	0.0	1.9	0.3	3.6	16.3	0.3	0.0	2.2	0.6	5.9	2.8	8.7	1.5	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	20.8	0.4	7.3	366.0	0.0	13.5	3.5	0.7	0.1	10.7	0.0	0.2	0.0	0.0	555.4	7.3	0.5	0.0	0.2	0.0	0.0	31.2	19.1	6.7	1.2	1.3	26.6	5.6	0.0	0.2	0.0	0.0	6.5	0.0	0.0	1.2	1.3	0.6	0.0	0.0	0.0	0.5	0.0	2.8	4.9	0.3	0.9	0.9	14.5	0.0	1.7	1.5	0.0	0.5
RANBP3L	FLJ25422	ENSG00000164188	"RAN binding protein 3 like"	Q86VV4	5	36246913-36302114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.9;kidney: 24.6"	"Cell type enriched"	"Detected in some"	7	"Astrocytes: 355.9"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.4;glioma: 3.7;prostate cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037471, HPA037472, HPA061526"	Approved		Uncertain	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA037471: AB_10671756, HPA037472: AB_2675489, HPA061526: AB_2684552"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.52e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.76e-4)"	"unprognostic (1.68e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.71e-2)"	3.8	1.7	25.2	0.3	27.0	0.0	7.6	4.6	29.9	1.2	5.4	0.8	0.2	0.7	1.8	0.5	1.2	1.8	1.5	25.1	12.2	24.6	9.9	2.0	0.2	9.9	18.9	2.1	0.4	0.2	2.9	5.0	7.4	13.5	0.4	5.3	0.6	2.9	0.4	0.4	0.4	0.6	12.6	0.2	1.8	4.7	18.6	0.1	2.2	2.9	0.6	6.9	0.8	15.2	0.0	0.0	0.1	0.2	12.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	27.0	4.6	29.9	25.1	12.2	9.9	18.9	7.4	12.6	18.6	15.2	0.3	0.0	0.0	355.9	0.0	0.0	0.1	0.0	0.6	0.4	4.1	2.3	0.3	0.0	0.0	9.2	0.0	0.0	1.3	0.0	46.9	0.0	0.1	0.1	0.7	0.4	0.0	0.0	5.1	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.4	1.3	1.9	0.0	4.5	0.0	0.0	0.0	0.3	0.8	2.1	0.2	1.8	23.4	0.0	16.1	0.0	5.5	2.8	0.0	0.0	2.2	0.0	1.3	0.0	0.2	0.0	0.6	13.1	0.6	8.3	0.0	0.1	0.0	0.0	0.1	0.0	3.0	0.0	0.1
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 142.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 441.1;Inhibitory neurons: 416.6;Microglial cells: 142.4;Oligodendrocyte precursor cells: 303.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 21.5;SCLC-21H: 8.3;U-266/70: 11.0;U-266/84: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	5.3	45.6	105.0	1.8	113.1	0.2	6.8	69.8	141.6	6.1	49.1	2.1	2.4	5.6	3.1	2.6	3.4	4.7	7.5	142.3	77.7	5.3	34.6	11.4	2.0	61.2	75.0	13.1	4.5	4.0	6.2	2.6	60.8	4.1	1.6	18.8	2.4	3.3	1.5	14.9	2.3	5.4	55.7	0.6	7.7	4.7	128.3	2.2	5.5	1.7	2.0	5.3	3.2	121.9	0.1	0.2	3.2	0.5	0.1	0.3	0.1	1.1	0.7	0.1	0.3	0.0	3.7	0.0	0.2	0.0	0.2	0.7	2.8	0.7	0.3	0.2	5.9	0.6	2.8	0.0	0.0	3.2	0.9	0.1	0.9	0.0	0.0	3.2	3.5	1.6	0.0	21.5	0.1	0.1	0.2	0.2	0.4	1.8	0.4	0.1	0.7	0.0	0.0	6.6	8.3	3.0	0.1	0.1	1.1	1.6	0.1	0.1	1.0	0.1	0.3	0.0	0.3	11.0	23.0	0.0	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.0	113.1	69.8	141.6	142.3	77.7	61.2	75.0	60.8	55.7	128.3	121.9	14.7	3.2	2.8	23.2	1.9	6.1	1.1	0.1	2.8	3.5	5.5	3.9	6.9	0.0	0.0	0.0	45.9	0.1	0.1	0.0	0.0	1.7	2.5	1.2	0.2	32.4	7.8	0.0	441.1	2.7	0.1	4.8	3.1	0.9	0.0	3.3	23.9	11.8	0.1	1.7	416.6	0.5	0.0	1.2	2.1	1.4	4.4	0.2	3.6	142.4	0.0	1.3	0.0	303.1	28.4	1.5	0.1	1.5	1.6	0.5	0.0	0.0	0.0	9.2	0.0	0.4	1.2	0.7	4.1	1.6	3.8	0.1	0.6	4.2	0.1	0.7
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118236-22357154	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 152.1;parathyroid gland: 387.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 504.6;Inhibitory neurons: 193.4;Microglial cells: 138.7;Oligodendrocytes: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 21.1;HUVEC TERT2: 45.0;SCLC-21H: 34.1;TIME: 25.8;U-698: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies"	"HPA057821: AB_2683538, HPA076772: AB_2686814"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	21.0	12.7	30.7	7.0	82.9	0.9	16.4	76.1	58.5	8.9	2.9	9.5	7.5	8.8	4.8	13.9	8.3	16.8	16.8	45.7	46.9	16.7	21.8	37.5	14.3	115.3	71.8	6.5	20.1	387.8	7.4	67.2	107.1	5.1	11.0	4.2	7.6	5.7	5.1	9.2	8.3	12.1	82.0	50.9	7.0	6.4	59.8	15.7	11.7	11.1	10.7	9.3	11.9	152.1	2.8	0.0	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	5.5	1.4	21.1	1.1	0.3	0.7	13.0	2.8	1.9	0.0	0.0	4.2	0.3	0.0	5.4	0.1	0.0	0.1	0.5	2.4	1.3	0.7	0.7	45.0	5.9	4.8	0.1	0.0	1.2	3.0	0.1	3.6	5.4	4.0	5.2	0.0	7.4	4.2	1.9	34.1	9.0	0.5	6.0	0.1	0.7	3.0	0.1	25.8	0.0	1.0	0.4	1.1	10.9	2.5	37.4	0.5	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	82.9	76.1	58.5	45.7	46.9	115.3	71.8	107.1	82.0	59.8	152.1	125.5	9.6	16.5	13.4	3.1	11.0	4.2	2.4	86.0	30.6	8.8	5.5	10.0	15.7	3.8	0.0	0.0	0.3	0.6	16.0	1.9	6.5	61.5	3.3	1.2	70.1	7.2	0.4	504.6	7.0	0.1	5.3	16.3	10.8	8.2	0.1	86.0	6.3	0.2	23.5	193.4	18.3	2.0	3.1	2.0	65.2	1.8	0.9	7.2	138.7	0.0	0.6	0.0	28.1	640.8	5.0	20.3	4.9	12.9	3.0	18.1	0.3	0.5	1.6	85.5	1.4	21.5	1.2	1.6	19.8	11.2	0.3	2.4	1.9	10.1	4.4
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 199.1;skin 1: 237.7;vagina: 113.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Microtubules"	"Cytokinetic bridge"	"HPA022895: AB_1856071"	"prognostic favorable (8.43e-4)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	6.3	4.4	38.4	6.8	36.1	4.4	9.1	12.1	58.3	48.7	1.8	53.8	48.3	4.6	9.9	199.1	6.6	8.8	6.8	55.1	12.9	3.8	10.5	8.0	2.2	12.0	11.4	3.7	7.9	1.1	14.2	2.3	10.9	17.7	44.5	6.1	27.4	6.9	12.6	237.7	40.6	4.0	8.3	7.3	31.8	10.2	15.2	3.3	4.5	2.8	20.7	21.9	113.2	30.6	5.3	2.6	13.7	10.2	1.5	3.3	6.6	1.9	1.4	2.7	3.2	6.0	7.6	4.2	1.9	2.7	2.4	92.4	2.7	3.3	3.8	7.7	6.9	2.5	3.6	6.0	1.7	5.2	8.5	3.9	45.8	2.8	1.3	4.0	4.1	13.9	1.9	2.8	2.1	14.6	4.9	6.3	4.3	26.1	2.6	8.8	1.6	2.6	1.7	27.6	26.2	5.3	3.3	31.2	1.3	11.5	80.7	3.9	7.9	3.3	6.8	3.5	3.2	4.6	4.7	3.4	7.8	3.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	38.4	36.1	12.1	58.3	55.1	12.9	12.0	11.4	10.9	8.3	15.2	30.6	1.9	0.0	1.1	7.5	1.0	45.5	9.7	14.0	13.1	5.7	2.6	3.7	2.4	11.5	10.9	1.8	6.2	0.2	0.7	87.7	0.0	0.9	2.7	5.9	2.1	2.2	4.9	2.7	47.8	0.8	0.3	1.4	32.6	9.4	5.7	1.7	3.9	4.4	0.5	1.7	32.1	31.9	6.1	1.2	5.2	2.2	3.4	1.9	5.4	1.0	2.4	2.9	1.0	8.0	5.0	1.6	44.6	3.8	0.1	10.9	55.3	0.1	6.5	4.4	0.0	2.1	1.9	12.0	15.0	95.4	97.0	0.7	1.1	1.8	44.1	39.2
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464544	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 23.5;intestine: 19.8;lung: 10.6;lymphoid tissue: 39.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 39.4;dendritic cells: 70.9;granulocytes: 39.3;NK-cells: 139.0;T-cells: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.6;HEL: 25.5;HMC-1: 46.7;Karpas-707: 52.5;NB-4: 27.8;RPMI-8226: 23.5;TIME: 35.5;U-937: 34.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	3.7	2.6	2.8	17.3	2.9	23.5	1.9	3.1	3.6	1.8	2.9	4.2	4.5	1.5	0.7	2.8	2.2	3.6	1.4	2.9	3.2	3.7	3.6	10.6	32.8	4.2	3.3	0.9	1.4	1.2	1.5	1.0	3.9	2.8	2.3	0.1	3.5	0.9	0.7	1.5	19.8	1.2	4.1	39.4	5.4	0.5	4.2	23.8	3.8	0.4	19.4	4.2	2.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	30.6	0.0	25.5	0.0	0.0	0.4	20.4	46.7	0.1	0.0	0.0	0.0	0.0	0.2	8.0	0.0	52.5	0.0	0.4	10.9	27.8	0.0	0.0	0.0	3.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.7	35.5	0.0	0.0	0.0	0.0	0.4	10.1	15.1	0.0	34.1	0.1	6.4	2.3	12.9	18.4	4.7	10.7	3.1	11.7	20.4	3.4	3.5	9.7	11.8	3.4	12.4	12.8	4.2	9.2	5.5	2.8	2.9	3.1	3.6	2.9	3.2	4.2	3.3	3.9	4.1	4.2	5.2	4.1	3.2	5.6	0.0	39.4	0.3	0.0	0.3	0.0	0.0	2.0	2.2	2.5	2.8	1.4	0.0	0.0	0.2	70.9	0.0	0.0	0.2	0.7	5.4	0.4	5.4	0.0	7.4	0.1	0.6	0.2	1.0	2.6	0.4	39.3	0.0	3.9	4.6	11.3	0.0	0.1	0.0	0.0	11.6	3.5	1.7	0.0	17.2	0.0	13.1	14.2	0.1	139.0	0.5	0.1	0.2	0.0	1.2	23.7	0.2	0.0	1.5	5.7	0.1	0.0	0.5	1.5	0.4	0.6	0.3	0.6	0.4	76.7	1.0	0.2	0.1
RASGRF1	"CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187"	ENSG00000058335	"Ras protein specific guanine nucleotide releasing factor 1"	Q13972	15	78959906-79090780	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 26.5;lung: 7.5;retina: 7.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010413, HPA041965"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"CAB010413: AB_2238127, HPA041965: AB_10793939"	"unprognostic (2.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-3)"	"unprognostic (5.37e-2)"	"unprognostic (6.16e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.02e-6)"	"unprognostic (2.35e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.81e-2)"	"unprognostic (8.81e-2)"	0.1	0.1	4.2	1.0	4.1	0.0	0.1	24.4	24.4	0.6	0.0	0.2	0.2	0.4	0.1	0.1	0.4	0.1	0.0	12.2	6.4	0.7	0.0	7.5	1.3	13.9	10.2	0.8	2.3	0.6	1.1	0.2	16.4	0.5	0.2	7.4	0.1	0.2	0.0	0.0	1.4	0.1	8.7	0.6	0.2	0.3	14.9	0.5	0.0	0.0	1.4	0.3	0.1	26.5	8.5	0.1	0.1	0.0	0.0	0.0	7.7	0.0	0.4	0.5	1.2	0.0	1.5	0.4	0.2	0.0	0.6	0.7	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	10.4	1.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.9	13.0	0.1	0.3	0.8	0.0	0.0	0.1	1.6	0.7	0.0	1.7	0.0	0.0	15.1	0.0	0.3	0.0	3.8	2.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.1	24.4	24.4	12.2	6.4	13.9	10.2	16.4	8.7	14.9	26.5	0.2	3.2	80.6	8.5	4.5	0.6	0.6	0.2	0.0	13.7	0.2	0.1	1.0	0.0	1.9	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.6	0.4	0.5	0.0	0.0	80.9	0.0	2.7	0.3	0.0	1.8	0.0	0.0	0.0	0.0	2.0	25.2	91.2	0.0	0.0	0.3	16.1	0.0	0.0	1.8	3.6	5.6	0.6	1.1	0.0	1.5	121.5	0.3	0.0	0.4	2.1	0.2	0.0	6.8	2.0	2.5	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.8	0.1	1.6	0.0	0.4
RASGRP3	"CalDAG-GEFIII, GRP3, KIAA0846"	ENSG00000152689	"RAS guanyl releasing protein 3"	Q8IV61	2	33436324-33564750	"Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.4;skeletal muscle: 42.0"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 186.5;Plasma cells: 64.8;Urothelial cells: 106.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 13.9;memory B-cell: 12.3;naive B-cell: 15.2"	"Group enriched"	"Detected in many"	16	"B-cells: 15.2;granulocytes: 13.9"	"Group enriched"	"Detected in many"	7	"Daudi: 88.7;HEL: 92.0;U-266/70: 143.5;U-266/84: 59.1;U-698: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058937			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA058937: AB_2683858"	"unprognostic (2.64e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.82e-2)"	7.8	2.9	17.7	15.1	35.2	4.8	5.3	29.8	21.6	3.7	10.2	4.7	7.3	2.5	1.1	2.4	2.5	6.5	34.2	15.1	20.2	6.5	5.5	7.7	27.9	37.4	27.1	1.0	3.4	6.8	2.4	11.0	34.6	1.6	6.6	1.0	6.1	2.0	42.0	1.8	4.7	4.7	25.0	14.8	7.4	0.9	30.7	4.2	6.7	17.6	33.6	6.7	1.2	56.4	0.1	0.0	0.0	0.0	0.0	0.5	0.2	1.2	0.7	4.3	12.4	2.3	0.5	88.7	0.4	0.7	1.0	0.1	0.0	0.0	1.1	9.0	0.8	92.0	0.6	0.0	1.3	0.4	12.4	0.1	0.0	0.1	0.2	1.8	5.3	0.8	0.3	4.8	2.0	0.0	0.7	7.2	0.4	0.5	0.1	0.2	4.1	0.1	1.0	5.3	0.6	0.0	0.0	0.3	4.6	0.1	0.1	0.4	1.7	0.3	0.3	0.4	0.8	143.5	59.1	38.7	0.2	0.4	0.3	13.9	0.0	0.0	0.3	0.0	0.4	12.3	0.6	0.6	0.3	15.2	0.9	0.2	0.0	0.3	0.1	0.0	0.8	1.1	17.7	35.2	29.8	21.6	15.1	20.2	37.4	27.1	34.6	25.0	30.7	56.4	41.4	0.0	5.8	2.0	46.7	5.4	31.2	0.9	0.0	1.6	4.8	2.8	50.8	1.5	3.7	5.5	0.0	0.5	3.6	1.1	11.7	21.1	1.6	10.0	3.9	57.9	0.0	7.4	4.9	54.6	1.3	4.4	3.6	31.0	17.8	2.4	60.7	6.0	44.5	0.0	3.5	0.0	2.0	9.4	26.1	0.8	0.9	29.1	40.9	34.7	13.8	0.2	0.0	2.5	186.5	44.8	0.1	1.9	64.8	37.0	0.2	14.3	3.9	1.3	0.0	5.5	4.1	1.4	2.1	0.4	3.7	0.5	8.1	3.8	0.4	106.4
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 20.8;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 39.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;HMC-1: 24.0;U-937: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	3.2	0.8	0.3	6.7	0.3	20.8	0.7	0.3	0.9	1.1	0.4	1.2	1.2	0.5	0.1	1.0	1.0	1.9	0.6	0.2	0.3	0.3	0.7	3.3	1.1	0.9	0.4	0.4	1.1	0.3	0.2	2.3	0.6	0.5	0.8	0.0	0.4	0.5	0.8	0.5	1.8	2.0	0.7	8.9	0.9	0.2	1.1	1.1	0.2	1.4	0.7	2.5	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	12.5	13.5	20.1	0.0	15.4	0.0	0.1	0.3	0.0	9.4	0.1	0.0	0.0	39.4	0.0	17.9	0.7	1.4	4.4	0.3	0.3	0.3	0.9	0.2	0.3	0.9	0.4	0.6	0.7	1.1	1.0	0.2	0.0	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.3	18.1	0.0	1.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.7	0.0	0.2	0.4	0.0	0.0	26.6	0.0	1.4	0.0	15.1	0.0	0.4	0.0	0.0	32.9	11.6	0.0	0.0	19.1	1.8	0.0	25.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.1
RASIP1	"FLJ20401, RAIN"	ENSG00000105538	"Ras interacting protein 1"	Q5U651	19	48720585-48740610	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 121.8;Endothelial cells: 83.9;Hepatic stellate cells: 94.2;Theca cells: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 14.7;HeLa: 13.9;HUVEC TERT2: 38.5;SiHa: 21.1;TIME: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077251	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA077251: AB_2732337"	"unprognostic (9.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (7.17e-5)"	"unprognostic (8.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.46e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	24.4	7.0	5.9	2.6	4.3	0.7	21.0	4.4	4.6	9.2	1.4	5.6	2.5	11.2	1.1	5.1	9.9	3.8	18.8	3.6	4.0	12.6	2.6	27.9	2.2	4.9	5.3	4.9	13.2	1.6	4.1	7.9	5.9	5.5	0.7	0.1	4.8	2.7	7.7	6.0	5.7	4.2	4.5	16.8	10.3	6.8	7.3	1.5	10.5	4.0	1.4	7.6	7.7	3.6	10.2	0.1	0.2	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.6	1.1	0.8	2.2	0.0	0.0	2.5	0.2	2.2	0.0	0.0	14.7	0.2	13.9	0.4	2.2	0.0	0.7	2.2	1.2	0.0	0.0	0.0	38.5	1.3	1.3	0.1	0.0	0.9	0.0	1.3	0.3	0.4	0.0	0.2	0.0	0.4	0.0	0.8	6.7	0.5	21.1	0.0	0.0	0.1	0.1	0.0	52.4	0.0	0.4	0.2	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	4.3	4.4	4.6	3.6	4.0	4.9	5.3	5.9	4.5	7.3	3.6	121.8	0.0	1.3	0.0	1.2	6.5	5.7	2.0	0.6	1.1	5.9	10.8	7.3	1.5	1.2	1.8	0.0	0.4	0.7	0.1	0.0	0.7	5.9	3.2	4.8	83.9	0.0	2.7	3.4	0.7	1.9	9.5	2.0	3.8	0.0	6.0	94.2	1.9	0.7	6.7	1.1	0.1	4.1	6.3	3.0	5.2	10.2	1.0	19.6	16.9	0.0	2.1	0.0	1.5	1.5	0.8	0.0	11.3	1.4	10.1	0.2	0.3	2.1	0.7	19.7	1.9	6.2	1.0	11.0	3.7	6.0	0.3	1.0	40.2	0.2	6.4
RASL12	RIS	ENSG00000103710	"RAS like family 12"	Q9NYN1	15	65053337-65076690	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (6.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (1.76e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.17e-4)"	27.9	3.9	32.9	5.1	36.8	0.0	15.7	30.8	24.4	49.8	8.5	35.6	3.6	61.6	27.9	19.2	54.7	13.2	53.4	26.0	38.4	6.9	1.1	38.4	3.3	39.4	57.4	16.5	2.4	1.8	7.0	17.0	38.0	52.5	6.7	3.3	8.0	76.4	37.1	12.1	9.4	33.0	38.8	9.6	7.7	15.6	66.1	0.9	8.4	20.6	1.7	40.2	33.5	32.6	0.1	0.1	0.2	0.0	0.6	5.0	0.2	0.0	0.5	0.0	0.0	14.5	0.1	0.0	22.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	17.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	36.8	30.8	24.4	26.0	38.4	39.4	57.4	38.0	38.8	66.1	32.6	7.4	0.0	0.0	22.5	0.0	1.5	3.9	0.0	0.0	0.3	2.0	5.6	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.7	0.3	12.6	3.6	0.0	0.0	0.1	0.0	0.1	15.2	0.5	0.5	0.0	12.3	1.4	0.1	0.3	0.0	0.1	0.0	2.0	0.0	1.3	3.9	13.1	0.2	0.0	2.8	0.0	17.9	0.0	0.0	0.0	0.1	0.0	57.9	0.0	0.4	0.5	0.0	0.0	0.8	98.6	0.9	55.7	0.7	1.1	0.4	0.1	0.3	0.2	0.4	0.2	0.1
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 77.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.0;monocytes: 258.7;Muller glia cells: 260.3;Proximal tubular cells: 128.0;Skeletal myocytes: 186.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 84.8;intermediate monocyte: 63.9;myeloid DC: 84.2;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 84.2;monocytes: 84.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;RH-30: 162.7;RPMI-8226: 54.9;U-937: 85.4;WM-115: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	35.3	7.1	57.4	21.7	67.9	8.3	22.7	64.3	58.6	6.5	43.8	18.5	13.6	3.0	8.6	4.7	6.0	10.8	44.8	53.9	58.9	77.3	17.1	11.9	19.7	63.4	64.0	3.6	39.5	5.0	13.0	12.7	65.9	7.9	6.0	26.9	16.7	10.9	14.8	4.8	13.8	8.7	55.8	20.1	9.4	9.0	65.3	10.4	40.7	17.6	9.1	11.4	7.0	69.7	1.4	0.3	6.0	11.4	17.9	1.0	4.1	0.7	1.1	2.0	3.5	5.0	0.6	0.1	2.3	0.8	3.9	0.0	2.6	2.8	2.8	37.8	0.0	0.1	0.2	39.7	19.0	2.6	0.0	13.1	0.0	1.9	0.2	10.9	3.0	1.6	0.0	64.3	2.9	0.0	3.0	43.1	1.2	0.2	1.2	8.1	162.7	54.9	0.4	1.2	1.0	0.8	0.0	0.5	2.0	10.7	1.1	32.4	0.0	0.4	3.6	3.0	6.5	0.7	0.7	0.1	18.9	85.4	54.8	0.0	84.8	0.1	8.7	63.9	0.2	0.0	0.6	3.7	84.2	0.0	0.6	2.6	3.0	6.9	37.9	2.2	0.3	48.9	57.4	67.9	64.3	58.6	53.9	58.9	63.4	64.0	65.9	55.8	65.3	69.7	8.9	19.2	17.2	77.4	3.7	3.7	1.4	3.2	1.2	22.5	9.7	7.0	47.9	37.1	13.1	16.5	4.2	1.2	20.3	10.1	17.6	45.3	1.4	6.4	13.7	9.2	11.5	0.0	17.0	3.8	1.2	28.6	1.5	14.8	1.3	4.2	6.1	20.1	157.0	37.0	33.6	7.4	12.2	84.7	94.3	4.4	10.5	91.0	8.8	35.6	258.7	260.3	54.6	37.7	38.2	4.0	11.3	2.2	4.1	1.0	45.0	128.0	5.9	13.3	26.3	186.4	25.9	0.6	1.9	0.8	1.7	2.6	8.0	4.9	15.0	0.7
RASSF5	"Maxp1, NORE1, RAPL"	ENSG00000266094	"Ras association domain family member 5"	Q8WWW0	1	206507531-206589448	"Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 109.3;lymphoid tissue: 83.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 119.3;granulocytes: 140.0;Langerhans cells: 147.7;Macrophages: 78.0;NK-cells: 118.4;T-cells: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 90.9;Karpas-707: 192.6;MOLT-4: 84.1;RPMI-8226: 218.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070480	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA070480: AB_2686271"	"unprognostic (1.92e-3)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.37e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.17e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.28e-3)"	6.8	15.1	3.4	48.1	2.9	109.3	4.9	1.2	3.6	10.8	0.4	8.9	9.1	3.9	1.8	41.7	10.2	18.2	10.8	3.2	2.9	4.3	14.0	26.4	63.4	4.1	4.4	3.6	10.8	8.4	10.3	5.3	4.1	8.1	9.3	1.0	30.3	7.2	14.8	28.8	17.7	6.7	2.3	56.2	17.3	1.4	5.5	83.1	5.7	3.7	60.0	30.3	20.7	4.6	9.3	4.2	0.1	1.6	3.2	1.8	0.0	0.6	4.9	1.7	2.3	0.4	19.5	32.4	2.5	2.1	0.3	13.5	3.5	2.2	1.5	22.4	12.7	35.2	1.0	0.2	1.2	59.1	90.9	2.2	8.9	2.0	2.4	3.2	0.3	76.0	14.4	192.6	0.9	1.1	84.1	37.8	1.8	0.1	3.6	39.4	4.6	218.8	0.1	14.7	4.7	0.3	15.6	1.7	0.6	0.1	3.7	37.5	0.1	0.4	6.4	8.0	2.1	67.7	52.8	30.2	3.0	34.1	1.0	211.8	40.3	268.7	112.3	53.7	99.7	28.4	82.6	117.0	43.9	26.6	112.1	105.8	157.2	131.2	84.0	34.2	78.2	154.7	3.4	2.9	1.2	3.6	3.2	2.9	4.1	4.4	4.1	2.3	5.5	4.6	2.1	38.5	27.9	1.6	64.0	32.8	16.6	8.6	27.9	1.8	7.4	4.4	7.7	15.7	11.3	0.0	0.0	0.2	119.3	1.0	3.9	8.1	0.3	0.5	0.5	4.4	2.4	16.4	19.4	8.9	0.1	11.6	9.2	0.6	140.0	0.1	5.7	6.2	12.1	8.4	16.8	1.0	10.2	49.0	147.7	0.1	7.5	78.0	14.2	6.5	54.2	0.1	118.4	2.0	0.7	8.3	2.6	9.1	41.1	13.7	0.0	0.8	9.6	0.2	0.0	2.1	6.8	0.1	0.6	48.6	27.3	0.1	97.7	0.2	2.1	49.6
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 125.9;Spermatocytes: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 36.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA039890: AB_10794756, HPA052946: AB_2681996"	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	10.1	8.7	6.8	10.0	6.8	18.2	29.4	9.2	11.3	20.9	41.6	14.5	9.3	20.1	23.4	22.1	28.0	12.7	7.0	7.4	9.2	42.2	14.4	13.5	14.0	6.3	7.3	6.4	18.5	22.1	17.5	8.5	6.4	10.8	12.9	6.2	19.5	23.3	2.3	28.5	12.9	16.4	6.2	7.6	13.1	28.7	8.5	32.4	18.2	3.5	17.3	18.3	18.0	7.3	32.9	24.8	36.0	41.9	18.2	19.4	28.2	44.2	31.1	40.3	56.5	45.7	36.3	95.4	19.9	27.9	38.5	67.3	41.2	89.9	78.5	68.3	33.2	41.8	32.0	44.0	22.2	151.5	43.7	13.9	86.0	61.0	105.3	23.6	16.6	65.7	25.0	69.2	41.6	49.1	112.8	50.6	34.2	60.1	41.5	57.6	65.9	58.9	117.4	34.7	84.1	39.8	74.1	22.4	39.0	20.5	129.1	39.4	12.0	107.2	49.3	52.4	78.0	92.9	108.4	105.3	49.1	72.2	58.8	17.0	6.5	3.9	1.2	24.0	0.5	6.6	1.7	2.1	8.2	5.3	0.9	1.5	2.4	7.9	36.7	8.1	4.7	3.8	6.8	6.8	9.2	11.3	7.4	9.2	6.3	7.3	6.4	6.2	8.5	7.3	13.1	35.3	42.8	10.1	22.9	27.4	44.7	125.9	76.8	4.3	22.6	72.6	10.4	35.8	41.9	29.5	4.2	12.7	25.0	14.5	43.0	30.5	17.7	56.0	19.5	14.2	7.7	37.0	20.3	33.0	9.4	13.2	23.0	67.3	66.1	22.3	5.7	16.4	11.7	1.7	15.5	9.3	16.2	11.4	23.5	14.5	6.5	27.5	23.2	8.4	9.0	2.1	4.1	9.5	2.7	44.9	8.6	5.3	53.8	37.5	17.5	26.1	28.2	7.9	0.0	20.4	14.0	116.6	83.4	36.2	19.7	15.2	13.6	9.8	14.9	45.5
RBBP8NL	"C20orf151, dJ908M14.3"	ENSG00000130701	"RBBP8 N-terminal like"	Q8NC74	20	62410237-62427539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 51.2;Intestinal goblet cells: 58.0;Paneth cells: 54.5;Proximal enterocytes: 157.4;Undifferentiated cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.6;CACO-2: 27.5;MCF7: 11.5;SK-BR-3: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (8.99e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.18e-1)"		"unprognostic (1.86e-2)"		"unprognostic (1.27e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.76e-1)"		"unprognostic (2.15e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.91e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.3	1.5	0.0	1.7	4.5	0.1	0.7	9.1	0.7	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.9	2.0	0.4	0.0	3.8	0.6	0.0	4.4	1.0	0.0	4.7	4.7	0.0	0.0	0.0	2.7	2.9	0.0	0.0	3.6	0.0	0.3	1.7	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	27.5	2.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	12.5	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.3	1.3	0.3	0.0	0.0	3.3	2.2	2.7	7.2	1.7	1.8	0.0	6.0	0.0	51.2	0.0	0.3	13.4	1.0	0.0	0.0	9.6	0.0	0.4	0.2	5.1	0.2	2.0	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	58.0	2.0	0.0	0.0	7.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	54.5	0.0	0.0	0.7	157.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	2.6	0.1	0.0	26.2	1.0
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713340	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 73.9;heart muscle: 25.2;skeletal muscle: 95.3;tongue: 45.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 5800.8;Inhibitory neurons: 5921.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Group enriched"	"Detected in many"	10	"basal ganglia: 28.1;cerebral cortex: 73.9;hippocampal formation: 26.6;white matter: 22.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746, HPA075862"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: , HPA075862: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		0.3	1.5	3.7	0.4	28.1	0.5	0.1	2.5	73.9	0.6	0.0	0.8	0.2	0.2	3.1	1.1	1.1	0.1	25.2	26.6	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	1.7	0.5	5.7	2.2	4.1	95.3	0.3	0.2	0.0	2.7	0.0	0.2	1.1	2.2	0.2	0.1	45.3	0.0	0.4	0.4	22.6	0.1	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	25.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.0	0.7	0.1	0.4	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.3	0.2	0.7	0.2	0.1	0.1	0.2	0.0	3.7	28.1	2.5	73.9	26.6	0.0	0.0	0.0	0.0	2.7	2.2	22.6	0.0	0.0	0.5	97.9	0.0	0.0	0.0	0.0	0.0	10.9	0.4	0.0	98.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	6.6	0.3	1.8	0.9	0.0	0.0	5800.8	0.2	0.0	3.5	0.0	0.1	0.0	47.8	0.0	0.0	0.1	0.0	5921.8	0.5	0.0	0.0	0.3	4.9	1.2	0.5	1.8	132.1	0.6	6.6	0.0	597.6	689.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.7	2.8	0.0	17.0	1.2	0.6	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095997	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.3;Inhibitory neurons: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	2.0	1.6	1.2	4.8	2.6	14.5	2.8	8.3	1.8	2.3	0.7	2.8	2.4	2.8	1.3	2.9	1.9	2.0	1.8	1.0	1.9	1.6	1.4	2.2	7.3	2.0	1.9	4.4	2.4	2.6	1.1	3.4	2.2	2.0	3.5	4.0	1.5	1.4	6.9	3.1	2.5	2.8	1.4	3.4	2.7	3.1	2.0	8.8	2.7	7.9	6.7	2.0	2.2	3.4	24.8	15.8	19.4	13.1	4.9	6.4	12.4	28.2	12.6	23.9	24.6	16.8	13.5	27.5	7.9	11.8	14.0	23.8	17.5	18.2	39.7	9.7	9.4	27.2	18.1	14.3	3.0	35.3	18.2	3.0	2.5	31.6	11.1	4.0	13.6	17.9	20.1	25.8	13.7	10.5	33.1	11.7	5.7	12.5	15.3	21.3	57.7	20.9	5.5	12.2	4.6	11.5	30.8	17.6	8.2	6.2	11.3	25.3	9.1	42.0	15.9	38.9	24.8	8.6	16.4	27.7	30.2	24.4	21.1	0.9	0.7	1.4	2.7	0.8	2.3	3.0	3.0	2.5	1.3	2.1	3.2	2.7	0.3	2.2	1.2	3.0	4.5	0.9	1.2	2.6	8.3	1.8	1.0	1.9	2.0	1.9	2.2	1.4	2.0	3.4	3.5	6.4	11.0	10.4	8.7	2.4	1.5	1.7	4.0	5.9	2.5	1.7	2.9	1.5	6.1	0.0	2.1	5.9	6.5	1.8	0.0	1.8	1.5	2.2	4.3	3.3	1.2	23.3	14.7	1.1	5.1	4.6	2.6	2.9	8.8	9.0	2.2	1.4	4.5	3.3	22.8	1.9	0.0	3.0	3.2	0.6	2.1	6.8	1.8	6.5	4.7	3.1	7.2	19.6	18.5	0.9	3.6	3.0	14.1	0.8	1.0	0.7	0.9	12.2	6.6	8.5	4.1	17.5	8.7	5.3	1.3	3.8	11.7	6.4	3.5	0.9
RBM11		ENSG00000185272	"RNA binding motif protein 11"	P57052	21	14216130-14228372	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"epididymis: 45.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Excitatory neurons: 13.0;Inhibitory neurons: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.4;REH: 1.0;SuSa: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045885			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA045885: AB_10963937"	"unprognostic (1.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.44e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.92e-4)"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.24e-3)"	0.2	0.7	2.4	0.3	2.1	0.5	0.4	1.8	2.9	0.3	1.5	0.3	0.2	0.7	45.2	0.6	0.9	0.2	0.6	2.2	2.2	1.2	0.0	0.3	0.3	2.2	2.4	2.0	0.3	1.2	1.6	0.1	2.5	0.5	0.1	2.4	0.4	1.1	0.0	0.1	0.3	0.4	2.2	0.4	0.3	1.5	2.3	0.6	1.1	0.0	0.2	0.4	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.3	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.0	1.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	1.8	2.9	2.2	2.2	2.2	2.4	2.5	2.2	2.3	2.5	0.3	3.2	2.7	2.0	2.9	1.8	6.5	0.7	1.8	7.0	2.8	3.7	0.1	0.0	0.8	1.8	0.0	2.3	1.5	0.2	15.6	2.5	9.3	0.7	0.7	0.8	7.7	0.8	13.0	1.2	0.8	1.5	2.6	0.6	2.5	1.3	0.0	0.0	0.8	5.0	14.7	0.9	2.0	0.0	0.4	5.2	0.6	0.3	0.0	0.0	0.8	9.4	2.1	4.0	6.3	0.8	0.4	0.7	0.3	5.1	0.0	0.8	0.8	4.4	0.0	2.1	2.4	7.2	9.8	2.8	1.1	1.2	1.6	1.8	0.4	5.6
RBM44	FLJ40411	ENSG00000177483	"RNA binding motif protein 44"	Q6ZP01	2	237798389-237842808	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 15.7"	"Group enriched"	"Detected in many"	4	"Spermatocytes: 104.7;Spermatogonia: 59.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003298	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 36: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA003298: AB_2284846"	"unprognostic (1.29e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.01e-5)"	"unprognostic (1.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.89e-3)"	0.3	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.1	15.7	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.3	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.1	1.6	0.4	0.8	0.7	0.3	0.6	0.0	0.8	0.3	0.7	1.5	1.5	1.8	0.0	0.1	2.2	0.0	0.0	0.1	16.8	2.0	0.5	2.4	0.0	0.0	2.4	0.2	0.3	1.0	0.0	4.6	0.0	0.3	0.0	0.2	0.3	0.0	3.3	0.0	0.0	0.8	2.3	16.1	2.8	1.5	1.8	1.9	1.4	0.0	1.0	3.0	0.4	0.6	0.0	1.5	1.0	2.0	0.1	0.1	1.8	0.0	6.6	2.6	0.7	104.7	59.8	0.2	0.6	0.0	0.8	0.7	0.0	1.6
RBMS1	"C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1"	ENSG00000153250	"RNA binding motif single stranded interacting protein 1"	P29558	2	160272151-160493807	"Predicted intracellular proteins"	"DNA replication"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 398.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047943, HPA061791"			Enhanced	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA047943: AB_2797235, HPA061791: AB_2684611"	"unprognostic (2.81e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.16e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (1.33e-7)"	"unprognostic (1.84e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.32e-1)"	58.2	22.6	8.7	43.3	13.3	35.8	34.5	9.7	11.9	36.6	17.2	38.9	12.8	51.7	12.6	28.9	31.6	34.1	41.0	7.2	10.7	36.5	22.3	47.7	28.3	13.8	12.3	44.1	10.2	50.4	16.0	83.8	15.0	24.0	15.8	6.8	19.2	28.6	16.4	29.4	20.5	56.9	10.9	40.7	20.1	10.4	13.4	26.1	23.0	23.8	22.0	57.0	31.6	10.2	50.5	18.2	63.9	8.4	90.2	155.6	77.1	62.7	89.1	42.4	43.8	50.9	36.9	0.4	76.3	106.6	20.0	30.0	31.1	46.0	69.2	40.9	23.2	18.9	44.2	41.0	82.3	30.8	1.1	187.9	35.6	73.7	32.8	56.7	67.5	15.1	1.2	23.0	103.2	39.4	28.8	31.2	39.3	8.3	40.1	21.6	55.7	25.5	64.9	61.1	8.3	21.7	39.1	22.9	60.2	78.8	11.7	47.9	81.7	75.3	47.7	69.7	57.5	12.2	0.7	21.2	60.7	46.2	49.2	4.0	20.5	26.2	8.6	12.0	29.5	0.9	14.9	13.3	13.7	1.9	24.1	10.9	44.4	13.7	6.9	7.6	2.7	11.0	8.7	13.3	9.7	11.9	7.2	10.7	13.8	12.3	15.0	10.9	13.4	10.2	102.8	112.2	97.8	12.1	37.3	91.1	110.0	59.1	55.2	3.0	44.7	43.2	62.3	18.6	48.1	69.9	0.0	99.1	83.9	0.4	25.4	24.5	59.2	39.8	141.4	126.0	0.0	38.3	132.7	47.3	112.6	161.8	36.7	42.0	20.3	40.8	162.8	29.1	126.3	1.7	136.1	0.5	22.4	123.4	80.2	15.5	88.9	103.8	55.2	153.6	81.2	20.8	93.7	116.1	19.7	96.4	1.3	98.9	23.3	107.0	0.3	36.4	54.1	1.4	78.9	113.6	185.9	6.7	14.5	47.3	82.5	398.3	113.0	53.4	0.5	175.5
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521820-56596193	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: AB_10963056, HPA058784: AB_2683819"	"unprognostic (1.35e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.63e-2)"	19.4	7.1	12.5	5.7	11.5	3.6	17.4	9.3	13.1	14.7	15.1	12.9	4.7	13.7	9.3	8.2	13.7	9.5	15.6	9.2	10.0	14.7	3.4	37.3	3.2	14.5	11.7	12.6	7.0	8.6	6.1	23.5	13.4	11.2	8.8	6.0	10.1	8.7	8.4	8.3	9.0	12.1	9.8	10.5	8.5	4.3	15.2	3.5	18.3	10.8	3.9	10.3	13.9	11.7	28.8	24.3	10.5	14.9	23.7	22.7	9.3	34.8	37.0	26.9	23.9	18.7	50.2	0.2	42.1	36.6	11.1	20.4	7.8	57.8	30.1	8.3	6.7	3.7	19.0	4.8	15.4	3.8	6.5	20.9	13.9	28.1	33.5	31.4	51.1	6.1	1.8	6.5	47.0	3.7	4.1	4.9	6.2	0.0	7.5	2.4	11.5	0.3	34.1	6.4	0.8	6.9	39.6	14.9	5.1	22.2	16.0	6.3	78.2	16.7	35.8	9.5	8.4	6.1	2.5	1.7	6.1	0.9	23.6	0.6	4.7	1.6	0.8	1.3	0.9	0.3	0.3	1.2	2.7	0.5	0.9	0.6	1.6	1.0	0.3	0.6	0.5	0.8	12.5	11.5	9.3	13.1	9.2	10.0	14.5	11.7	13.4	9.8	15.2	11.7	74.4	41.7	20.5	34.6	1.5	3.7	9.7	6.8	11.4	4.2	11.4	9.4	7.9	12.8	14.2	12.9	10.4	19.8	7.0	19.7	1.9	23.6	12.6	16.4	16.9	47.9	5.4	3.2	7.2	16.9	38.5	16.9	6.1	21.8	8.2	10.4	52.1	1.0	10.5	8.4	10.0	5.9	4.1	22.7	5.5	24.2	17.4	11.2	0.0	53.4	6.2	5.4	4.1	30.7	9.6	37.8	11.5	24.8	0.8	13.4	1.6	13.4	6.8	1.7	26.3	11.2	15.5	0.9	1.8	5.4	2.0	23.7	2.5	8.7	7.0	17.3
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 1366.7;pancreas: 632.7"	"Group enriched"	"Detected in many"	4	"Granulosa cells: 5988.6;Theca cells: 3228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"SH-SY5Y: 835.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 64.4"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		41000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	23.7	377.1	64.6	18.4	65.2	1.3	49.5	64.9	72.7	53.8	251.4	30.3	32.3	180.2	64.2	35.4	390.2	182.9	60.1	65.5	67.8	46.9	140.8	26.8	18.6	83.1	69.0	1366.7	632.7	46.8	257.8	63.6	64.7	44.8	14.2	23.2	50.2	41.3	15.2	31.3	26.2	119.3	68.2	47.0	29.3	56.1	75.2	9.4	23.0	15.5	12.0	65.7	24.3	67.5	7.8	2.9	7.4	164.2	0.3	0.0	0.9	0.1	0.0	0.0	0.1	0.4	76.1	0.0	53.8	0.1	2.6	0.1	38.2	0.5	0.0	0.1	5.3	0.1	2.7	75.5	155.1	0.2	0.1	3.0	0.0	0.1	0.0	160.9	0.0	0.0	0.2	29.9	0.2	0.0	0.2	0.5	18.4	0.2	0.0	0.1	32.0	0.5	0.1	0.1	19.6	835.4	35.3	0.1	0.1	13.9	3.2	1.1	0.0	0.3	120.0	0.2	0.3	0.6	0.5	0.5	1.3	0.0	2.3	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	64.6	65.2	64.9	72.7	65.5	67.8	83.1	69.0	64.7	68.2	75.2	67.5	24.8	32.1	5.9	8.8	3.5	17.6	53.5	91.9	2.8	26.3	70.4	47.8	21.4	77.2	30.3	23.9	2.1	3.2	1.0	0.1	13.7	1013.0	4.8	199.6	961.4	103.8	43.1	13.5	0.5	1042.7	6.2	158.8	19.9	58.1	0.0	5988.6	343.7	6.9	16.5	3.3	0.3	2.3	42.7	10.6	3.4	16.2	27.1	25.1	8.8	5.6	13.5	159.9	0.0	4.0	16.0	563.0	0.0	4.5	2.9	56.6	2.6	4.7	10.3	7.2	26.3	220.9	534.7	11.6	4.9	6.2	34.9	3.8	10.2	3228.5	2.7	32.7
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7115736-7128889	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 443.5;liver: 324.2"	"Cell type enriched"	"Detected in many"	8	"Proximal tubular cells: 3197.2"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.0;Hep G2: 13.4;K-562: 26.3"									HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	6.4	11.7	0.0	15.0	0.1	1.6	5.1	0.3	0.3	11.2	0.2	8.5	4.6	8.6	3.2	3.8	8.1	5.9	1.4	0.0	0.0	443.5	324.2	3.8	31.2	0.5	0.3	4.9	5.2	1.3	6.2	0.3	0.3	10.0	4.9	0.8	3.7	5.0	0.7	2.4	20.6	5.4	0.0	97.1	5.2	2.2	0.2	14.2	7.9	0.0	21.4	7.4	4.6	0.0	0.9	1.3	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.2	1.1	1.2	1.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	1.6	0.0	6.0	3.9	13.4	0.0	0.2	0.9	0.2	0.0	0.0	0.0	2.4	0.0	0.6	26.3	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.2	1.4	0.9	0.0	0.6	0.5	0.7	0.7	0.6	0.5	2.8	0.4	0.3	0.1	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.5	0.3	0.3	0.0	0.2	0.0	4.9	0.0	0.6	0.7	15.2	1.5	0.5	0.1	0.0	1.2	1.3	1.3	0.1	5.7	0.1	80.9	0.0	0.1	0.3	0.1	352.1	0.2	4.1	0.3	1.7	28.8	0.0	0.0	2.1	0.4	0.0	8.2	0.0	0.5	0.0	0.2	8.9	361.1	0.1	5.0	1.1	0.0	0.0	8.1	2.6	6.7	2.5	16.6	0.0	1.9	0.0	1.4	0.0	0.5	0.1	0.2	0.0	0.4	0.1	0.5	0.0	3197.2	0.9	1.7	0.0	0.1	4.3	0.7	0.4	0.2	2.3	0.0	7.3	2.4	0.1	0.3
RCBTB2	CHC1L	ENSG00000136161	"RCC1 and BTB domain containing protein 2"	O95199	13	48488963-48533256	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	9	"MOLT-4: 278.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040242	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus"		"HPA040242: AB_10795362"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.98e-1)"	12.9	11.1	10.0	12.9	11.2	5.2	10.8	11.1	13.9	15.6	17.4	8.9	5.3	15.0	12.3	13.0	12.9	12.3	12.5	9.5	13.2	16.6	9.5	10.5	11.3	11.9	11.7	19.9	6.8	6.6	13.4	17.7	12.5	13.5	8.0	8.3	23.3	19.9	7.0	5.4	7.2	13.7	13.0	17.4	8.8	7.1	10.8	11.8	27.5	10.8	10.7	11.5	12.4	14.4	1.5	1.2	22.0	1.4	17.1	15.1	0.0	6.8	8.4	4.0	3.0	0.8	1.4	4.7	5.0	10.7	2.7	3.1	3.2	2.8	4.6	5.7	4.3	12.2	3.2	1.2	6.6	5.6	7.4	15.6	6.5	5.3	2.6	9.2	12.3	29.8	0.9	7.1	14.6	0.5	278.7	15.6	12.3	0.5	3.7	23.9	2.2	20.3	7.5	3.7	5.1	4.3	5.3	1.1	8.7	9.1	0.5	14.2	10.3	4.6	2.0	1.2	2.7	0.3	0.4	5.7	2.7	12.5	9.1	4.6	39.8	4.6	14.0	28.8	8.7	1.1	11.4	14.2	27.1	1.1	6.6	10.2	55.0	15.5	27.9	0.5	15.5	20.5	10.0	11.2	11.1	13.9	9.5	13.2	11.9	11.7	12.5	13.0	10.8	14.4	23.1	3.2	3.3	9.1	5.5	6.1	11.6	9.5	21.1	1.9	4.9	9.3	16.1	4.3	9.8	5.5	2.1	1.4	20.7	1.3	7.9	1.2	9.0	5.1	6.6	19.7	8.3	6.1	12.3	0.8	1.4	11.6	2.6	5.0	8.8	9.9	24.7	5.2	25.0	1.7	17.0	2.2	2.0	26.6	24.4	8.1	9.3	30.6	8.8	66.5	38.3	33.7	24.7	6.6	13.2	1.3	1.6	14.3	17.4	6.0	0.7	11.2	6.9	4.9	13.1	14.9	14.1	9.6	4.4	12.6	5.7	1.0	24.0	11.9	2.4	6.7
RDH12	"FLJ30273, LCA13, RP53, SDR7C2"	ENSG00000139988	"Retinol dehydrogenase 12"	Q96NR8	14	67701886-67734451	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase	"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"retina: 222.7;skin 1: 63.8"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 146.0;Rod photoreceptor cells: 453.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (4.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.72e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.92e-1)"	0.1	4.1	1.3	0.1	1.0	0.1	2.2	1.0	1.4	11.0	0.4	0.0	0.3	0.0	8.7	22.1	0.5	17.6	0.0	0.9	1.2	13.6	3.8	0.1	0.0	1.2	2.3	0.0	3.2	0.0	0.9	0.1	1.2	0.5	0.0	222.7	1.7	0.1	0.1	63.8	0.1	0.0	0.6	0.0	12.4	0.1	4.6	0.4	1.2	0.0	1.6	0.0	23.6	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	1.0	1.4	0.9	1.2	1.2	2.3	1.2	0.6	4.6	1.1	0.0	0.0	0.0	0.7	0.0	4.7	0.3	0.0	0.6	39.8	0.1	0.1	0.0	20.0	0.3	1.8	146.0	0.0	0.0	0.1	0.0	0.7	0.2	1.8	1.1	2.2	0.0	0.0	1.2	1.7	0.0	0.4	14.3	1.7	0.0	0.0	0.0	5.7	0.2	20.2	0.9	0.0	0.0	0.6	0.9	0.0	0.3	0.2	1.8	1.0	0.0	53.0	0.0	1.5	0.2	1.5	2.6	0.0	0.0	0.3	0.1	12.5	0.2	453.2	0.0	0.0	0.2	0.0	0.1	4.7	38.6	0.0	0.1	0.1	0.1	0.3
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Steroid metabolism, Vision"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 94.5;liver: 58.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Proximal enterocytes: 49.9;Rod photoreceptor cells: 62.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 28.5;ASC TERT1: 24.3;hTEC/SVTERT24-B: 15.3;hTERT-RPE1: 24.5;LHCN-M2: 15.4;U-87 MG: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	94.5	1.8	2.2	4.1	2.5	1.0	34.2	2.2	2.6	2.5	3.5	13.6	18.5	4.2	7.8	3.1	4.6	4.2	9.2	2.0	2.2	9.0	58.9	1.9	1.8	2.7	2.5	2.1	3.5	0.3	1.7	0.6	2.4	4.4	4.4	3.2	3.3	2.2	6.1	2.7	15.5	19.5	2.5	2.2	5.9	2.4	2.8	0.9	2.7	7.6	0.7	5.5	2.2	3.4	0.7	1.4	0.8	0.5	28.5	24.3	0.6	3.8	4.2	0.7	1.4	0.5	7.9	1.0	0.7	2.1	0.2	0.3	0.3	0.1	0.6	1.0	1.3	0.1	2.0	2.1	0.8	0.1	0.3	10.5	1.0	15.3	0.1	24.5	0.3	0.5	0.2	1.3	15.4	0.7	0.4	0.2	0.3	3.7	2.3	0.6	0.4	0.5	0.2	0.8	0.2	1.1	0.2	0.5	3.4	0.2	0.7	0.6	0.5	1.5	1.5	1.1	0.9	1.1	0.5	0.2	26.7	0.4	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.5	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.5	0.0	0.0	2.2	2.5	2.2	2.6	2.0	2.2	2.7	2.5	2.4	2.5	2.8	3.4	2.5	9.6	2.2	0.0	4.6	1.9	4.5	3.9	0.6	24.3	2.7	5.0	3.9	10.0	2.4	1.8	62.6	2.2	5.3	23.5	1.9	2.1	0.8	1.8	2.9	3.7	11.5	0.0	0.0	2.6	1.2	3.9	11.2	1.5	0.0	4.9	3.6	18.4	0.6	16.8	0.0	10.3	0.0	4.5	7.9	2.3	13.4	2.3	5.4	0.0	4.7	8.2	12.3	0.0	0.0	3.6	18.6	6.8	0.7	3.2	49.9	13.0	4.7	62.9	13.1	14.0	9.3	3.9	6.4	0.8	1.7	1.5	4.8	5.3	15.9	3.1
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1491166-1497927	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 217.5;liver: 398.0;testis: 283.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 559.1;Late spermatids: 3135.0;Proximal enterocytes: 898.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 57.9;Hep G2: 56.2;K-562: 155.7;T-47d: 121.4"									"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA048015: AB_2680233"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	8.4	86.5	11.1	1.3	12.4	1.2	17.5	10.1	18.0	5.6	7.7	3.0	217.5	3.5	14.6	14.3	4.6	7.0	3.9	12.7	8.8	22.1	398.0	1.6	1.3	9.7	10.1	7.7	28.5	2.0	9.8	1.6	9.9	20.1	1.7	94.0	17.9	6.8	2.0	9.3	199.6	0.9	8.4	1.7	4.2	283.9	12.1	0.7	6.0	0.7	1.0	9.2	7.0	10.9	7.3	9.2	2.6	34.3	5.6	2.0	39.5	1.8	0.7	1.9	1.9	57.9	22.5	3.9	12.2	1.1	2.3	7.3	9.8	0.6	1.0	1.9	4.1	21.3	1.3	56.2	4.2	1.6	6.6	4.7	4.1	0.4	1.4	3.2	1.1	4.9	155.7	5.0	0.3	29.6	1.8	4.7	12.8	21.1	19.5	4.9	1.1	10.0	10.9	2.7	0.7	17.2	9.8	14.2	6.3	1.9	121.4	5.7	3.4	2.8	5.4	8.7	1.2	16.4	5.3	0.8	11.2	9.4	8.2	0.0	1.1	0.0	5.5	1.2	2.8	0.1	1.4	1.2	1.9	0.6	2.0	2.2	0.0	4.9	4.3	3.3	1.6	1.6	11.1	12.4	10.1	18.0	12.7	8.8	9.7	10.1	9.9	8.4	12.1	10.9	1.5	3.2	3.2	2.6	2.7	6.8	7.9	6.8	10.8	30.4	47.4	20.3	1.8	91.5	10.5	5.5	33.3	69.4	2.5	7.8	7.9	34.5	559.1	4.5	7.1	4.2	6.0	10.1	1.5	69.2	12.8	4.7	2.6	3.0	10.2	132.9	5.0	267.4	9.6	23.5	1.2	51.9	4.1	6.3	4.3	3135.0	34.2	4.1	30.2	0.0	1.7	44.2	2.1	0.0	1.5	25.0	53.6	16.6	1.9	13.1	898.7	52.0	8.3	292.8	19.7	0.8	3.3	29.9	36.5	17.5	6.7	36.0	4.3	50.1	70.7	14.7
RENBP	"RBP, RNBP"	ENSG00000102032	"Renin binding protein"	P51606	X	153935269-153944687	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.0;lymphoid tissue: 67.0"	"Cell type enhanced"	"Detected in many"		"granulocytes: 127.7;Hofbauer cells: 183.4;Kupffer cells: 70.7;Proximal tubular cells: 204.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 57.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 2.7;monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.5;HMC-1: 121.4;SK-MEL-30: 86.4;U-266/84: 74.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000428, HPA000522"	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000428: AB_1079799, HPA000522: AB_1079798"	"unprognostic (3.08e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-2)"	"unprognostic (3.29e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.39e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.51e-2)"	22.2	19.2	14.6	13.5	18.2	10.9	11.1	16.0	20.6	5.0	12.3	13.8	8.4	3.9	2.5	2.9	5.6	6.2	11.5	14.6	18.8	43.0	5.3	24.6	16.5	18.4	19.8	1.7	1.8	2.1	6.0	10.3	18.0	3.8	4.2	2.2	5.8	2.0	2.2	9.7	13.9	4.7	15.2	67.0	5.9	1.2	19.4	6.2	5.4	0.1	6.3	6.2	4.5	19.6	0.0	0.0	3.3	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	35.5	0.0	0.1	0.0	7.1	0.0	0.0	0.0	1.5	28.2	0.0	2.3	20.4	0.0	121.4	0.8	0.0	0.0	0.0	0.0	0.0	1.0	8.2	10.3	0.0	0.6	7.5	0.3	0.4	0.3	0.0	13.6	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.0	86.4	3.0	0.3	9.9	1.3	0.0	0.8	0.0	0.1	12.5	74.8	5.0	2.5	13.3	9.8	1.7	0.9	2.7	0.1	0.7	0.1	0.4	0.0	0.0	0.1	0.2	0.4	0.2	2.0	0.1	1.6	0.3	0.0	0.5	14.6	18.2	16.0	20.6	14.6	18.8	18.4	19.8	18.0	15.2	19.4	19.6	1.9	0.0	2.2	7.2	8.0	4.7	1.3	0.3	0.6	2.4	0.4	0.6	1.0	2.8	0.4	9.2	0.0	1.3	2.6	0.4	37.2	1.4	0.1	0.1	0.5	10.7	1.8	3.0	0.2	0.4	6.0	4.5	0.0	0.3	127.7	1.3	52.1	0.8	183.4	15.2	1.7	1.0	0.0	70.7	13.3	0.4	0.3	49.2	28.4	6.5	40.7	10.7	8.2	0.5	6.2	0.5	5.3	0.4	4.0	1.4	12.3	204.2	0.2	0.8	13.1	2.2	4.9	0.1	1.4	0.4	2.0	2.9	7.5	0.7	0.7	0.6
REPS2	POB1	ENSG00000169891	"RALBP1 associated Eps domain containing 2"	Q8NFH8	X	16946658-17153272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 117.9;Inhibitory neurons: 142.7;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 204.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 13.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"basophil: 5.8;eosinophil: 4.5;neutrophil: 14.3"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.2;Karpas-707: 11.7;RH-30: 8.4;RPMI-8226: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000565, HPA026073"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA000565: AB_1079800, HPA026073: AB_1856176"	"unprognostic (6.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.70e-3)"	"prognostic favorable (5.36e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.56e-4)"	2.4	11.1	7.6	1.2	9.4	3.0	3.3	2.4	29.1	15.9	1.6	4.3	2.1	4.2	12.6	1.3	2.1	2.1	1.6	11.2	9.2	11.0	7.6	4.6	0.5	2.4	4.4	4.0	10.3	9.4	6.0	2.6	3.4	8.2	4.6	9.3	5.1	7.8	0.9	0.9	2.0	4.2	0.9	1.2	6.3	2.1	9.3	0.7	2.0	1.3	0.6	1.8	0.9	12.5	1.4	0.6	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.1	0.2	0.1	5.2	0.0	0.6	0.0	3.9	0.2	1.1	2.8	0.5	30.2	0.6	0.0	0.7	0.0	0.7	0.0	0.1	5.3	0.9	0.0	4.7	4.9	1.6	0.0	0.0	11.7	0.3	1.4	0.0	0.4	0.2	4.3	0.9	0.0	8.4	9.4	0.3	2.8	4.2	0.3	2.2	2.1	1.7	1.7	3.9	0.2	0.2	0.0	0.2	0.1	0.4	0.5	0.0	0.4	0.0	0.4	0.2	5.8	0.3	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	14.3	0.0	0.2	0.3	0.0	0.1	7.6	9.4	2.4	29.1	11.2	9.2	2.4	4.4	3.4	0.9	9.3	12.5	11.7	32.1	13.5	6.5	0.9	0.6	9.6	4.4	1.2	49.5	7.9	5.5	6.6	4.3	8.8	14.7	0.0	0.2	1.5	10.4	1.9	3.0	0.2	7.1	4.0	2.3	9.5	4.4	117.9	14.6	9.1	4.1	9.7	9.6	0.0	7.9	4.2	15.1	4.2	38.7	142.7	7.8	0.0	5.7	6.4	0.9	9.3	6.6	1.8	21.5	4.9	0.9	0.0	84.9	204.0	7.9	5.1	12.8	1.3	10.6	2.3	11.6	2.7	2.6	0.0	0.8	2.0	0.7	2.6	0.9	1.3	0.7	0.5	16.3	10.2	6.5
RFFL	"CARP-2, CARP2, fring, rififylin, RNF189, RNF34L"	ENSG00000092871	"Ring finger and FYVE like domain containing E3 ubiquitin protein ligase"	Q8WZ73	17	35005990-35089319	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 119.5;Karpas-707: 112.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008096, HPA017910, HPA019492"	Approved		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles		"CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190"	"unprognostic (2.59e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.73e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.26e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.36e-1)"	9.9	7.1	23.9	17.7	59.5	41.4	12.2	49.2	38.0	11.9	11.6	26.7	28.1	9.6	8.8	35.9	9.3	19.4	8.2	24.3	36.4	17.7	48.3	12.6	17.6	74.2	53.0	8.5	18.8	12.1	6.8	11.9	71.2	18.3	23.2	21.1	13.1	12.7	15.8	7.5	22.8	13.3	48.6	19.2	23.3	26.6	52.2	26.0	39.0	13.1	29.4	20.3	16.2	93.8	22.9	43.4	10.7	15.0	21.6	28.1	6.1	15.6	25.8	15.5	18.7	15.4	50.5	7.0	19.4	21.4	33.0	32.2	18.4	30.8	22.4	119.5	11.2	40.5	11.0	38.6	18.0	20.2	20.0	19.0	18.8	23.7	46.9	22.6	15.6	21.2	18.2	112.2	16.0	8.7	4.9	19.4	15.2	51.1	24.9	17.3	18.7	43.2	22.8	48.6	12.0	15.8	8.9	10.3	9.1	24.4	15.9	27.7	29.7	8.6	14.9	8.7	24.1	41.4	33.0	9.4	36.4	15.8	7.4	28.6	16.2	33.7	16.8	9.3	20.6	7.8	18.5	16.3	10.8	6.9	16.0	14.5	55.3	14.4	9.9	1.3	29.6	15.5	23.9	59.5	49.2	38.0	24.3	36.4	74.2	53.0	71.2	48.6	52.2	93.8	6.5	41.7	27.4	0.0	12.6	6.0	11.9	7.4	5.2	10.6	9.9	3.8	1.3	20.0	17.3	0.0	14.6	9.4	12.1	33.7	1.9	8.4	41.0	13.0	6.8	6.6	15.0	23.8	0.0	15.1	1.7	9.3	23.0	18.1	25.3	5.4	9.3	35.2	7.2	6.7	0.0	26.4	6.1	16.3	16.9	109.1	3.1	16.1	1.8	0.0	22.6	20.8	25.7	0.0	0.0	16.8	19.3	4.5	12.9	28.1	16.7	20.4	11.7	34.9	6.6	15.2	5.7	15.9	10.8	16.2	6.1	5.1	23.7	3.1	18.9	39.5
RFLNB	"Cfm1, FAM101B, MGC45871, RefilinB"	ENSG00000183688	"Refilin B"	Q8N5W9	17	439978-445939	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.3;Endothelial cells: 51.1;Hofbauer cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 201.5"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 201.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 95.5;HMC-1: 222.1;NB-4: 74.8;U-937: 64.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030879, HPA060388"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Cytosol"	"HPA030879: AB_2673643, HPA060388: AB_2732649"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-3)"	19.8	5.9	2.4	7.4	2.5	77.9	15.6	2.3	2.8	8.7	10.1	13.7	3.2	10.1	3.5	3.1	7.1	4.6	12.8	3.3	2.2	8.6	3.5	13.3	5.4	2.5	2.4	5.7	3.5	3.9	4.3	10.4	2.2	9.5	1.9	1.5	4.1	2.8	7.9	6.3	9.6	6.1	2.7	10.5	8.6	3.7	2.4	16.7	8.2	3.9	4.8	11.8	5.4	2.1	30.5	8.0	4.0	18.9	13.0	9.4	20.8	48.8	21.4	15.8	7.7	0.5	1.1	0.0	1.2	95.5	7.0	3.0	11.2	1.1	14.5	0.2	6.5	1.3	1.5	2.2	19.0	11.4	222.1	5.2	0.3	5.0	1.9	6.1	16.0	4.8	4.7	0.3	18.1	0.4	0.6	74.8	8.6	0.8	0.3	3.2	8.6	0.0	2.9	0.1	0.3	43.6	19.8	0.0	17.6	14.9	0.4	34.7	3.2	12.4	11.0	7.5	0.1	7.1	7.7	0.0	0.2	64.1	19.5	201.5	6.9	80.7	6.1	5.4	6.2	0.1	6.1	5.2	2.1	0.1	9.7	8.7	35.5	2.2	7.3	9.1	4.3	3.8	2.4	2.5	2.3	2.8	3.3	2.2	2.5	2.4	2.2	2.7	2.4	2.1	101.3	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.1	7.4	0.0	0.0	1.8	1.8	0.0	0.8	16.5	0.0	0.0	1.1	0.0	2.3	1.9	51.1	0.0	0.0	0.0	0.9	1.2	9.2	0.0	6.0	1.3	12.5	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.9	0.0	0.0	0.5	1.5	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.5	10.7	4.2	0.0	0.0
RGMA	RGM	ENSG00000182175	"Repulsive guidance molecule BMP co-receptor a"	Q96B86	15	93035273-93089204	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.3;skeletal muscle: 199.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 26.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012343, HPA039880, HPA044222"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		2000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861"	"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (4.72e-3)"	"unprognostic (2.53e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.59e-4)"	"unprognostic (8.11e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.98e-5)"	30.2	3.2	62.1	22.5	73.8	0.4	30.3	72.5	59.1	55.9	7.7	79.4	9.9	50.9	2.9	57.4	39.9	7.7	29.4	60.4	68.0	3.6	0.6	4.6	2.4	126.3	113.9	38.5	11.4	0.8	6.9	1.3	70.4	12.8	6.2	1.0	24.2	6.4	199.1	17.1	42.9	60.6	91.5	1.3	73.6	33.5	120.6	2.6	10.0	45.0	3.4	10.0	29.2	62.8	2.1	0.3	50.0	0.8	10.3	5.7	14.6	0.3	0.0	0.0	0.0	0.6	0.6	0.1	0.2	0.4	0.0	3.4	8.4	0.2	0.0	0.0	9.2	0.1	0.3	0.0	0.0	0.1	0.2	6.1	0.2	0.0	0.0	0.3	0.0	0.9	0.0	0.1	0.0	1.0	15.5	0.2	22.2	0.1	0.0	13.1	11.4	0.1	0.0	0.5	5.1	3.0	0.5	0.2	0.0	2.6	4.0	2.7	0.0	0.1	10.4	0.3	0.1	0.1	0.0	0.2	0.2	0.2	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	62.1	73.8	72.5	59.1	60.4	68.0	126.3	113.9	70.4	91.5	120.6	62.8	4.2	0.0	1.5	143.3	0.5	5.5	20.4	10.2	40.5	1.9	7.5	4.4	4.4	0.0	3.9	0.0	2.1	4.4	0.5	0.3	0.0	6.5	1.2	0.6	10.9	2.7	0.0	0.4	16.8	0.7	1.2	40.5	1.5	2.3	0.0	0.6	1.8	0.3	2.1	0.0	2.8	0.0	12.2	2.5	2.3	6.4	119.0	1.6	3.6	9.4	0.6	4.5	0.0	11.1	1.6	0.4	0.0	116.9	0.1	61.3	0.0	0.1	1.3	1.2	13.1	69.3	20.3	0.9	43.8	58.3	2.8	2.5	1.4	0.1	0.1	29.2
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 184.7;liver: 383.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Granulosa cells: 67.8;Hepatocytes: 175.7;Muller glia cells: 54.5;Peritubular cells: 69.6;Proximal tubular cells: 174.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 21.7;fHDF/TERT166: 6.9;Hep G2: 32.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		280000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	7.8	184.7	19.2	0.7	20.8	0.0	3.4	23.0	19.9	12.2	25.9	8.4	13.2	7.2	4.5	3.2	5.4	5.0	13.9	19.0	20.2	56.7	383.7	18.9	1.0	21.6	19.8	21.4	34.0	5.8	8.8	12.1	20.7	13.4	2.1	8.0	14.4	17.3	11.8	1.5	13.6	4.4	21.3	3.7	11.9	3.5	19.3	0.5	18.9	11.3	0.5	7.6	6.0	21.2	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.4	0.8	0.0	0.0	21.7	0.0	0.0	1.1	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	32.8	1.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	20.8	23.0	19.9	19.0	20.2	21.6	19.8	20.7	21.3	19.3	21.2	0.6	6.4	3.6	16.3	0.6	0.5	4.9	0.2	1.8	9.6	2.4	7.0	27.5	8.6	0.7	14.7	0.0	0.1	0.0	0.2	58.7	13.9	0.4	3.4	7.4	2.4	4.8	2.7	10.8	8.9	0.3	11.2	3.1	0.5	0.0	67.8	11.4	175.7	0.1	5.0	4.9	0.2	0.0	5.3	1.2	2.1	24.8	1.2	1.8	4.7	0.0	54.5	0.0	27.2	13.7	5.0	1.2	69.6	0.7	1.1	0.2	174.4	1.7	3.1	13.1	22.3	11.3	0.2	0.2	0.5	0.3	0.3	0.7	14.5	0.7	1.3
RGPD8	"RanBP2alpha, RANBP2L1"	ENSG00000169629	"RANBP2 like and GRIP domain containing 8"	O14715	2	112368369-112434488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 16.2;hTEC/SVTERT24-B: 13.4"									"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-3)"	"unprognostic (3.17e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-2)"	4.3	1.8	2.7	2.8	3.6	10.6	4.5	8.6	7.6	2.8	4.5	2.1	1.6	3.1	5.4	1.4	2.2	2.9	1.8	3.7	3.5	2.4	5.1	3.3	2.4	2.2	2.4	3.2	3.0	2.2	2.6	3.3	1.9	2.6	2.3	7.9	2.5	2.9	1.7	3.8	2.1	2.6	1.1	3.0	1.7	15.6	2.6	3.2	2.4	2.2	3.0	2.6	1.6	5.5	6.1	2.6	4.3	2.6	1.6	3.6	0.1	2.4	1.9	2.3	1.5	5.3	0.4	0.0	1.7	4.0	2.0	2.9	12.3	1.7	2.4	8.7	4.0	16.2	4.5	4.1	2.2	0.1	0.2	0.6	2.2	13.4	3.4	5.7	1.9	2.8	8.4	0.4	3.6	2.5	8.7	2.1	3.0	0.9	3.7	0.0	0.5	0.1	1.3	2.5	2.7	0.5	8.1	0.1	1.7	3.0	1.2	6.8	8.9	1.3	1.8	6.9	4.4	0.0	0.0	0.0	0.5	2.9	0.3	1.3	0.4	0.4	1.0	0.3	1.4	0.5	0.7	0.9	0.4	0.6	1.0	0.6	0.3	0.5	0.8	0.7	0.4	0.3	2.7	3.6	8.6	7.6	3.7	3.5	2.2	2.4	1.9	1.1	2.6	5.5	1.0	9.6	3.6	1.6	2.8	0.4	0.4	0.2	5.2	0.8	0.3	0.3	8.0	1.5	1.9	0.0	2.1	0.2	0.7	0.1	0.0	0.5	24.3	0.6	0.5	1.5	0.0	2.5	9.8	1.1	0.1	2.2	2.6	0.6	5.1	0.6	0.7	0.2	0.4	0.0	7.0	0.4	0.0	0.6	0.8	10.1	0.3	2.0	0.0	9.4	2.3	0.4	0.0	7.5	5.2	0.9	0.0	0.0	2.4	0.0	0.0	0.1	6.7	0.7	0.0	0.9	0.9	6.8	2.7	2.7	0.0	0.4	3.1	0.0	0.0	0.3
RGS1	"1R20, BL34, IER1, IR20"	ENSG00000090104	"Regulator of G protein signaling 1"	Q08116	1	192575763-192580024	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 1398.7;Hofbauer cells: 390.4;Langerhans cells: 1133.6;Macrophages: 860.4;Plasma cells: 902.4;T-cells: 748.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 25.7;T-reg: 21.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 25.7;T-cells: 21.9"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 962.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 85.5"	HPA074572	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA074572: "	"unprognostic (3.68e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.37e-1)"	"unprognostic (3.87e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.91e-5)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.56e-2)"	34.7	88.2	18.2	170.3	17.4	151.6	57.9	22.1	77.4	50.7	42.2	75.4	24.7	19.2	5.2	68.3	22.8	112.8	31.4	14.6	43.7	19.9	59.9	78.9	142.9	39.1	21.7	14.3	19.1	25.6	40.0	22.2	27.9	50.7	112.7	26.6	56.0	13.8	2.9	17.9	72.7	44.9	29.3	74.6	36.6	8.5	25.3	154.2	23.9	5.1	90.7	127.7	39.3	46.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	4.3	0.0	0.0	2.8	4.6	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	220.6	0.0	0.0	0.4	5.6	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	962.6	4.1	3.5	0.0	0.1	0.2	0.0	0.0	25.7	0.8	0.1	1.9	0.0	5.1	4.5	0.7	0.0	0.4	3.7	0.1	0.7	0.1	4.9	21.9	0.7	18.2	17.4	22.1	77.4	14.6	43.7	39.1	21.7	27.9	29.3	25.3	46.7	10.8	12.8	103.2	0.0	170.6	49.2	6.9	0.3	5.7	0.7	11.7	18.7	1.2	4.3	13.2	0.0	0.0	2.1	148.8	1.4	0.0	1.4	1.8	1.7	2.0	32.7	4.8	16.4	0.0	2.8	2.8	15.4	47.4	2.5	1398.7	0.0	5.3	3.8	390.4	0.0	0.0	1.6	0.0	211.2	1133.6	7.4	3.1	860.4	250.8	7.5	333.9	0.9	2.1	0.0	0.0	0.2	3.5	0.7	902.4	3.7	1.3	1.2	11.3	1.9	19.7	2.0	8.5	0.4	1.2	3.5	40.2	6.0	748.2	0.2	4.0	8.3
RGS5		ENSG00000143248	"Regulator of G protein signaling 5"	O15539	1	163111121-163321791	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Sertoli cells: 5114.5;Smooth muscle cells: 1592.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 226.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1303.0;OE19: 692.4;SH-SY5Y: 4234.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001821		Supported	Supported	Vesicles,Cytosol		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	Vesicles	"HPA001821: AB_1079806"	"unprognostic (3.75e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.31e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.81e-3)"	"unprognostic (7.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.41e-1)"	138.1	312.4	75.5	29.7	87.2	0.1	58.4	84.2	136.5	160.5	73.1	95.7	64.5	73.7	63.1	71.8	65.5	142.7	238.2	65.9	90.7	88.1	34.1	55.5	33.8	95.6	89.1	19.5	30.6	83.3	45.4	19.9	108.2	75.1	42.9	15.3	27.8	190.0	116.5	21.8	75.8	278.0	68.8	16.7	93.5	40.5	99.6	21.2	164.7	236.8	39.4	136.1	60.5	83.7	0.4	0.0	62.9	8.0	1.3	3.0	2.6	1.1	4.4	2.0	1.3	5.3	1.6	0.5	9.2	1.1	0.7	0.4	0.8	0.8	3.3	3.0	1.0	1.3	0.9	0.1	2.6	0.8	0.7	2.0	1.9	2.1	2.6	14.3	1303.0	0.3	0.2	1.2	4.7	0.0	0.9	2.2	38.7	692.4	1.4	0.4	0.1	3.6	0.7	0.0	5.2	4234.9	0.9	0.0	1.5	185.8	0.0	1.3	5.3	1.0	2.3	0.9	2.0	1.5	1.2	0.4	1.4	0.2	2.9	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.2	0.1	0.2	0.4	0.4	0.1	0.2	0.1	0.0	0.2	0.1	75.5	87.2	84.2	136.5	65.9	90.7	95.6	89.1	108.2	68.8	99.6	83.7	458.3	3.2	5.6	61.4	1.7	17.1	6.0	1.0	0.6	1.8	9.8	12.1	0.0	0.0	7.3	1.8	4.2	1.5	2.4	0.3	1.9	1.0	32.7	3.4	11.6	353.7	0.0	0.0	24.4	1.1	0.8	43.0	223.3	8.1	1.3	0.9	0.0	0.0	1.2	0.0	60.5	0.2	0.0	0.0	26.3	17.0	6.8	11.9	23.2	80.6	0.6	2.6	0.0	25.1	69.7	3.9	0.2	2.6	0.4	12.7	0.2	2.5	5.9	5.8	5114.5	44.9	1592.3	5.7	1.7	5.2	12.6	1.2	5.8	5.5	0.2	7.0
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775514-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.0;brain: 28.1;retina: 12.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 288.3;Excitatory neurons: 1353.2;Inhibitory neurons: 1095.0;Oligodendrocyte precursor cells: 615.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 6.2;HaCaT: 5.3;hTERT-HME1: 7.2;RH-30: 6.4;SH-SY5Y: 5.6;U-2 OS: 5.9;U-251 MG: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 6: Brain - Smell perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.0	8.0	11.6	0.0	13.5	0.0	0.1	18.9	28.1	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.4	0.0	15.9	8.6	2.4	0.4	0.1	0.3	2.5	3.8	0.4	0.5	0.2	2.8	0.0	6.8	0.1	0.1	12.8	0.0	0.5	0.0	0.1	0.1	0.0	2.6	0.2	2.9	5.3	6.4	0.0	0.0	0.0	0.2	0.0	0.0	13.9	0.9	0.0	0.0	0.0	0.2	0.7	0.0	2.5	4.8	6.2	0.4	0.0	0.0	0.0	0.3	3.3	3.4	5.3	0.0	0.0	3.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.5	0.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.3	0.3	0.2	0.0	6.4	0.0	0.0	0.0	5.3	5.6	0.3	0.2	0.2	0.2	0.0	0.0	2.6	0.0	5.9	0.3	7.2	0.0	4.1	0.0	0.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.6	13.5	18.9	28.1	15.9	8.6	2.5	3.8	6.8	2.6	6.4	13.9	0.0	0.0	0.0	288.3	2.8	0.0	0.1	0.0	0.0	29.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.1	2.3	0.0	3.5	0.2	7.2	0.0	1353.2	0.0	0.0	0.5	1.5	0.1	0.0	10.0	0.4	0.4	0.1	62.2	1095.0	0.4	0.0	0.0	0.3	4.1	0.0	0.1	0.0	29.0	0.0	1.0	0.0	615.8	86.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.7	6.3	10.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1
RGS7BP	R7BP	ENSG00000186479	"Regulator of G protein signaling 7 binding protein"	Q6MZT1	5	64506015-64612319	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 122.5;Inhibitory neurons: 170.6;Oligodendrocyte precursor cells: 67.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 26.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HUVEC TERT2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039600	Approved		Uncertain	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039600: AB_2676591"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (8.59e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.81e-3)"	"unprognostic (1.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.50e-3)"	1.9	3.2	3.2	0.5	12.2	0.0	0.5	1.0	26.0	4.0	0.0	0.6	0.9	2.3	3.7	1.7	7.8	1.7	2.6	7.2	1.2	2.0	1.0	1.4	0.3	0.2	3.3	2.4	0.2	0.1	0.8	0.0	0.0	5.3	0.7	4.8	1.8	7.4	0.1	0.3	1.0	1.4	0.0	0.7	0.8	0.8	10.2	0.0	0.3	1.0	0.1	0.9	0.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	12.2	1.0	26.0	7.2	1.2	0.2	3.3	0.0	0.0	10.2	5.0	0.4	0.0	0.0	5.5	0.1	0.0	0.1	0.1	0.6	6.5	0.7	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.1	5.1	4.6	0.0	2.7	122.5	0.0	0.0	0.8	0.0	4.7	0.0	0.1	23.2	0.1	0.0	0.0	170.6	0.0	0.0	0.3	0.0	1.9	7.2	0.1	0.0	12.2	0.0	3.6	0.0	67.8	6.4	0.0	0.0	13.9	0.0	0.1	0.0	0.2	2.2	2.1	6.6	0.1	13.2	0.3	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.2
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675671-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.6;Excitatory neurons: 30.1;Inhibitory neurons: 27.1;Ionocytes: 18.3;Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8;MCF7: 9.2;U-266/70: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711"	"prognostic favorable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	0.8	5.0	9.2	0.4	9.7	1.0	1.0	9.1	17.7	2.0	0.0	2.2	2.4	1.0	0.6	1.2	1.6	0.4	2.4	7.9	6.1	4.1	2.0	1.1	0.4	5.5	4.8	2.1	2.6	0.6	8.3	0.3	4.9	2.7	0.3	2.1	2.4	0.9	0.5	2.6	2.5	0.2	3.2	0.9	2.7	4.2	7.4	1.4	0.9	0.0	0.1	1.5	1.5	7.7	1.7	2.1	1.2	1.8	0.9	2.3	6.1	0.7	1.1	0.4	0.1	4.4	1.2	0.6	1.4	0.4	0.2	1.1	0.1	0.3	0.0	1.5	7.7	0.8	9.8	1.8	0.8	1.6	1.1	1.6	2.8	0.3	0.0	0.9	0.1	2.8	1.3	1.2	0.1	9.2	0.4	4.4	1.1	2.3	0.6	7.6	1.1	1.6	0.1	1.5	1.5	2.0	0.9	0.4	2.2	0.7	3.2	4.5	0.5	2.5	2.2	0.8	0.6	10.5	1.5	2.2	0.9	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	9.2	9.7	9.1	17.7	7.9	6.1	5.5	4.8	4.9	3.2	7.4	7.7	0.6	0.0	0.0	15.3	2.8	2.2	3.8	10.3	12.5	17.6	2.5	4.2	0.9	0.0	2.4	0.0	12.5	0.2	0.3	2.7	0.0	0.7	2.7	1.4	1.1	0.3	2.4	0.0	30.1	0.5	0.2	1.1	3.1	1.0	0.0	1.9	0.4	0.7	0.3	15.2	27.1	6.1	18.3	0.9	1.2	1.4	1.5	0.4	0.0	1.9	0.2	2.9	0.0	10.6	4.1	1.4	3.8	2.6	0.9	1.6	17.3	9.9	10.8	31.8	0.0	0.4	1.2	1.5	1.7	1.4	1.8	0.3	0.6	3.0	5.5	2.8
RHBDL3	"RHBDL4, VRHO"	ENSG00000141314	"Rhomboid like 3"	P58872	17	32265832-32324659	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 23.0;heart muscle: 13.8;retina: 26.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 41.8;Excitatory neurons: 46.8;Horizontal cells: 102.6;Oligodendrocyte precursor cells: 75.9;Rod photoreceptor cells: 34.2"	"Cancer enriched"	"Detected in some"	4	"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;AF22: 4.7;AN3-CA: 3.8;GAMG: 5.5;HDLM-2: 6.0;NTERA-2: 6.5;U-2 OS: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059607	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA059607: AB_2684081"	"unprognostic (7.70e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.87e-2)"	0.4	5.1	9.4	0.4	10.6	0.1	0.4	14.1	23.0	2.2	3.4	0.8	0.2	1.6	0.7	0.5	2.3	0.2	13.8	13.6	9.6	0.6	0.0	0.3	0.1	14.2	19.0	2.2	0.5	0.8	2.9	0.2	15.9	1.6	0.5	26.1	0.3	3.0	0.1	0.3	0.4	0.7	12.1	0.1	0.7	2.0	11.6	0.2	0.3	0.1	0.2	2.3	1.8	14.8	0.0	4.6	4.7	3.8	0.7	0.0	0.1	0.2	0.5	1.4	1.7	0.0	0.0	0.0	0.2	0.5	5.5	0.0	1.2	0.0	0.3	6.0	1.5	0.8	3.1	0.2	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.2	0.0	0.3	0.5	0.0	0.3	0.1	0.1	0.0	6.5	0.0	0.0	0.8	0.0	0.0	0.0	2.6	0.1	1.3	0.6	0.1	0.1	1.5	0.3	0.0	0.0	0.0	4.4	0.2	2.2	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.6	14.1	23.0	13.6	9.6	14.2	19.0	15.9	12.1	11.6	14.8	0.6	0.0	0.0	41.8	0.0	0.4	0.5	0.0	0.0	12.1	0.8	0.6	7.4	0.0	0.0	0.0	6.2	1.5	0.1	0.0	0.0	0.1	3.2	0.3	0.2	0.7	0.0	0.0	46.8	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.4	0.0	0.4	102.6	15.2	0.4	0.0	0.3	0.3	2.4	0.9	0.1	0.0	4.7	0.0	7.4	0.0	75.9	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	34.2	0.0	0.1	0.5	0.1	1.2	0.0	0.1	0.5	0.1	0.0	0.0	0.6
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein"	Q9H310	1	156369211-156385219	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 9.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 89.9;Theca cells: 91.3"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in single"	17	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.8	1.9	0.0	0.0	0.1	0.0	2.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	19.6	0.3	10.3	0.3	0.0	0.1	0.0	0.0	0.2	0.6	0.1	1.3	0.0	0.1	0.0	89.9	0.0	10.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.4	0.0	0.0	91.3	0.0	0.1
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496589	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 4022.4;vagina: 1728.8"	"Cell type enriched"	"Detected in many"	21	"Squamous epithelial cells: 1544.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.8;hTCEpi: 2.0;RT4: 1.2"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 8.4"	"Low region specificity"	"Detected in some"			"HPA041874, HPA043317"	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	1.3	2.1	5.3	0.0	5.4	0.0	0.8	4.9	6.9	823.5	3.9	0.5	0.0	0.6	0.0	4022.4	0.7	0.7	1.4	5.1	4.9	117.4	3.4	0.3	0.0	4.8	4.9	0.8	3.2	0.0	4.3	0.0	4.8	3.4	0.0	2.5	593.6	0.8	1.0	14.6	0.9	0.3	5.1	0.6	3.5	1.3	5.0	0.8	0.5	0.0	461.7	3.7	1728.8	5.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.4	4.9	6.9	5.1	4.9	4.8	4.9	4.8	5.1	5.0	5.2	0.0	0.0	0.0	2.0	0.3	1.3	28.9	22.9	6.2	1.0	0.9	0.5	0.7	0.0	47.6	14.7	0.0	0.0	0.0	0.6	15.6	1.5	2.0	0.0	0.1	0.7	0.0	0.0	6.0	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.0	0.0	0.7	1.4	0.0	1.5	0.0	0.0	0.0	64.4	0.0	4.0	0.3	0.7	4.8	0.0	0.0	34.8	0.0	0.0	1.6	2.8	0.0	0.0	5.4	1.5	0.1	1544.7	17.8	0.0	0.3	0.0	0.2	70.5
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.8	13.9	5.6	4.1	6.6	0.9	7.1	5.2	7.8	15.7	5.3	8.1	6.6	14.5	2.4	3.0	10.9	11.5	13.5	4.6	4.7	30.8	6.8	10.6	2.8	6.1	6.1	10.2	9.2	8.6	3.2	37.1	6.3	7.7	4.8	24.3	2.1	9.9	144.2	3.6	5.6	12.1	4.9	14.9	20.8	15.1	7.6	1.9	3.3	19.6	1.2	7.4	7.5	7.8	0.2	12.0	17.8	0.0	8.3	7.3	0.0	5.3	4.8	4.3	6.4	0.6	0.2	0.0	21.9	28.0	2.0	0.3	5.3	1.6	5.0	0.0	4.8	1.1	8.8	67.3	9.0	1.4	0.4	10.6	3.0	2.6	2.7	16.5	20.6	3.8	10.2	0.0	19.1	0.4	5.2	0.0	7.7	0.2	7.9	4.5	24.9	6.4	14.1	0.7	4.9	19.0	6.3	6.9	6.9	11.1	1.4	2.4	18.5	8.2	21.1	0.2	5.9	0.0	0.0	0.0	4.1	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	5.6	6.6	5.2	7.8	4.6	4.7	6.1	6.1	6.3	4.9	7.6	7.8	13.7	16.0	8.7	3.6	1.0	1.8	1.0	0.5	0.6	3.4	3.7	2.5	29.5	1.5	2.3	1.8	135.5	66.1	0.2	0.7	1.9	3.8	75.2	11.0	14.7	13.6	8.3	3.8	74.3	16.0	3.4	8.6	34.1	4.5	0.0	59.0	17.9	9.6	11.3	334.8	23.1	7.7	4.1	21.5	1.4	35.3	8.1	14.1	1.8	57.1	0.4	16.0	0.0	14.1	155.5	16.4	2.5	4.9	0.1	1.2	1.5	36.4	10.2	25.1	6.6	16.7	11.8	2.8	1.4	0.6	1.4	302.4	0.8	15.2	4.3	0.4
RHOJ	"ARHJ, FLJ14445, RASL7B, TCL"	ENSG00000126785	"Ras homolog family member J"	Q9H4E5	14	63204114-63293508	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.0;Astrocytes: 176.0;Endothelial cells: 72.5;Hepatic stellate cells: 41.4;Microglial cells: 35.6;Oligodendrocyte precursor cells: 43.2;Skeletal myocytes: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 63.8;HUVEC TERT2: 375.4;TIME: 100.9;WM-115: 106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003050	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003050: AB_1079812"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (3.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-3)"	19.6	3.3	12.5	8.5	14.6	0.1	17.4	10.8	16.9	12.9	8.5	14.2	7.5	27.9	17.3	15.5	18.5	25.3	17.9	14.0	11.1	11.7	4.2	21.5	9.6	10.9	11.0	14.2	4.4	3.5	6.4	9.3	11.0	11.8	10.7	5.5	8.4	13.8	7.9	7.6	9.8	31.4	8.3	12.6	9.3	2.8	14.5	3.1	13.8	13.4	4.9	19.7	9.4	13.0	0.0	0.0	63.8	0.0	0.0	0.0	0.0	10.6	42.6	3.6	6.2	0.0	0.0	0.0	5.9	0.8	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.3	0.0	0.1	8.0	35.8	375.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	5.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	14.6	1.1	0.1	0.0	100.9	0.1	1.1	0.8	6.1	0.0	0.0	0.0	0.0	0.0	106.5	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	12.5	14.6	10.8	16.9	14.0	11.1	10.9	11.0	11.0	8.3	14.5	13.0	41.0	0.0	1.3	176.0	0.3	5.9	0.3	0.1	0.0	0.3	1.2	5.2	3.8	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.5	0.3	6.7	72.5	0.0	0.0	11.1	0.9	0.0	31.0	0.0	0.3	0.0	0.5	41.4	0.5	0.1	0.0	2.2	0.0	0.0	1.9	7.7	1.6	11.8	1.0	3.6	35.6	0.0	11.1	0.0	43.2	0.4	0.1	0.0	16.1	2.5	0.6	0.0	0.0	0.0	0.4	6.6	34.6	17.0	0.1	0.4	0.9	4.8	0.1	0.6	6.9	0.0	1.4
RHOU	"ARHU, CDC42L1, DJ646B12.2, fJ646B12.2, FLJ10616, hG28K, WRCH-1, WRCH1"	ENSG00000116574	"Ras homolog family member U"	Q7L0Q8	1	228735479-228746664	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 119.2;Endometrial stromal cells: 100.4;Extravillous trophoblasts: 91.5;Oligodendrocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 99.2;MOLT-4: 46.5;RT4: 43.3;THP-1: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049592	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"			"HPA049592: AB_2680827"	"unprognostic (7.90e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.26e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (3.56e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-2)"	29.2	11.1	21.9	5.6	34.2	8.4	16.5	25.9	39.8	17.0	14.6	15.2	23.6	13.8	5.7	6.1	18.9	16.8	12.2	21.8	24.9	11.4	26.0	13.8	3.8	28.6	31.3	25.6	18.6	13.8	7.3	17.5	27.1	17.8	9.9	2.3	18.5	10.4	37.3	6.2	23.9	8.5	25.4	15.4	22.5	9.5	31.9	4.7	13.7	5.0	1.1	18.3	8.9	41.5	1.0	2.5	7.9	0.6	1.8	0.9	99.2	0.5	0.9	0.6	0.4	11.0	14.8	0.0	5.8	1.3	0.5	0.6	2.9	0.0	0.5	16.0	5.6	0.1	0.7	3.4	11.0	8.1	0.9	0.5	0.8	0.2	0.5	0.1	0.2	4.0	0.0	0.0	0.5	2.5	46.5	8.5	2.5	13.5	0.9	0.2	2.5	1.3	0.4	43.3	2.9	8.7	0.9	6.7	0.0	16.9	0.0	29.9	0.7	0.1	1.2	0.0	0.1	2.3	10.6	0.0	0.0	20.5	5.2	0.0	0.3	0.4	0.4	0.5	0.8	0.0	0.3	0.6	0.4	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.0	0.1	21.9	34.2	25.9	39.8	21.8	24.9	28.6	31.3	27.1	25.4	31.9	41.5	76.4	16.0	16.4	16.6	0.7	4.6	3.6	0.5	0.0	4.5	27.4	18.9	77.3	38.6	15.6	1.8	0.0	25.9	5.1	82.1	0.0	4.7	0.7	119.2	100.4	28.9	3.0	3.2	13.6	8.9	91.5	28.9	20.4	83.7	0.0	56.8	30.7	40.8	21.9	8.4	6.9	10.3	4.1	28.3	38.6	3.1	1.8	29.9	16.0	5.6	15.1	5.5	1.0	24.6	139.5	5.1	35.7	1.2	1.9	23.0	64.3	1.2	21.0	0.9	0.0	21.5	10.2	1.5	2.8	0.3	3.3	33.9	5.9	1.2	9.6	18.6
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 496.2;liver: 1536.9"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1579.1"	"Group enriched"	"Detected in all"	5	"liver cancer: 162.2;renal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 191.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					NA	NA		5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	50.1	48.4	93.1	11.4	96.4	7.5	19.1	95.5	131.7	11.2	83.8	24.5	30.5	8.4	22.7	14.3	9.4	22.7	32.3	89.2	95.0	496.2	1536.9	9.5	10.1	91.6	97.8	23.4	27.0	24.6	10.0	10.8	95.5	19.3	24.6	26.6	16.4	11.6	40.0	10.6	21.8	10.8	92.6	7.4	24.8	17.2	100.0	11.2	15.9	41.0	12.3	15.5	7.9	91.0	44.0	37.5	29.3	36.6	65.5	50.4	33.0	39.7	28.0	26.4	31.0	51.4	28.4	62.5	49.6	29.4	34.5	30.8	65.4	56.9	52.5	22.3	28.6	45.0	25.6	55.6	29.9	17.6	7.0	44.4	19.5	36.6	39.9	32.4	34.2	65.3	82.7	12.9	35.5	57.8	35.6	50.1	47.0	191.4	67.8	41.0	21.7	18.4	64.6	31.6	32.2	15.7	25.5	17.4	29.2	37.4	44.5	23.5	20.9	20.6	12.5	33.7	16.3	31.2	46.1	30.9	35.0	39.0	13.2	0.2	9.0	5.6	6.6	7.8	8.7	13.8	9.4	10.1	11.1	11.5	12.0	13.0	1.9	10.3	8.3	8.5	13.9	8.1	93.1	96.4	95.5	131.7	89.2	95.0	91.6	97.8	95.5	92.6	100.0	91.0	7.8	25.6	22.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	13.8	15.1	0.0	0.0	1.8	47.8	0.0	31.1	3.2	0.0	285.7	19.7	0.0	25.1	12.3	5.0	0.0	0.0	0.0	8.5	29.9	7.9	0.0	9.4	2.5	17.7	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.8	0.0	0.0	1579.1	5.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	14.4	6.3	22.3	0.0	0.0
RIN1		ENSG00000174791	"Ras and Rab interactor 1"	Q13671	11	66330241-66336840	"Predicted intracellular proteins, RAS pathway related proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 26.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 25.7;Basal squamous epithelial cells: 23.3;Squamous epithelial cells: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 9.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 44.3;U-2197: 40.7"	"Low region specificity"	"Detected in many"							HPA035491	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear membrane"	Nucleoplasm	"HPA035491: AB_10601608"	"unprognostic (1.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (9.34e-7)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.82e-3)"	"unprognostic (2.46e-1)"	4.8	4.3	3.7	2.3	4.9	1.1	4.4	3.3	5.7	8.3	1.5	5.2	2.7	4.4	0.2	20.4	5.6	1.4	3.4	6.3	1.6	4.3	1.3	4.9	0.5	1.0	1.2	3.7	5.2	0.4	7.2	1.4	1.1	7.1	1.0	0.2	5.1	0.8	7.5	26.6	4.3	0.6	0.8	6.1	6.8	3.7	2.0	0.5	2.4	0.5	0.4	5.4	11.3	2.6	2.3	5.7	2.3	5.3	2.8	14.5	1.2	13.7	18.0	14.4	6.8	3.3	9.3	0.5	5.0	13.6	5.2	12.9	0.0	24.3	1.8	1.1	0.0	0.8	4.4	4.1	5.5	0.1	4.2	15.9	44.3	12.4	8.0	17.1	2.8	0.6	0.3	0.1	6.1	0.5	0.3	11.0	0.6	3.9	12.6	0.1	5.4	0.1	3.9	3.0	10.9	2.3	3.2	2.5	20.5	0.6	1.8	1.3	6.5	18.7	7.9	40.7	3.3	0.3	0.9	0.0	26.9	3.5	6.3	0.1	2.7	0.0	0.2	4.7	0.6	0.1	0.4	0.2	1.7	0.0	0.5	0.2	0.0	0.1	9.7	0.0	0.1	1.8	3.7	4.9	3.3	5.7	6.3	1.6	1.0	1.2	1.1	0.8	2.0	2.6	3.9	0.0	0.5	1.3	0.8	13.4	9.3	25.7	23.3	3.8	3.5	4.3	0.8	4.3	4.8	0.0	0.0	0.8	0.5	9.6	0.0	4.1	0.5	2.4	5.1	5.3	3.0	0.0	6.0	6.9	4.8	5.6	5.6	1.8	4.5	0.1	7.9	0.2	4.7	0.0	2.3	4.5	2.0	8.7	6.5	2.0	4.4	6.4	1.8	1.0	8.1	0.7	1.0	0.5	0.5	8.9	7.8	1.9	1.4	4.0	9.1	0.1	3.4	1.2	0.0	4.2	3.4	1.2	0.9	18.6	15.2	0.3	2.2	1.6	9.2	5.8
RIPPLY3	DSCR6	ENSG00000183145	"Ripply transcriptional repressor 3"	P57055	21	37006150-37019662	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 3.0;Extravillous trophoblasts: 2.9;Hepatic stellate cells: 1.8;Squamous epithelial cells: 1.6;Urothelial cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;PC-3: 1.0;RPTEC TERT1: 1.3;RT4: 1.2;SCLC-21H: 3.9;T-47d: 3.2"	"Low region specificity"	"Detected in many"							HPA055541	Uncertain					NA	NA					"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA055541: AB_2682840"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.57e-4)"	"unprognostic (2.69e-1)"	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	1.3	1.2	3.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	1.2	0.0	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.8	0.2	3.0	0.0	0.2	0.0	2.9	0.4	0.0	0.6	0.0	0.2	1.8	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.4	0.4	1.6	0.4	0.0	0.0	0.2	0.1	1.4
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955487-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"bone marrow: 1713.7"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 30.7;Kupffer cells: 174.3;Macrophages: 82.2;monocytes: 54.6"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 457.5;eosinophil: 1352.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1352.6"	"Group enriched"	"Detected in some"	303	"HL-60: 539.0;NB-4: 539.8;THP-1: 1405.4;U-937: 1295.9"									HPA044983	Enhanced				"Secreted to blood"	NA	NA		200000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	7.1	6.0	3.0	9.1	2.8	1713.7	1.7	2.9	5.5	2.3	4.4	2.2	0.2	2.1	0.3	0.9	5.7	2.6	4.0	2.8	4.2	1.7	4.6	12.2	1.9	5.4	4.1	1.5	1.7	0.5	1.7	1.8	4.4	1.7	0.7	1.7	1.9	0.2	0.7	2.9	1.4	9.7	4.5	35.1	2.1	0.7	4.2	14.8	0.9	0.6	0.6	5.2	1.4	6.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	0.0	539.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	539.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	1405.4	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.7	0.0	1295.9	0.0	457.5	109.0	1352.6	0.4	19.3	0.8	0.3	0.4	0.0	191.8	0.4	0.4	0.4	9.8	0.1	2.8	2.6	0.1	39.9	3.0	2.8	2.9	5.5	2.8	4.2	5.4	4.1	4.4	4.5	4.2	6.3	0.2	3.2	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.4	0.0	1.9	0.0	0.5	0.0	0.0	1.3	0.0	30.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.4	2.2	13.0	0.0	0.0	0.0	0.0	174.3	0.7	1.7	0.3	82.2	0.0	0.0	54.6	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	19.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RNASE6	"RAD1, RNaseK6, RNS6"	ENSG00000169413	"Ribonuclease A family member k6"	Q93091	14	20781268-20782467	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.0;dendritic cells: 221.7;Hofbauer cells: 207.9;Kupffer cells: 551.2;Langerhans cells: 198.4;Macrophages: 270.3;monocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 1238.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 65.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA000698	Approved				"Secreted to blood"	NA	NA		2600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA000698: AB_2181340"	"unprognostic (5.04e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.62e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.46e-2)"	"unprognostic (5.54e-2)"	25.2	29.5	8.0	59.6	7.5	27.5	24.0	7.8	13.6	31.6	10.0	27.7	17.3	10.6	78.4	16.0	11.3	47.7	11.7	7.3	10.9	12.2	21.1	29.6	110.5	13.6	10.1	9.9	8.4	9.0	4.3	44.8	11.9	7.9	34.0	1.8	11.2	17.2	2.0	8.6	33.4	23.6	10.8	62.1	14.9	4.5	12.6	43.8	5.5	6.0	84.5	43.3	5.1	19.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.1	2.1	0.0	0.0	0.0	0.0	0.0	1.7	4.7	0.6	0.2	0.0	0.0	1.9	4.6	0.0	0.0	0.0	0.2	0.0	65.6	1.1	0.7	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	441.1	537.3	12.8	5.3	124.8	12.0	324.7	13.6	5.6	513.3	410.3	6.4	1.0	199.0	36.7	2.0	1238.8	1.1	329.8	8.0	7.5	7.8	13.6	7.3	10.9	13.6	10.1	11.9	10.8	12.6	19.5	1.6	6.4	7.5	0.0	108.0	4.5	0.2	0.0	1.8	0.0	1.4	2.8	0.6	14.3	1.2	0.0	0.0	1.1	221.7	2.6	0.0	0.0	0.8	0.1	0.0	3.8	0.0	12.0	0.0	0.0	1.6	1.4	1.1	0.2	0.0	0.0	8.6	3.3	207.9	0.0	0.0	0.5	2.0	551.2	198.4	4.8	2.8	270.3	21.4	1.9	115.8	0.0	9.2	0.0	0.0	0.0	12.6	0.7	52.4	0.2	0.4	0.5	0.2	0.4	13.1	0.6	0.6	0.1	0.7	0.6	3.8	2.2	7.8	0.0	3.4	1.2
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 11.4;granulocytes: 16.0;T-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	27.4	39.3	13.7	39.4	15.9	20.4	28.2	16.2	16.1	24.7	18.6	26.4	12.2	21.0	30.9	53.1	16.9	48.3	18.8	15.6	19.8	19.5	15.3	73.6	38.7	11.1	13.1	29.0	12.3	47.7	19.4	52.4	11.6	25.9	29.3	33.8	25.6	32.7	9.0	22.3	16.6	27.4	14.3	29.2	26.7	12.1	20.3	26.5	33.8	13.7	48.4	68.1	24.4	14.7	65.5	63.5	95.2	115.1	98.5	43.6	18.6	51.3	88.9	46.3	74.6	22.2	52.9	22.4	89.7	45.3	87.9	83.1	75.9	67.3	80.9	92.7	27.2	47.2	68.5	18.4	42.1	31.4	43.2	27.0	118.8	43.2	63.0	64.7	46.2	53.6	47.7	83.6	44.1	1.9	36.1	9.8	41.3	20.5	32.0	47.3	41.6	44.8	61.4	22.3	34.5	63.9	51.8	54.7	86.5	64.7	38.5	28.4	49.7	51.6	47.0	41.9	92.1	18.4	27.6	20.6	60.3	38.4	113.1	3.5	2.5	16.0	3.0	2.6	3.5	11.4	4.4	3.6	1.9	5.1	5.8	4.0	9.5	2.3	2.3	2.7	6.3	1.3	13.7	15.9	16.2	16.1	15.6	19.8	11.1	13.1	11.6	14.3	20.3	14.7	34.1	112.2	244.1	25.1	62.9	122.7	102.0	90.0	73.4	106.7	97.2	77.3	12.7	65.8	114.0	36.8	58.4	2.8	55.1	98.4	19.6	75.0	28.9	27.5	37.1	75.7	54.1	67.5	89.2	114.4	24.3	45.7	52.0	36.7	69.1	30.2	127.8	19.5	45.5	114.4	74.2	41.8	32.6	115.0	240.8	39.5	46.3	69.4	65.8	52.5	153.9	56.1	47.4	40.2	38.9	108.6	53.7	51.9	38.1	123.8	16.9	10.6	65.6	53.4	46.0	25.4	46.5	19.2	34.8	81.9	99.4	10.9	69.3	19.0	72.0	163.1
RNF152	FLJ39176	ENSG00000176641	"Ring finger protein 152"	Q8N8N0	18	61808067-61894247	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.3;choroid plexus: 62.3;kidney: 56.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 96.4;Proximal tubular cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 21.5;SH-SY5Y: 13.4;TIME: 14.2;U-138 MG: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.14e-2)"	"unprognostic (6.73e-2)"	"prognostic favorable (1.13e-8)"	"prognostic unfavorable (2.85e-5)"	"unprognostic (3.26e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.83e-2)"	7.4	3.4	5.4	0.9	13.9	0.9	6.7	48.3	5.3	8.2	62.3	7.2	1.7	6.3	3.6	4.5	5.2	3.8	7.6	6.1	10.6	56.5	22.1	7.0	0.5	25.5	13.7	4.0	2.5	2.4	2.9	6.5	28.7	5.3	6.6	5.0	14.0	2.8	2.3	11.4	5.5	4.1	8.5	0.6	6.3	1.3	21.1	0.6	5.4	2.3	0.8	4.2	7.5	14.9	0.0	0.0	4.8	1.0	4.4	0.6	0.0	3.1	9.4	0.7	0.5	0.0	0.1	0.1	0.9	4.9	0.1	21.5	5.9	11.4	1.3	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.1	0.7	8.1	3.6	2.4	2.1	8.7	0.1	0.0	0.1	1.4	0.9	0.8	0.0	0.3	0.7	0.0	0.3	3.1	0.0	0.5	3.7	3.9	13.4	0.0	8.7	1.5	4.2	5.1	0.0	14.2	21.6	2.2	0.0	0.5	0.1	0.0	0.0	0.7	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	13.9	48.3	5.3	6.1	10.6	25.5	13.7	28.7	8.5	21.1	14.9	26.8	0.0	0.0	9.4	0.2	42.3	28.1	11.1	11.4	19.1	16.2	10.3	4.8	12.8	10.5	20.2	0.0	0.4	0.9	58.1	46.9	2.5	0.4	16.8	18.5	17.1	16.2	8.0	9.9	2.7	0.1	9.5	18.3	29.9	0.0	0.1	10.8	96.4	0.1	21.9	20.0	5.6	32.6	1.8	7.7	1.4	8.7	2.2	28.4	2.8	0.0	3.5	0.0	16.6	27.5	1.7	34.9	18.4	0.3	8.7	46.6	159.0	1.8	3.6	65.7	2.8	59.7	0.2	0.5	28.0	32.5	0.3	1.7	18.7	16.2	21.2
RNF157	KIAA1917	ENSG00000141576	"Ring finger protein 157"	Q96PX1	17	76142465-76240493	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 86.9;retina: 59.0;skeletal muscle: 73.9;testis: 31.4;tongue: 43.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 114.1;Cone photoreceptor cells: 189.7;Excitatory neurons: 64.6;Horizontal cells: 180.0;Inhibitory neurons: 92.7;Rod photoreceptor cells: 70.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.2;T-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 100.9;U-266/70: 50.6;U-266/84: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021854, HPA021991, HPA023922"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	Vesicles	"HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202"	"unprognostic (4.21e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.02e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-1)"	13.6	3.3	36.4	3.7	39.1	2.2	4.9	34.1	86.9	1.4	9.8	9.8	9.6	1.4	3.4	1.0	1.8	1.3	6.4	56.9	34.5	5.8	2.5	1.4	5.2	59.7	41.9	1.2	3.4	14.6	6.3	1.6	61.1	1.9	7.0	59.0	1.9	1.5	73.9	1.0	10.3	1.8	34.1	3.5	3.9	31.4	51.5	2.8	3.4	43.7	2.7	3.0	1.0	58.1	0.2	7.1	29.3	10.7	8.8	4.4	13.4	0.3	8.9	1.9	1.3	3.3	3.1	0.0	4.2	0.5	6.9	0.2	26.0	0.1	1.6	100.9	8.9	0.0	2.9	4.7	1.7	1.4	10.9	2.4	0.1	3.7	0.1	1.5	0.2	4.7	16.0	0.3	3.6	8.0	4.4	0.8	4.8	5.5	21.1	0.0	0.3	0.1	3.4	3.2	5.1	24.0	5.3	0.1	11.5	6.5	0.7	5.1	0.2	1.9	2.3	14.4	9.6	50.6	45.5	0.1	0.8	0.1	15.1	2.2	0.2	0.3	1.6	0.1	3.4	0.2	3.4	2.7	0.1	0.4	5.8	3.9	1.2	0.7	0.2	0.3	1.3	1.0	36.4	39.1	34.1	86.9	56.9	34.5	59.7	41.9	61.1	34.1	51.5	58.1	2.8	3.2	3.3	33.3	1.5	2.0	0.8	0.2	0.6	114.1	0.8	0.9	9.0	11.5	1.3	1.8	189.7	0.6	5.0	5.3	0.0	1.9	27.8	0.6	3.7	4.4	2.4	5.5	64.6	1.1	0.4	3.1	0.0	1.5	0.0	0.9	0.7	4.3	0.4	180.0	92.7	7.4	0.0	0.8	6.0	29.1	11.5	1.1	1.8	3.7	1.4	35.9	8.2	62.8	35.0	0.1	3.4	13.9	2.1	0.9	19.3	9.1	0.7	70.9	0.0	2.9	1.3	22.7	25.0	0.0	2.3	0.3	15.5	1.3	18.2	1.5
RNF175	FLJ34190	ENSG00000145428	"Ring finger protein 175"	Q8N4F7	4	153710160-153760024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;choroid plexus: 10.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 72.8;Excitatory neurons: 91.4;Inhibitory neurons: 95.7;Oligodendrocyte precursor cells: 38.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HSkMC: 5.8;REH: 6.7;SH-SY5Y: 7.6;THP-1: 17.5;U-87 MG: 4.5"									HPA035837	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035837: AB_10601609"	"unprognostic (3.23e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.63e-4)"	"unprognostic (7.25e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	1.5	2.5	18.8	2.9	19.2	6.1	0.8	15.0	27.6	3.0	10.8	0.6	0.1	0.2	0.9	0.6	0.5	1.0	4.0	18.3	21.8	0.2	0.4	1.4	1.2	17.7	15.3	0.1	0.3	0.0	4.0	0.1	17.6	2.4	0.1	3.5	1.4	3.4	0.1	0.7	0.5	0.1	14.1	2.5	0.3	1.6	18.0	0.1	0.2	0.5	0.6	0.5	1.5	17.5	0.2	0.0	8.8	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	6.7	0.0	0.3	0.0	0.1	0.0	7.6	0.0	0.0	0.2	0.1	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.0	2.4	0.0	2.1	0.0	0.6	0.6	18.8	19.2	15.0	27.6	18.3	21.8	17.7	15.3	17.6	14.1	18.0	17.5	0.1	0.0	0.5	6.8	0.0	0.4	0.1	0.6	0.6	0.7	0.1	0.6	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.2	0.0	0.4	91.4	0.0	0.0	2.9	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	95.7	0.0	0.0	5.9	2.9	14.6	0.0	1.5	1.8	2.8	0.7	0.8	0.0	38.7	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	1.6	0.0	0.0	0.3	1.5	1.3	0.0	0.3	0.0	0.6	0.0	0.0	0.2
RNF183	MGC4734	ENSG00000165188	"Ring finger protein 183"	Q96D59	9	113297093-113303376	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.4;kidney: 11.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 15.9;Club cells: 9.8;Endometrial ciliated cells: 13.4;Glandular and luminal cells: 20.5;Ionocytes: 22.4;Proximal tubular cells: 26.4;Respiratory ciliated cells: 13.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057675	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"			"HPA057675: AB_2683499"	"unprognostic (1.23e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.95e-6)"	"unprognostic (2.56e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.51e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.53e-3)"	0.1	0.1	0.3	0.4	0.2	0.0	1.0	0.2	0.4	1.5	0.2	0.5	0.4	1.2	16.4	4.9	1.3	5.7	0.1	0.2	0.1	11.5	0.2	0.3	0.0	0.2	0.2	0.3	0.3	0.1	2.0	0.0	0.2	1.0	0.4	1.2	6.8	0.3	0.0	0.4	0.3	0.0	0.3	0.1	3.4	5.0	0.4	0.0	0.4	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0.3	0.4	0.3	0.3	0.0	0.0	0.3	0.5	0.0	0.4	15.9	0.0	0.6	3.8	2.9	0.4	5.7	9.8	5.5	0.0	0.0	0.2	0.9	1.9	0.2	0.2	13.4	1.1	0.5	8.4	0.0	0.0	0.9	0.1	0.2	4.6	20.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	22.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.2	0.7	0.4	0.0	0.5	0.2	26.4	13.0	3.3	0.0	0.4	0.6	3.3	0.7	1.4	0.0	0.0	0.3	0.1	1.5	1.0
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815283	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 67.2;intestine: 131.1;pancreas: 43.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 41.6;Enteroendocrine cells: 86.6;Intestinal goblet cells: 46.6;Paneth cells: 123.4;Proximal tubular cells: 142.7;Undifferentiated cells: 110.3"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 18.5;renal cancer: 12.1;stomach cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034547, HPA035558"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.3	0.0	0.0	5.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	18.7	131.1	0.1	67.2	0.0	0.0	0.4	0.0	0.0	0.0	26.1	0.8	0.0	0.0	0.0	0.0	0.2	43.4	0.0	0.0	0.0	0.0	0.3	15.4	0.0	0.3	0.4	0.0	0.0	44.8	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	5.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	41.6	5.9	9.6	0.0	0.8	0.1	0.1	86.6	0.0	0.0	18.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	123.4	0.0	0.0	0.1	16.1	142.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	110.3	0.2
RNF212B	C14orf164	ENSG00000215277	"Ring finger protein 212B"	A8MTL3	14	23185316-23273477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 27.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 42.9;Proximal tubular cells: 44.9;Spermatocytes: 94.6;Spermatogonia: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;Daudi: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053574	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA053574: AB_2682195"	"unprognostic (2.88e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.45e-1)"	"unprognostic (7.33e-5)"	"unprognostic (9.60e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (5.39e-3)"	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	27.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	5.9	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.7	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.2	42.9	0.2	0.2	0.1	0.0	0.0	3.5	0.2	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	2.2	0.5	0.0	0.0	0.0	9.5	0.9	3.2	0.0	0.0	1.6	0.2	0.0	0.5	1.6	0.1	0.0	0.4	0.1	0.0	1.0	44.9	0.0	0.3	0.0	0.1	0.1	94.6	24.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0
RNF224		ENSG00000233198	"Ring finger protein 224"	P0DH78	9	137227502-137229640	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"esophagus: 3.4;pituitary gland: 5.8"	"Cell type enhanced"	"Detected in single"		"Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.5;HeLa: 4.3;MCF7: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA079078			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"		"HPA079078: "	"unprognostic (2.45e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.01e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	0.2	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.5	0.0	0.3	0.3	0.2	0.0	3.4	1.4	0.3	0.5	0.1	0.1	2.1	0.0	0.8	0.1	0.8	1.2	0.1	0.8	0.0	5.8	0.0	0.3	1.0	0.0	0.2	1.4	0.0	0.1	0.6	0.5	0.0	0.5	0.2	0.6	1.2	0.5	0.0	0.9	0.0	0.1	0.4	0.9	0.2	0.6	1.0	0.4	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	5.5	0.1	0.2	0.0	0.3	2.7	0.0	0.1	0.0	1.8	0.2	0.0	4.3	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.2	0.4	0.0	9.8	0.1	0.0	0.4	0.7	1.3	0.6	0.2	0.1	0.1	0.6	0.0	1.1	0.5	2.0	0.0	0.7	1.9	0.2	0.2	0.2	0.1	1.1	0.0	0.6	0.2	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.8	1.2	0.3	0.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.9	2.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;retina: 15.4"	"Group enriched"	"Detected in many"	24	"Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 29.8;HEL: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013371, HPA013975"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA		1900000		"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA013371: AB_1856391, HPA013975: "	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	0.7	2.4	10.1	0.5	13.6	0.0	0.6	0.0	14.2	2.4	0.0	0.8	0.5	2.1	0.4	4.8	0.1	2.3	0.6	10.4	1.7	1.8	1.2	10.0	1.5	14.8	13.1	7.0	1.6	2.8	1.5	5.2	14.3	1.2	0.4	15.4	1.6	5.7	0.1	2.3	0.7	1.4	16.7	2.9	0.7	3.7	4.9	9.3	0.1	0.4	2.2	1.2	1.7	8.1	0.0	0.0	2.2	0.0	7.5	8.1	0.1	0.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	9.8	83.9	1.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.1	9.1	0.0	0.0	1.1	5.1	12.2	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	13.6	0.0	14.2	10.4	1.7	14.8	13.1	14.3	16.7	4.9	8.1	0.7	0.0	0.5	164.6	0.0	1.8	2.0	0.4	19.4	30.8	0.2	1.0	2.4	1.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	1.0	1.7	1.1	0.0	0.0	3438.7	0.0	0.1	10.6	0.0	3.2	0.0	2.3	3.3	0.7	0.1	52.2	4706.0	3.0	0.0	0.0	2.8	3.4	3.1	0.1	0.0	54.4	0.0	2.0	0.0	63.3	52.4	0.2	0.0	6.0	0.0	0.8	0.3	0.1	0.1	5.6	0.0	0.1	0.9	2.9	1.1	15.7	1.1	0.1	0.2	40.5	0.5	0.2
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Adipocytes: 181.5;Endothelial cells: 119.7;Hepatic stellate cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 247.6;TIME: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"		NA	NA		380000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA065212: AB_2685434"	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	41.4	7.2	11.4	6.6	9.6	0.2	31.8	9.0	9.4	10.0	5.8	6.5	2.9	10.9	2.1	5.5	10.3	9.7	25.8	7.9	9.2	18.5	5.3	34.8	7.8	11.3	10.7	4.1	4.3	4.7	4.6	28.6	11.2	7.0	1.7	0.2	4.1	4.6	13.9	6.9	7.3	9.9	9.5	43.5	6.3	1.4	13.2	1.8	16.7	11.9	2.0	9.4	7.0	8.6	0.4	0.0	0.4	0.0	0.0	1.1	0.1	0.2	3.1	0.7	1.5	0.0	0.0	0.0	23.6	0.1	1.0	0.0	0.0	0.4	1.2	0.0	0.0	0.9	0.0	0.1	0.6	0.0	0.0	0.1	0.0	8.9	3.0	0.4	247.6	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	224.8	1.2	0.6	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	9.6	9.0	9.4	7.9	9.2	11.3	10.7	11.2	9.5	13.2	8.6	181.5	0.0	4.2	2.3	1.6	2.2	1.0	0.2	0.6	0.2	0.6	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.5	0.2	0.3	119.7	0.0	4.0	0.0	0.2	0.0	5.2	0.0	0.3	2.5	0.6	148.9	1.5	0.1	0.0	0.0	0.0	0.0	8.1	3.7	1.7	4.4	2.8	1.8	20.6	0.1	1.1	0.0	0.5	0.1	0.1	0.0	1.2	2.6	0.3	0.0	0.0	0.0	5.2	0.0	4.5	2.1	0.0	0.1	0.6	1.3	0.0	0.9	2.0	0.1	0.2
RPGR	"COD1, CORDX1, CRD, RP15, RP3"	ENSG00000156313	"Retinitis pigmentosa GTPase regulator"	Q92834	X	38269163-38327544	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"	"Guanine-nucleotide releasing factor"	"Cancer-related genes, Ciliopathy, Cone-rod dystrophy, Deafness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 146.1;Hepatic stellate cells: 121.7;Respiratory ciliated cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 14.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001593, HPA073455"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"		"HPA001593: AB_1079835, HPA073455: AB_2686603"	"unprognostic (3.22e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-6)"	"unprognostic (1.93e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.61e-3)"	19.2	5.7	4.7	4.4	4.6	12.2	16.8	5.2	5.5	10.2	15.5	9.1	3.0	11.6	2.5	5.5	15.0	5.5	9.8	4.6	6.3	6.2	3.7	14.8	3.7	7.6	7.0	6.2	7.5	2.6	32.9	3.7	5.8	6.9	3.6	12.1	5.2	2.6	12.1	6.0	9.4	4.5	6.6	5.1	6.8	8.1	5.3	4.7	9.7	3.7	3.2	8.7	8.2	5.4	4.7	6.0	3.4	3.2	3.6	5.2	2.7	5.8	6.5	4.1	4.8	2.7	2.6	7.1	1.8	3.9	3.4	4.4	4.1	1.8	5.6	7.5	7.9	2.5	2.7	5.5	3.3	31.8	5.8	8.0	2.4	8.7	9.2	1.6	18.9	7.5	3.3	0.0	5.7	1.5	9.1	17.7	8.7	2.9	7.5	6.8	11.7	6.4	3.6	3.0	2.7	5.2	6.4	2.6	7.2	5.1	1.7	5.4	22.4	4.5	8.0	10.7	7.2	1.9	3.9	6.0	10.6	6.1	6.2	1.3	2.6	5.9	1.3	2.4	2.9	1.9	1.5	1.8	2.6	1.5	2.2	1.8	14.6	1.7	2.0	1.8	1.9	1.8	4.7	4.6	5.2	5.5	4.6	6.3	7.6	7.0	5.8	6.6	5.3	5.4	75.2	16.0	32.6	21.2	21.8	7.9	13.5	6.6	7.4	29.5	8.8	8.8	8.0	8.6	18.0	1.8	62.6	5.8	14.0	12.6	3.9	15.3	51.4	146.1	30.4	61.3	17.4	5.5	21.8	8.6	9.5	11.8	9.2	21.0	20.3	73.5	121.7	9.7	7.8	35.3	20.0	13.5	10.2	16.2	8.4	9.1	7.8	14.5	5.4	18.7	15.5	9.4	14.4	9.0	17.1	9.9	8.9	4.5	11.0	10.2	5.0	3.1	119.2	85.7	0.0	23.1	12.9	24.9	25.3	4.8	5.8	8.2	17.2	6.6	8.9	11.2
RTL4	"FLJ46608, Mar4, Mart4, SIRH11, ZCCHC16"	ENSG00000187823	"Retrotransposon Gag like 4"	Q6ZR62	X	112454500-112457112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"testis cancer: 1.4;thyroid cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003272	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 15: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003272: AB_2257414"							"unprognostic (9.86e-2)"						"unprognostic (2.04e-4)"		"unprognostic (6.35e-2)"	"unprognostic (5.33e-3)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	1.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.3	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RTL5	"KIAA2001, Mar5, Mart5, RGAG4, SIRH8"	ENSG00000242732	"Retrotransposon Gag like 5"	Q5HYW3	X	72127110-72131901	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 7.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast myoepithelial cells: 5.0;Endometrial ciliated cells: 3.8;Endometrial stromal cells: 8.9;Theca cells: 7.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.4"	"Region enhanced"	"Detected in many"		"cerebellum: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.7;AN3-CA: 4.2;SCLC-21H: 5.0;SH-SY5Y: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003652	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003652: AB_1079805"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (4.23e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	1.3	1.3	1.0	0.3	1.0	0.2	1.2	3.4	0.8	2.3	1.8	2.2	0.4	2.6	2.0	0.5	2.2	1.1	0.8	0.5	1.2	1.4	0.8	1.4	0.3	0.1	0.0	2.8	0.6	1.1	7.2	1.0	0.2	1.5	0.4	0.7	0.8	1.3	0.3	0.4	1.0	1.2	0.0	0.8	1.9	1.4	1.2	0.1	3.8	0.4	0.1	1.7	1.5	0.1	0.0	0.1	3.7	4.2	0.9	1.1	0.2	1.4	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.1	0.7	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	7.0	0.2	0.0	0.0	1.5	0.1	0.0	0.4	0.5	0.4	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	3.4	0.8	0.5	1.2	0.1	0.0	0.2	0.0	1.2	0.1	2.9	3.2	3.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.0	1.8	0.0	0.0	0.1	2.7	0.0	1.9	0.1	0.0	3.8	8.9	0.6	0.0	0.0	0.0	0.0	0.4	2.0	0.0	2.3	2.5	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	2.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.3	1.1	7.0	0.0	0.0
RTN3	"ASYIP, HAP, NSPL2, NSPLII, RTN3-A1"	ENSG00000133318	"Reticulon 3"	O95197	11	63681446-63759891	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Stress response, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 514.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1074.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 1074.7;monocytes: 400.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015649, HPA015650"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		130000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA015649: AB_1856498, HPA015650: AB_1856499"	"unprognostic (8.11e-3)"	"unprognostic (8.51e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (5.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-2)"	207.5	81.8	361.4	54.1	412.2	108.5	93.3	338.4	514.5	87.6	190.7	88.1	54.0	62.5	81.2	55.7	88.5	56.3	57.4	428.4	378.9	92.8	87.5	77.8	36.0	404.5	309.1	48.1	91.1	109.9	81.0	62.2	417.2	53.3	79.9	194.4	138.8	76.1	70.2	103.7	65.2	80.1	329.2	51.7	57.0	46.6	334.0	53.7	175.5	43.7	48.5	55.7	54.2	384.0	157.5	113.8	134.0	128.4	242.3	170.9	53.4	139.3	147.5	120.5	128.4	99.6	338.1	184.2	231.7	210.0	115.7	157.2	194.0	68.7	157.5	149.5	103.5	236.5	151.3	70.4	201.1	212.8	182.4	113.5	199.2	146.7	162.3	200.7	165.2	158.9	136.2	290.1	107.4	129.2	113.4	235.2	156.7	127.3	127.3	148.4	93.8	342.9	239.7	87.5	282.7	164.0	226.2	245.3	271.5	95.4	271.1	172.7	155.2	71.3	95.6	251.1	108.4	183.4	169.9	145.6	274.7	173.8	77.2	441.0	400.1	487.7	41.4	187.6	44.8	28.6	41.6	41.3	130.8	19.4	30.1	32.7	1074.7	41.7	240.4	79.0	68.6	323.0	361.4	412.2	338.4	514.5	428.4	378.9	404.5	309.1	417.2	329.2	334.0	384.0	62.8	134.6	67.5	110.7	35.9	144.5	103.5	63.0	101.3	157.7	125.2	59.9	36.1	81.5	91.9	244.6	70.9	68.6	55.6	118.2	29.4	154.4	35.8	96.4	74.3	68.1	99.8	85.8	398.8	117.1	105.6	96.7	60.1	129.2	77.3	71.4	85.6	81.3	143.7	82.4	372.7	83.5	122.1	178.3	110.8	71.2	79.2	151.4	113.8	100.2	178.0	150.3	42.2	200.6	294.8	103.3	82.0	89.9	94.8	79.4	94.5	55.9	156.0	97.6	78.9	53.1	78.6	194.7	133.5	85.9	146.2	86.5	48.8	51.7	96.5	99.8
RUNDC3B	"RPIB9, RPIP9"	ENSG00000105784	"RUN domain containing 3B"	Q96NL0	7	87627548-87832296	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.3;brain: 6.3;liver: 5.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 167.5;Inhibitory neurons: 170.9;Microglial cells: 108.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.2;HEK 293: 1.0;SCLC-21H: 2.7;SH-SY5Y: 1.2;U-138 MG: 1.0;U-266/70: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056968, HPA057155, HPA075760"	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Vesicles	"HPA056968: AB_2683292, HPA057155: AB_2683353, HPA075760: "	"unprognostic (2.49e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.42e-5)"	"unprognostic (4.44e-1)"	"prognostic favorable (2.62e-6)"	"unprognostic (1.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.55e-2)"	0.4	7.3	3.1	0.1	2.9	0.0	0.6	6.3	3.9	1.4	0.0	1.3	2.8	1.9	0.6	0.5	1.0	0.9	0.7	2.0	3.7	1.9	5.6	0.4	0.2	2.5	1.5	1.2	0.1	0.3	0.2	0.0	2.2	0.6	1.5	1.7	0.3	0.4	0.1	0.5	2.5	2.1	0.8	0.1	0.1	1.9	4.0	0.1	0.2	0.1	0.2	0.5	0.3	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.0	0.0	0.5	0.4	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	2.7	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	2.9	6.3	3.9	2.0	3.7	2.5	1.5	2.2	0.8	4.0	1.3	15.3	0.0	0.0	5.5	0.6	4.8	0.1	0.1	2.2	7.9	1.0	1.1	2.5	7.2	0.1	0.0	6.2	0.5	0.9	12.2	1.9	1.1	4.6	5.6	0.5	30.8	0.0	2.7	167.5	0.2	0.8	1.1	0.0	2.0	0.0	0.7	1.4	18.9	0.1	11.8	170.9	2.9	0.0	0.0	2.3	1.7	4.1	0.6	3.6	108.7	0.2	0.7	4.1	15.1	5.7	0.6	6.5	1.5	0.1	0.2	18.2	11.6	0.2	8.0	0.0	0.3	2.0	21.2	18.8	0.4	3.0	1.2	0.8	1.6	4.2	0.1
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"RUNX family transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.8;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 336.4;Langerhans cells: 133.9;NK-cells: 251.3;Plasma cells: 87.1;T-cells: 215.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 124.9;Karpas-707: 155.6;SK-MEL-30: 92.4;U-266/70: 54.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.5	1.4	3.7	21.1	3.6	68.8	3.5	3.8	4.6	19.7	3.7	3.7	5.0	1.6	0.7	2.6	1.6	5.3	1.1	3.6	3.8	1.6	3.7	9.5	34.7	4.7	4.4	0.6	0.9	0.4	0.7	0.9	4.3	1.9	4.2	0.1	4.7	0.8	3.8	11.5	15.0	1.6	4.1	35.1	5.5	2.3	4.3	11.2	1.8	0.7	29.0	6.5	1.5	4.5	0.3	10.4	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.5	0.0	0.5	0.0	19.3	18.4	16.4	0.1	0.4	11.1	0.0	0.7	124.9	1.9	0.4	1.8	0.1	0.0	4.5	42.8	0.1	0.0	0.0	1.1	0.0	0.0	3.1	0.1	155.6	0.0	0.0	1.5	37.9	0.7	0.0	3.2	0.0	0.1	22.7	0.0	0.5	3.5	0.0	7.3	0.1	92.4	2.9	0.0	25.7	0.0	0.0	1.9	0.0	0.5	54.6	40.4	18.2	0.1	42.0	4.4	0.7	1.1	7.0	21.7	4.5	11.3	6.7	7.9	18.7	1.4	5.7	3.9	14.6	1.3	28.7	7.7	1.5	9.2	5.5	3.7	3.6	3.8	4.6	3.6	3.8	4.7	4.4	4.3	4.1	4.3	4.5	4.4	0.0	3.6	0.0	57.7	7.6	0.8	4.6	2.2	0.0	9.8	11.3	2.4	0.0	1.5	1.8	0.0	0.1	336.4	0.5	0.0	0.2	2.3	1.1	1.2	2.4	0.0	13.7	0.0	0.2	0.1	3.3	13.3	2.3	45.2	0.0	2.2	1.5	4.6	0.0	0.0	0.5	0.0	22.9	133.9	1.0	0.0	55.6	46.2	1.0	51.1	0.0	251.3	0.0	0.1	0.1	0.1	0.7	87.1	1.2	0.0	0.3	0.5	0.0	0.0	3.5	3.6	0.3	4.1	2.3	5.8	0.3	215.4	0.1	0.4	0.4
RXFP1	"LGR7, RXFPR1"	ENSG00000171509	"Relaxin family peptide receptor 1"	Q9HBX9	4	158315311-158653372	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.3;brain: 7.6;endometrium 1: 6.2"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 61.4;Excitatory neurons: 167.9;Glandular and luminal cells: 174.6"	"Cancer enriched"	"Detected in single"	9	"endometrial cancer: 3.9"	"Group enriched"	"Detected in many"	4	"amygdala: 4.6;basal ganglia: 5.3;cerebral cortex: 7.6;hippocampal formation: 4.6;white matter: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 29.0;HEL: 9.7;RPTEC TERT1: 14.4;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 11.8;hippocampal formation: 7.8"	HPA027067	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA027067: AB_10602127"	"unprognostic (3.07e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.13e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-6)"	"unprognostic (8.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.22e-3)"	0.1	5.3	4.6	0.2	5.3	0.0	0.1	0.0	7.6	2.7	0.0	0.2	0.1	6.2	1.0	0.1	0.8	0.7	0.0	4.6	1.2	2.1	1.4	3.8	0.4	0.0	0.0	0.3	0.1	0.2	0.1	2.7	0.0	0.4	0.1	0.0	0.1	2.8	0.0	0.0	0.2	0.8	0.0	0.3	0.4	0.2	0.0	0.0	1.3	0.0	0.3	0.1	0.8	3.5	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.3	0.0	7.6	4.6	1.2	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.5	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.4	23.5	4.2	0.0	1.7	167.9	0.0	0.0	0.2	0.0	174.6	0.0	0.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	7.5	0.0	0.0	0.0	10.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.6	0.8	0.0	0.1	0.1	0.6	0.0	0.0	0.0
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2477.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 995.4;Pancreatic endocrine cells: 1307.3;Prostatic glandular cells: 1141.1;Squamous epithelial cells: 1028.7;Suprabasal keratinocytes: 908.8;Theca cells: 1528.4;Urothelial cells: 1522.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1369.9;SK-BR-3: 1618.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	166.8	79.1	81.3	61.9	79.8	0.8	159.7	78.6	98.0	333.0	70.8	139.7	121.5	78.4	19.8	2477.7	68.2	81.6	122.3	79.8	80.1	219.0	209.9	161.3	28.4	104.2	80.9	83.4	41.0	76.6	42.0	71.8	84.9	77.8	105.0	7.0	438.1	38.1	51.7	474.9	109.8	79.0	84.8	118.5	100.4	60.3	103.4	25.0	72.4	52.1	205.0	163.2	713.3	84.6	670.4	318.1	16.0	36.7	102.5	386.8	42.8	367.9	341.4	302.7	265.2	315.4	366.1	0.3	577.5	553.0	69.0	479.6	1.1	839.2	175.3	1.9	0.6	0.4	260.5	90.8	117.5	0.2	0.9	182.7	787.6	731.6	567.9	390.9	1369.9	0.0	8.5	0.8	677.3	918.7	0.9	1.4	69.0	1171.0	887.9	0.9	187.4	1.8	1150.3	236.1	0.8	1.9	267.6	1618.0	55.7	140.5	504.7	3.5	743.9	178.2	289.5	171.5	848.6	0.5	3.5	2.4	525.0	0.9	122.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	81.3	79.8	78.6	98.0	79.8	80.1	104.2	80.9	84.9	84.8	103.4	84.6	275.6	38.5	25.5	10.4	6.8	633.9	995.4	531.6	157.6	0.5	225.4	191.3	33.0	124.4	290.6	108.5	2.1	20.3	4.4	500.7	72.4	610.9	4.9	50.9	172.5	293.5	139.0	16.0	0.0	193.9	8.7	112.2	96.8	128.5	19.1	154.1	365.9	132.7	5.0	0.0	0.1	286.4	164.8	15.7	95.4	17.4	67.1	7.4	112.1	5.6	7.2	72.5	0.0	7.5	0.7	1307.3	610.0	61.3	5.6	1141.1	353.3	169.7	48.6	2.1	6.6	70.9	91.2	8.0	1.3	1028.7	908.8	8.2	12.9	1528.4	320.2	1522.5
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549258	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 94.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.4;Ductal cells: 21.7;Endometrial stromal cells: 18.4;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 24.2;Skeletal myocytes: 24.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 3.1;non-classical monocyte: 6.2;plasmacytoid DC: 7.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 7.4;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 87.0;HBEC3-KT: 45.7;HeLa: 51.4;U-2197: 47.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 15.8"	"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		240000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA042674: AB_10796581, HPA056140: AB_2683050"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	7.6	1.1	0.9	3.6	1.1	1.8	4.2	0.8	1.3	6.9	0.6	2.8	0.5	3.9	0.2	17.2	3.3	1.7	2.6	0.8	1.4	13.8	0.2	16.6	1.8	1.4	1.6	1.1	0.8	0.1	0.7	2.2	1.2	3.0	1.1	0.0	4.2	1.7	1.0	94.6	1.9	2.1	1.1	0.8	1.4	0.5	2.8	0.4	1.5	1.9	5.1	6.9	9.6	1.4	7.3	87.0	0.1	0.1	8.1	5.2	0.0	6.1	31.4	7.9	12.8	2.6	2.8	0.1	19.0	16.1	10.7	22.2	0.1	45.7	3.7	0.3	0.0	0.3	51.4	15.3	2.2	0.0	0.3	4.1	24.9	17.9	19.9	4.5	1.7	0.0	0.0	0.0	39.8	0.5	0.0	0.0	0.6	0.2	11.5	0.0	5.9	4.7	26.0	18.3	1.2	0.0	5.4	6.1	2.0	24.7	0.2	0.6	8.6	2.9	4.8	47.4	6.3	1.4	1.6	0.2	38.2	0.7	19.1	0.0	0.1	0.0	0.0	3.1	0.2	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.2	7.4	0.1	0.4	0.9	1.1	0.8	1.3	0.8	1.4	1.4	1.6	1.2	1.1	2.8	1.4	2.0	3.2	0.5	0.7	0.0	10.3	2.3	15.4	4.0	0.0	0.3	0.4	0.3	1.5	5.9	0.0	0.0	0.3	0.0	0.0	1.9	21.7	0.0	2.3	18.4	7.4	0.0	1.3	0.0	24.0	4.4	8.4	0.0	1.3	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.1	0.1	4.1	0.4	1.8	0.0	3.6	0.0	0.0	0.0	0.0	24.2	0.0	0.4	0.0	1.5	0.0	0.3	1.1	0.0	0.0	24.7	9.6	0.1	0.0	5.6	6.5	1.5	0.5	1.1	0.0	2.0
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.1;Endothelial cells: 122.3;Hepatic stellate cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1248.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.0;HUVEC TERT2: 198.9;TIME: 113.3;U-251 MG: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	114.7	14.4	58.8	29.8	62.7	18.5	91.9	59.8	59.0	18.5	27.8	19.5	9.4	24.7	3.9	26.8	22.9	28.0	71.8	51.3	65.1	18.0	31.3	78.3	46.3	65.2	73.0	8.2	20.3	23.3	8.7	48.1	61.3	13.7	10.1	14.6	15.0	7.8	27.9	17.9	22.3	31.2	57.6	63.1	17.1	2.6	76.5	21.4	35.9	51.5	26.9	34.3	19.2	52.6	15.6	0.2	14.2	0.0	1.4	32.7	0.1	73.0	13.5	47.9	16.6	0.1	0.7	0.0	17.8	25.2	0.4	0.0	1.8	0.8	27.0	6.1	1.2	6.8	0.3	0.0	6.6	0.0	3.5	45.0	0.3	0.1	3.7	1.7	198.9	5.8	0.2	14.4	13.5	0.0	20.6	0.0	3.9	0.4	4.8	0.0	13.4	0.5	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.9	0.0	0.2	113.3	6.8	2.9	2.0	147.1	1.3	0.0	1.0	0.7	0.0	0.4	1248.4	2.2	55.4	589.4	2.1	441.5	294.7	502.6	492.1	2.6	346.9	383.3	396.3	15.4	397.5	3.4	3.1	329.4	438.7	58.8	62.7	59.8	59.0	51.3	65.1	65.2	73.0	61.3	57.6	76.5	52.6	236.1	0.0	8.9	37.9	36.0	7.6	0.2	0.0	2.2	0.4	1.1	1.1	23.8	2.8	1.3	0.0	0.0	5.9	25.0	0.0	0.0	0.0	0.0	1.1	1.0	122.3	0.0	0.4	0.1	0.0	0.3	11.7	0.5	1.8	7.6	9.7	114.2	8.9	9.9	0.0	0.3	0.0	0.0	6.5	5.7	0.0	0.9	3.0	5.4	13.1	9.9	31.1	40.2	0.5	0.2	0.0	0.0	0.0	18.2	0.5	0.0	0.1	0.0	1.4	0.0	3.6	4.8	0.7	0.7	0.6	5.1	2.6	29.9	1.8	0.1	0.4
SALL3	ZNF796	ENSG00000256463	"Spalt like transcription factor 3"	Q9BXA9	18	78980275-79002677	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.4;prostate: 6.0;vagina: 8.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 25.5;Bipolar cells: 14.7;Cone photoreceptor cells: 47.9;Horizontal cells: 25.2;Oligodendrocyte precursor cells: 21.1"	"Cancer enriched"	"Detected in some"	6	"glioma: 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;HEK 293: 2.7;NTERA-2: 9.5;SuSa: 1.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 12.5"	"Low region specificity"	"Detected in many"			HPA016656	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"			"HPA016656: AB_1856546"	"unprognostic (3.96e-2)"	"unprognostic (3.41e-3)"			"unprognostic (8.16e-2)"	"unprognostic (1.87e-2)"		"unprognostic (2.37e-1)"	"unprognostic (4.23e-1)"			"unprognostic (2.12e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.86e-3)"		0.0	0.0	5.7	0.0	6.2	0.0	0.0	5.8	5.7	1.0	3.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	5.2	8.2	3.3	0.0	0.0	0.0	9.0	6.5	0.0	0.0	0.0	1.2	0.0	7.2	6.0	0.0	1.8	0.7	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	1.3	6.3	0.0	0.0	0.0	0.0	0.4	8.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.2	5.8	5.7	5.2	8.2	9.0	6.5	7.2	9.4	6.3	7.5	0.2	0.0	0.0	25.5	0.0	0.0	7.4	0.0	0.0	14.7	0.0	0.1	1.8	0.0	0.0	1.8	47.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	25.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	4.8	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	1.8	6.6	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3
SAMD11	MGC45873	ENSG00000187634	"Sterile alpha motif domain containing 11"	Q96NU1	1	923923-944575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 266.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 87.6;HeLa: 142.1;SCLC-21H: 71.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030110			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"HPA030110: "	"unprognostic (9.96e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.18e-1)"	3.8	9.0	3.6	3.3	4.5	1.0	1.8	6.0	8.8	7.4	7.2	4.9	5.1	9.6	9.4	1.9	17.6	3.2	13.2	5.6	9.0	19.7	4.3	3.9	2.1	23.4	10.5	3.3	1.4	1.6	27.6	0.3	10.9	16.9	1.1	24.5	2.0	19.5	0.8	0.8	5.4	4.1	8.8	17.1	4.9	4.7	8.3	0.1	4.7	0.3	0.4	14.0	7.9	10.1	0.3	8.0	0.1	7.4	0.4	0.1	2.0	9.2	0.5	0.6	0.3	0.4	2.4	0.0	19.0	26.0	5.1	15.3	8.8	0.0	0.0	0.8	87.6	0.0	142.1	0.4	1.9	0.0	0.9	5.3	0.0	0.1	0.0	12.1	0.0	0.2	3.5	0.0	0.2	8.4	0.0	0.1	3.8	0.5	0.8	0.7	1.4	5.6	1.2	0.0	71.1	20.9	23.8	12.3	0.2	6.1	12.8	0.5	1.4	3.8	14.4	0.2	2.6	1.3	0.0	0.3	5.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	3.6	4.5	6.0	8.8	5.6	9.0	23.4	10.5	10.9	8.8	8.3	10.1	0.1	0.0	1.8	12.1	0.3	0.4	0.1	0.3	0.6	25.5	0.7	0.4	0.9	2.8	1.9	3.7	29.2	0.2	0.1	0.2	0.0	1.0	3.9	20.1	43.9	6.1	26.5	0.0	0.1	0.4	0.9	17.0	2.0	6.4	0.0	3.8	4.6	0.2	0.3	35.3	0.2	1.0	0.0	0.6	0.0	12.1	0.9	0.7	0.0	1.0	0.0	25.8	0.0	0.0	0.1	1.6	2.6	4.1	0.4	2.1	0.0	0.3	0.1	266.9	0.0	0.2	4.1	1.5	26.0	0.1	0.6	0.1	0.6	0.0	0.2	0.3
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 157.0;NK-cells: 271.9;Plasma cells: 43.7;T-cells: 84.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	47	"NK-cells: 128.4;T-cells: 113.8"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.8;HDLM-2: 3.4;hTEC/SVTERT24-B: 2.2;hTERT-RPE1: 1.9;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"HPA028992, HPA028993"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"	1.1	2.3	1.4	4.0	2.0	4.2	0.9	0.6	1.6	2.9	0.6	1.2	0.7	4.4	1.9	0.7	1.5	2.3	0.5	2.9	1.2	1.1	1.7	3.3	10.4	0.8	2.0	1.8	1.2	0.1	4.8	0.7	0.9	0.7	2.3	1.4	0.7	0.4	0.8	0.5	1.4	1.7	0.4	9.3	1.6	3.2	1.9	6.3	0.8	0.7	4.2	1.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.3	0.5	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	2.2	0.1	1.9	0.2	0.4	0.1	0.0	0.2	0.0	0.1	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	113.8	0.4	90.0	2.5	39.8	102.1	0.6	0.3	28.8	68.9	2.3	128.4	0.6	0.6	41.7	41.4	1.4	2.0	0.6	1.6	2.9	1.2	0.8	2.0	0.9	0.4	1.9	0.4	1.1	0.0	2.3	1.3	2.3	0.4	0.0	0.0	0.6	3.0	0.6	0.5	0.8	0.0	0.0	0.0	0.0	0.0	157.0	1.6	0.0	0.2	25.4	1.0	2.1	0.8	3.6	6.6	12.1	0.0	0.0	0.7	0.0	0.5	1.3	14.8	2.9	0.4	0.0	0.0	5.7	0.3	0.0	3.4	1.4	6.7	0.6	1.8	5.4	12.2	2.3	0.0	271.9	1.5	0.6	0.0	1.5	1.9	43.7	0.0	0.1	0.6	0.7	0.4	0.0	0.3	1.4	2.3	1.6	0.2	0.4	0.0	84.3	2.0	0.5	0.1
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508690-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 96.0;Inhibitory neurons: 276.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.6;Hep G2: 65.6;K-562: 44.7;RH-30: 29.0;WM-115: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067811	Uncertain		Supported	Vesicles		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA067811: AB_2685901"	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	0.6	1.8	2.8	1.3	5.6	0.1	4.1	1.0	2.6	1.4	0.1	6.0	3.0	4.2	0.8	8.9	0.9	2.2	1.2	2.7	4.0	7.4	7.5	3.4	0.3	8.7	4.1	0.4	1.3	5.7	3.8	12.2	9.1	1.4	8.1	8.9	2.3	2.4	0.2	1.9	4.4	3.1	0.0	1.4	4.5	7.6	7.2	0.1	2.1	0.1	0.7	1.5	1.9	0.8	11.2	1.4	1.4	2.0	0.0	0.0	0.1	3.6	1.3	0.3	0.2	16.6	0.1	0.6	3.6	0.0	0.6	0.1	0.3	2.5	0.4	0.0	2.0	0.8	1.5	65.6	0.2	0.0	1.3	0.0	0.1	0.3	0.1	0.0	6.8	0.0	44.7	0.6	4.8	0.1	0.0	0.0	0.1	8.4	2.8	0.0	29.0	6.5	0.1	2.3	0.5	0.1	0.9	0.2	2.8	0.3	0.0	0.0	4.9	0.5	1.5	0.5	1.3	0.1	1.1	0.0	0.1	0.1	20.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	5.6	1.0	2.6	2.7	4.0	8.7	4.1	9.1	0.0	7.2	0.8	1.7	3.2	5.9	1.3	1.0	1.8	5.6	0.5	2.2	96.0	2.9	23.5	2.6	0.0	0.0	18.4	2.1	0.2	0.0	5.4	9.8	2.2	0.5	1.1	10.7	11.1	16.9	0.0	15.7	0.2	0.3	6.9	19.4	1.8	0.0	7.0	6.1	28.1	0.8	0.0	276.9	11.6	0.0	1.0	1.4	1.3	0.3	0.7	0.0	45.0	0.0	9.2	0.0	5.5	0.9	0.6	3.4	3.4	0.1	3.0	5.2	19.7	0.0	4.0	0.0	3.1	2.0	0.5	0.2	36.4	1.6	0.3	0.5	3.6	25.7	4.2
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 47.9;liver: 114.4;pancreas: 43.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 120.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8"	"Lineage enriched"	"Detected in single"	16	"T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.4;Hep G2: 31.1;MOLT-4: 22.5;RH-30: 18.5;RPMI-8226: 39.1;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		230000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	1.1	2.2	3.6	2.5	3.5	0.9	0.8	1.9	3.9	2.6	0.7	1.1	1.8	2.0	47.9	0.6	1.9	1.3	2.4	3.3	3.5	12.0	114.4	2.6	4.1	4.4	3.1	3.0	43.2	2.1	4.1	0.9	3.4	2.3	0.4	0.6	5.3	1.8	0.6	0.4	1.3	0.9	2.9	1.3	3.0	0.7	4.2	4.3	1.6	0.3	2.4	1.1	1.0	3.1	0.0	0.1	1.4	17.4	0.1	0.5	2.3	0.1	0.7	0.9	1.1	0.3	0.2	0.0	2.4	0.3	2.2	0.1	0.0	0.3	0.7	0.0	0.3	2.5	0.0	31.1	1.9	0.1	0.3	4.2	0.0	2.0	0.1	0.4	0.2	13.1	0.1	0.4	11.1	3.2	22.5	2.4	2.8	1.7	0.2	1.6	18.5	39.1	0.0	0.1	1.7	14.7	0.0	0.4	3.9	0.8	2.4	0.2	0.1	3.3	3.0	0.3	0.0	0.3	0.0	1.3	2.1	1.4	0.1	0.3	0.1	0.1	0.3	0.0	0.8	0.0	3.3	0.8	0.0	0.3	6.7	1.2	0.5	0.1	0.0	0.3	8.8	1.4	3.6	3.5	1.9	3.9	3.3	3.5	4.4	3.1	3.4	2.9	4.2	3.1	0.1	0.0	1.9	6.8	0.4	0.3	0.4	0.0	1.2	0.1	0.2	0.8	0.8	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.8	1.2	5.7	1.5	1.1	0.1	2.3	0.0	0.3	1.3	0.8	2.9	120.6	0.1	0.0	0.7	0.0	0.0	1.6	0.6	0.8	4.7	0.2	0.0	1.9	0.0	4.2	1.0	0.5	0.3	0.1	0.0	3.0	0.7	0.3	0.0	21.3	0.0	0.3	0.0	1.6	3.5	0.1	0.8	0.0	0.1	0.0	4.2	1.6	0.0	0.2
SAT2	SSAT2	ENSG00000141504	"Spermidine/spermine N1-acetyltransferase family member 2"	Q96F10	17	7626234-7627876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.8"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1060.0;Proximal tubular cells: 1313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022136, HPA057096"	Enhanced					NA	NA		11000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022136: AB_1856592, HPA057096: AB_2683334"	"unprognostic (2.61e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (2.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (4.14e-2)"	"unprognostic (2.75e-1)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.83e-1)"	"unprognostic (6.66e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	28.3	102.8	27.7	9.6	28.4	11.3	26.8	28.7	37.5	26.2	32.9	30.5	92.7	25.2	25.1	17.2	26.1	15.8	33.5	27.9	29.2	97.6	139.8	19.0	9.5	28.4	28.5	44.5	47.4	36.0	30.4	8.6	28.3	27.4	15.4	21.1	27.0	16.4	31.8	19.0	65.5	17.1	28.9	29.1	33.4	17.1	29.2	8.0	28.2	20.5	11.8	22.6	19.8	28.8	17.9	27.3	24.1	44.9	37.5	43.6	3.0	12.2	44.3	27.2	33.8	9.3	8.9	3.3	6.8	11.9	30.4	15.3	15.4	11.1	18.0	5.1	41.9	3.6	15.8	49.2	45.3	0.1	12.3	54.6	28.3	16.2	11.9	36.6	39.9	3.5	2.5	5.3	28.8	1.6	0.3	4.1	9.9	10.2	16.6	6.6	11.8	4.2	42.8	20.6	2.6	22.4	11.4	23.4	26.3	21.4	15.5	3.3	17.3	13.2	8.5	0.3	19.3	9.9	9.6	0.7	44.5	5.2	19.7	7.6	41.9	9.5	14.2	28.3	16.7	13.6	12.0	14.6	30.7	12.7	17.8	12.7	2.7	12.4	14.9	14.0	19.5	22.5	27.7	28.4	28.7	37.5	27.9	29.2	28.4	28.5	28.3	28.9	29.2	28.8	70.3	44.8	121.2	76.4	76.2	82.6	90.6	83.2	134.3	121.9	124.1	140.8	62.8	257.4	82.6	80.9	68.8	70.8	68.7	80.4	422.6	135.9	19.4	66.9	79.0	69.8	132.7	25.9	86.2	66.2	33.7	97.3	43.3	59.2	62.1	181.4	114.5	289.0	165.3	129.5	64.6	116.4	124.1	142.7	165.1	28.0	181.7	110.7	94.3	25.3	103.4	156.9	49.4	32.6	36.9	92.8	129.1	119.2	92.9	108.6	1060.0	1313.7	83.9	148.6	72.3	91.2	92.2	30.4	7.8	79.6	56.1	79.2	67.0	321.2	116.8	103.9
SCARF1	"KIAA0149, SREC, SREC1"	ENSG00000074660	"Scavenger receptor class F member 1"	Q14162	17	1633858-1645744	"Predicted intracellular proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.9;Endothelial cells: 51.3;Hepatic stellate cells: 62.4;Langerhans cells: 37.7;Microglial cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 12.1;REH: 11.5;TIME: 37.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035108, HPA072936"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA035108: AB_10670289, HPA072936: AB_2686559"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.39e-2)"	15.2	5.0	1.5	3.1	1.8	0.4	12.7	1.4	3.4	5.6	1.4	5.2	0.0	6.0	0.9	2.7	6.5	2.2	11.8	1.6	1.8	7.5	7.5	16.3	2.1	2.7	1.7	2.6	3.1	0.1	3.8	4.3	2.2	4.6	1.2	0.2	4.2	0.0	5.3	3.1	5.4	1.2	1.7	25.6	4.2	1.6	1.7	0.5	18.8	1.9	1.0	5.6	4.6	2.8	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.3	12.1	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	11.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	37.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	1.8	1.4	3.4	1.6	1.8	2.7	1.7	2.2	1.7	1.7	2.8	65.9	22.4	17.6	6.5	0.6	3.4	0.4	0.7	1.2	1.2	0.8	0.9	3.5	0.0	2.9	3.7	4.2	0.4	2.0	4.9	1.9	0.4	0.3	0.5	0.9	51.3	0.0	3.4	5.4	0.2	0.2	2.5	4.1	1.1	3.8	0.3	62.4	2.3	9.0	0.0	3.5	4.4	0.0	15.7	37.7	0.4	1.2	10.1	3.6	26.2	4.8	0.7	0.0	0.5	1.1	0.3	1.2	1.2	0.0	0.7	3.0	0.2	3.0	2.0	0.0	2.1	3.0	0.5	0.6	0.3	2.7	1.2	1.0	1.3	2.2	0.8
SCIMP	"C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783"	ENSG00000161929	"SLP adaptor and CSK interacting membrane protein"	Q6UWF3	17	5208920-5234860	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 66.4;Hofbauer cells: 26.2;Kupffer cells: 120.3;Macrophages: 66.3;monocytes: 60.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.7"	"Group enriched"	"Detected in many"	8	"classical monocyte: 110.6;intermediate monocyte: 239.0;memory B-cell: 145.8;myeloid DC: 84.2;naive B-cell: 124.5;non-classical monocyte: 265.5"	"Group enriched"	"Detected in all"	9	"B-cells: 145.8;dendritic cells: 84.2;monocytes: 265.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 6.8;U-698: 10.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006117	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA006117: AB_1858633"	"unprognostic (2.53e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.95e-2)"	5.9	4.1	0.0	30.4	0.1	5.1	1.4	2.7	1.3	1.5	3.6	4.5	5.4	2.9	1.1	1.9	3.1	7.3	1.7	0.3	0.0	2.3	10.6	16.2	39.4	0.6	0.1	3.6	3.9	0.8	0.7	3.9	0.1	3.1	4.6	7.5	4.0	1.4	4.3	3.2	10.2	6.1	0.0	49.2	5.0	2.8	0.0	5.1	3.4	0.8	44.9	6.0	0.6	0.4	1.0	1.5	2.5	3.3	0.0	0.0	2.5	1.1	0.0	0.0	0.0	0.7	2.1	4.8	0.9	0.0	1.8	1.0	0.0	0.0	0.0	0.8	2.1	2.0	6.8	0.7	0.0	0.2	0.7	0.0	0.1	0.0	0.2	1.2	0.0	4.2	0.1	1.2	0.0	1.6	2.4	0.7	1.1	0.3	1.4	2.2	0.5	0.5	0.0	0.6	1.8	0.8	1.8	0.6	1.3	0.7	2.6	2.4	0.3	0.3	1.1	1.4	0.6	0.7	0.3	10.8	1.2	0.3	0.7	16.8	110.6	3.0	1.3	239.0	1.5	145.8	0.8	1.2	84.2	124.5	1.7	1.2	19.0	5.3	265.5	3.2	1.4	68.0	0.0	0.1	2.7	1.3	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.4	0.5	0.0	4.4	2.6	66.4	0.4	0.4	0.0	0.0	2.5	0.4	0.5	0.4	1.5	0.6	0.0	12.5	0.3	1.5	0.0	0.0	0.7	1.4	0.4	0.3	2.0	0.0	0.4	6.5	0.9	0.3	0.6	0.0	0.1	1.3	0.4	3.3	1.9	26.2	1.7	4.9	0.0	0.0	120.3	4.2	0.7	0.3	66.3	0.0	8.4	60.3	0.4	10.3	4.0	2.3	0.4	0.0	0.4	1.7	0.3	0.0	1.0	1.6	4.1	0.0	0.7	0.3	0.5	0.8	0.0	0.4	0.1	3.2	0.2	0.0	0.4
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107702154-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.1;lymphoid tissue: 12.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 31.7;Early spermatids: 72.1;Late spermatids: 168.4;NK-cells: 35.0;T-cells: 73.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 48.2;MAIT T-cell: 47.7;memory CD4 T-cell: 74.8;memory CD8 T-cell: 65.7;naive CD4 T-cell: 69.1;naive CD8 T-cell: 59.5;NK-cell: 53.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 53.2;T-cells: 74.8"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063326, HPA065958"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	0.6	0.8	0.8	7.2	0.6	3.3	1.0	1.2	0.7	0.5	0.2	2.3	10.1	0.5	4.6	0.9	0.7	1.4	0.6	0.6	0.9	0.6	1.6	1.7	12.1	0.5	0.5	0.6	0.7	0.2	1.9	0.3	0.3	0.6	2.0	0.9	1.0	0.4	0.4	0.9	8.2	0.5	0.1	7.4	2.8	2.2	1.3	9.3	0.8	0.2	9.8	1.1	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.0	0.0	0.0	1.4	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	65.1	0.0	0.1	0.4	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.3	0.1	0.1	13.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.3	0.2	0.7	0.1	0.1	0.1	4.2	0.3	3.5	48.2	0.1	47.7	10.1	74.8	65.7	0.2	5.8	69.1	59.5	6.6	53.2	0.4	1.2	5.8	26.6	0.8	0.6	1.2	0.7	0.6	0.9	0.5	0.5	0.3	0.1	1.3	0.6	0.5	0.0	0.0	0.7	18.0	1.5	0.0	0.0	0.6	0.6	0.4	0.4	1.1	0.0	0.0	0.0	0.0	1.3	31.7	0.4	0.0	1.2	72.1	0.0	0.1	0.7	0.0	1.3	2.7	0.0	0.2	1.0	4.6	0.1	1.3	0.0	1.1	1.8	0.2	1.7	2.5	1.4	0.0	0.8	1.4	168.4	0.9	1.2	3.6	1.9	2.0	0.0	35.0	0.5	0.1	0.1	2.6	0.7	11.6	0.0	5.5	0.4	0.7	0.0	0.0	0.3	0.6	1.1	0.5	0.3	0.1	0.1	73.3	0.0	4.7	0.1
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 21.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.2;Hofbauer cells: 67.5;Inhibitory neurons: 48.2;Langerhans cells: 42.8;Oligodendrocyte precursor cells: 133.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.6"	"Cell line enhanced"	"Detected in many"		"BJ: 23.0;BJ hTERT+: 16.8;HHSteC: 19.0;hTERT-RPE1: 15.6"	"Region enriched"	"Detected in many"	5	"hypothalamus: 9.3"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	1.7	1.7	5.3	0.9	4.2	2.0	0.6	0.1	3.4	0.6	0.0	3.2	0.5	0.2	0.1	0.5	0.4	1.2	0.4	2.9	21.9	1.7	3.9	2.0	0.6	8.2	19.4	0.3	2.0	0.1	1.5	4.3	12.0	0.3	3.1	0.7	0.4	0.4	0.2	0.7	1.8	2.4	2.2	3.1	0.4	5.1	18.2	1.6	0.3	0.6	0.4	0.5	0.5	1.7	0.0	2.5	0.1	0.0	9.6	7.9	0.0	23.0	16.8	5.2	1.7	0.5	0.1	0.0	0.0	2.8	0.2	0.1	6.5	0.6	8.6	0.0	2.1	1.7	1.8	1.9	19.0	0.1	0.0	0.6	0.2	9.1	1.7	15.6	1.1	1.2	6.1	6.6	0.8	0.0	3.6	0.0	1.9	0.1	0.6	0.8	3.3	9.0	2.4	9.5	1.0	9.5	0.0	0.1	0.3	4.8	0.3	0.0	0.1	0.0	1.5	0.1	0.4	0.1	0.1	0.0	3.2	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.5	0.1	23.6	0.0	0.1	5.3	4.2	0.1	3.4	2.9	21.9	8.2	19.4	12.0	2.2	18.2	1.7	0.9	12.8	23.8	0.7	1.3	1.0	0.4	0.5	0.6	0.6	0.8	0.9	2.5	8.6	4.4	5.5	0.0	0.3	43.2	9.0	3.9	23.4	2.5	0.1	0.1	5.7	33.0	4.2	15.8	31.5	0.3	2.0	0.0	0.1	3.8	18.1	13.6	9.5	67.5	0.0	48.2	19.3	10.2	1.9	42.8	3.2	1.2	11.3	3.6	2.8	1.0	2.3	0.0	133.7	0.4	12.7	7.8	0.0	1.2	0.3	14.7	11.5	2.2	0.2	0.0	7.8	1.6	1.3	0.4	0.5	0.4	1.1	0.9	4.4	12.9	0.2
SCRN2		ENSG00000141295	"Secernin 2"	Q96FV2	17	47837692-47841289	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 149.7;Proximal tubular cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022934, HPA023434"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		370000	"Cluster 44: Non-specific - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus"	"HPA022934: AB_1856638, HPA023434: AB_1856639"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.28e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.83e-4)"	81.2	22.9	18.9	11.1	19.4	13.4	48.9	18.8	22.3	28.2	22.0	23.8	43.8	24.5	11.5	19.2	26.5	12.0	31.9	18.5	20.6	68.6	37.2	17.4	12.9	19.9	19.6	25.4	26.4	25.4	31.5	12.9	18.8	28.5	10.4	6.5	33.8	19.7	38.1	22.1	36.7	10.2	20.1	34.0	21.5	10.6	19.4	12.0	39.9	25.0	10.1	22.2	23.3	20.1	28.0	43.8	12.1	11.0	33.7	25.7	36.6	13.7	27.6	20.6	21.0	32.5	33.2	15.3	27.5	7.1	11.0	14.7	3.9	24.6	6.9	37.6	29.7	15.5	33.8	29.2	12.0	7.9	12.7	25.7	18.1	12.8	9.8	31.5	23.5	35.6	5.4	18.2	28.9	25.4	24.6	12.8	6.0	12.1	17.5	32.7	9.0	62.4	16.9	12.9	8.9	37.6	8.0	17.3	17.8	8.3	37.9	14.5	10.7	18.2	20.8	5.6	6.6	70.2	9.8	7.7	52.1	13.2	4.2	24.5	19.9	43.4	24.6	21.1	24.1	24.8	20.4	24.2	25.7	25.3	31.7	17.8	5.4	29.3	10.8	30.1	23.0	16.5	18.9	19.4	18.8	22.3	18.5	20.6	19.9	19.6	18.8	20.1	19.4	20.1	21.9	38.5	29.9	15.0	18.7	15.7	31.5	41.8	20.5	12.0	24.5	25.7	19.3	15.7	35.9	16.5	10.4	43.1	12.4	33.2	74.3	27.7	3.9	16.9	10.0	24.6	22.3	7.2	12.4	61.0	9.3	25.7	17.3	12.4	16.5	22.1	24.3	26.7	22.7	20.2	10.5	33.6	48.8	11.1	13.7	2.8	33.2	12.8	42.7	7.5	13.9	28.8	26.8	11.1	6.0	33.3	36.5	16.6	30.9	14.1	149.7	332.7	40.9	16.8	6.6	19.1	16.0	5.2	16.7	21.9	11.5	33.8	21.6	23.9	40.7	27.0
SDHC	"CYB560, cybL, PGL3"	ENSG00000143252	"Succinate dehydrogenase complex subunit C"	Q99643	1	161314381-161363206	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 776.7;Proximal tubular cells: 916.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.48e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-3)"	"unprognostic (3.77e-1)"	128.9	143.7	73.7	64.1	79.7	60.5	100.3	84.5	85.1	78.7	92.9	118.9	127.8	70.9	76.0	109.7	98.6	63.3	154.1	68.4	83.4	285.7	319.4	65.5	74.7	78.8	79.1	69.2	62.5	173.6	52.4	73.1	76.7	77.3	132.2	84.3	74.8	84.7	277.4	69.8	101.4	101.4	85.1	62.8	89.9	52.7	84.8	93.1	89.5	288.4	105.1	88.4	61.3	85.6	161.1	129.7	157.5	147.7	248.3	213.3	196.3	150.9	190.3	180.3	137.3	185.4	208.7	53.7	190.6	214.8	121.6	178.5	244.3	214.2	193.2	185.6	205.6	110.2	106.6	196.7	126.9	193.8	109.1	211.5	181.7	174.3	119.4	167.9	177.5	164.0	178.9	43.8	266.3	167.0	152.4	112.5	145.4	376.3	123.7	131.6	151.0	217.1	330.3	167.8	118.3	180.7	211.0	385.1	225.4	207.9	342.1	259.3	133.5	103.7	125.1	127.9	147.3	173.3	287.8	269.4	140.3	139.2	193.6	88.6	111.0	65.7	76.6	99.6	79.6	68.6	66.2	75.4	136.1	65.7	71.2	71.0	52.0	66.9	87.5	100.6	78.3	130.0	73.7	79.7	84.5	85.1	68.4	83.4	78.8	79.1	76.7	85.1	84.8	85.6	50.9	44.8	59.4	14.7	70.1	61.8	151.2	342.6	59.7	74.9	81.4	58.3	94.0	131.5	163.5	150.8	64.6	248.0	65.5	95.9	776.7	218.4	18.6	87.1	63.8	80.7	66.8	81.4	19.3	145.2	248.5	79.8	79.5	62.6	58.3	66.6	83.2	249.1	237.3	72.3	27.4	103.4	215.7	100.6	74.4	34.7	102.9	94.6	129.9	9.4	176.1	107.8	107.1	17.6	24.5	142.7	89.5	109.1	71.9	100.2	139.1	916.5	177.9	69.3	52.6	74.5	94.4	115.3	114.4	111.2	76.4	307.6	72.0	215.7	154.2	155.0
SELENOK	SELK	ENSG00000113811	"Selenoprotein K"	Q9Y6D0	3	53884417-53891962	"Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 373.5;Proximal tubular cells: 415.0;Syncytiotrophoblasts: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 471.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 471.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA008196	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"		"HPA008196: AB_1856665"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.85e-1)"	"prognostic favorable (7.18e-4)"	"unprognostic (9.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.02e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (2.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.56e-3)"	39.6	51.9	52.3	27.0	53.0	70.1	35.8	55.2	67.9	29.8	52.3	35.9	23.3	29.1	64.4	27.8	33.9	23.4	90.1	52.0	55.8	42.1	74.2	38.3	23.7	55.0	53.7	48.6	51.7	55.7	62.8	26.5	55.5	34.6	29.3	86.5	29.7	28.5	86.7	24.1	30.4	18.7	55.7	32.3	39.6	32.0	53.3	26.7	43.0	61.2	29.4	35.5	26.1	58.4	22.4	14.9	34.3	23.3	52.1	32.8	36.8	32.0	40.5	43.4	48.9	33.4	33.1	33.8	13.8	23.4	48.7	13.8	40.7	24.5	37.8	59.6	50.3	21.1	61.4	77.6	49.1	28.3	48.6	19.8	40.3	30.1	39.4	25.2	35.3	25.1	20.1	86.3	38.5	24.7	18.5	33.5	33.4	27.5	55.1	11.5	20.9	61.9	51.3	37.1	17.5	49.5	21.9	29.4	32.7	37.5	19.6	44.0	20.6	24.4	28.7	62.2	45.7	62.8	76.3	31.4	36.8	37.3	38.2	471.4	41.7	110.7	69.5	47.2	67.5	60.3	63.0	70.0	36.6	49.0	55.0	63.0	94.1	52.2	56.6	66.3	72.1	82.6	52.3	53.0	55.2	67.9	52.0	55.8	55.0	53.7	55.5	55.7	53.3	58.4	223.1	134.6	103.9	0.0	173.5	0.0	0.0	0.0	0.0	0.0	233.7	237.5	0.0	0.0	53.9	149.0	0.0	162.3	373.5	0.0	189.8	258.5	0.0	150.1	113.5	62.7	0.0	0.0	0.0	199.6	239.6	86.9	0.0	237.9	237.1	59.1	0.0	0.0	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.6	0.0	0.0	74.9	0.0	0.0	0.0	0.0	282.5	0.0	0.0	110.6	0.0	0.0	415.0	53.9	0.0	0.0	0.0	86.0	0.0	0.0	0.0	0.0	350.1	155.9	94.7	0.0	0.0
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108621895-108633894	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 159.7;Kupffer cells: 84.9;Macrophages: 64.8;monocytes: 123.8;NK-cells: 154.5;Plasma cells: 65.1;T-cells: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 136.2;HMC-1: 130.0;JURKAT: 102.2;Karpas-707: 195.1;RPMI-8226: 286.7;U-266/70: 326.8;U-266/84: 214.5"	"Low region specificity"	"Detected in all"							"CAB002431, HPA011256, HPA069062"	Enhanced		Approved	Vesicles		NA	NA		2700000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB002431: AB_563509, HPA011256: , HPA069062: "	"unprognostic (2.32e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (3.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (5.88e-2)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (5.44e-2)"	17.5	9.1	12.1	47.4	10.5	21.1	6.9	11.7	12.1	9.2	8.2	9.6	8.6	3.7	2.1	8.6	7.8	17.0	5.0	12.0	14.1	4.0	6.5	40.8	62.2	17.8	13.5	2.8	3.4	4.4	3.0	13.0	16.4	3.3	8.4	0.7	7.0	3.9	2.2	4.7	15.5	11.5	17.0	86.6	11.3	2.2	17.2	52.1	3.4	7.3	30.6	21.5	3.3	24.5	0.5	0.4	1.4	0.8	0.7	1.5	0.8	4.9	4.8	1.8	1.4	0.3	1.9	0.5	1.7	7.4	2.0	0.3	0.1	0.1	1.3	136.2	0.0	45.7	0.2	0.2	0.4	35.1	130.0	1.8	0.5	2.5	0.6	5.0	0.4	102.2	0.8	195.1	6.0	0.0	28.3	18.9	0.2	0.1	1.6	0.3	0.5	286.7	2.9	0.0	0.3	0.0	0.6	0.2	2.2	3.3	0.1	42.6	1.7	2.6	0.8	3.5	1.4	326.8	214.5	6.4	1.5	74.2	1.9	1543.6	297.6	940.2	419.2	509.2	344.3	22.0	396.6	362.9	299.9	22.3	300.3	323.7	1257.2	309.2	762.7	518.3	662.2	1035.5	12.1	10.5	11.7	12.1	12.0	14.1	17.8	13.5	16.4	17.0	17.2	24.5	1.2	3.2	12.4	0.0	11.6	3.4	0.1	0.2	0.0	0.2	0.6	1.4	2.2	4.3	2.7	0.0	0.0	0.5	159.7	0.2	0.0	0.3	8.2	1.8	0.6	2.6	0.0	10.9	0.2	0.2	2.3	2.4	2.6	0.9	29.7	0.4	3.6	2.2	40.1	0.0	0.3	0.0	0.0	84.9	49.6	12.2	0.3	64.8	7.2	15.9	123.8	0.0	154.5	0.0	0.1	0.5	0.0	0.0	65.1	0.1	0.0	0.5	6.4	0.2	0.0	1.2	0.9	0.8	0.5	0.5	1.8	1.0	65.9	0.1	0.0	0.0
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.2;Bipolar cells: 23.4;Endothelial cells: 24.4;Hepatic stellate cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 108.1;HUVEC TERT2: 187.0;RT4: 112.3;SK-BR-3: 170.2;TIME: 338.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	NA	NA	1700000	7900000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	33.8	9.0	8.8	8.6	5.7	2.7	31.9	5.1	8.1	28.3	12.0	10.5	13.4	14.5	5.4	100.8	15.6	10.8	22.6	5.0	9.2	49.2	4.8	46.2	3.7	10.2	12.7	3.6	6.7	5.5	11.1	30.4	8.7	32.7	6.3	22.0	24.6	32.5	10.4	75.1	12.5	9.1	6.3	50.7	17.3	2.4	21.8	6.1	27.1	6.1	12.6	27.0	55.4	4.7	13.9	3.1	0.7	14.2	0.2	1.3	3.0	8.0	24.2	6.5	10.2	5.4	6.1	0.5	77.9	1.1	0.7	47.5	6.9	100.7	2.4	0.1	1.8	0.8	108.1	18.5	5.7	1.7	3.2	6.2	55.3	15.1	45.4	90.7	187.0	1.2	2.9	0.1	1.3	12.4	1.5	7.5	8.6	6.2	10.1	11.8	0.0	0.5	7.2	112.3	1.1	2.6	12.8	170.2	0.3	10.4	67.2	7.3	338.6	4.2	31.9	29.7	5.5	0.2	0.0	0.9	0.3	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	5.7	5.1	8.1	5.0	9.2	10.2	12.7	8.7	6.3	21.8	4.7	40.2	0.0	1.1	0.0	0.2	6.8	3.0	9.2	5.7	23.4	10.7	6.0	9.2	1.5	6.6	18.4	10.4	11.2	0.6	5.5	0.0	0.3	0.0	6.5	2.4	24.4	0.0	0.0	0.7	0.8	0.5	1.1	16.3	6.9	0.0	0.2	25.4	0.6	1.4	6.7	1.1	10.7	0.0	0.3	0.8	0.3	0.3	0.2	0.0	3.7	0.0	8.7	0.0	0.0	0.1	6.8	3.8	0.0	0.0	2.5	5.7	0.7	5.4	19.8	0.0	0.5	2.5	0.0	0.4	17.7	8.9	6.3	0.4	0.2	5.2	8.6
SEMA4C	"Semacl1, Semaf, SEMAI"	ENSG00000168758	"Semaphorin 4C"	Q9C0C4	2	96859718-96870757	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 137.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"BEWO: 298.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011090	Approved					NA	NA		700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA011090: AB_2185705"	"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (7.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (9.50e-7)"	"unprognostic (4.78e-3)"	"unprognostic (3.09e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.08e-1)"	21.3	8.9	11.5	11.3	24.2	3.0	17.7	16.8	19.9	29.0	0.5	42.1	7.4	37.2	6.0	14.0	33.3	15.3	20.2	11.8	15.6	14.9	13.3	14.4	9.8	24.9	21.1	23.1	9.4	7.1	10.2	41.8	21.0	20.8	5.7	7.0	16.5	20.6	7.5	15.9	14.6	19.3	18.7	28.5	15.1	2.7	19.0	6.5	12.3	13.4	5.3	32.3	22.3	39.1	8.0	11.7	35.6	39.7	8.4	10.5	298.5	13.9	17.4	13.4	13.5	11.8	13.3	0.0	22.3	8.5	13.3	8.1	10.2	6.9	6.5	15.2	11.8	5.4	10.5	22.2	19.2	2.2	13.7	16.1	5.4	12.3	10.4	14.9	9.9	2.6	36.5	11.6	12.7	41.0	0.1	17.4	49.1	0.4	10.6	12.5	20.0	13.8	4.8	17.1	22.4	32.4	11.2	24.6	60.8	27.6	8.7	21.4	3.1	21.9	27.3	30.9	14.6	0.2	1.0	0.1	10.6	17.2	37.1	0.5	0.0	0.0	0.6	0.2	0.8	0.0	0.2	0.4	0.0	0.0	0.4	0.1	0.0	1.4	1.5	0.8	0.3	0.4	11.5	24.2	16.8	19.9	11.8	15.6	24.9	21.1	21.0	18.7	19.0	39.1	28.1	0.0	10.3	15.3	1.1	11.5	7.9	7.6	18.2	32.2	9.9	8.3	6.9	12.8	8.6	5.5	10.4	46.8	9.7	1.8	1.9	9.7	0.5	7.4	15.8	26.6	5.4	2.1	7.2	5.0	137.3	17.3	3.1	11.6	1.3	10.2	23.9	9.8	7.9	15.2	4.1	5.7	6.1	4.4	6.1	1.5	13.4	9.2	21.4	18.7	3.2	23.6	12.3	4.5	35.5	10.5	1.2	9.1	3.6	9.4	0.1	0.8	7.4	38.8	19.7	11.4	24.1	0.6	4.2	13.0	10.2	45.0	9.5	4.9	3.9	4.8
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 84.6;liver: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 66.4;Gastric mucus-secreting cells: 27.0;Hepatocytes: 60.5;Intestinal goblet cells: 34.6;Paneth cells: 38.5;Proximal enterocytes: 47.6;Undifferentiated cells: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 31.7;CACO-2: 30.5;Hep G2: 113.8;OE19: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 37: B-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Vesicles, Lipid droplets"		"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	2.4	12.7	13.1	5.9	10.9	0.4	3.6	18.9	12.3	6.9	12.8	53.6	53.4	3.5	32.1	3.6	5.9	9.0	3.0	10.0	11.6	19.1	102.4	5.8	2.5	11.2	14.4	18.9	31.3	7.3	9.9	3.9	11.5	20.2	84.6	7.3	8.5	3.0	2.6	18.3	41.2	4.6	9.6	3.1	20.9	3.7	17.0	0.8	15.3	0.8	0.9	4.0	5.0	9.9	0.2	31.7	8.0	3.4	5.0	1.6	6.8	1.2	3.4	1.7	1.7	30.5	5.2	0.5	4.2	1.5	0.6	2.1	8.0	1.4	1.4	0.7	4.9	1.7	3.0	113.8	12.5	1.2	1.0	8.3	1.8	1.6	0.9	22.2	4.4	3.5	3.3	0.4	2.5	2.0	0.5	1.2	1.3	69.1	1.8	3.1	0.7	1.5	7.4	1.0	2.5	12.5	1.1	2.1	3.2	8.7	8.7	1.5	3.0	1.0	3.7	0.8	0.3	1.1	0.6	0.5	0.9	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	10.9	18.9	12.3	10.0	11.6	11.2	14.4	11.5	9.6	17.0	9.9	0.3	3.2	1.1	3.9	1.2	0.0	0.6	0.7	0.6	3.5	2.5	2.0	1.2	20.0	0.2	0.0	0.0	8.8	0.0	66.4	0.0	2.7	0.2	1.6	0.7	0.6	8.5	0.8	3.0	2.6	1.9	2.0	27.0	0.3	0.0	3.4	2.2	60.5	0.9	11.8	14.1	34.6	2.0	3.3	0.0	0.2	2.1	0.2	1.8	0.0	0.0	0.9	0.0	3.5	5.5	2.4	38.5	1.2	0.2	3.0	47.6	6.4	2.4	1.6	0.0	0.1	0.4	1.1	1.9	0.5	0.1	2.9	0.2	12.7	45.9	0.9
SEMA5A	"SEMAF, semF"	ENSG00000112902	"Semaphorin 5A"	Q13591	5	9035033-9546075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 1189.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.2;fHDF/TERT166: 37.1;RT4: 66.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004632	Approved					NA	NA		13000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA004632: AB_1079905"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-2)"	"unprognostic (8.15e-2)"	"prognostic favorable (3.66e-8)"	"unprognostic (8.51e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.01e-2)"	4.6	1.2	7.8	2.7	9.1	0.0	6.8	5.6	23.6	13.0	3.6	9.5	2.9	8.9	2.2	3.1	2.9	5.4	9.5	35.4	17.0	11.6	4.9	11.1	4.7	10.9	11.1	1.7	4.4	1.9	2.3	7.0	17.1	2.9	7.5	7.0	2.1	4.9	1.3	4.4	5.3	2.4	8.3	6.3	1.9	1.6	16.4	1.7	1.9	3.1	3.7	5.8	3.8	13.4	0.0	0.0	15.0	0.0	10.1	14.1	0.0	24.2	64.2	4.7	2.5	0.0	0.1	0.0	0.0	37.1	0.3	21.6	0.0	1.4	2.4	0.0	0.2	0.0	0.1	0.0	1.4	0.0	0.1	3.6	0.7	5.3	21.6	10.5	0.0	0.0	0.0	0.0	5.7	0.7	0.0	0.0	1.5	13.2	1.1	0.0	0.0	0.9	1.8	66.7	3.1	0.3	0.2	0.0	19.9	5.1	0.0	0.0	0.0	23.0	0.5	0.0	0.5	0.0	0.0	0.0	21.4	0.0	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	9.1	5.6	23.6	35.4	17.0	10.9	11.1	17.1	8.3	16.4	13.4	8.0	150.6	5.6	63.6	0.3	9.2	6.4	30.8	8.0	2.8	1.6	49.0	37.0	22.8	14.3	1.8	0.0	1.8	9.6	23.9	0.0	3.4	32.6	6.3	151.5	6.4	5.4	0.0	60.6	2.3	1.2	27.8	0.5	9.3	1.3	1.8	5.3	4.3	1.3	247.3	53.1	10.9	0.0	0.0	5.2	50.5	10.2	0.8	33.8	134.9	0.1	44.8	0.0	1189.7	152.3	1.2	8.0	14.7	0.0	8.2	16.9	14.4	2.0	3.6	39.5	4.3	40.5	0.6	0.5	11.4	4.8	1.9	1.4	29.0	20.5	14.1
SEMA6B	"SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ"	ENSG00000167680	"Semaphorin 6B"	Q9H3T3	19	4542593-4581776	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 43.6;Alveolar cells type 1: 28.9;Alveolar cells type 2: 44.6;Endothelial cells: 40.1;Excitatory neurons: 30.6;granulocytes: 29.7;Hepatic stellate cells: 37.5;Inhibitory neurons: 30.3;Macrophages: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 124.5;HMC-1: 198.1;HUVEC TERT2: 83.8;TIME: 107.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025157, HPA055778, HPA058523"	Enhanced					NA	NA		1100000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB025157: , HPA055778: AB_2682916, HPA058523: AB_2683741"	"unprognostic (4.03e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.38e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (9.55e-2)"	25.6	19.7	44.0	11.0	30.7	7.8	17.1	0.6	72.3	8.7	0.0	6.6	4.0	10.6	0.4	3.6	8.8	5.8	20.2	65.2	12.4	13.3	2.9	10.7	1.2	13.5	11.0	3.3	4.1	9.2	7.2	8.9	1.8	7.0	1.0	1.4	3.9	1.3	6.0	4.6	7.3	6.9	0.5	31.9	6.1	1.9	30.2	0.7	9.1	4.3	0.7	10.0	6.7	17.4	7.2	25.0	2.3	21.4	0.1	1.2	0.2	0.0	0.7	2.4	0.6	0.2	2.0	0.0	23.7	0.0	3.8	4.4	6.5	0.0	0.9	0.1	1.0	0.0	0.4	124.5	0.4	0.0	198.1	7.5	0.1	0.2	0.2	24.9	83.8	0.1	1.6	0.3	0.7	6.5	0.0	0.0	26.8	1.7	0.3	0.4	46.8	0.6	1.7	0.1	17.7	1.7	0.1	1.7	11.5	1.8	2.7	1.1	107.8	3.1	34.7	0.5	18.6	1.3	0.0	0.4	0.8	1.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	30.7	0.6	72.3	65.2	12.4	13.5	11.0	1.8	0.5	30.2	17.4	43.6	28.9	44.6	2.6	2.3	4.7	1.5	0.5	0.0	9.0	2.1	1.9	1.9	1.5	19.3	1.8	4.2	0.6	2.3	0.2	0.0	1.1	1.1	1.1	2.5	40.1	0.0	8.4	30.6	0.2	0.6	8.2	0.0	2.0	29.7	0.5	37.5	6.0	3.3	18.5	30.3	0.1	0.0	6.1	18.1	0.4	0.6	35.2	7.2	7.5	1.4	2.0	1.0	19.1	1.4	0.2	0.1	0.7	1.1	1.2	0.0	0.4	17.7	4.1	0.0	8.8	1.8	2.0	2.2	0.0	5.1	0.3	5.4	1.6	0.1	0.9
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774228	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.5;placenta: 43.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Horizontal cells: 79.1;Inhibitory neurons: 319.5;Oligodendrocytes: 140.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 14.9;SCLC-21H: 13.3;SH-SY5Y: 12.1;SuSa: 14.2;U-266/70: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.5	1.5	11.3	3.9	27.9	0.4	5.0	11.1	21.3	5.8	0.0	10.6	21.8	1.6	2.5	1.7	4.9	4.0	9.4	9.8	16.3	15.1	3.1	8.9	2.1	17.2	31.1	26.7	16.1	10.6	5.5	43.1	23.1	4.5	12.7	15.8	4.5	8.4	20.9	3.0	38.5	3.3	12.0	2.5	3.0	2.6	20.5	2.7	5.8	6.0	0.6	3.1	10.0	28.8	0.0	0.0	2.5	0.0	1.5	1.2	0.2	0.6	14.9	0.4	0.0	0.3	0.1	2.2	0.0	4.0	0.0	7.6	3.4	1.1	0.1	1.1	1.7	0.0	5.0	0.0	4.0	0.0	0.2	1.1	8.3	0.0	0.5	0.0	1.0	5.7	0.1	3.4	0.4	0.8	2.8	0.7	4.6	0.0	0.0	1.6	0.1	2.4	1.1	1.1	13.3	12.1	0.1	1.0	4.3	14.2	0.5	0.0	0.0	6.9	0.3	0.2	0.0	10.0	0.0	2.3	1.8	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.3	27.9	11.1	21.3	9.8	16.3	17.2	31.1	23.1	12.0	20.5	28.8	13.9	51.3	1.5	72.8	0.2	2.0	4.0	1.4	1.2	6.2	0.5	10.7	10.0	4.3	2.1	11.0	114.7	19.7	0.1	40.6	5.9	1.0	0.2	0.5	2.3	10.1	17.4	0.0	120.7	0.2	1.8	10.8	0.0	0.3	3.8	71.0	5.0	0.9	2.6	79.1	319.5	5.4	0.0	0.0	1.9	1.2	23.3	1.0	8.8	15.9	0.0	9.3	0.0	43.2	140.1	0.3	8.5	13.5	0.0	1.2	53.5	0.2	0.1	2.3	0.0	9.3	13.9	0.8	6.3	0.3	1.1	4.7	0.2	3.4	15.1	1.6
SEPTIN1	"DIFF6, PNUTL3, SEPT1"	ENSG00000180096	"Septin 1"	Q8WYJ6	16	30378133-30395991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 16.7;lymphoid tissue: 35.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.7;Cytotrophoblasts: 11.4;dendritic cells: 25.9;Fibroblasts: 4.9;Hofbauer cells: 9.2;Plasma cells: 10.2;Syncytiotrophoblasts: 4.9;T-cells: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;JURKAT: 48.5;MOLT-4: 66.3;REH: 39.0;U-266/70: 21.6;U-266/84: 33.4;U-698: 23.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA041566, HPA060339, HPA073635"	Enhanced		Approved	"Actin filaments"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA041566: AB_10794671, HPA060339: , HPA073635: "	"unprognostic (3.65e-3)"	"prognostic favorable (9.72e-5)"	"unprognostic (5.06e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.32e-4)"	"prognostic favorable (6.63e-4)"	"unprognostic (2.08e-1)"	"prognostic favorable (7.24e-5)"	"unprognostic (1.24e-2)"	"unprognostic (6.52e-3)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (2.40e-7)"	"unprognostic (1.48e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.72e-2)"	1.6	0.9	1.0	3.6	1.1	0.7	1.1	1.2	1.9	1.9	1.0	3.4	4.1	1.4	0.7	2.0	2.0	0.3	0.8	1.0	1.1	1.4	1.9	2.6	15.3	1.0	1.0	1.6	0.8	0.5	0.7	0.3	1.1	1.7	0.0	0.1	3.2	0.8	0.2	1.3	16.7	0.7	1.0	35.9	4.4	0.2	1.4	16.0	1.9	0.6	6.6	2.0	1.6	1.0	0.3	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	38.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.3	3.0	0.0	0.0	0.3	0.0	5.1	1.2	0.2	0.1	0.1	0.0	0.7	0.0	48.5	0.3	16.7	0.0	0.0	66.3	1.4	0.0	0.0	0.7	39.0	0.0	2.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	21.6	33.4	23.2	0.6	7.0	0.0	118.4	2.5	102.2	319.3	2.3	245.1	170.1	286.7	292.4	9.6	179.4	264.6	268.7	8.5	230.4	1.6	270.6	329.6	272.6	1.0	1.1	1.2	1.9	1.0	1.1	1.0	1.0	1.1	1.0	1.4	1.0	1.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	11.4	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	4.9	6.1	0.0	0.0	0.0
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323389	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 776.6"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 204.5;Hepatocytes: 390.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"T-47d: 961.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017864	Approved				"Secreted to blood"	NA	NA	60800000000	37000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 6: T47d - Mammary gland"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favorable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	1.9	0.0	3.5	0.1	0.5	0.0	0.0	12.6	35.1	0.0	0.0	0.0	43.5	776.6	0.1	0.0	0.0	0.0	0.3	17.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	114.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.4	0.4	4.5	0.1	0.4	0.0	0.1	0.7	0.0	0.0	961.9	0.0	0.0	0.5	0.0	0.6	0.0	0.3	0.0	0.5	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.0	4.4	0.0	0.4	204.5	0.3	0.0	0.0	0.3	0.0	0.4	1.9	33.1	0.0	62.6	0.3	0.4	9.0	16.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.2	9.7	390.8	0.0	0.0	0.0	0.8	2.0	8.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.0	1.2	0.0	0.0	0.0	0.1	43.0	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.8	0.1
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2841959	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 466.8;esophagus: 478.3"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1424.3;Pancreatic endocrine cells: 1067.8;Urothelial cells: 984.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.3;OE19: 162.5;U-937: 144.9"					"Low region specificity"	"Detected in all"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"	"Secreted to blood"	NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	36.6	54.4	10.7	69.7	14.4	466.8	25.0	11.1	14.0	55.6	17.3	77.7	140.4	15.6	22.2	478.3	35.8	57.4	26.8	10.7	12.7	33.2	32.1	81.7	51.3	15.1	13.0	18.1	232.1	29.8	32.9	27.0	14.6	15.9	87.5	13.4	99.6	16.9	54.2	15.8	107.3	24.9	13.6	67.4	97.9	7.1	13.7	31.9	30.7	22.9	122.8	88.6	112.4	14.8	42.9	49.7	2.7	0.3	10.6	21.8	41.2	11.8	36.1	14.5	26.1	47.1	125.3	0.3	86.6	26.6	15.6	26.8	4.8	11.4	11.1	59.4	7.5	76.6	16.0	37.0	37.2	13.5	46.2	26.8	18.4	7.3	3.3	7.2	48.7	0.0	27.1	9.9	13.4	19.9	1.7	35.4	4.5	162.5	22.1	3.9	0.5	44.4	51.0	9.3	8.8	4.8	28.8	11.2	64.2	5.9	5.6	43.2	29.1	4.6	10.4	10.2	3.6	0.1	2.2	0.5	17.4	144.9	2.4	118.0	207.1	109.4	53.3	103.7	45.8	43.5	48.1	48.4	150.4	32.3	47.4	50.6	182.3	85.1	82.8	48.6	58.5	175.8	10.7	14.4	11.1	14.0	10.7	12.7	15.1	13.0	14.6	13.6	13.7	14.8	79.9	240.4	269.9	0.7	90.7	35.1	165.1	699.1	38.1	4.2	55.0	51.2	17.6	72.9	420.9	46.0	2.1	124.5	120.8	264.1	56.7	490.3	1.7	210.6	28.7	118.9	96.3	176.3	0.9	1424.3	149.1	89.1	345.1	104.5	452.2	32.1	124.9	20.2	183.0	10.1	0.9	263.1	109.9	332.7	308.2	3.5	34.8	387.3	71.2	15.9	589.7	48.3	139.0	4.5	6.6	1067.8	308.4	27.8	65.2	147.5	333.7	81.3	343.8	17.2	13.1	109.7	67.2	2.0	11.2	461.5	38.1	99.7	112.9	59.2	242.6	984.3
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1341	"liver: 5056.6"	"Cell type enriched"	"Detected in some"	49	"Hepatocytes: 2707.9"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"Hep G2: 84.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		120000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.3	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.2	3.7	5056.6	0.3	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.1	0.3	0.1	0.0	0.7	0.1	0.0	0.3	0.1	0.2	0.0	0.2	1.5	0.2	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	84.2	0.0	1.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.2	1.8	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.3	0.1	3.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	37.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	1.6	0.0	34.7	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.1	42.1	2707.9	0.2	0.0	0.1	0.0	0.0	55.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.3	3.7	0.0	0.0	0.2
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755265	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 1578.5"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1007.7"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 44.7"	"Lineage enriched"	"Detected in many"	23	"dendritic cells: 44.7"	"Cell line enriched"	"Detected in some"	24	"Hep G2: 145.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	NA	NA	11900	61000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	11.6	2.0	1.4	4.3	1.5	0.4	18.3	1.2	2.2	7.1	11.1	4.2	0.7	8.7	101.4	3.0	19.6	0.7	2.5	2.0	1.4	74.1	1578.5	12.9	3.0	1.6	1.6	7.7	9.2	0.1	1.9	0.8	1.7	21.4	0.5	0.5	6.1	32.6	4.3	5.5	11.6	1.8	1.3	7.1	3.7	12.5	1.8	2.6	7.9	0.4	3.5	7.3	5.8	2.2	1.8	6.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.9	0.0	0.3	0.9	0.0	3.3	0.0	0.0	0.0	0.1	0.9	145.9	1.1	0.8	0.1	1.6	1.2	0.0	0.7	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.7	0.1	0.3	0.3	0.1	0.9	1.3	0.0	0.3	0.0	0.2	0.6	0.0	1.1	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.9	1.4	0.0	0.8	0.0	0.5	0.0	0.0	10.7	0.5	0.0	0.0	0.0	1.2	0.0	44.7	0.0	1.2	1.4	1.5	1.2	2.2	2.0	1.4	1.6	1.6	1.7	1.3	1.8	2.2	1.6	3.2	19.6	0.3	5.3	1.5	4.9	10.3	8.0	0.2	20.5	8.8	0.7	27.1	7.0	1.8	6.2	0.2	32.1	0.7	9.8	0.0	0.6	0.1	2.7	3.4	4.2	23.6	1.6	4.9	0.3	2.7	0.0	0.3	1.3	0.3	14.6	1007.7	7.7	0.0	1.9	2.1	12.2	32.2	20.1	0.8	33.8	8.2	1.8	1.0	10.9	0.1	0.0	1.0	0.7	3.8	2.7	26.7	3.2	2.8	2.2	87.5	4.4	0.4	0.0	1.3	1.2	0.4	0.5	1.3	1.6	0.3	2.6	0.0	3.3	1.8
SERPINI1	PI12	ENSG00000163536	"Serpin family I member 1"	Q99574	3	167735243-167825569	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 301.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 219.4;Excitatory neurons: 176.9;Inhibitory neurons: 228.8;Oligodendrocytes: 174.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.2;Karpas-707: 29.1;U-266/84: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001565, HPA056092"	Enhanced		Uncertain	Cytosol	"Secreted in brain"	NA	NA		750000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA001565: AB_1079924, HPA056092: AB_2683036"	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	13.1	15.8	138.8	4.1	157.7	2.3	11.7	115.9	301.4	8.4	82.1	5.1	2.2	8.6	8.2	5.5	7.9	6.3	14.0	162.0	129.1	32.1	4.1	6.4	4.6	122.8	153.6	6.9	39.5	6.9	42.8	6.7	123.9	11.8	4.4	84.4	23.0	7.4	3.2	3.1	4.4	6.1	134.6	8.7	10.8	15.8	134.5	4.4	11.2	8.1	8.2	4.9	6.0	164.8	0.8	3.5	5.5	0.4	10.3	2.2	0.3	1.9	2.7	1.3	2.2	1.5	5.9	29.2	9.5	1.3	4.5	1.3	3.9	3.8	1.5	7.7	6.5	8.9	22.5	10.7	0.7	1.4	1.1	3.8	1.4	0.8	1.3	2.9	0.4	10.5	18.9	29.1	1.2	2.7	0.8	1.9	3.3	4.2	4.5	2.7	0.4	3.2	11.2	1.0	2.2	13.4	3.6	6.8	8.3	12.4	10.6	4.4	1.0	5.5	0.5	0.5	10.3	23.0	28.4	18.8	4.2	7.7	3.2	1.5	0.3	0.8	9.3	0.7	6.9	22.1	9.7	10.2	0.5	25.2	6.9	8.1	0.9	9.5	0.5	7.2	27.2	5.2	138.8	157.7	115.9	301.4	162.0	129.1	122.8	153.6	123.9	134.6	134.5	164.8	49.8	6.4	1.5	43.1	10.7	3.7	13.2	6.4	14.2	219.4	3.6	14.1	8.2	1.5	6.7	5.5	14.6	6.1	6.2	0.7	7.9	1.8	0.4	2.0	1.0	16.0	4.8	7.4	176.9	18.0	6.0	8.9	2.6	1.7	2.5	2.3	3.9	0.6	2.3	5.0	228.8	0.3	73.2	0.6	3.2	2.4	4.1	0.9	7.2	25.3	1.2	78.0	2.1	31.2	174.7	3.0	0.0	2.6	14.6	6.7	0.0	39.9	13.6	35.4	26.3	5.2	54.7	3.0	27.4	0.5	1.7	5.1	6.2	1.1	0.3	2.3
SERPINI2	"MEPI, PANCPIN, PI14, TSA2004"	ENSG00000114204	"Serpin family I member 2"	O75830	3	167441789-167479004	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"pancreas: 1370.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 37.5;Exocrine glandular cells: 93.4;Respiratory ciliated cells: 22.9"	"Cancer enriched"	"Detected in some"	6	"pancreatic cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"THP-1: 9.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 8.7"						"Secreted to digestive system"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 25: Pancreas - Digestion"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (1.88e-2)"	"unprognostic (2.23e-3)"		"unprognostic (1.14e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.17e-2)"		"unprognostic (1.29e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.76e-5)"	"unprognostic (5.35e-2)"	"unprognostic (4.16e-2)"			0.1	0.1	3.7	0.0	2.9	0.4	0.1	4.4	1.5	0.2	10.2	0.1	1.0	0.2	0.2	0.2	3.9	0.0	0.5	2.5	3.7	0.2	0.0	1.0	0.1	9.6	7.7	0.5	1370.0	0.0	0.4	0.0	7.1	0.2	0.0	0.0	0.4	0.0	0.0	0.1	1.9	0.1	9.4	0.2	0.3	0.1	4.3	0.0	0.0	0.2	0.1	0.1	0.1	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	9.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	2.9	4.4	1.5	2.5	3.7	9.6	7.7	7.1	9.4	4.3	5.8	0.0	0.0	1.1	37.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	5.9	0.1	0.1	0.0	0.0	3.6	93.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	2.0	0.9	4.8	0.0	0.0	0.0	0.0	0.7	0.0	22.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
SESN3	"MGC29667, SEST3"	ENSG00000149212	"Sestrin 3"	P58005	11	95165513-95232541	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 680.7;Late spermatids: 529.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.7;ASC TERT1: 50.7;SuSa: 110.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037935			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA037935: AB_10670534"	"unprognostic (2.72e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.09e-3)"	"unprognostic (5.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.34e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.42e-2)"	9.6	17.5	42.3	14.3	56.4	17.9	14.7	24.3	37.8	11.8	26.0	5.7	6.5	11.4	14.1	8.9	8.4	12.4	5.4	32.6	30.7	10.5	7.5	9.1	24.4	21.4	40.6	21.9	3.1	25.8	11.2	7.1	22.5	10.2	6.5	23.4	9.9	5.5	5.3	10.7	12.5	9.2	28.8	17.3	4.9	57.7	54.6	21.8	21.7	13.1	24.2	11.2	8.8	26.6	0.0	1.0	28.2	0.1	46.7	50.7	0.1	0.2	0.0	0.0	0.1	1.2	0.9	7.7	3.4	0.1	1.3	5.7	17.3	12.5	0.0	6.4	9.0	3.9	15.4	1.2	0.9	3.4	0.7	28.1	21.4	0.1	6.3	8.7	1.1	4.5	0.4	1.4	2.3	0.2	2.5	9.0	11.5	0.2	1.2	5.7	1.7	0.6	6.2	19.1	3.6	7.9	0.3	0.2	1.6	110.9	0.0	11.0	0.3	3.2	7.1	0.6	1.1	0.3	0.0	1.0	1.4	4.0	6.9	0.5	0.3	0.2	0.2	0.7	0.3	1.8	0.8	0.5	0.3	1.1	1.6	0.6	0.3	0.3	1.5	0.4	1.7	0.3	42.3	56.4	24.3	37.8	32.6	30.7	21.4	40.6	22.5	28.8	54.6	26.6	13.4	25.6	7.9	152.8	97.6	23.1	26.2	38.3	76.2	48.2	16.1	25.5	7.6	2.8	15.6	35.0	22.9	0.7	7.1	6.9	1.9	6.0	680.7	7.7	45.4	36.4	7.3	73.4	130.8	2.3	0.6	36.5	10.7	14.5	7.0	28.0	35.3	6.4	23.4	0.0	95.1	11.4	8.2	54.8	58.8	529.5	40.7	36.7	32.0	97.4	82.0	98.9	10.3	48.2	37.2	2.2	7.3	87.3	11.9	13.6	27.7	22.5	4.5	14.8	6.6	31.5	28.9	45.4	11.1	38.2	12.5	1.6	41.3	76.4	14.8	14.9
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Karpas-707: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		66000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	7.3	1.9	2.0	3.7	3.7	1.8	6.3	11.6	5.7	11.6	0.0	10.9	1.7	8.3	7.2	4.5	7.2	5.0	4.3	2.6	0.2	7.4	4.7	6.6	5.3	0.0	0.1	7.7	5.8	3.7	2.7	7.2	0.1	7.8	3.5	3.0	4.3	9.2	10.7	4.4	4.6	7.4	0.0	3.7	5.6	1.8	0.0	4.4	5.1	9.7	4.7	8.1	8.5	3.8	0.0	2.4	16.1	0.0	4.1	1.2	1.0	1.3	3.0	1.5	1.3	0.2	0.0	1.0	0.5	1.8	1.0	4.8	1.8	4.9	1.0	1.4	0.8	0.0	1.8	1.2	0.0	0.0	0.0	3.8	2.0	0.0	3.0	2.7	0.5	0.0	0.1	44.7	0.4	0.8	0.0	0.1	2.0	0.0	1.1	5.6	0.0	5.5	4.9	3.9	8.2	4.2	0.0	0.0	0.9	7.1	2.2	0.0	0.0	9.5	3.3	0.0	7.7	8.6	0.5	0.0	5.8	0.2	5.5	0.1	0.0	0.0	0.4	0.6	0.0	2.0	0.0	0.2	0.0	3.0	0.0	0.1	0.0	0.0	1.0	2.8	0.0	0.1	2.0	3.7	11.6	5.7	2.6	0.2	0.0	0.1	0.1	0.0	0.0	3.8	7.6	0.0	1.8	85.5	42.4	15.4	8.6	8.3	7.4	12.5	11.0	12.6	3.9	14.3	4.2	16.5	18.8	1.5	25.5	1.6	3.9	4.5	1.3	12.9	15.6	8.3	12.0	0.8	349.0	3.5	1.4	29.3	4.1	14.8	0.0	0.7	17.9	16.5	2.0	3.3	548.3	4.4	10.2	2.4	8.7	3.7	62.7	4.6	3.6	88.1	1.5	10.7	6.2	170.4	62.9	3.7	9.1	39.9	29.6	8.1	0.4	10.5	5.8	18.2	6.6	18.4	28.6	0.3	0.8	4.0	15.2	0.8	5.9	0.1	4.7	1.5
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 99.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 99.8;T-cells: 36.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA		23000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	7.6	15.4	14.0	18.2	14.8	21.9	8.1	15.0	17.4	9.3	15.0	28.1	19.3	8.5	8.0	14.7	8.7	9.8	12.3	13.3	15.3	41.6	99.7	5.9	27.0	12.1	12.6	18.7	13.1	15.8	12.9	15.3	13.2	9.6	17.7	20.7	9.6	10.4	10.9	8.8	20.1	11.3	13.0	10.5	14.6	6.6	13.8	24.0	10.5	15.7	27.0	13.8	11.2	14.8	39.9	123.1	61.7	67.0	21.0	44.4	99.2	99.1	41.5	81.3	78.3	156.5	77.6	82.3	74.9	51.9	100.4	49.7	119.0	171.9	87.8	202.1	102.4	60.6	103.4	69.0	30.3	119.6	73.3	36.5	33.1	90.3	39.2	48.3	63.3	74.9	89.1	63.4	60.2	138.3	140.3	9.7	48.7	66.5	41.1	116.3	63.1	87.8	31.3	154.2	104.6	66.7	95.6	88.9	47.8	50.5	43.1	38.3	62.3	63.9	100.3	47.5	130.2	80.2	101.8	184.6	105.1	104.9	68.1	99.8	5.1	26.3	26.2	6.7	21.4	10.7	36.4	29.2	7.3	9.3	28.4	29.3	1.6	12.7	4.3	3.5	32.3	14.2	14.0	14.8	15.0	17.4	13.3	15.3	12.1	12.6	13.2	13.0	13.8	14.8	6.0	3.2	13.5	55.2	29.1	19.5	33.5	30.6	48.9	59.3	13.7	9.9	18.1	17.2	18.8	18.4	47.9	41.4	19.0	68.9	25.4	27.7	1.2	10.9	23.3	14.2	31.2	45.4	77.3	18.7	74.2	24.8	26.0	11.3	9.5	38.1	12.8	98.7	17.2	77.4	62.9	23.9	26.4	8.1	11.4	4.0	47.2	9.5	10.6	30.9	9.0	19.8	37.0	55.3	60.1	31.8	20.1	35.0	63.4	31.6	89.8	51.1	15.5	49.9	26.3	21.7	23.1	2.8	7.4	43.6	21.6	30.9	61.9	67.2	21.7	27.0
SFXN2	SLC56A2	ENSG00000156398	"Sideroflexin 2"	Q96NB2	10	102714538-102743492	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.9;parathyroid gland: 12.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Hepatocytes: 21.2;Proximal tubular cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018150, HPA026834"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018150: AB_1856790, HPA026834: AB_1856791"	"unprognostic (1.70e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.98e-3)"	"prognostic favorable (2.28e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.77e-2)"	"prognostic favorable (6.52e-4)"	1.5	1.1	1.2	1.9	2.8	3.0	2.8	3.9	1.7	1.6	3.6	1.9	2.5	2.7	3.6	1.4	3.6	1.1	0.6	1.8	0.8	17.9	4.2	1.6	2.6	1.0	0.5	3.4	3.1	12.7	2.7	3.4	1.2	2.2	3.0	2.7	4.9	1.3	0.7	1.9	1.9	1.1	0.2	2.1	3.3	1.2	1.8	3.2	3.8	0.2	1.9	0.9	0.7	2.1	4.2	2.3	3.5	3.7	1.3	0.9	5.1	1.4	0.6	1.8	0.9	7.2	1.9	9.1	2.7	1.2	1.0	3.0	0.7	4.8	1.0	1.6	2.8	13.1	4.4	4.5	0.6	7.5	1.1	1.0	0.7	1.8	1.8	1.1	1.7	7.7	6.0	4.2	1.1	4.0	11.5	2.5	2.3	4.0	0.8	5.5	4.3	1.3	1.7	3.5	2.6	2.5	1.2	3.1	0.6	1.4	38.4	1.6	1.2	1.4	4.4	1.8	3.1	4.6	6.5	7.9	1.7	9.0	1.2	1.6	0.5	0.2	1.9	0.2	1.7	0.8	1.9	2.0	0.7	2.5	3.0	2.5	0.9	1.9	0.3	1.7	2.0	0.7	1.2	2.8	3.9	1.7	1.8	0.8	1.0	0.5	1.2	0.2	1.8	2.1	1.0	0.0	10.1	5.2	3.8	0.9	3.0	0.8	4.0	6.1	7.3	5.2	2.5	4.3	2.0	1.8	33.3	9.1	2.4	2.5	9.8	1.9	0.8	7.3	4.2	2.2	3.6	4.2	5.4	2.8	4.4	3.2	8.2	10.0	0.0	9.2	5.0	21.2	9.6	0.0	5.5	5.0	0.0	7.5	0.6	0.5	2.1	2.4	0.0	8.4	0.8	1.1	4.1	7.1	2.9	1.4	0.8	1.5	6.7	4.4	2.4	43.1	0.4	15.1	0.0	2.7	1.7	1.2	1.3	3.3	1.3	4.5	2.8	2.6	7.3	2.9
SFXN5	"BBG-TCC, SLC56A5"	ENSG00000144040	"Sideroflexin 5"	Q8TD22	2	72942036-73075619	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 405.2;Early spermatids: 96.4;Late spermatids: 168.4"	"Cancer enhanced"	"Detected in all"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015473, HPA056866"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Mitochondria"		"HPA015473: AB_1856794, HPA056866: AB_2683261"	"unprognostic (7.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (2.26e-6)"	"unprognostic (1.57e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-2)"	3.2	11.7	52.1	4.6	45.5	13.7	2.5	40.0	63.6	3.2	21.9	6.1	6.9	3.1	16.6	3.1	4.2	4.0	3.5	48.0	45.2	11.4	29.4	3.6	3.9	51.5	49.2	2.6	2.4	2.0	3.5	3.7	41.4	4.2	5.7	6.2	2.2	4.5	7.7	4.5	6.5	3.9	42.6	5.6	4.6	2.4	57.0	4.9	3.7	4.6	3.0	3.8	2.3	37.4	4.2	9.1	13.7	11.5	3.0	5.0	5.4	8.4	5.4	13.3	6.9	13.7	10.7	2.3	8.8	8.9	9.2	3.7	10.8	11.1	6.0	10.2	6.7	10.7	11.0	18.7	4.4	5.9	11.1	5.8	3.5	9.0	1.1	4.9	7.4	3.2	9.5	2.9	4.3	8.7	1.5	9.5	17.1	8.1	6.6	10.6	12.2	3.1	8.1	10.5	9.0	2.7	8.6	4.3	3.5	7.7	2.2	5.3	6.8	4.1	13.5	6.1	10.2	4.0	4.1	3.1	15.0	10.3	5.3	4.7	6.0	3.5	0.6	2.6	0.9	1.6	0.3	0.7	2.7	2.4	0.4	0.5	4.6	4.3	3.2	1.9	0.7	1.7	52.1	45.5	40.0	63.6	48.0	45.2	51.5	49.2	41.4	42.6	57.0	37.4	7.1	0.0	4.4	405.2	4.8	4.7	4.3	7.6	4.6	26.8	6.9	5.5	5.8	7.2	4.8	36.8	33.3	12.4	6.8	18.4	3.9	5.1	96.4	5.1	13.1	7.6	13.8	13.7	84.4	9.1	2.4	8.9	9.2	11.2	0.0	42.8	9.3	61.3	12.4	20.2	57.4	8.6	2.0	8.7	9.6	168.4	10.5	9.6	8.8	43.1	19.7	65.8	10.3	40.2	29.9	8.0	6.5	11.3	7.1	3.6	17.5	22.2	3.2	42.3	13.1	12.2	8.8	11.2	15.7	7.3	9.2	4.2	6.3	15.9	8.8	2.3
SH2B3	"IDDM20, LNK"	ENSG00000111252	"SH2B adaptor protein 3"	Q9UQQ2	12	111405923-111451623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 113.6;Langerhans cells: 130.9;Macrophages: 84.1;monocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 122.2;hTEC/SVTERT24-B: 140.7;U-87 MG: 211.6;WM-115: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005483	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA005483: AB_1079260"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.17e-3)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (2.86e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.24e-2)"	22.2	10.9	10.2	21.9	6.8	60.7	13.3	3.5	9.3	8.6	8.5	11.4	8.1	8.5	3.3	7.7	8.1	18.6	23.4	5.8	6.5	14.3	17.4	20.5	21.0	12.0	7.3	5.5	10.2	5.8	8.0	24.4	10.0	7.3	13.5	3.7	5.3	5.9	9.6	4.1	12.5	13.6	10.1	37.1	7.1	9.5	12.1	10.5	11.1	9.5	15.8	15.7	6.0	14.7	9.2	5.5	7.0	7.3	23.9	35.5	4.8	29.2	79.5	21.9	23.3	8.4	5.2	15.6	20.3	44.6	73.6	1.7	5.5	16.9	35.2	13.3	2.7	53.2	2.6	6.2	23.3	23.5	122.2	21.2	3.8	140.7	12.7	48.4	119.1	12.8	38.9	6.1	80.2	3.2	9.7	46.7	11.0	2.4	21.0	9.5	15.9	10.2	10.5	3.7	4.6	4.9	5.4	0.6	42.2	6.2	3.5	33.4	93.0	20.0	11.3	17.4	48.1	13.9	15.8	17.6	211.6	16.6	165.3	0.9	3.5	1.2	1.2	8.4	1.0	1.5	1.1	1.3	4.8	0.5	0.7	1.0	3.0	1.8	6.6	4.9	0.4	1.8	10.2	6.8	3.5	9.3	5.8	6.5	12.0	7.3	10.0	10.1	12.1	14.7	26.8	3.2	22.0	2.6	26.2	6.8	1.5	4.2	1.2	4.6	4.3	3.8	17.5	4.3	4.3	1.8	2.1	0.4	40.6	15.0	1.9	3.6	13.1	1.0	2.2	39.2	3.5	11.2	11.0	9.0	1.4	8.1	0.5	1.2	38.6	0.8	46.1	11.1	40.4	3.3	7.3	3.0	6.1	113.6	130.9	5.3	2.8	84.1	16.0	38.4	67.1	1.1	18.6	11.1	9.0	7.2	5.9	4.1	4.9	3.0	0.8	1.5	3.5	3.4	0.0	4.0	12.7	12.5	4.5	0.7	4.1	1.0	12.1	4.4	3.2	1.2
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"lymphoid tissue: 262.5"	"Group enriched"	"Detected in some"	7	"dendritic cells: 77.6;NK-cells: 138.0;T-cells: 108.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	54	"gdT-cell: 120.2;MAIT T-cell: 162.9;memory CD4 T-cell: 90.4;memory CD8 T-cell: 175.8;naive CD4 T-cell: 91.2;naive CD8 T-cell: 108.3;NK-cell: 162.2;T-reg: 125.3"	"Group enriched"	"Detected in many"	70	"NK-cells: 162.2;T-cells: 175.8"	"Group enriched"	"Detected in some"	6	"HDLM-2: 101.1;JURKAT: 193.0;Karpas-707: 201.3;MOLT-4: 257.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA072265			Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA072265: "	"prognostic favorable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"	1.4	1.1	0.0	10.8	0.1	5.4	1.2	0.1	0.2	0.9	0.1	1.6	1.5	0.6	0.6	1.1	0.5	4.1	0.3	0.1	0.1	0.4	2.8	3.2	38.4	0.2	0.1	0.4	0.2	0.2	0.2	0.3	0.1	1.1	1.5	0.0	1.3	0.3	0.3	0.4	2.5	0.6	0.2	14.7	2.7	0.2	0.1	262.5	0.7	1.2	16.6	5.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	101.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	193.0	0.0	201.3	0.0	0.0	257.2	4.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	32.7	33.3	0.0	0.2	0.0	0.0	1.4	0.6	0.1	120.2	0.5	162.9	1.1	90.4	175.8	0.5	0.2	91.2	108.3	2.4	162.2	1.2	0.8	125.3	91.3	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	1.1	3.2	4.7	0.0	3.0	1.5	0.1	0.0	0.0	0.0	0.7	0.8	0.2	1.5	0.0	0.0	0.0	0.1	77.6	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	7.4	0.1	0.0	0.0	2.0	1.1	0.2	3.8	0.0	3.6	0.9	0.1	0.0	0.0	0.0	0.0	5.6	4.4	0.0	0.0	4.3	5.4	0.0	2.3	0.0	138.0	0.5	0.2	0.0	0.0	0.0	14.1	0.2	0.0	0.5	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.2	1.0	0.1	108.9	0.0	0.0	0.0
SH2D3C	NSP3	ENSG00000095370	"SH2 domain containing 3C"	Q8N5H7	9	127738317-127778710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.6;dendritic cells: 29.7;Endothelial cells: 52.2;Hepatic stellate cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.3;HUVEC TERT2: 60.0;REH: 60.7;RPMI-8226: 46.1;TIME: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047586	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047586: AB_2680093"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.47e-4)"	"unprognostic (5.23e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (3.75e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.28e-2)"	27.3	7.6	11.2	15.9	10.5	11.2	24.9	11.7	13.2	12.2	2.8	7.6	4.5	15.8	1.2	5.8	12.6	9.2	44.7	10.7	9.6	19.9	4.7	52.2	25.8	8.6	7.5	5.0	4.8	3.9	7.1	15.8	8.4	8.5	1.8	0.8	6.8	3.5	14.6	7.4	15.1	7.3	8.1	47.2	7.3	5.1	8.9	27.8	22.9	11.4	10.5	10.9	9.4	8.0	0.1	0.2	0.9	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	19.5	1.1	0.0	1.1	0.7	0.0	0.0	0.0	15.6	0.3	7.3	0.1	0.0	0.3	5.6	53.3	0.3	0.2	0.3	0.1	0.0	60.0	11.6	0.2	20.6	0.0	0.1	5.1	16.8	0.8	0.0	0.0	60.7	0.9	46.1	0.0	0.0	14.5	4.4	0.3	0.1	0.0	1.4	0.1	9.6	50.1	0.0	1.2	0.1	0.1	20.3	22.2	20.3	0.4	4.8	0.0	34.0	29.9	37.8	32.3	94.7	26.4	26.2	18.8	30.4	32.8	29.5	16.6	17.5	82.2	34.6	124.8	59.8	21.6	34.2	11.2	10.5	11.7	13.2	10.7	9.6	8.6	7.5	8.4	8.1	8.9	8.0	52.6	3.2	5.8	0.7	15.9	1.3	0.3	1.9	0.6	3.2	1.1	1.7	10.5	2.8	0.9	0.0	0.0	0.3	29.7	0.0	0.0	0.5	13.8	2.2	2.8	52.2	4.2	3.6	10.8	0.0	0.2	3.1	2.0	0.8	11.4	0.0	41.7	0.7	6.0	3.3	10.7	0.3	0.0	6.0	3.7	16.3	1.2	10.7	1.8	23.4	13.4	3.6	21.6	3.0	0.7	0.1	0.0	0.7	7.6	0.1	0.0	0.1	0.8	2.4	6.6	1.2	12.5	1.8	1.5	0.9	0.4	0.7	15.5	2.0	0.1	0.2
SH2D6	FLJ35993	ENSG00000152292	"SH2 domain containing 6"		2	85418931-85437029	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"intestine: 1.9"	"Group enriched"	"Detected in some"	5	"Enteroendocrine cells: 10.7;Gastric mucus-secreting cells: 18.3;Proximal tubular cells: 16.7;Spermatocytes: 6.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"LHCN-M2: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA053873	Uncertain					NA	NA					"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA053873: AB_2682286"	"unprognostic (4.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.06e-7)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.65e-3)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.8	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0		0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.4	0.1	0.2	0.3	0.2	0.3	0.1	0.3	0.4	0.0	0.0	0.0	1.3	0.2	0.0	0.5	0.0	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	1.9	0.0	0.3	0.1	0.1	0.0	10.7	0.0	0.6	0.0	0.0	0.1	18.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	2.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.0	2.4	0.1	2.3	0.4	0.1	0.3	0.6	16.7	0.0	0.2	0.0	0.8	0.2	6.8	2.3	0.0	0.0	0.1	0.3	0.1	1.5	0.0
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579066-17797124	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 123.8;retina: 75.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	0.3	0.2	63.0	0.1	69.0	0.0	0.1	92.3	123.8	2.3	1.9	0.5	0.2	2.2	1.2	0.5	2.0	0.0	4.3	77.7	26.6	16.8	0.2	1.1	0.0	27.9	28.5	1.8	3.0	0.3	26.2	0.0	25.9	1.8	0.6	75.0	0.1	0.1	0.1	0.1	0.5	1.7	29.3	0.1	8.7	6.5	41.1	0.7	1.5	0.0	0.0	4.3	0.4	55.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	7.5	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	9.3	0.0	21.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.1	0.2	2.5	0.0	2.4	0.0	0.0	0.0	0.0	41.8	26.5	0.0	0.3	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.2	0.0	1.5	0.0	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	69.0	92.3	123.8	77.7	26.6	27.9	28.5	25.9	29.3	41.1	55.5	0.0	0.0	0.0	16.3	0.0	0.1	0.4	0.0	0.0	89.4	0.1	0.0	1.8	0.0	0.0	7.3	22.9	0.0	0.0	0.1	11.7	0.0	16.7	0.2	0.1	0.3	5.3	0.0	390.8	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	13.5	140.9	0.7	0.0	0.0	0.3	47.4	1.2	0.1	0.0	13.1	0.1	9.0	0.0	41.7	10.2	0.2	0.1	0.4	0.0	2.2	0.0	22.2	0.0	28.0	0.0	0.0	0.1	2.4	6.1	0.0	0.0	0.1	0.0	1.2	0.7	0.4
SH3PXD2A	"FISH, KIAA0418, SH3MD1"	ENSG00000107957	"SH3 and PX domains 2A"	Q5TCZ1	10	103594027-103855543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.8;BJ hTERT+: 84.8;fHDF/TERT166: 68.5;HSkMC: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037922, HPA037923"	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA037922: AB_10697088, HPA037923: AB_10672612"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.62e-2)"	18.9	8.5	49.2	11.5	45.1	1.4	14.5	25.6	38.6	49.0	2.9	27.3	5.7	31.2	7.2	30.3	25.7	17.4	16.9	32.8	32.2	7.0	23.0	17.2	4.7	38.1	40.9	29.5	8.4	1.2	14.0	16.3	39.1	18.5	13.4	17.1	14.1	13.9	19.0	29.4	14.3	26.7	44.8	13.3	13.0	3.0	42.4	6.7	9.2	14.3	5.9	21.5	31.9	64.7	1.3	5.3	13.7	16.5	48.1	86.8	7.3	39.5	84.8	13.1	12.4	0.5	0.4	0.0	7.7	68.5	1.5	13.3	0.8	35.5	11.6	2.3	14.3	16.5	21.8	19.2	31.0	8.2	4.5	64.5	27.2	20.1	43.5	9.8	8.8	17.9	6.1	9.7	16.6	0.5	0.2	8.0	5.8	11.4	2.5	6.8	5.2	1.0	5.5	4.8	10.2	5.5	3.8	0.9	19.9	7.4	0.2	5.8	15.4	11.0	7.6	14.3	17.7	10.9	24.1	0.5	10.7	11.1	42.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	49.2	45.1	25.6	38.6	32.8	32.2	38.1	40.9	39.1	44.8	42.4	64.7	22.6	6.4	45.4	10.1	7.6	91.0	26.4	45.2	56.3	46.1	9.3	13.5	22.9	22.8	37.8	3.7	27.1	12.1	3.4	48.1	0.0	5.3	3.2	7.7	109.9	23.9	37.1	10.5	59.5	0.6	32.0	42.2	12.8	11.5	17.7	21.8	23.9	87.3	13.0	89.2	96.6	74.8	22.4	7.6	34.9	7.3	105.9	7.7	33.8	15.0	19.0	1.7	2.1	5.0	117.2	6.2	27.0	80.5	7.9	32.1	4.1	1.3	21.6	35.7	39.5	32.1	55.6	1.9	3.7	37.5	38.1	4.7	6.8	15.0	22.7	61.1
SH3RF3	"FLJ00204, POSH2, SH3MD4"	ENSG00000172985	"SH3 domain containing ring finger 3"	Q8TEJ3	2	109129205-109504634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 47.0;Excitatory neurons: 108.3;Inhibitory neurons: 160.9;Microglial cells: 164.9;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 19.8;RPMI-8226: 20.5;TIME: 23.2;U-266/84: 28.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044822, HPA048444"	Approved		Supported	Nucleoplasm		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA044822: AB_2679103, HPA048444: AB_2680396"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (4.57e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-2)"	6.1	6.7	4.7	3.0	6.1	0.8	4.3	1.3	6.5	5.5	1.6	5.6	1.1	3.7	0.7	2.8	4.8	4.4	6.0	6.3	3.2	6.8	1.1	7.2	2.1	3.0	4.5	3.2	2.0	0.5	1.9	5.2	2.8	4.7	1.4	0.6	1.6	4.4	5.7	3.1	3.3	3.8	3.1	2.1	2.9	4.2	3.9	3.2	2.5	7.3	1.2	5.5	4.2	3.5	0.0	0.1	0.1	2.2	9.0	6.9	0.0	4.2	12.2	3.1	1.1	1.1	0.0	0.0	3.1	3.1	0.7	0.0	0.2	1.8	1.3	0.0	4.2	0.0	0.2	0.0	19.8	0.1	0.0	12.0	2.9	14.1	6.3	1.8	11.4	2.2	0.0	11.7	7.3	0.0	0.0	6.5	1.1	0.0	12.0	2.6	0.0	20.5	0.0	0.0	0.7	2.5	0.0	0.0	0.4	0.1	0.2	0.0	23.2	4.0	12.0	11.5	5.5	4.0	28.6	0.0	0.0	6.3	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.7	6.1	1.3	6.5	6.3	3.2	3.0	4.5	2.8	3.1	3.9	3.5	5.3	0.0	0.0	47.0	0.2	1.9	0.4	0.2	1.8	0.5	0.6	0.5	10.7	0.0	0.7	0.0	0.0	0.0	1.5	0.1	0.0	1.1	2.6	9.4	9.6	6.7	1.8	0.0	108.3	0.2	0.2	4.8	0.0	1.1	0.0	0.2	7.5	0.0	4.7	10.1	160.9	0.8	0.0	2.5	1.5	5.2	2.1	1.2	5.4	164.9	0.0	1.7	0.0	42.3	1.9	0.1	0.0	3.0	1.6	0.2	0.0	0.6	2.1	0.0	13.1	3.2	6.8	0.7	9.6	0.8	0.9	0.1	0.5	2.3	0.1	0.0
SHANK3	"KIAA1650, prosap2, PSAP2, SPANK-2"	ENSG00000251322	"SH3 and multiple ankyrin repeat domains 3"		22	50674415-50733298	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"brain: 73.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.3;Endothelial cells: 65.0;Hepatic stellate cells: 70.3;Microglial cells: 44.0;Oligodendrocytes: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 33.3;TIME: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003446	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA003446: AB_1079958"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-1)"	34.9	4.0	38.9	4.9	21.6	1.1	33.5	73.5	54.7	12.8	0.0	7.5	3.4	13.4	2.0	5.2	12.4	5.8	26.2	44.7	14.9	11.9	4.4	20.3	4.2	10.0	15.3	4.3	4.0	3.5	5.2	13.7	2.6	8.3	1.2	0.7	8.2	4.2	23.3	7.1	6.4	5.1	0.0	50.4	5.7	2.2	38.6	1.7	14.8	8.9	1.4	10.7	10.1	16.2	6.6	2.6	6.2	4.8	0.5	1.6	3.2	1.3	0.0	0.4	0.5	1.6	2.4	0.0	4.0	1.0	3.1	1.2	0.9	2.3	0.0	0.0	10.4	8.0	1.8	7.1	1.9	1.8	0.4	2.2	1.8	0.1	0.3	0.1	33.3	1.9	0.2	0.2	0.5	2.6	1.4	0.5	3.2	0.6	2.2	7.5	0.0	1.7	0.4	1.3	2.3	3.0	2.7	0.0	3.1	0.7	0.3	0.7	37.6	0.4	9.3	2.0	0.7	0.3	0.4	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	21.6	73.5	54.7	44.7	14.9	10.0	15.3	2.6	0.0	38.6	16.2	195.3	0.0	1.1	4.6	0.5	0.3	0.1	0.5	4.0	1.2	1.3	2.4	27.6	0.0	0.8	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.9	3.9	2.4	65.0	2.4	0.0	28.3	0.0	0.0	3.3	0.0	1.5	0.0	0.3	70.3	6.5	0.4	0.0	21.7	0.0	2.0	3.1	0.0	0.4	0.0	0.3	0.0	44.0	0.0	1.4	0.0	25.1	31.3	0.1	0.0	0.4	0.0	0.2	0.0	0.9	0.9	0.0	0.0	1.0	3.8	0.2	0.8	1.0	0.3	0.0	0.6	0.7	0.1	0.3
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633382	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 63.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 51.6;Late spermatids: 124.5;Proximal enterocytes: 31.1"	"Cancer enriched"	"Detected in some"	28	"liver cancer: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.4;Hep G2: 3.0;HSkMC: 4.3"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA		9100000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (3.35e-3)"	"unprognostic (6.47e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.35e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.06e-1)"	0.7	1.3	1.8	0.0	1.8	0.1	0.4	1.7	2.0	0.7	1.9	0.3	5.3	0.5	0.9	0.2	0.6	0.3	0.6	1.9	1.8	3.5	63.4	0.3	0.1	1.8	1.8	0.7	0.4	0.5	0.7	0.3	1.9	0.5	0.2	0.9	0.2	0.4	0.8	0.1	7.1	0.2	1.7	0.4	0.3	12.4	1.7	0.2	0.8	0.7	0.1	0.3	0.2	1.8	0.1	2.4	2.4	0.3	4.4	2.0	0.1	0.6	0.9	0.9	0.5	0.9	0.3	0.0	0.5	0.8	1.2	0.3	0.1	0.1	0.5	0.1	0.3	0.0	0.6	3.0	1.4	0.0	0.1	4.3	0.3	1.6	0.8	0.8	0.1	0.0	0.2	0.1	0.2	0.5	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.1	0.3	1.8	0.0	0.2	0.8	0.4	0.0	0.8	0.4	0.0	0.0	0.2	0.3	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	1.7	2.0	1.9	1.8	1.8	1.8	1.9	1.7	1.7	1.8	0.2	0.0	0.0	0.7	0.5	0.0	0.3	0.1	0.0	0.4	0.5	0.6	0.5	0.0	0.2	0.0	0.0	0.4	0.0	0.2	5.9	0.5	51.6	0.4	0.6	0.1	0.0	0.0	1.0	0.2	0.1	0.4	0.0	0.2	0.0	0.6	1.1	13.8	0.3	0.0	0.9	1.3	2.0	0.8	0.0	124.5	0.9	0.5	0.0	0.0	0.0	2.4	0.0	0.5	0.6	0.1	1.3	0.7	0.0	0.3	31.1	12.8	0.4	1.3	6.6	0.2	0.3	7.2	0.8	0.0	0.0	0.3	0.1	1.1	0.5	0.3
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46578591-46621379	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.4;lymphoid tissue: 10.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.2;Extravillous trophoblasts: 28.7;Plasma cells: 38.3;Spermatocytes: 33.7;Spermatogonia: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	0.7	0.5	0.5	5.1	0.5	17.4	0.9	1.2	0.6	0.6	0.4	1.9	1.2	0.6	0.6	3.5	0.2	0.6	1.0	0.4	0.2	5.4	0.2	1.0	9.8	0.4	0.3	0.3	0.2	0.2	0.2	2.4	0.4	0.3	2.2	0.2	0.8	0.2	1.5	3.3	1.5	1.7	0.1	4.4	0.9	5.2	0.5	8.8	0.3	0.2	10.6	1.2	1.2	0.7	33.8	30.8	11.9	15.3	3.1	6.2	16.2	60.7	24.6	59.2	26.8	14.6	20.8	28.0	30.2	28.8	26.8	21.0	29.3	21.7	73.8	17.7	17.2	28.2	25.8	30.3	0.1	28.5	35.4	1.2	1.6	45.9	18.1	5.9	33.0	14.9	12.7	28.3	69.7	21.5	24.0	23.7	10.0	17.2	31.6	45.4	89.9	44.8	13.7	9.4	5.0	7.2	46.0	23.7	11.1	11.4	13.0	23.4	16.1	43.9	28.7	43.5	54.0	24.9	36.7	46.7	21.4	31.3	45.8	0.2	0.3	0.6	0.2	0.5	0.0	1.7	0.3	0.1	0.3	1.2	0.0	0.1	0.4	0.1	2.4	0.7	1.2	1.1	0.5	0.5	1.2	0.6	0.4	0.2	0.4	0.3	0.4	0.1	0.5	0.7	0.2	0.0	1.1	1.3	7.1	1.7	0.7	1.2	0.0	0.3	0.6	1.1	1.9	1.5	1.4	0.0	0.0	11.3	0.8	1.9	0.0	0.2	8.4	0.7	1.7	1.7	0.0	36.2	2.1	0.0	28.7	3.7	4.1	1.5	0.0	7.6	1.8	0.3	12.6	0.0	0.7	2.2	2.0	4.5	3.3	2.3	0.6	4.0	1.8	2.8	2.8	0.8	0.0	1.0	0.5	0.1	0.1	0.4	38.3	0.5	0.4	0.1	0.1	0.3	0.0	0.5	6.3	33.7	23.7	3.6	0.6	3.7	2.2	0.8	3.4	1.1
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502412	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 49.1;TIME: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037417	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	23.4	9.8	9.4	3.3	8.8	1.2	20.9	7.7	10.6	13.2	7.4	7.4	3.4	12.1	4.3	5.0	12.5	6.9	22.7	8.3	8.3	10.5	5.8	20.6	3.9	8.4	9.1	7.6	3.0	4.9	3.7	16.5	8.8	8.1	4.2	0.6	5.4	4.2	7.1	6.4	8.9	8.0	8.1	21.4	5.5	22.2	10.2	2.6	22.1	11.3	2.3	9.7	9.9	8.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	1.0	13.6	0.0	0.3	1.4	0.0	0.1	0.2	0.1	0.0	1.0	0.0	0.5	0.3	0.2	1.5	1.5	1.1	0.9	0.6	0.6	0.1	0.9	0.8	0.9	2.4	1.7	1.1	4.0	0.0	0.5	9.4	8.8	7.7	10.6	8.3	8.3	8.4	9.1	8.8	8.1	10.2	8.0	56.9	0.0	23.4	3.9	0.3	3.3	0.4	0.3	1.2	0.1	0.4	1.3	4.4	1.5	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	13.0	0.4	0.3	64.4	0.0	2.7	0.3	0.0	0.0	6.7	0.0	0.5	3.8	2.1	85.3	3.4	1.4	0.0	0.3	0.0	0.0	26.7	6.6	23.0	1.5	2.0	0.0	26.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.7	0.0	0.1	0.0	0.4	0.0	3.3	2.2	30.6	13.0	0.3	1.6	0.1	0.7	0.3	0.0	0.3
SHF		ENSG00000138606	"Src homology 2 domain containing F"	Q7M4L6	15	45167214-45201175	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 143.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.6;Granulosa cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 143.8"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 121.0;SH-SY5Y: 54.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 240.6"	"Region enriched"	"Detected in all"	4	"cerebellum: 106.2"	HPA057381			Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA057381: AB_2683423"	"unprognostic (4.05e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.83e-2)"	6.1	22.7	21.9	4.3	20.5	1.0	6.3	143.8	27.8	14.4	0.2	13.4	13.1	11.9	4.7	5.0	10.5	6.6	9.0	21.5	19.5	4.4	38.6	5.6	2.7	12.8	16.9	23.7	3.1	4.4	8.3	1.9	15.9	10.1	5.3	7.1	6.7	5.9	3.8	12.7	8.4	7.5	9.4	4.3	6.7	8.4	21.4	2.4	7.5	4.7	1.9	10.2	11.7	13.4	0.1	1.4	24.0	0.7	1.8	0.9	11.2	3.0	2.1	6.7	9.5	3.6	11.6	1.3	9.5	4.2	6.6	2.1	9.2	0.7	3.2	2.2	4.2	0.8	2.2	24.8	1.0	0.1	8.0	2.2	0.6	0.9	0.2	5.0	5.2	12.0	5.0	0.5	9.5	4.1	5.5	0.9	9.6	4.5	0.6	15.0	19.1	0.5	2.3	0.5	121.0	54.1	0.7	0.8	0.4	7.4	1.2	2.4	0.3	0.8	10.0	0.7	0.4	1.1	0.9	1.1	0.3	0.6	3.8	0.1	0.6	0.5	1.3	0.6	1.4	0.8	0.5	0.8	0.6	1.5	0.7	0.5	0.8	2.0	0.6	0.9	0.1	0.5	21.9	20.5	143.8	27.8	21.5	19.5	12.8	16.9	15.9	9.4	21.4	13.4	4.1	0.0	0.6	3.3	4.2	3.6	5.8	1.7	0.0	50.6	3.6	5.5	2.8	0.0	1.3	0.0	0.0	1.1	2.6	2.1	0.0	0.8	7.9	1.1	3.5	5.7	13.1	0.0	5.9	1.3	0.5	5.8	1.5	2.2	2.5	58.8	5.3	11.7	0.6	10.1	6.9	10.9	2.0	1.0	15.0	15.3	4.4	2.9	8.8	5.6	0.1	5.9	2.1	9.0	1.8	0.7	5.6	4.1	0.7	3.5	18.0	1.1	0.8	5.0	6.6	6.7	9.6	5.4	2.9	1.4	2.6	0.7	2.8	1.8	4.6	9.7
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26052016	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.4;skeletal muscle: 14.2;thyroid gland: 21.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.1;Basal prostatic cells: 14.6;Breast glandular cells: 24.1;Oligodendrocytes: 10.9;Urothelial cells: 19.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 25.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.7;JURKAT: 20.8;LHCN-M2: 18.7;NTERA-2: 15.5;RH-30: 46.3;U-2197: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.5	0.0	1.1	0.2	2.3	0.1	12.4	1.5	2.0	1.7	0.9	0.1	0.7	0.1	7.8	0.2	0.2	0.5	0.2	2.0	1.5	4.7	0.0	4.3	0.5	1.9	1.5	0.3	0.3	0.1	1.6	0.0	1.6	0.5	0.1	0.0	2.7	0.3	14.2	1.1	0.7	0.1	2.2	0.2	2.1	1.2	1.6	2.5	21.0	1.2	0.7	0.7	0.0	5.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.4	4.2	1.4	0.0	0.0	1.7	26.7	1.0	20.8	0.0	0.0	18.7	1.2	2.3	0.5	15.5	8.4	8.2	0.0	46.3	0.3	1.7	6.5	0.4	0.0	0.4	0.0	5.4	2.6	0.7	0.2	1.6	0.1	0.7	30.4	7.0	0.0	0.0	0.0	0.0	0.0	4.1	0.8	0.1	0.5	0.1	0.2	0.2	0.1	0.4	0.1	0.0	0.2	1.0	1.6	0.4	0.2	0.3	0.1	0.2	0.1	1.1	2.3	1.5	2.0	2.0	1.5	1.9	1.5	1.6	2.2	1.6	5.4	4.7	0.0	13.1	0.0	0.4	5.4	14.6	2.3	0.6	0.0	24.1	6.2	0.5	0.0	1.5	3.7	0.0	0.3	0.3	0.1	0.0	6.0	2.6	1.0	0.5	5.1	0.0	0.0	0.0	0.2	0.3	2.8	3.1	2.5	0.0	2.4	1.1	0.0	0.8	0.0	1.0	0.1	8.2	0.3	2.3	1.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.5	10.9	1.2	0.0	0.4	0.2	3.9	0.0	0.3	1.1	0.0	0.0	7.6	1.6	0.7	5.1	0.4	1.7	0.1	1.1	0.7	0.0	19.6
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 398.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 307.7;Proximal tubular cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023314, HPA078682"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA023314: AB_1856830, HPA078682: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favorable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	37.5	9.4	8.1	4.0	9.4	9.5	36.3	12.6	9.5	13.6	7.1	17.5	13.8	7.6	4.9	59.2	13.1	7.7	5.7	8.8	8.5	168.5	398.7	10.3	9.0	10.8	9.3	11.7	8.8	85.7	4.1	7.7	10.7	10.1	6.1	3.1	30.0	10.0	18.8	22.6	24.4	3.7	8.0	21.7	13.3	12.8	9.4	21.1	23.5	18.6	17.6	11.5	19.3	16.0	39.6	28.9	5.5	34.5	29.9	15.8	63.0	11.3	10.3	30.8	31.2	22.1	22.5	26.8	27.8	3.6	16.4	18.8	32.4	39.7	24.3	17.3	30.6	13.0	39.9	21.6	7.2	4.4	11.0	21.1	13.6	23.1	7.2	10.9	9.7	32.3	10.0	10.9	11.3	12.4	46.0	13.9	17.4	43.6	5.1	29.7	48.5	34.7	69.3	17.0	24.0	5.3	82.7	14.9	21.4	50.2	64.5	19.4	2.6	5.7	14.0	71.4	17.6	10.7	20.5	7.1	10.3	12.7	16.5	10.2	4.7	5.2	5.3	5.9	8.1	4.4	6.6	5.5	3.5	3.7	6.8	6.4	0.2	8.5	5.2	1.1	11.2	4.3	8.1	9.4	12.6	9.5	8.8	8.5	10.8	9.3	10.7	8.0	9.4	16.0	11.2	12.8	31.0	3.3	10.4	10.3	21.7	16.5	18.8	3.1	22.7	13.8	2.7	42.9	11.2	36.8	4.2	23.7	5.2	8.9	82.2	13.7	10.9	6.2	1.9	7.4	1.2	28.0	5.2	7.7	76.1	8.0	9.2	10.1	8.2	9.9	13.6	307.7	39.6	0.0	4.8	12.9	4.1	36.8	3.5	5.5	5.9	17.2	12.4	9.4	4.4	33.8	5.2	2.0	11.4	5.3	9.7	3.0	20.3	5.9	53.7	435.7	3.5	4.2	19.7	8.1	4.4	30.0	21.4	35.4	10.5	8.5	10.1	4.9	32.2	10.9
SHOC1	"C9orf84, FLJ32779, MZIP2, Zip2"	ENSG00000165181	"Shortage in chiasmata 1"	Q5VXU9	9	111686173-111795008	"Predicted intracellular proteins, Predicted membrane proteins"	Meiosis	"DNA-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.1"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Endothelial cells: 1.0"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA032108			Approved	Vesicles,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 43: Testis - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Vesicles, Cytosol"		"HPA032108: AB_10669884"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.33e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.31e-2)"	0.0	2.4	0.4	0.0	0.4	0.1	0.0	1.8	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.7	2.2	0.0	0.1	0.0	0.9	0.5	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.1	1.1	17.1	1.0	0.0	0.0	0.0	0.3	0.1	0.2	1.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	5.0	1.1	0.4	0.0	0.0	0.3	0.1	0.0	21.7	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.8	0.7	0.7	0.7	0.9	0.5	1.1	0.4	1.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHROOM4	KIAA1202	ENSG00000158352	"Shroom family member 4"	Q9ULL8	X	50591642-50814302	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 463.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.7;HUVEC TERT2: 26.7;RH-30: 5.0;RPTEC TERT1: 5.5;TIME: 10.0;WM-115: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010089, HPA010565"	Uncertain		Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Focal adhesion sites"	"Nucleoplasm, Vesicles"	"HPA010089: , HPA010565: AB_1079961"	"unprognostic (2.55e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (7.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	8.1	1.8	9.8	1.9	20.0	1.2	5.4	17.1	12.4	3.3	0.9	1.8	1.1	3.6	1.6	2.7	2.2	3.0	7.8	8.9	12.6	5.3	0.9	13.3	0.9	23.8	17.6	1.3	0.9	1.9	2.0	9.0	21.8	2.2	1.4	1.3	2.0	1.8	3.6	1.7	1.5	4.1	13.8	1.0	1.3	0.6	17.3	0.6	3.3	5.0	1.0	3.5	2.3	30.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	6.7	0.9	0.0	0.6	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	0.0	5.5	2.5	0.1	0.0	0.0	0.8	1.5	3.6	0.1	0.1	10.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.3	0.2	5.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	20.0	17.1	12.4	8.9	12.6	23.8	17.6	21.8	13.8	17.3	30.7	45.0	25.6	18.6	3.3	0.0	3.6	2.0	1.9	2.2	0.3	1.0	1.5	4.2	0.0	2.0	5.5	0.0	0.6	0.2	1.1	3.9	0.7	0.1	2.8	5.4	46.5	3.0	0.0	1.1	0.2	3.0	3.0	0.0	2.9	3.8	2.3	30.7	0.9	0.5	0.0	1.1	2.8	0.0	2.4	2.7	0.6	1.2	0.6	0.0	51.5	0.0	3.6	0.0	126.7	463.4	2.3	1.0	1.2	0.0	1.2	0.3	3.5	2.5	0.6	0.0	2.5	2.6	0.0	1.0	2.0	3.1	0.3	0.6	3.0	3.2	1.6
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777242-45851753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;fallopian tube: 3.1"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 28.6;Inhibitory neurons: 35.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.5;ovarian cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"EFO-21: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060576	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA060576: AB_2684325"	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.0	0.2	0.7	0.1	0.9	0.1	0.0	2.3	0.8	0.9	0.0	0.0	0.0	0.3	0.3	0.0	3.1	0.0	0.0	0.6	0.7	0.6	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.3	0.7	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	2.3	0.8	0.6	0.7	0.8	3.0	0.8	0.6	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	1.8	2.1	0.0	0.0	0.0	1.9	0.0	0.0	28.6	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1
SIGLEC1	"CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN"	ENSG00000088827	"Sialic acid binding Ig like lectin 1"	Q9BZZ2	20	3686970-3712600	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Hofbauer cells: 78.6;Kupffer cells: 93.4;Macrophages: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Cell line enriched"	"Detected in single"	19	"THP-1: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053457	Supported				"Intracellular and membrane"	NA	NA		260000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA053457: AB_2682158"	"unprognostic (2.05e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.83e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	23.0	13.7	2.0	7.7	2.9	12.3	8.6	1.9	6.5	1.8	7.5	10.2	5.1	2.0	1.8	2.2	7.0	8.5	6.4	1.8	2.2	3.9	8.4	16.7	12.7	10.2	3.3	2.7	1.6	0.5	2.3	18.8	10.9	1.9	6.6	0.3	5.4	1.2	3.7	3.0	11.2	7.7	5.0	18.9	5.1	2.5	10.9	3.6	3.7	2.6	1.9	7.6	3.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.0	2.9	1.9	6.5	1.8	2.2	10.2	3.3	10.9	5.0	10.9	3.9	0.5	3.2	4.4	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.3	2.4	0.0	0.6	0.0	2.1	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.3	0.0	0.0	93.4	6.3	0.1	0.0	42.6	0.0	3.7	2.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	1.4	1.0	0.0	0.1	0.6	0.6	1.9	0.4	0.0	0.0	0.0
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410020-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.0;granulocytes: 39.3;Kupffer cells: 93.9;Macrophages: 51.5"	"Cancer enhanced"	"Detected in all"		"glioma: 11.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 765.3;intermediate monocyte: 252.0;non-classical monocyte: 539.2"	"Group enriched"	"Detected in many"	16	"granulocytes: 765.3;monocytes: 539.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HDLM-2: 9.0;HEL: 14.9;HMC-1: 10.7;NB-4: 10.4;U-698: 21.3;U-937: 12.0"	"Not detected"	"Not detected"							"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	"Plasma membrane, Actin filaments"	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	3.5	6.4	3.9	33.9	4.8	14.9	2.1	4.3	6.0	2.1	3.5	5.4	7.0	2.1	1.0	2.0	2.4	3.7	1.4	3.9	6.2	1.7	3.2	8.5	19.9	11.4	6.9	1.6	3.5	1.0	1.4	1.8	8.8	3.0	4.6	1.1	2.2	1.1	0.7	1.2	12.2	4.5	6.3	38.5	4.7	1.3	6.3	4.0	1.0	1.1	19.5	5.5	1.2	9.4	0.2	0.0	0.5	0.5	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	1.3	28.8	0.9	0.1	0.3	0.5	0.0	0.2	0.0	9.0	2.5	14.9	0.3	0.1	0.0	6.4	10.7	0.1	0.0	0.1	0.0	0.1	0.0	1.7	0.7	1.4	0.0	0.6	0.2	10.4	0.8	0.7	0.4	1.9	0.1	0.5	0.0	0.3	0.4	0.4	0.3	0.1	0.2	0.5	0.1	5.2	0.7	0.7	1.3	0.6	0.2	1.3	0.3	21.3	0.5	12.0	0.5	14.0	41.9	765.3	0.8	252.0	0.4	41.4	0.5	0.5	38.0	27.4	0.3	0.5	87.2	0.4	539.2	2.2	1.1	40.7	3.9	4.8	4.3	6.0	3.9	6.2	11.4	6.9	8.8	6.3	6.3	9.4	0.7	3.2	1.3	0.3	33.0	0.1	1.2	0.0	0.0	1.4	0.4	0.9	0.3	0.0	0.0	1.8	2.1	0.1	0.6	0.1	0.0	0.0	0.9	0.0	0.0	4.2	0.0	5.2	0.6	0.0	0.1	0.8	0.0	0.1	39.3	0.1	0.4	1.0	8.1	0.0	0.2	0.1	0.0	93.9	6.3	0.4	0.0	51.5	0.0	15.0	14.8	0.2	6.2	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.7	0.0	2.0	0.4	0.5	0.7	0.0	1.3	0.1	2.7	0.1	0.0	0.9
SIGLEC9	CD329	ENSG00000129450	"Sialic acid binding Ig like lectin 9"	Q9Y336	19	51124906-51136651	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.7"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 42.1;Kupffer cells: 39.8;Langerhans cells: 13.4;Macrophages: 26.8;monocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 198.9;intermediate monocyte: 182.5;myeloid DC: 169.1;neutrophil: 212.0;non-classical monocyte: 121.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 169.1;granulocytes: 212.0;monocytes: 198.9"	"Group enriched"	"Detected in some"	10	"Karpas-707: 23.4;RPMI-8226: 16.5"									HPA010682	Uncertain					NA	NA		270000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA010682: AB_1079968"	"unprognostic (2.31e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.03e-3)"	"prognostic unfavorable (6.17e-5)"	"unprognostic (6.56e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-1)"	8.0	5.4	2.0	17.9	2.1	9.0	1.9	2.2	4.3	1.4	2.8	2.1	1.7	0.9	0.2	0.9	2.5	5.0	2.1	1.9	3.4	1.4	5.5	8.3	5.0	5.4	4.0	3.2	1.2	4.1	0.9	7.9	5.0	1.1	2.4	0.3	1.5	0.9	0.4	0.5	2.2	6.4	4.0	20.7	1.4	1.7	6.2	1.4	0.9	1.3	2.5	5.4	0.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	23.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	1.5	0.0	17.3	198.9	1.6	15.2	182.5	8.6	0.2	2.5	5.8	169.1	0.1	0.6	2.7	212.0	3.1	121.9	9.2	0.9	84.9	2.0	2.1	2.2	4.3	1.9	3.4	5.4	4.0	5.0	4.0	6.2	5.9	0.1	0.0	0.5	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.3	0.0	0.0	0.2	2.7	0.0	0.0	0.0	1.8	0.0	0.1	1.1	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.1	5.3	0.8	42.1	0.0	0.2	0.0	0.0	39.8	13.4	0.4	5.0	26.8	0.0	5.6	10.4	0.0	7.2	0.0	0.1	0.0	0.0	2.2	0.4	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.1	0.0	0.1	0.0	0.1	0.3	1.3	2.8	0.0	0.0
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"SIM bHLH transcription factor 2"	Q14190	21	36699115-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 31.1;kidney: 61.3"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 100.7;Squamous epithelial cells: 68.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 24.9;PC-3: 43.0;RPTEC TERT1: 54.3;RT4: 33.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.3	0.3	1.8	0.0	1.1	0.0	0.4	0.7	1.4	2.3	0.4	0.5	0.0	0.5	0.8	31.1	0.6	0.0	0.2	1.5	2.5	61.3	0.4	0.2	0.0	0.7	1.4	0.2	0.3	1.8	1.6	0.0	0.5	6.6	0.0	0.0	0.6	0.0	10.6	0.5	0.3	0.0	0.5	0.3	9.5	0.4	2.4	0.0	0.4	0.0	3.5	0.7	0.7	0.7	6.4	9.6	0.0	0.3	0.0	0.0	9.4	0.0	0.0	0.9	0.0	5.0	14.7	0.0	8.6	0.2	17.0	3.2	4.8	0.0	0.5	7.8	15.0	0.0	14.3	0.3	0.0	0.0	0.0	1.6	1.4	0.0	2.6	24.9	0.0	0.0	0.0	0.0	16.0	3.7	0.0	0.0	0.0	6.4	43.0	0.0	0.0	0.0	54.3	33.5	0.4	0.0	15.7	0.0	0.9	1.6	4.1	0.0	0.6	0.0	2.5	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	0.7	1.4	1.5	2.5	0.7	1.4	0.5	0.5	2.4	0.7	0.2	0.0	0.0	0.0	0.0	0.3	19.1	0.0	100.7	0.2	0.1	0.1	2.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	9.8	0.1	2.2	0.3	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.8	12.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	5.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	7.1	1.1	0.0	0.0	0.0	1.3	9.5	0.1	0.2	0.0	0.5	0.0	1.5	0.9	0.5	0.2	68.3	0.4	0.0	0.4	0.0	0.2	4.0
SIPA1L2	"KIAA1389, SPAR2"	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232630571	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 80.2;Inhibitory neurons: 95.9;Microglial cells: 183.6;Oligodendrocyte precursor cells: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 69.7;NTERA-2: 53.9;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Golgi apparatus"		No	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nuclear membrane, Nuclear bodies"	"Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: AB_2672165"	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	12.1	3.3	8.5	6.4	7.2	5.4	9.2	9.6	11.7	10.0	0.5	19.4	3.9	4.4	2.8	20.3	4.5	8.5	31.3	9.6	16.0	7.7	6.4	16.2	3.0	44.0	21.7	11.9	3.6	4.4	8.1	18.3	44.6	8.1	18.9	14.7	8.7	4.7	7.1	9.0	9.2	7.4	14.4	9.6	5.7	7.2	18.7	2.4	8.0	9.5	3.3	12.5	14.9	9.0	0.0	7.5	69.7	0.2	0.6	0.0	29.3	1.2	2.5	3.1	2.2	2.9	0.1	5.9	13.3	26.4	2.9	1.7	13.8	2.3	2.9	0.0	12.8	0.0	7.0	0.0	5.9	1.0	7.2	3.8	9.1	0.6	6.2	0.0	15.7	25.4	0.0	0.1	1.6	3.5	7.4	0.7	53.9	0.2	10.2	0.0	0.0	3.4	8.1	11.5	3.5	11.9	23.8	0.8	9.5	15.8	1.4	0.6	5.6	8.1	0.0	17.8	2.9	6.5	0.0	0.0	10.0	6.2	46.1	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.6	0.3	0.3	0.0	0.1	8.5	7.2	9.6	11.7	9.6	16.0	44.0	21.7	44.6	14.4	18.7	9.0	53.7	6.4	1.8	22.9	0.8	8.8	9.8	8.7	15.4	23.5	10.7	8.6	62.6	12.8	10.4	3.7	52.1	4.9	4.4	29.9	0.0	7.1	11.7	19.0	21.4	22.7	7.2	0.4	80.2	0.5	7.1	15.2	5.1	47.5	1.3	16.0	1.8	3.8	10.0	5.0	95.9	29.5	14.2	16.6	7.2	9.8	0.9	19.5	14.2	183.6	6.3	12.7	1.0	104.0	21.0	1.4	39.9	1.9	0.5	13.2	9.1	0.4	7.7	35.7	0.0	21.8	23.9	6.9	24.0	45.8	7.4	14.8	2.0	11.9	23.4	23.0
SIRPB2	"dJ776F14.2, PTPN1L, PTPNS1L3"	ENSG00000196209	"Signal regulatory protein beta 2"	Q5JXA9	20	1470741-1491587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 5.1;Kupffer cells: 20.0;Macrophages: 9.5;Microglial cells: 14.0;monocytes: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 51.1;eosinophil: 31.7;intermediate monocyte: 30.4;myeloid DC: 21.1;neutrophil: 69.5;non-classical monocyte: 24.4"	"Group enriched"	"Detected in many"	329	"dendritic cells: 21.1;granulocytes: 69.5;monocytes: 51.1"	"Cell line enhanced"	"Detected in some"		"A-431: 4.7;HBEC3-KT: 4.0;HMC-1: 7.8;hTCEpi: 8.5;HUVEC TERT2: 4.3;THP-1: 7.7;TIME: 3.7;U-937: 8.3"					"Low region specificity"	"Detected in all"			"HPA011548, HPA048032"	Uncertain		Approved	"Nuclear bodies"		NA	NA		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear bodies"		"HPA011548: AB_2668514, HPA048032: AB_2680236"	"unprognostic (3.22e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.50e-5)"	"unprognostic (3.59e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	5.6	2.4	1.1	12.0	1.2	6.5	1.6	1.3	1.6	1.8	1.8	1.5	0.9	0.9	0.1	1.8	1.6	3.7	1.4	1.1	1.5	1.1	1.8	7.2	7.0	2.7	2.1	0.5	0.7	0.6	0.6	7.5	2.4	0.9	1.7	0.2	1.3	0.6	0.5	0.9	2.0	4.1	1.6	13.1	1.2	0.5	2.7	1.4	0.7	1.8	3.2	3.9	0.9	2.6	4.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.8	0.0	8.5	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.7	3.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	8.3	0.0	3.0	51.1	31.7	0.1	30.4	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.0	69.5	0.0	24.4	0.6	0.0	18.9	1.1	1.2	1.3	1.6	1.1	1.5	2.7	2.1	2.4	1.6	2.7	2.6	0.0	0.0	1.1	0.0	0.5	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.1	1.3	0.0	1.4	0.2	5.1	0.0	0.1	0.0	0.0	20.0	3.3	0.0	0.0	9.5	0.0	14.0	8.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.1	0.7	0.3	0.1	0.0	0.6
SIRPG	"bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma"	ENSG00000089012	"Signal regulatory protein gamma"	Q9P1W8	20	1629152-1657779	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 39.1"	"Group enriched"	"Detected in some"	8	"Early spermatids: 48.9;Late spermatids: 14.1;T-cells: 41.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 369.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 369.4"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 4.8;JURKAT: 10.7;NB-4: 13.8;RT4: 3.6;THP-1: 2.3"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (3.35e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.23e-3)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (7.36e-7)"	"unprognostic (1.62e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.95e-3)"	0.4	0.7	0.0	12.9	0.0	2.9	0.9	0.0	0.2	1.0	0.0	2.5	1.8	0.4	0.2	1.1	0.4	2.3	0.6	0.0	0.0	0.3	1.0	1.5	34.3	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.7	3.0	0.0	1.2	0.6	0.0	0.3	5.8	0.7	0.1	9.4	3.0	0.3	0.0	39.1	0.7	0.1	28.1	3.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	4.8	0.0	10.7	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.9	1.5	1.2	67.6	0.7	186.4	0.7	207.6	157.7	0.9	0.7	215.8	176.2	6.0	59.1	1.1	6.7	369.4	101.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	1.3	1.4	0.3	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	48.9	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	0.2	0.5	0.1	1.3	0.0	0.4	0.2	0.0	0.0	0.4	0.2	0.0	1.0	0.4	14.1	0.3	0.7	0.0	1.0	1.4	0.0	2.1	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	41.3	0.0	0.0	0.0
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
SLC10A2	"ASBT, ISBT"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066417	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 80.8"	"Cell type enriched"	"Detected in some"	29	"Proximal enterocytes: 371.2"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 4.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004795	Approved					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA004795: AB_1856953"											"unprognostic (2.82e-2)"		"prognostic favorable (5.78e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.2	0.0	0.0	0.4	23.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	16.9	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	80.8	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.2	0.5	0.3	0.5	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	371.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.1
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	878	"kidney: 705.6"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in single"	4	"renal cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	705.6	0.4	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.4	0.2	0.6	0.5	0.6	0.4	0.2	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	38.6	0.0	0.0	0.0	0.0	209.4	0.0	13.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.2	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"kidney: 101.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 4.2;Distal tubular cells: 5.9;Endometrial ciliated cells: 2.1;Glandular and luminal cells: 4.7;monocytes: 4.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 14.9"	"Group enriched"	"Detected in some"	11	"BEWO: 7.0;HAP1: 4.0;HeLa: 8.9;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.3	0.4	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	101.7	0.0	0.1	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.1	0.3	0.8	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	4.2	0.0	5.9	0.0	0.4	2.1	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	4.2	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 81.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 452.1"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053615, HPA062714"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	0.1	27.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	75.3	452.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.1	0.0
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 119.6;kidney: 38.2;salivary gland: 44.9"	"Group enriched"	"Detected in some"	6	"Proximal enterocytes: 290.2;Proximal tubular cells: 97.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014963	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.7	6.1	119.6	0.0	3.0	0.0	0.0	6.8	0.0	0.0	0.0	38.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.8	44.9	11.4	0.0	3.1	90.8	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	13.7	10.9	0.6	27.1	1.6	3.7	12.5	0.0	0.7	29.3	9.8	0.7	0.0	0.0	0.0	0.2	4.8	0.0	0.1	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	31.4	0.0	0.0	0.4	0.0	0.0	0.7	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	15.7	0.0	0.0	0.0	290.2	97.8	0.3	0.4	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	25.8	0.5
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 407.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	1.3	2.4	12.5	0.7	22.8	0.2	1.9	16.5	16.1	2.0	4.9	0.8	0.3	1.8	1.0	0.9	2.4	1.9	1.0	10.1	16.2	407.6	21.7	1.4	0.6	18.3	19.5	4.5	9.0	0.2	2.6	43.2	19.0	6.3	0.5	1.1	4.9	0.8	1.0	2.2	0.4	1.9	12.5	0.6	4.7	8.7	19.9	1.1	1.4	0.3	0.7	1.8	1.4	37.4	0.1	0.0	1.6	5.6	8.3	7.7	16.1	3.5	2.0	1.9	1.4	0.0	0.1	0.2	18.8	0.2	0.1	2.1	0.1	2.6	4.5	0.0	0.6	6.8	0.4	56.1	18.4	0.1	4.8	10.5	7.5	10.9	5.4	5.4	0.0	0.0	15.3	0.3	0.0	0.6	0.1	0.7	10.3	0.2	0.0	0.2	0.0	0.1	1.2	0.4	0.7	0.2	0.0	4.0	0.8	1.0	2.9	0.3	0.2	0.1	4.0	8.7	0.1	0.5	1.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.0	12.5	22.8	16.5	16.1	10.1	16.2	18.3	19.5	19.0	12.5	19.9	37.4	0.3	0.0	2.2	53.8	3.8	1.3	1.0	0.8	6.2	0.7	1.2	1.7	1.7	0.0	0.5	7.3	0.0	106.6	0.0	0.1	15.6	0.2	23.3	0.5	2.0	0.6	0.0	0.0	65.0	0.9	7.1	2.3	3.1	0.8	0.0	3.0	0.4	17.5	9.5	0.0	40.3	0.0	0.0	0.3	0.7	27.8	3.1	2.0	0.0	11.2	0.0	0.4	0.0	24.1	178.1	0.9	0.0	0.4	1.2	3.5	0.0	245.9	6.4	0.2	0.0	0.4	1.0	6.6	1.2	1.2	0.6	79.4	1.5	2.2	0.0	0.6
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 53.7;skeletal muscle: 41.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.7;T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	2.9	5.5	1.4	3.0	8.6	0.8	0.8	4.2	3.4	0.6	53.7	1.2	8.5	0.5	1.4	0.8	0.8	1.5	2.3	2.0	1.2	10.0	13.5	4.6	0.9	1.1	5.0	0.9	29.7	7.9	1.0	23.7	2.8	1.3	1.8	0.7	3.1	0.2	41.2	15.3	5.0	0.3	0.2	1.8	5.3	4.2	9.6	10.9	2.7	6.0	1.3	1.9	1.2	1.1	0.9	1.0	0.4	2.2	0.1	0.1	3.1	0.0	0.2	0.8	1.2	9.0	0.4	5.2	1.4	0.3	2.5	0.1	49.4	0.1	1.0	0.1	20.2	8.2	0.7	7.4	0.1	7.6	7.4	0.0	0.0	0.1	0.0	0.2	0.0	10.9	1.4	0.2	0.1	3.6	9.8	0.8	14.6	0.2	3.2	5.4	6.8	37.2	0.0	0.5	10.7	3.3	0.2	0.7	1.8	3.6	1.8	0.9	0.1	0.1	1.8	0.5	2.5	2.6	0.1	1.5	0.3	5.8	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.2	1.7	1.5	0.3	0.1	0.0	0.1	1.6	0.1	1.4	8.6	4.2	3.4	2.0	1.2	1.1	5.0	2.8	0.2	9.6	1.1	0.4	9.6	32.8	2.0	1.5	9.7	10.7	0.0	4.6	6.9	2.0	1.3	9.1	0.0	3.1	5.5	2.1	1.9	0.7	2.1	1.9	0.2	9.0	0.4	0.8	1.4	6.6	1.7	33.9	12.5	1.8	8.9	3.6	1.3	1.3	2.5	4.2	25.4	21.4	1.7	47.8	4.8	0.0	12.4	12.4	8.2	0.0	33.8	44.4	0.0	0.7	1.6	0.0	16.6	0.3	2.0	0.9	0.0	4.8	3.9	10.9	17.7	0.7	0.7	0.0	18.5	1.0	11.6	11.2	1.2	14.8	1.2	5.8	9.2	8.5	1.2
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034982-230068993	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.0;Excitatory neurons: 18.5;Inhibitory neurons: 21.1;Microglial cells: 45.0;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"eosinophil: 11.3"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 24.2;Karpas-707: 15.2;REH: 19.5;RPMI-8226: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	4.6	3.9	7.9	1.7	7.2	5.6	3.2	8.9	7.7	5.0	2.4	3.7	1.0	3.9	2.3	4.0	3.1	2.8	2.4	7.1	7.2	2.3	2.0	1.9	1.3	5.2	6.1	7.3	0.8	7.0	1.4	1.2	4.7	4.5	4.0	2.5	18.6	3.6	1.0	11.0	1.3	3.8	3.8	5.9	1.4	1.2	9.4	2.2	1.5	2.0	1.5	2.0	2.7	4.7	2.9	1.6	1.3	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.4	0.0	0.5	0.0	0.3	0.1	0.0	0.5	5.1	1.4	0.1	0.0	9.7	0.2	3.1	0.0	0.3	24.2	0.0	0.5	3.6	0.0	0.0	3.9	0.2	4.7	0.0	15.2	0.3	0.0	2.4	2.7	1.0	0.3	2.7	19.5	0.0	17.3	5.6	2.6	6.3	2.3	4.9	0.0	0.1	0.1	7.7	1.9	0.0	0.0	1.3	3.3	2.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	11.3	0.4	0.0	0.3	0.3	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	7.2	8.9	7.7	7.1	7.2	5.2	6.1	4.7	3.8	9.4	4.7	17.0	0.0	0.0	2.3	1.5	2.5	0.5	1.9	3.4	3.3	1.2	0.8	3.9	0.0	3.5	0.0	2.1	0.0	0.1	1.8	0.0	0.8	0.0	0.5	2.6	10.8	3.6	0.0	18.5	0.6	0.0	2.3	0.0	0.3	0.0	0.2	4.2	2.1	0.1	3.3	21.1	0.3	4.1	0.3	0.6	0.0	1.2	0.1	1.8	45.0	0.0	1.9	0.0	13.6	1.8	0.8	1.0	3.0	8.4	0.9	0.0	0.3	1.6	1.6	0.0	0.5	1.4	0.2	0.2	6.8	4.7	0.3	1.4	8.4	1.3	0.3
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650764-59736002	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 151.3;kidney: 191.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	1.2	151.3	12.8	1.2	12.8	1.7	1.7	11.9	14.8	18.5	18.4	12.5	0.4	16.2	5.2	10.9	22.0	3.1	3.4	12.9	16.6	191.1	2.5	1.1	1.7	14.0	13.7	34.1	3.0	29.2	6.9	0.1	12.0	7.8	16.7	5.6	2.9	10.2	4.3	0.4	1.2	7.2	13.3	40.8	6.0	8.9	12.3	1.2	13.9	2.8	2.8	2.2	9.0	15.0	0.0	0.3	5.2	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.9	10.8	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.1	2.3	0.0	0.5	0.2	0.0	2.8	0.1	0.4	5.4	8.0	0.1	0.6	4.2	3.0	0.0	20.1	2.0	9.3	3.6	0.2	7.2	0.0	0.3	3.4	9.6	0.1	0.4	0.0	10.1	3.4	4.5	3.2	0.5	1.1	0.1	10.6	0.0	0.0	0.0	0.0	18.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	12.8	11.9	14.8	12.9	16.6	14.0	13.7	12.0	13.3	12.3	15.0	0.3	0.0	0.0	83.9	1.0	0.1	2.1	9.4	0.6	4.3	3.1	1.5	3.9	0.0	26.2	7.3	0.0	0.0	0.0	108.6	25.4	1.0	0.2	2.3	2.0	1.5	20.0	4.2	2.5	0.0	1.7	4.1	3.6	2.4	0.0	28.4	0.4	0.0	0.1	3.3	4.8	19.1	4.1	18.8	0.7	1.5	13.7	1.5	3.6	1.9	0.6	11.8	0.0	14.6	1.0	0.1	23.2	12.0	0.0	17.7	2.2	252.6	7.4	1.0	0.0	2.4	3.4	0.3	0.2	17.0	0.1	0.0	0.7	99.4	11.9	6.5
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782915-25832052	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"kidney: 169.3;liver: 49.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	647	"RPTEC TERT1: 64.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050513			Approved	"Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	169.3	49.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 164.3"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 197.8"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	210	"RPTEC TERT1: 114.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.3	37.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	1.8	0.0	0.0	0.2	0.1	7.9	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	197.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781199	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"gallbladder: 16.3;intestine: 31.9;liver: 47.3;pancreas: 22.7"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.5"	HPA055564	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	20.6	28.7	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	3.7	47.3	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.1	0.2	0.0	26.7	0.0	0.0	0.0	0.0	0.0	31.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	94.4	0.0	0.0	0.0	0.0	0.0	133.5	0.0	8.3	0.8	0.0	0.0	0.0	13.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	41.8	0.1	0.0	0.0	11.7	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	51.2	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	11.5	0.0
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490468-4587469	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.0;intestine: 64.7;kidney: 51.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Glandular and luminal cells: 98.7;Hepatocytes: 68.4;Microglial cells: 67.5;Oligodendrocyte precursor cells: 161.4;Proximal enterocytes: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.1;HDLM-2: 70.9;HUVEC TERT2: 32.5;RPTEC TERT1: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	4.6	1.7	13.2	2.3	15.4	0.1	4.1	9.5	14.8	5.8	12.9	12.4	34.8	3.7	45.0	2.3	2.6	25.5	2.8	16.5	12.6	51.0	41.2	20.9	2.6	10.8	13.0	0.6	2.1	0.3	6.8	8.1	13.6	6.3	10.2	6.0	4.8	3.2	1.4	1.5	64.7	3.2	10.9	0.4	5.2	0.8	13.9	0.4	29.5	1.3	8.2	5.6	1.5	10.1	0.1	2.0	1.6	9.5	24.3	29.1	8.3	10.4	21.4	3.2	3.1	17.2	0.5	13.7	0.6	5.4	3.9	0.0	3.6	5.7	2.9	70.9	4.5	0.0	13.6	0.1	0.8	0.9	0.0	2.0	0.2	12.1	0.0	1.6	32.5	0.2	0.0	0.0	2.2	0.3	0.0	0.3	4.2	10.5	1.8	0.0	0.0	0.2	66.4	6.1	2.2	2.0	0.8	3.8	0.0	7.7	1.4	0.5	17.6	4.9	0.4	9.5	3.0	0.1	0.1	0.0	23.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.2	15.4	9.5	14.8	16.5	12.6	10.8	13.0	13.6	10.9	13.9	10.1	12.2	163.5	3.2	4.2	0.4	0.0	1.1	0.6	4.6	3.9	2.0	0.8	2.3	28.6	6.1	0.0	0.0	0.1	0.0	52.4	3.9	8.1	4.3	10.7	13.3	10.6	0.0	0.0	48.4	0.8	0.0	1.8	2.0	98.7	0.0	0.6	2.5	68.4	0.1	0.0	50.3	10.1	0.0	1.3	0.3	11.2	0.3	1.1	0.0	67.5	0.0	0.8	0.0	161.4	3.5	9.3	10.6	0.0	0.0	2.4	110.6	43.1	3.3	1.1	0.0	0.5	3.1	0.1	0.2	1.0	0.6	0.1	1.4	0.4	8.5	1.8
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36596588-36688334	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"brain: 776.8;choroid plexus: 400.6;retina: 221.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.6;monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Vesicles"		"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	30.7	16.4	500.4	7.4	544.2	3.3	17.7	549.4	776.8	8.7	400.6	3.0	0.5	1.6	1.1	10.5	6.0	8.0	45.4	514.6	502.5	2.2	3.8	10.2	17.4	477.6	510.1	12.6	5.0	2.2	18.1	20.3	502.4	3.2	1.1	221.1	4.7	4.7	14.1	6.0	3.2	4.1	495.4	9.3	2.2	1.2	532.8	3.6	3.4	9.2	5.4	7.0	5.3	494.9	1.3	0.2	50.0	5.3	5.9	14.3	37.7	0.3	0.0	2.4	4.9	112.6	5.6	0.0	27.8	2.3	1.0	71.4	16.9	9.1	2.2	1.8	33.0	0.0	0.5	0.0	2.5	1.3	0.6	26.9	34.5	14.4	5.3	1.8	0.0	1.1	0.0	0.2	8.7	0.2	0.1	0.1	6.0	0.1	5.9	0.0	0.5	0.0	0.1	3.1	4.7	0.0	5.1	14.6	2.1	24.4	0.2	3.1	0.0	6.2	10.3	0.1	20.7	0.0	0.0	0.3	21.7	37.7	12.6	0.0	1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	500.4	544.2	549.4	776.8	514.6	502.5	477.6	510.1	502.4	495.4	532.8	494.9	1.1	3.2	0.5	1735.2	0.7	10.7	14.3	19.0	83.1	7.1	3.7	3.4	36.0	0.0	3.1	0.0	2.1	32.9	0.1	0.0	0.0	0.8	0.7	16.3	1.2	8.9	0.0	0.8	2.6	0.0	15.9	7.8	2.0	11.7	0.0	0.2	1.1	0.5	41.2	3.3	4.7	0.0	0.0	77.6	5.9	4.1	4.4	59.6	7.2	332.6	3.3	472.6	0.0	237.7	249.0	0.3	0.0	0.0	0.7	5.2	0.0	0.0	5.3	19.1	6.6	2.6	3.1	0.3	0.3	32.7	7.1	9.2	1.0	20.7	0.0	3.6
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555690-64572875	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	72	"epididymis: 10.6;kidney: 31.9;placenta: 33.4"	"Group enriched"	"Detected in some"	19	"Cytotrophoblasts: 654.0;Syncytiotrophoblasts: 1520.6"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;Hep G2: 1.0"					"Not detected"	"Not detected"			HPA026076	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	654.0	0.0	0.0	5.9	0.0	1.2	0.0	0.2	1.7	0.0	0.0	0.0	0.4	22.5	3.4	0.0	0.0	0.0	0.0	0.4	0.2	50.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.3	0.3	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1520.6	0.2	0.1	0.2	0.0
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	204	"kidney: 109.4"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 173.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024575	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA024575: AB_1858650"					"unprognostic (5.88e-2)"		"unprognostic (2.33e-1)"						"prognostic favorable (2.63e-4)"	"unprognostic (6.19e-2)"	"unprognostic (3.91e-2)"			0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	109.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	173.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278757	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"kidney: 9.0"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 2.3;Inhibitory neurons: 1.8;Proximal tubular cells: 7.1"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035603, HPA035962"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035603: AB_10672869, HPA035962: AB_2674890"	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.4	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887344-2903575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 17.7;kidney: 11.1;liver: 14.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 163.3;Paneth cells: 124.4;Proximal enterocytes: 75.7;Proximal tubular cells: 104.0;Syncytiotrophoblasts: 80.7;Undifferentiated cells: 48.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 7.0"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.9;granulocytes: 4.0;monocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"A549: 9.4;CAPAN-2: 9.4;MCF7: 18.8;OE19: 8.4;SK-MEL-30: 35.8;WM-115: 14.8"									HPA068288	Enhanced		Approved	Nucleoplasm		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	3.2	0.6	0.5	2.2	0.6	0.2	0.7	0.5	1.7	0.7	0.5	17.7	13.4	0.8	0.4	1.2	0.4	1.7	0.3	0.6	1.0	11.1	14.9	0.6	0.4	0.9	0.9	0.4	0.3	0.0	0.3	2.3	1.1	0.8	10.2	0.3	1.8	0.1	0.1	1.1	9.7	0.7	0.8	0.7	1.6	0.5	0.8	0.1	0.3	0.0	0.1	0.7	0.9	1.1	1.2	9.4	0.3	0.5	0.0	0.0	0.9	0.5	0.4	0.0	0.2	2.2	9.4	0.0	0.8	0.0	0.6	0.5	0.0	0.3	0.0	0.4	0.1	0.0	0.8	5.8	0.7	0.0	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.5	0.0	0.9	0.0	18.8	0.0	0.4	0.2	8.4	0.3	0.3	0.0	1.0	0.8	0.0	0.1	0.3	0.9	0.4	35.8	0.2	0.0	0.9	1.9	0.0	0.7	0.3	0.2	0.0	0.0	0.2	0.2	2.6	14.8	4.0	7.0	1.2	0.2	3.9	0.1	0.0	0.1	0.2	3.9	0.0	0.0	0.1	1.6	0.4	2.9	0.0	0.6	2.4	0.5	0.6	0.5	1.7	0.6	1.0	0.9	0.9	1.1	0.8	0.8	1.1	0.6	0.0	0.5	0.0	1.3	0.5	1.1	6.3	1.2	0.0	1.2	0.9	0.4	1.5	2.7	7.3	0.0	19.5	0.4	163.3	9.8	1.7	0.1	0.1	0.3	0.7	9.1	3.2	0.4	0.8	9.8	1.4	2.6	0.5	1.3	0.0	2.9	22.7	17.7	0.0	0.1	26.2	6.1	6.3	5.5	0.2	0.3	6.4	3.6	0.0	4.6	0.0	0.0	0.0	0.1	2.4	124.4	0.0	0.0	1.0	75.7	104.0	1.0	0.0	0.0	0.0	0.6	0.1	0.4	2.1	1.1	80.7	0.9	0.8	48.5	2.5
SLC22A24	"MGC34821, NET46"	ENSG00000197658	"Solute carrier family 22 member 24"	Q8N4F4	11	63079940-63144221	"Predicted membrane proteins"	"Ion transport, Lipid metabolism, Steroid metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 1.1;kidney: 4.4"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 5.9;Proximal tubular cells: 11.8"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045015	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045015: AB_2679183"							"unprognostic (5.72e-3)"						"unprognostic (1.80e-7)"					0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A4	"DFNB60, MGC34546, OCTN1"	ENSG00000197208	"Solute carrier family 22 member 4"	Q9H015	5	132294394-132344190	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.7"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 57.0;Proximal enterocytes: 25.6;Respiratory ciliated cells: 78.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 36.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.1;U-138 MG: 24.4"	"Region enhanced"	"Detected in all"		"cerebellum: 64.5"	"Low region specificity"	"Detected in all"			"CAB015468, HPA036974"	Approved		Approved	Mitochondria		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"CAB015468: , HPA036974: AB_2732474"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.42e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.17e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.06e-2)"	1.9	3.0	2.1	2.9	1.9	20.7	2.2	3.7	1.8	1.5	1.1	2.0	3.5	1.4	1.4	0.4	11.3	1.9	1.9	1.9	3.6	7.1	0.8	2.9	0.3	4.0	3.7	2.1	0.6	2.6	2.6	1.0	3.4	4.0	2.2	2.2	1.7	1.4	7.2	1.3	9.1	1.0	3.6	5.1	1.4	0.6	3.4	0.4	0.7	2.7	0.2	1.4	0.9	2.9	1.9	3.0	0.2	0.7	1.3	1.0	0.9	12.9	59.1	9.7	10.1	1.1	3.3	0.6	3.6	7.6	7.2	3.2	0.0	2.1	6.8	2.6	0.3	0.1	5.6	0.2	1.0	4.1	0.0	2.3	0.4	5.3	4.9	3.5	4.3	0.3	5.3	6.7	7.6	1.1	0.0	9.5	0.3	0.3	3.2	0.0	0.8	0.4	1.5	0.2	0.8	0.4	14.0	0.9	0.4	0.4	0.6	2.4	5.2	24.4	2.4	9.7	3.3	0.0	2.7	0.0	7.2	4.7	2.9	0.0	5.6	5.8	0.0	1.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	36.2	0.0	0.4	0.3	0.0	1.2	2.1	1.9	3.7	1.8	1.9	3.6	4.0	3.7	3.4	3.6	3.4	2.9	1.1	3.2	0.0	5.5	0.1	0.8	1.0	3.8	1.8	2.0	1.9	1.3	0.8	1.5	10.0	0.0	0.0	1.0	0.1	8.8	0.0	3.2	0.0	4.7	1.8	3.8	1.2	57.0	7.2	0.4	2.3	3.1	0.5	2.2	0.0	0.6	1.4	0.0	4.0	3.3	8.0	0.8	4.1	0.8	0.8	0.3	0.6	3.7	0.0	1.9	2.2	1.6	0.0	4.5	2.3	1.9	1.7	0.0	0.1	1.7	25.6	8.6	78.5	0.4	0.0	9.3	1.8	0.3	0.4	0.2	0.4	2.5	0.2	0.1	1.0	0.9
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984967	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"kidney: 196.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 310.4"	"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.0	0.0	1.3	0.0	2.5	0.0	0.0	3.6	2.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.8	196.5	0.0	0.0	0.0	7.0	5.5	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.5	3.6	2.3	1.3	3.8	7.0	5.5	3.1	3.3	7.6	1.2	0.0	0.0	0.0	4.9	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	310.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 427.9"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 254.5;Proximal tubular cells: 91.8"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	47.6	427.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.5	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	254.5	0.0	0.0	0.7	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	91.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015841	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	61	"choroid plexus: 111.4;kidney: 335.0"	"Cell type enriched"	"Detected in some"	38	"Proximal tubular cells: 347.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.7	0.0	111.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	335.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.7	3.6	0.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	1.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	347.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 54.2;intestine: 65.3;kidney: 40.2;liver: 22.5"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Region enhanced"	"Detected in some"		"midbrain: 3.2"	"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047612	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.2	0.1	0.1	1.2	0.2	2.8	0.2	1.1	0.2	2.3	0.1	3.3	26.3	0.7	0.0	0.3	54.2	2.4	0.1	0.2	0.4	40.2	22.5	0.9	1.7	1.1	3.2	0.3	1.2	0.3	0.2	0.1	0.8	6.3	1.5	0.6	3.2	0.6	0.4	1.9	65.3	0.2	0.1	1.3	1.5	0.2	0.2	5.5	0.2	0.0	1.2	0.4	0.3	0.6	0.3	2.1	0.4	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.4	1.3	5.8	3.0	0.0	0.1	0.3	0.0	0.0	0.1	8.3	0.1	0.2	0.8	13.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	15.5	0.1	10.9	0.0	0.2	5.7	1.0	0.1	0.8	0.1	6.8	0.3	10.9	0.5	0.4	0.3	0.3	0.3	1.9	0.0	0.7	5.0	0.1	0.3	0.3	0.3	0.1	0.0	16.6	2.2	7.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.1	0.2	1.1	0.2	0.2	0.4	1.1	3.2	0.8	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.3	1.5	2.0	0.0	4.2	0.4	0.4	1.9	5.9	0.2	0.0	65.2	0.7	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.5	0.0	0.1	0.4	19.3	0.1	0.0	1.2	3.6	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.1	3.1	0.0	0.4	0.9	131.7	27.0	13.4	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.2
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	8	"intestine: 18.4;kidney: 45.6"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 55.9;Proximal tubular cells: 14.4"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.9;U-266/70: 3.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Not detected"	"Not detected"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	1.1	0.4	1.0	0.9	1.0	0.1	0.9	1.2	0.9	2.8	1.0	3.8	7.6	1.6	0.5	2.2	1.5	0.5	1.0	1.0	1.0	45.6	4.0	1.3	0.7	1.1	1.0	1.8	1.1	0.8	0.5	1.0	1.0	2.4	1.5	0.2	1.0	0.6	0.2	1.9	18.4	0.7	1.0	1.5	1.2	0.1	1.1	0.3	2.4	0.1	0.8	1.1	2.3	1.0	0.5	0.2	0.1	0.6	2.0	1.1	0.4	1.2	0.3	0.2	0.7	1.1	0.7	0.2	0.4	0.8	0.0	1.7	0.4	0.1	0.3	1.1	0.9	1.1	1.2	0.1	0.4	0.1	0.4	0.4	4.9	0.4	1.5	1.9	0.6	0.6	0.1	0.4	0.3	0.2	0.0	0.5	0.0	0.4	0.1	0.3	0.3	0.4	1.6	1.9	0.2	0.5	0.1	0.0	1.3	0.5	0.5	0.5	1.4	1.1	0.7	1.0	0.4	3.1	0.1	1.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	1.2	0.9	1.0	1.0	1.1	1.0	1.0	1.0	1.1	1.0	0.6	0.0	0.5	0.0	1.7	1.5	1.4	0.5	0.6	1.1	0.9	1.1	0.3	1.5	0.3	1.8	0.0	0.3	0.5	3.8	1.9	0.2	0.0	0.2	0.8	1.0	1.8	0.4	0.3	0.0	0.1	0.8	0.0	0.9	0.0	0.5	1.1	1.2	0.2	0.0	0.3	4.0	0.0	0.9	0.8	0.0	1.5	1.0	1.8	1.0	1.1	1.2	0.0	0.0	0.0	0.4	6.0	1.2	0.2	1.5	55.9	14.4	0.1	0.2	0.0	0.8	1.0	0.0	0.2	0.7	1.6	0.4	0.8	0.6	3.9	0.9
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 183.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.3;Late spermatids: 76.9;Proximal enterocytes: 50.9;Proximal tubular cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"Hep G2: 158.9;SK-BR-3: 116.6"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	17.8	14.8	5.3	3.0	5.0	9.5	16.8	5.6	6.2	6.5	6.4	26.1	21.4	3.8	2.7	38.8	9.2	5.5	10.4	4.6	5.2	72.9	183.3	4.3	2.5	6.6	5.2	4.8	35.8	17.3	6.3	1.8	5.1	17.2	6.8	0.6	26.0	6.1	5.8	17.3	20.1	0.9	5.8	4.8	24.0	35.0	5.4	3.9	9.6	1.9	2.9	9.1	11.5	6.6	45.3	81.8	7.6	38.1	2.9	2.3	15.3	19.2	6.1	23.2	17.4	49.5	18.4	20.2	14.3	4.5	11.2	28.3	10.8	19.3	4.2	14.9	66.2	16.7	49.0	158.9	3.3	37.5	19.5	1.6	10.0	16.5	3.2	4.5	13.6	27.9	28.0	24.3	8.2	85.4	54.3	40.0	7.8	18.8	63.9	41.0	16.3	63.6	21.1	39.6	49.8	34.0	18.1	116.6	4.0	2.0	50.3	20.4	6.1	17.9	58.6	26.5	34.4	15.3	8.3	12.0	7.8	39.0	15.9	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.2	5.3	5.0	5.6	6.2	4.6	5.2	6.6	5.2	5.1	5.8	5.4	6.6	1.4	0.0	2.2	1.6	1.3	0.0	4.5	0.0	2.2	4.9	14.6	7.5	3.8	17.2	3.1	14.7	0.0	16.4	2.3	10.2	25.4	16.9	30.5	22.3	3.8	1.5	4.9	8.2	1.2	22.9	6.9	2.3	18.8	16.4	0.0	5.1	3.6	42.3	8.0	0.0	1.7	15.3	0.0	2.4	0.0	76.9	2.1	2.0	0.0	0.0	0.8	1.9	3.1	0.5	1.2	9.9	19.3	1.9	4.3	4.7	50.9	84.6	7.3	4.2	0.0	1.3	1.6	27.9	3.1	15.9	0.0	4.2	1.5	5.3	27.2	7.9
SLC25A2	ORNT2	ENSG00000120329	"Solute carrier family 25 member 2"	Q9BXI2	5	141302635-141304049	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 6.6"	"Group enriched"	"Detected in some"	21	"Early spermatids: 18.2;Late spermatids: 12.0;Spermatocytes: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042146	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA042146: AB_2677874"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.81e-1)"		"unprognostic (2.62e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.82e-10)"	"unprognostic (2.56e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	27.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063994-19113030	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.7;Hepatocytes: 52.1;Proximal tubular cells: 39.6;Rod photoreceptor cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.7;MAIT T-cell: 1.4;memory B-cell: 3.3;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.4;naive B-cell: 3.2;naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.4;NK-cell: 1.8;T-reg: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;NK-cells: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049449	Approved		Supported	Mitochondria		Yes	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	8.5	7.5	17.2	4.3	16.9	8.3	7.9	14.5	18.3	13.1	16.7	8.4	5.1	10.1	3.7	5.2	12.5	3.5	15.8	17.9	16.9	34.1	82.0	6.6	9.0	14.9	15.2	16.9	11.3	6.0	14.4	2.6	14.7	9.9	2.4	8.4	9.2	5.2	46.5	6.7	9.3	4.9	13.9	12.7	8.3	7.0	18.0	8.1	25.6	32.6	7.5	9.6	9.1	13.9	7.3	1.0	1.8	3.2	6.8	5.6	2.8	3.5	5.2	5.3	6.0	1.4	14.3	5.2	8.0	3.3	5.3	1.3	3.7	2.9	3.0	1.3	7.0	1.8	2.0	11.8	5.4	0.8	3.6	5.6	2.0	4.0	2.4	4.3	2.4	16.8	20.9	9.2	2.8	6.6	9.0	8.4	1.0	2.0	7.4	6.8	3.2	10.2	2.1	1.3	2.0	1.5	3.7	0.1	1.6	2.4	6.5	4.1	2.2	3.9	2.2	8.2	3.4	10.7	6.2	4.1	4.1	11.2	2.0	0.0	0.1	0.1	2.7	0.3	1.4	3.3	1.5	2.4	0.2	3.2	1.0	1.4	0.0	1.8	0.3	0.4	1.7	0.9	17.2	16.9	14.5	18.3	17.9	16.9	14.9	15.2	14.7	13.9	18.0	13.9	4.6	0.0	13.1	12.4	14.2	3.2	2.8	3.3	2.8	67.7	5.9	6.6	9.7	5.7	4.1	9.2	18.8	7.7	16.5	3.1	13.7	1.5	1.2	2.5	5.4	4.1	8.4	13.7	18.6	3.1	3.8	5.1	4.1	3.6	3.8	8.3	5.3	52.1	1.8	3.3	25.0	3.8	6.1	0.6	1.9	1.6	5.0	1.4	3.6	6.5	1.3	12.5	32.0	16.1	8.6	2.5	4.6	6.4	16.4	2.4	9.2	39.6	3.0	41.4	6.6	9.6	5.8	10.6	7.6	0.9	2.8	4.7	10.9	8.0	3.1	1.7
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.8	7.0	2.5	1.5	2.5	1.4	2.7	5.4	3.3	2.9	0.1	2.2	5.2	2.1	0.2	1.6	2.1	1.2	1.2	2.9	2.0	5.8	16.8	2.0	1.5	3.9	2.5	2.5	3.3	0.1	3.3	0.3	3.2	3.0	0.1	0.6	3.2	0.1	1.4	2.5	4.5	0.0	1.0	2.4	3.1	1.2	2.0	0.1	3.2	0.3	0.1	1.8	1.9	2.6	1.3	2.1	0.0	1.6	0.1	0.4	4.1	1.7	0.1	0.0	0.0	4.6	2.7	0.7	2.4	0.0	1.6	1.3	0.1	0.0	0.0	2.7	0.8	3.0	3.3	13.8	0.1	2.1	8.7	0.5	0.2	0.1	0.0	1.0	0.3	2.6	3.3	0.0	0.3	2.8	1.4	3.5	0.8	1.6	7.2	6.9	0.0	0.3	0.7	4.5	0.2	1.2	0.4	0.2	1.2	0.3	9.1	1.3	2.0	4.4	0.9	4.8	1.3	6.5	3.2	1.0	1.4	4.1	2.1	5.4	0.3	0.2	0.2	0.1	0.3	0.2	0.5	0.4	0.1	0.0	0.3	0.7	0.0	0.6	0.1	0.1	0.8	0.3	2.5	2.5	5.4	3.3	2.9	2.0	3.9	2.5	3.2	1.0	2.0	2.6	0.3	0.0	1.1	6.2	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.1	0.0	0.7	0.3	0.3	0.0	0.0	4.4	0.4	3.6	0.3	0.5	0.8	1.3	0.8	1.4	10.4	0.7	0.0	4.4	0.8	0.0	0.3	0.0	0.0	0.9	0.4	1.8	1.0	0.3	0.3	0.0	5.5	1.7	0.4	1.3	0.4	0.1	0.2	6.4	9.7	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.2	0.1	0.8	0.5	0.6	0.7	0.1
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660828-107717809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"thyroid gland: 263.7"	"Cell type enhanced"	"Detected in many"		"Club cells: 19.0;Excitatory neurons: 29.3;Inhibitory neurons: 53.9;Ionocytes: 54.9;Prostatic glandular cells: 17.3;Urothelial cells: 19.9"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Group enriched"	"Detected in many"	88	"amygdala: 4.0;basal ganglia: 10.2;cerebral cortex: 11.8;hippocampal formation: 8.8"	"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;hTERT-RPE1: 3.7;LHCN-M2: 2.1"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.8"	HPA042860	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.4	0.1	4.0	0.1	10.2	0.0	0.8	0.0	11.8	1.4	0.0	0.2	0.1	0.5	0.1	0.1	0.3	0.4	0.6	8.8	0.0	6.4	0.1	0.5	0.4	0.0	0.0	0.3	0.3	3.9	0.3	0.3	0.0	3.8	0.2	0.1	0.4	0.2	0.5	0.2	0.1	0.3	0.0	0.1	0.7	0.6	0.0	0.2	263.7	0.1	0.2	1.5	0.3	0.0	0.3	0.1	0.2	0.0	0.3	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.0	0.0	1.6	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.4	0.2	0.0	3.7	0.0	0.3	0.0	0.1	2.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.3	0.2	0.1	1.3	0.3	0.3	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	10.2	0.0	11.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	7.7	2.6	0.2	1.7	0.7	6.5	0.0	6.6	3.2	1.8	0.6	0.0	19.0	0.0	2.1	0.3	0.4	0.4	0.0	0.2	3.9	0.3	0.5	4.9	7.3	0.0	29.3	0.0	0.1	1.5	0.0	1.8	5.1	0.2	1.1	0.2	0.3	1.7	53.9	0.0	54.9	0.6	2.0	2.7	0.9	0.7	7.2	3.7	0.7	1.2	1.0	1.5	1.6	0.1	0.1	1.2	0.0	17.3	0.0	0.1	15.2	1.8	0.0	2.9	1.6	2.0	0.4	0.1	1.4	0.0	1.7	0.2	0.5	19.9
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446207	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"basal ganglia: 10.4"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	0.1	0.1	0.3	0.0	0.3	0.0	0.7	2.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.4	0.1	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.2	0.1	0.4	0.4	0.5	0.3	0.4	0.3	0.5	0.3	6.4	2.6	5.5	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.0	0.0	4.1	0.0	0.0	2.2	7.1	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.5	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	6.5	0.0	0.3	0.0	2.0	4.2	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.2	1.2	0.0	0.2	0.1	0.3	0.5	0.0	0.3	0.0	0.6	0.0	0.0	0.6
SLC26A7	SUT2	ENSG00000147606	"Solute carrier family 26 member 7"	Q8TE54	8	91209494-91398155	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 330.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 23.9;Endometrial ciliated cells: 31.6;Endometrial stromal cells: 23.9;Enteroendocrine cells: 45.2;Glandular and luminal cells: 52.0;Hepatic stellate cells: 24.7"	"Group enriched"	"Detected in some"	11	"renal cancer: 8.7;thyroid cancer: 32.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 1: Thyroid gland - Transcription"		"Cluster 44: Endometrium - Transcription"				"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.83e-3)"	1.5	0.1	0.1	0.0	0.2	0.0	0.3	0.2	0.1	1.4	0.2	0.2	0.1	2.7	0.1	0.0	0.5	0.6	0.7	0.0	0.1	23.8	0.0	0.1	3.7	0.1	0.1	0.1	1.2	0.2	0.3	0.3	0.2	0.1	0.4	0.0	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	6.1	0.5	0.2	0.0	330.3	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.4	3.9	0.0	1.5	5.9	0.1	0.3	0.4	0.2	0.0	0.0	1.9	0.6	1.1	0.0	0.3	23.9	0.0	0.0	0.0	0.3	13.7	0.1	11.9	31.6	23.9	1.5	45.2	0.0	0.5	0.2	0.0	1.5	1.5	52.0	0.0	0.1	24.7	0.1	0.1	0.0	0.7	0.7	2.0	0.6	0.3	2.9	3.7	0.2	3.6	0.0	0.0	0.1	0.0	0.0	3.8	1.4	0.2	0.0	0.0	0.3	0.0	0.3	1.9	0.2	0.0	0.0	4.4	0.6	1.1	0.0	0.1	0.0	0.4	0.5	0.3	0.1
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"salivary gland: 72.4;stomach 1: 33.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 50.1;Cardiomyocytes: 26.2;Gastric mucus-secreting cells: 29.0;Proximal tubular cells: 25.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;Hep G2: 5.1;OE19: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	1.3	0.2	0.0	0.0	0.1	0.0	7.7	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	72.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	33.9	0.0	0.1	0.0	0.4	0.3	5.3	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.1	0.1	0.0	3.2	50.1	1.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.2	0.0	2.7	1.8	0.0	0.0	0.0	0.0	1.9	4.3	0.5	0.2	0.0	0.3	0.0	0.0	0.1	2.2	0.0	1.7	29.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.4	0.0	25.4	2.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	1.5	0.0	0.4
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236385	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 157.7;liver: 288.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	30	"basophil: 63.5"	"Lineage enriched"	"Detected in many"	30	"granulocytes: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026089	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	4.8	16.0	1.7	2.9	2.0	6.5	13.3	1.7	3.2	1.6	9.2	18.2	11.1	0.3	65.9	2.6	10.9	2.3	0.0	2.7	2.4	157.7	288.0	1.7	1.5	0.8	1.1	0.1	7.2	4.1	12.4	17.3	0.8	5.4	16.2	3.4	0.9	1.0	0.0	1.2	21.3	0.8	0.8	0.4	1.8	0.9	2.5	0.5	4.6	0.0	1.7	3.6	1.2	0.7	0.0	50.0	0.0	0.0	0.0	0.0	0.1	0.9	0.4	0.9	1.3	26.2	6.9	0.0	0.6	1.2	0.6	89.3	22.8	0.7	2.3	36.0	27.9	37.5	43.0	23.6	0.5	66.3	25.8	0.0	2.1	0.2	0.1	0.0	0.0	16.9	11.6	0.0	0.0	8.3	1.8	44.5	1.7	101.8	1.8	0.0	0.0	1.8	4.7	45.7	40.4	2.6	8.7	1.1	0.0	1.1	4.7	22.8	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	21.2	0.0	63.5	0.0	0.9	0.8	0.0	0.7	0.3	0.7	0.8	0.0	0.2	0.1	0.2	0.3	2.0	0.0	0.0	0.9	0.5	1.7	2.0	1.7	3.2	2.7	2.4	0.8	1.1	0.8	0.8	2.5	0.7	0.3	0.0	1.1	0.7	2.2	1.0	1.3	8.7	1.2	1.1	1.1	0.3	0.3	0.0	13.6	9.2	0.0	265.5	1.6	17.2	11.7	0.6	0.7	9.8	0.1	0.8	4.2	8.0	4.9	2.0	7.6	0.9	1.5	0.7	6.3	0.1	3.9	205.7	16.4	1.7	6.6	18.9	10.2	3.2	0.3	0.9	0.3	1.2	0.0	1.0	0.0	0.6	1.0	0.0	0.4	1.4	26.6	0.0	0.8	3.3	81.0	198.9	70.2	1.9	0.0	0.0	1.0	4.4	4.2	5.1	0.3	54.9	4.6	0.2	25.9	4.9
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945798	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 49.1;kidney: 48.2;liver: 111.3"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.0	37.9	0.0	0.5	0.1	0.7	0.2	1.0	0.1	0.3	48.2	111.3	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	1.2	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	49.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.3	0.7	0.4	0.2	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.3	2.2	4.3	0.6	7.3	0.0	0.5	0.0	0.0	11.7	3.0	0.0	0.4	0.1	0.1	0.0	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.0	0.4	38.6	54.3	0.0	0.5	2.8	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.5	1.1	0.3	2.5	0.0	0.0	0.0	86.9	93.4	1.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	1.5	0.1
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252234-45277846	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 92.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Paneth cells: 35.7;Proximal enterocytes: 43.4;Undifferentiated cells: 48.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046068, HPA055623"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.4	0.7	0.4	0.1	0.0	0.3	0.4	2.6	0.0	9.5	68.0	0.5	0.4	0.1	0.1	9.8	0.3	0.3	0.1	3.5	0.8	0.1	0.3	0.4	0.0	0.3	0.3	0.0	0.0	0.6	0.4	0.1	34.6	0.7	0.2	0.0	0.3	0.3	92.3	0.0	0.1	0.2	22.8	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.4	0.1	0.2	0.6	0.5	0.0	8.1	1.6	0.9	0.1	0.4	0.4	0.0	2.9	0.3	0.0	0.7	8.6	4.5	0.0	2.1	12.3	0.3	19.6	0.0	0.1	0.7	1.0	0.4	1.0	13.9	2.7	1.8	0.0	2.7	1.0	4.6	1.2	8.8	0.7	0.7	0.3	0.9	1.7	1.5	14.5	0.0	0.3	0.4	0.4	0.0	1.3	0.0	0.0	0.2	1.0	2.1	2.0	2.0	0.0	35.7	0.7	0.4	0.2	43.4	1.2	4.6	6.6	0.0	0.3	0.2	2.4	2.1	0.0	0.3	4.7	1.3	0.2	48.9	0.2
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709649-46736347	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 43.6;Intestinal goblet cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	75	"basophil: 20.9"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 20.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 45.8;HSkMC: 56.6;OE19: 49.8;SK-MEL-30: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041015, HPA055673"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA041015: AB_2677252, HPA055673: AB_2682879"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	7.0	5.9	4.0	3.5	4.1	1.2	15.3	3.4	3.9	19.4	18.9	12.7	5.4	7.9	8.7	5.1	9.9	10.3	5.2	3.8	3.7	3.5	41.4	6.9	1.7	5.2	4.7	9.9	17.4	19.5	6.3	11.6	4.0	31.3	16.0	1.6	24.0	9.9	1.5	3.6	5.3	8.5	3.8	2.6	22.8	2.6	4.0	1.6	19.5	2.7	2.1	9.3	8.4	3.4	0.0	0.1	11.3	11.7	45.8	38.9	34.2	22.2	30.2	10.1	12.0	0.9	38.9	0.0	16.3	40.6	0.0	0.2	0.0	1.1	4.8	0.0	0.3	3.3	0.0	18.6	32.2	0.0	0.0	56.6	1.0	6.2	0.0	11.8	4.2	0.0	0.2	0.1	17.5	41.3	0.0	1.2	4.3	49.8	2.9	0.0	1.6	0.1	0.0	10.6	0.0	1.8	4.3	7.2	60.3	8.1	5.4	9.2	2.6	21.7	9.1	17.2	2.9	0.3	0.1	0.0	0.1	0.0	4.6	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.0	4.1	3.4	3.9	3.8	3.7	5.2	4.7	4.0	3.8	4.0	3.4	4.2	6.4	6.3	12.4	0.8	0.6	6.1	7.8	5.2	0.0	29.6	14.4	6.4	7.2	15.8	1.8	0.0	2.7	0.4	11.4	0.0	7.4	0.2	3.2	17.8	4.6	3.6	6.1	0.1	5.6	16.3	16.7	23.4	4.0	6.3	10.7	8.6	43.6	1.1	0.0	0.4	56.6	12.2	1.9	1.3	1.6	26.4	0.4	1.8	2.8	0.0	5.5	0.0	10.1	0.3	5.1	10.3	17.3	2.8	23.9	1.7	0.8	27.5	0.5	13.1	5.1	6.3	0.8	0.3	4.2	1.0	2.1	0.5	3.6	14.6	10.9
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 836.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.4	0.0	0.2	0.0	66.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.3	30.8	836.1	0.0	0.0	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.4	0.3	0.3	0.5	0.4	0.8	0.4	0.4	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035106-9088478	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 97.3;intestine: 109.1;skeletal muscle: 78.8;testis: 76.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.3;Paneth cells: 55.6;Plasma cells: 35.3;Proximal enterocytes: 189.4;Spermatocytes: 83.2"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 23.3"	"Lineage enriched"	"Detected in many"	5	"B-cells: 23.3"	"Group enriched"	"Detected in some"	5	"Daudi: 190.3;THP-1: 47.8;U-266/70: 154.0;U-698: 178.2;U-937: 68.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005449, HPA075145"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA005449: AB_1078985, HPA075145: "	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	7.7	3.4	9.2	5.4	9.2	97.3	5.1	10.5	11.8	2.6	10.1	4.8	109.1	1.3	10.5	3.9	2.6	1.1	2.3	10.3	12.0	38.4	0.6	1.2	20.4	24.1	14.5	2.8	0.6	1.5	2.9	4.9	20.4	15.1	3.6	2.7	2.4	5.1	78.8	6.9	85.3	4.4	14.3	5.6	0.9	76.4	16.1	1.7	0.8	65.9	18.3	3.0	4.2	19.6	0.3	0.1	0.0	0.2	0.2	1.2	0.5	0.2	0.7	0.0	0.6	1.3	0.0	190.3	0.2	0.4	0.1	0.4	1.7	0.1	0.4	25.1	0.2	0.2	3.4	0.0	0.3	3.0	1.6	2.7	2.6	0.6	0.0	2.9	0.0	0.1	0.3	2.0	0.0	0.0	0.1	10.0	0.2	0.0	0.2	4.9	0.0	5.9	0.2	2.0	0.6	0.3	0.3	0.5	0.7	0.1	0.3	47.8	0.2	3.0	0.9	0.5	0.2	154.0	0.2	178.2	0.2	68.2	0.2	4.8	2.5	0.2	0.2	0.5	0.2	4.3	0.2	0.2	0.9	23.3	0.2	0.2	1.4	0.3	0.1	0.2	0.1	1.2	9.2	9.2	10.5	11.8	10.3	12.0	24.1	14.5	20.4	14.3	16.1	19.6	0.3	0.0	0.0	2.0	5.2	2.0	2.0	0.2	10.2	0.0	0.1	0.4	1.9	0.0	0.0	1.8	0.0	0.1	0.0	1.4	7.9	0.3	64.3	0.1	0.3	4.9	1.2	0.0	1.0	0.0	1.1	0.8	0.0	0.4	1.3	0.1	0.4	0.1	4.3	0.0	1.2	7.6	0.0	0.8	1.2	19.3	2.8	2.7	0.0	31.9	0.6	0.6	0.0	2.5	0.9	0.6	55.6	0.4	35.3	2.1	189.4	24.2	0.0	0.1	6.6	2.1	0.4	83.2	8.2	2.7	0.6	0.5	0.3	0.3	8.0	0.2
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.3;liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 27.4;Proximal tubular cells: 72.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 36.9;myeloid DC: 30.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 30.5;monocytes: 36.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 48.1;Hep G2: 23.6;hTCEpi: 19.9;THP-1: 20.5;U-937: 13.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	1.6	2.6	1.0	2.0	1.2	2.1	4.2	1.3	1.2	2.5	2.7	1.8	10.7	1.4	2.4	5.2	3.5	2.4	2.3	1.1	1.6	29.3	21.4	4.2	2.0	2.3	1.5	1.6	1.0	2.4	1.4	7.6	2.0	3.5	1.6	1.2	16.6	18.8	0.5	2.2	8.4	2.0	1.8	1.8	1.0	0.7	2.0	4.2	2.7	0.5	1.4	6.4	4.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.1	0.0	0.3	2.4	0.0	3.5	0.7	0.0	7.3	0.0	48.1	0.0	8.2	0.3	0.0	0.0	23.6	1.6	0.1	6.3	3.4	19.9	0.0	4.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.3	2.4	0.0	0.4	0.1	1.5	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.5	0.1	0.0	36.9	0.9	0.3	7.6	0.3	0.3	0.3	0.1	30.5	0.1	0.2	0.1	1.1	0.2	0.9	12.2	0.2	9.1	1.0	1.2	1.3	1.2	1.1	1.6	2.3	1.5	2.0	1.8	2.0	3.0	1.4	0.0	0.0	8.1	1.3	0.9	13.4	27.4	6.2	0.0	4.6	6.1	2.4	0.0	5.7	3.7	2.1	18.7	0.5	1.7	3.9	0.5	5.1	4.1	2.1	1.5	0.0	1.3	4.4	1.1	1.8	1.6	1.1	11.5	1.3	0.5	2.2	5.2	10.3	0.0	5.6	0.9	10.2	8.7	3.7	3.4	0.0	8.8	0.0	15.9	4.4	1.2	1.0	10.6	1.1	0.6	0.5	0.4	0.3	2.0	8.1	72.6	3.0	0.4	0.0	4.6	1.6	1.1	1.9	5.4	0.6	8.5	0.9	0.7	2.5	7.7
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046118	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 99.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 31.0;Endometrial ciliated cells: 30.5;Glandular and luminal cells: 93.7;Proximal tubular cells: 36.2;Syncytiotrophoblasts: 85.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.1;RPTEC TERT1: 4.5;WM-115: 3.5"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	1.2	0.4	0.3	0.5	0.6	1.1	1.9	1.0	0.2	0.3	0.5	0.5	0.5	0.3	0.1	0.4	6.7	6.3	0.4	0.3	20.2	0.1	0.2	0.2	0.2	0.0	0.1	99.8	2.2	0.0	4.5	0.1	0.2	0.1	0.5	1.6	2.3	3.8	1.0	0.8	0.1	0.0	0.3	0.3	0.2	0.6	0.0	19.8	0.7	0.1	0.5	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	2.1	0.1	0.1	0.0	0.0	0.3	0.4	0.1	0.4	0.0	0.1	0.3	0.1	0.2	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.3	0.3	4.5	0.1	0.4	0.1	0.3	0.5	0.1	0.7	0.3	0.1	0.2	0.2	0.5	0.2	0.1	0.3	0.2	0.3	0.2	0.2	3.5	0.9	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.4	0.5	1.9	1.0	0.4	0.3	0.2	0.0	0.1	0.0	0.6	0.2	0.2	3.2	3.0	0.0	0.6	0.4	0.7	0.0	0.0	4.5	9.1	0.4	13.9	8.6	0.0	9.2	0.0	31.0	0.1	0.5	5.9	11.5	0.0	30.5	9.7	1.0	0.0	0.0	0.0	21.1	2.8	0.5	0.0	93.7	4.5	0.1	0.0	0.0	3.6	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.9	3.6	0.0	1.0	0.7	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	3.9	36.2	0.0	2.3	6.6	2.1	1.0	0.2	0.4	0.0	0.9	85.1	0.9	0.1	1.1	0.7
SLC30A8	"ZnT-8, ZNT8"	ENSG00000164756	"Solute carrier family 30 member 8"	Q8IWU4	8	116950273-117176714	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 61.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.9;Late spermatids: 7.5;Pancreatic endocrine cells: 5.0;Proximal tubular cells: 3.6;Spermatogonia: 5.0"	"Group enriched"	"Detected in some"	28	"breast cancer: 10.6;pancreatic cancer: 15.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"U-266/70: 48.0;U-266/84: 36.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 4.1"	HPA076165	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA076165: AB_2732304"	"unprognostic (2.14e-2)"		"unprognostic (1.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"		"unprognostic (5.57e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.66e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.16e-3)"	0.0	0.0	0.3	0.0	0.4	0.3	0.6	0.2	0.2	0.1	0.0	0.3	0.6	0.7	0.0	0.2	0.1	0.2	0.2	0.3	0.2	4.3	0.0	0.1	0.1	0.2	0.1	0.0	61.8	0.3	0.3	0.3	0.3	0.1	0.2	0.2	12.9	0.0	0.0	0.8	1.0	0.2	0.0	0.0	1.1	2.0	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	48.0	36.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.2	0.3	0.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236555	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 9.7;kidney: 13.6"	"Group enriched"	"Detected in some"	9	"Proximal enterocytes: 83.7;Proximal tubular cells: 40.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.0;HDLM-2: 2.8;HeLa: 3.3;MCF7: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA023776	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.5	0.2	0.0	2.9	0.4	0.5	0.2	0.2	0.2	13.6	0.0	0.3	0.2	1.8	2.0	0.0	0.6	0.0	1.2	0.0	0.5	0.3	0.0	0.2	1.6	0.0	0.1	0.4	9.7	0.0	0.5	0.2	0.4	0.4	0.8	0.0	0.3	0.0	0.0	0.1	0.5	1.1	0.6	1.2	0.7	1.5	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	4.0	0.5	0.1	0.0	0.1	1.8	0.0	0.0	0.1	2.8	0.3	0.1	3.3	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.6	0.0	7.6	0.0	0.1	0.3	0.7	0.8	0.9	0.5	0.0	0.0	0.6	0.0	1.3	0.4	0.9	0.2	0.6	2.2	0.0	0.3	0.3	0.3	1.5	0.1	0.7	0.3	0.3	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.2	0.2	1.8	2.0	0.5	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	83.7	40.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904676-234324511	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.7"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	35	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	35	"dendritic cells: 3.5"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.0	1.1	6.9	0.3	17.7	0.1	2.5	9.5	15.5	0.3	0.0	0.4	0.1	0.3	0.7	0.5	0.4	0.1	0.0	5.4	0.7	0.7	0.0	0.2	0.8	1.6	0.3	0.1	3.5	1.4	2.6	0.0	1.9	0.5	0.1	0.3	2.5	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.7	0.2	2.5	2.3	0.5	0.1	0.5	0.0	0.5	9.5	3.0	7.9	1.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.1	0.2	0.6	0.1	7.7	0.0	111.9	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.1	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	9.0	0.0	0.0	0.0	7.7	0.0	4.2	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.9	17.7	9.5	15.5	5.4	0.7	1.6	0.3	1.9	0.2	2.5	9.5	0.1	0.0	0.0	8.5	0.9	0.4	2.4	0.3	10.8	2.1	3.0	8.9	0.7	0.0	0.1	0.0	0.0	0.0	9.5	0.0	3.9	1.4	0.7	5.9	1.6	0.1	1.8	0.0	485.2	3.4	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	216.1	0.1	26.4	0.0	0.0	0.9	0.0	0.6	0.0	9.4	0.9	0.0	0.0	190.5	45.4	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.5	0.0	0.8	0.1	0.6	1.5	0.8	0.1	0.0	0.4	0.0	0.0	0.2
SLC35F6	"ANT2BP, C2orf18, FLJ20555, TANGO9"	ENSG00000213699	"Solute carrier family 35 member F6"	Q8N357	2	26764284-26781231	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 129.9;Karpas-707: 117.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034655	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034655: AB_10696359"	"unprognostic (2.26e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.11e-4)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-2)"	18.6	20.7	9.6	7.3	10.5	4.6	16.2	10.1	9.2	14.5	8.4	10.1	7.9	11.9	7.3	22.0	10.7	7.3	13.8	9.6	11.8	19.5	17.7	11.9	6.5	13.9	12.9	8.5	10.3	21.3	10.8	9.4	12.3	11.4	5.7	5.8	14.5	8.1	12.8	21.2	10.0	10.1	10.4	10.8	11.3	5.1	13.0	5.7	16.0	9.9	7.6	12.1	13.0	11.6	24.6	43.6	12.3	32.6	41.7	19.4	20.4	14.9	20.3	16.8	15.2	27.9	44.5	6.6	23.4	18.7	42.0	29.4	18.1	26.9	11.8	11.5	10.1	7.6	16.4	23.3	129.9	7.8	36.4	29.8	26.9	18.9	62.7	7.6	19.9	9.6	14.2	117.3	16.9	40.5	10.0	7.0	7.6	17.2	10.9	8.9	35.9	10.9	44.1	20.3	9.6	12.7	22.8	37.4	25.4	10.1	14.1	8.2	19.2	21.8	24.0	30.7	15.2	23.9	32.6	12.9	23.6	13.4	21.0	12.1	18.1	8.0	11.9	25.6	7.0	4.8	8.2	10.8	11.4	3.6	5.3	7.9	11.7	13.6	30.9	7.8	5.9	9.5	9.6	10.5	10.1	9.2	9.6	11.8	13.9	12.9	12.3	10.4	13.0	11.6	39.0	12.8	10.5	11.8	5.9	17.0	13.2	10.2	7.4	17.2	17.5	10.2	13.5	28.6	11.1	33.1	6.2	24.1	12.0	21.5	7.9	34.2	1.7	13.4	29.7	20.8	9.1	0.8	6.9	38.7	22.3	25.2	12.2	22.8	1.3	11.9	31.8	25.4	51.2	15.2	7.9	11.2	8.2	61.0	16.8	1.5	18.3	28.8	28.4	4.7	19.8	19.2	11.3	9.0	10.8	48.2	14.3	12.0	5.5	18.3	21.5	57.2	9.0	11.1	26.3	17.8	20.2	3.7	7.1	14.9	25.7	38.0	10.6	16.8	11.2	11.7
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855888	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.2;Early spermatids: 65.4;Inhibitory neurons: 42.4;Spermatocytes: 35.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA052054: AB_2681709, HPA064728: AB_2685336"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	14.9	15.4	20.9	2.1	21.2	0.5	11.1	23.1	26.4	5.1	16.5	3.8	1.0	4.3	4.6	2.6	5.7	5.3	8.1	20.0	24.4	3.9	4.4	7.0	1.9	21.4	25.0	5.5	7.6	6.7	19.3	7.4	26.9	4.1	2.0	5.3	3.1	2.6	2.4	3.7	2.9	5.1	22.1	3.2	2.9	14.4	22.6	2.8	8.5	5.4	1.2	6.5	5.0	21.0	3.9	10.7	10.6	4.8	20.8	17.1	0.0	16.9	73.1	24.7	37.0	10.1	5.7	0.0	12.7	17.5	39.3	1.3	12.7	0.7	22.8	0.1	3.5	3.2	12.0	6.3	26.6	0.1	0.0	24.2	1.8	21.5	5.9	18.0	18.8	6.8	1.8	0.1	32.1	0.0	4.7	3.3	2.3	0.0	7.9	4.2	7.1	0.2	21.1	0.9	17.5	11.7	13.7	0.0	24.0	3.6	0.0	1.8	13.1	18.4	4.7	8.2	18.6	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	20.9	21.2	23.1	26.4	20.0	24.4	21.4	25.0	26.9	22.1	22.6	21.0	22.4	12.8	7.0	54.2	2.5	3.3	4.9	12.0	7.4	4.7	0.7	0.8	2.5	1.5	7.1	1.8	12.5	1.3	2.7	0.8	1.9	3.3	65.4	1.0	1.6	30.6	4.2	4.4	34.0	10.7	1.3	12.4	0.5	1.3	2.5	3.6	27.8	2.3	0.7	6.7	42.4	1.0	0.0	2.2	7.3	30.3	9.9	2.1	3.6	17.8	3.7	7.8	15.5	15.6	6.1	10.0	0.1	3.0	3.7	4.7	0.6	0.7	1.4	4.6	6.6	4.7	4.8	35.5	16.1	1.2	3.0	2.2	3.8	3.1	0.6	2.0
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314972-151347590	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 67.6;skeletal muscle: 80.2;tongue: 29.8"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 53.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044002, HPA062229"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.2	0.1	0.0	67.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.2	0.9	0.0	80.2	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	29.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.4	0.2	0.2	1.1	0.4	0.1	0.4	0.1	0.1	0.2	0.1	0.8	0.6	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.9	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063302-125090516	"Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 78.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 13.4;Hofbauer cells: 36.5;Kupffer cells: 22.0;Macrophages: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 12.3;intermediate monocyte: 14.1;myeloid DC: 5.5;non-classical monocyte: 19.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.5;monocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;CAPAN-2: 70.3;hTCEpi: 34.9;hTERT-HME1: 64.8;U-138 MG: 47.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	4.2	24.2	1.7	16.9	2.6	1.4	4.6	2.4	3.7	2.3	2.1	8.0	9.1	1.0	1.3	13.4	1.2	5.1	1.5	1.9	2.3	0.7	5.9	5.9	5.7	4.3	2.7	1.0	1.2	1.1	0.2	7.4	3.8	2.6	10.2	0.5	78.8	1.4	0.6	20.9	7.7	3.1	3.2	15.8	2.1	1.6	5.2	2.1	0.6	0.9	5.1	11.9	7.7	7.3	33.8	0.1	1.0	0.4	0.6	0.8	0.6	1.6	2.8	1.0	2.5	0.2	70.3	0.4	9.4	0.4	2.5	21.0	0.4	20.9	3.8	0.9	0.6	6.6	1.6	2.4	0.1	0.3	0.9	0.7	34.9	2.6	64.8	2.7	1.7	1.3	0.5	2.2	3.1	0.3	0.3	4.6	1.9	0.2	1.0	0.4	2.7	0.8	1.0	17.6	0.3	0.3	4.8	2.9	2.6	0.5	0.3	1.8	3.7	47.2	1.9	0.7	1.6	1.8	1.5	1.1	1.7	2.4	4.1	0.2	12.3	0.0	0.0	14.1	0.0	0.4	0.0	0.1	5.5	0.1	0.1	0.1	1.3	0.0	19.2	0.2	0.0	5.4	1.7	2.6	2.4	3.7	1.9	2.3	4.3	2.7	3.8	3.2	5.2	7.3	0.7	0.0	0.6	0.3	3.8	0.3	1.4	0.5	1.2	1.5	1.4	1.1	1.1	1.5	1.6	0.0	2.1	0.6	0.7	13.4	0.0	0.1	1.6	1.9	1.4	1.3	0.0	2.7	0.3	0.0	0.8	0.5	0.0	4.9	2.5	0.4	1.8	0.3	36.5	0.0	0.3	0.1	0.0	22.0	1.4	2.2	0.9	22.7	0.0	8.4	7.3	0.3	3.1	1.0	0.2	0.1	3.3	1.2	1.7	1.0	0.0	0.1	0.2	0.8	0.0	0.8	0.6	2.7	1.1	5.7	0.9	3.4	1.2	0.4	0.1	3.2
SLC37A4	"G6PT1, G6PT2, G6PT3, GSD1b, GSD1c, GSD1d"	ENSG00000137700	"Solute carrier family 37 member 4"		11	119024114-119030906	"Human disease related genes, Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"liver: 139.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 171.6;Hepatocytes: 175.9;Proximal enterocytes: 277.2;Proximal tubular cells: 183.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 29.3;HEK 293: 28.0;Hep G2: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038939, HPA038940"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA038939: AB_2676279, HPA038940: AB_2676280"	"unprognostic (4.77e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.70e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.34e-2)"	"unprognostic (5.39e-2)"	4.5	8.0	4.6	2.5	4.7	2.4	5.0	4.5	6.9	5.1	4.6	10.8	36.1	3.5	20.8	4.7	5.5	1.7	5.4	4.8	4.7	49.4	139.9	4.6	1.5	4.9	4.7	5.3	40.1	3.4	6.3	2.5	4.7	9.4	6.6	4.6	7.0	5.5	30.0	4.9	27.3	1.3	4.8	7.1	12.0	7.1	4.7	1.1	5.3	3.8	0.9	4.6	4.7	4.9	1.2	12.2	5.6	6.2	7.5	3.2	4.9	0.7	9.7	2.6	6.9	29.3	2.8	3.8	7.2	3.9	5.4	0.7	2.3	14.9	4.4	4.1	28.0	10.3	3.4	37.1	2.8	6.0	2.0	0.5	4.2	1.5	7.1	10.7	8.7	0.6	4.7	11.2	4.5	25.9	0.3	13.3	0.1	3.6	13.6	8.4	0.0	21.1	5.5	12.9	7.3	6.4	0.0	2.6	5.4	5.8	5.4	4.2	0.0	0.0	4.9	1.3	5.4	1.7	2.9	1.3	1.2	15.6	2.0	0.0	0.9	1.3	1.4	1.6	1.2	0.7	1.0	1.7	0.3	0.5	1.0	1.1	0.0	0.9	0.7	0.1	1.0	0.6	4.6	4.7	4.5	6.9	4.8	4.7	4.9	4.7	4.7	4.8	4.7	4.9	7.9	3.2	7.8	7.5	5.8	1.8	8.3	10.1	5.7	7.5	13.0	10.7	4.5	171.6	8.2	16.5	0.0	30.1	3.2	23.8	31.3	29.5	14.0	11.5	6.6	9.2	24.7	28.6	4.5	25.3	21.4	5.5	13.7	11.2	0.0	72.3	19.2	175.9	28.8	16.8	4.2	26.3	14.2	11.1	2.4	3.3	9.6	7.9	3.6	7.5	10.0	93.4	2.1	3.5	2.9	19.7	27.5	10.5	5.7	12.5	277.2	183.0	12.6	11.3	0.0	4.4	5.6	11.2	25.8	5.9	2.7	15.2	5.4	6.7	50.3	8.4
SLC39A4	"AEZ, AWMS2, ZIP4"	ENSG00000147804	"Solute carrier family 39 member 4"	Q6P5W5	8	144409742-144416844	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 88.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 406.4;Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CAPAN-2: 36.4;Hep G2: 97.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.59e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.04e-4)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.87e-1)"	0.1	0.2	0.1	1.4	0.2	0.5	0.3	0.0	0.7	0.7	0.0	33.1	88.1	0.4	0.1	0.2	0.9	0.5	0.0	0.2	0.0	18.4	1.3	3.1	0.1	0.0	0.0	3.3	1.4	0.0	0.2	1.0	0.0	1.3	0.5	0.0	1.2	0.3	0.0	0.5	74.9	0.1	0.0	0.7	2.9	1.3	0.0	0.0	3.9	0.0	0.0	0.6	0.6	0.0	2.3	0.2	0.0	0.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	2.1	36.4	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	6.4	0.8	1.6	0.6	97.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	2.2	0.0	1.7	0.0	0.4	0.1	0.5	0.1	0.4	0.0	1.1	0.0	0.4	0.9	1.9	0.2	0.4	0.1	0.4	1.7	0.1	0.0	0.1	0.2	0.0	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	19.2	24.8	0.3	21.3	18.7	36.6	46.9	38.7	0.2	45.0	50.3	7.4	20.0	24.1	42.3	0.0	17.0	15.4	112.8	50.9	40.0	1.4	41.8	12.9	10.9	42.6	26.3	1.0	42.9	69.7	16.8	29.6	51.9	37.4	8.5	8.9	27.4	32.1	3.3	0.2	95.0	30.5	18.2	21.0	2.0	8.1	23.5	21.4	0.0	25.9	11.3	23.7	0.0	0.1	75.6	135.0	6.4	31.9	60.8	406.4	230.3	26.9	1.0	6.6	7.5	11.1	2.9	33.1	46.4	30.0	11.2	15.4	23.2	98.2	46.3
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"intestine: 237.4;kidney: 110.0;liver: 171.1;pancreas: 306.8"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 798.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 30.6;liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	53	"CACO-2: 39.9;Hep G2: 58.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.3	0.1	0.2	5.5	0.2	0.1	0.3	0.5	0.4	0.3	0.2	73.7	237.4	0.4	0.0	0.1	0.3	6.5	0.2	0.1	0.1	110.0	171.1	0.2	0.4	0.2	0.1	0.4	306.8	0.0	0.2	0.1	0.1	0.3	45.9	6.4	0.1	0.3	0.1	0.3	219.0	2.6	0.1	0.3	1.4	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.2	0.3	0.5	0.0	0.0	0.1	0.0	39.9	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.6	0.1	0.2	0.2	58.5	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.8	0.0	0.9	0.1	0.2	0.2	0.3	0.5	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.6	0.1	0.0	0.0	0.9	0.1	0.3	0.2	15.7	0.0	3.7	116.7	0.0	0.0	171.9	19.6	0.3	0.6	0.0	0.1	0.2	25.3	2.7	0.2	20.6	0.0	0.1	0.0	0.0	0.0	0.0	2.2	138.9	0.1	0.0	0.2	112.7	0.0	1.6	1.2	1.4	0.0	1.3	0.0	0.0	0.6	0.6	0.0	0.0	0.1	7.4	192.8	0.0	0.0	0.1	798.4	169.9	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.8	0.0	168.7	0.0
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 136.2;kidney: 649.3;pancreas: 217.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 106.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.5	0.3	1.2	1.1	1.7	0.6	0.4	6.8	3.4	1.0	0.1	22.4	113.9	1.4	1.9	0.2	0.6	51.5	0.4	1.6	1.3	649.3	36.6	0.4	0.4	0.6	0.6	0.5	217.5	0.0	0.5	0.1	0.7	1.0	22.7	3.5	0.3	0.3	1.0	0.6	136.2	0.5	0.0	0.5	0.9	1.7	1.0	0.0	0.4	0.1	0.1	0.3	0.3	1.7	0.0	1.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.1	4.9	0.0	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.1	1.2	0.5	0.1	0.1	0.2	106.1	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.3	0.2	0.4	0.3	0.3	0.7	0.3	0.4	0.5	0.6	0.3	0.1	1.0	0.6	0.7	0.4	0.4	0.1	0.3	0.2	0.1	1.2	1.7	6.8	3.4	1.6	1.3	0.6	0.6	0.7	0.0	1.0	1.7	0.2	3.2	1.5	0.3	6.1	0.0	0.3	0.0	0.0	12.1	0.2	0.0	0.4	74.4	0.0	42.3	10.4	0.1	0.8	18.2	62.6	37.0	12.4	62.2	14.4	0.6	0.0	0.0	9.1	13.8	0.0	0.9	1.1	128.9	0.0	0.1	0.4	4.6	0.1	21.9	9.0	8.4	0.0	0.0	0.0	8.5	1.2	3.2	0.0	1.0	1.6	1.0	1.0	3.0	3.7	4.8	18.6	0.4	1.5	1.1	258.9	363.0	0.0	11.2	0.0	2.6	1.2	0.8	0.4	0.7	0.1	0.1	2.8	0.2	15.7	1.2
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 780.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 1441.0;SiHa: 1287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		170000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	103.3	105.6	130.5	46.7	138.0	122.0	108.9	140.1	160.4	101.6	115.6	60.6	51.5	97.2	65.3	112.9	94.0	35.8	52.0	123.1	133.3	171.2	71.9	117.8	34.9	138.4	132.6	93.0	109.7	189.7	65.3	55.4	134.0	100.8	23.1	22.8	110.6	41.9	122.3	127.1	79.7	33.8	135.8	77.4	90.2	65.1	154.5	30.1	110.2	26.0	28.8	77.7	95.1	130.6	155.5	675.7	60.2	213.2	89.7	69.7	596.7	267.5	106.2	154.0	126.3	643.3	293.0	173.9	290.5	185.4	284.5	540.0	123.1	588.9	84.3	319.3	114.0	117.5	422.4	299.2	825.7	136.0	169.4	144.9	1441.0	175.3	528.8	46.2	83.6	380.7	232.9	347.4	95.1	792.6	149.8	181.3	106.9	222.5	214.2	153.8	92.7	341.8	113.9	84.0	112.5	53.5	1287.0	499.6	948.5	121.2	161.5	182.6	146.2	138.3	200.0	204.4	195.5	436.0	556.1	561.2	135.0	225.1	418.0	37.8	149.0	49.7	117.9	147.4	157.7	58.3	107.3	122.1	88.6	72.1	90.1	97.2	31.2	90.3	123.9	304.7	112.5	186.3	130.5	138.0	140.1	160.4	123.1	133.3	138.4	132.6	134.0	135.8	154.5	130.6	97.8	48.1	37.3	91.1	78.8	218.1	244.2	321.7	399.5	58.4	124.2	120.8	13.4	30.0	141.1	49.7	66.7	222.5	136.2	109.6	33.2	161.9	31.5	122.0	96.3	149.2	84.3	117.7	16.9	151.1	143.7	102.9	71.4	179.7	84.3	43.2	99.2	27.0	202.9	53.8	25.1	60.4	223.8	54.1	140.9	28.9	30.4	141.5	224.1	29.0	104.7	188.4	40.2	21.1	11.3	130.6	58.7	30.5	140.9	156.9	120.7	227.4	63.4	61.2	6.6	71.8	114.6	21.3	31.9	160.7	150.6	780.7	118.1	52.4	60.7	194.9
SLC45A1	DNB5	ENSG00000162426	"Solute carrier family 45 member 1"	Q9Y2W3	1	8318114-8344167	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.0;Horizontal cells: 10.1;Inhibitory neurons: 11.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;GAMG: 2.7;HHSteC: 4.9;U-87 MG: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078818	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA078818: "	"unprognostic (1.77e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-3)"	2.2	1.8	3.4	0.5	3.3	0.0	2.1	2.6	5.6	3.5	1.9	4.0	0.5	5.1	0.8	0.9	4.3	1.1	1.9	3.4	3.7	4.2	0.2	0.9	0.4	5.0	3.3	3.0	1.0	1.1	6.7	0.3	6.0	2.9	0.3	1.6	0.9	2.1	1.2	0.8	1.9	1.1	1.1	1.4	1.7	1.4	3.9	0.1	1.4	1.3	0.1	3.0	2.6	2.9	0.0	1.8	0.3	0.8	3.7	2.6	0.0	0.1	0.8	0.2	0.5	0.0	0.2	0.0	0.2	0.5	2.7	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.1	0.0	4.9	0.0	1.4	1.2	0.1	0.6	0.0	0.9	0.4	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	1.2	0.0	0.8	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.3	1.5	0.2	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.1	0.0	0.6	0.6	0.8	0.3	0.4	0.4	0.1	0.0	0.2	0.3	0.0	0.0	3.9	0.0	0.3	0.4	3.4	3.3	2.6	5.6	3.4	3.7	5.0	3.3	6.0	1.1	3.9	2.9	6.3	0.0	0.0	5.2	0.6	0.4	1.8	0.8	0.6	7.0	0.3	0.0	1.4	0.0	0.1	1.8	4.2	0.1	0.2	0.0	0.0	0.6	2.5	0.6	2.4	2.9	0.0	0.0	10.0	0.2	0.0	3.1	0.0	0.9	0.0	1.6	1.1	0.0	0.1	10.1	11.1	0.2	0.0	0.3	1.5	5.4	3.4	0.7	0.0	0.0	0.0	6.1	0.0	5.0	4.4	0.1	0.0	5.7	0.3	0.9	0.0	0.5	0.1	5.0	6.6	2.7	2.5	0.6	0.5	0.0	0.3	0.0	1.0	1.4	0.1	0.4
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 127.3;kidney: 100.3;liver: 103.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 189.2;Hepatocytes: 43.3;Proximal tubular cells: 52.9;Skeletal myocytes: 67.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 12.2;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.6;granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"A549: 21.3;AN3-CA: 16.7;Hep G2: 41.5;U-266/70: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced					NA	NA		18000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	1.9	127.3	2.1	0.8	2.6	2.7	1.3	3.5	15.8	29.4	9.3	2.0	1.3	16.2	2.5	1.9	7.4	3.8	5.4	15.7	1.6	100.3	103.9	7.0	1.6	3.0	2.5	7.7	0.3	1.4	16.5	0.4	3.1	6.3	1.0	1.2	2.6	12.3	34.1	25.0	1.3	7.7	2.5	3.7	1.2	14.5	4.3	1.5	6.2	37.7	1.3	1.0	10.6	3.3	0.1	21.3	0.6	16.7	0.5	0.1	0.1	0.6	0.5	2.5	2.3	0.0	0.6	0.2	3.9	3.1	8.3	0.1	7.4	0.6	0.6	0.1	9.8	0.2	10.6	41.5	0.2	0.2	0.5	0.4	3.7	1.9	0.3	2.8	5.9	0.0	0.0	0.0	0.0	3.0	0.1	0.4	2.2	0.3	0.8	0.2	0.2	0.2	0.0	1.3	3.9	3.4	7.0	0.1	1.9	5.6	7.1	1.9	0.0	0.1	0.8	0.3	2.0	31.0	13.1	0.1	0.8	0.1	3.6	0.3	1.4	12.2	0.3	0.9	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.0	0.1	6.6	0.0	0.5	2.1	2.6	3.5	15.8	15.7	1.6	3.0	2.5	3.1	2.5	4.3	3.3	0.5	6.4	3.7	0.7	1.3	4.7	2.3	0.4	6.2	0.9	0.1	0.8	4.1	4.3	0.1	1.8	0.0	0.0	1.7	0.0	3.9	0.1	15.5	3.0	1.3	1.2	0.0	0.0	3.5	0.0	0.0	4.4	0.0	9.2	5.7	189.2	0.0	43.3	1.5	0.0	14.4	0.0	0.0	2.9	1.2	4.8	3.7	2.5	1.8	3.7	0.4	1.4	0.0	2.5	0.3	0.0	0.0	1.5	3.9	2.3	0.0	52.9	0.8	0.9	6.6	67.8	3.3	0.6	1.1	1.1	6.7	0.0	1.7	0.3	0.0	1.5
SLC47A2	"FLJ31196, MATE2, MATE2-K"	ENSG00000180638	"Solute carrier family 47 member 2"	Q86VL8	17	19678288-19718979	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.3;choroid plexus: 39.6;kidney: 55.8"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 91.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6;renal cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 2.1"					"Not detected"	"Not detected"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.52e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (5.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.71e-2)"	0.1	0.2	2.5	0.0	2.1	0.0	0.2	2.0	1.5	0.1	39.6	0.0	0.0	0.1	6.7	0.4	10.0	0.0	0.1	3.5	6.4	55.8	0.0	0.0	0.0	11.6	22.3	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.6	0.4	0.2	1.1	2.3	0.3	0.1	8.4	0.0	0.0	0.0	5.0	0.0	0.2	0.2	0.0	0.0	0.1	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.1	2.0	1.5	3.5	6.4	11.6	22.3	11.5	8.4	5.0	4.7	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.6	0.0	0.0	0.9	0.7	0.0	0.2	5.5	0.0	0.1	0.0	0.2	5.9	0.0	0.6	20.9	0.4	0.1	0.0	0.0	3.3	0.0	0.0	0.5	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	2.0	0.0	0.0	0.7	0.3	0.9	0.0	1.9	0.0	1.3	0.0	2.0	1.4	0.1	0.0	0.0	0.0	0.8	1.7	91.3	2.5	0.5	0.0	3.5	0.1	0.6	0.8	1.0	0.3	0.0	0.6	0.0	0.2	0.2
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248390-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 407.2"	"Cell type enriched"	"Detected in some"	80	"Erythroid cells: 1629.2"	"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015584, CAB034438, HPA063911"	Enhanced					NA	NA		22000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.5	0.3	0.7	0.3	0.7	407.2	0.2	2.2	1.4	0.1	1.7	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.9	0.6	0.5	72.1	2.2	1.8	0.4	0.8	0.6	0.1	0.2	0.0	0.6	10.9	0.9	0.1	0.1	0.7	0.4	0.1	2.2	0.5	0.2	0.0	0.3	12.8	0.3	0.3	1.1	0.7	0.3	1.5	0.1	0.1	0.1	1.7	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.6	0.0	0.3	0.1	0.1	0.4	0.2	0.3	0.3	0.1	0.1	0.6	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.4	0.5	0.2	3.0	0.3	0.5	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	2.7	1.1	0.4	0.3	0.1	0.2	0.7	0.7	2.2	1.4	0.6	0.5	0.8	0.6	0.9	0.3	1.1	1.7	0.8	6.4	0.6	0.3	2.0	0.0	1.3	0.0	0.0	0.4	1.0	1.1	0.7	0.0	0.6	20.2	0.0	0.4	0.1	0.2	3.9	0.1	0.8	0.2	0.4	0.7	0.0	1629.2	0.2	0.0	1.6	0.5	0.0	0.5	0.0	0.1	0.7	0.9	1.4	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	1.9	0.0	1.0	0.6	0.2	2.1	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.2	0.4	0.0	0.2	0.0	1.2	0.2	0.7	0.5	0.0	0.0	0.8	1.5	0.7	0.1	0.6
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71062667-71572087	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 119.5;pancreas: 260.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	5.1	0.7	30.0	2.2	43.6	0.5	1.0	47.0	32.5	11.5	0.0	41.1	54.3	0.4	0.3	1.2	0.9	29.4	6.2	21.5	37.9	119.5	21.7	6.9	0.2	38.6	28.0	0.8	260.3	17.2	5.8	2.7	24.8	34.7	41.2	5.1	2.5	1.1	2.2	0.1	14.6	1.7	38.2	0.8	18.6	0.5	38.5	3.5	22.0	3.5	0.0	4.5	0.4	33.2	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.0	1.9	2.2	1.6	0.0	0.1	0.0	0.1	6.1	0.5	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.7	0.0	0.5	1.2	0.0	4.8	0.2	0.1	0.2	0.0	0.0	0.0	0.9	15.4	4.1	0.9	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	7.7	0.7	5.5	0.6	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	30.0	43.6	47.0	32.5	21.5	37.9	38.6	28.0	24.8	38.2	38.5	33.2	1.5	3.2	37.1	819.1	2.2	0.0	4.3	3.2	0.6	3.2	0.9	0.3	24.0	133.0	31.1	25.8	0.0	0.3	7.2	282.9	15.6	129.2	11.5	2.8	0.5	1.3	8.5	4.0	51.4	24.2	0.1	4.9	33.1	5.8	1.3	0.6	3.9	35.8	0.2	0.0	93.4	65.6	2.0	0.6	0.2	1.5	0.0	2.3	1.8	34.7	1.0	3.9	1.0	29.1	3.7	16.2	60.8	0.0	1.7	40.8	31.8	211.0	10.4	1.5	6.6	1.0	6.2	0.1	1.0	5.5	0.0	0.3	6.8	2.4	68.1	12.3
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360194-140375141	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"kidney: 35.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 2.4;Inhibitory neurons: 2.4;Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 6.4;Spermatocytes: 1.7;Spermatogonia: 1.9"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051307	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.5	35.5	0.0	0.1	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.7	0.3	0.5	0.9	0.6	1.0	0.5	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.4	1.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	6.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.7	1.9	0.0	0.1	0.0	0.1	0.1	0.1	0.2
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 subunit alpha"	Q86UW1	3	196211487-196243178	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"intestine: 64.5;liver: 71.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 49.1;Leydig cells: 61.5;Peritubular cells: 101.5;Proximal enterocytes: 271.8;Sertoli cells: 144.7"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 3.9;U-266/84: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045488	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA045488: "	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	1.3	5.2	0.2	1.3	0.2	5.9	1.2	0.1	0.7	2.0	0.0	11.3	30.5	0.8	0.8	1.4	1.6	0.6	1.3	0.2	0.4	5.5	71.3	2.0	0.6	0.2	0.1	1.4	0.9	2.7	1.2	0.2	0.3	1.1	0.7	0.7	1.2	0.0	1.6	2.5	64.5	0.2	0.0	1.8	0.9	4.1	0.7	0.1	1.5	0.0	0.5	1.0	1.8	0.5	0.5	0.7	0.6	0.7	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.8	0.5	0.0	0.4	0.0	0.0	0.0	0.3	1.3	0.5	0.4	0.8	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	1.5	0.0	0.3	0.0	0.6	0.0	0.1	0.9	3.9	0.0	0.2	0.0	0.4	0.1	0.2	0.2	1.4	0.1	0.1	1.1	0.2	0.2	0.7	0.3	0.6	0.4	1.5	2.0	0.2	0.5	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.7	0.2	0.4	0.2	0.1	0.3	0.0	0.7	0.5	1.1	0.0	0.5	0.3	1.0	3.3	2.5	10.9	0.0	0.5	0.6	0.3	4.1	1.5	18.2	0.0	4.2	0.7	3.0	43.5	3.9	0.2	20.7	2.7	1.6	1.6	0.0	2.7	1.0	0.2	0.4	2.4	0.0	1.6	0.0	2.3	3.9	49.1	0.6	1.7	0.7	8.4	22.4	4.4	7.3	12.9	61.5	1.3	3.6	1.0	0.8	0.4	1.0	0.5	0.2	0.1	12.1	101.5	0.8	1.5	271.8	11.5	18.0	1.1	144.7	2.3	2.6	2.4	1.3	0.0	2.6	1.0	3.0	13.6	11.8	2.8
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 subunit beta"	Q86UW2	15	65045387-65053397	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 41.8;intestine: 107.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.7	1.1	5.8	3.5	5.5	0.8	0.3	4.0	3.9	41.8	0.0	41.9	86.9	3.0	0.3	2.4	3.6	2.8	2.3	3.8	6.5	19.5	2.2	6.1	0.6	7.3	10.9	1.1	0.3	0.0	0.4	0.6	7.7	2.7	29.4	0.7	1.0	0.6	1.0	0.8	107.1	1.7	6.5	0.8	0.8	9.6	11.8	0.0	0.7	0.0	0.0	1.5	0.9	4.2	0.0	1.5	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	18.5	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.1	0.4	0.4	0.1	0.4	0.0	0.0	0.9	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	4.0	3.9	3.8	6.5	7.3	10.9	7.7	6.5	11.8	4.2	0.0	0.0	1.1	0.3	1.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.1	0.0	354.6	13.7	0.0	60.8	10.4	0.2	1.2	1.8	2.7	0.0	0.0	0.0	0.5	0.0	1.9	4.5	0.0	0.4	1.8	0.1	0.0	0.0	23.0	0.0	0.3	0.0	14.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.1	0.0	0.0	0.0	721.4	73.3	15.6	0.0	6.6	1.0	0.4	27.9	0.5	0.0	0.0	0.1	0.6	0.1	45.8	0.0
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC5A10	SGLT5	ENSG00000154025	"Solute carrier family 5 member 10"	A0PJK1	17	18950345-19022595	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 41.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 33.7;Proximal tubular cells: 76.9"	"Cancer enriched"	"Detected in some"	11	"renal cancer: 6.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.8;non-classical monocyte: 4.8"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.8"	"Cell line enriched"	"Detected in some"	5	"U-937: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052014	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052014: AB_2681694"	"unprognostic (3.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.36e-4)"	"unprognostic (7.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.11e-1)"	0.2	0.2	0.1	0.6	0.1	2.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.0	0.0	41.6	0.5	0.4	0.9	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.9	1.4	0.0	0.1	3.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.8	0.3	8.8	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.6	0.0	0.0	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	33.7	0.0	0.5	1.8	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	0.0	0.7	0.1	0.0	76.9	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.3	0.6	0.0	0.0	0.0
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 43.9"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 677.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 8.3;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.1	0.1	8.5	0.0	24.2	0.0	0.6	22.0	22.6	0.0	5.0	0.3	3.3	0.0	0.0	0.0	0.1	0.2	0.1	8.6	17.0	3.0	0.8	0.1	0.0	27.2	21.5	0.1	0.3	0.0	0.3	0.0	27.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	8.1	0.0	14.5	0.2	0.1	0.4	20.7	0.0	0.1	0.2	0.0	0.1	0.1	43.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	24.2	22.0	22.6	8.6	17.0	27.2	21.5	27.3	14.5	20.7	43.9	0.0	0.0	0.0	2.9	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	2.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	677.9	0.0	2.4	0.0	0.1	0.0	35.2	7.2	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.2	0.6	0.0
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667020-26723427	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 47.7;intestine: 30.1;kidney: 171.7"	"Group enriched"	"Detected in some"	23	"Proximal enterocytes: 286.0;Proximal tubular cells: 181.0"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.1	0.1	0.3	0.0	0.5	0.9	0.1	0.9	0.4	0.0	0.3	0.2	4.9	0.1	47.7	0.0	0.1	0.1	4.3	0.3	0.4	171.7	1.7	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.0	0.1	0.1	0.1	0.3	30.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.2	1.7	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.1	0.7	0.1	0.0	3.3	1.2	0.2	0.2	0.2	0.1	0.2	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.9	0.4	0.3	0.4	0.2	0.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	3.7	0.0	0.1	0.0	2.4	9.8	0.0	1.4	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	286.0	181.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.6	4.5	3.5	0.1
SLC5A2	SGLT2	ENSG00000140675	"Solute carrier family 5 member 2"	P31639	16	31483002-31490860	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 54.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 59.7;Late spermatids: 145.7;Proximal tubular cells: 142.9;Spermatocytes: 31.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041603	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA041603: AB_10960540"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.22e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	54.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	3.7	0.3	0.2	0.3	0.1	0.2	0.0	0.5	0.2	0.4	0.5	1.5	0.1	9.2	0.0	0.2	0.1	0.1	7.9	0.6	59.7	0.6	0.5	0.2	0.0	0.0	0.1	0.5	0.1	0.4	1.5	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.5	2.0	0.0	0.5	145.7	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.1	1.5	0.0	0.1	4.7	142.9	1.7	0.2	0.0	0.1	0.2	31.7	1.1	0.0	0.3	0.1	1.4	0.1	0.6	0.0
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 43.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 22.4;Proximal enterocytes: 84.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.8	43.3	0.1	1.2	0.2	0.1	2.5	0.0	0.0	0.0	3.8	7.8	3.0	0.0	0.2	0.2	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.1	1.1	42.0	0.0	0.0	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.3	0.2	22.4	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	2.8	0.0	0.0	0.0	0.0	0.0	3.1	1.9	0.5	6.3	0.5	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.5	4.5	0.0	0.7	4.4	0.1	0.0	0.2	2.9	0.0	1.3	0.0	11.0	0.3	0.3	0.0	1.9	0.1	0.0	0.0	7.5	2.9	0.1	1.7	0.4	0.0	0.0	84.0	4.1	0.0	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	3.0	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 153.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 324.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 4.6;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.2	0.3	13.4	0.0	16.5	0.1	0.1	11.0	20.1	0.1	13.9	0.1	2.6	0.1	0.3	0.0	7.1	0.0	2.6	12.2	11.9	153.1	36.8	0.8	0.0	11.6	12.6	0.2	0.0	0.0	3.0	0.0	11.7	0.5	0.0	1.1	0.1	0.1	0.5	0.2	0.6	0.0	12.1	0.3	0.1	3.1	13.8	0.1	6.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.5	11.0	20.1	12.2	11.9	11.6	12.6	11.7	12.1	13.8	11.7	0.0	0.0	0.6	1.3	1.9	0.0	0.0	0.4	0.0	0.4	0.1	0.1	1.5	0.0	0.1	18.4	2.1	0.0	0.1	0.0	49.0	0.0	1.4	0.6	0.1	0.2	0.0	5.3	3.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	27.0	0.0	0.0	1.2	0.0	2.0	1.6	0.0	0.6	0.3	1.7	0.0	17.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.5	324.9	0.7	0.7	0.0	0.4	0.1	0.6	0.4	0.0	0.0	0.3	0.9	0.0	0.0	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 142.4;kidney: 88.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	139.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	88.7	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	142.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 149.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in some"	10	"pons: 149.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.9	21.7	0.1	0.0	0.1	0.0	0.8	0.0	0.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	3.8	14.6	0.1	0.0	0.5	0.0	12.6	149.4	0.2	0.3	0.0	1.9	0.6	0.0	13.3	0.2	0.8	0.1	0.0	0.1	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	3.8	14.6	149.4	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 131.6;kidney: 300.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 457.1"	"Group enriched"	"Detected in many"	4	"BEWO: 217.2;CACO-2: 385.7;OE19: 329.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	15.1	9.0	3.1	37.4	3.2	19.7	6.8	3.8	7.5	7.3	4.3	13.8	107.0	5.3	2.0	3.7	7.8	17.0	5.1	2.8	3.8	300.6	16.4	54.1	29.1	6.9	4.7	2.1	5.2	78.4	1.4	18.2	6.4	3.5	15.0	1.0	5.4	2.8	2.0	3.2	131.6	15.6	5.1	56.8	8.6	32.8	7.1	9.6	4.6	2.8	25.2	14.7	4.1	8.1	0.2	11.2	1.2	0.5	1.9	3.7	217.2	2.2	16.3	0.4	1.4	385.7	34.4	17.0	72.2	1.4	1.2	13.3	0.1	0.0	0.6	0.6	0.2	0.9	0.4	3.7	9.1	1.9	1.6	7.1	1.0	1.0	0.5	1.8	25.3	1.5	0.1	12.8	2.9	0.6	0.4	1.7	3.6	329.0	0.1	2.9	35.5	9.8	0.8	1.3	0.4	0.8	0.6	0.5	2.5	9.4	0.4	8.3	1.3	0.8	1.7	0.6	0.5	2.7	0.9	8.9	0.9	0.8	0.2	0.2	299.9	1.1	0.5	410.0	0.4	19.1	0.2	0.2	99.5	13.8	0.7	0.4	36.5	0.3	457.1	3.4	0.9	155.1	3.1	3.2	3.8	7.5	2.8	3.8	6.9	4.7	6.4	5.1	7.1	8.1	5.3	12.8	7.1	2.0	14.3	1.0	0.2	6.7	1.8	0.2	0.5	1.7	0.9	67.2	5.6	3.7	0.0	1.2	5.7	3.0	11.7	8.2	61.1	1.7	1.2	5.0	1.2	0.0	0.6	6.4	5.2	4.4	2.6	0.4	1.3	0.7	16.1	3.0	216.5	0.0	1.4	7.2	2.0	410.6	16.8	11.8	3.7	146.2	5.4	20.6	164.0	0.4	4.1	0.0	0.8	8.9	12.5	0.0	20.1	0.1	423.1	327.6	9.2	1.3	6.6	0.8	1.4	17.8	2.2	0.4	0.4	1.8	2.7	38.8	6.4	0.1
SLC7A8	"LAT2, LPI-PC1"	ENSG00000092068	"Solute carrier family 7 member 8"	Q9UHI5	14	23125295-23183674	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 331.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 74.1;Kupffer cells: 90.0;Proximal tubular cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 9.3;eosinophil: 14.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 68.8;BEWO: 110.6;K-562: 136.9;NTERA-2: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046015, HPA051950, HPA060672"	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.97e-4)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.39e-3)"	"unprognostic (9.44e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.52e-4)"	27.6	15.2	1.2	7.0	7.1	1.6	27.7	5.5	7.6	31.3	42.8	12.5	36.3	43.6	4.8	37.5	45.9	18.6	7.9	3.4	6.5	119.3	6.9	15.4	4.5	3.4	3.1	67.5	19.9	331.1	15.8	16.0	5.8	39.2	13.7	13.9	23.8	35.5	49.4	31.6	24.2	20.9	0.0	18.5	63.4	21.2	6.7	4.9	23.7	15.4	9.0	29.9	37.5	1.4	1.6	0.0	52.9	0.1	68.8	8.5	110.6	6.0	26.3	0.3	2.0	60.4	3.6	0.4	0.8	13.9	5.4	11.7	8.5	3.5	0.3	0.0	5.2	0.6	0.3	0.0	25.5	0.2	35.8	54.1	33.2	0.9	0.9	11.6	5.2	5.4	136.9	0.3	1.5	1.2	0.3	0.8	64.0	12.9	47.4	0.1	0.9	12.5	0.7	21.4	8.2	0.3	0.2	12.0	32.3	60.1	42.8	0.6	0.5	2.3	1.8	0.7	0.0	0.3	15.9	0.2	6.9	0.0	0.4	9.3	0.1	14.0	0.0	0.1	1.1	0.1	0.9	0.1	0.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.5	2.3	1.2	7.1	5.5	7.6	3.4	6.5	3.4	3.1	5.8	0.0	6.7	1.4	0.5	16.0	15.0	2.3	1.8	3.1	28.8	6.4	29.0	26.4	31.6	15.2	5.7	0.0	9.0	16.5	0.0	18.7	0.5	8.3	5.9	1.9	2.2	13.6	74.1	2.1	33.0	0.0	24.8	2.4	4.4	15.5	53.5	18.4	5.1	27.3	66.4	1.3	59.2	26.9	53.5	33.7	4.1	90.0	3.3	3.1	9.6	15.3	19.6	15.9	0.5	39.3	0.0	4.0	2.6	3.0	6.5	7.9	1.6	26.4	27.3	144.8	1.0	4.4	0.0	2.8	4.7	1.1	1.3	25.3	3.0	41.3	2.9	3.4	18.5	32.3
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869767	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 124.6;kidney: 68.2"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 772.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.2	0.1	0.7	0.1	0.7	0.0	0.3	0.7	0.9	0.8	0.6	0.8	78.3	0.4	1.4	0.2	0.5	0.2	0.1	0.7	0.7	68.2	17.3	0.2	0.1	0.7	0.7	0.6	0.3	0.0	0.7	0.1	0.7	1.0	0.2	1.0	0.2	0.2	0.0	0.3	124.6	0.2	0.6	0.3	0.2	0.4	0.7	0.2	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.6	0.7	0.7	0.1	0.0	0.0	2.3	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.6	0.4	0.0	0.0	5.5	4.2	0.2	0.1	0.0	1.9	0.1	1.6	0.3	0.2	0.1	0.0	0.0	3.1	7.2	8.8	0.2	0.0	0.2	0.0	0.4	0.0	12.2	0.2	0.0	3.0	18.2	0.0	0.0	0.0	0.1	0.6	0.5	0.0	2.8	0.0	0.2	0.0	0.0	1.7	0.6	27.5	0.0	0.0	0.0	772.0	97.8	1.8	1.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.1	11.7	0.0
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 117.5"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.2;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	6.1	4.0	25.7	7.2	25.8	2.0	1.6	0.0	28.0	4.7	0.0	9.6	5.0	19.7	5.6	5.9	5.6	6.5	117.5	30.6	11.0	17.5	3.1	5.8	3.3	1.5	19.8	2.5	1.8	0.7	0.8	11.2	0.7	18.8	4.8	5.9	1.0	27.1	0.3	1.5	5.5	23.4	2.7	7.3	3.5	0.7	19.5	2.0	0.8	0.9	1.5	8.9	2.5	24.1	3.0	2.2	2.1	0.2	3.1	6.4	0.0	28.9	11.1	9.4	6.1	0.0	4.7	0.1	2.2	70.4	10.1	1.1	0.5	4.8	9.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	3.7	0.0	10.8	19.8	4.3	0.7	0.0	0.0	0.4	12.1	0.0	0.9	0.1	1.4	0.3	4.0	7.8	14.8	0.0	3.3	0.4	3.2	0.6	0.0	0.0	0.0	9.7	0.1	0.6	9.8	8.8	0.3	0.0	3.1	1.6	0.0	0.0	1.4	1.7	1.4	0.0	8.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	44.2	0.0	11.5	0.3	0.0	1.1	25.7	25.8	0.0	28.0	30.6	11.0	1.5	19.8	0.7	2.7	19.5	24.1	10.3	3.2	2.8	39.5	3.6	1.3	0.0	0.2	1.2	79.1	0.5	5.8	743.1	2.8	0.6	35.0	4.2	0.5	0.3	0.0	0.0	0.0	1.1	2.3	52.8	15.1	0.0	3.0	1267.5	0.0	1.6	26.6	1.5	3.0	0.0	0.2	12.1	0.3	29.3	0.0	631.3	2.5	0.0	78.0	26.7	1.4	0.0	88.8	1.8	574.3	42.7	32.0	1.0	753.0	20.5	0.1	3.8	8.2	0.7	0.2	24.7	0.5	0.0	7.2	13.1	1.4	46.6	0.2	1.2	0.5	3.1	1.1	1.2	0.7	2.5	0.1
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.4;intestine: 94.3;kidney: 62.5;stomach 1: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	2.9	4.4	3.0	10.4	2.5	1.9	3.1	6.1	5.0	3.8	1.7	94.3	46.0	2.9	4.0	8.7	4.9	45.4	3.2	4.7	2.5	62.5	2.4	2.8	3.8	3.8	2.3	4.3	6.7	6.2	0.7	2.1	3.7	7.3	10.8	1.7	9.9	3.8	6.2	19.0	68.1	3.3	1.3	3.7	50.1	5.8	3.4	3.5	4.9	3.9	3.4	2.5	2.5	2.6	6.7	5.1	10.4	10.5	2.5	3.0	7.8	5.3	3.9	8.0	5.0	11.0	7.4	14.0	7.5	3.0	5.5	10.0	6.1	4.0	3.9	37.8	10.7	6.7	23.4	5.4	3.9	5.5	8.2	4.2	8.1	3.5	5.4	3.9	2.4	6.3	9.6	7.5	2.9	9.0	6.0	24.3	4.0	17.8	8.3	8.6	9.3	8.3	2.8	4.8	11.5	5.0	19.0	5.3	4.2	4.5	12.3	4.2	2.9	8.0	7.2	5.3	3.9	12.4	5.8	8.5	5.2	21.2	5.6	0.0	0.7	0.1	2.6	0.3	2.2	0.9	3.3	2.4	0.9	1.0	3.9	3.1	0.1	2.4	0.2	1.2	2.7	1.8	3.0	2.5	6.1	5.0	4.7	2.5	3.8	2.3	3.7	1.3	3.4	2.6	3.8	16.0	5.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.9	0.7	0.0	5.6	16.5	0.0	0.0	3.4	0.7	5.9	9.0	0.0	3.8	3.6	2.3	0.0	0.0	0.3	8.8	0.0	2.2	0.0	2.6	2.5	5.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.6	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.7	0.0	1.1	40.7	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.0
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748628-74769353	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 352.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 295.8;Proximal enterocytes: 536.9;Proximal tubular cells: 433.0;Squamous epithelial cells: 303.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 572.4;SK-BR-3: 450.7;T-47d: 873.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		940000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	27.0	146.3	98.9	43.7	103.0	115.7	64.1	105.6	118.1	58.3	127.5	85.1	257.8	22.6	26.0	352.8	89.7	96.6	24.3	98.3	91.0	203.5	269.2	26.5	67.9	100.2	97.6	11.1	85.4	110.3	20.8	33.6	95.6	43.9	59.3	13.0	192.2	71.1	5.2	51.1	274.4	11.6	92.2	61.1	78.2	22.5	102.0	57.7	21.4	10.0	89.2	25.7	103.3	106.1	102.1	82.6	40.4	42.1	23.9	17.5	179.9	24.1	22.4	60.3	58.2	259.6	59.6	22.2	23.9	51.4	32.3	142.2	69.8	46.4	28.3	25.9	66.2	167.4	210.9	350.8	48.6	110.3	108.9	14.4	25.6	48.0	20.6	124.9	50.2	65.8	54.0	115.9	93.8	572.4	262.5	246.7	36.1	286.3	47.6	28.0	45.4	100.6	83.5	71.7	34.6	45.3	25.2	450.7	51.9	110.4	873.8	87.3	17.0	18.7	53.5	43.8	40.2	200.0	98.9	40.9	30.2	145.4	11.2	581.6	91.9	440.8	421.5	133.0	279.8	58.6	255.5	360.4	87.8	52.1	147.5	266.1	318.8	308.8	172.1	90.8	309.0	345.9	98.9	103.0	105.6	118.1	98.3	91.0	100.2	97.6	95.6	92.2	102.0	106.1	12.3	6.4	17.2	29.0	41.8	46.1	21.4	128.7	50.1	2.2	135.3	78.7	17.8	163.0	120.8	31.3	4.2	74.5	122.9	295.8	66.5	194.9	15.8	61.8	7.8	12.0	18.7	24.8	0.4	99.0	56.6	24.7	45.3	85.0	25.3	7.3	7.9	190.6	85.4	5.0	0.5	58.0	105.8	25.7	18.8	9.9	8.7	43.5	28.4	3.7	27.0	86.2	203.9	5.0	11.4	76.5	143.8	41.8	151.1	27.5	536.9	433.0	76.0	5.0	6.6	27.6	20.0	22.5	19.5	303.4	57.4	111.5	126.1	17.1	57.1	34.6
SLCO1C1	"OATP-F, OATP1, OATP1C1, SLC21A14"	ENSG00000139155	"Solute carrier organic anion transporter family member 1C1"	Q9NYB5	12	20695332-20753386	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 22.2;choroid plexus: 28.3;pituitary gland: 8.1"	"Cell type enriched"	"Detected in some"	12	"Astrocytes: 292.2"	"Cancer enriched"	"Detected in single"	17	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.37e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.76e-2)"	1.6	0.1	14.1	0.1	19.6	0.0	0.4	12.9	22.2	0.0	28.3	0.2	0.1	0.0	0.2	0.1	0.0	0.7	0.5	16.4	13.5	0.1	0.0	0.1	0.2	12.8	13.9	0.0	0.1	0.2	8.1	0.0	12.9	0.1	0.2	2.8	0.1	0.0	0.0	0.2	0.3	0.1	12.4	0.0	0.1	1.5	16.6	0.1	0.7	0.5	0.2	0.2	0.0	14.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.6	12.9	22.2	16.4	13.5	12.8	13.9	12.9	12.4	16.6	14.5	2.4	0.0	0.0	292.2	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	9.5	0.0	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.8	0.1	0.0	0.0	0.0	13.4	1.8	0.0	0.0	23.4	0.1	4.8	0.0	3.5	0.5	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	5.3	0.5	0.2	0.0	0.0	0.0	0.0	1.2	0.4	0.0
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 229.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 204.5;Hofbauer cells: 122.2;Kupffer cells: 155.8;Macrophages: 92.4;Microglial cells: 232.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 90.3;GAMG: 21.2;Hep G2: 20.4;HMC-1: 25.8;OE19: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	39.9	31.5	40.1	34.0	35.9	2.9	12.1	34.0	37.4	18.1	21.3	30.9	42.1	9.5	3.6	19.7	13.2	28.4	15.6	31.9	47.2	21.0	229.6	60.7	60.1	75.7	53.4	9.4	22.1	7.9	5.1	43.9	63.0	6.1	23.6	1.5	8.4	9.6	5.6	4.3	51.3	26.3	49.7	46.4	15.0	6.0	80.4	16.7	10.1	8.0	28.5	26.3	6.2	55.1	0.0	0.7	2.8	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	90.3	0.0	0.1	0.1	0.0	21.2	0.2	0.0	0.0	0.0	1.1	0.0	15.0	1.0	20.4	0.0	1.1	25.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.3	8.7	0.0	0.1	0.0	0.1	0.1	111.1	0.0	0.0	2.4	9.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.3	0.0	1.5	1.8	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	35.9	34.0	37.4	31.9	47.2	75.7	53.4	63.0	49.7	80.4	55.1	4.7	0.0	8.9	1.3	0.7	1.9	0.0	0.0	1.8	3.4	0.9	1.4	2.8	11.5	1.8	0.0	0.0	0.9	0.1	14.7	1.9	0.0	2.8	0.0	0.1	28.8	0.0	2.7	0.5	0.2	2.3	3.6	0.5	0.0	22.9	6.1	3.6	204.5	122.2	0.0	0.5	6.6	0.0	155.8	8.9	1.7	10.8	92.4	0.0	232.3	2.0	0.2	0.0	1.5	0.6	0.1	14.6	10.5	1.4	0.0	46.7	8.2	0.7	0.7	0.0	3.0	1.1	0.4	0.2	4.5	0.4	2.5	0.7	0.4	13.3	0.1
SLFN12L		ENSG00000205045	"Schlafen family member 12 like"	Q6IEE8	17	35464249-35487857	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	8	"dendritic cells: 16.0;NK-cells: 42.2;T-cells: 31.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.0;NK-cells: 3.6;T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.7;Karpas-707: 5.5"									HPA024447	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA024447: AB_1856614"	"unprognostic (1.93e-3)"	"unprognostic (2.10e-4)"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.18e-3)"	"unprognostic (2.98e-5)"	"unprognostic (4.59e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.25e-6)"	"unprognostic (2.30e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (8.88e-3)"	0.6	0.3	0.9	2.4	0.9	3.0	0.6	2.5	1.8	0.5	0.9	0.6	1.7	0.5	0.3	0.3	0.3	1.0	0.2	0.7	0.4	0.3	0.6	1.3	3.0	0.3	0.0	0.4	0.3	0.1	0.0	0.2	0.3	0.3	0.8	0.8	0.9	0.2	0.5	0.6	1.5	0.4	0.0	3.1	1.2	0.3	0.5	1.0	0.4	0.3	2.2	0.7	0.1	1.5	0.5	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.6	1.4	0.1	0.3	0.5	0.1	0.0	0.1	0.3	0.0	0.0	0.7	9.7	0.1	1.3	0.8	0.1	0.0	0.3	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.3	5.5	0.1	0.0	0.4	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.4	0.1	0.1	0.1	0.0	2.0	0.6	0.3	1.2	0.5	0.2	2.0	2.0	0.1	0.2	0.3	0.5	1.0	0.3	1.0	1.9	0.0	0.8	0.3	0.8	1.4	0.2	0.3	1.0	1.0	0.9	3.6	0.1	0.2	0.5	0.4	0.9	0.9	2.5	1.8	0.7	0.4	0.3	0.0	0.3	0.0	0.5	1.5	3.5	3.2	2.7	0.0	1.5	0.3	0.6	0.4	0.0	0.0	0.3	0.3	1.3	1.5	0.7	0.0	0.0	0.0	16.0	0.0	0.0	0.2	0.8	0.5	0.2	1.4	0.0	0.4	0.0	0.0	0.0	0.5	1.5	0.3	1.3	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	1.1	0.0	1.0	0.8	0.0	42.2	0.0	0.1	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.7	0.4	0.0	0.3	0.1	0.0	31.7	0.1	0.1	0.2
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301139	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.3;Fibroblasts: 112.7;Sertoli cells: 85.5;Smooth muscle cells: 99.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 12.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 310.3;fHDF/TERT166: 116.0;RT4: 101.1;SH-SY5Y: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	61.9	20.7	10.0	11.9	10.6	0.1	32.7	11.9	7.5	36.4	0.3	20.0	5.4	23.9	8.8	21.4	22.2	43.5	39.7	12.3	4.3	16.7	1.5	38.1	6.2	12.9	0.7	17.0	7.8	44.9	4.4	21.7	11.6	10.3	9.7	3.1	16.8	15.4	4.4	25.8	10.4	27.1	0.3	14.3	10.1	2.7	6.9	20.0	23.3	6.5	4.2	55.5	24.3	2.2	0.0	11.0	0.1	0.0	310.3	5.7	0.0	18.1	3.1	4.0	8.4	0.1	0.0	0.0	4.2	116.0	13.1	0.0	2.9	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.8	4.2	0.5	3.9	44.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	101.1	1.1	73.3	0.0	0.0	0.0	12.5	0.0	0.0	0.0	3.0	1.9	25.5	0.1	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	10.0	10.6	11.9	7.5	12.3	4.3	12.9	0.7	11.6	0.3	6.9	2.2	11.7	0.0	2.3	4.2	0.5	26.6	1.8	5.5	3.4	8.6	1.1	3.8	25.9	0.0	0.4	0.0	0.0	2.3	0.5	0.0	0.0	0.2	11.9	1.3	35.7	5.4	0.0	0.0	202.3	0.0	0.5	112.7	4.6	3.6	1.3	0.5	1.8	0.0	1.2	0.0	20.2	0.0	0.0	0.0	32.5	8.2	0.9	1.1	35.6	14.0	0.0	13.7	0.0	8.0	2.9	0.0	0.0	0.4	0.8	1.1	0.1	1.9	0.2	0.9	85.5	1.8	99.3	1.2	2.2	1.1	17.6	1.1	1.8	0.3	0.0	0.8
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 246.5;Inhibitory neurons: 263.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 1486.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"		NA	NA		19000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	51.9	55.9	68.9	36.1	73.9	95.7	62.0	87.4	81.7	42.1	40.2	31.0	20.2	53.2	57.3	41.7	57.4	46.0	43.8	60.3	53.7	45.9	58.3	40.3	50.9	43.2	54.4	166.0	36.8	170.3	32.7	48.2	50.6	42.5	31.7	63.6	50.7	53.2	97.7	48.2	27.7	44.2	40.3	52.3	32.0	56.3	55.7	42.2	55.7	60.1	47.8	31.8	28.8	52.9	45.7	32.9	23.7	33.8	47.2	56.6	71.7	59.4	44.6	24.9	19.5	0.5	17.7	76.2	22.0	50.7	13.5	18.8	12.9	46.5	17.6	1486.7	20.2	208.3	88.2	16.2	18.7	88.3	118.1	37.6	17.5	24.9	46.4	44.9	40.3	35.4	7.3	255.1	43.0	19.1	22.2	72.3	23.4	26.4	12.6	97.6	30.5	69.4	57.6	40.9	15.3	14.0	36.2	8.3	14.9	34.1	16.3	55.8	49.1	40.6	19.8	25.8	27.3	22.9	31.8	33.6	43.5	32.5	11.4	26.1	5.2	15.8	10.8	7.2	10.4	12.3	10.5	11.2	6.4	9.4	13.1	10.3	14.6	9.9	10.3	12.5	12.6	5.0	68.9	73.9	87.4	81.7	60.3	53.7	43.2	54.4	50.6	40.3	55.7	52.9	83.9	73.7	70.6	246.5	57.2	58.6	18.3	55.0	82.6	57.6	103.7	74.3	95.2	31.5	54.1	106.7	37.5	99.3	102.8	32.0	31.3	30.6	38.0	44.1	61.6	69.0	37.2	41.2	216.2	22.4	24.5	65.7	19.4	45.2	48.0	27.9	36.8	62.0	31.5	35.3	263.2	31.2	48.8	54.9	34.7	22.6	76.7	57.5	49.8	142.4	45.2	53.4	43.3	120.6	100.8	18.7	15.1	86.9	71.4	13.9	26.9	18.5	88.3	37.4	13.1	58.7	40.3	42.9	14.6	66.2	52.7	88.7	74.8	56.1	28.2	12.7
SMARCAL1	"HARP, HHARP"	ENSG00000138375	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1"	Q9NZC9	2	216412414-216483053	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020337	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA020337: AB_2670410"	"unprognostic (4.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.35e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.16e-1)"	9.2	9.8	7.5	8.9	10.3	9.1	8.8	8.0	9.7	10.6	7.6	8.0	6.8	10.7	7.5	9.8	11.0	9.5	8.9	8.0	9.0	7.2	6.7	7.9	13.1	10.6	9.1	16.3	8.2	10.8	9.3	9.1	10.6	8.1	7.4	5.6	8.0	8.9	10.5	10.6	7.9	10.1	8.4	9.7	8.0	10.3	10.2	15.1	10.2	10.6	11.9	8.8	9.0	14.2	16.7	16.3	22.2	12.7	21.5	25.1	21.3	22.0	22.7	23.0	26.1	26.7	20.3	15.0	21.8	27.6	28.8	12.3	19.1	24.4	30.5	45.7	18.9	42.8	12.0	19.9	22.0	11.5	23.9	16.7	25.7	24.9	24.4	24.0	27.6	23.5	42.6	15.8	26.3	12.3	22.2	26.8	16.1	14.7	8.9	24.6	14.6	9.3	18.2	11.4	18.4	11.9	12.0	9.1	18.7	38.2	12.4	18.1	21.3	28.3	13.0	13.7	13.9	18.0	18.6	13.3	28.8	15.6	20.2	25.9	9.5	14.1	12.2	10.5	11.6	9.6	11.5	14.3	14.9	9.2	9.6	11.8	1.7	21.0	18.1	18.0	14.7	8.5	7.5	10.3	8.0	9.7	8.0	9.0	10.6	9.1	10.6	8.4	10.2	14.2	6.3	6.4	6.1	20.2	8.2	0.9	3.3	4.6	8.6	5.1	4.3	3.4	5.0	7.2	3.7	0.0	0.0	10.4	6.7	3.4	5.9	7.4	14.5	10.4	7.2	7.0	3.6	11.4	20.6	3.8	12.2	8.0	5.6	5.8	17.7	11.0	4.2	3.2	9.7	8.4	30.8	3.7	2.0	8.9	3.1	13.7	6.2	6.2	1.8	12.2	10.1	4.7	10.3	24.6	35.9	4.0	13.3	8.6	7.0	1.3	4.7	5.8	4.4	4.8	13.1	6.0	6.8	7.7	4.4	5.3	1.3	7.3	6.5	7.5	5.3	2.0
SMCO3	"C12orf69, LOC440087"	ENSG00000179256	"Single-pass membrane protein with coiled-coil domains 3"	A2RU48	12	14804650-14814182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.4;kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 5.9;Erythroid cells: 2.7;Hepatic stellate cells: 4.6;Proximal tubular cells: 7.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"spinal cord: 3.6"	"HPA040574, HPA047804"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"HPA040574: AB_2677026, HPA047804: AB_2680160"	"unprognostic (1.16e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.40e-4)"	"unprognostic (5.10e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.45e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-8)"	"unprognostic (2.85e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-1)"	0.5	0.4	0.0	0.1	0.2	0.3	0.2	0.1	0.1	3.4	0.3	0.2	0.0	0.3	0.1	0.0	0.3	1.8	0.9	0.1	0.2	3.0	1.5	1.1	0.5	0.1	0.2	0.2	0.2	0.5	0.2	1.1	0.1	0.8	0.1	1.3	0.1	1.6	0.1	0.1	0.1	0.1	0.1	1.8	0.1	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	1.9	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.5	2.8	0.0	1.8	0.0	0.1	0.0	0.0	5.9	0.2	0.0	0.0	0.2	0.3	0.0	2.7	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.0	4.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
SMIM1	Vel	ENSG00000235169	"Small integral membrane protein 1 (Vel blood group)"	B2RUZ4	1	3772749-3775982	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;testis: 42.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 84.1;Erythroid cells: 404.4;Granulosa cells: 81.5;Proximal tubular cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"eosinophil: 48.5"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 48.5"	"Group enriched"	"Detected in many"	4	"HEL: 68.0;Hep G2: 32.5;K-562: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA069088	Enhanced					NA	NA		340000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA069088: AB_2686080"	"unprognostic (9.50e-3)"	"unprognostic (7.19e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.32e-2)"	2.6	2.7	1.8	0.4	2.6	32.1	3.2	3.8	3.0	5.8	6.2	2.9	0.7	2.8	1.1	1.4	3.4	1.3	40.3	1.4	3.9	16.9	13.1	3.7	1.0	8.7	5.3	8.7	9.4	4.3	16.0	2.1	9.0	6.9	0.1	0.4	17.3	5.5	1.1	2.1	2.1	0.2	5.5	4.0	6.6	42.2	3.6	0.4	9.3	0.2	0.5	3.4	3.6	6.2	0.3	1.4	1.4	3.0	0.0	0.0	5.0	0.9	1.2	0.0	0.0	3.5	3.9	0.1	6.3	0.0	0.2	1.3	0.4	1.5	0.0	6.1	3.6	68.0	0.0	32.5	2.4	0.0	1.2	2.1	0.8	0.3	0.5	2.9	0.0	0.3	33.9	1.2	0.0	7.8	0.0	2.1	0.3	3.4	6.0	0.0	0.0	9.9	3.8	1.0	1.6	6.3	0.2	6.8	4.8	0.5	7.0	3.7	0.4	0.0	0.8	0.0	0.0	2.8	0.8	0.2	0.0	0.0	0.2	4.4	2.0	48.5	1.1	1.0	0.4	2.5	1.6	0.6	0.6	3.7	4.0	1.9	3.2	0.2	0.4	0.6	1.2	2.2	1.8	2.6	3.8	3.0	1.4	3.9	8.7	5.3	9.0	5.5	3.6	6.2	1.1	6.4	20.1	0.7	5.9	1.7	13.1	4.4	10.2	0.4	31.1	35.9	57.0	8.6	8.1	16.5	0.0	23.4	1.4	1.6	84.1	17.2	10.8	3.7	1.2	3.9	5.4	404.4	0.1	14.5	18.8	10.1	6.6	3.5	1.3	81.5	3.9	50.2	10.4	1.7	0.1	3.9	8.2	8.9	1.0	27.8	9.9	8.5	42.7	0.0	4.3	47.0	2.1	0.0	1.6	13.7	1.7	9.8	11.1	10.2	1.9	247.9	2.2	1.5	0.0	3.6	4.3	8.7	20.4	1.7	1.1	6.7	4.6	3.0	4.3	9.1
SMIM10L2A	"LED, LINC00086, LINC0086, MGC39606, NCRNA00086"	ENSG00000178947	"Small integral membrane protein 10 like 2A"	P0DMW4	X	135421944-135428075	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 30.3;brain: 28.2;epididymis: 14.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.5;Distal tubular cells: 7.9;Granulosa cells: 8.4;Proximal tubular cells: 12.4;Rod photoreceptor cells: 6.6;Theca cells: 16.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.1;CACO-2: 2.6;HAP1: 10.3;hTCEpi: 5.4"															NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.22e-2)"	"unprognostic (4.72e-2)"	"unprognostic (4.50e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (8.62e-3)"	"unprognostic (5.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (5.29e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.28e-2)"	0.8	30.3	17.7	0.4	20.1	0.1	1.9	8.9	24.4	2.0	3.9	0.9	0.2	1.5	14.4	1.4	2.3	0.6	3.4	19.3	28.2	5.8	0.2	2.1	0.5	14.5	16.2	4.7	3.1	4.6	3.9	0.3	21.1	2.1	0.3	5.1	2.8	1.8	0.3	2.3	0.6	0.8	10.5	3.1	1.4	5.4	18.4	0.4	3.6	0.5	0.5	0.8	1.4	14.6	0.0	0.1	0.2	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.8	0.1	1.9	0.0	10.3	1.3	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.0	0.4	0.4	5.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	1.0	0.5	2.4	0.0	0.0	0.0	1.5	0.1	0.3	0.9	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	20.1	8.9	24.4	19.3	28.2	14.5	16.2	21.1	10.5	18.4	14.6	0.9	0.0	3.3	0.0	0.0	0.0	1.0	0.0	4.6	6.5	1.6	5.7	3.8	2.8	0.0	5.5	0.0	0.0	0.0	0.0	7.9	0.7	0.4	0.8	0.6	1.8	1.2	0.0	0.0	0.4	0.0	0.7	0.0	1.0	1.3	8.4	3.3	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.4	0.1	12.4	0.0	6.6	0.0	1.2	0.6	1.1	0.4	1.3	0.0	0.3	0.3	16.3	0.1	0.7
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638580-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;pituitary gland: 5.4;retina: 3.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.3;Excitatory neurons: 2.9;Horizontal cells: 5.0;Inhibitory neurons: 5.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Proximal tubular cells: 4.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Centrosome	"HPA066648: AB_2685697"	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.0	0.9	2.2	0.0	1.9	0.9	0.0	4.0	3.7	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.8	0.9	0.0	0.0	0.0	2.3	4.4	0.0	0.4	0.0	5.4	0.0	3.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.2	0.6	0.6	1.1	0.4	1.1	0.9	0.7	0.6	0.3	0.9	0.9	1.3	0.7	0.0	0.8	1.4	1.0	0.1	2.2	1.9	4.0	3.7	2.0	3.8	2.3	4.4	3.0	1.7	2.7	1.6	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.1	1.8	0.0	2.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.9	0.0	5.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480525	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"epididymis: 1580.8;intestine: 753.9;kidney: 844.8"	"Group enriched"	"Detected in many"	12	"Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.0	4.2	2.7	5.0	91.3	0.8	4.1	6.8	0.6	5.5	30.4	753.9	0.7	1580.8	0.4	2.8	82.0	0.1	4.7	4.3	844.8	35.8	0.4	1.6	4.3	4.6	0.3	8.0	0.2	3.5	0.1	4.3	1.0	24.5	91.6	0.3	2.3	0.3	1.2	628.2	0.8	4.0	1.2	150.1	2.9	4.6	50.4	0.2	0.1	2.0	0.2	0.2	4.4	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	154.9	0.5	0.2	7.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.0	1.0	117.7	0.0	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	1.5	0.1	0.1	0.0	113.8	15.8	0.0	185.0	0.3	61.5	0.1	4.3	1.6	0.1	1.4	2.3	0.1	0.1	1.6	0.4	0.0	1.9	0.0	0.0	0.4	1.2	0.1	0.0	0.0	6.5	0.0	87.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.4	1.0	0.0	5.9	0.0	1.5	1.6	0.8	4.2	5.0	4.1	6.8	4.7	4.3	4.3	4.6	4.3	4.0	4.6	4.4	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	14.1	0.1	0.8	0.2	188.8	0.0	58.8	27.1	0.0	0.5	35.1	238.7	4.0	5.1	7.7	0.8	0.3	139.0	22.3	0.7	12.4	0.2	0.3	205.4	13.0	1.3	0.2	0.4	36.3	0.1	0.0	0.1	136.6	0.0	0.6	0.0	15.0	0.3	11.6	0.0	0.0	0.7	4.1	0.0	0.0	0.2	12.4	178.9	0.0	1.7	0.3	4096.4	1884.8	0.0	34.9	0.0	0.2	0.3	0.6	0.7	0.0	0.0	0.0	7.4	0.0	141.3	0.2
SMIM32		ENSG00000271824	"Small integral membrane protein 32"	A0A1B0GUA5	5	136191468-136193162	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	13	"brain: 17.7;intestine: 12.9;kidney: 49.2"	"Cell type enriched"	"Detected in some"	11	"Proximal tubular cells: 394.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 12.4"	"Group enriched"	"Detected in many"	6	"basal ganglia: 17.7;cerebral cortex: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.35e-5)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.13e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.86e-2)"		"unprognostic (1.75e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.05e-2)"	0.0	0.0	1.0	0.2	17.7	0.0	0.0	1.8	4.5	0.0	0.0	4.9	12.9	0.0	0.0	0.0	0.0	2.0	0.0	1.1	1.4	49.2	0.3	0.0	0.0	1.0	1.4	0.0	0.4	0.0	0.0	0.0	0.8	0.4	1.5	0.0	0.1	0.0	0.6	0.0	6.2	0.0	0.8	0.0	1.4	0.3	0.9	0.0	1.2	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	17.7	1.8	4.5	1.1	1.4	1.0	1.4	0.8	0.8	0.9	1.7	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	33.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	394.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0
SMIM6	"C17orf110, ELN"	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647975	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.1;kidney: 22.1;stomach 1: 33.1;testis: 26.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 34.2"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	3.4	0.8	5.8	1.1	0.1	4.9	5.1	2.4	2.5	6.5	9.5	1.1	2.8	0.1	24.1	9.6	0.0	3.6	3.9	22.1	6.6	2.4	0.4	5.4	5.6	0.1	5.6	2.1	0.0	0.3	5.8	0.2	6.6	0.1	0.1	1.4	0.1	0.3	5.9	0.1	4.1	0.2	33.1	26.1	4.7	0.1	0.1	0.0	0.3	1.8	0.1	8.2	0.7	11.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	3.3	0.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	6.7	0.4	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	4.2	1.9	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	34.2	0.0	0.3	3.4	5.8	4.9	5.1	3.6	3.9	5.4	5.6	5.8	4.1	4.7	8.2	0.1	3.2	3.1	0.0	0.9	0.1	3.4	2.3	0.0	0.0	0.2	0.1	0.1	35.8	5.4	35.0	0.0	0.5	9.5	56.2	137.0	35.9	565.7	233.1	2.9	0.8	197.1	0.0	0.0	16.6	3.7	0.3	70.3	22.1	0.0	0.0	0.4	7.0	0.6	0.0	0.0	51.5	8.2	0.0	0.3	1243.9	6.5	1.4	0.0	0.0	1.6	0.0	0.0	0.0	4.5	55.8	129.5	1.9	0.5	2.6	32.7	24.5	38.4	0.0	6.6	0.2	0.4	5.2	2.6	0.0	0.0	4.1	0.9	0.0	4.4	9.6
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 56.6"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 243.3;Proximal enterocytes: 144.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 81.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066060	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.2	56.6	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	10.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.7	1.4	243.3	0.1	0.0	0.0	3.1	0.0	5.2	0.0	0.2	0.0	0.1	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	144.8	17.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	2.0	1.5	0.0
SMOC2	SMAP2	ENSG00000112562	"SPARC related modular calcium binding 2"	Q9H3U7	6	168441151-168673445	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 149.8;Leydig cells: 321.8;Peritubular cells: 769.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.1;EFO-21: 2.8;RPMI-8226: 11.3;RPTEC TERT1: 3.8;SuSa: 9.1"	"Region enhanced"	"Detected in many"		"hippocampal formation: 25.7"	"Region enhanced"	"Detected in single"		"spinal cord: 1.4"						"Secreted to extracellular matrix"	NA	NA		120000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (3.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.20e-3)"	67.8	14.0	10.6	13.0	12.7	0.0	61.0	10.8	16.2	82.1	42.3	44.1	21.4	164.0	147.2	53.1	119.6	100.8	57.2	10.6	11.3	13.0	4.0	14.7	14.7	11.8	11.8	124.1	25.2	12.2	4.5	18.8	11.9	31.0	24.9	2.8	17.1	54.6	42.1	28.9	27.8	76.5	10.2	4.4	144.7	44.2	12.2	10.9	43.5	54.8	11.1	68.7	21.8	10.0	2.4	0.0	8.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	1.0	0.0	0.0	0.0	0.0	11.3	3.8	0.0	1.7	0.3	0.0	0.3	0.1	9.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	12.7	10.8	16.2	10.6	11.3	11.8	11.8	11.9	10.2	12.2	10.0	8.1	0.0	1.7	0.7	0.0	11.1	8.0	0.0	1.2	7.1	12.5	12.1	7.7	0.0	1.8	11.0	0.0	2.5	0.0	3.6	0.0	0.0	2.6	40.3	42.3	11.0	19.7	0.0	0.5	0.0	1.7	149.8	1.1	58.4	0.0	17.2	3.3	0.0	1.2	0.0	9.7	4.5	0.0	0.0	3.9	17.2	321.8	2.9	3.6	6.5	0.0	0.4	0.0	2.0	0.1	0.1	0.4	769.2	0.1	6.7	2.0	0.0	2.2	0.8	46.0	14.7	63.3	3.9	5.1	0.8	2.7	2.6	1.7	17.3	47.4	1.1
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"basophil: 80.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		26000000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	15.0	23.3	4.6	18.7	5.1	22.9	23.7	8.2	9.4	72.8	8.9	60.7	45.5	13.3	6.5	13.6	7.9	17.2	5.6	5.3	5.7	47.4	80.0	14.1	21.4	5.9	5.4	9.1	20.8	32.4	7.5	44.0	5.9	21.8	65.7	6.0	13.7	16.6	39.8	64.5	77.3	8.5	5.7	27.0	30.5	2.9	5.4	5.1	9.1	55.8	16.2	35.5	30.9	7.7	0.3	2.6	6.1	2.8	44.2	19.9	19.5	10.4	27.8	3.1	6.6	3.3	2.7	0.0	1.4	6.6	8.2	4.9	1.7	5.3	2.6	0.0	5.4	2.5	9.8	9.0	28.3	0.0	0.1	24.4	36.9	3.0	5.3	12.0	5.5	0.0	3.8	0.0	12.7	9.3	0.0	0.2	1.1	58.8	8.0	0.0	10.8	0.4	15.1	4.2	4.4	0.1	1.5	18.5	27.9	3.9	3.1	1.4	11.0	5.9	3.5	0.6	6.8	0.0	0.0	0.0	8.7	4.9	13.7	80.9	4.0	1.1	0.0	4.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	7.5	0.0	0.0	1.4	4.6	5.1	8.2	9.4	5.3	5.7	5.9	5.4	5.9	5.7	5.4	7.7	11.8	3.2	17.8	5.2	2.4	53.7	24.5	13.7	15.9	3.0	12.2	6.6	4.0	25.8	9.7	5.5	4.2	156.3	0.4	291.5	56.7	24.6	0.2	4.2	12.6	7.1	48.7	5.7	7.4	25.7	40.4	46.3	34.7	5.2	10.1	0.8	18.9	77.8	62.7	3.3	10.5	61.7	59.0	126.3	10.0	1.2	15.5	33.4	35.6	11.2	9.9	11.5	2.1	11.1	11.0	19.5	157.5	14.3	0.9	16.7	383.1	129.3	7.5	6.2	13.1	12.8	9.9	1.1	3.7	15.5	76.0	115.1	2.0	11.4	38.9	16.6
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 126.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	37.6	10.3	9.7	17.2	9.7	58.4	26.5	27.7	13.2	21.7	9.8	14.6	16.1	23.1	7.8	19.7	13.6	20.4	16.3	9.5	12.5	20.0	25.4	26.4	19.8	14.0	11.5	14.4	22.7	18.5	11.4	33.3	14.7	11.2	11.9	18.8	11.4	10.8	14.3	30.3	17.2	22.9	9.5	33.0	14.4	11.1	13.2	40.5	27.3	21.6	14.7	19.8	21.7	8.7	8.4	5.0	9.1	8.8	26.6	9.5	8.7	8.8	14.8	9.4	9.1	6.9	11.8	13.2	6.8	11.2	6.2	5.3	10.7	18.9	9.6	15.1	8.8	15.0	9.1	8.1	13.8	17.1	16.1	10.5	12.7	10.6	17.9	9.5	126.0	14.9	6.7	14.9	8.7	4.4	17.3	15.0	10.1	4.6	22.6	11.7	6.7	14.0	24.2	14.1	6.4	13.4	7.7	8.1	11.1	7.9	5.5	21.4	74.1	8.2	8.3	9.5	10.4	23.7	18.3	11.0	5.8	20.1	12.0	9.4	4.2	7.6	9.5	7.5	13.0	3.6	8.3	9.6	4.0	3.6	12.1	13.1	27.7	11.0	7.1	1.2	9.7	9.7	9.7	9.7	27.7	13.2	9.5	12.5	14.0	11.5	14.7	9.5	13.2	8.7	88.4	32.1	24.1	30.0	29.0	52.8	10.3	6.4	12.5	52.1	9.7	8.6	17.7	15.7	15.0	16.5	16.7	7.7	57.6	37.0	11.7	10.9	50.4	23.3	16.2	84.2	10.8	10.3	21.6	8.9	3.2	16.4	12.8	19.8	14.5	8.9	98.6	25.2	13.7	30.3	43.2	10.7	12.2	24.8	19.0	7.5	12.5	26.5	23.2	34.7	21.9	16.3	65.9	24.6	10.7	11.2	20.6	11.7	27.3	12.7	25.2	12.2	19.2	18.3	124.9	31.3	49.1	11.1	16.2	13.7	51.3	8.2	61.2	9.5	11.1	18.0
SNX18	"SH3PX2, SH3PXD3B, SNAG1"	ENSG00000178996	"Sorting nexin 18"	Q96RF0	5	54517759-54546586	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 90.0;Kupffer cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037800	Approved		Approved	Cytosol		NA	NA		12000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA037800: AB_10672465"	"unprognostic (2.22e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.81e-3)"	"prognostic favorable (1.58e-4)"	"unprognostic (6.79e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	14.9	8.7	12.1	11.2	21.3	68.0	9.1	20.4	13.1	11.5	9.1	9.2	9.3	13.5	6.4	10.1	9.4	11.4	7.4	10.3	12.2	12.8	15.1	11.3	13.3	22.8	19.9	26.6	9.3	12.0	3.6	21.8	19.6	8.6	5.5	14.8	11.2	11.5	7.2	7.6	9.5	14.1	18.8	18.8	12.0	7.3	18.6	5.6	15.6	8.0	7.0	11.2	7.7	25.2	9.0	7.4	11.4	13.0	26.2	27.8	61.7	14.8	37.1	7.6	12.6	9.1	16.4	0.4	23.1	23.1	13.9	8.2	10.8	14.5	9.6	4.6	7.7	2.7	4.6	5.7	43.5	5.0	2.5	44.1	17.2	10.4	10.8	13.5	16.1	6.5	4.8	60.7	13.3	8.6	4.7	5.7	5.7	3.7	7.6	12.4	6.4	14.5	7.4	26.0	14.1	8.3	12.4	14.2	16.2	17.4	16.7	8.4	5.5	28.4	13.8	21.1	15.6	40.0	41.8	2.5	11.0	11.8	29.9	0.0	0.9	0.1	0.7	1.5	0.1	0.8	0.3	0.4	1.1	0.6	0.1	0.5	3.8	1.0	3.8	2.5	0.2	0.3	12.1	21.3	20.4	13.1	10.3	12.2	22.8	19.9	19.6	18.8	18.6	25.2	14.4	54.5	26.8	7.5	16.6	9.8	4.4	12.8	10.2	10.0	13.6	10.5	16.5	7.2	22.5	22.0	73.0	26.5	48.2	4.2	15.6	14.2	0.3	7.5	9.8	16.5	6.1	3.4	10.3	15.2	30.3	23.0	27.5	6.2	5.7	90.0	43.9	28.1	41.6	5.0	9.2	7.3	12.2	87.4	26.2	2.5	14.0	52.1	10.6	37.5	42.6	11.2	35.0	6.6	21.6	12.8	7.3	17.7	12.7	5.6	8.6	6.9	24.0	47.5	0.0	13.3	38.5	3.6	13.1	8.9	11.8	8.2	12.5	58.6	10.8	13.1
SNX30	ATG24A	ENSG00000148158	"Sorting nexin family member 30"	Q5VWJ9	9	112750760-112881671	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.9;Oligodendrocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019346	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA019346: AB_2286395"	"unprognostic (1.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (4.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-2)"	3.5	3.6	8.0	7.3	16.5	8.4	6.8	9.7	12.3	9.1	0.0	10.2	7.1	5.5	3.4	3.8	3.1	4.7	3.0	7.9	13.5	21.2	4.6	21.3	8.6	14.5	12.9	5.7	4.6	5.2	3.0	4.5	12.2	3.4	10.3	4.0	5.0	3.5	2.0	4.8	8.2	6.5	8.6	7.0	4.2	11.9	16.1	3.8	2.6	2.1	8.1	4.0	3.2	25.8	8.2	5.0	8.5	6.8	10.5	9.6	7.2	6.9	14.2	5.7	5.4	18.1	1.9	13.6	5.7	17.9	10.2	9.6	10.4	4.1	8.8	4.4	4.9	4.2	4.6	7.3	7.5	4.2	7.2	7.8	5.6	8.8	6.5	14.4	4.9	3.4	6.7	7.5	7.8	5.7	2.8	4.9	9.4	13.2	5.2	5.9	19.9	3.5	11.1	14.2	12.6	4.0	9.0	12.3	17.6	8.7	9.2	7.4	5.6	8.4	9.0	25.0	5.9	19.6	19.5	6.3	10.8	3.9	16.9	0.0	2.0	0.6	0.2	0.7	0.6	0.0	0.3	0.4	1.6	0.2	0.2	0.2	0.2	0.3	0.8	0.2	0.6	0.7	8.0	16.5	9.7	12.3	7.9	13.5	14.5	12.9	12.2	8.6	16.1	25.8	4.4	6.4	77.9	11.4	3.5	8.2	2.0	3.1	7.4	5.9	10.5	5.5	4.3	2.8	7.6	5.5	10.4	0.6	3.6	26.2	5.9	2.6	9.1	16.2	7.5	4.8	4.8	6.6	39.0	3.2	2.1	5.3	5.6	20.1	7.0	15.6	8.9	7.7	13.4	8.4	24.1	10.8	2.0	22.4	17.0	8.1	5.6	19.8	21.4	36.5	22.3	2.4	2.1	22.6	91.2	4.4	20.3	7.9	5.8	2.5	11.9	34.2	2.3	3.1	0.0	4.7	2.8	6.6	10.0	7.3	11.1	0.4	5.7	3.7	9.6	6.3
SOCS2	"CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2"	ENSG00000120833	"Suppressor of cytokine signaling 2"	O14508	12	93569814-93583487	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 203.6;Hepatic stellate cells: 134.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 177.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 177.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 192.0;K-562: 145.6;REH: 336.6;THP-1: 142.3"	"Low region specificity"	"Detected in all"							CAB010356	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"CAB010356: AB_2239660"	"unprognostic (4.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	"prognostic favorable (1.09e-6)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.35e-3)"	"prognostic favorable (8.17e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.40e-2)"	"unprognostic (9.09e-2)"	71.5	34.8	7.8	10.4	12.0	11.5	68.0	7.2	8.5	92.6	23.1	40.5	11.7	91.8	42.0	16.5	42.4	20.7	28.6	9.8	9.2	42.8	59.1	61.9	9.2	8.1	10.9	19.2	13.8	64.5	55.3	36.5	8.8	81.4	17.0	4.8	9.5	45.4	9.5	9.4	17.3	89.5	6.6	8.5	30.8	8.7	10.4	21.4	32.8	6.1	9.1	32.1	50.4	7.8	3.5	4.9	16.8	15.2	9.1	16.6	19.8	20.8	77.0	15.2	6.6	192.0	7.8	1.0	0.7	19.3	4.1	39.8	88.6	5.9	17.3	69.0	2.5	13.9	1.2	2.7	13.8	4.2	28.5	28.3	4.9	16.7	22.7	1.6	2.1	8.7	145.6	3.1	2.4	1.8	0.8	6.8	47.4	3.2	7.4	336.6	0.3	3.6	4.1	7.4	28.8	34.2	7.3	11.5	57.5	16.0	0.2	142.3	2.3	47.2	0.7	0.3	11.7	2.0	1.1	1.4	0.9	12.0	28.8	177.8	0.2	7.7	25.4	0.5	34.2	0.4	31.2	23.3	0.2	4.3	30.6	18.4	1.1	26.8	0.4	2.0	19.8	14.4	7.8	12.0	7.2	8.5	9.8	9.2	8.1	10.9	8.8	6.6	10.4	7.8	203.6	9.6	78.7	1.0	1.4	18.0	46.0	3.2	1.2	8.2	30.5	16.9	6.5	0.0	24.3	22.0	4.2	36.3	15.5	20.8	62.6	13.7	9.8	10.5	94.9	100.5	8.3	33.2	10.9	37.4	6.7	34.6	7.1	20.2	24.1	9.9	134.6	11.6	14.2	69.0	12.3	13.3	4.1	8.9	20.7	20.3	91.6	6.0	17.8	8.4	108.4	1.5	18.6	1.0	1.3	8.8	21.2	101.2	6.4	95.2	20.0	27.5	5.4	1.2	78.9	15.8	32.9	9.9	10.5	1.8	10.5	35.0	15.7	12.7	15.7	30.1
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023147-45077185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 163.8;liver: 247.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2"	"Group enriched"	"Detected in all"	4	"liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"basophil: 86.3;eosinophil: 55.9"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 86.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		2800000	"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	2.0	15.7	4.9	3.1	3.8	2.8	53.8	7.4	8.4	163.8	1.9	5.3	7.5	4.3	6.9	10.2	6.7	8.2	5.6	5.0	4.5	50.3	247.0	3.2	2.6	4.3	3.7	2.4	5.7	4.4	3.1	2.5	4.0	87.9	7.8	4.8	5.3	27.0	2.2	16.6	7.2	3.5	4.2	2.3	9.2	12.2	3.9	3.7	89.4	2.8	3.4	9.1	6.9	6.3	12.3	12.2	4.7	20.8	4.4	5.3	5.9	1.8	3.5	12.2	7.0	12.2	5.8	2.7	8.0	5.4	4.1	17.6	19.9	19.1	9.2	29.9	12.3	13.5	12.1	50.3	0.2	18.0	25.5	6.7	18.0	6.6	9.5	5.4	12.5	15.1	11.7	10.6	14.9	8.1	18.4	38.3	39.0	29.4	13.8	0.9	16.6	6.4	16.8	12.1	25.1	12.2	2.1	57.3	5.9	5.2	16.4	22.5	4.7	3.5	38.0	1.6	5.8	8.7	4.5	4.4	14.2	18.6	10.6	86.3	1.7	55.9	1.6	1.5	1.7	5.4	1.3	1.6	1.7	6.9	1.6	1.4	3.8	1.1	2.1	2.4	2.5	2.0	4.9	3.8	7.4	8.4	5.0	4.5	4.3	3.7	4.0	4.2	3.9	6.3	3.9	0.0	3.1	5.5	11.9	7.8	26.5	14.8	17.6	10.8	24.7	17.5	3.2	25.8	28.1	33.1	0.0	1.3	2.3	15.0	29.4	68.2	31.7	40.2	17.4	4.9	84.8	37.5	4.8	138.7	5.1	7.5	31.1	43.7	8.8	11.5	15.7	649.4	16.0	3.3	5.4	32.5	22.4	24.2	6.4	24.1	3.7	12.2	16.0	1.0	13.3	9.0	2.1	7.1	8.9	89.0	18.1	6.0	7.9	218.8	8.0	270.2	42.5	4.7	0.0	8.9	8.9	7.4	2.8	35.1	20.3	1.0	6.5	15.3	39.4	131.2
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894152-76898144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Gastric mucus-secreting cells: 4.6;Squamous epithelial cells: 2.7;Urothelial cells: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.3;CACO-2: 3.9;OE19: 7.4;RT4: 19.4;T-47d: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"		"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.0	0.3	1.2	0.7	1.4	0.0	1.3	0.0	2.8	1.0	0.7	7.7	5.5	0.3	0.8	6.2	1.1	1.3	0.0	1.8	0.1	7.7	19.1	1.6	0.0	0.5	0.0	0.0	5.8	6.9	0.4	0.6	0.6	0.8	6.3	0.2	2.4	2.7	0.0	1.5	8.1	0.2	0.0	0.0	4.6	0.0	0.0	0.2	2.4	0.0	2.3	6.0	2.2	1.1	3.9	0.1	0.3	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	3.9	2.6	0.0	0.1	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.5	19.4	0.1	0.0	0.0	1.7	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.0	2.8	1.8	0.1	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	1.5	1.9	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	4.6	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.1	1.1	0.9	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.5	6.1
SOX13	"ICA12, MGC117216, Sox-13"	ENSG00000143842	"SRY-box transcription factor 13"	Q9UN79	1	204073115-204127743	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.8;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 65.9;SK-BR-3: 138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051790, HPA054843"			Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA051790: AB_2681610, HPA054843: AB_2682622"	"unprognostic (4.88e-3)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (4.74e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	39.9	15.4	16.8	4.9	18.5	0.5	29.2	16.3	14.7	36.6	13.0	28.5	14.0	41.0	8.8	15.9	39.8	9.5	17.4	12.1	14.8	31.4	22.6	36.8	4.7	21.6	23.5	19.2	17.2	24.3	8.6	25.9	18.6	35.4	8.1	2.0	21.8	17.8	21.1	17.5	21.4	17.9	18.2	14.2	14.6	7.1	18.3	1.9	17.2	13.9	3.9	29.7	33.2	19.8	24.8	15.6	32.7	2.2	30.6	9.2	65.9	9.4	5.5	14.7	9.0	13.1	18.0	0.2	30.4	6.0	3.8	39.0	12.6	12.2	6.9	11.5	6.4	0.0	11.2	14.6	6.9	0.2	14.0	9.5	6.1	9.2	8.0	7.0	21.7	0.5	0.2	0.1	3.0	30.1	0.3	0.2	43.6	39.5	18.6	0.2	11.1	15.3	11.0	55.9	5.1	2.7	9.5	138.2	42.4	29.0	61.7	3.0	12.4	3.2	8.6	14.2	6.6	0.1	0.1	0.0	5.2	0.5	8.8	0.0	0.0	0.1	0.8	0.0	0.8	0.0	0.4	0.5	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.0	0.1	16.8	18.5	16.3	14.7	12.1	14.8	21.6	23.5	18.6	18.2	18.3	19.8	20.5	6.4	7.7	26.8	0.2	2.2	8.7	3.5	2.8	0.9	8.7	7.6	28.3	5.7	4.9	9.2	0.0	5.2	3.9	16.3	1.9	3.6	9.2	13.3	13.0	17.4	7.7	0.0	0.5	1.5	5.6	8.4	5.1	22.3	17.1	0.2	8.9	6.0	1.4	0.0	7.6	5.3	8.2	0.9	2.1	27.7	20.8	1.2	1.8	21.5	0.0	4.9	4.1	50.8	16.8	3.7	7.6	19.5	0.5	7.8	16.0	4.5	4.1	1.0	39.5	9.7	22.3	0.3	0.5	6.6	1.6	1.9	2.3	2.9	5.5	7.7
SOX7		ENSG00000171056	"SRY-box transcription factor 7"	Q9BT81	8	10723768-10730511	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 42.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal keratinocytes: 61.2;Basal prostatic cells: 67.6;Basal squamous epithelial cells: 148.5;Endothelial cells: 115.1;Squamous epithelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 11.8;hTCEpi: 21.3;HUVEC TERT2: 25.2;TIME: 6.8"	"Low region specificity"	"Detected in many"							HPA009065	Approved		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.45e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.41e-3)"	"unprognostic (4.84e-3)"	22.6	3.8	2.5	1.0	2.3	0.1	11.9	1.9	2.6	27.0	1.4	4.2	0.1	4.3	1.1	26.8	4.5	3.6	18.5	2.1	1.8	5.1	4.3	23.2	1.7	2.6	2.2	1.5	2.6	1.0	5.6	17.3	2.5	5.4	1.1	0.4	10.5	2.7	9.8	20.2	3.6	2.3	2.5	2.4	3.7	0.7	2.7	1.5	7.6	6.4	1.9	4.6	42.4	2.0	5.8	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.6	11.8	3.4	4.2	0.1	0.1	0.4	0.1	0.3	0.1	0.0	0.2	0.2	0.1	21.3	0.0	4.3	0.0	25.2	0.0	0.6	0.3	0.0	0.2	0.2	0.2	1.6	0.9	3.2	1.2	0.0	0.0	0.0	2.1	0.6	3.4	2.2	0.0	0.0	1.4	0.0	0.1	6.8	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	1.9	2.6	2.1	1.8	2.6	2.2	2.5	2.5	2.7	2.0	115.4	0.0	11.5	0.3	1.1	61.2	67.6	24.5	148.5	1.2	5.2	4.7	4.8	1.5	6.3	0.0	4.2	4.3	0.1	0.2	0.0	0.2	0.2	14.9	1.9	115.1	0.0	0.0	4.6	0.2	0.8	4.7	0.0	22.9	3.8	0.5	48.5	4.9	0.7	0.0	2.9	0.2	10.2	1.9	8.7	0.1	0.9	0.9	3.6	10.3	0.3	0.5	0.0	1.5	0.8	0.5	0.0	0.4	1.2	17.8	0.1	0.6	3.2	2.2	0.0	8.5	4.4	2.4	1.6	98.9	40.6	12.4	1.8	1.2	0.4	26.6
SPAAR	"LINC00961, SPAR"	ENSG00000235387	"Small regulatory polypeptide of amino acid response"	A0A1B0GVQ0	9	35909490-35937153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.4;breast: 10.8"	"Cell type enriched"	"Detected in some"	7	"Adipocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HUVEC TERT2: 34.0;TIME: 40.1"	"Not detected"	"Not detected"													NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (3.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.40e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.22e-1)"	12.4	1.2	2.9	0.6	2.5	0.0	10.8	2.2	3.3	0.7	1.1	1.2	0.3	1.2	0.1	0.5	1.2	0.6	8.9	2.3	2.2	4.2	0.8	3.2	0.4	3.0	2.6	0.7	0.5	0.5	0.6	4.7	3.1	1.0	0.4	1.4	0.7	0.5	3.1	0.9	0.9	0.6	2.3	0.7	0.9	7.5	3.3	0.2	1.9	1.8	0.0	1.5	0.8	2.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.4	0.1	0.2	0.0	0.0	34.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	40.1	0.0	0.8	2.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.5	2.2	3.3	2.3	2.2	3.0	2.6	3.1	2.3	3.3	2.4	42.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599025	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;kidney: 37.8;testis: 74.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 126.0;Erythroid cells: 37.2;Spermatocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 11.7;T-reg: 4.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 11.7;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.2	3.3	7.8	7.8	7.6	37.9	2.4	5.8	9.1	2.6	3.4	8.3	7.9	1.9	2.4	8.3	1.7	1.8	1.4	7.6	7.7	37.8	14.8	3.4	14.5	6.7	6.8	2.7	1.5	1.1	4.3	5.7	6.7	2.2	10.7	10.8	2.4	0.8	1.0	5.5	9.1	3.4	5.0	7.4	3.6	74.0	7.7	22.4	8.7	0.7	17.3	2.6	3.6	7.5	84.7	87.7	103.3	78.4	5.2	8.6	42.4	65.9	42.4	98.1	78.3	69.2	25.5	59.8	34.2	46.8	91.7	70.2	114.5	42.7	103.8	108.6	72.9	62.9	87.9	80.2	0.6	83.1	76.1	2.9	3.8	78.6	40.4	14.5	52.1	90.6	69.7	101.5	80.7	52.6	109.4	92.9	54.2	68.3	44.5	72.1	144.4	70.9	29.0	43.0	78.6	45.8	96.4	114.9	31.6	84.9	82.2	70.6	25.7	56.4	91.3	46.6	114.6	46.7	72.9	87.3	37.8	60.6	91.8	11.7	0.0	0.0	0.4	0.4	0.7	0.6	1.2	0.9	0.1	1.4	1.1	0.9	0.2	0.8	0.3	0.3	4.9	0.9	7.8	7.6	5.8	9.1	7.6	7.7	6.7	6.8	6.7	5.0	7.7	7.5	0.5	3.2	1.7	0.7	3.3	2.0	0.9	1.3	1.2	5.0	1.1	1.0	0.7	0.0	1.9	0.0	0.0	9.0	1.3	4.7	1.9	0.5	126.0	6.0	1.1	1.5	13.1	37.2	5.2	0.4	12.2	2.6	5.1	1.8	1.3	12.6	3.3	6.3	6.5	3.3	6.0	4.6	4.1	2.7	4.0	25.2	0.9	6.1	0.0	1.9	0.9	0.7	0.0	2.0	1.7	0.4	4.7	0.0	13.1	0.8	8.1	12.5	7.7	3.9	6.6	2.0	2.2	72.6	21.0	5.2	1.0	3.8	2.8	0.9	5.1	1.1
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 179.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 179.7"	"Cell line enhanced"	"Detected in some"		"HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	36.5	19.7	12.0	107.3	13.1	335.1	17.7	14.3	19.4	7.9	15.8	15.6	21.5	7.3	2.1	9.1	19.1	21.3	13.5	11.7	16.4	10.6	15.6	101.0	65.0	31.2	20.9	5.2	7.8	3.1	7.6	28.0	24.7	10.3	10.2	1.0	14.6	6.1	5.0	13.8	29.3	21.9	19.8	172.7	17.0	3.7	26.2	15.7	8.8	8.3	32.0	29.9	7.6	30.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	72.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	0.0	159.7	282.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.7	0.0	0.0	0.2	267.8	0.2	0.0	0.0	48.7	0.2	47.5	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	206.7	0.3	0.0	0.5	0.5	0.1	0.1	0.3	85.3	0.3	117.5	0.1	14.1	19.2	179.7	0.0	27.4	0.0	3.9	0.0	0.0	16.4	2.4	0.0	0.0	83.8	0.0	34.7	0.9	0.0	7.3	12.0	13.1	14.3	19.4	11.7	16.4	31.2	20.9	24.7	19.8	26.2	30.3	2.1	3.2	1.1	10.4	72.6	10.5	0.5	0.0	1.2	1.3	2.1	5.0	2.9	4.3	0.6	5.5	0.0	2.3	6.3	0.5	19.6	0.1	7.5	0.1	0.3	5.5	4.2	39.7	3.1	0.4	3.1	2.6	1.1	0.3	33.7	0.2	7.9	3.2	432.9	0.0	3.3	0.3	0.0	411.9	537.6	27.5	1.8	453.3	10.6	36.5	357.5	7.0	8.2	3.5	1.5	0.0	0.1	0.0	21.8	0.4	0.2	2.3	0.7	1.7	13.1	1.5	1.4	5.1	9.3	0.8	9.9	4.2	4.8	1.1	0.4	0.5
SPOCK1	"SPOCK, testican-1, TIC1"	ENSG00000152377	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1"	Q08629	5	136975298-137598379	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 172.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 252.8;Inhibitory neurons: 349.9;Muller glia cells: 243.8;Oligodendrocyte precursor cells: 273.4;Oligodendrocytes: 913.1;Peritubular cells: 150.1"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 83.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 573.1;hTERT-RPE1: 1112.8;HUVEC TERT2: 594.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007450, HPA026770"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA007450: AB_10603116, HPA026770: "	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.77e-5)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.90e-2)"	29.7	41.4	67.9	4.1	116.3	0.3	19.0	129.2	99.5	25.6	9.9	24.9	1.2	44.2	34.3	6.1	18.6	18.6	54.2	100.5	50.9	24.3	0.2	2.9	0.6	80.7	84.5	4.8	5.5	13.7	9.9	9.3	89.8	65.6	3.2	48.7	7.6	25.5	17.5	9.3	4.6	30.7	78.4	8.5	9.1	21.7	102.6	7.5	9.4	7.1	0.4	11.4	21.7	172.9	4.6	0.9	299.4	0.4	573.1	116.0	0.4	100.6	90.0	207.7	115.9	0.0	0.6	0.4	0.2	206.7	53.3	4.4	1.4	70.3	65.3	17.8	0.6	0.2	16.7	0.0	4.0	0.0	0.4	203.8	28.5	128.6	23.2	1112.8	594.4	0.2	0.0	0.4	60.5	0.5	0.0	0.2	19.1	0.0	28.4	0.0	0.2	0.0	140.3	9.4	3.7	14.4	49.9	0.8	0.1	35.6	0.4	1.2	98.9	294.0	10.6	102.1	28.5	0.1	0.1	0.1	159.4	4.4	136.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	67.9	116.3	129.2	99.5	100.5	50.9	80.7	84.5	89.8	78.4	102.6	172.9	2.0	0.0	0.0	91.7	0.0	1.8	1.6	5.8	0.0	9.7	0.4	0.4	58.8	1.5	0.4	22.0	2.1	0.4	0.0	0.2	1.9	0.6	12.0	4.2	37.9	8.4	35.0	0.0	252.8	1.4	0.3	58.8	0.0	2.9	0.0	0.1	1.1	0.0	0.9	8.4	349.9	0.1	16.2	1.2	3.0	9.5	17.4	1.6	7.2	17.8	2.3	243.8	0.0	273.4	913.1	2.0	0.1	150.1	0.1	40.9	0.0	3.1	0.9	7.3	13.1	11.6	16.4	7.4	7.1	0.7	1.4	0.1	0.4	0.0	0.3	3.2
SPOCK2	"KIAA0275, testican-2"	ENSG00000107742	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2"	Q92563	10	72059034-72089032	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 220.1;lymphoid tissue: 114.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 288.4;Bipolar cells: 116.5;dendritic cells: 86.4;Inhibitory neurons: 81.1;Microglial cells: 75.9;NK-cells: 90.6;T-cells: 195.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 117.5;MAIT T-cell: 198.8;memory CD4 T-cell: 115.9;memory CD8 T-cell: 93.5;naive CD4 T-cell: 87.8;naive CD8 T-cell: 89.4;T-reg: 174.3"	"Lineage enriched"	"Detected in all"	8	"T-cells: 198.8"	"Group enriched"	"Detected in some"	7	"Hep G2: 50.2;SCLC-21H: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044605	Enhanced				"Secreted to blood"	NA	NA		34000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"			"HPA044605: AB_10965991"	"prognostic favorable (4.05e-4)"	"unprognostic (3.11e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.18e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (4.72e-4)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (4.53e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.24e-2)"	9.4	46.6	152.6	44.5	108.0	58.1	3.8	160.4	143.2	4.2	2.8	7.6	9.2	4.0	3.1	3.3	6.2	15.3	10.0	117.4	150.1	68.0	2.7	86.5	67.3	212.1	157.7	7.1	1.6	2.0	44.0	3.4	220.1	4.7	5.4	33.4	3.3	5.6	5.1	1.8	32.3	4.4	127.9	29.1	13.6	25.1	207.3	114.4	10.4	6.7	45.3	9.9	3.8	95.6	0.2	0.4	0.3	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	8.2	0.3	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.8	0.2	1.4	50.2	1.6	0.4	1.2	0.1	0.4	0.0	0.0	0.2	0.1	2.7	0.1	0.8	0.0	0.3	0.9	0.3	0.1	0.0	0.2	0.2	0.3	0.1	0.0	0.3	68.2	4.1	0.1	1.5	0.4	0.3	0.0	1.9	0.2	0.0	0.3	0.3	0.1	0.7	1.7	7.3	0.3	0.1	0.2	0.6	0.4	0.2	117.5	1.2	198.8	23.6	115.9	93.5	0.3	18.3	87.8	89.4	13.5	14.4	0.4	3.5	174.3	48.4	152.6	108.0	160.4	143.2	117.4	150.1	212.1	157.7	220.1	127.9	207.3	95.6	17.3	288.4	10.0	51.9	54.6	3.8	0.4	2.1	0.0	116.5	1.9	2.0	3.1	1.5	4.1	14.7	6.2	0.1	86.4	2.4	0.0	3.6	8.1	2.5	1.0	29.9	4.9	3.6	39.6	0.8	0.1	8.4	3.6	1.0	3.8	0.2	7.9	0.4	0.2	3.3	81.1	1.3	2.0	1.6	7.9	10.5	5.3	5.5	5.4	75.9	4.1	5.0	90.6	28.6	8.3	0.0	4.4	6.0	34.2	0.5	0.1	0.5	2.4	17.6	0.0	17.9	2.4	6.3	1.1	0.5	4.4	0.4	195.1	0.8	0.7	0.3
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962723-14268133	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 101.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.9;Endometrial stromal cells: 78.9;Muller glia cells: 141.9"	"Cancer enriched"	"Detected in all"	5	"ovarian cancer: 199.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 3.3"	"Lineage enriched"	"Detected in single"	33	"T-cells: 3.3"	"Group enriched"	"Detected in some"	36	"EFO-21: 213.7;RPTEC TERT1: 604.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	Yes	No	11500000	28000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: AB_2732351"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (1.88e-4)"	54.2	16.9	25.8	18.6	33.7	0.1	19.5	26.3	22.3	43.8	7.8	31.8	31.6	36.5	15.2	17.3	63.1	101.4	30.6	28.2	28.3	12.2	2.0	49.2	1.6	25.6	33.6	23.9	4.6	0.8	10.0	41.3	26.4	16.9	46.6	63.8	7.0	8.8	0.8	8.8	28.4	46.9	14.9	8.3	28.8	2.5	34.0	1.7	5.2	1.6	1.2	51.5	12.5	21.8	0.1	0.1	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	9.8	0.2	0.2	213.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.7	0.0	0.1	1.7	0.0	0.1	604.1	0.1	0.1	0.2	0.0	0.0	0.0	4.1	0.0	0.1	2.6	0.2	0.7	0.5	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.8	33.7	26.3	22.3	28.2	28.3	25.6	33.6	26.4	14.9	34.0	21.8	0.2	0.0	2.3	399.9	13.5	0.0	17.3	0.0	1.2	13.5	2.0	5.5	1.9	5.7	0.0	0.0	2.1	3.4	4.8	38.9	3.9	4.3	1.5	36.1	78.9	2.5	16.7	0.0	17.0	2.0	4.2	41.2	0.5	61.5	2.5	1.8	2.5	0.2	1.9	1.7	16.8	24.0	0.0	0.3	0.0	1.3	4.4	1.0	0.0	11.2	0.5	141.9	20.6	62.4	1.6	6.8	20.6	30.1	0.9	9.0	18.4	2.1	0.7	26.8	6.6	5.8	7.0	0.4	0.8	0.6	0.0	4.9	7.8	1.1	40.9	9.4
SPRED3		ENSG00000188766	"Sprouty related EVH1 domain containing 3"	Q2MJR0	19	38388421-38399587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.0;pituitary gland: 5.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.6;Enteroendocrine cells: 10.8;Excitatory neurons: 9.8;Inhibitory neurons: 10.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.9;TIME: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071521			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA071521: "	"unprognostic (1.09e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.71e-3)"	"unprognostic (3.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.09e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-11)"	"unprognostic (6.21e-4)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.45e-3)"	0.7	0.4	3.2	1.0	3.7	0.3	0.5	0.5	5.0	0.6	0.4	0.5	1.8	0.4	0.3	0.4	0.6	0.7	0.7	4.5	8.0	2.3	0.2	0.7	0.2	4.4	5.0	0.3	1.1	1.7	5.6	0.3	4.6	1.0	0.2	1.5	0.5	0.3	0.9	0.8	1.3	0.8	1.1	0.1	0.4	1.1	5.0	0.1	0.6	0.0	0.2	0.6	0.5	2.7	0.3	1.2	4.0	3.3	0.6	1.9	2.3	8.1	5.3	2.6	2.4	0.4	0.8	0.2	2.9	2.7	2.1	0.1	0.7	1.0	2.4	0.8	1.5	0.1	0.3	0.5	1.4	2.2	0.1	1.3	0.9	6.2	1.8	12.9	8.3	0.6	0.7	1.5	8.1	0.4	0.0	0.1	1.8	0.5	4.0	1.0	1.4	0.1	5.7	0.7	0.2	3.1	0.2	0.2	0.4	1.7	0.7	0.1	15.9	2.9	9.0	2.4	4.5	0.6	0.3	0.6	9.8	0.3	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	3.2	3.7	0.5	5.0	4.5	8.0	4.4	5.0	4.6	1.1	5.0	2.7	1.1	0.0	0.0	2.0	0.4	0.0	1.3	0.4	1.2	6.6	1.5	2.4	1.2	0.0	0.3	1.8	2.1	0.5	0.3	0.5	0.0	1.0	2.0	0.7	1.1	1.5	10.8	0.0	9.8	0.6	0.3	0.5	0.0	1.6	0.0	0.3	0.7	0.0	0.1	1.7	10.4	1.2	0.0	0.0	0.0	0.2	0.3	0.5	0.0	1.0	0.0	1.9	1.0	5.0	2.2	3.0	0.1	0.0	0.0	1.2	2.7	0.1	0.1	0.3	0.0	2.3	1.2	1.5	1.0	0.5	0.1	0.8	0.4	0.2	0.8	0.7
SPRY1	hSPRY1	ENSG00000164056	"Sprouty RTK signaling antagonist 1"	O43609	4	123396795-123403760	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 238.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 771.3;Endothelial cells: 352.8;Fibroblasts: 222.3;Leydig cells: 448.0;Skeletal myocytes: 245.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 61.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 95.4;AN3-CA: 194.1;ASC diff: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013538, HPA051369, HPA070554"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"	Nucleoplasm	"CAB013538: AB_2533452, HPA051369: AB_2681457, HPA070554: AB_2686280"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.21e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	238.1	38.4	6.5	22.3	7.9	22.7	154.3	7.6	9.0	71.9	26.6	46.6	15.7	40.9	24.1	42.5	81.2	83.8	73.1	7.5	8.4	35.6	21.5	58.3	13.0	5.5	5.4	30.0	31.8	37.4	27.3	49.6	5.8	52.0	27.5	19.0	45.2	24.7	49.9	79.8	25.2	57.7	5.6	17.0	35.1	10.2	7.6	29.2	92.7	49.9	10.1	74.4	71.0	6.0	6.3	1.8	95.4	194.1	76.5	51.6	6.4	0.4	4.9	0.3	2.0	5.8	10.3	0.0	42.4	2.9	0.4	1.2	2.6	4.6	0.7	0.1	10.0	2.2	0.0	31.0	21.7	14.2	0.1	21.1	2.5	0.7	2.1	10.5	8.1	2.2	1.7	1.9	4.7	0.7	16.4	34.8	22.8	22.6	32.0	7.1	10.3	0.2	13.2	14.5	14.5	12.3	0.1	19.4	19.6	10.1	1.9	0.0	20.2	1.2	0.2	0.4	2.9	1.0	0.1	0.2	1.4	2.6	3.2	0.1	0.4	6.5	1.1	0.2	33.1	29.8	4.0	9.2	0.1	61.2	5.7	6.4	0.4	14.2	0.1	1.7	0.0	2.0	6.5	7.9	7.6	9.0	7.5	8.4	5.5	5.4	5.8	5.6	7.6	6.0	771.3	28.9	28.3	14.4	16.2	49.6	17.3	37.3	68.9	86.2	22.8	69.6	16.9	32.9	20.6	27.6	33.3	12.7	21.6	10.4	80.3	5.0	2.5	45.9	41.9	352.8	26.5	5.7	5.0	10.9	1.7	222.3	8.2	67.4	9.5	0.2	166.3	5.9	10.1	6.7	2.2	15.0	14.2	15.3	37.9	10.5	448.0	17.1	46.2	5.6	0.7	158.3	0.0	7.5	0.3	7.0	6.3	57.9	6.1	16.8	8.1	38.7	11.7	84.5	151.2	245.0	81.6	6.2	9.6	37.0	43.3	3.1	57.3	1.8	17.9	13.5
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.5;skeletal muscle: 123.9;tongue: 69.8"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 81.0;Excitatory neurons: 16.0;Horizontal cells: 16.8;Inhibitory neurons: 32.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 39.2;K-562: 47.8;U-937: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol		NA	NA		7800000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	2.2	1.5	5.3	0.2	11.2	62.5	0.3	28.3	11.4	0.3	27.7	0.2	0.1	0.2	5.2	2.0	0.5	0.4	22.7	10.8	4.0	1.0	0.1	0.4	0.0	28.5	5.3	0.2	2.6	11.1	5.3	6.7	28.2	1.5	0.1	1.6	2.2	1.1	123.9	0.2	0.2	0.8	8.5	0.8	0.2	0.7	9.3	0.4	0.1	69.8	0.0	0.2	0.2	4.4	0.3	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.3	2.3	6.3	0.2	0.0	0.4	3.7	39.2	0.3	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	47.8	0.0	0.0	0.3	0.0	0.3	0.0	0.5	2.1	0.0	0.0	0.2	0.0	0.2	6.1	2.6	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	6.7	0.0	0.6	1.5	7.7	0.0	0.1	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	5.3	11.2	28.3	11.4	10.8	4.0	28.5	5.3	28.2	8.5	9.3	4.4	0.1	0.0	0.0	0.7	0.0	0.8	0.7	0.6	0.0	10.3	0.5	0.1	6.3	1.5	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.4	0.9	0.4	3.0	81.0	16.0	0.2	0.3	0.8	0.0	0.9	2.5	0.2	0.0	0.0	0.2	16.8	32.1	0.3	0.0	0.0	0.4	0.4	0.3	0.3	1.8	1.9	0.0	5.0	1.0	11.1	2.1	0.3	0.0	1.2	0.1	0.7	0.0	0.2	0.0	2.6	6.6	11.6	3.8	0.1	1.1	0.5	0.4	0.1	0.6	0.4	0.1	0.6
SRARP	"C1orf64, ERRF, MGC24047"	ENSG00000183888	"Steroid receptor associated and regulated protein"	Q8NEQ6	1	16004236-16008807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.3;breast: 5.1;choroid plexus: 6.2"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 25.0;Distal tubular cells: 90.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 7.7;endometrial cancer: 2.2;prostate cancer: 6.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	13	"Hep G2: 7.9;SK-BR-3: 13.6;T-47d: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026676	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA026676: AB_1853866"	"unprognostic (8.55e-2)"	"unprognostic (1.01e-1)"		"prognostic favorable (1.68e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.41e-2)"		"unprognostic (3.49e-1)"		"unprognostic (8.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-3)"	"unprognostic (6.32e-2)"	0.1	0.2	10.3	0.2	9.7	0.7	5.1	8.9	11.3	2.3	6.2	0.1	0.2	1.1	0.1	0.2	0.1	0.2	0.9	8.8	9.3	1.5	0.1	0.1	0.3	9.4	9.4	0.2	0.2	0.0	0.0	0.1	10.0	0.7	0.0	0.8	3.1	0.0	0.2	0.6	0.1	0.0	8.6	0.2	0.3	0.2	11.2	0.0	1.2	0.0	0.0	0.1	0.0	9.2	0.3	0.1	0.3	0.4	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.4	0.6	7.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.6	0.5	0.0	0.4	0.3	0.3	0.1	0.1	0.2	0.2	0.3	0.2	0.0	0.1	0.4	0.6	0.3	13.6	0.2	0.4	4.3	0.4	0.2	0.4	0.3	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.6	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.2	1.8	0.3	0.1	0.1	0.0	0.0	10.3	9.7	8.9	11.3	8.8	9.3	9.4	9.4	10.0	8.6	11.2	9.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	25.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	1.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31580938	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"epididymis: 23.5;fallopian tube: 20.4;liver: 60.8;prostate: 16.8;seminal vesicle: 18.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 71.7;Endometrial ciliated cells: 29.6;Hepatocytes: 20.0;Late spermatids: 59.9"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"	"Region enriched"	"Detected in single"	11	"midbrain: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	23.5	0.0	20.4	0.0	0.0	0.0	0.0	0.3	60.8	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.1	0.0	18.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.0	0.0	1.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.7	29.6	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.4	20.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	59.9	0.6	0.1	0.0	3.7	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.2	0.0	0.7	0.0	0.3	7.3	0.0	0.0	0.0	0.2	1.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.6
SRGAP1	"ARHGAP13, KIAA1304"	ENSG00000196935	"SLIT-ROBO Rho GTPase activating protein 1"	Q7Z6B7	12	63844700-64162217	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 159.0;Early spermatids: 192.4;Microglial cells: 151.8;Muller glia cells: 136.2;Oligodendrocyte precursor cells: 159.8;Oligodendrocytes: 135.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 30.4;hTERT-HME1: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052416, HPA078079"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA052416: AB_2681824, HPA078079: "	"unprognostic (3.05e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.54e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.56e-2)"	4.0	3.7	5.5	1.8	8.9	0.4	3.9	7.9	4.3	4.9	0.8	3.0	1.4	4.3	1.4	2.9	3.6	2.4	2.1	4.0	8.3	3.0	0.8	6.2	1.0	11.6	12.0	4.7	4.8	6.5	1.4	1.9	9.2	2.3	2.6	6.1	4.6	0.9	1.6	1.9	2.5	2.5	7.7	2.4	1.9	3.9	10.4	0.7	4.4	1.0	0.9	2.8	3.3	7.2	5.3	11.2	17.6	1.7	13.3	23.2	3.7	16.4	14.7	6.0	5.2	5.9	4.3	0.1	6.6	30.4	14.9	3.3	1.5	9.4	6.1	4.2	1.7	0.2	7.9	6.0	16.4	0.1	0.2	21.6	8.8	16.8	46.8	8.2	5.5	0.3	0.1	0.2	8.0	3.2	0.1	0.1	1.5	2.8	6.5	0.1	3.3	0.1	7.4	2.8	2.8	5.3	6.5	6.7	4.4	2.8	1.8	0.1	11.8	12.4	2.3	13.2	7.6	0.1	0.1	0.1	10.4	1.3	5.0	0.4	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	5.5	8.9	7.9	4.3	4.0	8.3	11.6	12.0	9.2	7.7	10.4	7.2	19.1	0.0	3.3	159.0	3.5	7.8	53.3	20.4	0.0	7.8	19.7	15.1	6.4	37.1	21.7	9.2	6.2	31.7	0.9	42.5	11.7	37.3	192.4	8.3	33.3	24.8	16.7	0.0	19.6	26.0	8.6	43.5	26.0	26.0	1.3	26.8	25.0	2.0	12.2	3.3	38.4	26.6	44.7	34.3	22.2	58.4	22.1	43.5	17.8	151.8	25.1	136.2	0.0	159.8	135.8	41.7	39.8	15.8	0.8	50.5	5.2	14.7	22.1	8.1	0.0	55.1	19.7	5.5	29.1	11.6	3.8	7.3	3.6	2.0	19.6	50.7
SRGAP2C	SRGAP2P1	ENSG00000171943	"SLIT-ROBO Rho GTPase activating protein 2C"	P0DJJ0	1	121184811-121392874	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.2"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 180.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 80.0"									HPA078079			Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA078079: "	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.48e-6)"	"unprognostic (2.40e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.18e-4)"	"unprognostic (6.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.71e-7)"	"unprognostic (4.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.66e-2)"	8.3	6.5	11.1	3.7	13.2	7.2	5.7	31.2	12.5	5.8	3.9	6.5	2.1	5.4	2.2	4.3	5.0	4.6	5.8	11.7	11.8	7.1	4.7	7.3	4.6	16.1	12.3	6.8	2.2	13.7	3.3	8.0	17.6	3.6	2.8	3.5	3.0	4.6	2.8	15.5	3.6	6.0	16.6	10.7	3.2	1.5	12.4	4.2	3.9	10.7	3.4	4.6	5.5	21.9	11.1	14.1	30.7	6.8	23.1	20.1	16.8	12.3	9.8	10.2	13.2	0.2	11.0	7.0	10.8	16.8	7.3	5.9	11.0	8.9	13.4	9.2	11.2	10.0	24.5	11.1	13.3	6.8	11.4	15.2	8.9	13.1	16.6	11.6	24.5	4.3	9.3	12.8	7.6	6.6	4.3	8.6	9.7	3.5	6.7	6.2	35.9	6.2	9.7	6.5	5.9	3.8	21.2	7.5	38.6	15.8	9.5	19.8	21.9	19.1	18.7	28.9	18.1	7.3	5.6	4.2	16.7	13.7	80.0	0.3	3.4	0.6	1.1	2.8	0.7	0.9	1.3	1.2	2.5	0.9	0.6	0.8	3.2	0.6	5.3	2.4	1.3	0.9	11.1	13.2	31.2	12.5	11.7	11.8	16.1	12.3	17.6	16.6	12.4	21.9	39.9	54.5	11.5	5.2	14.4	0.0	5.6	0.0	6.2	14.2	5.8	6.7	4.3	15.7	5.0	11.0	2.1	5.5	15.5	1.2	1.9	10.9	1.0	11.7	15.4	34.6	2.4	29.7	42.0	5.0	24.8	15.9	5.1	6.4	6.3	7.8	55.3	8.7	19.9	0.0	62.6	2.7	0.0	64.2	0.0	2.1	19.6	41.6	0.0	180.8	39.6	8.4	18.6	35.2	27.4	7.2	1.4	25.6	10.7	5.0	0.5	1.0	8.7	4.3	32.9	20.2	14.5	10.1	10.8	12.5	0.0	2.5	12.6	7.0	2.0	4.5
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 79.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 140.8;Leydig cells: 185.8;Peritubular cells: 267.4;Skeletal myocytes: 139.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"memory B-cell: 57.4;naive B-cell: 16.9"	"Lineage enriched"	"Detected in many"	19	"B-cells: 57.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 24.4;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane"	Nucleoplasm	"HPA066432: AB_2685669"	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	21.3	10.7	18.0	6.4	26.5	0.1	20.1	26.2	15.4	39.5	8.6	21.2	4.4	23.9	17.8	18.3	25.2	21.9	46.0	16.1	30.1	6.1	1.4	8.9	7.0	26.5	29.1	33.8	8.0	3.2	3.8	4.6	27.9	22.4	12.7	2.9	9.4	34.4	60.7	4.4	7.7	24.3	31.5	8.7	7.7	8.3	21.5	8.7	17.1	79.0	12.1	19.2	15.4	38.4	0.8	1.6	4.0	0.0	24.4	14.5	0.2	6.9	10.8	1.1	3.1	0.1	9.5	0.0	1.8	11.0	6.0	3.0	0.0	0.5	2.1	0.1	0.0	0.0	0.1	0.0	2.9	0.1	0.0	9.3	1.0	3.5	0.8	91.6	0.4	0.0	0.0	0.1	8.4	1.9	0.6	1.9	7.9	0.6	2.7	0.3	10.7	3.2	2.4	8.3	0.4	6.3	2.7	0.6	7.0	4.0	0.9	0.3	3.0	2.5	1.8	3.4	1.8	0.3	1.2	0.2	5.3	0.0	8.6	0.0	0.0	2.7	0.0	0.0	0.5	57.4	0.0	0.0	0.1	16.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.7	18.0	26.5	26.2	15.4	16.1	30.1	26.5	29.1	27.9	31.5	21.5	38.4	10.8	3.2	3.2	39.2	30.7	13.6	23.1	21.6	30.1	2.1	21.8	89.2	95.4	10.0	14.8	18.4	0.0	74.0	1.4	36.0	5.9	11.4	4.0	12.4	52.1	10.2	4.9	1.3	3.5	7.1	7.5	140.8	3.6	6.0	0.0	10.7	9.7	0.2	15.3	6.7	5.8	10.1	0.0	0.6	11.1	5.8	185.8	6.6	19.6	18.7	18.6	41.2	0.0	41.7	18.4	2.8	7.3	267.4	41.2	19.4	0.6	3.1	7.9	2.7	39.5	139.9	56.3	0.7	3.8	7.7	7.1	27.8	2.1	30.7	7.7	24.7
SSTR3		ENSG00000278195	"Somatostatin receptor 3"	P32745	22	37204237-37212477	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;lymphoid tissue: 11.1;testis: 7.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.3;Late spermatids: 2.0;Microglial cells: 1.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.1"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 23.3;SCLC-21H: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022647	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022647: "	"unprognostic (1.63e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.26e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-2)"	0.1	0.3	2.2	1.0	2.2	0.4	0.0	1.2	6.4	0.0	0.0	0.2	1.3	1.1	0.0	0.0	0.1	0.0	0.0	1.9	2.2	0.1	0.0	0.0	1.8	6.8	3.5	3.3	1.8	0.0	2.6	0.0	6.7	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.5	1.0	1.2	0.6	0.2	7.8	7.6	11.1	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	8.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.9	0.0	0.0	0.0	0.0	0.1	0.2	2.2	2.2	1.2	6.4	1.9	2.2	6.8	3.5	6.7	1.2	7.6	2.3	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0
ST18	"KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387"	ENSG00000147488	"ST18 C2H2C-type zinc finger transcription factor"	O60284	8	52110839-52460959	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 82.1"	"Cell type enriched"	"Detected in some"	39	"Oligodendrocytes: 4055.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;SCLC-21H: 9.6;U-87 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Low region specificity"	"Detected in all"			HPA044919	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA044919: AB_10959756"	"unprognostic (3.66e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-5)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.84e-3)"	0.0	0.9	18.4	0.1	48.6	0.0	0.0	44.1	24.1	0.0	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	18.0	29.0	0.3	0.1	0.1	0.0	47.8	37.4	0.0	1.9	0.0	4.4	0.1	43.5	0.1	0.3	8.5	0.0	0.0	0.0	0.0	0.5	0.0	22.3	0.0	1.5	0.3	35.7	0.1	0.0	0.0	0.1	0.0	0.0	82.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	48.6	44.1	24.1	18.0	29.0	47.8	37.4	43.5	22.3	35.7	82.1	0.0	0.0	0.0	4.9	0.6	0.1	0.1	0.0	0.0	101.5	0.0	0.0	1.1	4.3	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	0.2	49.6	1.3	3.4	0.0	0.4	0.2	5.1	0.0	0.0	0.0	0.0	0.2	1.3	1.7	8.5	0.8	10.2	1.6	11.0	1.7	0.0	3.4	0.0	0.0	0.7	2.4	0.0	13.0	4055.3	0.3	0.0	0.0	0.1	0.3	0.1	0.8	0.0	4.5	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.1	0.1	0.0	0.3	0.0
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074746-76634603	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.0"	"Group enriched"	"Detected in many"	4	"Microglial cells: 912.5;Oligodendrocytes: 698.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 35.8;HUVEC TERT2: 45.9;SK-MEL-30: 62.3;TIME: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	8.8	1.4	5.8	1.8	13.3	3.1	6.4	14.3	8.4	1.9	10.4	2.0	0.7	5.9	0.5	1.9	2.7	2.5	4.4	6.9	9.0	8.7	2.0	5.2	2.0	15.2	10.6	2.3	0.9	4.4	2.1	3.1	17.2	1.1	2.4	3.9	1.1	1.6	1.6	0.8	1.4	4.5	13.3	1.4	1.5	0.3	11.3	0.9	13.3	6.5	0.7	2.6	1.6	21.0	0.2	0.0	35.8	0.0	0.6	0.0	0.0	0.0	4.2	0.6	0.4	11.9	0.1	0.6	2.4	0.3	2.3	0.1	0.0	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.6	0.0	0.0	1.1	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	2.9	0.0	1.8	1.7	0.0	0.0	0.0	2.7	8.8	0.0	0.0	62.3	8.3	0.0	0.2	20.6	0.3	2.8	0.1	3.3	0.0	0.0	0.0	0.0	8.4	5.5	0.0	6.3	2.8	0.0	2.2	0.0	2.6	0.3	0.5	2.3	3.8	1.3	1.4	3.9	0.3	4.3	0.0	0.0	1.9	5.8	13.3	14.3	8.4	6.9	9.0	15.2	10.6	17.2	13.3	11.3	21.0	59.8	3.2	1.5	174.3	5.6	0.3	0.2	0.0	0.6	3.2	0.6	1.0	1.2	0.0	0.0	3.7	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.1	4.5	23.2	0.0	0.4	107.0	0.0	0.1	2.5	3.6	0.1	0.0	0.8	66.0	0.8	1.1	0.0	101.4	0.5	0.0	9.8	0.7	0.8	0.0	3.7	5.4	912.5	3.0	12.3	1.0	23.1	698.3	0.2	3.4	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.3	0.2	0.7	0.1	0.4	0.1	2.0	6.9	0.3	0.1
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins, Transporters"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 439.5"	"Cell type enriched"	"Detected in many"	4	"Hepatic stellate cells: 745.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	59	"classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	60	"dendritic cells: 2.5;monocytes: 9.4"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		96000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	194.2	160.4	41.0	50.4	42.9	13.8	84.5	41.4	58.3	54.4	62.8	87.7	29.6	45.3	8.5	29.2	79.3	25.8	74.6	41.9	44.4	85.6	102.1	104.7	12.9	50.0	48.4	32.2	32.2	5.0	52.0	55.4	53.7	57.6	31.0	0.6	45.7	16.0	25.9	24.0	95.1	33.8	43.0	439.5	53.2	21.0	65.3	6.8	55.1	4.6	8.2	105.7	48.6	47.8	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.2	0.2	0.6	0.0	0.0	1.8	0.1	0.0	0.1	0.0	103.1	0.1	0.3	0.1	0.0	0.0	0.0	146.9	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	128.8	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	9.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	41.0	42.9	41.4	58.3	41.9	44.4	50.0	48.4	53.7	43.0	65.3	47.8	31.3	0.0	3.8	0.0	5.5	6.0	0.6	0.0	1.8	1.0	1.5	2.7	2.4	11.5	0.0	3.7	0.0	1.7	1.9	0.0	0.0	0.0	0.5	0.4	0.5	43.0	1.2	21.5	0.3	0.0	2.0	3.3	0.5	0.3	18.3	0.0	745.0	19.7	130.7	0.0	0.3	0.0	0.0	185.4	30.3	2.9	4.4	147.0	12.4	30.0	21.9	0.5	2.1	0.5	0.1	0.0	0.0	20.3	2.0	0.2	0.0	0.8	0.0	0.1	19.7	2.0	1.4	0.9	2.2	1.5	4.8	2.2	2.3	0.5	0.0	0.2
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558727-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 51.0"	"Group enriched"	"Detected in some"	5	"B-cells: 60.8;granulocytes: 80.8;Ionocytes: 65.1;Plasma cells: 147.2"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 88.1;naive B-cell: 107.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 185.4;U-698: 83.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.4	0.1	0.0	15.5	0.0	5.8	0.8	0.0	0.0	0.3	0.0	2.3	1.8	0.6	1.9	0.7	0.1	1.4	0.2	0.5	0.0	9.2	0.4	1.4	40.8	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	2.3	0.0	1.3	2.8	0.1	0.1	8.1	0.4	0.0	16.0	2.3	2.7	0.0	6.4	0.4	0.0	51.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	83.2	0.0	24.7	0.0	5.3	0.1	24.3	0.9	0.1	1.9	88.1	2.0	0.8	1.2	107.8	7.9	0.2	1.0	38.9	0.1	5.2	0.4	4.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	60.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	5.5	0.0	0.0	5.8	0.0	9.8	0.0	13.0	0.1	0.0	0.6	0.0	2.5	0.3	0.0	0.0	0.1	0.0	0.0	80.8	0.0	0.4	0.0	0.8	0.0	0.2	0.1	65.1	0.3	0.7	7.1	0.3	1.2	16.0	0.0	0.2	0.0	6.2	0.0	0.3	0.0	0.0	0.4	147.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.1	0.0	4.3	0.1	0.0	0.2
STAT4		ENSG00000138378	"Signal transducer and activator of transcription 4"	Q14765	2	191029576-191151596	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.0;testis: 29.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 139.0;Early spermatids: 275.1;Excitatory neurons: 85.9;Late spermatids: 66.0;NK-cells: 108.1;Plasma cells: 83.8;T-cells: 137.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 76.6;T-cells: 121.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 58.8;U-266/70: 32.9;U-266/84: 12.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001860, CAB013108"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB013108: , HPA001860: AB_1080104"	"unprognostic (3.90e-5)"	"unprognostic (1.30e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (2.65e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	4.7	4.0	3.4	11.5	4.4	15.7	3.0	0.1	10.4	1.6	0.1	2.8	4.5	1.9	2.6	1.4	1.6	5.1	23.0	3.8	3.6	4.5	9.5	7.8	18.0	2.1	1.7	1.5	2.2	1.2	15.0	2.6	2.0	1.8	3.4	2.1	2.2	1.3	1.2	1.1	6.9	1.4	0.6	15.5	4.4	29.2	3.4	9.0	2.4	1.0	10.4	5.9	1.8	4.5	0.1	1.7	1.1	0.0	0.0	3.6	0.3	0.6	2.2	0.6	2.2	0.4	0.8	0.0	0.2	2.8	1.6	0.9	0.0	4.7	1.2	0.0	0.8	1.3	0.0	0.0	0.6	0.0	0.1	1.5	2.3	1.1	0.5	0.1	0.0	6.0	0.0	58.8	0.2	0.0	3.5	0.0	0.3	0.0	0.9	0.0	0.0	4.3	0.2	0.1	0.1	1.2	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.1	1.6	0.0	32.9	12.8	0.0	1.2	0.0	0.1	15.7	0.4	0.1	121.2	0.8	107.3	1.8	71.6	101.2	0.6	1.0	68.1	95.8	2.8	76.6	0.8	9.3	28.1	55.3	3.4	4.4	0.1	10.4	3.8	3.6	2.1	1.7	2.0	0.6	3.4	4.5	2.9	3.2	4.2	2.6	14.5	1.3	0.6	2.9	0.0	0.9	0.9	1.1	20.3	4.3	0.6	1.8	8.4	0.4	139.0	0.5	0.0	0.6	275.1	1.1	0.5	1.2	0.0	10.5	85.9	0.2	2.9	2.9	8.6	0.7	1.3	0.8	1.1	1.1	1.1	0.0	59.4	0.3	0.0	6.3	10.6	66.0	0.3	14.4	5.4	7.5	6.3	0.0	108.1	6.0	2.4	0.1	0.3	0.4	83.8	1.0	0.0	0.8	2.4	0.2	0.0	0.6	3.7	8.3	1.2	0.4	1.7	0.5	137.4	0.1	0.3	0.7
STEAP1	"PRSS24, STEAP"	ENSG00000164647	"STEAP family member 1"	Q9UHE8	7	90154456-90164829	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 83.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 140.5;Club cells: 72.6;Prostatic glandular cells: 85.1;Theca cells: 64.4;Urothelial cells: 54.0"	"Cancer enriched"	"Detected in all"	6	"prostate cancer: 94.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.1;CAPAN-2: 135.2;U-138 MG: 169.2"	"Low region specificity"	"Detected in many"							HPA030985	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA030985: AB_2673686"	"unprognostic (2.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-3)"	"unprognostic (9.20e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.45e-3)"	"unprognostic (8.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.38e-1)"	32.9	2.2	1.0	32.9	1.4	0.0	18.5	0.8	2.3	9.6	1.4	18.1	5.2	4.2	0.8	12.6	10.7	16.4	7.2	1.3	1.0	6.6	27.6	14.2	0.3	1.3	0.8	6.0	6.0	0.3	3.7	0.7	1.0	83.8	13.7	0.7	15.1	2.1	1.3	4.6	7.8	26.9	0.8	2.5	13.9	4.2	1.0	0.9	5.0	2.5	4.6	34.5	5.8	1.1	26.9	52.5	3.3	9.8	105.1	89.5	0.9	17.8	20.5	2.4	2.7	38.8	135.2	0.3	0.9	28.9	43.5	5.3	22.0	22.6	5.1	0.0	7.6	0.1	0.5	13.0	4.3	0.0	0.1	59.7	3.7	68.0	37.4	16.6	92.6	7.3	1.2	74.0	29.6	0.4	0.0	0.9	15.7	1.3	23.2	0.1	0.0	0.3	20.8	5.5	0.0	1.2	6.4	0.2	12.1	1.9	29.4	0.4	50.8	169.2	8.0	83.9	22.8	14.0	0.5	0.1	83.4	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.8	2.3	1.3	1.0	1.3	0.8	1.0	0.8	1.0	1.1	1.8	0.0	0.5	2.3	0.3	4.2	41.9	140.5	7.4	0.1	12.8	11.4	0.8	5.7	72.6	1.8	0.0	0.0	0.6	7.0	0.0	3.4	0.4	1.3	4.9	4.5	7.2	0.0	5.3	38.6	0.1	25.2	10.7	4.6	0.0	10.5	1.8	33.1	0.5	0.0	1.7	4.3	24.4	0.8	5.4	1.1	0.9	1.3	7.2	0.0	0.0	10.5	0.0	1.5	1.3	44.4	20.5	1.5	1.3	85.1	2.5	14.7	13.1	0.3	6.6	6.0	26.9	17.1	36.9	12.2	2.3	0.3	0.4	64.4	16.6	54.0
STMN1	"C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN"	ENSG00000117632	"Stathmin 1"	P16949	1	25884181-25906991	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 951.6;lymphoid tissue: 1343.2"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 2537.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 424.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 424.6;T-cells: 143.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 3270.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010107, HPA068438"	Enhanced		Approved	Cytosol		NA	NA		320000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB010107: AB_628297, HPA068438: "	"unprognostic (6.30e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (9.90e-7)"	"unprognostic (9.45e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-2)"	56.4	69.1	526.8	103.8	568.0	260.5	60.6	514.2	951.6	57.7	333.6	93.2	70.5	129.8	40.7	115.9	45.2	51.1	56.0	573.2	568.2	77.7	35.8	60.7	253.2	560.1	516.8	172.4	23.2	43.8	103.5	120.1	552.4	31.7	110.6	304.7	43.4	32.7	29.5	56.3	89.1	100.0	537.1	72.8	54.5	387.0	531.7	1343.2	33.6	29.9	246.0	58.9	76.0	791.9	1026.8	226.1	2191.0	882.5	128.9	126.0	225.7	776.3	609.7	1081.9	1037.9	157.2	1018.3	1260.3	426.3	572.0	425.8	304.6	618.6	450.9	1616.1	390.4	310.9	786.0	363.3	547.6	51.9	994.6	529.3	77.0	65.6	439.6	496.8	405.5	833.6	1594.4	1074.4	1203.0	1429.6	268.0	3270.7	1441.5	1350.8	615.1	302.8	1907.9	1709.2	740.7	536.9	91.7	1479.2	1282.3	710.0	348.3	638.4	695.8	500.7	1240.1	406.2	721.8	853.6	634.3	664.8	702.5	1212.0	1535.8	357.7	1904.8	798.2	13.4	4.1	23.5	53.9	8.6	32.2	37.0	47.8	68.2	23.2	45.6	77.8	71.6	1.9	56.3	4.5	424.6	143.3	57.2	526.8	568.0	514.2	951.6	573.2	568.2	560.1	516.8	552.4	537.1	531.7	791.9	257.3	41.7	31.6	32.7	125.1	201.6	148.9	350.0	577.7	454.6	91.0	175.1	77.2	31.5	100.0	174.7	64.6	439.3	261.7	35.1	226.9	148.9	917.2	92.8	100.3	196.3	250.8	505.7	109.5	20.1	604.1	134.9	121.3	141.1	262.0	712.4	109.2	15.4	530.1	195.2	73.0	100.9	567.6	87.3	287.0	2537.2	44.7	130.0	268.6	32.8	32.1	252.4	84.5	38.2	217.4	59.0	69.3	47.0	261.7	63.5	21.0	221.4	59.1	183.6	39.5	68.0	267.6	873.0	260.8	423.9	90.4	130.4	224.9	66.5	177.1	95.7
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338987-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 591.3;hTCEpi: 497.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	339.0	117.3	100.4	101.0	108.1	358.2	243.8	94.7	103.9	129.3	74.8	226.0	46.1	139.9	72.2	87.8	141.7	153.3	219.7	90.5	113.1	123.9	355.4	290.7	67.7	120.7	115.1	81.3	38.9	45.3	49.8	272.7	108.9	111.6	58.4	15.0	95.5	93.4	102.6	118.3	114.1	155.9	105.2	121.6	139.3	24.7	111.0	33.8	112.9	106.2	46.4	182.4	129.6	108.7	8.4	55.0	4.8	26.0	591.3	170.3	0.4	138.6	149.3	40.7	64.5	7.6	10.8	66.5	34.3	186.6	23.9	14.7	31.7	133.0	79.3	41.7	12.0	144.7	108.8	23.1	299.0	61.4	32.4	272.2	497.3	60.9	88.0	11.7	152.5	21.0	33.3	88.2	96.8	45.2	2.2	47.0	64.4	3.5	16.6	8.7	0.2	147.7	34.7	1.7	5.9	0.5	114.5	107.8	62.1	44.9	36.6	47.4	172.8	92.0	28.1	91.3	13.6	36.5	44.9	4.4	35.1	58.1	51.0	21.4	35.5	4.1	168.9	55.8	165.7	5.9	84.2	153.3	35.8	4.2	15.0	81.1	20.8	147.1	41.0	6.1	8.7	128.8	100.4	108.1	94.7	103.9	90.5	113.1	120.7	115.1	108.9	105.2	111.0	108.7	454.6	160.3	96.6	30.0	13.2	105.5	251.8	107.0	62.0	5.0	135.8	72.3	36.7	121.5	159.0	35.0	6.2	121.9	72.1	26.3	3.9	56.6	3.6	97.0	75.4	313.6	0.0	535.1	3.2	22.0	54.7	140.3	17.9	11.7	36.1	76.0	282.7	371.2	92.1	3.3	4.8	1.1	54.9	226.3	92.3	9.0	66.5	105.9	88.9	70.3	37.9	8.6	127.7	6.6	4.5	39.1	18.3	103.0	16.9	90.2	33.8	92.8	216.0	5.0	138.1	73.2	188.1	40.8	13.7	48.4	119.1	172.8	98.8	81.8	2.2	200.0
STRA6	FLJ12541	ENSG00000137868	"Signaling receptor and transporter of retinol STRA6"	Q9BX79	15	74179466-74212267	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.5"	"Cell type enhanced"	"Detected in many"		"Club cells: 17.6;Endometrial stromal cells: 43.1;Extravillous trophoblasts: 12.1;Fibroblasts: 16.1;Proximal tubular cells: 10.3;Syncytiotrophoblasts: 26.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 33.7;CAPAN-2: 94.5;SH-SY5Y: 59.2;WM-115: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040839	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.1	1.0	0.1	0.3	0.0	0.0	0.9	0.0	0.4	24.5	0.4	0.1	0.0	4.3	0.5	1.1	3.6	0.3	0.1	0.1	0.1	4.3	0.0	0.2	0.8	0.1	0.0	0.6	0.1	0.0	5.5	7.6	0.0	5.2	0.0	0.0	0.7	1.4	0.0	0.3	0.2	0.2	0.1	0.1	0.0	3.1	0.3	0.2	0.1	0.1	0.5	1.3	2.4	0.0	0.5	33.7	1.9	0.1	0.0	0.0	6.0	1.0	0.2	0.0	0.0	11.7	94.5	0.0	22.1	0.1	0.7	3.4	1.8	0.0	0.0	0.0	0.2	3.0	1.3	2.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	6.1	0.6	2.9	0.1	0.0	0.4	0.0	0.0	0.0	2.9	17.4	59.2	0.0	3.6	0.0	3.6	0.2	0.1	0.0	0.2	7.3	0.6	1.6	0.1	0.2	0.0	0.6	0.0	142.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	9.7	0.0	0.0	0.2	0.3	1.0	0.0	17.6	0.0	0.0	4.2	0.0	0.0	1.9	0.3	1.7	2.1	43.1	1.3	0.0	0.0	0.1	0.0	12.1	16.1	0.0	1.8	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	2.0	0.0	0.8	0.8	6.8	0.4	1.8	1.9	0.1	0.0	0.0	0.0	0.0	4.7	0.0	4.1	0.0	0.4	0.0	10.3	6.6	0.0	0.0	1.3	4.7	0.5	0.5	0.0	0.0	26.4	0.3	0.1	0.0	1.3
STRADB	"ALS2CR2, CALS-21, ILPIP, ILPIPA, PAPK"	ENSG00000082146	"STE20 related adaptor beta"	Q9C0K7	2	201387858-201480846	"Enzymes, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 412.8;Proximal enterocytes: 124.0;Proximal tubular cells: 217.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 188.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026549, HPA028520"	Approved		Uncertain	Aggresome,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Cytosol	Aggresome	"HPA026549: AB_1844779, HPA028520: AB_10604100"	"unprognostic (6.34e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.65e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (7.83e-2)"	"prognostic favorable (4.45e-4)"	"unprognostic (4.93e-2)"	29.9	53.2	24.1	8.9	26.3	80.9	16.8	26.2	30.8	10.6	22.4	27.6	37.0	13.2	17.4	17.0	10.4	14.3	38.0	25.3	26.2	73.3	104.9	10.6	14.5	27.7	25.9	14.1	17.6	6.2	17.4	19.7	27.3	11.1	30.3	40.5	13.9	7.7	109.0	8.4	42.9	10.2	26.7	13.7	9.1	15.8	25.6	11.4	17.9	69.5	11.6	9.7	9.3	30.2	12.6	21.5	36.2	47.0	58.5	73.8	25.6	25.6	43.4	34.9	51.6	29.6	11.9	0.1	16.0	40.7	42.4	12.6	35.8	23.9	62.7	14.9	30.1	15.2	9.6	62.9	43.9	18.4	16.7	62.5	21.6	43.7	39.0	63.5	26.5	28.5	33.4	5.3	188.5	6.8	17.2	31.1	49.2	11.7	22.6	22.8	14.5	9.6	29.2	9.9	6.0	29.3	17.6	13.1	76.8	66.0	6.7	34.4	25.7	20.6	16.1	26.6	19.3	21.1	39.0	5.8	35.8	8.2	20.5	5.5	12.9	16.3	9.2	14.4	8.3	28.8	12.2	13.4	17.2	35.8	15.5	15.6	2.6	29.0	13.1	7.7	16.4	15.8	24.1	26.3	26.2	30.8	25.3	26.2	27.7	25.9	27.3	26.7	25.6	30.2	5.0	9.6	4.2	17.0	20.2	2.2	6.8	6.5	11.4	13.8	24.9	10.8	27.8	28.6	6.1	14.7	83.4	51.0	6.3	40.9	39.2	12.4	3.9	7.5	7.4	5.6	16.9	412.8	20.8	15.4	27.6	13.6	6.6	10.2	5.7	12.0	7.9	94.6	19.2	11.8	19.8	22.6	8.2	16.9	5.2	8.1	10.8	13.5	16.0	15.0	14.8	19.6	7.2	26.7	26.0	9.0	35.2	3.8	10.9	10.2	124.0	217.8	5.3	19.1	6.6	21.7	6.6	45.0	46.7	15.2	1.4	27.9	8.9	26.8	25.0	9.1
STRIP2	"FAM40B, FAR11B, KIAA1170"	ENSG00000128578	"Striatin interacting protein 2"	Q9ULQ0	7	129434432-129488399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0;choroid plexus: 80.0;skeletal muscle: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.9;Cardiomyocytes: 49.5;Muller glia cells: 62.1;Oligodendrocyte precursor cells: 29.7;Spermatocytes: 79.1;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 41.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 44.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 102.5"	HPA019657	Approved		Approved	Cytosol		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA019657: AB_1848399"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.87e-6)"	"prognostic favorable (5.41e-4)"	"unprognostic (4.06e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.50e-2)"	0.4	2.3	3.7	1.6	41.0	3.6	0.4	3.9	10.2	0.3	80.0	0.6	0.5	0.4	0.3	1.1	0.2	0.8	9.5	4.4	1.8	4.7	0.5	1.0	2.4	0.8	8.0	0.7	0.9	0.1	8.2	0.9	1.0	1.1	0.9	22.1	1.3	0.1	28.6	0.9	0.9	0.5	2.8	1.2	0.7	14.2	8.9	1.3	0.4	19.4	1.7	0.7	0.4	2.4	15.4	6.5	5.9	9.3	2.3	2.0	25.5	6.1	7.7	10.2	9.8	3.6	8.5	6.4	0.8	2.6	33.2	16.9	6.4	5.5	15.4	37.6	5.3	4.9	11.5	3.7	1.5	3.1	25.0	2.4	1.9	17.3	10.6	16.8	17.8	5.7	21.7	3.8	39.7	0.8	8.2	7.8	5.7	3.3	13.4	5.4	10.9	1.2	3.7	5.7	1.3	1.3	14.2	1.0	3.1	4.4	1.8	7.6	6.4	5.9	5.8	44.7	18.0	3.6	2.5	7.6	39.4	7.9	8.5	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	3.7	41.0	3.9	10.2	4.4	1.8	0.8	8.0	1.0	2.8	8.9	2.4	0.4	3.2	1.1	54.9	0.8	0.3	0.3	0.3	0.0	10.5	0.5	0.4	49.5	0.0	0.3	0.0	2.1	0.7	0.8	2.1	0.0	0.9	5.7	0.2	0.9	1.1	0.0	9.1	18.6	3.8	3.8	3.2	2.0	0.4	7.6	1.0	0.4	0.2	0.8	1.7	16.7	1.0	0.0	0.3	0.3	9.9	0.6	2.1	1.8	7.5	7.8	62.1	0.0	29.7	1.0	5.0	4.4	0.7	1.4	0.6	0.1	13.7	0.8	3.5	0.0	2.3	0.9	79.1	37.1	0.5	0.1	0.3	1.3	0.5	0.8	0.6
STRIT1	DWORF	ENSG00000240045	"Small transmembrane regulator of ion transport 1"	P0DN84	3	155290227-155293683	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	79	"skeletal muscle: 1711.3;tongue: 698.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.1;prostate cancer: 1.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Not detected"	"Not detected"																	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 50: Fibroblasts - ECM organization"							"unprognostic (6.77e-4)"		"unprognostic (1.60e-2)"					"unprognostic (6.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.33e-2)"				0.6	0.1	3.5	0.2	15.2	0.2	0.5	4.5	3.5	0.0	2.8	0.2	6.3	0.2	0.5	14.1	0.1	0.4	5.5	3.3	2.8	5.9	0.3	0.2	0.3	3.1	4.1	0.1	0.3	0.1	0.1	0.1	4.2	12.1	0.2	0.3	8.7	0.1	1711.3	2.2	3.6	0.0	1.7	0.2	0.2	0.2	7.5	0.0	0.4	698.4	0.1	0.0	0.1	5.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	15.2	4.5	3.5	3.3	2.8	3.1	4.1	4.2	1.7	7.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SUCLG1		ENSG00000163541	"Succinate-CoA ligase GDP/ADP-forming subunit alpha"	P53597	2	84423528-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 554.0"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 935.2;Proximal enterocytes: 647.5;Proximal tubular cells: 2949.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA		350000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Plasma membrane, Cytosol"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	118.7	73.3	70.6	43.1	73.2	48.2	80.0	76.2	92.5	49.9	91.1	156.9	231.1	42.4	78.8	86.9	54.6	41.9	258.1	71.1	74.5	554.0	193.0	41.6	47.8	71.7	70.2	45.7	93.6	244.2	46.8	48.8	72.9	54.3	165.9	38.4	120.6	66.6	274.1	55.4	195.4	63.5	73.8	39.6	81.1	36.9	73.3	61.7	97.6	368.1	63.1	66.4	58.5	76.9	90.2	94.9	73.8	91.1	137.8	91.2	127.7	98.4	85.2	126.0	91.2	224.5	72.0	122.4	67.0	119.8	100.2	126.8	156.7	118.4	149.8	119.3	141.4	105.9	75.4	129.2	116.0	110.6	82.7	109.1	95.6	106.3	143.7	76.7	115.1	97.9	110.1	98.1	117.5	137.4	158.2	101.1	39.4	334.1	170.0	98.3	172.6	134.5	172.2	106.4	89.8	49.3	78.9	163.7	162.3	69.0	99.8	85.4	93.1	96.6	94.6	119.9	124.9	84.2	131.0	107.8	113.9	150.4	88.0	101.6	91.0	80.8	79.0	110.2	88.5	70.2	72.0	88.4	115.4	55.4	79.1	84.3	49.7	102.3	114.3	63.2	107.7	142.7	70.6	73.2	76.2	92.5	71.1	74.5	71.7	70.2	72.9	73.8	73.3	76.9	52.7	64.1	96.5	32.7	61.0	35.4	108.9	129.6	44.3	33.3	105.0	109.1	408.6	131.5	115.2	141.6	22.9	232.3	49.9	218.1	935.2	131.8	49.2	67.1	56.9	57.0	106.3	68.4	45.8	113.2	129.3	69.8	79.5	80.8	91.3	46.0	57.5	210.0	131.7	45.4	43.5	202.1	105.8	71.3	46.0	35.9	54.7	82.2	119.2	16.9	89.8	68.2	58.7	28.1	46.2	67.1	215.4	74.1	57.1	64.2	647.5	2949.2	83.7	36.1	52.6	61.1	98.3	138.9	54.4	111.3	41.3	188.4	64.4	90.7	388.7	111.0
SUGCT	"C7orf10, DERP13, FLJ11808, ORF19"	ENSG00000175600	"Succinyl-CoA:glutarate-CoA transferase"	Q9HAC7	7	40135005-40860763	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 44.4;liver: 28.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.0;Inhibitory neurons: 38.5;Oligodendrocyte precursor cells: 58.3;Proximal tubular cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 43.9;LHCN-M2: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026698, HPA026704, HPA026705"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026698: AB_10600191, HPA026704: AB_10600230, HPA026705: AB_10601003"	"unprognostic (4.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.27e-3)"	"unprognostic (7.65e-2)"	"prognostic favorable (3.93e-7)"	"unprognostic (2.62e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.41e-3)"	"prognostic unfavorable (2.53e-4)"	2.4	9.0	1.7	0.9	1.8	0.1	2.3	1.7	2.2	2.2	4.4	4.5	0.7	2.2	1.0	2.1	1.7	2.8	3.9	1.7	2.0	44.4	28.4	0.6	0.8	2.0	2.1	4.1	2.3	4.1	0.9	0.6	1.9	2.0	2.4	2.0	1.4	1.8	10.3	0.9	5.3	2.2	1.8	0.8	1.0	2.8	1.8	0.8	1.8	8.2	1.0	2.0	1.6	1.8	0.8	0.1	4.8	3.4	5.0	11.5	1.8	2.5	4.6	3.2	3.8	2.0	1.0	3.1	1.2	3.5	3.4	0.2	1.4	43.9	5.3	0.0	2.1	2.8	0.3	7.3	6.2	0.4	0.3	14.6	9.7	3.7	2.2	6.9	0.9	1.2	3.9	0.3	26.2	0.0	0.1	0.4	8.1	0.1	3.7	2.9	0.4	0.0	7.4	0.0	0.3	2.7	4.0	1.8	5.8	7.9	0.1	0.7	3.7	14.6	4.2	0.2	1.0	0.3	0.0	0.2	2.8	1.2	3.3	0.0	0.0	0.1	0.2	0.0	0.4	0.5	0.7	0.3	0.0	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.2	1.7	1.8	1.7	2.2	1.7	2.0	2.0	2.1	1.9	1.8	1.8	1.8	0.6	3.2	0.5	76.0	1.9	2.0	2.1	26.0	10.2	1.0	1.3	23.0	5.1	1.5	4.4	1.8	8.4	1.5	0.0	10.1	17.6	1.2	31.0	0.9	2.5	0.7	3.6	0.4	19.8	0.8	2.4	3.5	0.0	1.3	0.0	2.2	0.0	21.1	0.3	0.0	38.5	1.5	0.0	1.3	1.0	16.7	6.2	0.7	3.6	14.0	0.1	5.3	0.0	58.3	22.8	0.6	5.6	3.0	0.1	0.8	13.9	81.6	0.8	4.5	6.6	1.4	15.3	2.7	3.1	3.2	0.6	0.8	0.7	7.4	5.3	0.7
SUSD2	"BK65A6.2, FLJ22778, W5C5"	ENSG00000099994	"Sushi domain containing 2"	Q9UGT4	22	24181487-24189106	"Predicted membrane proteins"		Receptor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 99.8"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 250.0;Alveolar cells type 2: 151.5;Proximal enterocytes: 154.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 64.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	29	"SK-BR-3: 898.7"	"Low region specificity"	"Detected in all"							HPA004117	Enhanced		Approved	"Plasma membrane"		NA	NA		6800000		"Cluster 19: Lung - Lung function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA004117: AB_1857674"	"unprognostic (5.24e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.74e-3)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.33e-3)"	12.1	9.6	4.9	1.9	2.8	0.2	9.5	1.7	5.8	13.6	2.2	4.8	12.8	9.8	0.5	2.8	15.0	1.8	12.5	1.6	5.3	32.6	2.9	99.8	2.2	22.9	6.9	5.4	4.3	1.5	7.1	3.6	26.5	5.6	1.0	0.1	4.7	5.6	2.2	28.2	34.6	3.4	6.8	3.6	6.3	3.2	13.2	0.8	17.8	1.4	1.3	5.4	11.0	10.0	5.1	10.4	0.1	0.0	18.8	24.3	0.8	2.4	0.1	0.1	0.0	7.8	0.6	1.4	21.5	0.5	0.4	1.4	0.1	0.5	0.0	0.6	0.3	0.0	0.4	30.6	8.0	0.0	0.3	21.5	0.4	0.1	6.2	0.0	0.1	0.0	0.5	0.3	0.0	9.1	0.3	0.4	0.7	2.5	0.3	0.3	0.0	2.5	0.1	0.2	1.7	13.5	0.7	898.7	0.2	3.6	3.0	0.0	0.0	0.1	0.9	0.7	0.1	1.1	1.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	2.8	1.7	5.8	1.6	5.3	22.9	6.9	26.5	6.8	13.2	10.0	1.7	250.0	151.5	0.3	0.6	0.3	0.3	2.6	0.0	0.0	3.4	3.4	6.8	0.0	20.9	1.8	0.0	13.8	0.3	0.7	5.9	0.1	0.0	1.3	0.7	1.1	1.8	0.0	0.2	0.0	0.7	6.7	0.5	1.3	3.8	0.1	2.9	0.5	1.1	0.0	0.1	5.5	2.0	0.0	0.3	0.4	0.6	0.8	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.4	154.9	27.8	3.6	0.0	0.0	0.6	22.1	1.7	1.3	0.7	2.7	26.4	1.1	0.0	1.6	0.6
SUSD3	MGC26847	ENSG00000157303	"Sushi domain containing 3"	Q96L08	9	93058688-93085133	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 57.3;testis: 77.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 32.4;Granulosa cells: 30.8;Hepatocytes: 66.6;Hofbauer cells: 49.4;Proximal tubular cells: 59.4;T-cells: 37.5;Theca cells: 34.7"	"Cancer enhanced"	"Detected in all"		"breast cancer: 50.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 150.7;Karpas-707: 32.6;MCF7: 36.8;NB-4: 78.0;RPMI-8226: 82.5;THP-1: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042310	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"			"HPA042310: AB_10796902"	"prognostic favorable (5.13e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.34e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.33e-2)"	6.1	1.8	4.5	17.6	3.9	41.3	15.4	4.6	4.3	16.7	4.4	3.8	4.9	19.8	10.0	4.2	35.4	4.2	1.3	4.3	5.6	21.2	27.8	4.1	57.3	6.4	5.7	40.1	1.0	1.3	5.4	2.0	6.5	2.4	2.2	6.4	11.4	3.2	1.2	3.6	18.7	6.1	6.6	36.3	4.5	77.2	5.9	31.8	4.2	0.6	30.5	4.4	6.1	8.0	7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.5	0.6	0.3	3.4	1.3	150.7	0.6	0.6	0.1	0.3	2.4	0.1	0.0	13.4	0.1	20.7	0.1	2.4	9.5	0.1	4.6	9.9	0.7	0.0	0.0	0.0	0.0	0.0	6.2	32.6	0.0	36.8	0.2	78.0	1.8	1.1	4.6	6.5	0.0	82.5	0.0	0.0	0.2	0.2	0.1	1.1	0.0	1.7	19.4	34.6	0.5	0.0	0.0	0.0	0.0	6.6	3.8	9.7	0.0	0.0	0.2	0.6	16.7	79.1	24.0	15.5	27.4	88.7	124.8	43.4	41.1	70.1	214.8	87.7	5.8	11.2	3.0	3.6	182.9	68.3	4.5	3.9	4.6	4.3	4.3	5.6	6.4	5.7	6.5	6.6	5.9	8.0	2.6	0.0	6.7	0.0	32.4	0.6	0.2	0.3	0.0	0.5	24.2	11.0	0.8	17.2	0.2	0.0	4.2	1.0	2.4	0.4	9.8	0.7	3.0	0.4	2.9	3.4	0.0	2.5	0.1	0.2	2.1	9.0	1.1	0.3	3.8	30.8	1.4	66.6	49.4	0.0	0.1	0.4	8.2	10.5	9.2	11.2	5.6	29.1	1.8	17.8	8.3	1.7	2.1	0.5	0.1	0.6	0.1	5.3	17.9	1.4	0.2	59.4	0.7	9.2	0.0	0.1	1.6	3.4	3.9	0.1	0.3	1.4	37.5	34.7	0.7	0.2
SUSD4	FLJ10052	ENSG00000143502	"Sushi domain containing 4"	Q5VX71	1	223220819-223364233	"Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;esophagus: 51.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.7;Inhibitory neurons: 89.7;Oligodendrocyte precursor cells: 101.6;Squamous epithelial cells: 68.3;Theca cells: 65.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 6.8;naive CD4 T-cell: 10.2"	"Lineage enriched"	"Detected in single"	40	"T-cells: 10.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 9.7;RPTEC TERT1: 11.1;SCLC-21H: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058296	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA058296: AB_2683672"	"unprognostic (2.90e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (4.28e-4)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.82e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.51e-6)"	"unprognostic (3.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.11e-2)"	0.4	6.0	28.4	0.8	21.7	0.4	8.7	5.4	63.7	9.5	0.0	1.3	1.0	0.3	25.1	51.1	3.5	0.7	23.0	69.0	26.8	19.5	3.8	2.8	1.6	9.4	10.4	45.3	10.7	14.9	26.0	0.5	15.9	6.0	0.2	12.2	17.0	4.3	3.5	7.8	0.6	0.4	5.0	0.4	11.0	6.6	21.4	3.4	1.0	2.2	15.0	3.6	25.3	16.2	5.9	0.5	0.2	0.0	0.0	0.0	0.1	0.8	0.4	1.0	0.5	5.8	1.8	0.0	1.8	0.2	0.0	9.7	0.2	1.5	0.9	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.0	6.6	0.5	0.0	0.5	3.9	3.8	0.0	0.2	3.0	1.3	0.0	0.2	0.1	11.1	2.8	36.3	0.4	0.0	3.2	0.0	0.8	2.1	0.2	0.0	1.7	6.2	0.0	2.9	0.7	0.1	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.3	0.1	5.5	0.0	6.8	1.7	0.0	0.0	10.2	1.9	0.0	0.2	0.0	0.0	0.9	1.4	28.4	21.7	5.4	63.7	69.0	26.8	9.4	10.4	15.9	5.0	21.4	16.2	0.2	0.0	4.8	6.2	0.0	0.6	8.6	8.4	10.2	17.9	9.7	5.0	9.5	5.7	14.8	16.5	10.4	0.1	0.3	0.1	31.3	0.6	3.1	4.0	0.4	0.6	1.2	0.0	83.7	6.9	0.0	3.8	2.6	6.1	0.0	9.1	0.4	1.8	2.8	21.9	89.7	0.1	2.0	0.6	0.3	3.4	20.5	0.3	5.4	8.4	0.0	1.6	0.0	101.6	2.5	2.6	0.0	12.4	0.1	4.6	0.0	0.3	5.4	6.2	0.0	1.4	2.8	1.3	10.7	68.3	1.7	0.0	1.7	65.5	0.3	25.7
SV2B	"HsT19680, KIAA0735"	ENSG00000185518	"Synaptic vesicle glycoprotein 2B"	Q7L1I2	15	91099950-91302565	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 34.5;retina: 56.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 137.1;Cone photoreceptor cells: 150.1;Excitatory neurons: 455.0;Rod photoreceptor cells: 139.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 2.1;SCLC-21H: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046247	Approved					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046247: AB_10963538"	"unprognostic (2.92e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.01e-5)"	"unprognostic (2.66e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.10e-4)"	1.8	1.1	17.2	0.2	17.5	0.1	0.8	7.3	34.5	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.8	22.4	0.0	0.3	0.1	0.2	0.4	8.5	0.0	0.0	1.4	0.1	1.0	0.2	10.7	0.8	0.3	56.3	1.0	0.1	0.6	0.2	0.4	0.2	0.0	0.2	0.3	0.8	1.4	0.6	0.2	1.0	1.2	0.1	0.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.2	17.5	7.3	34.5	22.4	0.0	8.5	0.0	10.7	0.0	1.4	14.8	10.9	0.0	0.0	7.2	0.1	0.4	0.1	0.1	0.0	137.1	0.2	0.5	3.0	1.5	0.0	0.0	150.1	0.0	0.0	0.0	0.0	4.2	6.4	0.0	0.0	3.3	0.0	0.0	455.0	5.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.3	11.4	0.0	0.0	0.0	0.4	2.0	0.0	0.2	0.0	27.2	0.0	43.4	0.0	5.5	39.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	139.0	0.0	0.5	0.2	8.0	0.4	0.1	0.1	0.0	0.1	0.1	0.0	0.2
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365248-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 38.6;placenta: 61.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 92.8;Inhibitory neurons: 50.3;Leydig cells: 42.0;Oligodendrocytes: 140.5;Syncytiotrophoblasts: 67.3;Theca cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 147.1;ASC TERT1: 84.7;BJ hTERT+: 62.3;HHSteC: 53.8;HSkMC: 66.7"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 20.8"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"	NA	NA		160000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	38.6	4.2	1.5	2.5	8.6	0.0	23.2	8.9	2.8	10.6	0.9	9.7	1.2	8.6	5.6	3.5	12.4	6.2	6.5	1.1	3.4	3.9	2.9	19.7	3.8	2.7	5.3	3.9	4.7	5.3	0.8	61.7	3.3	1.7	5.1	0.0	4.1	2.1	4.4	11.3	8.7	9.5	1.0	5.2	7.7	1.0	4.3	1.8	7.4	5.5	2.4	9.7	12.1	6.1	0.0	0.1	1.2	0.0	147.1	84.7	0.0	16.3	62.3	1.2	1.9	1.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	12.2	1.0	0.0	0.3	0.1	1.4	0.0	53.8	0.0	2.9	66.7	0.0	12.1	3.2	1.4	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.2	7.5	2.0	0.0	10.6	0.0	0.0	0.0	2.3	0.0	1.0	0.0	1.3	2.5	0.0	7.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	8.6	8.9	2.8	1.1	3.4	2.7	5.3	3.3	1.0	4.3	6.1	7.4	0.0	0.5	2.9	0.1	5.7	0.6	0.5	1.2	0.5	0.4	0.9	1.8	5.7	0.1	0.0	0.0	12.2	0.3	0.0	0.0	0.9	0.3	0.5	13.8	2.0	0.0	0.0	16.9	0.2	1.6	92.8	4.1	0.3	0.0	0.0	2.2	0.0	3.0	0.0	50.3	0.0	0.0	0.0	8.2	0.6	42.0	0.6	7.2	13.1	0.0	0.0	0.0	3.0	140.5	0.0	1.2	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	3.5	7.8	0.4	1.5	0.4	3.3	67.3	1.2	34.1	0.2	0.2
SVOP	DKFZp761H039	ENSG00000166111	"SV2 related protein"	Q8N4V2	12	108907741-109021068	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 14.3;pituitary gland: 7.4;retina: 13.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 41.7;Early spermatids: 65.4;Excitatory neurons: 70.3;Inhibitory neurons: 75.8;Late spermatids: 121.5"	"Group enriched"	"Detected in some"	9	"glioma: 0.6;pancreatic cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Karpas-707: 2.8;RPMI-8226: 3.0;SCLC-21H: 1.5;SH-SY5Y: 1.3;U-266/84: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016573	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA016573: AB_2197027"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.38e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.26e-2)"		"unprognostic (6.17e-2)"	0.0	1.5	11.2	0.1	12.4	0.1	0.0	2.2	14.3	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	1.0	11.3	9.5	0.1	0.2	0.0	0.0	2.9	2.1	0.0	0.7	0.0	7.4	0.0	3.7	0.0	0.1	13.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.7	0.5	6.4	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	1.5	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	11.2	12.4	2.2	14.3	11.3	9.5	2.9	2.1	3.7	0.4	6.4	6.0	0.2	12.8	9.6	2.6	0.1	0.0	0.7	0.0	0.0	19.7	0.1	0.0	1.3	0.0	5.0	1.8	41.7	1.3	0.0	0.1	0.0	0.1	65.4	0.1	0.1	1.0	16.8	0.0	70.3	0.0	0.3	0.6	0.0	0.2	2.5	0.1	1.1	0.1	0.1	11.8	75.8	0.0	0.0	0.0	0.0	121.5	0.3	1.0	0.0	1.0	0.1	2.1	0.0	4.0	2.8	0.1	0.0	0.7	0.0	0.3	0.0	0.1	0.0	21.9	0.0	1.5	0.7	0.7	0.9	0.0	0.0	0.8	0.5	0.1	0.0	0.4
SYN2	"SYNII, SYNIIa, SYNIIb"	ENSG00000157152	"Synapsin II"	Q92777	3	12004388-12192032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Schizophrenia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 96.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 338.3;Inhibitory neurons: 543.3;Oligodendrocyte precursor cells: 128.2"	"Cancer enhanced"	"Detected in many"		"glioma: 4.5"	"Group enriched"	"Detected in many"	5	"amygdala: 67.0;basal ganglia: 77.7;cerebral cortex: 96.8;hippocampal formation: 92.9;white matter: 44.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;HMC-1: 4.5;NTERA-2: 3.3;SCLC-21H: 2.7;SH-SY5Y: 11.1;SuSa: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037012, CAB079005"		Supported	Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB079005: , HPA037012: AB_2675431"	"unprognostic (1.62e-3)"	"unprognostic (1.60e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-4)"	"unprognostic (9.94e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.78e-2)"	7.0	3.1	67.0	0.4	77.7	0.1	7.1	3.8	96.8	1.4	0.0	2.3	0.4	2.0	1.0	0.3	1.2	0.4	1.0	92.9	2.9	1.5	0.0	1.1	0.0	13.4	0.0	1.5	0.5	4.1	3.4	2.8	10.8	0.5	0.5	7.8	2.4	0.2	0.9	2.5	1.6	1.8	0.0	0.6	1.8	3.6	15.3	0.1	0.2	0.4	0.0	0.3	1.3	44.9	0.0	0.2	0.0	0.0	1.8	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.2	0.0	0.0	0.0	0.0	0.2	2.7	11.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.0	77.7	3.8	96.8	92.9	2.9	13.4	0.0	10.8	0.0	15.3	44.9	43.4	0.0	0.0	7.8	0.0	0.0	0.4	0.0	0.6	13.9	0.4	2.4	1.4	0.0	0.0	0.0	6.2	1.7	0.1	0.0	0.0	0.0	0.6	0.2	0.1	4.5	0.0	0.0	338.3	0.0	0.4	0.9	0.0	0.3	0.0	0.2	0.7	0.0	0.6	13.5	543.3	0.0	0.0	1.8	0.0	1.8	0.0	0.3	0.0	4.7	0.1	2.5	0.0	128.2	8.3	0.3	0.0	0.0	0.0	0.3	0.0	2.7	0.0	3.7	0.0	0.7	0.7	4.9	6.9	0.0	0.0	0.8	0.1	0.1	0.0	0.2
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
SYT6		ENSG00000134207	"Synaptotagmin 6"	Q5T7P8	1	114089291-114153880	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 13.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.1;Early spermatids: 6.1;Excitatory neurons: 5.9;Late spermatids: 14.1;Microglial cells: 27.2;Oligodendrocyte precursor cells: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 22.0;WM-115: 15.2"	"Group enriched"	"Detected in all"	7	"basal ganglia: 31.2;olfactory bulb: 71.2"	"Low region specificity"	"Detected in many"			HPA058362			Approved	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA058362: "	"unprognostic (7.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	0.0	0.8	2.7	0.2	4.2	0.0	0.7	1.5	2.8	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.0	13.5	1.5	0.0	0.0	0.0	4.8	4.5	0.8	3.1	0.1	0.1	0.5	3.9	0.4	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.2	1.5	2.8	3.0	13.5	4.8	4.5	3.9	7.9	9.5	4.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	6.1	0.0	0.2	0.3	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	2.4	0.0	0.0	0.0	0.4	14.1	0.0	1.2	3.6	27.2	0.0	0.7	0.0	7.5	0.6	0.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.7	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.1	3.9	0.0	0.0
SYT7	"IPCA-7, MGC150517, PCANAP7, SYT-VII"	ENSG00000011347	"Synaptotagmin 7"	O43581	11	61513714-61581148	"Predicted intracellular proteins, Predicted membrane proteins"	Exocytosis	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;liver: 86.7;salivary gland: 57.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 45.2;Enteroendocrine cells: 49.8;Excitatory neurons: 82.1;Hepatocytes: 70.7;Prostatic glandular cells: 36.8;Syncytiotrophoblasts: 66.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 54.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 78.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.0;hTERT-HME1: 89.5;RT4: 37.8;SCLC-21H: 28.4;SK-BR-3: 40.7;T-47d: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012869	Enhanced					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA012869: AB_1857698"	"unprognostic (7.09e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (4.37e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.47e-1)"	3.8	4.3	17.7	1.2	33.8	0.1	9.2	0.0	78.4	3.1	0.0	5.0	2.3	2.6	1.8	3.5	3.4	1.2	19.0	30.7	1.9	24.7	86.7	1.9	0.3	0.0	1.9	1.3	16.7	5.7	51.6	18.4	0.0	50.8	5.3	8.0	57.0	0.9	3.6	4.2	5.2	1.8	0.0	2.1	3.7	4.0	13.9	0.4	8.0	1.8	0.3	1.9	3.3	38.5	13.4	1.9	0.5	0.2	1.0	14.1	10.4	0.2	35.0	0.6	0.5	3.5	6.9	0.0	0.6	0.2	1.3	6.9	0.9	0.2	0.2	0.2	1.7	0.0	1.7	2.1	0.9	0.1	0.1	0.4	7.8	4.2	89.5	0.2	0.2	0.8	0.1	0.2	0.5	21.6	0.1	0.3	2.4	24.8	14.1	0.0	0.7	1.7	0.0	37.8	28.4	5.2	1.9	40.7	0.3	5.6	39.8	0.0	0.0	8.6	3.1	10.1	0.2	0.0	0.0	0.1	0.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	33.8	0.0	78.4	30.7	1.9	0.0	1.9	0.0	0.0	13.9	38.5	10.6	0.0	0.5	4.2	0.2	0.3	0.4	5.1	0.0	22.6	23.2	16.3	22.3	1.5	5.0	5.5	0.0	45.2	0.6	1.9	5.9	1.2	8.4	0.3	4.3	4.9	49.8	2.7	82.1	1.6	3.4	3.0	0.0	0.5	0.0	5.9	4.6	70.7	4.0	21.9	17.8	30.2	6.1	1.0	0.0	7.6	3.4	0.1	1.8	7.5	0.0	0.6	0.0	6.0	2.5	1.0	4.6	2.2	0.0	36.8	3.5	0.1	1.3	3.5	0.0	2.8	1.4	0.8	3.9	0.9	0.1	66.4	0.2	0.6	2.4	1.7
SYT9		ENSG00000170743	"Synaptotagmin 9"	Q86SS6	11	7238778-7469043	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9;retina: 7.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.6;Late spermatids: 23.5;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 139.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEK 293: 10.3;RT4: 17.9;SH-SY5Y: 13.2;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.47e-1)"	"unprognostic (9.41e-2)"		"unprognostic (1.39e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.31e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.22e-4)"	0.0	2.0	9.1	0.0	9.2	0.0	0.8	11.7	5.9	0.4	1.4	0.1	0.0	1.2	0.0	0.0	0.1	0.1	0.3	4.7	7.6	2.0	3.6	0.0	0.0	9.9	11.8	0.1	1.3	0.9	1.5	0.0	9.6	1.0	0.0	7.6	0.0	3.6	0.0	0.1	0.1	0.1	8.1	0.0	0.1	0.9	15.9	0.0	1.1	0.0	0.0	0.2	0.3	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	17.9	3.2	13.2	0.0	0.0	0.0	0.4	0.0	0.0	20.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	9.2	11.7	5.9	4.7	7.6	9.9	11.8	9.6	8.1	15.9	11.7	0.0	0.0	0.0	48.6	0.5	0.0	0.1	0.0	0.0	13.6	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.9	0.0	0.2	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	3.3	9.8	0.0	0.0	0.3	0.0	23.5	0.0	0.0	0.0	5.6	0.0	2.0	0.0	55.3	139.2	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	3.5	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;pancreas: 106.3;skin 1: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;cerebellum: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	2.0	0.6	4.3	19.1	0.7	46.7	7.7	8.8	1.4	22.6	6.1	6.7	7.8	1.3	1.2	103.9	15.5	8.6	0.9	1.0	1.0	2.8	2.1	13.1	32.9	0.7	0.8	0.6	106.3	4.2	15.6	2.9	0.8	63.6	3.3	0.0	47.6	12.7	0.5	87.2	17.6	0.4	0.5	42.0	41.8	0.9	1.2	21.4	9.8	0.5	20.0	21.6	50.9	0.6	11.3	0.2	0.0	0.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	1.2	55.8	8.5	10.9	0.0	0.3	34.7	0.0	21.0	0.0	0.0	2.1	1.0	0.9	15.3	0.8	21.9	0.0	0.0	37.8	0.0	7.8	0.2	0.0	28.2	0.7	9.5	0.0	15.5	12.9	81.8	0.5	19.1	5.7	14.9	0.1	40.2	8.6	9.6	15.9	0.9	0.0	15.9	0.6	0.5	40.4	23.3	0.2	0.1	5.1	0.0	0.0	44.3	11.7	8.0	1.6	27.7	0.0	47.0	18.9	176.5	65.0	49.1	58.4	42.8	51.5	53.2	51.0	32.3	30.6	37.3	34.1	49.0	100.8	3.0	63.4	40.0	4.3	0.7	8.8	1.4	1.0	1.0	0.7	0.8	0.8	0.5	1.2	0.6	1.9	22.4	13.6	0.0	68.6	41.2	78.2	84.4	158.8	0.6	33.6	49.8	3.9	8.6	69.2	0.0	0.0	37.4	92.3	4.8	7.9	3.7	0.8	67.8	2.4	2.3	11.4	15.8	0.3	25.5	10.1	3.1	100.9	18.3	1.3	0.2	2.2	1.1	3.2	0.0	0.3	47.6	32.6	6.7	12.7	0.7	0.3	15.7	10.6	0.0	18.8	2.0	208.1	0.0	0.1	12.1	3.7	0.7	52.3	46.8	3.1	6.4	62.8	0.8	0.0	1.3	5.6	30.3	23.1	179.1	55.3	14.1	74.9	0.2	9.4	95.3
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600882-63608365	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 87.9;Proximal enterocytes: 81.2;Proximal tubular cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	12.8	18.6	16.6	8.2	17.4	8.3	10.9	18.9	18.4	8.8	17.7	17.8	18.9	11.1	9.7	13.4	9.3	5.5	42.3	16.5	17.5	30.1	69.2	7.7	10.4	17.4	17.4	8.3	12.0	18.2	9.5	8.3	17.3	9.5	16.1	9.4	11.4	9.2	61.5	11.3	16.7	9.7	16.9	11.5	15.1	12.1	17.6	9.9	9.4	55.9	12.2	11.8	9.2	16.7	39.6	61.2	19.4	20.2	16.5	23.5	25.7	28.5	26.8	56.2	44.4	40.5	23.2	32.6	21.2	33.1	38.9	35.8	43.0	41.5	52.6	17.3	58.1	32.0	29.8	72.3	45.5	38.3	21.7	29.0	28.6	48.5	51.1	20.9	29.6	24.2	44.4	24.1	26.6	71.6	44.7	28.7	16.8	42.5	62.9	28.1	47.7	40.8	33.2	27.6	29.5	32.4	19.6	64.0	55.3	25.3	53.3	29.1	26.4	39.9	29.9	27.5	50.7	25.9	27.2	38.7	30.4	26.0	29.6	2.2	9.4	9.0	9.8	8.5	10.7	7.5	13.7	9.7	10.6	9.9	12.4	10.3	1.4	17.8	7.4	7.0	10.2	9.4	16.6	17.4	18.9	18.4	16.5	17.5	17.4	17.4	17.3	16.9	17.6	16.7	9.8	3.2	6.3	2.6	12.0	2.5	8.0	21.1	8.6	8.2	7.8	10.9	54.0	17.2	11.5	14.7	2.1	32.1	8.2	32.9	54.8	29.1	15.3	8.0	11.4	14.2	13.8	17.4	4.0	27.4	28.9	14.1	16.8	6.4	9.5	16.2	8.6	87.9	26.3	6.7	3.9	21.7	12.2	10.7	3.9	46.0	11.8	9.2	10.6	2.8	22.0	15.5	14.4	1.5	3.2	30.0	25.8	11.3	10.7	11.6	81.2	109.7	9.1	13.4	19.7	10.7	14.6	26.8	13.9	18.6	4.3	19.8	10.1	40.7	32.8	7.1
TACR1	"NK1R, NKIR, SPR, TAC1R"	ENSG00000115353	"Tachykinin receptor 1"	P25103	2	75046463-75199520	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell type enriched"	"Detected in some"	7	"Inhibitory neurons: 83.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	23	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074573	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA074573: AB_2686701"	"unprognostic (5.74e-4)"	"unprognostic (2.41e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.91e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-2)"	6.2	0.3	1.7	0.7	3.6	0.0	5.0	0.0	7.2	4.9	0.0	1.0	0.2	3.0	0.7	1.2	2.9	1.1	0.1	0.6	3.7	0.7	0.0	0.8	1.3	2.2	4.3	0.6	0.1	0.2	0.1	0.5	10.0	1.5	0.5	1.0	1.5	1.0	0.3	4.0	0.7	2.7	0.8	0.0	0.5	0.0	2.5	1.1	0.5	0.3	1.3	2.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.6	0.0	7.2	0.6	3.7	2.2	4.3	10.0	0.8	2.5	0.9	7.6	0.0	0.0	1.0	0.0	2.5	0.0	0.0	0.0	1.0	0.3	0.3	1.4	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	11.8	0.0	0.0	4.5	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	83.2	0.2	0.0	0.0	2.6	0.9	0.0	0.0	7.2	2.8	0.0	0.4	0.0	3.5	4.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.3	0.0	0.2	0.2	0.0	0.0	0.1	1.8	0.1	0.1	0.0	0.0	0.2
TACR3	"NK3R, NKR, TAC3R"	ENSG00000169836	"Tachykinin receptor 3"	P29371	4	103586031-103719985	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.4;retina: 2.7;urinary bladder: 1.9"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 13.1;Excitatory neurons: 6.7;Extravillous trophoblasts: 4.5;Oligodendrocytes: 10.5;Skeletal myocytes: 11.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"BEWO: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA009418	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA009418: AB_1857727"	"unprognostic (3.81e-2)"				"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"		"unprognostic (3.50e-1)"		"unprognostic (3.21e-1)"				"unprognostic (5.52e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	0.0	0.0	2.7	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.0	0.1	0.0	1.4	1.5	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	1.9	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.1	0.4	0.3	2.4	1.4	1.5	8.4	1.7	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	6.7	0.0	4.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	1.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAF7L	"CT40, TAF2Q"	ENSG00000102387	"TATA-box binding protein associated factor 7 like"	Q5H9L4	X	101268253-101293057	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 31.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.1;Late spermatids: 15.8;Spermatocytes: 39.4;Spermatogonia: 25.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SiHa: 47.9"					"Low region specificity"	"Detected in many"			"HPA001879, HPA072008"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA001879: AB_1857751, HPA072008: "	"unprognostic (1.70e-2)"	"prognostic favorable (8.71e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.12e-2)"	0.1	0.0	1.2	0.1	0.8	0.3	0.1	0.0	1.3	1.6	1.7	0.5	0.1	0.5	2.4	0.1	0.1	0.0	0.1	1.4	0.2	0.5	1.1	0.0	0.0	0.0	0.4	0.1	0.1	3.9	0.3	0.3	0.0	0.7	0.1	0.1	0.1	1.7	0.1	0.9	0.1	0.1	0.0	0.0	0.1	31.6	0.5	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.2	1.0	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.2	0.9	0.0	0.2	0.3	0.2	2.2	0.1	0.4	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.7	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	47.9	0.3	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	1.3	1.4	0.2	0.0	0.4	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.3	26.1	1.2	5.5	0.2	0.0	0.0	2.9	0.0	0.2	0.2	0.0	0.4	0.0	0.5	0.4	2.1	0.1	0.0	2.4	0.1	0.0	0.3	0.2	15.8	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	39.4	25.2	0.0	0.1	1.6	0.1	0.6	0.1	0.1
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	5.0	2.8	1.0	28.9	1.1	146.6	3.9	1.3	2.1	3.4	3.0	5.9	4.4	9.5	2.3	4.1	2.0	6.9	1.6	1.2	3.4	1.3	4.1	8.4	39.6	2.7	2.0	2.2	0.9	0.7	0.8	3.4	2.1	2.8	8.2	1.5	3.0	1.8	0.7	1.2	10.2	26.0	2.2	22.8	7.2	1.6	2.2	24.3	1.6	2.3	47.6	10.0	1.2	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	6.2	0.0	0.0	0.0	15.6	42.5	0.3	0.0	0.0	0.0	0.0	0.0	9.0	0.1	43.8	0.0	0.0	4.0	8.2	12.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	1.2	0.0	6.9	0.2	0.0	0.0	0.0	0.0	4.7	20.6	39.6	0.0	33.4	0.0	163.6	27.8	88.4	54.8	20.4	62.6	45.9	73.9	64.6	27.9	46.6	56.9	40.8	169.7	45.6	27.6	9.3	57.5	60.9	1.0	1.1	1.3	2.1	1.2	3.4	2.7	2.0	2.1	2.2	2.2	4.2	5.2	3.2	6.6	0.0	249.5	2.8	0.3	0.2	3.4	0.3	4.4	6.0	0.6	0.0	1.4	0.0	0.0	0.7	152.3	0.2	0.0	0.1	0.3	0.5	0.4	5.2	0.0	8.8	1.2	0.0	0.6	4.3	16.8	0.5	19.0	1.8	1.4	0.8	24.9	0.0	1.0	0.0	0.0	21.9	60.2	1.1	1.2	91.1	28.4	20.6	21.5	0.4	86.5	1.5	0.0	0.0	0.0	22.6	272.1	0.3	0.0	0.3	1.2	0.2	0.0	0.8	2.0	0.1	0.1	2.0	2.7	0.8	223.6	4.6	0.4	0.3
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.5	2.5	4.9	1.0	4.5	29.4	6.3	4.7	4.4	2.9	3.0	2.1	0.8	2.9	0.6	1.8	3.5	2.3	5.9	4.6	4.6	4.4	1.5	13.0	1.4	6.5	7.1	1.2	0.9	0.9	1.7	6.9	6.8	2.1	1.3	0.2	1.1	0.8	2.1	1.7	3.1	2.7	6.9	7.1	1.8	0.9	6.4	0.4	5.4	2.5	0.7	2.4	2.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	4.9	4.5	4.7	4.4	4.6	4.6	6.5	7.1	6.8	6.9	6.4	6.8	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TAMALIN	GRASP	ENSG00000161835	"Trafficking regulator and scaffold protein tamalin"	Q7Z6J2	12	52006946-52015889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 243.8;B-cells: 60.6;dendritic cells: 114.1;Macrophages: 60.6;Plasma cells: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 37.4;TIME: 27.4;WM-115: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040664, HPA062028"	Approved		Approved	"Nuclear bodies,Vesicles"		No	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles	"Nuclear bodies"	"HPA040664: AB_10794066, HPA062028: AB_2684664"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.16e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.99e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.77e-2)"	31.9	6.3	9.8	4.1	14.9	23.8	26.9	3.2	21.5	17.6	0.4	9.4	2.2	22.0	1.6	7.1	22.2	9.6	24.2	10.5	3.7	12.2	4.2	46.8	3.8	5.0	4.9	14.9	5.7	2.8	6.2	8.9	4.8	13.0	1.9	0.1	6.5	3.1	10.6	10.7	9.8	6.0	4.1	18.2	8.6	2.6	7.6	3.7	16.3	8.4	2.3	12.5	17.1	7.1	0.0	0.0	4.4	0.2	1.9	3.6	1.0	0.2	1.1	0.0	1.1	0.0	0.0	0.0	10.0	0.0	0.4	0.1	1.3	0.0	0.4	0.2	1.3	0.3	0.0	6.2	7.4	0.3	3.3	7.2	0.0	0.3	0.0	0.0	37.4	1.0	1.6	0.0	0.9	0.2	3.1	10.5	4.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	1.1	1.6	0.0	0.2	7.5	2.7	0.0	0.3	27.4	0.0	2.5	0.2	0.0	0.2	0.0	0.1	0.6	0.0	50.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	9.8	14.9	3.2	21.5	10.5	3.7	5.0	4.9	4.8	4.1	7.6	7.1	243.8	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.2	114.1	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6"	"Group enriched"	"Detected in many"	4	"B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069743	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA069743: AB_2686186"	"prognostic favorable (3.83e-4)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favorable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	2.3	0.7	0.7	25.8	1.2	40.4	1.1	0.4	1.2	1.4	0.8	4.1	5.5	0.9	0.1	2.3	1.9	3.2	0.9	0.6	0.6	2.5	2.6	8.9	56.7	0.9	0.5	0.5	0.8	0.2	0.5	0.8	0.6	1.9	1.5	0.0	3.8	0.7	0.9	1.4	25.6	0.5	0.5	58.6	7.6	0.5	0.7	46.0	7.6	0.6	21.8	3.2	1.7	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.1	1.2	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.1	0.0	0.0	0.3	47.1	64.7	0.0	0.0	0.0	6.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.2	0.0	0.4	0.5	12.2	0.0	24.6	0.0	191.0	46.0	270.4	237.7	120.4	169.7	177.3	201.5	208.3	65.6	184.2	206.7	192.0	237.6	148.0	167.0	55.8	286.6	261.6	0.7	1.2	0.4	1.2	0.6	0.6	0.9	0.5	0.6	0.5	0.7	1.1	2.5	6.4	19.5	0.0	109.6	1.1	0.1	0.1	0.6	1.0	1.4	1.9	1.5	2.8	2.5	0.0	0.0	0.2	144.4	0.2	0.0	0.2	0.2	2.4	0.4	1.9	1.2	12.6	0.2	0.0	0.3	2.0	2.0	1.1	23.4	0.1	5.0	1.4	23.7	0.0	0.1	0.0	0.0	16.0	6.9	0.6	0.0	23.1	3.6	1.0	24.5	0.3	284.2	0.0	0.5	0.0	0.0	0.0	40.2	0.1	0.1	1.1	1.3	0.5	0.0	1.3	1.1	0.1	0.2	0.0	1.0	0.4	147.7	0.1	0.1	0.1
TBC1D15	"DKFZp761D0223, FLJ12085"	ENSG00000121749	"TBC1 domain family member 15"	Q8TC07	12	71839707-71927248	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013388, HPA015592"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA013388: AB_2199233, HPA015592: AB_1857789"	"unprognostic (3.87e-2)"	"prognostic favorable (7.06e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (5.34e-4)"	"unprognostic (5.73e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-1)"	28.4	25.9	9.9	15.7	13.2	42.2	25.4	11.8	17.0	21.0	8.4	15.5	15.5	21.3	13.0	16.3	15.1	21.6	15.3	9.4	11.1	22.6	30.6	21.4	22.5	13.2	12.4	22.3	23.8	23.0	14.3	23.4	13.2	17.8	14.9	14.1	22.6	13.0	43.4	18.1	17.8	18.3	11.3	21.8	17.2	18.5	10.5	24.9	27.9	25.5	19.8	17.8	14.9	18.5	21.0	20.3	17.1	18.4	35.2	38.8	25.6	20.8	58.5	30.6	39.7	13.9	18.4	26.9	14.0	21.6	21.9	13.7	22.3	15.7	32.6	23.1	18.0	23.5	17.0	12.3	29.9	33.1	17.1	35.0	20.5	23.1	39.3	39.7	26.9	25.7	27.9	16.0	25.4	15.3	24.9	25.3	37.4	19.2	17.4	17.9	19.1	29.3	23.3	18.6	18.9	17.3	29.5	25.9	26.2	23.7	26.5	23.1	25.3	23.9	10.6	26.5	14.4	38.1	36.1	35.5	14.3	22.6	21.8	2.6	5.7	7.8	6.1	5.5	6.8	4.3	7.5	5.8	5.1	4.2	9.5	8.6	11.7	5.7	8.1	2.8	10.8	5.4	9.9	13.2	11.8	17.0	9.4	11.1	13.2	12.4	13.2	11.3	10.5	18.5	83.4	48.1	69.3	42.4	34.7	58.6	33.6	23.8	25.6	33.7	30.2	25.5	24.8	24.3	38.5	18.4	10.4	20.4	43.1	18.3	13.7	29.3	160.8	38.1	40.4	53.3	13.8	27.8	60.3	25.5	15.5	44.5	17.3	82.0	34.1	30.8	79.2	35.6	24.0	52.2	57.7	22.0	20.3	54.2	41.8	26.7	34.8	46.0	32.0	35.6	27.5	29.9	16.5	45.2	85.7	25.1	11.0	32.7	33.9	39.9	21.5	39.8	49.8	25.6	19.7	58.2	35.7	76.9	24.5	18.1	68.5	38.3	39.2	38.8	15.0	37.1
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	17.9	17.4	13.7	17.0	21.1	25.2	18.6	18.2	15.5	20.1	6.0	13.5	10.8	17.6	12.1	16.8	22.5	19.2	15.8	13.8	16.1	19.9	14.7	18.0	23.1	21.9	17.7	28.1	18.3	25.7	8.5	17.5	22.8	14.0	13.9	10.9	14.1	16.4	9.3	14.0	13.8	18.3	18.3	24.0	13.8	18.9	16.0	20.3	30.0	11.3	23.2	14.8	10.1	29.9	26.3	28.8	23.2	22.0	45.0	65.5	25.4	27.6	39.7	17.7	15.3	14.0	23.2	48.5	29.1	56.3	27.1	8.0	20.6	33.6	36.6	43.0	7.9	46.6	11.1	16.5	28.8	45.7	39.0	42.6	39.3	38.5	23.2	39.8	40.9	28.3	29.6	43.6	43.5	17.6	22.5	10.5	19.1	16.8	30.0	48.9	29.6	34.7	26.3	20.0	8.8	41.0	52.5	12.2	18.6	21.7	34.6	37.6	44.7	48.7	21.6	25.6	30.4	25.2	36.6	46.7	37.5	42.3	46.5	11.7	8.1	11.9	5.8	6.5	7.5	10.3	4.4	4.2	9.2	11.3	3.2	3.8	10.4	4.3	6.3	5.8	5.2	4.8	13.7	21.1	18.2	15.5	13.8	16.1	21.9	17.7	22.8	18.3	16.0	29.9	40.4	16.0	35.0	226.6	56.0	18.4	20.0	15.8	42.7	20.3	23.0	19.9	18.6	25.8	27.8	14.7	10.4	17.1	28.9	9.2	5.9	17.7	64.1	19.6	28.9	30.7	13.1	31.3	333.2	9.9	16.7	32.5	20.4	28.2	18.9	31.5	34.6	19.9	21.4	35.3	350.5	13.4	10.2	35.6	22.9	40.2	30.7	34.9	14.2	324.2	23.2	26.6	32.0	341.8	565.6	12.3	9.1	30.5	20.7	9.8	13.7	15.9	16.3	22.3	6.6	34.0	20.4	20.7	25.5	28.4	17.0	8.2	30.0	35.5	14.5	17.6
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007228-101252866	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 30.1;non-classical monocyte: 38.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 38.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.9;ASC TERT1: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear speckles"		"CAB015211: , HPA037496: AB_2675507"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	17.3	6.3	4.7	8.9	4.4	12.7	21.8	8.7	5.0	14.4	8.3	9.0	7.1	10.6	7.8	15.4	19.9	18.1	38.6	5.1	6.3	17.0	24.8	23.2	7.2	6.8	5.3	8.4	34.3	17.5	13.0	3.1	6.7	44.0	6.0	6.5	19.0	30.3	83.7	28.1	28.7	6.9	4.3	14.5	27.2	18.1	5.9	6.4	9.6	79.7	6.8	13.1	17.5	4.1	5.1	30.1	2.6	8.6	82.9	57.8	24.4	3.1	51.8	2.1	2.6	10.8	8.0	2.6	27.1	2.3	42.5	15.5	5.0	23.5	1.4	1.5	4.6	1.5	11.1	37.7	5.7	0.3	26.0	27.4	21.8	2.8	21.6	1.7	30.2	4.5	0.7	2.6	2.7	13.3	2.8	15.8	6.7	3.6	32.3	6.4	7.5	0.6	17.0	32.3	18.7	9.2	4.2	7.4	10.8	4.0	2.1	23.1	26.0	1.3	4.5	4.4	2.1	5.0	0.4	0.2	10.9	7.7	8.0	0.0	9.7	0.4	0.2	30.1	0.3	0.4	0.3	0.2	5.0	1.5	0.6	0.4	0.3	0.0	38.2	7.2	0.2	4.1	4.7	4.4	8.7	5.0	5.1	6.3	6.8	5.3	6.7	4.3	5.9	4.1	4.3	3.2	4.6	10.7	2.8	4.1	38.3	7.2	23.9	6.4	15.0	3.9	12.2	18.6	14.4	5.5	4.2	4.6	4.8	1.1	0.0	8.2	6.0	42.6	4.7	9.8	3.0	0.8	43.5	3.0	2.8	4.3	31.6	23.7	7.0	0.9	11.7	5.6	3.7	1.7	42.8	2.2	10.2	13.8	17.7	10.9	3.1	27.7	5.4	22.5	28.1	1.0	0.0	23.6	6.5	2.6	2.4	1.9	1.4	35.0	4.8	1.2	31.9	3.7	6.6	24.7	4.3	3.6	4.0	29.8	6.3	3.4	1.6	2.7	1.1	29.7
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.3"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	10.3	2.0	1.6	0.9	3.1	0.0	6.1	1.1	3.4	1.9	4.6	0.7	0.1	1.4	0.4	3.1	1.8	1.5	6.6	1.3	1.3	0.4	0.2	0.3	1.8	1.7	1.2	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.7	1.1	0.5	1.5	0.0	0.4	1.0	2.1	0.6	1.7	1.4	0.2	4.5	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.1	3.4	1.3	1.3	1.7	1.2	1.6	1.5	2.1	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box transcription factor 21"	Q9UL17	17	47733236-47746122	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.1;lung: 3.3;lymphoid tissue: 11.7"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 92.8;NK-cells: 119.4;Plasma cells: 22.8;T-cells: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 15.7;NK-cell: 14.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 14.3;T-cells: 15.7"	"Cell line enriched"	"Detected in single"	113	"HDLM-2: 16.3"	"Region enriched"	"Detected in single"	27	"olfactory bulb: 22.1"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.2"	"CAB009524, CAB030043"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB009524: AB_2200557, CAB030043: AB_1595503"	"unprognostic (3.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.35e-6)"	"unprognostic (3.93e-1)"	"unprognostic (2.56e-4)"	"unprognostic (5.86e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.26e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.04e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (4.43e-3)"	0.9	0.4	0.3	1.9	0.3	11.1	0.4	0.3	0.3	0.4	0.4	0.5	0.9	0.3	0.4	0.3	0.4	0.8	0.3	0.2	0.3	0.5	1.2	3.3	7.5	0.4	0.3	0.2	0.2	0.0	0.2	0.2	0.3	0.4	0.5	0.0	0.6	0.2	0.5	0.2	1.6	0.4	0.3	11.7	1.2	0.4	0.3	1.0	0.7	0.2	2.2	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	3.6	2.0	3.1	8.9	0.0	0.5	0.4	7.8	0.2	14.3	0.0	0.1	0.1	2.4	0.3	0.3	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.3	0.3	0.3	1.1	0.0	0.6	0.0	7.6	0.0	0.0	0.0	0.6	0.0	0.6	0.9	1.3	1.5	0.0	0.0	0.0	0.1	92.8	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.3	0.1	0.0	0.0	0.2	1.1	0.2	2.5	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	1.9	0.0	1.9	0.8	0.0	119.4	0.0	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.1	0.0	45.6	0.0	0.0	0.0
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.2;Hepatocytes: 12.3;Syncytiotrophoblasts: 15.7;T-cells: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.6;HUVEC TERT2: 11.6;TIME: 18.5;U-87 MG: 13.8"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	2.1	1.9	1.5	4.0	1.5	4.1	5.8	4.6	3.4	4.0	0.0	1.2	1.0	1.7	0.8	9.2	1.9	2.2	1.2	1.5	1.9	2.6	4.5	3.7	4.2	2.2	2.5	2.6	2.0	2.1	2.6	5.2	2.5	2.8	1.1	3.2	3.7	1.2	0.7	4.3	2.4	1.5	0.7	2.8	2.0	1.6	1.7	3.3	1.3	0.7	3.4	2.8	5.9	3.2	5.5	0.3	0.1	0.2	1.0	1.0	2.0	1.5	3.1	0.7	2.2	0.1	0.3	0.2	2.1	1.3	0.5	0.8	0.1	3.0	2.3	10.6	0.5	0.8	0.6	0.1	1.2	0.3	0.4	2.9	1.3	0.3	0.9	2.1	11.6	0.7	3.0	5.1	4.3	0.8	0.6	0.8	0.2	5.0	2.7	0.4	2.1	2.4	0.0	1.9	0.1	0.1	0.5	4.3	0.2	0.8	1.9	0.2	18.5	1.3	0.9	5.5	0.4	7.7	2.6	0.1	13.8	0.4	3.2	5.7	0.2	0.2	2.9	0.2	3.1	1.9	4.8	3.1	0.2	1.8	4.2	3.3	0.9	2.2	0.2	0.7	5.6	1.2	1.5	1.5	4.6	3.4	1.5	1.9	2.2	2.5	2.5	0.7	1.7	3.2	0.5	0.0	1.8	0.0	4.5	0.0	1.3	0.0	3.4	0.7	5.6	3.4	0.4	0.0	1.8	0.0	0.0	16.2	5.6	0.2	0.0	0.9	1.0	0.8	1.4	3.5	0.0	0.4	3.7	0.4	4.9	2.4	2.6	1.3	2.5	0.3	0.7	12.3	2.0	0.0	3.6	0.2	0.0	1.6	0.0	1.1	1.8	1.8	0.0	0.0	0.4	2.1	7.2	1.5	0.1	1.3	0.1	0.7	5.0	2.1	2.1	0.4	0.0	0.1	0.0	2.3	1.1	3.5	2.0	4.9	0.0	15.7	9.1	0.8	0.4	1.1
TCEAL6	WEX2	ENSG00000204071	"Transcription elongation factor A like 6"	Q6IPX3	X	102140476-102142970	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 73.4;testis: 26.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.4;Excitatory neurons: 9.1;Horizontal cells: 15.2;Inhibitory neurons: 10.4;Late spermatids: 6.7"	"Cancer enriched"	"Detected in single"	9	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045564, HPA058982"	Supported		Uncertain	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (5.43e-2)"			"unprognostic (6.54e-2)"	"unprognostic (1.87e-3)"			"unprognostic (6.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.18e-1)"		1.6	10.7	27.3	0.2	24.3	0.0	0.6	23.1	41.4	1.5	3.6	1.7	0.2	3.6	1.4	0.0	5.7	0.1	0.5	23.8	35.4	1.0	0.0	0.1	0.0	27.3	32.9	8.5	0.4	1.8	73.4	0.0	26.3	0.8	0.2	16.7	1.8	0.6	0.0	0.3	0.7	0.7	19.2	0.0	0.8	26.8	26.0	0.0	0.5	0.2	0.0	0.0	1.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	27.3	24.3	23.1	41.4	23.8	35.4	27.3	32.9	26.3	19.2	26.0	22.5	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	40.4	0.0	0.1	4.6	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.0	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	15.2	10.4	0.0	0.0	0.0	0.3	6.7	2.5	0.1	1.8	1.0	0.0	1.9	0.0	4.5	1.7	0.4	0.0	0.7	0.0	0.5	0.0	0.0	0.0	4.3	0.0	1.4	0.9	1.9	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.1
TCF15	"bHLHa40, EC2, PARAXIS"	ENSG00000125878	"Transcription factor 15"	Q12870	20	603797-610398	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 27.8;skeletal muscle: 13.2;tongue: 9.1"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 260.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 10.6;HMC-1: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050998, HPA060221"	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"		"HPA050998: AB_2681302, HPA060221: AB_2684225"	"unprognostic (2.12e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.11e-1)"	"unprognostic (6.99e-2)"	7.0	0.6	1.3	0.1	1.2	0.0	4.6	1.2	1.4	0.2	0.9	1.6	0.1	0.8	0.0	0.3	0.4	0.1	27.8	1.1	1.2	1.5	0.2	0.6	0.1	1.3	1.3	0.2	0.3	0.1	0.4	3.3	1.4	0.3	0.0	0.0	0.6	0.0	13.2	0.2	0.5	0.2	1.3	0.0	0.6	2.0	1.3	0.0	0.5	9.1	0.0	0.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.9	10.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.5	0.0	1.3	0.0	3.0	0.0	1.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.2	1.4	1.1	1.2	1.3	1.3	1.4	1.3	1.3	1.2	260.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.5	0.6	1.0	15.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.2	0.2	41.2	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.6	0.0	0.1	7.1	0.0	0.1	1.7	0.5	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	2.8	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.1	3.7	23.3	2.3	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.0
TCF4	"bHLHb19, E2-2, ITF2, SEF2-1B"	ENSG00000196628	"Transcription factor 4"	P15884	18	55222185-55664787	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Disease variant, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 820.0;Endothelial cells: 574.5;Inhibitory neurons: 1177.6;Oligodendrocyte precursor cells: 719.8;Oligodendrocytes: 573.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.1"	"Group enriched"	"Detected in many"	14	"memory B-cell: 173.6;naive B-cell: 146.8;plasmacytoid DC: 559.8"	"Group enriched"	"Detected in many"	33	"B-cells: 173.6;dendritic cells: 559.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 140.4;SH-SY5Y: 157.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020722, HPA025958"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"		"CAB020722: , HPA025958: AB_1857849"	"unprognostic (2.11e-1)"	"unprognostic (9.10e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.03e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (1.99e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.76e-3)"	"prognostic unfavorable (9.95e-4)"	20.3	9.6	3.7	12.8	12.5	9.5	11.6	65.1	26.5	28.5	0.0	7.4	5.1	23.0	2.1	9.7	13.4	17.4	17.5	29.8	0.0	4.4	4.4	15.5	14.7	5.5	1.0	25.9	5.8	8.0	6.5	28.9	3.9	6.6	7.9	14.0	6.8	10.2	6.1	6.4	5.0	24.1	2.2	13.1	6.0	15.4	2.4	9.8	13.3	16.7	14.7	13.1	7.3	14.4	0.1	4.1	36.8	11.4	8.5	14.4	0.1	18.4	40.6	13.2	17.2	23.1	3.6	28.8	0.1	41.9	2.7	4.5	17.9	17.1	9.2	140.4	13.9	12.1	0.1	0.0	4.0	5.3	2.8	19.6	5.3	18.5	0.7	9.1	45.8	1.6	19.5	22.0	11.0	0.0	7.6	0.0	10.4	0.1	2.4	41.6	14.9	65.4	0.0	0.9	12.6	157.7	0.0	1.5	0.0	11.1	1.6	1.3	49.1	48.5	17.4	2.1	14.6	16.3	32.2	25.7	11.0	5.2	15.5	0.9	7.4	0.8	0.9	8.3	0.7	173.6	0.2	0.5	20.6	146.8	0.5	0.3	1.8	11.2	7.4	559.8	0.7	11.3	3.7	12.5	65.1	26.5	29.8	0.0	5.5	1.0	3.9	2.2	2.4	14.4	820.0	6.4	13.1	501.1	217.4	117.0	37.8	34.0	80.8	293.0	6.5	23.4	35.5	4.3	32.6	22.0	83.4	1.8	446.8	0.1	0.0	1.5	103.2	17.5	201.4	574.5	5.4	34.2	503.8	7.1	1.5	296.7	1.5	12.2	13.9	105.7	316.3	6.6	39.6	25.2	1177.6	0.3	26.4	112.4	129.2	116.3	205.3	80.4	64.0	474.1	32.7	372.8	13.4	719.8	573.6	2.1	0.1	182.1	131.7	20.8	0.0	2.3	25.9	54.7	236.7	304.5	221.0	8.7	14.5	47.5	84.4	2.6	15.1	164.8	0.2	17.8
TCL1B	TML1	ENSG00000213231	"TCL1 family AKT coactivator B"	O95988	14	95686426-95692628	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;lymphoid tissue: 2.5;testis: 2.5"	"Cell type enriched"	"Detected in some"	8	"Syncytiotrophoblasts: 72.7"	"Cancer enriched"	"Detected in single"	72	"testis cancer: 8.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	24	"naive B-cell: 11.7;plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	24	"B-cells: 11.7;dendritic cells: 6.2"	"Cell line enriched"	"Detected in some"	7	"U-698: 511.8"					"Not detected"	"Not detected"			HPA053163	Uncertain		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA053163: AB_2682064"															"unprognostic (1.55e-1)"			0.1	0.0	0.1	0.4	0.7	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	2.2	0.6	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	2.5	0.4	0.2	0.0	0.0	2.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	73.5	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	2.5	0.6	0.4	0.0	0.0	1.3	0.0	0.2	0.2	0.4	511.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.3	0.3	0.0	6.2	0.0	0.3	0.1	0.7	0.1	0.2	0.1	0.2	0.6	0.4	0.5	0.1	0.4	1.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.1	9.0	0.0	0.0	72.7	0.0	0.1	0.0	0.1
TCN2	"D22S676, D22S750, TC2"	ENSG00000185339	"Transcobalamin 2"	P20062	22	30607003-30627271	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.0;Hepatic stellate cells: 137.4;Kupffer cells: 144.1;Proximal enterocytes: 563.6;Proximal tubular cells: 125.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 43.8;intermediate monocyte: 66.5;non-classical monocyte: 24.4"	"Lineage enriched"	"Detected in many"	8	"monocytes: 66.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 117.6;HUVEC TERT2: 142.6;Karpas-707: 184.0;RPTEC TERT1: 70.7;TIME: 85.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000837			Approved	Cytosol	"Secreted to blood"	NA	NA		19000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA000837: AB_1080235"	"unprognostic (6.43e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (1.53e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.95e-3)"	"unprognostic (4.94e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.50e-1)"	49.6	30.6	24.6	16.0	24.1	5.5	37.9	25.5	30.6	25.9	27.1	23.4	23.6	28.7	20.3	8.6	21.5	50.1	28.7	22.7	25.3	115.8	17.3	37.7	35.3	27.1	26.1	14.8	12.1	8.6	15.1	18.6	27.7	16.0	27.8	11.1	13.2	45.4	6.0	9.0	59.5	36.8	25.5	46.7	17.4	21.9	29.7	6.4	26.4	13.7	10.0	22.0	14.7	25.3	0.2	9.5	41.8	0.2	24.6	117.6	1.4	3.1	30.9	8.0	13.1	4.6	21.2	0.6	45.7	6.2	0.7	1.5	3.7	2.2	2.5	0.0	2.3	0.2	1.2	2.0	58.5	0.6	33.7	19.8	2.5	6.1	5.1	8.8	142.6	0.0	0.8	184.0	12.7	0.1	0.1	3.3	16.4	11.7	1.0	4.9	6.0	64.2	70.7	1.1	14.4	1.9	0.3	0.6	12.0	2.8	0.4	2.0	85.3	26.4	3.5	3.3	1.3	5.1	1.4	0.2	9.5	1.7	0.6	0.0	43.8	0.0	0.1	66.5	0.7	0.0	0.8	0.4	7.9	0.0	0.3	0.6	1.4	0.0	24.4	1.5	0.2	18.8	24.6	24.1	25.5	30.6	22.7	25.3	27.1	26.1	27.7	25.5	29.7	25.3	105.0	3.2	3.9	3.9	3.7	5.2	2.2	4.7	0.6	8.0	7.1	5.1	6.5	27.1	13.7	12.9	20.9	0.4	0.5	70.9	7.9	7.8	1.1	3.5	5.4	64.6	6.7	0.8	0.2	6.0	0.8	19.5	5.1	6.2	4.5	23.4	137.4	5.6	45.9	1.7	1.9	28.6	4.1	144.1	9.4	1.4	10.5	53.8	23.2	8.4	8.8	7.4	0.0	5.5	1.7	5.1	50.2	9.8	13.5	2.0	563.6	125.8	2.8	29.1	13.1	0.9	5.5	1.0	12.6	0.5	5.3	0.4	2.2	5.6	21.0	2.7
TCTEX1D1	FLJ40873	ENSG00000152760	"Tctex1 domain containing 1"	Q8N7M0	1	66752459-66779047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.9;liver: 7.1"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 55.7;granulocytes: 25.9;Inhibitory neurons: 21.6;Respiratory ciliated cells: 104.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 14.6;HUVEC TERT2: 13.4;THP-1: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028420	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028420: AB_10603995"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.72e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.53e-6)"	"unprognostic (9.28e-4)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.65e-2)"	1.1	0.3	2.5	0.4	2.2	4.4	1.0	2.8	2.2	1.1	6.6	0.8	0.2	0.4	0.1	0.3	8.9	0.3	3.0	2.3	2.7	3.3	7.1	2.5	0.0	6.3	5.5	0.0	0.2	0.0	0.7	5.7	5.0	0.6	0.3	0.9	0.5	0.6	0.7	0.5	0.5	0.4	4.6	0.2	0.4	0.0	3.5	0.1	0.5	0.2	0.1	0.7	0.7	4.9	0.0	0.0	0.2	0.0	0.2	2.3	0.0	0.3	0.7	0.3	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	13.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.2	2.8	2.2	2.3	2.7	6.3	5.5	5.0	4.6	3.5	4.9	7.5	0.0	3.2	2.9	0.3	1.3	0.0	4.5	0.0	0.3	0.1	0.0	0.6	0.0	11.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	55.7	0.5	12.5	0.0	0.8	13.2	0.0	0.0	0.5	0.0	0.5	25.9	0.0	0.7	3.5	2.7	0.0	21.6	0.0	0.0	0.6	0.8	0.1	0.0	3.0	0.0	1.9	0.3	6.1	0.0	0.5	0.5	0.0	0.0	0.4	1.2	0.5	0.0	0.0	104.2	0.6	0.0	0.4	1.3	0.0	0.1	0.0	0.6	0.0	3.1	0.1	0.0	0.1
TEAD2	"ETF, TEF-4, TEF4"	ENSG00000074219	"TEA domain transcription factor 2"	Q15562	19	49340595-49362457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 51.1;Early spermatids: 76.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"memory B-cell: 1.7;naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	27	"B-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"AF22: 135.3;AN3-CA: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066292, HPA069963"			Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA066292: AB_2685651, HPA069963: AB_2686222"	"unprognostic (2.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	32.8	17.8	7.5	15.4	7.1	0.2	31.6	6.6	7.9	41.8	16.2	50.4	7.6	39.6	12.4	11.0	34.2	15.5	55.5	7.5	6.8	34.5	11.9	35.7	9.0	8.7	8.3	33.5	26.8	19.4	9.2	17.7	7.7	26.5	11.2	3.4	18.5	22.7	12.9	10.7	18.5	38.4	7.6	14.8	31.3	26.6	8.3	3.1	16.9	22.1	7.3	27.2	24.4	6.6	12.5	28.6	135.3	147.6	14.2	20.8	24.3	22.8	23.9	25.6	29.7	2.3	6.8	1.2	29.6	38.5	13.1	13.9	37.5	7.7	14.1	0.1	17.5	0.0	27.2	19.3	24.6	0.1	0.3	24.8	17.8	17.4	8.4	50.6	92.1	0.1	22.0	0.0	36.1	15.3	0.0	0.2	45.4	35.2	36.2	0.0	40.8	0.2	23.3	0.2	0.2	82.0	38.1	5.6	10.1	46.1	40.5	3.5	55.0	45.9	28.1	9.9	1.8	0.1	0.1	4.8	1.7	0.6	18.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	7.1	6.6	7.9	7.5	6.8	8.7	8.3	7.7	7.6	8.3	6.6	26.1	3.2	3.2	0.0	3.8	3.3	6.9	5.9	8.6	0.4	21.1	9.5	1.0	8.6	3.4	12.9	0.0	0.6	0.4	1.3	1.9	51.1	76.6	7.3	20.7	29.5	7.1	3.2	0.1	26.2	23.7	15.0	9.7	6.5	0.0	14.7	21.4	2.8	0.6	0.0	0.1	6.6	8.2	0.9	3.6	29.6	15.2	0.7	5.4	1.9	0.0	15.9	0.0	0.0	0.1	22.7	4.9	22.2	0.1	7.2	0.1	0.2	1.2	0.4	32.9	7.6	28.7	2.1	2.4	2.0	1.6	1.2	0.5	4.4	6.8	2.8
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
TENM2	"KIAA1127, ODZ2, Ten-M2, TEN2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 9.8;heart muscle: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 512.9;Excitatory neurons: 706.2;Inhibitory neurons: 965.9"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 66.1;HBEC3-KT: 43.0;HDLM-2: 43.3;U-138 MG: 74.6;U-2 OS: 64.0;U-251 MG: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli		No	No		11000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019"	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavorable (7.52e-4)"	0.1	0.5	2.9	0.0	4.7	0.0	1.9	0.0	9.8	1.3	0.0	0.2	0.4	0.0	0.5	1.9	0.1	0.4	35.1	6.0	1.2	0.8	1.3	0.2	0.0	0.6	0.1	0.7	0.1	0.0	0.7	0.0	1.6	2.2	0.1	4.1	0.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.1	1.3	4.3	2.2	0.4	0.5	1.0	0.1	2.0	0.0	0.1	0.0	13.4	0.0	0.0	0.4	0.0	1.9	0.0	0.7	1.8	0.0	0.0	0.0	0.0	66.1	1.7	0.0	0.0	43.0	0.8	43.3	0.0	0.0	0.2	0.0	2.0	0.0	0.0	3.0	7.4	0.3	5.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	9.8	0.2	0.0	0.0	6.6	0.0	0.1	0.0	0.1	2.4	3.8	0.1	0.0	74.6	64.0	0.1	50.0	0.0	0.0	0.0	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.7	0.0	9.8	6.0	1.2	0.6	0.1	1.6	0.0	4.3	0.0	0.5	0.0	0.0	512.9	0.0	14.8	1.1	20.3	33.6	15.5	0.3	13.0	144.0	0.0	1.4	0.0	18.8	0.0	0.0	1.0	0.0	3.4	23.5	0.1	0.3	1.7	0.0	0.0	706.2	0.2	0.0	2.2	0.0	0.2	1.3	1.6	0.4	5.1	0.1	121.1	965.9	0.7	0.0	0.0	1.2	18.2	4.4	0.2	1.8	36.5	0.0	2.3	0.0	21.6	12.8	0.0	0.0	61.7	0.0	1.4	0.3	0.0	0.6	1.8	0.0	0.4	1.5	1.2	1.1	1.4	1.7	0.0	0.1	0.0	0.4	0.1
TESPA1	"ITPRID3, KIAA0748"	ENSG00000135426	"Thymocyte expressed, positive selection associated 1"	A2RU30	12	54948015-54984762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.3;lymphoid tissue: 75.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 202.7;granulocytes: 120.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HEL: 247.1;HMC-1: 187.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058823, HPA079222"	Approved		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058823: AB_2683828, HPA079222: "	"unprognostic (1.98e-5)"	"unprognostic (3.70e-4)"	"unprognostic (3.87e-4)"	"unprognostic (1.13e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.55e-4)"	"unprognostic (2.29e-3)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-4)"	"unprognostic (1.35e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	1.3	0.5	19.6	13.9	37.6	14.5	1.7	12.0	81.3	1.9	11.9	3.7	3.0	2.3	4.8	1.9	1.3	4.8	1.0	36.6	13.2	0.8	0.9	5.8	36.4	11.6	12.2	6.9	0.9	0.7	0.6	0.5	12.1	1.5	4.8	1.0	1.4	1.1	1.4	1.0	7.5	2.1	11.4	13.5	3.9	0.9	16.1	75.2	1.1	0.6	36.4	4.0	1.1	44.2	0.2	0.4	0.6	0.4	0.7	0.7	3.2	0.0	0.7	0.2	0.3	0.0	0.4	17.5	0.2	0.7	0.6	0.4	0.7	0.4	0.3	20.0	0.6	247.1	0.8	0.3	0.6	13.6	187.7	0.5	0.4	0.4	0.7	0.5	0.0	41.5	1.0	16.3	0.4	0.4	39.1	1.5	0.5	0.2	0.2	9.3	0.3	2.7	0.6	0.9	0.5	0.2	0.6	0.1	0.5	0.7	0.2	3.6	0.3	0.4	0.4	0.2	0.2	11.1	0.4	12.0	1.7	4.0	0.4	43.1	1.4	1.6	38.3	1.3	43.5	17.9	126.0	57.5	16.0	15.0	175.8	98.8	3.1	57.2	1.5	5.6	92.6	64.5	19.6	37.6	12.0	81.3	36.6	13.2	11.6	12.2	12.1	11.4	16.1	44.2	0.7	0.0	4.3	10.1	9.9	0.5	0.0	0.0	0.0	0.0	0.2	0.3	1.5	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	32.4	202.7	0.0	0.0	1.3	0.0	0.1	120.1	0.0	0.4	0.5	0.1	0.0	2.5	0.0	0.0	1.3	1.6	0.0	0.9	4.6	1.8	2.8	3.3	0.0	25.7	7.1	5.1	0.0	0.0	1.2	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.3	0.0	37.0	0.8	0.1	0.0
TEX51		ENSG00000237524	"Testis expressed 51"	A0A1B0GUA7	2	126898864-126902097	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	183	"testis: 59.9"	"Cell type enriched"	"Detected in single"	11	"Proximal tubular cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX55	"C3orf30, FLJ32859, TSCPA"	ENSG00000163424	"Testis expressed 55"	Q96M34	3	119146151-119160042	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	168	"testis: 53.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA062468, HPA068480"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Vesicles		"HPA062468: AB_2684772, HPA068480: "				"unprognostic (4.06e-3)"				"unprognostic (3.67e-2)"									"unprognostic (2.66e-1)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847619	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 33.3;retina: 14.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in many"	6	"cerebellum: 3.5;medulla oblongata: 3.9;midbrain: 9.0;pons: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 109.6;SH-SY5Y: 208.1"	"Region enhanced"	"Detected in many"		"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.1	3.4	0.0	0.0	0.0	0.0	8.2	3.5	0.1	0.1	0.0	0.1	0.0	0.0	33.3	3.9	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	3.9	9.0	0.0	0.0	0.0	0.6	0.2	10.2	0.0	0.0	14.8	6.4	0.7	0.0	8.6	0.0	0.0	0.6	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	109.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	35.5	0.1	0.2	208.1	0.0	0.8	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.1	3.9	9.0	10.2	0.6	1.1	0.2	0.2	0.0	0.0	0.0	0.0	11.7	0.0	0.0	145.7	76.4	43.0	29.7	0.9	0.0	0.0	51.5	8.4	14.9	0.1	0.0	54.8	0.0	17.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	437.4	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.5	106.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.7	0.0	11.8	0.0	0.0	0.3	1.9	0.6	31.1	4.3	4.9	0.2	0.0	0.0	0.0
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.2;kidney: 20.5;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	29	"B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	3.5	2.4	1.3	19.2	1.2	17.2	2.6	1.5	1.6	1.9	2.1	2.7	4.2	1.4	0.6	1.0	1.0	4.9	1.0	0.8	1.7	20.5	3.1	9.9	22.1	3.3	1.9	1.3	1.0	0.4	0.6	4.7	2.7	1.0	4.2	0.1	1.3	0.9	0.3	0.4	9.7	3.1	2.7	14.6	3.0	1.6	3.7	2.8	0.9	0.4	12.6	4.0	0.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	1.7	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	21.5	12.5	2.1	0.2	1.3	0.0	5.5	0.0	0.0	0.1	24.4	1.1	0.0	7.1	0.0	0.0	2.8	0.0	3.8	0.0	0.0	6.3	2.5	0.0	0.0	0.1	0.0	0.4	3.3	0.0	1.5	1.3	1.2	1.5	1.6	0.8	1.7	3.3	1.9	2.7	2.7	3.7	4.8	0.5	0.0	2.2	0.3	18.1	0.5	0.0	0.0	0.0	0.0	0.3	0.8	0.8	1.5	0.0	3.7	0.0	0.2	8.3	0.0	0.0	0.0	2.4	0.0	0.0	1.7	0.0	7.2	0.6	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	45.5	0.0	0.5	0.4	0.0	56.3	17.8	3.8	0.0	61.6	0.0	60.0	44.1	0.0	1.0	1.0	0.1	0.1	0.0	0.0	1.3	0.1	15.6	77.8	0.0	0.0	0.0	0.3	0.1	0.3	2.5	0.1	0.4	0.8	0.8	0.1	0.7	0.1
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606601-30694142	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 391.5;Endothelial cells: 236.4;Hepatic stellate cells: 478.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.6;ASC TERT1: 472.3;HSkMC: 430.0;LHCN-M2: 381.7;TIME: 418.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	230.0	56.1	16.5	73.8	12.9	29.4	145.7	13.8	19.3	90.0	30.6	96.0	44.2	69.1	18.2	44.9	69.6	91.9	95.2	10.6	13.4	67.9	59.1	148.0	70.1	17.6	16.5	26.6	52.0	59.0	16.9	81.6	16.7	44.1	54.1	2.1	49.2	60.8	31.1	39.1	77.7	107.2	17.3	111.1	63.4	7.8	21.5	49.7	91.8	62.2	60.7	98.0	55.1	17.2	16.6	100.2	5.3	0.1	313.6	472.3	15.9	83.9	116.1	28.5	27.7	22.9	86.6	2.2	298.2	117.2	32.2	33.3	4.0	125.4	42.0	7.0	8.9	10.1	10.7	104.5	128.5	14.9	76.6	430.0	93.6	126.3	114.4	117.0	296.0	10.9	1.8	0.0	381.7	1.3	16.2	10.5	2.2	75.7	39.8	14.1	36.4	2.1	113.5	40.5	0.1	5.6	24.9	6.1	22.0	6.6	0.0	14.0	418.6	134.7	33.2	61.4	32.0	2.8	0.3	12.5	80.1	16.1	55.8	9.0	3.0	11.5	3.4	3.1	3.3	4.5	4.8	3.3	2.6	6.4	16.6	7.3	13.1	1.9	8.0	6.6	0.7	3.8	16.5	12.9	13.8	19.3	10.6	13.4	17.6	16.5	16.7	17.3	21.5	17.2	391.5	144.2	99.7	0.7	77.0	37.3	18.9	23.5	39.9	5.1	23.7	24.1	84.5	50.1	39.5	27.6	0.0	6.8	85.3	10.5	3.9	13.1	2.5	28.3	57.5	236.4	8.4	20.4	0.4	15.8	5.1	129.2	39.3	30.8	29.8	0.7	478.0	55.5	30.4	0.0	1.0	12.4	22.4	147.0	58.0	3.8	32.9	67.9	30.2	170.5	47.5	0.2	56.7	6.0	2.4	37.6	12.1	47.4	37.5	8.6	13.6	7.2	14.7	1.2	32.9	60.8	53.4	0.3	1.2	8.0	30.5	3.7	68.2	1.7	14.5	10.8
TGFBR3L		ENSG00000260001	"Transforming growth factor beta receptor 3 like"	H3BV60	19	7914830-7919097	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"pituitary gland: 106.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.3;Late spermatids: 8.6;Plasma cells: 9.2;Proximal tubular cells: 8.9;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;REH: 4.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA074356	Enhanced		Approved	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA074356: AB_2686681"	"unprognostic (1.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.63e-1)"	"unprognostic (7.65e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.62e-3)"	0.0	0.3	0.3	0.1	0.2	0.3	0.0	1.2	1.0	1.1	0.0	0.3	2.0	1.3	0.1	0.0	0.9	0.1	0.8	0.4	0.2	0.8	1.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	106.0	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.1	0.2	1.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.0	0.2	0.2	0.4	0.1	0.0	2.4	0.7	0.0	0.0	0.0	0.4	0.1	0.2	0.8	0.0	0.0	0.8	0.1	0.0	0.0	1.5	0.5	0.2	0.6	0.3	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.7	0.0	0.7	0.5	0.2	0.2	0.1	1.5	4.3	0.0	1.1	0.0	0.1	0.4	0.8	0.1	0.0	0.3	0.0	0.4	0.6	0.1	0.9	1.4	1.4	0.3	0.6	0.6	0.4	0.1	0.3	0.4	0.6	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.2	1.2	1.0	0.4	0.2	0.6	0.0	0.2	0.0	0.0	0.4	0.3	0.0	0.0	2.0	2.4	1.5	2.9	0.3	0.0	1.6	1.6	2.3	1.8	0.0	0.6	0.0	0.0	0.1	1.8	0.1	3.9	0.3	0.5	1.4	3.7	0.2	0.0	0.0	7.3	0.2	0.8	0.8	0.0	0.5	0.0	0.2	1.4	2.9	0.3	0.0	3.3	0.2	0.0	0.3	0.4	8.6	1.2	0.6	5.4	1.9	0.1	3.4	0.0	0.5	1.8	0.3	0.0	1.2	9.2	4.3	0.5	8.9	0.3	2.4	13.1	0.2	3.5	0.4	1.9	0.0	1.4	0.4	4.4	0.1	0.2	0.4
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 47.1;Microglial cells: 15.0;T-cells: 59.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	4	"HDLM-2: 32.6;JURKAT: 54.1;MOLT-4: 51.6;RPMI-8226: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	0.4	0.5	0.5	3.3	3.2	1.7	0.6	0.1	2.3	0.4	0.3	0.7	1.6	0.2	0.4	0.6	0.2	1.4	0.1	0.9	0.1	0.2	0.7	1.4	7.5	0.6	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.9	0.1	0.1	0.2	2.3	0.3	0.3	3.2	1.5	0.1	0.3	32.9	0.4	0.1	4.0	1.1	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	26.7	0.1	34.0	0.1	33.5	48.9	0.2	0.2	30.0	58.3	0.6	0.1	0.2	0.2	1.7	20.3	0.5	3.2	0.1	2.3	0.9	0.1	0.6	0.3	0.4	0.3	0.3	1.9	0.5	0.0	3.0	2.9	2.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.9	0.1	0.2	0.4	0.0	1.7	47.1	0.0	0.0	0.7	5.1	0.1	1.3	0.0	1.1	0.1	0.1	0.0	0.9	0.0	0.0	0.8	0.8	0.2	0.0	1.5	7.2	15.0	1.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.1	1.4	0.0	59.9	0.0	0.0	0.1
THPO	"MGDF, MPLLG, TPO"	ENSG00000090534	Thrombopoietin	P40225	3	184371935-184381968	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 35.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Hepatocytes: 12.7;Late spermatids: 4.0;Proximal tubular cells: 9.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.0;Hep G2: 15.6;K-562: 2.8;RPMI-8226: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	1070000			"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (5.57e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.40e-3)"	"unprognostic (4.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.25e-2)"	1.8	2.5	5.2	0.5	3.9	0.0	1.4	4.7	4.8	3.9	2.4	0.7	0.2	3.8	1.3	0.4	2.0	0.4	1.2	4.5	2.8	4.5	35.4	0.8	0.2	3.3	2.9	2.8	1.7	0.1	0.7	0.5	3.0	1.3	0.3	0.0	0.5	0.5	1.9	0.6	0.7	1.5	3.0	1.3	0.9	3.9	2.8	0.0	0.8	0.9	0.1	0.9	1.9	3.6	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	15.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.6	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.9	4.7	4.8	4.5	2.8	3.3	2.9	3.0	3.0	2.8	3.6	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	1.6	0.1	0.0	0.0	2.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	12.7	0.6	0.0	1.3	0.0	0.0	0.8	0.0	4.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	1.1	0.8	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
THRA	"AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3"	ENSG00000126351	"Thyroid hormone receptor alpha"	P10827	17	40058290-40093867	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 236.7"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009654, CAB023349"	Approved		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB023349: AB_619577, HPA009654: AB_1854603"	"unprognostic (2.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.41e-3)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.47e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (6.05e-8)"	"unprognostic (3.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.88e-3)"	40.7	43.7	199.1	12.0	236.7	23.0	38.9	159.3	218.3	67.5	108.5	67.2	31.1	49.9	22.0	19.1	57.7	25.8	63.8	189.7	181.8	34.1	10.2	32.2	9.7	162.4	172.1	90.7	31.3	29.9	50.0	17.1	149.4	34.5	18.8	35.4	27.3	35.5	90.7	50.2	36.2	34.6	166.5	13.9	48.0	18.7	183.6	12.8	32.6	52.8	6.3	45.0	45.9	179.9	4.9	37.6	11.5	28.9	77.4	28.2	4.2	19.3	23.0	19.6	18.2	31.5	27.2	5.6	31.3	37.6	8.7	11.4	22.6	11.7	10.6	2.1	21.6	10.4	44.5	13.4	26.0	16.9	11.2	45.1	9.5	18.4	7.1	45.4	26.6	16.7	21.2	5.2	16.5	7.1	22.8	27.4	10.6	24.6	11.8	32.1	22.7	27.6	6.4	3.3	19.5	17.7	14.8	23.3	33.7	17.5	27.3	19.5	18.7	19.4	18.9	17.7	5.9	11.9	9.0	3.4	12.0	19.1	10.6	0.2	0.3	1.9	2.0	0.1	0.8	0.2	0.8	1.2	0.3	0.4	1.4	1.7	1.1	2.1	0.3	0.6	1.0	0.7	199.1	236.7	159.3	218.3	189.7	181.8	162.4	172.1	149.4	166.5	183.6	179.9	32.2	19.2	7.3	27.1	6.2	10.6	28.1	3.3	31.3	76.4	19.6	21.2	45.4	38.6	2.7	33.1	20.9	0.8	16.5	37.9	50.9	12.3	1.1	20.5	29.5	20.8	25.1	17.9	19.1	14.8	1.4	36.8	29.0	12.1	14.0	23.1	24.7	13.8	11.6	62.2	24.2	22.6	6.1	10.6	5.1	2.7	51.6	8.6	19.6	8.4	5.1	95.2	37.0	15.6	26.5	6.9	14.6	49.7	3.9	17.2	58.8	29.9	7.5	22.5	19.7	84.7	44.4	0.3	27.3	14.6	10.4	0.3	18.1	16.3	39.9	13.8
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 103.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 106.4;Basal squamous epithelial cells: 449.0;Microglial cells: 247.3;Squamous epithelial cells: 141.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 45.3;BJ hTERT+: 53.0;T-47d: 43.3;TIME: 66.6;U-2197: 44.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.0"						"Secreted - unknown location"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	4.8	8.4	9.8	1.6	7.8	0.0	14.7	6.1	8.6	103.7	9.5	7.0	7.9	22.2	7.8	60.3	37.0	10.9	41.6	8.5	7.2	14.2	7.0	10.3	0.9	7.8	9.1	3.1	6.4	0.7	9.7	3.6	7.6	34.0	6.9	1.2	11.4	15.0	3.0	8.5	8.7	10.3	7.0	1.9	12.0	3.1	15.9	1.6	8.8	2.5	2.5	13.3	38.5	5.9	6.0	45.3	0.8	13.0	6.7	40.2	0.2	22.0	53.0	11.2	5.8	0.3	8.7	0.0	17.7	7.8	38.5	17.0	1.8	9.1	6.8	2.0	2.0	0.0	4.4	0.0	4.3	0.0	0.0	3.0	6.7	6.7	26.6	30.5	20.7	0.0	0.0	0.5	9.2	9.1	0.0	0.1	3.9	0.1	7.8	0.0	0.7	0.8	29.5	6.0	0.7	5.5	8.8	10.9	0.0	5.0	43.3	0.1	66.6	0.2	1.0	44.4	11.8	0.0	0.3	0.0	10.4	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	7.8	6.1	8.6	8.5	7.2	7.8	9.1	7.6	7.0	15.9	5.9	1.1	19.2	9.0	6.5	0.0	13.9	106.4	11.3	449.0	3.0	48.7	43.9	60.1	58.6	7.5	5.5	6.2	0.4	0.8	16.2	1.9	18.3	7.5	19.3	13.2	9.8	3.0	0.0	17.1	1.8	0.4	12.5	2.6	31.8	0.0	0.3	6.1	12.3	0.2	0.0	19.1	6.1	0.0	0.0	2.1	16.9	17.4	1.6	8.8	247.3	0.0	0.3	0.0	8.5	6.7	13.6	11.0	74.4	1.2	94.6	29.3	0.5	11.0	0.9	0.0	16.8	6.6	0.9	1.7	141.5	10.9	0.8	3.1	42.2	13.2	29.7
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300982-43323108	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 130.8;Endothelial cells: 108.8;Hepatic stellate cells: 128.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 2.1;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"granulocytes: 2.1;NK-cells: 2.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 106.3;HUVEC TERT2: 238.4;TIME: 210.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		87000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	47.0	10.1	16.6	8.1	14.8	0.9	37.8	14.6	16.9	14.0	10.1	11.2	5.2	20.4	5.3	6.5	16.0	13.3	34.2	13.1	14.2	19.8	6.7	35.3	10.1	16.4	16.5	7.5	4.2	3.2	8.0	48.6	16.8	10.8	3.1	0.4	7.4	6.5	14.0	7.9	11.0	14.1	13.9	19.9	8.8	3.0	21.1	2.1	24.2	20.7	2.9	15.1	11.8	14.8	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	106.3	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	41.9	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.7	238.4	0.0	0.0	0.0	0.0	0.0	0.0	20.4	1.3	0.0	0.1	8.1	16.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.1	210.0	1.2	0.4	0.0	0.2	0.0	0.2	0.4	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	16.6	14.8	14.6	16.9	13.1	14.2	16.4	16.5	16.8	13.9	21.1	14.8	130.8	0.0	4.2	0.0	0.4	2.2	0.6	0.0	1.2	0.3	1.0	0.9	4.9	1.5	1.8	0.0	0.0	0.3	0.7	0.9	0.0	0.0	2.0	0.1	0.4	108.8	0.0	2.5	0.4	0.2	0.1	3.1	0.0	0.4	20.3	0.1	128.8	1.3	0.5	0.0	0.2	0.1	0.0	5.6	3.1	2.5	2.1	1.1	1.8	29.0	0.1	0.1	1.0	1.0	1.1	0.0	0.0	0.7	0.1	0.7	0.1	0.9	3.6	0.9	0.0	2.2	2.2	0.9	0.7	0.5	1.4	0.3	2.3	0.5	0.2	0.7
TIGIT	"DKFZp667A205, FLJ39873, VSIG9, VSTM3"	ENSG00000181847	"T cell immunoreceptor with Ig and ITIM domains"	Q495A1	3	114276913-114310288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 38.7"	"Group enriched"	"Detected in some"	10	"dendritic cells: 64.2;NK-cells: 69.0;T-cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 195.5"	"Lineage enriched"	"Detected in many"	11	"T-cells: 195.5"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.24e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.22e-6)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.50e-4)"	"unprognostic (3.51e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.18e-3)"	0.7	0.3	0.3	12.1	0.5	2.1	0.7	0.6	0.5	0.8	0.2	2.1	1.7	0.9	0.7	2.1	0.5	3.6	0.7	0.4	0.4	0.4	2.9	2.9	38.7	0.8	0.5	0.5	0.2	0.1	0.2	0.3	0.7	1.4	2.4	0.3	1.8	0.2	0.1	1.0	5.2	0.9	0.4	15.0	3.7	0.8	0.7	9.0	0.9	0.0	20.4	5.1	0.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.5	0.0	0.2	0.1	0.0	0.4	0.2	0.1	29.8	0.2	3.5	1.4	48.5	90.3	0.2	0.9	5.2	39.8	0.7	17.3	0.2	1.0	195.5	22.0	0.3	0.5	0.6	0.5	0.4	0.4	0.8	0.5	0.7	0.4	0.7	0.9	0.9	0.0	3.3	0.0	3.7	3.1	0.1	0.0	0.6	0.4	0.4	0.6	0.6	0.0	1.3	0.0	2.1	0.1	64.2	0.0	0.0	0.0	0.0	0.2	1.0	0.6	0.0	0.4	0.0	0.0	0.0	0.9	2.6	0.4	1.3	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	1.8	4.2	0.3	0.0	2.3	3.6	0.0	0.9	0.1	69.0	0.0	0.1	0.0	0.0	0.0	6.9	0.2	0.0	0.1	0.0	0.6	0.0	1.0	0.5	0.7	3.0	0.2	3.3	0.0	78.4	0.0	0.2	0.0
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 941.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 475.9;Late spermatids: 491.0;Leydig cells: 353.6;Peritubular cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.6;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1327.4;ASC TERT1: 1618.4;BJ hTERT+: 960.2;fHDF/TERT166: 1070.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	461.0	185.1	171.5	92.3	140.8	20.1	290.6	110.6	122.1	576.3	117.9	280.5	71.0	525.4	116.8	176.0	272.7	397.9	244.8	128.6	157.0	120.7	62.8	231.7	77.7	157.4	161.5	941.0	79.1	64.0	103.6	218.1	156.2	196.2	107.6	43.5	107.2	267.5	56.6	245.2	149.5	381.6	141.5	172.0	140.9	150.4	178.0	80.0	155.6	119.8	38.7	261.2	331.0	168.1	170.0	84.0	93.0	178.8	1327.4	1618.4	50.2	585.0	960.2	280.1	221.1	30.8	288.6	0.2	200.8	1070.2	307.4	32.9	29.1	25.2	291.4	3.4	16.6	0.1	156.0	48.1	392.7	2.6	1.2	641.1	12.0	276.8	44.3	722.5	375.9	54.4	0.2	0.5	292.5	19.5	176.8	29.7	16.6	34.2	122.8	118.0	213.2	73.4	178.7	2.3	47.6	290.3	366.6	170.8	776.3	111.6	86.8	42.2	450.3	744.2	140.5	438.0	102.8	84.1	74.9	1.5	171.0	32.0	367.6	0.0	5.0	7.4	0.0	3.4	0.0	0.1	0.1	0.0	2.2	0.2	0.2	0.3	13.6	0.2	4.3	1.4	0.1	0.9	171.5	140.8	110.6	122.1	128.6	157.0	157.4	161.5	156.2	141.5	178.0	168.1	147.9	112.2	34.3	24.2	18.7	98.9	9.0	5.7	9.1	37.5	9.7	37.6	41.9	52.9	20.8	25.8	8.4	4.3	6.1	46.0	0.0	78.0	143.7	17.0	190.3	115.0	7.8	12.4	9.8	22.0	87.7	475.9	17.9	24.4	7.0	97.5	259.5	7.9	208.8	3.3	107.7	14.3	12.2	177.4	171.4	491.0	353.6	184.8	275.7	96.5	87.3	39.9	5.2	60.8	143.5	83.3	6.0	770.7	33.1	10.1	12.8	0.8	5.4	12.7	92.1	111.8	171.9	8.5	7.7	5.6	75.9	14.8	17.5	96.0	2.3	6.9
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390142	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"kidney: 110.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.6;Distal tubular cells: 23.5;Proximal enterocytes: 72.5;Proximal tubular cells: 207.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.8"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 1.7;pons: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"RPTEC TERT1: 91.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.0	11.7	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.0	110.4	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.8	0.0	0.0	0.0	0.2	0.0	14.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	91.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	1.7	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.3	0.0	0.0	0.0	48.6	23.5	0.0	1.0	0.1	0.0	0.0	9.7	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	72.5	207.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	18.4	0.0
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873237-166104457	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.0;placenta: 6.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 115.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;Karpas-707: 9.6;PC-3: 3.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 45.8"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		560000		"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	3.1	0.5	0.7	1.0	5.9	0.0	2.7	20.0	8.9	1.8	0.0	1.2	0.6	1.1	0.3	0.7	1.3	2.4	0.7	9.9	5.4	1.6	0.1	1.2	1.0	3.5	6.9	0.3	2.3	0.8	0.9	6.4	4.4	0.9	0.9	1.8	0.8	0.8	0.4	1.4	1.8	1.4	0.0	0.0	0.7	0.4	3.0	0.3	1.4	0.4	0.8	1.6	1.5	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	1.3	0.0	0.9	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.9	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.9	20.0	8.9	9.9	5.4	3.5	6.9	4.4	0.0	3.0	1.1	10.2	0.0	0.6	0.0	0.0	1.8	0.3	1.3	0.6	14.1	0.2	0.1	7.1	1.5	1.8	0.0	0.0	4.4	0.0	0.0	0.0	1.5	0.1	0.0	2.0	18.9	0.0	0.0	24.9	2.0	1.4	2.4	0.0	0.1	0.0	0.0	2.5	0.0	0.3	8.4	8.0	0.1	0.0	0.0	1.0	0.0	3.1	0.1	1.8	10.3	0.0	0.1	0.0	115.1	0.5	0.1	0.0	4.5	0.0	1.1	4.0	1.1	0.8	0.7	0.0	0.2	0.3	0.1	0.2	0.1	1.7	1.9	0.8	0.0	0.6	0.2
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;TIME: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	31.1	11.0	12.4	25.7	15.7	22.3	12.0	11.7	8.3	6.5	1.7	6.7	4.3	5.6	1.2	4.8	4.8	10.8	8.4	10.3	17.8	6.8	16.7	16.2	13.1	12.3	14.0	6.0	2.6	2.5	2.1	23.9	12.4	4.6	7.3	2.9	6.0	3.2	3.1	3.5	5.8	10.8	14.9	32.6	4.4	1.5	14.2	3.5	5.5	12.0	7.7	13.3	2.7	10.1	0.0	0.0	25.5	0.0	11.1	23.0	0.1	10.2	17.9	2.5	1.5	0.0	2.6	3.6	0.5	26.7	7.5	0.1	0.0	2.2	3.7	0.0	0.0	5.7	5.1	0.4	8.1	19.1	0.1	14.2	0.0	5.4	0.7	22.5	31.4	0.0	0.0	60.0	29.2	0.0	0.0	2.9	3.1	2.4	1.2	0.0	28.0	19.8	0.9	28.9	0.0	0.1	6.4	0.0	1.0	2.2	0.0	10.4	43.5	1.4	18.4	0.1	4.8	0.0	0.0	0.0	0.9	19.1	15.2	64.0	64.9	21.5	0.1	57.5	0.0	1.7	0.1	0.0	22.4	0.5	0.0	0.0	86.8	0.1	65.6	0.9	0.0	25.5	12.4	15.7	11.7	8.3	10.3	17.8	12.3	14.0	12.4	14.9	14.2	10.1	38.6	0.0	5.0	50.9	2.3	0.8	0.3	0.1	0.6	0.2	3.5	1.0	2.9	2.8	2.9	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.1	3.5	29.2	31.6	0.0	1.3	0.2	0.2	0.2	11.5	1.5	6.8	15.8	1.2	62.8	1.9	38.2	0.0	0.2	2.0	0.0	106.0	8.6	0.4	0.0	64.5	1.8	26.2	54.0	8.8	2.1	7.5	0.3	0.5	6.1	0.0	0.1	0.1	0.0	0.4	3.7	1.3	6.6	5.5	4.5	0.1	0.3	0.3	0.0	0.8	0.9	3.1	1.2	3.3
TLR8	CD288	ENSG00000101916	"Toll like receptor 8"	Q9NR97	X	12906620-12923169	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.7;lymphoid tissue: 16.8"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 49.8;Macrophages: 21.1;monocytes: 39.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	74	"classical monocyte: 16.7;intermediate monocyte: 14.9;myeloid DC: 8.4;neutrophil: 27.6;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	78	"dendritic cells: 8.4;granulocytes: 27.6;monocytes: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001608	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA001608: AB_1080295"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.43e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	3.6	0.5	0.2	16.8	0.2	5.7	0.9	0.2	0.3	0.7	0.5	1.7	0.8	0.4	0.1	0.9	0.6	2.5	0.8	0.1	0.3	0.5	2.2	10.7	6.1	1.1	0.7	0.4	0.6	0.3	0.1	4.3	0.8	0.3	1.8	0.0	0.3	0.2	0.2	0.2	1.5	3.8	0.5	13.3	0.8	0.4	0.4	1.7	0.4	1.3	1.9	3.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	14.9	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.0	27.6	0.0	15.6	0.0	0.0	3.8	0.2	0.2	0.2	0.3	0.1	0.3	1.1	0.7	0.8	0.5	0.4	0.9	0.0	0.0	3.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.7	5.3	0.0	0.0	0.0	0.0	49.8	5.1	0.0	0.0	21.1	0.0	0.0	39.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TM4SF1	"L6, M3S1"	ENSG00000169908	"Transmembrane 4 L six family member 1"	P30408	3	149369022-149377692	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 5463.1;Endothelial cells: 1843.0;Pancreatic endocrine cells: 2557.3;Prostatic glandular cells: 2717.0;Urothelial cells: 4902.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 703.8;hTERT-RPE1: 925.5;HUVEC TERT2: 633.3;LHCN-M2: 687.7;OE19: 672.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002760, HPA002823"	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB002760: , HPA002823: AB_1079221"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (4.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.43e-6)"	365.9	71.3	41.9	50.5	43.1	2.6	192.8	44.1	68.2	82.6	65.6	61.6	38.3	74.9	58.2	210.9	74.7	237.6	181.7	42.2	45.2	155.1	92.6	229.8	25.2	45.1	43.9	49.7	211.7	19.9	20.2	194.6	47.7	79.9	59.9	6.0	180.9	32.0	50.2	63.5	62.2	94.6	45.4	120.5	129.7	19.5	53.5	17.0	72.5	64.2	60.2	150.9	115.5	45.9	367.9	401.9	0.0	1.0	108.4	422.2	0.6	115.2	455.5	23.9	8.8	159.7	703.8	0.1	351.3	23.5	545.5	434.0	1.9	80.0	22.9	0.9	0.0	3.9	391.8	521.8	39.4	0.0	0.5	40.0	19.1	169.7	81.5	925.5	633.3	0.0	0.3	0.8	687.7	0.5	0.0	0.7	1.5	672.9	170.7	0.2	0.9	0.8	449.3	54.8	0.2	0.5	46.8	25.1	4.4	6.0	0.8	1.7	404.7	233.6	38.9	4.8	244.3	0.5	0.7	1.1	337.4	0.4	62.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	43.1	44.1	68.2	42.2	45.2	45.1	43.9	47.7	45.4	53.5	45.9	1131.0	576.9	342.3	0.3	7.5	278.0	5463.1	668.3	272.6	0.1	956.5	363.1	24.0	274.5	984.3	57.0	0.0	0.8	17.0	176.6	0.0	1383.5	5.2	514.1	168.0	1843.0	39.2	15.6	0.0	1600.9	0.9	297.2	147.8	1807.5	31.5	0.2	1263.6	21.8	1.9	0.0	0.0	15.9	382.5	27.8	222.1	11.3	255.7	35.6	300.6	30.9	26.4	0.0	0.0	0.0	0.3	2557.3	251.8	176.0	11.1	2717.0	0.3	1.2	238.5	0.0	322.1	37.7	311.0	6.6	1.4	925.8	253.7	1.4	44.1	44.2	46.6	4902.9
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins, Transporters"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 174.7;liver: 204.6"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 115.2;Hepatocytes: 275.4;Intestinal goblet cells: 143.9;Paneth cells: 285.4;Proximal enterocytes: 618.4"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 53.7;Hep G2: 96.0;OE19: 60.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	174.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.6	204.6	0.0	0.2	0.0	0.0	0.0	1.4	8.1	0.0	0.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	53.7	2.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	96.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.0	60.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	1.8	0.0	0.1	0.0	40.5	5.9	0.9	2.0	0.0	0.0	0.1	115.2	5.3	0.1	8.9	4.6	0.0	57.6	0.0	4.5	0.0	4.6	275.4	0.1	0.0	0.1	143.9	0.0	4.8	0.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	285.4	0.0	0.1	0.0	618.4	72.8	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	47.8	0.0
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins, Transporters"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 75.5;liver: 33.7"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 231.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;HHSteC: 1.8;LHCN-M2: 1.5;NTERA-2: 1.0;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in single"							HPA066026	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.2	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.5	1.0	0.4	2.2	75.5	0.6	0.2	0.1	0.3	0.5	0.5	0.2	0.7	3.3	33.7	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.5	0.2	0.6	2.0	0.0	0.1	0.3	0.0	0.1	68.8	0.3	0.1	0.1	2.4	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.8	0.4	0.4	0.5	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.7	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.9	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.8	0.2	0.3	1.2	21.4	0.1	4.5	0.0	1.1	35.6	0.1	0.0	1.1	8.6	0.0	0.3	0.4	0.0	0.6	0.0	1.8	1.0	0.0	0.0	0.0	3.5	0.1	0.1	29.7	0.4	0.0	0.0	231.1	5.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.1	0.1	0.1	0.1	9.6	0.0
TM7SF3		ENSG00000064115	"Transmembrane 7 superfamily member 3"	Q9NS93	12	26971579-27014434	"Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 258.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 553.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057640			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA057640: "	"unprognostic (4.24e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.04e-3)"	"unprognostic (8.80e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.58e-1)"	38.0	48.8	23.1	28.2	25.1	66.0	33.2	19.2	27.3	37.8	34.6	60.5	40.4	29.9	48.6	61.2	40.7	58.3	18.3	23.1	25.2	258.0	138.4	53.7	29.1	25.8	22.8	32.9	117.9	42.4	20.1	36.0	24.6	36.1	69.1	38.9	41.6	43.9	13.7	40.5	35.3	45.8	26.1	32.7	48.7	30.6	26.3	101.4	44.0	35.4	39.9	47.5	28.6	30.7	70.0	147.8	82.6	104.7	122.1	74.3	438.7	74.3	132.8	65.1	109.9	73.3	289.2	80.9	92.3	78.1	61.1	71.5	85.9	553.0	77.0	84.1	46.7	126.9	168.2	134.1	76.7	439.5	84.9	48.7	382.6	144.3	111.7	191.8	177.2	242.2	53.8	60.1	97.1	114.9	232.4	189.3	170.5	266.8	75.4	216.9	131.8	164.2	93.7	278.2	14.4	72.9	84.8	56.6	121.0	391.6	151.8	77.2	62.4	53.9	92.1	140.3	93.4	38.5	97.3	152.9	115.5	133.7	78.5	11.2	7.4	19.0	6.0	8.1	5.4	8.7	8.0	7.8	12.4	13.5	11.1	7.1	6.2	13.7	3.8	10.1	13.9	4.7	23.1	25.1	19.2	27.3	23.1	25.2	25.8	22.8	24.6	26.1	26.3	30.7	23.2	12.8	27.6	28.4	20.2	28.8	52.4	78.7	96.8	50.0	17.2	19.8	10.3	127.2	46.0	42.3	43.8	40.0	35.2	22.2	17.6	62.1	82.4	23.0	5.7	19.4	13.2	49.0	83.1	39.6	15.2	23.5	32.1	21.1	14.0	48.5	22.5	42.5	39.5	23.5	50.4	24.0	28.5	25.7	11.1	148.8	15.5	27.1	65.8	26.2	27.4	30.8	27.8	63.8	40.0	25.3	28.1	23.0	38.2	18.1	25.5	143.7	24.9	38.4	6.6	27.4	18.4	10.1	22.3	65.0	27.8	16.3	21.8	21.6	31.3	37.6
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	7.8	3.0	3.6	56.0	4.4	91.8	3.7	3.7	5.1	3.7	3.5	8.2	10.3	2.5	0.7	4.8	4.0	7.4	2.7	3.6	4.8	5.2	7.1	18.4	100.5	5.8	4.7	1.3	2.0	0.5	2.2	3.9	5.6	4.9	4.5	0.1	5.8	1.3	1.8	3.6	54.6	2.4	5.0	117.0	10.4	1.2	7.8	60.1	6.4	0.9	46.7	6.4	5.0	7.2	0.5	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	46.3	2.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	16.4	0.1	0.8	0.0	63.0	119.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	4.0	103.9	0.0	1.3	20.9	2.8	0.2	3.5	0.5	1.4	0.3	66.6	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.1	6.9	12.7	0.1	0.0	0.1	0.1	0.0	49.3	2.0	4.6	0.1	51.9	0.1	2.6	2.0	6.6	13.4	3.4	9.7	5.5	10.8	13.3	2.3	4.8	9.4	8.6	3.3	7.5	7.9	2.1	6.5	5.5	3.6	4.4	3.7	5.1	3.6	4.8	5.8	4.7	5.6	5.0	7.8	7.2	3.6	3.2	10.2	1.0	44.9	5.4	10.4	4.9	4.6	0.2	1.2	1.5	1.9	1.5	6.5	0.0	0.0	0.4	52.3	3.7	0.0	1.0	0.7	1.0	0.6	3.2	1.2	17.1	0.4	1.3	1.4	2.3	2.0	1.8	41.2	0.1	5.7	0.5	30.5	0.0	0.4	1.4	14.2	28.2	44.6	0.5	0.0	22.0	7.2	24.4	30.2	0.2	85.5	1.0	2.7	0.6	3.6	0.4	20.2	2.9	0.9	0.4	2.1	0.2	0.0	0.3	2.0	0.4	0.6	8.4	4.5	0.5	68.6	2.7	7.0	10.7
TMED6	"MGC23911, p24g5, p24gamma5"	ENSG00000157315	"Transmembrane p24 trafficking protein 6"	Q8WW62	16	69343250-69351786	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 298.9"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 28.3;Exocrine glandular cells: 36.6;Pancreatic endocrine cells: 12.8;Paneth cells: 10.6;Proximal tubular cells: 19.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.5;OE19: 7.4"									HPA012532	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA012532: AB_1858065"	"unprognostic (6.85e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.31e-3)"	"prognostic favorable (7.74e-5)"	"unprognostic (9.84e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.94e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.52e-3)"	0.5	0.6	0.1	0.7	0.3	1.1	0.6	0.8	0.7	2.5	0.1	4.3	12.5	0.9	18.1	0.4	22.5	0.7	0.4	0.3	0.0	16.1	5.5	1.9	1.3	0.1	0.1	0.6	298.9	0.1	0.2	0.4	0.1	0.7	7.8	1.0	0.5	2.4	0.3	1.0	7.7	0.5	0.1	0.9	61.2	0.4	0.2	0.2	0.5	0.0	0.6	0.3	0.2	0.4	0.6	1.6	1.4	1.0	0.1	0.0	0.9	2.0	0.1	0.0	0.3	2.2	0.8	4.2	0.7	0.0	0.6	1.1	0.2	0.2	0.4	0.6	1.7	2.1	0.6	15.5	0.1	2.7	0.9	0.2	0.8	0.1	0.3	0.8	0.1	1.9	1.4	0.5	0.3	1.6	1.1	2.9	1.9	7.4	1.4	2.3	1.2	1.6	0.4	1.7	3.2	1.3	2.7	0.9	1.0	0.5	0.5	1.7	1.9	2.2	1.3	0.8	1.4	1.4	1.3	4.5	1.2	2.2	0.7	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.7	0.3	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.0	0.5	1.3	0.5	0.0	0.1	0.1	0.6	0.5	0.5	0.3	0.2	1.5	0.1	1.8	2.1	0.1	0.0	5.0	0.0	6.6	0.1	28.3	0.7	0.4	8.4	3.2	1.4	36.6	0.0	0.1	9.7	5.0	1.3	0.1	0.4	4.7	0.3	0.0	0.8	2.6	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	1.0	12.8	10.6	0.0	0.3	0.3	8.0	19.1	0.4	0.6	0.0	0.5	0.2	0.1	0.1	0.6	0.0	0.1	0.5	0.1	7.0	0.2
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 237.2;Glandular and luminal cells: 507.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039739, HPA075651"			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA039739: AB_2676657, HPA075651: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	17.2	19.8	22.6	12.9	26.8	11.5	107.0	23.2	24.0	44.4	24.2	20.6	16.9	63.5	27.6	28.0	37.9	15.9	23.1	22.2	22.7	93.9	24.1	18.7	19.4	24.2	24.0	22.7	39.2	26.4	15.4	21.6	23.2	24.0	16.9	12.1	30.1	111.8	33.3	29.0	17.4	16.1	23.5	20.4	28.8	23.6	23.9	16.5	23.0	24.9	17.7	20.4	23.0	23.4	23.5	56.0	19.7	16.2	45.7	43.9	19.6	24.1	36.1	46.5	43.8	42.0	59.5	26.1	6.5	24.9	36.0	35.3	22.9	41.5	35.2	28.5	46.1	19.5	45.7	86.2	39.3	31.7	32.8	39.4	46.5	32.8	46.3	41.8	40.8	45.0	40.7	50.1	29.2	31.7	34.6	36.6	9.1	25.4	62.6	29.8	42.8	47.4	39.1	18.7	25.3	20.2	14.6	0.5	59.6	24.9	27.3	59.9	24.7	42.1	28.5	18.8	46.9	52.1	38.0	12.0	44.3	29.7	38.2	20.1	42.8	15.3	31.2	43.4	35.7	37.3	39.6	36.4	44.9	39.8	43.2	35.7	15.9	44.1	32.9	44.0	44.6	31.1	22.6	26.8	23.2	24.0	22.2	22.7	24.2	24.0	23.2	23.5	23.9	23.4	22.1	19.2	15.4	0.0	22.8	20.6	31.6	72.0	21.6	10.4	64.2	61.2	27.3	24.3	34.5	40.5	6.2	68.5	19.6	18.5	37.2	36.6	13.1	237.2	70.8	28.2	23.4	33.2	0.0	49.8	47.3	21.1	13.7	507.4	22.9	34.4	36.0	20.6	37.6	11.8	0.0	37.3	28.5	32.4	11.8	11.1	13.1	23.8	33.8	0.0	47.7	17.7	29.9	0.0	0.0	41.8	20.7	12.4	29.4	23.4	27.7	30.2	27.1	11.7	6.6	13.2	19.8	45.8	24.7	26.9	22.6	44.6	20.9	25.6	45.7	25.2
TMEM106A	MGC20235	ENSG00000184988	"Transmembrane protein 106A"	Q96A25	17	43211835-43220041	"Predicted membrane proteins, Transporters"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 21.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 45.6;Hofbauer cells: 45.3;Kupffer cells: 44.8;Langerhans cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 26.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 26.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (9.71e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (4.95e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.30e-2)"	4.9	2.4	1.7	10.2	2.1	3.3	4.1	1.2	2.9	3.8	2.4	3.6	4.0	3.6	1.7	1.5	3.3	3.6	2.1	1.6	2.5	21.9	3.5	5.2	6.9	6.2	3.0	7.8	3.1	2.4	1.6	10.1	3.8	2.5	5.3	0.8	2.8	3.1	1.1	1.3	3.4	8.8	2.8	9.7	4.8	3.3	6.1	4.0	5.3	1.5	6.1	4.8	2.4	4.1	3.1	0.9	0.4	0.2	3.8	4.1	2.3	7.8	5.0	6.7	10.5	2.3	6.4	4.5	1.5	12.1	2.6	1.3	0.8	1.0	7.8	7.1	0.0	3.2	2.7	10.7	2.2	0.1	16.8	2.6	0.2	12.5	0.3	2.4	6.0	5.3	0.1	3.2	8.5	1.3	5.5	2.1	0.3	0.0	0.0	4.0	1.3	2.7	2.9	0.2	0.6	0.0	1.5	3.7	1.8	1.6	5.5	4.5	6.8	3.3	0.4	3.3	1.6	5.0	0.5	1.4	2.8	5.4	6.7	26.7	5.1	5.7	1.5	5.6	0.7	1.9	1.0	1.5	4.2	3.2	0.7	1.3	1.4	2.1	2.0	6.0	2.9	2.2	1.7	2.1	1.2	2.9	1.6	2.5	6.2	3.0	3.8	2.8	6.1	4.1	4.5	3.2	4.5	1.3	13.6	2.4	11.0	2.4	0.6	4.3	6.5	4.2	1.2	0.0	3.9	7.3	2.1	5.0	22.7	3.9	3.9	2.0	5.9	2.6	7.1	6.5	3.0	2.5	1.0	4.0	8.3	6.6	10.7	3.9	8.2	45.6	5.0	1.7	45.3	0.0	1.0	4.5	0.0	44.8	35.6	2.7	14.0	25.2	0.0	17.8	16.5	1.2	14.4	3.5	4.0	5.5	3.4	7.2	5.4	10.9	2.1	17.8	6.0	3.7	13.1	4.0	4.6	7.4	3.6	0.5	1.7	5.2	7.3	3.2	2.9	13.1
TMEM119	OBIF	ENSG00000183160	"Transmembrane protein 119"	Q4V9L6	12	108589851-108598320	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Biomineralization, Differentiation, Osteogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.3;Fibroblasts: 30.5;Late spermatids: 9.3;Melanocytes: 8.8;Microglial cells: 15.0;Peritubular cells: 24.0;Smooth muscle cells: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 559.2;ASC TERT1: 152.6;BJ hTERT+: 168.0;fHDF/TERT166: 81.9;HSkMC: 238.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051870, HPA052650"	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA051870: AB_2681645, HPA052650: AB_2681901"	"unprognostic (4.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (1.29e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	29.6	8.0	7.6	16.2	8.9	3.0	27.1	8.5	9.2	61.0	5.3	12.6	15.1	18.9	14.1	6.9	11.9	35.8	9.4	7.7	9.3	6.0	0.9	37.6	47.8	17.2	12.1	1.4	7.5	5.6	6.1	6.6	14.9	12.7	15.1	0.9	6.8	26.0	1.6	13.9	23.1	11.2	13.4	11.4	10.5	5.9	16.4	5.1	21.7	1.7	27.2	32.2	18.4	21.9	0.1	0.3	1.3	0.7	559.2	152.6	0.8	11.8	168.0	0.4	3.0	0.2	0.6	0.3	0.4	81.9	0.3	0.2	0.1	0.2	0.1	0.5	0.0	0.3	0.6	1.0	7.2	0.3	1.2	238.4	0.3	7.0	0.1	0.7	0.1	0.2	0.5	0.5	0.5	0.7	0.3	1.6	0.1	0.0	0.9	0.6	0.9	0.8	0.1	0.7	0.2	39.5	0.0	0.3	0.3	4.5	0.2	1.8	1.2	13.1	0.4	11.2	0.5	2.6	3.1	0.6	6.8	0.5	0.1	1.4	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.4	0.3	0.3	1.4	0.2	0.4	0.2	0.1	0.1	7.6	8.9	8.5	9.2	7.7	9.3	17.2	12.1	14.9	13.4	16.4	21.9	1.3	0.0	0.0	0.0	0.2	3.8	0.1	0.0	0.6	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	8.3	0.2	5.8	1.3	0.0	0.0	0.0	0.0	0.2	30.5	0.0	0.2	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	1.9	4.4	9.3	4.1	1.1	8.8	15.0	1.6	0.0	0.0	0.0	0.0	0.1	1.1	24.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	9.7	0.1	0.1	0.0	3.7	0.3	0.7	0.5	0.0	0.1
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116297-17121367	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hofbauer cells: 2.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 1.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;SCLC-21H: 14.2;THP-1: 11.9;U-937: 9.8"	"Low region specificity"	"Detected in all"							HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA068790: AB_2686036"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	0.3	0.6	6.4	0.9	7.5	1.0	0.7	3.5	7.6	0.2	1.5	0.2	0.2	0.3	0.9	0.3	0.3	0.2	1.2	8.7	3.9	0.3	0.1	0.3	0.1	3.8	3.3	0.2	1.1	0.1	1.6	0.7	3.3	6.6	0.2	1.3	0.4	0.2	1.3	0.5	0.2	0.3	3.6	0.7	0.2	1.9	4.9	0.1	0.1	0.4	0.1	0.3	0.2	5.1	0.0	0.0	6.0	0.8	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.1	0.3	0.0	0.8	3.2	2.1	0.0	0.1	0.2	3.0	0.0	0.3	0.1	14.2	2.1	0.0	0.0	0.3	0.8	0.0	11.9	0.6	0.6	0.2	0.2	0.0	0.2	0.4	0.9	0.0	9.8	0.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	6.4	7.5	3.5	7.6	8.7	3.9	3.8	3.3	3.3	3.6	4.9	5.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	1.3	0.9	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924460-60937159	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 187.8;choroid plexus: 117.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced	Supported	Approved	Mitochondria		No	No		4100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	7.7	21.0	137.9	8.6	134.3	0.3	7.7	119.4	187.8	12.0	117.3	5.5	2.5	13.6	1.2	19.5	4.8	5.5	13.7	134.1	136.9	13.9	2.1	10.1	1.7	154.5	131.2	18.8	6.8	12.4	23.6	16.6	126.4	9.4	1.0	28.1	25.9	1.8	3.9	6.1	6.0	3.7	123.0	5.7	32.4	6.7	144.6	1.3	4.8	3.1	5.4	4.2	9.2	114.7	37.0	50.7	44.1	88.0	3.6	1.7	78.1	27.0	84.5	24.6	20.3	18.0	33.3	0.3	174.1	7.8	79.9	67.6	10.3	46.0	9.5	0.5	14.8	1.1	33.3	32.7	30.8	0.5	1.3	7.7	8.6	45.8	7.1	38.7	42.1	7.0	2.3	2.3	7.8	177.8	0.9	0.2	58.5	1.2	26.9	0.4	18.6	4.2	36.4	18.7	43.7	104.1	19.3	176.4	16.7	22.3	123.7	0.6	49.4	9.5	43.2	2.7	52.3	0.4	0.3	2.1	78.5	0.1	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.9	134.3	119.4	187.8	134.1	136.9	154.5	131.2	126.4	123.0	144.6	114.7	11.8	0.0	0.0	82.3	0.6	1.3	2.7	56.2	5.7	62.8	17.1	11.7	0.8	4.3	22.2	5.5	18.8	31.4	0.1	0.7	1.9	80.0	0.5	12.4	7.0	11.9	15.6	0.0	22.6	13.3	28.7	7.7	9.2	27.7	0.0	57.5	11.4	0.0	3.3	254.1	29.1	2.7	20.3	0.3	1.0	1.0	1.8	0.7	0.0	7.5	3.1	188.8	0.0	12.1	3.3	63.2	1.6	3.4	0.0	9.7	0.0	0.4	4.0	165.3	6.6	4.4	15.2	1.2	4.0	5.7	0.9	27.1	0.3	19.2	2.3	7.2
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM150A	"FLJ90024, TM6P1, TMEM150, TTN1"	ENSG00000168890	"Transmembrane protein 150A"	Q86TG1	2	85598547-85603196	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 133.5;Early spermatids: 137.5;Proximal tubular cells: 85.0;Syncytiotrophoblasts: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HHSteC: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019015	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA019015: AB_2204758"	"unprognostic (2.80e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.09e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.54e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.87e-3)"	18.7	16.3	10.0	5.2	10.8	1.2	17.0	9.8	11.1	16.3	11.1	21.0	6.5	17.7	6.3	11.0	17.1	10.4	15.5	9.7	10.3	32.8	38.5	19.3	6.0	11.9	10.7	17.1	37.9	8.0	11.7	22.4	10.9	17.4	4.1	1.4	14.9	10.2	53.7	9.3	12.9	11.5	10.6	9.7	20.6	24.4	11.3	2.5	14.9	27.2	4.2	22.2	13.1	10.1	2.7	5.1	6.3	9.3	52.9	23.7	15.3	5.2	9.1	4.3	2.0	23.6	7.1	0.8	19.8	15.3	8.0	2.2	6.8	13.7	2.0	1.2	6.7	1.5	3.0	39.9	49.6	0.4	4.7	28.5	18.4	7.0	9.9	20.6	15.2	1.0	14.0	1.5	17.5	11.9	0.4	6.9	11.5	10.8	5.1	4.1	0.6	15.8	13.4	10.6	1.0	3.9	5.4	35.4	13.5	5.9	8.7	6.2	12.6	5.2	4.4	4.5	1.8	10.6	2.8	5.2	8.5	6.0	2.3	0.0	15.2	7.2	5.5	17.9	6.5	5.3	6.2	5.6	12.8	8.1	6.9	4.2	0.7	8.4	15.1	7.6	1.5	6.0	10.0	10.8	9.8	11.1	9.7	10.3	11.9	10.7	10.9	10.6	11.3	10.1	24.1	9.6	14.9	10.7	9.0	4.5	15.3	16.0	10.2	6.8	15.3	12.7	5.2	12.8	16.2	14.7	0.0	133.5	10.4	3.5	29.4	16.9	137.5	5.0	9.0	14.9	3.0	1.7	3.9	14.4	18.2	14.3	5.6	6.0	10.2	5.2	15.7	19.7	37.9	3.3	5.0	5.2	16.2	10.3	13.1	64.8	19.9	14.6	10.6	9.4	15.2	6.5	7.2	5.5	5.9	12.8	7.0	24.5	5.9	20.3	16.4	85.0	8.3	3.4	13.1	14.6	11.7	2.4	5.6	7.9	3.7	146.0	7.0	9.2	7.0	13.1
TMEM150B	"DRAM3, TMEM224, TTN2"	ENSG00000180061	"Transmembrane protein 150B"	A6NC51	19	55312801-55334048	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"intestine: 64.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 18.1;Kupffer cells: 11.8;monocytes: 8.0;Proximal enterocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;HMC-1: 3.8;THP-1: 2.9;U-937: 18.1"	"Not detected"	"Not detected"													NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.18e-2)"	3.7	1.8	0.5	5.8	0.8	0.7	1.1	0.4	1.0	0.3	1.2	10.2	64.1	0.4	0.1	0.6	0.8	2.9	0.8	0.4	0.7	3.2	2.2	11.9	3.5	1.3	0.7	0.3	0.9	0.1	0.2	5.6	1.6	0.3	7.3	0.0	0.6	0.4	0.2	0.2	57.0	4.1	0.5	5.7	1.4	0.5	3.4	0.7	0.3	0.2	1.6	2.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.6	0.0	1.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.1	0.1	0.1	1.8	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	18.1	0.1	1.9	5.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.5	0.8	0.4	1.0	0.4	0.7	1.3	0.7	1.6	0.5	3.4	1.3	0.0	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.5	1.5	0.0	1.8	0.0	0.0	0.0	18.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.7	3.5	0.0	11.8	1.3	0.0	0.0	3.2	0.0	0.0	8.0	0.0	0.0	0.0	0.9	0.3	1.4	0.0	0.9	0.6	68.9	0.6	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.7	0.3
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 134.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 23.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	13.1	43.1	12.9	4.6	15.3	1.9	22.0	9.7	16.8	15.1	6.3	7.7	7.4	4.9	134.9	3.6	7.4	6.5	12.7	15.7	12.7	17.3	13.9	6.2	14.7	12.9	15.9	31.5	3.4	5.4	8.4	9.8	14.7	12.6	4.3	4.5	17.0	7.6	6.9	4.3	6.9	6.9	12.0	14.3	5.0	3.2	12.2	9.1	11.4	9.7	12.8	5.0	5.2	12.5	0.1	1.0	8.8	10.9	0.1	0.1	0.4	1.9	4.7	1.3	1.2	0.0	0.6	0.3	0.9	0.3	3.6	0.2	5.0	0.0	1.4	0.4	2.3	0.7	1.2	0.1	0.0	0.0	1.0	4.5	0.6	0.0	0.0	0.8	2.7	5.3	0.0	0.0	0.2	32.2	0.6	0.8	3.9	0.0	0.5	1.0	0.2	1.2	0.2	4.8	20.1	3.5	0.5	0.4	2.8	4.1	0.5	0.2	0.8	0.5	0.3	0.1	1.1	0.1	0.5	0.4	0.6	0.1	2.2	2.6	0.3	0.5	0.2	0.2	0.1	1.0	0.3	0.2	0.1	1.1	0.2	0.2	1.4	0.5	0.3	0.6	0.1	0.1	12.9	15.3	9.7	16.8	15.7	12.7	12.9	15.9	14.7	12.0	12.2	12.5	30.7	0.0	1.1	36.6	0.2	2.4	3.5	1.9	0.6	1.1	19.3	13.6	10.1	5.7	6.1	14.7	2.1	88.6	1.4	0.2	0.0	7.2	5.5	2.6	11.2	24.8	1.2	3.0	35.6	2.5	1.3	13.1	0.5	10.5	6.3	104.7	25.4	20.4	5.7	1.7	24.2	1.1	0.0	1.0	3.6	2.9	14.3	1.8	1.8	7.5	7.8	14.8	0.0	17.6	13.1	1.4	0.2	9.8	1.2	4.9	0.4	2.6	7.1	2.2	0.0	3.9	7.8	1.1	4.1	1.6	1.1	117.3	0.6	1.8	4.3	0.9
TMEM174	"FLJ31268, MGC13034"	ENSG00000164325	"Transmembrane protein 174"	Q8WUU8	5	73173193-73175143	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	309	"kidney: 153.2"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 160.6"	"Cancer enriched"	"Detected in single"	126	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA037975	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA037975: AB_10672732"					"unprognostic (8.11e-2)"								"prognostic favorable (3.30e-6)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	153.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805118	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 377.7;liver: 1170.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1043.9;Paneth cells: 779.4;Proximal enterocytes: 1294.5;Proximal tubular cells: 1103.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 146.5;intermediate monocyte: 98.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 146.5"	"Cell line enriched"	"Detected in some"	31	"HSkMC: 730.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	76.6	33.1	46.5	124.8	48.0	6.8	49.3	49.2	50.8	45.7	39.1	143.9	113.2	18.6	17.9	28.5	48.9	129.8	90.9	43.6	56.2	377.7	1170.6	58.5	85.6	64.0	56.2	104.7	29.8	3.9	11.6	66.6	58.2	26.5	151.3	20.6	24.2	15.9	6.4	20.6	203.1	50.2	61.3	51.0	48.7	6.1	49.9	15.5	21.3	17.4	66.0	98.0	54.5	63.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	3.5	14.2	0.2	0.6	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.3	730.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	23.3	0.0	0.0	2.7	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	146.5	12.6	0.3	98.4	0.4	2.1	0.1	0.2	30.9	0.0	0.2	0.0	1.8	0.3	46.0	2.4	0.4	53.3	46.5	48.0	49.2	50.8	43.6	56.2	64.0	56.2	58.2	61.3	49.9	63.9	15.8	0.0	5.2	3.9	9.8	7.4	0.4	0.9	5.2	56.2	40.6	63.8	24.9	118.7	10.9	200.5	4.2	0.6	2.0	348.5	152.6	64.6	0.3	4.9	14.8	20.5	74.1	6.6	0.0	27.2	0.6	185.3	17.9	2.5	29.0	29.9	23.2	1043.9	52.2	0.0	0.2	237.7	73.2	56.9	26.2	1.5	60.3	109.4	5.4	1.9	313.0	80.8	1.0	1.0	0.0	56.0	779.4	7.5	0.9	1.8	1294.5	1103.9	10.6	5.3	0.0	5.7	32.8	0.9	1.6	2.9	8.4	1.4	6.4	0.1	262.4	2.7
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 135.5"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 138.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	5.9	7.6	65.4	0.6	71.3	0.2	6.2	135.5	104.1	4.1	38.6	8.9	1.9	3.6	1.5	1.8	6.3	2.7	4.5	71.7	51.3	42.7	9.9	6.7	0.5	64.7	54.9	5.9	4.6	2.3	12.9	3.2	65.5	11.6	1.7	15.7	21.9	1.6	2.8	3.3	3.2	2.4	65.7	2.6	8.6	2.2	51.5	0.5	12.3	1.9	0.5	3.9	3.0	108.0	0.0	0.0	138.7	0.1	0.1	3.3	0.2	0.6	0.1	0.0	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.3	4.5	0.0	0.5	0.3	0.1	0.0	0.0	0.4	1.1	0.1	0.0	2.6	0.3	0.0	0.4	4.3	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	17.7	0.2	0.1	1.7	0.0	0.0	1.0	0.2	25.7	0.6	0.0	0.6	0.3	23.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	71.3	135.5	104.1	71.7	51.3	64.7	54.9	65.5	65.7	51.5	108.0	3.2	0.0	2.0	14.7	0.0	0.4	0.5	0.6	1.8	9.1	1.1	32.4	3.9	0.0	1.3	12.9	6.2	0.3	0.1	0.8	0.0	0.2	0.4	3.0	1.2	4.3	16.1	0.0	109.1	0.2	0.0	2.6	0.0	6.5	0.0	1.4	0.7	0.5	0.2	1.7	109.2	0.4	2.0	0.0	0.4	0.1	0.0	0.2	1.8	7.5	0.0	1.1	0.0	33.7	19.3	0.4	0.3	0.0	0.0	3.7	0.5	0.7	4.3	6.1	0.0	0.9	0.6	0.2	0.5	0.1	0.6	0.5	0.1	0.5	0.4	0.3
TMEM200C	TTMA	ENSG00000206432	"Transmembrane protein 200C"	A6NKL6	18	5882072-5895955	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.7;salivary gland: 5.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.3;Cone photoreceptor cells: 6.2;Inhibitory neurons: 8.0;Oligodendrocyte precursor cells: 17.6"	"Cancer enhanced"	"Detected in single"		"glioma: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.1;NTERA-2: 4.7;PC-3: 22.0;U-2 OS: 10.9;U-251 MG: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA047253, HPA050490"	Uncertain		Approved	Microtubules		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules		"HPA047253: AB_2680001, HPA050490: AB_2681144"	"unprognostic (6.57e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.82e-4)"	"unprognostic (2.48e-10)"	"unprognostic (2.94e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.38e-2)"	0.2	3.9	2.2	0.3	2.2	0.0	0.6	0.3	2.2	0.7	0.0	0.5	0.1	0.5	1.1	0.2	0.5	0.4	2.1	1.0	2.5	1.6	1.0	0.1	0.4	2.2	7.7	0.7	0.0	0.1	2.3	0.0	2.6	0.7	0.0	0.8	5.5	0.2	0.0	0.2	0.6	0.1	2.5	0.6	0.4	0.9	2.6	0.1	0.1	0.0	0.3	0.4	0.1	0.9	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	22.0	1.3	0.0	0.0	0.0	0.0	1.1	3.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	10.9	0.0	3.9	0.0	0.0	0.0	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.2	0.3	2.2	1.0	2.5	2.2	7.7	2.6	2.5	2.6	0.9	0.1	0.0	1.1	0.3	0.0	0.1	0.0	0.0	0.0	9.3	0.5	2.0	2.4	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	2.0	3.4	0.1	0.7	0.0	0.0	1.6	0.0	0.1	2.2	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.0	0.0	0.4	1.1	1.2	0.2	0.0	1.0	0.0	0.8	0.0	17.6	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.2	1.3	0.0	0.0	1.4	0.3	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.1
TMEM213		ENSG00000214128	"Transmembrane protein 213"	A2RRL7	7	138797952-138838101	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 76.0;salivary gland: 52.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 53.3;Distal tubular cells: 144.8;Melanocytes: 26.6"	"Cancer enriched"	"Detected in some"	22	"renal cancer: 21.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 2.1;neutrophil: 1.1;NK-cell: 2.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA054059	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA054059: AB_2682361"	"unprognostic (2.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.84e-2)"		"unprognostic (1.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (5.54e-7)"	"unprognostic (4.33e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	0.1	0.1	0.5	0.2	0.5	1.1	4.7	0.6	0.7	2.8	0.4	0.1	1.3	0.2	0.6	0.3	0.1	0.2	0.0	0.6	0.1	76.0	0.1	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.4	0.4	0.1	0.3	52.3	1.2	0.1	5.3	0.3	0.1	0.0	0.2	0.4	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.1	2.1	0.2	0.2	0.3	0.2	0.4	0.2	0.1	0.2	0.1	0.3	0.2	0.1	1.1	2.0	0.2	0.2	0.1	0.1	0.5	0.5	0.6	0.7	0.6	0.1	0.2	0.1	0.4	0.0	0.5	1.0	0.1	3.2	9.9	0.0	0.1	0.0	0.9	3.0	0.0	0.4	14.1	7.9	0.4	0.0	4.4	53.3	0.0	0.0	0.2	0.0	144.8	0.0	0.0	0.9	0.4	0.5	0.0	0.0	0.6	0.2	0.1	0.2	0.0	1.3	1.3	0.1	0.0	0.0	0.1	1.7	0.4	0.0	2.0	0.0	0.8	0.0	0.0	0.1	26.6	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.9	3.5	1.3	0.0	0.5	0.2	0.0	0.2	0.0	0.4	0.0	0.6	0.0	0.2	0.6
TMEM218		ENSG00000150433	"Transmembrane protein 218"	A2RU14	11	125096545-125111763	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038489	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"HPA038489: AB_10672748"	"unprognostic (3.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.86e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.63e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.95e-2)"	"prognostic favorable (5.50e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.72e-2)"	17.7	18.1	4.8	9.5	5.5	5.3	14.0	5.3	6.5	15.5	5.3	13.5	8.4	16.6	6.9	11.6	14.8	7.4	10.2	4.6	5.4	12.7	12.9	12.0	10.5	6.0	5.5	15.0	14.5	10.3	15.2	5.9	5.8	13.0	6.0	6.5	10.9	6.8	9.2	8.9	11.8	8.3	5.7	16.6	13.2	5.6	5.1	8.4	10.9	5.7	7.0	13.8	13.2	6.3	12.5	24.0	14.9	18.2	13.5	18.6	9.0	12.2	9.2	9.3	12.0	2.5	35.9	15.6	29.9	7.5	14.2	14.2	9.4	11.6	12.2	22.0	13.5	35.1	6.1	10.0	13.3	11.1	12.6	14.7	15.2	16.5	19.6	14.9	13.7	19.1	14.4	19.4	16.2	6.4	2.9	23.3	12.2	34.0	22.6	16.3	18.0	12.0	8.3	12.3	12.9	19.4	16.6	6.6	9.1	8.7	31.3	15.7	17.6	11.4	10.3	13.4	13.5	11.1	10.1	12.9	9.1	22.9	20.3	43.7	40.1	17.4	21.6	31.6	18.7	29.6	20.5	20.5	47.4	23.9	17.2	20.4	15.7	32.5	30.9	41.1	20.5	27.0	4.8	5.5	5.3	6.5	4.6	5.4	6.0	5.5	5.8	5.7	5.1	6.3	21.0	19.2	13.4	7.8	17.8	12.1	19.6	34.6	19.4	7.0	22.1	24.6	8.1	15.7	16.6	14.7	0.0	28.0	18.1	5.7	27.4	20.5	3.4	23.1	22.4	15.8	10.8	14.5	4.4	16.2	18.4	21.1	8.6	10.6	3.8	22.2	18.5	15.1	42.2	23.5	7.4	11.7	20.3	21.0	17.5	1.9	10.2	21.9	17.8	14.0	26.0	26.0	18.6	9.5	11.2	13.1	3.9	16.6	15.8	9.4	8.5	19.7	29.4	12.4	26.3	16.7	18.3	16.6	13.8	18.0	14.2	9.7	14.5	27.0	13.7	16.6
TMEM236	"bA162I21.2, bA16O1.2, FAM23A, FAM23B"	ENSG00000148483	"Transmembrane protein 236"	Q5W0B7	10	17752201-17800868	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 33.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 81.1;Enteroendocrine cells: 23.4;Intestinal goblet cells: 28.8;Paneth cells: 48.1;Proximal enterocytes: 96.5;Undifferentiated cells: 19.0"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 1.7;pancreatic cancer: 0.5;stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"MOLT-4: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045096	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA045096: AB_2732516"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.54e-2)"	0.7	0.6	0.3	1.7	0.3	0.5	0.4	0.8	0.5	0.5	0.4	14.1	21.8	0.3	0.2	0.3	0.2	0.4	0.3	0.3	0.1	0.2	0.1	0.7	0.3	0.1	0.0	0.3	0.5	0.1	0.0	1.5	0.2	0.1	14.0	0.3	0.1	0.2	0.3	0.3	33.5	1.0	0.0	0.3	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.2	0.0	0.2	0.9	0.1	0.2	0.1	0.0	0.1	0.2	0.4	0.1	0.2	0.1	0.2	10.3	0.1	0.1	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.8	0.5	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.7	0.2	0.0	0.5	0.0	0.2	0.1	0.5	0.0	0.0	0.3	7.3	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.1	81.1	0.0	0.1	1.1	0.1	0.1	0.2	23.4	0.4	0.4	0.9	0.2	0.2	0.0	0.5	1.3	0.1	1.1	0.0	7.2	0.0	0.4	28.8	0.0	4.8	0.8	1.1	0.0	5.9	0.0	3.7	0.0	0.1	0.0	0.0	0.6	0.7	48.1	0.0	0.0	0.4	96.5	0.0	0.0	0.9	0.0	0.7	0.3	0.4	0.1	0.2	0.0	0.3	0.4	0.2	19.0	0.6
TMEM237	"ALS2CR4, JBTS14"	ENSG00000155755	"Transmembrane protein 237"	Q96Q45	2	201620184-201643570	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 89.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 81.7;Rod photoreceptor cells: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052596, HPA054732"	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 79: Retina - Phototransduction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA052596: AB_2681879, HPA054732: AB_2682587"	"unprognostic (1.70e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.06e-1)"	"unprognostic (8.30e-6)"	"unprognostic (4.15e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.96e-6)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	4.1	15.1	6.3	1.7	6.5	2.3	11.0	7.1	7.8	5.0	6.0	3.0	0.8	6.0	4.6	6.0	5.8	4.1	7.7	6.8	6.7	5.4	1.9	5.1	2.3	6.9	6.9	8.4	1.9	5.0	3.0	5.2	7.2	7.8	3.7	89.3	5.1	4.8	7.7	18.5	1.8	5.8	7.1	1.4	2.2	3.0	6.4	7.0	4.6	9.2	3.1	4.1	3.4	6.8	3.7	7.2	32.3	16.4	7.8	10.1	3.1	22.6	9.9	14.7	28.4	5.9	5.3	3.7	6.9	21.9	12.7	6.8	5.6	24.4	27.1	6.9	20.6	10.7	21.4	19.4	15.1	10.4	2.1	9.0	5.0	20.4	5.1	24.8	25.5	23.4	7.8	13.0	29.8	5.2	29.7	16.3	32.7	1.9	23.8	43.9	30.8	7.6	12.2	9.7	33.7	47.4	21.4	8.4	12.6	20.3	12.5	18.7	6.8	26.8	7.3	8.6	9.5	6.0	14.9	11.4	22.7	9.7	17.0	0.0	0.0	0.0	1.0	1.1	0.9	0.7	1.0	1.6	1.3	0.1	1.1	1.4	0.0	0.9	0.7	0.3	1.8	0.5	6.3	6.5	7.1	7.8	6.8	6.7	6.9	6.9	7.2	7.1	6.4	6.8	6.8	6.4	9.6	12.4	1.6	71.2	81.7	46.7	50.7	33.3	17.1	41.4	20.2	2.8	18.9	18.4	41.7	21.0	3.1	0.6	13.7	11.1	8.9	16.3	10.9	11.6	4.8	8.6	16.5	7.6	26.8	25.8	3.1	7.7	5.1	19.9	10.4	2.7	9.4	32.0	15.3	4.5	18.3	2.2	12.2	7.0	21.8	2.9	12.4	4.7	5.7	38.5	0.0	14.1	10.8	6.5	1.9	21.4	3.0	36.9	0.7	3.9	19.8	160.3	6.6	33.2	20.6	33.3	22.0	30.0	45.3	15.1	4.2	39.8	5.3	29.2
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759226-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.0;Endothelial cells: 81.5;granulocytes: 39.3;Hepatic stellate cells: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 28.6;HUVEC TERT2: 38.8;PC-3: 39.3;RPMI-8226: 25.1;TIME: 35.9;U-87 MG: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	14.2	6.1	1.3	3.7	1.3	0.7	10.6	1.1	2.2	10.1	2.1	4.0	1.6	8.4	0.3	3.9	8.1	3.6	6.6	1.6	3.7	10.1	3.4	13.2	2.4	2.1	1.3	4.3	3.1	1.6	3.5	1.0	1.7	7.0	1.4	0.4	4.2	2.2	2.9	4.2	4.8	5.0	1.4	8.2	4.3	3.3	1.9	0.8	11.2	3.9	1.8	7.5	7.1	1.5	10.3	0.0	0.6	0.0	2.8	0.0	0.1	4.8	10.7	5.5	3.5	0.4	0.2	0.2	0.1	7.7	12.5	1.5	1.1	0.7	2.3	0.1	0.9	0.3	0.4	0.0	1.4	2.9	28.6	1.8	2.3	11.7	4.6	15.7	38.8	0.6	0.1	0.2	12.0	0.2	1.5	0.9	1.0	1.6	39.3	1.8	0.8	25.1	5.4	0.5	2.2	5.1	0.2	1.5	0.1	1.0	0.6	8.2	35.9	1.6	10.3	0.6	1.7	0.0	0.0	1.9	40.6	2.7	0.3	31.2	5.4	0.7	0.0	5.5	0.0	0.9	0.0	0.0	1.5	2.8	0.0	0.0	2.7	0.0	4.0	0.0	0.0	1.4	1.3	1.3	1.1	2.2	1.6	3.7	2.1	1.3	1.7	1.4	1.9	1.5	65.0	6.4	4.8	2.3	1.9	5.9	1.2	0.9	1.2	0.9	1.1	1.7	9.1	0.0	0.2	1.8	0.0	0.1	0.3	0.0	1.9	8.2	0.8	0.3	0.8	81.5	1.2	3.2	2.7	1.7	0.1	4.7	0.0	0.2	39.3	2.3	105.0	0.7	12.9	0.0	0.1	0.2	0.0	17.4	14.6	1.1	7.8	16.3	8.8	7.5	3.4	0.5	0.0	0.0	0.6	1.3	0.1	3.0	1.4	1.7	0.0	0.1	0.5	0.8	6.6	0.9	3.6	5.1	19.1	0.2	4.7	0.0	1.8	2.1	0.3	1.0
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059958-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 8.4;skeletal muscle: 5.8;tongue: 2.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.4;Cytotrophoblasts: 16.0;Early spermatids: 7.0;Late spermatids: 19.7;Rod photoreceptor cells: 9.1;Sertoli cells: 6.6;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 58.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 26.8"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.0	0.9	0.9	0.0	1.0	0.0	0.1	8.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.5	0.0	0.5	0.1	0.6	0.8	0.0	1.1	0.0	1.2	0.9	0.7	0.1	0.0	1.1	0.0	0.0	5.8	0.5	0.0	0.0	0.5	0.1	0.0	0.6	1.4	0.3	0.0	2.2	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	8.4	1.7	1.2	0.9	0.6	0.8	0.7	0.5	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.5	0.5	0.0	0.0	0.0	1.8	10.4	16.0	0.0	0.0	1.9	0.0	7.0	0.2	0.1	0.4	0.0	0.0	0.0	0.2	2.2	0.9	1.5	0.1	0.0	0.2	0.4	0.4	4.5	1.7	0.0	0.0	0.0	0.3	0.0	19.7	0.0	0.4	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.0	0.0	0.7	1.5	9.1	6.6	1.3	0.2	0.5	6.3	0.0	0.0	5.9	0.2	0.5	0.0	0.7
TMEM45A	"DERP7, FLJ10134"	ENSG00000181458	"Transmembrane protein 45A"	Q9NWC5	3	100492619-100577444	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skin 1: 475.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 425.3;Club cells: 841.5;Early spermatids: 207.3;Suprabasal keratinocytes: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 406.9;ASC TERT1: 118.3;HSkMC: 125.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA062101	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	Vesicles	"HPA062101: AB_2684682"	"unprognostic (5.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.43e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.18e-11)"	"unprognostic (1.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-5)"	"unprognostic (2.68e-2)"	19.4	18.1	1.4	11.7	3.3	2.0	42.8	1.7	2.5	38.4	2.3	10.3	3.6	18.3	3.2	16.5	20.9	18.9	21.9	1.5	1.8	3.7	99.0	13.1	2.6	1.9	1.9	11.9	23.3	2.7	22.9	40.9	1.8	9.1	6.6	1.7	26.9	6.3	3.2	475.1	6.4	25.4	1.7	5.0	7.0	13.3	1.9	1.6	9.1	2.5	50.7	19.5	79.5	2.1	28.6	2.0	2.7	9.6	406.9	118.3	0.3	66.9	62.0	9.4	84.8	2.5	0.6	0.0	32.6	44.1	24.6	31.9	2.4	13.0	23.4	7.2	8.4	23.9	9.3	8.0	25.7	0.4	1.5	125.4	7.4	17.1	25.4	39.0	3.5	0.0	0.6	3.2	22.6	0.3	0.1	0.7	3.2	0.0	16.8	0.0	23.3	0.4	0.6	1.0	2.9	19.4	16.4	8.5	7.3	18.2	0.8	13.6	9.3	62.9	44.3	0.5	15.2	53.8	32.9	0.1	49.7	1.9	42.6	0.0	0.9	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.6	1.4	3.3	1.7	2.5	1.5	1.8	1.9	1.9	1.8	1.7	1.9	2.1	1.6	60.9	61.4	0.7	3.0	94.6	5.4	425.3	9.6	3.2	19.1	8.9	2.5	1.5	841.5	0.0	0.0	2.6	0.4	0.2	0.0	7.5	207.3	3.0	79.1	8.9	1.2	1.3	0.8	14.9	46.3	56.3	2.0	2.0	65.0	10.7	15.0	137.1	5.8	8.4	2.4	2.0	63.1	6.5	25.4	25.4	16.1	6.6	23.2	13.1	1.1	3.5	0.0	16.1	11.8	6.5	2.6	27.8	26.8	3.1	0.3	0.2	121.0	0.9	6.6	22.8	56.6	1.5	3.3	5.4	254.9	7.5	6.4	26.7	0.1	4.4
TMEM52B	"C12orf59, FLJ31166"	ENSG00000165685	"Transmembrane protein 52B"	Q4KMG9	12	10170542-10191801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"kidney: 175.8"	"Cell type enriched"	"Detected in some"	15	"Distal tubular cells: 712.1"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 95.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058096	Enhanced		Approved	"Focal adhesion sites"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Focal adhesion sites"		"HPA058096: AB_2683603"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.14e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.18e-1)"	0.1	0.1	0.6	0.8	0.9	3.4	0.3	0.8	0.9	0.1	0.9	0.1	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.7	0.7	175.8	0.2	0.7	0.2	1.3	0.8	0.0	0.3	0.1	0.0	6.0	1.2	0.1	0.1	0.1	1.9	0.0	0.0	0.4	0.2	0.4	1.0	0.1	0.4	0.3	1.2	0.1	0.2	0.0	0.2	0.2	0.0	1.6	2.3	0.1	0.0	0.1	0.0	0.0	1.1	2.2	0.0	0.1	0.0	95.9	0.1	0.0	0.1	0.7	4.9	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	11.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.1	0.0	0.0	7.0	8.9	0.0	3.0	5.0	1.4	0.0	0.2	0.4	0.0	0.0	0.1	0.1	0.1	0.2	4.7	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.6	0.9	0.8	0.9	0.7	0.7	1.3	0.8	1.2	1.0	1.2	1.6	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	12.9	0.0	44.7	0.0	0.1	712.1	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.8	0.0	2.5	3.2	0.0	0.1	0.0	0.0	0.0	0.0	10.8	0.0	0.2	0.0	0.0	0.8	1.1	0.1	0.3	4.2	1.8	2.8	1.7	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	19.4	0.1	0.0	0.0	0.1
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;heart muscle: 37.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.9;Kupffer cells: 20.7;Langerhans cells: 25.7;Macrophages: 26.2;monocytes: 25.5;NK-cells: 54.6;T-cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 9.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 269.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.7;HDLM-2: 54.5;Karpas-707: 11.1;U-937: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	5.6	2.0	1.0	13.1	1.3	33.5	8.5	1.0	9.7	2.5	2.2	11.3	2.2	1.3	1.1	2.8	1.9	5.5	37.1	1.1	1.8	2.6	3.9	8.2	13.2	1.6	1.3	1.0	2.4	0.7	1.1	1.8	2.1	2.0	3.4	0.5	5.7	2.2	1.6	1.1	7.3	3.6	1.1	18.4	2.8	1.0	2.4	19.2	2.0	4.6	10.6	4.6	1.9	1.6	0.4	0.0	4.9	0.0	0.0	0.0	0.0	1.3	12.7	0.5	0.9	0.0	0.0	0.1	0.6	4.1	0.1	0.0	0.0	0.3	1.5	54.5	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.1	0.0	0.1	2.0	1.4	1.0	6.7	0.0	11.1	2.4	0.0	2.9	2.2	1.2	0.0	0.4	0.1	1.8	0.8	4.8	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.1	0.5	0.9	1.2	5.7	0.1	2.9	0.0	9.0	31.6	3.7	61.9	55.9	101.6	31.3	16.1	57.9	6.6	22.8	22.2	33.7	4.7	33.9	25.1	269.0	12.9	14.7	1.1	3.0	39.0	1.0	1.3	1.0	9.7	1.1	1.8	1.6	1.3	2.1	1.1	2.4	1.6	0.5	0.0	3.0	0.0	6.9	0.9	1.0	2.5	0.6	0.0	4.2	2.7	15.9	0.0	5.5	0.0	0.0	0.0	39.9	0.1	0.0	0.0	6.5	0.1	0.3	1.5	0.0	8.8	0.5	0.0	0.0	4.1	1.1	0.2	1.3	0.0	3.3	0.2	3.2	0.0	1.3	0.2	0.0	20.7	25.7	5.1	0.0	26.2	5.4	17.8	25.5	1.9	54.6	0.0	0.1	0.1	0.0	0.0	11.3	0.1	0.0	0.4	2.9	0.0	0.0	3.7	0.8	0.0	0.6	0.4	0.3	0.3	35.9	0.1	0.0	4.5
TMEM72	"bA285G1.3, C10orf127, KSP37"	ENSG00000187783	"Transmembrane protein 72"	A0PK05	10	44911316-44937010	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 51.2;kidney: 74.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 27.6;Distal enterocytes: 21.1;Distal tubular cells: 33.2;Late spermatids: 15.9;Paneth cells: 8.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	123	"RPMI-8226: 44.0;U-937: 26.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039894, HPA062907"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA039894: AB_10795261, HPA062907: AB_2684900"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.08e-1)"		"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"		"unprognostic (8.58e-2)"	"unprognostic (5.45e-2)"		"prognostic favorable (1.01e-4)"	"unprognostic (4.99e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"		0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.7	0.5	0.0	51.2	6.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	1.5	74.4	0.1	0.0	0.0	1.7	1.5	0.0	9.1	0.5	0.2	0.0	1.4	0.0	7.7	0.2	2.4	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.2	2.8	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	3.5	1.5	1.7	1.5	1.4	0.2	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	0.0	21.1	33.2	0.1	5.5	0.7	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742499-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 24.4;kidney: 11.5;liver: 52.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 42.8;Hepatocytes: 49.3;Paneth cells: 60.2;Proximal enterocytes: 173.6;Proximal tubular cells: 53.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"CACO-2: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favorable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	24.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	52.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	1.6	0.0	42.8	7.9	0.0	0.0	0.0	0.0	0.0	2.4	2.7	0.0	0.2	2.9	0.0	1.5	0.1	0.0	0.0	0.4	49.3	0.1	0.0	0.0	9.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	60.2	0.0	0.0	0.0	173.6	53.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	12.5	0.0
TMEM88	"FLJ20025, MGC71744"	ENSG00000167874	"Transmembrane protein 88"	Q6PEY1	17	7855066-7856099	"Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.5"	"Group enriched"	"Detected in many"	7	"Adipocytes: 177.3;Endothelial cells: 142.1;Hepatic stellate cells: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.3"	"Group enriched"	"Detected in many"	6	"AN3-CA: 65.2;HHSteC: 42.3;HUVEC TERT2: 51.4;NTERA-2: 26.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052991	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA052991: AB_2682006"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (3.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.49e-2)"	"prognostic favorable (4.43e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.68e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.72e-1)"	63.2	22.3	11.2	7.9	11.0	6.9	29.5	12.4	24.4	20.0	14.3	18.1	5.7	24.1	3.6	6.4	26.4	12.7	98.5	11.3	11.6	37.7	5.9	14.1	3.6	12.6	11.6	8.5	10.8	7.4	21.4	23.7	12.0	19.3	2.7	2.4	9.3	6.3	35.4	3.8	15.4	10.1	11.0	15.9	18.2	4.9	12.9	2.5	39.6	36.8	0.8	19.1	14.0	10.9	0.2	0.8	8.1	65.2	0.0	0.3	3.9	0.4	0.2	0.1	0.2	1.9	0.3	0.4	0.3	0.7	0.4	0.5	0.6	0.4	0.1	0.0	0.1	0.5	1.2	1.1	42.3	0.6	2.6	1.0	1.8	1.2	0.3	0.6	51.4	0.9	1.2	0.1	0.8	5.0	0.5	1.2	26.5	0.3	0.0	0.3	0.2	0.1	0.6	1.6	0.7	3.7	0.5	0.8	2.0	2.2	1.4	0.2	5.2	0.4	1.6	2.2	0.5	0.2	0.1	0.4	0.2	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	11.0	12.4	24.4	11.3	11.6	12.6	11.6	12.0	11.0	12.9	10.9	177.3	6.4	2.2	2.0	6.2	4.1	4.0	1.4	2.2	4.7	7.9	5.2	5.9	0.0	2.4	1.8	4.2	3.1	3.1	2.0	0.0	2.2	3.0	3.1	2.0	142.1	6.6	0.0	0.6	2.2	1.0	19.2	4.6	6.7	4.5	1.8	109.9	2.4	2.6	3.3	0.9	2.5	0.0	7.3	9.3	8.6	0.9	9.9	0.0	5.6	0.2	0.6	0.0	0.0	0.1	4.0	5.7	0.0	1.0	6.5	2.4	0.6	1.5	1.4	0.0	11.3	6.5	1.7	1.8	2.7	3.1	5.2	2.5	0.8	1.5	3.2
TMEM88B		ENSG00000205116	"Transmembrane protein 88B"	A6NKF7	1	1426128-1427787	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	196	"brain: 437.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.2;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065743	Enhanced					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"				"HPA065743: AB_2685552"	"unprognostic (3.17e-2)"	"unprognostic (1.42e-2)"		"unprognostic (1.63e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.30e-5)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"			"unprognostic (3.53e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.95e-2)"	0.0	0.0	95.5	0.1	285.1	0.0	0.0	192.8	193.1	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	82.8	125.8	1.0	0.0	0.1	0.0	312.3	232.8	0.1	0.0	0.0	0.0	0.0	199.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	129.9	0.0	0.0	2.2	242.8	0.0	0.0	0.0	0.0	0.3	0.1	437.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	285.1	192.8	193.1	82.8	125.8	312.3	232.8	199.0	129.9	242.8	437.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	0.7	6.2	14.2	0.5	14.1	0.0	0.4	14.0	18.0	0.7	10.5	1.0	0.4	0.5	0.7	1.5	0.6	0.2	0.7	14.1	19.3	2.3	0.8	1.0	0.8	19.6	15.7	1.5	0.2	0.1	9.9	0.4	19.2	0.5	0.3	0.7	0.5	1.0	3.6	0.7	0.5	0.4	16.0	0.7	0.3	1.5	18.7	0.5	0.9	1.2	0.8	0.6	0.9	14.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	2.7	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.5	10.7	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.1	1.2	0.0	0.3	0.1	0.1	0.3	2.3	0.3	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	14.2	14.1	14.0	18.0	14.1	19.3	19.6	15.7	19.2	16.0	18.7	14.9	1.9	0.0	0.0	0.3	0.0	0.8	0.2	0.5	0.0	3.8	0.2	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.4	0.5	0.2	0.0	0.7	0.0	0.0	1.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.4	1.5	0.6	0.3	0.0	1.9	0.1	1.4	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.0	1.1	1.0	2.6	3.2	0.0	0.9	0.1	0.2	0.1	0.0	0.2
TMIGD1	"TMIGD, UNQ9372"	ENSG00000182271	"Transmembrane and immunoglobulin domain containing 1"	Q6UXZ0	17	30316333-30334059	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"intestine: 140.5"	"Group enriched"	"Detected in some"	28	"Distal enterocytes: 291.9;Paneth cells: 125.5;Proximal enterocytes: 476.6"	"Cancer enriched"	"Detected in single"	5	"colorectal cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021946			Approved	Mitochondria		NA	NA				"Cluster 9: Intestine - Unknown function"		"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA021946: AB_1858140"			"unprognostic (1.28e-1)"										"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"				0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	140.5	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	291.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	125.5	0.0	0.0	0.0	476.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.5	0.0
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464300-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 280.4;stomach 1: 146.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.8;Gastric mucus-secreting cells: 155.4;Paneth cells: 368.3;Prostatic glandular cells: 203.4;Proximal enterocytes: 159.6;Urothelial cells: 166.6"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.8;MCF7: 10.5;OE19: 35.9;RT4: 57.8;SK-BR-3: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA034493, HPA035787"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.6	0.2	0.4	13.9	0.4	0.1	20.1	0.2	0.4	5.0	3.1	104.0	78.5	1.0	2.8	36.1	10.7	24.1	0.2	0.3	0.3	47.7	33.5	39.9	0.2	0.4	0.3	0.2	111.4	4.0	1.5	0.2	0.3	280.4	78.0	0.2	76.2	7.7	0.1	7.3	89.6	3.3	0.1	0.2	146.2	1.5	0.3	0.8	19.2	0.1	10.2	35.7	7.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.1	22.8	3.3	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	3.7	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	10.5	0.3	1.0	2.3	35.9	0.2	0.1	0.0	2.6	1.3	57.8	0.2	0.7	0.3	11.7	0.3	0.4	8.8	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.5	0.1	51.3	109.8	0.0	1.7	0.3	30.9	6.8	0.0	0.0	34.0	25.8	0.6	32.9	42.1	47.8	0.0	0.7	1.1	404.8	23.5	39.2	21.3	7.4	0.5	1.3	18.0	2.7	0.2	60.4	0.1	1.0	155.4	5.8	7.0	0.0	0.4	32.0	0.1	0.0	0.1	84.1	44.7	0.3	0.3	4.8	0.0	2.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	65.1	368.3	0.0	0.0	203.4	159.6	3.8	36.6	0.0	0.0	1.6	2.0	0.4	1.4	2.1	0.1	0.3	1.1	0.0	105.7	166.6
TMPRSS5	"MGC141886, MGC148044"	ENSG00000166682	"Transmembrane serine protease 5"	Q9H3S3	11	113687547-113706373	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.6;choroid plexus: 20.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 26.4;Excitatory neurons: 5.4;Horizontal cells: 5.0;Oligodendrocytes: 15.5"	"Cancer enhanced"	"Detected in some"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.0;CAPAN-2: 3.2;OE19: 2.0;WM-115: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010992			Approved	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA010992: AB_1858152"	"unprognostic (1.53e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.19e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.04e-3)"	1.3	0.5	28.1	0.2	34.7	1.4	2.0	24.9	39.0	0.8	20.8	0.7	0.1	0.5	0.2	0.5	0.7	0.7	1.0	28.2	27.0	1.0	1.0	0.7	0.2	34.0	29.8	0.6	0.5	0.0	1.6	0.2	33.1	0.8	0.3	1.1	9.6	0.3	2.6	2.1	0.7	0.3	28.5	0.8	0.8	2.1	32.1	0.3	0.6	0.5	0.3	0.7	1.0	50.6	0.2	0.3	2.0	1.1	0.2	0.1	0.3	0.5	0.2	0.3	0.4	1.1	3.2	0.1	1.4	0.2	0.3	0.4	0.1	0.2	0.1	0.2	0.6	0.4	0.3	0.0	0.1	0.5	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.7	0.4	0.2	0.4	0.0	0.4	0.6	0.2	2.0	0.1	0.4	0.2	0.0	0.3	0.2	0.3	0.4	0.2	0.0	1.6	0.2	0.2	0.2	0.2	0.4	0.7	0.3	0.3	0.2	0.1	0.0	0.1	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	34.7	24.9	39.0	28.2	27.0	34.0	29.8	33.1	28.5	32.1	50.6	0.2	0.0	0.0	26.4	0.2	0.3	0.2	0.0	0.0	0.5	1.0	0.9	0.5	0.0	0.1	1.8	2.1	0.0	0.2	0.2	0.0	0.3	0.1	0.3	0.2	0.3	0.0	1.3	5.4	0.9	0.0	0.3	0.0	0.4	0.0	0.4	0.4	0.2	0.1	5.0	2.8	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	2.8	0.1	3.2	0.0	3.5	15.5	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	1.3	0.0	0.5	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2
TNFAIP8L2	FLJ23467	ENSG00000163154	"TNF alpha induced protein 8 like 2"	Q6P589	1	151156649-151159749	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 70.4;Kupffer cells: 65.4;Macrophages: 35.8;monocytes: 34.7;NK-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 29.8;HL-60: 17.6;HMC-1: 44.1;NB-4: 25.2;THP-1: 95.2;U-937: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062742			Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA062742: "	"unprognostic (3.19e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.15e-3)"	"prognostic favorable (3.64e-4)"	"unprognostic (9.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.23e-1)"	4.7	4.3	4.9	19.6	5.4	6.1	3.4	5.1	7.5	2.3	5.7	4.5	5.3	1.5	1.4	2.5	2.2	5.5	2.3	4.7	5.2	2.0	5.6	10.8	32.0	6.5	5.7	1.0	1.4	1.2	1.2	6.9	7.0	2.1	6.1	0.9	2.6	1.8	0.8	3.8	7.6	5.4	6.4	39.2	3.4	0.8	6.3	19.2	1.3	2.2	17.7	7.8	1.4	8.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	29.8	0.4	0.0	0.0	17.6	44.1	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.1	0.1	0.0	0.1	0.4	25.2	0.0	0.0	0.1	5.3	0.1	4.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	95.2	2.5	0.2	0.1	0.1	0.2	0.3	0.0	1.9	0.1	37.8	0.1	317.0	238.8	246.7	103.2	220.2	101.9	78.3	125.7	105.2	265.4	83.2	189.5	137.3	292.3	232.9	210.6	63.0	155.7	249.5	4.9	5.4	5.1	7.5	4.7	5.2	6.5	5.7	7.0	6.4	6.3	8.1	0.3	0.0	1.7	0.0	6.9	0.3	0.0	0.0	0.0	0.8	0.8	0.3	0.1	2.8	1.3	0.0	0.0	0.3	11.1	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	8.8	0.0	0.0	0.5	0.2	0.0	0.0	5.1	0.0	0.7	0.3	70.4	0.0	0.0	0.0	0.0	65.4	12.8	0.4	0.3	35.8	0.0	0.0	34.7	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.4	10.6	0.0	0.0	0.0
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391288	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.5;salivary gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.6;Intestinal goblet cells: 24.0;Paneth cells: 42.3;Proximal enterocytes: 25.5;Undifferentiated cells: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 5.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 5.3"	"Cell line enriched"	"Detected in many"	6	"HDLM-2: 125.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		110000	"Cluster 48: NK-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	1.8	1.1	0.8	5.7	1.6	0.4	4.1	0.1	1.9	1.4	0.3	17.1	30.5	0.9	0.3	2.8	0.9	7.6	0.6	2.0	1.1	0.4	0.6	1.0	1.2	0.7	1.1	0.4	1.7	0.9	6.8	3.2	0.2	1.3	17.6	0.2	25.4	2.7	0.3	2.7	18.6	1.7	0.7	0.8	5.5	0.9	1.2	1.0	1.2	0.1	1.9	1.6	1.6	2.1	3.2	2.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.6	0.4	0.6	0.0	3.5	0.4	1.4	2.2	8.3	0.9	0.2	125.9	5.4	0.0	1.3	1.7	0.0	0.5	1.3	0.2	0.4	0.8	3.1	4.2	3.1	0.3	0.0	0.0	0.0	1.1	0.0	0.1	5.9	7.0	19.3	0.4	0.0	0.6	1.5	1.5	20.4	0.7	0.6	3.0	0.1	0.8	1.3	0.4	2.0	0.0	0.1	0.1	0.0	1.2	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.3	0.6	0.0	0.8	1.6	0.1	1.9	2.0	1.1	0.7	1.1	0.2	0.7	1.2	2.1	0.4	0.0	2.2	0.0	0.4	1.3	3.8	1.1	0.6	0.6	4.5	3.3	1.3	8.6	2.3	0.0	0.0	0.1	3.3	35.6	0.0	8.3	0.3	3.2	0.5	5.3	10.8	0.0	4.0	7.5	0.6	0.7	11.7	6.2	0.0	2.0	7.1	0.3	15.5	3.3	0.2	24.0	0.0	17.0	2.4	0.4	0.6	7.7	1.8	8.4	19.7	0.0	3.1	0.5	0.4	14.7	42.3	0.0	0.5	2.8	25.5	0.0	3.8	0.2	0.0	0.5	0.4	0.8	1.9	1.7	2.3	0.1	0.7	0.0	42.2	4.4
TNFSF12	"APO3L, DR3LG, TWEAK"	ENSG00000239697	"TNF superfamily member 12"	O43508	17	7549058-7557890	"Predicted secreted proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Cytokine, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.7;BJ hTERT+: 18.4;HDLM-2: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035984, HPA052967"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	853000	130000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA035984: , HPA052967: AB_2682000"	"unprognostic (2.96e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.71e-2)"	"prognostic favorable (5.70e-5)"	"unprognostic (5.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.09e-2)"	"unprognostic (6.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.38e-1)"	41.6	28.5	57.4	9.8	55.3	3.1	36.6	49.4	66.5	37.6	48.9	68.2	9.7	38.2	7.0	13.9	37.7	15.6	39.6	54.8	50.4	32.9	16.5	37.7	15.8	55.7	54.2	42.7	23.2	11.1	18.0	11.2	53.2	39.4	5.7	2.9	26.1	27.2	16.9	15.8	26.7	13.3	52.8	38.4	38.8	5.6	57.0	4.8	22.9	9.3	5.5	47.1	30.1	52.1	0.0	0.5	0.7	0.0	14.9	17.7	4.0	6.9	18.4	7.7	5.7	0.1	2.5	0.0	5.8	16.3	0.8	1.4	1.4	0.6	1.6	20.3	2.0	0.9	0.4	2.3	12.8	0.0	0.0	15.0	2.6	2.8	0.3	3.0	12.1	0.0	0.0	0.0	7.0	0.0	0.0	0.5	0.6	0.1	7.5	0.1	0.0	0.1	11.6	0.0	0.0	7.9	2.5	0.0	12.6	0.1	1.4	0.6	16.1	15.1	1.1	0.1	8.8	0.0	0.0	0.0	2.4	0.0	10.5	2.6	3.5	11.6	5.1	5.9	6.0	2.9	4.3	3.1	2.2	1.8	4.1	4.2	2.0	2.8	1.5	2.5	4.0	1.1	57.4	55.3	49.4	66.5	54.8	50.4	55.7	54.2	53.2	52.8	57.0	52.1	115.9	9.6	12.2	0.0	20.4	6.1	11.1	1.5	6.8	6.7	21.7	41.7	4.3	17.2	3.4	16.5	0.0	1.6	38.3	2.5	7.9	15.2	0.4	4.1	15.2	33.9	1.2	3.2	0.0	12.1	0.8	42.7	4.6	8.5	34.3	6.8	48.5	3.4	44.3	20.2	0.0	3.4	0.0	59.7	26.8	1.2	50.7	62.1	19.6	0.0	28.6	46.6	40.2	0.0	0.0	8.1	1.7	50.4	3.6	6.7	0.4	39.6	0.6	2.6	59.2	34.4	56.7	0.2	1.1	2.1	7.5	0.8	38.7	9.4	4.1	6.0
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377764	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	205	"heart muscle: 10670.6"	"Cell type enriched"	"Detected in many"	32	"Cardiomyocytes: 12561.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"RH-30: 1077.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.8"	"CAB015371, HPA015774, HPA017888"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Focal adhesion sites,Microtubules"		No	No		57000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli"	"Focal adhesion sites, Microtubules"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	2.2	4.9	12.4	0.6	13.9	0.1	11.9	11.7	20.4	2.3	11.7	1.3	0.3	3.2	0.8	7.8	1.9	3.8	10670.6	16.8	11.6	51.9	2.3	22.0	2.7	11.6	11.6	1.3	5.0	0.0	4.5	10.3	11.6	6.1	0.1	0.4	3.6	0.7	16.5	21.7	1.6	0.1	11.6	0.7	2.0	1.7	11.6	2.1	2.0	9.4	0.5	19.3	5.0	15.8	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.5	0.0	0.0	6.7	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.0	44.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	1.1	0.0	0.0	2.2	3.3	0.0	0.0	1077.7	0.0	0.7	0.4	1.1	0.8	0.1	2.0	0.0	61.2	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	13.9	11.7	20.4	16.8	11.6	11.6	11.6	11.6	11.6	11.6	15.8	0.6	3.2	3.0	0.3	0.0	3.4	1.4	1.7	1.8	3.9	0.9	1.7	12561.8	0.0	1.1	1.8	0.0	3.5	0.0	2.3	0.0	0.4	11.6	1.2	0.2	93.3	0.0	0.0	9.4	0.4	1.2	385.3	1.1	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.5	1.7	0.0	0.0	0.8	19.3	0.6	0.3	0.0	1.9	2.6	0.0	0.0	0.5	0.7	1.2	1.4	1.2	0.0	2.1	0.8	0.9	0.7	0.6	0.0	8.7	145.8	0.5	0.2	2.5	7.2	4.2	0.1	0.8	3.2	1.5
TOX2	"C20orf100, dJ1108D11.2, GCX-1"	ENSG00000124191	"TOX high mobility group box family member 2"	Q96NM4	20	43914852-44069616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 22.3;Excitatory neurons: 20.5;Hepatic stellate cells: 34.2;Inhibitory neurons: 76.9;Oligodendrocyte precursor cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 92.0;U-266/70: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA049900, HPA058396"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049900: AB_2680942, HPA058396: AB_2683704"	"unprognostic (2.15e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.97e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (7.45e-8)"	"unprognostic (1.60e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.60e-2)"	"unprognostic (3.12e-1)"	10.0	4.0	11.2	6.2	8.2	1.8	6.8	4.9	18.4	10.2	2.3	7.6	1.3	6.2	1.1	12.8	3.6	2.9	3.6	8.3	35.7	5.1	5.2	36.4	13.3	12.3	18.8	3.1	2.0	10.1	24.6	2.6	15.9	16.7	2.4	1.9	3.8	2.7	1.5	5.1	10.2	1.6	5.8	5.7	9.7	20.8	25.9	50.2	7.4	6.4	8.1	17.6	8.9	10.6	9.9	12.5	4.9	0.9	4.7	13.3	0.1	11.5	5.3	8.1	8.9	0.0	4.0	0.0	16.8	16.6	35.2	5.1	3.2	0.3	8.4	15.5	2.7	0.0	1.1	0.0	92.0	0.1	19.4	31.0	14.0	27.0	1.6	25.8	9.4	9.5	0.0	14.5	4.6	11.3	3.2	4.5	3.0	0.3	42.2	0.0	10.1	15.4	0.0	1.2	4.3	35.8	2.4	0.0	18.0	0.5	0.0	9.2	11.3	0.0	7.5	0.3	0.1	57.4	13.5	9.0	16.9	0.1	27.0	0.0	0.2	6.5	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.7	1.1	0.0	2.6	1.2	0.1	11.2	8.2	4.9	18.4	8.3	35.7	12.3	18.8	15.9	5.8	25.9	10.6	8.0	0.0	0.6	3.9	3.4	1.0	1.0	0.7	0.0	0.8	0.2	0.1	0.8	1.5	0.1	0.0	0.0	0.0	7.3	0.3	0.0	0.1	22.3	0.3	8.9	8.9	0.0	0.0	20.5	0.2	0.1	6.7	1.5	0.3	0.0	10.7	34.2	0.5	1.5	3.3	76.9	0.6	0.0	2.9	3.6	17.3	1.8	1.2	1.8	3.7	0.2	4.6	1.0	45.2	0.5	0.1	2.2	0.7	12.1	0.5	0.0	0.1	0.0	0.1	0.0	0.4	8.7	1.3	1.8	0.2	1.3	0.3	10.5	0.1	1.8	0.3
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52436417-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.9;retina: 17.6;stomach 1: 20.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Enteroendocrine cells: 61.7;Inhibitory neurons: 138.9;Muller glia cells: 162.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 75.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 46.1;HAP1: 22.1;Hep G2: 20.8;OE19: 25.8;RT4: 97.1;SCLC-21H: 30.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favorable (3.95e-4)"	0.4	3.0	4.7	1.4	5.6	0.0	3.8	1.2	6.0	7.6	0.3	15.6	9.3	1.3	4.4	0.6	3.1	6.9	0.0	5.3	4.4	9.5	5.2	1.4	0.1	4.6	3.5	0.9	2.6	0.0	2.3	0.2	3.0	1.8	17.9	17.6	8.9	0.5	4.0	0.7	9.3	1.0	5.1	0.0	20.3	0.6	8.4	1.3	0.0	0.5	0.2	5.7	1.0	6.8	0.0	5.8	46.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	3.5	0.0	0.3	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	25.8	0.0	0.0	8.0	0.2	10.7	97.1	30.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.6	1.2	6.0	5.3	4.4	4.6	3.5	3.0	5.1	8.4	6.8	0.2	6.4	8.2	1.3	0.0	1.0	0.5	2.8	0.6	4.1	20.0	12.6	0.7	52.9	7.7	35.0	0.0	0.0	0.0	47.6	3.9	1.6	3.2	1.6	0.4	0.3	61.7	0.0	3.9	5.1	0.0	1.5	29.6	6.1	0.0	0.1	0.7	4.6	0.1	40.4	138.9	31.7	2.0	0.0	0.3	1.8	0.6	0.2	0.0	8.4	0.0	162.1	0.0	51.8	75.0	15.3	15.2	0.0	0.2	11.8	16.6	14.0	12.3	3.8	0.0	3.3	0.8	0.1	0.8	0.3	0.3	0.0	0.4	9.7	32.6	6.5
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 13012.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 3141.3;SuSa: 3810.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		120000000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	372.0	103.6	49.8	232.9	53.2	21.6	348.8	52.4	53.9	577.4	59.3	2947.3	289.6	1566.9	250.5	639.0	823.8	288.0	10621.0	53.3	42.2	215.5	94.8	247.1	48.1	42.5	44.3	320.3	383.4	37.5	70.6	206.4	43.7	809.6	523.1	83.9	258.2	1545.5	12678.0	150.7	680.8	1754.9	44.8	134.3	976.5	52.3	50.0	21.1	156.8	5183.6	29.4	1511.0	425.8	42.2	554.5	357.3	418.1	20.9	143.1	89.9	1335.5	1509.1	552.8	905.9	669.2	253.9	107.6	1.7	677.7	1517.1	602.7	295.9	361.8	243.4	597.0	14.5	50.9	81.2	376.3	124.5	403.3	3.8	17.9	125.7	138.0	742.1	198.2	3141.3	243.2	14.7	8.7	20.4	695.3	286.4	25.6	7.1	496.0	129.0	61.1	9.0	146.5	15.8	1308.7	298.8	101.1	71.7	180.9	284.4	65.1	3810.3	204.8	15.3	1095.8	1178.8	572.0	181.6	1094.8	5.9	4.3	7.8	335.9	22.4	842.1	48.7	9.9	4.8	4.0	19.2	3.1	5.5	3.6	4.3	14.1	5.6	4.0	3.6	10.7	1.9	14.3	2.4	6.3	15.6	49.8	53.2	52.4	53.9	53.3	42.2	42.5	44.3	43.7	44.8	50.0	42.2	542.3	57.7	86.3	19.9	12.1	71.9	202.0	344.1	18.2	49.0	450.1	953.1	13012.4	346.0	147.0	318.2	383.7	212.1	20.6	561.3	187.9	2502.6	6.5	147.2	614.4	294.3	267.7	137.0	44.2	1671.1	3094.8	557.1	279.3	211.2	52.0	85.3	175.6	138.1	201.5	52.2	53.2	964.7	183.1	42.5	72.1	27.3	205.0	114.3	81.8	111.5	47.5	47.4	28.8	36.2	6.0	2372.3	623.4	1130.3	8.8	244.3	724.7	361.1	104.2	447.5	1038.7	484.0	1685.9	27.4	82.2	29.4	50.4	103.0	29.0	130.7	385.3	198.2
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155077	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 76.4;liver: 68.8;thyroid gland: 76.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 144.6;Proximal tubular cells: 307.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced					NA	NA		39000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA019851: AB_1858213, HPA062364: "	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.8	16.4	9.2	12.9	12.2	10.0	10.0	10.5	12.2	7.7	9.6	34.5	34.5	6.9	17.5	10.3	7.0	10.4	12.2	10.4	9.7	76.4	68.8	9.3	10.0	9.8	9.7	4.5	11.6	18.0	7.5	5.6	9.9	10.8	35.1	13.1	12.1	6.6	13.2	10.3	28.9	10.5	9.3	11.0	12.2	6.7	9.9	9.2	76.9	11.7	10.1	15.9	7.4	9.8	24.5	7.3	7.9	19.9	12.9	24.9	19.5	27.7	30.8	23.3	36.2	17.1	5.9	3.1	20.3	37.0	18.0	12.0	11.3	20.0	38.6	16.2	16.2	20.0	12.0	25.2	14.1	9.3	17.4	14.5	21.2	26.0	16.5	15.1	32.9	13.5	40.6	5.6	17.2	11.1	9.6	12.7	13.2	33.9	20.7	11.9	19.6	13.8	27.2	24.8	13.0	10.0	18.3	31.9	36.9	19.9	22.9	9.0	14.0	53.1	10.3	28.0	40.0	8.1	38.9	8.0	19.0	12.3	54.5	8.7	22.1	7.2	11.6	46.7	14.9	2.7	9.2	11.1	32.3	2.6	8.1	11.2	2.2	10.4	40.7	6.5	16.2	17.2	9.2	12.2	10.5	12.2	10.4	9.7	9.8	9.7	9.9	9.3	9.9	9.8	13.9	16.0	15.5	4.6	12.6	42.7	41.3	23.0	13.6	15.3	20.9	15.0	22.9	25.8	15.8	35.0	22.9	20.7	20.5	144.6	115.4	52.7	1.2	38.4	15.3	14.3	24.0	18.1	18.7	37.4	25.3	11.3	14.8	39.4	22.9	4.3	17.5	86.5	44.9	6.7	13.2	34.8	22.4	48.5	60.9	2.8	4.1	41.1	24.9	9.4	32.6	33.5	29.9	11.1	10.2	76.8	106.6	10.1	9.7	38.8	80.8	307.6	12.2	19.5	0.0	9.3	13.9	0.7	7.7	19.5	34.5	17.5	21.1	9.5	50.7	78.9
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 858.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 61.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 65.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		43000	"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"		"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	44.3	27.1	199.2	8.0	200.1	1.0	81.0	186.0	225.7	50.3	168.7	96.4	23.7	29.3	9.7	99.3	858.4	21.9	81.4	188.1	222.0	60.7	4.4	148.0	4.4	258.7	291.6	8.6	23.9	13.6	40.7	78.5	231.2	18.9	14.1	9.6	39.5	13.3	72.2	170.5	38.0	21.4	223.6	17.7	43.6	15.4	228.3	4.7	18.4	55.8	9.1	32.8	36.4	296.2	0.4	59.9	0.6	0.4	0.4	9.4	0.2	1.7	0.4	0.4	0.9	3.9	12.0	0.0	0.9	0.8	0.2	11.3	9.2	0.0	0.1	0.0	3.5	0.0	1.5	1.7	0.1	0.0	0.0	2.4	0.3	3.6	0.0	1.8	0.6	0.0	0.1	0.0	5.4	0.3	0.0	0.2	1.9	40.8	0.0	0.0	31.1	0.2	0.0	0.0	47.8	20.7	0.0	0.1	2.4	1.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.9	0.0	25.4	12.4	0.0	37.6	0.2	0.0	0.0	0.0	33.1	0.1	0.0	0.0	5.8	0.0	65.8	0.3	0.0	9.4	199.2	200.1	186.0	225.7	188.1	222.0	258.7	291.6	231.2	223.6	228.3	296.2	14.7	16.0	129.8	17.0	0.2	303.9	8.8	92.5	5.7	3.8	5.9	5.0	4.1	30.0	160.4	18.4	4.2	8.3	0.2	28.4	5.9	166.8	60.1	962.0	30.9	31.6	177.9	0.0	0.5	1.8	4.3	141.9	7.1	14.7	25.4	1.0	5.0	0.1	2.9	0.0	0.7	65.1	132.2	3.8	82.5	23.7	29.2	13.7	501.6	1.0	10.7	68.7	1.0	1.0	30.0	8.4	39.7	3.4	0.0	5.6	29.8	0.9	1825.2	8.9	236.7	259.3	163.7	8.1	5.8	1.6	495.3	80.0	5.5	0.8	27.3	10.1
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 79.8"	"Cell type enriched"	"Detected in some"	10	"T-cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Group enriched"	"Detected in some"	25	"JURKAT: 29.9;MOLT-4: 76.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	1.1	0.6	0.0	11.0	0.0	2.7	0.8	0.0	0.0	0.4	0.0	1.3	1.4	0.4	0.4	1.0	0.3	2.5	0.4	0.1	0.0	0.3	1.3	2.1	23.9	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.8	1.5	0.0	0.6	0.1	0.1	0.6	3.0	0.5	0.0	8.5	2.4	0.4	0.0	79.8	0.4	0.4	12.4	2.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	2.1	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	395.1	0.6	0.2	57.0	0.2	116.4	1.0	229.5	119.6	0.3	0.4	313.1	77.7	3.5	2.2	0.7	0.8	111.1	139.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	0.0	3.3	8.4	0.1	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	1.8	0.0	0.0	8.9	0.1	0.0	0.0	2.3	0.1	0.1	1.1	0.0	2.7	0.1	0.0	0.0	1.7	7.7	0.1	2.5	0.0	1.8	0.6	0.2	0.0	0.2	0.0	0.0	1.0	12.2	2.2	0.0	1.8	3.6	0.0	3.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	5.1	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.8	0.0	0.1	0.0	8.0	0.1	129.3	0.6	0.0	0.2
TRAV8-2		ENSG00000211786	"T cell receptor alpha variable 8-2"	A0A0B4J237	14	21846537-21847221	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 24.1"	"Cell type enriched"	"Detected in some"	9	"T-cells: 10.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	99	"MAIT T-cell: 59.1;memory CD4 T-cell: 143.4;memory CD8 T-cell: 81.1;naive CD4 T-cell: 143.2;naive CD8 T-cell: 80.1;T-reg: 190.6"	"Lineage enriched"	"Detected in many"	184	"T-cells: 190.6"	"Cell line enriched"	"Detected in single"	6	"JURKAT: 1.9"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (5.88e-3)"	"unprognostic (9.98e-4)"	"unprognostic (2.31e-2)"	"unprognostic (2.23e-2)"		"unprognostic (9.88e-5)"	"unprognostic (1.94e-3)"	"unprognostic (7.22e-3)"	"unprognostic (9.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.57e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.02e-1)"	0.3	0.1	0.0	3.2	0.0	1.9	0.2	0.0	0.0	0.2	0.0	0.7	1.1	0.2	1.6	0.5	0.2	1.4	0.1	0.0	0.0	2.7	0.2	1.2	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.0	0.4	0.0	0.0	0.4	1.3	0.1	0.0	4.1	1.3	0.3	0.0	24.1	0.3	0.0	6.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.0	1.1	0.1	59.1	0.2	143.4	81.1	0.3	0.3	143.2	80.1	0.7	0.2	0.2	0.1	190.6	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	0.0	0.0
TRBC1	"BV05S1J2.2, TCRBC1"	ENSG00000211751	"T cell receptor beta constant 1"		7	142791694-142793368	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	28	"lymphoid tissue: 1520.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 338.0;NK-cells: 580.9;T-cells: 399.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 3232.4"	"Lineage enriched"	"Detected in all"	9	"T-cells: 3232.4"	"Cell line enriched"	"Detected in some"	5	"JURKAT: 1467.5"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.08e-4)"	"unprognostic (7.96e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.81e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.76e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.36e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.18e-6)"	"unprognostic (3.98e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.19e-3)"	9.2	5.1	1.3	140.0	1.5	53.5	9.5	1.1	2.1	7.7	1.5	18.5	26.8	6.4	5.7	12.0	7.0	26.7	5.0	1.0	1.1	5.4	11.4	31.5	322.2	2.0	1.2	6.4	2.7	0.9	2.0	2.3	1.7	9.0	19.4	0.0	19.0	4.6	1.0	9.9	49.7	4.2	1.7	92.5	27.1	2.7	1.6	1520.1	8.4	2.1	227.0	33.2	6.2	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	1467.5	2.0	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	296.5	2.0	0.0	1.9	0.0	45.6	7.2	4.7	869.6	3.5	693.8	17.1	1893.1	1259.3	5.8	15.7	1989.8	1450.7	37.3	359.8	8.3	9.7	3232.4	1917.5	1.3	1.5	1.1	2.1	1.0	1.1	2.0	1.2	1.7	1.7	1.6	1.9	7.3	19.2	40.8	0.0	11.7	0.0	0.3	0.0	0.0	0.0	5.9	5.5	0.0	0.0	3.1	1.8	0.0	0.2	338.0	0.0	0.0	0.5	0.6	1.1	0.7	1.5	0.0	10.7	0.0	0.0	0.1	3.2	4.6	0.8	20.2	0.0	5.3	1.5	0.3	0.0	0.0	0.1	0.0	8.4	0.0	1.9	17.4	13.9	0.0	0.0	17.3	0.0	580.9	0.0	0.0	0.0	0.1	8.2	23.6	0.3	0.0	2.4	0.7	0.0	0.0	1.1	3.5	0.0	0.1	0.5	0.0	0.1	399.0	0.1	0.1	0.4
TRBC2	TCRBC2	ENSG00000211772	"T cell receptor beta constant 2"		7	142801041-142802748	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"intestine: 115.8;lymphoid tissue: 190.2"	"Group enriched"	"Detected in many"	4	"B-cells: 164.7;dendritic cells: 358.8;NK-cells: 264.7;T-cells: 498.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 76.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 76.0"	"Cell line enriched"	"Detected in some"	45	"MOLT-4: 277.9"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"				"prognostic favorable (8.04e-5)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.19e-3)"	"prognostic favorable (3.42e-8)"	"unprognostic (5.53e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.53e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.09e-3)"	18.9	3.1	0.4	3.9	0.3	1.5	8.6	0.1	1.2	11.9	0.1	21.2	1.7	8.7	0.0	14.6	15.7	2.2	4.9	0.3	0.0	9.6	12.7	32.3	8.6	0.2	0.3	18.3	3.5	0.1	4.0	0.0	0.2	14.2	2.7	0.0	7.9	0.1	3.3	6.5	115.8	0.5	0.1	190.2	16.9	8.7	0.3	109.2	16.4	1.2	10.9	14.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	3.5	0.0	0.0	0.0	0.0	277.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	14.4	0.0	35.0	8.1	47.6	47.3	0.3	7.7	46.6	40.3	2.0	10.5	0.1	0.0	76.0	42.4	0.4	0.3	0.1	1.2	0.3	0.0	0.2	0.3	0.2	0.1	0.3	0.1	8.3	9.6	52.4	0.0	164.7	0.0	0.3	0.0	1.8	0.1	6.2	9.7	4.8	5.7	3.7	1.8	0.0	0.4	358.8	1.4	0.0	2.9	1.0	1.1	0.8	4.0	0.0	16.6	0.0	1.3	0.1	10.8	8.6	0.9	20.2	0.0	15.0	1.6	0.4	0.0	0.0	0.8	0.0	9.0	0.0	4.2	63.6	18.9	0.0	0.0	19.0	15.6	264.7	0.0	0.0	20.1	0.1	70.3	30.6	0.4	0.1	2.2	2.9	0.4	65.7	4.2	12.4	0.1	0.8	1.3	0.0	0.3	498.0	1.4	0.9	0.2
TRBV7-2	"TCRBV6S5A1N1, TCRBV7S2, TRBV72"	ENSG00000282939	"T cell receptor beta variable 7-2"	A0A1B0GXF2	7	142352819-142353358	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	11	"epididymis: 35.6;lymphoid tissue: 85.5"	"Cell type enriched"	"Detected in some"	5	"T-cells: 33.0"					"Region enriched"	"Detected in single"	5	"hypothalamus: 1.1"	"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 397.4;T-reg: 570.3"	"Lineage enriched"	"Detected in many"	79	"T-cells: 570.3"	"Group enriched"	"Detected in some"	9	"JURKAT: 55.7;MOLT-4: 93.6;U-937: 49.0"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"																					0.9	0.1	0.0	15.0	0.1	0.0	2.2	0.0	0.2	2.2	0.0	1.2	1.7	0.0	35.6	0.6	0.5	0.0	0.2	0.0	1.1	0.5	0.3	5.5	49.0	0.0	0.0	0.1	0.2	0.0	1.0	0.1	0.0	0.3	4.6	0.0	0.4	0.4	0.0	0.2	4.7	1.1	0.0	5.8	4.7	0.0	0.2	85.5	0.7	0.0	43.0	2.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	0.0	0.0	93.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.3	0.0	0.0	49.0	0.0	1.1	2.3	0.7	11.9	1.2	55.5	0.7	397.4	178.6	2.7	0.7	302.2	110.6	1.2	0.5	1.9	7.2	570.3	104.9	0.0	0.1	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 66.3"	"Group enriched"	"Detected in some"	5	"Late spermatids: 315.7;Proximal enterocytes: 186.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039913, HPA042045"	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		12000000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.7	0.2	1.6	0.3	3.7	0.0	0.4	0.6	3.8	0.3	0.0	1.6	60.0	0.4	0.6	1.6	0.3	2.6	1.0	1.1	2.7	13.4	6.1	0.2	0.1	2.1	2.0	0.2	1.8	0.0	0.3	0.1	1.9	0.5	1.3	0.0	0.2	0.0	0.0	0.1	66.3	0.1	0.6	0.1	1.7	1.8	2.5	0.0	0.4	0.0	0.0	0.4	0.3	6.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.6	3.8	1.1	2.7	2.1	2.0	1.9	0.6	2.5	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.3	1.5	0.0	1.8	0.0	0.1	0.0	2.3	7.9	0.2	45.6	0.8	1.6	0.1	3.0	0.0	0.1	2.5	0.0	0.3	4.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	7.0	0.0	0.0	0.4	315.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	5.3	0.9	6.3	1.9	0.1	0.3	186.3	32.8	0.0	0.0	0.0	0.3	0.2	1.7	0.8	2.1	0.0	0.0	0.1	0.0	3.7	0.0
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.8;lung: 30.1"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 1014.1"	"Cancer enhanced"	"Detected in all"		"glioma: 93.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.0"	"Group enriched"	"Detected in some"	4	"hTCEpi: 74.6;THP-1: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved				"Secreted in brain"	NA	NA		50000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"HPA010917: AB_1080365, HPA012571: AB_1858260"	"unprognostic (3.89e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.85e-2)"	10.7	13.2	28.1	3.5	31.1	0.2	9.8	33.7	61.5	6.5	29.1	3.5	0.9	1.6	2.3	0.6	7.4	9.7	2.1	27.5	32.3	1.3	2.3	30.1	2.6	44.5	34.4	2.4	3.9	7.4	3.9	10.7	42.7	2.0	4.3	1.9	6.0	3.1	0.4	0.5	1.4	4.5	46.7	0.5	2.5	0.7	43.5	1.8	1.7	0.0	0.4	4.5	0.6	69.8	0.0	0.3	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.2	74.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	42.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	28.1	31.1	33.7	61.5	27.5	32.3	44.5	34.4	42.7	46.7	43.5	69.8	1.8	6.4	7.5	0.0	0.7	0.8	0.2	79.8	0.0	0.3	1.8	58.8	0.1	1.5	9.6	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	10.4	0.0	0.0	0.0	0.0	4.9	1.2	0.0	0.0	2.5	0.0	2.2	0.2	1014.1	0.0	0.0	0.0	2.0	34.7	5.2	1.0	0.6	120.5	0.0	12.2	8.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.3	1.0	6.6	0.1	1.0	0.0	0.0	0.0	0.1	7.3	0.8	0.0	0.0	0.1
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.9;Inhibitory neurons: 111.4;Microglial cells: 52.5;Oligodendrocyte precursor cells: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	3.4	5.7	1.3	5.8	2.2	13.9	2.6	1.1	3.8	7.7	0.0	3.7	3.2	6.0	2.9	8.8	5.1	3.9	1.8	0.8	0.6	2.9	1.0	2.9	7.7	0.3	0.7	7.1	1.6	3.9	3.5	2.6	0.0	5.4	3.4	2.0	2.3	3.6	1.1	6.4	4.7	3.9	0.2	7.2	4.2	6.0	1.6	10.3	2.0	1.2	5.0	7.0	8.0	0.8	13.7	9.4	10.3	13.2	4.7	10.4	14.5	10.2	16.2	11.4	9.4	0.1	7.1	12.7	2.2	15.5	15.6	16.2	13.2	12.6	9.1	144.3	1.0	13.7	8.0	0.0	3.2	25.4	42.1	4.3	17.3	10.2	4.1	10.3	0.0	8.5	0.1	4.1	5.0	3.0	6.6	42.9	11.3	10.1	9.6	11.8	0.8	4.7	6.7	16.7	8.3	4.4	6.1	0.2	1.0	5.6	5.9	34.1	4.5	6.5	7.5	10.7	2.9	1.7	9.5	13.7	4.4	22.7	0.1	1.1	0.6	4.6	1.5	0.2	1.4	0.2	1.1	1.3	0.7	0.0	0.9	1.0	2.0	1.5	0.1	0.6	1.2	0.7	1.3	2.2	1.1	3.8	0.8	0.6	0.3	0.7	0.0	0.2	1.6	0.8	2.7	3.2	1.3	37.9	3.6	8.3	2.9	3.2	6.2	9.9	4.1	2.5	1.9	1.5	5.9	5.5	0.0	3.4	20.9	8.4	0.0	1.8	2.7	3.3	16.2	5.4	3.0	0.4	96.9	1.0	0.9	11.8	11.2	1.7	12.0	14.7	6.4	0.3	2.6	8.4	111.4	2.1	4.1	4.7	10.4	3.2	14.0	8.0	3.6	52.5	7.9	4.2	12.3	80.4	3.8	1.2	2.5	22.2	7.2	1.6	1.0	0.2	8.5	0.5	26.3	4.4	7.9	10.0	7.4	23.5	7.4	1.2	18.0	4.2	3.8	4.3
TRGC2	"TCRGC2, TRGC2(2X), TRGC2(3X)"	ENSG00000227191	"T cell receptor gamma constant 2"		7	38239580-38249572	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 30.5;lymphoid tissue: 34.6;prostate: 23.7"	"Group enriched"	"Detected in some"	7	"dendritic cells: 149.1;NK-cells: 90.6;T-cells: 122.0"	"Cancer enriched"	"Detected in many"	18	"prostate cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 720.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 720.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.4;JURKAT: 36.6;NB-4: 29.9;SK-BR-3: 9.8;U-937: 53.9"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.79e-3)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.62e-4)"	"unprognostic (3.52e-5)"	"unprognostic (3.34e-1)"	"unprognostic (1.46e-3)"	"unprognostic (8.79e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-3)"	3.6	1.1	8.8	5.1	9.0	30.5	1.8	8.6	19.6	1.5	7.1	3.5	4.5	1.3	3.2	1.1	2.2	3.9	0.9	8.4	8.5	1.6	3.6	9.7	17.5	9.6	8.9	0.5	0.8	0.2	1.0	0.5	9.2	23.7	4.0	0.1	1.8	0.8	0.4	0.6	8.0	1.0	9.3	29.7	3.8	2.2	10.2	34.6	2.1	0.1	7.0	3.4	2.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	3.7	1.2	29.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.9	0.0	1.1	1.3	1.4	720.5	1.2	287.4	0.6	64.8	341.6	1.0	0.3	13.5	212.9	4.9	149.7	1.0	1.2	1.3	167.5	8.8	9.0	8.6	19.6	8.4	8.5	9.6	8.9	9.2	9.3	10.2	9.5	1.2	0.0	2.4	0.0	2.4	0.0	0.2	0.0	0.0	0.0	1.0	1.3	0.7	1.5	0.6	0.0	0.0	0.0	149.1	0.3	0.0	0.2	15.5	0.2	0.1	0.8	0.0	6.6	0.0	0.0	0.0	0.4	2.6	0.2	0.0	0.2	3.9	1.0	0.0	0.0	0.0	0.5	0.0	3.5	0.0	6.7	0.0	2.8	0.0	0.0	10.6	0.0	90.6	0.0	0.0	0.0	0.0	0.4	14.2	2.8	0.0	0.5	0.0	0.0	0.0	0.2	1.3	0.8	0.2	0.3	0.0	0.3	122.0	0.0	0.2	0.3
TRGV10	"TCRGV10, V3P"	ENSG00000211694	"T cell receptor gamma variable 10 (non-functional)"		7	38299811-38300322	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.5;Plasma cells: 7.1;T-cells: 29.9"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 7.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 196.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 196.5"	"Group enriched"	"Detected in some"	24	"NB-4: 79.7;U-937: 20.5"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.59e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-4)"	"unprognostic (2.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.07e-2)"	1.7	0.6	0.1	2.7	0.3	14.1	1.8	0.1	0.4	1.2	0.6	2.0	2.1	0.8	0.7	1.1	1.3	3.3	0.4	0.0	0.1	0.6	1.8	4.1	11.0	0.4	0.1	0.3	0.2	0.1	0.2	0.4	0.3	6.1	2.7	0.0	1.1	0.7	0.2	0.6	4.1	0.6	0.2	13.9	2.6	0.3	0.2	12.5	1.1	0.0	5.0	3.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.5	0.0	0.7	0.4	1.0	196.5	0.1	156.1	0.5	47.2	137.6	0.2	0.1	11.3	159.7	2.9	26.0	0.3	0.8	0.1	33.3	0.1	0.3	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.2	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0
TRIL	KIAA0644	ENSG00000255690	"TLR4 interactor with leucine rich repeats"	Q7L0X0	7	28953358-28958330	"Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.0"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 72.1"	"Cancer enhanced"	"Detected in many"		"glioma: 20.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 22.2;SH-SY5Y: 40.0;SK-BR-3: 35.7;T-47d: 15.8"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.26e-3)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (4.27e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.07e-2)"	4.7	2.3	40.8	0.6	61.3	0.0	4.1	57.4	35.0	2.9	7.3	2.0	2.0	3.6	1.7	2.4	2.3	1.0	4.3	32.5	40.8	5.9	0.6	2.6	0.4	58.2	65.2	1.6	0.5	0.8	1.6	1.1	46.1	1.9	1.8	1.0	8.2	1.4	3.1	1.9	2.4	3.4	49.7	2.6	2.3	0.5	68.0	0.4	2.9	0.7	0.3	2.3	3.5	35.9	0.0	0.0	22.2	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	6.1	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.8	40.0	0.1	35.7	0.0	3.2	15.8	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	61.3	57.4	35.0	32.5	40.8	58.2	65.2	46.1	49.7	68.0	35.9	7.0	12.8	5.3	72.1	0.0	0.0	0.2	0.0	4.0	0.4	7.4	11.0	2.7	0.0	0.6	1.8	0.0	0.2	0.0	0.1	3.9	0.1	0.0	0.4	0.2	4.3	0.0	0.0	0.7	0.0	1.9	15.9	0.0	1.1	0.0	0.2	2.5	0.4	0.1	6.7	0.6	0.4	0.0	0.0	0.0	0.2	1.2	0.5	0.0	5.6	0.0	17.1	0.0	13.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.8	13.1	15.2	4.9	0.5	0.7	2.2	0.0	0.1	0.1	2.0	0.8	0.1
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151943-30161211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.8;kidney: 2.0;liver: 2.9"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 126.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HEL: 22.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 3.4"	HPA043325	Uncertain					NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.1	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	126.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.9	0.0	0.0	0.0	3.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0
TRIM14	KIAA0129	ENSG00000106785	"Tripartite motif containing 14"	Q14142	9	98069275-98119222	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 75.0;Kupffer cells: 80.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053217	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"			"HPA053217: AB_2682082"	"unprognostic (1.62e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.55e-3)"	"unprognostic (4.57e-2)"	6.4	5.3	9.0	18.4	7.6	12.1	10.0	4.7	7.7	5.8	4.7	18.9	29.5	4.3	1.8	19.5	6.3	9.6	1.6	7.7	7.3	11.4	22.3	14.9	25.6	14.1	8.1	2.9	3.1	13.5	5.1	5.0	8.4	9.4	16.8	2.7	10.6	5.6	1.0	9.9	30.4	8.8	9.4	26.8	11.6	7.8	9.7	32.7	2.9	1.0	21.8	12.7	9.1	8.9	25.5	12.9	0.6	11.3	0.0	3.9	8.3	14.8	28.1	79.3	67.8	24.8	14.9	33.5	11.8	16.1	47.2	28.6	24.9	16.5	24.1	43.3	20.0	9.9	20.3	24.6	17.1	53.1	10.7	2.4	8.0	11.6	14.8	10.6	10.1	37.4	39.6	15.5	7.3	32.6	42.2	16.7	14.2	56.3	39.5	27.4	1.4	17.2	6.3	15.6	4.0	3.3	20.8	43.2	14.3	2.8	11.4	30.4	7.1	3.3	8.5	1.2	20.5	6.7	8.3	11.1	9.1	41.1	11.4	1.0	14.4	2.1	15.1	28.4	16.1	8.3	17.1	15.7	15.8	5.6	13.1	11.4	4.0	13.0	59.0	15.3	23.1	17.2	9.0	7.6	4.7	7.7	7.7	7.3	14.1	8.1	8.4	9.4	9.7	8.9	2.1	3.2	8.8	3.3	15.3	2.8	14.3	11.8	15.4	35.1	8.7	8.3	1.0	7.2	14.2	5.5	75.0	5.0	28.8	40.0	3.9	4.9	8.8	4.8	8.9	4.1	12.6	5.9	7.0	13.6	16.9	3.2	13.3	5.4	1.3	12.0	7.5	22.4	15.4	3.3	5.4	15.3	10.2	80.6	2.4	9.9	0.3	32.6	1.8	2.8	16.5	1.9	30.9	12.1	0.9	15.0	13.5	1.5	8.5	19.1	38.1	21.1	17.0	4.4	0.0	1.4	2.0	16.3	3.8	17.3	3.3	3.3	21.3	5.8	19.4	21.1
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 17.1;kidney: 6.0;liver: 14.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 139.1;Intestinal goblet cells: 41.5;Paneth cells: 332.0;Proximal enterocytes: 80.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 14.4;liver cancer: 5.6;pancreatic cancer: 7.7;renal cancer: 4.4;stomach cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 16.5;Hep G2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047527			Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.8	17.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	6.0	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.7	12.2	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.5	0.0	0.0	0.0	0.0	0.0	139.1	1.9	1.8	0.0	0.0	0.1	0.0	0.0	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	332.0	0.0	0.0	0.0	80.0	21.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.5	0.0	29.1	0.0
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282429-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 213.2;skeletal muscle: 580.7;tongue: 177.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 81.7;Ductal cells: 35.5;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 46.5;Skeletal myocytes: 17.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.1"	"Immune cell enriched"	"Detected in single"	17	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 3.6"	"Group enriched"	"Detected in some"	8	"HAP1: 7.3;NTERA-2: 15.6"	"Region enhanced"	"Detected in some"		"amygdala: 3.1"					HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	0.4	9.3	1.5	0.0	0.9	0.0	0.3	0.9	5.1	0.9	0.1	0.3	4.3	0.8	24.5	5.0	0.8	0.2	213.2	2.3	0.0	1.7	0.1	0.2	0.2	0.6	0.3	0.5	0.5	0.0	0.1	0.0	0.3	3.4	0.0	0.0	9.5	0.1	580.7	0.9	2.1	0.0	0.3	0.9	0.1	22.3	0.1	0.1	0.5	177.3	0.0	0.1	0.5	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	15.6	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	1.5	0.9	0.9	5.1	2.3	0.0	0.6	0.3	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.4	81.7	10.0	0.1	3.7	0.0	0.0	0.3	2.3	0.0	35.5	1.5	0.1	0.0	0.8	0.0	2.7	11.3	42.5	0.0	2.2	0.0	0.2	4.5	0.0	0.4	0.0	0.1	0.0	0.8	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	46.5	1.9	0.7	0.0	0.2	2.4	3.1	0.2	0.0	0.0	17.9	16.8	6.8	2.4	0.0	0.0	0.0	0.3	0.2	6.4	0.3
TRIM6	RNF89	ENSG00000121236	"Tripartite motif containing 6"	Q9C030	11	5596109-5612958	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 20.9"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 74.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 22.2;SuSa: 36.7;TIME: 19.2;U-2 OS: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060514	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA060514: AB_2684300"	"unprognostic (9.00e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.16e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.25e-3)"	"unprognostic (2.35e-2)"	"unprognostic (3.26e-3)"	"unprognostic (8.59e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.65e-4)"	"unprognostic (4.77e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-1)"	2.8	3.8	0.4	1.7	0.4	2.0	3.2	0.2	0.4	2.2	0.8	2.1	0.5	3.2	4.8	4.3	3.2	2.3	0.9	0.4	0.6	20.9	0.8	2.1	0.6	0.9	0.6	4.3	1.3	1.3	0.9	5.4	0.6	2.5	1.7	0.2	10.5	3.6	0.8	1.0	1.1	5.2	0.6	3.7	1.0	9.3	0.8	1.3	3.8	0.6	1.3	2.6	2.8	0.7	0.7	16.2	1.1	0.0	2.0	2.9	18.7	4.4	3.3	4.3	4.2	0.4	3.6	0.0	2.5	4.5	12.1	2.9	7.5	6.7	6.1	0.6	5.0	2.0	1.6	0.1	0.7	6.6	8.7	5.1	6.4	6.2	4.3	6.4	3.8	0.1	8.0	0.2	1.8	0.2	0.0	0.9	22.2	2.6	5.7	7.7	0.0	0.1	0.9	6.6	0.1	0.2	0.0	8.4	0.8	36.7	3.2	1.1	19.2	4.0	21.3	0.1	4.7	0.2	0.1	0.0	3.7	0.0	3.5	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.1	0.4	0.4	0.2	0.4	0.4	0.6	0.9	0.6	0.6	0.6	0.8	0.7	1.2	0.0	4.8	0.0	0.1	0.5	0.6	0.5	1.8	0.0	3.1	1.8	0.4	0.0	0.8	1.8	0.0	12.5	0.0	0.2	3.9	1.2	1.2	0.7	1.7	1.5	0.0	2.1	0.0	0.2	15.5	2.1	0.0	1.0	0.0	4.1	0.0	0.5	3.1	0.0	0.0	0.3	2.0	3.5	0.3	0.8	0.9	1.1	1.8	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.4	0.3	74.4	1.1	0.0	0.0	0.5	0.7	10.8	3.3	1.8	0.4	5.7	0.4	4.1	0.2	0.3
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051301-26068436	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Muscle protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 1935.8"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 272.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"ASC diff: 16.1;SK-MEL-30: 55.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 5.1"							NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	1.2	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.1	1.5	0.0	0.7	0.3	8.8	0.3	7.1	0.6	2.7	243.0	0.0	0.0	1.5	0.4	1.3	0.0	0.1	0.1	0.2	0.8	0.0	0.2	4.0	0.0	1.5	0.2	0.1	9.6	0.4	1935.8	4.2	0.8	3.5	0.0	0.2	0.8	0.2	0.2	0.3	0.5	387.6	0.2	8.9	1.1	0.1	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.0	272.2	5.7	0.0	1.8	0.0	0.5	0.0	0.0	1.9	1.8	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.1	8.1	0.0	0.1	10.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	3.3	29.7	0.0	0.0	0.0	34.7	1.4	0.0	0.0	0.0	0.1	1.6	6.1	0.0	0.1	0.1
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32817997-32897824	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 4.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Extravillous trophoblasts: 15.6;Inhibitory neurons: 4.5;Oligodendrocyte precursor cells: 4.5;Spermatogonia: 13.7"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 31.4;BEWO: 94.5;Hep G2: 63.8;NTERA-2: 84.3;SuSa: 76.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: AB_2675857, HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.0	0.0	1.0	0.0	1.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.9	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	31.4	0.0	0.0	0.0	94.5	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.6	0.0	63.8	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.4	0.0	0.0	0.6	6.9	84.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	76.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.8	0.9	0.8	0.1	0.1	0.1	0.0	0.8	0.2	0.0	9.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	2.7	0.0	1.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	3.1	0.0	15.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	4.5	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	3.6	0.7	0.5	0.0	0.0	0.1	0.3	13.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136212745-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022592, HPA031126"	Uncertain					NA	NA						"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.6	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.1	0.9	0.6	0.4	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.2;brain: 26.4;lymphoid tissue: 18.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.7;Hofbauer cells: 18.3;Inhibitory neurons: 45.1;Macrophages: 16.7;Microglial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.8;plasmacytoid DC: 15.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 41.7;NB-4: 58.6;OE19: 41.3;THP-1: 71.3;U-266/84: 31.8;U-937: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035260	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favorable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favorable (7.59e-4)"	4.8	4.1	14.0	6.7	14.5	28.2	3.0	11.1	26.4	2.1	7.7	3.8	3.6	1.6	0.7	1.6	2.1	4.7	1.8	13.9	11.8	2.5	2.3	5.0	8.0	20.9	14.5	0.9	1.8	1.1	4.8	6.0	20.8	2.7	2.3	0.9	2.3	0.8	0.9	2.3	6.9	2.5	12.2	18.4	2.5	2.7	16.0	3.3	1.8	0.4	4.1	3.5	1.6	17.4	20.8	7.5	0.0	0.1	0.0	0.0	20.9	0.0	0.0	0.6	0.4	0.0	0.0	0.5	24.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.9	0.0	0.0	41.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	6.7	58.6	0.0	41.3	23.5	2.3	7.2	8.0	0.0	0.0	14.4	0.1	0.0	23.5	0.1	0.0	27.7	71.3	0.0	1.2	20.9	0.1	0.7	0.3	31.8	0.1	0.0	67.7	0.0	0.0	7.8	0.0	1.0	2.7	0.5	0.3	0.3	0.4	2.6	1.9	0.3	0.4	0.4	0.5	2.5	15.5	1.3	2.0	14.0	14.5	11.1	26.4	13.9	11.8	20.9	14.5	20.8	12.2	16.0	17.4	2.0	0.0	0.5	1.3	2.0	0.4	0.0	0.0	0.6	1.4	2.8	3.0	1.7	0.0	0.0	0.0	0.0	1.8	9.9	0.8	0.0	0.1	2.1	0.7	0.2	2.7	0.0	0.0	52.7	0.2	8.8	0.5	1.1	1.2	1.3	0.3	0.4	0.4	18.3	0.0	45.1	1.0	0.0	11.0	5.5	2.0	0.6	16.7	0.0	27.2	5.5	0.5	6.2	4.0	1.7	1.2	0.1	0.0	1.4	0.0	0.0	0.3	0.0	1.0	6.6	0.5	0.4	1.0	0.1	0.1	0.3	1.4	4.2	0.0	0.7	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529060-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"choroid plexus: 801.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 905.0;Excitatory neurons: 390.3;Inhibitory neurons: 186.9;Muller glia cells: 184.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HAP1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.7	0.6	22.0	0.1	30.4	0.2	0.1	40.5	9.6	1.0	801.0	0.2	0.8	1.1	1.3	0.1	0.4	0.4	0.8	39.3	27.8	16.5	0.2	0.1	0.1	36.7	46.8	3.6	0.5	0.0	2.9	0.1	20.8	0.5	0.1	23.0	0.1	2.5	0.3	0.1	0.0	0.2	25.2	0.3	0.6	5.1	41.6	0.2	0.9	0.1	0.0	0.1	0.4	15.4	0.0	0.0	0.9	0.0	1.1	2.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.2	0.0	0.0	1.0	4.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.9	0.0	1.1	0.0	0.2	0.0	0.3	0.2	0.0	0.0	3.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	22.0	30.4	40.5	9.6	39.3	27.8	36.7	46.8	20.8	25.2	41.6	15.4	0.3	3.2	3.0	905.0	0.5	0.4	0.9	0.0	0.6	16.4	0.3	0.5	5.3	5.7	2.5	16.5	66.7	0.1	0.2	0.1	5.9	0.1	4.8	1.4	1.0	1.3	15.4	0.0	390.3	0.2	0.1	3.0	0.0	3.2	0.0	1.4	0.7	0.3	0.2	1.7	186.9	0.1	0.0	0.9	1.4	2.3	5.6	0.8	0.0	56.2	0.2	184.5	1.0	105.6	8.3	0.1	0.1	9.1	0.0	0.5	0.1	33.3	0.8	10.1	0.0	3.5	1.3	1.3	0.6	0.0	0.9	0.3	0.9	0.6	0.0	0.3
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.6;intestine: 16.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 128.9;Glandular and luminal cells: 36.5;Microglial cells: 39.4;Oligodendrocytes: 81.1;Proximal enterocytes: 23.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 23.1;neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 23.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;HeLa: 2.4;Karpas-707: 1.3;RT4: 3.8;U-266/70: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	0.6	0.0	2.1	0.6	3.5	2.6	0.6	3.0	2.4	0.3	0.2	13.2	7.0	0.3	0.2	0.3	0.2	0.3	0.2	1.6	2.8	1.9	0.1	0.3	0.3	4.2	3.4	0.0	0.1	1.4	0.5	0.3	4.1	0.5	16.6	0.4	0.3	0.1	0.1	0.7	7.9	0.5	2.7	0.5	0.2	1.4	3.1	0.4	0.2	0.1	0.3	0.4	0.3	6.6	0.0	0.8	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	2.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.1	0.0	1.4	0.0	0.1	0.0	0.1	0.1	23.1	0.1	2.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	7.5	0.5	0.2	0.3	0.0	0.1	2.1	3.5	3.0	2.4	1.6	2.8	4.2	3.4	4.1	2.7	3.1	6.6	3.3	0.0	1.7	1.0	0.3	0.1	1.9	0.3	2.2	0.3	0.2	0.4	0.9	0.0	1.3	3.7	0.0	0.2	0.2	128.9	0.0	0.0	4.0	11.3	3.4	3.2	3.6	0.0	1.3	0.0	0.1	0.3	0.0	36.5	0.0	0.1	3.3	0.1	0.0	0.0	0.5	3.0	0.0	0.3	0.6	0.9	0.0	0.4	0.0	39.4	0.0	0.3	0.0	0.5	81.1	0.0	13.8	0.4	0.1	1.3	23.3	0.0	0.8	2.7	0.0	0.7	0.4	1.6	2.4	0.5	1.0	0.1	0.5	0.2	7.5	0.8
TSHZ2	"C20orf17, OVC10-2, TSH2, ZABC2, ZNF218"	ENSG00000182463	"Teashirt zinc finger homeobox 2"	Q9NRE2	20	52972358-53495330	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 395.6;Leydig cells: 468.2;Peritubular cells: 803.8;Theca cells: 396.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 26.7;ASC diff: 11.3;HeLa: 23.6;SiHa: 15.3;U-2197: 13.7"	"Low region specificity"	"Detected in all"							HPA038123	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA038123: AB_10670657"	"unprognostic (9.24e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.21e-4)"	"unprognostic (3.30e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.88e-8)"	"unprognostic (6.26e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.37e-7)"	"unprognostic (2.97e-3)"	21.5	14.8	3.4	4.5	4.7	0.2	10.6	2.9	4.3	9.0	0.0	7.3	2.3	6.8	16.5	8.2	8.7	12.4	3.7	5.7	8.9	3.3	12.6	2.9	3.9	5.9	8.2	18.4	3.5	5.4	2.7	1.3	5.5	5.4	2.0	1.7	12.9	13.6	1.6	5.9	2.8	8.8	10.3	5.1	6.1	4.8	8.1	2.0	5.3	2.6	3.4	7.6	5.7	7.5	0.0	0.0	1.8	26.7	11.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.8	0.0	0.1	0.0	0.1	0.0	5.2	1.4	0.0	23.6	0.0	0.3	0.0	0.6	4.1	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.7	4.4	15.3	0.1	0.0	0.7	0.0	0.0	0.0	0.1	2.6	13.7	0.0	0.1	0.3	0.0	2.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.4	3.0	0.2	0.6	0.1	0.0	0.1	2.4	0.5	3.4	4.7	2.9	4.3	5.7	8.9	5.9	8.2	5.5	10.3	8.1	7.5	171.4	0.0	0.6	32.7	7.0	45.4	19.9	43.8	37.0	6.7	24.4	161.5	2.8	54.3	41.6	36.8	2.1	1.3	1.3	0.1	0.0	52.2	11.1	32.7	144.4	125.7	6.6	0.0	188.2	9.8	0.5	93.3	3.1	68.9	1.3	395.6	11.7	92.1	1.2	0.0	58.1	1.9	18.3	1.3	16.6	20.3	468.2	2.8	12.4	104.9	1.9	39.0	1.0	23.6	4.9	6.8	2.7	803.8	16.0	27.5	0.8	0.4	19.9	1.9	39.5	10.9	48.2	2.6	1.8	43.9	40.5	0.8	24.2	396.9	2.6	8.2
TSPAN13	"NET-6, TM4SF13"	ENSG00000106537	"Tetraspanin 13"	O95857	7	16753755-16784536	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 303.4;Alveolar cells type 1: 496.8;Cytotrophoblasts: 293.7;Intestinal goblet cells: 404.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 99.6;plasmacytoid DC: 231.7"	"Group enriched"	"Detected in many"	42	"B-cells: 99.6;dendritic cells: 231.7"	"Cell line enhanced"	"Detected in many"		"OE19: 484.5;SCLC-21H: 215.3;SK-BR-3: 314.0;T-47d: 587.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007426	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA007426: AB_10603137"	"unprognostic (3.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (5.69e-2)"	"unprognostic (6.63e-2)"	"prognostic favorable (2.20e-4)"	"unprognostic (1.50e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	65.6	81.1	32.1	29.1	37.2	26.1	76.3	20.5	95.8	60.7	17.0	83.5	88.9	20.0	36.9	19.7	19.9	55.5	23.9	36.2	67.1	7.8	47.4	185.5	56.2	24.1	28.3	3.1	95.8	14.1	83.6	67.1	28.7	51.1	99.9	19.4	168.0	35.8	9.3	16.6	77.3	20.3	19.8	26.3	108.0	8.9	27.1	20.4	35.1	13.7	47.2	41.0	16.1	29.3	47.4	38.6	47.8	50.9	6.0	0.2	13.2	99.0	16.1	2.6	4.9	137.4	70.9	1.4	24.7	35.8	12.3	71.2	56.2	83.2	21.6	1.4	60.3	20.3	15.3	14.8	13.3	1.9	4.0	5.6	35.4	5.2	5.9	27.4	30.1	20.7	67.0	0.4	2.9	135.4	2.8	2.6	33.4	484.5	46.5	54.0	0.2	48.5	153.1	90.1	215.3	32.5	18.0	314.0	4.8	68.1	587.9	5.2	2.9	1.4	17.0	1.5	33.1	28.4	0.8	1.0	44.2	0.8	69.1	0.6	0.0	0.2	0.0	0.0	0.1	47.9	0.1	0.0	1.1	99.6	0.0	0.1	3.9	3.6	0.1	231.7	0.0	5.6	32.1	37.2	20.5	95.8	36.2	67.1	24.1	28.3	28.7	19.8	27.1	29.3	303.4	496.8	82.5	10.1	94.0	42.6	84.9	96.0	31.9	78.2	141.7	46.7	19.1	41.5	137.6	29.5	8.4	293.7	131.6	95.4	7.9	68.0	1.6	27.8	6.5	97.9	107.7	60.2	79.3	203.9	109.3	22.5	89.2	67.1	9.5	1.0	7.5	26.3	40.8	15.2	56.8	404.6	122.1	18.9	22.6	2.5	0.6	9.4	32.0	9.4	61.3	3.5	2.1	23.6	7.6	109.1	88.8	0.7	49.9	127.4	99.8	0.9	63.2	8.1	32.9	2.2	22.0	1.7	19.5	39.4	39.6	201.1	8.9	6.1	125.3	173.6
TSPAN18	TSPAN	ENSG00000157570	"Tetraspanin 18"	Q96SJ8	11	44726465-44932423	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 83.5"	"Group enriched"	"Detected in many"	6	"Adipocytes: 72.2;Cardiomyocytes: 22.3;Early spermatids: 29.7;Endothelial cells: 51.8;Hepatic stellate cells: 70.3;Proximal tubular cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 36.7;CAPAN-2: 61.5;GAMG: 35.2;HDLM-2: 48.7;NTERA-2: 33.0;RH-30: 38.4;SCLC-21H: 31.9;SH-SY5Y: 36.2;SuSa: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.09e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-2)"	22.2	46.1	5.8	10.4	4.3	1.2	10.0	30.5	8.2	14.4	3.6	47.9	6.7	46.7	3.6	21.0	20.8	13.3	83.5	26.1	4.6	14.5	4.9	22.4	7.7	5.1	10.4	7.4	1.6	3.9	5.4	30.2	4.9	15.8	9.9	1.0	3.3	41.4	14.7	6.3	16.4	46.6	8.9	14.1	16.6	4.0	10.8	4.0	14.8	19.9	4.2	23.1	10.2	2.3	0.0	0.6	36.7	0.5	0.0	0.0	0.0	0.6	0.5	2.3	0.1	7.3	61.5	0.0	16.4	1.0	35.2	0.0	6.6	0.2	0.6	48.7	2.4	0.2	5.0	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.0	0.0	14.3	0.2	1.1	0.0	0.1	0.0	0.0	0.1	33.0	0.1	1.0	0.1	38.4	0.2	0.0	0.0	31.9	36.2	0.4	0.1	0.1	99.8	0.2	0.1	1.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	1.6	1.0	0.0	0.0	1.6	0.1	0.0	0.8	0.2	1.1	0.5	0.0	0.0	1.3	0.2	0.3	0.5	0.0	0.0	0.3	1.7	5.8	4.3	30.5	8.2	26.1	4.6	5.1	10.4	4.9	8.9	10.8	2.3	72.2	0.0	3.7	5.5	1.5	1.7	0.1	0.0	0.6	1.8	1.0	0.3	22.3	0.0	0.0	7.3	0.0	0.1	1.1	0.0	0.0	0.4	29.7	0.7	0.9	51.8	0.0	3.6	2.7	0.2	0.2	6.8	0.5	1.4	1.3	0.0	70.3	1.0	0.4	1.7	4.1	0.0	0.0	2.5	2.6	5.6	2.8	3.4	7.2	2.8	0.2	0.1	0.0	4.0	1.3	0.7	0.0	1.5	0.6	0.2	0.0	20.2	0.0	0.5	0.0	4.9	2.0	0.6	1.0	0.0	1.1	0.3	3.0	3.2	0.0	0.1
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 561.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 565.8;Hepatocytes: 414.9;Paneth cells: 463.4;Proximal enterocytes: 278.5;Proximal tubular cells: 254.5;Undifferentiated cells: 217.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 177.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 25.0;granulocytes: 21.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"OE19: 264.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		NA	NA		560000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.04e-4)"	51.4	154.1	31.3	20.9	40.5	27.1	37.3	38.2	36.0	34.1	31.3	190.7	147.7	18.9	2.9	96.7	25.7	75.9	69.9	29.1	33.1	100.8	561.2	22.7	8.1	34.4	35.2	26.9	63.6	9.4	12.4	7.9	34.4	26.4	80.3	1.3	39.8	18.2	52.9	33.8	114.2	13.2	35.4	16.9	88.4	8.1	35.8	4.3	17.1	34.9	16.2	30.0	56.7	39.0	42.6	86.1	10.8	36.8	25.9	10.6	21.4	23.0	18.6	12.6	18.3	25.4	25.7	11.1	18.8	17.0	11.9	35.1	7.9	22.3	2.7	33.6	50.0	11.5	15.5	49.7	64.9	16.4	26.4	20.1	23.9	9.1	7.6	17.5	31.1	5.9	14.2	18.2	6.0	90.8	0.5	49.9	18.7	264.4	39.3	37.0	11.7	19.7	35.9	36.7	6.4	17.1	24.2	41.4	31.7	10.2	43.4	39.3	25.1	14.0	27.2	24.2	7.4	14.0	15.4	3.4	5.3	46.4	8.5	10.9	17.7	8.0	0.8	4.7	1.7	2.8	0.8	0.6	25.0	1.7	0.4	0.2	21.8	3.7	1.5	1.7	2.1	8.1	31.3	40.5	38.2	36.0	29.1	33.1	34.4	35.2	34.4	35.4	35.8	39.0	13.9	28.9	74.8	10.1	7.8	1.3	9.5	20.4	12.0	1.3	32.7	16.6	39.2	170.1	23.7	20.2	0.0	11.6	2.5	565.8	46.9	45.3	1.9	53.3	30.2	13.4	34.3	35.3	0.3	44.0	6.4	14.6	126.9	74.3	14.0	60.9	39.3	414.9	15.1	1.7	0.5	162.8	8.2	28.9	6.8	3.5	13.1	23.2	1.8	1.0	18.6	27.3	3.1	3.5	7.4	36.8	463.4	7.9	24.5	10.5	278.5	254.5	19.2	0.8	0.0	10.7	11.5	2.4	0.5	39.8	2.4	11.4	5.0	57.5	217.4	17.3
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243481-43288258	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.7;pituitary gland: 9.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 6.6;Excitatory neurons: 12.1;Inhibitory neurons: 13.0;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 12.4"	"Group enriched"	"Detected in some"	4	"glioma: 3.0;liver cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 20.3;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	0.0	1.3	11.8	0.2	10.6	0.0	0.0	3.8	20.7	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.1	12.0	1.1	0.4	1.9	0.0	0.1	5.0	2.2	0.0	0.2	0.3	9.2	0.0	3.5	0.1	0.1	3.0	0.0	0.1	0.0	0.0	2.8	0.0	0.5	0.1	0.1	0.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	20.3	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.6	3.8	20.7	12.0	1.1	5.0	2.2	3.5	0.5	6.0	11.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	12.1	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.4	2.5	0.1	5.0	13.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	2.8	0.0	1.4	0.0	12.1	12.4	0.0	1.1	0.0	0.0	0.0	3.8	3.5	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0
TTC29	NYD-SP14	ENSG00000137473	"Tetratricopeptide repeat domain 29"	Q8NA56	4	146706617-146945882	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"fallopian tube: 20.0;testis: 71.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 697.9;Late spermatids: 445.9;Respiratory ciliated cells: 97.7;Spermatocytes: 157.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;hTERT-HME1: 1.4;U-266/70: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037006, HPA061473"	Uncertain					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA037006: AB_10670379, HPA061473: AB_2684534"	"unprognostic (1.28e-3)"			"unprognostic (1.52e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.70e-1)"		"unprognostic (6.70e-2)"		"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.67e-4)"	"unprognostic (9.81e-4)"	"unprognostic (7.30e-2)"	"unprognostic (6.88e-4)"		0.1	0.0	1.1	0.0	0.8	0.0	0.1	0.5	0.5	0.5	4.6	0.0	0.0	0.2	2.2	0.0	20.0	0.0	0.0	0.9	1.3	0.2	0.0	2.0	0.0	3.8	4.2	0.0	0.0	0.7	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	71.8	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	1.4	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.5	0.5	0.9	1.3	3.8	4.2	2.9	3.4	1.1	2.1	0.2	0.0	1.8	7.8	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.4	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	697.9	48.9	0.3	0.7	0.0	0.0	5.3	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	2.0	0.0	0.0	445.9	7.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	4.9	0.0	0.1	0.0	0.1	97.7	0.0	0.0	0.0	1.4	157.6	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TTC36	HBP21	ENSG00000172425	"Tetratricopeptide repeat domain 36"	A6NLP5	11	118527472-118531197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 171.5"	"Group enriched"	"Detected in many"	13	"Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9"	"Group enriched"	"Detected in some"	7	"breast cancer: 5.0;liver cancer: 12.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038731	Enhanced		Uncertain	Nucleoplasm		NA	NA		100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA038731: AB_10672651"	"unprognostic (1.57e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.81e-5)"	"unprognostic (6.32e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.38e-2)"	"unprognostic (5.77e-7)"	"unprognostic (5.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-3)"	8.0	1.3	0.8	0.1	0.8	0.0	11.1	0.8	0.7	0.3	0.7	0.5	5.9	0.4	18.5	0.5	0.5	0.1	1.0	0.3	0.6	8.9	171.5	0.3	0.1	1.1	0.7	0.6	1.2	0.0	1.6	0.1	0.6	1.0	0.0	0.3	0.9	0.0	1.4	0.5	4.1	0.0	0.6	0.2	0.7	0.8	0.6	0.0	0.7	0.4	0.0	0.5	0.3	1.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.0	0.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.8	0.8	0.7	0.3	0.6	1.1	0.7	0.6	0.6	0.6	1.0	0.3	0.0	0.0	0.3	2.4	0.3	0.6	0.2	0.6	0.1	21.2	11.3	0.3	11.5	0.1	12.9	0.0	1.5	0.1	0.8	17.6	0.2	0.1	1.2	0.6	1.1	2.4	16.4	0.2	0.5	0.2	0.3	2.0	1.7	0.0	0.4	9.7	492.9	0.1	0.0	0.3	9.3	0.0	14.2	0.3	0.2	0.3	0.9	0.0	0.0	0.6	1.1	0.0	0.0	0.1	0.2	7.6	0.0	0.3	1.9	185.5	172.9	0.2	0.8	0.0	0.2	0.2	0.3	0.3	0.3	0.1	2.1	1.1	0.4	11.7	1.3
TTC38	FLJ20699	ENSG00000075234	"Tetratricopeptide repeat domain 38"	Q5R3I4	22	46267961-46294008	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 233.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 134.2;NK-cells: 182.3;Proximal enterocytes: 144.5;Proximal tubular cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 90.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 29.9;NK-cells: 38.0;T-cells: 90.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029302, HPA075893"	Approved		Approved	Cytosol		NA	NA		170000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA029302: AB_10601704, HPA075893: "	"unprognostic (7.78e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.92e-3)"	"prognostic favorable (3.21e-6)"	"unprognostic (8.34e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.02e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.97e-1)"	"unprognostic (8.33e-2)"	24.7	23.6	9.5	10.2	11.6	46.9	25.7	10.3	10.7	16.8	12.8	42.1	79.4	13.8	6.4	12.5	17.2	15.5	23.2	9.7	11.0	64.4	233.6	15.6	10.7	13.3	12.3	26.0	35.5	7.6	13.2	7.8	11.9	23.6	31.9	4.7	27.0	7.3	20.6	12.2	80.9	10.3	10.3	22.8	29.1	6.8	12.2	2.5	15.2	12.3	5.9	16.9	13.5	11.3	12.0	13.2	16.4	34.5	15.2	13.1	15.7	17.2	11.5	18.7	14.6	21.8	8.5	0.1	10.8	17.9	7.4	10.8	16.8	13.9	6.8	27.0	36.9	15.6	28.4	76.0	21.0	9.0	59.8	22.6	7.3	8.5	9.7	12.9	15.9	0.2	11.9	19.4	12.2	12.1	0.3	28.2	12.5	22.6	13.1	0.0	8.0	8.0	12.6	13.8	2.9	22.8	23.7	16.3	13.3	7.5	26.1	18.0	18.5	13.0	14.1	10.3	11.0	14.7	9.2	1.7	8.8	13.7	13.8	29.9	11.9	22.5	90.5	11.4	9.7	2.3	8.5	41.0	10.8	1.7	3.5	36.9	7.6	38.0	8.7	4.3	4.5	42.5	9.5	11.6	10.3	10.7	9.7	11.0	13.3	12.3	11.9	10.3	12.2	11.3	9.2	0.0	7.5	13.7	6.5	3.3	5.9	4.3	3.4	2.6	10.2	6.7	9.2	38.6	4.3	9.2	6.2	10.4	69.1	69.0	23.5	10.4	0.3	7.4	9.6	8.9	20.9	10.5	0.3	10.2	9.3	7.5	11.7	6.9	17.2	13.3	9.7	134.2	13.4	5.0	1.8	37.8	4.1	14.9	4.3	0.9	7.5	9.6	5.4	9.4	12.8	9.3	182.3	5.5	5.6	9.7	51.6	13.9	16.2	8.6	144.5	149.6	5.3	5.4	6.6	7.4	5.9	1.8	3.7	5.3	8.2	6.4	29.2	22.7	51.7	4.6
TTLL6	FLJ35808	ENSG00000170703	"Tubulin tyrosine ligase like 6"	Q8N841	17	48762235-48817214	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 49.7;Late spermatids: 176.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HDLM-2: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052397	Enhanced		Approved	Vesicles,Microtubules		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules	Vesicles	"HPA052397: AB_2681812"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.21e-5)"	"unprognostic (1.10e-2)"	"unprognostic (6.01e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.09e-3)"	0.1	0.0	0.6	0.1	0.6	0.0	0.1	0.5	1.0	0.2	1.6	2.8	1.3	0.1	0.0	0.0	3.6	0.5	0.0	0.7	0.6	2.5	0.0	0.6	0.0	0.8	0.9	0.0	0.6	0.0	0.4	0.0	0.6	0.1	3.9	0.4	0.0	0.0	0.0	0.0	1.7	0.1	0.6	0.0	0.2	18.9	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.0	0.7	0.6	0.8	0.9	0.6	0.6	0.8	0.6	0.1	3.2	2.6	5.2	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.6	0.0	3.8	1.8	0.0	0.0	0.0	7.4	1.9	0.3	49.7	2.6	0.1	0.5	4.2	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	1.0	2.6	0.0	0.0	0.0	176.1	1.2	0.1	0.0	0.0	0.0	0.4	0.0	13.0	0.7	0.0	2.2	0.0	0.0	0.4	4.1	3.2	23.8	0.7	0.0	0.0	0.0	11.2	0.4	0.0	0.0	0.0	0.0	0.4	3.5	0.1
TTPA	AVED	ENSG00000137561	"Alpha tocopherol transfer protein"	P49638	8	63048553-63086053	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 165.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Hepatocytes: 72.0"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;SK-BR-3: 6.0;T-47d: 2.1;U-2 OS: 2.9;U-2197: 3.7"	"Low region specificity"	"Detected in all"													NA	NA		10000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.30e-7)"	"unprognostic (1.78e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.57e-2)"	"unprognostic (5.46e-3)"	"unprognostic (6.16e-3)"	1.6	0.2	2.7	0.4	2.7	0.2	0.5	3.0	2.3	0.1	0.7	3.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	2.5	2.5	2.4	165.0	0.7	0.2	2.5	3.2	0.0	1.2	3.6	0.1	1.7	2.4	0.1	4.3	0.9	0.1	0.1	0.2	0.2	0.3	0.2	2.1	0.0	0.3	0.3	3.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.8	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	6.0	0.6	0.0	2.1	0.2	0.1	0.0	2.9	3.7	0.6	0.2	0.0	0.0	1.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	2.7	3.0	2.3	2.5	2.5	2.5	3.2	2.4	2.1	3.0	2.3	0.0	3.2	1.1	37.9	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	7.2	1.3	0.0	0.0	11.2	0.0	2.1	1.9	1.1	0.0	0.0	0.1	0.2	2.4	0.0	1.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	1.8	72.0	0.6	0.0	2.7	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	10.6	0.1	0.1	1.2	0.0	0.0	0.1	0.0	5.5	0.0	0.2	0.0	0.7	0.1	0.0	1.0	0.0	0.1	9.9	0.1	0.0	4.9	0.1
TUBA4B	"FLJ13940, TUBA4"	ENSG00000243910	"Tubulin alpha 4b"	Q9H853	2	219253243-219272197	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	8	"fallopian tube: 40.0"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 148.9;Respiratory ciliated cells: 83.1"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (3.20e-5)"	"unprognostic (1.47e-4)"	"unprognostic (1.85e-1)"	"unprognostic (3.70e-3)"	"unprognostic (9.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-3)"	"unprognostic (3.78e-2)"	"unprognostic (9.57e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.08e-1)"	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.1	1.5	4.7	0.0	0.1	0.5	0.7	0.0	40.0	0.0	0.0	0.4	0.8	1.5	0.2	3.5	0.1	1.9	3.6	0.1	0.0	0.0	0.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.2	0.3	0.3	0.6	0.1	0.1	0.0	0.3	1.4	0.8	0.6	0.2	0.1	0.4	0.8	1.9	3.6	1.8	1.8	0.7	1.4	0.0	0.0	3.2	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.3	1.8	0.0	0.0	0.0	0.0	1.9	0.0	1.8	148.9	0.9	0.1	1.8	0.0	0.3	0.2	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	27.9	83.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1
TUBAL3	FLJ21665	ENSG00000178462	"Tubulin alpha like 3"	A6NHL2	10	5393101-5404828	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 28.3"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 19.8;Proximal enterocytes: 19.7"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 13.3;JURKAT: 7.7;K-562: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045900, HPA063394"	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA045900: AB_10961130, HPA063394: AB_2685003"	"unprognostic (2.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.13e-2)"		"unprognostic (3.02e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.35e-4)"	"unprognostic (7.93e-4)"	0.1	0.0	0.4	0.5	0.3	0.1	0.4	0.4	0.6	0.1	1.4	11.9	24.3	0.0	0.0	0.3	0.2	0.1	0.7	0.3	0.4	5.8	0.0	0.2	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.1	10.8	0.0	0.8	0.0	0.1	0.3	28.3	0.3	0.6	0.0	0.2	1.0	0.8	0.3	0.0	1.4	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	13.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.7	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.6	0.3	0.4	0.8	0.5	0.9	0.6	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	19.7	4.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.4	0.1
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3223324-3231730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 387.9;choroid plexus: 154.0"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 414.8;Horizontal cells: 430.7;Muller glia cells: 847.3;Skeletal myocytes: 350.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 541.9;CACO-2: 415.3;NTERA-2: 268.0;RPMI-8226: 277.7;SCLC-21H: 797.7;SH-SY5Y: 390.2;SuSa: 245.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	4.0	7.2	298.1	8.1	324.5	1.0	5.0	348.4	387.9	9.9	154.0	17.0	2.4	4.2	45.5	2.4	3.3	3.8	4.6	258.8	356.9	11.6	1.0	1.4	8.1	363.3	349.9	1.1	5.7	0.0	35.1	4.4	354.5	3.7	2.6	65.3	10.8	4.6	6.2	3.9	6.1	7.3	337.2	0.7	4.5	1.0	369.1	2.3	0.9	1.6	5.7	2.6	5.6	383.9	0.0	8.2	541.9	164.2	0.6	0.2	0.9	5.1	7.4	20.8	45.0	415.3	2.0	0.9	5.6	5.7	0.0	1.3	212.8	0.7	12.0	1.6	98.3	0.2	0.0	33.2	1.1	0.1	6.1	3.1	0.0	2.3	0.0	7.6	1.4	0.5	6.8	1.2	7.6	0.3	1.5	0.4	268.0	1.0	17.6	0.6	26.3	277.7	2.9	0.8	797.7	390.2	0.3	1.7	4.3	245.9	3.2	0.0	0.0	1.9	89.9	6.3	2.2	51.6	0.1	0.0	0.8	0.1	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	298.1	324.5	348.4	387.9	258.8	356.9	363.3	349.9	354.5	337.2	369.1	383.9	3.6	0.0	0.0	109.4	1.9	8.7	2.3	1.8	4.6	63.5	3.9	31.9	40.1	5.7	0.3	7.3	16.7	0.7	1.0	0.9	414.8	15.4	5.8	2.7	3.3	7.6	66.7	0.0	2.4	3.5	1.2	18.7	7.1	3.9	0.0	0.5	0.7	0.6	3.0	430.7	19.4	1.0	24.4	0.0	12.4	7.1	0.3	1.0	92.5	9.4	3.6	847.3	0.0	37.2	21.6	12.0	0.1	0.0	8.4	3.9	0.2	2.0	0.0	43.1	0.0	350.1	19.1	1.3	6.2	3.1	2.7	0.8	0.6	0.0	0.6	1.1
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 190.2;Extravillous trophoblasts: 494.3;Pancreatic endocrine cells: 221.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 157.3"	"Group enriched"	"Detected in many"	6	"B-cells: 58.7;dendritic cells: 157.3"	"Cell line enhanced"	"Detected in many"		"TIME: 821.6"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 19.9"	"Region enhanced"	"Detected in all"		"spinal cord: 10.3"	"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		52000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (9.69e-4)"	197.9	37.9	12.3	82.1	11.7	34.8	134.6	14.7	14.6	106.5	28.6	193.6	31.4	173.5	24.9	217.5	121.2	66.4	166.2	11.8	13.7	66.0	40.8	92.9	31.6	19.2	16.3	81.2	52.7	5.6	33.1	59.7	15.1	84.2	28.8	3.6	69.6	91.3	37.3	78.2	75.8	151.9	14.1	34.0	89.1	28.3	18.4	12.2	52.2	20.2	31.3	129.9	124.2	12.5	211.8	142.3	149.5	76.1	149.0	208.8	108.1	648.5	424.2	492.0	459.1	113.0	65.2	1.3	281.7	440.8	148.6	99.5	84.7	653.6	380.6	1.8	46.1	32.3	159.2	73.6	151.0	2.7	59.5	219.1	146.0	429.4	222.7	148.8	366.1	12.5	159.7	2.5	432.5	216.1	0.8	162.4	79.1	3.3	70.0	1.6	260.0	2.2	99.7	5.8	19.3	27.2	360.3	34.8	113.9	153.7	76.5	203.8	821.6	600.0	510.6	565.7	574.2	11.5	3.8	3.8	458.9	46.9	219.8	2.0	19.4	0.3	0.6	7.6	0.3	42.0	0.1	0.2	25.5	58.7	0.2	0.3	0.4	0.9	7.5	157.3	0.2	13.2	12.3	11.7	14.7	14.6	11.8	13.7	19.2	16.3	15.1	14.1	18.4	12.5	67.0	83.3	7.9	0.7	16.1	69.6	42.7	151.4	16.5	1.2	30.4	44.8	54.3	8.6	37.4	7.3	0.0	53.8	23.6	0.6	1.9	167.6	190.2	6.4	76.9	128.9	0.0	12.2	0.8	104.9	494.3	112.8	1.5	7.1	45.6	7.4	82.5	0.4	69.4	0.0	0.6	0.4	42.7	13.2	85.2	114.9	70.2	36.5	33.8	12.2	65.9	0.2	0.0	0.5	0.4	221.1	0.1	91.4	1.0	51.5	0.1	1.2	18.2	1.6	26.3	89.2	130.5	4.3	6.3	55.7	66.9	22.2	3.6	9.5	0.5	65.2
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243810-110256507	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1058.8"	"Cell type enriched"	"Detected in all"	4	"monocytes: 15775.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 1642.2;granulocytes: 1355.4"	"Cell line enhanced"	"Detected in all"		"OE19: 3836.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	144.2	127.7	149.9	145.4	155.3	367.5	218.6	154.5	225.4	153.9	140.5	455.2	349.3	130.9	168.4	1058.8	240.7	142.1	90.8	156.2	161.7	430.6	436.0	158.4	131.6	163.3	156.2	83.8	119.1	73.0	61.2	105.8	163.0	113.6	435.0	46.2	391.7	128.9	84.8	240.1	332.2	140.3	158.1	105.4	222.7	36.6	156.4	261.3	93.8	76.4	208.3	218.1	230.8	164.8	672.9	920.0	238.7	265.6	601.0	782.3	352.7	792.5	756.2	555.6	419.4	606.8	785.6	598.9	331.5	754.7	1181.3	1464.8	351.0	1081.1	544.6	887.6	778.5	298.2	804.7	1061.8	684.7	747.2	864.2	556.2	703.5	809.0	607.8	504.7	498.7	369.7	515.9	553.1	775.4	557.1	621.9	1119.7	505.4	3836.3	1110.5	256.6	810.3	696.3	721.7	479.4	520.9	183.7	860.0	687.5	572.7	458.6	661.2	508.6	587.9	556.4	357.3	1050.2	1006.1	271.4	872.5	512.7	804.8	654.4	789.5	484.8	311.2	1355.4	169.2	195.5	165.2	154.2	237.7	207.3	475.7	75.9	87.4	129.3	1212.7	195.0	131.6	1642.2	337.0	279.2	149.9	155.3	154.5	225.4	156.2	161.7	163.3	156.2	163.0	158.1	156.4	164.8	458.7	391.0	298.2	12.4	165.9	1304.5	1072.4	3654.4	435.4	38.0	514.2	752.8	108.5	418.9	1810.0	263.0	20.9	637.2	443.0	1297.7	972.4	1172.8	31.2	1560.7	1465.0	587.0	556.4	388.4	18.2	1341.7	993.1	526.8	662.1	775.9	268.6	247.1	216.0	842.8	571.8	28.6	18.3	1111.2	2191.1	286.1	1752.9	31.6	403.2	682.7	763.1	10.3	15775.8	86.3	128.8	7.5	21.9	1994.7	1227.7	285.5	388.5	2151.2	1439.2	3670.6	1516.8	34.8	144.7	211.8	557.8	10.6	76.3	2725.7	1491.0	468.2	266.6	879.4	1621.8	1742.1
TXNDC17	"MGC14353, TRP14, TXNL5"	ENSG00000129235	"Thioredoxin domain containing 17"	Q9BRA2	17	6640985-6644541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 182.9"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 785.8;Proximal tubular cells: 814.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022931	Approved					NA	NA		820000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA022931: AB_1858479"	"unprognostic (8.94e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.97e-2)"	"unprognostic (5.02e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.88e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.86e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.09e-2)"	"unprognostic (9.01e-2)"	25.9	45.3	16.7	22.6	17.3	21.8	28.0	17.7	24.0	35.5	18.5	54.1	56.8	20.4	40.3	182.9	16.1	27.0	31.3	17.8	18.5	62.3	69.8	23.2	22.1	17.3	17.3	13.3	40.4	24.5	27.6	15.0	17.5	32.2	44.7	7.4	47.5	14.6	21.7	27.7	38.8	20.4	18.2	41.9	54.5	15.5	17.2	25.8	20.7	10.1	27.0	68.7	58.5	18.7	130.8	154.4	62.1	134.1	38.1	54.4	29.1	65.4	56.4	59.2	57.0	84.8	44.0	27.8	62.4	50.6	62.3	200.0	67.6	223.5	73.2	93.0	109.3	33.1	138.6	153.3	43.3	54.1	70.7	55.1	83.6	72.7	72.3	58.2	79.8	88.2	45.1	13.3	83.1	91.8	55.1	69.7	90.3	91.9	123.9	53.2	41.4	69.5	126.7	253.3	28.8	74.9	65.9	66.7	54.6	42.1	63.3	48.2	59.8	48.8	61.7	55.7	117.2	20.0	47.8	43.1	98.9	56.9	57.1	77.2	105.0	93.6	35.3	117.3	37.2	54.9	41.7	42.4	115.8	47.5	32.2	37.8	180.9	35.5	120.9	109.3	66.9	56.7	16.7	17.3	17.7	24.0	17.8	18.5	17.3	17.3	17.5	18.2	17.2	18.7	91.8	93.0	157.2	3.9	66.9	189.3	185.3	785.8	330.6	18.1	141.5	162.6	110.3	175.8	236.4	125.0	2.1	180.7	76.6	560.2	389.4	326.8	362.5	110.0	81.6	99.6	135.1	70.7	3.9	451.8	291.6	84.9	181.0	126.9	50.0	92.2	88.2	371.7	245.0	40.4	3.6	316.4	221.8	114.9	83.7	303.2	74.9	118.9	113.8	1.9	170.2	86.8	80.3	4.0	5.3	534.5	378.6	67.0	112.5	169.9	420.3	814.9	142.9	26.8	26.3	58.5	103.9	34.6	116.4	500.1	143.3	104.9	67.7	151.0	332.1	300.0
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583589	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;ovary: 49.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 42.4;Leydig cells: 44.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 46.8;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved					NA	NA		17000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071245: AB_2686371"	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	21.5	3.5	18.2	1.4	30.3	0.8	5.2	17.7	27.1	2.1	0.0	2.3	1.6	4.6	3.5	13.1	11.5	2.5	2.2	27.7	10.7	11.3	0.8	3.3	1.3	20.9	22.6	49.7	9.8	0.9	0.9	5.7	18.6	2.6	0.9	2.6	1.9	6.1	0.9	13.8	2.4	4.4	14.4	5.5	3.2	18.8	15.7	0.4	1.1	1.8	3.7	2.1	4.1	32.0	10.3	6.7	20.7	22.7	18.9	12.8	69.2	14.6	9.3	14.2	13.1	37.7	3.4	0.4	18.3	11.9	19.9	23.7	23.3	3.6	6.5	5.8	15.5	3.2	20.2	18.1	13.3	5.2	0.4	4.1	7.3	10.9	3.6	5.8	10.6	9.8	19.1	4.3	7.9	9.8	2.4	1.0	47.7	16.0	6.7	31.9	18.6	3.8	1.2	19.7	24.6	7.0	13.7	21.6	16.3	29.8	17.8	6.0	8.4	28.0	12.2	21.0	22.5	1.7	3.5	3.1	17.2	33.8	17.2	1.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.2	1.5	0.3	0.1	0.3	0.1	0.1	18.2	30.3	17.7	27.1	27.7	10.7	20.9	22.6	18.6	14.4	15.7	32.0	3.4	3.2	1.1	17.6	0.9	6.8	8.5	0.4	0.6	2.7	2.2	2.2	2.9	2.8	0.7	3.7	6.2	2.9	1.1	1.3	0.0	3.9	3.6	1.1	13.0	5.4	1.8	0.0	42.4	3.6	10.2	10.5	8.6	1.9	0.0	7.6	9.7	0.4	1.2	0.0	4.6	0.9	0.0	1.9	1.3	5.1	44.4	0.9	8.8	1.0	0.1	8.3	1.0	29.1	46.8	4.6	0.1	47.0	0.3	6.4	1.2	1.2	0.5	4.0	0.0	3.9	4.3	4.0	6.5	4.2	10.9	18.9	0.7	5.8	2.3	5.7
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107570	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 492.9;Basal respiratory cells: 406.9;Ionocytes: 266.5;Langerhans cells: 374.7;Suprabasal keratinocytes: 433.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 607.7"	"Low region specificity"	"Detected in all"							"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	62.9	47.6	36.8	31.1	39.9	85.9	58.7	39.8	46.9	57.6	38.0	79.3	25.8	68.9	27.8	64.3	60.8	18.7	43.0	37.7	41.1	42.8	48.0	57.3	45.2	39.3	40.2	69.3	41.8	32.7	60.1	34.6	38.5	48.0	26.8	28.9	49.1	40.8	74.9	47.5	57.2	35.8	38.3	65.4	58.2	54.4	38.8	61.8	62.6	24.8	55.9	60.7	50.7	40.8	101.1	27.7	250.5	71.3	28.7	38.8	248.1	88.2	82.4	105.4	115.3	486.0	59.8	20.8	35.1	54.3	125.6	33.0	161.1	36.3	104.9	114.6	134.0	607.7	61.2	117.9	77.0	264.0	115.2	45.5	90.6	177.1	100.6	43.5	62.8	238.0	105.8	113.4	97.2	324.4	271.1	358.1	287.6	123.4	108.3	485.1	166.9	211.9	99.8	15.4	125.9	77.6	212.6	98.6	147.6	36.5	125.5	147.5	12.1	79.2	59.6	82.0	236.3	191.4	178.3	48.8	80.3	333.6	118.6	211.9	141.0	153.1	101.2	140.4	106.7	140.2	112.7	95.5	150.4	134.2	112.9	109.1	213.1	93.1	196.9	240.7	149.3	188.7	36.8	39.9	39.8	46.9	37.7	41.1	39.3	40.2	38.5	38.3	38.8	40.8	9.5	19.2	18.1	3.9	37.8	492.9	32.5	406.9	86.6	23.9	5.7	2.8	5.0	17.2	153.5	1.8	43.8	19.5	15.3	16.5	1.9	5.2	3.1	4.2	4.4	51.7	18.2	45.0	5.2	6.0	20.7	51.8	44.4	4.2	28.4	3.8	31.8	16.2	23.2	18.5	4.6	17.0	266.5	33.0	374.7	4.1	18.3	30.6	202.7	4.7	19.3	13.0	27.8	3.0	6.2	4.8	17.0	22.6	60.3	31.1	43.2	3.1	107.6	60.7	6.6	39.1	110.7	16.4	18.9	79.8	433.6	23.8	46.6	1.3	20.2	39.1
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.9;Erythroid cells: 3.8;T-cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9"	"Lineage enriched"	"Detected in many"	12	"T-cells: 32.2"	"Group enriched"	"Detected in some"	7	"HEL: 23.0;JURKAT: 39.0;MOLT-4: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	0.4	0.6	0.0	5.2	0.0	2.5	0.2	0.0	0.1	0.5	0.1	0.8	1.6	0.5	0.0	0.4	0.4	2.0	0.4	0.0	0.1	0.4	0.7	1.7	11.1	0.2	0.0	0.3	0.1	0.0	0.1	0.2	0.1	0.4	0.9	0.0	0.9	0.1	0.2	0.3	2.4	0.1	0.1	4.4	1.9	0.1	0.0	18.9	0.5	0.1	5.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	23.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.4	0.0	0.0	0.0	47.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.9	0.0	22.9	0.1	28.2	24.8	0.0	0.0	32.2	24.0	0.5	2.5	0.1	0.1	27.9	10.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.8	0.0	0.0	0.2	0.3	1.0	0.0	0.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	3.8	0.0	0.0	0.0	0.4	1.1	0.5	1.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.0	20.5	0.0	0.0	0.0
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334979-58370751	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.7;tongue: 65.3"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 194.4;Suprabasal keratinocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 112.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	13.0	11.8	5.3	16.7	5.7	32.4	7.8	6.6	8.1	8.9	4.4	11.4	7.0	12.6	7.5	11.6	7.1	9.5	33.3	6.1	6.2	8.1	8.3	8.9	13.8	6.6	6.4	8.4	5.5	8.9	3.9	8.9	6.6	9.5	12.0	5.4	5.5	6.7	138.7	5.9	8.3	13.6	6.4	13.4	6.4	4.5	6.3	7.8	8.4	65.3	11.4	15.1	5.6	6.7	19.1	10.2	18.8	24.4	37.5	30.0	12.1	12.4	21.2	13.9	20.3	20.9	16.4	0.0	19.0	18.6	10.3	17.1	36.6	18.0	19.5	19.8	21.2	4.9	3.7	12.2	24.4	15.3	11.8	34.8	19.9	14.4	26.8	18.7	28.1	13.1	10.0	7.8	19.1	6.1	16.5	17.1	23.0	11.7	15.7	13.8	16.9	10.6	21.2	11.2	14.0	18.8	24.2	40.3	20.6	28.5	14.8	10.2	22.8	5.3	18.6	18.2	13.7	19.7	16.4	16.8	16.7	31.3	6.2	10.1	38.5	17.8	6.2	27.1	7.2	8.9	7.3	7.9	20.0	9.8	7.5	6.2	112.3	8.2	23.4	8.3	9.8	23.4	5.3	5.7	6.6	8.1	6.1	6.2	6.6	6.4	6.6	6.4	6.3	6.7	41.6	12.8	11.2	5.5	54.3	194.4	94.1	60.6	46.1	23.7	45.6	45.5	92.4	17.2	39.0	27.6	18.8	29.9	41.7	27.4	76.3	62.3	5.0	32.6	46.9	42.5	41.7	12.0	18.5	42.0	50.4	51.9	38.7	51.2	22.9	19.6	27.5	15.6	73.7	16.8	17.1	40.1	69.2	90.6	104.0	3.0	33.2	147.7	53.4	4.7	94.6	17.9	22.6	12.5	21.2	81.2	52.7	32.4	26.4	108.4	16.1	54.3	33.6	16.1	6.6	51.4	59.1	33.5	19.9	47.1	190.2	149.0	42.8	14.9	28.5	118.2
UBE2QL1	FLJ25076	ENSG00000215218	"Ubiquitin conjugating enzyme E2 Q family like 1"	A1L167	5	6448859-6496723	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.1;heart muscle: 16.8;retina: 28.3;skeletal muscle: 54.5;tongue: 13.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.0;Cardiomyocytes: 27.6;Excitatory neurons: 47.8;Granulosa cells: 45.5;Horizontal cells: 45.4;Inhibitory neurons: 35.3;Rod photoreceptor cells: 63.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 29.7;PC-3: 24.6;SCLC-21H: 23.1;U-266/70: 54.4;U-266/84: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057414			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Plasma membrane"	"HPA057414: "	"unprognostic (1.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.41e-2)"	"prognostic favorable (6.81e-8)"	"unprognostic (3.18e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.41e-2)"	1.2	1.4	14.3	0.4	14.6	0.0	1.1	16.5	26.1	2.1	1.8	5.3	0.3	0.8	1.0	0.4	0.7	0.4	16.8	17.9	11.4	3.4	1.2	0.1	0.1	12.0	7.9	2.6	0.6	0.1	3.2	0.0	11.6	3.5	0.3	28.3	0.8	5.5	54.5	1.5	1.4	0.7	5.6	0.2	2.9	0.7	10.1	0.3	1.2	13.9	0.2	0.3	1.3	17.7	0.1	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.7	0.0	5.3	0.0	0.0	0.3	0.0	24.6	0.1	0.0	11.5	0.0	0.0	23.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	54.4	52.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.6	16.5	26.1	17.9	11.4	12.0	7.9	11.6	5.6	10.1	17.7	0.2	0.0	0.0	5.5	0.3	1.3	0.5	0.5	0.0	30.0	0.4	1.0	27.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	5.9	0.0	0.0	0.2	0.4	1.0	5.4	0.0	47.8	0.2	0.0	3.6	1.1	0.1	0.0	45.5	0.0	1.0	0.1	45.4	35.3	0.0	0.0	0.3	0.3	0.3	4.1	0.1	0.0	2.8	0.0	9.4	0.0	12.1	5.4	0.1	0.0	6.8	1.8	0.9	0.0	0.2	0.0	63.6	0.0	3.2	1.4	0.1	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0
UCN3	"SPC, UCNIII"	ENSG00000178473	"Urocortin 3"	Q969E3	10	5364966-5374692	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.8;pancreas: 5.8;stomach 1: 3.4"	"Cell type enriched"	"Detected in some"	29	"Enteroendocrine cells: 242.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.4"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 1.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 5.1"					HPA038281	Uncertain				"Secreted to blood"	NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA038281: AB_10672408"			"unprognostic (2.00e-2)"	"unprognostic (2.31e-1)"				"unprognostic (1.60e-1)"		"unprognostic (2.10e-1)"	"unprognostic (3.18e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-2)"				0.0	0.8	1.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	2.3	8.8	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.8	0.7	0.0	0.6	0.0	1.9	0.5	0.0	5.8	0.0	2.7	0.1	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.0	0.8	1.9	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.1	242.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	0.0	0.0	0.3	0.6	2.9	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2
UFM1	"bA131P10.1, C13orf20"	ENSG00000120686	"Ubiquitin fold modifier 1"	P61960	13	38349849-38363619	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039758	Approved					NA	NA		240000	"Cluster 6: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA039758: AB_10697555"	"unprognostic (8.08e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (9.67e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.90e-1)"	41.9	43.1	35.6	47.8	38.1	100.1	47.4	35.6	44.0	43.5	40.5	39.7	48.5	58.4	64.8	29.9	37.1	42.2	35.8	37.6	42.1	45.3	52.9	41.6	52.3	39.1	37.5	50.3	67.0	32.7	37.2	53.1	39.4	49.9	50.6	32.1	58.5	50.3	24.8	42.8	47.8	39.2	40.1	46.9	52.3	19.8	36.9	31.9	52.1	26.2	48.5	41.7	35.8	44.5	31.3	18.1	47.4	46.2	81.8	97.4	43.3	94.1	72.8	47.7	50.3	56.2	63.1	50.9	29.1	81.8	94.5	51.6	44.9	57.4	67.6	71.4	27.5	42.5	33.9	50.0	107.8	63.3	59.1	81.6	84.3	46.4	127.6	69.9	47.7	39.6	28.5	68.5	68.6	35.6	42.8	52.5	48.9	94.4	45.8	48.9	84.8	50.6	60.2	40.6	17.9	40.6	32.4	54.8	80.8	64.9	40.0	49.1	56.5	55.1	33.5	88.1	53.1	64.7	43.9	67.6	116.6	32.2	84.5	71.5	30.6	41.1	30.7	42.0	37.3	40.1	31.2	28.7	26.7	37.6	30.4	31.8	15.5	39.6	40.3	45.0	32.4	34.7	35.6	38.1	35.6	44.0	37.6	42.1	39.1	37.5	39.4	40.1	36.9	44.5	92.1	80.1	73.3	20.9	141.6	136.9	151.7	147.8	108.1	24.0	102.7	64.4	66.3	64.3	115.3	62.5	20.9	87.2	112.7	84.8	99.7	91.5	38.6	126.8	113.4	78.8	31.7	52.6	29.0	102.3	140.2	121.5	92.8	148.1	115.3	53.4	68.9	119.6	97.6	6.7	34.9	113.5	107.8	94.3	148.3	13.3	59.0	102.0	94.3	43.1	92.3	26.7	62.8	26.2	58.9	161.9	102.2	40.3	330.9	215.8	95.2	136.5	141.2	22.3	19.7	87.3	88.1	56.6	44.9	110.2	173.3	140.4	93.0	45.2	80.8	220.3
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760270-233773300	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"intestine: 201.2;liver: 322.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 105.0"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;OE19: 64.5;RT4: 34.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"						"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.1	0.6	0.2	0.5	0.5	0.2	1.5	0.8	0.1	0.2	3.0	201.2	0.2	0.4	3.5	0.1	1.0	0.2	0.4	0.8	4.0	322.4	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	2.4	0.9	0.5	0.3	0.1	1.8	79.2	0.1	0.0	0.2	2.4	0.6	0.3	0.1	0.2	0.1	0.3	10.0	0.9	0.6	0.3	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.0	0.0	0.1	5.4	0.3	0.2	2.5	0.1	0.1	14.0	0.0	0.2	0.0	0.2	0.1	0.1	0.6	1.6	0.0	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.8	0.1	0.3	0.5	64.5	6.5	0.1	0.1	0.6	0.0	34.7	0.2	0.4	2.6	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.2	0.1	0.7	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.4	0.3	0.1	0.1	0.1	0.0	0.6	0.5	1.5	0.8	0.4	0.8	0.2	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.1	6.9	14.6	2.2	1.5	0.0	0.0	0.4	0.1	0.2	0.1	1.5	0.0	0.0	0.1	0.0	0.7	7.3
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 22.0;intestine: 79.5;stomach 1: 32.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 1.8;Gastric mucus-secreting cells: 3.6;Intestinal goblet cells: 1.0;Paneth cells: 1.4;Proximal enterocytes: 3.9;Squamous epithelial cells: 4.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	143	"RT4: 523.3"														"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"						"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.5	79.5	0.1	0.0	14.6	0.0	22.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	36.5	0.0	0.9	0.0	0.0	0.9	53.1	1.9	0.0	0.0	32.7	1.5	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	1.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	523.3	0.0	0.1	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.3
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 71.3;liver: 143.3;urinary bladder: 88.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 12.5;Early spermatids: 52.4;Gastric mucus-secreting cells: 14.3;Late spermatids: 23.3;Squamous epithelial cells: 17.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 7.2;lung cancer: 3.1;renal cancer: 7.6;urothelial cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 1194.0"	"Not detected"	"Not detected"							"CAB009819, HPA054065, HPA056023"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB009819: AB_2241481, HPA054065: AB_2682367, HPA056023: "		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	1.8	0.0	1.8	5.8	0.1	2.6	16.1	0.0	3.5	0.0	0.0	0.0	71.3	143.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	1.3	0.0	2.6	3.6	0.0	11.1	2.6	0.0	0.0	0.0	17.4	0.4	0.0	1.2	0.5	0.0	5.8	88.8	5.5	0.0	4.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	53.8	1.6	0.0	80.2	0.1	0.8	294.5	0.1	4.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.3	0.0	31.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	1194.0	0.0	0.1	0.2	0.1	3.2	149.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.2	12.5	0.0	0.0	0.0	0.3	0.0	2.9	1.8	0.0	0.0	0.0	0.4	0.0	0.0	52.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.5	0.0	0.0	0.4	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.5	1.8	0.1	0.0	0.0	0.0	0.0	1.2	0.2	17.3	1.1	0.0	0.0	0.0	0.1	3.0
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"esophagus: 83.8"	"Cell type enriched"	"Detected in some"	4	"Squamous epithelial cells: 40.7"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"SiHa: 112.2"															NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"					"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	1.3	0.2	0.0	0.2	0.0	0.4	0.5	0.8	1.2	0.4	0.3	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.3	0.2	0.7	4.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	5.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	5.2	0.4	7.1	1.0	0.0	1.8	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	112.2	7.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.8	0.3	0.2	0.2	0.5	0.2	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.4	2.3	1.3	4.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.8	0.7	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	40.7	1.7	0.0	0.0	0.0	0.5	8.5
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 15.9;liver: 20.1;urinary bladder: 30.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 4.5;Club cells: 1.0;Ionocytes: 2.0;Paneth cells: 2.5;Proximal enterocytes: 1.3;Squamous epithelial cells: 1.1"	"Cancer enriched"	"Detected in some"	5	"urothelial cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	64	"RT4: 121.4"															NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"						"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	2.8	0.0	0.0	1.9	0.0	6.5	0.0	0.0	0.0	1.8	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.8	0.0	0.5	0.0	0.0	0.1	4.3	1.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	30.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	121.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.4	0.2
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671898-233773300	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	370	"kidney: 458.6;liver: 195.6"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 7.5;Proximal tubular cells: 6.6"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"A549: 1.4;RT4: 1.2"															NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"										"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	458.6	195.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	P0DTE4	4	69588417-69653249	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 3.6;kidney: 2.3;liver: 3.6;pituitary gland: 5.6"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 107.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;lung cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA017261, HPA045108"	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951804	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 31.4;kidney: 21.0;liver: 13.3;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 91.5;Distal enterocytes: 89.8;Hepatocytes: 53.5;Paneth cells: 54.7;Proximal enterocytes: 248.9;Proximal tubular cells: 130.8;Undifferentiated cells: 101.1"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"Hep G2: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045108	Supported					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	21.0	13.3	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	91.5	0.0	3.7	0.0	0.0	0.0	89.8	11.7	26.3	0.0	0.0	0.0	0.0	12.2	2.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	53.5	0.0	0.0	0.0	34.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	54.7	0.0	0.0	0.0	248.9	130.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	101.1	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815994-68832023	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"liver: 233.7"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 245.3"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	116	"Hep G2: 12.0"									HPA045108	Uncertain					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	233.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.1	0.0	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	245.3	0.0	0.0	0.0	0.3	0.0	7.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"kidney: 1299.8;liver: 1612.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.6;Glandular and luminal cells: 234.7;Hepatocytes: 550.8;Proximal tubular cells: 1249.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 310.8"									HPA045108	Uncertain					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.2	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	32.0	0.0	3.8	68.7	8.9	24.2	0.2	49.9	10.4	0.0	0.0	0.0	1299.8	1612.1	0.4	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.1	0.0	0.3	6.9	0.0	3.6	27.5	0.0	0.3	66.6	0.3	0.0	0.0	0.9	0.1	0.0	0.9	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.3	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	41.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.6	0.1	310.8	2.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	43.2	0.0	0.0	0.0	0.2	0.3	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.6	1.6	0.0	0.0	1.2	0.6	0.1	38.6	2.1	125.0	0.0	0.0	0.0	5.7	97.8	6.6	0.3	150.6	14.0	1.0	3.5	2.7	0.4	10.6	0.0	0.1	0.0	234.7	0.0	0.0	8.9	550.8	0.1	0.0	0.3	37.3	0.0	13.8	0.0	0.0	1.8	7.6	3.6	0.0	0.0	0.0	0.0	1.5	0.4	13.0	10.7	0.0	0.0	0.6	70.6	1249.5	0.5	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	6.3	0.1	5.9	2.3
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951006-36001028	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 51.1;liver: 58.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 49.7;Early spermatids: 125.9;Hepatocytes: 72.1;Late spermatids: 24.5;Proximal tubular cells: 87.0"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	42	"RH-30: 28.2"									"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Cytosol"		"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.1	58.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.2	0.0	0.1	0.3	0.0	0.7	0.1	0.2	3.0	0.0	6.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	49.7	0.0	0.0	0.0	0.0	3.9	0.0	125.9	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	72.1	0.1	0.0	0.3	0.7	0.0	2.6	0.0	24.5	0.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.5	0.4	0.0	0.0	3.8	87.0	0.0	0.2	6.6	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.5	0.0	1.8	0.1
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035021-36071358	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0"	"Low region specificity"	"Detected in many"							HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.0	0.8	0.0	0.0	0.0	6.5	1.1	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	2.6	0.6	0.0	0.0	1.0	1.1	0.0	0.0	0.1	0.9	0.2	1.2	0.4	0.0	0.1	0.1	0.0	0.1	10.3	0.0	0.0	0.1	1.2	0.1	2.9	0.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.3	0.4	0.0	1.3	0.0	0.5	6.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.4	0.0	5.3	0.0	0.0	29.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.2	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	1.1	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	1.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942014-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 6.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 12.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"SiHa: 66.7;U-2197: 47.4"									"CAB018974, HPA066741"	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"		"CAB018974: , HPA066741: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	1.5	0.7	1.3	0.6	1.6	1.8	0.7	1.6	2.6	0.9	0.7	0.2	0.2	0.1	0.1	6.1	0.2	0.5	2.0	3.0	1.0	2.1	0.5	3.4	0.3	1.8	1.2	0.0	0.4	0.6	0.5	1.6	1.8	0.2	0.1	0.2	0.7	0.1	0.3	0.5	0.2	0.7	0.8	0.2	0.3	1.5	1.1	0.7	1.2	0.7	0.8	1.4	1.6	1.7	19.9	1.8	0.5	6.1	1.1	5.6	3.3	20.1	11.8	20.6	16.8	7.4	11.0	0.0	29.9	23.0	29.6	13.9	7.6	18.4	11.8	9.1	3.9	1.1	2.8	0.0	7.1	0.0	1.5	2.7	13.9	18.3	8.0	16.7	11.9	16.6	2.5	0.0	15.4	13.9	1.8	0.0	0.0	3.6	10.2	3.0	4.5	0.0	29.0	5.7	0.6	0.0	66.7	1.4	1.9	3.2	1.8	8.5	18.8	13.5	17.1	47.4	23.5	0.0	0.1	0.9	19.2	10.7	9.9	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.8	1.5	0.0	0.0	0.3	1.8	0.0	0.4	0.0	0.0	1.7	0.5	1.3	1.6	1.6	2.6	3.0	1.0	1.8	1.2	1.8	0.8	1.1	1.7	28.9	0.0	1.3	0.0	1.2	3.7	6.5	17.9	7.4	0.0	1.3	4.4	0.3	0.0	9.4	1.8	0.0	0.0	12.1	0.5	0.0	7.5	7.0	0.3	0.5	9.1	0.0	0.0	3.0	8.8	0.5	3.0	1.1	0.2	0.0	0.1	7.1	0.2	2.2	0.0	0.7	0.3	2.0	0.8	2.1	8.0	0.0	3.1	1.8	0.0	0.0	0.4	4.1	0.5	0.3	4.5	0.0	0.0	1.4	1.4	0.0	0.1	1.4	0.0	0.0	1.0	4.2	3.1	7.0	11.8	2.8	0.0	11.0	0.6	0.4	5.2
UMOD		ENSG00000169344	Uromodulin	P07911	16	20333051-20356301	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Ciliopathy, Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	693	"kidney: 2277.8"	"Group enriched"	"Detected in some"	146	"Collecting duct cells: 248.3;Distal tubular cells: 950.9"	"Cancer enriched"	"Detected in single"	39	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009446, HPA043420, HPA054721"	Enhanced				"Secreted in other tissues"	NA	NA	55000000	66000000		"Cluster 7: Kidney - Transmembrane transport"		"Cluster 39: Non-specific - Basic cellular processes"			"CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585"	"unprognostic (2.51e-2)"										"unprognostic (1.33e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.43e-1)"			0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2277.8	0.8	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	248.3	0.0	0.0	0.0	0.0	950.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844552	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.9;lymphoid tissue: 66.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 68.3;Hofbauer cells: 58.5;NK-cells: 61.8;Pancreatic endocrine cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 245.7;HeLa: 136.3;HMC-1: 245.9;SK-BR-3: 189.7"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.0"	"Low region specificity"	"Detected in many"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol		NA	NA		1500000	"Cluster 38: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Vesicles	"HPA067117: AB_2685784, HPA073525: AB_2686615"	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	7.7	7.3	5.6	23.5	6.8	58.9	7.8	5.8	7.3	18.6	5.0	10.7	8.0	8.6	2.0	23.6	13.8	6.5	14.3	5.0	5.6	6.6	12.6	38.1	25.9	7.9	6.5	19.3	8.8	0.5	11.6	9.0	7.5	8.1	4.5	5.5	7.7	5.1	8.5	6.0	18.5	4.9	6.2	66.2	13.8	6.1	8.2	20.7	5.9	1.5	17.6	10.7	19.6	8.7	44.0	18.7	0.4	0.3	0.5	1.0	47.6	0.1	0.0	0.0	0.1	41.4	97.0	3.4	46.4	0.0	7.5	15.4	0.0	2.2	0.0	0.4	0.5	245.7	136.3	24.2	3.9	94.1	245.9	0.6	2.0	0.5	2.1	2.3	17.9	42.5	87.1	1.1	0.0	71.2	100.9	50.8	0.9	69.9	1.7	32.8	1.0	1.5	1.6	17.7	0.3	66.7	19.2	189.7	0.9	0.5	47.1	56.5	48.1	0.8	65.9	0.5	0.5	1.3	5.9	4.0	0.6	31.3	0.2	59.1	16.0	31.2	19.3	16.9	17.4	6.7	11.4	13.6	12.3	3.6	8.8	11.9	40.1	14.7	25.6	7.2	10.8	18.1	5.6	6.8	5.8	7.3	5.0	5.6	7.9	6.5	7.5	6.2	8.2	8.7	3.8	44.8	8.3	6.8	16.6	1.1	1.7	1.0	0.6	12.0	4.9	2.4	68.3	7.2	4.4	3.7	20.9	4.7	27.0	40.9	0.0	7.2	5.3	1.3	3.3	6.6	6.0	14.9	1.2	6.0	11.6	2.2	2.0	2.3	45.0	9.9	7.9	1.2	58.5	5.0	1.5	3.6	2.0	21.6	8.2	0.5	2.8	22.2	1.8	5.6	22.5	4.5	61.8	3.0	7.9	47.3	30.7	1.5	27.4	1.6	5.5	0.7	1.6	16.2	0.0	4.5	2.6	1.2	1.4	1.5	1.4	25.9	30.9	2.0	6.3	2.3
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026895-41039221	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 37.1;kidney: 58.6;liver: 52.8;pancreas: 36.2;stomach 1: 23.6"	"Group enriched"	"Detected in many"	6	"Cholangiocytes: 30.0;Collecting duct cells: 22.0;Ductal cells: 25.7;Exocrine glandular cells: 68.6;Gastric mucus-secreting cells: 36.7;Hepatocytes: 30.0;Pancreatic endocrine cells: 19.8;Proximal enterocytes: 37.3;Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 44.8;RPTEC TERT1: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015725	Enhanced		Approved	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Centrosome		"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	1.2	1.0	1.3	1.0	1.6	0.9	1.6	1.3	1.7	1.5	1.2	3.1	37.1	1.1	0.3	1.3	1.9	9.2	1.2	1.3	1.3	58.6	52.8	2.1	1.0	1.7	1.4	1.5	36.2	0.3	0.8	0.4	1.6	1.5	1.3	0.8	1.7	0.6	0.7	1.9	29.4	0.4	1.4	3.3	23.6	2.2	1.5	2.7	1.6	0.2	0.7	1.1	1.1	2.3	0.5	0.2	0.6	0.9	0.2	0.1	0.6	0.0	0.1	0.0	0.0	7.0	0.1	0.1	2.5	0.0	0.0	0.2	0.1	0.2	0.1	1.1	1.3	0.6	0.0	3.8	0.1	0.3	0.2	0.1	0.6	0.0	0.4	0.1	0.0	2.8	0.5	0.4	0.0	0.1	0.9	2.3	0.2	44.8	0.2	0.9	0.1	0.5	13.0	0.0	0.6	0.6	0.0	0.0	1.3	0.7	0.1	0.2	0.2	0.0	0.4	0.3	0.1	4.3	2.3	0.6	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.3	1.6	1.3	1.7	1.3	1.3	1.7	1.4	1.6	1.4	1.5	2.3	0.3	3.2	1.1	4.2	1.3	0.8	0.6	0.4	0.6	0.6	1.0	1.0	0.8	30.0	0.3	22.0	4.2	0.4	1.8	2.3	3.9	25.7	2.4	0.6	0.3	0.4	1.2	0.4	0.3	68.6	0.8	0.5	36.7	1.6	0.0	0.3	1.4	30.0	0.3	1.7	0.2	5.0	0.0	0.8	0.3	0.4	0.3	0.8	1.8	0.0	0.8	0.2	2.1	0.0	3.5	19.8	3.1	0.7	0.3	0.6	37.3	41.8	0.9	0.3	0.0	0.3	0.4	0.9	0.8	0.5	0.1	0.8	1.0	0.1	5.4	0.4
UNC80	"C2orf21, FLJ33496, KIAA1843, UNC-80"	ENSG00000144406	"Unc-80 homolog, NALCN channel complex subunit"	Q8N2C7	2	209771832-209999300	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 13.6;retina: 18.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8;prostate cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042472, HPA050959"	Enhanced		Approved	"Nuclear bodies,Vesicles"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"	Vesicles	"HPA042472: AB_10965318, HPA050959: "	"unprognostic (7.91e-3)"	"unprognostic (2.25e-4)"	"unprognostic (1.44e-2)"	"unprognostic (3.20e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.16e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.40e-3)"	0.0	3.9	6.4	0.0	9.9	0.0	0.0	15.6	21.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.4	1.1	0.0	6.9	4.9	0.1	0.0	0.1	0.0	6.7	1.5	0.5	1.0	0.2	13.6	0.0	5.8	0.9	0.1	18.9	0.1	0.2	0.0	0.1	0.1	0.2	1.1	0.2	0.4	3.5	2.6	0.1	0.3	0.0	0.0	0.2	0.0	5.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.9	15.6	21.0	6.9	4.9	6.7	1.5	5.8	1.1	2.6	5.0	0.2	0.0	1.1	49.0	0.0	0.8	0.3	1.9	0.0	117.7	0.2	0.1	2.1	0.0	0.7	0.0	66.7	0.0	0.0	0.0	0.0	0.0	31.9	1.1	1.7	0.5	0.0	0.0	432.0	0.0	0.0	1.1	0.0	0.1	1.3	0.6	0.0	0.0	0.1	52.2	354.7	0.0	0.0	0.0	0.0	10.5	0.9	0.3	0.0	10.3	0.0	26.6	0.0	290.5	12.8	0.1	0.0	1.9	0.0	1.2	0.0	0.2	0.8	75.6	0.0	0.2	0.1	7.5	3.8	0.0	0.1	0.0	0.0	15.1	0.0	0.3
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232872-1237326	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 17.5"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"NB-4: 98.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.2"	"Region enriched"	"Detected in single"	8	"cerebellum: 7.5"	HPA063294			Approved	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.0	0.0	0.7	0.0	0.1	0.0	0.0	17.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.4	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	17.5	0.5	0.0	2.8	2.2	3.0	3.2	0.6	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 216.0"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 146.5;Proximal tubular cells: 68.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	14	"basophil: 2.1;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	7	"CACO-2: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000728, HPA076321"	Enhanced					NA	NA		1400000	"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000728: AB_1080471, HPA076321: "	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favorable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.2	0.2	0.2	0.2	0.6	2.0	0.1	0.7	1.8	0.2	0.2	0.2	1.2	0.2	0.2	0.1	0.3	0.1	1.9	0.2	0.0	25.7	216.0	0.8	0.2	0.1	0.1	0.2	0.1	0.0	0.4	0.0	0.4	0.3	0.1	1.1	0.1	0.1	0.5	0.9	0.4	0.1	0.0	0.8	0.2	3.0	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.7	1.8	0.2	0.0	0.1	0.1	0.4	0.0	0.4	0.1	0.8	0.0	2.0	0.3	0.6	0.6	1.3	0.1	0.0	4.0	0.3	0.3	2.4	4.3	0.0	1.8	10.4	0.1	0.1	0.0	11.7	0.1	1.2	0.2	0.6	1.9	2.4	5.3	0.7	0.4	0.1	1.4	0.0	0.5	0.0	0.6	3.6	146.5	0.1	0.0	1.2	0.0	0.0	5.1	2.7	1.4	0.3	1.0	0.0	0.0	21.3	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.7	1.2	0.0	68.5	0.0	1.8	0.0	2.7	3.7	12.8	6.8	0.0	1.1	0.3	0.9	0.2	0.1	1.1
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 45.8;liver: 23.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Distal tubular cells: 13.7;Excitatory neurons: 32.5;Inhibitory neurons: 20.8;Oligodendrocyte precursor cells: 27.6;Proximal tubular cells: 82.1"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	0.0	0.1	3.3	0.0	2.9	0.0	0.0	1.8	3.0	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	3.7	1.9	45.8	23.9	0.0	0.1	1.3	1.3	0.3	0.1	0.0	0.2	0.0	1.1	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.1	0.0	1.4	0.0	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	2.9	1.8	3.0	3.7	1.9	1.3	1.3	1.1	1.4	1.6	2.4	0.0	0.0	0.0	24.2	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	13.7	0.0	0.1	0.2	0.1	0.1	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	8.2	0.0	0.0	20.8	0.0	0.0	0.9	0.0	0.1	0.3	0.5	0.0	2.8	0.0	0.1	0.0	27.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	82.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.8;kidney: 54.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	2.8	5.9	6.8	0.0	0.2	2.8	3.9	0.1	1.5	51.5	97.8	0.1	0.3	0.0	2.9	25.9	0.1	9.0	4.7	54.0	0.6	0.1	0.1	6.1	5.7	0.0	3.9	0.0	6.7	0.0	7.0	0.0	48.3	19.0	0.0	0.3	0.0	0.0	96.5	2.1	4.1	0.0	26.7	0.2	5.9	0.1	1.1	0.0	0.0	0.6	0.1	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	2.8	3.9	9.0	4.7	6.1	5.7	7.0	4.1	5.9	8.3	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
USHBP1	"AIEBP, FLJ38709, MCC2"	ENSG00000130307	"USH1 protein network component harmonin binding protein 1"	Q8N6Y0	19	17249171-17282786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 41.5;Endothelial cells: 28.3;Hepatic stellate cells: 21.4;Ionocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.9;HeLa: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA052471	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA052471: AB_2681843"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-3)"	"unprognostic (3.94e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.12e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.88e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.88e-1)"	8.8	1.9	5.0	1.6	4.9	2.9	8.2	7.2	5.2	2.9	4.1	1.9	1.9	3.6	1.1	1.3	3.1	1.7	12.6	5.0	4.1	4.5	1.2	6.9	2.6	4.6	4.5	1.4	4.8	0.8	1.2	5.6	5.1	2.3	0.5	1.1	2.0	0.9	6.2	2.1	2.2	1.3	3.3	3.5	1.7	1.0	5.1	0.5	4.5	4.8	0.5	2.8	2.3	4.6	0.6	0.9	1.7	0.4	0.0	0.0	10.9	0.3	0.0	0.0	0.0	1.9	0.9	2.9	3.4	0.0	0.1	1.2	0.1	0.2	0.0	0.7	1.3	0.7	5.0	1.1	0.0	2.4	2.4	0.3	0.0	0.2	0.2	0.6	3.2	1.1	1.4	1.5	0.0	0.1	0.4	2.4	1.3	0.3	2.7	1.4	0.2	0.7	0.0	1.3	1.1	0.7	0.7	0.7	0.2	0.9	1.3	0.9	1.9	1.8	0.5	1.5	1.0	2.6	0.9	2.8	0.6	1.5	0.6	2.0	0.4	0.7	0.7	0.3	0.6	0.6	0.6	0.7	0.1	1.0	0.9	0.8	1.6	0.7	0.2	0.8	0.8	0.5	5.0	4.9	7.2	5.2	5.0	4.1	4.6	4.5	5.1	3.3	5.1	4.6	41.5	3.2	0.5	0.7	0.0	0.5	0.9	0.1	0.6	0.3	0.5	0.1	6.7	0.0	0.7	0.0	0.0	1.1	3.1	0.2	0.0	0.1	0.7	0.7	0.8	28.3	0.0	0.0	0.4	0.6	0.9	0.9	0.0	1.5	1.3	0.1	21.4	0.3	0.1	0.0	0.5	0.2	20.3	0.6	1.2	0.2	0.6	0.3	5.4	6.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	1.3	0.1	1.7	0.0	2.2	1.5	0.2	0.4	0.2	1.0	4.5	0.7	0.3	0.0	0.8
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179653032-179804366	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 149.2;tongue: 108.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 93.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.2	11.9	3.9	2.8	13.6	1.5	5.3	8.6	12.0	3.3	0.0	2.9	1.2	5.7	3.4	4.0	3.4	4.5	42.5	3.7	4.7	3.0	4.6	5.4	3.6	11.3	10.5	12.5	4.1	4.0	5.8	2.6	12.7	4.3	2.2	7.1	6.2	2.7	149.2	2.2	1.9	6.3	6.4	2.1	1.7	6.0	8.1	2.4	9.7	108.9	3.5	3.5	2.2	34.4	27.6	11.3	20.0	14.8	8.9	14.1	11.6	18.6	17.4	23.7	18.8	17.1	9.6	35.6	18.0	17.2	27.6	2.6	21.4	9.1	26.4	93.3	14.8	9.0	23.6	14.4	6.3	26.5	1.1	10.5	3.0	18.8	18.5	9.1	16.6	11.9	4.7	43.0	15.7	15.0	22.5	3.0	17.9	1.3	13.1	29.3	20.2	27.4	11.7	7.9	13.0	14.5	14.1	16.9	7.2	5.4	37.0	12.7	24.1	28.6	27.6	23.7	64.1	29.5	21.2	78.3	13.0	15.0	27.2	0.1	0.3	0.0	2.6	0.5	15.6	3.2	1.8	3.8	1.5	0.9	1.2	1.3	0.0	0.0	0.7	4.5	0.7	1.3	3.9	13.6	8.6	12.0	3.7	4.7	11.3	10.5	12.7	6.4	8.1	34.4	45.0	9.6	35.9	14.0	5.3	2.5	1.9	1.4	0.6	13.7	7.1	5.2	208.5	5.7	5.4	1.8	6.2	10.7	5.6	1.4	15.6	1.1	2.6	13.9	11.4	10.1	9.6	5.5	23.2	4.4	2.4	12.0	4.1	2.5	2.5	35.5	22.1	7.6	4.3	16.8	52.2	2.9	0.0	4.8	3.5	3.6	9.3	5.0	14.2	16.9	1.7	7.0	3.1	36.2	42.5	1.0	12.2	9.4	4.5	4.4	0.1	2.7	3.7	10.2	13.1	17.8	12.0	6.1	2.8	4.8	1.6	5.1	4.1	58.8	4.5	1.4
UTP4	"CIRH1A, CIRHIN, FLJ14728, KIAA1988, NAIC, TEX292"	ENSG00000141076	"UTP4 small subunit processome component"	Q969X6	16	69131291-69231130	"Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 100.0;Spermatogonia: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 398.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041139, HPA043542"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center"		"HPA041139: AB_10961278, HPA043542: AB_2678542"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.16e-3)"	"prognostic unfavorable (9.05e-5)"	"prognostic unfavorable (8.18e-7)"	"unprognostic (1.31e-1)"	"unprognostic (4.76e-2)"	"prognostic favorable (2.88e-5)"	"unprognostic (2.12e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.32e-3)"	"unprognostic (9.57e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.20e-2)"	25.4	17.4	7.7	17.5	8.6	27.1	21.0	7.3	10.1	16.3	7.3	21.1	10.8	20.6	9.9	23.0	19.5	12.7	19.2	10.3	7.5	31.7	19.1	16.3	19.1	6.1	6.9	18.3	24.1	16.6	14.2	15.5	6.6	16.1	17.6	11.4	15.7	14.4	61.7	20.2	13.9	22.7	5.9	14.0	19.1	31.4	8.0	17.6	23.2	26.3	23.3	28.8	16.8	7.3	79.6	95.6	56.9	79.8	48.5	42.9	94.5	83.7	57.2	152.1	112.8	188.1	68.8	166.4	68.0	57.7	63.1	106.0	130.8	102.7	167.4	33.2	74.6	82.2	58.6	99.7	58.6	96.5	52.7	41.0	55.2	143.0	129.5	40.7	68.6	88.8	169.4	22.9	90.0	96.2	105.4	50.5	139.1	80.3	66.7	174.3	85.3	163.4	63.6	77.7	96.4	67.1	178.3	45.3	48.3	63.3	80.2	53.4	48.2	83.3	83.6	73.4	119.2	59.5	116.1	398.1	56.5	76.5	87.4	4.5	18.6	3.5	26.7	26.1	38.5	30.6	30.0	26.9	25.6	20.1	34.7	31.6	1.7	35.0	19.4	21.6	31.5	30.2	7.7	8.6	7.3	10.1	10.3	7.5	6.1	6.9	6.6	5.9	8.0	7.3	12.1	6.4	11.4	0.0	14.6	0.0	30.0	0.0	28.5	5.7	12.4	11.6	0.0	5.7	9.9	5.5	8.4	18.9	7.4	1.7	9.8	27.4	17.9	7.0	13.2	12.1	0.0	12.4	0.0	25.4	22.1	14.8	10.2	9.0	2.5	12.0	9.3	7.9	16.7	6.7	0.0	6.4	0.0	8.9	0.0	7.6	15.8	9.8	0.0	0.0	8.2	7.6	11.3	0.0	0.0	24.4	5.4	14.7	13.4	26.7	4.5	100.0	5.8	5.7	6.6	26.7	12.8	30.1	49.5	25.1	0.0	12.9	11.0	16.5	10.0	22.6
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584431-85593406	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 487.9;Endothelial cells: 337.8;Hepatic stellate cells: 486.2;Kupffer cells: 340.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 364.7;LHCN-M2: 428.9;TIME: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	134.0	117.4	71.0	59.9	74.1	41.2	118.4	72.9	89.1	78.6	66.8	76.4	23.3	79.4	33.2	45.3	84.3	58.0	114.7	69.4	76.1	90.0	79.3	134.6	92.7	79.1	71.4	52.8	29.0	14.7	31.9	74.1	74.2	72.8	20.5	2.9	36.9	36.7	217.3	44.5	54.1	77.2	73.8	97.5	54.0	11.4	78.0	50.9	63.8	199.6	41.2	87.1	69.7	71.7	0.8	0.2	2.4	0.0	89.3	155.8	2.4	98.5	155.9	95.5	104.5	39.5	15.1	0.3	2.3	172.2	50.7	1.1	0.0	2.4	42.2	142.9	2.8	1.9	2.5	56.1	187.2	4.5	0.9	108.4	9.6	40.1	1.1	138.9	364.7	61.7	0.4	0.3	428.9	14.5	63.1	13.8	0.1	27.2	0.6	92.4	0.4	2.7	2.7	3.6	0.2	3.4	0.6	27.4	0.5	2.2	3.2	5.1	250.0	2.3	6.7	7.5	0.2	0.1	3.1	2.4	110.5	5.4	65.9	59.1	222.6	176.5	180.5	503.8	171.7	60.7	136.1	135.2	79.0	54.5	102.4	125.1	70.2	94.4	424.9	86.4	248.7	283.0	71.0	74.1	72.9	89.1	69.4	76.1	79.1	71.4	74.2	73.8	78.0	71.7	487.9	19.2	21.2	3.6	43.9	60.8	39.8	104.1	39.3	0.8	14.9	27.3	84.4	71.4	70.1	44.1	0.0	22.9	64.5	38.8	29.4	29.9	1.8	7.7	64.7	337.8	12.6	35.6	0.1	49.1	7.2	148.0	9.7	7.9	44.4	22.2	486.2	198.6	80.3	3.3	0.2	20.5	36.7	340.8	91.5	10.2	192.6	147.8	275.7	4.7	136.0	17.5	112.3	0.5	1.6	44.2	51.9	165.1	68.4	64.7	126.5	91.2	50.6	1.0	59.2	152.2	83.9	5.5	6.6	19.8	45.3	21.6	88.5	19.2	7.8	49.4
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 349.4;Muller glia cells: 265.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 79.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 398.9;U-87 MG: 628.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	NA	NA	562000	57000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.73e-4)"	155.8	52.7	17.6	36.5	20.3	45.5	92.4	34.2	28.2	45.2	46.8	32.6	50.9	104.0	10.5	61.3	40.9	80.1	208.3	22.8	25.1	116.9	217.3	94.1	9.3	27.0	38.5	25.0	68.1	105.0	22.3	46.2	26.8	120.3	21.4	229.1	32.1	17.8	221.2	44.2	44.6	57.1	19.6	70.1	63.9	5.3	32.0	5.6	270.9	150.9	9.5	122.3	61.7	24.9	76.5	13.4	12.5	71.8	21.0	32.9	84.2	45.6	81.1	29.7	58.4	43.1	9.9	24.9	35.5	27.7	305.4	30.6	34.0	92.0	52.0	27.4	10.4	19.0	17.8	29.2	220.3	20.8	40.4	58.0	178.6	290.6	286.2	398.9	7.7	21.0	35.7	121.7	109.4	31.3	2.3	28.3	7.9	221.2	19.2	2.3	12.0	60.5	114.8	62.9	22.3	46.8	65.6	44.4	162.0	16.1	17.3	75.1	10.4	122.6	32.9	179.2	76.1	68.8	43.6	49.1	628.6	47.9	43.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	20.3	34.2	28.2	22.8	25.1	27.0	38.5	26.8	19.6	32.0	24.9	63.6	349.4	84.7	121.5	9.8	70.5	51.2	76.8	60.3	37.8	67.0	57.1	164.7	77.2	85.7	22.0	31.3	1.3	11.6	92.9	1.9	54.7	0.0	38.4	59.1	29.0	27.4	21.3	12.1	40.8	6.3	69.7	124.4	121.2	112.0	111.7	17.5	116.0	13.9	180.0	17.0	71.8	12.2	16.2	199.0	0.3	1.8	144.1	28.4	10.3	11.3	265.8	0.0	124.1	1.8	86.0	47.1	3.4	15.9	119.4	61.9	20.5	11.4	43.9	0.0	42.1	79.1	1.1	1.9	82.0	78.3	7.9	11.4	17.4	51.0	137.5
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237855-133241928	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2"	"Group enriched"	"Detected in some"	10	"NB-4: 18.2;NTERA-2: 10.9"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Cytosol	"HPA050955: AB_2681288"	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	4.8	2.3	1.6	3.6	1.1	2.8	1.9	1.6	1.5	1.5	1.9	1.9	0.4	1.6	0.5	0.5	1.8	1.5	1.5	1.5	1.5	1.7	0.5	3.8	0.5	1.9	1.7	1.5	1.2	0.5	1.4	0.5	1.5	1.3	0.4	0.2	1.3	0.8	0.9	1.2	1.0	1.2	0.9	5.7	0.9	1.0	2.5	0.2	0.8	0.1	0.4	1.4	1.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.2	10.9	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	1.9	2.6	0.3	0.1	3.2	0.0	0.3	0.1	0.0	1.8	0.2	0.1	0.1	0.9	0.3	2.4	0.1	0.0	0.7	1.6	1.1	1.6	1.5	1.5	1.5	1.9	1.7	1.5	0.9	2.5	1.8	0.0	0.0	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	7.9	0.2	0.0	7.8	0.0	0.0	5.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419121-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 436.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 243.8;Enteroendocrine cells: 113.6;Intestinal goblet cells: 143.6;Paneth cells: 216.2;Proximal enterocytes: 558.5;Undifferentiated cells: 161.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 56.4;stomach cancer: 23.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	97	"CACO-2: 762.5;Hep G2: 365.3;OE19: 321.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		6800	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.6	1.1	0.0	10.3	0.1	0.3	0.8	0.3	0.2	0.7	0.0	175.9	395.0	0.5	0.0	0.9	0.7	28.1	1.0	0.0	0.0	25.9	31.4	0.7	0.3	0.0	0.0	1.1	29.4	0.0	1.4	0.3	0.0	1.0	184.0	0.0	0.6	0.4	0.4	1.1	436.3	8.1	0.0	1.2	6.9	2.0	0.0	0.0	0.6	0.0	0.0	0.8	0.9	0.1	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	762.5	0.5	0.1	5.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.3	365.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.0	1.7	0.8	321.9	0.0	0.0	0.0	1.4	0.0	0.2	0.3	0.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.3	0.8	0.4	0.1	0.0	1.8	0.3	0.6	0.5	24.3	0.1	0.0	2.1	0.3	0.8	243.8	3.9	12.3	1.9	1.3	0.9	0.4	113.6	3.2	0.7	42.9	0.2	0.8	6.6	1.6	8.9	0.3	0.7	32.6	0.1	1.7	0.5	143.6	0.0	2.2	1.5	0.5	0.0	5.1	0.0	0.0	0.2	0.5	0.0	0.0	0.3	10.9	216.2	0.0	0.3	0.9	558.5	35.1	0.0	1.2	0.0	1.7	0.7	0.8	0.8	0.6	0.9	0.3	1.5	0.0	161.8	0.3
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132680849-132714055	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"gallbladder: 89.2;intestine: 136.3;liver: 218.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 13.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	80	"dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5"	"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"			"HPA046103, HPA064145"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		980000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA046103: , HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	2.7	0.6	0.3	3.1	0.6	9.4	1.1	0.5	1.5	1.0	0.0	6.2	136.3	8.9	0.2	0.6	2.6	89.2	0.6	0.2	0.3	21.7	218.7	4.7	2.5	0.6	0.3	0.3	1.4	0.1	0.1	2.7	1.2	0.3	1.8	1.0	2.3	0.2	0.3	0.9	79.5	0.9	0.2	10.1	1.5	0.5	0.5	0.6	0.4	1.1	2.5	1.6	0.7	0.9	2.5	0.0	0.3	0.1	0.0	0.7	0.5	0.2	0.2	0.0	0.0	0.0	2.5	0.1	8.7	0.0	0.4	0.0	0.0	2.3	0.6	0.0	0.0	0.1	0.1	1.4	1.3	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.1	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.3	3.0	13.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	8.5	0.0	11.9	0.2	0.0	3.8	0.3	0.6	0.5	1.5	0.2	0.3	0.6	0.3	1.2	0.2	0.5	0.9	0.0	0.0	3.0	0.0	0.3	1.3	0.2	14.9	0.0	0.0	1.2	0.4	0.2	50.1	11.4	1.8	0.0	0.1	0.2	12.5	0.0	244.2	0.0	7.6	4.1	0.2	0.0	0.0	0.0	19.4	0.1	0.3	4.6	39.6	0.0	0.0	1.1	70.6	18.1	0.0	0.0	11.2	22.4	12.0	3.9	0.0	0.0	23.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	98.0	1.6	0.0	0.5	6.6	61.7	21.9	16.0	0.0	0.0	0.4	1.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	2.0	14.7
VSIG4	"CRIg, Z39IG"	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 989.8;Kupffer cells: 590.9;Macrophages: 328.4"	"Cancer enriched"	"Detected in all"	5	"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8"	"Group enriched"	"Detected in many"	31	"dendritic cells: 17.8;monocytes: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		59000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"		"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	137.1	68.8	17.9	44.2	18.8	7.8	44.2	17.0	36.6	14.1	21.5	40.9	22.5	15.5	5.3	15.4	66.8	39.6	30.0	18.2	18.3	17.9	51.0	166.0	27.8	25.1	23.6	12.9	14.3	6.8	7.0	139.6	25.8	10.6	31.7	2.2	24.5	9.3	8.2	10.8	43.9	108.3	18.9	69.3	22.9	7.3	37.6	5.4	12.3	12.5	1.8	61.5	11.6	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	18.7	0.1	0.0	11.1	0.0	0.0	0.0	0.2	17.8	0.1	0.0	0.0	0.5	0.0	0.4	0.1	0.0	5.6	17.9	18.8	17.0	36.6	18.2	18.3	25.1	23.6	25.8	18.9	37.6	26.7	1.3	3.2	16.1	0.0	1.2	2.3	0.3	0.0	0.0	0.0	2.6	0.5	1.8	7.2	3.1	0.0	0.0	5.3	0.3	0.0	0.0	0.1	7.9	0.0	0.0	10.4	0.0	0.0	0.0	0.0	4.9	2.7	0.0	0.0	3.8	0.0	5.0	3.2	989.8	0.0	0.0	0.0	0.0	590.9	111.8	16.6	1.5	328.4	3.6	12.2	1.5	0.5	0.0	0.5	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.1	4.4	0.0	6.6	0.6	2.0	0.3	0.9	0.5	1.7	12.3	1.5	0.0	0.0	0.2
VSIG8		ENSG00000243284	"V-set and immunoglobulin domain containing 8"	P0DPA2	1	159854316-159862657	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 25.6"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 11.2;Collecting duct cells: 5.5;Gastric mucus-secreting cells: 5.1;Suprabasal keratinocytes: 4.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA023219	Uncertain					NA	NA		650000		"Cluster 61: Skin - Cornification"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA023219: AB_1845635"	"unprognostic (8.66e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.93e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.94e-7)"	"unprognostic (1.72e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.99e-1)"	0.6	0.1	0.5	0.1	0.5	0.0	0.1	2.0	0.3	3.4	1.8	0.1	0.1	0.1	0.0	4.0	1.3	0.1	0.2	0.2	0.0	5.5	0.0	0.5	0.1	1.4	0.8	0.8	0.1	0.0	0.2	0.1	1.4	0.1	0.0	0.0	5.5	0.0	0.1	25.6	0.1	0.0	0.6	0.2	0.1	0.4	0.1	0.4	0.2	0.0	6.5	0.1	3.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.5	2.0	0.3	0.2	0.0	1.4	0.8	1.4	0.6	0.1	0.4	0.5	0.0	0.0	0.0	0.1	11.2	0.7	0.2	1.2	2.6	0.5	0.4	0.2	1.5	0.3	5.5	0.0	0.2	0.6	0.6	0.0	0.1	0.6	1.7	0.8	0.5	3.6	0.0	0.0	0.0	0.2	0.9	5.1	0.9	0.0	2.3	0.4	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.9	0.2	0.6	0.4	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.8	2.1	0.1	2.2	0.4	0.0	0.9	0.6	0.5	0.0	1.8	4.5	0.1	1.1	1.1	1.1	0.8
VSTM5	"C11orf90, LOC387804"	ENSG00000214376	"V-set and transmembrane domain containing 5"	A8MXK1	11	93818232-93850618	"Predicted membrane proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;placenta: 4.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 22.3;Excitatory neurons: 5.2;Inhibitory neurons: 9.2;Syncytiotrophoblasts: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.2;OE19: 3.7;PC-3: 5.4;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029525, HPA063591"	Uncertain		Uncertain	"Endoplasmic reticulum"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA029525: AB_10600789, HPA063591: AB_2732704"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-4)"	"unprognostic (2.45e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	0.2	0.2	2.2	0.1	1.9	0.0	0.4	1.0	3.4	1.1	0.1	1.1	0.1	0.4	1.2	0.1	0.2	0.4	0.1	1.8	3.7	0.8	0.0	0.1	0.0	3.1	2.0	0.1	0.5	0.1	0.6	4.4	3.3	0.5	1.7	0.5	0.4	0.4	0.0	0.1	0.7	0.7	1.4	0.0	1.9	0.2	3.3	0.0	0.1	0.0	0.1	0.2	0.1	2.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.0	0.0	0.1	0.0	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	1.0	3.4	1.8	3.7	3.1	2.0	3.3	1.4	3.3	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.9	0.5	0.5	0.3	0.0	0.1	0.0	0.0	22.3	0.1	1.1	0.0	0.4	0.0	0.3	0.2	0.1	0.0	0.0	5.2	3.0	0.7	0.3	1.5	0.7	0.0	0.1	0.0	0.0	1.5	0.0	9.2	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	1.1	2.1	0.4	0.0	0.1	0.5	1.5	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	5.9	0.0	0.0	1.6	0.1
VWA1	"FLJ22215, VWA-1, WARP"	ENSG00000179403	"Von Willebrand factor A domain containing 1"	Q6PCB0	1	1434861-1442882	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 275.1;Endothelial cells: 142.7;Syncytiotrophoblasts: 290.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 47.2;CACO-2: 46.7;CAPAN-2: 136.6;Hep G2: 84.4;SCLC-21H: 47.6;T-47d: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		250000		"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (2.78e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.52e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.08e-2)"	"unprognostic (6.71e-2)"	36.2	15.2	55.3	31.5	91.7	0.2	38.4	79.4	76.7	51.0	24.4	114.3	15.3	70.4	11.5	41.3	50.4	22.4	38.0	59.4	58.9	58.6	133.3	29.6	13.7	103.4	81.6	22.5	55.3	12.5	20.0	38.4	87.9	131.3	5.3	2.3	64.0	203.6	10.1	26.2	37.6	20.4	74.2	11.7	52.6	27.1	88.3	3.0	67.4	3.4	5.1	118.5	50.6	151.2	47.2	15.4	2.2	15.7	0.4	1.4	24.5	3.1	0.1	2.2	0.1	46.7	136.6	0.0	43.0	1.3	5.0	12.1	15.9	8.1	0.3	3.0	11.3	1.5	0.1	84.4	3.5	0.0	5.5	2.7	0.4	1.0	0.0	0.4	0.6	0.0	1.6	0.0	0.1	11.7	0.1	0.9	6.1	16.5	4.3	0.6	0.8	2.2	2.7	7.9	47.6	7.4	0.0	41.7	5.8	3.7	61.1	0.6	1.4	0.1	0.6	0.4	15.2	0.3	0.2	0.2	2.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	91.7	79.4	76.7	59.4	58.9	103.4	81.6	87.9	74.2	88.3	151.2	103.4	19.2	36.1	5.9	2.8	6.5	19.1	5.2	12.0	7.6	40.4	59.4	3.6	44.3	14.2	53.3	4.2	275.1	1.4	24.2	7.9	82.0	0.6	16.0	46.2	142.7	12.5	2.7	0.5	65.0	99.2	28.3	16.8	17.7	1.3	2.0	8.2	49.4	22.8	15.2	1.5	8.9	6.1	1.0	4.3	4.0	34.2	1.1	24.9	18.7	2.6	52.1	0.0	13.0	48.7	48.0	11.0	59.0	2.6	21.5	0.8	5.4	10.7	4.3	6.6	62.4	17.2	0.8	2.1	11.9	8.5	290.3	1.3	6.3	10.4	14.9
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;choroid plexus: 19.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 10.9;Inhibitory neurons: 1.8;Late spermatids: 9.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"SCLC-21H: 1.2"	"Low region specificity"	"Detected in many"							"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria	"Plasma membrane, Cytosol"	"HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	0.4	0.8	0.1	0.9	0.0	0.0	0.1	0.1	0.0	19.1	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	1.1	2.9	1.3	0.0	0.1	0.1	3.7	6.3	0.0	0.0	1.1	2.9	0.1	5.1	0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	3.2	3.0	0.0	0.2	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.1	0.1	1.1	2.9	3.7	6.3	5.1	1.5	3.0	0.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1
WARS1	"IFI53, IFP53, WARS"	ENSG00000140105	"Tryptophanyl-tRNA synthetase 1"	P23381	14	100333790-100376805	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 324.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 1345.3;non-classical monocyte: 1608.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 908.5;SK-MEL-30: 1012.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		49000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	100.7	67.9	40.3	185.6	44.4	70.5	65.4	40.1	45.5	35.9	45.2	67.8	44.8	39.6	70.3	54.4	50.8	48.7	157.6	44.2	56.0	83.6	47.9	207.5	139.0	72.0	52.6	21.2	47.5	39.2	63.4	324.4	65.3	49.1	72.0	37.8	49.5	38.3	74.7	28.4	67.7	76.2	47.6	110.6	70.1	67.7	55.0	61.7	159.9	67.0	86.2	107.7	30.7	44.9	91.2	85.7	54.6	319.1	78.7	110.7	87.3	117.4	220.7	232.1	301.4	57.4	80.2	101.7	105.5	277.4	59.7	151.1	158.8	130.3	153.1	154.4	48.3	64.1	60.9	72.3	908.5	184.9	101.6	126.9	186.9	141.3	290.1	74.5	225.0	66.1	202.8	255.0	107.5	178.0	64.3	87.1	55.4	94.1	152.2	51.4	86.5	64.9	119.3	80.8	145.7	84.9	69.4	58.7	1012.4	70.5	153.6	234.7	153.1	25.7	58.9	269.2	61.3	446.4	277.1	191.9	295.0	144.2	205.5	96.5	471.7	610.4	41.5	1345.3	38.4	71.4	34.5	38.4	337.9	68.0	24.8	28.6	170.9	44.5	1608.2	54.7	44.8	672.7	40.3	44.4	40.1	45.5	44.2	56.0	72.0	52.6	65.3	47.6	55.0	44.9	66.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	16.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	11.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	0.0
WDR49	FLJ33620	ENSG00000174776	"WD repeat domain 49"	Q8IV35	3	167478684-167653983	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 31.3;choroid plexus: 29.3;fallopian tube: 10.0"	"Group enriched"	"Detected in some"	5	"Astrocytes: 79.0;Endometrial ciliated cells: 43.4;Respiratory ciliated cells: 47.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.7;myeloid DC: 2.2;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 2.9;monocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;NTERA-2: 3.0;THP-1: 14.5;U-937: 7.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 9.5"	"HPA036225, HPA036226"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA036225: AB_10696652, HPA036226: AB_2675007"	"unprognostic (1.68e-3)"	"unprognostic (1.24e-3)"		"unprognostic (2.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-2)"		"unprognostic (5.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-9)"	"unprognostic (1.79e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.07e-1)"	0.1	0.1	10.2	0.4	8.2	2.0	0.1	16.6	3.4	0.3	29.3	0.1	2.0	0.4	0.0	0.9	10.0	0.2	2.1	7.0	15.6	0.3	0.0	1.9	0.3	30.1	27.0	0.1	0.3	0.0	0.5	0.0	23.8	0.2	0.1	0.0	0.2	0.0	0.0	0.1	4.6	0.1	31.3	0.4	0.2	0.6	15.5	0.4	0.0	0.2	0.3	0.2	0.2	23.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	2.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.5	10.2	8.2	16.6	3.4	7.0	15.6	30.1	27.0	23.8	31.3	15.5	23.4	0.2	0.0	0.6	79.0	0.1	0.0	0.9	1.7	9.1	0.0	0.1	0.1	1.1	0.0	10.9	0.0	0.0	0.0	1.6	0.1	0.0	0.1	2.4	43.4	0.3	0.2	0.0	1.7	4.5	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	4.1	1.6	2.5	0.8	0.0	1.8	0.0	0.0	4.0	0.0	0.0	2.5	3.0	0.0	0.0	0.0	0.1	0.4	3.3	0.0	47.7	0.0	6.6	0.3	0.6	0.1	0.2	1.0	0.1	0.0	0.1	0.0	0.2	0.8
WDR72	FLJ38736	ENSG00000166415	"WD repeat domain 72"	Q3MJ13	15	53513741-53762878	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 105.7;liver: 33.1;thyroid gland: 57.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 12.8;Collecting duct cells: 22.0;Glandular and luminal cells: 13.2;Hepatocytes: 44.3;Proximal tubular cells: 93.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.9;OE19: 18.3;RPMI-8226: 17.5;RPTEC TERT1: 10.1;SuSa: 15.2;U-266/70: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048212, HPA057410, HPA059819"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133"	"unprognostic (6.39e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (3.33e-16)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (7.67e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.8	0.0	0.1	7.2	0.0	0.6	2.6	1.4	0.5	0.4	2.6	3.9	0.1	0.0	0.1	105.7	33.1	0.8	0.1	0.1	0.4	0.2	3.5	1.8	0.3	0.1	0.1	0.1	0.8	0.7	18.4	0.6	0.0	2.0	0.9	0.0	0.0	0.1	1.1	0.5	0.1	0.0	57.9	0.0	0.0	1.7	0.0	0.3	0.0	9.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	3.2	0.1	6.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.9	18.3	0.1	0.0	0.1	17.5	10.1	3.5	1.9	0.0	0.0	0.1	0.0	15.2	2.4	0.0	0.1	0.3	0.5	0.0	0.1	7.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	6.4	3.6	0.0	0.5	0.1	1.1	0.0	0.6	0.5	0.0	0.1	0.6	12.8	0.0	22.0	0.0	0.6	0.0	0.2	9.8	3.2	1.2	4.9	1.0	0.1	0.0	0.0	0.4	0.5	2.1	0.2	0.0	13.2	0.0	0.0	0.0	44.3	0.1	3.3	0.5	0.0	0.0	0.6	0.0	0.3	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	93.2	0.1	0.1	0.0	0.0	0.1	1.0	1.6	0.9	0.4	0.1	0.7	0.0	0.3	6.4
WEE2	"FLJ16107, WEE1B"	ENSG00000214102	"WEE2 oocyte meiosis inhibiting kinase"	P0C1S8	7	141708353-141731271	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Distal tubular cells: 1.9;Proximal tubular cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA					"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.2	0.6	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WIPF3	"CR16, FLJ36931"	ENSG00000122574	"WAS/WASL interacting protein family member 3"	A6NGB9	7	29806486-29917066	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 41.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 45.1;Granulosa cells: 149.4;Leydig cells: 50.7;Peritubular cells: 100.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 22.1;cerebral cortex: 49.9;hippocampal formation: 40.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.1;HEK 293: 4.1;K-562: 6.6;NTERA-2: 5.1;RPMI-8226: 11.3;SK-MEL-30: 4.5"	"Region enhanced"	"Detected in all"		"hippocampal formation: 213.9"	"Region enhanced"	"Detected in all"		"hippocampal formation: 156.3"	"HPA041145, HPA041211"	Uncertain		Uncertain	Mitochondria		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA041145: AB_10795001, HPA041211: AB_10795003"	"prognostic favorable (7.93e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.12e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.41e-1)"	1.0	5.6	8.7	1.0	22.1	0.5	1.1	0.0	49.9	0.4	0.0	0.7	2.9	3.3	19.7	1.2	8.8	1.4	4.0	40.3	4.2	2.5	0.5	0.5	0.7	0.4	2.6	41.7	1.7	1.2	0.9	0.2	0.1	4.4	0.5	3.8	4.0	4.8	25.0	0.9	2.6	4.1	0.5	1.0	5.9	18.8	7.4	0.4	2.0	8.8	0.7	1.4	0.2	8.1	0.3	1.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	18.1	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.1	0.0	0.1	0.0	0.0	5.1	0.0	3.6	0.0	0.0	11.3	0.0	0.0	1.8	1.5	0.1	0.1	4.5	2.4	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.1	0.0	8.7	22.1	0.0	49.9	40.3	4.2	0.4	2.6	0.1	0.5	7.4	8.1	1.5	0.0	0.0	6.2	0.0	2.2	1.5	0.6	1.2	8.2	4.9	4.6	9.3	0.0	1.4	3.7	2.1	0.0	0.3	0.5	3.9	3.8	1.8	5.0	0.4	4.1	1.8	3.0	45.1	3.5	0.1	7.3	11.7	1.2	0.0	149.4	0.4	0.5	4.5	5.0	27.0	0.7	0.0	0.0	1.0	4.8	50.7	1.0	5.4	1.9	0.0	6.2	0.0	2.0	1.9	2.4	1.5	100.4	0.1	1.1	5.5	5.5	5.1	2.9	6.6	7.2	16.0	4.4	9.9	0.9	0.4	0.0	1.0	8.7	2.0	0.4
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752579-911452	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 293.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046541, HPA059157"	Enhanced		Supported	Cytosol		NA	NA		92000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA046541: AB_2679690, HPA059157: AB_2683935"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	56.7	20.6	190.8	36.4	236.8	54.2	33.5	179.4	166.1	32.8	110.8	22.8	14.4	26.7	30.4	72.1	29.4	27.1	63.8	132.3	161.1	84.0	31.6	44.6	39.2	232.3	238.4	30.1	22.5	51.1	17.0	36.0	217.0	29.7	24.2	87.4	24.0	33.4	79.7	52.0	17.4	36.1	225.4	30.2	27.6	48.3	238.0	61.3	27.7	79.8	46.9	35.8	43.8	293.0	53.9	97.5	131.8	11.3	88.1	80.0	52.2	48.3	61.6	58.2	51.3	59.4	55.7	71.0	16.8	107.8	73.5	39.8	93.8	56.7	84.3	124.7	51.4	169.4	122.2	46.1	66.7	86.9	68.2	64.0	82.1	97.6	164.4	61.6	73.4	68.0	76.4	158.2	77.8	54.1	154.6	15.6	105.8	47.8	24.3	78.0	138.8	20.8	80.6	96.8	35.1	40.7	121.8	82.9	33.6	183.3	86.8	97.2	78.3	67.1	77.3	86.2	70.8	23.8	43.1	103.8	59.4	44.6	53.2	0.7	1.8	1.6	1.9	2.1	1.9	1.7	1.9	2.1	1.4	1.2	1.2	1.9	5.6	1.4	4.7	1.2	3.4	1.6	190.8	236.8	179.4	166.1	132.3	161.1	232.3	238.4	217.0	225.4	238.0	293.0	261.1	102.5	141.6	77.1	65.3	112.8	42.3	38.3	85.4	87.9	50.6	39.5	241.6	50.1	47.1	90.1	150.1	32.5	83.0	27.8	86.1	28.0	29.7	63.0	68.6	106.7	58.7	304.2	182.3	24.4	32.9	58.3	37.2	70.2	52.6	46.2	52.5	71.7	57.3	84.1	165.0	26.3	16.2	121.4	80.8	21.2	61.8	96.7	37.4	114.3	95.7	64.0	61.8	126.7	336.4	41.7	34.8	55.7	76.5	59.0	24.2	21.8	64.6	96.1	13.1	69.6	63.8	186.5	74.6	147.2	136.0	28.5	112.9	33.2	25.8	55.2
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.0;kidney: 37.6;prostate: 11.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.3	0.0	0.7	1.1	0.9	0.0	2.8	0.8	3.3	0.6	0.3	9.8	1.9	0.2	0.7	8.9	0.4	0.0	0.1	1.7	1.1	37.6	0.2	0.1	0.1	1.1	0.7	4.3	0.2	0.0	1.2	0.0	0.7	11.6	11.0	0.6	1.8	1.1	0.0	0.5	3.7	0.4	0.6	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.0	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.8	3.3	1.7	1.1	1.1	0.7	0.7	0.6	1.0	1.0	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3
WNT10B	"SHFM6, WNT-12"	ENSG00000169884	"Wnt family member 10B"	O00744	12	48965340-48971735	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.3;Extravillous trophoblasts: 21.7;Fibroblasts: 4.8;Inhibitory neurons: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 7.3;T-47d: 8.2;U-266/84: 7.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA055048, HPA062539"	Enhanced		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA055048: AB_2682683, HPA062539: AB_2684793"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.73e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.99e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.39e-6)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.25e-1)"	1.5	0.2	13.1	1.5	14.9	1.2	0.6	4.2	17.9	0.8	3.2	1.4	1.4	0.3	1.5	1.4	1.0	0.5	1.5	15.3	7.3	0.4	0.4	1.1	1.7	8.6	7.6	0.2	0.3	0.1	2.4	0.3	8.2	0.8	0.7	0.1	0.9	0.6	0.7	3.4	4.3	0.1	5.1	4.1	1.1	3.3	10.4	1.9	1.0	0.4	1.5	1.3	1.0	9.8	1.9	1.2	0.0	1.7	0.0	0.0	4.6	1.3	2.4	0.5	0.1	3.6	4.0	0.0	0.3	0.2	1.5	2.2	4.8	0.3	0.2	1.1	6.3	2.1	1.7	0.1	0.0	0.7	2.9	0.0	0.4	0.1	2.1	4.1	0.0	1.5	7.3	0.3	0.7	2.4	0.1	2.5	0.0	1.3	2.5	0.0	0.6	2.2	0.0	0.4	0.1	0.0	0.3	0.1	0.6	2.2	8.2	2.7	0.0	2.5	4.9	0.4	0.6	2.6	7.8	0.0	1.0	5.4	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.1	14.9	4.2	17.9	15.3	7.3	8.6	7.6	8.2	5.1	10.4	9.8	0.2	0.0	0.0	0.7	0.2	0.4	0.0	0.0	1.8	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.0	7.3	0.0	21.7	4.8	0.0	0.1	0.0	0.0	0.7	0.0	0.3	0.0	4.7	0.2	0.0	0.0	1.2	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.7	3.0	0.9	1.3	1.4	1.6	0.0	0.0	0.1
WNT11		ENSG00000085741	"Wnt family member 11"	O96014	11	76186325-76210736	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 37.4"	"Group enriched"	"Detected in some"	5	"Adipocytes: 41.5;Fibroblasts: 23.2;Theca cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 2.9"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 36.2;CACO-2: 12.1;CAPAN-2: 17.8;EFO-21: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA050101	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA050101: AB_2681015"	"prognostic favorable (5.97e-4)"	"unprognostic (9.27e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.87e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.09e-3)"	37.4	20.8	1.7	0.4	3.5	0.9	23.7	4.1	2.2	4.8	14.3	3.6	2.5	2.7	1.3	1.2	6.7	2.1	8.3	3.8	3.5	2.8	8.0	6.3	1.1	7.4	2.7	4.5	9.5	1.2	3.1	4.1	6.9	4.3	1.1	0.3	4.3	1.1	12.3	8.1	3.3	0.6	2.8	3.5	1.4	0.9	2.8	0.9	17.2	7.1	0.2	4.0	3.8	2.1	0.0	0.0	0.0	0.0	2.9	0.2	36.2	0.0	0.0	0.1	0.2	12.1	17.8	0.0	57.0	0.1	0.2	5.5	1.1	0.0	0.0	5.5	2.1	2.9	1.4	2.2	0.0	0.0	0.4	0.1	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	1.4	0.3	0.0	0.4	0.9	0.0	2.9	0.4	0.0	2.1	0.2	0.0	2.5	0.1	1.4	0.0	0.0	2.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.2	1.7	3.5	4.1	2.2	3.8	3.5	7.4	2.7	6.9	2.8	2.8	2.1	41.5	0.0	0.0	0.3	0.5	1.3	0.5	0.0	1.2	0.0	0.9	1.9	4.7	0.0	0.0	0.0	0.0	0.9	2.3	2.2	0.0	0.0	0.0	5.0	2.9	1.8	0.0	0.0	0.2	0.2	3.3	23.2	0.0	1.1	0.0	0.4	0.7	2.5	0.1	0.0	0.5	0.5	0.0	0.3	2.3	0.0	0.0	0.7	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.6	0.7	0.7	0.1	3.8	0.0	0.0	0.0	0.0	1.8	5.7	0.4	0.5	0.1	0.9	1.4	0.9	24.3	1.5	0.1
WNT5B		ENSG00000111186	"Wnt family member 5B"	Q9H1J7	12	1529891-1647212	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 32.4"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 25.6;Microglial cells: 19.7;Muller glia cells: 40.4;Urothelial cells: 16.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8;eosinophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 231.4;BJ hTERT+: 143.5;BJ hTERT+ SV40 Large T+: 165.4;BJ hTERT+ SV40 Large T+ RasG12V: 136.4;fHDF/TERT166: 162.6;HBF TERT88: 144.1;hTEC/SVTERT24-B: 144.8;U-138 MG: 142.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061991			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA061991: "	"unprognostic (7.44e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.71e-2)"	3.0	2.3	3.6	4.1	4.1	0.5	3.0	2.8	3.7	5.5	1.8	24.6	4.3	7.2	5.0	14.9	6.2	2.8	4.0	2.8	5.3	1.9	4.6	3.0	2.6	4.7	3.9	8.2	1.5	9.0	11.2	3.9	4.6	32.4	5.8	5.4	15.7	20.0	1.4	5.3	5.0	5.4	3.9	5.2	6.4	1.8	4.2	3.7	2.0	6.7	3.0	13.9	9.7	3.1	0.3	0.1	1.4	0.2	34.6	61.2	0.0	231.4	143.5	165.4	136.4	8.7	0.9	2.9	0.4	162.6	111.1	3.5	3.3	0.0	144.1	55.0	7.9	12.8	0.0	0.0	8.5	0.2	0.1	51.3	3.3	144.8	41.3	66.6	0.0	0.1	9.5	51.9	39.4	0.1	0.0	0.3	5.7	0.2	0.5	0.0	2.3	4.0	2.0	0.0	1.0	3.2	4.9	0.5	0.2	17.7	0.2	0.9	0.0	142.4	5.9	56.7	119.7	13.9	2.2	0.7	13.9	0.0	1.5	0.0	1.8	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	3.6	4.1	2.8	3.7	2.8	5.3	4.7	3.9	4.6	3.9	4.2	3.1	0.9	0.0	0.6	7.5	1.5	0.9	11.0	1.9	25.6	1.8	0.7	6.5	2.2	0.0	3.3	0.0	0.0	1.0	0.2	2.4	0.0	1.1	0.2	1.7	10.4	1.4	0.0	0.0	6.9	0.7	1.1	8.0	0.5	2.7	0.0	0.3	0.4	1.7	5.3	0.0	7.9	1.9	2.0	2.1	2.9	0.5	2.1	2.7	3.6	19.7	4.1	40.4	0.0	4.0	5.6	2.8	5.0	2.6	4.5	8.8	1.0	0.2	4.3	2.7	6.6	7.9	4.3	0.7	5.7	7.7	1.3	0.7	0.2	0.0	1.7	16.2
WNT8B		ENSG00000075290	"Wnt family member 8B"	Q93098	10	100463009-100483744	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"parathyroid gland: 1.2"	"Cell type enhanced"	"Detected in single"		"Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.3;JURKAT: 3.1;RPMI-8226: 1.0;SCLC-21H: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036570	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA036570: AB_10670113"	"unprognostic (6.92e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.16e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.24e-2)"	0.0	0.8	0.1	0.0	0.4	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.4	1.2	0.1	0.0	0.0	0.2	0.0	0.9	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.6	0.8	0.0	0.0	0.0	0.1	0.2	0.0	1.0	0.0	0.7	1.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"WT1 transcription factor"	P19544	11	32387775-32435564	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 67.6;fallopian tube: 52.3;ovary: 45.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Endometrial stromal cells: 70.1;Endothelial cells: 16.3;Granulosa cells: 9.3;Late spermatids: 9.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.7;HMC-1: 29.9;K-562: 19.6;NB-4: 37.2;THP-1: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279"	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	26.5	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.1	18.4	0.0	0.7	0.0	67.6	5.3	0.0	52.3	1.3	4.5	0.1	0.0	16.3	0.1	0.8	0.0	0.2	0.1	45.8	0.1	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	33.1	0.0	19.0	0.2	24.2	0.0	0.0	0.0	0.0	0.0	0.2	8.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	8.4	20.7	0.0	1.2	4.7	10.8	29.9	0.0	0.0	3.4	0.0	0.0	0.0	0.7	19.6	0.0	2.0	0.0	11.2	37.2	0.8	0.0	6.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	2.1	19.6	0.2	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	20.2	0.0	1.0	0.0	0.0	0.0	0.0	3.6	2.2	70.1	16.3	0.0	0.0	0.1	0.0	0.5	7.3	0.0	1.4	0.0	9.3	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.3	8.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	2.3	0.0	0.0	6.6	0.0	2.0	4.5	1.0	0.0	0.0	0.8	0.5	0.4	0.0	0.1
WWTR1	"DKFZp586I1419, TAZ"	ENSG00000018408	"WW domain containing transcription regulator 1"	Q9GZV5	3	149517235-149736714	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 229.3;Endothelial cells: 221.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 212.1;RPTEC TERT1: 151.1;SK-MEL-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007415, CAB017483, CAB068248"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB017483: AB_2216639, CAB068248: AB_2665648, HPA007415: AB_1080602"	"unprognostic (1.85e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.01e-3)"	41.6	13.8	19.2	22.4	20.8	0.2	37.2	18.9	19.6	41.8	32.6	74.9	8.0	42.1	13.4	35.8	33.7	39.6	36.4	20.7	53.9	45.9	19.0	41.2	7.2	52.6	39.9	43.9	31.8	14.1	13.6	44.0	35.9	34.5	13.5	4.2	27.6	32.1	13.2	24.8	21.6	43.7	37.1	19.5	32.7	7.2	23.0	4.7	31.6	15.0	6.1	59.2	34.3	41.0	58.9	80.5	40.6	48.7	48.6	86.8	43.0	32.6	57.5	17.7	17.8	46.7	53.2	0.1	212.1	45.0	53.3	36.1	28.4	28.5	17.9	22.0	19.3	0.0	18.6	37.8	27.3	0.0	0.1	45.3	7.4	61.8	26.6	65.4	136.3	0.0	0.0	0.2	61.7	9.2	0.2	0.2	8.2	0.2	96.6	0.0	50.6	0.4	151.1	9.4	0.0	0.4	21.1	17.2	160.2	31.5	26.5	1.6	94.2	29.0	16.2	24.8	67.4	0.6	0.5	0.8	66.8	0.1	78.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.1	19.2	20.8	18.9	19.6	20.7	53.9	52.6	39.9	35.9	37.1	23.0	41.0	125.7	64.1	89.7	60.4	1.1	51.7	229.3	34.6	60.9	2.2	58.1	56.8	46.8	141.5	87.8	49.7	4.2	12.2	2.0	0.5	7.9	72.0	21.9	136.3	89.1	221.2	0.0	3.2	8.7	27.1	82.3	77.9	10.2	144.4	7.6	45.0	111.4	21.9	4.1	0.0	6.1	1.2	10.2	6.0	32.3	7.9	57.8	4.6	30.2	94.6	2.1	11.0	0.0	7.5	12.7	45.8	0.0	126.4	2.9	86.7	1.2	59.8	53.9	2.0	59.2	76.1	58.0	2.2	0.8	46.3	35.5	14.8	6.5	48.4	2.4	93.5
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540768-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 513.6;NK-cells: 277.1;T-cells: 240.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"NK-cell: 423.5"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 423.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;RT4: 1.1;SuSa: 1.1"									HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"	1.1	0.8	0.3	3.2	0.3	14.1	0.9	0.3	0.5	1.0	0.4	1.9	3.2	3.6	0.9	0.6	1.8	1.9	0.7	0.3	0.4	0.4	5.6	3.3	5.6	0.5	0.3	0.4	0.6	0.3	0.2	1.4	0.4	0.5	1.5	0.0	1.9	1.0	0.3	0.1	2.0	1.4	0.4	13.4	2.9	0.3	0.6	3.8	0.6	0.5	3.6	2.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.1	0.4	47.2	0.2	2.7	0.3	3.6	50.1	0.3	0.1	2.1	37.1	1.9	423.5	0.3	0.1	0.0	17.1	0.3	0.3	0.3	0.5	0.3	0.4	0.5	0.3	0.4	0.4	0.6	0.4	2.9	0.0	1.1	0.0	3.3	2.4	0.0	0.0	1.8	0.0	1.6	1.4	0.8	0.0	0.0	0.0	0.0	0.1	513.6	0.3	0.0	0.1	0.0	2.4	2.0	1.0	0.0	19.2	0.0	0.0	0.0	1.1	8.2	2.2	1.3	0.0	1.4	0.6	0.4	0.0	0.0	0.7	0.0	5.0	4.0	0.0	0.0	3.7	33.8	0.0	0.8	0.0	277.1	0.0	0.0	0.0	1.1	0.0	13.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.9	1.1	0.0	240.6	0.0	0.1	0.1
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 166.6;kidney: 156.0"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	7.5	0.9	0.1	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	5.5	99.0	2.4	0.1	2.2	6.3	4.3	5.3	0.1	0.1	156.0	23.1	2.1	0.5	0.2	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.3	0.0	1.5	0.4	0.5	4.4	166.6	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
XYLB	"FLJ10343, FLJ12539"	ENSG00000093217	Xylulokinase	O75191	3	38346760-38421348	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Xylose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.3;Hepatocytes: 49.3;Inhibitory neurons: 35.9;Proximal tubular cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037863, HPA038415"	Uncertain		Approved	"Nuclear speckles"		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA037863: AB_10672729, HPA038415: AB_10672592"	"unprognostic (2.48e-1)"	"unprognostic (9.72e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.37e-2)"	1.4	2.3	1.3	1.5	1.0	2.2	3.0	5.4	2.0	1.6	0.0	4.1	5.8	1.9	0.8	1.9	1.1	1.6	0.5	0.9	0.7	11.4	33.4	0.7	1.0	0.9	0.2	2.2	2.5	1.1	0.8	0.9	1.1	1.6	4.6	2.1	5.3	0.9	0.6	1.5	6.4	1.4	0.0	1.0	3.5	1.0	0.9	1.6	0.7	0.5	0.8	1.2	1.3	0.6	3.5	6.4	2.8	6.7	4.2	4.3	6.3	5.9	2.0	4.5	4.4	8.2	3.6	3.7	1.4	7.6	5.4	2.5	8.1	2.5	5.6	5.0	6.2	7.5	5.0	24.1	2.2	10.1	7.7	3.0	5.2	5.8	2.7	1.9	4.7	8.5	18.0	6.2	5.0	2.4	8.3	1.4	3.8	8.9	7.9	4.2	5.5	5.0	0.6	6.3	3.6	3.2	3.7	16.0	12.7	2.4	7.2	6.1	2.6	9.0	7.3	15.6	2.5	3.5	6.6	8.5	5.4	9.1	7.2	1.4	0.9	2.0	0.6	1.6	0.5	0.2	0.5	0.3	1.7	0.3	0.6	0.6	1.9	0.5	1.4	0.6	1.5	0.4	1.3	1.0	5.4	2.0	0.9	0.7	0.9	0.2	1.1	0.0	0.9	0.6	1.0	0.0	1.3	14.0	0.9	0.9	2.1	1.8	6.8	3.2	3.0	3.4	1.1	2.8	1.5	0.0	0.0	4.3	1.7	3.8	1.9	1.0	0.5	0.4	3.5	1.8	0.0	3.4	39.3	3.0	3.8	2.3	8.6	1.0	0.0	1.3	1.1	49.3	4.0	0.0	35.9	5.7	2.0	1.0	3.7	1.0	1.5	2.0	0.0	17.8	1.0	0.4	0.0	17.1	17.7	1.3	5.8	1.9	1.6	1.7	13.0	31.7	1.3	5.1	0.0	2.4	1.4	0.5	2.7	4.1	0.9	1.4	0.8	1.8	5.1	2.1
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 20.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 20.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	25.2	13.5	11.9	10.5	12.7	4.1	21.8	12.7	14.3	17.4	11.5	21.8	24.8	16.0	17.9	22.7	13.9	18.9	13.1	11.7	13.7	27.9	50.6	17.2	6.2	13.9	13.2	12.4	26.5	20.0	6.1	41.7	13.5	15.0	22.7	8.3	21.0	11.9	8.3	16.7	23.7	15.9	14.2	27.4	21.3	19.0	14.3	10.5	22.0	14.6	8.8	20.3	11.5	14.1	42.7	20.8	64.3	50.6	37.8	46.5	75.6	27.9	56.2	32.0	43.7	49.9	30.7	0.1	28.8	47.3	41.0	24.3	60.8	49.1	62.3	0.2	20.7	12.6	19.4	35.1	30.6	9.9	21.7	35.7	51.7	48.5	53.6	39.8	109.8	7.0	56.1	18.4	46.1	29.3	6.0	13.0	40.9	26.0	26.4	7.4	50.6	3.6	46.8	49.6	13.1	15.3	57.5	42.9	37.1	42.3	29.7	20.5	95.6	78.4	86.2	59.9	75.8	15.7	8.3	2.6	29.7	13.8	47.6	20.2	0.0	1.0	2.2	0.0	1.5	0.1	0.4	1.2	0.0	0.0	1.0	1.7	0.0	1.1	0.0	0.0	0.1	0.6	11.9	12.7	12.7	14.3	11.7	13.7	13.9	13.2	13.5	14.2	14.3	14.1	120.3	25.6	36.8	18.9	3.3	60.2	46.8	21.4	50.1	6.0	38.1	26.7	18.2	24.3	31.3	29.5	6.2	37.1	52.9	40.3	3.9	29.6	29.4	32.8	35.0	91.0	22.8	12.0	0.4	39.2	26.6	35.4	57.6	43.6	13.9	35.9	39.7	44.9	4.9	3.3	10.3	37.2	14.2	5.4	14.7	11.7	18.3	5.0	24.9	46.9	2.0	16.8	16.5	31.7	30.2	51.0	28.8	12.8	28.9	65.4	33.1	45.6	29.0	8.6	19.7	35.9	23.8	20.3	13.6	53.1	49.7	45.6	27.5	42.4	36.7	66.6
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713576-97739862	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;lymphoid tissue: 79.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 101.0;NK-cells: 155.5;T-cells: 105.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	41	"gdT-cell: 137.4;MAIT T-cell: 93.2;memory CD4 T-cell: 71.7;memory CD8 T-cell: 108.3;naive CD4 T-cell: 50.8;naive CD8 T-cell: 79.8;NK-cell: 112.2;T-reg: 80.1"	"Group enriched"	"Detected in many"	56	"NK-cells: 112.2;T-cells: 137.4"	"Group enriched"	"Detected in some"	11	"JURKAT: 121.0;MOLT-4: 183.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002625, HPA003134"	Enhanced					NA	NA		14000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favorable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favorable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favorable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	3.3	1.3	0.5	28.0	0.6	24.8	1.9	0.5	0.9	1.7	0.7	4.0	5.8	1.4	0.5	2.3	2.2	5.4	1.4	0.5	0.7	2.8	3.9	8.7	57.0	0.8	1.3	0.8	1.0	0.4	1.1	0.9	0.7	2.5	1.5	0.0	2.3	0.8	2.0	2.4	18.5	0.5	0.6	35.5	6.7	2.7	1.2	79.9	3.5	2.8	17.7	4.9	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	121.0	0.0	0.7	0.0	0.0	183.4	0.5	0.1	0.0	0.0	7.2	0.1	9.1	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	14.1	0.1	0.0	0.0	0.3	0.3	0.5	137.4	0.4	93.2	0.2	71.7	108.3	0.3	1.6	50.8	79.8	2.2	112.2	1.0	0.9	80.1	64.2	0.5	0.6	0.5	0.9	0.5	0.7	0.8	1.3	0.7	0.6	1.2	0.6	0.8	9.6	13.6	0.3	3.9	1.5	0.0	0.0	0.0	0.0	0.8	0.5	3.0	0.0	0.0	0.0	0.0	0.1	101.0	0.2	1.9	0.2	1.0	1.6	0.5	0.8	0.0	8.8	0.2	0.0	0.0	1.8	4.6	0.4	2.5	0.1	2.5	0.7	2.2	0.0	0.2	0.0	0.0	2.8	2.2	0.7	0.0	3.4	1.8	2.8	5.0	0.0	155.5	0.0	0.1	0.0	0.0	0.0	28.0	0.1	0.0	0.5	0.0	0.0	0.0	14.3	0.6	1.3	2.1	0.2	1.4	0.0	105.6	0.1	0.1	0.2
ZC4H2	"HCA127, KIAA1166, MCS, MRXS4, WWS"	ENSG00000126970	"Zinc finger C4H2-type containing"	Q9NQZ6	X	64915802-65034713	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 37.4;Inhibitory neurons: 39.4;Oligodendrocyte precursor cells: 58.3;Oligodendrocytes: 59.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 37.3;REH: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049584	Approved		Approved	Vesicles,Microtubules		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Microtubules"		"HPA049584: AB_2680825"	"unprognostic (9.55e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-3)"	"unprognostic (9.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.51e-5)"	"unprognostic (5.34e-2)"	4.5	6.3	7.1	2.5	7.2	2.5	4.1	7.0	8.0	5.9	6.9	9.6	3.9	7.0	4.3	3.4	6.1	3.7	5.7	7.0	7.9	5.4	5.3	3.4	2.8	7.5	7.6	7.2	3.6	11.8	8.6	0.9	7.6	5.3	4.4	5.0	4.3	5.8	1.8	3.8	5.3	7.9	7.2	4.2	6.3	1.0	7.2	8.0	5.4	1.9	2.6	5.3	4.1	7.3	0.0	1.5	23.4	11.0	0.2	0.0	3.7	4.4	9.3	6.3	11.5	2.2	8.8	4.4	2.5	3.9	0.0	0.1	10.4	4.0	6.2	0.0	9.5	7.4	3.3	3.2	1.4	6.8	2.2	4.7	3.3	2.9	6.5	9.5	11.5	25.1	2.4	9.9	7.5	0.0	20.2	0.0	37.3	4.2	10.2	29.8	11.3	0.2	6.5	0.0	0.0	16.8	0.0	0.1	0.9	13.9	2.0	1.3	7.2	3.2	6.7	0.3	0.0	1.8	0.2	14.9	9.9	6.2	0.0	0.0	0.7	0.0	1.7	1.0	3.0	2.6	2.4	2.4	0.9	1.9	3.9	2.4	0.0	2.1	0.2	2.4	1.2	1.4	7.1	7.2	7.0	8.0	7.0	7.9	7.5	7.6	7.6	7.2	7.2	7.3	2.9	3.2	0.0	20.5	6.6	0.6	2.0	1.9	1.8	3.8	1.5	2.2	4.0	4.3	1.8	1.8	4.2	0.1	1.2	1.9	1.9	7.7	0.6	1.7	3.0	4.5	3.6	3.4	37.4	5.7	0.8	4.0	3.6	0.5	2.5	5.2	5.0	4.1	1.1	0.0	39.4	1.9	8.2	0.9	0.0	0.8	7.2	0.8	0.0	22.5	0.5	5.1	2.1	58.3	59.0	4.7	2.2	8.6	1.5	1.0	3.8	5.6	0.6	1.6	13.1	2.8	4.1	0.6	0.5	1.8	0.6	0.0	1.9	4.5	3.3	1.0
ZDHHC6	"FLJ21952, ZNF376"	ENSG00000023041	"Zinc finger DHHC-type palmitoyltransferase 6"	Q9H6R6	10	112424428-112446917	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014357	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA014357: AB_2304658"	"unprognostic (1.21e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.21e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.87e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.22e-2)"	19.5	19.9	15.2	24.6	16.0	21.8	22.7	16.7	18.9	21.2	20.2	24.5	44.6	24.0	33.2	23.7	19.3	23.2	17.0	15.4	16.1	59.3	29.5	20.0	30.6	15.5	15.7	25.7	21.3	21.4	15.4	25.9	15.6	22.4	29.9	21.3	23.9	20.6	14.9	20.5	45.8	17.8	15.9	24.8	25.9	13.6	16.9	25.0	26.2	18.1	30.6	23.9	20.8	17.9	51.7	39.4	40.3	50.2	38.2	28.8	28.5	49.3	46.7	38.2	45.3	37.7	89.6	28.4	22.1	30.2	43.0	60.0	33.8	31.5	44.3	67.0	41.4	29.4	46.4	47.3	24.7	67.9	49.5	21.9	20.7	41.9	48.9	58.7	48.6	42.0	32.4	46.1	41.7	43.3	38.1	75.6	23.6	57.0	32.1	31.4	51.1	26.6	45.3	28.1	15.0	20.9	25.5	40.1	49.1	31.4	22.4	49.2	34.8	43.7	27.6	29.5	47.3	25.7	31.7	37.5	38.7	118.0	29.0	10.4	17.4	21.6	14.7	16.2	18.9	16.7	16.7	18.5	16.6	14.0	14.1	15.9	11.3	16.0	13.7	13.6	23.9	15.9	15.2	16.0	16.7	18.9	15.4	16.1	15.5	15.7	15.6	15.9	16.9	17.9	21.0	22.4	20.1	11.8	35.9	20.3	31.9	23.2	23.9	11.0	21.9	16.1	14.3	31.5	27.4	35.0	8.4	34.8	25.7	31.3	60.7	35.8	72.4	14.9	15.5	18.7	11.4	26.1	15.0	29.8	46.9	17.9	16.3	23.8	23.5	17.8	19.2	21.2	34.4	15.2	15.7	22.7	10.2	20.2	35.9	17.7	16.1	28.6	12.4	12.2	22.2	21.0	23.7	15.1	14.4	31.2	27.9	19.5	23.7	25.7	66.9	39.7	13.4	15.5	6.6	13.9	18.2	11.7	12.5	27.6	22.3	36.5	33.0	10.9	28.5	47.7
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 113.1;TIME: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	26.6	8.6	16.4	12.9	16.2	8.6	16.8	14.0	20.1	33.2	9.9	49.2	6.0	38.7	13.4	11.7	18.6	20.0	34.8	15.2	22.8	7.5	10.4	16.0	9.6	21.1	19.2	9.3	3.8	3.4	7.9	17.5	21.2	14.5	12.3	14.8	8.0	26.9	54.4	7.0	11.8	39.9	16.8	8.1	18.1	10.1	18.2	29.9	11.2	60.5	9.7	24.4	16.4	18.5	0.1	11.1	35.1	43.9	58.4	113.1	0.0	32.7	44.9	6.6	9.3	0.2	0.1	11.3	15.6	39.6	9.3	0.0	14.9	0.0	11.8	19.1	7.9	0.0	7.0	6.3	44.4	9.8	0.3	53.4	0.1	19.6	17.6	21.4	54.9	9.5	7.5	14.4	42.7	0.1	33.7	6.2	2.3	0.0	6.6	11.6	66.0	5.1	12.9	0.0	0.9	15.6	11.1	0.0	0.0	7.2	0.0	6.7	87.7	40.8	9.4	10.0	16.7	9.1	6.3	12.8	10.9	0.0	4.2	4.9	0.0	5.4	2.4	0.0	3.2	4.1	3.2	1.7	1.3	3.1	6.8	3.5	8.5	6.6	0.0	3.1	5.0	1.6	16.4	16.2	14.0	20.1	15.2	22.8	21.1	19.2	21.2	16.8	18.2	18.5	104.4	0.0	7.7	212.9	34.6	11.2	3.0	2.0	0.6	42.7	1.4	2.8	106.3	1.5	3.6	1.8	45.9	0.3	22.0	0.0	0.0	2.1	110.1	7.2	287.8	110.6	0.0	12.2	276.1	2.7	0.5	66.1	2.0	6.5	1.3	17.0	49.6	13.4	1.2	10.1	261.9	0.0	0.0	3.8	25.6	141.8	30.7	6.3	26.6	479.7	10.7	7.2	7.2	968.6	7.3	2.5	0.0	102.0	33.2	3.7	0.0	1.6	1.5	43.4	78.9	99.2	74.2	17.4	15.7	1.1	8.7	0.7	36.2	12.0	0.0	3.8
ZFAND2A	AIRAP	ENSG00000178381	"Zinc finger AN1-type containing 2A"	Q8N6M9	7	1152071-1160759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 490.1;Paneth cells: 310.4;Prostatic glandular cells: 255.2;Urothelial cells: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019469	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA019469: AB_1859009"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.52e-2)"	"unprognostic (8.78e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavorable (5.47e-7)"	"unprognostic (5.44e-3)"	"unprognostic (7.60e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.59e-2)"	27.0	26.0	57.7	10.6	58.9	80.5	24.1	62.8	98.9	18.1	52.7	26.4	17.8	20.7	14.7	21.5	18.8	18.1	18.5	63.0	61.3	30.8	81.1	32.5	15.4	58.7	60.4	20.9	33.8	16.4	22.4	21.1	60.8	23.2	18.1	15.1	19.6	12.1	13.2	20.3	19.9	14.4	60.3	24.3	32.5	26.9	59.3	13.4	27.0	7.9	11.8	25.2	21.7	66.2	44.7	50.6	12.8	29.3	28.6	20.3	20.3	40.1	32.6	40.1	30.6	35.7	35.4	14.5	15.8	33.5	63.3	59.8	10.2	10.6	40.5	11.9	21.1	9.8	22.7	179.8	54.4	29.2	19.3	19.1	34.2	32.9	58.3	28.2	14.0	32.8	56.0	33.0	29.6	69.6	8.3	32.8	51.8	105.8	69.3	25.3	2.4	23.0	16.5	19.0	18.6	19.0	14.3	39.1	50.5	26.7	40.1	58.5	18.2	29.6	23.2	34.3	54.7	40.0	51.2	27.3	29.1	32.5	64.3	71.6	25.8	34.2	31.3	24.7	28.8	32.3	28.1	33.0	18.7	34.5	26.9	23.4	31.8	33.2	25.3	34.6	39.5	30.0	57.7	58.9	62.8	98.9	63.0	61.3	58.7	60.4	60.8	60.3	59.3	66.2	65.4	32.1	17.2	4.2	40.6	22.6	490.1	27.6	46.7	15.6	39.8	34.7	17.9	22.8	17.4	7.3	16.7	18.9	49.1	211.8	23.5	21.6	9.7	46.3	33.4	40.7	126.9	17.2	5.6	39.5	46.6	50.8	54.0	83.8	116.4	9.7	20.3	50.3	40.6	11.8	5.8	207.9	18.3	29.2	119.6	12.6	13.4	121.1	32.0	1.0	31.6	23.7	21.6	2.5	7.4	65.7	310.4	18.0	89.7	255.2	29.3	34.1	13.1	25.6	0.0	16.6	40.5	47.1	39.0	64.8	27.7	65.9	156.4	13.3	123.6	322.2
ZFHX4	"FLJ20980, ZFH4"	ENSG00000091656	"Zinc finger homeobox 4"	Q86UP3	8	76681239-76867281	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 358.5;Bipolar cells: 87.2;Oligodendrocyte precursor cells: 234.2;Oligodendrocytes: 222.6;Skeletal myocytes: 120.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 16.8;TIME: 33.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023837	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA023837: AB_1859013"	"unprognostic (2.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.63e-3)"	"unprognostic (6.14e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.15e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.20e-7)"	"unprognostic (3.50e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.50e-4)"	"unprognostic (5.89e-4)"	3.0	3.6	7.5	0.5	12.0	0.0	2.1	0.9	9.3	3.2	0.0	3.2	0.0	0.8	3.2	0.3	0.6	0.9	0.4	6.0	18.9	0.3	2.8	0.1	0.3	11.3	23.3	1.9	0.2	0.2	2.8	0.1	17.7	1.0	0.5	2.2	0.6	5.5	2.8	0.4	0.3	1.1	7.0	0.1	0.8	6.7	15.3	0.6	0.3	3.1	0.0	2.7	2.6	15.0	0.0	2.2	3.8	0.0	7.2	8.7	0.0	3.3	4.6	3.8	3.9	0.0	0.0	0.0	5.8	5.7	1.7	0.4	7.8	1.0	7.6	0.0	10.3	0.1	0.0	0.0	1.9	0.0	0.5	16.8	0.4	9.5	3.0	6.5	0.7	0.0	0.1	0.3	7.0	0.0	0.0	0.0	0.6	0.4	7.1	0.0	6.8	0.0	5.8	0.0	0.0	6.5	0.0	0.8	0.0	0.0	0.9	0.0	33.4	3.7	5.6	10.6	7.4	10.9	1.2	0.0	1.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	12.0	0.9	9.3	6.0	18.9	11.3	23.3	17.7	7.0	15.3	15.0	5.4	0.0	1.5	358.5	0.3	0.5	0.1	1.0	2.2	87.2	2.4	2.2	4.0	42.9	0.3	5.5	2.1	0.1	0.2	0.0	0.0	0.1	70.0	0.0	1.1	2.0	0.0	0.0	13.7	0.0	0.0	37.5	0.0	0.0	0.0	0.1	1.1	30.5	0.4	5.0	12.6	0.2	0.0	0.6	1.8	24.3	13.7	0.7	0.0	29.0	0.0	15.0	0.0	234.2	222.6	0.0	0.0	21.4	0.1	0.3	0.0	0.3	0.3	5.8	0.0	120.6	8.1	12.4	2.3	1.2	1.1	0.0	0.6	10.0	0.0	0.9
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.8;HMC-1: 3.5;THP-1: 2.4;U-937: 6.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA003030: AB_2666758"	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	1.8	2.2	2.1	0.5	2.0	3.0	1.1	2.6	1.9	1.7	2.4	0.9	0.3	1.2	2.6	0.2	3.2	0.4	1.1	1.4	2.0	1.2	0.6	2.6	0.4	1.3	1.9	3.8	0.7	4.3	2.6	0.7	1.9	0.9	0.2	0.5	0.2	1.6	0.3	0.2	0.9	1.1	0.5	1.1	0.6	0.7	2.6	0.2	0.7	0.5	0.5	0.3	0.3	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	0.8	0.4	0.0	0.0	0.5	0.6	0.2	0.4	0.3	0.4	0.6	3.8	0.0	1.4	0.0	0.0	1.4	0.4	3.5	0.2	0.5	0.0	0.0	0.0	1.4	0.9	1.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.9	0.0	0.0	2.4	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.9	0.0	6.2	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	2.6	1.9	1.4	2.0	1.3	1.9	1.9	0.5	2.6	1.4	3.4	0.0	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.1	3.1	0.5	0.0	0.0	1.5	0.0	0.0	0.7	0.0	2.2	0.0	1.1	0.4	0.1	0.8	0.0	1.7	0.0	0.0	0.8	0.0	0.2	2.5	0.5	0.0	0.0	0.5	0.2	1.0	2.0	0.1	0.2	0.0	3.4	0.2	0.0	0.0	0.3	0.0	0.2	19.7	0.8	1.4	0.4	0.8	0.0	0.0	0.0	0.3	0.8	0.0	0.0
ZNF222		ENSG00000159885	"Zinc finger protein 222"	Q9UK12	19	44025342-44033110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004086	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear bodies"	"HPA004086: AB_2273259"	"unprognostic (1.91e-3)"	"unprognostic (3.41e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.75e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.58e-2)"	"prognostic favorable (5.56e-7)"	"unprognostic (2.19e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-3)"	2.8	4.1	3.7	3.0	3.7	5.3	4.5	6.0	5.3	3.2	3.6	2.5	1.6	2.8	3.9	1.9	2.9	3.4	4.3	3.6	4.5	3.8	2.8	3.2	4.4	4.3	4.5	4.7	3.1	3.7	5.1	3.1	4.4	3.5	2.7	6.8	2.6	3.3	2.3	2.6	2.7	3.2	3.4	4.6	3.1	9.1	4.2	5.8	4.1	2.3	4.3	3.8	2.0	4.9	3.8	4.5	7.4	6.7	5.5	5.5	0.3	4.1	7.3	4.7	7.4	2.1	2.4	1.2	6.1	4.4	5.5	1.3	5.2	3.6	5.9	4.9	4.7	6.4	6.5	3.8	7.0	0.2	5.2	4.2	5.4	3.9	6.5	7.4	4.5	5.2	1.2	2.4	5.9	0.5	4.3	2.4	4.5	1.8	1.7	0.1	7.7	2.1	3.8	12.1	4.0	9.0	6.4	1.2	5.4	6.3	1.6	6.2	3.3	5.1	4.9	2.9	5.0	10.6	9.1	0.1	2.7	0.1	5.8	7.7	2.4	5.0	5.9	1.6	4.8	4.7	5.4	5.7	2.5	5.9	6.2	4.6	4.8	4.9	2.0	2.9	4.2	2.8	3.7	3.7	6.0	5.3	3.6	4.5	4.3	4.5	4.4	3.4	4.2	4.9	2.1	0.0	1.5	1.0	1.9	2.5	1.9	2.3	0.0	5.3	2.1	2.0	1.9	0.0	1.8	5.5	0.0	1.8	3.1	0.8	7.9	2.4	78.5	1.6	1.7	2.4	3.0	4.8	3.7	1.2	1.1	3.0	1.5	2.7	4.5	3.5	3.3	1.1	2.3	6.7	4.2	2.1	6.1	1.3	1.5	6.9	1.8	1.5	1.8	1.0	1.7	6.3	3.1	3.5	3.6	0.8	0.4	2.2	1.5	0.8	1.1	1.3	0.3	2.8	0.0	2.8	3.0	9.9	3.5	0.7	1.7	1.1	3.7	3.5	1.2	1.1
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87265943	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: AB_2681190"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	6.8	6.3	4.4	7.8	4.6	25.4	9.6	17.8	8.7	8.7	1.8	7.3	7.9	10.3	9.5	6.6	6.2	6.7	6.2	3.9	3.1	6.3	6.4	5.7	10.9	3.2	2.5	13.7	6.9	13.8	8.5	8.8	3.8	8.2	6.8	26.4	8.3	7.2	5.5	8.6	8.8	6.4	2.2	8.0	8.1	6.2	3.7	14.3	9.6	5.6	9.1	7.1	7.3	10.3	8.3	4.7	16.1	14.2	9.0	8.1	16.8	6.4	8.1	7.4	10.1	8.2	5.7	12.8	9.0	8.4	10.4	8.4	10.1	9.6	15.9	29.3	7.6	17.3	6.4	6.8	6.7	14.0	7.6	8.1	9.2	7.3	9.4	11.8	6.9	13.6	12.8	19.1	8.1	4.6	8.1	12.0	8.1	2.9	4.4	16.9	15.9	4.9	6.2	17.8	11.9	16.8	8.0	5.3	6.1	9.2	5.4	16.0	7.8	9.8	6.8	7.2	10.1	17.5	12.3	8.6	10.8	11.8	7.2	60.3	16.9	20.0	15.7	5.4	14.8	46.6	16.8	17.3	8.0	42.8	18.7	16.1	83.6	11.2	5.7	25.0	18.3	8.3	4.4	4.6	17.8	8.7	3.9	3.1	3.2	2.5	3.8	2.2	3.7	10.3	64.2	60.9	72.4	147.2	99.0	66.2	31.2	46.1	70.0	167.7	48.0	47.9	76.8	48.6	51.8	25.8	123.0	27.0	89.9	64.9	9.8	122.3	44.4	119.3	89.6	55.6	47.3	43.5	176.6	38.5	36.6	52.3	66.3	203.1	29.1	135.6	40.0	19.0	26.8	186.7	225.7	52.7	40.7	29.2	53.1	12.4	60.0	46.3	32.0	124.6	53.0	62.5	65.9	210.6	209.8	52.2	49.5	66.2	90.8	49.4	72.5	14.5	50.1	99.4	32.9	84.6	59.5	56.3	34.1	36.7	51.4	211.8	90.8	66.8	44.5	58.5
ZNF419	"ZAPHIR, ZNF419A"	ENSG00000105136	"Zinc finger protein 419"	Q96HQ0	19	57487711-57496098	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 31.9"									"HPA003152, HPA003274"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA003152: AB_1080716, HPA003274: AB_1080714"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.55e-5)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.53e-5)"	6.0	8.7	10.0	4.6	10.1	3.0	6.2	10.7	12.6	4.8	9.9	6.3	3.8	5.3	9.7	4.7	6.2	3.5	8.2	10.0	10.1	8.1	6.6	7.0	7.4	9.4	8.9	7.8	4.6	9.1	13.4	6.1	8.8	8.9	3.6	11.1	6.4	6.3	10.4	7.4	6.2	4.0	8.9	10.6	5.3	5.3	10.2	8.0	10.8	7.8	8.9	5.4	4.6	10.1	5.4	6.0	10.3	10.5	4.7	7.1	8.9	6.4	8.8	5.8	31.9	3.8	3.4	1.8	5.1	4.5	5.2	1.6	4.9	13.3	8.0	0.5	22.4	8.3	9.1	4.2	16.8	6.5	6.0	9.7	19.3	5.8	13.8	12.0	6.4	8.0	0.9	1.3	7.3	0.9	10.9	6.7	6.8	0.7	7.9	10.1	9.9	7.6	6.3	11.5	8.4	9.4	6.5	6.0	6.2	8.8	5.3	9.7	6.6	7.0	7.7	2.5	5.6	15.2	18.0	4.5	5.6	3.5	5.7	4.5	2.7	6.1	5.2	3.3	8.9	14.3	8.9	6.6	4.7	15.8	13.8	7.4	3.2	9.7	2.7	3.4	6.5	4.4	10.0	10.1	10.7	12.6	10.0	10.1	9.4	8.9	8.8	8.9	10.2	10.1	3.1	0.0	5.3	3.6	7.2	4.1	5.7	4.9	2.8	8.1	4.3	5.2	5.3	4.3	5.2	7.3	6.2	5.0	4.2	1.3	0.0	5.8	0.3	2.0	2.1	4.8	1.2	2.5	3.3	1.8	2.4	3.7	0.5	1.7	4.5	7.4	5.7	4.6	3.2	10.1	2.8	1.8	8.2	3.2	1.7	0.5	1.8	1.8	5.4	0.0	4.1	6.8	7.2	3.5	1.9	2.5	2.8	5.7	1.6	9.0	2.0	1.9	1.8	9.5	6.6	2.9	3.3	4.9	10.4	2.1	3.8	8.3	4.8	4.2	1.8	5.6
ZNF432	KIAA0798	ENSG00000256087	"Zinc finger protein 432"	O94892	19	52031378-52095738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 26.9;Rod photoreceptor cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA052082, HPA060274, HPA065606"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518"	"unprognostic (1.62e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.41e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.49e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (4.11e-5)"	6.3	13.4	3.2	3.7	3.9	8.0	6.5	5.7	3.7	6.5	8.8	5.5	5.2	7.0	8.7	6.6	6.0	3.5	6.0	3.4	5.5	5.1	4.1	5.6	4.3	3.9	3.7	6.8	18.0	5.6	12.4	4.4	3.9	11.8	4.3	24.6	7.1	4.5	4.1	7.8	5.2	4.3	2.9	4.4	6.4	7.2	4.3	4.0	6.7	4.4	4.1	5.0	6.5	4.8	4.6	3.7	8.2	13.0	5.6	7.2	2.8	5.2	3.9	3.7	5.9	3.2	2.7	3.1	1.6	5.6	4.0	3.4	4.8	4.5	6.4	3.2	11.8	9.5	9.2	6.0	2.6	0.0	8.5	7.3	3.6	5.4	7.9	7.1	4.9	3.7	2.6	14.0	6.8	2.6	9.3	5.2	3.0	2.4	6.3	4.9	9.5	5.4	5.5	22.2	4.8	5.0	8.1	4.4	2.6	5.8	3.9	3.7	7.0	3.1	4.7	3.7	5.5	7.2	10.7	7.5	7.2	0.8	6.1	0.9	1.1	1.3	1.4	1.3	1.0	1.9	0.8	0.8	0.9	1.2	1.5	1.1	1.0	0.6	0.6	0.6	1.2	0.8	3.2	3.9	5.7	3.7	3.4	5.5	3.9	3.7	3.9	2.9	4.3	4.8	6.2	16.0	10.0	8.1	8.0	2.0	3.3	3.4	3.4	9.8	3.8	3.2	6.0	2.8	11.6	9.2	16.7	2.7	6.4	3.7	3.9	3.5	14.7	11.9	6.4	5.7	10.2	2.5	9.4	1.6	5.8	5.8	6.6	9.0	12.6	7.8	3.9	1.3	2.3	26.9	6.7	4.9	4.1	4.1	1.3	12.4	3.7	3.2	3.6	9.4	3.8	7.7	10.3	9.0	6.9	2.1	5.2	4.5	4.0	3.6	2.0	2.7	11.6	30.7	6.6	7.1	6.4	10.0	8.4	2.2	2.3	4.9	6.5	4.2	3.1	3.3
ZNF578	FLJ31384	ENSG00000258405	"Zinc finger protein 578"	Q96N58	19	52453553-52516882	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 6.7;NK-cells: 8.2;Oligodendrocyte precursor cells: 10.1;Rod photoreceptor cells: 8.2"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 5.5;U-266/84: 9.4"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"				"unprognostic (6.57e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.96e-3)"	"unprognostic (5.42e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.14e-2)"	"unprognostic (9.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.42e-1)"	0.7	0.6	2.1	0.7	3.1	0.8	0.8	5.1	2.7	0.9	1.4	0.5	0.4	1.1	1.8	0.4	1.3	0.6	1.2	2.0	3.0	0.9	0.3	0.7	0.7	2.5	2.2	1.7	0.7	1.0	0.3	1.3	2.4	1.4	0.7	3.1	0.7	1.2	0.9	1.2	0.4	0.9	1.6	1.2	0.6	6.3	2.6	1.0	1.7	0.6	0.7	0.5	0.2	3.2	0.5	0.3	2.1	2.7	1.2	0.7	1.2	1.3	0.7	0.5	0.9	0.9	0.7	0.9	0.5	2.0	2.5	0.7	1.1	0.6	0.6	0.2	1.5	0.8	1.6	0.5	1.1	0.2	2.7	1.9	0.3	0.9	0.8	1.0	0.9	0.8	0.6	0.6	2.6	0.8	0.9	1.2	4.1	0.6	0.7	0.8	0.8	0.3	1.8	2.7	0.6	1.5	0.6	0.6	0.2	5.5	2.0	0.6	1.3	0.6	0.7	0.8	0.7	0.5	9.4	0.8	0.1	0.2	1.7	1.4	0.3	0.4	0.9	0.3	0.7	0.5	0.6	0.5	0.1	0.8	0.7	0.8	0.5	1.1	0.3	0.5	0.3	0.3	2.1	3.1	5.1	2.7	2.0	3.0	2.5	2.2	2.4	1.6	2.6	3.2	3.9	0.0	0.0	4.9	1.3	0.9	1.7	0.2	0.0	4.4	0.5	0.5	4.1	0.0	0.2	0.0	4.2	0.7	4.0	0.0	0.0	0.2	5.9	0.9	1.4	1.6	0.0	0.8	3.9	0.2	0.8	1.4	0.0	2.1	1.3	3.9	0.7	0.0	0.2	6.7	5.8	0.1	0.0	0.3	0.6	6.1	0.6	0.4	0.0	0.0	0.4	1.8	8.2	10.1	6.2	0.0	0.0	0.0	0.4	1.0	0.2	0.8	0.1	8.2	0.0	0.7	1.8	0.2	2.3	0.1	0.4	0.8	1.8	2.6	0.1	1.7
ZNF597	"FLJ33071, HIT-4"	ENSG00000167981	"Zinc finger protein 597"	Q96LX8	16	3432414-3443504	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA001556	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA001556: AB_1080740"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.75e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.99e-3)"	1.6	1.9	1.1	1.5	1.1	1.9	1.7	1.0	1.3	1.4	0.8	1.1	1.2	1.5	2.1	1.1	1.4	1.9	1.3	1.0	1.5	1.3	1.7	2.4	2.1	0.9	1.1	2.0	1.6	1.4	1.3	2.3	1.0	1.4	1.0	2.3	1.1	1.2	0.7	1.3	1.3	1.2	1.0	1.8	1.2	3.9	1.4	1.5	2.0	1.1	1.8	1.6	0.9	1.2	0.0	1.2	1.5	3.7	1.1	1.7	5.9	1.8	2.2	1.7	2.1	0.0	2.3	3.1	1.7	2.0	1.3	1.0	3.5	1.6	2.2	1.9	1.4	5.3	3.6	2.2	1.6	3.2	3.1	2.2	2.5	1.9	2.1	1.7	4.7	1.6	1.1	2.0	2.0	1.0	2.3	3.3	5.0	1.4	0.0	1.4	4.5	2.1	1.4	4.9	2.0	2.8	3.5	1.8	1.4	4.1	1.5	4.7	3.1	2.8	1.4	0.0	1.7	2.6	2.9	0.4	0.0	1.8	1.7	3.1	0.8	8.8	0.9	1.7	1.5	0.9	0.7	0.8	0.8	0.7	1.2	0.9	0.2	0.7	0.8	0.4	1.2	0.6	1.1	1.1	1.0	1.3	1.0	1.5	0.9	1.1	1.0	1.0	1.4	1.2	8.3	25.6	2.6	0.0	4.3	0.1	1.8	0.3	2.8	2.1	4.3	3.8	1.9	1.5	5.2	1.8	0.0	1.2	3.6	1.4	0.0	1.1	8.1	3.8	2.1	4.2	2.4	0.4	2.9	1.0	1.8	2.6	1.5	4.5	3.8	3.0	2.5	1.4	1.2	0.0	1.9	2.1	0.0	1.0	0.7	4.1	1.2	2.7	0.0	4.7	3.0	1.8	0.0	1.0	2.0	1.8	1.0	2.2	2.1	2.4	0.7	1.3	0.9	3.1	6.6	2.7	2.6	5.3	8.0	1.9	0.4	1.5	3.3	1.1	2.4	2.3
ZNF792	FLJ38451	ENSG00000180884	"Zinc finger protein 792"	Q3KQV3	19	34956354-34964229	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 7.0;Endothelial cells: 7.5;Hepatic stellate cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 12.8;HMC-1: 16.1;HUVEC TERT2: 11.0;OE19: 9.7;SH-SY5Y: 10.2"					"Low region specificity"	"Detected in many"			"HPA035157, HPA035158"	Supported		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA035157: AB_2674497, HPA035158: AB_10603010"	"unprognostic (1.31e-1)"	"unprognostic (7.31e-2)"	"prognostic favorable (2.72e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-1)"	"unprognostic (6.88e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.77e-3)"	3.8	1.3	1.1	2.2	1.6	1.3	3.6	3.6	1.3	2.4	1.1	1.9	2.1	2.2	1.9	1.0	2.6	1.7	2.0	0.9	1.2	1.6	1.3	4.1	3.8	1.2	1.4	2.3	1.8	2.8	1.1	3.4	1.2	1.8	2.3	2.5	2.2	2.2	1.2	1.5	2.4	2.6	0.9	3.6	2.5	0.9	1.3	4.0	1.9	2.1	2.8	2.3	1.4	0.9	1.1	3.8	1.8	2.7	1.8	1.4	0.0	1.1	2.0	1.3	1.6	1.5	1.8	1.6	3.4	1.5	0.6	0.7	2.6	2.0	2.0	4.6	0.6	12.8	1.1	2.9	1.3	1.1	16.1	1.6	0.6	1.1	0.5	2.3	11.0	1.1	3.4	0.0	2.2	0.9	4.5	1.1	1.3	9.7	0.8	2.9	0.0	0.2	1.0	3.5	0.9	10.2	1.0	1.0	1.3	1.6	1.2	3.4	4.5	1.9	2.4	0.8	1.2	0.3	1.0	0.9	2.1	0.2	0.9	5.4	0.5	4.1	1.9	0.4	2.3	1.3	3.0	2.7	0.7	0.9	3.3	2.8	0.1	3.0	0.3	0.1	3.2	1.7	1.1	1.6	3.6	1.3	0.9	1.2	1.2	1.4	1.2	0.9	1.3	0.9	7.0	0.0	1.1	0.7	2.1	0.5	0.1	0.6	0.6	0.8	1.2	0.9	2.0	0.0	0.2	0.0	2.1	0.1	2.9	0.7	0.0	1.8	0.2	0.7	0.7	7.5	1.8	3.4	0.3	2.6	0.4	1.0	2.0	0.8	1.3	1.4	6.4	0.6	1.5	0.0	0.6	1.7	0.0	3.5	1.4	0.4	1.5	1.6	0.0	1.0	1.6	0.5	2.1	2.5	0.3	2.7	1.0	0.0	1.6	0.2	0.5	0.5	0.2	1.8	0.0	0.9	0.6	0.0	1.5	0.4	0.4	0.1	3.0	0.7	1.4	0.1
ZNF799	"HIT-40, MGC71805, ZNF842"	ENSG00000196466	"Zinc finger protein 799"	Q96GE5	19	12390016-12401271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA003150, HPA018683"	Approved		Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Centriolar satellite"	"HPA003150: AB_1080725, HPA018683: AB_2669920"	"unprognostic (2.96e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.84e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (3.63e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.47e-5)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-3)"	2.9	3.0	2.4	1.5	2.5	1.6	3.8	3.5	2.6	3.4	2.3	2.5	2.1	2.9	2.0	1.8	3.9	2.1	2.0	2.5	2.3	3.4	3.8	2.9	2.6	2.7	2.4	4.4	2.2	2.4	1.1	4.7	2.5	2.6	2.6	1.6	2.2	2.2	1.8	2.4	2.5	2.4	2.4	2.9	2.0	2.7	2.8	3.1	2.0	2.3	2.3	2.7	2.6	2.9	3.0	2.4	3.0	7.2	1.6	1.5	6.0	1.6	2.2	3.9	3.7	4.6	1.2	3.8	2.8	1.9	1.9	2.1	2.4	2.8	3.7	0.0	2.2	3.0	2.0	7.5	0.5	2.3	5.3	1.8	1.7	2.8	2.2	1.2	1.9	3.6	3.1	0.0	2.5	4.2	4.8	3.3	1.6	3.9	6.1	0.5	4.5	3.9	4.0	7.2	1.9	2.2	2.9	0.7	0.9	2.2	3.2	4.2	1.8	4.0	2.3	4.8	1.8	2.6	4.4	3.0	0.4	2.4	1.7	3.1	2.6	2.9	3.9	2.6	4.5	4.7	3.6	5.7	2.1	4.4	3.4	2.7	2.5	2.8	1.6	2.7	4.5	2.3	2.4	2.5	3.5	2.6	2.5	2.3	2.7	2.4	2.5	2.4	2.8	2.9	7.5	6.4	1.5	5.2	3.8	2.4	3.1	1.4	4.6	1.8	5.6	4.3	5.4	1.5	2.0	3.7	0.0	15.2	3.0	3.2	5.9	4.6	8.6	8.0	2.4	7.3	4.2	0.8	5.4	1.3	2.9	2.9	2.6	8.5	3.8	2.9	3.3	1.4	4.4	0.0	4.0	5.7	6.1	1.2	2.6	2.3	2.5	2.2	0.0	10.3	2.1	1.3	6.2	8.0	4.7	2.5	2.3	1.2	2.0	2.1	3.6	2.9	4.7	3.1	13.1	2.8	4.6	4.5	5.6	4.0	1.4	4.5	3.7	1.9	4.0	2.6
ZNF80	pT17	ENSG00000174255	"Zinc finger protein 80"	P51504	3	114234631-114237578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"lymphoid tissue: 3.1"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 3.2;granulocytes: 1.3;NK-cells: 2.1;Plasma cells: 1.4;T-cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.2"	"Not detected"	"Not detected"											HPA065484	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"		"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA065484: AB_2685496"	"unprognostic (6.27e-3)"	"unprognostic (3.00e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-5)"	"unprognostic (5.36e-1)"	"unprognostic (6.52e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.69e-12)"	"unprognostic (1.85e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-2)"	0.1	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.1	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.7	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.7	0.0	0.4	0.0	5.2	0.1	0.1	0.0
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598529-184939492	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;retina: 3.8"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 267.9;Inhibitory neurons: 676.0;Oligodendrocyte precursor cells: 186.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.3;RH-30: 17.7;THP-1: 13.9;U-698: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA029195: AB_10603011"	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.0	0.2	1.6	1.0	4.7	0.6	0.0	4.7	5.0	0.1	0.0	0.2	0.5	0.0	0.0	0.1	0.0	1.1	0.0	3.3	3.5	0.6	0.1	0.3	0.9	2.1	0.8	0.2	0.0	0.0	0.0	0.1	1.6	1.2	0.3	3.8	0.1	1.3	0.0	0.0	1.2	0.1	0.5	0.6	0.4	0.2	1.8	0.0	1.4	0.0	1.0	0.4	0.0	0.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.9	6.3	2.1	1.9	0.0	0.0	28.3	0.0	0.0	2.6	0.0	0.4	0.0	4.6	0.2	0.0	7.4	1.0	0.1	10.0	7.1	0.0	3.1	0.0	0.0	1.6	3.2	4.9	0.0	0.0	1.2	0.0	0.0	0.0	6.8	0.0	0.0	4.8	0.0	17.7	1.1	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.1	0.0	13.9	0.0	6.8	0.1	0.2	2.8	3.1	0.0	20.5	7.7	2.0	2.2	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	4.7	4.7	5.0	3.3	3.5	2.1	0.8	1.6	0.5	1.8	0.6	0.1	0.0	0.6	13.4	9.2	0.0	0.0	0.0	0.0	38.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	2.2	0.6	0.0	5.5	267.9	0.0	0.0	2.2	0.0	0.3	0.0	0.9	0.0	0.2	2.9	3.3	676.0	1.1	0.0	1.6	3.7	0.6	0.3	5.4	0.0	6.5	3.5	1.0	0.0	186.5	5.4	0.0	0.0	0.0	21.5	0.0	1.5	0.1	0.0	2.9	6.6	0.1	0.7	5.3	1.2	0.0	0.0	0.0	0.5	1.1	2.7	0.1
ZNF804B	FLJ32110	ENSG00000182348	"Zinc finger protein 804B"	A4D1E1	7	88759700-89338528	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.0;thyroid gland: 3.9"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 608.6;Inhibitory neurons: 266.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026702	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA026702: AB_1859459"					"unprognostic (1.10e-1)"							"unprognostic (5.00e-2)"			"unprognostic (1.29e-1)"	"unprognostic (1.99e-1)"		0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.9	0.0	0.0	0.0	0.2	0.9	0.1	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.5	0.2	0.7	0.2	0.9	0.4	0.0	0.8	0.5	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	608.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	266.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	1.8	29.0	0.0	0.0	0.0	7.1	6.9	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	1.2	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lymphoid tissue: 6.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.5;Excitatory neurons: 19.5;NK-cells: 17.5;Plasma cells: 9.5;T-cells: 31.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 1.2;T-cells: 2.1"	"Group enriched"	"Detected in some"	6	"Daudi: 4.0;HMC-1: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	25	"amygdala: 4.6;basal ganglia: 4.1;cerebral cortex: 3.4;hippocampal formation: 5.0;olfactory bulb: 5.4"	HPA016839	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"	0.3	0.1	2.2	2.3	1.6	0.9	0.3	0.0	2.7	0.1	0.0	0.3	0.2	0.1	0.2	0.2	0.2	0.5	0.0	3.4	0.3	0.1	0.2	0.6	6.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.1	1.9	0.0	0.0	2.6	0.6	0.2	0.9	1.5	0.3	0.0	3.8	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	1.4	0.2	1.0	1.5	0.0	0.1	0.8	1.0	0.1	1.2	0.0	0.0	2.1	0.4	2.2	1.6	0.0	2.7	3.4	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.6	0.7	4.8	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.0	0.0	1.8	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	19.5	0.0	0.0	0.1	0.5	0.1	2.5	0.0	0.7	0.0	0.0	0.0	2.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	17.5	0.5	0.9	0.0	0.0	0.0	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	0.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0
ZYG11A	ZYG11	ENSG00000203995	"Zyg-11 family member A, cell cycle regulator"	Q6WRX3	1	52842511-52894998	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 2.9;testis: 3.8;thyroid gland: 2.3"	"Cell type enhanced"	"Detected in some"		"Prostatic glandular cells: 2.5;Spermatocytes: 3.5;Spermatogonia: 7.9"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 11.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 12.5;hTEC/SVTERT24-B: 10.4;K-562: 10.7;SiHa: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030378, HPA030379"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA030378: AB_10604159, HPA030379: AB_2673451"	"unprognostic (7.94e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.06e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.00e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	0.3	0.1	0.1	0.5	0.8	0.2	0.2	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.3	2.9	1.2	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	3.8	0.2	0.3	2.3	0.0	0.7	0.1	0.4	0.4	0.0	2.0	0.3	0.0	0.0	0.0	4.5	1.2	1.4	5.8	4.7	0.1	0.0	0.0	3.0	1.8	0.0	0.1	3.8	0.1	6.8	0.3	7.5	0.0	12.5	0.0	2.7	0.0	0.9	0.0	0.3	10.4	0.0	0.3	1.3	0.0	10.7	5.6	0.2	5.6	0.0	5.6	1.4	0.0	1.0	0.0	1.2	4.9	3.5	0.2	1.4	2.1	10.8	0.4	0.0	4.3	6.0	3.0	0.0	0.0	0.1	0.0	0.0	2.7	4.9	0.0	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	0.5	1.6	0.5	0.7	0.0	0.1	0.0	0.0	1.1	0.3	0.4	0.0	0.0	0.3	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.5	0.0	0.1	0.4	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.0	0.0	0.9	2.5	0.0	1.3	0.2	1.3	0.0	0.6	0.3	3.5	7.9	1.5	0.1	0.3	0.1	0.0	0.1	0.3